<SEC-DOCUMENT>0001628280-22-028033.txt : 20221103
<SEC-HEADER>0001628280-22-028033.hdr.sgml : 20221103
<ACCEPTANCE-DATETIME>20221103111120
ACCESSION NUMBER:		0001628280-22-028033
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		81
CONFORMED PERIOD OF REPORT:	20220930
FILED AS OF DATE:		20221103
DATE AS OF CHANGE:		20221103

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CROSS COUNTRY HEALTHCARE INC
		CENTRAL INDEX KEY:			0001141103
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-HELP SUPPLY SERVICES [7363]
		IRS NUMBER:				134066229
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-33169
		FILM NUMBER:		221356837

	BUSINESS ADDRESS:	
		STREET 1:		6551 PARK OF COMMERCE BOULEVARD, N.W.
		CITY:			BOCA RATON
		STATE:			FL
		ZIP:			33487
		BUSINESS PHONE:		8003472264

	MAIL ADDRESS:	
		STREET 1:		6551 PARK OF COMMERCE BOULEVARD, N.W.
		CITY:			BOCA RATON
		STATE:			FL
		ZIP:			33487

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CROSS COUNTRY INC
		DATE OF NAME CHANGE:	20010521
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>ccrn-20220930.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:9f036714-f865-4798-af5a-08fe5047afca,g:b4ca6da5-78c3-4063-9a30-7dfc7d463cab,d:5b47dd1c3d5a40ff8e040a94ae232d75--><html xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:srt="http://fasb.org/srt/2022" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ccrn="http://www.crosscountryhealthcare.com/20220930" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>ccrn-20220930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80L2ZyYWc6NWQwNjQ0MGUyNmRmNDhkNWJkOTMxNzNjYTJmOWRlYWQvdGFibGU6YmI1YjNiYjUxYzlkNDhjMWFiOWU5ZjVhMTZmNmI0Y2UvdGFibGVyYW5nZTpiYjViM2JiNTFjOWQ0OGMxYWI5ZTlmNWExNmY2YjRjZV8zLTEtMS0xLTQ2MzM0_72170866-5c0d-428e-813c-7692cd960765">0001141103</ix:nonNumeric><ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80L2ZyYWc6NWQwNjQ0MGUyNmRmNDhkNWJkOTMxNzNjYTJmOWRlYWQvdGFibGU6YmI1YjNiYjUxYzlkNDhjMWFiOWU5ZjVhMTZmNmI0Y2UvdGFibGVyYW5nZTpiYjViM2JiNTFjOWQ0OGMxYWI5ZTlmNWExNmY2YjRjZV80LTEtMS0xLTQ2MzM0_f6bf8ebc-66ac-4eaf-b313-20ccbe823c61">12/31</ix:nonNumeric><ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80L2ZyYWc6NWQwNjQ0MGUyNmRmNDhkNWJkOTMxNzNjYTJmOWRlYWQvdGFibGU6YmI1YjNiYjUxYzlkNDhjMWFiOWU5ZjVhMTZmNmI0Y2UvdGFibGVyYW5nZTpiYjViM2JiNTFjOWQ0OGMxYWI5ZTlmNWExNmY2YjRjZV81LTEtMS0xLTQ2MzM0_2676fab4-ecc7-4c56-8ab7-a2ab14359920">2022</ix:nonNumeric><ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80L2ZyYWc6NWQwNjQ0MGUyNmRmNDhkNWJkOTMxNzNjYTJmOWRlYWQvdGFibGU6YmI1YjNiYjUxYzlkNDhjMWFiOWU5ZjVhMTZmNmI0Y2UvdGFibGVyYW5nZTpiYjViM2JiNTFjOWQ0OGMxYWI5ZTlmNWExNmY2YjRjZV82LTEtMS0xLTQ2MzM0_4f3ba951-d810-4611-949e-f8f62032ec25">Q3</ix:nonNumeric><ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80L2ZyYWc6NWQwNjQ0MGUyNmRmNDhkNWJkOTMxNzNjYTJmOWRlYWQvdGFibGU6YmI1YjNiYjUxYzlkNDhjMWFiOWU5ZjVhMTZmNmI0Y2UvdGFibGVyYW5nZTpiYjViM2JiNTFjOWQ0OGMxYWI5ZTlmNWExNmY2YjRjZV83LTEtMS0xLTQ2MzM0_e09e8e91-1e03-433c-89ec-b6d076ab2730">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930" name="us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfNC0wLTEtMS00NjMzNA_7f0cb4b5-60f2-4271-bceb-9dc3c10c40e8">http://fasb.org/us-gaap/2022#ServiceMember</ix:nonNumeric><ix:nonNumeric contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930" name="us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfNC0wLTEtMS00NjMzNA_a67cd947-3a68-403c-8e8c-ba747270e9d1">http://fasb.org/us-gaap/2022#ServiceMember</ix:nonNumeric><ix:nonNumeric contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" name="us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfNC0wLTEtMS00NjMzNA_cf74a3bf-47ff-4a52-9ecb-7fdf95acc284">http://fasb.org/us-gaap/2022#ServiceMember</ix:nonNumeric><ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfNC0wLTEtMS00NjMzNA_fe67965c-2b70-4154-8270-1dfa06b11c02">http://fasb.org/us-gaap/2022#ServiceMember</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="ccrn-20220930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied6e0a816b61418c9a09c38a78d39512_I20221020"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-10-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i8ad9340f357e45ba914eff9e31b0661b_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i51f0077b9e4442588bd8299663a1ef5a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i710725bce0f34e3784365685f226641d_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id786e43d12924467a670b39ccb2288b8_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i26fb2cd916aa4101ac98bfb0aeed6193_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23e6ed6a9fed48d29307fabb2d2666ab_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if342abafe0424c4cbbb239c9eeb5a10b_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68cf390bfea94f56a817690cbbf4744d_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaff6ed2ab3394341b1987107614ed158_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c0a4267d8174093be4955cfd3a6d031_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37a23fb61a8646c29cb106b4e9684e9b_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3fb9c1cd31c4e1181518b558a62bf13_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0f02a13f7ad4906acc11dee942a7413_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if62eba6a38e6444bbfe404803ad71c18_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i677effe12d9f4d44bd5f1ca7944e48b0_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f59e0723d41435fbc923108afeebf77_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i849d2660af354dc7b3da49f0e86fc52c_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e8d1bdde3804c1baf7ae857af6e5e52_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4401d4d9ee924023b8f1ec25533e9a67_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1252820f59e947b4976a678884ff7d91_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3fc079c274124a6cac569e4f34366c7b_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i532e051d438e418eb3e83be7ed3362f2_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i725e0cb0ad514e69b7e4c7c6064bc911_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc57b01ed27040b3bf77a29981bb957d_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61328c0ca95341349cdc1ca533a6d2bf_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic538be4345284146ae03043536ae0bfa_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8bc3a63bad324d3b92636e8a32d4f412_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe8f646189004462a689d8e6ab700027_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1c4bd146f604316b819aa100137bf51_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iadcfed8870184b00ac8df3ef3a6c7332_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3edda426942249bf91dae3b40fcf7ae9_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i661f31a4c8174df5accdb1e19dbc9603_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic78b970907494e82bd28d42c18310a5f_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89f83f5578c9454b87f8cf964b36d386_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4fefba535da24f6faa17aa6af4553338_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb81780210de40218de77358d91c73ba_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0adb8d88d43c4f0699c9c108560ff3c3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3eb9dcc1ff645df99ce9eb18565e9a4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76c4c8c1ba544b218b38c4841b734300_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7e684e1ca5746c9987a351de57e7a33_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d0df14b23af42f8bf234fae71fdabce_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36a03f0a3609488882bcc1d53ba8b90a_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ebd46f32725469a851e253627061ba5_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55f1d59f3df544b3b26a366b71c31170_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4db29b7907044e1ca81a2082beb7444a_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46d38e032f6045d5811f4c3961253386_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6641a1756e67403d810b23655f4e192e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24f2241f06ba4fd28714f067a2014198_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1ae1d5ee1d14280ac3f645f56e7bb1a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5affaa8d5f934c798b6c95e386f76904_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i119af728c7ce4ee8bb64043a29f00ca5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i702dc94df8644dde8f1cce342f5d1e3b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0e5daec688e4f149d1bb1d3c238f468_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8aff35e423dc48b2880bbf459a28b4cb_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ea4b9a9c7024e24b7056df5589337d5_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i253197afe06e45bca28e963b592a33ea_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i657bd17dcadf4f3f873d0850b774cdc3_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie61694e1851449ffa2f39478d3d2f3ea_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc853726046a4b378bd788e398d13c55_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6501a0fcaad471fa6d6fbf55f3864ae_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i320641181a3f49a494c3423b25911ae6_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie812f572e01c4d7abf8b2fd4eddf3b89_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95a7cda144014872b12df15aa0c33624_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5982bacc53f943e49e2bf300695325b5_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c3d33c67aba46cb8fc17a6c9810c45e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57398b99b0b54c5392ab2d17dc37cf50_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ccrn:ExitCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if703479963674b69a8f48728a5151e98_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic15931a9518a4f40ad076daec66714fd_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ccrn:ExitCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e32834817d9496dad1cbdc249093f30_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73c497336ca74c4cb8a55c150456d5e0_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ccrn:ExitCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91f31431ce5340419942d52145b80cc7_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i443dd9fb273b4d53a90b0b46a22ab602_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ccrn:ExitCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3adac1127fa4edf8e0147861c16ad9b_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4bc6735e5214a54a2a33460e10c2956_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ccrn:ExitCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5db7b078db0441d0a155ca8727612378_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5f07aa56cb14c10aa23331198ec4f7c_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ccrn:ExitCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i181005f5e3c34e41a45e7b5a7e5a9e66_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i869ddd0d1a6943ae82d12eccf68afcde_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ccrn:ExitCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20197ff1c85d452da87fc706b7d58649_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:TemporaryStaffingServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1fe76aa84e634f068c08458605422754_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:TemporaryStaffingServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ae604777193442b9bf2a6f5b9f7aae1_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:TemporaryStaffingServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic24c88a8321b4d8dba9854a06196bffe_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:OtherServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27fae63222bc430e9e3478596f2ad536_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:OtherServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i873a486d6fa84b97a6f676f640c8635e_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:OtherServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i755b00d6551346d08633c51f6fffcbd4_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60312c6dd2494d66bf19248b38166eaf_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0bb46cc7c58c478889fb6b980f9b2f4d_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:TemporaryStaffingServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0348b7044e44bc5bb758dc707fdab77_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:TemporaryStaffingServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6ef97c37f2146c5ba8dfa5c5720ad24_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:TemporaryStaffingServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44f9d44db6904ef587268af1cde4de4f_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:OtherServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e5ea3b7faeb44c297e0371081833165_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:OtherServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i970c8a42e53c487fae9182764d96ad09_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:OtherServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15f558e83a4a479e8674ab636a78ba79_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibeef5c5a5e6e4d08b2e5036ccd0186a0_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a40960a329848b3b4404d32532a0aed_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:TemporaryStaffingServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ideb77c0531ff491fa1c4616654d0b2ba_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:TemporaryStaffingServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i525c2bf9e1cf47589d1b503039abb3a7_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:TemporaryStaffingServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2bed4acdcaa54423bb59a2fc3eeb6cce_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:OtherServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifea86757fdc544f2b14e84330796599b_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:OtherServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98bb8473f28b40109171e65f44dcded9_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:OtherServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7aaf74b211ba45b9bea92196b8c48cd7_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4be1f35efe045ebabfe8d9154e1c3cb_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i108501803abb4e229cf67a62dd7cd7ae_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:TemporaryStaffingServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib62929d26b494926b11bb88b62b6ef78_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:TemporaryStaffingServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iebb1b15335074656a1c0ac1d3c9f6eb6_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:TemporaryStaffingServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib20154f39f37474fa466a1c719e5b181_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:OtherServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i375deb87100c4072a7f2a5d3d9e2e846_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:OtherServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f29bfe22ab24268b44e0608ba26a4ad_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:OtherServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id76ab6905df5463b9046aaf30a35075d_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c425883600f44a6aedb244f1adafb03_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia84d03e68bab4f9592492ba9084b94f0_D20211216-20211216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:SelectedIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-16</xbrli:startDate><xbrli:endDate>2021-12-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab7b6d3f615249b3813ea0de2e0a5b00_I20211216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:SelectedIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide7cad6e03e54feaafb84434e9dee12b_I20211216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:SelectedIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86b3f925edb2419baa7dc8060115c5af_D20211216-20211216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:SelectedIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-16</xbrli:startDate><xbrli:endDate>2021-12-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52e3ba7395c24be49c40b9fc7a7fe5c3_I20211216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:SelectedIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3eb40c4ead40484d99ab7accabf6eb87_D20211216-20211216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:SelectedIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-16</xbrli:startDate><xbrli:endDate>2021-12-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a4b1bc6463449928078dc019cd5ef53_I20211216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DatabasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:SelectedIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i096a7bcfbf9b4f69a384857b9b34921a_D20211216-20211216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DatabasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:SelectedIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-16</xbrli:startDate><xbrli:endDate>2021-12-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29d504aa7a7e4656aed1f0f0211e399c_D20210608-20210608"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:WorkforceSolutionsGroupIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-08</xbrli:startDate><xbrli:endDate>2021-06-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29e631219d674e4fae9fb8f7e977e6af_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:WorkforceSolutionsGroupIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ae5c1283dfc4659b9287a5a52e51af8_I20210608"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:WorkforceSolutionsGroupIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9fe5b9beae44701b72bcee962193e53_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:WorkforceSolutionsGroupIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3eab37833864980aa79e31112a0c6e2_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:WorkforceSolutionsGroupIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b533d4786024f299c29a873781660b2_I20210608"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:WorkforceSolutionsGroupIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc7d3370d9844826a664e9ed960c303a_D20210608-20210608"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:WorkforceSolutionsGroupIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-08</xbrli:startDate><xbrli:endDate>2021-06-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2caa7dba2bf946eeba1cabe94a429f67_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ccrn:ShareBasedPaymentAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2bdc4ad60944e738242ef9a6814d745_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ccrn:ShareBasedPaymentAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i955dad9273e74d0b9b508f98c422598d_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ccrn:ShareBasedPaymentAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2bf81d4651a84b7d903fab0b74c4d6c6_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ccrn:ShareBasedPaymentAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8596209ef08040d2bfd996b39f79a2cc_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DatabasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4f8278712e840b2b0b1388f6f6d449a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DatabasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee283e580b834384a505bf9085488f0c_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1393e7a548df431795ee6a40b27a3d83_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifffbe09f8f09467eb7e5b113f3801e46_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66cd55e77f1246b18919d2e35b249926_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id346bd8243c84b70924309b05565c2d3_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d2f558a2d464d13a6a45fd804204c56_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f28bc2f1f144f9b8079211ca0ac2719_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6df5cca2f9f94120b8172ac27441142a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9689395cb7444c7c8ae6b2bb1d17f429_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3141d307889e400f8613ac4e53dfd7bf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92f6c3cc4f5c4abda295b3072437fb45_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98085908a4ff4bfabc746d90f51c8c01_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a09ea9a925140449a60d73ca6cea3cb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4a8ed4c652b409b9c9e62d38384449a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0b4574bdbb84488a12b61c871791cd5_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50f6f534fc28456f8f17929b1cef9416_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87608f5be1294b2c81227b913215f1f0_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie01c32b128c342b89c4718d3db15e20c_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide03ccfd1d5f459fbf0f366e300c2751_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:A2021TermLoanCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="if64036e453b84955b51e99497013571c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:A2021TermLoanCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaed1e277c72c475e9d7788035f2b51e8_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e5c22515f804ea29736c66d5982b201_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2fc39805f3624e12ba3b38847a2f8810_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:EarnoutNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7bf7274f80f465789bbdcc936e17070_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:EarnoutNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i679839afbf554bacadf5512f89216250_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:A2021TermLoanCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i870a1a5ad08d4d2187f8499d8bb665d1_D20210608-20210608"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:A2021TermLoanCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-08</xbrli:startDate><xbrli:endDate>2021-06-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9754d616f5a4ee8a091ad6be918e235_I20210608"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:A2021TermLoanCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iedb34638d63143a8b4c18058a909b8c5_D20210608-20210608"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:A2021TermLoanCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-08</xbrli:startDate><xbrli:endDate>2021-06-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34f7f97d2f20459aa4e94c8f8c9526d2_D20210930-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:A2021TermLoanCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-30</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f569e337ebb415d913c1f6a219076e4_I20211118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:A2021TermLoanCreditAgreementIncrementalTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-11-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41f166769fd2450f9e1ac7343566e768_I20211118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:A2021TermLoanCreditAgreementAggregateAmountOfAllPossibleIncreasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-11-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1203eeee9648493cab15c9a9c56887ea_D20211231-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:A2021TermLoanCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-31</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2b5f4df2dca4db3b15dfee015bb5eb9_D20220623-20220623"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:A2021TermLoanCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-23</xbrli:startDate><xbrli:endDate>2022-06-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6158fa637abd4af3ae6d409e2ff6470e_D20191025-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-25</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7e12eb577054a99aa4bc801b8f7a4e2_I20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-10-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4c7c74b2761411095a93a4e4420b8ba_I20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ccrn:LineOfCreditSublimitAxis">ccrn:SwingLoansSublimitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-10-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i939e68a3ba5c42dba3abaaad4215f029_I20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ccrn:LineOfCreditSublimitAxis">ccrn:StandbyLettersOfCreditSublimitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-10-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04b66ed81c9249438ac7e6deac027e0c_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a067d85b7ce45c29144e8ce39c70993_I20210308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i624be7ef98974a18acd4dff1b7f88e73_I20211118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-11-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i270723f4cdb7481096cce56fef2c5108_I20220321"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9318eec3ae14553b2ee10834ffd5fa2_D20220321-20220321"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-21</xbrli:startDate><xbrli:endDate>2022-03-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i429f9d7a920e4e42bf93ded0492112f6_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9a9d68a6c6e40568eec79a197a10ad1_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">ccrn:SecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8d17efeeb2945f986a5af6c590ab452_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30a646dd77584028b2f4405de20d759d_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i817acb52936447dcac8bfc2fdc5f10c2_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ccrn:DeferredCompensationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb72a3bcd2bb48b4bb23ea38343be599_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ccrn:DeferredCompensationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e7a429958f04663bc3d74b1a3aab9a6_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ccrn:DeferredCompensationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ed93b80dd314c62b7cd4dea1d5c7981_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ccrn:DeferredCompensationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04893fd47a664b8aa11c6aef5de1bfea_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ccrn:EarnoutNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i355e48f54cd24775841d981acdad6c9f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ccrn:EarnoutNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9435c564ca74ddbb50ac50871543b66_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ccrn:EarnoutNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib59536cd34df4b5c927d7dfd92e21775_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ccrn:EarnoutNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25845230e0a34aa3b524e0cd4fac58b2_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ab3f84da58d407297c219a1e6bee204_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ca241ad2cc548f6a38311595d2c1a51_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8042af3a5af441cbbd4f8aa3c656853_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia987e32d35a64bc58e5674f1e07ff056_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i736980e5039d40a593f5402597dcedea_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifec1ee9f27f84876ae61fc5e20677f66_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i877c790a76d546a8a90babc735c8b376_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba8724e196ad45edae8eaee777dfc4d7_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:WorkforceSolutionsGroupIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3b246daadb64fa58cf94501ca9e81e5_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:WorkforceSolutionsGroupIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1946fe4694af480aa180b00058e1d6d9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:WorkforceSolutionsGroupIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba126d3e52b14305be4c3c515f9637d2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:WorkforceSolutionsGroupIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iadeeceae9c3742b0916a9a12a86f2fe7_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:SelectedIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17bfcb8a0ca943179adb5a32cc2af8ba_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:SelectedIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8da530a9cdbc4804980eefdbbd0e900a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:SelectedIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b515cd81555467898b20fbdbc0994cb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:SelectedIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39fd50bbb06e42f18218bf500c01d1b1_I20220816"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">ccrn:NewRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-08-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9313064d9eac40ad83fdaf7a1b2db9e0_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">ccrn:PriorRepurchaseProgramAndNewRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d6c70caf3ac4c6493c60fe74f5d510e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">ccrn:NewRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60a43dc77674425480d2db76cf79177d_I20200519"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ccrn:OmnibusPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d793cc2e5cf4606b38b48e7c4f5d2b2_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ccrn:OmnibusPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0898a126dbc046e795ecb209d0f68153_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94cacdf9f5e14894bd9a7ee09ceefd0b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b01283f3c6e441b93fffe6cdf6495d8_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife7c8285d238454bad645c20b406a43d_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57cbf98f9a5e41dbb52fc4305ececb04_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i850fcfe043314c1a9fece0d4d68b2919_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b68237ebf9d475aaf3f35fd14b2fefc_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ccrn:OmnibusPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="installment"><xbrli:measure>ccrn:installment</xbrli:measure></xbrli:unit><xbrli:context id="ia1b0163339fb42deac2d52ca0dc626cd_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice9fa15cb07246a2819aa90ca0b090f2_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00ee87f771334f0c8220e9eb0575e200_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69cc0e8a27234c22915bdde908a717c2_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ccrn:RestrictedStockAndPerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic57dcdd480124d9d9ce70d9d0fe56d2b_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ccrn:RestrictedStockAndPerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51e864c08ce54f8c91f98492c469e4a5_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01b4eae42d8043bc9669c54efc17b3be_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i259a723688ef4b07876c5e5858c322e8_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3d043883a0640a8beb08731478b973f_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d13486d3d1b4e47be1e347be955262c_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72783f7b11ce4ca8bd07eb8c76ae894f_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ccrn:HealthCareSystemAffiliatedWithABoardMemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4db74b0466540ea968402c2e9e28c01_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ccrn:HealthCareSystemAffiliatedWithABoardMemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee3c22d82f244073ab396a419446f087_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ccrn:HealthCareSystemAffiliatedWithABoardMemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05804f1d8c774ac48c5ecb8daa790dd0_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ccrn:HealthCareSystemAffiliatedWithABoardMemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i5b47dd1c3d5a40ff8e040a94ae232d75_1"></div><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Washington, DC 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xL2ZyYWc6NTYzYjU3ZGYxMWNlNDc5MGJhNWY5ZjRhYTM3NzU2NWEvdGV4dHJlZ2lvbjo1NjNiNTdkZjExY2U0NzkwYmE1ZjlmNGFhMzc3NTY1YV85Mzgy_8f2e2dad-79b6-4c0c-8ca8-c983b493723e">10-Q</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xL2ZyYWc6NTYzYjU3ZGYxMWNlNDc5MGJhNWY5ZjRhYTM3NzU2NWEvdGV4dHJlZ2lvbjo1NjNiNTdkZjExY2U0NzkwYmE1ZjlmNGFhMzc3NTY1YV85Mzcw_bdcf28ca-5885-4478-b358-d40663b9cd7d">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;Quarterly Report Pursuant to Section&#160;13 or 15(d) of the Securities Exchange Act of 1934</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">For the Quarterly Period Ended <ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xL2ZyYWc6NTYzYjU3ZGYxMWNlNDc5MGJhNWY5ZjRhYTM3NzU2NWEvdGV4dHJlZ2lvbjo1NjNiNTdkZjExY2U0NzkwYmE1ZjlmNGFhMzc3NTY1YV83Mjc1_d97f0cff-9c00-4532-9de3-a7668b52f3d4">September 30, 2022</ix:nonNumeric> </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Or</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xL2ZyYWc6NTYzYjU3ZGYxMWNlNDc5MGJhNWY5ZjRhYTM3NzU2NWEvdGV4dHJlZ2lvbjo1NjNiNTdkZjExY2U0NzkwYmE1ZjlmNGFhMzc3NTY1YV85Mzg0_a17555e3-1db8-46d5-9852-00ac9fdb3073">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;Transition Report Pursuant to Section&#160;13 or 15(d) of the Securities Exchange Act of 1934</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">For the Transition Period From</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> _________ </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> _________</span></div><div style="text-align:center"><img src="ccrn-20220930_g1.jpg" alt="ccrn-20220930_g1.jpg" style="height:100px;margin-bottom:5pt;vertical-align:text-bottom;width:249px"/></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xL2ZyYWc6NTYzYjU3ZGYxMWNlNDc5MGJhNWY5ZjRhYTM3NzU2NWEvdGV4dHJlZ2lvbjo1NjNiNTdkZjExY2U0NzkwYmE1ZjlmNGFhMzc3NTY1YV85Mzg5_cd66d79e-d1a8-4e1d-8e48-cf93ea282c56">CROSS COUNTRY HEALTHCARE, INC</ix:nonNumeric>.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:31.744%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.064%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xL2ZyYWc6NTYzYjU3ZGYxMWNlNDc5MGJhNWY5ZjRhYTM3NzU2NWEvdGFibGU6MDhhYzJkZGQ5MDhhNGI2Yzk4MjIzMWQwOGQxZjFjNGEvdGFibGVyYW5nZTowOGFjMmRkZDkwOGE0YjZjOTgyMjMxZDA4ZDFmMWM0YV8wLTAtMS0xLTQ2MzM0_a0067837-d65e-4763-b68b-bffe53755694">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xL2ZyYWc6NTYzYjU3ZGYxMWNlNDc5MGJhNWY5ZjRhYTM3NzU2NWEvdGFibGU6MDhhYzJkZGQ5MDhhNGI2Yzk4MjIzMWQwOGQxZjFjNGEvdGFibGVyYW5nZTowOGFjMmRkZDkwOGE0YjZjOTgyMjMxZDA4ZDFmMWM0YV8wLTEtMS0xLTQ2MzM0_086f07e9-190e-4e0f-b361-1a932e438a56">0-33169</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xL2ZyYWc6NTYzYjU3ZGYxMWNlNDc5MGJhNWY5ZjRhYTM3NzU2NWEvdGFibGU6MDhhYzJkZGQ5MDhhNGI2Yzk4MjIzMWQwOGQxZjFjNGEvdGFibGVyYW5nZTowOGFjMmRkZDkwOGE0YjZjOTgyMjMxZDA4ZDFmMWM0YV8wLTItMS0xLTQ2MzM0_49930de6-84d0-4702-8869-793a241d6ab8">13-4066229</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(State or other jurisdiction of<br/>Incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Commission<br/>file number</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(I.R.S. Employer<br/>Identification Number)</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xL2ZyYWc6NTYzYjU3ZGYxMWNlNDc5MGJhNWY5ZjRhYTM3NzU2NWEvdGV4dHJlZ2lvbjo1NjNiNTdkZjExY2U0NzkwYmE1ZjlmNGFhMzc3NTY1YV85Mzc1_9bae633c-0a94-418d-a276-4b7a3c2a090a">6551 Park of Commerce Boulevard, N.W.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xL2ZyYWc6NTYzYjU3ZGYxMWNlNDc5MGJhNWY5ZjRhYTM3NzU2NWEvdGV4dHJlZ2lvbjo1NjNiNTdkZjExY2U0NzkwYmE1ZjlmNGFhMzc3NTY1YV85Mzc2_707caf62-470e-4cb7-aa67-4c46cf07563d">Boca Raton</ix:nonNumeric>, <ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xL2ZyYWc6NTYzYjU3ZGYxMWNlNDc5MGJhNWY5ZjRhYTM3NzU2NWEvdGV4dHJlZ2lvbjo1NjNiNTdkZjExY2U0NzkwYmE1ZjlmNGFhMzc3NTY1YV85Mzkx_8d036ccf-398f-485a-90fb-00db5870501f">Florida</ix:nonNumeric> <ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xL2ZyYWc6NTYzYjU3ZGYxMWNlNDc5MGJhNWY5ZjRhYTM3NzU2NWEvdGV4dHJlZ2lvbjo1NjNiNTdkZjExY2U0NzkwYmE1ZjlmNGFhMzc3NTY1YV85Mzg2_ec0020f1-609a-4e89-9a56-444be5225550">33487</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(Address of principal executive offices)(Zip Code)</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xL2ZyYWc6NTYzYjU3ZGYxMWNlNDc5MGJhNWY5ZjRhYTM3NzU2NWEvdGV4dHJlZ2lvbjo1NjNiNTdkZjExY2U0NzkwYmE1ZjlmNGFhMzc3NTY1YV85Mzc3_c7b07ee5-06c9-4cff-be37-5431f1025cc4">561</ix:nonNumeric>) <ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xL2ZyYWc6NTYzYjU3ZGYxMWNlNDc5MGJhNWY5ZjRhYTM3NzU2NWEvdGV4dHJlZ2lvbjo1NjNiNTdkZjExY2U0NzkwYmE1ZjlmNGFhMzc3NTY1YV85Mzg3_7f58f9be-9892-4530-bd5f-8101373a8e15">998-2232</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Not Applicable</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(Former name, former address and former fiscal year, if changed since last report)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:33.892%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.936%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.872%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Trading Symbol</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xL2ZyYWc6NTYzYjU3ZGYxMWNlNDc5MGJhNWY5ZjRhYTM3NzU2NWEvdGFibGU6YzgyZGYyYWNhMmE2NDYyZDg0ZTAwMGQ3NDI1MzEzOTEvdGFibGVyYW5nZTpjODJkZjJhY2EyYTY0NjJkODRlMDAwZDc0MjUzMTM5MV8xLTAtMS0xLTQ2MzM0_4d5df14f-37e4-4319-93a0-832041f39c9e">Common stock, par value $0.0001 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xL2ZyYWc6NTYzYjU3ZGYxMWNlNDc5MGJhNWY5ZjRhYTM3NzU2NWEvdGFibGU6YzgyZGYyYWNhMmE2NDYyZDg0ZTAwMGQ3NDI1MzEzOTEvdGFibGVyYW5nZTpjODJkZjJhY2EyYTY0NjJkODRlMDAwZDc0MjUzMTM5MV8xLTEtMS0xLTQ2MzM0_0ed91fe1-c06e-48a5-a465-2a6317f76c2e">CCRN</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xL2ZyYWc6NTYzYjU3ZGYxMWNlNDc5MGJhNWY5ZjRhYTM3NzU2NWEvdGFibGU6YzgyZGYyYWNhMmE2NDYyZDg0ZTAwMGQ3NDI1MzEzOTEvdGFibGVyYW5nZTpjODJkZjJhY2EyYTY0NjJkODRlMDAwZDc0MjUzMTM5MV8xLTItMS0xLTQ2MzM0_99f75e3d-74ed-4fc1-b28a-0b71051e8843">The Nasdaq Stock Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Sections 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.&#160;<ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xL2ZyYWc6NTYzYjU3ZGYxMWNlNDc5MGJhNWY5ZjRhYTM3NzU2NWEvdGV4dHJlZ2lvbjo1NjNiNTdkZjExY2U0NzkwYmE1ZjlmNGFhMzc3NTY1YV85Mzc4_ad82941e-1586-4753-9b3b-fc1665675856">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> No&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&#160;405 of Regulation&#160;S-T during the preceding 12&#160;months (or for such shorter period that the registrant was required to submit and post such files).&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;<ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xL2ZyYWc6NTYzYjU3ZGYxMWNlNDc5MGJhNWY5ZjRhYTM3NzU2NWEvdGV4dHJlZ2lvbjo1NjNiNTdkZjExY2U0NzkwYmE1ZjlmNGFhMzc3NTY1YV85Mzcy_bc9a4c71-721a-4f4f-8352-a0853b685ed8">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;No</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of &#8220;accelerated filer and large accelerated filer&#8221; in Rule&#160;12b-2 of the Exchange Act:</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Large&#160;accelerated filer&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xL2ZyYWc6NTYzYjU3ZGYxMWNlNDc5MGJhNWY5ZjRhYTM3NzU2NWEvdGV4dHJlZ2lvbjo1NjNiNTdkZjExY2U0NzkwYmE1ZjlmNGFhMzc3NTY1YV85Mzc5_77e0e93e-f744-4845-aee3-0def2d6c7a98">Accelerated filer</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Non-accelerated&#160;filer&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744; </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Smaller reporting company&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xL2ZyYWc6NTYzYjU3ZGYxMWNlNDc5MGJhNWY5ZjRhYTM3NzU2NWEvdGV4dHJlZ2lvbjo1NjNiNTdkZjExY2U0NzkwYmE1ZjlmNGFhMzc3NTY1YV85Mzg4_7ce31ca7-65f5-498d-b4d0-4ee525e1cf70">&#9744;</ix:nonNumeric>  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Emerging growth company </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xL2ZyYWc6NTYzYjU3ZGYxMWNlNDc5MGJhNWY5ZjRhYTM3NzU2NWEvdGV4dHJlZ2lvbjo1NjNiNTdkZjExY2U0NzkwYmE1ZjlmNGFhMzc3NTY1YV85Mzgx_1a4858fe-a1ae-46b6-966c-3e55e3ae04ba">&#9744;</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act). Yes&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> No&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xL2ZyYWc6NTYzYjU3ZGYxMWNlNDc5MGJhNWY5ZjRhYTM3NzU2NWEvdGV4dHJlZ2lvbjo1NjNiNTdkZjExY2U0NzkwYmE1ZjlmNGFhMzc3NTY1YV85Mzk0_9b7ff721-642e-4b79-8bc6-d481e496406c">&#9746;</ix:nonNumeric></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The registrant had outstandin</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">g <ix:nonFraction unitRef="shares" contextRef="ied6e0a816b61418c9a09c38a78d39512_I20221020" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xL2ZyYWc6NTYzYjU3ZGYxMWNlNDc5MGJhNWY5ZjRhYTM3NzU2NWEvdGV4dHJlZ2lvbjo1NjNiNTdkZjExY2U0NzkwYmE1ZjlmNGFhMzc3NTY1YV85MzA2_d3ffccdc-ed54-4cbc-9d2b-d670dec0dd9b">37,295,465</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> shares of common stock, par value $0.0001 per share, as of October&#160;20, 2022.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i5b47dd1c3d5a40ff8e040a94ae232d75_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INFORMATION RELATING TO FORWARD-LOOKING STATEMENTS</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to historical information, this Quarterly Report on Form&#160;10-Q contains statements relating to our future results (including certain projections and business trends) that are &#8220;forward-looking statements&#8221; within the meaning of Section&#160;27A of the Securities Act of 1933, as amended, Section&#160;21E of the Securities Exchange Act of 1934, as amended (the Exchange Act), and the Private Securities Litigation Reform Act of 1995, and are subject to the &#8220;safe harbor&#8221; created by those sections. Forward-looking statements consist of statements that are predictive in nature, depend upon or refer to future events. Words such as &#8220;expects&#8221;, &#8220;anticipates&#8221;, &#8220;intends&#8221;, &#8220;plans&#8221;, &#8220;believes&#8221;, &#8220;estimates&#8221;, &#8220;suggests&#8221;, &#8220;appears&#8221;, &#8220;seeks&#8221;, &#8220;will&#8221;, &#8220;could&#8221;, and variations of such words and similar expressions are intended to identify forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause our actual results and performance to be materially different from any future results or performance expressed or implied by these forward-looking statements. These factors include, but are not limited to, the following: </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the overall macroeconomic environment, including increased inflation and interest rates, dema</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nd for the healthcare services we provide, both nationally and in the regions in which we operate, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the ongoing impacts of the coronavirus pandemic (COVID or COVID-19) on our business, financial condition, and results of operations, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">our ability to attract and retain qualified nurses, physicians and other healthcare personnel, costs and availability of short-term housing for our travel healthcare professionals, the functioning of our information systems, the effect of cyber security risks and cyber incidents on our business, the effect of existing or future government regulation and federal and state legislative and enforcement initiatives on our business, our clients&#8217; ability to pay us for our services, our ability to successfully implement our acquisition and development strategies, including our ability to successfully integrate acquired businesses and realize synergies from such acquisitions, the effect of liabilities and other claims asserted against us, the effect of competition in the markets we serve, our ability to successfully defend the Company, its subsidiaries, and its officers and directors on the merits of any lawsuit or determine its potential liability, if any, and other factors, including, without limitation, the risk factors set forth in Item 1A. &#8220;Risk Factors&#8221; in the Company&#8217;s Annual Report on Form&#160;10-K for the year ended December 31, 2021 (2021 Form 10-K), as filed and updated in our Quarterly Reports on Form&#160;10-Q and other filings with the Securities and Exchange Commission (SEC).</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we believe that these statements are based upon reasonable assumptions, we cannot guarantee future results</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management&#8217;s opinions only as of the date of this filing. There can be no assurance that (i)&#160;we have correctly measured or identified all of the factors affecting our business or the extent of these factors&#8217; likely impact, (ii)&#160;the available information with respect to these factors on which such analysis is based is complete or accurate, (iii)&#160;such analysis is correct or (iv)&#160;our strategy, which is based in part on this analysis, will be successful. Except as may be required by law, the Company undertakes no obligation to update or revise forward-looking statements.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All references to &#8220;the Company&#8221;, &#8220;we&#8221;, &#8220;us&#8221;, &#8220;our&#8221;, or &#8220;Cross Country&#8221; in this Quarterly Report on Form&#160;10-Q mean Cross Country Healthcare, Inc. and its consolidated subsidiaries.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i5b47dd1c3d5a40ff8e040a94ae232d75_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CROSS COUNTRY HEALTHCARE, INC.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM 10-Q</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">September&#160;30, 2022</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:7.111%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.504%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PAGE</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5b47dd1c3d5a40ff8e040a94ae232d75_13">PART I. &#8211; FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5b47dd1c3d5a40ff8e040a94ae232d75_13">1</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5b47dd1c3d5a40ff8e040a94ae232d75_16">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5b47dd1c3d5a40ff8e040a94ae232d75_16">Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5b47dd1c3d5a40ff8e040a94ae232d75_16">1</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5b47dd1c3d5a40ff8e040a94ae232d75_19">Condensed Consolidated Balance Sheets (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5b47dd1c3d5a40ff8e040a94ae232d75_19">1</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5b47dd1c3d5a40ff8e040a94ae232d75_22">Condensed Consolidated Statements of Operations (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5b47dd1c3d5a40ff8e040a94ae232d75_22">2</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5b47dd1c3d5a40ff8e040a94ae232d75_25">Condensed Consolidated Statements of Stockholders' Equity (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5b47dd1c3d5a40ff8e040a94ae232d75_25">3</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5b47dd1c3d5a40ff8e040a94ae232d75_31">Condensed Consolidated Statements of Cash Flows (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5b47dd1c3d5a40ff8e040a94ae232d75_31">5</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5b47dd1c3d5a40ff8e040a94ae232d75_34">Notes to Condensed Consolidated Financial Statements (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5b47dd1c3d5a40ff8e040a94ae232d75_34">6</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5b47dd1c3d5a40ff8e040a94ae232d75_88">Item 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5b47dd1c3d5a40ff8e040a94ae232d75_88">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5b47dd1c3d5a40ff8e040a94ae232d75_88">24</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5b47dd1c3d5a40ff8e040a94ae232d75_130">Item 3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5b47dd1c3d5a40ff8e040a94ae232d75_130">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5b47dd1c3d5a40ff8e040a94ae232d75_130">36</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5b47dd1c3d5a40ff8e040a94ae232d75_133">Item 4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5b47dd1c3d5a40ff8e040a94ae232d75_133">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5b47dd1c3d5a40ff8e040a94ae232d75_133">36</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5b47dd1c3d5a40ff8e040a94ae232d75_136">PART II. &#8211; OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5b47dd1c3d5a40ff8e040a94ae232d75_136">37</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5b47dd1c3d5a40ff8e040a94ae232d75_139">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5b47dd1c3d5a40ff8e040a94ae232d75_139">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5b47dd1c3d5a40ff8e040a94ae232d75_139">37</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5b47dd1c3d5a40ff8e040a94ae232d75_142">Item 1A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5b47dd1c3d5a40ff8e040a94ae232d75_142">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5b47dd1c3d5a40ff8e040a94ae232d75_142">37</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Item 6.</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5b47dd1c3d5a40ff8e040a94ae232d75_145">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5b47dd1c3d5a40ff8e040a94ae232d75_145">38</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5b47dd1c3d5a40ff8e040a94ae232d75_148">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5b47dd1c3d5a40ff8e040a94ae232d75_148">39</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i</span></div></div></div><div id="i5b47dd1c3d5a40ff8e040a94ae232d75_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I.&#160;FINANCIAL INFORMATION</span></div><div style="text-align:center"><span><br/></span></div><div id="i5b47dd1c3d5a40ff8e040a94ae232d75_16"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1.&#160;CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div><span><br/></span></div><div id="i5b47dd1c3d5a40ff8e040a94ae232d75_19"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CROSS COUNTRY HEALTHCARE, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited, amounts in thousands)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.391%"><tr><td style="width:1.0%"></td><td style="width:73.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.827%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.542%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.343%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfNC0xLTEtMS00NjMzNA_f7cbb14c-e1b2-4aff-8a2e-51907163d1bf">30,320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfNC0zLTEtMS00NjMzNA_b11e23b2-62a0-4599-a977-600d6e0de683">1,036</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable, net of allowances of $<ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfNS0wLTEtMS00NjMzNC90ZXh0cmVnaW9uOjk3ODcxZWQwYmViYzQ4NTk5MTM2OGY4YWNhNzY4Yzc4XzQ3_352269cf-186e-420b-b29f-f9f5173f1933">12,763</ix:nonFraction> in 2022 and $<ix:nonFraction unitRef="usd" contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfNS0wLTEtMS00NjMzNC90ZXh0cmVnaW9uOjk3ODcxZWQwYmViYzQ4NTk5MTM2OGY4YWNhNzY4Yzc4XzYz_65c6a284-77b7-4a7a-8b0f-5da3a59acc0f">6,881</ix:nonFraction> in 2021</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfNS0xLTEtMS00NjMzNA_19d7e0f3-ca06-4ca1-8d9d-0ce27ee51f08">610,897</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfNS0zLTEtMS00NjMzNA_0e923d77-88d5-486e-b19d-f7eddde463ee">493,910</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:PrepaidExpenseCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfNi0xLTEtMS00NjMzNA_1192a05d-0605-4ec0-9b18-9c55435c5037">3,952</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231" decimals="-3" name="us-gaap:PrepaidExpenseCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfNi0zLTEtMS00NjMzNA_d3ba9ff4-54cd-4d25-a7a8-fc03e4506673">7,648</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Insurance recovery receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:InsuranceSettlementsReceivableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfNy0xLTEtMS00NjMzNA_3ce7faad-63fd-4685-b1a2-451e36935475">6,202</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231" decimals="-3" name="us-gaap:InsuranceSettlementsReceivableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfNy0zLTEtMS00NjMzNA_de5318e4-922d-4f74-af6d-284752d640ac">5,041</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfOC0xLTEtMS00NjMzNA_e29b09a5-1f23-4c5d-9d65-703c3e0d7a95">8,646</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231" decimals="-3" name="us-gaap:OtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfOC0zLTEtMS00NjMzNA_42de2c9d-8e8f-4e48-9af0-fc231951a8f3">638</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfOS0xLTEtMS00NjMzNA_8730582c-7451-43ce-b610-9d616832e3d5">660,017</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfOS0zLTEtMS00NjMzNA_5a9a36e5-7484-49a0-90f5-26674a2b609b">508,273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property and equipment, net of accumulated depreciation of $<ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMTAtMC0xLTEtNDYzMzQvdGV4dHJlZ2lvbjozYzUyMjkwODFmYTY0MmFmOGVhZDAzMjk2N2Y2YzVkMF82NA_b3e2a9c8-464f-4520-bd81-5ba052fa975d">19,846</ix:nonFraction> in 2022 and $<ix:nonFraction unitRef="usd" contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMTAtMC0xLTEtNDYzMzQvdGV4dHJlZ2lvbjozYzUyMjkwODFmYTY0MmFmOGVhZDAzMjk2N2Y2YzVkMF84MA_2ab0166f-7cab-4ae0-afff-5ff69f88030c">17,729</ix:nonFraction>  in 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMTAtMS0xLTEtNDYzMzQ_61248d63-5a44-4777-8349-4fd906c0f741">18,556</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMTAtMy0xLTEtNDYzMzQ_9639dce9-9cb5-484e-9b70-e96dbbce3c95">15,833</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMTEtMS0xLTEtNDYzMzQ_3c8796c4-7017-42fa-afd1-5fe922e7b9b0">3,249</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMTEtMy0xLTEtNDYzMzQ_bba993a4-1ed7-48df-8044-d6f90a3cbd97">7,488</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMTItMS0xLTEtNDYzMzQ_4ce2b0a4-697c-451e-a7df-511ea8aacd47">113,360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMTItMy0xLTEtNDYzMzQ_150345d5-42af-4ac1-8399-7fe8c3583fac">119,490</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade names, indefinite-lived</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:IndefiniteLivedTradeNames" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMTMtMS0xLTEtNDYzMzQ_a13c4d8d-a2a2-4334-a946-68a78ddabd38">5,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231" decimals="-3" name="us-gaap:IndefiniteLivedTradeNames" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMTMtMy0xLTEtNDYzMzQ_d1cf26a4-42cf-4778-8c88-ddf3c513e212">5,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMTQtMS0xLTEtNDYzMzQ_fa7c86a4-a499-4fef-92fb-c691a522266e">40,843</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMTQtMy0xLTEtNDYzMzQ_5c5d3a51-8108-490f-8e28-856539edc5c6">42,344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMTUtMS0xLTEtNDYzMzQ_f600a9ff-1f5d-46af-b032-ae44452429d0">8,791</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMTUtMy0xLTEtNDYzMzQ_8ed12ed9-f514-4a8d-bd63-394d05322f11">11,525</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current insurance recovery receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:InsuranceSettlementsReceivableNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMTYtMS0xLTEtNTEwNjQ_8b379a81-20ed-41c3-86bc-91dadebf5155">20,753</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231" decimals="-3" name="us-gaap:InsuranceSettlementsReceivableNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMTYtMy0xLTEtNTEwNjQ_93488d53-a2d2-45be-881a-2f7e9ba836c8">13,998</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMTYtMS0xLTEtNDYzMzQ_18ab8c40-3e77-40e5-a460-bdcebcbfa1d7">11,043</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMTYtMy0xLTEtNDYzMzQ_149ff6ed-6937-40ef-aceb-ba629be07ea1">7,958</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMTctMS0xLTEtNDYzMzQ_7a6a2f35-1e1b-40d9-a7a4-32c781aae49a">882,512</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMTctMy0xLTEtNDYzMzQ_72720633-a652-467e-97fd-913d3c7cff1d">732,809</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities and Stockholders' Equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMjEtMS0xLTEtNDYzMzQ_e7b48b79-1327-4c94-81e4-a5754eebc0c6">192,032</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231" decimals="-3" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMjEtMy0xLTEtNDYzMzQ_d2ed297e-3be3-4ecd-9365-89046149252d">109,753</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued compensation and benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMjItMS0xLTEtNDYzMzQ_795fcfde-9c61-4de6-bcac-27c30a3b0b09">70,947</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMjItMy0xLTEtNDYzMzQ_8489ddbd-f3f7-466a-a9cf-ba70c3ff8b44">65,580</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMjMtMS0xLTEtNDYzMzQ_6995c3ca-d4d0-4317-aeb0-a7a1f119079a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMjMtMy0xLTEtNDYzMzQ_9eb8235b-59e1-405f-8d99-0b4e5fd03398">4,176</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities - current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMjQtMS0xLTEtNDYzMzQ_5efce532-d10e-4ab2-83b8-5114d5131ed9">4,489</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMjQtMy0xLTEtNDYzMzQ_c8cb9809-e88f-4a3f-bed7-1bf1c59cccf9">4,090</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:TaxesPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMjUtMS0xLTEtNDYzMzQ_e0d7a952-bb3d-4692-bf62-a9582fce29af">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231" decimals="-3" name="us-gaap:TaxesPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMjUtMy0xLTEtNDYzMzQ_ace7a8de-4cd4-406f-aab2-42527f343222">7,307</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of earnout liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMjYtMS0xLTEtNDYzMzQ_845b7f95-31db-4634-b1e2-f4b813660f89">7,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMjYtMy0xLTEtNDYzMzQ_cd8f3e3f-89a1-47b6-9816-6df1c792fb6d">7,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMjctMS0xLTEtNDYzMzQ_75eebc8f-84c7-41fa-8aba-6cbe0d1fc213">1,803</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMjctMy0xLTEtNDYzMzQ_5a53403e-dc52-4d7d-862a-7a1ff69cfae8">1,364</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMjgtMS0xLTEtNDYzMzQ_af877fbe-e4d7-4acd-a007-a0265ddc48fa">276,790</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMjgtMy0xLTEtNDYzMzQ_8574ce0a-7fae-4a5d-90aa-1166faff2496">199,770</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt, less current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:OtherLongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMjktMS0xLTEtNDYzMzQ_4087a5c6-3053-49a1-9391-a3c5c6800c37">129,755</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231" decimals="-3" name="us-gaap:OtherLongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMjktMy0xLTEtNDYzMzQ_a6c57f66-aaee-4073-b56f-6cc79c09e765">176,366</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities - non-current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMzAtMS0xLTEtNDYzMzQ_cdf50d07-26d5-45a3-90e1-7ef7b4143541">5,493</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMzAtMy0xLTEtNDYzMzQ_56e712e7-4788-4d72-9490-b953d3ca3a47">10,853</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMzEtMS0xLTEtNDYzMzQ_22b83efb-0499-485e-8bdd-5fa6f42660c6">237</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMzEtMy0xLTEtNDYzMzQ_59f80dff-763f-4c2e-980d-bafad16882ee">190</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term accrued claims</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMzItMS0xLTEtNDYzMzQ_351e026e-0ca2-4851-846c-716bab43004e">33,104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231" decimals="-3" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMzItMy0xLTEtNDYzMzQ_b5f00376-4cba-405c-b007-17122e470ed4">25,314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current earnout liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMzMtMS0xLTEtNDYzMzQ_253bd0e2-e32b-431d-8d31-af0d71c62ba8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMzMtMy0xLTEtNDYzMzQ_c0f42a6d-ecd6-4a72-9581-bf41acadee76">9,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMzQtMS0xLTEtNDYzMzQ_05bae783-9147-4b2f-a94f-35209df4a47a">14,424</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMzQtMy0xLTEtNDYzMzQ_2815ec9d-9b27-493d-a714-d93870291d1d">13,788</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMzUtMS0xLTEtNDYzMzQ_f20a4334-5c22-4257-a41c-696369d861ef">459,803</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMzUtMy0xLTEtNDYzMzQ_1abf8b86-1b62-490c-bf9f-486b9631c231">435,281</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMzctMS0xLTEtNDYzMzQ_f4938aba-cd07-41c4-8dd3-1ce5cca7220b"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMzctMy0xLTEtNDYzMzQ_a910ea14-c4a5-486e-9b51-63c355632681"></ix:nonFraction></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stockholders' equity:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfNDAtMS0xLTEtNDYzMzQ_723fd940-3fa0-4692-92ff-df26b5ac7429">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfNDAtMy0xLTEtNDYzMzQ_844d8032-f195-44c8-864f-0cb4bb737c2b">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfNDEtMS0xLTEtNDYzMzQ_071d8a1b-91e5-4320-b985-8dacd05b58ec">297,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfNDEtMy0xLTEtNDYzMzQ_b23232fc-8486-43bc-8792-b6089b98b006">321,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfNDItMS0xLTEtNDYzMzQ_d6f23d0d-6c93-4a27-b487-90ae7bc09a57">1,373</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfNDItMy0xLTEtNDYzMzQ_71411697-642c-4460-be70-a4683df983d7">1,293</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Retained earnings (accumulated deficit)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfNDMtMS0xLTEtNDYzMzQ_f0e69d4c-e704-49eb-856c-cb6ccd9f2c7d">126,935</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfNDMtMy0xLTEtNDYzMzQ_92d2ea5c-8b2c-4d71-baa3-9ba15bbe2eeb">22,735</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total stockholders' equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfNDYtMS0xLTEtNDYzMzQ_3483af4d-e797-4410-9d86-68d8849038c6">422,709</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfNDYtMy0xLTEtNDYzMzQ_e8b82cf7-9f1b-4ad9-8f37-889152cb8fcb">297,528</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities and stockholders' equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfNDctMS0xLTEtNDYzMzQ_32530ca0-3e37-40f7-96a3-6a237640933e">882,512</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfNDctMy0xLTEtNDYzMzQ_b7bfbaf0-31ee-468b-b8b5-ffa0fec6cc94">732,809</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">                                                                                                                     </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to the condensed consolidated financial statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="i5b47dd1c3d5a40ff8e040a94ae232d75_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CROSS COUNTRY HEALTHCARE, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited, amounts in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.430%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfNC0wLTEtMS00NjMzNA_7f0cb4b5-60f2-4271-bceb-9dc3c10c40e8"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfNC0wLTEtMS00NjMzNA_a67cd947-3a68-403c-8e8c-ba747270e9d1"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfNC0wLTEtMS00NjMzNA_cf74a3bf-47ff-4a52-9ecb-7fdf95acc284"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfNC0wLTEtMS00NjMzNA_fe67965c-2b70-4154-8270-1dfa06b11c02">Revenue from services</span></span></span></span> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfNC0xLTEtMS00NjMzNA_b00450e7-f963-4c5c-91b3-0d0f75ed8bbf">636,098</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfNC0zLTEtMS00NjMzNA_d0eb2111-0aa7-4260-8227-c8f1d312e3d8">374,905</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfNC01LTEtMS00NjMzNA_1e7c8aa9-efe6-4abf-aed6-99b4b7864de6">2,178,391</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfNC03LTEtMS00NjMzNA_ada37fd3-bbbe-4d50-bb47-de8cd1845fdf">1,035,973</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct operating expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930" decimals="-3" name="us-gaap:DirectOperatingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfNi0xLTEtMS00NjMzNA_180307d7-abb2-4098-9c4a-81a3d205141b">492,553</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930" decimals="-3" name="us-gaap:DirectOperatingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfNi0zLTEtMS00NjMzNA_c3c51c58-8de0-45b6-a1e3-382d6201fbc5">291,111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="us-gaap:DirectOperatingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfNi01LTEtMS00NjMzNA_96a87e17-c38c-4e90-b28d-3cdeb986fa6a">1,689,647</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="us-gaap:DirectOperatingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfNi03LTEtMS00NjMzNA_d52b7ae2-3a81-4e78-90c7-3710873b011e">808,124</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfNy0xLTEtMS00NjMzNA_20116dff-edff-4dc9-905d-6e675118f9ca">80,216</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfNy0zLTEtMS00NjMzNA_6cd59ad5-eb5a-4bb9-b9ec-b5c169f05a2b">52,847</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfNy01LTEtMS00NjMzNA_5496f2f9-7d69-44aa-8e07-465b091dec64">243,038</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfNy03LTEtMS00NjMzNA_b148065d-bd47-416d-b549-21b6d5931b69">149,518</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bad debt expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfOC0xLTEtMS00NjMzNA_0eeb75e1-c4d0-4bd0-b9c5-a64fa8ad5ea2">1,101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfOC0zLTEtMS00NjMzNA_5b292ea2-78d6-4922-95b1-be01ca8639b2">1,441</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfOC01LTEtMS00NjMzNA_f1edbc43-516b-4f23-9391-2530fc942e92">6,662</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfOC03LTEtMS00NjMzNA_76e30aca-f35d-4b8a-accb-7e95d82b39b7">2,411</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfOS0xLTEtMS00NjMzNA_7c8c095b-5523-444d-a75a-07170a48d340">3,214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfOS0zLTEtMS00NjMzNA_9022feb2-33b0-42b8-8793-9b9b75ff230b">2,680</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfOS01LTEtMS00NjMzNA_36fc341e-c911-4179-992f-db99e3d6d3c0">9,414</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfOS03LTEtMS00NjMzNA_ea3a6d43-e876-427d-9055-73fd59d15d68">7,132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and integration-related costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930" decimals="-3" name="ccrn:AcquisitionAndIntegrationRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTAtMS0xLTEtNDYzMzQ_18f56545-362d-43d1-8248-b29f3a08373c">490</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930" decimals="-3" name="ccrn:AcquisitionAndIntegrationRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTAtMy0xLTEtNDYzMzQ_996b1ec3-639c-4d86-bd12-662eb1bd1aa8">61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="ccrn:AcquisitionAndIntegrationRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTAtNS0xLTEtNDYzMzQ_cf9b94a9-f910-4886-88f1-9268daa2fedc">530</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="ccrn:AcquisitionAndIntegrationRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTAtNy0xLTEtNDYzMzQ_c6682a0b-f9c1-4fa2-8d55-4237e0081034">985</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTEtMS0xLTEtNDYzMzQ_dc9ae810-4da9-4492-8c4d-d43df782b383">2,493</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTEtMy0xLTEtNDYzMzQ_abc21ad0-0ba4-461b-97d4-0aa1f0c44a3b">318</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTEtNS0xLTEtNDYzMzQ_ef0db481-67fc-4459-ae97-fc62a9749d0e">1,859</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTEtNy0xLTEtNDYzMzQ_cab1d26b-32ce-40ca-8573-1666560c79ae">2,391</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930" decimals="-3" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTItMS0xLTEtNDYzMzQ_6a6d4177-3b2d-4563-93d1-79dc46c8fe7b">3,856</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930" decimals="-3" name="us-gaap:AssetImpairmentCharges" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTItMy0xLTEtNDYzMzQ_d27eb0e5-e4ba-459e-98de-b1dcee73d206">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTItNS0xLTEtNDYzMzQ_99b5a20a-ed37-4d3b-9221-df9c566ec4b6">5,597</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTItNy0xLTEtNDYzMzQ_9925d9ba-dc2c-4c67-b26a-982bdfa821b6">2,070</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTMtMS0xLTEtNDYzMzQ_b1eceb9a-1323-49d9-9b39-4d7dbcf5a266">583,923</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTMtMy0xLTEtNDYzMzQ_537d1b58-bf28-42dd-94a7-a7561c762cae">348,458</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTMtNS0xLTEtNDYzMzQ_0baae02c-cb66-4cce-a151-4a68456006e7">1,956,747</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTMtNy0xLTEtNDYzMzQ_ae5f8c0b-5f54-4e37-9565-1cbbd0a42da7">972,631</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTQtMS0xLTEtNDYzMzQ_7965c58c-1968-48da-a954-5e5ef0604d10">52,175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTQtMy0xLTEtNDYzMzQ_9226d29d-a0ea-4d5d-8402-322da6886c87">26,447</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTQtNS0xLTEtNDYzMzQ_6ba766c2-660d-4047-9f54-aa9b721ddaca">221,644</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTQtNy0xLTEtNDYzMzQ_a2f13035-1765-499f-90a3-2f18d840f76b">63,342</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expenses (income):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTYtMS0xLTEtNDYzMzQ_a4ff4d21-f3a6-4f63-bd55-8d33bff002fc">3,498</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTYtMy0xLTEtNDYzMzQ_d4c64ff4-0a48-4eb8-8e48-de07f6a6b3d7">2,182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTYtNS0xLTEtNDYzMzQ_c916d241-7d4b-41eb-b19b-451da36b1bfc">10,876</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTYtNy0xLTEtNDYzMzQ_b02557d8-5bed-4b0a-ae06-0fdc9045991a">4,049</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on early extinguishment of debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTctMS0xLTEtNDYzMzQ_8839a86f-b27d-4903-a6ce-99fe9e6f5e49">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTctMy0xLTEtNDYzMzQ_5f7844ee-4e02-4448-8b6a-9c0d56c3ac30">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTctNS0xLTEtNDYzMzQ_2bf1ebe8-5622-48ac-947d-f40000d0dae9">1,912</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTctNy0xLTEtNDYzMzQ_a5ea1a5a-d12a-40da-a418-c0a0fc605b48">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTgtMS0xLTEtNDYzMzQ_401136fe-da19-4e6e-9688-b54323e83d5f">27</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTgtMy0xLTEtNDYzMzQ_aa597015-12ec-4e35-b751-50b86082c9ac">375</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTgtNS0xLTEtNDYzMzQ_7effdfb2-f8b8-4cdb-a679-4c2f32169ced">1,119</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTgtNy0xLTEtNDYzMzQ_f6bf1359-5b2f-4ed2-84e7-cd4a6d18cb46">616</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTktMS0xLTEtNDYzMzQ_88084327-4129-4a24-9ae9-5b7c3a3ce668">48,704</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTktMy0xLTEtNDYzMzQ_931de9e8-74f4-4b34-a1ca-36cb30158463">24,640</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTktNS0xLTEtNDYzMzQ_cb40946d-612f-4fd0-bb6b-9aec329151f2">209,975</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTktNy0xLTEtNDYzMzQ_5e570d54-d166-4ea0-8f6a-b7e09b96c787">59,909</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMjAtMS0xLTEtNDYzMzQ_06529471-d0ae-4862-b35b-3cebfbd44fc9">13,911</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMjAtMy0xLTEtNDYzMzQ_b8086078-9876-42d5-870e-be3da7fe71ec">1,207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMjAtNS0xLTEtNDYzMzQ_ccb6b763-6939-45d9-95ec-2e2f1998886b">60,305</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMjAtNy0xLTEtNDYzMzQ_996a21ff-1ab2-4e8f-8c17-241969185016">5,480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to common stockholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMjMtMS0xLTEtNDYzMzQ_b69c6e13-181b-4f11-ac6a-c922b98c0222">34,793</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMjMtMy0xLTEtNDYzMzQ_7cc5b1ee-97a1-4c97-9c70-543b97436a0f">23,433</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMjMtNS0xLTEtNDYzMzQ_524d6fd4-cd81-4f12-843d-6aa13caf245a">149,670</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMjMtNy0xLTEtNDYzMzQ_85bf906f-686b-4d21-b527-2017d3b88967">54,429</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized foreign currency translation loss, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMjYtMS0xLTEtNDYzMzQ_39bc7c42-edbe-4e63-9fa8-2d171a5281e7">38</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMjYtMy0xLTEtNDYzMzQ_e8528fa5-b989-43cb-bab5-b205527cdc54">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMjYtNS0xLTEtNDYzMzQ_bf7acc6b-d528-4953-949e-8a220b5dc678">80</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMjYtNy0xLTEtNDYzMzQ_895c9088-2d20-4ab7-ae25-09cc5aa791e9">32</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMjctMS0xLTEtNDYzMzQ_f608c67c-8420-457e-8e29-cd3654f6ce43">34,755</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMjctMy0xLTEtNDYzMzQ_72ce214e-ac5c-4f7e-9bfd-4f50e132edcf">23,431</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMjctNS0xLTEtNDYzMzQ_0e832cb0-1ca2-475f-83a2-7a67b431836b">149,590</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMjctNy0xLTEtNDYzMzQ_9c430520-b1f8-4531-aff3-09d1d30e1b2a">54,397</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share attributable to common stockholders - Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMjktMS0xLTEtNDYzMzQ_d669096e-50a4-48b1-842a-f48e66ef2d2c">0.94</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMjktMy0xLTEtNDYzMzQ_10ae553e-0486-44f2-81a8-43d92129c126">0.63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMjktNS0xLTEtNDYzMzQ_8cdfea8e-f184-48d8-b4e4-56949125c9f1">4.02</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMjktNy0xLTEtNDYzMzQ_96b0404e-142a-45d8-a128-467585a711cc">1.49</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share attributable to common stockholders - Diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMzEtMS0xLTEtNDYzMzQ_5a8d3721-df48-44b4-91cf-5f27948c9027">0.93</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMzEtMy0xLTEtNDYzMzQ_dba6b928-63e4-4abd-be0d-45427a8f14b7">0.62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMzEtNS0xLTEtNDYzMzQ_91b038db-cd04-4353-ae04-1b3dcd55e534">3.97</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMzEtNy0xLTEtNDYzMzQ_49b6de5d-ad5a-4a65-ad0e-b404b419fb1e">1.46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMzQtMS0xLTEtNDYzMzQ_0c37c1a3-cecb-4779-8dd1-de55627cff7b">37,101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMzQtMy0xLTEtNDYzMzQ_035f8b8e-7e3c-40fa-9af2-86c1a9151d22">36,963</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMzQtNS0xLTEtNDYzMzQ_a1066aa0-939b-46f9-a08a-24c03a67e6e2">37,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMzQtNy0xLTEtNDYzMzQ_207f8657-552d-4f80-ab64-76b225070210">36,593</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMzUtMS0xLTEtNDYzMzQ_ed6251e5-6544-4cfa-837b-0a05dd594535">37,492</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMzUtMy0xLTEtNDYzMzQ_53675095-4b71-480a-9241-559f3a6b6edf">37,582</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMzUtNS0xLTEtNDYzMzQ_e7edcf59-43b3-4be3-a78e-56d8de5be40a">37,741</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMzUtNy0xLTEtNDYzMzQ_93b678be-160a-48d5-8986-266cafedb483">37,276</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to the condensed consolidated financial statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i5b47dd1c3d5a40ff8e040a94ae232d75_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CROSS COUNTRY HEALTHCARE, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended September 30, 2022 and 2021</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited, amounts in thousands)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:24.597%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.388%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.801%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.381%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.794%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.919%"></td><td style="width:0.1%"></td></tr><tr style="height:21pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Additional<br/>Paid-In Capital</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Accumulated Other <br/>Comprehensive Loss, net</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Noncontrolling Interest in Subsidiary</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Stockholders&#8217; Equity</span></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Dollars</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Balances at June 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i26fb2cd916aa4101ac98bfb0aeed6193_I20220630" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMi0xLTEtMS00NjMzNA_eff2fc9a-7f69-42fa-911d-b0f02b1105a2">37,523</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26fb2cd916aa4101ac98bfb0aeed6193_I20220630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMi0zLTEtMS00NjMzNA_9c176327-af68-49ad-a850-518e41fc34f6">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23e6ed6a9fed48d29307fabb2d2666ab_I20220630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMi01LTEtMS00NjMzNA_8b15326b-37c9-4362-a57a-80aaa1e085a4">320,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if342abafe0424c4cbbb239c9eeb5a10b_I20220630" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMi03LTEtMS00NjMzNA_33f2ffb1-ad1a-4157-899f-08383a3e4f9e">1,335</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68cf390bfea94f56a817690cbbf4744d_I20220630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMi05LTEtMS00NjMzNA_6161fc6f-faed-400f-a0c4-121d6f105ba4">92,142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaff6ed2ab3394341b1987107614ed158_I20220630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMi0xMS0xLTEtNDYzMzQ_ff093f88-2e6e-419f-b7d6-20e52b7e4d52">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c0a4267d8174093be4955cfd3a6d031_I20220630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMi0xMy0xLTEtNDYzMzQ_0edd2211-8aa0-4089-9cc7-36eade0e13c3">410,811</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Equity compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37a23fb61a8646c29cb106b4e9684e9b_D20220701-20220930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfNC01LTEtMS00NjMzNA_90db00f7-6f1e-4742-9065-7fdfd5005f53">1,491</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfNC0xMy0xLTEtNDYzMzQ_78be4e48-321c-4c38-ac78-81523e7c5fa0">1,491</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Stock repurchase and retirement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ia3fb9c1cd31c4e1181518b558a62bf13_D20220701-20220930" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfNS0xLTEtMS00OTA0Nw_d54b0947-37a7-4385-9176-ab445b68dd3e">1,015</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37a23fb61a8646c29cb106b4e9684e9b_D20220701-20220930" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfNS01LTEtMS00OTA0Nw_bba1eba2-c8dc-4a98-9141-9e0e9f1d1387">24,348</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfNS0xMy0xLTEtNDkwNDc_c30ba9ef-6e7a-4561-b866-2c5b201b7ac2">24,348</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Foreign currency translation adjustment, net of taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie0f02a13f7ad4906acc11dee942a7413_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfNS03LTEtMS00NjMzNA_307b78d9-fb44-4ac7-ab20-d655c209b9e4">38</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfNS0xMy0xLTEtNDYzMzQ_912dcf55-9d93-4af4-bf80-8d5b81077024">38</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if62eba6a38e6444bbfe404803ad71c18_D20220701-20220930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfOC05LTEtMS00NjMzNA_884caa12-e92a-429a-9230-235645c2f2d4">34,793</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfOC0xMy0xLTEtNDYzMzQ_6035e648-7fc5-4697-ac68-0ed9869ae03e">34,793</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Balances at September 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i677effe12d9f4d44bd5f1ca7944e48b0_I20220930" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfOS0xLTEtMS00NjMzNA_99946ecd-6ce3-4006-a677-57bc4f32699e">36,508</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i677effe12d9f4d44bd5f1ca7944e48b0_I20220930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfOS0zLTEtMS00NjMzNA_235ae5a7-ef35-495f-9316-0a354fdefd17">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f59e0723d41435fbc923108afeebf77_I20220930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfOS01LTEtMS00NjMzNA_4703085e-ad47-4dd9-aedf-545a1f218d3f">297,143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i849d2660af354dc7b3da49f0e86fc52c_I20220930" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfOS03LTEtMS00NjMzNA_8f098cff-5ffc-426c-bd80-798a06d821d8">1,373</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e8d1bdde3804c1baf7ae857af6e5e52_I20220930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfOS05LTEtMS00NjMzNA_45bd3a7d-a454-4503-8a29-18e4b42965ef">126,935</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4401d4d9ee924023b8f1ec25533e9a67_I20220930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfOS0xMS0xLTEtNDYzMzQ_d6f26285-9cb8-4286-b6d6-3c496a342b62">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfOS0xMy0xLTEtNDYzMzQ_c84653f0-ab03-4868-8e39-ac811596b198">422,709</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Additional<br/>Paid-In Capital</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Accumulated Other <br/>Comprehensive Loss, net</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">(Accumulated Deficit) Retained Earnings</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Noncontrolling Interest in Subsidiary</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Stockholders&#8217; Equity</span></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Dollars</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Balances at June&#160;30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1252820f59e947b4976a678884ff7d91_I20210630" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMTMtMS0xLTEtNDYzMzQ_43405d9a-bc1d-4bd7-bdbb-25fa09c0868b">36,962</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1252820f59e947b4976a678884ff7d91_I20210630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMTMtMy0xLTEtNDYzMzQ_729ce86f-6760-4f60-82aa-b88cdddcdd71">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fc079c274124a6cac569e4f34366c7b_I20210630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMTMtNS0xLTEtNDYzMzQ_238d9fec-92cc-4625-987a-c850503ecbae">316,644</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i532e051d438e418eb3e83be7ed3362f2_I20210630" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMTMtNy0xLTEtNDYzMzQ_cd388d8c-e896-41d8-b361-34c5306d9adf">1,310</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i725e0cb0ad514e69b7e4c7c6064bc911_I20210630" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMTMtOS0xLTEtNDYzMzQ_5c986483-70da-447e-ab47-17a4bbd90a53">123,741</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc57b01ed27040b3bf77a29981bb957d_I20210630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMTMtMTEtMS0xLTQ2MzM0_65265df7-3957-4ba8-85cc-d3279342e029">534</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61328c0ca95341349cdc1ca533a6d2bf_I20210630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMTMtMTMtMS0xLTQ2MzM0_4b48b0e5-62c1-48b1-a4c2-93859b75d794">192,131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Vesting of restricted stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic538be4345284146ae03043536ae0bfa_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMTQtMS0xLTEtNDYzMzQ_ed43c159-8578-472b-adcc-36ad87fbf1cd">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Equity compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bc3a63bad324d3b92636e8a32d4f412_D20210701-20210930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMTUtNS0xLTEtNDYzMzQ_299baef0-441b-4cd4-b67e-06c6e1b52978">1,771</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMTUtMTMtMS0xLTQ2MzM0_93091db9-1570-4670-af91-20ccdf7b327e">1,771</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Foreign currency translation adjustment, net of taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe8f646189004462a689d8e6ab700027_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMTYtNy0xLTEtNDYzMzQ_8ee9aac2-7790-4bbd-8e02-f8435e694e97">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMTYtMTMtMS0xLTQ2MzM0_480f1e31-741b-4e2a-8e3c-565cff3bbffd">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Dissolution of noncontrolling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1c4bd146f604316b819aa100137bf51_D20210701-20210930" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMTgtMTEtMS0xLTQ3NzA2_f95ef268-b0f4-4fa0-b62b-2df4bdc50edb">324</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMTgtMTMtMS0xLTQ3NzA2_8062e2a7-551d-4338-b990-9852111f40b5">324</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Distribution to noncontrolling shareholder</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1c4bd146f604316b819aa100137bf51_D20210701-20210930" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMTktMTEtMS0xLTQ3NzA2_c930a064-113b-4176-ba11-cdcce03d1026">210</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMTktMTMtMS0xLTQ3NzA2_97b5395a-3148-4196-a2e8-bb4485c2d6c6">210</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadcfed8870184b00ac8df3ef3a6c7332_D20210701-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMTgtOS0xLTEtNDYzMzQ_92e4910b-96a8-447b-8799-9ea55f1dc4ea">23,433</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMTgtMTMtMS0xLTQ2MzM0_93ae70aa-f281-40c6-be88-bfccf3f3be5a">23,433</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Balances at September 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3edda426942249bf91dae3b40fcf7ae9_I20210930" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMTktMS0xLTEtNDYzMzQ_bf750998-8957-4af9-b264-70afe611775a">36,964</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3edda426942249bf91dae3b40fcf7ae9_I20210930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMTktMy0xLTEtNDYzMzQ_b2007b9c-907e-411f-bfb5-bb2a69407468">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i661f31a4c8174df5accdb1e19dbc9603_I20210930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMTktNS0xLTEtNDYzMzQ_41029410-2664-4940-be28-f725a7a3e8f0">318,415</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic78b970907494e82bd28d42c18310a5f_I20210930" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMTktNy0xLTEtNDYzMzQ_66ac27a8-c88e-4a28-b9f6-04eff52e7e9a">1,312</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i89f83f5578c9454b87f8cf964b36d386_I20210930" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMTktOS0xLTEtNDYzMzQ_1e361594-c0d1-4ca8-a5c7-968a5fbad963">100,308</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fefba535da24f6faa17aa6af4553338_I20210930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMTktMTEtMS0xLTQ2MzM0_e969489f-4815-4c09-bfdb-663aedce8535">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb81780210de40218de77358d91c73ba_I20210930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMTktMTMtMS0xLTQ2MzM0_a7937e0c-2ea5-4c2e-ab8c-2f58ca8f8f1d">216,799</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div id="i5b47dd1c3d5a40ff8e040a94ae232d75_28"></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to the condensed consolidated financial statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CROSS COUNTRY HEALTHCARE, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nine Months Ended September 30, 2022 and 2021</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited, amounts in thousands)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:24.597%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.388%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.801%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.381%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.794%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.919%"></td><td style="width:0.1%"></td></tr><tr style="height:21pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Additional<br/>Paid-In Capital</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Accumulated Other <br/>Comprehensive Loss, net</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">(Accumulated Deficit) Retained Earnings</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Noncontrolling Interest in Subsidiary</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Stockholders&#8217; Equity</span></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Dollars</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Balances at December&#160;31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0adb8d88d43c4f0699c9c108560ff3c3_I20211231" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMi0xLTEtMS00NjMzNA_4a031624-3ca0-4a01-ac9c-72e10280ebe0">37,024</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0adb8d88d43c4f0699c9c108560ff3c3_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMi0zLTEtMS00NjMzNA_dca1aa4c-b80f-4961-bd5f-b533408d8136">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3eb9dcc1ff645df99ce9eb18565e9a4_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMi01LTEtMS00NjMzNA_708cf1f4-1376-4b5d-ae65-04e70606ec4e">321,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76c4c8c1ba544b218b38c4841b734300_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMi03LTEtMS00NjMzNA_c4901cc2-4087-4eda-a2d3-0aa0ddf13927">1,293</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7e684e1ca5746c9987a351de57e7a33_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMi05LTEtMS00NjMzNA_98a54fa8-03b6-4a16-837a-1fe54ab2919c">22,735</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d0df14b23af42f8bf234fae71fdabce_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMi0xMS0xLTEtNDYzMzQ_8724b103-b8f9-4703-b38b-d5d7ead67804">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMi0xMy0xLTEtNDYzMzQ_d27e6329-40cd-4ee1-a9ed-a0714741237f">297,528</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Vesting of restricted stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i36a03f0a3609488882bcc1d53ba8b90a_D20220101-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMy0xLTEtMS00NjMzNA_9cf20d48-20f0-4ce0-84ec-68c42d59d135">499</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ebd46f32725469a851e253627061ba5_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMy01LTEtMS00NjMzNA_83073cb3-5a0a-4969-8d28-0d8194a6a9ba">5,267</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMy0xMy0xLTEtNDYzMzQ_f2ed7303-654b-4ece-a899-68347dcfb143">5,267</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Equity compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ebd46f32725469a851e253627061ba5_D20220101-20220930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfNC01LTEtMS00NjMzNA_ab90c5d9-7e3c-4126-beb3-cc70a6160589">5,206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfNC0xMy0xLTEtNDYzMzQ_0078f2e5-2b79-4434-b06d-efe9de934db5">5,206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Stock repurchase and retirement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i36a03f0a3609488882bcc1d53ba8b90a_D20220101-20220930" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfNS0xLTEtMS00OTA1Nw_db3f1dbd-657b-441d-8764-ff067b135c75">1,015</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ebd46f32725469a851e253627061ba5_D20220101-20220930" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfNS01LTEtMS00OTA1Nw_0191923e-5f14-4cf6-8689-60c5206de712">24,348</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfNS0xMy0xLTEtNDkwNTc_374b070e-0e8c-483d-ae42-3c80589ccaab">24,348</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Foreign currency translation adjustment, net of taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55f1d59f3df544b3b26a366b71c31170_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfNS03LTEtMS00NjMzNA_d85ee0fa-59f4-4dbe-a0f0-a4870426fcc2">80</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfNS0xMy0xLTEtNDYzMzQ_aee81ad2-c19b-4236-999e-ab61f8083208">80</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4db29b7907044e1ca81a2082beb7444a_D20220101-20220930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfOS05LTEtMS00NjMzNA_a06c1292-c441-4e5f-945e-29dea74baf15">149,670</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfOS0xMy0xLTEtNDYzMzQ_e638a823-c6a8-4815-87a8-6570258a1284">149,670</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Balances at September&#160;30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i677effe12d9f4d44bd5f1ca7944e48b0_I20220930" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMTAtMS0xLTEtNDYzMzQ_2b0e8848-58f1-4ef6-965b-a44e142ca248">36,508</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i677effe12d9f4d44bd5f1ca7944e48b0_I20220930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMTAtMy0xLTEtNDYzMzQ_1d3e1303-2971-44b2-9972-e95bb04fee4c">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f59e0723d41435fbc923108afeebf77_I20220930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMTAtNS0xLTEtNDYzMzQ_70000dad-0d44-435b-ba44-34e34826d9be">297,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i849d2660af354dc7b3da49f0e86fc52c_I20220930" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMTAtNy0xLTEtNDYzMzQ_482af2b3-5251-4000-a58b-0520154f6d89">1,373</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e8d1bdde3804c1baf7ae857af6e5e52_I20220930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMTAtOS0xLTEtNDYzMzQ_fba5a2f4-443b-4157-9714-873f7f9b4e4a">126,935</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4401d4d9ee924023b8f1ec25533e9a67_I20220930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMTAtMTEtMS0xLTQ2MzM0_4623bbb6-e9c2-478c-b887-ea53b127bdfb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMTAtMTMtMS0xLTQ2MzM0_2005693f-3627-47f0-ab1a-820554cead50">422,709</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Additional<br/>Paid-In Capital</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Accumulated Other <br/>Comprehensive Loss, net</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">(Accumulated Deficit) Retained Earnings</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Noncontrolling Interest in Subsidiary</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Stockholders&#8217; Equity</span></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Dollars</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Balances at December&#160;31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i46d38e032f6045d5811f4c3961253386_I20201231" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMTQtMS0xLTEtNDYzMzQ_45911051-16d7-45b1-9d7b-a74e43906f5d">36,177</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46d38e032f6045d5811f4c3961253386_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMTQtMy0xLTEtNDYzMzQ_ea0520b1-8668-4caa-af06-938efb255111">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6641a1756e67403d810b23655f4e192e_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMTQtNS0xLTEtNDYzMzQ_fb6af5cb-3c6e-460d-b444-61ce94c27a5d">310,388</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24f2241f06ba4fd28714f067a2014198_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMTQtNy0xLTEtNDYzMzQ_a4f7d35f-a56b-4e8d-b196-67bf4ca5bc90">1,280</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1ae1d5ee1d14280ac3f645f56e7bb1a_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMTQtOS0xLTEtNDYzMzQ_b8a14752-1b44-414d-b498-034138b7636a">154,737</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5affaa8d5f934c798b6c95e386f76904_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMTQtMTEtMS0xLTQ2MzM0_aa700887-3275-44a9-96d0-4d7d7d6c7a7d">534</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i119af728c7ce4ee8bb64043a29f00ca5_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMTQtMTMtMS0xLTQ2MzM0_aa3f748c-c7c7-4fb8-921e-9c2569d0da6a">154,909</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Vesting of restricted stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i702dc94df8644dde8f1cce342f5d1e3b_D20210101-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMTUtMS0xLTEtNDYzMzQ_ee777ae8-11a1-44eb-8828-549aba41ae3e">479</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0e5daec688e4f149d1bb1d3c238f468_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMTUtNS0xLTEtNDYzMzQ_81df6c19-3c5f-48ce-85d0-e38ac4d863cf">2,230</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMTUtMTMtMS0xLTQ2MzM0_1711c957-3ba7-435a-8116-35f18dc70326">2,230</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Equity compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0e5daec688e4f149d1bb1d3c238f468_D20210101-20210930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMTYtNS0xLTEtNDYzMzQ_76ad008a-2105-4ceb-8d07-0e2252eb957d">5,257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMTYtMTMtMS0xLTQ2MzM0_732c7be4-09f3-4d3c-9ea1-3109fa54c961">5,257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Foreign currency translation adjustment, net of taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8aff35e423dc48b2880bbf459a28b4cb_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMTctNy0xLTEtNDYzMzQ_50577a1a-203c-45f2-9f36-8e930ea4641a">32</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMTctMTMtMS0xLTQ2MzM0_fcf86537-14ea-463e-b70b-17d95666d701">32</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Acquisition of WSG</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i702dc94df8644dde8f1cce342f5d1e3b_D20210101-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMTgtMS0xLTEtNDYzMzQ_0e65c996-7af9-47cb-9358-0df25bcb1d3c">308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0e5daec688e4f149d1bb1d3c238f468_D20210101-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMTgtNS0xLTEtNDYzMzQ_fe29b8ba-14ab-4819-8a08-ee45f4be0a0a">5,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMTgtMTMtMS0xLTQ2MzM0_6e058d5b-0f5d-420c-8943-3d1e443e586c">5,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Dissolution of noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ea4b9a9c7024e24b7056df5589337d5_D20210101-20210930" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMTktMTEtMS0xLTQ3NzE3_39423cf1-0264-412a-810d-80688029d9f0">324</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMTktMTMtMS0xLTQ3NzE3_c618be52-cca4-4493-a133-8317c1ed4951">324</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Distribution to noncontrolling shareholder</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ea4b9a9c7024e24b7056df5589337d5_D20210101-20210930" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMjAtMTEtMS0xLTQ3NzE3_046c94c8-85af-4dc6-9fc8-4faee680a2a1">210</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMjAtMTMtMS0xLTQ3NzE3_520ed7bc-58cd-47b6-a884-24f61a3e115b">210</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i253197afe06e45bca28e963b592a33ea_D20210101-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMTktOS0xLTEtNDYzMzQ_0de5ecae-8cd3-48c1-a20a-7bd1d360c8b9">54,429</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMTktMTMtMS0xLTQ2MzM0_e8101e71-89b7-41d9-9c75-091ef285d2a5">54,429</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Balances at September&#160;30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3edda426942249bf91dae3b40fcf7ae9_I20210930" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMjAtMS0xLTEtNDYzMzQ_cb306190-30ac-4645-98e3-4a629e55be94">36,964</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3edda426942249bf91dae3b40fcf7ae9_I20210930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMjAtMy0xLTEtNDYzMzQ_05221ec2-4e8e-4f7b-a1e0-42c6e948efaa">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i661f31a4c8174df5accdb1e19dbc9603_I20210930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMjAtNS0xLTEtNDYzMzQ_0b6cc071-9239-445a-a73d-7b5cef2c1257">318,415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic78b970907494e82bd28d42c18310a5f_I20210930" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMjAtNy0xLTEtNDYzMzQ_23979cca-92e3-4bf2-8991-1ec3ed448099">1,312</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i89f83f5578c9454b87f8cf964b36d386_I20210930" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMjAtOS0xLTEtNDYzMzQ_d1020cbb-ccc9-4702-bbc1-251ca42dd5eb">100,308</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fefba535da24f6faa17aa6af4553338_I20210930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMjAtMTEtMS0xLTQ2MzM0_4c416505-47c6-4fdc-aa2a-b55d956c29f1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb81780210de40218de77358d91c73ba_I20210930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMjAtMTMtMS0xLTQ2MzM0_f5e58e7a-c97f-4b8e-a8e6-f488a82dfaad">216,799</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to the condensed consolidated financial statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i5b47dd1c3d5a40ff8e040a94ae232d75_31"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CROSS COUNTRY HEALTHCARE, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited, amounts in thousands)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from operating activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfNC0xLTEtMS00NjMzNA_7316b42a-5808-4b4c-bb45-fe059a1200c0">149,670</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfNC0zLTEtMS00NjMzNA_676a43b7-2d28-4b99-8be5-8dec292e2aae">54,429</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by (used in) operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfNi0xLTEtMS00NjMzNA_5f8bf8f0-9741-4e93-9523-c3e92cf4e454">9,414</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfNi0zLTEtMS00NjMzNA_5aa7e102-cfbe-4e71-b645-1cfb04119050">7,132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for allowances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="ccrn:ProvisionForDoubtfulAccountsAndOtherAllowances" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfNy0xLTEtMS00NjMzNA_ee0a63d5-c31d-49ac-8d86-fb037c0be7b6">10,016</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="ccrn:ProvisionForDoubtfulAccountsAndOtherAllowances" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfNy0zLTEtMS00NjMzNA_4a7582fa-739c-45cc-891b-eba0e8cf51d1">3,836</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfOC0xLTEtMS00NjMzNA_5c65d79c-57a4-4a0d-b936-e741755cb787">2,797</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfOC0zLTEtMS00NjMzNA_bdf03d3b-9861-4e30-a176-dcc7fbcd9c81">2,797</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash lease expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="ccrn:OperatingLeaseExpenseNonCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfOS0xLTEtMS00NjMzNA_a0d48e5b-7b55-44fb-842c-a7dea5ace413">1,437</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="ccrn:OperatingLeaseExpenseNonCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfOS0zLTEtMS00NjMzNA_1137a8c7-7d79-483f-a54e-6362e4f58c69">1,866</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMTAtMS0xLTEtNDYzMzQ_96021f6f-74bf-4b68-9dfd-334fbe55bdd0">5,597</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMTAtMy0xLTEtNDYzMzQ_075c9b3d-cb9e-41db-9e8e-b97d1c55d508">2,070</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on early extinguishment of debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMTEtMS0xLTEtNDYzMzQ_2eebb0e1-d3ae-4ed4-a095-3f6c5c515da0">1,912</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMTEtMy0xLTEtNDYzMzQ_b74d917c-da54-4712-8eec-90cd988da813">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMTItMS0xLTEtNDYzMzQ_32a67d51-e2bf-4d00-9ca8-fc404a1f68d4">5,206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMTItMy0xLTEtNDYzMzQ_b8358571-12ef-425e-93af-a73f064a2d81">5,257</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-cash costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMTMtMS0xLTEtNDYzMzQ_d800fc6a-ddf3-4a29-98a0-cd2a0670bf47">64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMTMtMy0xLTEtNDYzMzQ_025881e3-bc93-4b19-a4fd-6eb69947a66d">833</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMTUtMS0xLTEtNDYzMzQ_2146f8b3-8ecd-4fc1-b0d9-43d5f4c6c320">127,003</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMTUtMy0xLTEtNDYzMzQ_77e9cb52-3943-493f-bcb3-e46e31b6c8e1">122,887</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMTYtMS0xLTEtNDYzMzQ_77674c47-cb86-4ce4-a834-27ddcc7b98e6">1,236</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMTYtMy0xLTEtNDYzMzQ_f0c450fd-2900-4615-bbd4-2bc186949103">259</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMTctMS0xLTEtNDYzMzQ_b931446a-3228-4a6f-a5f7-daacb6cadb2a">13,220</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMTctMy0xLTEtNDYzMzQ_a5a51d91-8eb6-440b-8ec8-1c2668b77c28">759</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMTgtMS0xLTEtNDYzMzQ_d163f48f-8488-4c7f-9b0c-56727e118fc2">87,156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMTgtMy0xLTEtNDYzMzQ_d90e96f8-6c5a-49c7-8652-bbd8aff41a5f">36,675</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" sign="-" name="ccrn:IncreaseDecreaseInOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMTktMS0xLTEtNDYzMzQ_b10fdbfd-c77c-454b-abac-6d41bbbd18f5">3,817</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" sign="-" name="ccrn:IncreaseDecreaseInOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMTktMy0xLTEtNDYzMzQ_8b83eee5-9409-4789-a75f-4a25abfb83e7">4,592</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMjAtMS0xLTEtNDYzMzQ_eaf13f87-598a-4fb4-98d7-a2e30c3605cd">735</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMjAtMy0xLTEtNDYzMzQ_b4abdf26-55ce-4c3c-8c40-6b6292308eb2">169</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMjEtMS0xLTEtNDYzMzQ_68ae6cc5-af60-4df5-ade2-90d1983b474a">129,730</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMjEtMy0xLTEtNDYzMzQ_f0d3d082-c353-43d8-bdb4-af65a032d0e6">12,253</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from investing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions, net of cash acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMjQtMS0xLTEtNDYzMzQ_1dfec5a4-7ed2-499b-8ddf-14b838a5415f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMjQtMy0xLTEtNDYzMzQ_a75091ae-112a-490f-88db-a47f5c762ded">24,470</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMjUtMS0xLTEtNDYzMzQ_2a0de595-1597-4b02-ad1c-73a8efa4cb6b">6,763</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMjUtMy0xLTEtNDYzMzQ_85cd5b01-7871-4161-80cf-7b2cef025659">4,890</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMjYtMS0xLTEtNDYzMzQ_81143c4c-a5aa-45b1-9be2-38640613560f">6,763</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMjYtMy0xLTEtNDYzMzQ_4a76099f-b789-43cc-8e28-3ad7f7128093">29,360</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from financing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from term loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSecuredDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMjktMS0xLTEtNDYzMzQ_3b9d1989-0655-4b50-983b-b7d9481123ee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMjktMy0xLTEtNDYzMzQ_931cd3df-1d30-45a8-b67d-463cee44f5c8">100,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal payments on term loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="us-gaap:RepaymentsOfSecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMzAtMS0xLTEtNDYzMzQ_76487915-ed7c-48aa-bba1-06808c0ae022">50,438</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="us-gaap:RepaymentsOfSecuredDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMzAtMy0xLTEtNDYzMzQ_9d454dab-0f28-4d88-b72d-b85ec0e1f312">250</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMzEtMS0xLTEtNDYzMzQ_6018d55a-0bc8-4b77-8d98-82dbc455b8ce">3,159</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMzEtMy0xLTEtNDYzMzQ_0f789b27-3b49-4bc2-abac-ff276397964f">4,573</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrowings under Senior Secured Asset-Based revolving credit facility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="us-gaap:ProceedsFromLongTermLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMzItMS0xLTEtNDYzMzQ_bee49ad5-fd15-4dc0-abc6-ed10aeeb4c24">1,275,808</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="us-gaap:ProceedsFromLongTermLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMzItMy0xLTEtNDYzMzQ_2d43c5fa-a3a9-47cd-b8b0-4ee8084991d3">288,467</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayments on Senior Secured Asset-Based revolving credit facility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="us-gaap:RepaymentsOfLongTermLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMzMtMS0xLTEtNDYzMzQ_d34b91b6-94f8-48da-83d2-9c5e5a3f5755">1,275,808</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="us-gaap:RepaymentsOfLongTermLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMzMtMy0xLTEtNDYzMzQ_985493c5-4237-4ac8-9d56-68bd45f27961">337,876</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for shares withheld for taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMzQtMS0xLTEtNDYzMzQ_50679674-451c-4580-a82b-6ad8edf296b0">5,267</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMzQtMy0xLTEtNDYzMzQ_6da060cf-c0cf-47b3-ab5e-0063cf94408f">2,230</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal payments on note payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="us-gaap:RepaymentsOfNotesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMzUtMS0xLTEtNDYzMzQ_c24cdc82-fa2d-4cc4-b888-9ab6d13b9a83">2,426</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="us-gaap:RepaymentsOfNotesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMzUtMy0xLTEtNDYzMzQ_0637c2c2-fe85-40e1-8391-bfa964e6c61c">2,426</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock repurchase and retirement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMzctMS0xLTEtNTAxOTQ_7974c1bf-c73e-45bd-a68c-b9452612c747">24,348</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMzctMy0xLTEtNTAxOTQ_9543af2d-110d-46ca-9450-049067893f29">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment of contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMzctMS0xLTEtNTE1ODk_d490fdd4-f666-4440-8175-d313fa58271b">7,500</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMzctMy0xLTEtNTE1ODk_823a94fb-a2df-4793-aca1-c76860cfcffd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMzctMS0xLTEtNDYzMzQ_d2fc1087-1d69-437e-80a3-516fd1e2c76b">536</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMzctMy0xLTEtNDYzMzQ_c3b7608a-e8f0-43d8-894c-d8d66eb65471">243</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash (used in) provided by financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMzgtMS0xLTEtNDYzMzQ_f155b602-08ba-48b9-b274-b5ffa421948b">93,674</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMzgtMy0xLTEtNDYzMzQ_e8225ed8-1dbf-4499-9592-f3604668818d">40,869</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfNDAtMS0xLTEtNDYzMzQ_5c1cfec7-f27e-4dcd-8912-e39270325ae8">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfNDAtMy0xLTEtNDYzMzQ_0670e5e5-2a00-47c8-8884-f89acb67a67b">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfNDEtMS0xLTEtNDYzMzQ_bb591d5e-68e6-40b3-879c-fdf22ffefc2f">29,284</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfNDEtMy0xLTEtNDYzMzQ_8903cb12-a448-467e-84dd-c65a358dbeda">758</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfNDItMS0xLTEtNDYzMzQ_f4851bfc-6f50-4f69-be32-654e2208dea2">1,036</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i119af728c7ce4ee8bb64043a29f00ca5_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfNDItMy0xLTEtNDYzMzQ_53150104-94bc-4dbf-914d-1e237636e3a9">1,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents at end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfNDMtMS0xLTEtNDYzMzQ_e6cc5810-aec9-4c71-9acc-a40c288defac">30,320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb81780210de40218de77358d91c73ba_I20210930" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfNDMtMy0xLTEtNDYzMzQ_fc93fb75-88e6-43bc-91a8-0c2da461ecab">842</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">                                                                                                                                                      </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to the condensed consolidated financial statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i5b47dd1c3d5a40ff8e040a94ae232d75_34"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CROSS COUNTRY HEALTHCARE, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)</span></div><div style="text-align:justify"><span><br/></span></div><div id="i5b47dd1c3d5a40ff8e040a94ae232d75_37"></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zNy9mcmFnOjhjYWYyYTQyZjhjYzQ2NDhhZDgwMDgyOGIwNzJjMWNiL3RleHRyZWdpb246OGNhZjJhNDJmOGNjNDY0OGFkODAwODI4YjA3MmMxY2JfMTYzMg_167000cc-1461-4551-befb-bd3534d67f77" continuedAt="i1cd5242990e44704aef6653978084713" escape="true">ORGANIZATION AND BASIS OF PRESENTATION</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i1cd5242990e44704aef6653978084713"><ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zNy9mcmFnOjhjYWYyYTQyZjhjYzQ2NDhhZDgwMDgyOGIwNzJjMWNiL3RleHRyZWdpb246OGNhZjJhNDJmOGNjNDY0OGFkODAwODI4YjA3MmMxY2JfMTYyNA_3059a92a-82d1-4c2c-87f6-faa908d520dc" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nature of Business</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements include the accounts of Cross Country Healthcare, Inc. and its direct and indirect wholly-owned subsidiaries (collectively, the Company). In the opinion of management, all adjustments necessary for a fair presentation of such unaudited condensed consolidated financial statements have been included. All such adjustments consisted of all normal recurring items, including the elimination of all intercompany transactions and balances.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cross Country Talent Acquisition Group, LLC was a joint venture controlled but not wholly-owned by the Company. Effective December 31, 2020, the sole professional staffing services agreement held by this joint venture was terminated and, as a result, the Company dissolved Cross Country Talent Acquisition Group, LLC in the third quarter of 2021.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zNy9mcmFnOjhjYWYyYTQyZjhjYzQ2NDhhZDgwMDgyOGIwNzJjMWNiL3RleHRyZWdpb246OGNhZjJhNDJmOGNjNDY0OGFkODAwODI4YjA3MmMxY2JfMTYyMQ_4001de67-6419-4737-8a8e-41341c897a9b" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (U.S. GAAP) for interim financial information and with the instructions to Form&#160;10-Q and Article 10 of Regulation&#160;S-X. Accordingly, they do not include all of the information and notes required by U.S. GAAP for complete financial statements. These operating results are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These unaudited interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended December 31, 2021 included in the 2021 Form 10-K. The December&#160;31, 2021 condensed consolidated balance sheet included herein was derived from the December&#160;31, 2021 audited consolidated balance sheet included in the 2021 Form&#160;10-K.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior year amounts have been reclassified to conform to the current year presentation. See the condensed consolidated balance sheets and statements of cash flows.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i5b47dd1c3d5a40ff8e040a94ae232d75_40"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RleHRyZWdpb246Y2FkODJmNTczYmFkNGUzNjg2YzhmZjFjYjY2MDVhNTZfNjc1Ng_5f564b1f-ba66-4573-baf8-24c659d6a09a" continuedAt="i7b75a116d69b4ec78eb8c83c1f7d3467" escape="true">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i7b75a116d69b4ec78eb8c83c1f7d3467" continuedAt="ibbac049f92d9431db7ecc957148d792c"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RleHRyZWdpb246Y2FkODJmNTczYmFkNGUzNjg2YzhmZjFjYjY2MDVhNTZfNjc3NA_3ef7e19a-96ad-45a4-b648-1771150b2f20" continuedAt="ida65be346b4646ef8996176c109c5be1" escape="true">Use of Estimates</ix:nonNumeric></span></div><div><span><br/></span></div><div><ix:continuation id="ida65be346b4646ef8996176c109c5be1" continuedAt="i90ba112db72f46709df7fd1d7fb77df5"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts in the condensed consolidated financial statements and accompanying notes. Management has assessed various accounting estimates and other matters, including those that require consideration of forecasted financial information, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in context of the unknown future impacts of the global COVID pandemic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> using information that is reasonably available to the Company at the time. Significant estimates and assumptions are used for, but not limited to: (i) the valuation of accounts receivable; (ii) goodwill, trade names, and other intangible assets; (iii) other long-lived assets; (iv) revenue recognition; (v) accruals for health, workers&#8217; compensation, and professional liability claims; (vi) valuation of deferred tax assets; (vii) legal contingencies; and (viii) income taxes. Accrued insurance claims and reserves include estimated settlements from known claims and actuarial estimates for claims incurred but not reported. As additional information becomes available to the Company, its future assessment of these estimates</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, including management's expectations at the time regarding the duration, scope, and severity of the pandemic, as well as other factors,</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i90ba112db72f46709df7fd1d7fb77df5"> could materially and adversely impact the Company's consolidated financial statements in future reporting periods. Actual results could differ from those estimates.</ix:continuation>  </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="ccrn:RisksAndUncertaintiesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RleHRyZWdpb246Y2FkODJmNTczYmFkNGUzNjg2YzhmZjFjYjY2MDVhNTZfMjE5OTAyMzI2NjU0Nw_fdc04ff6-d981-4156-b96e-4de948f0cb8c" escape="true"><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks and Uncertainties</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s future results of operations and liquidity could be materially adversely affected by macroeconomic factors contributing to delays in payments from clients and inflationary pressure, uncertain or reduced demand, and the impact of any initiatives or programs that the Company may undertake to address financial and operational challenges faced by its clients.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company is also subject to additional risks and uncertainties due to the ongoing COVID pandemic. The extent of the impact on the Company&#8217;s business is highly uncertain and difficult to predict.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="us-gaap:TradeAndOtherAccountsReceivablePolicy" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RleHRyZWdpb246Y2FkODJmNTczYmFkNGUzNjg2YzhmZjFjYjY2MDVhNTZfNjc1OA_09a1982e-fba2-4b7d-a603-b37d21abc2b5" continuedAt="if14e2fee5ae54b7f82559f7c68ebb7f6" escape="true"><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounts Receivable, net</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The timing of revenue recognition, billings, and collections results in billed and unbilled accounts receivable from customers, which are classified as accounts receivable on the condensed consolidated balance sheets and are presented net of allowances for doubtful accounts and sales allowances. Estimated revenue for the Company employees', subcontracted employees', and independent contractors&#8217; time worked but not yet billed at September 30, 2022 and December 31, 2021 totaled $<ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-5" name="us-gaap:UnbilledContractsReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RleHRyZWdpb246Y2FkODJmNTczYmFkNGUzNjg2YzhmZjFjYjY2MDVhNTZfMzY0Mg_603a1ea3-f48e-4448-9efd-38ea36b6ac0b">161.2</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231" decimals="-5" name="us-gaap:UnbilledContractsReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RleHRyZWdpb246Y2FkODJmNTczYmFkNGUzNjg2YzhmZjFjYjY2MDVhNTZfMzY0OQ_3377525d-063d-4ac4-b5e8-6877ece1299c">140.0</ix:nonFraction>&#160;million, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generally does not require collateral and mitigates its credit risk by performing credit evaluations and monitoring at-risk accounts. The allowance for doubtful accounts is established for losses expected to be incurred on accounts receivable balances. Accounts receivable are written off against the allowance for doubtful accounts when the Company determines amounts are no longer collectible. Judgment is required in the estimation of the allowance and the Company evaluates the collectability of its accounts receivable and contract assets based on a combination of factors. The Company bases its allowance for doubtful account estimates on its historical write-off experience, current conditions, an analysis of the aging of outstanding receivable and customer payment patterns, and specific reserves for customers in adverse condition adjusted for current expectations for the customers or industry. Based on the information currently available, the Company also considered current expectations of future economic condition</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s, including the impact of COVID, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">when estimating its allowance for doubtful accounts.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ibbac049f92d9431db7ecc957148d792c"><div><ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RleHRyZWdpb246Y2FkODJmNTczYmFkNGUzNjg2YzhmZjFjYjY2MDVhNTZfNjc3NQ_4b7e4932-c83e-4456-89ff-12cd43035f76" escape="true"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The opening balance of the allowance for doubtful accounts is reconciled to the closing balance for expected credit losses as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.422%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOmVkMWU0OTIyZjA3NzQyZmViNDJkYTQwMGJhN2Q3ODdmL3RhYmxlcmFuZ2U6ZWQxZTQ5MjJmMDc3NDJmZWI0MmRhNDAwYmE3ZDc4N2ZfNC0xLTEtMS00NjMzNA_fb40f234-2f4a-47c8-b80c-236139609c12">6,087</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i119af728c7ce4ee8bb64043a29f00ca5_I20201231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOmVkMWU0OTIyZjA3NzQyZmViNDJkYTQwMGJhN2Q3ODdmL3RhYmxlcmFuZ2U6ZWQxZTQ5MjJmMDc3NDJmZWI0MmRhNDAwYmE3ZDc4N2ZfNC0zLTEtMS00NjMzNA_fb35645c-96e8-45b0-bbad-3902ef1a1ea2">3,416</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bad Debt Expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i657bd17dcadf4f3f873d0850b774cdc3_D20220101-20220331" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOmVkMWU0OTIyZjA3NzQyZmViNDJkYTQwMGJhN2Q3ODdmL3RhYmxlcmFuZ2U6ZWQxZTQ5MjJmMDc3NDJmZWI0MmRhNDAwYmE3ZDc4N2ZfNS0xLTEtMS00NjMzNA_dec361cd-d77a-4b59-b423-04fd57978552">2,369</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie61694e1851449ffa2f39478d3d2f3ea_D20210101-20210331" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOmVkMWU0OTIyZjA3NzQyZmViNDJkYTQwMGJhN2Q3ODdmL3RhYmxlcmFuZ2U6ZWQxZTQ5MjJmMDc3NDJmZWI0MmRhNDAwYmE3ZDc4N2ZfNS0zLTEtMS00NjMzNA_185150ab-54f1-45b7-a808-0f8d2b090c49">504</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-Offs, net of Recoveries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i657bd17dcadf4f3f873d0850b774cdc3_D20220101-20220331" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOmVkMWU0OTIyZjA3NzQyZmViNDJkYTQwMGJhN2Q3ODdmL3RhYmxlcmFuZ2U6ZWQxZTQ5MjJmMDc3NDJmZWI0MmRhNDAwYmE3ZDc4N2ZfNi0xLTEtMS00NjMzNA_ee66e166-69b1-4b20-8fce-f6e832377af2">365</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie61694e1851449ffa2f39478d3d2f3ea_D20210101-20210331" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOmVkMWU0OTIyZjA3NzQyZmViNDJkYTQwMGJhN2Q3ODdmL3RhYmxlcmFuZ2U6ZWQxZTQ5MjJmMDc3NDJmZWI0MmRhNDAwYmE3ZDc4N2ZfNi0zLTEtMS00NjMzNA_0f1f3510-eca2-4930-82f2-c953a53e0238">699</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc853726046a4b378bd788e398d13c55_I20220331" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOmVkMWU0OTIyZjA3NzQyZmViNDJkYTQwMGJhN2Q3ODdmL3RhYmxlcmFuZ2U6ZWQxZTQ5MjJmMDc3NDJmZWI0MmRhNDAwYmE3ZDc4N2ZfNy0xLTEtMS00NjMzNA_9eb26b63-1eea-4e54-960e-e6c4b4fddab9">8,091</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6501a0fcaad471fa6d6fbf55f3864ae_I20210331" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOmVkMWU0OTIyZjA3NzQyZmViNDJkYTQwMGJhN2Q3ODdmL3RhYmxlcmFuZ2U6ZWQxZTQ5MjJmMDc3NDJmZWI0MmRhNDAwYmE3ZDc4N2ZfNy0zLTEtMS00NjMzNA_99e506f4-ff84-4a4a-9c25-140e1a8cd3fe">3,221</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bad Debt Expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i320641181a3f49a494c3423b25911ae6_D20220401-20220630" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOmVkMWU0OTIyZjA3NzQyZmViNDJkYTQwMGJhN2Q3ODdmL3RhYmxlcmFuZ2U6ZWQxZTQ5MjJmMDc3NDJmZWI0MmRhNDAwYmE3ZDc4N2ZfOC0xLTEtMS00NjMzNA_ca2b8292-9e7c-4c26-9a8b-ce27dfa6ff22">3,192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie812f572e01c4d7abf8b2fd4eddf3b89_D20210401-20210630" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOmVkMWU0OTIyZjA3NzQyZmViNDJkYTQwMGJhN2Q3ODdmL3RhYmxlcmFuZ2U6ZWQxZTQ5MjJmMDc3NDJmZWI0MmRhNDAwYmE3ZDc4N2ZfOC0zLTEtMS00NjMzNA_7f60c10c-7686-4612-87a9-22f346e20914">466</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-Offs, net of Recoveries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i320641181a3f49a494c3423b25911ae6_D20220401-20220630" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOmVkMWU0OTIyZjA3NzQyZmViNDJkYTQwMGJhN2Q3ODdmL3RhYmxlcmFuZ2U6ZWQxZTQ5MjJmMDc3NDJmZWI0MmRhNDAwYmE3ZDc4N2ZfOS0xLTEtMS00NjMzNA_d9bfde2a-eadb-4c82-bd63-041857c8eacc">426</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie812f572e01c4d7abf8b2fd4eddf3b89_D20210401-20210630" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOmVkMWU0OTIyZjA3NzQyZmViNDJkYTQwMGJhN2Q3ODdmL3RhYmxlcmFuZ2U6ZWQxZTQ5MjJmMDc3NDJmZWI0MmRhNDAwYmE3ZDc4N2ZfOS0zLTEtMS00NjMzNA_52a79295-bc76-4c75-b092-6476a23f83f6">358</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c0a4267d8174093be4955cfd3a6d031_I20220630" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOmVkMWU0OTIyZjA3NzQyZmViNDJkYTQwMGJhN2Q3ODdmL3RhYmxlcmFuZ2U6ZWQxZTQ5MjJmMDc3NDJmZWI0MmRhNDAwYmE3ZDc4N2ZfMTAtMS0xLTEtNDYzMzQ_c05c0d4d-b252-4c29-aa66-f9867ccc99d4">10,857</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61328c0ca95341349cdc1ca533a6d2bf_I20210630" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOmVkMWU0OTIyZjA3NzQyZmViNDJkYTQwMGJhN2Q3ODdmL3RhYmxlcmFuZ2U6ZWQxZTQ5MjJmMDc3NDJmZWI0MmRhNDAwYmE3ZDc4N2ZfMTAtMy0xLTEtNDYzMzQ_07204eb3-032a-4b81-8ab0-ce0cd8a5a454">3,329</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bad Debt Expense</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOmVkMWU0OTIyZjA3NzQyZmViNDJkYTQwMGJhN2Q3ODdmL3RhYmxlcmFuZ2U6ZWQxZTQ5MjJmMDc3NDJmZWI0MmRhNDAwYmE3ZDc4N2ZfMTEtMS0xLTEtNDYzMzQ_fc24622a-45cd-43b1-aa51-d879b7c60137">1,101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOmVkMWU0OTIyZjA3NzQyZmViNDJkYTQwMGJhN2Q3ODdmL3RhYmxlcmFuZ2U6ZWQxZTQ5MjJmMDc3NDJmZWI0MmRhNDAwYmE3ZDc4N2ZfMTEtMy0xLTEtNDYzMzQ_69a99f75-7795-4287-8828-b5f969d05111">1,441</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-Offs, net of Recoveries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOmVkMWU0OTIyZjA3NzQyZmViNDJkYTQwMGJhN2Q3ODdmL3RhYmxlcmFuZ2U6ZWQxZTQ5MjJmMDc3NDJmZWI0MmRhNDAwYmE3ZDc4N2ZfMTItMS0xLTEtNDYzMzQ_3ff66520-baed-432c-87d6-b15510179cb5">593</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOmVkMWU0OTIyZjA3NzQyZmViNDJkYTQwMGJhN2Q3ODdmL3RhYmxlcmFuZ2U6ZWQxZTQ5MjJmMDc3NDJmZWI0MmRhNDAwYmE3ZDc4N2ZfMTItMy0xLTEtNDYzMzQ_16acbf68-7a95-47a1-b925-0a005aec744c">138</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOmVkMWU0OTIyZjA3NzQyZmViNDJkYTQwMGJhN2Q3ODdmL3RhYmxlcmFuZ2U6ZWQxZTQ5MjJmMDc3NDJmZWI0MmRhNDAwYmE3ZDc4N2ZfMTMtMS0xLTEtNDYzMzQ_ad5d9e6e-137f-493b-9382-e74c6e213d60">11,365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb81780210de40218de77358d91c73ba_I20210930" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOmVkMWU0OTIyZjA3NzQyZmViNDJkYTQwMGJhN2Q3ODdmL3RhYmxlcmFuZ2U6ZWQxZTQ5MjJmMDc3NDJmZWI0MmRhNDAwYmE3ZDc4N2ZfMTMtMy0xLTEtNDYzMzQ_c354458f-aebe-4781-aa88-ea799bc42378">4,632</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if14e2fee5ae54b7f82559f7c68ebb7f6" continuedAt="i244ae3ef8b2743cdb8bb417d33845adb">In addition to the allowance for doubtful accounts, the Company maintains a sales allowance for billing-related adjustments which may arise in the ordinary course of business and adjustments to the reserve are recorded as contra-revenue. The balance of this allowance as of September 30, 2022 and December 31, 2021 was $<ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-5" name="ccrn:SalesAllowanceBillingRelatedAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RleHRyZWdpb246Y2FkODJmNTczYmFkNGUzNjg2YzhmZjFjYjY2MDVhNTZfNTI0OA_75f706b3-f9c5-47d8-a4c0-03c4e6e241d9">1.4</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231" decimals="-5" name="ccrn:SalesAllowanceBillingRelatedAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RleHRyZWdpb246Y2FkODJmNTczYmFkNGUzNjg2YzhmZjFjYjY2MDVhNTZfNTI1NQ_2f6c1442-dcc6-41fc-9a57-8553887e7e8c">0.8</ix:nonFraction>&#160;million, respectively.</ix:continuation></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i244ae3ef8b2743cdb8bb417d33845adb">The Company&#8217;s contract terms typically require payment between <ix:nonNumeric contextRef="i95a7cda144014872b12df15aa0c33624_D20220101-20220930" name="ccrn:ThresholdPeriodPastDueForPaymentOfServicesProvided" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RleHRyZWdpb246Y2FkODJmNTczYmFkNGUzNjg2YzhmZjFjYjY2MDVhNTZfNTMzNw_73ae9213-c8ef-43b2-90bb-273b221386b6">30</ix:nonNumeric> to <ix:nonNumeric contextRef="i5982bacc53f943e49e2bf300695325b5_D20220101-20220930" name="ccrn:ThresholdPeriodPastDueForPaymentOfServicesProvided" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RleHRyZWdpb246Y2FkODJmNTczYmFkNGUzNjg2YzhmZjFjYjY2MDVhNTZfNTM0Mw_02c099e8-7c53-4760-bd78-6ac74680e975">60</ix:nonNumeric> days from the date of invoice and are considered past due based on the particular negotiated contract terms. The majority of the Company's customers are U.S. based healthcare systems with a significant percentage in acute-care facilities.</ix:continuation> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No single customer accounted for more than 10% of the Company&#8217;s revenue for the three and nine months ended September 30, 2022 and 2021, or the accounts receivable balance as of September 30, 2022 and December 31, 2021.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RleHRyZWdpb246Y2FkODJmNTczYmFkNGUzNjg2YzhmZjFjYjY2MDVhNTZfNjc2OQ_ac04026c-6aa4-4302-8e1f-b4a790d05879" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restructuring Costs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers restructuring activities to be programs whereby it fundamentally changes its operations, such as closing and consolidating facilities, reducing headcount, and realigning operations in response to changing market conditions. As a result, restructuring (benefits) costs on the condensed consolidated statements of operations primarily include employee termination costs and lease-related exit costs.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RleHRyZWdpb246Y2FkODJmNTczYmFkNGUzNjg2YzhmZjFjYjY2MDVhNTZfNjc2OA_2ec61189-6630-49d1-9f72-aff80b59bbd7" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reconciliation of the employee termination costs and lease-related exit costs (benefits) beginning and ending liability balance is presented below:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:50.437%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.593%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.728%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.742%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Employee Termination</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lease-Related</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c3d33c67aba46cb8fc17a6c9810c45e_I20211231" decimals="-3" name="us-gaap:RestructuringReserve" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOjljMGQ5ZDAzNWVlMDQyNjI4ODA1NzY0MDkyNzMwODNkL3RhYmxlcmFuZ2U6OWMwZDlkMDM1ZWUwNDI2Mjg4MDU3NjQwOTI3MzA4M2RfMy0xLTEtMS00NjMzNA_38c2951b-a17f-49cc-8c02-348f03756cb0">160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57398b99b0b54c5392ab2d17dc37cf50_I20211231" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOjljMGQ5ZDAzNWVlMDQyNjI4ODA1NzY0MDkyNzMwODNkL3RhYmxlcmFuZ2U6OWMwZDlkMDM1ZWUwNDI2Mjg4MDU3NjQwOTI3MzA4M2RfMy0zLTEtMS00NjMzNA_7de54ff9-79da-4eca-b8d6-40f1b60be429">2,423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charged to restructuring</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if703479963674b69a8f48728a5151e98_D20220101-20220331" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOjljMGQ5ZDAzNWVlMDQyNjI4ODA1NzY0MDkyNzMwODNkL3RhYmxlcmFuZ2U6OWMwZDlkMDM1ZWUwNDI2Mjg4MDU3NjQwOTI3MzA4M2RfNC0xLTEtMS00NjMzNA_8a828ee3-08ab-4e9b-8bed-f49b78238489">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic15931a9518a4f40ad076daec66714fd_D20220101-20220331" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOjljMGQ5ZDAzNWVlMDQyNjI4ODA1NzY0MDkyNzMwODNkL3RhYmxlcmFuZ2U6OWMwZDlkMDM1ZWUwNDI2Mjg4MDU3NjQwOTI3MzA4M2RfNC0zLTEtMS00NjMzNA_a69c94da-e541-480a-af42-05a710f5f111">389</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments and adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if703479963674b69a8f48728a5151e98_D20220101-20220331" decimals="-3" name="ccrn:PaymentsForRestructuringAndAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOjljMGQ5ZDAzNWVlMDQyNjI4ODA1NzY0MDkyNzMwODNkL3RhYmxlcmFuZ2U6OWMwZDlkMDM1ZWUwNDI2Mjg4MDU3NjQwOTI3MzA4M2RfNS0xLTEtMS00NjMzNA_1b90be6b-aa76-4bd1-80d0-30d24ad8680a">160</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic15931a9518a4f40ad076daec66714fd_D20220101-20220331" decimals="-3" name="ccrn:PaymentsForRestructuringAndAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOjljMGQ5ZDAzNWVlMDQyNjI4ODA1NzY0MDkyNzMwODNkL3RhYmxlcmFuZ2U6OWMwZDlkMDM1ZWUwNDI2Mjg4MDU3NjQwOTI3MzA4M2RfNS0zLTEtMS00NjMzNA_926d9115-04df-471b-bfd8-d0d7128ece85">192</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2022</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e32834817d9496dad1cbdc249093f30_I20220331" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOjljMGQ5ZDAzNWVlMDQyNjI4ODA1NzY0MDkyNzMwODNkL3RhYmxlcmFuZ2U6OWMwZDlkMDM1ZWUwNDI2Mjg4MDU3NjQwOTI3MzA4M2RfNi0xLTEtMS00NjMzNA_3b83b965-2e56-4edd-a2a9-532e65f935c3">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73c497336ca74c4cb8a55c150456d5e0_I20220331" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOjljMGQ5ZDAzNWVlMDQyNjI4ODA1NzY0MDkyNzMwODNkL3RhYmxlcmFuZ2U6OWMwZDlkMDM1ZWUwNDI2Mjg4MDU3NjQwOTI3MzA4M2RfNi0zLTEtMS00NjMzNA_cf780e78-8508-42b2-97f5-362147a44d97">2,620</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charged to restructuring</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91f31431ce5340419942d52145b80cc7_D20220401-20220630" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOjljMGQ5ZDAzNWVlMDQyNjI4ODA1NzY0MDkyNzMwODNkL3RhYmxlcmFuZ2U6OWMwZDlkMDM1ZWUwNDI2Mjg4MDU3NjQwOTI3MzA4M2RfNy0xLTEtMS00NjMzNA_2d749ebe-fd56-4c97-8bcb-6d741e9a8b62">200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i443dd9fb273b4d53a90b0b46a22ab602_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOjljMGQ5ZDAzNWVlMDQyNjI4ODA1NzY0MDkyNzMwODNkL3RhYmxlcmFuZ2U6OWMwZDlkMDM1ZWUwNDI2Mjg4MDU3NjQwOTI3MzA4M2RfNy0zLTEtMS00NjMzNA_cf05c471-efe1-40f0-aeea-332b17bdd866">1,379</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91f31431ce5340419942d52145b80cc7_D20220401-20220630" decimals="-3" name="us-gaap:PaymentsForRestructuring" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOjljMGQ5ZDAzNWVlMDQyNjI4ODA1NzY0MDkyNzMwODNkL3RhYmxlcmFuZ2U6OWMwZDlkMDM1ZWUwNDI2Mjg4MDU3NjQwOTI3MzA4M2RfOC0xLTEtMS00NjMzNA_11e36b08-3e82-4c9a-b6b1-616eb6457b67">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i443dd9fb273b4d53a90b0b46a22ab602_D20220401-20220630" decimals="-3" name="us-gaap:PaymentsForRestructuring" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOjljMGQ5ZDAzNWVlMDQyNjI4ODA1NzY0MDkyNzMwODNkL3RhYmxlcmFuZ2U6OWMwZDlkMDM1ZWUwNDI2Mjg4MDU3NjQwOTI3MzA4M2RfOC0zLTEtMS00NjMzNA_c1da0dea-479b-465e-86f7-31eeb7da002d">202</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3adac1127fa4edf8e0147861c16ad9b_I20220630" decimals="-3" name="us-gaap:RestructuringReserve" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOjljMGQ5ZDAzNWVlMDQyNjI4ODA1NzY0MDkyNzMwODNkL3RhYmxlcmFuZ2U6OWMwZDlkMDM1ZWUwNDI2Mjg4MDU3NjQwOTI3MzA4M2RfOS0xLTEtMS00NjMzNA_81d0bd06-fd5c-40fc-8307-442960a7ecd2">200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bc6735e5214a54a2a33460e10c2956_I20220630" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOjljMGQ5ZDAzNWVlMDQyNjI4ODA1NzY0MDkyNzMwODNkL3RhYmxlcmFuZ2U6OWMwZDlkMDM1ZWUwNDI2Mjg4MDU3NjQwOTI3MzA4M2RfOS0zLTEtMS00NjMzNA_3f6c47b9-9e6a-485b-b6f4-ad672521e086">1,039</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charged to restructuring</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5db7b078db0441d0a155ca8727612378_D20220701-20220930" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOjljMGQ5ZDAzNWVlMDQyNjI4ODA1NzY0MDkyNzMwODNkL3RhYmxlcmFuZ2U6OWMwZDlkMDM1ZWUwNDI2Mjg4MDU3NjQwOTI3MzA4M2RfMTAtMS0xLTEtNDYzMzQ_681b05e0-7a0a-44b3-9bd1-09b603615c2f">735</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5f07aa56cb14c10aa23331198ec4f7c_D20220701-20220930" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOjljMGQ5ZDAzNWVlMDQyNjI4ODA1NzY0MDkyNzMwODNkL3RhYmxlcmFuZ2U6OWMwZDlkMDM1ZWUwNDI2Mjg4MDU3NjQwOTI3MzA4M2RfMTAtMy0xLTEtNDYzMzQ_4d85632c-a9d6-43e0-b60e-7b0b67bf8861">1,755</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5db7b078db0441d0a155ca8727612378_D20220701-20220930" decimals="-3" name="us-gaap:PaymentsForRestructuring" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOjljMGQ5ZDAzNWVlMDQyNjI4ODA1NzY0MDkyNzMwODNkL3RhYmxlcmFuZ2U6OWMwZDlkMDM1ZWUwNDI2Mjg4MDU3NjQwOTI3MzA4M2RfMTEtMS0xLTEtNDYzMzQ_c151836b-72e8-4cf1-bf6c-5b1d90390b50">24</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5f07aa56cb14c10aa23331198ec4f7c_D20220701-20220930" decimals="-3" name="us-gaap:PaymentsForRestructuring" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOjljMGQ5ZDAzNWVlMDQyNjI4ODA1NzY0MDkyNzMwODNkL3RhYmxlcmFuZ2U6OWMwZDlkMDM1ZWUwNDI2Mjg4MDU3NjQwOTI3MzA4M2RfMTEtMy0xLTEtNDYzMzQ_b388c268-1b6b-4e0a-af76-4f06fbe3b051">254</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i181005f5e3c34e41a45e7b5a7e5a9e66_I20220930" decimals="-3" name="us-gaap:RestructuringReserve" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOjljMGQ5ZDAzNWVlMDQyNjI4ODA1NzY0MDkyNzMwODNkL3RhYmxlcmFuZ2U6OWMwZDlkMDM1ZWUwNDI2Mjg4MDU3NjQwOTI3MzA4M2RfMTItMS0xLTEtNDYzMzQ_b6257be4-41c7-4f8a-a9bd-7392f70808fa">911</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i869ddd0d1a6943ae82d12eccf68afcde_I20220930" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOjljMGQ5ZDAzNWVlMDQyNjI4ODA1NzY0MDkyNzMwODNkL3RhYmxlcmFuZ2U6OWMwZDlkMDM1ZWUwNDI2Mjg4MDU3NjQwOTI3MzA4M2RfMTItMy0xLTEtNDYzMzQ_c5cbddef-0610-4928-9f4b-60357fac1219">2,540</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Restructuring costs in the condensed consolidated statements of operations for the nine months ended September 30, 2022 include a benefit of $<ix:nonFraction unitRef="usd" contextRef="i320641181a3f49a494c3423b25911ae6_D20220401-20220630" decimals="-5" name="us-gaap:BusinessExitCosts1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RleHRyZWdpb246Y2FkODJmNTczYmFkNGUzNjg2YzhmZjFjYjY2MDVhNTZfNjU2NA_264c035a-4365-4de8-af58-4541400c0aaa">1.4</ix:nonFraction>&#160;million in the second quarter of 2022 associated with the early termination of the lease for one of the Company's corporate offices which was previously restructured.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="i5b47dd1c3d5a40ff8e040a94ae232d75_43"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RleHRyZWdpb246YThhNmQ2MWIwZDdiNDczOTg3ODIyMmE3ZWQ5NTc4ZjZfMzk0_f7290d4b-20e8-46ce-a724-e62d3fc85d7d" continuedAt="id9c5226bf68b41c3bc6767326f18aa0b" escape="true">REVENUE RECOGNITION</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="id9c5226bf68b41c3bc6767326f18aa0b" continuedAt="ic913d0c902c04e2090ada2f7337b6fd6"><ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RleHRyZWdpb246YThhNmQ2MWIwZDdiNDczOTg3ODIyMmE3ZWQ5NTc4ZjZfMzk1_d845c157-3952-4f94-9f68-24d48ccbe7a6" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's revenues from customer contracts are generated from temporary staffing services and other services. Revenue is disaggregated by segment in the following table. Sales and usage-based taxes are excluded from revenue.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.961%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months ended September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nurse<br/>And Allied<br/>Staffing</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Physician<br/>Staffing</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Segments</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Temporary Staffing Services</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20197ff1c85d452da87fc706b7d58649_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfMy0xLTEtMS00NjMzNA_f4263f34-6e99-4850-a767-ef9622c0abab">592,398</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fe76aa84e634f068c08458605422754_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfMy0zLTEtMS00NjMzNA_c164996d-28b2-454f-8654-0162a8338e56">22,811</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ae604777193442b9bf2a6f5b9f7aae1_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfMy03LTEtMS00NjMzNA_e829eaa6-ead5-47e5-8592-fc4935adb464">615,209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic24c88a8321b4d8dba9854a06196bffe_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfNC0xLTEtMS00NjMzNA_1002b7e7-23cd-46b0-8514-6ee38a1d5f2b">19,872</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27fae63222bc430e9e3478596f2ad536_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfNC0zLTEtMS00NjMzNA_ef19db21-c45b-4097-b56e-a1b2891596dc">1,017</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i873a486d6fa84b97a6f676f640c8635e_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfNC03LTEtMS00NjMzNA_eafbba53-d9c8-435a-8b9d-b5991a916156">20,889</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i755b00d6551346d08633c51f6fffcbd4_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfNS0xLTEtMS00NjMzNA_078b9d65-d223-4cc4-96e8-1c747693896a">612,270</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60312c6dd2494d66bf19248b38166eaf_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfNS0zLTEtMS00NjMzNA_8b095d0d-7a9e-4ad1-8a36-764524f837a5">23,828</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfNS03LTEtMS00NjMzNA_eef5f7eb-5603-4451-8d01-1510aa1980a7">636,098</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nurse<br/>And Allied<br/>Staffing</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Physician<br/>Staffing</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Segments</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Temporary Staffing Services</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bb46cc7c58c478889fb6b980f9b2f4d_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfMTAtMS0xLTEtNDYzMzQ_b1a10933-8981-4199-aae2-7e492a7399ec">347,115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0348b7044e44bc5bb758dc707fdab77_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfMTAtMy0xLTEtNDYzMzQ_393f3112-a9d5-4654-a682-cbb5d5f51345">18,055</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6ef97c37f2146c5ba8dfa5c5720ad24_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfMTAtNy0xLTEtNDYzMzQ_668ffb59-1cbe-4530-918a-46b132061b5c">365,170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44f9d44db6904ef587268af1cde4de4f_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfMTEtMS0xLTEtNDYzMzQ_4429d394-b402-412d-834c-6c0e639a93a3">9,024</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e5ea3b7faeb44c297e0371081833165_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfMTEtMy0xLTEtNDYzMzQ_f88c9991-251b-49cb-b194-37b482380616">711</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i970c8a42e53c487fae9182764d96ad09_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfMTEtNy0xLTEtNDYzMzQ_5b416a8b-fa27-412f-b2f3-b9abd90fb301">9,735</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15f558e83a4a479e8674ab636a78ba79_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfMTItMS0xLTEtNDYzMzQ_7da464fe-2a25-4310-af36-92d8f9173da4">356,139</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibeef5c5a5e6e4d08b2e5036ccd0186a0_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfMTItMy0xLTEtNDYzMzQ_7cc3dd97-0864-4bbd-a9b8-71e36b6d30f6">18,766</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfMTItNy0xLTEtNDYzMzQ_5bd3514c-e8a0-458b-bfc8-f039a0a5c8bf">374,905</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">  Nine Months ended September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nurse<br/>And Allied<br/>Staffing</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Physician<br/>Staffing</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Segments</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Temporary Staffing Services</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a40960a329848b3b4404d32532a0aed_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfMTctMS0xLTEtNDYzMzQ_06259539-37b6-407d-bd8f-d9c3ab69b55d">2,053,935</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideb77c0531ff491fa1c4616654d0b2ba_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfMTctMy0xLTEtNDYzMzQ_cd34e384-46b9-4864-b626-9b3d66742953">66,122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i525c2bf9e1cf47589d1b503039abb3a7_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfMTctNy0xLTEtNDYzMzQ_0a0a7cfe-f101-42fa-bd44-c8d8a4decfcf">2,120,057</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bed4acdcaa54423bb59a2fc3eeb6cce_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfMTgtMS0xLTEtNDYzMzQ_ff5004dc-ee88-4e66-a29c-c702e3dfa9e1">55,358</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifea86757fdc544f2b14e84330796599b_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfMTgtMy0xLTEtNDYzMzQ_3eee3b4c-4f4b-4d8c-afa6-82fc1a96f7f7">2,976</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bb8473f28b40109171e65f44dcded9_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfMTgtNy0xLTEtNDYzMzQ_bcefdc76-5b06-4c61-8a5b-b5212d8d1d0c">58,334</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7aaf74b211ba45b9bea92196b8c48cd7_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfMTktMS0xLTEtNDYzMzQ_cd03bc9e-4340-4a71-9581-02a23877f809">2,109,293</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4be1f35efe045ebabfe8d9154e1c3cb_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfMTktMy0xLTEtNDYzMzQ_5487e4bd-fea3-4a59-b336-329d7fe93e04">69,098</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfMTktNy0xLTEtNDYzMzQ_0cad15b4-5be1-4655-8027-938bed68eb30">2,178,391</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> Nine Months ended September 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nurse<br/>And Allied<br/>Staffing</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Physician<br/>Staffing</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Segments</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Temporary Staffing Services</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i108501803abb4e229cf67a62dd7cd7ae_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfMjQtMS0xLTEtNDYzMzQ_3585a06b-bac3-412f-a853-05461f9432e0">961,608</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib62929d26b494926b11bb88b62b6ef78_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfMjQtMy0xLTEtNDYzMzQ_d91b7d4d-0696-49a5-a37d-419adad4a05d">48,534</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebb1b15335074656a1c0ac1d3c9f6eb6_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfMjQtNy0xLTEtNDYzMzQ_5fd3b808-f053-4077-9331-3a8d7f34f705">1,010,142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib20154f39f37474fa466a1c719e5b181_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfMjUtMS0xLTEtNDYzMzQ_cda63440-32a0-4cce-9a59-646ffc92b6ca">23,727</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i375deb87100c4072a7f2a5d3d9e2e846_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfMjUtMy0xLTEtNDYzMzQ_a44e3dcb-ba3d-4e99-919e-0ce80ddfdf91">2,104</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f29bfe22ab24268b44e0608ba26a4ad_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfMjUtNy0xLTEtNDYzMzQ_e70fe885-f3d1-45be-9aac-76a10afe3d5f">25,831</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id76ab6905df5463b9046aaf30a35075d_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfMjYtMS0xLTEtNDYzMzQ_607c713f-6f95-4ff9-99ab-b9714c452398">985,335</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c425883600f44a6aedb244f1adafb03_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfMjYtMy0xLTEtNDYzMzQ_52f03c29-9c35-4666-ae46-eb326cf43508">50,638</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfMjYtNy0xLTEtNDYzMzQ_515361ae-1c6b-4ce8-a093-4a4f7cd62791">1,035,973</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">     </span></div></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic913d0c902c04e2090ada2f7337b6fd6">See Note 12 - Segment Data.</ix:continuation>                                                                                                </span></div><div><span><br/></span></div><div id="i5b47dd1c3d5a40ff8e040a94ae232d75_46"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RleHRyZWdpb246YmQ5M2Y5MWY0NzRlNGMzMzgxZGRlNjE0MDVlMjdlZWNfMzcwMw_0c1a40f6-9710-4f1e-b82b-44804ec5139f" continuedAt="if0fa55355fd746c2a5525ddff8b4fe31" escape="true">ACQUISITIONS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="if0fa55355fd746c2a5525ddff8b4fe31" continuedAt="i288afb8c3e094e84b457e5f1c2630369"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selected</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 16, 2021, the Company purchased and acquired substantially all of the assets and assumed certain liabilities of Selected, Inc. (Selected) for a purchase price of $<ix:nonFraction unitRef="usd" contextRef="ia84d03e68bab4f9592492ba9084b94f0_D20211216-20211216" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RleHRyZWdpb246YmQ5M2Y5MWY0NzRlNGMzMzgxZGRlNjE0MDVlMjdlZWNfMjA2_19665828-a092-47c2-a522-ee88cfa683f0">3.5</ix:nonFraction>&#160;million in cash, subject to adjustment, and $<ix:nonFraction unitRef="usd" contextRef="ia84d03e68bab4f9592492ba9084b94f0_D20211216-20211216" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RleHRyZWdpb246YmQ5M2Y5MWY0NzRlNGMzMzgxZGRlNjE0MDVlMjdlZWNfMjQ1_47c9d87f-ec40-4d88-b6f6-fa02454b9566">1.5</ix:nonFraction>&#160;million in shares (or <ix:nonFraction unitRef="shares" contextRef="ia84d03e68bab4f9592492ba9084b94f0_D20211216-20211216" decimals="INF" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RleHRyZWdpb246YmQ5M2Y5MWY0NzRlNGMzMzgxZGRlNjE0MDVlMjdlZWNfMjYy_58ffc5be-cbc8-477e-becc-d14aa9fa86ab">59,429</ix:nonFraction> shares) of the Company's common stock. The transaction was treated as a purchase of assets for income tax purposes. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The sellers were eligible to receive up to an additional $<ix:nonFraction unitRef="usd" contextRef="iab7b6d3f615249b3813ea0de2e0a5b00_I20211216" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RleHRyZWdpb246YmQ5M2Y5MWY0NzRlNGMzMzgxZGRlNjE0MDVlMjdlZWNfNDQw_25a97c04-0570-4037-9d6e-01862a070611">1.5</ix:nonFraction>&#160;million in earnout cash consideration, based on Selected's revenues for each of the twelve-month periods ending on the first and second anniversaries of the first day after the closing date. In the </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i288afb8c3e094e84b457e5f1c2630369" continuedAt="i47a4e32f8c0946e7930f32a18b2061c5"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">second quarter of 2022, the Company determined that the contingent consideration earnout related to the Selected acquisition would not be achieved for 2022 and 2023 and, as a result, the entire liability was reversed. See Note 10 - Fair Value Measurements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assigned the following values to other identifiable intangible assets: (i) an <ix:nonFraction unitRef="usd" contextRef="ide7cad6e03e54feaafb84434e9dee12b_I20211216" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RleHRyZWdpb246YmQ5M2Y5MWY0NzRlNGMzMzgxZGRlNjE0MDVlMjdlZWNfOTgx_7f621107-a306-4984-8004-c5634e509c94">immaterial</ix:nonFraction> amount to trade names with a weighted average estimated useful life of <ix:nonNumeric contextRef="i86b3f925edb2419baa7dc8060115c5af_D20211216-20211216" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RleHRyZWdpb246YmQ5M2Y5MWY0NzRlNGMzMzgxZGRlNjE0MDVlMjdlZWNfMzY5Ng_3b6e3757-4538-4983-9f3e-0f11bfb5d72e">2</ix:nonNumeric> years; (ii) $<ix:nonFraction unitRef="usd" contextRef="i52e3ba7395c24be49c40b9fc7a7fe5c3_I20211216" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RleHRyZWdpb246YmQ5M2Y5MWY0NzRlNGMzMzgxZGRlNjE0MDVlMjdlZWNfMTA3MA_046ed0ec-5888-46b6-83a6-6e68771cb5d0">1.7</ix:nonFraction>&#160;million to software with a weighted average estimated useful life of <ix:nonNumeric contextRef="i3eb40c4ead40484d99ab7accabf6eb87_D20211216-20211216" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RleHRyZWdpb246YmQ5M2Y5MWY0NzRlNGMzMzgxZGRlNjE0MDVlMjdlZWNfMzY5OA_933b0de2-fadb-4afd-aeb4-406e42d5bcee">5</ix:nonNumeric> years; and (iii) $<ix:nonFraction unitRef="usd" contextRef="i5a4b1bc6463449928078dc019cd5ef53_I20211216" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RleHRyZWdpb246YmQ5M2Y5MWY0NzRlNGMzMzgxZGRlNjE0MDVlMjdlZWNfMTE1NA_a186898b-4016-43a3-929d-181ccec434e1">2.9</ix:nonFraction>&#160;million to a database, consisting of education professionals, with a weighted average estimated useful life of <ix:nonNumeric contextRef="i096a7bcfbf9b4f69a384857b9b34921a_D20211216-20211216" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RleHRyZWdpb246YmQ5M2Y5MWY0NzRlNGMzMzgxZGRlNjE0MDVlMjdlZWNfMzcwMA_cbcf1a77-5292-42f4-bf86-5fe1dc0c4467">5</ix:nonNumeric> years, for a total of $<ix:nonFraction unitRef="usd" contextRef="iab7b6d3f615249b3813ea0de2e0a5b00_I20211216" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RleHRyZWdpb246YmQ5M2Y5MWY0NzRlNGMzMzgxZGRlNjE0MDVlMjdlZWNfMTI4NQ_15f3aa59-56ec-48cc-973d-b944f0c77011">4.6</ix:nonFraction>&#160;million in definite life intangible assets with a weighted average estimated useful life of <ix:nonNumeric contextRef="ia84d03e68bab4f9592492ba9084b94f0_D20211216-20211216" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RleHRyZWdpb246YmQ5M2Y5MWY0NzRlNGMzMzgxZGRlNjE0MDVlMjdlZWNfMzcwMQ_0cef6f58-18a5-4864-9ccd-f55e9f2a5104">5</ix:nonNumeric> years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The remaining excess purchase price over the fair value of net assets acquired of $<ix:nonFraction unitRef="usd" contextRef="iab7b6d3f615249b3813ea0de2e0a5b00_I20211216" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RleHRyZWdpb246YmQ5M2Y5MWY0NzRlNGMzMzgxZGRlNjE0MDVlMjdlZWNfMTQ2NQ_85ea9a87-b3f6-4c90-ae2e-a54598915503">0.4</ix:nonFraction>&#160;million was recorded as goodwill on the Company's condensed consolidated balance sheets. See Note 7 - Goodwill, Trade Names, and Other Intangible Assets. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisition was not significant and has been accounted for using the acquisition method of accounting. Associated immaterial acquisition-related costs incurred have been included in acquisition and integration-related costs on the Company's condensed consolidated statements of operations for the nine months ended September 30, 2022. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cross Country Workforce Solutions Group (CCWSG)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 8, 2021, the Company purchased and acquired substantially all of the assets and assumed certain liabilities of Workforce Solutions Group, Inc. (WSG) for a purchase price of $<ix:nonFraction unitRef="usd" contextRef="i29d504aa7a7e4656aed1f0f0211e399c_D20210608-20210608" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RleHRyZWdpb246YmQ5M2Y5MWY0NzRlNGMzMzgxZGRlNjE0MDVlMjdlZWNfMjE4MQ_2b038404-9945-497e-8be9-8613ca895de6">25.0</ix:nonFraction>&#160;million in cash and $<ix:nonFraction unitRef="usd" contextRef="i29d504aa7a7e4656aed1f0f0211e399c_D20210608-20210608" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RleHRyZWdpb246YmQ5M2Y5MWY0NzRlNGMzMzgxZGRlNjE0MDVlMjdlZWNfMjE5Ng_3a5013dd-e211-4d56-8638-23f20c809c02">5.0</ix:nonFraction>&#160;million in shares (or <ix:nonFraction unitRef="shares" contextRef="i29d504aa7a7e4656aed1f0f0211e399c_D20210608-20210608" decimals="INF" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RleHRyZWdpb246YmQ5M2Y5MWY0NzRlNGMzMzgxZGRlNjE0MDVlMjdlZWNfMjIxMw_571f92de-ec65-4418-a0b7-ff94a9a44599">307,730</ix:nonFraction> shares) of the Company's common stock. The parties agreed to a final net working capital reduction of $<ix:nonFraction unitRef="usd" contextRef="i29e631219d674e4fae9fb8f7e977e6af_D20211001-20211231" decimals="-5" name="ccrn:BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RleHRyZWdpb246YmQ5M2Y5MWY0NzRlNGMzMzgxZGRlNjE0MDVlMjdlZWNfMjMxOA_95bec285-ffc2-4cc9-bd09-71324c1681a3">1.1</ix:nonFraction>&#160;million, which was received in the fourth quarter of 2021. The transaction was treated as a purchase of assets for income tax purposes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The sellers are also eligible to receive an earnout based on the business' performance through <ix:nonNumeric contextRef="i29d504aa7a7e4656aed1f0f0211e399c_D20210608-20210608" name="ccrn:BusinessCombinationContingentConsiderationTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RleHRyZWdpb246YmQ5M2Y5MWY0NzRlNGMzMzgxZGRlNjE0MDVlMjdlZWNfMjU0NA_e515dc9c-aabc-4ac1-a536-92ef9b9379c5">three years</ix:nonNumeric> after the acquisition date that could provide up to an additional $<ix:nonFraction unitRef="usd" contextRef="i8ae5c1283dfc4659b9287a5a52e51af8_I20210608" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RleHRyZWdpb246YmQ5M2Y5MWY0NzRlNGMzMzgxZGRlNjE0MDVlMjdlZWNfMjYxMw_7756d8c7-7885-42a6-b157-b1b6aaa323f9">15.0</ix:nonFraction>&#160;million in cash. In the third quarter of 2022, the Company determined that the contingent consideration earnout was achieved for the 2021 through 2022 period and, as a result, the Company made a $<ix:nonFraction unitRef="usd" contextRef="id9fe5b9beae44701b72bcee962193e53_D20220701-20220930" decimals="-5" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RleHRyZWdpb246YmQ5M2Y5MWY0NzRlNGMzMzgxZGRlNjE0MDVlMjdlZWNfNTQ5NzU1ODE3OTAx_f922a4d2-e406-4156-927f-cd17a0bd3765">7.5</ix:nonFraction>&#160;million earnout payment. The remaining earnout liability's carrying amount of $<ix:nonFraction unitRef="usd" contextRef="ic3eab37833864980aa79e31112a0c6e2_I20220930" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RleHRyZWdpb246YmQ5M2Y5MWY0NzRlNGMzMzgxZGRlNjE0MDVlMjdlZWNfMjY2NQ_fbedfbea-c5ce-466e-8463-908b5ac8f1d5">7.5</ix:nonFraction>&#160;million is included in current portion of earnout liability on the condensed consolidated balance sheets. See Note 10 - Fair Value Measurements.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RleHRyZWdpb246YmQ5M2Y5MWY0NzRlNGMzMzgxZGRlNjE0MDVlMjdlZWNfMzcwMg_74202cc8-2f46-4e4f-81c4-e87ceb4a8b91" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value of the assets acquired and liabilities assumed on June 8, 2021:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.784%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ae5c1283dfc4659b9287a5a52e51af8_I20210608" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RhYmxlOjhiNzRjOTJiYzUwZDQ4ZjM4YmI3MDEwZWJjZjExYWE5L3RhYmxlcmFuZ2U6OGI3NGM5MmJjNTBkNDhmMzhiYjcwMTBlYmNmMTFhYTlfMS0xLTEtMS00NjMzNA_e3db1d17-902c-41cd-802d-0aaac98c1e0a">957</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ae5c1283dfc4659b9287a5a52e51af8_I20210608" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RhYmxlOjhiNzRjOTJiYzUwZDQ4ZjM4YmI3MDEwZWJjZjExYWE5L3RhYmxlcmFuZ2U6OGI3NGM5MmJjNTBkNDhmMzhiYjcwMTBlYmNmMTFhYTlfMi0xLTEtMS00NjMzNA_ca4cdc79-3ac5-406a-88d7-c1f02205a1c7">11,991</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ae5c1283dfc4659b9287a5a52e51af8_I20210608" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RhYmxlOjhiNzRjOTJiYzUwZDQ4ZjM4YmI3MDEwZWJjZjExYWE5L3RhYmxlcmFuZ2U6OGI3NGM5MmJjNTBkNDhmMzhiYjcwMTBlYmNmMTFhYTlfMy0xLTEtMS00NjMzNA_e8911872-b75b-45a8-8ee1-2d39ff878e0f">59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ae5c1283dfc4659b9287a5a52e51af8_I20210608" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RhYmxlOjhiNzRjOTJiYzUwZDQ4ZjM4YmI3MDEwZWJjZjExYWE5L3RhYmxlcmFuZ2U6OGI3NGM5MmJjNTBkNDhmMzhiYjcwMTBlYmNmMTFhYTlfNC0xLTEtMS00NjMzNA_23c5f9f7-e66a-4f90-b42d-555ed2473353">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ae5c1283dfc4659b9287a5a52e51af8_I20210608" decimals="-3" name="ccrn:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RhYmxlOjhiNzRjOTJiYzUwZDQ4ZjM4YmI3MDEwZWJjZjExYWE5L3RhYmxlcmFuZ2U6OGI3NGM5MmJjNTBkNDhmMzhiYjcwMTBlYmNmMTFhYTlfNS0xLTEtMS00NjMzNA_6e7f8f3b-6fa0-402d-b9eb-f2c5884e6afe">1,078</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ae5c1283dfc4659b9287a5a52e51af8_I20210608" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RhYmxlOjhiNzRjOTJiYzUwZDQ4ZjM4YmI3MDEwZWJjZjExYWE5L3RhYmxlcmFuZ2U6OGI3NGM5MmJjNTBkNDhmMzhiYjcwMTBlYmNmMTFhYTlfNi0xLTEtMS00NjMzNA_89d29219-4144-4621-bc14-a666fb3c31db">22,066</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ae5c1283dfc4659b9287a5a52e51af8_I20210608" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RhYmxlOjhiNzRjOTJiYzUwZDQ4ZjM4YmI3MDEwZWJjZjExYWE5L3RhYmxlcmFuZ2U6OGI3NGM5MmJjNTBkNDhmMzhiYjcwMTBlYmNmMTFhYTlfNy0xLTEtMS00NjMzNA_c5f9dbdc-e067-4fe3-af79-f6c69ae80921">14,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ae5c1283dfc4659b9287a5a52e51af8_I20210608" decimals="-3" name="ccrn:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RhYmxlOjhiNzRjOTJiYzUwZDQ4ZjM4YmI3MDEwZWJjZjExYWE5L3RhYmxlcmFuZ2U6OGI3NGM5MmJjNTBkNDhmMzhiYjcwMTBlYmNmMTFhYTlfOC0xLTEtMS00NjMzNA_60c03bd1-8aca-4abe-95be-56d77d341bc3">50,361</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ae5c1283dfc4659b9287a5a52e51af8_I20210608" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RhYmxlOjhiNzRjOTJiYzUwZDQ4ZjM4YmI3MDEwZWJjZjExYWE5L3RhYmxlcmFuZ2U6OGI3NGM5MmJjNTBkNDhmMzhiYjcwMTBlYmNmMTFhYTlfOS0xLTEtMS00NjMzNA_e9d2ca77-a6cc-4d1e-b190-c175a6ea32d3">3,562</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation and benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ae5c1283dfc4659b9287a5a52e51af8_I20210608" decimals="-3" name="ccrn:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensationAndBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RhYmxlOjhiNzRjOTJiYzUwZDQ4ZjM4YmI3MDEwZWJjZjExYWE5L3RhYmxlcmFuZ2U6OGI3NGM5MmJjNTBkNDhmMzhiYjcwMTBlYmNmMTFhYTlfMTAtMS0xLTEtNDYzMzQ_cb34133b-8a19-403d-9174-ae4733eca9eb">1,387</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability - current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ae5c1283dfc4659b9287a5a52e51af8_I20210608" decimals="-3" name="ccrn:BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RhYmxlOjhiNzRjOTJiYzUwZDQ4ZjM4YmI3MDEwZWJjZjExYWE5L3RhYmxlcmFuZ2U6OGI3NGM5MmJjNTBkNDhmMzhiYjcwMTBlYmNmMTFhYTlfMTEtMS0xLTEtNDYzMzQ_99468ed8-941b-4337-a725-ea871d80539d">316</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability - non-current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ae5c1283dfc4659b9287a5a52e51af8_I20210608" decimals="-3" name="ccrn:BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RhYmxlOjhiNzRjOTJiYzUwZDQ4ZjM4YmI3MDEwZWJjZjExYWE5L3RhYmxlcmFuZ2U6OGI3NGM5MmJjNTBkNDhmMzhiYjcwMTBlYmNmMTFhYTlfMTItMS0xLTEtNDYzMzQ_97c31a11-11d4-4a35-a009-f01a85a6ed78">762</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnout liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ae5c1283dfc4659b9287a5a52e51af8_I20210608" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RhYmxlOjhiNzRjOTJiYzUwZDQ4ZjM4YmI3MDEwZWJjZjExYWE5L3RhYmxlcmFuZ2U6OGI3NGM5MmJjNTBkNDhmMzhiYjcwMTBlYmNmMTFhYTlfMTMtMS0xLTEtNDYzMzQ_50a7befe-7313-4cc7-b9f1-b3b0d56e6722">15,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities assumed</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ae5c1283dfc4659b9287a5a52e51af8_I20210608" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RhYmxlOjhiNzRjOTJiYzUwZDQ4ZjM4YmI3MDEwZWJjZjExYWE5L3RhYmxlcmFuZ2U6OGI3NGM5MmJjNTBkNDhmMzhiYjcwMTBlYmNmMTFhYTlfMTQtMS0xLTEtNDYzMzQ_d50aba1d-f349-4ef6-95fd-2acef015ac52">21,027</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets acquired</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ae5c1283dfc4659b9287a5a52e51af8_I20210608" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RhYmxlOjhiNzRjOTJiYzUwZDQ4ZjM4YmI3MDEwZWJjZjExYWE5L3RhYmxlcmFuZ2U6OGI3NGM5MmJjNTBkNDhmMzhiYjcwMTBlYmNmMTFhYTlfMTUtMS0xLTEtNDYzMzQ_74fd79a8-29f7-4824-8e0b-579fd2b0c3cf">29,334</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assigned a value to other identifiable intangible assets of $<ix:nonFraction unitRef="usd" contextRef="i4b533d4786024f299c29a873781660b2_I20210608" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RleHRyZWdpb246YmQ5M2Y5MWY0NzRlNGMzMzgxZGRlNjE0MDVlMjdlZWNfMzA3MQ_b6d5575d-ef87-44c0-8a7b-be5aa6022594">14.2</ix:nonFraction>&#160;million in customer relationships with a weighted average estimated useful life of <ix:nonNumeric contextRef="icc7d3370d9844826a664e9ed960c303a_D20210608-20210608" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RleHRyZWdpb246YmQ5M2Y5MWY0NzRlNGMzMzgxZGRlNjE0MDVlMjdlZWNfMzE0OQ_a66effee-2752-4250-ae50-ec030aed5847">11.5</ix:nonNumeric> years.</span></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i47a4e32f8c0946e7930f32a18b2061c5" continuedAt="i3193612691574af79b67b5fead0b6b4d">The remaining excess purchase price over the fair value of net assets acquired of $<ix:nonFraction unitRef="usd" contextRef="i8ae5c1283dfc4659b9287a5a52e51af8_I20210608" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RleHRyZWdpb246YmQ5M2Y5MWY0NzRlNGMzMzgxZGRlNjE0MDVlMjdlZWNfMzIzNg_f2574fbd-bac0-4d24-a7ad-eaa52d1cfdd7">22.1</ix:nonFraction>&#160;million was recorded as goodwill on the Company's condensed consolidated balance sheets. See Note 7 - Goodwill, Trade Names, and Other Intangible Assets. </ix:continuation></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3193612691574af79b67b5fead0b6b4d">The acquisition was not significant and has been accounted for using the acquisition method of accounting. The pro-forma impact on the Company's consolidated revenue from services and net income, including the pro forma effect of events that are directly attributable to the acquisition, was not significant.</ix:continuation> </span></div><div><span><br/></span></div><div id="i5b47dd1c3d5a40ff8e040a94ae232d75_49"></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80OS9mcmFnOjlkZDExOWI1ODI0YjQxOGFhZGNiYTQ2OWVjM2UzMmM5L3RleHRyZWdpb246OWRkMTE5YjU4MjRiNDE4YWFkY2JhNDY5ZWMzZTMyYzlfODM3_78ecea3b-641d-49cf-9285-2533d85ec86c" continuedAt="i578be08a0a8e43e39dc6a6e6e5350363" escape="true">COMPREHENSIVE INCOME</ix:nonNumeric></span></div><ix:continuation id="i578be08a0a8e43e39dc6a6e6e5350363"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total comprehensive income includes net income or loss and foreign currency translation adjustments, net of any related deferred taxes, and is included within the accompanying condensed consolidated statements of operations. Certain of the Company&#8217;s foreign subsidiaries use their respective local currency as their functional currency. Assets and liabilities of these operations are translated at the exchange rates in effect on the balance sheet date. Income statement items are translated at the average exchange rates for the period. The cumulative impact of currency fluctuations related to the balance sheet translation is included in accumulated other comprehensive loss in the accompanying condensed consolidated balance sheets and was an unrealized loss of</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $<ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-5" sign="-" name="ccrn:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80OS9mcmFnOjlkZDExOWI1ODI0YjQxOGFhZGNiYTQ2OWVjM2UzMmM5L3RleHRyZWdpb246OWRkMTE5YjU4MjRiNDE4YWFkY2JhNDY5ZWMzZTMyYzlfNzk3_d48114ee-76f9-4e64-8ebb-633602b21a8c">1.4</ix:nonFraction>&#160;million at September 30, 2022 and $<ix:nonFraction unitRef="usd" contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231" decimals="-5" sign="-" name="ccrn:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80OS9mcmFnOjlkZDExOWI1ODI0YjQxOGFhZGNiYTQ2OWVjM2UzMmM5L3RleHRyZWdpb246OWRkMTE5YjU4MjRiNDE4YWFkY2JhNDY5ZWMzZTMyYzlfODIx_d11b77e0-4a08-4ee7-8b8c-030de949dcf5">1.3</ix:nonFraction> million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> at December&#160;31, 2021.</span></div></ix:continuation><div><span><br/></span></div><div id="i5b47dd1c3d5a40ff8e040a94ae232d75_52"></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RleHRyZWdpb246ZDNkN2Y0NGMyNzVmNDU3MWE3NTYwNWNlZmUzNWVhYTdfNTI4_2c1185c3-d15a-43a3-a39d-9c97596c95b9" continuedAt="i7895f166bbaa40a49df318eaa1959d5c" escape="true">EARNINGS PER SHARE</ix:nonNumeric></span></div><div style="padding-left:36pt;text-indent:-36pt"><span><br/></span></div><ix:continuation id="i7895f166bbaa40a49df318eaa1959d5c"><div><ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RleHRyZWdpb246ZDNkN2Y0NGMyNzVmNDU3MWE3NTYwNWNlZmUzNWVhYTdfNTI0_8aeaaebe-a711-4f6f-8fe1-aadbf998998d" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the components of the numerator and denominator for the computation of the basic and diluted earnings per share:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.115%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr style="height:15pt"><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(amounts in thousands, except per share data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to common stockholders - Basic and Diluted</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOjY4NmQ0ZDAxNDg0ZTQxYzI5YzRjZGZlYTBlYzIzYzI4L3RhYmxlcmFuZ2U6Njg2ZDRkMDE0ODRlNDFjMjljNGNkZmVhMGVjMjNjMjhfNS0xLTEtMS00NjMzNA_55a49eca-2328-4e9f-aa26-3131877417d0"><ix:nonFraction unitRef="usd" contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOjY4NmQ0ZDAxNDg0ZTQxYzI5YzRjZGZlYTBlYzIzYzI4L3RhYmxlcmFuZ2U6Njg2ZDRkMDE0ODRlNDFjMjljNGNkZmVhMGVjMjNjMjhfNS0xLTEtMS00NjMzNA_80181fd1-4c52-4b4a-9797-73d4e026edf2">34,793</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOjY4NmQ0ZDAxNDg0ZTQxYzI5YzRjZGZlYTBlYzIzYzI4L3RhYmxlcmFuZ2U6Njg2ZDRkMDE0ODRlNDFjMjljNGNkZmVhMGVjMjNjMjhfNS0zLTEtMS00NjMzNA_24abf0e2-4ac3-485e-b571-c61551e65186"><ix:nonFraction unitRef="usd" contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOjY4NmQ0ZDAxNDg0ZTQxYzI5YzRjZGZlYTBlYzIzYzI4L3RhYmxlcmFuZ2U6Njg2ZDRkMDE0ODRlNDFjMjljNGNkZmVhMGVjMjNjMjhfNS0zLTEtMS00NjMzNA_fae7bfed-c307-4f6f-b3fa-b04efd02933e">23,433</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOjY4NmQ0ZDAxNDg0ZTQxYzI5YzRjZGZlYTBlYzIzYzI4L3RhYmxlcmFuZ2U6Njg2ZDRkMDE0ODRlNDFjMjljNGNkZmVhMGVjMjNjMjhfNS01LTEtMS00NjMzNA_437ba786-6f36-45a9-9a03-31fd29714826"><ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOjY4NmQ0ZDAxNDg0ZTQxYzI5YzRjZGZlYTBlYzIzYzI4L3RhYmxlcmFuZ2U6Njg2ZDRkMDE0ODRlNDFjMjljNGNkZmVhMGVjMjNjMjhfNS01LTEtMS00NjMzNA_a541d251-1ab5-4a0c-a2a7-8bc7f059b509">149,670</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOjY4NmQ0ZDAxNDg0ZTQxYzI5YzRjZGZlYTBlYzIzYzI4L3RhYmxlcmFuZ2U6Njg2ZDRkMDE0ODRlNDFjMjljNGNkZmVhMGVjMjNjMjhfNS03LTEtMS00NjMzNA_e3c928f0-6949-43a6-b437-c76802602388"><ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOjY4NmQ0ZDAxNDg0ZTQxYzI5YzRjZGZlYTBlYzIzYzI4L3RhYmxlcmFuZ2U6Njg2ZDRkMDE0ODRlNDFjMjljNGNkZmVhMGVjMjNjMjhfNS03LTEtMS00NjMzNA_e5615f2b-c442-45db-b4bd-b108788ae51d">54,429</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares - Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOjY4NmQ0ZDAxNDg0ZTQxYzI5YzRjZGZlYTBlYzIzYzI4L3RhYmxlcmFuZ2U6Njg2ZDRkMDE0ODRlNDFjMjljNGNkZmVhMGVjMjNjMjhfOC0xLTEtMS00NjMzNA_63004e17-6b26-479b-b5b7-ae0c921462d8">37,101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOjY4NmQ0ZDAxNDg0ZTQxYzI5YzRjZGZlYTBlYzIzYzI4L3RhYmxlcmFuZ2U6Njg2ZDRkMDE0ODRlNDFjMjljNGNkZmVhMGVjMjNjMjhfOC0zLTEtMS00NjMzNA_b39c1fe5-a0c0-40ab-aa95-67e44aa67cba">36,963</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOjY4NmQ0ZDAxNDg0ZTQxYzI5YzRjZGZlYTBlYzIzYzI4L3RhYmxlcmFuZ2U6Njg2ZDRkMDE0ODRlNDFjMjljNGNkZmVhMGVjMjNjMjhfOC01LTEtMS00NjMzNA_21b48c99-a2d2-484d-b3fd-250d5cf38f33">37,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOjY4NmQ0ZDAxNDg0ZTQxYzI5YzRjZGZlYTBlYzIzYzI4L3RhYmxlcmFuZ2U6Njg2ZDRkMDE0ODRlNDFjMjljNGNkZmVhMGVjMjNjMjhfOC03LTEtMS00NjMzNA_6d441565-e881-4b98-a456-3c41e39e2d58">36,593</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of diluted shares:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Share-based awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOjY4NmQ0ZDAxNDg0ZTQxYzI5YzRjZGZlYTBlYzIzYzI4L3RhYmxlcmFuZ2U6Njg2ZDRkMDE0ODRlNDFjMjljNGNkZmVhMGVjMjNjMjhfMTAtMS0xLTEtNDYzMzQ_d66d464f-b9d2-41db-a8ee-13b27225aa04">391</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOjY4NmQ0ZDAxNDg0ZTQxYzI5YzRjZGZlYTBlYzIzYzI4L3RhYmxlcmFuZ2U6Njg2ZDRkMDE0ODRlNDFjMjljNGNkZmVhMGVjMjNjMjhfMTAtMy0xLTEtNDYzMzQ_1661e8bd-b7e8-4cd6-93da-7a0ef43c595a">619</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOjY4NmQ0ZDAxNDg0ZTQxYzI5YzRjZGZlYTBlYzIzYzI4L3RhYmxlcmFuZ2U6Njg2ZDRkMDE0ODRlNDFjMjljNGNkZmVhMGVjMjNjMjhfMTAtNS0xLTEtNDYzMzQ_e5a6aae2-b57b-4cca-93f6-327c14dce96a">541</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOjY4NmQ0ZDAxNDg0ZTQxYzI5YzRjZGZlYTBlYzIzYzI4L3RhYmxlcmFuZ2U6Njg2ZDRkMDE0ODRlNDFjMjljNGNkZmVhMGVjMjNjMjhfMTAtNy0xLTEtNDYzMzQ_bf49d86a-4631-4e43-b5e0-9ca235be56f9">683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares - Diluted</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOjY4NmQ0ZDAxNDg0ZTQxYzI5YzRjZGZlYTBlYzIzYzI4L3RhYmxlcmFuZ2U6Njg2ZDRkMDE0ODRlNDFjMjljNGNkZmVhMGVjMjNjMjhfMTEtMS0xLTEtNDYzMzQ_3d9c1c87-f3d3-47b9-8e82-aed0827651d0">37,492</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOjY4NmQ0ZDAxNDg0ZTQxYzI5YzRjZGZlYTBlYzIzYzI4L3RhYmxlcmFuZ2U6Njg2ZDRkMDE0ODRlNDFjMjljNGNkZmVhMGVjMjNjMjhfMTEtMy0xLTEtNDYzMzQ_48206876-a723-43cf-96f3-31daecd6ab9c">37,582</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOjY4NmQ0ZDAxNDg0ZTQxYzI5YzRjZGZlYTBlYzIzYzI4L3RhYmxlcmFuZ2U6Njg2ZDRkMDE0ODRlNDFjMjljNGNkZmVhMGVjMjNjMjhfMTEtNS0xLTEtNDYzMzQ_bedd6d99-e8db-4202-bcd3-a4b3a18791c8">37,741</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOjY4NmQ0ZDAxNDg0ZTQxYzI5YzRjZGZlYTBlYzIzYzI4L3RhYmxlcmFuZ2U6Njg2ZDRkMDE0ODRlNDFjMjljNGNkZmVhMGVjMjNjMjhfMTEtNy0xLTEtNDYzMzQ_612ac084-d2ec-445e-a25e-46715e6f2185">37,276</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share attributable to common stockholders - Basic</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOjY4NmQ0ZDAxNDg0ZTQxYzI5YzRjZGZlYTBlYzIzYzI4L3RhYmxlcmFuZ2U6Njg2ZDRkMDE0ODRlNDFjMjljNGNkZmVhMGVjMjNjMjhfMTMtMS0xLTEtNDYzMzQ_1ff5a045-3ccd-40b9-80b2-5227a7235661">0.94</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOjY4NmQ0ZDAxNDg0ZTQxYzI5YzRjZGZlYTBlYzIzYzI4L3RhYmxlcmFuZ2U6Njg2ZDRkMDE0ODRlNDFjMjljNGNkZmVhMGVjMjNjMjhfMTMtMy0xLTEtNDYzMzQ_d43b1875-339f-4a7d-a174-8dee4c41c229">0.63</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOjY4NmQ0ZDAxNDg0ZTQxYzI5YzRjZGZlYTBlYzIzYzI4L3RhYmxlcmFuZ2U6Njg2ZDRkMDE0ODRlNDFjMjljNGNkZmVhMGVjMjNjMjhfMTMtNS0xLTEtNDYzMzQ_6b70651d-c728-47b7-8c38-0b579887a7d1">4.02</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOjY4NmQ0ZDAxNDg0ZTQxYzI5YzRjZGZlYTBlYzIzYzI4L3RhYmxlcmFuZ2U6Njg2ZDRkMDE0ODRlNDFjMjljNGNkZmVhMGVjMjNjMjhfMTMtNy0xLTEtNDYzMzQ_29c38e28-cfff-40ee-96ea-fa18f495e122">1.49</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share attributable to common stockholders - Diluted</span></td><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOjY4NmQ0ZDAxNDg0ZTQxYzI5YzRjZGZlYTBlYzIzYzI4L3RhYmxlcmFuZ2U6Njg2ZDRkMDE0ODRlNDFjMjljNGNkZmVhMGVjMjNjMjhfMTUtMS0xLTEtNDYzMzQ_a817aeea-433c-42d6-95e4-964a3b69a14c">0.93</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOjY4NmQ0ZDAxNDg0ZTQxYzI5YzRjZGZlYTBlYzIzYzI4L3RhYmxlcmFuZ2U6Njg2ZDRkMDE0ODRlNDFjMjljNGNkZmVhMGVjMjNjMjhfMTUtMy0xLTEtNDYzMzQ_50b1172d-effe-4428-b2ef-32eaef2ac27e">0.62</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOjY4NmQ0ZDAxNDg0ZTQxYzI5YzRjZGZlYTBlYzIzYzI4L3RhYmxlcmFuZ2U6Njg2ZDRkMDE0ODRlNDFjMjljNGNkZmVhMGVjMjNjMjhfMTUtNS0xLTEtNDYzMzQ_99f4f1d9-8e25-437a-a5e7-708499394b66">3.97</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOjY4NmQ0ZDAxNDg0ZTQxYzI5YzRjZGZlYTBlYzIzYzI4L3RhYmxlcmFuZ2U6Njg2ZDRkMDE0ODRlNDFjMjljNGNkZmVhMGVjMjNjMjhfMTUtNy0xLTEtNDYzMzQ_ed486507-ff22-487e-bc9d-15e433a5f9b5">1.46</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RleHRyZWdpb246ZDNkN2Y0NGMyNzVmNDU3MWE3NTYwNWNlZmUzNWVhYTdfNTIx_1276e958-fdfb-4c4f-a368-cd3e45a665f8" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the share-based awards that could potentially dilute net income per share attributable to common stockholders in the future that were not included in the computation of diluted net income per share attributable to common stockholders because to do so would have been anti-dilutive for the periods presented.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.699%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based awards</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2caa7dba2bf946eeba1cabe94a429f67_D20220701-20220930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOmRiZWRiOGRjMTBhMzQxNjNiMDQxMzc0ZmQyMWExM2FjL3RhYmxlcmFuZ2U6ZGJlZGI4ZGMxMGEzNDE2M2IwNDEzNzRmZDIxYTEzYWNfNC0xLTEtMS00NjMzNA_13d10746-1b84-457a-9807-c05264e588c0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia2bdc4ad60944e738242ef9a6814d745_D20210701-20210930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOmRiZWRiOGRjMTBhMzQxNjNiMDQxMzc0ZmQyMWExM2FjL3RhYmxlcmFuZ2U6ZGJlZGI4ZGMxMGEzNDE2M2IwNDEzNzRmZDIxYTEzYWNfNC0zLTEtMS00NjMzNA_6a0bd348-22b3-454b-90ed-8ec859a951ee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i955dad9273e74d0b9b508f98c422598d_D20220101-20220930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOmRiZWRiOGRjMTBhMzQxNjNiMDQxMzc0ZmQyMWExM2FjL3RhYmxlcmFuZ2U6ZGJlZGI4ZGMxMGEzNDE2M2IwNDEzNzRmZDIxYTEzYWNfNC01LTEtMS00NjMzNA_f6c18caf-9faf-4f37-b9a4-721607eafdfd">73</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2bf81d4651a84b7d903fab0b74c4d6c6_D20210101-20210930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOmRiZWRiOGRjMTBhMzQxNjNiMDQxMzc0ZmQyMWExM2FjL3RhYmxlcmFuZ2U6ZGJlZGI4ZGMxMGEzNDE2M2IwNDEzNzRmZDIxYTEzYWNfNC03LTEtMS00NjMzNA_20805b4e-d6bd-4d87-8c7d-69b2fd035444">9</ix:nonFraction></span></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><div id="i5b47dd1c3d5a40ff8e040a94ae232d75_55"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RleHRyZWdpb246YTllYmQyNjJjYTVmNDkzYTg3MGVlOWNiNzM3NzA5NTdfMjU4Mg_84e5ec1f-fbe6-4728-85eb-fd363781a395" continuedAt="iaf6f5b993f294b6780670ec40efb91b4" escape="true">GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="iaf6f5b993f294b6780670ec40efb91b4" continuedAt="ieb922831dc9a4f44ad703c65a750765f"><div><ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RleHRyZWdpb246YTllYmQyNjJjYTVmNDkzYTg3MGVlOWNiNzM3NzA5NTdfMjU4Ng_449c084b-3177-4658-be5a-3d9f5d5d120c" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had the following acquired intangible assets:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.846%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="36" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets subject to amortization:</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Databases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8596209ef08040d2bfd996b39f79a2cc_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfNC0xLTEtMS00NjMzNA_542b76f2-adca-4ee4-9ad3-74b60da50960">33,430</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8596209ef08040d2bfd996b39f79a2cc_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfNC0zLTEtMS00NjMzNA_5123b3db-b002-41c7-9e1f-44c6b9f7dc66">21,125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8596209ef08040d2bfd996b39f79a2cc_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfNC01LTEtMS00NjMzNA_053cf007-6652-4d69-b609-d52bd076ddb4">12,305</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f8278712e840b2b0b1388f6f6d449a_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfNC03LTEtMS00NjMzNA_7d19a2b7-65be-4491-914e-9945d13e9009">30,530</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f8278712e840b2b0b1388f6f6d449a_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfNC05LTEtMS00NjMzNA_c61b2e82-3fb9-47bf-b03b-fd1a5e04bb98">18,375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f8278712e840b2b0b1388f6f6d449a_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfNC0xMS0xLTEtNDYzMzQ_93453b2a-69de-461b-9419-ad14a08ebcc4">12,155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee283e580b834384a505bf9085488f0c_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfNS0xLTEtMS00NjMzNA_caf4dea4-e0a7-4d35-9841-4ecb67490b38">47,738</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee283e580b834384a505bf9085488f0c_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfNS0zLTEtMS00NjMzNA_4041809f-f416-4032-b1d3-60e3709a3ffb">20,649</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee283e580b834384a505bf9085488f0c_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfNS01LTEtMS00NjMzNA_d0e80c35-bced-43c3-8efe-e33fc9c4284b">27,089</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1393e7a548df431795ee6a40b27a3d83_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfNS03LTEtMS00NjMzNA_df682b4d-8a80-4e4e-a9c4-638ee72f4259">47,738</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1393e7a548df431795ee6a40b27a3d83_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfNS05LTEtMS00NjMzNA_7996b0a9-fd2b-4875-a360-57c597af7585">17,581</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1393e7a548df431795ee6a40b27a3d83_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfNS0xMS0xLTEtNDYzMzQ_d1dc5617-c803-485c-aacc-ba2fa2f32680">30,157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifffbe09f8f09467eb7e5b113f3801e46_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfNi0xLTEtMS00NjMzNA_97cb3ab3-fdaa-4c7b-9938-c2be12e4ce1b">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifffbe09f8f09467eb7e5b113f3801e46_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfNi0zLTEtMS00NjMzNA_8f652b8a-cd11-41a1-a26e-594d4e4a3fd0">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifffbe09f8f09467eb7e5b113f3801e46_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfNi01LTEtMS00NjMzNA_e607c233-1db8-4535-93f0-e0d86153d065">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66cd55e77f1246b18919d2e35b249926_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfNi03LTEtMS00NjMzNA_a9387ec9-ad81-4d88-9193-9506280cd2d4">304</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66cd55e77f1246b18919d2e35b249926_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfNi05LTEtMS00NjMzNA_0dc4d257-2ddf-42f0-a4c7-01d7ae7daee7">272</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66cd55e77f1246b18919d2e35b249926_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfNi0xMS0xLTEtNDYzMzQ_e9046757-8b0c-4a5a-a373-b36ab13df6c1">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id346bd8243c84b70924309b05565c2d3_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfNy0xLTEtMS00NjMzNA_855cf020-e7bf-44f3-a735-2bcea792f873">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id346bd8243c84b70924309b05565c2d3_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfNy0zLTEtMS00NjMzNA_471c805d-8d6b-4f6d-a5c1-031220f3a632">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id346bd8243c84b70924309b05565c2d3_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfNy01LTEtMS00NjMzNA_647ad8d5-f4f1-449f-8577-c0fa1bde6731">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d2f558a2d464d13a6a45fd804204c56_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfNy03LTEtMS00NjMzNA_34e05066-966d-4b66-873b-0bb28101a8c8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d2f558a2d464d13a6a45fd804204c56_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfNy05LTEtMS00NjMzNA_8676ec3d-7ab9-460b-a29b-09b3e8716b7b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d2f558a2d464d13a6a45fd804204c56_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfNy0xMS0xLTEtNDYzMzQ_ff435c89-85af-4d94-8fe6-7f41c6b6ead4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f28bc2f1f144f9b8079211ca0ac2719_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfOC0xLTEtMS00NjMzNA_3ac8f0c6-5ceb-4f1c-8d14-90826727fa35">1,700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f28bc2f1f144f9b8079211ca0ac2719_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfOC0zLTEtMS00NjMzNA_e9ae594d-623e-4ac9-b223-4b1a6bde8144">270</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f28bc2f1f144f9b8079211ca0ac2719_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfOC01LTEtMS00NjMzNA_4cde058e-1831-4913-b886-1d620e0235a8">1,430</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6df5cca2f9f94120b8172ac27441142a_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfOC03LTEtMS00NjMzNA_26dcc791-6e85-4c0e-b424-7cd144c2c248">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6df5cca2f9f94120b8172ac27441142a_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfOC05LTEtMS00NjMzNA_34ab06f3-6682-4dcb-8301-0ae4a69fe7e8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6df5cca2f9f94120b8172ac27441142a_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfOC0xMS0xLTEtNDYzMzQ_992fb4cf-4511-4612-9ff6-42decdc00bfe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfOS0xLTEtMS00NjMzNA_be5ded49-9103-466d-ad1f-0ae2748b014a">82,902</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfOS0zLTEtMS00NjMzNA_042a6edc-32c5-4ad9-aa6d-9dd585e7e742">42,059</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfOS01LTEtMS00NjMzNA_fb23bd28-e67a-4526-a69f-9916056cdeb0">40,843</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfOS03LTEtMS00NjMzNA_d071ce89-9cb5-477a-beb2-07c17943ac58">78,572</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfOS05LTEtMS00NjMzNA_b1383290-c31f-42c5-88b0-2e82a92fad36">36,228</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfOS0xMS0xLTEtNDYzMzQ_9cd7c4a3-3394-4fe8-b027-bb053326cafa">42,344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets not subject to amortization:</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names, indefinite-lived</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:IndefiniteLivedTradeNames" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfMTItNS0xLTEtNDYzMzQ_1636f331-ed76-4b78-8608-78df258520ab">5,900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231" decimals="-3" name="us-gaap:IndefiniteLivedTradeNames" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfMTItMTEtMS0xLTQ2MzM0_f2c87cb1-9d3b-4292-a410-173f8eb00c26">5,900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:center"><span><br/></span></div><ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RleHRyZWdpb246YTllYmQyNjJjYTVmNDkzYTg3MGVlOWNiNzM3NzA5NTdfMjU5MQ_ed01488d-82de-4feb-ab1e-6ac83abd6d77" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, estimated annual amortization expense was as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:80.811%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ending December&#160;31:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjBmYmRmM2Q5MzUyZjQ2NjZhMjE2YjU0NmU5OWRjOGE5L3RhYmxlcmFuZ2U6MGZiZGYzZDkzNTJmNDY2NmEyMTZiNTQ2ZTk5ZGM4YTlfMi0xLTEtMS00NjMzNA_894e8e6c-14a7-492c-a70c-d24006770b44">2,020</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjBmYmRmM2Q5MzUyZjQ2NjZhMjE2YjU0NmU5OWRjOGE5L3RhYmxlcmFuZ2U6MGZiZGYzZDkzNTJmNDY2NmEyMTZiNTQ2ZTk5ZGM4YTlfMy0xLTEtMS00NjMzNA_ff04c5cf-83a0-4a69-90ec-5d3ae815346e">8,051</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjBmYmRmM2Q5MzUyZjQ2NjZhMjE2YjU0NmU5OWRjOGE5L3RhYmxlcmFuZ2U6MGZiZGYzZDkzNTJmNDY2NmEyMTZiNTQ2ZTk5ZGM4YTlfNC0xLTEtMS00NjMzNA_5a54803d-b8a5-4e1d-9802-2b19388d6611">7,399</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjBmYmRmM2Q5MzUyZjQ2NjZhMjE2YjU0NmU5OWRjOGE5L3RhYmxlcmFuZ2U6MGZiZGYzZDkzNTJmNDY2NmEyMTZiNTQ2ZTk5ZGM4YTlfNS0xLTEtMS00NjMzNA_b4420518-f77f-455e-9464-95347efbdf5f">6,840</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjBmYmRmM2Q5MzUyZjQ2NjZhMjE2YjU0NmU5OWRjOGE5L3RhYmxlcmFuZ2U6MGZiZGYzZDkzNTJmNDY2NmEyMTZiNTQ2ZTk5ZGM4YTlfNi0xLTEtMS00NjMzNA_323bf913-e83c-4d38-98d6-e491809aea07">5,632</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="ccrn:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjBmYmRmM2Q5MzUyZjQ2NjZhMjE2YjU0NmU5OWRjOGE5L3RhYmxlcmFuZ2U6MGZiZGYzZDkzNTJmNDY2NmEyMTZiNTQ2ZTk5ZGM4YTlfNy0xLTEtMS00NjMzNA_e482d510-6d61-41ce-be67-a759ea2f728e">10,901</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjBmYmRmM2Q5MzUyZjQ2NjZhMjE2YjU0NmU5OWRjOGE5L3RhYmxlcmFuZ2U6MGZiZGYzZDkzNTJmNDY2NmEyMTZiNTQ2ZTk5ZGM4YTlfOC0xLTEtMS00NjMzNA_86cbb1f2-9e81-4ed3-a303-6bd6e5056bc4">40,843</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ieb922831dc9a4f44ad703c65a750765f"><ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RleHRyZWdpb246YTllYmQyNjJjYTVmNDkzYTg3MGVlOWNiNzM3NzA5NTdfMjU5OQ_3d2bff40-e11d-4654-ac20-6d8f4cc829dd" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The changes in the carrying amount of goodwill by reportable segment are as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.447%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nurse<br/>And Allied<br/>Staffing</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Physician<br/>Staffing</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances as of December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate goodwill acquired</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9689395cb7444c7c8ae6b2bb1d17f429_I20211231" decimals="-3" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjI2NjU3ZDU1MmM1YjQ0ZTVhZjhmY2RlYWRhMDJjOGU2L3RhYmxlcmFuZ2U6MjY2NTdkNTUyYzViNDRlNWFmOGZjZGVhZGEwMmM4ZTZfMy0xLTEtMS00NjMzNA_9e73831b-95d6-41dd-ac59-c19bc816b4ee">396,446</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3141d307889e400f8613ac4e53dfd7bf_I20211231" decimals="-3" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjI2NjU3ZDU1MmM1YjQ0ZTVhZjhmY2RlYWRhMDJjOGU2L3RhYmxlcmFuZ2U6MjY2NTdkNTUyYzViNDRlNWFmOGZjZGVhZGEwMmM4ZTZfMy0zLTEtMS00NjMzNA_24f6a94e-1a2c-4551-ae8d-3540b9042080">43,405</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231" decimals="-3" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjI2NjU3ZDU1MmM1YjQ0ZTVhZjhmY2RlYWRhMDJjOGU2L3RhYmxlcmFuZ2U6MjY2NTdkNTUyYzViNDRlNWFmOGZjZGVhZGEwMmM4ZTZfMy01LTEtMS00NjMzNA_26d1fed9-bc5b-4d51-818e-ddf422f1ed59">439,851</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sale of business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92f6c3cc4f5c4abda295b3072437fb45_I20211231" decimals="-3" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjI2NjU3ZDU1MmM1YjQ0ZTVhZjhmY2RlYWRhMDJjOGU2L3RhYmxlcmFuZ2U6MjY2NTdkNTUyYzViNDRlNWFmOGZjZGVhZGEwMmM4ZTZfNC0xLTEtMS00NjMzNA_012f3bf7-c9f6-47d0-ac5d-d85fd2b3a0b3">9,889</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98085908a4ff4bfabc746d90f51c8c01_I20211231" decimals="-3" name="us-gaap:GoodwillGross" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjI2NjU3ZDU1MmM1YjQ0ZTVhZjhmY2RlYWRhMDJjOGU2L3RhYmxlcmFuZ2U6MjY2NTdkNTUyYzViNDRlNWFmOGZjZGVhZGEwMmM4ZTZfNC0zLTEtMS00NjMzNA_8c7bf239-2b7c-4a46-9a23-4a94ea6f1526">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a09ea9a925140449a60d73ca6cea3cb_I20211231" decimals="-3" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjI2NjU3ZDU1MmM1YjQ0ZTVhZjhmY2RlYWRhMDJjOGU2L3RhYmxlcmFuZ2U6MjY2NTdkNTUyYzViNDRlNWFmOGZjZGVhZGEwMmM4ZTZfNC01LTEtMS00NjMzNA_dd575bef-9197-4a3f-be3b-bc0c31d348bd">9,889</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated impairment loss</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9689395cb7444c7c8ae6b2bb1d17f429_I20211231" decimals="-3" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjI2NjU3ZDU1MmM1YjQ0ZTVhZjhmY2RlYWRhMDJjOGU2L3RhYmxlcmFuZ2U6MjY2NTdkNTUyYzViNDRlNWFmOGZjZGVhZGEwMmM4ZTZfNS0xLTEtMS00NjMzNA_9c4e1562-f497-4c7e-af55-e289104a89ea">269,874</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3141d307889e400f8613ac4e53dfd7bf_I20211231" decimals="-3" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjI2NjU3ZDU1MmM1YjQ0ZTVhZjhmY2RlYWRhMDJjOGU2L3RhYmxlcmFuZ2U6MjY2NTdkNTUyYzViNDRlNWFmOGZjZGVhZGEwMmM4ZTZfNS0zLTEtMS00NjMzNA_c59ad7a5-77c4-410c-b5c7-ce73eaf2b19a">40,598</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231" decimals="-3" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjI2NjU3ZDU1MmM1YjQ0ZTVhZjhmY2RlYWRhMDJjOGU2L3RhYmxlcmFuZ2U6MjY2NTdkNTUyYzViNDRlNWFmOGZjZGVhZGEwMmM4ZTZfNS01LTEtMS00NjMzNA_6f2f7d01-749f-4022-9235-f717917fe27c">310,472</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill, net of impairment loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9689395cb7444c7c8ae6b2bb1d17f429_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjI2NjU3ZDU1MmM1YjQ0ZTVhZjhmY2RlYWRhMDJjOGU2L3RhYmxlcmFuZ2U6MjY2NTdkNTUyYzViNDRlNWFmOGZjZGVhZGEwMmM4ZTZfNi0xLTEtMS00NjMzNA_6751c264-7f29-47b2-8659-093b9417cd57">116,683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3141d307889e400f8613ac4e53dfd7bf_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjI2NjU3ZDU1MmM1YjQ0ZTVhZjhmY2RlYWRhMDJjOGU2L3RhYmxlcmFuZ2U6MjY2NTdkNTUyYzViNDRlNWFmOGZjZGVhZGEwMmM4ZTZfNi0zLTEtMS00NjMzNA_f23e1117-91b3-4bcf-b4f7-b91b550dffad">2,807</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjI2NjU3ZDU1MmM1YjQ0ZTVhZjhmY2RlYWRhMDJjOGU2L3RhYmxlcmFuZ2U6MjY2NTdkNTUyYzViNDRlNWFmOGZjZGVhZGEwMmM4ZTZfNi01LTEtMS00NjMzNA_5de5bf33-3ade-4492-8dff-fa5164bf358c">119,490</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Changes to aggregate goodwill in 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquisition adjustment - Selected </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7aaf74b211ba45b9bea92196b8c48cd7_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjI2NjU3ZDU1MmM1YjQ0ZTVhZjhmY2RlYWRhMDJjOGU2L3RhYmxlcmFuZ2U6MjY2NTdkNTUyYzViNDRlNWFmOGZjZGVhZGEwMmM4ZTZfOS0xLTEtMS00NjMzNA_a373fb21-9494-40f0-8331-33c9a19b7901">6,130</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4be1f35efe045ebabfe8d9154e1c3cb_D20220101-20220930" decimals="-3" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjI2NjU3ZDU1MmM1YjQ0ZTVhZjhmY2RlYWRhMDJjOGU2L3RhYmxlcmFuZ2U6MjY2NTdkNTUyYzViNDRlNWFmOGZjZGVhZGEwMmM4ZTZfOS0zLTEtMS00NjMzNA_3249e1c7-6482-449f-9fa1-6a1a97ed3c3b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjI2NjU3ZDU1MmM1YjQ0ZTVhZjhmY2RlYWRhMDJjOGU2L3RhYmxlcmFuZ2U6MjY2NTdkNTUyYzViNDRlNWFmOGZjZGVhZGEwMmM4ZTZfOS01LTEtMS00NjMzNA_d5e41c68-7bb4-49a4-aabf-fb451b564f50">6,130</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances as of September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate goodwill acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4a8ed4c652b409b9c9e62d38384449a_I20220930" decimals="-3" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjI2NjU3ZDU1MmM1YjQ0ZTVhZjhmY2RlYWRhMDJjOGU2L3RhYmxlcmFuZ2U6MjY2NTdkNTUyYzViNDRlNWFmOGZjZGVhZGEwMmM4ZTZfMTItMS0xLTEtNDYzMzQ_b3ef18ee-c41e-4e88-bcf2-9aebf53ddb84">390,316</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0b4574bdbb84488a12b61c871791cd5_I20220930" decimals="-3" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjI2NjU3ZDU1MmM1YjQ0ZTVhZjhmY2RlYWRhMDJjOGU2L3RhYmxlcmFuZ2U6MjY2NTdkNTUyYzViNDRlNWFmOGZjZGVhZGEwMmM4ZTZfMTItMy0xLTEtNDYzMzQ_674b72fa-0e99-47e3-a6e1-f9f1b83d33eb">43,405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjI2NjU3ZDU1MmM1YjQ0ZTVhZjhmY2RlYWRhMDJjOGU2L3RhYmxlcmFuZ2U6MjY2NTdkNTUyYzViNDRlNWFmOGZjZGVhZGEwMmM4ZTZfMTItNS0xLTEtNDYzMzQ_b17cb3f5-7283-4f3f-b4dd-d8b9ad2ba2db">433,721</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sale of business</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i50f6f534fc28456f8f17929b1cef9416_I20220930" decimals="-3" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjI2NjU3ZDU1MmM1YjQ0ZTVhZjhmY2RlYWRhMDJjOGU2L3RhYmxlcmFuZ2U6MjY2NTdkNTUyYzViNDRlNWFmOGZjZGVhZGEwMmM4ZTZfMTMtMS0xLTEtNDYzMzQ_e79d156e-412c-49e9-b668-b0804bc52cd6">9,889</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87608f5be1294b2c81227b913215f1f0_I20220930" decimals="-3" name="us-gaap:GoodwillGross" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjI2NjU3ZDU1MmM1YjQ0ZTVhZjhmY2RlYWRhMDJjOGU2L3RhYmxlcmFuZ2U6MjY2NTdkNTUyYzViNDRlNWFmOGZjZGVhZGEwMmM4ZTZfMTMtMy0xLTEtNDYzMzQ_23a28b00-4be9-4d56-8b61-561d90192dda">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie01c32b128c342b89c4718d3db15e20c_I20220930" decimals="-3" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjI2NjU3ZDU1MmM1YjQ0ZTVhZjhmY2RlYWRhMDJjOGU2L3RhYmxlcmFuZ2U6MjY2NTdkNTUyYzViNDRlNWFmOGZjZGVhZGEwMmM4ZTZfMTMtNS0xLTEtNDYzMzQ_25328b5a-1693-44ff-9615-fb72f765de06">9,889</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated impairment loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4a8ed4c652b409b9c9e62d38384449a_I20220930" decimals="-3" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjI2NjU3ZDU1MmM1YjQ0ZTVhZjhmY2RlYWRhMDJjOGU2L3RhYmxlcmFuZ2U6MjY2NTdkNTUyYzViNDRlNWFmOGZjZGVhZGEwMmM4ZTZfMTQtMS0xLTEtNDYzMzQ_37f3f078-95d9-4599-a469-6658ca85fd83">269,874</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0b4574bdbb84488a12b61c871791cd5_I20220930" decimals="-3" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjI2NjU3ZDU1MmM1YjQ0ZTVhZjhmY2RlYWRhMDJjOGU2L3RhYmxlcmFuZ2U6MjY2NTdkNTUyYzViNDRlNWFmOGZjZGVhZGEwMmM4ZTZfMTQtMy0xLTEtNDYzMzQ_396f8b2a-c11a-4838-8869-1d30de8c0afa">40,598</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjI2NjU3ZDU1MmM1YjQ0ZTVhZjhmY2RlYWRhMDJjOGU2L3RhYmxlcmFuZ2U6MjY2NTdkNTUyYzViNDRlNWFmOGZjZGVhZGEwMmM4ZTZfMTQtNS0xLTEtNDYzMzQ_ded0bb5c-b518-4973-b36b-f56716c5457f">310,472</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill, net of impairment loss</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4a8ed4c652b409b9c9e62d38384449a_I20220930" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjI2NjU3ZDU1MmM1YjQ0ZTVhZjhmY2RlYWRhMDJjOGU2L3RhYmxlcmFuZ2U6MjY2NTdkNTUyYzViNDRlNWFmOGZjZGVhZGEwMmM4ZTZfMTUtMS0xLTEtNDYzMzQ_92c641f0-5b77-474d-b3e9-8ffec4238144">110,553</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0b4574bdbb84488a12b61c871791cd5_I20220930" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjI2NjU3ZDU1MmM1YjQ0ZTVhZjhmY2RlYWRhMDJjOGU2L3RhYmxlcmFuZ2U6MjY2NTdkNTUyYzViNDRlNWFmOGZjZGVhZGEwMmM4ZTZfMTUtMy0xLTEtNDYzMzQ_89000c83-551b-4ad5-9d7b-31f2d621de28">2,807</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjI2NjU3ZDU1MmM1YjQ0ZTVhZjhmY2RlYWRhMDJjOGU2L3RhYmxlcmFuZ2U6MjY2NTdkNTUyYzViNDRlNWFmOGZjZGVhZGEwMmM4ZTZfMTUtNS0xLTEtNDYzMzQ_2dcd032f-678c-4a0a-9d9f-518aed5fb71a">113,360</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Represents an adjustment to the fair value of the identifiable net assets acquired, with a corresponding offset to goodwill, made during the measurement period related to the acquisition of Selected. See Note 4 - Acquisitions.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Goodwill, Trade Names, and Other Intangible Assets Impairment </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company tests reporting units&#8217; goodwill and intangible assets with indefinite lives for impairment annually during the fourth quarter and more frequently if impairment indicators exist. The Company performs quarterly qualitative assessments of significant events and circumstances such as reporting units&#8217; historical and current results, assumptions regarding future performance, strategic initiatives and overall economic factors,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> including COVID,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and macro-economic developments, to determine the existence of potential indicators of impairment and assess if it is more likely than not that the fair value of reporting units or intangible assets is less than their carrying value. If indicators of impairments are identified a quantitative impairment test is performed.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2022 and 2021, the Company performed a qualitative assessment of each of its reporting units and determined it was not more likely than not that the fair value of its reporting units dropped below their carrying value. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">lthough management believes that the Company's current estimates and assumptions utilized in its qualitative testing are reasonable and supportable, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">including its assumptions on the impact and timing related to COVID,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> there can be no assurance that the estimates and assumptions management used for purposes of its qualitative assessment as of September 30, 2022 will prove to be accurate predictions of future performance.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For its long-lived assets and definite-lived intangible assets, the Company reviews for impairment whenever events or changes in circumstances indicate the carrying amount may not be recoverable. As of September 30, 2022, the Company performed a qualitative assessment of its trade names and other intangible assets and, as a result, the Company wrote off a discontinued IT project and recorded a $<ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-5" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RleHRyZWdpb246YTllYmQyNjJjYTVmNDkzYTg3MGVlOWNiNzM3NzA5NTdfNTQ5NzU1ODE2ODkx_3ee17431-3627-4656-b2a8-1895474b8f08">1.9</ix:nonFraction>&#160;million impairment charge. During the nine months ended September 30, 2021, the Company wrote off a discontinued software development project, resulting in an immaterial impairment charge.</span></div></ix:continuation><div><span><br/></span></div><div id="i5b47dd1c3d5a40ff8e040a94ae232d75_58"></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfOTc3MA_10e4e0de-ef8e-4765-b279-f24a01376a40" continuedAt="ib94c03bb300c4729b87e64d49bf664df" escape="true">DEBT</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ib94c03bb300c4729b87e64d49bf664df" continuedAt="if15a80cd80b441689b02f82de21b3cea"><ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfOTc3NQ_fba29c0c-1c3c-4505-a10f-61ad807df0d8" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's long-term debt consists of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.478%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.699%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Principal</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Debt Issuance Costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Principal</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Debt Issuance Costs</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="21" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan, interest of <ix:nonFraction unitRef="number" contextRef="ide03ccfd1d5f459fbf0f366e300c2751_I20220930" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOjk0OGJlNDUxNjA3YzRkYzFiNTYwMjIzNDI5ZmViZmI0L3RhYmxlcmFuZ2U6OTQ4YmU0NTE2MDdjNGRjMWI1NjAyMjM0MjlmZWJmYjRfMy0wLTEtMS00NjMzNC90ZXh0cmVnaW9uOjMzZDRmMGJjMThkMDQ0MWFiOGQyNmRiOTUyMjg1MGRmXzI3_3733e49b-f6b0-466f-9160-88275b573215">8.83</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="if64036e453b84955b51e99497013571c_I20211231" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOjk0OGJlNDUxNjA3YzRkYzFiNTYwMjIzNDI5ZmViZmI0L3RhYmxlcmFuZ2U6OTQ4YmU0NTE2MDdjNGRjMWI1NjAyMjM0MjlmZWJmYjRfMy0wLTEtMS00NjMzNC90ZXh0cmVnaW9uOjMzZDRmMGJjMThkMDQ0MWFiOGQyNmRiOTUyMjg1MGRmXzM0_fd90c9dc-2e50-49c2-a639-268becda472f">6.50</ix:nonFraction>% at September 30, 2022 and December 31, 2021, respectively</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide03ccfd1d5f459fbf0f366e300c2751_I20220930" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOjk0OGJlNDUxNjA3YzRkYzFiNTYwMjIzNDI5ZmViZmI0L3RhYmxlcmFuZ2U6OTQ4YmU0NTE2MDdjNGRjMWI1NjAyMjM0MjlmZWJmYjRfMy0xLTEtMS00NjMzNA_93ca010f-4e0e-4724-962d-52c30141a497">123,875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide03ccfd1d5f459fbf0f366e300c2751_I20220930" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOjk0OGJlNDUxNjA3YzRkYzFiNTYwMjIzNDI5ZmViZmI0L3RhYmxlcmFuZ2U6OTQ4YmU0NTE2MDdjNGRjMWI1NjAyMjM0MjlmZWJmYjRfMy0zLTEtMS00NjMzNA_fb51f4bc-2edf-4f95-a847-6f7667b89d34">3,320</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if64036e453b84955b51e99497013571c_I20211231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOjk0OGJlNDUxNjA3YzRkYzFiNTYwMjIzNDI5ZmViZmI0L3RhYmxlcmFuZ2U6OTQ4YmU0NTE2MDdjNGRjMWI1NjAyMjM0MjlmZWJmYjRfMy01LTEtMS00NjMzNA_20ebbb05-c147-4fd9-9fc0-0a47678a336e">174,312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if64036e453b84955b51e99497013571c_I20211231" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOjk0OGJlNDUxNjA3YzRkYzFiNTYwMjIzNDI5ZmViZmI0L3RhYmxlcmFuZ2U6OTQ4YmU0NTE2MDdjNGRjMWI1NjAyMjM0MjlmZWJmYjRfMy03LTEtMS00NjMzNA_5d6847d7-94e4-4925-8dd7-b4efbc73f187">5,396</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Secured Asset-Based Loan, interest of <ix:nonFraction unitRef="number" contextRef="iaed1e277c72c475e9d7788035f2b51e8_I20220930" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOjk0OGJlNDUxNjA3YzRkYzFiNTYwMjIzNDI5ZmViZmI0L3RhYmxlcmFuZ2U6OTQ4YmU0NTE2MDdjNGRjMWI1NjAyMjM0MjlmZWJmYjRfNC0wLTEtMS00NjMzNC90ZXh0cmVnaW9uOjdhMDgyYzEyOWU1MjRjNDc5MDE3MWIwMDUwY2RkMDA1XzQ5_3b9a8589-a51b-4197-b04d-5a9ac2d10066">4.58</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i6e5c22515f804ea29736c66d5982b201_I20211231" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOjk0OGJlNDUxNjA3YzRkYzFiNTYwMjIzNDI5ZmViZmI0L3RhYmxlcmFuZ2U6OTQ4YmU0NTE2MDdjNGRjMWI1NjAyMjM0MjlmZWJmYjRfNC0wLTEtMS00NjMzNC90ZXh0cmVnaW9uOjdhMDgyYzEyOWU1MjRjNDc5MDE3MWIwMDUwY2RkMDA1XzU2_098d627c-f9c1-4e3f-ba63-89a8e0abb6b0">1.60</ix:nonFraction>% at September 30, 2022 and December 31, 2021, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaed1e277c72c475e9d7788035f2b51e8_I20220930" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOjk0OGJlNDUxNjA3YzRkYzFiNTYwMjIzNDI5ZmViZmI0L3RhYmxlcmFuZ2U6OTQ4YmU0NTE2MDdjNGRjMWI1NjAyMjM0MjlmZWJmYjRfNC0xLTEtMS00NjMzNA_1e6ff19a-09cd-4897-ba19-9d13b3426060">9,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaed1e277c72c475e9d7788035f2b51e8_I20220930" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOjk0OGJlNDUxNjA3YzRkYzFiNTYwMjIzNDI5ZmViZmI0L3RhYmxlcmFuZ2U6OTQ4YmU0NTE2MDdjNGRjMWI1NjAyMjM0MjlmZWJmYjRfNC0zLTEtMS00NjMzNA_16aa541a-66a3-44a4-89c7-14f0d9e92582">3,642</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e5c22515f804ea29736c66d5982b201_I20211231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOjk0OGJlNDUxNjA3YzRkYzFiNTYwMjIzNDI5ZmViZmI0L3RhYmxlcmFuZ2U6OTQ4YmU0NTE2MDdjNGRjMWI1NjAyMjM0MjlmZWJmYjRfNC01LTEtMS00NjMzNA_e37a2e22-5a43-4ea8-9e93-0d850c598cb4">9,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e5c22515f804ea29736c66d5982b201_I20211231" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOjk0OGJlNDUxNjA3YzRkYzFiNTYwMjIzNDI5ZmViZmI0L3RhYmxlcmFuZ2U6OTQ4YmU0NTE2MDdjNGRjMWI1NjAyMjM0MjlmZWJmYjRfNC03LTEtMS00NjMzNA_76fee0ee-31b9-41af-9022-1960b02e48ac">991</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Note Payable, interest of <ix:nonFraction unitRef="number" contextRef="i2fc39805f3624e12ba3b38847a2f8810_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOjk0OGJlNDUxNjA3YzRkYzFiNTYwMjIzNDI5ZmViZmI0L3RhYmxlcmFuZ2U6OTQ4YmU0NTE2MDdjNGRjMWI1NjAyMjM0MjlmZWJmYjRfNS0wLTEtMS00NjMzNC90ZXh0cmVnaW9uOmNjM2I3YTJmNjJlMzRmZTdiOGQ2MTQ3YTY1ZmUwYTRiXzMw_27f17496-d21b-4a38-be5d-bec2b6105698">2.00</ix:nonFraction>% per annum at December 31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7bf7274f80f465789bbdcc936e17070_I20220930" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOjk0OGJlNDUxNjA3YzRkYzFiNTYwMjIzNDI5ZmViZmI0L3RhYmxlcmFuZ2U6OTQ4YmU0NTE2MDdjNGRjMWI1NjAyMjM0MjlmZWJmYjRfNS0xLTEtMS00NjMzNA_f05233b1-22ac-4bef-8ffe-48524e726059">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7bf7274f80f465789bbdcc936e17070_I20220930" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOjk0OGJlNDUxNjA3YzRkYzFiNTYwMjIzNDI5ZmViZmI0L3RhYmxlcmFuZ2U6OTQ4YmU0NTE2MDdjNGRjMWI1NjAyMjM0MjlmZWJmYjRfNS0zLTEtMS00NjMzNA_6ff4ce4e-e13f-41af-878b-0422f2a7c041">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fc39805f3624e12ba3b38847a2f8810_I20211231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOjk0OGJlNDUxNjA3YzRkYzFiNTYwMjIzNDI5ZmViZmI0L3RhYmxlcmFuZ2U6OTQ4YmU0NTE2MDdjNGRjMWI1NjAyMjM0MjlmZWJmYjRfNS01LTEtMS00NjMzNA_69cdb70a-15fb-4434-bc41-0f7775d5beab">2,426</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fc39805f3624e12ba3b38847a2f8810_I20211231" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOjk0OGJlNDUxNjA3YzRkYzFiNTYwMjIzNDI5ZmViZmI0L3RhYmxlcmFuZ2U6OTQ4YmU0NTE2MDdjNGRjMWI1NjAyMjM0MjlmZWJmYjRfNS03LTEtMS00NjMzNA_a1f93422-7973-4361-95b9-b521d486c852">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOjk0OGJlNDUxNjA3YzRkYzFiNTYwMjIzNDI5ZmViZmI0L3RhYmxlcmFuZ2U6OTQ4YmU0NTE2MDdjNGRjMWI1NjAyMjM0MjlmZWJmYjRfNi0xLTEtMS00NjMzNA_d6f9f35f-9df7-4730-a4f5-4e725a7117f2">133,075</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOjk0OGJlNDUxNjA3YzRkYzFiNTYwMjIzNDI5ZmViZmI0L3RhYmxlcmFuZ2U6OTQ4YmU0NTE2MDdjNGRjMWI1NjAyMjM0MjlmZWJmYjRfNi0zLTEtMS00NjMzNA_2d5d27a9-ca45-4e26-a40c-d0751931da7d">6,962</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOjk0OGJlNDUxNjA3YzRkYzFiNTYwMjIzNDI5ZmViZmI0L3RhYmxlcmFuZ2U6OTQ4YmU0NTE2MDdjNGRjMWI1NjAyMjM0MjlmZWJmYjRfNi01LTEtMS00NjMzNA_3b0ad32c-a6c1-4b89-9d39-53f4367240d6">185,938</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOjk0OGJlNDUxNjA3YzRkYzFiNTYwMjIzNDI5ZmViZmI0L3RhYmxlcmFuZ2U6OTQ4YmU0NTE2MDdjNGRjMWI1NjAyMjM0MjlmZWJmYjRfNi03LTEtMS00NjMzNA_f9e471e8-6379-4fd3-9311-f0e9218102d6">6,387</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion - Note Payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7bf7274f80f465789bbdcc936e17070_I20220930" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOjk0OGJlNDUxNjA3YzRkYzFiNTYwMjIzNDI5ZmViZmI0L3RhYmxlcmFuZ2U6OTQ4YmU0NTE2MDdjNGRjMWI1NjAyMjM0MjlmZWJmYjRfNy0xLTEtMS00NjMzNA_867ab110-9de8-4f9a-b170-7f4dbd52aaba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fc39805f3624e12ba3b38847a2f8810_I20211231" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOjk0OGJlNDUxNjA3YzRkYzFiNTYwMjIzNDI5ZmViZmI0L3RhYmxlcmFuZ2U6OTQ4YmU0NTE2MDdjNGRjMWI1NjAyMjM0MjlmZWJmYjRfNy01LTEtMS00NjMzNA_c6f9ba96-d2a7-4f22-a430-370d44e9fa24">2,426</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion - Term Loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide03ccfd1d5f459fbf0f366e300c2751_I20220930" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOjk0OGJlNDUxNjA3YzRkYzFiNTYwMjIzNDI5ZmViZmI0L3RhYmxlcmFuZ2U6OTQ4YmU0NTE2MDdjNGRjMWI1NjAyMjM0MjlmZWJmYjRfOC0xLTEtMS00NjMzNA_ee79cb7f-6b96-456f-840f-39f7e198fdd8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if64036e453b84955b51e99497013571c_I20211231" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOjk0OGJlNDUxNjA3YzRkYzFiNTYwMjIzNDI5ZmViZmI0L3RhYmxlcmFuZ2U6OTQ4YmU0NTE2MDdjNGRjMWI1NjAyMjM0MjlmZWJmYjRfOC01LTEtMS00NjMzNA_ec16b17e-5965-44d8-a78f-d0735d94c436">1,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOjk0OGJlNDUxNjA3YzRkYzFiNTYwMjIzNDI5ZmViZmI0L3RhYmxlcmFuZ2U6OTQ4YmU0NTE2MDdjNGRjMWI1NjAyMjM0MjlmZWJmYjRfOS0xLTEtMS00NjMzNA_073d50d1-4269-4dd8-9ad7-9d88db0a7d52">133,075</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOjk0OGJlNDUxNjA3YzRkYzFiNTYwMjIzNDI5ZmViZmI0L3RhYmxlcmFuZ2U6OTQ4YmU0NTE2MDdjNGRjMWI1NjAyMjM0MjlmZWJmYjRfOS0zLTEtMS00NjMzNA_ed15188b-6274-4a58-877d-e167b9f173de">6,962</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOjk0OGJlNDUxNjA3YzRkYzFiNTYwMjIzNDI5ZmViZmI0L3RhYmxlcmFuZ2U6OTQ4YmU0NTE2MDdjNGRjMWI1NjAyMjM0MjlmZWJmYjRfOS01LTEtMS00NjMzNA_c5b49ed7-00c4-4d10-b835-7face04987e1">181,762</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOjk0OGJlNDUxNjA3YzRkYzFiNTYwMjIzNDI5ZmViZmI0L3RhYmxlcmFuZ2U6OTQ4YmU0NTE2MDdjNGRjMWI1NjAyMjM0MjlmZWJmYjRfOS03LTEtMS00NjMzNA_e1831728-b561-44ac-88f1-9315f3051535">6,387</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, the current portion of the term loan and the note payable are included in current portion of debt on the condensed consolidated balance sheets. The final installment of the note payable, related to contingent consideration assumed as part of a prior period acquisition, was paid in the first quarter of 2022. The Company has elected to present the debt issuance costs associated with its revolving line-of-credit as an asset, which is included in other non-current assets on the                                                                                                                                                                   condensed consolidated balance sheets. As a result, the long-term debt in the above table will not agree to long-term debt, net of current portion on the condensed consolidated balance sheets herein.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Late in the second quarter of 2022, the Company made an optional prepayment of $<ix:nonFraction unitRef="usd" contextRef="i679839afbf554bacadf5512f89216250_D20220401-20220630" decimals="-5" name="ccrn:PaymentForDebtPrepayment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfODY1_33d1811e-61b4-4f12-9ee2-eca070ed13b9">50.0</ix:nonFraction>&#160;million on its term loan. The Company was entitled to determine the application of the prepayment, which was applied to all future amortization payments, with the balance applied to the remaining balloon payment in 2027. <ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfOTc4MA_f30212e8-069f-4f4f-8208-8c93ffec9e16" continuedAt="id98e9f566db14205a488456dda1cffaf" escape="true">As of September 30, 2022, the aggregate schedule for maturities of debt are as follows:</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:justify"><ix:continuation id="id98e9f566db14205a488456dda1cffaf"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.882%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Term Loan</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Senior Secured Asset-Based Loan</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Through Years Ending December&#160;31:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide03ccfd1d5f459fbf0f366e300c2751_I20220930" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOmYxNDIxZDY5NWEzNDQyNTU4MGE0OWYyOWE3N2VmZjBlL3RhYmxlcmFuZ2U6ZjE0MjFkNjk1YTM0NDI1NTgwYTQ5ZjI5YTc3ZWZmMGVfMy0xLTEtMS00NjMzNA_46033dc6-2a8e-4e63-880c-9a6a1835960a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaed1e277c72c475e9d7788035f2b51e8_I20220930" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOmYxNDIxZDY5NWEzNDQyNTU4MGE0OWYyOWE3N2VmZjBlL3RhYmxlcmFuZ2U6ZjE0MjFkNjk1YTM0NDI1NTgwYTQ5ZjI5YTc3ZWZmMGVfMy0zLTEtMS00NjMzNA_6b068527-c79c-43d7-af05-a824c152f0ea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide03ccfd1d5f459fbf0f366e300c2751_I20220930" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOmYxNDIxZDY5NWEzNDQyNTU4MGE0OWYyOWE3N2VmZjBlL3RhYmxlcmFuZ2U6ZjE0MjFkNjk1YTM0NDI1NTgwYTQ5ZjI5YTc3ZWZmMGVfNC0xLTEtMS00NjMzNA_22e00431-b567-476f-8715-d708f1efbe73">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaed1e277c72c475e9d7788035f2b51e8_I20220930" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOmYxNDIxZDY5NWEzNDQyNTU4MGE0OWYyOWE3N2VmZjBlL3RhYmxlcmFuZ2U6ZjE0MjFkNjk1YTM0NDI1NTgwYTQ5ZjI5YTc3ZWZmMGVfNC0zLTEtMS00NjMzNA_e482b4f9-b491-40de-9b6d-f6bd8712aabe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide03ccfd1d5f459fbf0f366e300c2751_I20220930" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOmYxNDIxZDY5NWEzNDQyNTU4MGE0OWYyOWE3N2VmZjBlL3RhYmxlcmFuZ2U6ZjE0MjFkNjk1YTM0NDI1NTgwYTQ5ZjI5YTc3ZWZmMGVfNS0xLTEtMS00NjMzNA_d92e5e25-2091-417e-b37f-150015d199dc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaed1e277c72c475e9d7788035f2b51e8_I20220930" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOmYxNDIxZDY5NWEzNDQyNTU4MGE0OWYyOWE3N2VmZjBlL3RhYmxlcmFuZ2U6ZjE0MjFkNjk1YTM0NDI1NTgwYTQ5ZjI5YTc3ZWZmMGVfNS0zLTEtMS00NjMzNA_7f318b23-8188-4b9b-90da-4be1a6df577b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide03ccfd1d5f459fbf0f366e300c2751_I20220930" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOmYxNDIxZDY5NWEzNDQyNTU4MGE0OWYyOWE3N2VmZjBlL3RhYmxlcmFuZ2U6ZjE0MjFkNjk1YTM0NDI1NTgwYTQ5ZjI5YTc3ZWZmMGVfNi0xLTEtMS00NjMzNA_3b90f438-8810-4b69-ad9f-7ab54c513fba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaed1e277c72c475e9d7788035f2b51e8_I20220930" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOmYxNDIxZDY5NWEzNDQyNTU4MGE0OWYyOWE3N2VmZjBlL3RhYmxlcmFuZ2U6ZjE0MjFkNjk1YTM0NDI1NTgwYTQ5ZjI5YTc3ZWZmMGVfNi0zLTEtMS00NjMzNA_5e7e49d3-1fb4-442a-9967-b49b21763f66">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide03ccfd1d5f459fbf0f366e300c2751_I20220930" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOmYxNDIxZDY5NWEzNDQyNTU4MGE0OWYyOWE3N2VmZjBlL3RhYmxlcmFuZ2U6ZjE0MjFkNjk1YTM0NDI1NTgwYTQ5ZjI5YTc3ZWZmMGVfNy0xLTEtMS00NjMzNA_f95384bf-a81a-4d2f-b132-33eb8bc15e4e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaed1e277c72c475e9d7788035f2b51e8_I20220930" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOmYxNDIxZDY5NWEzNDQyNTU4MGE0OWYyOWE3N2VmZjBlL3RhYmxlcmFuZ2U6ZjE0MjFkNjk1YTM0NDI1NTgwYTQ5ZjI5YTc3ZWZmMGVfNy0zLTEtMS00NjMzNA_f448bb7a-ed32-47b0-8e38-3f59ffe87155">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide03ccfd1d5f459fbf0f366e300c2751_I20220930" decimals="-3" name="ccrn:LongTermDebtMaturityAfterYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOmYxNDIxZDY5NWEzNDQyNTU4MGE0OWYyOWE3N2VmZjBlL3RhYmxlcmFuZ2U6ZjE0MjFkNjk1YTM0NDI1NTgwYTQ5ZjI5YTc3ZWZmMGVfOC0xLTEtMS00NjMzNA_bf14ff66-99ac-451d-9b29-f1dd0afb231e">123,875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaed1e277c72c475e9d7788035f2b51e8_I20220930" decimals="-3" name="ccrn:LongTermDebtMaturityAfterYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOmYxNDIxZDY5NWEzNDQyNTU4MGE0OWYyOWE3N2VmZjBlL3RhYmxlcmFuZ2U6ZjE0MjFkNjk1YTM0NDI1NTgwYTQ5ZjI5YTc3ZWZmMGVfOC0zLTEtMS00NjMzNA_1b18b85c-5938-490f-a250-6869a30f1472">9,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide03ccfd1d5f459fbf0f366e300c2751_I20220930" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOmYxNDIxZDY5NWEzNDQyNTU4MGE0OWYyOWE3N2VmZjBlL3RhYmxlcmFuZ2U6ZjE0MjFkNjk1YTM0NDI1NTgwYTQ5ZjI5YTc3ZWZmMGVfOS0xLTEtMS00NjMzNA_0955eb0c-9f3c-4fd9-a2f8-a5b99489bbfa">123,875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaed1e277c72c475e9d7788035f2b51e8_I20220930" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOmYxNDIxZDY5NWEzNDQyNTU4MGE0OWYyOWE3N2VmZjBlL3RhYmxlcmFuZ2U6ZjE0MjFkNjk1YTM0NDI1NTgwYTQ5ZjI5YTc3ZWZmMGVfOS0zLTEtMS00NjMzNA_6bcfc552-e834-47bf-b775-3a061036759b">9,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2021 Term Loan Credit Agreement</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On June 8, 2021, the Company entered into a Term Loan Credit Agreement (Term Loan Agreement) with</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> certain lenders identified therein (collectively, the Lenders) and Wilmington Trust</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, National Association as administrative agent and collateral agent, pursuant to which the Lenders extended to the Company a <ix:nonNumeric contextRef="i870a1a5ad08d4d2187f8499d8bb665d1_D20210608-20210608" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfOTc4MQ_ef78dc45-7f1e-4228-9880-55d020586086">six-year</ix:nonNumeric> second lien subordinated term loan in the amount of $<ix:nonFraction unitRef="usd" contextRef="ib9754d616f5a4ee8a091ad6be918e235_I20210608" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfMTU2NA_31ee8f89-3e36-471c-bf68-7c821b7f5220">100.0</ix:nonFraction>&#160;million (term loan). The term loan has an interest rate of one-month London Inter-Bank Offered Rate (LIBOR) plus <ix:nonFraction unitRef="number" contextRef="iedb34638d63143a8b4c18058a909b8c5_D20210608-20210608" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfMTY3Mg_3f2fce38-18fd-48ca-b66c-7dd53f41019e">5.75</ix:nonFraction>% per annum, subject to a <ix:nonFraction unitRef="number" contextRef="iedb34638d63143a8b4c18058a909b8c5_D20210608-20210608" decimals="INF" name="ccrn:DebtInstrumentVariableInterestRateFloor" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfMTY5OQ_d90accce-ece7-4354-87ba-18bfa483f3da">0.75</ix:nonFraction>% LIBOR floor. The term loan was used to pay the cash consideration, as well as any costs, fees, and expenses in connection with the WSG acquisition (see Note 4 - Acquisitions), with the remainder used to pay down a  portion of the asset-based credit facility. Fees paid in connection with the Term Loan Agreement have been included as debt issuance costs and as a reduction to the carrying amount of the term loan and are expected to be amortized to interest expense over the term of the Term Loan Agreement.</span></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="if15a80cd80b441689b02f82de21b3cea" continuedAt="i33097cf1390c454a9a0e2579e00291f7"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The borrowings under the Term Loan Agreement generally bear interest at a variable rate based on either LIBOR or Base Rate (as defined in the Term Loan Agreement) and are subject to mandatory prepayments of principal payable in quarterly installments, commencing on September 30, 2021, with each installment being in the aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="i34f7f97d2f20459aa4e94c8f8c9526d2_D20210930-20210930" decimals="-5" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfMjU1NA_830ce139-1cd3-48fc-bca1-6a296c73b799">0.3</ix:nonFraction> million (subject to adjustment as a result of prepayments) provided that, to the extent not previously paid, the aggregate unpaid principal balance would be due and payable on the maturity date. The Term Loan Agreement contains various restrictions and covenants applicable to the Company and its subsidiaries, including a covenant to maintain a minimum net leverage ratio. The Company was in compliance with this covenant as of September 30, 2022. Obligations under the Term Loan Agreement are secured by substantially all the assets of the borrowers and guarantors under the Term Loan Agreement, subject to customary exceptions.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 18, 2021, the Company amended its Term Loan Agreement (Term Loan First Amendment), which provided the Company an incremental term loan in an aggregate amount equal to $<ix:nonFraction unitRef="usd" contextRef="i9f569e337ebb415d913c1f6a219076e4_I20211118" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfMzM1NA_0359231f-94f0-49ba-9121-d46867135ead">75.0</ix:nonFraction>&#160;million. Additionally, the Term Loan First Amendment increased the aggregate amount of all increases (as defined in the Term Loan Agreement) to be no greater than $<ix:nonFraction unitRef="usd" contextRef="i41f166769fd2450f9e1ac7343566e768_I20211118" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfMzUxMg_a3f1b7c0-e84a-4153-ac03-ec3469c8fcc0">115.0</ix:nonFraction>&#160;million. The borrowings will be used primarily to fund organic growth. Commencing on December 31, 2021, installments of the mandatory prepayments will be in the aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="i1203eeee9648493cab15c9a9c56887ea_D20211231-20211231" decimals="-5" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfMzY5OA_edbd62e3-f3c9-458e-9d79-e5229e9ab8b3">0.4</ix:nonFraction>&#160;million. All other terms, conditions, covenants, and pricing of the Term Loan Agreement remain the same. In conjunction with the Term Loan First Amendment, the Company entered into the Term Loan First Amendment to the Intercreditor Agreement, effective as of November 18, 2021, which sets forth the lien priority, relative rights, and other creditors&#8217; rights issues in respect of the collateral lenders.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to its scheduled payments, on June 23, 2022, the Company made an optional prepayment of $<ix:nonFraction unitRef="usd" contextRef="ie2b5f4df2dca4db3b15dfee015bb5eb9_D20220623-20220623" decimals="-5" name="ccrn:PaymentForDebtPrepayment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfNDE5NA_4b6e8eee-24f2-434e-b569-c83777c067cc">50.0</ix:nonFraction>&#160;million to reduce interest costs, and paid a prepayment premium of $<ix:nonFraction unitRef="usd" contextRef="ie2b5f4df2dca4db3b15dfee015bb5eb9_D20220623-20220623" decimals="-5" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfNDI1Ng_5ad462aa-d41d-4f7f-b1b1-85e8dd4ef28b">0.5</ix:nonFraction>&#160;million pursuant to the Term Loan Agreement. As a result of the early prepayment, debt issuance costs of $<ix:nonFraction unitRef="usd" contextRef="i679839afbf554bacadf5512f89216250_D20220401-20220630" decimals="-5" name="us-gaap:WriteOffOfDeferredDebtIssuanceCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfNDM1Ng_48f79eac-5111-46f7-94f9-715cdaea0c7f">1.4</ix:nonFraction>&#160;million were written off in the three months ended June 30, 2022. The prepayment premium and the write-off of debt issuance costs are included as loss on early extinguishment of debt in the condensed consolidated statements of operations. </span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The term loan is secured by a second-priority security interest in the collateral as defined in the ABL Credit Agreement (Loan Agreement) (as described below), and Wells Fargo Bank, National Association as agent, as amended by the First Amendment, Second Amendment, Third Amendment, Fourth Amendment, and Fifth Amendment to the Loan Agreement. The lien priority, relative rights, and other creditors&#8217; rights issues in respect of the collateral lenders are set forth in the Intercreditor Agreement, by and among Wells Fargo Bank, National Association, as first lien agent, and Wilmington Trust, National Association, as second lien agent, as amended, restated, amended and restated, supplemented or otherwise modified from time to time in accordance with the terms thereof dated June 8, 2021 (Intercreditor Agreement).</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2019 Loan Agreement</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective October 25, 2019, the Company terminated its commitments under its prior senior credit facility entered into in August 2017 and entered into a Loan Agreement, by and among the Company and certain of its domestic subsidiaries, as borrowers or guarantors, Wells Fargo, PNC Bank N.A., as well as other Lenders (as defined therein) from time to time parties thereto. The Loan Agreement provides for a <ix:nonNumeric contextRef="i6158fa637abd4af3ae6d409e2ff6470e_D20191025-20191025" name="us-gaap:LineOfCreditFacilityExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfOTc3Ng_4cf6d4e3-09a3-47f4-b699-a99671edf134">five-year</ix:nonNumeric> revolving senior secured asset-based credit facility (ABL) in the aggregate principal amount of up to $<ix:nonFraction unitRef="usd" contextRef="ic7e12eb577054a99aa4bc801b8f7a4e2_I20191025" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfNTk2MA_c3020ba7-2b2a-42d9-9830-04178d3ba53d">120.0</ix:nonFraction>&#160;million (as described below), including a sublimit for swing loans up to $<ix:nonFraction unitRef="usd" contextRef="if4c7c74b2761411095a93a4e4420b8ba_I20191025" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfNjAyOA_d06314bd-58d3-4097-9335-86af7b0bacca">15.0</ix:nonFraction>&#160;million and a $<ix:nonFraction unitRef="usd" contextRef="i939e68a3ba5c42dba3abaaad4215f029_I20191025" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfNjAzNw_f0b74d79-afc1-4095-bc4a-d2cf35fbcf64">35.0</ix:nonFraction>&#160;million sublimit for standby letters of credit.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 30, 2020, the Company amended its Loan Agreement (First Amendment), which increased the current aggregate committed size of the ABL from $<ix:nonFraction unitRef="usd" contextRef="ic7e12eb577054a99aa4bc801b8f7a4e2_I20191025" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfNjIyNQ_5c58f340-6dac-48be-ace0-71be8bc57c47">120.0</ix:nonFraction>&#160;million to $<ix:nonFraction unitRef="usd" contextRef="i04b66ed81c9249438ac7e6deac027e0c_I20200630" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfNjIzMQ_f84df364-0652-456c-b17d-b77942b46b90">130.0</ix:nonFraction>&#160;million. All other terms, conditions, covenants, and pricing of the Loan Agreement remained the same. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 8, 2021, the Company amended its Loan Agreement (Second Amendment), which increased the current aggregate committed size of the ABL from $<ix:nonFraction unitRef="usd" contextRef="i04b66ed81c9249438ac7e6deac027e0c_I20200630" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfNjQ3NQ_92254a75-306b-49c8-a490-1952121f3b2e">130.0</ix:nonFraction>&#160;million to $<ix:nonFraction unitRef="usd" contextRef="i0a067d85b7ce45c29144e8ce39c70993_I20210308" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfNjQ4MQ_414feffc-4069-463e-bd23-0d84cac295a0">150.0</ix:nonFraction>&#160;million, increased certain borrowing base sub-limits, and decreased both the cash dominion event and financial reporting triggers.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 8, 2021, the Company amended its Loan Agreement (Third Amendment), which permits the incurrence of indebtedness and grant of security as set forth in the Loan Agreement and in accordance with the Intercreditor Agreement, and provides mechanics relating to a transition away from LIBOR as a benchmark interest rate to a replacement alternative benchmark rate or mechanism for loans made in U.S. dollars.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 18, 2021, the Company amended its Loan Agreement (Fourth Amendment), whereby the permitted indebtedness (as defined in the Loan Agreement), was increased to $<ix:nonFraction unitRef="usd" contextRef="i624be7ef98974a18acd4dff1b7f88e73_I20211118" decimals="INF" name="ccrn:LineOfCreditAmountOfIndebtednessPermittedBySeniorSecuredAssetBasedLoanToBeBorrowedFromOtherSources" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfNzE4Nw_b09442f9-5194-4302-868b-2fac2a5b2200">175.0</ix:nonFraction> million.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 21, 2022, the Company amended its Loan Agreement (Fifth Amendment), which increased the current aggregate committed size of the ABL from $<ix:nonFraction unitRef="usd" contextRef="i0a067d85b7ce45c29144e8ce39c70993_I20210308" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfNzMzNw_429fd22d-ce03-43bd-8f1a-444df94bf47c">150.0</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="i270723f4cdb7481096cce56fef2c5108_I20220321" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfNzM0Mw_4ca88f33-c17a-434b-a1cd-22bf025085ba">300.0</ix:nonFraction> million, extended the credit facility for an additional <ix:nonNumeric contextRef="id9318eec3ae14553b2ee10834ffd5fa2_D20220321-20220321" name="us-gaap:LineOfCreditFacilityExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfOTc4Mg_fa2c82c8-7051-4f94-8a91-95f48ca95c86">five years</ix:nonNumeric>, and increased certain borrowing base sub-limits. In addition, the agreement provides the option for all or a portion of the borrowings to bear interest at a rate based on the Secured Overnight Financing Rate (SOFR) or Base Rate, at the election of the </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i33097cf1390c454a9a0e2579e00291f7"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">borrowers, plus an applicable margin. The applicable margin will increase <ix:nonFraction unitRef="number" contextRef="id9318eec3ae14553b2ee10834ffd5fa2_D20220321-20220321" decimals="INF" name="ccrn:LineOfCreditFacilityBasisSpreadOnVariableRateAdditionalCreditSpreadAssociatedWithSOFR" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfNzczMg_e7536cc8-7e79-4ef1-b02b-c109922d9521">10</ix:nonFraction> basis points due to the credit spread associated with the transition to SOFR.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These amendments were treated as modifications of debt and, as a result, the associated fees and costs were included in debt issuance costs and will be amortized ratably over the remaining term of the Loan Agreement.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Availability of the ABL commitments is subject to a borrowing base of up to <ix:nonFraction unitRef="number" contextRef="ic7e12eb577054a99aa4bc801b8f7a4e2_I20191025" decimals="INF" name="ccrn:LineOfCreditBorrowingBasePercentageOfAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfODEwNg_1e9b714e-9aa9-4e98-9669-8670ff880f96">85</ix:nonFraction>% of secured eligible accounts receivable, subject to adjustment at certain quality levels, minus customary reserves and subject to customary adjustments. Revolving loans and letters of credit issued under the Loan Agreement reduce availability under the ABL on a dollar-for-dollar basis. Availability under the ABL will be used for general corporate purposes. At September 30, 2022, borrowing base availability under the ABL was $<ix:nonFraction unitRef="usd" contextRef="i429f9d7a920e4e42bf93ded0492112f6_I20220930" decimals="INF" name="ccrn:LineOfCreditFacilityBorrowingBaseAvailability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfODUzMg_98372e22-855e-44e5-9d50-32bc5dde5abd">300.0</ix:nonFraction>&#160;million and the Company had $<ix:nonFraction unitRef="usd" contextRef="i429f9d7a920e4e42bf93ded0492112f6_I20220930" decimals="-5" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfODU1NQ_934df52a-304b-418c-a53c-6d6998e16027">9.2</ix:nonFraction>&#160;million of borrowings drawn, as well as $<ix:nonFraction unitRef="usd" contextRef="i429f9d7a920e4e42bf93ded0492112f6_I20220930" decimals="-5" name="us-gaap:LettersOfCreditOutstandingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfODU5MA_78c6bd3c-20b7-43e4-b182-1dce06b13d29">17.5</ix:nonFraction>&#160;million of letters of credit outstanding related to workers' compensation and professional liability policies, leaving $<ix:nonFraction unitRef="usd" contextRef="i429f9d7a920e4e42bf93ded0492112f6_I20220930" decimals="-5" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfODcwNA_fdfa3813-49fb-473a-9b8d-98cbf0bef605">273.3</ix:nonFraction>&#160;million of excess availability.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2022, the interest rate spreads and fees under the Loan Agreement were based on SOFR plus <ix:nonFraction unitRef="number" contextRef="ib9a9d68a6c6e40568eec79a197a10ad1_D20220101-20220930" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfODgzNg_f6b6aca8-e52c-4468-bc9a-e31e6a808e28">1.60</ix:nonFraction>% for the revolving portion of the borrowing base. The Base Rate (as defined by the Loan Agreement) margin would have been <ix:nonFraction unitRef="number" contextRef="ib8d17efeeb2945f986a5af6c590ab452_D20220101-20220930" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfODk2MA_9b6d75ea-6200-4f44-9628-fb593b1b1713">0.50</ix:nonFraction>%  for the revolving portion</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The SOFR and Base Rate margins are subject to monthly pricing adjustments, pursuant to a pricing matrix based on the Company&#8217;s excess availability under the revolving credit facility. In addition, the facility is subject to an unused line fee, letter of credit fees, and an administrative fee. The unused line fee is <ix:nonFraction unitRef="number" contextRef="i30a646dd77584028b2f4405de20d759d_D20220101-20220930" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfOTMwOA_5535c443-d4d4-450f-8ecc-2c28e3a7551b">0.375</ix:nonFraction>% of the average daily unused portion of the revolving credit facility.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Loan Agreement contains various restrictions and covenants applicable to the Company and its subsidiaries, including a covenant to maintain a minimum fixed charge coverage ratio. The Company was in compliance with this covenant as of September 30, 2022. Obligations under the ABL are secured by substantially all the assets of the borrowers and guarantors, subject to customary exceptions.</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div id="i5b47dd1c3d5a40ff8e040a94ae232d75_61"></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RleHRyZWdpb246ZTk3ZmNkODQ3Y2IxNDRkOWE0YzZhZWEwYjkxMTFlZGJfMzU4Mg_4cfaf14f-f19b-490c-b7ca-261cc058af69" continuedAt="ia364861c53df495191d4b4d3e943f9ab" escape="true">LEASES</ix:nonNumeric></span></div><div style="padding-left:36pt;text-indent:-36pt"><span><br/></span></div><ix:continuation id="ia364861c53df495191d4b4d3e943f9ab" continuedAt="i7a913cbc9ff040ec9fbcb753fc1033a3"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's lease population of its right-of-use assets and lease liabilities is substantially related to the rental of office space. The Company enters into lease agreements as a lessee that may include options to extend or terminate early. Some of these real estate leases require variable payments of property taxes, insurance, and common area maintenance, in addition to base rent. Certain of the leases have provisions for free rent months during the lease term and/or escalating rent payments and, particularly for the Company&#8217;s longer-term leases for its corporate offices, it has received incentives to enter into the leases, such as receiving up to a specified dollar amount to construct tenant improvements. These leases do not include residual value guarantees, covenants, or other restrictions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in the second quarter of 2020, in connection with the continuing developments from COVID, the Company expedited restructuring plans and either reduced or fully vacated leased office space. The Company is in the process of seeking to sublet some of the space where possible. The decision and change in the use of space resulted in a right-of-use asset impairment charge of $<ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-5" name="us-gaap:OperatingLeaseImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RleHRyZWdpb246ZTk3ZmNkODQ3Y2IxNDRkOWE0YzZhZWEwYjkxMTFlZGJfMTMxMw_6da96a09-832c-4b0f-8cd8-2e78f7a0f8fa">2.8</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-5" name="us-gaap:OperatingLeaseImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RleHRyZWdpb246ZTk3ZmNkODQ3Y2IxNDRkOWE0YzZhZWEwYjkxMTFlZGJfMTM2Mg_21f2c82a-38f5-42c6-bd8b-20ec67fda798">1.7</ix:nonFraction>&#160;million for the nine months ended September 30, 2022 and 2021, respectively. This loss was determined by comparing the fair value of the impacted right-of-use assets to the carrying value of the assets as of the impairment measurement date. The fair value of the right-of-use assets was based on the estimated sublease income for the space taking into consideration the time period it will take to obtain a subtenant, the applicable discount rate, and the sublease rate. For the nine months ended September 30, 2022 and 2021, the Company wrote off an immaterial amount of leasehold improvements and other property and equipment related to these locations. The measurement of the right-of-use asset impairments, using the assumptions described, is a Level 3 fair value measurement. See Note 10 - Fair Value Measurements for a description of Level 3 inputs.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="ccrn:AssetsAndLiabilitiesLeasesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RleHRyZWdpb246ZTk3ZmNkODQ3Y2IxNDRkOWE0YzZhZWEwYjkxMTFlZGJfMzU4Mw_22e8787c-206a-44ed-9d0f-34a4f985c718" continuedAt="ib81d3d57acd942ca8a3f872d309b31e7" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the lease-related assets and liabilities included on the condensed consolidated balance sheets:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.853%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.854%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Classification on Condensed Consolidated Balance Sheets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOjlhYjVmOWZjZDhhYzQ1Zjg5NDA2YWI4YWE4ZDUxZmQxL3RhYmxlcmFuZ2U6OWFiNWY5ZmNkOGFjNDVmODk0MDZhYjhhYThkNTFmZDFfMi0xLTEtMS00NjMzNA_3c8796c4-7017-42fa-afd1-5fe922e7b9b0">3,249</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOjlhYjVmOWZjZDhhYzQ1Zjg5NDA2YWI4YWE4ZDUxZmQxL3RhYmxlcmFuZ2U6OWFiNWY5ZmNkOGFjNDVmODk0MDZhYjhhYThkNTFmZDFfMi0zLTEtMS00NjMzNA_badde80e-483d-4d13-98a7-f8490ca0a2be">7,488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities - current</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOjlhYjVmOWZjZDhhYzQ1Zjg5NDA2YWI4YWE4ZDUxZmQxL3RhYmxlcmFuZ2U6OWFiNWY5ZmNkOGFjNDVmODk0MDZhYjhhYThkNTFmZDFfMy0xLTEtMS00NjMzNA_5efce532-d10e-4ab2-83b8-5114d5131ed9">4,489</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOjlhYjVmOWZjZDhhYzQ1Zjg5NDA2YWI4YWE4ZDUxZmQxL3RhYmxlcmFuZ2U6OWFiNWY5ZmNkOGFjNDVmODk0MDZhYjhhYThkNTFmZDFfMy0zLTEtMS00NjMzNA_d1a8c80f-233d-40a3-8210-900d239ace8f">4,090</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities - non-current</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOjlhYjVmOWZjZDhhYzQ1Zjg5NDA2YWI4YWE4ZDUxZmQxL3RhYmxlcmFuZ2U6OWFiNWY5ZmNkOGFjNDVmODk0MDZhYjhhYThkNTFmZDFfNC0xLTEtMS00NjMzNA_cdf50d07-26d5-45a3-90e1-7ef7b4143541">5,493</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOjlhYjVmOWZjZDhhYzQ1Zjg5NDA2YWI4YWE4ZDUxZmQxL3RhYmxlcmFuZ2U6OWFiNWY5ZmNkOGFjNDVmODk0MDZhYjhhYThkNTFmZDFfNC0zLTEtMS00NjMzNA_4a44b9e2-5082-4a66-a114-c5d29fffd9d9">10,853</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i7a913cbc9ff040ec9fbcb753fc1033a3" continuedAt="i2aa48db4fb744a408d6d9327569cfe0b"><div style="text-align:center"><ix:continuation id="ib81d3d57acd942ca8a3f872d309b31e7"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.853%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.854%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOmI5Zjg4ZTFlOWZlMDRhZGRiZjE1MmM3NDk5MGQ3NGIwL3RhYmxlcmFuZ2U6YjlmODhlMWU5ZmUwNGFkZGJmMTUyYzc0OTkwZDc0YjBfMS0xLTEtMS00NjMzNA_91238271-4aaf-4dda-97b1-8810d135b77a">2.4</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOmI5Zjg4ZTFlOWZlMDRhZGRiZjE1MmM3NDk5MGQ3NGIwL3RhYmxlcmFuZ2U6YjlmODhlMWU5ZmUwNGFkZGJmMTUyYzc0OTkwZDc0YjBfMS0zLTEtMS00NjMzNA_fc6f1b00-029c-4b12-abf5-7320d6666871">3.4</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOmI5Zjg4ZTFlOWZlMDRhZGRiZjE1MmM3NDk5MGQ3NGIwL3RhYmxlcmFuZ2U6YjlmODhlMWU5ZmUwNGFkZGJmMTUyYzc0OTkwZDc0YjBfMi0xLTEtMS00NjMzNA_80aea736-6ee7-4ca1-bbab-cfda8cd8b902">6.31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOmI5Zjg4ZTFlOWZlMDRhZGRiZjE1MmM3NDk5MGQ3NGIwL3RhYmxlcmFuZ2U6YjlmODhlMWU5ZmUwNGFkZGJmMTUyYzc0OTkwZDc0YjBfMi0zLTEtMS00NjMzNA_2a093bfa-6104-4d2b-a4c6-6034245498f3">6.39</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:continuation></div><div><span><br/></span></div><ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RleHRyZWdpb246ZTk3ZmNkODQ3Y2IxNDRkOWE0YzZhZWEwYjkxMTFlZGJfMzU4NQ_91898afe-01a4-436d-b0a6-b0b6b63897ca" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below reconciles the undiscounted cash flows for each of, and total of, the remaining years to the operating lease liabilities (which do not include short-term leases) recorded on the condensed consolidated balance sheets as of September 30, 2022:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:75.811%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ending December&#160;31:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOjMzMDM1OTUxNDhjNjQxZTA5ODY5NDM2NGUzMmI4MjU5L3RhYmxlcmFuZ2U6MzMwMzU5NTE0OGM2NDFlMDk4Njk0MzY0ZTMyYjgyNTlfMi0xLTEtMS00NjMzNA_2093ac8e-0fa9-4490-b825-b7a8de94f698">854</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOjMzMDM1OTUxNDhjNjQxZTA5ODY5NDM2NGUzMmI4MjU5L3RhYmxlcmFuZ2U6MzMwMzU5NTE0OGM2NDFlMDk4Njk0MzY0ZTMyYjgyNTlfMy0xLTEtMS00NjMzNA_78cbf9cb-9786-4046-a851-6061a4b23c9d">5,135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOjMzMDM1OTUxNDhjNjQxZTA5ODY5NDM2NGUzMmI4MjU5L3RhYmxlcmFuZ2U6MzMwMzU5NTE0OGM2NDFlMDk4Njk0MzY0ZTMyYjgyNTlfNC0xLTEtMS00NjMzNA_afc64d82-9fc4-40ce-9590-19ac1c670753">3,047</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOjMzMDM1OTUxNDhjNjQxZTA5ODY5NDM2NGUzMmI4MjU5L3RhYmxlcmFuZ2U6MzMwMzU5NTE0OGM2NDFlMDk4Njk0MzY0ZTMyYjgyNTlfNS0xLTEtMS00NjMzNA_4f965e93-927b-451a-9236-8fcbca3b2068">1,886</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total minimum lease payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOjMzMDM1OTUxNDhjNjQxZTA5ODY5NDM2NGUzMmI4MjU5L3RhYmxlcmFuZ2U6MzMwMzU5NTE0OGM2NDFlMDk4Njk0MzY0ZTMyYjgyNTlfNy0xLTEtMS00NjMzNA_faf849bf-870c-4a48-9358-adcf835f4047">10,922</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amount of lease payments representing interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOjMzMDM1OTUxNDhjNjQxZTA5ODY5NDM2NGUzMmI4MjU5L3RhYmxlcmFuZ2U6MzMwMzU5NTE0OGM2NDFlMDk4Njk0MzY0ZTMyYjgyNTlfOC0xLTEtMS00NjMzNA_da380a13-c249-43da-8de0-f62bced49c52">940</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of future minimum lease payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOjMzMDM1OTUxNDhjNjQxZTA5ODY5NDM2NGUzMmI4MjU5L3RhYmxlcmFuZ2U6MzMwMzU5NTE0OGM2NDFlMDk4Njk0MzY0ZTMyYjgyNTlfOS0xLTEtMS00NjMzNA_5490e653-aded-478b-99b0-e915a9e494fe">9,982</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: operating lease liabilities - current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOjMzMDM1OTUxNDhjNjQxZTA5ODY5NDM2NGUzMmI4MjU5L3RhYmxlcmFuZ2U6MzMwMzU5NTE0OGM2NDFlMDk4Njk0MzY0ZTMyYjgyNTlfMTAtMS0xLTEtNDYzMzQ_9950e4de-be22-4e60-9b94-f91679f21d94">4,489</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities - non-current</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOjMzMDM1OTUxNDhjNjQxZTA5ODY5NDM2NGUzMmI4MjU5L3RhYmxlcmFuZ2U6MzMwMzU5NTE0OGM2NDFlMDk4Njk0MzY0ZTMyYjgyNTlfMTEtMS0xLTEtNDYzMzQ_1051b231-b739-49e2-bbfa-25005c87b8e8">5,493</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Information</span></div><div><span><br/></span></div><div><ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RleHRyZWdpb246ZTk3ZmNkODQ3Y2IxNDRkOWE0YzZhZWEwYjkxMTFlZGJfMzU4Nw_2b7a6848-1c63-42ac-be8c-78197d4bb9ab" continuedAt="i79712610d4be41418123b8cf6e51069d" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below provides information regarding supplemental cash flows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.422%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental Cash Flow Information:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of operating lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOmFjNjgxNzRmOWExZDQzOTA5NDVkZmY0NjQyNDYxMjlkL3RhYmxlcmFuZ2U6YWM2ODE3NGY5YTFkNDM5MDk0NWRmZjQ2NDI0NjEyOWRfNS0xLTEtMS00NjMzNA_d41fe614-951c-4f92-8dfe-b93a2a7a9914">4,446</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOmFjNjgxNzRmOWExZDQzOTA5NDVkZmY0NjQyNDYxMjlkL3RhYmxlcmFuZ2U6YWM2ODE3NGY5YTFkNDM5MDk0NWRmZjQ2NDI0NjEyOWRfNS0zLTEtMS00NjMzNA_5c3a1050-06f0-4c9f-87e5-dd007a3d7817">4,692</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets acquired under operating lease</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOmFjNjgxNzRmOWExZDQzOTA5NDVkZmY0NjQyNDYxMjlkL3RhYmxlcmFuZ2U6YWM2ODE3NGY5YTFkNDM5MDk0NWRmZjQ2NDI0NjEyOWRfNi0xLTEtMS00NjMzNA_b4fe0dce-9bf1-45f3-af74-35df439746e0">59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOmFjNjgxNzRmOWExZDQzOTA5NDVkZmY0NjQyNDYxMjlkL3RhYmxlcmFuZ2U6YWM2ODE3NGY5YTFkNDM5MDk0NWRmZjQ2NDI0NjEyOWRfNi0zLTEtMS00NjMzNA_2f618ab8-2946-46b0-ad87-ce7c1fce399e">1,088</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i2aa48db4fb744a408d6d9327569cfe0b"><div><ix:continuation id="i79712610d4be41418123b8cf6e51069d"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense are as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.422%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts Included in Condensed Consolidated Statements of Operations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease expense</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930" decimals="-3" name="us-gaap:OperatingLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOmJlNDFmNmYwMDBhZTRlOTY5MDZiMjE3M2YxMTRjYmIwL3RhYmxlcmFuZ2U6YmU0MWY2ZjAwMGFlNGU5NjkwNmIyMTczZjExNGNiYjBfNS0xLTEtMS00NjMzNA_a8a6e111-7193-4c05-b7b1-83fb44aba8d7">596</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930" decimals="-3" name="us-gaap:OperatingLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOmJlNDFmNmYwMDBhZTRlOTY5MDZiMjE3M2YxMTRjYmIwL3RhYmxlcmFuZ2U6YmU0MWY2ZjAwMGFlNGU5NjkwNmIyMTczZjExNGNiYjBfNS0zLTEtMS00NjMzNA_693aa2ac-a80f-4336-a93c-bdf82b1e81d3">848</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease expense</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930" decimals="-3" name="us-gaap:ShortTermLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOmJlNDFmNmYwMDBhZTRlOTY5MDZiMjE3M2YxMTRjYmIwL3RhYmxlcmFuZ2U6YmU0MWY2ZjAwMGFlNGU5NjkwNmIyMTczZjExNGNiYjBfNi0xLTEtMS00NjMzNA_d434f8de-d3b1-4673-aa44-569cdf7d95bf">1,743</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930" decimals="-3" name="us-gaap:ShortTermLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOmJlNDFmNmYwMDBhZTRlOTY5MDZiMjE3M2YxMTRjYmIwL3RhYmxlcmFuZ2U6YmU0MWY2ZjAwMGFlNGU5NjkwNmIyMTczZjExNGNiYjBfNi0zLTEtMS00NjMzNA_f519b090-aa30-4714-9d68-615d281b09e5">1,033</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable and other lease costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930" decimals="-3" name="ccrn:VariableAndOtherLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOmJlNDFmNmYwMDBhZTRlOTY5MDZiMjE3M2YxMTRjYmIwL3RhYmxlcmFuZ2U6YmU0MWY2ZjAwMGFlNGU5NjkwNmIyMTczZjExNGNiYjBfNy0xLTEtMS00NjMzNA_71e4819c-b9af-4ab4-a351-9866bfe53e28">2,027</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930" decimals="-3" name="ccrn:VariableAndOtherLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOmJlNDFmNmYwMDBhZTRlOTY5MDZiMjE3M2YxMTRjYmIwL3RhYmxlcmFuZ2U6YmU0MWY2ZjAwMGFlNGU5NjkwNmIyMTczZjExNGNiYjBfNy0zLTEtMS00NjMzNA_889b24aa-f08f-4de5-883f-90d6d27168f4">419</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts Included in Condensed Consolidated Statements of Operations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease expense</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOmJlNDFmNmYwMDBhZTRlOTY5MDZiMjE3M2YxMTRjYmIwL3RhYmxlcmFuZ2U6YmU0MWY2ZjAwMGFlNGU5NjkwNmIyMTczZjExNGNiYjBfMTQtMS0xLTEtNDYzMzQ_b937e433-3d10-443e-ba1a-581c5314582a">2,043</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOmJlNDFmNmYwMDBhZTRlOTY5MDZiMjE3M2YxMTRjYmIwL3RhYmxlcmFuZ2U6YmU0MWY2ZjAwMGFlNGU5NjkwNmIyMTczZjExNGNiYjBfMTQtMy0xLTEtNDYzMzQ_8712c35e-ef6b-48f1-9a98-c4d5646ea280">2,700</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease expense</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="us-gaap:ShortTermLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOmJlNDFmNmYwMDBhZTRlOTY5MDZiMjE3M2YxMTRjYmIwL3RhYmxlcmFuZ2U6YmU0MWY2ZjAwMGFlNGU5NjkwNmIyMTczZjExNGNiYjBfMTUtMS0xLTEtNDYzMzQ_03d634b9-bc3f-4067-8df4-0dbbaa414226">4,128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="us-gaap:ShortTermLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOmJlNDFmNmYwMDBhZTRlOTY5MDZiMjE3M2YxMTRjYmIwL3RhYmxlcmFuZ2U6YmU0MWY2ZjAwMGFlNGU5NjkwNmIyMTczZjExNGNiYjBfMTUtMy0xLTEtNDYzMzQ_aa7e11db-bb69-4b7f-a307-0ec1ff992008">2,523</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable and other lease costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="ccrn:VariableAndOtherLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOmJlNDFmNmYwMDBhZTRlOTY5MDZiMjE3M2YxMTRjYmIwL3RhYmxlcmFuZ2U6YmU0MWY2ZjAwMGFlNGU5NjkwNmIyMTczZjExNGNiYjBfMTYtMS0xLTEtNDYzMzQ_94977d41-e135-4a65-bbba-92d2abfb9576">1,674</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="ccrn:VariableAndOtherLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOmJlNDFmNmYwMDBhZTRlOTY5MDZiMjE3M2YxMTRjYmIwL3RhYmxlcmFuZ2U6YmU0MWY2ZjAwMGFlNGU5NjkwNmIyMTczZjExNGNiYjBfMTYtMy0xLTEtNDYzMzQ_fdf7c852-77a3-4420-b57d-0e56514a1ec0">1,638</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease expense, short-term lease expense, and variable and other lease costs are included in selling, general and administrative expenses, direct operating expenses, and restructuring costs in the condensed consolidated statements of operations, depending on the nature of the leased asset. Operating lease expense is reported net of sublease income, which is not material. Variable and other lease costs for the nine months ended September 30, 2022 include a benefit associated with the early termination of a lease for one of the Company's corporate offices which was previously restructured.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2022, the Company did not have any material operating leases which had not yet commenced. The Company has an immaterial</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">amount of finance lease contracts related to other equipment rentals which are not included in the above disclosures.</span></div></ix:continuation><div><span><br/></span></div><div id="i5b47dd1c3d5a40ff8e040a94ae232d75_64"></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82NC9mcmFnOjkxNWIyYjk1NWNjYTRjOWViZTJmYWM0NzhlN2QwZTU1L3RleHRyZWdpb246OTE1YjJiOTU1Y2NhNGM5ZWJlMmZhYzQ3OGU3ZDBlNTVfNTMxNw_0dc46db6-ea22-4141-b6de-4972fb63a63a" continuedAt="icff9d4d24ca549c98463335748cba7c7" escape="true">FAIR VALUE MEASUREMENTS</ix:nonNumeric></span></div><ix:continuation id="icff9d4d24ca549c98463335748cba7c7" continuedAt="i410eb5f700204c36b4c981c0b6ebfb06"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. A fair value hierarchy was established which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. There are three levels of inputs that may be used to measure fair value:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Quoted prices in active markets for identical assets or liabilities.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Items Measured at Fair Value on a Recurring Basis:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s financial assets/liabilities required to be measured on a recurring basis were its: (i) deferred compensation asset included in other non-current assets; and (ii) deferred compensation liability included in other long-term liabilities on its condensed consolidated balance sheets.</span></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i410eb5f700204c36b4c981c0b6ebfb06" continuedAt="i16dfe32cef4645f5a143a8ebf585c5a3"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;The Company utilizes Level 1 inputs to value its deferred compensation assets and liabilities. The Company&#8217;s deferred compensation assets and liabilities are measured using publicly available indices, as per the plan documents.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82NC9mcmFnOjkxNWIyYjk1NWNjYTRjOWViZTJmYWM0NzhlN2QwZTU1L3RleHRyZWdpb246OTE1YjJiOTU1Y2NhNGM5ZWJlMmZhYzQ3OGU3ZDBlNTVfNTMyOA_296f18cb-17e4-4790-9fa1-9d4b402a0816" continuedAt="i88415a80704e46c8a4cf6215de4c10f7" escape="true">The estimated fair value of the Company&#8217;s financial assets and liabilities measured on a recurring basis is as follows:&#160;</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-align:center"><ix:continuation id="i88415a80704e46c8a4cf6215de4c10f7"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value Measurements</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:58.284%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.401%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.412%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.403%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Level 1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation asset</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i817acb52936447dcac8bfc2fdc5f10c2_I20220930" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82NC9mcmFnOjkxNWIyYjk1NWNjYTRjOWViZTJmYWM0NzhlN2QwZTU1L3RhYmxlOjIwYWVlNDNjYTM4MjQ1OTZhYWM2MGYwNjE0NzgzNTljL3RhYmxlcmFuZ2U6MjBhZWU0M2NhMzgyNDU5NmFhYzYwZjA2MTQ3ODM1OWNfNC0xLTEtMS00NjMzNA_137e8cdf-034f-4620-8a5e-1e8337e6dcd5">2,219</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72a3bcd2bb48b4bb23ea38343be599_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82NC9mcmFnOjkxNWIyYjk1NWNjYTRjOWViZTJmYWM0NzhlN2QwZTU1L3RhYmxlOjIwYWVlNDNjYTM4MjQ1OTZhYWM2MGYwNjE0NzgzNTljL3RhYmxlcmFuZ2U6MjBhZWU0M2NhMzgyNDU5NmFhYzYwZjA2MTQ3ODM1OWNfNC0zLTEtMS00NjMzNA_290e9626-2394-4c8b-bb23-216b30d40773">1,398</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Liabilities:</span></td><td colspan="9" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Level 1)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liability</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e7a429958f04663bc3d74b1a3aab9a6_I20220930" decimals="-3" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82NC9mcmFnOjkxNWIyYjk1NWNjYTRjOWViZTJmYWM0NzhlN2QwZTU1L3RhYmxlOjIwYWVlNDNjYTM4MjQ1OTZhYWM2MGYwNjE0NzgzNTljL3RhYmxlcmFuZ2U6MjBhZWU0M2NhMzgyNDU5NmFhYzYwZjA2MTQ3ODM1OWNfNy0xLTEtMS00NjMzNA_9a22d99a-7573-4ec8-b5e9-77782b8e2036">2,317</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ed93b80dd314c62b7cd4dea1d5c7981_I20211231" decimals="-3" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82NC9mcmFnOjkxNWIyYjk1NWNjYTRjOWViZTJmYWM0NzhlN2QwZTU1L3RhYmxlOjIwYWVlNDNjYTM4MjQ1OTZhYWM2MGYwNjE0NzgzNTljL3RhYmxlcmFuZ2U6MjBhZWU0M2NhMzgyNDU5NmFhYzYwZjA2MTQ3ODM1OWNfNy0zLTEtMS00NjMzNA_ac2189cb-c236-44df-b92d-984aab167af5">2,457</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Items Measured at Fair Value on a Non-Recurring Basis:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's non-financial assets, such as goodwill, trade names, other intangible assets, right-of-use assets, and property and equipment, are measured at fair value when there is an indicator of impairment and are recorded at fair value only when an impairment charge is recognized. </span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The nine months ended September 30, 2022 and 2021 included impairment charges to right-of-use assets along with related property and equipment in connection with leases that were vacated. The nine months ended September 30, 2022 also included impairment charges primarily related to the write-off of a discontinued IT project in the third quarter of 2022. Accordingly, as of September 30, 2022 and 2021, these assets were recorded at fair value using Level 3 inputs. See Note 7 - Goodwill, Trade Names, and Other Intangible Assets and Note 9 - Leases for more information about these fair value measurements. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Fair Value Disclosures:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Financial instruments not measured or recorded at fair value in the condensed consolidated balance sheets consist of cash and cash equivalents, accounts receivable, and accounts payable and accrued expenses. The estimated fair value of accounts receivable and accounts payable and&#160;accrued expenses approximate their carrying amount due to the short-term nature of these instruments. Other financial instruments not measured or recorded at fair value include: (i) note payable, (ii) ABL, (iii) term loan, (iv) earnout liabilities related to the WSG acquisition, and (v) earnout liabilities related to the Selected acquisition, as discussed below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(i) The Company paid the third and final installment on its note payable in the first quarter of 2022. Due to its relatively short-term nature, the carrying value of the note payable approximated its fair value. (ii) The carrying amount of the Company's ABL approximates fair value because the interest rates are variable and reflective of market rates. (iii) The estimated fair value of the Company's term loan was calculated applying an interest rate lattice model using Level 2 inputs from available market information. (iv) Potential earnout payments related to the WSG acquisition are contingent upon meeting certain performance requirements based on 2021 through 2023 performance. The Company performed an analysis using multiple forecasted scenarios to determine the fair value of the earnout liability. In the third quarter of 2022, the Company determined that the contingent consideration earnout related to the WSG acquisition was achieved for the 2021 through 2022 period and, as a result, the Company made a $<ix:nonFraction unitRef="usd" contextRef="id9fe5b9beae44701b72bcee962193e53_D20220701-20220930" decimals="-5" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82NC9mcmFnOjkxNWIyYjk1NWNjYTRjOWViZTJmYWM0NzhlN2QwZTU1L3RleHRyZWdpb246OTE1YjJiOTU1Y2NhNGM5ZWJlMmZhYzQ3OGU3ZDBlNTVfMjc0ODc3OTA3NTIzMA_415be30f-de5a-4303-a45a-95c13d72fb96">7.5</ix:nonFraction>&#160;million earnout payment. The remaining earnout liability's carrying amount approximates fair value and is included in current portion of earnout liability on the condensed consolidated balance sheets. See Note 4 - Acquisitions. (v) Potential earnout payments related to the Selected acquisition were contingent upon meeting certain performance requirements based on 2022 and 2023 revenues. The earnout liability's carrying amount approximates fair value and was included in current portion of earnout liability and non-current earnout liability on the condensed consolidated balance sheets. In the second quarter of 2022, the Company determined that the contingent consideration earnout related to the Selected acquisition would not be achieved for 2022 and 2023 and, as a result, the entire liability was reversed. See Note 4 - Acquisitions.</span></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i16dfe32cef4645f5a143a8ebf585c5a3"><div><ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="us-gaap:FairValueByBalanceSheetGroupingTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82NC9mcmFnOjkxNWIyYjk1NWNjYTRjOWViZTJmYWM0NzhlN2QwZTU1L3RleHRyZWdpb246OTE1YjJiOTU1Y2NhNGM5ZWJlMmZhYzQ3OGU3ZDBlNTVfNTMzMQ_0d9b68a9-43a8-4bcf-b051-e944a23977bc" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts and estimated fair value of the Company&#8217;s significant financial instruments that were not measured at fair value are as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.256%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.104%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.104%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.104%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.108%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Level 2)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Note Payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04893fd47a664b8aa11c6aef5de1bfea_I20220930" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82NC9mcmFnOjkxNWIyYjk1NWNjYTRjOWViZTJmYWM0NzhlN2QwZTU1L3RhYmxlOmVkMzAwNGU1NjdjNTQyYTZiMTEyM2M1ZWMzOGI0MDc2L3RhYmxlcmFuZ2U6ZWQzMDA0ZTU2N2M1NDJhNmIxMTIzYzVlYzM4YjQwNzZfNS0xLTEtMS00NjMzNA_505ea950-b1da-4614-8a8b-5d47fb01ac5a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i355e48f54cd24775841d981acdad6c9f_I20220930" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82NC9mcmFnOjkxNWIyYjk1NWNjYTRjOWViZTJmYWM0NzhlN2QwZTU1L3RhYmxlOmVkMzAwNGU1NjdjNTQyYTZiMTEyM2M1ZWMzOGI0MDc2L3RhYmxlcmFuZ2U6ZWQzMDA0ZTU2N2M1NDJhNmIxMTIzYzVlYzM4YjQwNzZfNS0zLTEtMS00NjMzNA_9b74f8e0-edf5-44e4-9495-4f01bf3cbb84">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9435c564ca74ddbb50ac50871543b66_I20211231" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82NC9mcmFnOjkxNWIyYjk1NWNjYTRjOWViZTJmYWM0NzhlN2QwZTU1L3RhYmxlOmVkMzAwNGU1NjdjNTQyYTZiMTEyM2M1ZWMzOGI0MDc2L3RhYmxlcmFuZ2U6ZWQzMDA0ZTU2N2M1NDJhNmIxMTIzYzVlYzM4YjQwNzZfNS01LTEtMS00NjMzNA_74b5cf18-26f0-4ffc-b315-1ef3555d2cf5">2,426</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib59536cd34df4b5c927d7dfd92e21775_I20211231" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82NC9mcmFnOjkxNWIyYjk1NWNjYTRjOWViZTJmYWM0NzhlN2QwZTU1L3RhYmxlOmVkMzAwNGU1NjdjNTQyYTZiMTEyM2M1ZWMzOGI0MDc2L3RhYmxlcmFuZ2U6ZWQzMDA0ZTU2N2M1NDJhNmIxMTIzYzVlYzM4YjQwNzZfNS03LTEtMS00NjMzNA_01f2f41a-6f4e-4755-871f-bafd45087bf2">2,426</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Secured Asset-Based Loan</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25845230e0a34aa3b524e0cd4fac58b2_I20220930" decimals="-3" name="us-gaap:LinesOfCreditFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82NC9mcmFnOjkxNWIyYjk1NWNjYTRjOWViZTJmYWM0NzhlN2QwZTU1L3RhYmxlOmVkMzAwNGU1NjdjNTQyYTZiMTEyM2M1ZWMzOGI0MDc2L3RhYmxlcmFuZ2U6ZWQzMDA0ZTU2N2M1NDJhNmIxMTIzYzVlYzM4YjQwNzZfNi0xLTEtMS00NjMzNA_d350d939-e7b7-4ef1-99d8-c36d1ee946f6">9,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ab3f84da58d407297c219a1e6bee204_I20220930" decimals="-3" name="us-gaap:LinesOfCreditFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82NC9mcmFnOjkxNWIyYjk1NWNjYTRjOWViZTJmYWM0NzhlN2QwZTU1L3RhYmxlOmVkMzAwNGU1NjdjNTQyYTZiMTEyM2M1ZWMzOGI0MDc2L3RhYmxlcmFuZ2U6ZWQzMDA0ZTU2N2M1NDJhNmIxMTIzYzVlYzM4YjQwNzZfNi0zLTEtMS00NjMzNA_190cbe2b-1bc8-4d30-9070-922fd7055a1b">9,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca241ad2cc548f6a38311595d2c1a51_I20211231" decimals="-3" name="us-gaap:LinesOfCreditFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82NC9mcmFnOjkxNWIyYjk1NWNjYTRjOWViZTJmYWM0NzhlN2QwZTU1L3RhYmxlOmVkMzAwNGU1NjdjNTQyYTZiMTEyM2M1ZWMzOGI0MDc2L3RhYmxlcmFuZ2U6ZWQzMDA0ZTU2N2M1NDJhNmIxMTIzYzVlYzM4YjQwNzZfNi01LTEtMS00NjMzNA_8b45aef6-7014-4050-9b0b-ed54c8774742">9,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8042af3a5af441cbbd4f8aa3c656853_I20211231" decimals="-3" name="us-gaap:LinesOfCreditFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82NC9mcmFnOjkxNWIyYjk1NWNjYTRjOWViZTJmYWM0NzhlN2QwZTU1L3RhYmxlOmVkMzAwNGU1NjdjNTQyYTZiMTEyM2M1ZWMzOGI0MDc2L3RhYmxlcmFuZ2U6ZWQzMDA0ZTU2N2M1NDJhNmIxMTIzYzVlYzM4YjQwNzZfNi03LTEtMS00NjMzNA_e0e8ef55-f554-4cad-82c5-42f5c57b37c4">9,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan, net</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia987e32d35a64bc58e5674f1e07ff056_I20220930" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82NC9mcmFnOjkxNWIyYjk1NWNjYTRjOWViZTJmYWM0NzhlN2QwZTU1L3RhYmxlOmVkMzAwNGU1NjdjNTQyYTZiMTEyM2M1ZWMzOGI0MDc2L3RhYmxlcmFuZ2U6ZWQzMDA0ZTU2N2M1NDJhNmIxMTIzYzVlYzM4YjQwNzZfNy0xLTEtMS00NjMzNA_2d4320ff-7c79-4b47-8fff-35aba5cf5eb7">123,875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i736980e5039d40a593f5402597dcedea_I20220930" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82NC9mcmFnOjkxNWIyYjk1NWNjYTRjOWViZTJmYWM0NzhlN2QwZTU1L3RhYmxlOmVkMzAwNGU1NjdjNTQyYTZiMTEyM2M1ZWMzOGI0MDc2L3RhYmxlcmFuZ2U6ZWQzMDA0ZTU2N2M1NDJhNmIxMTIzYzVlYzM4YjQwNzZfNy0zLTEtMS00NjMzNA_ec7f064c-0220-4ad4-b79a-a794139e0061">120,023</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifec1ee9f27f84876ae61fc5e20677f66_I20211231" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82NC9mcmFnOjkxNWIyYjk1NWNjYTRjOWViZTJmYWM0NzhlN2QwZTU1L3RhYmxlOmVkMzAwNGU1NjdjNTQyYTZiMTEyM2M1ZWMzOGI0MDc2L3RhYmxlcmFuZ2U6ZWQzMDA0ZTU2N2M1NDJhNmIxMTIzYzVlYzM4YjQwNzZfNy01LTEtMS00NjMzNA_f1c47c7c-b0f2-4b55-aebd-9b951242573e">174,312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i877c790a76d546a8a90babc735c8b376_I20211231" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82NC9mcmFnOjkxNWIyYjk1NWNjYTRjOWViZTJmYWM0NzhlN2QwZTU1L3RhYmxlOmVkMzAwNGU1NjdjNTQyYTZiMTEyM2M1ZWMzOGI0MDc2L3RhYmxlcmFuZ2U6ZWQzMDA0ZTU2N2M1NDJhNmIxMTIzYzVlYzM4YjQwNzZfNy03LTEtMS00NjMzNA_39ea7a94-becf-4a2a-850a-084853c2c734">174,845</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnout Liability (WSG)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba8724e196ad45edae8eaee777dfc4d7_I20220930" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82NC9mcmFnOjkxNWIyYjk1NWNjYTRjOWViZTJmYWM0NzhlN2QwZTU1L3RhYmxlOmVkMzAwNGU1NjdjNTQyYTZiMTEyM2M1ZWMzOGI0MDc2L3RhYmxlcmFuZ2U6ZWQzMDA0ZTU2N2M1NDJhNmIxMTIzYzVlYzM4YjQwNzZfOC0xLTEtMS00NjMzNA_63fc7fa6-f4f5-428c-ae19-d64b308aebe3">7,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3b246daadb64fa58cf94501ca9e81e5_I20220930" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82NC9mcmFnOjkxNWIyYjk1NWNjYTRjOWViZTJmYWM0NzhlN2QwZTU1L3RhYmxlOmVkMzAwNGU1NjdjNTQyYTZiMTEyM2M1ZWMzOGI0MDc2L3RhYmxlcmFuZ2U6ZWQzMDA0ZTU2N2M1NDJhNmIxMTIzYzVlYzM4YjQwNzZfOC0zLTEtMS00NjMzNA_7bfcc109-0c65-47c7-9ddb-ed94b4ddc22e">7,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1946fe4694af480aa180b00058e1d6d9_I20211231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82NC9mcmFnOjkxNWIyYjk1NWNjYTRjOWViZTJmYWM0NzhlN2QwZTU1L3RhYmxlOmVkMzAwNGU1NjdjNTQyYTZiMTEyM2M1ZWMzOGI0MDc2L3RhYmxlcmFuZ2U6ZWQzMDA0ZTU2N2M1NDJhNmIxMTIzYzVlYzM4YjQwNzZfOC01LTEtMS00NjMzNA_941b13c7-3cdc-4446-905f-e567a4282d6e">15,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba126d3e52b14305be4c3c515f9637d2_I20211231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82NC9mcmFnOjkxNWIyYjk1NWNjYTRjOWViZTJmYWM0NzhlN2QwZTU1L3RhYmxlOmVkMzAwNGU1NjdjNTQyYTZiMTEyM2M1ZWMzOGI0MDc2L3RhYmxlcmFuZ2U6ZWQzMDA0ZTU2N2M1NDJhNmIxMTIzYzVlYzM4YjQwNzZfOC03LTEtMS00NjMzNA_ab8c19d9-c27f-4683-991d-ef61c903a55d">15,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnout Liability (Selected)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadeeceae9c3742b0916a9a12a86f2fe7_I20220930" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82NC9mcmFnOjkxNWIyYjk1NWNjYTRjOWViZTJmYWM0NzhlN2QwZTU1L3RhYmxlOmVkMzAwNGU1NjdjNTQyYTZiMTEyM2M1ZWMzOGI0MDc2L3RhYmxlcmFuZ2U6ZWQzMDA0ZTU2N2M1NDJhNmIxMTIzYzVlYzM4YjQwNzZfOS0xLTEtMS00NjMzNA_5d47c47e-f8ce-4408-839a-c8ef63b2188a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17bfcb8a0ca943179adb5a32cc2af8ba_I20220930" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82NC9mcmFnOjkxNWIyYjk1NWNjYTRjOWViZTJmYWM0NzhlN2QwZTU1L3RhYmxlOmVkMzAwNGU1NjdjNTQyYTZiMTEyM2M1ZWMzOGI0MDc2L3RhYmxlcmFuZ2U6ZWQzMDA0ZTU2N2M1NDJhNmIxMTIzYzVlYzM4YjQwNzZfOS0zLTEtMS00NjMzNA_340bc15e-0955-4c68-a0f6-0e8aad447b5f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8da530a9cdbc4804980eefdbbd0e900a_I20211231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82NC9mcmFnOjkxNWIyYjk1NWNjYTRjOWViZTJmYWM0NzhlN2QwZTU1L3RhYmxlOmVkMzAwNGU1NjdjNTQyYTZiMTEyM2M1ZWMzOGI0MDc2L3RhYmxlcmFuZ2U6ZWQzMDA0ZTU2N2M1NDJhNmIxMTIzYzVlYzM4YjQwNzZfOS01LTEtMS00NjMzNA_ff9e8f73-ac41-499c-9541-29762c234fc4">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b515cd81555467898b20fbdbc0994cb_I20211231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82NC9mcmFnOjkxNWIyYjk1NWNjYTRjOWViZTJmYWM0NzhlN2QwZTU1L3RhYmxlOmVkMzAwNGU1NjdjNTQyYTZiMTEyM2M1ZWMzOGI0MDc2L3RhYmxlcmFuZ2U6ZWQzMDA0ZTU2N2M1NDJhNmIxMTIzYzVlYzM4YjQwNzZfOS03LTEtMS00NjMzNA_5dddffb0-9cf9-447b-8b90-f2230cff1fe9">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentration of Credit Risk:</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See discussion of credit losses and allowance for doubtful accounts in Note 2 - Summary of Significant Accounting Policies. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Overall, based on the large number of customers in differing geographic areas, primarily throughout the United States and its territories, the Company believes the concentration of credit risk is limited.</span></div></ix:continuation><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i5b47dd1c3d5a40ff8e040a94ae232d75_67"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RleHRyZWdpb246YWIxMGRlY2Q5MDAzNGIxYTkwZDgyMzI1YWRiZjI3ZjlfMzY2Mw_157f86c9-dc5d-42df-b403-328b6d15af4d" continuedAt="i97ff358da67a436fa9535a997fe6bf6c" escape="true">STOCKHOLDERS&#8217; EQUITY</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i97ff358da67a436fa9535a997fe6bf6c" continuedAt="i07ad50b5579d48769934d65ca262861d"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Repurchase Program</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 16, 2022, the Company's Board of Directors authorized a new stock repurchase program (the New Repurchase Program), whereby the Company may repurchase up to $<ix:nonFraction unitRef="usd" contextRef="i39fd50bbb06e42f18218bf500c01d1b1_I20220816" decimals="-5" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RleHRyZWdpb246YWIxMGRlY2Q5MDAzNGIxYTkwZDgyMzI1YWRiZjI3ZjlfNTQ5NzU1ODE4OTcy_34624ce1-71a8-422a-924b-9f76d23cf0a3">100.0</ix:nonFraction>&#160;million of its shares of common stock, subject to the terms of its current credit agreements. The shares may be repurchased from time-to-time in the open market or in privately negotiated transactions. The New Repurchase Program was effective immediately and may be discontinued at any time at the Board's discretion. In addition to the repurchase of $<ix:nonFraction unitRef="usd" contextRef="i39fd50bbb06e42f18218bf500c01d1b1_I20220816" decimals="-5" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RleHRyZWdpb246YWIxMGRlY2Q5MDAzNGIxYTkwZDgyMzI1YWRiZjI3ZjlfNDM5ODA0NjUxODQzMw_dbedf0a0-2a90-4caf-851e-c9d7ba261afe">100.0</ix:nonFraction>&#160;million of its shares of common stock under the New Repurchase Program, the Company was authorized to continue to repurchase any remaining shares available for repurchase under the Company's previous stock repurchase program, which was approved by the Board of Directors on February 28, 2008 (the Prior Repurchase Program). Upon completion of the authorized number of shares available for repurchase under the Prior Repurchase Program, the Company commenced repurchases under the New Repurchase Program during the third quarter of 2022. During the third quarter, the Company repurchased and retired, under both the Prior Repurchase Program and the New Repurchase Program, a total of <ix:nonFraction unitRef="shares" contextRef="i9313064d9eac40ad83fdaf7a1b2db9e0_D20220701-20220930" decimals="INF" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RleHRyZWdpb246YWIxMGRlY2Q5MDAzNGIxYTkwZDgyMzI1YWRiZjI3ZjlfNTQ5NzU1ODE5NzY3_2d0876f8-0432-4409-ab07-12e0fb3d809b">1,014,815</ix:nonFraction> shares of common stock for $<ix:nonFraction unitRef="usd" contextRef="i9313064d9eac40ad83fdaf7a1b2db9e0_D20220701-20220930" decimals="-5" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RleHRyZWdpb246YWIxMGRlY2Q5MDAzNGIxYTkwZDgyMzI1YWRiZjI3ZjlfNTQ5NzU1ODE5Nzg2_9fe13ff4-c306-41ca-878f-aa46ec0e7d8f">24.3</ix:nonFraction>&#160;million, at an average market price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i9313064d9eac40ad83fdaf7a1b2db9e0_D20220701-20220930" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RleHRyZWdpb246YWIxMGRlY2Q5MDAzNGIxYTkwZDgyMzI1YWRiZjI3ZjlfNTQ5NzU1ODE5ODA2_85002cef-db32-43f3-9f25-5181d79f5792">23.97</ix:nonFraction> per share. During the three and nine months ended September 30, 2021, the Company did <ix:nonFraction unitRef="shares" contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930" decimals="INF" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RleHRyZWdpb246YWIxMGRlY2Q5MDAzNGIxYTkwZDgyMzI1YWRiZjI3ZjlfNDc4_4a1dbdf6-fecd-43bf-b229-a14bd871a793"><ix:nonFraction unitRef="shares" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="INF" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RleHRyZWdpb246YWIxMGRlY2Q5MDAzNGIxYTkwZDgyMzI1YWRiZjI3ZjlfNDc4_844dd011-84ce-4d43-9b7e-6436eeeab373">no</ix:nonFraction></ix:nonFraction>t repurchase any shares of its common stock.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, the Company had $<ix:nonFraction unitRef="usd" contextRef="i8d6c70caf3ac4c6493c60fe74f5d510e_I20220930" decimals="-5" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RleHRyZWdpb246YWIxMGRlY2Q5MDAzNGIxYTkwZDgyMzI1YWRiZjI3ZjlfNTQ5NzU1ODIwMDc3_29466d34-22d3-4490-b9ea-fa444a4b0785">87.2</ix:nonFraction>&#160;million remaining for share repurchase under the New Repurchase Program, subject to certain conditions in the Company's Loan Agreement and Term Loan Agreement. At September 30, 2022, the Company had <ix:nonFraction unitRef="shares" contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RleHRyZWdpb246YWIxMGRlY2Q5MDAzNGIxYTkwZDgyMzI1YWRiZjI3ZjlfNTQ5NzU1ODE5OTkz_7bb22bd7-3108-4e47-9877-1184f41f24ce">36,508,529</ix:nonFraction> unrestricted shares of common stock outstanding.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share-Based Payments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 19, 2020, the Company's stockholders approved the Cross Country Healthcare, Inc. 2020 Omnibus Incentive Plan (2020 Plan), which replaced the 2017 Omnibus Incentive Plan (2017 Plan), and applies to awards granted after May 19, 2020. The remaining shares available for grant under the 2017 Plan were cancelled and no further awards will be granted under that plan. The 2020 Plan generally mirrors the terms of the 2017 Plan and includes the following provisions: (i) an aggregate share reserve of <ix:nonFraction unitRef="shares" contextRef="i60a43dc77674425480d2db76cf79177d_I20200519" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RleHRyZWdpb246YWIxMGRlY2Q5MDAzNGIxYTkwZDgyMzI1YWRiZjI3ZjlfMTI1Ng_a0e59c18-2d9d-4219-9a14-f4c8ddc074a2">3,000,000</ix:nonFraction> shares; (2) annual dollar and share limits of awards granted to employees and consultants, as well as non-employee directors, based on type of award; (3) awards granted generally will be subject to a minimum <ix:nonNumeric contextRef="i3d793cc2e5cf4606b38b48e7c4f5d2b2_D20220101-20220930" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RleHRyZWdpb246YWIxMGRlY2Q5MDAzNGIxYTkwZDgyMzI1YWRiZjI3ZjlfMzY1MA_78c73029-b12b-478a-aa92-91045f8e6d3f">one-year</ix:nonNumeric> vesting schedule; and (4) awards may be granted under the 2020 Plan until March 24, 2030.</span></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i07ad50b5579d48769934d65ca262861d"><ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RleHRyZWdpb246YWIxMGRlY2Q5MDAzNGIxYTkwZDgyMzI1YWRiZjI3ZjlfMzY1OQ_49afe9bc-174e-4ee8-861a-54273e6fd94b" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes restricted stock awards and performance stock awards activity issued under the 2017 Plan and the 2020 Plan (Plans) for the nine months ended September&#160;30, 2022:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:42.741%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.389%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.389%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.389%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.393%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restricted Stock Awards</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Performance Stock Awards</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant Date<br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of Target <br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant Date<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested restricted stock awards, January&#160;1, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0898a126dbc046e795ecb209d0f68153_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RhYmxlOmNhYjdkOTEzNjY0MDRmNzNhYjYxYjRlZDEzMTc4NWFlL3RhYmxlcmFuZ2U6Y2FiN2Q5MTM2NjQwNGY3M2FiNjFiNGVkMTMxNzg1YWVfMi0xLTEtMS00NjMzNA_33fe16a7-5da7-4b88-87ef-81bae84169ad">1,039,455</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0898a126dbc046e795ecb209d0f68153_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RhYmxlOmNhYjdkOTEzNjY0MDRmNzNhYjYxYjRlZDEzMTc4NWFlL3RhYmxlcmFuZ2U6Y2FiN2Q5MTM2NjQwNGY3M2FiNjFiNGVkMTMxNzg1YWVfMi0zLTEtMS00NjMzNA_6fbdcaac-8611-4bc3-b4b1-8f2dc5380fea">9.75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i94cacdf9f5e14894bd9a7ee09ceefd0b_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RhYmxlOmNhYjdkOTEzNjY0MDRmNzNhYjYxYjRlZDEzMTc4NWFlL3RhYmxlcmFuZ2U6Y2FiN2Q5MTM2NjQwNGY3M2FiNjFiNGVkMTMxNzg1YWVfMi01LTEtMS00NjMzNA_352d5304-cc96-477a-b3a4-2bf9781796b2">522,166</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i94cacdf9f5e14894bd9a7ee09ceefd0b_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RhYmxlOmNhYjdkOTEzNjY0MDRmNzNhYjYxYjRlZDEzMTc4NWFlL3RhYmxlcmFuZ2U6Y2FiN2Q5MTM2NjQwNGY3M2FiNjFiNGVkMTMxNzg1YWVfMi03LTEtMS00NjMzNA_412967e8-27d0-45b4-80c7-4b53e476f53b">8.64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7b01283f3c6e441b93fffe6cdf6495d8_D20220101-20220930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RhYmxlOmNhYjdkOTEzNjY0MDRmNzNhYjYxYjRlZDEzMTc4NWFlL3RhYmxlcmFuZ2U6Y2FiN2Q5MTM2NjQwNGY3M2FiNjFiNGVkMTMxNzg1YWVfMy0xLTEtMS00NjMzNA_d1315fab-ad21-4dd2-87a9-f08f0748b042">287,774</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7b01283f3c6e441b93fffe6cdf6495d8_D20220101-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RhYmxlOmNhYjdkOTEzNjY0MDRmNzNhYjYxYjRlZDEzMTc4NWFlL3RhYmxlcmFuZ2U6Y2FiN2Q5MTM2NjQwNGY3M2FiNjFiNGVkMTMxNzg1YWVfMy0zLTEtMS00NjMzNA_b7fd6647-4a0c-4487-ac6b-61c59babf1e8">20.76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ife7c8285d238454bad645c20b406a43d_D20220101-20220930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RhYmxlOmNhYjdkOTEzNjY0MDRmNzNhYjYxYjRlZDEzMTc4NWFlL3RhYmxlcmFuZ2U6Y2FiN2Q5MTM2NjQwNGY3M2FiNjFiNGVkMTMxNzg1YWVfMy01LTEtMS00NjMzNA_a3de0afc-48e9-4e7d-8e9e-c3186bfe1571">171,873</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ife7c8285d238454bad645c20b406a43d_D20220101-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RhYmxlOmNhYjdkOTEzNjY0MDRmNzNhYjYxYjRlZDEzMTc4NWFlL3RhYmxlcmFuZ2U6Y2FiN2Q5MTM2NjQwNGY3M2FiNjFiNGVkMTMxNzg1YWVfMy03LTEtMS00NjMzNA_c2311d2f-879c-4ca8-b45c-085676c7b048">18.94</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i7b01283f3c6e441b93fffe6cdf6495d8_D20220101-20220930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RhYmxlOmNhYjdkOTEzNjY0MDRmNzNhYjYxYjRlZDEzMTc4NWFlL3RhYmxlcmFuZ2U6Y2FiN2Q5MTM2NjQwNGY3M2FiNjFiNGVkMTMxNzg1YWVfNC0xLTEtMS00NjMzNA_45842715-17d2-4983-87ba-c2cf0decddd0">575,051</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7b01283f3c6e441b93fffe6cdf6495d8_D20220101-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RhYmxlOmNhYjdkOTEzNjY0MDRmNzNhYjYxYjRlZDEzMTc4NWFlL3RhYmxlcmFuZ2U6Y2FiN2Q5MTM2NjQwNGY3M2FiNjFiNGVkMTMxNzg1YWVfNC0zLTEtMS00NjMzNA_4a0feb4c-8ed8-4cc9-b64b-21e221755491">9.14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ife7c8285d238454bad645c20b406a43d_D20220101-20220930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RhYmxlOmNhYjdkOTEzNjY0MDRmNzNhYjYxYjRlZDEzMTc4NWFlL3RhYmxlcmFuZ2U6Y2FiN2Q5MTM2NjQwNGY3M2FiNjFiNGVkMTMxNzg1YWVfNC01LTEtMS00NjMzNA_f470f17b-000d-47d2-b249-cac11695704d">170,278</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ife7c8285d238454bad645c20b406a43d_D20220101-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RhYmxlOmNhYjdkOTEzNjY0MDRmNzNhYjYxYjRlZDEzMTc4NWFlL3RhYmxlcmFuZ2U6Y2FiN2Q5MTM2NjQwNGY3M2FiNjFiNGVkMTMxNzg1YWVfNC03LTEtMS00NjMzNA_d947bd4c-0b06-4996-92f7-7fd17606819b">7.03</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i7b01283f3c6e441b93fffe6cdf6495d8_D20220101-20220930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RhYmxlOmNhYjdkOTEzNjY0MDRmNzNhYjYxYjRlZDEzMTc4NWFlL3RhYmxlcmFuZ2U6Y2FiN2Q5MTM2NjQwNGY3M2FiNjFiNGVkMTMxNzg1YWVfNS0xLTEtMS00NjMzNA_c2d37329-e1fb-4961-8a53-8115ef09f7f4">79,520</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7b01283f3c6e441b93fffe6cdf6495d8_D20220101-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RhYmxlOmNhYjdkOTEzNjY0MDRmNzNhYjYxYjRlZDEzMTc4NWFlL3RhYmxlcmFuZ2U6Y2FiN2Q5MTM2NjQwNGY3M2FiNjFiNGVkMTMxNzg1YWVfNS0zLTEtMS00NjMzNA_58c223a8-0aee-41ec-a222-16d4cec3efc7">14.10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ife7c8285d238454bad645c20b406a43d_D20220101-20220930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RhYmxlOmNhYjdkOTEzNjY0MDRmNzNhYjYxYjRlZDEzMTc4NWFlL3RhYmxlcmFuZ2U6Y2FiN2Q5MTM2NjQwNGY3M2FiNjFiNGVkMTMxNzg1YWVfNS01LTEtMS00NjMzNA_1541771a-ad42-473f-9b88-cf2894f70e7d">47,675</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ife7c8285d238454bad645c20b406a43d_D20220101-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RhYmxlOmNhYjdkOTEzNjY0MDRmNzNhYjYxYjRlZDEzMTc4NWFlL3RhYmxlcmFuZ2U6Y2FiN2Q5MTM2NjQwNGY3M2FiNjFiNGVkMTMxNzg1YWVfNS03LTEtMS00NjMzNA_ea1137d4-4b03-44a4-9266-95ee15d79dd6">12.33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested restricted stock awards, September 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i57cbf98f9a5e41dbb52fc4305ececb04_I20220930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RhYmxlOmNhYjdkOTEzNjY0MDRmNzNhYjYxYjRlZDEzMTc4NWFlL3RhYmxlcmFuZ2U6Y2FiN2Q5MTM2NjQwNGY3M2FiNjFiNGVkMTMxNzg1YWVfNi0xLTEtMS00NjMzNA_5e45c046-addb-4ee8-8368-c54c6e6c5a65">672,658</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i57cbf98f9a5e41dbb52fc4305ececb04_I20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RhYmxlOmNhYjdkOTEzNjY0MDRmNzNhYjYxYjRlZDEzMTc4NWFlL3RhYmxlcmFuZ2U6Y2FiN2Q5MTM2NjQwNGY3M2FiNjFiNGVkMTMxNzg1YWVfNi0zLTEtMS00NjMzNA_7337febb-373f-42c1-b788-e74e0740bfc5">14.47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i850fcfe043314c1a9fece0d4d68b2919_I20220930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RhYmxlOmNhYjdkOTEzNjY0MDRmNzNhYjYxYjRlZDEzMTc4NWFlL3RhYmxlcmFuZ2U6Y2FiN2Q5MTM2NjQwNGY3M2FiNjFiNGVkMTMxNzg1YWVfNi01LTEtMS00NjMzNA_c19b4dcf-025c-44ae-9c62-43dc0b736108">476,086</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i850fcfe043314c1a9fece0d4d68b2919_I20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RhYmxlOmNhYjdkOTEzNjY0MDRmNzNhYjYxYjRlZDEzMTc4NWFlL3RhYmxlcmFuZ2U6Y2FiN2Q5MTM2NjQwNGY3M2FiNjFiNGVkMTMxNzg1YWVfNi03LTEtMS00NjMzNA_9c5d4a8d-c90f-490c-92b0-931a6cb37e99">12.56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted stock awards granted under the Company&#8217;s Plans entitle the holder to receive, at the end of a vesting period, a specified number of shares of the Company&#8217;s common stock. Share-based compensation expense is measured by the market value of the Company&#8217;s stock on the date of grant. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Awards granted to non-employee directors under the 2017 Plan, prior to the adoption of the 2020 Plan, vest in <ix:nonFraction unitRef="installment" contextRef="i4b68237ebf9d475aaf3f35fd14b2fefc_D20220101-20220930" decimals="INF" name="ccrn:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RleHRyZWdpb246YWIxMGRlY2Q5MDAzNGIxYTkwZDgyMzI1YWRiZjI3ZjlfMjE0Nw_72e778eb-5b92-4678-ba99-24c35006c0eb">three</ix:nonFraction> equal installments on the first, second, and third anniversaries of the grant date, while restricted shares granted under the 2020 Plan on and subsequent to June 2020 will vest on the first anniversary of such grant date, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or earlier subject to retirement eligibility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In addition, effective in the three months ended June 30, 2020, the Company implemented modified guidelines that provide for accelerated vesting of restricted stock grants on the last date of service when a retirement-eligible director retires.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Plans, the number of target shares that are issued for performance-based stock awards are determined based on the level of attainment of the targets. During the first quarter of 2022, the Company's Compensation Committee of the Board of Directors approved a <ix:nonFraction unitRef="number" contextRef="i657bd17dcadf4f3f873d0850b774cdc3_D20220101-20220331" decimals="INF" name="ccrn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAttainmentPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RleHRyZWdpb246YWIxMGRlY2Q5MDAzNGIxYTkwZDgyMzI1YWRiZjI3ZjlfMjkzOA_e040f02d-f1ea-4449-b756-2b0298d56d1f">120</ix:nonFraction>% level of attainment for the 2019 performance-based share awards, resulting in the issuance of <ix:nonFraction unitRef="shares" contextRef="ia1b0163339fb42deac2d52ca0dc626cd_D20220101-20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RleHRyZWdpb246YWIxMGRlY2Q5MDAzNGIxYTkwZDgyMzI1YWRiZjI3ZjlfMzAzNQ_2f58c8c6-37f1-4412-8f94-9d9a9be79e1a">170,278</ix:nonFraction> performance shares that vested on March 31, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the three and nine months ended September 30, 2022, $<ix:nonFraction unitRef="usd" contextRef="ice9fa15cb07246a2819aa90ca0b090f2_D20220701-20220930" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RleHRyZWdpb246YWIxMGRlY2Q5MDAzNGIxYTkwZDgyMzI1YWRiZjI3ZjlfMzEzMQ_d7c09a5f-7187-4e6c-8ba0-7f3d1506147c">1.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i00ee87f771334f0c8220e9eb0575e200_D20220101-20220930" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RleHRyZWdpb246YWIxMGRlY2Q5MDAzNGIxYTkwZDgyMzI1YWRiZjI3ZjlfMzEzOA_90f8cbd5-d761-4b06-b975-82a7f0334e4f">5.2</ix:nonFraction>&#160;million, respectively, was included in selling, general and administrative expenses related to share-based payments. During the nine months ended September 30, 2022, a net of <ix:nonFraction unitRef="shares" contextRef="i69cc0e8a27234c22915bdde908a717c2_D20220101-20220930" decimals="INF" name="ccrn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RleHRyZWdpb246YWIxMGRlY2Q5MDAzNGIxYTkwZDgyMzI1YWRiZjI3ZjlfMzI3MA_cff50142-3dc4-4950-ae45-aeb091e0c386">499,700</ix:nonFraction> shares of common stock were issued upon the vesting of restricted and performance stock. <ix:nonFraction unitRef="shares" contextRef="ic57dcdd480124d9d9ce70d9d0fe56d2b_D20220701-20220930" decimals="INF" name="ccrn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RleHRyZWdpb246YWIxMGRlY2Q5MDAzNGIxYTkwZDgyMzI1YWRiZjI3ZjlfNTQ5NzU1ODIwMjk0_f0bd1d58-c5db-4eef-8381-4047abed3944">No</ix:nonFraction> shares vested during the three months ended September 30, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and nine months ended September 30, 2021, $<ix:nonFraction unitRef="usd" contextRef="i51e864c08ce54f8c91f98492c469e4a5_D20210701-20210930" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RleHRyZWdpb246YWIxMGRlY2Q5MDAzNGIxYTkwZDgyMzI1YWRiZjI3ZjlfMzQyMA_b6d1d30d-666b-469e-b173-760670380d98">1.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i01b4eae42d8043bc9669c54efc17b3be_D20210101-20210930" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RleHRyZWdpb246YWIxMGRlY2Q5MDAzNGIxYTkwZDgyMzI1YWRiZjI3ZjlfMzQyNw_b30860d1-506c-49a4-bdce-d6c822b3c7b6">5.3</ix:nonFraction>&#160;million, respectively, was included in selling, general and administrative expenses related to share-based payments, and a net of <ix:nonFraction unitRef="shares" contextRef="i259a723688ef4b07876c5e5858c322e8_D20210701-20210930" decimals="INF" name="ccrn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RleHRyZWdpb246YWIxMGRlY2Q5MDAzNGIxYTkwZDgyMzI1YWRiZjI3ZjlfMzU1Mg_c6e06b98-e405-4375-bf44-4a5d1286e778">2,576</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="ic3d043883a0640a8beb08731478b973f_D20210101-20210930" decimals="INF" name="ccrn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RleHRyZWdpb246YWIxMGRlY2Q5MDAzNGIxYTkwZDgyMzI1YWRiZjI3ZjlfMzU1OQ_90847616-6239-43a1-a866-0eb29989eb60">479,206</ix:nonFraction> shares, respectively, of common stock were issued upon the vesting of restricted stock.</span></div></ix:continuation><div><span><br/></span></div><div id="i5b47dd1c3d5a40ff8e040a94ae232d75_70"></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RleHRyZWdpb246MjMwNDNmMzMxN2JhNGE0M2JmMWQwMzc4ODMzZWQyOWZfMjU4MA_d644d40e-d42f-421e-974e-e4474e94e6fb" continuedAt="ib7d22049311040679135be59c00a981f" escape="true">SEGMENT DATA</ix:nonNumeric></span></div><div style="padding-left:36pt;text-indent:-36pt"><span><br/></span></div><ix:continuation id="ib7d22049311040679135be59c00a981f" continuedAt="i8db05ef632654619900b8537372da453"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s segments offer services to its customers as described below:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9679;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nurse and Allied Staffing </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211; Nurse and Allied Staffing provides traditional staffing, recruiting, and value-added total talent solutions including: temporary and permanent placement of travel and local nurse and allied professionals, managed services programs (MSP) services, education healthcare services, in-home care services, and outsourcing services. In addition, Nurse and Allied Staffing provides retained search services for healthcare professionals, as well as contingent search and recruitment process outsourcing services. Its clients include: public and private acute-care and non-acute care hospitals, government facilities, local and national healthcare plans, managed care providers, public schools and charter schools, outpatient clinics, ambulatory care facilities, physician practice groups, and many other healthcare providers throughout the United States.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9679;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Physician Staffing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Physician Staffing provides physicians in many specialties, as well as certified registered nurse anesthetists, nurse practitioners, and physician assistants as independent contractors on temporary assignments throughout the United States at various healthcare facilities, such as acute and non-acute care facilities, medical group practices, government facilities, and managed care organizations.</span></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i8db05ef632654619900b8537372da453"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates performance of each segment primarily based on revenue and contribution income. The Company defines contribution income as income (loss) from operations before depreciation and amortization, acquisition and integration-related costs, restructuring (benefits) costs, legal settlement charges, impairment charges, and corporate overhead. The Company does not evaluate, manage, or measure performance of segments using asset information; accordingly, total asset information by segment is not prepared or disclosed. The information in the following table is derived from the segments&#8217; internal financial information as used for corporate management purposes. Certain corporate expenses are not allocated to and/or among the operating segments.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RleHRyZWdpb246MjMwNDNmMzMxN2JhNGE0M2JmMWQwMzc4ODMzZWQyOWZfMjU4OQ_25277468-1646-4b6c-914d-da3dab79ea0b" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information on operating segments and a</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reconciliation to income from operations for the periods indicated are as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.057%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.526%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from services:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nurse and Allied Staffing</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i755b00d6551346d08633c51f6fffcbd4_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfNS0xLTEtMS00NjMzNA_a652c8ab-d950-4d2a-b89a-013e0f7f6858">612,270</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15f558e83a4a479e8674ab636a78ba79_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfNS0zLTEtMS00NjMzNA_d3e2c77e-f61c-4473-9c72-b8362f9ab925">356,139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7aaf74b211ba45b9bea92196b8c48cd7_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfNS01LTEtMS00NjMzNA_3cd886f3-45a5-49ac-85b1-f7400521de29">2,109,293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id76ab6905df5463b9046aaf30a35075d_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfNS03LTEtMS00NjMzNA_c5b20f2b-a3f5-4091-92e1-5fd69d3407d6">985,335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Physician Staffing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60312c6dd2494d66bf19248b38166eaf_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfNi0xLTEtMS00NjMzNA_13e85084-c069-40b0-9875-9d3fbaa126f1">23,828</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibeef5c5a5e6e4d08b2e5036ccd0186a0_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfNi0zLTEtMS00NjMzNA_b37e9fac-29e6-4f46-af68-402998b981d1">18,766</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4be1f35efe045ebabfe8d9154e1c3cb_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfNi01LTEtMS00NjMzNA_1980166b-1f79-4973-a5b7-70d071a6a9b3">69,098</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c425883600f44a6aedb244f1adafb03_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfNi03LTEtMS00NjMzNA_e7a22a49-289b-44e1-876e-8b1979e033ad">50,638</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfNy0xLTEtMS00NjMzNA_9e2ad9ce-b8af-4562-a297-023b45edf529">636,098</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfNy0zLTEtMS00NjMzNA_146304c3-cb8e-4852-b0c4-2bea3ce76a96">374,905</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfNy01LTEtMS00NjMzNA_a01790c7-a14f-46ae-ae6d-42ecad2eb510">2,178,391</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfNy03LTEtMS00NjMzNA_272d3962-6fe7-4164-a435-edb1a0c064e4">1,035,973</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution income:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nurse and Allied Staffing</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i755b00d6551346d08633c51f6fffcbd4_D20220701-20220930" decimals="-3" name="ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTAtMS0xLTEtNDYzMzQ_72a890a6-5e6b-4d0b-8584-a094d33e7a52">77,838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15f558e83a4a479e8674ab636a78ba79_D20210701-20210930" decimals="-3" name="ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTAtMy0xLTEtNDYzMzQ_98ed19fa-ddb0-40e2-8cd7-4e8ee1359cbb">40,645</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7aaf74b211ba45b9bea92196b8c48cd7_D20220101-20220930" decimals="-3" name="ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTAtNS0xLTEtNDYzMzQ_6e5d83d4-88bc-4641-8eb1-ceb8e8a5d821">285,506</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id76ab6905df5463b9046aaf30a35075d_D20210101-20210930" decimals="-3" name="ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTAtNy0xLTEtNDYzMzQ_96917070-7b88-405a-adfa-a4f6cc237402">113,346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Physician Staffing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60312c6dd2494d66bf19248b38166eaf_D20220701-20220930" decimals="-3" name="ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTEtMS0xLTEtNDYzMzQ_dbeaefef-4446-4f00-9dd8-c41cfbc9eacb">837</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibeef5c5a5e6e4d08b2e5036ccd0186a0_D20210701-20210930" decimals="-3" name="ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTEtMy0xLTEtNDYzMzQ_8ded68dc-7944-4cb0-95a2-e89cd21f5eb6">910</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4be1f35efe045ebabfe8d9154e1c3cb_D20220101-20220930" decimals="-3" name="ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTEtNS0xLTEtNDYzMzQ_d296bf2d-77c8-4f51-b05e-645c834d95c5">3,822</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c425883600f44a6aedb244f1adafb03_D20210101-20210930" decimals="-3" name="ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTEtNy0xLTEtNDYzMzQ_660b777f-6c7f-4954-a85e-91cbc6d02bbd">2,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930" decimals="-3" name="ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTItMS0xLTEtNDYzMzQ_98116f71-a87e-41bf-ade4-e338f8b09daf">78,675</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930" decimals="-3" name="ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTItMy0xLTEtNDYzMzQ_0c91911b-d434-4946-afcc-42cf608b4808">41,555</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTItNS0xLTEtNDYzMzQ_bd3caf52-45f3-4030-ab1a-b87be713c7fd">289,328</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTItNy0xLTEtNDYzMzQ_9c1432a9-2640-4743-9933-2c554905f990">116,246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate overhead </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930" decimals="-3" name="ccrn:SegmentReportingUnallocatedCorporateExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTQtMS0xLTEtNDYzMzQ_0cc7fb46-dbd3-4dbe-b9a0-ac10673aee3e">16,447</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930" decimals="-3" name="ccrn:SegmentReportingUnallocatedCorporateExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTQtMy0xLTEtNDYzMzQ_e7c01c92-9e3f-4efd-9a47-3ee4a3f65d15">12,049</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="ccrn:SegmentReportingUnallocatedCorporateExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTQtNS0xLTEtNDYzMzQ_a0e251c1-d975-43ff-9d9d-9f813ada29b0">50,284</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="ccrn:SegmentReportingUnallocatedCorporateExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTQtNy0xLTEtNDYzMzQ_083a0a86-0c8c-4a92-a4eb-a6dbd67febf6">40,326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTUtMS0xLTEtNDYzMzQ_107d0bfa-0607-4dea-9a56-76ffb736b2dc">3,214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTUtMy0xLTEtNDYzMzQ_839ee671-a7a0-4fb9-a059-ce94a3c039b0">2,680</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTUtNS0xLTEtNDYzMzQ_c0d8fe9d-dfc4-48f6-92b7-19836c8d1214">9,414</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTUtNy0xLTEtNDYzMzQ_cda98d86-4392-492e-8c4f-d7c280664008">7,132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and integration-related costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930" decimals="-3" name="ccrn:AcquisitionAndIntegrationRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTYtMS0xLTEtNDYzMzQ_bda9c268-f373-42c2-95f3-7491d5cef5a9">490</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930" decimals="-3" name="ccrn:AcquisitionAndIntegrationRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTYtMy0xLTEtNDYzMzQ_c747cf48-e36a-4d92-95e7-f7c313c6a11a">61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="ccrn:AcquisitionAndIntegrationRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTYtNS0xLTEtNDYzMzQ_32b2abb7-b9f3-436c-b8ca-214acd151149">530</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="ccrn:AcquisitionAndIntegrationRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTYtNy0xLTEtNDYzMzQ_2340ff13-9079-4486-aa8e-a94151e40af3">985</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTctMS0xLTEtNDYzMzQ_cb1b2526-af6f-455b-9412-67dfebbf36b0">2,493</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTctMy0xLTEtNDYzMzQ_eccf8bca-a6b7-4869-b96e-c5c6c7ec8c04">318</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTctNS0xLTEtNDYzMzQ_d71d4eb8-b49e-46d7-8d6d-cd388db87c3b">1,859</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTctNy0xLTEtNDYzMzQ_4e1ffc23-9494-45a0-8aa3-63d160a4b3d4">2,391</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930" decimals="-3" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTgtMS0xLTEtNDYzMzQ_4b7bae98-1e4b-48fe-a5ed-204ef37482df">3,856</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930" decimals="-3" name="us-gaap:AssetImpairmentCharges" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTgtMy0xLTEtNDYzMzQ_72f2069c-5f00-45a1-a729-fae895a30b78">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTgtNS0xLTEtNDYzMzQ_bb53aec5-1bd9-4f06-8474-c5e63e67abfb">5,597</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTgtNy0xLTEtNDYzMzQ_4f07f971-c394-41f1-8b42-c93b67e28d08">2,070</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTktMS0xLTEtNDYzMzQ_43efb997-e810-4fe7-b7c1-77f3eee0708e">52,175</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTktMy0xLTEtNDYzMzQ_cf90b04d-79c0-4b27-8fc5-8deb10eb4fe7">26,447</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTktNS0xLTEtNDYzMzQ_8eab2238-70b4-47a8-81fc-735304952702">221,644</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTktNy0xLTEtNDYzMzQ_1c3a55f8-9834-447e-9302-1096a8552ebf">63,342</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Corporate overhead includes unallocated executive leadership and other centralized corporate functional support costs such as finance, IT, legal, human resources, and marketing, as well as public company expenses and corporate-wide projects (initiatives).</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="i5b47dd1c3d5a40ff8e040a94ae232d75_73"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.&#160;&#160;&#160;&#160;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83My9mcmFnOjY4YzFkMDk3MzNmYjQ3MDU4ODNiOGY0YjE0NzA0ZDMxL3RleHRyZWdpb246NjhjMWQwOTczM2ZiNDcwNTg4M2I4ZjRiMTQ3MDRkMzFfMjg1Mw_0dc509fc-0a71-4208-8b46-3bbd32fd4574" continuedAt="i6502da142f404f66b40f09c2a99bc87d" escape="true">CONTINGENCIES</ix:nonNumeric></span></div><ix:continuation id="i6502da142f404f66b40f09c2a99bc87d" continuedAt="i6d61d54b72f841f9b5f315d1a235e2e4"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Legal Proceedings</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company is involved in various litigation, claims, investigations, and other proceedings that arise in the ordinary course of its business. These matters primarily relate to employee-related matters that include individual and collective claims, professional liability, tax, and payroll practices. The Company establishes reserves when available information indicates that a loss is probable and an amount or range of loss can be reasonably estimated. These assessments are performed at least quarterly and are based on the information available to management at the time and involve significant management judgment to determine the probability and estimated amount of potential losses, if any. Based on the available information considered in its reviews, the Company adjusts its loss contingency accruals and its disclosures as may be required. Actual outcomes or losses may differ materially from those estimated by the Company's current assessments, including available insurance recoveries, which would impact the Company's profitability. Adverse developments in existing litigation claims or legal proceedings involving the Company or new claims could require management to establish or increase litigation reserves or enter into unfavorable settlements or satisfy judgments for monetary damages for amounts in excess of current reserves, which could adversely affect the Company's financial results. The Company believes the outcome of any outstanding loss contingencies as of September 30, 2022 will not have a material adverse effect on its business, financial condition, results of operations, or cash flows.</span></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:continuation id="i6d61d54b72f841f9b5f315d1a235e2e4" continuedAt="ibe3d087955dc48ce918f947cfe095c54">Sales and Other State Non-Income Tax Liabilities </ix:continuation></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ibe3d087955dc48ce918f947cfe095c54">The Company's sales and other state non-income tax filings are subject to routine audits by authorities in the jurisdictions where it conducts business in the United States which may result in assessments of additional taxes. The Company accrues sales and other non-income tax liabilities based on the Company's best estimate of its probable liability utilizing currently available information and interpretation of relevant tax regulations. Given the nature of the Company's business, significant subjectivity exists as to both whether sales and other state non-income taxes can be assessed on its activity and how the sales tax will ultimately be measured by the relevant jurisdictions. The Company makes a determination for each reporting period whether the estimates for sales and other non-income taxes in certain states should be revised. The expense is included in selling, general and administrative expenses in the Company's condensed consolidated statements of operations and the liability is reflected in sales tax payable within other current liabilities in its condensed consolidated balance sheets.</ix:continuation> </span></div><div><span><br/></span></div><div id="i5b47dd1c3d5a40ff8e040a94ae232d75_76"></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83Ni9mcmFnOjdhYjU3Y2Q2MDlhYTRmMDc5OTM5MjMyNGNjMDlmNTY3L3RleHRyZWdpb246N2FiNTdjZDYwOWFhNGYwNzk5MzkyMzI0Y2MwOWY1NjdfMTc3Nw_55791ead-bfc0-4f85-8642-c25ca65c9092" continuedAt="i96440a0307734988b2dd2a0e99290b31" escape="true">INCOME TAXES</ix:nonNumeric></span></div><ix:continuation id="i96440a0307734988b2dd2a0e99290b31"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended September 30, 2022, the Company calculated its effective tax rate estimating its annual effective tax rate, as opposed to the three and nine months ended September 30, 2021 whereby the Company calculated its effective tax rate based on year-to-date results. The Company&#8217;s effective tax rate for the three and nine months ended September 30, 2022 was <ix:nonFraction unitRef="number" contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83Ni9mcmFnOjdhYjU3Y2Q2MDlhYTRmMDc5OTM5MjMyNGNjMDlmNTY3L3RleHRyZWdpb246N2FiNTdjZDYwOWFhNGYwNzk5MzkyMzI0Y2MwOWY1NjdfMzky_b5e1db9d-8a08-489e-84ae-638b602b9721">28.6</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83Ni9mcmFnOjdhYjU3Y2Q2MDlhYTRmMDc5OTM5MjMyNGNjMDlmNTY3L3RleHRyZWdpb246N2FiNTdjZDYwOWFhNGYwNzk5MzkyMzI0Y2MwOWY1NjdfMzk5_de9ef6e0-5303-4b2b-8c2e-40de668a4fcd">28.7</ix:nonFraction>%, respectively, including the impact of discrete items, and <ix:nonFraction unitRef="number" contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930" decimals="3" name="ccrn:EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83Ni9mcmFnOjdhYjU3Y2Q2MDlhYTRmMDc5OTM5MjMyNGNjMDlmNTY3L3RleHRyZWdpb246N2FiNTdjZDYwOWFhNGYwNzk5MzkyMzI0Y2MwOWY1NjdfNDYx_d442ec51-f37b-4353-9dbc-8039ec58d4e0">28.6</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" decimals="3" name="ccrn:EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83Ni9mcmFnOjdhYjU3Y2Q2MDlhYTRmMDc5OTM5MjMyNGNjMDlmNTY3L3RleHRyZWdpb246N2FiNTdjZDYwOWFhNGYwNzk5MzkyMzI0Y2MwOWY1NjdfNDY4_d967058a-4aef-4c29-a5f4-2192a6801d72">29.3</ix:nonFraction>%, respectively, excluding discrete items. The Company's effective tax rate for the three and nine months ended September 30, 2021 was <ix:nonFraction unitRef="number" contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83Ni9mcmFnOjdhYjU3Y2Q2MDlhYTRmMDc5OTM5MjMyNGNjMDlmNTY3L3RleHRyZWdpb246N2FiNTdjZDYwOWFhNGYwNzk5MzkyMzI0Y2MwOWY1NjdfNTk4_bdc8640a-b0a5-4c59-808c-8d3679b49c9b">4.9</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83Ni9mcmFnOjdhYjU3Y2Q2MDlhYTRmMDc5OTM5MjMyNGNjMDlmNTY3L3RleHRyZWdpb246N2FiNTdjZDYwOWFhNGYwNzk5MzkyMzI0Y2MwOWY1NjdfNjA1_89109b97-243d-4631-9c06-7516fd50300a">9.1</ix:nonFraction>%, respectively, including the impact of discrete items, and <ix:nonFraction unitRef="number" contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930" decimals="3" name="ccrn:EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83Ni9mcmFnOjdhYjU3Y2Q2MDlhYTRmMDc5OTM5MjMyNGNjMDlmNTY3L3RleHRyZWdpb246N2FiNTdjZDYwOWFhNGYwNzk5MzkyMzI0Y2MwOWY1NjdfNjY3_3c9538bc-fcbc-4e8a-a136-e91715630ae2">4.9</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930" decimals="3" name="ccrn:EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83Ni9mcmFnOjdhYjU3Y2Q2MDlhYTRmMDc5OTM5MjMyNGNjMDlmNTY3L3RleHRyZWdpb246N2FiNTdjZDYwOWFhNGYwNzk5MzkyMzI0Y2MwOWY1NjdfNjc0_b090821a-f1e9-4c9c-905e-947d60a68d49">5.9</ix:nonFraction>%, respectively, excluding discrete items. The effective tax rate for the three and nine months ended September 30, 2022 was primarily impacted by federal and state taxes. As a result of the Company's valuation allowance on substantially all of its domestic deferred tax assets, the effective tax rate for the three and nine months ended September 30, 2021 was primarily impacted by international taxes and state taxes, while the effective tax rate for the nine months ended September 30, 2021 was also impacted by additional valuation allowance required as a result of the WSG acquisition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2021, the Company concluded that it was more likely than not that a benefit from a substantial portion of its United States federal and state deferred tax assets would be realized and released the majority of its valuation allowance. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, the Company had an immaterial amount of valuation allowance on its deferred tax assets related to state net operating losses not expected to be realized before expiration. There was <ix:nonFraction unitRef="usd" contextRef="i0d13486d3d1b4e47be1e347be955262c_I20220930" decimals="INF" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83Ni9mcmFnOjdhYjU3Y2Q2MDlhYTRmMDc5OTM5MjMyNGNjMDlmNTY3L3RleHRyZWdpb246N2FiNTdjZDYwOWFhNGYwNzk5MzkyMzI0Y2MwOWY1NjdfMjc0ODc3OTA3MzU1NA_e82592ad-6ce5-49f3-b67c-6ce376135728">no</ix:nonFraction> valuation allowance related to state net operating losses as of September 30, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 16, 2022, President Biden signed the Inflation Reduction Act (the IRA) into law in the U.S. Among other changes, the IRA introduced an excise tax on certain stock repurchases by certain covered corporations for taxable years beginning after December 31, 2022. Based on its current estimates and pending future guidance to be issued by the Internal Revenue Service, the Company does not believe these provisions will have a material impact on its consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax years 2012 through 2021 remain open to examination by certain taxing jurisdictions to which the Company is subject to tax.</span></div></ix:continuation><div><span><br/></span></div><div id="i5b47dd1c3d5a40ff8e040a94ae232d75_79"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83OS9mcmFnOjk2ZGU3ZTMzYmE5ZjQwMTU4MjhjZjIyZjM3ZGYyZGNhL3RleHRyZWdpb246OTZkZTdlMzNiYTlmNDAxNTgyOGNmMjJmMzdkZjJkY2FfMjA2OQ_e977de57-7911-4e4e-b620-c7bf47cb8d7d" continuedAt="i8d18b40d96ae458c9a039fb9ec2d19c9" escape="true">RELATED PARTY TRANSACTIONS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i8d18b40d96ae458c9a039fb9ec2d19c9" continuedAt="ia14609ba5459468ba7aa2018b248797f"><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company has entered into an arrangement for digital marketing services provided by a firm that is related to Mr. Clark, the Company's non-executive Chairman of the Board of Directors since April 1, 2022, and the Company's Co-Founder &amp; Chief Executive Officer through March 31, 2022. Mr. Clark is a minority shareholder in the firm's parent company and is a member of the parent company's Board of Directors. Management believes the terms of the arrangement are equivalent to those prevailing in an arm's-length transaction and have been approved by the Company through its related party process. The digital marketing firm manages a limited number of digital publishers covering various Company brands for a monthly management fee. During the three and nine months ended September 30, 2022 and 2021, the Company incurred an immaterial amount in expenses. The Company had immaterial payable balances at September 30, 2022 and December 31, 2021.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides services to entities which are affiliated with certain members of the Company&#8217;s Board of Directors. Management believes the services were conducted on terms equivalent to those prevailing in an arm's-length transaction. Revenue related to these transactions was $<ix:nonFraction unitRef="usd" contextRef="i72783f7b11ce4ca8bd07eb8c76ae894f_D20220701-20220930" decimals="-5" name="us-gaap:RevenueFromRelatedParties" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83OS9mcmFnOjk2ZGU3ZTMzYmE5ZjQwMTU4MjhjZjIyZjM3ZGYyZGNhL3RleHRyZWdpb246OTZkZTdlMzNiYTlmNDAxNTgyOGNmMjJmMzdkZjJkY2FfMTI0Nw_5a47ab65-585c-4d5e-9637-af5e76fcc60a">0.7</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ia4db74b0466540ea968402c2e9e28c01_D20220101-20220930" decimals="-5" name="us-gaap:RevenueFromRelatedParties" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83OS9mcmFnOjk2ZGU3ZTMzYmE5ZjQwMTU4MjhjZjIyZjM3ZGYyZGNhL3RleHRyZWdpb246OTZkZTdlMzNiYTlmNDAxNTgyOGNmMjJmMzdkZjJkY2FfMTI1NA_a7388ef4-00da-4d6a-b293-c8b4ccb0c519">1.5</ix:nonFraction> million for the three and nine months ended September 30, 2022, respectively, and an <ix:nonFraction unitRef="usd" contextRef="iee3c22d82f244073ab396a419446f087_D20210701-20210930" decimals="-5" name="us-gaap:RevenueFromRelatedParties" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83OS9mcmFnOjk2ZGU3ZTMzYmE5ZjQwMTU4MjhjZjIyZjM3ZGYyZGNhL3RleHRyZWdpb246OTZkZTdlMzNiYTlmNDAxNTgyOGNmMjJmMzdkZjJkY2FfMjc0ODc3OTA3MTg5Mg_5a881990-f000-4e9b-aa92-8d5c89a25944"><ix:nonFraction unitRef="usd" contextRef="i05804f1d8c774ac48c5ecb8daa790dd0_D20210101-20210930" decimals="-5" name="us-gaap:RevenueFromRelatedParties" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83OS9mcmFnOjk2ZGU3ZTMzYmE5ZjQwMTU4MjhjZjIyZjM3ZGYyZGNhL3RleHRyZWdpb246OTZkZTdlMzNiYTlmNDAxNTgyOGNmMjJmMzdkZjJkY2FfMjc0ODc3OTA3MTg5Mg_efb7c8c2-5921-4bbd-94ec-0e4032b45ce9">immaterial</ix:nonFraction></ix:nonFraction> amount for the three and nine months ended September 30, 2021. Accounts receivable due from these entities was an immaterial amount at September 30, 2022 and December 31, 2021.</span></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ia14609ba5459468ba7aa2018b248797f">Following the WSG acquisition on June 8, 2021, the Company continued to rent WSG's headquarters. The Chief Executive Officer and Founder of WSG, who is currently a business unit president with the Company, is an agent of the lessor. The lease term for WSG's headquarters expires on December 31, 2024. The Company paid an immaterial amount in rent expense for these premises for the three and nine months ended September 30, 2022 and the three months ended September 30, 2021. The Company had no payable balance at September 30, 2022 and December 31, 2021.</ix:continuation></span></div><div><span><br/></span></div><div id="i5b47dd1c3d5a40ff8e040a94ae232d75_85"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV84NS9mcmFnOjMzZjk2MDQ5MTcwYTQ5MjJhNjU4YzEwNmFjMTc3YjFlL3RleHRyZWdpb246MzNmOTYwNDkxNzBhNDkyMmE2NThjMTA2YWMxNzdiMWVfMTE5Mw_e9aed9b4-3cef-4fd6-8594-3892d00aab4e" continuedAt="i52fda51788f04dd99972ccc1ee6ce1e2" escape="true">RECENT ACCOUNTING PRONOUNCEMENTS</ix:nonNumeric></span></div><div><span><br/></span></div><div><ix:continuation id="i52fda51788f04dd99972ccc1ee6ce1e2"><ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV84NS9mcmFnOjMzZjk2MDQ5MTcwYTQ5MjJhNjU4YzEwNmFjMTc3YjFlL3RleHRyZWdpb246MzNmOTYwNDkxNzBhNDkyMmE2NThjMTA2YWMxNzdiMWVfMTIwMg_a3df96b7-59f5-4ed5-aefd-35233863fb74" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 28, 2021, the FASB issued ASU No. 2021-08, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which requires contract assets and contract liabilities such as deferred revenue acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, Revenue from Contracts with Customers. Generally, this amendment will result in the acquirer recognizing contract assets and contract liabilities at the same amounts recorded by the acquiree. Historically such amounts were recognized by the acquirer at fair value in acquisition accounting. This guidance is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The amendments should be applied prospectively to business combinations occurring on or after the effective date of the amendments. Early adoption is permitted, including adoption in an interim period. The Company is currently in the process of evaluating this standard and expects to adopt this standard in its first quarter of 2023.</span></ix:nonNumeric></ix:continuation></div><div><span><br/></span></div><div id="i5b47dd1c3d5a40ff8e040a94ae232d75_1383"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">17.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930" name="us-gaap:SubsequentEventsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xMzgzL2ZyYWc6YTY2NjE5NzU0MTQzNDMzM2IzZjU5OTZmMjZkOWJkOTQvdGV4dHJlZ2lvbjphNjY2MTk3NTQxNDM0MzMzYjNmNTk5NmYyNmQ5YmQ5NF8yNzQ4Nzc5MDcwMzQ4_ffa58c8b-3685-4773-ba84-603bd8d31ee0" continuedAt="i6d7067273de740d3b5125bad3fce2293" escape="true">SUBSEQUENT EVENTS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i6d7067273de740d3b5125bad3fce2293"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 3, 2022, the Company completed the acquisition of substantially all of the assets and certain liabilities of Mint Medical Physician Staffing, LP (Mint) and Lotus Medical Staffing LLC (Lotus). Mint and Lotus place healthcare professionals in locum tenens positions throughout the country. The purchase price of the acquisition was paid for with a proportional combination of cash and shares of the Company's common stock. The acquisition was not significant to the Company's condensed consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt Prepayment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 26, 2022, the Company made an optional prepayment on its term loan, resulting in a prepayment premium and the write-off of debt issuance costs. The prepayment was applied to the remaining balloon payment in 2027.</span></div></ix:continuation><div><span><br/></span></div><div id="i5b47dd1c3d5a40ff8e040a94ae232d75_88"></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2.&#160;&#160;&#160;&#160;MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purpose of the following Management&#8217;s Discussion and Analysis (MD&amp;A) is to help facilitate the understanding of significant factors influencing the quarterly operating results, financial condition, and cash flows of the Company. Additionally, MD&amp;A also conveys our current expectations of the potential impact of known trends, events, or uncertainties that may impact future results. MD&amp;A is provided as a supplement to, and should be read in conjunction with, our Annual Report on Form&#160;10-K for the year ended December 31, 2021 (2021 Form 10-K) (including Part I, Item 1A. "Risk Factors"), our financial statements and the accompanying notes to our financial statements, as well as the Risk Factors contained herein.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i5b47dd1c3d5a40ff8e040a94ae232d75_91"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Overview</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide total talent management services, including strategic workforce solutions, contingent staffing, permanent placement, and consultative services for healthcare customers across the continuum of care, by recruiting and placing highly qualified healthcare professionals in virtually every specialty and area of expertise. In addition to clinical roles such as school nurses, speech language, and behavioral therapists, we place non-clinical professionals such as teachers, substitute teachers, and other education specialties at educational facilities across the nation. Our diverse customer base includes both public and private acute care and non-acute care hospitals, outpatient clinics, ambulatory care facilities, single- and multi-specialty physician practices, rehabilitation facilities, Program of All-Inclusive Care for the Elderly (PACE) programs, urgent care centers, local and national healthcare systems, managed care providers, public and charter schools, correctional facilities, government facilities, pharmacies, and many other healthcare providers. Through our national staffing teams, we offer our workforce solutions and place clinicians on travel and per diem assignments, local short-term contracts, and permanent positions. In addition, we continually evaluate opportunities to acquire companies that would complement or enhance our business, like Selected and Workforce Solutions Group, Inc. (WSG).</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our workforce solutions include managed service programs (MSPs), recruitment process outsourcing (RPO), project management, and other outsourcing and consultative services as described in Item 1. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Business</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in our 2021 Form 10-K. By utilizing the solutions we offer, customers are able to better plan their personnel needs, optimize their talent acquisition and management processes, strategically flex and balance their workforce, have access to quality healthcare personnel, and provide continuity of care for improved patient outcomes. We have a history of investing in diversity, equality, and inclusion as a key component of the organization&#8217;s overall corporate social responsibility program, which we believe is closely aligned with our core values to create a better future for our people, communities, and our stockholders.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The operating results of our business segments are regularly reviewed by the chief operating decision maker.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9679;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nurse and Allied Staffing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Nurse and Allied Staffing represented approximately 96% of our total revenue in the third quarter of 2022. The Nurse and Allied Staffing segment provides workforce solutions and traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, as well as per diem and contract nurses and allied personnel. We also provide clinical and non-clinical professionals on short-term and long-term assignments to clients such as local and national healthcare plans, managed care providers, public and charter schools, correctional facilities, skilled nursing facilities, and other non-acute settings. In addition, Nurse and Allied Staffing provides retained search services for healthcare professionals, as well as contingent search and recruitment process outsourcing services. We provide flexible workforce solutions to our healthcare customers through diversified offerings designed to meet their unique needs, including: MSP, RPO, and consulting services.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9679;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Physician Staffing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Physician Staffing represented approximately 4% of our total revenue in the third quarter of 2022. Physician Staffing provides physicians in many specialties, as well as certified registered nurse anesthetists, nurse practitioners, and physician assistants as independent contractors on temporary assignments throughout the United States.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Summary of Operations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the quarter ended September 30, 2022, revenue from services increased 70% year-over-year to $636.1 million, due to continued growth in both our Nurse and Allied Staffing and Physician Staffing segments. The year-over-year revenue increase was primarily driven by a</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">n increase in professionals on assignment and volume growth. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the third quarter of 2022, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">r</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">evenue decreased 16% sequentially, primarily due to </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">average bill rates declining in the low double digits and a decrease in billable hours, as anticipated</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Net income attributable to common stockholders in the third quarter of 2022 was $34.8 million, as compared to $23.4 million for the same period in the prior year.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the remainder of 2022, average travel bill rates are anticipated to experience a high single-digit sequential decline. Looking to 2023, we anticipate continued organic growth, driving further market share gains despite potential headwinds from changing bill rates or demand from certain specialties. We remain committed to continued investments in our people and technology, including the ongoing rollout of our proprietary vendor-neutral offering, Intellify.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On September 13, 2022, we entered into an agreement to acquire locums companies Mint and Lotus, which closed on October 3, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September 30, 2022, cash flow provided by operating activities was $140.6 million, with net borrowings of $9.2 million on our senior secured asset-based credit facility (ABL), and an increase in working capital stemming from an increase in accounts receivable partly offset by the timing of disbursements. As of September 30, 2022, we had $30.3 million of cash and cash equivalents, a portion of which was subsequently used to complete the acquisition of Mint and Lotus as noted above. As of September 30, 2022, we had a principal balance of $123.9 million outstanding on our term loan, and borrowing base availability under the ABL was $300.0 million, with $9.2 million of borrowings drawn under our ABL, and $17.5 million of undrawn letters of credit outstanding, leaving $273.3 million of excess availability.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the third quarter of 2022, our Board of Directors authorized the New Repurchase Program, whereby we may repurchase up to $100.0 million of our shares of common stock. Upon completion of the authorized number of shares available for repurchase under the Prior Repurchase Program, we commenced repurchases under the New Repurchase Program during the third quarter of 2022. During the quarter, we repurchased, under both the Prior Repurchase Program and the New Repurchase Program, a total of 1,014,815 shares of common stock for $24.3 million, at an average market price of $23.97 per share.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">See Results of Operations, Segment Results, and Liquidity and Capital Resources sections that follow for further information.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Operating Metrics</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate our financial condition by tracking operating metrics and financial results specific to each of our segments. Key operating metrics include hours worked, days filled, number of contract personnel on a full-time equivalent (FTE) basis, revenue per FTE, and revenue per day filled. Other operating metrics include number of open orders, candidate applications, contract bookings, length of assignment, bill and pay rates, and renewal and fill rates, number of active searches, and number of placements. These operating metrics are representative of trends that assist management in evaluating business performance. Due to the timing of our business process and other factors, certain of these operating metrics may not necessarily correlate to the reported U.S. GAAP results for the periods presented. Some of the segment financial results analyzed include revenue, operating expenses, and contribution income. In addition, we monitor cash flow, as well as operating and leverage ratios, to help us assess our liquidity needs.</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:43.848%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:53.952%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Business Segment</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Business Measurement</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nurse and Allied Staffing </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FTEs represent the average number of Nurse and Allied Staffing contract personnel on a full-time equivalent basis.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average revenue per FTE per day is calculated by dividing the Nurse and Allied Staffing revenue, excluding permanent placement, per FTE by the number of days worked in the respective periods.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Physician Staffing</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Days filled is calculated by dividing the total hours invoiced during the period, including an estimate for the impact of accrued revenue,  by eight hours.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue per day filled is calculated by dividing revenue as reported by days filled for the period presented.</span></td></tr></table></div><div><span><br/></span></div><div id="i5b47dd1c3d5a40ff8e040a94ae232d75_94"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Results of Operations</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes, for the periods indicated, selected condensed consolidated statements of operations data expressed as a&#160;percentage of revenue. Our historical results of operations are not necessarily indicative of future operating results.&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.284%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from services</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct operating expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bad debt expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and integration-related costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on early extinguishment of debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to common stockholders</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><div id="i5b47dd1c3d5a40ff8e040a94ae232d75_106"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Comparison of Results for the Three Months Ended September 30, 2022 and the Three Months Ended September 30, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.578%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Increase (Decrease)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Increase (Decrease)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from services</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">636,098&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374,905&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261,193&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct operating expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492,553&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291,111&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201,442&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,216&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,847&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,369&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bad debt expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,101&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,441&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(340)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,214&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,680&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">534&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and integration-related costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">490&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">703.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,493&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">684.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,856&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,856&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,175&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,447&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,728&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(375)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,704&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,640&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,064&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,911&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,207&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,704&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to common stockholders</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,793&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,433&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,360&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NM - Not meaningful</span></div><div style="margin-top:3pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue from services</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Revenue from services increased 69.7% to $636.1 million for the three months ended September&#160;30, 2022, as compared to $374.9 million for the three months ended September&#160;30, 2021, due to strong performance in both our Nurse and Allied Staffing and Physician Staffing segments, primarily driven by an increase in the number of professionals on assignment, as well as higher bill rates in Nurse and Allied. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">See further discussion in Segment Results. </span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Direct operating expenses</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Direct operating expenses are comprised primarily of field employee compensation and independent contractor expenses, housing expenses, travel expenses, and related insurance expenses. Direct operating expenses increased $201.4 million, or 69.2%, to $492.6 million for the three months ended September&#160;30, 2022, as compared to $291.1 million for the three months ended September&#160;30, 2021, as a result of revenue increases. As a percentage of total revenue, direct operating expenses slightly decreased to 77.4% compared to 77.6% in the prior year period.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selling, general and administrative expenses</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses increased 51.8% to $80.2 million for the three months ended September&#160;30, 2022, as compared to $52.8 million for the three months ended September&#160;30, 2021, primarily </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">due to increases in compensation and benefit expense, as well as marketing and consulting expense and computer subscription fees. As a&#160;percentage of total revenue, selling, general and administrative expenses decreased to 12.6% for the three months ended September&#160;30, 2022, as compared to 14.1% for the three months ended September&#160;30, 2021.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Depreciation and amortization expense</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expense&#160;for the three months ended September&#160;30, 2022 was $3.2 million, as compared to $2.7 million for the three months ended September&#160;30, 2021. The increase was primarily due to the additional amortization of other intangible assets from the WSG and Selected acquisitions. See Note 7 - Goodwill, Trade Names, and Other Intangible Assets to our condensed consolidated financial statements. As a percentage of revenue, depreciation and amortization expense was 0.5% for the three months ended September&#160;30, 2022 and 0.7% for the three months ended September&#160;30, 2021.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisition and integration-related costs</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquisition and integration-related costs for the three months ended September 30, 2022 included costs for legal and advisory fees for the Mint and Lotus acquisition that closed on October 3, 2022. Acquisition and integration-related costs for the three months ended September 30, 2021 included costs for legal and advisory fees for the WSG acquisition that closed on June 8, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restructuring costs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring costs for the three months ended September 30, 2022 and 2021 were primarily comprised of ongoing lease costs related to the Company's strategic reduction of its real estate footprint and totaled $2.5 million and $0.3 million, respectively. Restructuring costs for the three months ended September 30, 2022 also included employee termination costs. </span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairment charges</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-cash impairment charges totaled $3.9 million for the three months ended September 30, 2022 and related to real estate</span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">restructuring activities and the write-off of a discontinued IT project. There were no such charges for the three months ended September 30, 2021. See Note 7 - Goodwill, Trade Names, and Other Intangible Assets and Note 9 - Leases to our condensed consolidated financial statements. </span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest expense</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">was $3.5 million for the three months ended September&#160;30, 2022, as compared to $2.2 million for the three months ended September&#160;30, 2021, due to higher average borrowings and a higher effective interest rate. The effective interest rate on our borrowings was 8.2% and 7.5% for the three months ended September&#160;30, 2022 and 2021, respectively. </span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income tax expense</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense totaled $13.9 million for the three months ended September&#160;30, 2022, compared to $1.2 million for the three months ended September&#160;30, 2021. The increase in income tax expense was primarily driven by federal and state taxes, as in the prior year there was a valuation allowance on substantially all of our domestic deferred tax assets. See Note 14 - Income Taxes to our condensed consolidated financial statements.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:115%">Comparison of Results for the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Nine Months Ended September 30, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:115%"> and the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Nine Months Ended September 30, 2021</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.578%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Increase (Decrease)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Increase (Decrease)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from services</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,178,391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,035,973&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,142,418&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct operating expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,689,647&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">808,124&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">881,523&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243,038&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,518&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,520&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bad debt expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,662&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,411&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,251&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,282&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and integration-related costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">530&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">985&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(455)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,859&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(532)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,070&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,527&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221,644&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,342&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158,302&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,876&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,049&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,827&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on early extinguishment of debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,912&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,912&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,119)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(616)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(503)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209,975&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,909&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,066&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,305&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,480&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,825&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to common shareholders</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,670&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,429&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,241&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">NM - Not meaningful</span></div><div style="margin-top:3pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Revenue from services</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from services increased 110.3% to $2.2 billion for the nine months ended September&#160;30, 2022, as compared to $1.0 billion for the nine months ended September&#160;30, 2021, due to strong performance in both our Nurse and Allied Staffing and Physician Staffing segments, primarily driven by an increase in the number of professionals on assignment, as well as higher bill rates in Nurse and Allied. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See further discussion in Segment Results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Direct operating expenses</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Direct operating expenses increased $881.5 million, or 109.1%, to $1.7 billion for the nine months ended September&#160;30, 2022, as compared to $808.1 million for the nine months ended September&#160;30, 2021 as a result of revenue increases. As a percentage of total revenue, direct operating expenses decreased to 77.6% compared to 78.0% in the prior year period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selling, general and administrative expenses</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses increased 62.5% to $243.0 million for the nine months ended September&#160;30, 2022, as compared to $149.5 million for the nine months ended September&#160;30, 2021, primarily </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">due to increases in compensation and benefits, as well as marketing and consulting expense and computer subscription fees. As a&#160;percentage of total revenue, selling, general and administrative expenses decreased to 11.2% for the nine months ended September&#160;30, 2022 as compared to 14.4% for the nine months ended September&#160;30, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Depreciation and amortization expense</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expense&#160;for the nine months ended September&#160;30, 2022 was $9.4 million as compared to $7.1 million for the nine months ended September&#160;30, 2021. The increase is primarily due to the additional amortization of other intangible assets from the WSG and Selected acquisitions. See Note 7 - Goodwill, Trade Names, and Other Intangible Assets to our condensed consolidated financial statements. As a percentage of revenue, depreciation and amortization expense was 0.4% for the nine months ended September&#160;30, 2022 and 0.7% for the nine months ended September&#160;30, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisition and integration-related costs</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquisition and integration-related costs for the nine months ended September 30, 2022 included costs for legal and advisory fees for the Mint and Lotus acquisition that closed on October 3, 2022, and an immaterial amount for the Selected acquisition that closed late in the fourth quarter of 2021. Acquisition and integration-related costs for the nine months ended September 30, 2021 included costs for legal and advisory fees for the WSG acquisition that closed on June 8, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restructuring costs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring costs for the nine months ended September 30, 2022 and 2021 were primarily comprised of employee termination costs and ongoing lease costs related to the Company's strategic reduction of its real estate footprint and totaled $1.9 million and $2.4 million, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairment charges</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-cash impairment charges totaled $5.6 million for the nine months ended September 30, 2022 and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">related to real estate restructuring activities and the write-off of a discontinued IT project.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Non-cash impairment charges totaled $2.1 million for the nine months ended September 30, 2021 and related to real estate restructuring activities and the write-off of a discontinued software development project. See Note 7 - Goodwill, Trade Names, and Other Intangible Assets and Note 9 - Leases to our condensed consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest expense</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">was $10.9 million for the nine months ended September&#160;30, 2022 as compared to $4.0 million for the nine months ended September&#160;30, 2021, due to higher average borrowings and a higher effective interest rate. The effective interest rate on our borrowings was 8.8% for the nine months ended September&#160;30, 2022 compared to 5.1% for the nine months ended September&#160;30, 2021. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Loss on early extinguishment of debt</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss on early extinguishment of debt for the nine months ended September 30, 2022 consisted of a prepayment premium and the write-off of debt issuance costs related to the optional prepayment on our term loan made in the second quarter of 2022. There were no such expenses for the nine months ended September 30, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other income, net</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September 30, 2022, other income, net included a $1.1 million gain on lease termination as a result of the early termination of one of our corporate offices.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income tax expense</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense totaled $60.3 million for the nine months ended September 30, 2022 compared to $5.5 million for the nine months ended September 30, 2021. The increase in income tax expense was primarily driven by federal and state taxes as in the prior year there was a valuation allowance on substantially all of our domestic deferred tax assets. See Note 14 - Income Taxes to our condensed consolidated financial statements.</span></div><div><span><br/></span></div><div style="margin-top:3pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><div id="i5b47dd1c3d5a40ff8e040a94ae232d75_109"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Segment Results</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information on operating segments and a reconciliation to income from operations for the periods indicated are as follows:  </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.500%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from services:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nurse and Allied Staffing</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">612,270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356,139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,109,293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">985,335&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Physician Staffing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,828&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,766&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,098&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,638&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">636,098&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374,905&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,178,391&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,035,973&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution income:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nurse and Allied Staffing</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,838&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,645&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285,506&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Physician Staffing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">837&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">910&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,822&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,675&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,555&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289,328&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,246&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate overhead</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,447&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,049&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,284&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,326&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,214&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,680&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and integration-related costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">490&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">530&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">985&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,493&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,859&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,391&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,856&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,597&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,070&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,175&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,447&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221,644&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,342&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 12 - Segment Data to our condensed consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain statistical data for our business segments for the periods indicated are as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:44.260%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.418%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.714%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.714%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.714%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.686%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Nurse and Allied Staffing statistical data:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">FTEs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,524&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,003&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,521&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Average Nurse and Allied Staffing revenue per FTE per day </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">526&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">425&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Physician Staffing statistical data:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Days filled </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,219&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,187&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,032&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue per day filled </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,803&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,540&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Nurse and Allied Staffing statistical data:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">FTEs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,157&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,732&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,425&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Average Nurse and Allied Staffing revenue per FTE per day </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">462&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Physician Staffing statistical data:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Days filled </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,703&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,430&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,273&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue per day filled </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,785&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,611&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See definition of Business Measurements under the Operating Metrics section of our MD&amp;A.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Segment Comparison - Three Months Ended September 30, 2022 and Three Months Ended September 30, 2021</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Nurse and Allied Staffing</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Revenue increased $256.2 million, or 71.9%, to $612.3 million for the three months ended September&#160;30, 2022, compared to $356.1 million for the three months ended September&#160;30, 2021, through strong performance driven by volume increases and higher bill rates</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contribution income increased $37.2 million, or 91.5%, to $77.8 million for the three months ended September&#160;30, 2022, compared to $40.6 million for the three months ended September&#160;30, 2021, driven by increased revenue and lower costs. As a&#160;percentage of segment revenue, contribution income margin was 12.7% for the three months ended September&#160;30, 2022, compared to 11.4% for the three months ended September&#160;30, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The average number of FTEs on contract during the three months ended September&#160;30, 2022 increased 39.1% from the three months ended September&#160;30, 2021, primarily due to headcount growth in travel nurse and allied. The average revenue per FTE per day increased 23.8%, due to the increase in the average bill rates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Physician Staffing</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue increased $5.0 million, or 27.0%, to $23.8 million for the three months ended September&#160;30, 2022, compared to $18.8 million for the three months ended September&#160;30, 2021, primarily due to an increase in volume in both hospitalists and certified registered nurse anesthetists.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contribution income was $0.8 million for the three months ended September&#160;30, 2022, compared to $0.9 million for the three months ended September&#160;30, 2021. As a&#160;percentage of segment revenue, contribution income was 3.5% for the three months ended September&#160;30, 2022, compared to 4.8% for the three months ended September&#160;30, 2021, driven by higher indirect costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total days filled for the three months ended September&#160;30, 2022 were 13,219, as compared with 12,187 in the prior year. Revenue per day filled was $1,803 as compared with $1,540 in the prior year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Corporate Overhead</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate overhead includes unallocated executive leadership and other centralized corporate functional support costs such as finance, IT, legal, human resources, and marketing, as well as public company expenses and corporate-wide projects. Corporate overhead increased to $16.4 million for the three months ended September&#160;30, 2022, from $12.0 million for the three months ended September&#160;30, 2021, primarily </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">due to increases in compensation and benefit expense, as well as legal and computer expense.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As a percentage of consolidated revenue, corporate overhead was 2.6% for the three months ended September&#160;30, 2022 and 3.2% for the three months ended September&#160;30, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Segment Comparison - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nine Months Ended September 30, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nine Months Ended September 30, 2021</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Nurse and Allied Staffing</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Revenue increased $1.1 billion, or 114.1%, to $2.1 billion for the nine months ended September&#160;30, 2022, compared to $1.0 billion for the nine months ended September&#160;30, 2021, through strong performance driven by volume increases and higher bill rates</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contribution income increased $172.2 million, or 151.9%, to $285.5 million for the nine months ended September&#160;30, 2022, compared to $113.3 million for the nine months ended September&#160;30, 2021, driven by increased revenue and lower costs. As a&#160;percentage of segment revenue, contribution income margin was 13.5% for the nine months ended September&#160;30, 2022, compared to 11.5% for the nine months ended September&#160;30, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The average number of FTEs on contract during the nine months ended September&#160;30, 2022 increased 70.2% from the nine months ended September&#160;30, 2021, primarily due to headcount growth in travel nurse and allied, as well as additional headcount resulting from the WSG acquisition. The average revenue per FTE per day increased 26.0%, due to the increase in the average bill rates.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Physician Staffing</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue increased $18.5 million, or 36.5%, to $69.1 million for the nine months ended September&#160;30, 2022, compared to $50.6 million for the nine months ended September&#160;30, 2021, primarily due to an increase in volume in primary care physicians, hospitalists, and certified registered nurse anesthetists.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contribution income was $3.8 million for the nine months ended September&#160;30, 2022, compared to $2.9 million for the nine months ended September&#160;30, 2021. As a&#160;percentage of segment revenue, contribution income was 5.5% for the nine months ended September&#160;30, 2022, compared to 5.7% for the nine months ended September&#160;30, 2021, driven by higher revenue, partially offset by higher direct and indirect costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total days filled for the nine months ended September 30, 2022 were 38,703, as compared with 31,430 in the prior year. Revenue per day filled was $1,785 as compared with $1,611 in the prior year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Corporate Overhead</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate overhead increased to $50.3 million for the nine months ended September 30, 2022, from $40.3 million for the nine months ended September 30, 2021, primarily </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">due to increases in compensation and benefit expense, as well as legal, consulting,  and computer expense.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As a percentage of consolidated revenue, corporate overhead was 2.3% for the nine months ended September 30, 2022 and 3.9% for the nine months ended September 30, 2021.</span></div><div><span><br/></span></div><div id="i5b47dd1c3d5a40ff8e040a94ae232d75_112"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Liquidity and Capital Resources</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2022, we reported $30.3 million in cash and cash equivalents, $123.9 million of term loan outstanding, at par, and $9.2 million of borrowings drawn under our ABL. Working capital increased by $74.7 million to $383.2 million as of September&#160;30, 2022, compared to $308.5 million as of December&#160;31, 2021, primarily due to an increase in accounts receivable, partially offset by the timing of disbursements. As of September 30, 2022, our days' sales outstanding, net of amounts owed to subcontractors, was 67 days, up</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 6 days year-over-year and up 1 day sequentially, primarily due to the timing of revenue recognized throughout the year.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As of September 30, 2022, we do not have any off-balance sheet arrangements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating cash flow constitutes our primary source of liquidity and, historically, has been sufficient to fund our working capital, capital expenditures, internal business expansion, and debt service. This includes our commitments, both short-term and long-term, of interest expense on our debt and operating lease commitments, and future principal payments on our term loan and our ABL credit facility.&#160;We expect to meet our future needs from a combination of cash on hand, operating cash flows, and funds available through the ABL. See debt discussion which follows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have an effective &#8220;shelf&#8221; registration statement on Form S-3 on file with the Securities and Exchange Commission (SEC) that enables us, in one or more offerings, to sell up to an aggregate of 5,000,000 shares of common stock. Although we do not have any current plans to use the shelf registration statement, the proceeds from any offering could be used for working capital and other general corporate purposes, or to fund acquisitions of businesses, products, and technologies.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by operating activities was $129.7 million in the nine months ended September&#160;30, 2022, compared to $12.3 million used in operating activities in the nine months ended September&#160;30, 2021, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">primarily due to the strength of collections of accounts receivable.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities was $6.8 million in the nine months ended September&#160;30, 2022, compared to $29.4 million in the nine months ended September&#160;30, 2021. Net cash used in the nine months ended September 30, 2022 was for capital expenditures, primarily related to multiple IT projects. Net cash used in the nine months ended September 30, 2021 included $24.5 million related to the acquisition of WSG, as well as capital expenditures and the build-out of our corporate office.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in financing activities during the nine months ended September&#160;30, 2022 was $93.7 million, compared to $40.9 million provided by financing activities during the nine months ended September&#160;30, 2021. During the nine months ended September 30, 2022, we used cash to repay borrowings of $50.4 million on our term loan, $2.4 million on our note payable, $5.3 million for income taxes on share-based compensation, $3.2 million in debt issuance costs, $24.3 million for share repurchases, $7.5 million for contingent consideration, and an immaterial amount for other financing activities. During the nine months ended September 30, 2021, we reported net borrowings of $100.0 million on our term loan, and used cash to repay borrowing on our ABL of $49.4 million, $0.3 million principal payment on our term loan, $2.4 million on our note payable, $4.6 million of debt issuance costs, $2.2 million for income taxes on share-based compensation, and an immaterial amount for other financing activities. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i5b47dd1c3d5a40ff8e040a94ae232d75_115"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Debt</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 Term Loan Credit Agreement</span></div><div style="margin-top:3pt;text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As more fully described in Note 8 - Debt to our condensed consolidated financial statements, on June 8, 2021, we entered into a Term Loan Credit Agreement (Term Loan Agreement), which provides for a six-year second lien subordinated term loan in the amount of $100.0&#160;million (term loan). The term loan has an interest rate of one-month London Inter-Bank Offered Rate (LIBOR) plus 5.75% per annum, subject to a 0.75% LIBOR floor. The term loan was used to pay the cash consideration, as well as any costs, fees, and expenses in connection with the WSG acquisition (see Note 4 - Acquisitions to our condensed consolidated financial statements), with the remainder used to pay down a portion of the asset-based credit facility.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The borrowings under the Term Loan Agreement generally bear interest at a variable rate based on either LIBOR or Base Rate (as defined in the Term Loan Agreement) and are subject to mandatory prepayments of principal payable in quarterly installments, commencing on September 30, 2021, with each installment being in the aggregate principal amount of $0.3 million (subject to adjustment as a result of prepayments) provided that, to the extent not previously paid, the aggregate unpaid principal balance would be due and payable on the maturity date. The Term Loan Agreement contains various restrictions and covenants applicable to the Company and its subsidiaries, including a covenant to maintain a minimum net leverage ratio. The Company was in compliance with this covenant as of September 30, 2022. Obligations under the Term Loan Agreement are secured by substantially all the assets of the borrowers and guarantors under the Term Loan Agreement, subject to customary exceptions.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 18, 2021, we amended the Term Loan Agreement (Term Loan First Amendment), which provided the Company an incremental term loan in an aggregate amount equal to $75.0 million. Additionally, the Term Loan First Amendment increased the aggregate amount of all increases (as defined in the Term Loan Agreement) to be no greater than $115.0 million. The borrowings will be used primarily to fund organic growth. Commencing on December 31, 2021, installments of the mandatory prepayments will be in the aggregate principal amount of $0.4 million. All other terms, conditions, covenants, and pricing of the Term Loan Agreement remain the same.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aside from our scheduled payments, on June 23, 2022, we made an optional prepayment of $50.0&#160;million, and paid a prepayment premium of $0.5&#160;million pursuant to the Term Loan Agreement. As a result of the early prepayment, debt issuance costs of $1.4&#160;million were written off in the nine months ended September 30, 2022. The prepayment premium and the write-off of debt issuance costs are included as loss on early extinguishment of debt in the condensed consolidated statements of operations. We were entitled to determine the application of the prepayment, which was applied to all future amortization payments, with the balance applied to the remaining balloon payment in 2027.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2019 Loan Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective October 25, 2019, our prior senior credit facility entered into in August 2017 was replaced by a $120.0&#160;million Loan Agreement, which provides for a five-year senior secured revolving credit facility. On June 30, 2020, we amended the Loan Agreement (First Amendment), which increased the current aggregate committed size of the ABL from $120.0&#160;million to $130.0&#160;million. All other terms, conditions, covenants, and pricing of the Loan Agreement remained the same. On March 8, 2021, we amended the Loan Agreement (Second Amendment), which increased the current aggregate committed size of the ABL from $130.0&#160;million to $150.0&#160;million, increased certain borrowing base sub-limits, and decreased both the cash dominion event and financial reporting triggers. On June 8, 2021, we amended the Loan Agreement (Third Amendment), which permits the incurrence of indebtedness and grant of security as set forth in the Loan Agreement and in accordance with the Intercreditor Agreement, and provides mechanics relating to a transition away from LIBOR as a benchmark interest rate to a replacement alternative benchmark rate or mechanism for loans made in U.S. dollars. On November 18, 2021, we amended the Loan Agreement (Fourth Amendment), whereby the permitted indebtedness (as defined in the Loan Agreement) was increased to $175.0 million. On March 21, 2022, we amended the Loan Agreement (Fifth Amendment), which increased the current aggregate committed size of the ABL from $150.0 million to $300.0 million, extended the credit facility for an additional five years, increased certain borrowing base sub-limits, and provided the option for all or a portion of the borrowings to bear interest at a rate based on the Secured Overnight Financing Rate (SOFR) or Base Rate, at the election of the borrowers, plus an applicable margin.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2022, the interest rate spreads and fees under the Loan Agreement were based on SOFR plus 1.60% for the revolving portion of the borrowing base. The Base Rate (as defined by the Loan Agreement) margin would have been 0.50%  for the revolving portion</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The SOFR and Base Rate margins are subject to monthly pricing adjustments, pursuant to a pricing </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">matrix based on the Company&#8217;s excess availability under the revolving credit facility. In addition, the facility is subject to an unused line fee, letter of credit fees, and an administrative fee. The Loan Agreement contains various restrictions and covenants, including a covenant to maintain a minimum fixed charge coverage ratio. We were in compliance with the fixed charge coverage ratio covenant as of September 30, 2022. Borrowing base availability under the ABL was $300.0&#160;million at September 30, 2022, with $9.2&#160;million of borrowings drawn as well as $17.5&#160;million of letters of credit outstanding, leaving $273.3&#160;million of excess availability.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 8 - Debt to our condensed consolidated financial statements.</span></div><div><span><br/></span></div><div id="i5b47dd1c3d5a40ff8e040a94ae232d75_118"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Stockholders&#8217; Equity</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 11 - Stockholders' Equity to our condensed consolidated financial statements.</span></div><div><span><br/></span></div><div id="i5b47dd1c3d5a40ff8e040a94ae232d75_121"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Critical Accounting Policies and Estimates</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our critical accounting policies and estimates remain consistent with those reported in our 2021 Form 10-K.</span></div><div><span><br/></span></div><div id="i5b47dd1c3d5a40ff8e040a94ae232d75_124"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Transactions with Related Parties</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 15 - Related Party Transactions to our condensed consolidated financial statements.</span></div><div><span><br/></span></div><div id="i5b47dd1c3d5a40ff8e040a94ae232d75_127"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Recent Accounting Pronouncements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 16 - Recent Accounting Pronouncements to our condensed consolidated financial statements.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><div id="i5b47dd1c3d5a40ff8e040a94ae232d75_130"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3.&#160;&#160;&#160;&#160;QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Rate Risk</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to variable interest rate risk associated with our Term Loan Agreement entered into on June 8, 2021 and our Loan Agreement entered into on October 25, 2019. These agreements charge interest at a rate based on either SOFR, LIBOR, or Base Rate (as defined in the agreements) plus an applicable margin.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A 1% change in interest rates would have resulted in interest expense fluctuating approximately $1.2 million and $0.7 million for the nine months ended September 30, 2022 and 2021, respectively. See Note 8 - Debt to our condensed consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to our 2021 Form 10-K Item 1A. Risk Factors under </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">"The interest rates under our Term Loan Agreement and our ABL Credit Agreement may be impacted by the phase-out of LIBOR"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for discussion of the interest rate risk related to the continued phase-out of LIBOR.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Risks</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes to our other exposures as disclosed in our 2021 Form&#160;10-K.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i5b47dd1c3d5a40ff8e040a94ae232d75_133"></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4.&#160;&#160;&#160;&#160;CONTROLS AND PROCEDURES </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We carried out an evaluation, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our &#8220;disclosure controls and procedures&#8221; (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended, or the Exchange Act), as of the end of the period covered by this report. Based upon the evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures are effective. Disclosure controls and procedures are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized, communicated to management, including the Chief Executive Officer and the Chief Financial Officer, and reported within the time periods specified in the SEC&#8217;s rules and forms. The disclosure controls and procedures are designed to ensure that information required to be disclosed by us in reports required under the Exchange Act of 1934, as amended, is accumulated and communicated to our management, including the Chief Executive Officer and Chief Financial Officer, in order to allow timely decisions regarding any required disclosure.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting as defined in Exchange Act Rules&#160;13a-15(f) that occurred during our most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have not experienced any material impact to our internal controls over financial reporting despite the fact that most of our employees are working remotely </span><span style="background-color:#ffffff;color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">due to the COVID pandemic</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><div id="i5b47dd1c3d5a40ff8e040a94ae232d75_136"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II. &#8211; OTHER INFORMATION</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i5b47dd1c3d5a40ff8e040a94ae232d75_139"></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1.&#160;&#160;&#160;&#160;LEGAL PROCEEDINGS</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information with respect to certain legal proceedings is included in Part I, Item 1, Note 13 - Contingencies - </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Legal Proceedings</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of this Quarterly Report on Form 10-Q, and is incorporated herein by reference.</span></div><div><span><br/></span></div><div id="i5b47dd1c3d5a40ff8e040a94ae232d75_142"></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A.&#160;&#160;&#160;&#160;RISK FACTORS</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">There are no material changes to our Risk Factors as previously disclosed in our 2021 Form 10-K.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><div id="i5b47dd1c3d5a40ff8e040a94ae232d75_145"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 6.&#160;&#160;&#160;&#160;EXHIBITS</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.732%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.265%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*31.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ccrn20220930-10qex31x1.htm">Certification pursuant to Rule&#160;13a-14(a) and Rule&#160;15d-14(a) by John A. Martins,&#160;President, Chief Executive Officer, Director (Principal Executive Officer)</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*31.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ccrn20220930-10qex31x2.htm">Certification pursuant to Rule 13a-14(a) and Rule 15d-14(a) by William J. Burns, Executive Vice President, Chief Financial Officer (Principal Accounting and Financial Officer)</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**32.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ccrn20220930-10qex32x1.htm">Certification pursuant to 18 U.S.C. Section&#160;1350 by John A. Martins,&#160;President, Chief Executive Officer, Director (Principal Executive Officer)</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**32.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ccrn20220930-10qex32x2.htm">Certification pursuant to 18 U.S.C. Section&#160;1350 by William J. Burns, Executive Vice President, Chief Financial Officer (Principal Accounting and Financial Officer)</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*101.INS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*101.SCH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Document</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*101.DEF</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase Document</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*101.LAB</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Label Linkbase Document</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*101.CAL</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase Document</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*101.PRE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Linkbase Document</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Represents a management contract or compensatory plan or arrangement</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furnished herewith</span></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><div id="i5b47dd1c3d5a40ff8e040a94ae232d75_148"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.192%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.930%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CROSS&#160;COUNTRY&#160;HEALTHCARE,&#160;INC.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: November&#160;3, 2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ William J. Burns</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">William J. Burns<br/>Executive Vice President &amp; Chief&#160;Financial&#160;Officer                         (Principal Accounting and Financial Officer)</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>ccrn20220930-10qex31x1.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i8df525528fa54f77bc2f29bab0e58415_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.1</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, John A. Martins, certify that&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this Quarterly Report on Form&#160;10-Q of Cross Country Healthcare, Inc.&#59;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59; </font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58; </font></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59; </font></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and </font></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting. </font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.014%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:72.361%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 3, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; John A. Martins</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John A. Martins<br>President &#38; Chief&#160;Executive Officer<br>(Principal&#160;Executive&#160;Officer)</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>ccrn20220930-10qex31x2.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i0ae7dcd4c62b4bd5ba44019df71d0ca8_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.2</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, William J. Burns, certify that&#58;</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this Quarterly Report on Form&#160;10-Q of Cross Country Healthcare, Inc.&#59;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59; </font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58; </font></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59; </font></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and </font></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.014%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:72.361%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 3, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; William J. Burns</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">William J. Burns<br>Executive Vice President &#38; Chief&#160;Financial&#160;Officer                                                                                    (Principal Accounting and Financial Officer)</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>ccrn20220930-10qex32x1.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i078e9f0ce93649698fc10a851299f47f_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32.1</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the accompanying Quarterly Report on Form&#160;10-Q of Cross Country Healthcare, Inc. (the Company) for the quarterly period ended September&#160;30, 2022, (the &#34;Periodic Report&#34;), I, John A. Martins, President and Chief Executive Officer of the Company, hereby certify pursuant to 18&#160;U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that to my knowledge the Periodic Report fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:71.961%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 3, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; John A. Martins</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John A. Martins<br>President &#38; Chief&#160;Executive Officer<br>(Principal&#160;Executive&#160;Officer)</font></td></tr></table></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section&#160;906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section&#160;906, has been provided to Cross Country Healthcare, Inc. and will be retained by Cross Country Healthcare, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing certification is provided solely for purposes of complying with the provisions of Section&#160;906 of the Sarbanes-Oxley Act of 2002.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>ccrn20220930-10qex32x2.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i5b96b69ac25741aa97d5fa15c52a9a58_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32.2</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the accompanying Quarterly Report on Form&#160;10-Q of Cross Country Healthcare, Inc. (the &#34;Company&#34;) for the quarterly period ended September&#160;30, 2022, (the &#34;Periodic Report&#34;), I, William J. Burns, Executive Vice President and Chief Financial Officer of the Company, hereby certify pursuant to 18&#160;U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that to my knowledge the Periodic Report fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.014%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:72.361%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 3, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; William J. Burns</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">William J. Burns<br>Executive Vice President &#38; Chief&#160;Financial&#160;Officer                                                                                    (Principal Accounting and Financial Officer)</font></td></tr></table></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section&#160;906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section&#160;906, has been provided to Cross Country Healthcare, Inc. and will be retained by Cross Country Healthcare, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing certification is provided solely for purposes of complying with the provisions of Section&#160;906 of the Sarbanes-Oxley Act of 2002.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>ccrn-20220930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:9f036714-f865-4798-af5a-08fe5047afca,g:b4ca6da5-78c3-4063-9a30-7dfc7d463cab-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ccrn="http://www.crosscountryhealthcare.com/20220930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.crosscountryhealthcare.com/20220930">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ccrn-20220930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ccrn-20220930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ccrn-20220930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ccrn-20220930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.crosscountryhealthcare.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETS" roleURI="http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS">
        <link:definition>0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" roleURI="http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
        <link:definition>0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ORGANIZATIONANDBASISOFPRESENTATION" roleURI="http://www.crosscountryhealthcare.com/role/ORGANIZATIONANDBASISOFPRESENTATION">
        <link:definition>0000007 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES">
        <link:definition>0000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUERECOGNITION" roleURI="http://www.crosscountryhealthcare.com/role/REVENUERECOGNITION">
        <link:definition>0000009 - Disclosure - REVENUE RECOGNITION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONS" roleURI="http://www.crosscountryhealthcare.com/role/ACQUISITIONS">
        <link:definition>0000010 - Disclosure - ACQUISITIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMPREHENSIVEINCOME" roleURI="http://www.crosscountryhealthcare.com/role/COMPREHENSIVEINCOME">
        <link:definition>0000011 - Disclosure - COMPREHENSIVE INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHARE" roleURI="http://www.crosscountryhealthcare.com/role/EARNINGSPERSHARE">
        <link:definition>0000012 - Disclosure - EARNINGS PER SHARE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETS" roleURI="http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETS">
        <link:definition>0000013 - Disclosure - GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBT" roleURI="http://www.crosscountryhealthcare.com/role/DEBT">
        <link:definition>0000014 - Disclosure - DEBT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASES" roleURI="http://www.crosscountryhealthcare.com/role/LEASES">
        <link:definition>0000015 - Disclosure - LEASES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTS" roleURI="http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTS">
        <link:definition>0000016 - Disclosure - FAIR VALUE MEASUREMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITY" roleURI="http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITY">
        <link:definition>0000017 - Disclosure - STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTDATA" roleURI="http://www.crosscountryhealthcare.com/role/SEGMENTDATA">
        <link:definition>0000018 - Disclosure - SEGMENT DATA</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONTINGENCIES" roleURI="http://www.crosscountryhealthcare.com/role/CONTINGENCIES">
        <link:definition>0000019 - Disclosure - CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXES" roleURI="http://www.crosscountryhealthcare.com/role/INCOMETAXES">
        <link:definition>0000020 - Disclosure - INCOME TAXES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RELATEDPARTYTRANSACTIONS" roleURI="http://www.crosscountryhealthcare.com/role/RELATEDPARTYTRANSACTIONS">
        <link:definition>0000021 - Disclosure - RELATED PARTY TRANSACTIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RECENTACCOUNTINGPRONOUNCEMENTS" roleURI="http://www.crosscountryhealthcare.com/role/RECENTACCOUNTINGPRONOUNCEMENTS">
        <link:definition>0000022 - Disclosure - RECENT ACCOUNTING PRONOUNCEMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUBSEQUENTEVENTS" roleURI="http://www.crosscountryhealthcare.com/role/SUBSEQUENTEVENTS">
        <link:definition>0000023 - Disclosure - SUBSEQUENT EVENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" roleURI="http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies">
        <link:definition>0000024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" roleURI="http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables">
        <link:definition>0000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUERECOGNITIONTables" roleURI="http://www.crosscountryhealthcare.com/role/REVENUERECOGNITIONTables">
        <link:definition>0000026 - Disclosure - REVENUE RECOGNITION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSTables" roleURI="http://www.crosscountryhealthcare.com/role/ACQUISITIONSTables">
        <link:definition>0000027 - Disclosure - ACQUISITIONS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHARETables" roleURI="http://www.crosscountryhealthcare.com/role/EARNINGSPERSHARETables">
        <link:definition>0000028 - Disclosure - EARNINGS PER SHARE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSTables" roleURI="http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSTables">
        <link:definition>0000029 - Disclosure - GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTTables" roleURI="http://www.crosscountryhealthcare.com/role/DEBTTables">
        <link:definition>0000030 - Disclosure - DEBT (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESTables" roleURI="http://www.crosscountryhealthcare.com/role/LEASESTables">
        <link:definition>0000031 - Disclosure - LEASES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSTables" roleURI="http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSTables">
        <link:definition>0000032 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYTables" roleURI="http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYTables">
        <link:definition>0000033 - Disclosure - STOCKHOLDERS' EQUITY (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTDATATables" roleURI="http://www.crosscountryhealthcare.com/role/SEGMENTDATATables">
        <link:definition>0000034 - Disclosure - SEGMENT DATA (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails" roleURI="http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails">
        <link:definition>0000035 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAllowanceforDoubtfulAccountsDetails" roleURI="http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAllowanceforDoubtfulAccountsDetails">
        <link:definition>0000036 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Allowance for Doubtful Accounts (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRestructuringBenefitsCostsDetails" roleURI="http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRestructuringBenefitsCostsDetails">
        <link:definition>0000037 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Restructuring (Benefits) Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUERECOGNITIONDetails" roleURI="http://www.crosscountryhealthcare.com/role/REVENUERECOGNITIONDetails">
        <link:definition>0000038 - Disclosure - REVENUE RECOGNITION (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSAdditionalInformationDetails" roleURI="http://www.crosscountryhealthcare.com/role/ACQUISITIONSAdditionalInformationDetails">
        <link:definition>0000039 - Disclosure - ACQUISITIONS - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails" roleURI="http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails">
        <link:definition>0000040 - Disclosure - ACQUISITIONS - Recognized Identified Assets Acquired and Liabilities Assumed (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMPREHENSIVEINCOMEDetails" roleURI="http://www.crosscountryhealthcare.com/role/COMPREHENSIVEINCOMEDetails">
        <link:definition>0000041 - Disclosure - COMPREHENSIVE INCOME (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHAREComponentsofNumeratorandDenominatorforComputationofBasicandDilutedEarningsperShareDetails" roleURI="http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREComponentsofNumeratorandDenominatorforComputationofBasicandDilutedEarningsperShareDetails">
        <link:definition>0000042 - Disclosure - EARNINGS PER SHARE - Components of Numerator and Denominator for Computation of Basic and Diluted Earnings per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHAREAntidilutiveSecuritiesDetails" roleURI="http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREAntidilutiveSecuritiesDetails">
        <link:definition>0000043 - Disclosure - EARNINGS PER SHARE - Anti-dilutive Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails" roleURI="http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails">
        <link:definition>0000044 - Disclosure - GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS - Acquired Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSEstimatedAnnualAmortizationExpenseDetails" roleURI="http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSEstimatedAnnualAmortizationExpenseDetails">
        <link:definition>0000045 - Disclosure - GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS - Estimated Annual Amortization Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails" roleURI="http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails">
        <link:definition>0000046 - Disclosure - GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS - Goodwill Rollforward (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAdditionalInformationDetails" roleURI="http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAdditionalInformationDetails">
        <link:definition>0000047 - Disclosure - GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTLongtermDebtDetails" roleURI="http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails">
        <link:definition>0000048 - Disclosure - DEBT - Long-term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBT2021TermLoanCreditAgreementNarrativeDetails" roleURI="http://www.crosscountryhealthcare.com/role/DEBT2021TermLoanCreditAgreementNarrativeDetails">
        <link:definition>0000049 - Disclosure - DEBT - 2021 Term Loan Credit Agreement Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTMaturitiesofDebtDetails" roleURI="http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails">
        <link:definition>0000050 - Disclosure - DEBT - Maturities of Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBT2019LoanAgreementDetails" roleURI="http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails">
        <link:definition>0000051 - Disclosure - DEBT - 2019 Loan Agreement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESAdditionalInformationDetails" roleURI="http://www.crosscountryhealthcare.com/role/LEASESAdditionalInformationDetails">
        <link:definition>0000052 - Disclosure - LEASES - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESSupplementalBalanceSheetInformationDetails" roleURI="http://www.crosscountryhealthcare.com/role/LEASESSupplementalBalanceSheetInformationDetails">
        <link:definition>0000053 - Disclosure - LEASES - Supplemental Balance Sheet Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESOperatingLeaseMaturityDetails" roleURI="http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails">
        <link:definition>0000054 - Disclosure - LEASES - Operating Lease Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESOperatingLeaseMaturityDetails_1" roleURI="http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails_1">
        <link:definition>0000054 - Disclosure - LEASES - Operating Lease Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESLeaseCostsDetails" roleURI="http://www.crosscountryhealthcare.com/role/LEASESLeaseCostsDetails">
        <link:definition>0000055 - Disclosure - LEASES - Lease Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSEstimatedFairValuesofFinancialAssetsandLiabilitiesMeasuredonaRecurringBasisDetails" roleURI="http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSEstimatedFairValuesofFinancialAssetsandLiabilitiesMeasuredonaRecurringBasisDetails">
        <link:definition>0000056 - Disclosure - FAIR VALUE MEASUREMENTS - Estimated Fair Values of Financial Assets and Liabilities Measured on a Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSNarrativeDetails" roleURI="http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails">
        <link:definition>0000057 - Disclosure - FAIR VALUE MEASUREMENTS - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails" roleURI="http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails">
        <link:definition>0000058 - Disclosure - FAIR VALUE MEASUREMENTS - Carrying Amounts and Estimated Fair Values of Significant Financial Instrument that were not Measured at Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYAdditionalInformationDetails" roleURI="http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails">
        <link:definition>0000059 - Disclosure - STOCKHOLDERS' EQUITY - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYRestrictedStockActivityDetails" roleURI="http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYRestrictedStockActivityDetails">
        <link:definition>0000060 - Disclosure - STOCKHOLDERS' EQUITY - Restricted Stock Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTDATADetails" roleURI="http://www.crosscountryhealthcare.com/role/SEGMENTDATADetails">
        <link:definition>0000061 - Disclosure - SEGMENT DATA (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESDetails" roleURI="http://www.crosscountryhealthcare.com/role/INCOMETAXESDetails">
        <link:definition>0000062 - Disclosure - INCOME TAXES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RELATEDPARTYTRANSACTIONSDetails" roleURI="http://www.crosscountryhealthcare.com/role/RELATEDPARTYTRANSACTIONSDetails">
        <link:definition>0000063 - Disclosure - RELATED PARTY TRANSACTIONS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="ccrn_SelectedIncMember" abstract="true" name="SelectedIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ccrn_FairValueMeasurementLineItems" abstract="true" name="FairValueMeasurementLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ccrn_AssetsAndLiabilitiesLeasesTableTextBlock" abstract="false" name="AssetsAndLiabilitiesLeasesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="ccrn_LineOfCreditFacilityBorrowingBaseAvailability" abstract="false" name="LineOfCreditFacilityBorrowingBaseAvailability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ccrn_OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard" abstract="false" name="OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ccrn_SalesAllowanceBillingRelatedAdjustments" abstract="false" name="SalesAllowanceBillingRelatedAdjustments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ccrn_A2021TermLoanCreditAgreementAggregateAmountOfAllPossibleIncreasesMember" abstract="true" name="A2021TermLoanCreditAgreementAggregateAmountOfAllPossibleIncreasesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationNoncurrent" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ccrn_DebtInstrumentVariableInterestRateFloor" abstract="false" name="DebtInstrumentVariableInterestRateFloor" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="ccrn_A2021TermLoanCreditAgreementMember" abstract="true" name="A2021TermLoanCreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ccrn_DeferredCompensationMember" abstract="true" name="DeferredCompensationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ccrn_OperatingLeaseExpenseNonCash" abstract="false" name="OperatingLeaseExpenseNonCash" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ccrn_EarnoutNotesPayableMember" abstract="true" name="EarnoutNotesPayableMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ccrn_OtherServicesMember" abstract="true" name="OtherServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationCurrent" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ccrn_BusinessCombinationContingentConsiderationTerm" abstract="false" name="BusinessCombinationContingentConsiderationTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="ccrn_HealthCareSystemAffiliatedWithABoardMemberMember" abstract="true" name="HealthCareSystemAffiliatedWithABoardMemberMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ccrn_AcquisitionAndIntegrationRelatedCosts" abstract="false" name="AcquisitionAndIntegrationRelatedCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ccrn_LineOfCreditFacilityBasisSpreadOnVariableRateAdditionalCreditSpreadAssociatedWithSOFR" abstract="false" name="LineOfCreditFacilityBasisSpreadOnVariableRateAdditionalCreditSpreadAssociatedWithSOFR" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="ccrn_IncreaseDecreaseInOperatingLeaseLiabilities" abstract="false" name="IncreaseDecreaseInOperatingLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ccrn_PaymentForDebtPrepayment" abstract="false" name="PaymentForDebtPrepayment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ccrn_LongTermDebtMaturityAfterYearFour" abstract="false" name="LongTermDebtMaturityAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ccrn_PhysicianStaffingMember" abstract="true" name="PhysicianStaffingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ccrn_OmnibusPlanMember" abstract="true" name="OmnibusPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ccrn_VariableAndOtherLeaseCost" abstract="false" name="VariableAndOtherLeaseCost" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment" abstract="false" name="BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ccrn_WorkforceSolutionsGroupIncMember" abstract="true" name="WorkforceSolutionsGroupIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ccrn_PriorRepurchaseProgramAndNewRepurchaseProgramMember" abstract="true" name="PriorRepurchaseProgramAndNewRepurchaseProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ccrn_SecuredOvernightFinancingRateSOFRMember" abstract="true" name="SecuredOvernightFinancingRateSOFRMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ccrn_FairValueMeasurementTable" abstract="true" name="FairValueMeasurementTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="ccrn_TemporaryStaffingServicesMember" abstract="true" name="TemporaryStaffingServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ccrn_LineOfCreditSublimitAxis" abstract="true" name="LineOfCreditSublimitAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="ccrn_LineOfCreditSublimitDomain" abstract="true" name="LineOfCreditSublimitDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ccrn_SwingLoansSublimitMember" abstract="true" name="SwingLoansSublimitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ccrn_EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems" abstract="false" name="EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAttainmentPercentage" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAttainmentPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensationAndBenefits" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensationAndBenefits" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ccrn_ThresholdPeriodPastDueForPaymentOfServicesProvided" abstract="false" name="ThresholdPeriodPastDueForPaymentOfServicesProvided" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="ccrn_SeniorSecuredAssetBasedLoanMember" abstract="true" name="SeniorSecuredAssetBasedLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ccrn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" abstract="false" name="FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ccrn_RestrictedStockAndPerformanceSharesMember" abstract="true" name="RestrictedStockAndPerformanceSharesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" abstract="true" name="FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ccrn_StandbyLettersOfCreditSublimitMember" abstract="true" name="StandbyLettersOfCreditSublimitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ccrn_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax" abstract="false" name="AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ccrn_NurseAndAlliedStaffingMember" abstract="true" name="NurseAndAlliedStaffingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ccrn_A2021TermLoanCreditAgreementIncrementalTermLoanMember" abstract="true" name="A2021TermLoanCreditAgreementIncrementalTermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="ccrn_LineOfCreditAmountOfIndebtednessPermittedBySeniorSecuredAssetBasedLoanToBeBorrowedFromOtherSources" abstract="false" name="LineOfCreditAmountOfIndebtednessPermittedBySeniorSecuredAssetBasedLoanToBeBorrowedFromOtherSources" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ccrn_SegmentReportingUnallocatedCorporateExpenses" abstract="false" name="SegmentReportingUnallocatedCorporateExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ccrn_ExitCostsMember" abstract="true" name="ExitCostsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ccrn_LineOfCreditBorrowingBasePercentageOfAssets" abstract="false" name="LineOfCreditBorrowingBasePercentageOfAssets" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable" abstract="true" name="ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="ccrn_ShareBasedPaymentAwardsMember" abstract="true" name="ShareBasedPaymentAwardsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ccrn_RisksAndUncertaintiesPolicyTextBlock" abstract="false" name="RisksAndUncertaintiesPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ccrn_ProvisionForDoubtfulAccountsAndOtherAllowances" abstract="false" name="ProvisionForDoubtfulAccountsAndOtherAllowances" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ccrn_PaymentsForRestructuringAndAdjustments" abstract="false" name="PaymentsForRestructuringAndAdjustments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ccrn_NewRepurchaseProgramMember" abstract="true" name="NewRepurchaseProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>ccrn-20220930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:9f036714-f865-4798-af5a-08fe5047afca,g:b4ca6da5-78c3-4063-9a30-7dfc7d463cab-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="ccrn-20220930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_1159f0d9-772e-428c-833f-88d00ad035a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_c9fe46ae-5c5c-4001-9639-5b574d121e0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_1159f0d9-772e-428c-833f-88d00ad035a3" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_c9fe46ae-5c5c-4001-9639-5b574d121e0e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_f8776a45-5342-4bc4-901f-9780ea6e7af5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_1159f0d9-772e-428c-833f-88d00ad035a3" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_f8776a45-5342-4bc4-901f-9780ea6e7af5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_a1f7f876-5367-4cea-ae29-56343e0df591" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_1159f0d9-772e-428c-833f-88d00ad035a3" xlink:to="loc_us-gaap_LiabilitiesCurrent_a1f7f876-5367-4cea-ae29-56343e0df591" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_5837cc2d-b778-484c-b512-23bf02c0ef30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_1159f0d9-772e-428c-833f-88d00ad035a3" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_5837cc2d-b778-484c-b512-23bf02c0ef30" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_8ac1d6f2-aba2-4d51-821f-539b6f559f24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_1159f0d9-772e-428c-833f-88d00ad035a3" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_8ac1d6f2-aba2-4d51-821f-539b6f559f24" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermDebtNoncurrent_7a5a11e7-d4b8-48dc-82e2-3fbf73df3f0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermDebtNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_1159f0d9-772e-428c-833f-88d00ad035a3" xlink:to="loc_us-gaap_OtherLongTermDebtNoncurrent_7a5a11e7-d4b8-48dc-82e2-3fbf73df3f0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_17f79711-3a83-4d34-a188-28ee0b948143" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_1159f0d9-772e-428c-833f-88d00ad035a3" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_17f79711-3a83-4d34-a188-28ee0b948143" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_8a3ff8b6-497d-4e05-8e8d-e9496724486e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_3bdb9a95-a2e0-4b33-9df2-fb943003d1af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8a3ff8b6-497d-4e05-8e8d-e9496724486e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_3bdb9a95-a2e0-4b33-9df2-fb943003d1af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_c999025b-4d85-4fd8-ae67-c8edfa9b7bc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8a3ff8b6-497d-4e05-8e8d-e9496724486e" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_c999025b-4d85-4fd8-ae67-c8edfa9b7bc8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_d4f2fddb-f1d4-4850-8c50-8dea0d761081" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8a3ff8b6-497d-4e05-8e8d-e9496724486e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_d4f2fddb-f1d4-4850-8c50-8dea0d761081" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_d8763061-9a36-478a-99e3-835d0796c07b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8a3ff8b6-497d-4e05-8e8d-e9496724486e" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_d8763061-9a36-478a-99e3-835d0796c07b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_f4cc0388-b320-4a57-91d4-5a1172b7638c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8a3ff8b6-497d-4e05-8e8d-e9496724486e" xlink:to="loc_us-gaap_Goodwill_f4cc0388-b320-4a57-91d4-5a1172b7638c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_2a55293c-f304-4778-9e0b-e0f24efebf65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8a3ff8b6-497d-4e05-8e8d-e9496724486e" xlink:to="loc_us-gaap_AssetsCurrent_2a55293c-f304-4778-9e0b-e0f24efebf65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_59a8f9de-2d9f-4bf2-9ccc-ccabe63126d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8a3ff8b6-497d-4e05-8e8d-e9496724486e" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_59a8f9de-2d9f-4bf2-9ccc-ccabe63126d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceSettlementsReceivableNoncurrent_90c00eec-3b34-4db0-b344-401e92cdddfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceSettlementsReceivableNoncurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8a3ff8b6-497d-4e05-8e8d-e9496724486e" xlink:to="loc_us-gaap_InsuranceSettlementsReceivableNoncurrent_90c00eec-3b34-4db0-b344-401e92cdddfa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedTradeNames_c060a4e3-96ba-4c96-a9b8-7055c3bbb37f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedTradeNames"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8a3ff8b6-497d-4e05-8e8d-e9496724486e" xlink:to="loc_us-gaap_IndefiniteLivedTradeNames_c060a4e3-96ba-4c96-a9b8-7055c3bbb37f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_d2a3f852-13e4-48b5-8e90-c7182738aeab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_bb820f6c-aba2-49cc-925e-deadd4641803" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_d2a3f852-13e4-48b5-8e90-c7182738aeab" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_bb820f6c-aba2-49cc-925e-deadd4641803" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_fd95fa0d-f244-4833-b2c8-ba5f87bcfe91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_d2a3f852-13e4-48b5-8e90-c7182738aeab" xlink:to="loc_us-gaap_TaxesPayableCurrent_fd95fa0d-f244-4833-b2c8-ba5f87bcfe91" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_094b0961-2be4-4945-add9-a4acd93d2389" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_d2a3f852-13e4-48b5-8e90-c7182738aeab" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_094b0961-2be4-4945-add9-a4acd93d2389" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_a414c7ea-d7ed-4bbf-adb5-0dda3fecf61a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_d2a3f852-13e4-48b5-8e90-c7182738aeab" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_a414c7ea-d7ed-4bbf-adb5-0dda3fecf61a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_5230fc09-eed5-4f5a-91ae-6b61c87a5ad1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_d2a3f852-13e4-48b5-8e90-c7182738aeab" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_5230fc09-eed5-4f5a-91ae-6b61c87a5ad1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_691086ba-cff8-42b4-9fbc-c625ed304197" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_d2a3f852-13e4-48b5-8e90-c7182738aeab" xlink:to="loc_us-gaap_LongTermDebtCurrent_691086ba-cff8-42b4-9fbc-c625ed304197" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_8652ddfa-08bd-49fa-a593-8431461ea21a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_d2a3f852-13e4-48b5-8e90-c7182738aeab" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_8652ddfa-08bd-49fa-a593-8431461ea21a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_4a849f1c-c4d0-403c-b9f3-93dc9bf1b607" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_0aa880d1-6815-441e-a1d7-fac9ef07cffc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_4a849f1c-c4d0-403c-b9f3-93dc9bf1b607" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_0aa880d1-6815-441e-a1d7-fac9ef07cffc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_ef20c9c9-4793-4262-bf02-4712a6854bc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_4a849f1c-c4d0-403c-b9f3-93dc9bf1b607" xlink:to="loc_us-gaap_CommonStockValue_ef20c9c9-4793-4262-bf02-4712a6854bc0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_fec0ecc5-3653-4617-85c5-a20f8723135f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_4a849f1c-c4d0-403c-b9f3-93dc9bf1b607" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_fec0ecc5-3653-4617-85c5-a20f8723135f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_d5794c92-37d1-4d4e-9f9e-21abe0586f32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_4a849f1c-c4d0-403c-b9f3-93dc9bf1b607" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_d5794c92-37d1-4d4e-9f9e-21abe0586f32" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_e2d9fc85-63f4-4bdc-95ad-2bedbf239393" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_eced9b31-1a33-48e8-a0d5-c0ed373acc56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_e2d9fc85-63f4-4bdc-95ad-2bedbf239393" xlink:to="loc_us-gaap_CommitmentsAndContingencies_eced9b31-1a33-48e8-a0d5-c0ed373acc56" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_cd540325-00c8-44ab-95c6-81333e986d9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_e2d9fc85-63f4-4bdc-95ad-2bedbf239393" xlink:to="loc_us-gaap_StockholdersEquity_cd540325-00c8-44ab-95c6-81333e986d9c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_c379d7c2-d837-49e8-9f58-780282e1c79b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_e2d9fc85-63f4-4bdc-95ad-2bedbf239393" xlink:to="loc_us-gaap_Liabilities_c379d7c2-d837-49e8-9f58-780282e1c79b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_9362d4b2-621c-4287-9adb-8dc75872dc0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_27a5c656-c150-43b8-bd11-1bf829fefdec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_9362d4b2-621c-4287-9adb-8dc75872dc0c" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_27a5c656-c150-43b8-bd11-1bf829fefdec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_d3316b86-b6c7-4518-8077-34c7b8fad663" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_9362d4b2-621c-4287-9adb-8dc75872dc0c" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_d3316b86-b6c7-4518-8077-34c7b8fad663" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_2e750bc1-0637-4fa2-a3c4-576ffd1aaf8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_9362d4b2-621c-4287-9adb-8dc75872dc0c" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_2e750bc1-0637-4fa2-a3c4-576ffd1aaf8b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceSettlementsReceivableCurrent_b41f62bc-8136-418b-8b3b-14f5685291c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceSettlementsReceivableCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_9362d4b2-621c-4287-9adb-8dc75872dc0c" xlink:to="loc_us-gaap_InsuranceSettlementsReceivableCurrent_b41f62bc-8136-418b-8b3b-14f5685291c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_6c599dcd-cfc0-47b9-aa98-c8541eec0ebf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_9362d4b2-621c-4287-9adb-8dc75872dc0c" xlink:to="loc_us-gaap_OtherAssetsCurrent_6c599dcd-cfc0-47b9-aa98-c8541eec0ebf" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="ccrn-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_d2ee2680-2aa2-4a74-805d-59132a207c11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_cda77ed3-4bd8-4b1d-a7dc-9e7eae8cf855" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_d2ee2680-2aa2-4a74-805d-59132a207c11" xlink:to="loc_us-gaap_AssetImpairmentCharges_cda77ed3-4bd8-4b1d-a7dc-9e7eae8cf855" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_28393a05-c297-40dd-913f-1f901285a50a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_d2ee2680-2aa2-4a74-805d-59132a207c11" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_28393a05-c297-40dd-913f-1f901285a50a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_a8d330e5-277f-4a0c-8d89-af07dc44c0ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_d2ee2680-2aa2-4a74-805d-59132a207c11" xlink:to="loc_us-gaap_RestructuringCharges_a8d330e5-277f-4a0c-8d89-af07dc44c0ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_AcquisitionAndIntegrationRelatedCosts_942e9c6b-2b0d-48c2-8908-1f9ebc65779f" xlink:href="ccrn-20220930.xsd#ccrn_AcquisitionAndIntegrationRelatedCosts"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_d2ee2680-2aa2-4a74-805d-59132a207c11" xlink:to="loc_ccrn_AcquisitionAndIntegrationRelatedCosts_942e9c6b-2b0d-48c2-8908-1f9ebc65779f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_219e361c-8379-4e90-a2b2-26980fa10fa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_d2ee2680-2aa2-4a74-805d-59132a207c11" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_219e361c-8379-4e90-a2b2-26980fa10fa3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_0eb41bd0-255e-47cb-b17e-ecaab222e48e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_d2ee2680-2aa2-4a74-805d-59132a207c11" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_0eb41bd0-255e-47cb-b17e-ecaab222e48e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectOperatingCosts_d3693c30-148b-4b93-89af-1a6efd92bcba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DirectOperatingCosts"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_d2ee2680-2aa2-4a74-805d-59132a207c11" xlink:to="loc_us-gaap_DirectOperatingCosts_d3693c30-148b-4b93-89af-1a6efd92bcba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_eafeb533-385b-4d10-9af1-61bc61f2a1c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_7e41e36d-8434-4cfe-a001-5772b976ca97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_eafeb533-385b-4d10-9af1-61bc61f2a1c8" xlink:to="loc_us-gaap_NetIncomeLoss_7e41e36d-8434-4cfe-a001-5772b976ca97" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_19b5fe4d-6eb7-4056-9f4f-589edffab5f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_eafeb533-385b-4d10-9af1-61bc61f2a1c8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_19b5fe4d-6eb7-4056-9f4f-589edffab5f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9bbecdff-6a89-4eef-98c4-b7dd59eaf9d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_139b2d9b-6d60-4bdd-bed0-6a676931c7b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9bbecdff-6a89-4eef-98c4-b7dd59eaf9d7" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_139b2d9b-6d60-4bdd-bed0-6a676931c7b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_b5ec4178-cdc6-418f-9599-f9d4fa07f717" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9bbecdff-6a89-4eef-98c4-b7dd59eaf9d7" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_b5ec4178-cdc6-418f-9599-f9d4fa07f717" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_393bc80d-6822-4b0d-9375-c312db4597e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9bbecdff-6a89-4eef-98c4-b7dd59eaf9d7" xlink:to="loc_us-gaap_InterestExpense_393bc80d-6822-4b0d-9375-c312db4597e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_0815a57e-4b29-4de7-b78f-56f1be40116f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9bbecdff-6a89-4eef-98c4-b7dd59eaf9d7" xlink:to="loc_us-gaap_OperatingIncomeLoss_0815a57e-4b29-4de7-b78f-56f1be40116f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_97fac9f1-ea78-469c-a54c-a9751d122756" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_46ab1951-db2d-492e-a785-ce97e4aafd87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_97fac9f1-ea78-469c-a54c-a9751d122756" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_46ab1951-db2d-492e-a785-ce97e4aafd87" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_65745d1e-4cb8-4051-b3fb-9263ddb76684" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_97fac9f1-ea78-469c-a54c-a9751d122756" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_65745d1e-4cb8-4051-b3fb-9263ddb76684" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_50d81e6a-1668-42d1-9c48-c603bdf60a12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_8b7b26d5-b966-4ae9-9ee6-c07cd0dc7d46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_50d81e6a-1668-42d1-9c48-c603bdf60a12" xlink:to="loc_us-gaap_CostsAndExpenses_8b7b26d5-b966-4ae9-9ee6-c07cd0dc7d46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8a428bab-5d77-40d5-b3ea-90cd387de23d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_50d81e6a-1668-42d1-9c48-c603bdf60a12" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8a428bab-5d77-40d5-b3ea-90cd387de23d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="ccrn-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_59ce8d4e-fbe8-4670-95c9-d89ce7e46aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_3e4c7ad9-99d6-4dd9-ad12-493e341010e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_59ce8d4e-fbe8-4670-95c9-d89ce7e46aa9" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_3e4c7ad9-99d6-4dd9-ad12-493e341010e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_f75effba-0ef7-45df-99e6-8a532f225ed3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_59ce8d4e-fbe8-4670-95c9-d89ce7e46aa9" xlink:to="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_f75effba-0ef7-45df-99e6-8a532f225ed3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_832e1fa3-3214-44c3-be78-23f9cfb5bd65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_59ce8d4e-fbe8-4670-95c9-d89ce7e46aa9" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_832e1fa3-3214-44c3-be78-23f9cfb5bd65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_a9a41f15-b82e-41a7-b15f-a9a1ad5256d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_59ce8d4e-fbe8-4670-95c9-d89ce7e46aa9" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_a9a41f15-b82e-41a7-b15f-a9a1ad5256d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt_00c3e17f-d56b-40b0-92e8-c63de922b475" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_59ce8d4e-fbe8-4670-95c9-d89ce7e46aa9" xlink:to="loc_us-gaap_RepaymentsOfSecuredDebt_00c3e17f-d56b-40b0-92e8-c63de922b475" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_b45d9ff8-9de0-4aee-893b-c1d53e86f066" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_59ce8d4e-fbe8-4670-95c9-d89ce7e46aa9" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_b45d9ff8-9de0-4aee-893b-c1d53e86f066" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_6898c8b2-dec6-4e21-8b09-50841ab2cfd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_59ce8d4e-fbe8-4670-95c9-d89ce7e46aa9" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_6898c8b2-dec6-4e21-8b09-50841ab2cfd2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_56cf37eb-2083-45be-b575-b5b95b6ec2c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_59ce8d4e-fbe8-4670-95c9-d89ce7e46aa9" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_56cf37eb-2083-45be-b575-b5b95b6ec2c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_b52b0c8c-8efb-429f-9ae7-e0c143426c77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_59ce8d4e-fbe8-4670-95c9-d89ce7e46aa9" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_b52b0c8c-8efb-429f-9ae7-e0c143426c77" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_93b794c4-c9b4-493f-81c0-5ce43fb90a32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_59ce8d4e-fbe8-4670-95c9-d89ce7e46aa9" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_93b794c4-c9b4-493f-81c0-5ce43fb90a32" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2582c6b6-0a29-4058-bb6b-7da02a01e061" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_902f5135-e2f5-4cea-948c-d899578671e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2582c6b6-0a29-4058-bb6b-7da02a01e061" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_902f5135-e2f5-4cea-948c-d899578671e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_ff6ef817-c175-4fe0-819e-8f739c100c96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2582c6b6-0a29-4058-bb6b-7da02a01e061" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_ff6ef817-c175-4fe0-819e-8f739c100c96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7279606d-a0f2-41f4-befd-e25bc140bdb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_ProvisionForDoubtfulAccountsAndOtherAllowances_274dda7c-40c4-4f91-9a8a-65c5a518be34" xlink:href="ccrn-20220930.xsd#ccrn_ProvisionForDoubtfulAccountsAndOtherAllowances"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7279606d-a0f2-41f4-befd-e25bc140bdb4" xlink:to="loc_ccrn_ProvisionForDoubtfulAccountsAndOtherAllowances_274dda7c-40c4-4f91-9a8a-65c5a518be34" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_8756abce-d73c-47f8-adc5-6831a506d364" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7279606d-a0f2-41f4-befd-e25bc140bdb4" xlink:to="loc_us-gaap_NetIncomeLoss_8756abce-d73c-47f8-adc5-6831a506d364" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_cd3a3e28-c17b-41dc-8eb8-0fdc81568bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7279606d-a0f2-41f4-befd-e25bc140bdb4" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_cd3a3e28-c17b-41dc-8eb8-0fdc81568bfa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_4a512d5d-e3da-4271-9265-da3b6a027a69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7279606d-a0f2-41f4-befd-e25bc140bdb4" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_4a512d5d-e3da-4271-9265-da3b6a027a69" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_2995ee49-712f-4279-ba2e-2f9d10ca28be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7279606d-a0f2-41f4-befd-e25bc140bdb4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_2995ee49-712f-4279-ba2e-2f9d10ca28be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_9a279bb6-fbe2-434e-b21d-584ad6665d1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7279606d-a0f2-41f4-befd-e25bc140bdb4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_9a279bb6-fbe2-434e-b21d-584ad6665d1c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_48b4bbb7-1c58-437d-b5f1-2c80b804e686" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7279606d-a0f2-41f4-befd-e25bc140bdb4" xlink:to="loc_us-gaap_ShareBasedCompensation_48b4bbb7-1c58-437d-b5f1-2c80b804e686" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_IncreaseDecreaseInOperatingLeaseLiabilities_d2c4bdff-83b3-48b4-bb93-e65a35f12122" xlink:href="ccrn-20220930.xsd#ccrn_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7279606d-a0f2-41f4-befd-e25bc140bdb4" xlink:to="loc_ccrn_IncreaseDecreaseInOperatingLeaseLiabilities_d2c4bdff-83b3-48b4-bb93-e65a35f12122" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_8835d277-f58e-49e6-847a-5d96eeedd91a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7279606d-a0f2-41f4-befd-e25bc140bdb4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_8835d277-f58e-49e6-847a-5d96eeedd91a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_d0ca49b4-7f52-4520-b2c5-82558e1936ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7279606d-a0f2-41f4-befd-e25bc140bdb4" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_d0ca49b4-7f52-4520-b2c5-82558e1936ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_66d15af6-c8c9-4a94-bf0e-3c469a3a8187" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7279606d-a0f2-41f4-befd-e25bc140bdb4" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_66d15af6-c8c9-4a94-bf0e-3c469a3a8187" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_70d3c4d0-ef45-402b-a793-25495bda7fea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7279606d-a0f2-41f4-befd-e25bc140bdb4" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_70d3c4d0-ef45-402b-a793-25495bda7fea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_OperatingLeaseExpenseNonCash_a0594536-2665-4a5d-929e-6cda1e344838" xlink:href="ccrn-20220930.xsd#ccrn_OperatingLeaseExpenseNonCash"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7279606d-a0f2-41f4-befd-e25bc140bdb4" xlink:to="loc_ccrn_OperatingLeaseExpenseNonCash_a0594536-2665-4a5d-929e-6cda1e344838" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_c3261eee-ed0a-4e39-b500-688c33109806" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7279606d-a0f2-41f4-befd-e25bc140bdb4" xlink:to="loc_us-gaap_AssetImpairmentCharges_c3261eee-ed0a-4e39-b500-688c33109806" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_08e7d4f2-a5fc-4491-9b41-25f5612dcde7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7279606d-a0f2-41f4-befd-e25bc140bdb4" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_08e7d4f2-a5fc-4491-9b41-25f5612dcde7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f2480ca2-a216-499b-9514-f6cbd438569d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_02ed9261-3ef8-4fc4-aa60-f8b160855a57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f2480ca2-a216-499b-9514-f6cbd438569d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_02ed9261-3ef8-4fc4-aa60-f8b160855a57" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_82837041-e71d-4aca-bca6-34bdcf2f1514" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f2480ca2-a216-499b-9514-f6cbd438569d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_82837041-e71d-4aca-bca6-34bdcf2f1514" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_953f04c9-18c8-4e89-a8a6-69c1546878d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f2480ca2-a216-499b-9514-f6cbd438569d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_953f04c9-18c8-4e89-a8a6-69c1546878d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_65485a74-8cf5-4de8-ab37-1e6422a85adf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f2480ca2-a216-499b-9514-f6cbd438569d" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_65485a74-8cf5-4de8-ab37-1e6422a85adf" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="ccrn-20220930.xsd#ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_816923d8-52a0-4e8f-9af2-3dd1ed13f3df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_85fb704d-487f-4489-b66e-1fb12aa58791" xlink:href="ccrn-20220930.xsd#ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_816923d8-52a0-4e8f-9af2-3dd1ed13f3df" xlink:to="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_85fb704d-487f-4489-b66e-1fb12aa58791" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_227b1462-7739-42f6-8ac1-6517d0921a2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_816923d8-52a0-4e8f-9af2-3dd1ed13f3df" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_227b1462-7739-42f6-8ac1-6517d0921a2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_cbb0a705-a492-4bd0-af4e-ddab52f40a71" xlink:href="ccrn-20220930.xsd#ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_37d4e99e-164e-43c9-baff-114f7cc35021" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_cbb0a705-a492-4bd0-af4e-ddab52f40a71" xlink:to="loc_us-gaap_Goodwill_37d4e99e-164e-43c9-baff-114f7cc35021" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_6fb53c10-ed54-46be-9868-c06cb29f3258" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_cbb0a705-a492-4bd0-af4e-ddab52f40a71" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_6fb53c10-ed54-46be-9868-c06cb29f3258" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_76c0714c-c39b-4a0f-9fe1-bdb29d56700f" xlink:href="ccrn-20220930.xsd#ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_cbb0a705-a492-4bd0-af4e-ddab52f40a71" xlink:to="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_76c0714c-c39b-4a0f-9fe1-bdb29d56700f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_a8c357d1-b6fe-494a-943c-47b5527c7ce9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_cbb0a705-a492-4bd0-af4e-ddab52f40a71" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_a8c357d1-b6fe-494a-943c-47b5527c7ce9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_d5f9ed74-ae6b-413d-9bf6-c228103406a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_cbb0a705-a492-4bd0-af4e-ddab52f40a71" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_d5f9ed74-ae6b-413d-9bf6-c228103406a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_6c881095-f385-41b0-8b61-faf3176156fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_cbb0a705-a492-4bd0-af4e-ddab52f40a71" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_6c881095-f385-41b0-8b61-faf3176156fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_10c49efd-65f4-4fe5-860a-2095551f65de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_cbb0a705-a492-4bd0-af4e-ddab52f40a71" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_10c49efd-65f4-4fe5-860a-2095551f65de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_93199879-b46f-4d49-bb32-2b8b9c68eaca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_d0a29135-114a-4317-9c06-f55fdc92ecd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_93199879-b46f-4d49-bb32-2b8b9c68eaca" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_d0a29135-114a-4317-9c06-f55fdc92ecd0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationNoncurrent_9c725af0-2c7e-41e9-a65a-085c9e569291" xlink:href="ccrn-20220930.xsd#ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_93199879-b46f-4d49-bb32-2b8b9c68eaca" xlink:to="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationNoncurrent_9c725af0-2c7e-41e9-a65a-085c9e569291" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensationAndBenefits_8c412105-a860-4906-84e2-586363145428" xlink:href="ccrn-20220930.xsd#ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensationAndBenefits"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_93199879-b46f-4d49-bb32-2b8b9c68eaca" xlink:to="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensationAndBenefits_8c412105-a860-4906-84e2-586363145428" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_6e137735-1155-4dac-accc-c31400365040" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_93199879-b46f-4d49-bb32-2b8b9c68eaca" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_6e137735-1155-4dac-accc-c31400365040" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationCurrent_dffcdd97-4a0e-4e76-b13e-cb7e841c7f90" xlink:href="ccrn-20220930.xsd#ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_93199879-b46f-4d49-bb32-2b8b9c68eaca" xlink:to="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationCurrent_dffcdd97-4a0e-4e76-b13e-cb7e841c7f90" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREComponentsofNumeratorandDenominatorforComputationofBasicandDilutedEarningsperShareDetails" xlink:type="simple" xlink:href="ccrn-20220930.xsd#EARNINGSPERSHAREComponentsofNumeratorandDenominatorforComputationofBasicandDilutedEarningsperShareDetails"/>
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREComponentsofNumeratorandDenominatorforComputationofBasicandDilutedEarningsperShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e5908ff8-3266-4876-9c05-fa84c300b49c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a6f67c28-50c2-4311-8433-93af2dcc9c06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e5908ff8-3266-4876-9c05-fa84c300b49c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a6f67c28-50c2-4311-8433-93af2dcc9c06" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_46f93847-8a68-4b1e-b581-18663b98bd25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e5908ff8-3266-4876-9c05-fa84c300b49c" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_46f93847-8a68-4b1e-b581-18663b98bd25" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails" xlink:type="simple" xlink:href="ccrn-20220930.xsd#GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d27bb1b2-325b-4cb2-b65d-224dc0c0c34c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_d0a155a6-3148-444e-b036-89082afe7712" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d27bb1b2-325b-4cb2-b65d-224dc0c0c34c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_d0a155a6-3148-444e-b036-89082afe7712" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_4c1d6b12-9c60-420b-b214-aa993cf0ad1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d27bb1b2-325b-4cb2-b65d-224dc0c0c34c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_4c1d6b12-9c60-420b-b214-aa993cf0ad1f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSEstimatedAnnualAmortizationExpenseDetails" xlink:type="simple" xlink:href="ccrn-20220930.xsd#GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSEstimatedAnnualAmortizationExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSEstimatedAnnualAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_853e9f00-670c-4245-b0fe-6f0a3ae2ef72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_472c1a77-6694-4ff3-ad0e-bfcbba92d3bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_853e9f00-670c-4245-b0fe-6f0a3ae2ef72" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_472c1a77-6694-4ff3-ad0e-bfcbba92d3bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_b231e7f8-23a5-442a-82ca-7f270178504a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_853e9f00-670c-4245-b0fe-6f0a3ae2ef72" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_b231e7f8-23a5-442a-82ca-7f270178504a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_67c359c3-0f33-4bdb-8c92-f65c92d89843" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_853e9f00-670c-4245-b0fe-6f0a3ae2ef72" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_67c359c3-0f33-4bdb-8c92-f65c92d89843" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_236666e6-5b2b-4169-8776-847e77eb3c4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_853e9f00-670c-4245-b0fe-6f0a3ae2ef72" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_236666e6-5b2b-4169-8776-847e77eb3c4c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_2cb44c87-9bb2-46ae-906f-c74447e135b8" xlink:href="ccrn-20220930.xsd#ccrn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_853e9f00-670c-4245-b0fe-6f0a3ae2ef72" xlink:to="loc_ccrn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_2cb44c87-9bb2-46ae-906f-c74447e135b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_603895e7-96b7-4339-af64-a85e5d8dcee7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_853e9f00-670c-4245-b0fe-6f0a3ae2ef72" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_603895e7-96b7-4339-af64-a85e5d8dcee7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails" xlink:type="simple" xlink:href="ccrn-20220930.xsd#DEBTLongtermDebtDetails"/>
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_1b776cb4-c05f-4db6-974a-5ddea65c993a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_fda2e5c4-5e02-4403-8288-14de43d39ef7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_1b776cb4-c05f-4db6-974a-5ddea65c993a" xlink:to="loc_us-gaap_LongTermDebtCurrent_fda2e5c4-5e02-4403-8288-14de43d39ef7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_be9edf1e-1657-4c1a-acb3-ed02b6434615" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_1b776cb4-c05f-4db6-974a-5ddea65c993a" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_be9edf1e-1657-4c1a-acb3-ed02b6434615" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails" xlink:type="simple" xlink:href="ccrn-20220930.xsd#DEBTMaturitiesofDebtDetails"/>
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_21f4983e-eb8a-4ef7-a592-fd674146e68f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_6e1fcd59-4db8-4dcd-ad88-9149f037b5ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_21f4983e-eb8a-4ef7-a592-fd674146e68f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_6e1fcd59-4db8-4dcd-ad88-9149f037b5ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_d32a52e9-6241-45b6-bbec-86665ab33121" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_21f4983e-eb8a-4ef7-a592-fd674146e68f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_d32a52e9-6241-45b6-bbec-86665ab33121" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_8902c8a9-6a0e-42cd-9c31-3bd41bdcd8d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_21f4983e-eb8a-4ef7-a592-fd674146e68f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_8902c8a9-6a0e-42cd-9c31-3bd41bdcd8d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_LongTermDebtMaturityAfterYearFour_9e689cfe-8ad5-45a7-9292-e75e05e6a204" xlink:href="ccrn-20220930.xsd#ccrn_LongTermDebtMaturityAfterYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_21f4983e-eb8a-4ef7-a592-fd674146e68f" xlink:to="loc_ccrn_LongTermDebtMaturityAfterYearFour_9e689cfe-8ad5-45a7-9292-e75e05e6a204" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_1bfa557d-31c4-4a25-b621-7f42d8d8f33b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_21f4983e-eb8a-4ef7-a592-fd674146e68f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_1bfa557d-31c4-4a25-b621-7f42d8d8f33b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_65ed87be-5682-4d0b-8a0d-5773ab6bca5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_21f4983e-eb8a-4ef7-a592-fd674146e68f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_65ed87be-5682-4d0b-8a0d-5773ab6bca5d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails" xlink:type="simple" xlink:href="ccrn-20220930.xsd#LEASESOperatingLeaseMaturityDetails"/>
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_be3e6846-28be-4d7d-bc83-152b12dcd88e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_8e256633-3428-452e-a149-ada6d5c494ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_be3e6846-28be-4d7d-bc83-152b12dcd88e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_8e256633-3428-452e-a149-ada6d5c494ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_8f8a86c9-43f7-452b-89b5-938442e64218" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_be3e6846-28be-4d7d-bc83-152b12dcd88e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_8f8a86c9-43f7-452b-89b5-938442e64218" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_e0ef8b7d-4d81-436f-8d4e-0aec3d74cde3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_be3e6846-28be-4d7d-bc83-152b12dcd88e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_e0ef8b7d-4d81-436f-8d4e-0aec3d74cde3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_82569c21-f2d6-4afb-85c1-7cfbb0361dee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_be3e6846-28be-4d7d-bc83-152b12dcd88e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_82569c21-f2d6-4afb-85c1-7cfbb0361dee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_399ea8c5-5f7a-4db1-ba43-519151d93536" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_63a5abda-d0c0-418a-b56f-2affc310f4b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_399ea8c5-5f7a-4db1-ba43-519151d93536" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_63a5abda-d0c0-418a-b56f-2affc310f4b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_2186f899-0c27-4035-a46c-57b7f7d1760d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_399ea8c5-5f7a-4db1-ba43-519151d93536" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_2186f899-0c27-4035-a46c-57b7f7d1760d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails_1" xlink:type="simple" xlink:href="ccrn-20220930.xsd#LEASESOperatingLeaseMaturityDetails_1"/>
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_93d93607-627f-4d4c-9fdc-0d6a13e3309c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_78dd7d75-3983-4102-a77f-572595d3bbe6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_93d93607-627f-4d4c-9fdc-0d6a13e3309c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_78dd7d75-3983-4102-a77f-572595d3bbe6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_bd809dcb-d60a-4730-a0de-7fa1074649e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_93d93607-627f-4d4c-9fdc-0d6a13e3309c" xlink:to="loc_us-gaap_OperatingLeaseLiability_bd809dcb-d60a-4730-a0de-7fa1074649e7" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>ccrn-20220930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:9f036714-f865-4798-af5a-08fe5047afca,g:b4ca6da5-78c3-4063-9a30-7dfc7d463cab-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="ccrn-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended" id="idf2d122355bc4502919d75df7b157ea7_CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_2b5eb006-8e5b-4fe8-82b5-faf8b60314ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_680ed177-002d-416c-89fe-c10d09572962" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2b5eb006-8e5b-4fe8-82b5-faf8b60314ae" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_680ed177-002d-416c-89fe-c10d09572962" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_0f9f92f8-d505-4b5f-98a7-8f179d37f78e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_680ed177-002d-416c-89fe-c10d09572962" xlink:to="loc_us-gaap_SharesOutstanding_0f9f92f8-d505-4b5f-98a7-8f179d37f78e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1224f0f9-e5fc-439f-8336-413510a9123e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_680ed177-002d-416c-89fe-c10d09572962" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1224f0f9-e5fc-439f-8336-413510a9123e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_aae03a77-179e-4038-acf6-c432d2658b1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_680ed177-002d-416c-89fe-c10d09572962" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_aae03a77-179e-4038-acf6-c432d2658b1c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_2b548ed8-af20-432a-a3f9-dd54f0aeb3d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_680ed177-002d-416c-89fe-c10d09572962" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_2b548ed8-af20-432a-a3f9-dd54f0aeb3d1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1ea5d49c-4fd8-441b-89f6-e65dcbb8510d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_680ed177-002d-416c-89fe-c10d09572962" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1ea5d49c-4fd8-441b-89f6-e65dcbb8510d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_4142a8e0-1fe7-4558-92df-035089b4ac2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_680ed177-002d-416c-89fe-c10d09572962" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_4142a8e0-1fe7-4558-92df-035089b4ac2f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_f786a828-580e-4033-b4bd-e0c601cf4d11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_680ed177-002d-416c-89fe-c10d09572962" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_f786a828-580e-4033-b4bd-e0c601cf4d11" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_6b90a189-d185-4339-b9a0-449fdacb5b68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_680ed177-002d-416c-89fe-c10d09572962" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_6b90a189-d185-4339-b9a0-449fdacb5b68" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_ca154a07-9b4f-4cbf-af06-4a7f016d883d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_680ed177-002d-416c-89fe-c10d09572962" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_ca154a07-9b4f-4cbf-af06-4a7f016d883d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_4932820b-2399-4bb8-a67e-feaa3c5d765f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_680ed177-002d-416c-89fe-c10d09572962" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_4932820b-2399-4bb8-a67e-feaa3c5d765f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_5ec20a32-e0d4-41fa-971e-67fb0d3ee22b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_680ed177-002d-416c-89fe-c10d09572962" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_5ec20a32-e0d4-41fa-971e-67fb0d3ee22b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_1471aff5-8fb9-4cc7-8685-88295246cb4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_680ed177-002d-416c-89fe-c10d09572962" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_1471aff5-8fb9-4cc7-8685-88295246cb4e" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_17c14d39-0413-46c5-a815-5cee33835b58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_680ed177-002d-416c-89fe-c10d09572962" xlink:to="loc_us-gaap_NetIncomeLoss_17c14d39-0413-46c5-a815-5cee33835b58" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_304b5459-e3af-458f-a335-64d6a3f04d70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d8c43c9e-935d-45ff-8dc3-aa6e55171af6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_e3c7daa3-3ede-4444-84b4-f5b22832448e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_2b5eb006-8e5b-4fe8-82b5-faf8b60314ae" xlink:to="loc_us-gaap_StatementTable_e3c7daa3-3ede-4444-84b4-f5b22832448e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_cfb918a0-80c4-4527-bc5d-7577ed8da7c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_e3c7daa3-3ede-4444-84b4-f5b22832448e" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_cfb918a0-80c4-4527-bc5d-7577ed8da7c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_cfb918a0-80c4-4527-bc5d-7577ed8da7c4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_cfb918a0-80c4-4527-bc5d-7577ed8da7c4" xlink:to="loc_us-gaap_EquityComponentDomain_cfb918a0-80c4-4527-bc5d-7577ed8da7c4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d1ca93a0-bfb9-4ca1-8386-2639790704b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_cfb918a0-80c4-4527-bc5d-7577ed8da7c4" xlink:to="loc_us-gaap_EquityComponentDomain_d1ca93a0-bfb9-4ca1-8386-2639790704b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_245b5e3b-7e51-4360-8273-84bbe9fd3a52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d1ca93a0-bfb9-4ca1-8386-2639790704b3" xlink:to="loc_us-gaap_CommonStockMember_245b5e3b-7e51-4360-8273-84bbe9fd3a52" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_8b4d7233-6fa4-4a5b-832e-8051e462423a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d1ca93a0-bfb9-4ca1-8386-2639790704b3" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_8b4d7233-6fa4-4a5b-832e-8051e462423a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_0ac509c5-6a86-4a40-966c-0b56e2cf979f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d1ca93a0-bfb9-4ca1-8386-2639790704b3" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_0ac509c5-6a86-4a40-966c-0b56e2cf979f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_2fdf0375-90f7-4abd-a0c9-b746311e72ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d1ca93a0-bfb9-4ca1-8386-2639790704b3" xlink:to="loc_us-gaap_RetainedEarningsMember_2fdf0375-90f7-4abd-a0c9-b746311e72ef" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_1c84bf34-84f0-4e9f-9caa-5a28fb47539f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d1ca93a0-bfb9-4ca1-8386-2639790704b3" xlink:to="loc_us-gaap_NoncontrollingInterestMember_1c84bf34-84f0-4e9f-9caa-5a28fb47539f" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails" xlink:type="simple" xlink:href="ccrn-20220930.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails" xlink:type="extended" id="i3e32b3ab795f4c088907b4ab5e265753_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_b4c5ed4f-8579-4d85-83e6-88ee20887c8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnbilledContractsReceivable_e50c3393-00a5-44d5-825a-c9d70fe50a19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnbilledContractsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_b4c5ed4f-8579-4d85-83e6-88ee20887c8d" xlink:to="loc_us-gaap_UnbilledContractsReceivable_e50c3393-00a5-44d5-825a-c9d70fe50a19" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_SalesAllowanceBillingRelatedAdjustments_c45f981d-7ea5-481e-a983-cf196fa96212" xlink:href="ccrn-20220930.xsd#ccrn_SalesAllowanceBillingRelatedAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_b4c5ed4f-8579-4d85-83e6-88ee20887c8d" xlink:to="loc_ccrn_SalesAllowanceBillingRelatedAdjustments_c45f981d-7ea5-481e-a983-cf196fa96212" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_ThresholdPeriodPastDueForPaymentOfServicesProvided_0365342e-40af-444a-b41f-af288491628a" xlink:href="ccrn-20220930.xsd#ccrn_ThresholdPeriodPastDueForPaymentOfServicesProvided"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_b4c5ed4f-8579-4d85-83e6-88ee20887c8d" xlink:to="loc_ccrn_ThresholdPeriodPastDueForPaymentOfServicesProvided_0365342e-40af-444a-b41f-af288491628a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_31d06cb3-cc13-44ed-8177-428968380331" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_b4c5ed4f-8579-4d85-83e6-88ee20887c8d" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_31d06cb3-cc13-44ed-8177-428968380331" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_75ca002a-a24b-4bc9-8fba-c1d4003593be" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_31d06cb3-cc13-44ed-8177-428968380331" xlink:to="loc_srt_RangeAxis_75ca002a-a24b-4bc9-8fba-c1d4003593be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_75ca002a-a24b-4bc9-8fba-c1d4003593be_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_75ca002a-a24b-4bc9-8fba-c1d4003593be" xlink:to="loc_srt_RangeMember_75ca002a-a24b-4bc9-8fba-c1d4003593be_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7c5fc214-783c-41d2-80b5-e5e7da16b482" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_75ca002a-a24b-4bc9-8fba-c1d4003593be" xlink:to="loc_srt_RangeMember_7c5fc214-783c-41d2-80b5-e5e7da16b482" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_40da1972-3d4b-410c-96d9-82e2a14940f4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_7c5fc214-783c-41d2-80b5-e5e7da16b482" xlink:to="loc_srt_MinimumMember_40da1972-3d4b-410c-96d9-82e2a14940f4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_582b1760-a46b-4bb8-b2f0-d0908ebdcd90" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_7c5fc214-783c-41d2-80b5-e5e7da16b482" xlink:to="loc_srt_MaximumMember_582b1760-a46b-4bb8-b2f0-d0908ebdcd90" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRestructuringBenefitsCostsDetails" xlink:type="simple" xlink:href="ccrn-20220930.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRestructuringBenefitsCostsDetails"/>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRestructuringBenefitsCostsDetails" xlink:type="extended" id="ic5ef7d5d9c2a400f98eee492d553d1c4_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRestructuringBenefitsCostsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_5248534b-857c-4d95-a7f0-862c8c9e3277" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_00a22f8b-ffee-41d4-b101-ae0860558fb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5248534b-857c-4d95-a7f0-862c8c9e3277" xlink:to="loc_us-gaap_RestructuringReserveRollForward_00a22f8b-ffee-41d4-b101-ae0860558fb5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_2be25edd-a767-402f-af06-52ca3e654186" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_00a22f8b-ffee-41d4-b101-ae0860558fb5" xlink:to="loc_us-gaap_RestructuringReserve_2be25edd-a767-402f-af06-52ca3e654186" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_9b39e985-a437-4fac-b3e3-f4dd068dafab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_00a22f8b-ffee-41d4-b101-ae0860558fb5" xlink:to="loc_us-gaap_RestructuringCharges_9b39e985-a437-4fac-b3e3-f4dd068dafab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_PaymentsForRestructuringAndAdjustments_57309bae-aafe-4d9c-b8fd-ea03b2872f99" xlink:href="ccrn-20220930.xsd#ccrn_PaymentsForRestructuringAndAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_00a22f8b-ffee-41d4-b101-ae0860558fb5" xlink:to="loc_ccrn_PaymentsForRestructuringAndAdjustments_57309bae-aafe-4d9c-b8fd-ea03b2872f99" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_9c8f8062-1520-4ee3-89d3-b7950a6886f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_00a22f8b-ffee-41d4-b101-ae0860558fb5" xlink:to="loc_us-gaap_PaymentsForRestructuring_9c8f8062-1520-4ee3-89d3-b7950a6886f3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_13f73075-39a3-4a6f-b557-113e06ae272a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1_6c273140-b382-4199-a1d6-5a68b8b1cb20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessExitCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5248534b-857c-4d95-a7f0-862c8c9e3277" xlink:to="loc_us-gaap_BusinessExitCosts1_6c273140-b382-4199-a1d6-5a68b8b1cb20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f165617f-44ab-4693-ac19-7cf972ca045a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5248534b-857c-4d95-a7f0-862c8c9e3277" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f165617f-44ab-4693-ac19-7cf972ca045a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_8f81f60f-68f1-4659-a521-770c5e98672b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f165617f-44ab-4693-ac19-7cf972ca045a" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_8f81f60f-68f1-4659-a521-770c5e98672b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_8f81f60f-68f1-4659-a521-770c5e98672b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_8f81f60f-68f1-4659-a521-770c5e98672b" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_8f81f60f-68f1-4659-a521-770c5e98672b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_39c41bfb-4d5a-40ac-bfef-f9261e12d5b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_8f81f60f-68f1-4659-a521-770c5e98672b" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_39c41bfb-4d5a-40ac-bfef-f9261e12d5b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_62189c83-c05f-40ff-8166-439679a9459a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_39c41bfb-4d5a-40ac-bfef-f9261e12d5b7" xlink:to="loc_us-gaap_EmployeeSeveranceMember_62189c83-c05f-40ff-8166-439679a9459a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_ExitCostsMember_e88bbfe4-16d6-4904-a208-1d493bfc5c85" xlink:href="ccrn-20220930.xsd#ccrn_ExitCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_39c41bfb-4d5a-40ac-bfef-f9261e12d5b7" xlink:to="loc_ccrn_ExitCostsMember_e88bbfe4-16d6-4904-a208-1d493bfc5c85" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/REVENUERECOGNITIONDetails" xlink:type="simple" xlink:href="ccrn-20220930.xsd#REVENUERECOGNITIONDetails"/>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/REVENUERECOGNITIONDetails" xlink:type="extended" id="i4e48566b752e4cc58818ff361f66f54f_REVENUERECOGNITIONDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_371a8929-8c63-4d15-bae5-ddb5e7032db9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_79dbe620-fab8-4d65-94e2-2ae3cd4393ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_371a8929-8c63-4d15-bae5-ddb5e7032db9" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_79dbe620-fab8-4d65-94e2-2ae3cd4393ad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_a39b35ab-6945-4913-81b7-ff92e679e5bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_371a8929-8c63-4d15-bae5-ddb5e7032db9" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_a39b35ab-6945-4913-81b7-ff92e679e5bf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_5eb47678-9d92-4960-8dc7-b5975771ec8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_a39b35ab-6945-4913-81b7-ff92e679e5bf" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_5eb47678-9d92-4960-8dc7-b5975771ec8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_5eb47678-9d92-4960-8dc7-b5975771ec8d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_5eb47678-9d92-4960-8dc7-b5975771ec8d" xlink:to="loc_us-gaap_SegmentDomain_5eb47678-9d92-4960-8dc7-b5975771ec8d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_64e0c42e-a642-4cbd-800d-3459214b7773" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_5eb47678-9d92-4960-8dc7-b5975771ec8d" xlink:to="loc_us-gaap_SegmentDomain_64e0c42e-a642-4cbd-800d-3459214b7773" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_NurseAndAlliedStaffingMember_918650f2-cafc-4ca7-a4d8-1385c0844ccf" xlink:href="ccrn-20220930.xsd#ccrn_NurseAndAlliedStaffingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_64e0c42e-a642-4cbd-800d-3459214b7773" xlink:to="loc_ccrn_NurseAndAlliedStaffingMember_918650f2-cafc-4ca7-a4d8-1385c0844ccf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_PhysicianStaffingMember_8ff40de3-ada5-413d-8a75-ec9ac8536d2d" xlink:href="ccrn-20220930.xsd#ccrn_PhysicianStaffingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_64e0c42e-a642-4cbd-800d-3459214b7773" xlink:to="loc_ccrn_PhysicianStaffingMember_8ff40de3-ada5-413d-8a75-ec9ac8536d2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_c194d117-e7a5-4c0b-aefb-b3c93aaf54ac" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_a39b35ab-6945-4913-81b7-ff92e679e5bf" xlink:to="loc_srt_ProductOrServiceAxis_c194d117-e7a5-4c0b-aefb-b3c93aaf54ac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c194d117-e7a5-4c0b-aefb-b3c93aaf54ac_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_c194d117-e7a5-4c0b-aefb-b3c93aaf54ac" xlink:to="loc_srt_ProductsAndServicesDomain_c194d117-e7a5-4c0b-aefb-b3c93aaf54ac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_cb9e820c-bbcb-4841-94d1-1142d1884fa4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_c194d117-e7a5-4c0b-aefb-b3c93aaf54ac" xlink:to="loc_srt_ProductsAndServicesDomain_cb9e820c-bbcb-4841-94d1-1142d1884fa4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_TemporaryStaffingServicesMember_175a75b0-e59e-4dc0-9646-49514f3e90b3" xlink:href="ccrn-20220930.xsd#ccrn_TemporaryStaffingServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_cb9e820c-bbcb-4841-94d1-1142d1884fa4" xlink:to="loc_ccrn_TemporaryStaffingServicesMember_175a75b0-e59e-4dc0-9646-49514f3e90b3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_OtherServicesMember_a0360756-0176-4355-b24b-75321ba8f80f" xlink:href="ccrn-20220930.xsd#ccrn_OtherServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_cb9e820c-bbcb-4841-94d1-1142d1884fa4" xlink:to="loc_ccrn_OtherServicesMember_a0360756-0176-4355-b24b-75321ba8f80f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/ACQUISITIONSAdditionalInformationDetails" xlink:type="simple" xlink:href="ccrn-20220930.xsd#ACQUISITIONSAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/ACQUISITIONSAdditionalInformationDetails" xlink:type="extended" id="iaa4027628c1740e2b99ad4817e1a3bd3_ACQUISITIONSAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_bd489b33-cd33-43e8-8f74-3f40aecc11eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_e74675ca-2fae-442e-92ba-f0f3329574c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bd489b33-cd33-43e8-8f74-3f40aecc11eb" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_e74675ca-2fae-442e-92ba-f0f3329574c2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_5747e825-82a4-4440-8a10-713404c3bf04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bd489b33-cd33-43e8-8f74-3f40aecc11eb" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_5747e825-82a4-4440-8a10-713404c3bf04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_d490418f-cd7a-478a-a4cd-fb446df592f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bd489b33-cd33-43e8-8f74-3f40aecc11eb" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_d490418f-cd7a-478a-a4cd-fb446df592f0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_24329039-a7cd-41ff-a377-1ea98e6dde57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bd489b33-cd33-43e8-8f74-3f40aecc11eb" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_24329039-a7cd-41ff-a377-1ea98e6dde57" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_a04957d6-7e9d-444a-a2dd-e75a232042fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bd489b33-cd33-43e8-8f74-3f40aecc11eb" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_a04957d6-7e9d-444a-a2dd-e75a232042fa" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_ed05130e-868e-4710-b76e-e4c064b942a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bd489b33-cd33-43e8-8f74-3f40aecc11eb" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_ed05130e-868e-4710-b76e-e4c064b942a0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_953cc97d-a343-4592-9ddd-1b0de80d7575" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bd489b33-cd33-43e8-8f74-3f40aecc11eb" xlink:to="loc_us-gaap_Goodwill_953cc97d-a343-4592-9ddd-1b0de80d7575" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment_9551b535-694a-4374-929c-5ca24a297da7" xlink:href="ccrn-20220930.xsd#ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bd489b33-cd33-43e8-8f74-3f40aecc11eb" xlink:to="loc_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment_9551b535-694a-4374-929c-5ca24a297da7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_BusinessCombinationContingentConsiderationTerm_2d5a8d26-6c54-4b06-b252-762b354dd7ee" xlink:href="ccrn-20220930.xsd#ccrn_BusinessCombinationContingentConsiderationTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bd489b33-cd33-43e8-8f74-3f40aecc11eb" xlink:to="loc_ccrn_BusinessCombinationContingentConsiderationTerm_2d5a8d26-6c54-4b06-b252-762b354dd7ee" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_1d941130-3701-426c-997d-a6a723e0c30d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bd489b33-cd33-43e8-8f74-3f40aecc11eb" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_1d941130-3701-426c-997d-a6a723e0c30d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_0a549383-b44b-4938-a56d-dba72fd181c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bd489b33-cd33-43e8-8f74-3f40aecc11eb" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_0a549383-b44b-4938-a56d-dba72fd181c3" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e9c16159-2661-4c18-b08b-bf9bcafe3113" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bd489b33-cd33-43e8-8f74-3f40aecc11eb" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e9c16159-2661-4c18-b08b-bf9bcafe3113" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_000cad95-a752-4256-88ad-0eb310bf8bce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e9c16159-2661-4c18-b08b-bf9bcafe3113" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_000cad95-a752-4256-88ad-0eb310bf8bce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_000cad95-a752-4256-88ad-0eb310bf8bce_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_000cad95-a752-4256-88ad-0eb310bf8bce" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_000cad95-a752-4256-88ad-0eb310bf8bce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0f31305d-a88c-4607-866e-477690d51697" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_000cad95-a752-4256-88ad-0eb310bf8bce" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0f31305d-a88c-4607-866e-477690d51697" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_SelectedIncMember_59a22fdf-cc61-48ed-832d-4d1fcaf90ba5" xlink:href="ccrn-20220930.xsd#ccrn_SelectedIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0f31305d-a88c-4607-866e-477690d51697" xlink:to="loc_ccrn_SelectedIncMember_59a22fdf-cc61-48ed-832d-4d1fcaf90ba5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_WorkforceSolutionsGroupIncMember_cb306978-420b-4a43-8105-3b916b432909" xlink:href="ccrn-20220930.xsd#ccrn_WorkforceSolutionsGroupIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0f31305d-a88c-4607-866e-477690d51697" xlink:to="loc_ccrn_WorkforceSolutionsGroupIncMember_cb306978-420b-4a43-8105-3b916b432909" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ff46a853-d49a-41f4-bda1-05ef0f1d1efc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e9c16159-2661-4c18-b08b-bf9bcafe3113" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ff46a853-d49a-41f4-bda1-05ef0f1d1efc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ff46a853-d49a-41f4-bda1-05ef0f1d1efc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ff46a853-d49a-41f4-bda1-05ef0f1d1efc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ff46a853-d49a-41f4-bda1-05ef0f1d1efc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5f45dcac-97b7-4d87-8d05-350cec6e4c80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ff46a853-d49a-41f4-bda1-05ef0f1d1efc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5f45dcac-97b7-4d87-8d05-350cec6e4c80" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_017a0456-973f-463b-9f78-16c91cf2e48f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5f45dcac-97b7-4d87-8d05-350cec6e4c80" xlink:to="loc_us-gaap_TradeNamesMember_017a0456-973f-463b-9f78-16c91cf2e48f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_9b7539d6-c97c-46be-829b-3d38f4de5149" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5f45dcac-97b7-4d87-8d05-350cec6e4c80" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_9b7539d6-c97c-46be-829b-3d38f4de5149" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DatabasesMember_47518144-1d81-48b6-ba2b-b6504c10ddfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DatabasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5f45dcac-97b7-4d87-8d05-350cec6e4c80" xlink:to="loc_us-gaap_DatabasesMember_47518144-1d81-48b6-ba2b-b6504c10ddfc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_3482d499-6072-4c86-a589-2c4c69976200" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5f45dcac-97b7-4d87-8d05-350cec6e4c80" xlink:to="loc_us-gaap_CustomerRelationshipsMember_3482d499-6072-4c86-a589-2c4c69976200" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="ccrn-20220930.xsd#ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended" id="i8f2dc4091491458bb9a53288628b0758_ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_ea937ff2-3609-48f0-b544-3afe4637b0f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_7e8943f1-ee93-4eb6-88bc-62827ea97e9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ea937ff2-3609-48f0-b544-3afe4637b0f7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_7e8943f1-ee93-4eb6-88bc-62827ea97e9e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_af69c5b6-63a7-4b05-af90-2b503a3f00ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ea937ff2-3609-48f0-b544-3afe4637b0f7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_af69c5b6-63a7-4b05-af90-2b503a3f00ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_7a478d8e-01a7-4eee-9d66-2ab7b73a5aa5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ea937ff2-3609-48f0-b544-3afe4637b0f7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_7a478d8e-01a7-4eee-9d66-2ab7b73a5aa5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_db2f63d2-3f67-4756-a0f0-665f082ec3b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ea937ff2-3609-48f0-b544-3afe4637b0f7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_db2f63d2-3f67-4756-a0f0-665f082ec3b9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_b46927e5-9f61-4259-a953-f3820a3fd64e" xlink:href="ccrn-20220930.xsd#ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ea937ff2-3609-48f0-b544-3afe4637b0f7" xlink:to="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_b46927e5-9f61-4259-a953-f3820a3fd64e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_babeecab-9f71-4b5b-a5da-15bc40965cd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ea937ff2-3609-48f0-b544-3afe4637b0f7" xlink:to="loc_us-gaap_Goodwill_babeecab-9f71-4b5b-a5da-15bc40965cd9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_eb441b70-d2d7-4784-8577-17be78d168d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ea937ff2-3609-48f0-b544-3afe4637b0f7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_eb441b70-d2d7-4784-8577-17be78d168d2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_35fe825e-62e8-484d-b46b-e9a8211298a6" xlink:href="ccrn-20220930.xsd#ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ea937ff2-3609-48f0-b544-3afe4637b0f7" xlink:to="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_35fe825e-62e8-484d-b46b-e9a8211298a6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_b8cd071f-5530-4dcf-bf0e-f434766d8938" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ea937ff2-3609-48f0-b544-3afe4637b0f7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_b8cd071f-5530-4dcf-bf0e-f434766d8938" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensationAndBenefits_6552390d-562c-459c-ab1f-cf1ce51be14c" xlink:href="ccrn-20220930.xsd#ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensationAndBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ea937ff2-3609-48f0-b544-3afe4637b0f7" xlink:to="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensationAndBenefits_6552390d-562c-459c-ab1f-cf1ce51be14c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationCurrent_22f5ab8e-7c82-487f-9e75-cf6c467541b4" xlink:href="ccrn-20220930.xsd#ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ea937ff2-3609-48f0-b544-3afe4637b0f7" xlink:to="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationCurrent_22f5ab8e-7c82-487f-9e75-cf6c467541b4" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationNoncurrent_822e1de2-344c-4a16-9809-98986dc26e9d" xlink:href="ccrn-20220930.xsd#ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ea937ff2-3609-48f0-b544-3afe4637b0f7" xlink:to="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationNoncurrent_822e1de2-344c-4a16-9809-98986dc26e9d" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_5054f488-7ff0-4c5e-90e2-28e80299b3e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ea937ff2-3609-48f0-b544-3afe4637b0f7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_5054f488-7ff0-4c5e-90e2-28e80299b3e8" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_1fc25e96-86a1-4a98-9503-eea9a3695bad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ea937ff2-3609-48f0-b544-3afe4637b0f7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_1fc25e96-86a1-4a98-9503-eea9a3695bad" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_999aa24c-fb89-4a6c-87fa-0d55b638d546" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ea937ff2-3609-48f0-b544-3afe4637b0f7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_999aa24c-fb89-4a6c-87fa-0d55b638d546" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_883204ba-beee-4dcc-8100-b698b9be4eec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ea937ff2-3609-48f0-b544-3afe4637b0f7" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_883204ba-beee-4dcc-8100-b698b9be4eec" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_f05874a4-83d6-481d-8694-41c2ddcff3ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_883204ba-beee-4dcc-8100-b698b9be4eec" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_f05874a4-83d6-481d-8694-41c2ddcff3ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f05874a4-83d6-481d-8694-41c2ddcff3ea_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f05874a4-83d6-481d-8694-41c2ddcff3ea" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f05874a4-83d6-481d-8694-41c2ddcff3ea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3305d38b-1ec5-4cca-b873-b4d536a1ddc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f05874a4-83d6-481d-8694-41c2ddcff3ea" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3305d38b-1ec5-4cca-b873-b4d536a1ddc6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_WorkforceSolutionsGroupIncMember_ce48a44f-3643-4436-923a-aa6ad8a1a34d" xlink:href="ccrn-20220930.xsd#ccrn_WorkforceSolutionsGroupIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3305d38b-1ec5-4cca-b873-b4d536a1ddc6" xlink:to="loc_ccrn_WorkforceSolutionsGroupIncMember_ce48a44f-3643-4436-923a-aa6ad8a1a34d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREAntidilutiveSecuritiesDetails" xlink:type="simple" xlink:href="ccrn-20220930.xsd#EARNINGSPERSHAREAntidilutiveSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREAntidilutiveSecuritiesDetails" xlink:type="extended" id="i6606afa118744638a7fdfc32a0e636ee_EARNINGSPERSHAREAntidilutiveSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_59973eca-517f-48a2-bf75-1a68bdfced8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2bfd36e1-e625-4b12-bd52-8e6b2f1b8b17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_59973eca-517f-48a2-bf75-1a68bdfced8c" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2bfd36e1-e625-4b12-bd52-8e6b2f1b8b17" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_a893adbc-d682-4a4b-912c-54d33a828d5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_59973eca-517f-48a2-bf75-1a68bdfced8c" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_a893adbc-d682-4a4b-912c-54d33a828d5a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a3b6b948-65b3-4f50-81c5-b973bc1c4cd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_a893adbc-d682-4a4b-912c-54d33a828d5a" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a3b6b948-65b3-4f50-81c5-b973bc1c4cd6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a3b6b948-65b3-4f50-81c5-b973bc1c4cd6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a3b6b948-65b3-4f50-81c5-b973bc1c4cd6" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a3b6b948-65b3-4f50-81c5-b973bc1c4cd6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_502fd690-2e0e-45f2-a6b1-78c79b5550b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a3b6b948-65b3-4f50-81c5-b973bc1c4cd6" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_502fd690-2e0e-45f2-a6b1-78c79b5550b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_ShareBasedPaymentAwardsMember_182d5ec1-d8eb-4041-95c1-d342575c78bb" xlink:href="ccrn-20220930.xsd#ccrn_ShareBasedPaymentAwardsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_502fd690-2e0e-45f2-a6b1-78c79b5550b8" xlink:to="loc_ccrn_ShareBasedPaymentAwardsMember_182d5ec1-d8eb-4041-95c1-d342575c78bb" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails" xlink:type="simple" xlink:href="ccrn-20220930.xsd#GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails" xlink:type="extended" id="ia589607f7ac049a3aa87273ac1a0b74b_GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_073f833d-12c4-4fb1-b096-6271d7bfac06" xlink:href="ccrn-20220930.xsd#ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_719ac280-1bec-4b3a-853b-05a805bddb01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_073f833d-12c4-4fb1-b096-6271d7bfac06" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_719ac280-1bec-4b3a-853b-05a805bddb01" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_98d68974-d76a-4164-8c64-72a1d71254cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_719ac280-1bec-4b3a-853b-05a805bddb01" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_98d68974-d76a-4164-8c64-72a1d71254cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_6cc027a6-c6a1-44aa-978f-eefc460ad236" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_719ac280-1bec-4b3a-853b-05a805bddb01" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_6cc027a6-c6a1-44aa-978f-eefc460ad236" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f963c453-96d4-44e1-b458-b72bf4e96631" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_719ac280-1bec-4b3a-853b-05a805bddb01" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f963c453-96d4-44e1-b458-b72bf4e96631" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_949bbe6d-cd91-475e-9102-9085c666918d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_073f833d-12c4-4fb1-b096-6271d7bfac06" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_949bbe6d-cd91-475e-9102-9085c666918d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedTradeNames_d9f303eb-e108-4879-b61f-cda2572a3207" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedTradeNames"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_949bbe6d-cd91-475e-9102-9085c666918d" xlink:to="loc_us-gaap_IndefiniteLivedTradeNames_d9f303eb-e108-4879-b61f-cda2572a3207" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable_e428dd88-0200-4607-9917-5fd1d1faddba" xlink:href="ccrn-20220930.xsd#ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_073f833d-12c4-4fb1-b096-6271d7bfac06" xlink:to="loc_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable_e428dd88-0200-4607-9917-5fd1d1faddba" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e590e258-1881-4b0f-8366-c422d916b79a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable_e428dd88-0200-4607-9917-5fd1d1faddba" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e590e258-1881-4b0f-8366-c422d916b79a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e590e258-1881-4b0f-8366-c422d916b79a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e590e258-1881-4b0f-8366-c422d916b79a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e590e258-1881-4b0f-8366-c422d916b79a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c24764ba-416c-4ef0-83d7-e2173403c2f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e590e258-1881-4b0f-8366-c422d916b79a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c24764ba-416c-4ef0-83d7-e2173403c2f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DatabasesMember_7c65aaf3-ee62-4652-a6de-ea620ab0eeaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DatabasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c24764ba-416c-4ef0-83d7-e2173403c2f1" xlink:to="loc_us-gaap_DatabasesMember_7c65aaf3-ee62-4652-a6de-ea620ab0eeaf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_1fbd9d18-a3b4-45c5-98eb-ef62b6253f83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c24764ba-416c-4ef0-83d7-e2173403c2f1" xlink:to="loc_us-gaap_CustomerRelationshipsMember_1fbd9d18-a3b4-45c5-98eb-ef62b6253f83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_b7d9db71-501c-47d0-9378-10e0e73c63d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c24764ba-416c-4ef0-83d7-e2173403c2f1" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_b7d9db71-501c-47d0-9378-10e0e73c63d1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_9d28c7cd-b6f4-426f-9941-9d33a8a8a025" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c24764ba-416c-4ef0-83d7-e2173403c2f1" xlink:to="loc_us-gaap_TradeNamesMember_9d28c7cd-b6f4-426f-9941-9d33a8a8a025" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_cfb89433-9ae4-4342-bff0-88b13c07bb02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c24764ba-416c-4ef0-83d7-e2173403c2f1" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_cfb89433-9ae4-4342-bff0-88b13c07bb02" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails" xlink:type="simple" xlink:href="ccrn-20220930.xsd#GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails"/>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails" xlink:type="extended" id="i3db4a6155f6f453ab6a531b6aa24c35e_GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_e8d25f82-bc73-4f41-a556-3c856c799b16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_61aa3cbf-c5bb-4063-aceb-6ac41db3dab6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_e8d25f82-bc73-4f41-a556-3c856c799b16" xlink:to="loc_us-gaap_GoodwillRollForward_61aa3cbf-c5bb-4063-aceb-6ac41db3dab6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_605cc896-0963-45ab-a4e3-e29c47ee5a10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_61aa3cbf-c5bb-4063-aceb-6ac41db3dab6" xlink:to="loc_us-gaap_GoodwillGross_605cc896-0963-45ab-a4e3-e29c47ee5a10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_06f8a5bd-6c0c-4611-8ebb-f4ad0bf93aff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_61aa3cbf-c5bb-4063-aceb-6ac41db3dab6" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_06f8a5bd-6c0c-4611-8ebb-f4ad0bf93aff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_89690875-6ebd-499c-8f71-a6a6e394f2e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_61aa3cbf-c5bb-4063-aceb-6ac41db3dab6" xlink:to="loc_us-gaap_Goodwill_89690875-6ebd-499c-8f71-a6a6e394f2e5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_97b318d8-a729-4372-a09d-825e78a2f150" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_61aa3cbf-c5bb-4063-aceb-6ac41db3dab6" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_97b318d8-a729-4372-a09d-825e78a2f150" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_8aecf45e-1bef-4ada-97d0-9955a8b16ce2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_b803f658-d20b-4333-86be-a815bd017a3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_aaa7bc47-fe30-4daa-8f00-28361802f915" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_d87c8c83-4cc2-43ee-a705-cef755cbadd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_e8d25f82-bc73-4f41-a556-3c856c799b16" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_d87c8c83-4cc2-43ee-a705-cef755cbadd0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_837d2b58-0e57-46c4-970c-d8edd71bd6bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_d87c8c83-4cc2-43ee-a705-cef755cbadd0" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_837d2b58-0e57-46c4-970c-d8edd71bd6bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_837d2b58-0e57-46c4-970c-d8edd71bd6bc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_837d2b58-0e57-46c4-970c-d8edd71bd6bc" xlink:to="loc_us-gaap_SegmentDomain_837d2b58-0e57-46c4-970c-d8edd71bd6bc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f14eb066-e807-49c9-ad31-70c9e97057fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_837d2b58-0e57-46c4-970c-d8edd71bd6bc" xlink:to="loc_us-gaap_SegmentDomain_f14eb066-e807-49c9-ad31-70c9e97057fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_NurseAndAlliedStaffingMember_62463bd6-ce2f-4ec8-bc3a-15b2e6abfcdc" xlink:href="ccrn-20220930.xsd#ccrn_NurseAndAlliedStaffingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f14eb066-e807-49c9-ad31-70c9e97057fb" xlink:to="loc_ccrn_NurseAndAlliedStaffingMember_62463bd6-ce2f-4ec8-bc3a-15b2e6abfcdc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_PhysicianStaffingMember_3ebb8e8d-273b-4c49-b2d8-4e3fb53598cf" xlink:href="ccrn-20220930.xsd#ccrn_PhysicianStaffingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f14eb066-e807-49c9-ad31-70c9e97057fb" xlink:to="loc_ccrn_PhysicianStaffingMember_3ebb8e8d-273b-4c49-b2d8-4e3fb53598cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_00d60041-32bc-4e3e-9db0-c43070088bba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_d87c8c83-4cc2-43ee-a705-cef755cbadd0" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_00d60041-32bc-4e3e-9db0-c43070088bba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_00d60041-32bc-4e3e-9db0-c43070088bba_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_00d60041-32bc-4e3e-9db0-c43070088bba" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_00d60041-32bc-4e3e-9db0-c43070088bba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_118746a9-04dd-4bf9-9ab6-98566dafd468" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_00d60041-32bc-4e3e-9db0-c43070088bba" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_118746a9-04dd-4bf9-9ab6-98566dafd468" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_2ad55d63-397a-4ca7-b84d-071d7a4a743d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_118746a9-04dd-4bf9-9ab6-98566dafd468" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_2ad55d63-397a-4ca7-b84d-071d7a4a743d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails" xlink:type="simple" xlink:href="ccrn-20220930.xsd#DEBTLongtermDebtDetails"/>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails" xlink:type="extended" id="i1c04a79b215f4d0ab49966797bdbe430_DEBTLongtermDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_ebc17f55-bb2d-4fd8-8162-7bf65c3f402f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_d7c5ecbe-9d50-4e2d-90dd-381ea839ae78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebc17f55-bb2d-4fd8-8162-7bf65c3f402f" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_d7c5ecbe-9d50-4e2d-90dd-381ea839ae78" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_24ab8646-2346-49e6-9359-590bec420903" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebc17f55-bb2d-4fd8-8162-7bf65c3f402f" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_24ab8646-2346-49e6-9359-590bec420903" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_009ef3fb-a517-4715-83fe-e2dbce747d43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebc17f55-bb2d-4fd8-8162-7bf65c3f402f" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_009ef3fb-a517-4715-83fe-e2dbce747d43" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_f732be18-6736-4d95-b0ab-a49e68f3bff2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebc17f55-bb2d-4fd8-8162-7bf65c3f402f" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_f732be18-6736-4d95-b0ab-a49e68f3bff2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_3a9df7c3-85eb-4355-a718-69c2f2ef0d89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebc17f55-bb2d-4fd8-8162-7bf65c3f402f" xlink:to="loc_us-gaap_LongTermDebtCurrent_3a9df7c3-85eb-4355-a718-69c2f2ef0d89" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_49ac0915-8ee4-4be5-b9ed-977185cd8779" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebc17f55-bb2d-4fd8-8162-7bf65c3f402f" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_49ac0915-8ee4-4be5-b9ed-977185cd8779" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_dabb96d4-4544-4faa-92ff-44ea2cbc863e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebc17f55-bb2d-4fd8-8162-7bf65c3f402f" xlink:to="loc_us-gaap_DebtInstrumentTable_dabb96d4-4544-4faa-92ff-44ea2cbc863e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_249c57eb-f4db-483b-b70c-9a5411ef40fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_dabb96d4-4544-4faa-92ff-44ea2cbc863e" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_249c57eb-f4db-483b-b70c-9a5411ef40fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_249c57eb-f4db-483b-b70c-9a5411ef40fb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_249c57eb-f4db-483b-b70c-9a5411ef40fb" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_249c57eb-f4db-483b-b70c-9a5411ef40fb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_783bce22-cfe8-4330-b226-c345de4a6d3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_249c57eb-f4db-483b-b70c-9a5411ef40fb" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_783bce22-cfe8-4330-b226-c345de4a6d3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_670b07d2-48c5-4b81-8a5b-4a634fc41f62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_783bce22-cfe8-4330-b226-c345de4a6d3e" xlink:to="loc_us-gaap_SecuredDebtMember_670b07d2-48c5-4b81-8a5b-4a634fc41f62" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_e655c914-6df2-4946-adc8-a43f4eef74be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_783bce22-cfe8-4330-b226-c345de4a6d3e" xlink:to="loc_us-gaap_LineOfCreditMember_e655c914-6df2-4946-adc8-a43f4eef74be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_f054f43e-a848-42bd-9557-0e0703d34dd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_783bce22-cfe8-4330-b226-c345de4a6d3e" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_f054f43e-a848-42bd-9557-0e0703d34dd5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_13831b43-e536-408b-b4a6-63d6a9e910a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_dabb96d4-4544-4faa-92ff-44ea2cbc863e" xlink:to="loc_us-gaap_DebtInstrumentAxis_13831b43-e536-408b-b4a6-63d6a9e910a4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_13831b43-e536-408b-b4a6-63d6a9e910a4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_13831b43-e536-408b-b4a6-63d6a9e910a4" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_13831b43-e536-408b-b4a6-63d6a9e910a4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_046cdda5-e01a-4877-b72c-353cda05610e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_13831b43-e536-408b-b4a6-63d6a9e910a4" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_046cdda5-e01a-4877-b72c-353cda05610e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_A2021TermLoanCreditAgreementMember_413c5d69-8fd1-4640-913d-07104ceaac8b" xlink:href="ccrn-20220930.xsd#ccrn_A2021TermLoanCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_046cdda5-e01a-4877-b72c-353cda05610e" xlink:to="loc_ccrn_A2021TermLoanCreditAgreementMember_413c5d69-8fd1-4640-913d-07104ceaac8b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_EarnoutNotesPayableMember_80be26be-34db-4e5f-b070-fd6910834b98" xlink:href="ccrn-20220930.xsd#ccrn_EarnoutNotesPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_046cdda5-e01a-4877-b72c-353cda05610e" xlink:to="loc_ccrn_EarnoutNotesPayableMember_80be26be-34db-4e5f-b070-fd6910834b98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_b473a61a-f978-4d5f-ab4f-745f48ec6fab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_dabb96d4-4544-4faa-92ff-44ea2cbc863e" xlink:to="loc_us-gaap_CreditFacilityAxis_b473a61a-f978-4d5f-ab4f-745f48ec6fab" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_b473a61a-f978-4d5f-ab4f-745f48ec6fab_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_b473a61a-f978-4d5f-ab4f-745f48ec6fab" xlink:to="loc_us-gaap_CreditFacilityDomain_b473a61a-f978-4d5f-ab4f-745f48ec6fab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_d6892715-7732-484d-8c30-fc033727930c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_b473a61a-f978-4d5f-ab4f-745f48ec6fab" xlink:to="loc_us-gaap_CreditFacilityDomain_d6892715-7732-484d-8c30-fc033727930c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_SeniorSecuredAssetBasedLoanMember_195b8d26-ec1e-41ec-ae68-56ee7acd0900" xlink:href="ccrn-20220930.xsd#ccrn_SeniorSecuredAssetBasedLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_d6892715-7732-484d-8c30-fc033727930c" xlink:to="loc_ccrn_SeniorSecuredAssetBasedLoanMember_195b8d26-ec1e-41ec-ae68-56ee7acd0900" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DEBT2021TermLoanCreditAgreementNarrativeDetails" xlink:type="simple" xlink:href="ccrn-20220930.xsd#DEBT2021TermLoanCreditAgreementNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/DEBT2021TermLoanCreditAgreementNarrativeDetails" xlink:type="extended" id="if147e69a32054238802571fdf6356b21_DEBT2021TermLoanCreditAgreementNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_047b0fc1-303d-4f0d-9bfd-c80b66830f9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_PaymentForDebtPrepayment_bcdd1545-32c9-4042-82db-64ee0261f29e" xlink:href="ccrn-20220930.xsd#ccrn_PaymentForDebtPrepayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_047b0fc1-303d-4f0d-9bfd-c80b66830f9b" xlink:to="loc_ccrn_PaymentForDebtPrepayment_bcdd1545-32c9-4042-82db-64ee0261f29e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_05fef9b0-d55c-4833-9312-bb5cf50d3361" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_047b0fc1-303d-4f0d-9bfd-c80b66830f9b" xlink:to="loc_us-gaap_DebtInstrumentTerm_05fef9b0-d55c-4833-9312-bb5cf50d3361" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_34eec517-d529-426e-bf76-f07006308d75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_047b0fc1-303d-4f0d-9bfd-c80b66830f9b" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_34eec517-d529-426e-bf76-f07006308d75" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_efd0de77-7a02-4beb-b990-44126ad484e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_047b0fc1-303d-4f0d-9bfd-c80b66830f9b" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_efd0de77-7a02-4beb-b990-44126ad484e3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_DebtInstrumentVariableInterestRateFloor_c667256f-780a-4981-9341-96a27558d8a3" xlink:href="ccrn-20220930.xsd#ccrn_DebtInstrumentVariableInterestRateFloor"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_047b0fc1-303d-4f0d-9bfd-c80b66830f9b" xlink:to="loc_ccrn_DebtInstrumentVariableInterestRateFloor_c667256f-780a-4981-9341-96a27558d8a3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_dac554cf-d187-4117-9a22-6273be5c83d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_047b0fc1-303d-4f0d-9bfd-c80b66830f9b" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_dac554cf-d187-4117-9a22-6273be5c83d0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_bb648269-1957-4180-8b37-bfcd1bd6418e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_047b0fc1-303d-4f0d-9bfd-c80b66830f9b" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_bb648269-1957-4180-8b37-bfcd1bd6418e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_3cadd080-2fa4-4b9d-b02b-7abaf7eec67b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_047b0fc1-303d-4f0d-9bfd-c80b66830f9b" xlink:to="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_3cadd080-2fa4-4b9d-b02b-7abaf7eec67b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_c4a04060-0526-4e90-9052-2691098f322b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_047b0fc1-303d-4f0d-9bfd-c80b66830f9b" xlink:to="loc_us-gaap_DebtInstrumentTable_c4a04060-0526-4e90-9052-2691098f322b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_f3339721-a003-4276-b7c7-d45887639774" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c4a04060-0526-4e90-9052-2691098f322b" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_f3339721-a003-4276-b7c7-d45887639774" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f3339721-a003-4276-b7c7-d45887639774_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f3339721-a003-4276-b7c7-d45887639774" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f3339721-a003-4276-b7c7-d45887639774_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_bf044dda-7cf9-4a11-b409-07d34a3e598d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f3339721-a003-4276-b7c7-d45887639774" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_bf044dda-7cf9-4a11-b409-07d34a3e598d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_4979d454-60fa-4883-8dc7-afb74f616632" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_bf044dda-7cf9-4a11-b409-07d34a3e598d" xlink:to="loc_us-gaap_SecuredDebtMember_4979d454-60fa-4883-8dc7-afb74f616632" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_681cf294-9de3-4244-9731-1ec66d23bc1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c4a04060-0526-4e90-9052-2691098f322b" xlink:to="loc_us-gaap_DebtInstrumentAxis_681cf294-9de3-4244-9731-1ec66d23bc1e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_681cf294-9de3-4244-9731-1ec66d23bc1e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_681cf294-9de3-4244-9731-1ec66d23bc1e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_681cf294-9de3-4244-9731-1ec66d23bc1e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e9bedfbb-b9b7-418d-b854-a09e7e53ae59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_681cf294-9de3-4244-9731-1ec66d23bc1e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e9bedfbb-b9b7-418d-b854-a09e7e53ae59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_A2021TermLoanCreditAgreementMember_07617354-3228-490b-887e-2fa20b6aaf22" xlink:href="ccrn-20220930.xsd#ccrn_A2021TermLoanCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e9bedfbb-b9b7-418d-b854-a09e7e53ae59" xlink:to="loc_ccrn_A2021TermLoanCreditAgreementMember_07617354-3228-490b-887e-2fa20b6aaf22" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_A2021TermLoanCreditAgreementIncrementalTermLoanMember_c89d5e7c-1cc1-45f1-8d9e-a1f89b510902" xlink:href="ccrn-20220930.xsd#ccrn_A2021TermLoanCreditAgreementIncrementalTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_A2021TermLoanCreditAgreementMember_07617354-3228-490b-887e-2fa20b6aaf22" xlink:to="loc_ccrn_A2021TermLoanCreditAgreementIncrementalTermLoanMember_c89d5e7c-1cc1-45f1-8d9e-a1f89b510902" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_A2021TermLoanCreditAgreementAggregateAmountOfAllPossibleIncreasesMember_10bb02e3-4479-41f1-a626-6c03ffa27627" xlink:href="ccrn-20220930.xsd#ccrn_A2021TermLoanCreditAgreementAggregateAmountOfAllPossibleIncreasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_A2021TermLoanCreditAgreementMember_07617354-3228-490b-887e-2fa20b6aaf22" xlink:to="loc_ccrn_A2021TermLoanCreditAgreementAggregateAmountOfAllPossibleIncreasesMember_10bb02e3-4479-41f1-a626-6c03ffa27627" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_287d3abe-7364-4761-a0b8-5df5c20086aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c4a04060-0526-4e90-9052-2691098f322b" xlink:to="loc_us-gaap_VariableRateAxis_287d3abe-7364-4761-a0b8-5df5c20086aa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_287d3abe-7364-4761-a0b8-5df5c20086aa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_287d3abe-7364-4761-a0b8-5df5c20086aa" xlink:to="loc_us-gaap_VariableRateDomain_287d3abe-7364-4761-a0b8-5df5c20086aa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_00d7c551-f21d-4ae9-a736-88dcad4a48c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_287d3abe-7364-4761-a0b8-5df5c20086aa" xlink:to="loc_us-gaap_VariableRateDomain_00d7c551-f21d-4ae9-a736-88dcad4a48c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_3a568f8b-a55e-442e-a104-de9bbb749495" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_00d7c551-f21d-4ae9-a736-88dcad4a48c1" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_3a568f8b-a55e-442e-a104-de9bbb749495" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails" xlink:type="simple" xlink:href="ccrn-20220930.xsd#DEBTMaturitiesofDebtDetails"/>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails" xlink:type="extended" id="id73079d2851546e6adde2185ccc59f92_DEBTMaturitiesofDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_75837fb5-58cc-4bc0-aaeb-3381b00d7952" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtByMaturityAbstract_79bec060-bb1d-4eaa-8ed9-58cee172afed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtByMaturityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_75837fb5-58cc-4bc0-aaeb-3381b00d7952" xlink:to="loc_us-gaap_LongTermDebtByMaturityAbstract_79bec060-bb1d-4eaa-8ed9-58cee172afed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_ced93a34-d2ba-4248-9f52-b39170926253" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_79bec060-bb1d-4eaa-8ed9-58cee172afed" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_ced93a34-d2ba-4248-9f52-b39170926253" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_9edb7b96-2ac8-4da1-a583-7d2536cdb0e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_79bec060-bb1d-4eaa-8ed9-58cee172afed" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_9edb7b96-2ac8-4da1-a583-7d2536cdb0e8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_01076505-50d5-4e11-bf85-0eb93e9f6ecc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_79bec060-bb1d-4eaa-8ed9-58cee172afed" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_01076505-50d5-4e11-bf85-0eb93e9f6ecc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_660c1328-b378-49aa-bd82-c28cf1507692" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_79bec060-bb1d-4eaa-8ed9-58cee172afed" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_660c1328-b378-49aa-bd82-c28cf1507692" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_d0c934ef-fb7d-4b79-b8ee-7e5f26aa8927" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_79bec060-bb1d-4eaa-8ed9-58cee172afed" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_d0c934ef-fb7d-4b79-b8ee-7e5f26aa8927" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_LongTermDebtMaturityAfterYearFour_890d6fbe-a4a7-4fd3-b176-c652febbb85a" xlink:href="ccrn-20220930.xsd#ccrn_LongTermDebtMaturityAfterYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_79bec060-bb1d-4eaa-8ed9-58cee172afed" xlink:to="loc_ccrn_LongTermDebtMaturityAfterYearFour_890d6fbe-a4a7-4fd3-b176-c652febbb85a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_6d025dff-59c7-40a7-b308-76803dc4e3fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_79bec060-bb1d-4eaa-8ed9-58cee172afed" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_6d025dff-59c7-40a7-b308-76803dc4e3fe" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_9d26cb43-7c53-44e1-b5aa-1e0830356edb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_75837fb5-58cc-4bc0-aaeb-3381b00d7952" xlink:to="loc_us-gaap_DebtInstrumentTable_9d26cb43-7c53-44e1-b5aa-1e0830356edb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_942b5fcf-5e04-486d-9d6f-258bcadf8f0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9d26cb43-7c53-44e1-b5aa-1e0830356edb" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_942b5fcf-5e04-486d-9d6f-258bcadf8f0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_942b5fcf-5e04-486d-9d6f-258bcadf8f0a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_942b5fcf-5e04-486d-9d6f-258bcadf8f0a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_942b5fcf-5e04-486d-9d6f-258bcadf8f0a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_ea1957e1-e558-47db-be80-3e645b2381c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_942b5fcf-5e04-486d-9d6f-258bcadf8f0a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_ea1957e1-e558-47db-be80-3e645b2381c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_856d1dcc-db0b-4556-9943-0b62435740bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_ea1957e1-e558-47db-be80-3e645b2381c0" xlink:to="loc_us-gaap_SecuredDebtMember_856d1dcc-db0b-4556-9943-0b62435740bf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_897ba653-d340-4438-80dd-71700c3d2ad6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_ea1957e1-e558-47db-be80-3e645b2381c0" xlink:to="loc_us-gaap_LineOfCreditMember_897ba653-d340-4438-80dd-71700c3d2ad6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_5ba02cfa-bd2f-42cc-a4f6-0a4a46254de6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9d26cb43-7c53-44e1-b5aa-1e0830356edb" xlink:to="loc_us-gaap_DebtInstrumentAxis_5ba02cfa-bd2f-42cc-a4f6-0a4a46254de6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_5ba02cfa-bd2f-42cc-a4f6-0a4a46254de6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_5ba02cfa-bd2f-42cc-a4f6-0a4a46254de6" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_5ba02cfa-bd2f-42cc-a4f6-0a4a46254de6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8921b654-d389-4462-894c-79d420ca9d96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_5ba02cfa-bd2f-42cc-a4f6-0a4a46254de6" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8921b654-d389-4462-894c-79d420ca9d96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_A2021TermLoanCreditAgreementMember_89fc5767-8006-41ec-8227-dc1c1260939c" xlink:href="ccrn-20220930.xsd#ccrn_A2021TermLoanCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8921b654-d389-4462-894c-79d420ca9d96" xlink:to="loc_ccrn_A2021TermLoanCreditAgreementMember_89fc5767-8006-41ec-8227-dc1c1260939c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_8b364e41-e4b7-4693-af8a-34faff78c058" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9d26cb43-7c53-44e1-b5aa-1e0830356edb" xlink:to="loc_us-gaap_CreditFacilityAxis_8b364e41-e4b7-4693-af8a-34faff78c058" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_8b364e41-e4b7-4693-af8a-34faff78c058_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_8b364e41-e4b7-4693-af8a-34faff78c058" xlink:to="loc_us-gaap_CreditFacilityDomain_8b364e41-e4b7-4693-af8a-34faff78c058_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_95132634-063c-4d91-b23f-4c9c9740899b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_8b364e41-e4b7-4693-af8a-34faff78c058" xlink:to="loc_us-gaap_CreditFacilityDomain_95132634-063c-4d91-b23f-4c9c9740899b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_SeniorSecuredAssetBasedLoanMember_1812519b-a444-463d-a61e-6f2c5973e49c" xlink:href="ccrn-20220930.xsd#ccrn_SeniorSecuredAssetBasedLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_95132634-063c-4d91-b23f-4c9c9740899b" xlink:to="loc_ccrn_SeniorSecuredAssetBasedLoanMember_1812519b-a444-463d-a61e-6f2c5973e49c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails" xlink:type="simple" xlink:href="ccrn-20220930.xsd#DEBT2019LoanAgreementDetails"/>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails" xlink:type="extended" id="ie03f9c34edec40cc8da388551c850ae7_DEBT2019LoanAgreementDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_d0727938-4355-42f7-9f07-a57438bfc323" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityExpirationPeriod_335267f5-2cbd-4958-b2c7-a53d0eb5c9da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_d0727938-4355-42f7-9f07-a57438bfc323" xlink:to="loc_us-gaap_LineOfCreditFacilityExpirationPeriod_335267f5-2cbd-4958-b2c7-a53d0eb5c9da" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_48eb4b9e-8f74-4c51-b837-e39b3e097148" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_d0727938-4355-42f7-9f07-a57438bfc323" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_48eb4b9e-8f74-4c51-b837-e39b3e097148" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_LineOfCreditAmountOfIndebtednessPermittedBySeniorSecuredAssetBasedLoanToBeBorrowedFromOtherSources_687c5096-2cf1-429c-b137-2365352e8be0" xlink:href="ccrn-20220930.xsd#ccrn_LineOfCreditAmountOfIndebtednessPermittedBySeniorSecuredAssetBasedLoanToBeBorrowedFromOtherSources"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_d0727938-4355-42f7-9f07-a57438bfc323" xlink:to="loc_ccrn_LineOfCreditAmountOfIndebtednessPermittedBySeniorSecuredAssetBasedLoanToBeBorrowedFromOtherSources_687c5096-2cf1-429c-b137-2365352e8be0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_LineOfCreditFacilityBasisSpreadOnVariableRateAdditionalCreditSpreadAssociatedWithSOFR_560547e5-8290-40ac-a0aa-4d7495fa97a5" xlink:href="ccrn-20220930.xsd#ccrn_LineOfCreditFacilityBasisSpreadOnVariableRateAdditionalCreditSpreadAssociatedWithSOFR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_d0727938-4355-42f7-9f07-a57438bfc323" xlink:to="loc_ccrn_LineOfCreditFacilityBasisSpreadOnVariableRateAdditionalCreditSpreadAssociatedWithSOFR_560547e5-8290-40ac-a0aa-4d7495fa97a5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_LineOfCreditBorrowingBasePercentageOfAssets_bc25b71a-4a2b-4245-90e8-db8b48ec665e" xlink:href="ccrn-20220930.xsd#ccrn_LineOfCreditBorrowingBasePercentageOfAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_d0727938-4355-42f7-9f07-a57438bfc323" xlink:to="loc_ccrn_LineOfCreditBorrowingBasePercentageOfAssets_bc25b71a-4a2b-4245-90e8-db8b48ec665e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_LineOfCreditFacilityBorrowingBaseAvailability_ff0174d1-384c-4cd9-b290-baa545dc5707" xlink:href="ccrn-20220930.xsd#ccrn_LineOfCreditFacilityBorrowingBaseAvailability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_d0727938-4355-42f7-9f07-a57438bfc323" xlink:to="loc_ccrn_LineOfCreditFacilityBorrowingBaseAvailability_ff0174d1-384c-4cd9-b290-baa545dc5707" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_b5e85eff-0965-448b-bc3c-f1ab0ea92763" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_d0727938-4355-42f7-9f07-a57438bfc323" xlink:to="loc_us-gaap_LineOfCredit_b5e85eff-0965-448b-bc3c-f1ab0ea92763" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_ab83e55d-5a5e-4840-a74c-5831b0e1c04c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_d0727938-4355-42f7-9f07-a57438bfc323" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_ab83e55d-5a5e-4840-a74c-5831b0e1c04c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_447a6f95-39a3-408e-ae3d-6e0b09b78d02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_d0727938-4355-42f7-9f07-a57438bfc323" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_447a6f95-39a3-408e-ae3d-6e0b09b78d02" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_8988182e-f514-430a-9833-c04448c3d9e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_d0727938-4355-42f7-9f07-a57438bfc323" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_8988182e-f514-430a-9833-c04448c3d9e0" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_b1ecf88d-690a-4f2c-b60a-a6f1e65d0f2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_d0727938-4355-42f7-9f07-a57438bfc323" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_b1ecf88d-690a-4f2c-b60a-a6f1e65d0f2d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_4a5e520b-3d48-4438-8c93-b7e306f360cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_d0727938-4355-42f7-9f07-a57438bfc323" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_4a5e520b-3d48-4438-8c93-b7e306f360cd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_9d9068a2-9814-4edd-968e-5db206afb568" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_4a5e520b-3d48-4438-8c93-b7e306f360cd" xlink:to="loc_us-gaap_CreditFacilityAxis_9d9068a2-9814-4edd-968e-5db206afb568" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_9d9068a2-9814-4edd-968e-5db206afb568_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_9d9068a2-9814-4edd-968e-5db206afb568" xlink:to="loc_us-gaap_CreditFacilityDomain_9d9068a2-9814-4edd-968e-5db206afb568_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_0cee9449-b4b4-423d-ba55-ecbac65aee41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_9d9068a2-9814-4edd-968e-5db206afb568" xlink:to="loc_us-gaap_CreditFacilityDomain_0cee9449-b4b4-423d-ba55-ecbac65aee41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_SeniorSecuredAssetBasedLoanMember_14b7c889-1a9f-4675-9567-db9a7c0397a6" xlink:href="ccrn-20220930.xsd#ccrn_SeniorSecuredAssetBasedLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_0cee9449-b4b4-423d-ba55-ecbac65aee41" xlink:to="loc_ccrn_SeniorSecuredAssetBasedLoanMember_14b7c889-1a9f-4675-9567-db9a7c0397a6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_LineOfCreditSublimitAxis_21c2c0ed-aa35-4608-a069-71d4189c6201" xlink:href="ccrn-20220930.xsd#ccrn_LineOfCreditSublimitAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_4a5e520b-3d48-4438-8c93-b7e306f360cd" xlink:to="loc_ccrn_LineOfCreditSublimitAxis_21c2c0ed-aa35-4608-a069-71d4189c6201" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_LineOfCreditSublimitDomain_21c2c0ed-aa35-4608-a069-71d4189c6201_default" xlink:href="ccrn-20220930.xsd#ccrn_LineOfCreditSublimitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ccrn_LineOfCreditSublimitAxis_21c2c0ed-aa35-4608-a069-71d4189c6201" xlink:to="loc_ccrn_LineOfCreditSublimitDomain_21c2c0ed-aa35-4608-a069-71d4189c6201_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_LineOfCreditSublimitDomain_146186ba-03e0-4cc5-ab0a-907c8e40e9d9" xlink:href="ccrn-20220930.xsd#ccrn_LineOfCreditSublimitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ccrn_LineOfCreditSublimitAxis_21c2c0ed-aa35-4608-a069-71d4189c6201" xlink:to="loc_ccrn_LineOfCreditSublimitDomain_146186ba-03e0-4cc5-ab0a-907c8e40e9d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_SwingLoansSublimitMember_b154d429-4a18-4e7e-9a5a-303ba8ebd164" xlink:href="ccrn-20220930.xsd#ccrn_SwingLoansSublimitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_LineOfCreditSublimitDomain_146186ba-03e0-4cc5-ab0a-907c8e40e9d9" xlink:to="loc_ccrn_SwingLoansSublimitMember_b154d429-4a18-4e7e-9a5a-303ba8ebd164" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_StandbyLettersOfCreditSublimitMember_ee41bc7a-8a64-4235-8ce6-4764888847ed" xlink:href="ccrn-20220930.xsd#ccrn_StandbyLettersOfCreditSublimitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_LineOfCreditSublimitDomain_146186ba-03e0-4cc5-ab0a-907c8e40e9d9" xlink:to="loc_ccrn_StandbyLettersOfCreditSublimitMember_ee41bc7a-8a64-4235-8ce6-4764888847ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_b3ecc199-0132-4463-8aa3-c6c1f8b0a4ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_4a5e520b-3d48-4438-8c93-b7e306f360cd" xlink:to="loc_us-gaap_VariableRateAxis_b3ecc199-0132-4463-8aa3-c6c1f8b0a4ae" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_b3ecc199-0132-4463-8aa3-c6c1f8b0a4ae_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_b3ecc199-0132-4463-8aa3-c6c1f8b0a4ae" xlink:to="loc_us-gaap_VariableRateDomain_b3ecc199-0132-4463-8aa3-c6c1f8b0a4ae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_407e6fa8-dd17-4ae1-9860-8a1d6d1884e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_b3ecc199-0132-4463-8aa3-c6c1f8b0a4ae" xlink:to="loc_us-gaap_VariableRateDomain_407e6fa8-dd17-4ae1-9860-8a1d6d1884e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_SecuredOvernightFinancingRateSOFRMember_1af0a02a-14af-47d4-a021-6c60dac22a8e" xlink:href="ccrn-20220930.xsd#ccrn_SecuredOvernightFinancingRateSOFRMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_407e6fa8-dd17-4ae1-9860-8a1d6d1884e7" xlink:to="loc_ccrn_SecuredOvernightFinancingRateSOFRMember_1af0a02a-14af-47d4-a021-6c60dac22a8e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_e27848a9-d819-4bef-b156-5d16bb1bf6c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_407e6fa8-dd17-4ae1-9860-8a1d6d1884e7" xlink:to="loc_us-gaap_BaseRateMember_e27848a9-d819-4bef-b156-5d16bb1bf6c1" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSEstimatedFairValuesofFinancialAssetsandLiabilitiesMeasuredonaRecurringBasisDetails" xlink:type="simple" xlink:href="ccrn-20220930.xsd#FAIRVALUEMEASUREMENTSEstimatedFairValuesofFinancialAssetsandLiabilitiesMeasuredonaRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSEstimatedFairValuesofFinancialAssetsandLiabilitiesMeasuredonaRecurringBasisDetails" xlink:type="extended" id="ibb79b93c4021487b88ac5fcf307bb2b4_FAIRVALUEMEASUREMENTSEstimatedFairValuesofFinancialAssetsandLiabilitiesMeasuredonaRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a16a8f6b-f130-4e16-87f2-c628ad1006be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_ee2bf8e9-8cc4-473d-9247-5d97347f2020" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a16a8f6b-f130-4e16-87f2-c628ad1006be" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_ee2bf8e9-8cc4-473d-9247-5d97347f2020" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_6dc97337-7e50-4e06-85e8-a7ba147e3a48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a16a8f6b-f130-4e16-87f2-c628ad1006be" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_6dc97337-7e50-4e06-85e8-a7ba147e3a48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fa2c6945-c2c8-4614-9f33-a86ad4bea244" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a16a8f6b-f130-4e16-87f2-c628ad1006be" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fa2c6945-c2c8-4614-9f33-a86ad4bea244" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_60c1cf84-883e-4f3d-83d0-e51aa831f7a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fa2c6945-c2c8-4614-9f33-a86ad4bea244" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_60c1cf84-883e-4f3d-83d0-e51aa831f7a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_60c1cf84-883e-4f3d-83d0-e51aa831f7a5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_60c1cf84-883e-4f3d-83d0-e51aa831f7a5" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_60c1cf84-883e-4f3d-83d0-e51aa831f7a5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_d92e513a-0c55-4e07-957f-580839e88a71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_60c1cf84-883e-4f3d-83d0-e51aa831f7a5" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_d92e513a-0c55-4e07-957f-580839e88a71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_DeferredCompensationMember_23a37838-8ecc-409f-b1a8-f6266913efad" xlink:href="ccrn-20220930.xsd#ccrn_DeferredCompensationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_d92e513a-0c55-4e07-957f-580839e88a71" xlink:to="loc_ccrn_DeferredCompensationMember_23a37838-8ecc-409f-b1a8-f6266913efad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_ed151215-a050-465b-a49c-824c2ce84d17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fa2c6945-c2c8-4614-9f33-a86ad4bea244" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_ed151215-a050-465b-a49c-824c2ce84d17" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ed151215-a050-465b-a49c-824c2ce84d17_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_ed151215-a050-465b-a49c-824c2ce84d17" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ed151215-a050-465b-a49c-824c2ce84d17_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_88d90375-7eb1-4c5c-9f74-11ebb10c675f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_ed151215-a050-465b-a49c-824c2ce84d17" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_88d90375-7eb1-4c5c-9f74-11ebb10c675f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_DeferredCompensationMember_cdaade3d-5045-45c6-b351-b9abcb313cb0" xlink:href="ccrn-20220930.xsd#ccrn_DeferredCompensationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_88d90375-7eb1-4c5c-9f74-11ebb10c675f" xlink:to="loc_ccrn_DeferredCompensationMember_cdaade3d-5045-45c6-b351-b9abcb313cb0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_580b1383-6912-4dbb-a256-a6f162b4d58e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fa2c6945-c2c8-4614-9f33-a86ad4bea244" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_580b1383-6912-4dbb-a256-a6f162b4d58e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_580b1383-6912-4dbb-a256-a6f162b4d58e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_580b1383-6912-4dbb-a256-a6f162b4d58e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_580b1383-6912-4dbb-a256-a6f162b4d58e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_74358771-0ac7-4574-8d2e-fdea5da9878b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_580b1383-6912-4dbb-a256-a6f162b4d58e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_74358771-0ac7-4574-8d2e-fdea5da9878b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_a443bb51-493b-4597-8f3a-99aaff4e6603" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_74358771-0ac7-4574-8d2e-fdea5da9878b" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_a443bb51-493b-4597-8f3a-99aaff4e6603" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="simple" xlink:href="ccrn-20220930.xsd#FAIRVALUEMEASUREMENTSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="extended" id="i2a5afcf010764a7abd217b6570f3790b_FAIRVALUEMEASUREMENTSNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_FairValueMeasurementLineItems_461fb89a-c6cc-4bd8-b9f3-80256f316825" xlink:href="ccrn-20220930.xsd#ccrn_FairValueMeasurementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_ae47ceea-d6f2-4375-baa8-d17b2e8d93cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_FairValueMeasurementLineItems_461fb89a-c6cc-4bd8-b9f3-80256f316825" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_ae47ceea-d6f2-4375-baa8-d17b2e8d93cf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_FairValueMeasurementTable_f78c5c65-eb35-45f5-b884-ef62dbacfecb" xlink:href="ccrn-20220930.xsd#ccrn_FairValueMeasurementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ccrn_FairValueMeasurementLineItems_461fb89a-c6cc-4bd8-b9f3-80256f316825" xlink:to="loc_ccrn_FairValueMeasurementTable_f78c5c65-eb35-45f5-b884-ef62dbacfecb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_bdb2460c-0e7b-4106-ad6c-1b69f589aa27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ccrn_FairValueMeasurementTable_f78c5c65-eb35-45f5-b884-ef62dbacfecb" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_bdb2460c-0e7b-4106-ad6c-1b69f589aa27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bdb2460c-0e7b-4106-ad6c-1b69f589aa27_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_bdb2460c-0e7b-4106-ad6c-1b69f589aa27" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bdb2460c-0e7b-4106-ad6c-1b69f589aa27_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9ddcee12-d5da-41d9-a7af-4f0f908eec84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_bdb2460c-0e7b-4106-ad6c-1b69f589aa27" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9ddcee12-d5da-41d9-a7af-4f0f908eec84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_WorkforceSolutionsGroupIncMember_8bdce88a-bb3d-4535-b848-210cf071ffb6" xlink:href="ccrn-20220930.xsd#ccrn_WorkforceSolutionsGroupIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9ddcee12-d5da-41d9-a7af-4f0f908eec84" xlink:to="loc_ccrn_WorkforceSolutionsGroupIncMember_8bdce88a-bb3d-4535-b848-210cf071ffb6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails" xlink:type="simple" xlink:href="ccrn-20220930.xsd#FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails"/>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails" xlink:type="extended" id="ic6adfc21a474472ea0a06e04fad2967a_FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_260a01be-014d-453a-8f14-3b5eda119af4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOptionQuantitativeDisclosuresLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_5de859a2-4168-40c2-b4a6-21877b95155d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_260a01be-014d-453a-8f14-3b5eda119af4" xlink:to="loc_us-gaap_DebtInstrumentFairValue_5de859a2-4168-40c2-b4a6-21877b95155d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditFairValueDisclosure_f88cd8d0-4769-4366-a012-e2b0afb63ea8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LinesOfCreditFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_260a01be-014d-453a-8f14-3b5eda119af4" xlink:to="loc_us-gaap_LinesOfCreditFairValueDisclosure_f88cd8d0-4769-4366-a012-e2b0afb63ea8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_eb375a21-b8a7-4283-9984-098dd412029f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_260a01be-014d-453a-8f14-3b5eda119af4" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_eb375a21-b8a7-4283-9984-098dd412029f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_a5ecf73b-37bd-4fcb-89fb-1daf47683893" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOptionQuantitativeDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_260a01be-014d-453a-8f14-3b5eda119af4" xlink:to="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_a5ecf73b-37bd-4fcb-89fb-1daf47683893" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4ebb8b4b-51c6-4648-9a71-c6ba7d440607" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_a5ecf73b-37bd-4fcb-89fb-1daf47683893" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4ebb8b4b-51c6-4648-9a71-c6ba7d440607" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4ebb8b4b-51c6-4648-9a71-c6ba7d440607_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4ebb8b4b-51c6-4648-9a71-c6ba7d440607" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4ebb8b4b-51c6-4648-9a71-c6ba7d440607_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_529701f2-fd11-46f8-9cdd-19f6838493ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4ebb8b4b-51c6-4648-9a71-c6ba7d440607" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_529701f2-fd11-46f8-9cdd-19f6838493ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_bbbaa95b-9781-48d9-bb41-fcc70c23203c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_529701f2-fd11-46f8-9cdd-19f6838493ce" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_bbbaa95b-9781-48d9-bb41-fcc70c23203c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_994c46dc-539f-4e93-84cf-3beb49f04c90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_a5ecf73b-37bd-4fcb-89fb-1daf47683893" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_994c46dc-539f-4e93-84cf-3beb49f04c90" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_994c46dc-539f-4e93-84cf-3beb49f04c90_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_994c46dc-539f-4e93-84cf-3beb49f04c90" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_994c46dc-539f-4e93-84cf-3beb49f04c90_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_70756c0f-185b-4764-8b5b-fc90538d991a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_994c46dc-539f-4e93-84cf-3beb49f04c90" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_70756c0f-185b-4764-8b5b-fc90538d991a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_EarnoutNotesPayableMember_d798bd84-ce27-41f5-9b19-dc50fd826d17" xlink:href="ccrn-20220930.xsd#ccrn_EarnoutNotesPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_70756c0f-185b-4764-8b5b-fc90538d991a" xlink:to="loc_ccrn_EarnoutNotesPayableMember_d798bd84-ce27-41f5-9b19-dc50fd826d17" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_02a56fa3-7a38-40b4-a80e-b5592be1ffc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_70756c0f-185b-4764-8b5b-fc90538d991a" xlink:to="loc_us-gaap_SecuredDebtMember_02a56fa3-7a38-40b4-a80e-b5592be1ffc0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_65e3c92f-c549-49a1-b2a0-850ea36024e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_a5ecf73b-37bd-4fcb-89fb-1daf47683893" xlink:to="loc_us-gaap_CreditFacilityAxis_65e3c92f-c549-49a1-b2a0-850ea36024e1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_65e3c92f-c549-49a1-b2a0-850ea36024e1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_65e3c92f-c549-49a1-b2a0-850ea36024e1" xlink:to="loc_us-gaap_CreditFacilityDomain_65e3c92f-c549-49a1-b2a0-850ea36024e1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_d94d0aaf-5781-42e6-844c-567cc411a498" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_65e3c92f-c549-49a1-b2a0-850ea36024e1" xlink:to="loc_us-gaap_CreditFacilityDomain_d94d0aaf-5781-42e6-844c-567cc411a498" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_SeniorSecuredAssetBasedLoanMember_dfa48b83-18a0-4d45-a4e1-2a7635cdbd9d" xlink:href="ccrn-20220930.xsd#ccrn_SeniorSecuredAssetBasedLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_d94d0aaf-5781-42e6-844c-567cc411a498" xlink:to="loc_ccrn_SeniorSecuredAssetBasedLoanMember_dfa48b83-18a0-4d45-a4e1-2a7635cdbd9d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_af64b0c5-de26-4903-b44a-2d40130bc5a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_a5ecf73b-37bd-4fcb-89fb-1daf47683893" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_af64b0c5-de26-4903-b44a-2d40130bc5a7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_af64b0c5-de26-4903-b44a-2d40130bc5a7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_af64b0c5-de26-4903-b44a-2d40130bc5a7" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_af64b0c5-de26-4903-b44a-2d40130bc5a7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_e74478d6-2267-4bc5-a567-4dd925f94839" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_af64b0c5-de26-4903-b44a-2d40130bc5a7" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_e74478d6-2267-4bc5-a567-4dd925f94839" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_afdc4658-93a5-440c-afcb-756fe3a3b54d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_e74478d6-2267-4bc5-a567-4dd925f94839" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_afdc4658-93a5-440c-afcb-756fe3a3b54d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_b285a420-f9ce-4c87-9396-9e7635ed04f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_afdc4658-93a5-440c-afcb-756fe3a3b54d" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_b285a420-f9ce-4c87-9396-9e7635ed04f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_1bc51b16-08e9-405f-a2ca-1e06a9f7123c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_afdc4658-93a5-440c-afcb-756fe3a3b54d" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_1bc51b16-08e9-405f-a2ca-1e06a9f7123c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_3e0b6e17-fa08-48fb-b5b9-31e8bf95d0a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_a5ecf73b-37bd-4fcb-89fb-1daf47683893" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_3e0b6e17-fa08-48fb-b5b9-31e8bf95d0a9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3e0b6e17-fa08-48fb-b5b9-31e8bf95d0a9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3e0b6e17-fa08-48fb-b5b9-31e8bf95d0a9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3e0b6e17-fa08-48fb-b5b9-31e8bf95d0a9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ec18783d-96de-4b8a-9089-c51d062ec516" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3e0b6e17-fa08-48fb-b5b9-31e8bf95d0a9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ec18783d-96de-4b8a-9089-c51d062ec516" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_WorkforceSolutionsGroupIncMember_5d278845-b8f4-48d4-a0b2-0b5535ded480" xlink:href="ccrn-20220930.xsd#ccrn_WorkforceSolutionsGroupIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ec18783d-96de-4b8a-9089-c51d062ec516" xlink:to="loc_ccrn_WorkforceSolutionsGroupIncMember_5d278845-b8f4-48d4-a0b2-0b5535ded480" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_SelectedIncMember_176e61b8-cda8-4095-82a0-c735452f6ca8" xlink:href="ccrn-20220930.xsd#ccrn_SelectedIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ec18783d-96de-4b8a-9089-c51d062ec516" xlink:to="loc_ccrn_SelectedIncMember_176e61b8-cda8-4095-82a0-c735452f6ca8" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails" xlink:type="simple" xlink:href="ccrn-20220930.xsd#STOCKHOLDERSEQUITYAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails" xlink:type="extended" id="ie8f4a619ec964a419f3cdfc692c219f2_STOCKHOLDERSEQUITYAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_277cf4a7-7f54-4dd8-ac74-8c8b921c30c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_a49f7849-f76b-424d-9cba-46f0fa2807b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_277cf4a7-7f54-4dd8-ac74-8c8b921c30c6" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_a49f7849-f76b-424d-9cba-46f0fa2807b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_cdc71879-ef1e-48ba-9b5d-86d933629475" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_277cf4a7-7f54-4dd8-ac74-8c8b921c30c6" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_cdc71879-ef1e-48ba-9b5d-86d933629475" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_f942eaab-3887-4321-9e3b-117c291e99e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_277cf4a7-7f54-4dd8-ac74-8c8b921c30c6" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_f942eaab-3887-4321-9e3b-117c291e99e4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_4bd69e58-b9c4-4b33-aa37-1c36e743120c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_277cf4a7-7f54-4dd8-ac74-8c8b921c30c6" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_4bd69e58-b9c4-4b33-aa37-1c36e743120c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_51640aeb-51f8-4f6e-a8e3-e38e523c7265" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_277cf4a7-7f54-4dd8-ac74-8c8b921c30c6" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_51640aeb-51f8-4f6e-a8e3-e38e523c7265" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_2e4ea8eb-2396-4856-bcbe-b76950db2da9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_277cf4a7-7f54-4dd8-ac74-8c8b921c30c6" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_2e4ea8eb-2396-4856-bcbe-b76950db2da9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_c8020433-bdc5-4ac1-9ff3-5524d6b5e6b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_277cf4a7-7f54-4dd8-ac74-8c8b921c30c6" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_c8020433-bdc5-4ac1-9ff3-5524d6b5e6b5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_6a5f3d50-11eb-4391-9a4a-8f27069e6383" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_277cf4a7-7f54-4dd8-ac74-8c8b921c30c6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_6a5f3d50-11eb-4391-9a4a-8f27069e6383" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments_9b64006c-4791-4434-b6ad-13cbf2757bf4" xlink:href="ccrn-20220930.xsd#ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_277cf4a7-7f54-4dd8-ac74-8c8b921c30c6" xlink:to="loc_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments_9b64006c-4791-4434-b6ad-13cbf2757bf4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAttainmentPercentage_1a41967c-deb8-4193-a78a-712724643da2" xlink:href="ccrn-20220930.xsd#ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAttainmentPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_277cf4a7-7f54-4dd8-ac74-8c8b921c30c6" xlink:to="loc_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAttainmentPercentage_1a41967c-deb8-4193-a78a-712724643da2" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1a541fc5-0a89-4547-abcc-f5d43bcde022" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_277cf4a7-7f54-4dd8-ac74-8c8b921c30c6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1a541fc5-0a89-4547-abcc-f5d43bcde022" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_f4c9d110-6411-4c26-a7e2-741d3f7e4bdd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_277cf4a7-7f54-4dd8-ac74-8c8b921c30c6" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_f4c9d110-6411-4c26-a7e2-741d3f7e4bdd" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet_96b7eed9-d091-486d-989e-ab983c0d4cb2" xlink:href="ccrn-20220930.xsd#ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_277cf4a7-7f54-4dd8-ac74-8c8b921c30c6" xlink:to="loc_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet_96b7eed9-d091-486d-989e-ab983c0d4cb2" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_08b0db42-ead9-4959-859b-78c9768e7bda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_277cf4a7-7f54-4dd8-ac74-8c8b921c30c6" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_08b0db42-ead9-4959-859b-78c9768e7bda" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_112a9f0d-0671-4605-b355-e0a27033dc1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_08b0db42-ead9-4959-859b-78c9768e7bda" xlink:to="loc_us-gaap_PlanNameAxis_112a9f0d-0671-4605-b355-e0a27033dc1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_112a9f0d-0671-4605-b355-e0a27033dc1c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_112a9f0d-0671-4605-b355-e0a27033dc1c" xlink:to="loc_us-gaap_PlanNameDomain_112a9f0d-0671-4605-b355-e0a27033dc1c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_41706697-d9d6-4ef2-b8ed-ac9bcb8e3dce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_112a9f0d-0671-4605-b355-e0a27033dc1c" xlink:to="loc_us-gaap_PlanNameDomain_41706697-d9d6-4ef2-b8ed-ac9bcb8e3dce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_OmnibusPlanMember_d375068c-a0ef-4ccf-927b-6ccde9a9c4c4" xlink:href="ccrn-20220930.xsd#ccrn_OmnibusPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_41706697-d9d6-4ef2-b8ed-ac9bcb8e3dce" xlink:to="loc_ccrn_OmnibusPlanMember_d375068c-a0ef-4ccf-927b-6ccde9a9c4c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_b0365561-87c7-4e0f-9451-86b9ea4494d2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_08b0db42-ead9-4959-859b-78c9768e7bda" xlink:to="loc_srt_RangeAxis_b0365561-87c7-4e0f-9451-86b9ea4494d2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b0365561-87c7-4e0f-9451-86b9ea4494d2_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_b0365561-87c7-4e0f-9451-86b9ea4494d2" xlink:to="loc_srt_RangeMember_b0365561-87c7-4e0f-9451-86b9ea4494d2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a3d9628a-c0bc-4634-b75a-422c8bc78497" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_b0365561-87c7-4e0f-9451-86b9ea4494d2" xlink:to="loc_srt_RangeMember_a3d9628a-c0bc-4634-b75a-422c8bc78497" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f682006f-32a5-4a0b-aec9-641e67a34f83" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a3d9628a-c0bc-4634-b75a-422c8bc78497" xlink:to="loc_srt_MinimumMember_f682006f-32a5-4a0b-aec9-641e67a34f83" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_7524f87f-8cf7-4544-baf8-988e4080405e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_08b0db42-ead9-4959-859b-78c9768e7bda" xlink:to="loc_srt_TitleOfIndividualAxis_7524f87f-8cf7-4544-baf8-988e4080405e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_7524f87f-8cf7-4544-baf8-988e4080405e_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_7524f87f-8cf7-4544-baf8-988e4080405e" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_7524f87f-8cf7-4544-baf8-988e4080405e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_59d64244-7ff1-417e-83c7-a5b135be1d3a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_7524f87f-8cf7-4544-baf8-988e4080405e" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_59d64244-7ff1-417e-83c7-a5b135be1d3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_6233680f-0fd7-48a1-a254-434fffdaed36" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_DirectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_59d64244-7ff1-417e-83c7-a5b135be1d3a" xlink:to="loc_srt_DirectorMember_6233680f-0fd7-48a1-a254-434fffdaed36" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_d579eba1-9642-438a-a782-9235916235d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_08b0db42-ead9-4959-859b-78c9768e7bda" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_d579eba1-9642-438a-a782-9235916235d7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_d579eba1-9642-438a-a782-9235916235d7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_d579eba1-9642-438a-a782-9235916235d7" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_d579eba1-9642-438a-a782-9235916235d7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_9b1a0606-9f58-4dc2-a1df-1497a37bf44e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_d579eba1-9642-438a-a782-9235916235d7" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_9b1a0606-9f58-4dc2-a1df-1497a37bf44e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_7b78b084-b299-4e0e-a56c-0db0737aff25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_9b1a0606-9f58-4dc2-a1df-1497a37bf44e" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_7b78b084-b299-4e0e-a56c-0db0737aff25" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_e76e6d2e-8fd2-446c-8628-e8d4831f485c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_08b0db42-ead9-4959-859b-78c9768e7bda" xlink:to="loc_us-gaap_AwardTypeAxis_e76e6d2e-8fd2-446c-8628-e8d4831f485c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e76e6d2e-8fd2-446c-8628-e8d4831f485c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_e76e6d2e-8fd2-446c-8628-e8d4831f485c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e76e6d2e-8fd2-446c-8628-e8d4831f485c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_eb6ef45a-a65e-4f7b-a864-cade179d5b31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_e76e6d2e-8fd2-446c-8628-e8d4831f485c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_eb6ef45a-a65e-4f7b-a864-cade179d5b31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_RestrictedStockAndPerformanceSharesMember_cd2617bd-84ef-4dbf-80f8-0ce7015dfbb8" xlink:href="ccrn-20220930.xsd#ccrn_RestrictedStockAndPerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_eb6ef45a-a65e-4f7b-a864-cade179d5b31" xlink:to="loc_ccrn_RestrictedStockAndPerformanceSharesMember_cd2617bd-84ef-4dbf-80f8-0ce7015dfbb8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_840a3dce-ee56-46ae-9dbb-d8403adc9db4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_RestrictedStockAndPerformanceSharesMember_cd2617bd-84ef-4dbf-80f8-0ce7015dfbb8" xlink:to="loc_us-gaap_PerformanceSharesMember_840a3dce-ee56-46ae-9dbb-d8403adc9db4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_e3c4fd75-d2d9-429e-bcc5-cd639beb0214" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_RestrictedStockAndPerformanceSharesMember_cd2617bd-84ef-4dbf-80f8-0ce7015dfbb8" xlink:to="loc_us-gaap_RestrictedStockMember_e3c4fd75-d2d9-429e-bcc5-cd639beb0214" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_34b5bfb8-ea90-450a-a8a4-0f34538b0800" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_08b0db42-ead9-4959-859b-78c9768e7bda" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_34b5bfb8-ea90-450a-a8a4-0f34538b0800" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_34b5bfb8-ea90-450a-a8a4-0f34538b0800_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_34b5bfb8-ea90-450a-a8a4-0f34538b0800" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_34b5bfb8-ea90-450a-a8a4-0f34538b0800_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_df67e472-138c-45c8-8b55-367745aa5e4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_34b5bfb8-ea90-450a-a8a4-0f34538b0800" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_df67e472-138c-45c8-8b55-367745aa5e4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_PriorRepurchaseProgramAndNewRepurchaseProgramMember_c97311bb-5666-46e1-899b-b18ca8bf39a9" xlink:href="ccrn-20220930.xsd#ccrn_PriorRepurchaseProgramAndNewRepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_df67e472-138c-45c8-8b55-367745aa5e4b" xlink:to="loc_ccrn_PriorRepurchaseProgramAndNewRepurchaseProgramMember_c97311bb-5666-46e1-899b-b18ca8bf39a9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_NewRepurchaseProgramMember_ded4738e-9312-46bb-bd9b-0d43427a573b" xlink:href="ccrn-20220930.xsd#ccrn_NewRepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_PriorRepurchaseProgramAndNewRepurchaseProgramMember_c97311bb-5666-46e1-899b-b18ca8bf39a9" xlink:to="loc_ccrn_NewRepurchaseProgramMember_ded4738e-9312-46bb-bd9b-0d43427a573b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYRestrictedStockActivityDetails" xlink:type="simple" xlink:href="ccrn-20220930.xsd#STOCKHOLDERSEQUITYRestrictedStockActivityDetails"/>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYRestrictedStockActivityDetails" xlink:type="extended" id="i800b15b9123a4614a0ea45111b029b92_STOCKHOLDERSEQUITYRestrictedStockActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_74563561-5fe5-455e-a448-7f05f3bad8fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_3563795a-58ba-456f-ae1b-8db1d308ad39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_74563561-5fe5-455e-a448-7f05f3bad8fa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_3563795a-58ba-456f-ae1b-8db1d308ad39" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4d241b6c-3133-4fa1-a83f-f6903c007df5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_3563795a-58ba-456f-ae1b-8db1d308ad39" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4d241b6c-3133-4fa1-a83f-f6903c007df5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_17f1da4d-0701-44a8-b5e2-8370c1c3ab5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_3563795a-58ba-456f-ae1b-8db1d308ad39" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_17f1da4d-0701-44a8-b5e2-8370c1c3ab5d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_960f86a7-f83e-4b24-83b8-50ccfad06cdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_3563795a-58ba-456f-ae1b-8db1d308ad39" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_960f86a7-f83e-4b24-83b8-50ccfad06cdb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_39416b04-94e3-42b9-8cdf-241216eba667" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_3563795a-58ba-456f-ae1b-8db1d308ad39" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_39416b04-94e3-42b9-8cdf-241216eba667" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_e2cb2650-ea6b-4181-9f5e-44cb267eb023" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_cb4abfd4-6b9b-4bdc-9848-aa9ca8ea9dce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_74563561-5fe5-455e-a448-7f05f3bad8fa" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_cb4abfd4-6b9b-4bdc-9848-aa9ca8ea9dce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_a0171c18-a664-4e55-a57f-2a8e2df7822b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_cb4abfd4-6b9b-4bdc-9848-aa9ca8ea9dce" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_a0171c18-a664-4e55-a57f-2a8e2df7822b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1740889e-9bda-4f13-bfed-0a747a8a3fcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_cb4abfd4-6b9b-4bdc-9848-aa9ca8ea9dce" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1740889e-9bda-4f13-bfed-0a747a8a3fcf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_7b3f9170-2a27-4d69-bd24-e5b4cb09c2b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_cb4abfd4-6b9b-4bdc-9848-aa9ca8ea9dce" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_7b3f9170-2a27-4d69-bd24-e5b4cb09c2b1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_5f2b525f-b5d9-4d5b-836e-41472bc42c65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_cb4abfd4-6b9b-4bdc-9848-aa9ca8ea9dce" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_5f2b525f-b5d9-4d5b-836e-41472bc42c65" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_affd8002-93c4-4708-8517-90546a6d2512" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0fb3652f-7bab-4319-9288-e8282a20db54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_74563561-5fe5-455e-a448-7f05f3bad8fa" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0fb3652f-7bab-4319-9288-e8282a20db54" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_e23b0772-b5a8-4d80-8128-62ae4c72b09f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0fb3652f-7bab-4319-9288-e8282a20db54" xlink:to="loc_us-gaap_AwardTypeAxis_e23b0772-b5a8-4d80-8128-62ae4c72b09f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e23b0772-b5a8-4d80-8128-62ae4c72b09f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_e23b0772-b5a8-4d80-8128-62ae4c72b09f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e23b0772-b5a8-4d80-8128-62ae4c72b09f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_397bb2ec-cea8-4ea0-b8a3-413e72fc61af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_e23b0772-b5a8-4d80-8128-62ae4c72b09f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_397bb2ec-cea8-4ea0-b8a3-413e72fc61af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_2d3b27cf-62c1-4f06-a3f9-9cabe9a9ab57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_397bb2ec-cea8-4ea0-b8a3-413e72fc61af" xlink:to="loc_us-gaap_RestrictedStockMember_2d3b27cf-62c1-4f06-a3f9-9cabe9a9ab57" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_bcf42d68-f76f-4292-872f-d64864d1864e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_397bb2ec-cea8-4ea0-b8a3-413e72fc61af" xlink:to="loc_us-gaap_PerformanceSharesMember_bcf42d68-f76f-4292-872f-d64864d1864e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SEGMENTDATADetails" xlink:type="simple" xlink:href="ccrn-20220930.xsd#SEGMENTDATADetails"/>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/SEGMENTDATADetails" xlink:type="extended" id="i3c52907742fc46c7b09e09fb229b36fa_SEGMENTDATADetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_ec3b4f7d-de62-4a59-8dd6-203dc29dcb8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_25d86ef5-f8b6-41ca-8283-35664fa83ab5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_ec3b4f7d-de62-4a59-8dd6-203dc29dcb8e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_25d86ef5-f8b6-41ca-8283-35664fa83ab5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard_a892d8c2-b215-469a-9a8c-c495ca3c2b41" xlink:href="ccrn-20220930.xsd#ccrn_OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_ec3b4f7d-de62-4a59-8dd6-203dc29dcb8e" xlink:to="loc_ccrn_OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard_a892d8c2-b215-469a-9a8c-c495ca3c2b41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_SegmentReportingUnallocatedCorporateExpenses_0f16c345-eb09-449f-a50a-d7c30f840fb3" xlink:href="ccrn-20220930.xsd#ccrn_SegmentReportingUnallocatedCorporateExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_ec3b4f7d-de62-4a59-8dd6-203dc29dcb8e" xlink:to="loc_ccrn_SegmentReportingUnallocatedCorporateExpenses_0f16c345-eb09-449f-a50a-d7c30f840fb3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_4982d65b-0922-4771-ba54-0f8d38b6fba4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_ec3b4f7d-de62-4a59-8dd6-203dc29dcb8e" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_4982d65b-0922-4771-ba54-0f8d38b6fba4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_AcquisitionAndIntegrationRelatedCosts_61cfd538-b16c-4c5b-948a-bdb564b3644b" xlink:href="ccrn-20220930.xsd#ccrn_AcquisitionAndIntegrationRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_ec3b4f7d-de62-4a59-8dd6-203dc29dcb8e" xlink:to="loc_ccrn_AcquisitionAndIntegrationRelatedCosts_61cfd538-b16c-4c5b-948a-bdb564b3644b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_9feaed60-bd1d-4023-9c3c-0785b75698fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_ec3b4f7d-de62-4a59-8dd6-203dc29dcb8e" xlink:to="loc_us-gaap_RestructuringCharges_9feaed60-bd1d-4023-9c3c-0785b75698fd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_4342ce48-38e6-4b3d-8fb2-f54dae6e3a16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_ec3b4f7d-de62-4a59-8dd6-203dc29dcb8e" xlink:to="loc_us-gaap_AssetImpairmentCharges_4342ce48-38e6-4b3d-8fb2-f54dae6e3a16" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_f13686d8-0b82-4849-92ab-cefbf55f7d35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_ec3b4f7d-de62-4a59-8dd6-203dc29dcb8e" xlink:to="loc_us-gaap_OperatingIncomeLoss_f13686d8-0b82-4849-92ab-cefbf55f7d35" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_98c985d5-8e7a-4948-a606-55eea25d3b4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_ec3b4f7d-de62-4a59-8dd6-203dc29dcb8e" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_98c985d5-8e7a-4948-a606-55eea25d3b4e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b70c70ff-9122-4cfc-980f-96e040b10851" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_98c985d5-8e7a-4948-a606-55eea25d3b4e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b70c70ff-9122-4cfc-980f-96e040b10851" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b70c70ff-9122-4cfc-980f-96e040b10851_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b70c70ff-9122-4cfc-980f-96e040b10851" xlink:to="loc_us-gaap_SegmentDomain_b70c70ff-9122-4cfc-980f-96e040b10851_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_36d74f41-377e-4e43-87a9-f365a732bbfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b70c70ff-9122-4cfc-980f-96e040b10851" xlink:to="loc_us-gaap_SegmentDomain_36d74f41-377e-4e43-87a9-f365a732bbfe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_NurseAndAlliedStaffingMember_6c1754c3-55b7-4c5b-a62b-be35c75153cd" xlink:href="ccrn-20220930.xsd#ccrn_NurseAndAlliedStaffingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_36d74f41-377e-4e43-87a9-f365a732bbfe" xlink:to="loc_ccrn_NurseAndAlliedStaffingMember_6c1754c3-55b7-4c5b-a62b-be35c75153cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_PhysicianStaffingMember_219a2318-0c91-49eb-adb3-ac1b53243c67" xlink:href="ccrn-20220930.xsd#ccrn_PhysicianStaffingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_36d74f41-377e-4e43-87a9-f365a732bbfe" xlink:to="loc_ccrn_PhysicianStaffingMember_219a2318-0c91-49eb-adb3-ac1b53243c67" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/INCOMETAXESDetails" xlink:type="simple" xlink:href="ccrn-20220930.xsd#INCOMETAXESDetails"/>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/INCOMETAXESDetails" xlink:type="extended" id="if98dd709e8c74152a7492456ea985570_INCOMETAXESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationLineItems_8dac8612-1168-4d40-b5fc-4b247d47690f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_3e92ca57-6aba-45bb-87b5-9bd7a62f2975" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_8dac8612-1168-4d40-b5fc-4b247d47690f" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_3e92ca57-6aba-45bb-87b5-9bd7a62f2975" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems_10f93d17-b0b9-47fa-a206-131356ff7f7d" xlink:href="ccrn-20220930.xsd#ccrn_EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_8dac8612-1168-4d40-b5fc-4b247d47690f" xlink:to="loc_ccrn_EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems_10f93d17-b0b9-47fa-a206-131356ff7f7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_23cb4f57-ec29-427c-aec9-3a2c11776130" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_8dac8612-1168-4d40-b5fc-4b247d47690f" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_23cb4f57-ec29-427c-aec9-3a2c11776130" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationTable_5b1adaa7-908b-44b3-a8b2-e4a570243ea3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_8dac8612-1168-4d40-b5fc-4b247d47690f" xlink:to="loc_us-gaap_IncomeTaxExaminationTable_5b1adaa7-908b-44b3-a8b2-e4a570243ea3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_51170757-e745-48c7-8858-de03e2383177" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_5b1adaa7-908b-44b3-a8b2-e4a570243ea3" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_51170757-e745-48c7-8858-de03e2383177" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_51170757-e745-48c7-8858-de03e2383177_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_51170757-e745-48c7-8858-de03e2383177" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_51170757-e745-48c7-8858-de03e2383177_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_157a35b5-ff4a-4aa3-962a-01523eb02197" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_51170757-e745-48c7-8858-de03e2383177" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_157a35b5-ff4a-4aa3-962a-01523eb02197" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_8b826134-823a-4b64-b765-b2d4d6092459" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_157a35b5-ff4a-4aa3-962a-01523eb02197" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_8b826134-823a-4b64-b765-b2d4d6092459" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/RELATEDPARTYTRANSACTIONSDetails" xlink:type="simple" xlink:href="ccrn-20220930.xsd#RELATEDPARTYTRANSACTIONSDetails"/>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/RELATEDPARTYTRANSACTIONSDetails" xlink:type="extended" id="i23857e0db29f48228fb4952bcc0fcbdb_RELATEDPARTYTRANSACTIONSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_c7c96197-917f-4408-91e4-dc295d842514" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromRelatedParties_f437026c-b599-4079-ac4d-307a0cf9b516" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromRelatedParties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_c7c96197-917f-4408-91e4-dc295d842514" xlink:to="loc_us-gaap_RevenueFromRelatedParties_f437026c-b599-4079-ac4d-307a0cf9b516" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_b70f6a41-34d0-4870-ba89-ad56df543a12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_c7c96197-917f-4408-91e4-dc295d842514" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_b70f6a41-34d0-4870-ba89-ad56df543a12" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2b770dd8-f43b-40c8-bcd8-100afa339edc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_b70f6a41-34d0-4870-ba89-ad56df543a12" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2b770dd8-f43b-40c8-bcd8-100afa339edc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_2b770dd8-f43b-40c8-bcd8-100afa339edc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2b770dd8-f43b-40c8-bcd8-100afa339edc" xlink:to="loc_us-gaap_RelatedPartyDomain_2b770dd8-f43b-40c8-bcd8-100afa339edc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_2052b35d-23ff-4f4d-8b29-ef4e17679023" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2b770dd8-f43b-40c8-bcd8-100afa339edc" xlink:to="loc_us-gaap_RelatedPartyDomain_2052b35d-23ff-4f4d-8b29-ef4e17679023" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_HealthCareSystemAffiliatedWithABoardMemberMember_43e8d1ed-e249-43b8-98b3-d576b133b103" xlink:href="ccrn-20220930.xsd#ccrn_HealthCareSystemAffiliatedWithABoardMemberMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_2052b35d-23ff-4f4d-8b29-ef4e17679023" xlink:to="loc_ccrn_HealthCareSystemAffiliatedWithABoardMemberMember_43e8d1ed-e249-43b8-98b3-d576b133b103" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>ccrn-20220930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:9f036714-f865-4798-af5a-08fe5047afca,g:b4ca6da5-78c3-4063-9a30-7dfc7d463cab-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_ccrn_A2021TermLoanCreditAgreementAggregateAmountOfAllPossibleIncreasesMember_0f962d8d-25f3-4f9c-88f5-5e414ffae81f_terseLabel_en-US" xlink:label="lab_ccrn_A2021TermLoanCreditAgreementAggregateAmountOfAllPossibleIncreasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Term Loan Credit Agreement, Aggregate Amount of All Possible Increases</link:label>
    <link:label id="lab_ccrn_A2021TermLoanCreditAgreementAggregateAmountOfAllPossibleIncreasesMember_label_en-US" xlink:label="lab_ccrn_A2021TermLoanCreditAgreementAggregateAmountOfAllPossibleIncreasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Term Loan Credit Agreement, Aggregate Amount Of All Possible Increases [Member]</link:label>
    <link:label id="lab_ccrn_A2021TermLoanCreditAgreementAggregateAmountOfAllPossibleIncreasesMember_documentation_en-US" xlink:label="lab_ccrn_A2021TermLoanCreditAgreementAggregateAmountOfAllPossibleIncreasesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Term Loan Credit Agreement, Aggregate Amount Of All Possible Increases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_A2021TermLoanCreditAgreementAggregateAmountOfAllPossibleIncreasesMember" xlink:href="ccrn-20220930.xsd#ccrn_A2021TermLoanCreditAgreementAggregateAmountOfAllPossibleIncreasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_A2021TermLoanCreditAgreementAggregateAmountOfAllPossibleIncreasesMember" xlink:to="lab_ccrn_A2021TermLoanCreditAgreementAggregateAmountOfAllPossibleIncreasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_56428724-8b59-4f91-825e-0c0edb103f69_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c0637e7b-f279-4568-91de-873f77404a38_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_95184574-7cc0-4145-8ccb-e887234e723d_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total minimum lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_4c1735a9-cc8f-41a9-8c6c-b55188692703_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_f28de7a5-66fe-40d6-83fa-dc8ee1a6f621_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bad debt expense</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_1f652036-36aa-4b8f-b979-6ba3781dc9f8_verboseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bad Debt Expense</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_BusinessCombinationContingentConsiderationTerm_6b46f47b-917a-45b3-b747-ad727358e101_terseLabel_en-US" xlink:label="lab_ccrn_BusinessCombinationContingentConsiderationTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration liability, term</link:label>
    <link:label id="lab_ccrn_BusinessCombinationContingentConsiderationTerm_label_en-US" xlink:label="lab_ccrn_BusinessCombinationContingentConsiderationTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Term</link:label>
    <link:label id="lab_ccrn_BusinessCombinationContingentConsiderationTerm_documentation_en-US" xlink:label="lab_ccrn_BusinessCombinationContingentConsiderationTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_BusinessCombinationContingentConsiderationTerm" xlink:href="ccrn-20220930.xsd#ccrn_BusinessCombinationContingentConsiderationTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_BusinessCombinationContingentConsiderationTerm" xlink:to="lab_ccrn_BusinessCombinationContingentConsiderationTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_4c500dfe-4576-41a7-b9a1-01448687539e_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_43381ca6-558f-4202-a5df-af1c54191af1_totalLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_88a4e260-4456-44d0-832a-50e8cb3bfdd4_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LinesOfCreditFairValueDisclosure_6ea8db71-d9ca-475c-a0a6-53c8406ac83a_terseLabel_en-US" xlink:label="lab_us-gaap_LinesOfCreditFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Asset-Based Loan</link:label>
    <link:label id="lab_us-gaap_LinesOfCreditFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LinesOfCreditFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lines of Credit, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LinesOfCreditFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LinesOfCreditFairValueDisclosure" xlink:to="lab_us-gaap_LinesOfCreditFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_LineOfCreditFacilityBasisSpreadOnVariableRateAdditionalCreditSpreadAssociatedWithSOFR_5e33376f-d000-454a-b2cd-58ce8b05f11b_terseLabel_en-US" xlink:label="lab_ccrn_LineOfCreditFacilityBasisSpreadOnVariableRateAdditionalCreditSpreadAssociatedWithSOFR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on variable rate, additional credit spread associated with SOFR</link:label>
    <link:label id="lab_ccrn_LineOfCreditFacilityBasisSpreadOnVariableRateAdditionalCreditSpreadAssociatedWithSOFR_label_en-US" xlink:label="lab_ccrn_LineOfCreditFacilityBasisSpreadOnVariableRateAdditionalCreditSpreadAssociatedWithSOFR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Basis Spread On Variable Rate, Additional Credit Spread Associated With SOFR</link:label>
    <link:label id="lab_ccrn_LineOfCreditFacilityBasisSpreadOnVariableRateAdditionalCreditSpreadAssociatedWithSOFR_documentation_en-US" xlink:label="lab_ccrn_LineOfCreditFacilityBasisSpreadOnVariableRateAdditionalCreditSpreadAssociatedWithSOFR" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Basis Spread On Variable Rate, Additional Credit Spread Associated With SOFR</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_LineOfCreditFacilityBasisSpreadOnVariableRateAdditionalCreditSpreadAssociatedWithSOFR" xlink:href="ccrn-20220930.xsd#ccrn_LineOfCreditFacilityBasisSpreadOnVariableRateAdditionalCreditSpreadAssociatedWithSOFR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_LineOfCreditFacilityBasisSpreadOnVariableRateAdditionalCreditSpreadAssociatedWithSOFR" xlink:to="lab_ccrn_LineOfCreditFacilityBasisSpreadOnVariableRateAdditionalCreditSpreadAssociatedWithSOFR" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessExitCosts1_5df63f63-70af-402b-8c1e-380fc1b2961c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessExitCosts1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Early termination benefit</link:label>
    <link:label id="lab_us-gaap_BusinessExitCosts1_label_en-US" xlink:label="lab_us-gaap_BusinessExitCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Exit Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessExitCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessExitCosts1" xlink:to="lab_us-gaap_BusinessExitCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_f8bb7137-9902-4a5e-81f3-208be4db8ba1_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedTradeNames_a3ced048-2c82-4a43-84f6-0dd2be0dcd04_verboseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedTradeNames" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade names, indefinite-lived</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedTradeNames_00538934-2ca8-4dee-b5ae-5e29c87f2313_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedTradeNames" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade names, indefinite-lived</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedTradeNames_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedTradeNames" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Trade Names</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedTradeNames" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedTradeNames"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedTradeNames" xlink:to="lab_us-gaap_IndefiniteLivedTradeNames" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_DeferredCompensationMember_dd83eac4-f947-4d68-aefd-6785d585ebee_terseLabel_en-US" xlink:label="lab_ccrn_DeferredCompensationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation</link:label>
    <link:label id="lab_ccrn_DeferredCompensationMember_label_en-US" xlink:label="lab_ccrn_DeferredCompensationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation [Member]</link:label>
    <link:label id="lab_ccrn_DeferredCompensationMember_documentation_en-US" xlink:label="lab_ccrn_DeferredCompensationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_DeferredCompensationMember" xlink:href="ccrn-20220930.xsd#ccrn_DeferredCompensationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_DeferredCompensationMember" xlink:to="lab_ccrn_DeferredCompensationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_72ca18f7-4237-4bd0-b9ca-0f688a0665de_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_f26e94f8-cf57-4b30-9072-3cfb58c34b2b_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_22191b86-96ae-4457-80b5-8e8564ffe150_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_5401dc40-5836-4a58-99d3-3e2f37709b3c_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note payable, fair value</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList_711700ce-861c-4627-90bc-73ec54ccc739_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Product and Service [Extensible List]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Product and Service [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_da0960cb-e35e-48a8-bf5d-abf42c30aebd_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_63058476-c355-46ff-a404-aad6f6c13369_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_0ac40c30-4683-4eb2-bc65-907cd46902dc_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized foreign currency translation loss, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_76755c1a-45a9-4142-a2c8-8b967daa872a_terseLabel_en-US" xlink:label="lab_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite Lived And Indefinite Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_documentation_en-US" xlink:label="lab_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:href="ccrn-20220930.xsd#ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:to="lab_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_11569186-71ad-4d55-9611-288198835003_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term accrued claims</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_92311ab3-8605-478b-a5d1-9bfb0af4f3f6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_SelectedIncMember_1996360d-4857-441c-a876-f904d1477469_terseLabel_en-US" xlink:label="lab_ccrn_SelectedIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selected, Inc</link:label>
    <link:label id="lab_ccrn_SelectedIncMember_label_en-US" xlink:label="lab_ccrn_SelectedIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selected, Inc [Member]</link:label>
    <link:label id="lab_ccrn_SelectedIncMember_documentation_en-US" xlink:label="lab_ccrn_SelectedIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selected, Inc</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_SelectedIncMember" xlink:href="ccrn-20220930.xsd#ccrn_SelectedIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_SelectedIncMember" xlink:to="lab_ccrn_SelectedIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_d2c415f5-2111-4d07-bcfc-f071cbc7dad8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest margin percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_30bb754a-0f64-42e6-89b5-7cbf1a13121c_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_545f18dc-11cf-4689-8601-faf44c9ad43b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_SwingLoansSublimitMember_befb65c8-3cb7-4532-b93f-e05ae7193363_terseLabel_en-US" xlink:label="lab_ccrn_SwingLoansSublimitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swingline Sublimit</link:label>
    <link:label id="lab_ccrn_SwingLoansSublimitMember_label_en-US" xlink:label="lab_ccrn_SwingLoansSublimitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swing Loans Sublimit [Member]</link:label>
    <link:label id="lab_ccrn_SwingLoansSublimitMember_documentation_en-US" xlink:label="lab_ccrn_SwingLoansSublimitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swing Loans Sublimit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_SwingLoansSublimitMember" xlink:href="ccrn-20220930.xsd#ccrn_SwingLoansSublimitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_SwingLoansSublimitMember" xlink:to="lab_ccrn_SwingLoansSublimitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_066500e5-03b0-4df2-b69d-7c9b0c6cfc27_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stated interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_73eb2152-faee-4f4a-8735-ed8dfd115838_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_SecuredOvernightFinancingRateSOFRMember_1e03f5fb-6189-46d2-9043-62c3182f8bb3_terseLabel_en-US" xlink:label="lab_ccrn_SecuredOvernightFinancingRateSOFRMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SOFR</link:label>
    <link:label id="lab_ccrn_SecuredOvernightFinancingRateSOFRMember_label_en-US" xlink:label="lab_ccrn_SecuredOvernightFinancingRateSOFRMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) [Member]</link:label>
    <link:label id="lab_ccrn_SecuredOvernightFinancingRateSOFRMember_documentation_en-US" xlink:label="lab_ccrn_SecuredOvernightFinancingRateSOFRMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_SecuredOvernightFinancingRateSOFRMember" xlink:href="ccrn-20220930.xsd#ccrn_SecuredOvernightFinancingRateSOFRMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_SecuredOvernightFinancingRateSOFRMember" xlink:to="lab_ccrn_SecuredOvernightFinancingRateSOFRMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_92728d72-bdb6-4f4d-b5ae-1bf5877f98b9_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition of WSG (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_1390a87d-26cb-4796-8623-9440723abd69_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-cash costs</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_5662263e-330b-4c88-babb-faf1944fb982_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to common stockholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_93786a91-1601-4cb8-88ea-3d3cc4ab4536_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_46903167-8e45-475e-85a7-c0aaab48aba4_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a2091119-4a5d-4b5d-8288-855ff1516969_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1964326e-7d76-4f84-8be4-95aac301676c_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares excluded from diluted weighted average shares (shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_b4b6bd3d-5888-4d5d-ab9c-b515b33e16f9_totalLabel_en-US" xlink:label="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets acquired</link:label>
    <link:label id="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_label_en-US" xlink:label="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired Including Goodwill</link:label>
    <link:label id="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_documentation_en-US" xlink:label="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired Including Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" xlink:href="ccrn-20220930.xsd#ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" xlink:to="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_e1ff0abe-808d-45be-8d96-f2dfdee3aebe_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Aggregate Scheduled Maturities of Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-Term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_24c38754-5f2c-453e-b92c-881417af58d3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_13fe1f9f-bd50-42dc-9396-27c0925030fd_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebtMember_34c0f659-41ca-453b-a503-ef95272e3f42_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan</link:label>
    <link:label id="lab_us-gaap_SecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtMember" xlink:to="lab_us-gaap_SecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_c41adb78-e02b-46f5-90ee-206a161f3b5e_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation asset</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_e07d1e05-de7f-4aee-8740-b4132c28e90f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LEASES</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_9349af68-93a7-4ad6-9483-433100153719_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_e883b14e-0a33-4c63-8816-579cc581984b_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_4a22d686-f860-4998-af75-8cbdb70b0393_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets subject to amortization:</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_WorkforceSolutionsGroupIncMember_f6afd9ef-da5e-4b5c-8d46-9dbe8c8dafb1_terseLabel_en-US" xlink:label="lab_ccrn_WorkforceSolutionsGroupIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workforce Solutions Group, Inc.</link:label>
    <link:label id="lab_ccrn_WorkforceSolutionsGroupIncMember_label_en-US" xlink:label="lab_ccrn_WorkforceSolutionsGroupIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workforce Solutions Group, Inc. [Member]</link:label>
    <link:label id="lab_ccrn_WorkforceSolutionsGroupIncMember_documentation_en-US" xlink:label="lab_ccrn_WorkforceSolutionsGroupIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workforce Solutions Group, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_WorkforceSolutionsGroupIncMember" xlink:href="ccrn-20220930.xsd#ccrn_WorkforceSolutionsGroupIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_WorkforceSolutionsGroupIncMember" xlink:to="lab_ccrn_WorkforceSolutionsGroupIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_bee9d1f4-a8e3-43f1-aca1-c2bb08af4dfa_terseLabel_en-US" xlink:label="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets</link:label>
    <link:label id="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_label_en-US" xlink:label="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right-Of-Use Assets</link:label>
    <link:label id="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_documentation_en-US" xlink:label="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right-Of-Use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" xlink:href="ccrn-20220930.xsd#ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" xlink:to="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_SegmentReportingUnallocatedCorporateExpenses_ab80d7a3-45db-4b8f-b8eb-b453f044118e_terseLabel_en-US" xlink:label="lab_ccrn_SegmentReportingUnallocatedCorporateExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate overhead</link:label>
    <link:label id="lab_ccrn_SegmentReportingUnallocatedCorporateExpenses_label_en-US" xlink:label="lab_ccrn_SegmentReportingUnallocatedCorporateExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Unallocated Corporate Expenses</link:label>
    <link:label id="lab_ccrn_SegmentReportingUnallocatedCorporateExpenses_documentation_en-US" xlink:label="lab_ccrn_SegmentReportingUnallocatedCorporateExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Unallocated Corporate Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_SegmentReportingUnallocatedCorporateExpenses" xlink:href="ccrn-20220930.xsd#ccrn_SegmentReportingUnallocatedCorporateExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_SegmentReportingUnallocatedCorporateExpenses" xlink:to="lab_ccrn_SegmentReportingUnallocatedCorporateExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_cbb0020b-b7b1-4f5c-a1c7-018e5dccd96f_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_f177be49-201e-4391-81bb-0000bf87235c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_b6e4b859-0a34-4a36-8a32-f826b7224fad_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_c379ae63-6679-4dd7-9ad9-111f4c2a1cf9_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_4d279a77-9af0-4dd2-9db5-352f2660d553_verboseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit, carrying amount</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_3bdb150b-06f4-475e-bc6e-eacc690163cf_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_826648b0-b414-4209-9932-a60ee1e27157_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_27e95aef-a77f-4336-9665-8cf1399e7b95_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_1e5caf83-3dd2-4bb6-a34f-95de697d05ab_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_71f1592b-8009-4d23-917d-0cba0fb2d2bc_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_ce2edbd0-218b-40fa-b6de-81f27835d126_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities - current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_74b47ea2-e5de-40a6-86aa-fda3e51d0523_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities - current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_80f69bd9-b7b1-40a1-862d-07dbf6a2cab7_negatedLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: operating lease liabilities - current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_78871dea-46bd-4127-91c2-a4510b503284_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_label_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_ebcb6aa4-332e-4ddb-86cb-f7ae776bc08a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Restricted Stock Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_2ea272b8-ea18-4af9-8b94-2d8ac121044d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_21bbd953-965b-4b61-8b45-9760ae100ba5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_d8902f65-e223-4f77-a092-afda876421e7_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_a4e20996-9a3e-49a9-a4b0-30afb5d3199c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard_f4ef09d0-1b4d-47d3-a4da-754b7737629f_terseLabel_en-US" xlink:label="lab_ccrn_OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contribution income:</link:label>
    <link:label id="lab_ccrn_OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard_label_en-US" xlink:label="lab_ccrn_OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income Loss Before D And A Acquisition And Integration Contingent Consideration Restructuring Legal Impairment And Corporate Overheard</link:label>
    <link:label id="lab_ccrn_OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard_documentation_en-US" xlink:label="lab_ccrn_OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income Loss Before D And A Acquisition And Integration Contingent Consideration Restructuring Legal Impairment And Corporate Overheard</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard" xlink:href="ccrn-20220930.xsd#ccrn_OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard" xlink:to="lab_ccrn_OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_db843d65-0b06-4af6-8bea-a2b56b633738_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_cd3ed9bd-261f-4529-8be2-164bf6d1839c_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_ffb82acc-070f-4b62-a9fb-c86b822d1c1f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ca40e278-c91d-4572-85c3-b36b2852f556_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_a30b6bd1-25ff-4182-a15e-c7eb326c0e9d_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill acquisition adjustment - Selected</link:label>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_267049da-728f-4588-93ea-040f429dec58_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_01a36fb8-6792-4427-804a-b0402730318b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_acf1378d-5a4c-4a74-a0b1-b42bf864b269_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_af1ab834-28e5-435f-85de-f7681ca7d6ec_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurements, Fair Value Hierarchy [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_081b3993-484e-4145-8433-607054641e42_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements and Changes in Accounting Principles [Abstract]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_fec54664-4851-4e16-bb2b-9be1b05b1f5c_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_39856aab-5b3e-440d-ab06-d258975f196c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bb660f60-9da4-48e2-afd5-6259bb1326db_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_abec0c5f-13fc-4a69-8a66-2a61c846e8fe_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_AssetsAndLiabilitiesLeasesTableTextBlock_66feb0f6-27d1-4c5f-8a3d-9123328f996d_terseLabel_en-US" xlink:label="lab_ccrn_AssetsAndLiabilitiesLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Supplemental Balance Sheet Information</link:label>
    <link:label id="lab_ccrn_AssetsAndLiabilitiesLeasesTableTextBlock_label_en-US" xlink:label="lab_ccrn_AssetsAndLiabilitiesLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Leases [Table Text Block]</link:label>
    <link:label id="lab_ccrn_AssetsAndLiabilitiesLeasesTableTextBlock_documentation_en-US" xlink:label="lab_ccrn_AssetsAndLiabilitiesLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Leases [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_AssetsAndLiabilitiesLeasesTableTextBlock" xlink:href="ccrn-20220930.xsd#ccrn_AssetsAndLiabilitiesLeasesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_AssetsAndLiabilitiesLeasesTableTextBlock" xlink:to="lab_ccrn_AssetsAndLiabilitiesLeasesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_609a4f78-c852-47eb-b491-fc5ab75b852a_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested restricted stock awards, beginning balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_d53fa6ea-ab3d-4c95-8a1c-761590634f0e_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested restricted stock awards, ending balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_c37a11c9-7cfe-4819-bed9-361eaf1b8789_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_b64f8c59-857e-480b-9543-e8ca5a303f04_verboseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Segments</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_f5841d28-b459-4917-be72-15967040939c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DEBT</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet_b957089c-c559-4a43-b152-cb43410ab819_terseLabel_en-US" xlink:label="lab_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested in period, net (in shares)</link:label>
    <link:label id="lab_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet_label_en-US" xlink:label="lab_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other than Options, Vested In Period, Net</link:label>
    <link:label id="lab_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet_documentation_en-US" xlink:label="lab_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other than Options, Vested In Period, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet" xlink:href="ccrn-20220930.xsd#ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet" xlink:to="lab_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_eb17156e-3cb0-42ff-b145-fa5a550771c3_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_eee60f08-4208-436c-8462-6e2c65405ef9_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_a69cebf2-d8bf-422d-a958-fbbb1f53d399_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax expense</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_e424c021-6f7a-44e4-b343-8b61e1d3b630_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_f307f286-4515-4794-af97-7fe4cda0282d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity consideration for acquisition (shares)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_c7752282-bd81-4339-a93f-391ca1092a8a_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_EarnoutNotesPayableMember_c66ef2a9-c71b-4ec7-8d2c-d018e38f581e_terseLabel_en-US" xlink:label="lab_ccrn_EarnoutNotesPayableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnout Notes Payable</link:label>
    <link:label id="lab_ccrn_EarnoutNotesPayableMember_label_en-US" xlink:label="lab_ccrn_EarnoutNotesPayableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnout Notes Payable [Member]</link:label>
    <link:label id="lab_ccrn_EarnoutNotesPayableMember_documentation_en-US" xlink:label="lab_ccrn_EarnoutNotesPayableMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnout Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_EarnoutNotesPayableMember" xlink:href="ccrn-20220930.xsd#ccrn_EarnoutNotesPayableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_EarnoutNotesPayableMember" xlink:to="lab_ccrn_EarnoutNotesPayableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_ed7ca021-66ac-41fb-a0fb-b7e819f25263_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExaminationTable_2c2f85d1-a3ed-4490-bbdc-89ed19e9495a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationTable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationTable" xlink:to="lab_us-gaap_IncomeTaxExaminationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_A2021TermLoanCreditAgreementIncrementalTermLoanMember_87709370-b817-4e55-b018-cf6b57c478ac_terseLabel_en-US" xlink:label="lab_ccrn_A2021TermLoanCreditAgreementIncrementalTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Term Loan Credit Agreement, Incremental Term Loan</link:label>
    <link:label id="lab_ccrn_A2021TermLoanCreditAgreementIncrementalTermLoanMember_label_en-US" xlink:label="lab_ccrn_A2021TermLoanCreditAgreementIncrementalTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Term Loan Credit Agreement, Incremental Term Loan [Member]</link:label>
    <link:label id="lab_ccrn_A2021TermLoanCreditAgreementIncrementalTermLoanMember_documentation_en-US" xlink:label="lab_ccrn_A2021TermLoanCreditAgreementIncrementalTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Term Loan Credit Agreement, Incremental Term Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_A2021TermLoanCreditAgreementIncrementalTermLoanMember" xlink:href="ccrn-20220930.xsd#ccrn_A2021TermLoanCreditAgreementIncrementalTermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_A2021TermLoanCreditAgreementIncrementalTermLoanMember" xlink:to="lab_ccrn_A2021TermLoanCreditAgreementIncrementalTermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_80780bbe-cc0e-4bce-9b92-6446e70e4ca0_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_d546caa6-c90c-45e4-9f1a-c01da9e669cb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write-Offs, net of Recoveries</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Writeoff</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_00a4b88b-2af7-450c-9521-6af0ba01797c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_e6cfac4f-a4f7-44f0-84b7-ae93bfe45205_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy_0a8a5552-c251-4985-9280-f696e437b486_terseLabel_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, net</link:label>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy_label_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_f81e7f02-515f-454f-9bfc-6af5a1c6e8b8_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_14e68f45-1a59-4630-8763-50e91e830001_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Stock Awards</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_8fa38550-2ac6-415c-8cdb-7130e4c45491_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InsuranceSettlementsReceivableCurrent_07a70e65-ac26-45a2-a2a1-a38593268d4e_terseLabel_en-US" xlink:label="lab_us-gaap_InsuranceSettlementsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance recovery receivable</link:label>
    <link:label id="lab_us-gaap_InsuranceSettlementsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_InsuranceSettlementsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Settlements Receivable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceSettlementsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceSettlementsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InsuranceSettlementsReceivableCurrent" xlink:to="lab_us-gaap_InsuranceSettlementsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_37537d63-557d-45ee-b81f-4a776774e773_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_9445de36-a417-4da2-be1f-8dc9162a2661_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_d6f23abc-804d-440e-9c29-687c16e487fb_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_fc408e0d-09e3-426b-9f52-6199a81aca17_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash (used in) provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_271a9442-35c2-40a7-871e-821c1b9d856a_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_3080fa56-cc0b-45a4-805b-a0081a1f7272_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, authorized amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_c7280bb6-71e0-4236-9c5b-73cc7add9633_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation and benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_f378d8cd-6688-4ec9-801a-daca3ff0492d_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Asset-Based Loan</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b3e6dafd-798f-4f8f-967e-fca6a4e2f666_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_e749977a-47f5-4a9f-8388-b183fc51c0b2_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_ShareBasedPaymentAwardsMember_69314f63-e89d-47c5-8d8a-ddb2ba7c4b1c_terseLabel_en-US" xlink:label="lab_ccrn_ShareBasedPaymentAwardsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Awards</link:label>
    <link:label id="lab_ccrn_ShareBasedPaymentAwardsMember_label_en-US" xlink:label="lab_ccrn_ShareBasedPaymentAwardsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Awards [Member]</link:label>
    <link:label id="lab_ccrn_ShareBasedPaymentAwardsMember_documentation_en-US" xlink:label="lab_ccrn_ShareBasedPaymentAwardsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Awards [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_ShareBasedPaymentAwardsMember" xlink:href="ccrn-20220930.xsd#ccrn_ShareBasedPaymentAwardsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_ShareBasedPaymentAwardsMember" xlink:to="lab_ccrn_ShareBasedPaymentAwardsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_13002053-cbed-4248-930e-e930db26d25b_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_2f3515d3-5f6a-4662-9caa-e72700476296_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_c4ab41aa-0e46-4bc0-9d85-6f806692d3d1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable_3900d10d-7a2d-4b45-906a-5013e7b2ab0e_terseLabel_en-US" xlink:label="lab_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Indefinite Lived And Finite Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Indefinite Lived And Finite Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable_documentation_en-US" xlink:label="lab_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Indefinite Lived And Finite Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable" xlink:href="ccrn-20220930.xsd#ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable" xlink:to="lab_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_2ef44cba-4c09-4758-8b53-2d0682b3f0dc_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EARNINGS PER SHARE</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillGross_1334b322-8730-4ecc-bf81-ee78ec876363_periodStartLabel_en-US" xlink:label="lab_us-gaap_GoodwillGross" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate goodwill acquired, beginning balance</link:label>
    <link:label id="lab_us-gaap_GoodwillGross_583e4332-f1e6-4271-adee-81be9d6f70cc_periodEndLabel_en-US" xlink:label="lab_us-gaap_GoodwillGross" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate goodwill acquired, ending balance</link:label>
    <link:label id="lab_us-gaap_GoodwillGross_label_en-US" xlink:label="lab_us-gaap_GoodwillGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillGross" xlink:to="lab_us-gaap_GoodwillGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_0d3c6ae8-448f-410b-b56d-ec8b6e0d7472_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of business</link:label>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_937e461c-a4bc-4b5a-a68b-00f099f26a89_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dissolution of noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_28b9e06f-3a23-4cde-9f98-f0c940ba1749_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1949cbc4-2188-49cd-9ab3-f28c8a5d5566_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_e8bfde36-a038-482a-92b9-0c159ffd76fc_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:to="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_9d269e5f-8631-47b3-b42d-1f86e93531f6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on early extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_a2f7ead8-1efa-4769-961e-4ed908aba0a9_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash consideration, gross</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_0eec6825-d1b8-4ccf-b3dd-fa921edaa170_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Carrying Amounts and Estimated Fair Values of Significant Financial Instrument that were not Measured at Fair Value</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_LineOfCreditSublimitAxis_f1df883d-baa2-4db2-9c3d-7fdaffbe6ef2_terseLabel_en-US" xlink:label="lab_ccrn_LineOfCreditSublimitAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Sublimit [Axis]</link:label>
    <link:label id="lab_ccrn_LineOfCreditSublimitAxis_label_en-US" xlink:label="lab_ccrn_LineOfCreditSublimitAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Sublimit [Axis]</link:label>
    <link:label id="lab_ccrn_LineOfCreditSublimitAxis_documentation_en-US" xlink:label="lab_ccrn_LineOfCreditSublimitAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Sublimit [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_LineOfCreditSublimitAxis" xlink:href="ccrn-20220930.xsd#ccrn_LineOfCreditSublimitAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_LineOfCreditSublimitAxis" xlink:to="lab_ccrn_LineOfCreditSublimitAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_02890a3f-bcd0-4141-8c3b-3339609da631_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_93e53b83-2f50-4f0f-8070-58df17b24384_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUBSEQUENT EVENTS</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DirectOperatingCosts_82c50175-1286-4d41-8b86-0614e0a1433d_terseLabel_en-US" xlink:label="lab_us-gaap_DirectOperatingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Direct operating expenses</link:label>
    <link:label id="lab_us-gaap_DirectOperatingCosts_label_en-US" xlink:label="lab_us-gaap_DirectOperatingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Direct Operating Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectOperatingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DirectOperatingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DirectOperatingCosts" xlink:to="lab_us-gaap_DirectOperatingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_0badf355-16f4-4c9d-a60b-00b5b326edbd_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator:</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SoftwareDevelopmentMember_470ceea2-5255-409d-8197-418115669e36_terseLabel_en-US" xlink:label="lab_us-gaap_SoftwareDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software</link:label>
    <link:label id="lab_us-gaap_SoftwareDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_SoftwareDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SoftwareDevelopmentMember" xlink:to="lab_us-gaap_SoftwareDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_5ee40425-73d1-48e6-8f52-f7246f210f02_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward" xlink:to="lab_us-gaap_RestructuringReserveRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_21bd0251-a511-407e-8f48-811aa01494e3_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_7b23e33b-a4f6-4526-8ecd-5a57cbb7d98e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_224f36ef-5683-4081-9f8d-acf2959c83b0_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_465d6be4-5733-416e-8a50-2856d1fe2538_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f27256c3-336e-4966-add4-f2dba3bafc76_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9dcd68a4-1a58-4d5b-80ca-b35288b8ff4c_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_6a79cba3-cdbd-464e-bd4d-892d6ed4828d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation liability</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Obligations, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_c3d0ca25-d0e2-4e52-a90c-a2ca2c0df8a9_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Business</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_710b9998-08d3-453f-a0b0-3820a8bc1487_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_PhysicianStaffingMember_add4fd7f-9ad4-40e8-879e-e5a2a515f115_terseLabel_en-US" xlink:label="lab_ccrn_PhysicianStaffingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Physician Staffing</link:label>
    <link:label id="lab_ccrn_PhysicianStaffingMember_bd19953a-28dd-4e3c-bba0-59b40187f838_verboseLabel_en-US" xlink:label="lab_ccrn_PhysicianStaffingMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Physician Staffing</link:label>
    <link:label id="lab_ccrn_PhysicianStaffingMember_668700f0-9006-4a86-8092-eaa9e87182a4_netLabel_en-US" xlink:label="lab_ccrn_PhysicianStaffingMember" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Physician Staffing</link:label>
    <link:label id="lab_ccrn_PhysicianStaffingMember_label_en-US" xlink:label="lab_ccrn_PhysicianStaffingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Physician Staffing [Member]</link:label>
    <link:label id="lab_ccrn_PhysicianStaffingMember_documentation_en-US" xlink:label="lab_ccrn_PhysicianStaffingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Physician staffing [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_PhysicianStaffingMember" xlink:href="ccrn-20220930.xsd#ccrn_PhysicianStaffingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_PhysicianStaffingMember" xlink:to="lab_ccrn_PhysicianStaffingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_448e87bf-2c66-47eb-9218-8adfbf3f9f19_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_0062fbba-9a40-40c4-be8b-22773375be47_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_f433e934-ef7f-47e0-8899-a6a193ad317d_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt_051efca0-9f47-46dc-919b-e9fae90bfb11_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from term loan</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Secured Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExaminationLineItems_0afe3252-41f8-43ba-a54c-ea6bdeec7fd4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems" xlink:to="lab_us-gaap_IncomeTaxExaminationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_0c4471ea-aaba-4f52-bce2-2894b453eab5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_fa8e658f-a246-4a5a-ac8f-b643cea0fabb_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_4e28f1c4-c6a8-4b1d-85f1-c576ff6f4690_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FAIR VALUE MEASUREMENTS</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_6f9d180d-8bd4-416d-91ce-736fb348ff8b_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_235eb834-5223-4ab0-91ca-2822725070a2_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_992af4da-6c28-4c86-9233-8d09cc13a0fc_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average market price (in usd per share)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_label_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Acquired, Average Cost Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:to="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationNoncurrent_601b15ec-72fe-4eda-b0f9-9750a8f56871_terseLabel_en-US" xlink:label="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liability - non-current</link:label>
    <link:label id="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationNoncurrent_label_en-US" xlink:label="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation, Noncurrent</link:label>
    <link:label id="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationNoncurrent_documentation_en-US" xlink:label="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationNoncurrent" xlink:href="ccrn-20220930.xsd#ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationNoncurrent" xlink:to="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_4f9e04d2-19f6-498e-8ef3-c6f892d503f1_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_0bb3a27f-dc85-4b97-8bc5-e2cfb1b0fbc9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly installment amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Principal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:to="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_99c0b5cd-1347-4c9c-8925-9d0cf4ad4aae_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_20ba277a-23d7-4e76-beb1-38483c1a6ad1_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_98584bb1-7b40-4e46-9f1a-e43b4adc73bf_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_90cd67c7-4c0d-441d-8864-1e5055c922d0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_5a37c1ca-f426-420c-ab87-0df692c65b99_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_c3fafa50-6a93-4185-b5e9-a8dae83625c8_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_e805eb78-bac4-416e-b7c3-ad685f387dc0_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACQUISITIONS</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_375bf7e4-a54a-47b5-8162-c7fcf7d5f09b_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIBOR</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_a567d855-a482-4cad-8495-c87c596c12b1_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOptionQuantitativeDisclosuresTable_405f011c-d9c1-42dd-94ad-f3007c1f1211_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOptionQuantitativeDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Option, Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueOptionQuantitativeDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_FairValueOptionQuantitativeDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Option, Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOptionQuantitativeDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable" xlink:to="lab_us-gaap_FairValueOptionQuantitativeDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_042b0b9b-50db-4c25-82ad-22cdff42b5c1_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_e64cf503-b297-4716-b3c5-ec56f6f94909_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_c71a2dae-8f32-43c3-921b-51eadc5ecca9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromRelatedParties_3d5179d5-44f2-4293-87bd-f55d5b63d5c2_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromRelatedParties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from related parties</link:label>
    <link:label id="lab_us-gaap_RevenueFromRelatedParties_label_en-US" xlink:label="lab_us-gaap_RevenueFromRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromRelatedParties" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromRelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromRelatedParties" xlink:to="lab_us-gaap_RevenueFromRelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_a744605c-290f-4db0-9068-3365021f3449_verboseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepayment premium paid</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Debt Extinguishment or Debt Prepayment Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:to="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_6133e787-6db2-44e9-a944-6e1f0f510e90_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_94d40434-4760-41c4-bc32-f84512965ba6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Carrying Amount of Goodwill by Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_28fb64c3-5e4a-4eeb-80b3-dd5ae5f8f04d_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per share attributable to common stockholders - Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax_20a404fb-15c1-4d87-a23d-452ba73f4f34_negatedTerseLabel_en-US" xlink:label="lab_ccrn_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on currency fluctuations</link:label>
    <link:label id="lab_ccrn_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax_label_en-US" xlink:label="lab_ccrn_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Before Tax</link:label>
    <link:label id="lab_ccrn_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax_documentation_en-US" xlink:label="lab_ccrn_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax" xlink:href="ccrn-20220930.xsd#ccrn_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax" xlink:to="lab_ccrn_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_22fb813d-7367-47c2-a4d9-03a4a2681031_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_d1e7b895-99d3-4a51-ba72-db7edb0fcfa7_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_VariableAndOtherLeaseCost_0e52e799-3288-422c-8afe-d335c7b12004_terseLabel_en-US" xlink:label="lab_ccrn_VariableAndOtherLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable and other lease costs</link:label>
    <link:label id="lab_ccrn_VariableAndOtherLeaseCost_label_en-US" xlink:label="lab_ccrn_VariableAndOtherLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable And Other Lease, Cost</link:label>
    <link:label id="lab_ccrn_VariableAndOtherLeaseCost_documentation_en-US" xlink:label="lab_ccrn_VariableAndOtherLeaseCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable And Other Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_VariableAndOtherLeaseCost" xlink:href="ccrn-20220930.xsd#ccrn_VariableAndOtherLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_VariableAndOtherLeaseCost" xlink:to="lab_ccrn_VariableAndOtherLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_18683176-95c8-4e33-9119-cd890a7a36fd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_3f4be54f-12bd-4819-aae3-7e6e86a0090c_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_29d200b0-d83f-43f8-88ee-231db0b221ac_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseCurrent" xlink:to="lab_us-gaap_PrepaidExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_DirectorMember_211665e8-293c-43c0-9b61-2cf2d255829f_terseLabel_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Member of the Board of Directors</link:label>
    <link:label id="lab_srt_DirectorMember_label_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Director [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_DirectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_DirectorMember" xlink:to="lab_srt_DirectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_TemporaryStaffingServicesMember_c5fec96c-1ddd-462e-bd61-59c93ac6516f_terseLabel_en-US" xlink:label="lab_ccrn_TemporaryStaffingServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Staffing Services</link:label>
    <link:label id="lab_ccrn_TemporaryStaffingServicesMember_label_en-US" xlink:label="lab_ccrn_TemporaryStaffingServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Staffing Services [Member]</link:label>
    <link:label id="lab_ccrn_TemporaryStaffingServicesMember_documentation_en-US" xlink:label="lab_ccrn_TemporaryStaffingServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Staffing Services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_TemporaryStaffingServicesMember" xlink:href="ccrn-20220930.xsd#ccrn_TemporaryStaffingServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_TemporaryStaffingServicesMember" xlink:to="lab_ccrn_TemporaryStaffingServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_0bb93e58-b856-476f-8efa-5be5a3ab2953_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_36e3e156-8577-47da-b7dc-93f7575dff50_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems_53c5069f-d714-4f62-b764-3f9f9ffd0a74_terseLabel_en-US" xlink:label="lab_ccrn_EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective tax rate, excluding discrete items</link:label>
    <link:label id="lab_ccrn_EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems_label_en-US" xlink:label="lab_ccrn_EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate, Continuing Operations, Excluding Discrete Items</link:label>
    <link:label id="lab_ccrn_EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems_documentation_en-US" xlink:label="lab_ccrn_EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate, Continuing Operations, Excluding Discrete Items</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems" xlink:href="ccrn-20220930.xsd#ccrn_EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems" xlink:to="lab_ccrn_EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_ff3b7e96-9479-4a02-9baf-cd774a8bb44d_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_87878b83-bbb0-44e0-b3c8-89a14f807cf4_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_07b0e48e-5805-48cf-8708-ce069a2601ed_terseLabel_en-US" xlink:label="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity and Share-Based Payments [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6c58930b-2cf5-4d0b-9905-964300df6bf6_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_ad26cddc-b679-4a01-a811-c2b5ab0d6227_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_c29a056a-cd33-4c40-a92c-417f69cf83b1_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_ec5f0c38-1882-4117-a702-704d11749241_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Accumulated Deficit) Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_70350031-b081-4f3e-8f9b-df5357068bd1_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_86f30199-ba5c-4aa0-ad37-238f9a66ec2e_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting of restricted stock</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_854c980e-0df1-49f1-b8b7-fa8b26ef0747_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Lease Costs</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_78dcb2ad-1025-4ca3-aab9-a65f082fa641_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase and retirement</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_cae4970a-d27d-4a98-b6af-b8d0ac873fd5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnout liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_dba4c8c2-de89-4aee-85de-f7522849ce88_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnout liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_820f8234-3b38-4ae3-83a3-c35bac3309c3_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_d144525d-fd02-4495-a62a-82e43d7f6261_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_c8d7f67a-1dde-4834-a528-76d12416cef3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective interest rate percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_c67fd27f-dc84-44a6-b117-f92eaf0ad223_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition of WSG</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_PaymentForDebtPrepayment_c3fe9988-cf2d-4d25-83eb-3c81be6c8a13_terseLabel_en-US" xlink:label="lab_ccrn_PaymentForDebtPrepayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for debt prepayment</link:label>
    <link:label id="lab_ccrn_PaymentForDebtPrepayment_label_en-US" xlink:label="lab_ccrn_PaymentForDebtPrepayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment For Debt Prepayment</link:label>
    <link:label id="lab_ccrn_PaymentForDebtPrepayment_documentation_en-US" xlink:label="lab_ccrn_PaymentForDebtPrepayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment For Debt Prepayment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_PaymentForDebtPrepayment" xlink:href="ccrn-20220930.xsd#ccrn_PaymentForDebtPrepayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_PaymentForDebtPrepayment" xlink:to="lab_ccrn_PaymentForDebtPrepayment" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_0ed6d1f8-e2a8-4973-88c1-5bf0a6e3a956_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_56cc7c91-c6af-4c59-8ac6-178d00eb8cd9_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_IncreaseDecreaseInOperatingLeaseLiabilities_b2f33e18-5a56-4a93-9217-c873cd23be04_terseLabel_en-US" xlink:label="lab_ccrn_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_ccrn_IncreaseDecreaseInOperatingLeaseLiabilities_label_en-US" xlink:label="lab_ccrn_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Operating Lease Liabilities</link:label>
    <link:label id="lab_ccrn_IncreaseDecreaseInOperatingLeaseLiabilities_documentation_en-US" xlink:label="lab_ccrn_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Operating Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:href="ccrn-20220930.xsd#ccrn_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:to="lab_ccrn_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_4c5fee4f-da01-4029-ad84-ff2790d092c1_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities - non-current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_bcfa96a5-25e0-411a-90cf-af97b26feba1_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities - non-current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_d5cc980e-f577-4f5c-a0b7-2ca7fac0d25d_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_64e26611-95e9-4afb-96e3-b5311ef25cba_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of contingent consideration</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_86a197dd-4a82-4ff5-a9e4-3d5f2b0e665b_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of contingent consideration</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Contingent Consideration Liability, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:to="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InsuranceSettlementsReceivableNoncurrent_ebe3ba38-c9e6-46c4-a4f6-2b41c6dca9d8_terseLabel_en-US" xlink:label="lab_us-gaap_InsuranceSettlementsReceivableNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current insurance recovery receivable</link:label>
    <link:label id="lab_us-gaap_InsuranceSettlementsReceivableNoncurrent_label_en-US" xlink:label="lab_us-gaap_InsuranceSettlementsReceivableNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Settlements Receivable, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceSettlementsReceivableNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceSettlementsReceivableNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InsuranceSettlementsReceivableNoncurrent" xlink:to="lab_us-gaap_InsuranceSettlementsReceivableNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_fa74a13c-e235-4351-870b-ec2ff40c3f6c_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings (accumulated deficit)</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_19ae8327-c99a-401a-a2b3-151173f4e971_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net of allowances of $12,763 in 2022 and $6,881 in 2021</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_03174117-43dd-4245-93bd-3dcdc81e3004_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_a0bd8cc1-a4c6-4064-84f5-206dcb500dfa_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RELATED PARTY TRANSACTIONS</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_e390d7e7-45c7-44ec-b2ef-d7d9a53e1e6c_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8959504b-ddaf-44d1-9074-fa6ea0a1720c_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_ddc44d07-08dd-4e54-b3bf-e617d67fc74c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_371f72ef-e59b-4b7f-ace4-35b0bc0952de_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_8cf1d951-59b8-44a1-9f46-3920a6dc72c3_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested restricted stock awards, beginning balance (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7c0486e5-fd06-4144-bd34-5e8ac6a3fdf9_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested restricted stock awards, ending balance (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_10cdf8b4-53af-43f7-bebd-2c8fcc6e0cd1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of earnout liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_795d8fff-66b2-45e3-97f7-1f0bb72692d0_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of earnout liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_6b45429e-f8b7-44f2-855e-89ac5bce44bb_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_de15f6c0-03fe-43b3-bd84-b5b73516db8a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_578d39e8-1123-464a-a45e-7680804a451c_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_7b81efdf-83f2-4e0c-911d-dc674c7654e0_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_ffa18b65-b4af-4279-b48f-3762f53c56db_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RECENT ACCOUNTING PRONOUNCEMENTS</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_8864ec43-86c1-442f-b5e9-468e8b7bbba4_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_c870f655-3965-4456-93a3-3669939e7251_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_418005f7-75cb-4eb6-a1de-169fb875bfa4_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss, net</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_bd22b06c-e9cc-48a2-8bbc-fa75eb3a6820_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMPREHENSIVE INCOME</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_5d6d202a-79dc-4b38-b8f2-234a94728d7c_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_372dd01b-6d40-4e74-8736-d205da53e492_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_2d278505-869e-4dd7-b81a-c975c820d551_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_cfad9ce8-990b-45fb-8ba8-496cfd4b0e14_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_827923c0-ec14-406c-b797-7c1994b2d743_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_5e2f5821-9ba2-4b4e-add4-8b15619f4119_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Accounting Pronouncement</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_a9649845-ed3e-4901-95f7-0b2a1ad9e1c5_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of diluted shares:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted, Adjustment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_d5175e96-e445-4117-a00e-3c079a8bec86_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_LineOfCreditFacilityBorrowingBaseAvailability_4d556e86-2e4e-4885-8210-e2fa676d6683_terseLabel_en-US" xlink:label="lab_ccrn_LineOfCreditFacilityBorrowingBaseAvailability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowing base availability</link:label>
    <link:label id="lab_ccrn_LineOfCreditFacilityBorrowingBaseAvailability_label_en-US" xlink:label="lab_ccrn_LineOfCreditFacilityBorrowingBaseAvailability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Borrowing Base Availability</link:label>
    <link:label id="lab_ccrn_LineOfCreditFacilityBorrowingBaseAvailability_documentation_en-US" xlink:label="lab_ccrn_LineOfCreditFacilityBorrowingBaseAvailability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Borrowing Base Availability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_LineOfCreditFacilityBorrowingBaseAvailability" xlink:href="ccrn-20220930.xsd#ccrn_LineOfCreditFacilityBorrowingBaseAvailability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_LineOfCreditFacilityBorrowingBaseAvailability" xlink:to="lab_ccrn_LineOfCreditFacilityBorrowingBaseAvailability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_15eef83f-9ea3-4ede-b0cc-f045e523b6c1_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrestricted shares of common stock outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_LineOfCreditSublimitDomain_20c25c45-e1f2-4ede-8f57-ae22b6ac5aaa_terseLabel_en-US" xlink:label="lab_ccrn_LineOfCreditSublimitDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Sublimit [Domain]</link:label>
    <link:label id="lab_ccrn_LineOfCreditSublimitDomain_label_en-US" xlink:label="lab_ccrn_LineOfCreditSublimitDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Sublimit [Domain]</link:label>
    <link:label id="lab_ccrn_LineOfCreditSublimitDomain_documentation_en-US" xlink:label="lab_ccrn_LineOfCreditSublimitDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Line Of Credit Sublimit [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_LineOfCreditSublimitDomain" xlink:href="ccrn-20220930.xsd#ccrn_LineOfCreditSublimitDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_LineOfCreditSublimitDomain" xlink:to="lab_ccrn_LineOfCreditSublimitDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_e7225c7d-0154-4842-864c-e63552436279_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_LongTermDebtMaturityAfterYearFour_b3f155e4-06f3-43cd-8d41-2b8fb74423c1_terseLabel_en-US" xlink:label="lab_ccrn_LongTermDebtMaturityAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_ccrn_LongTermDebtMaturityAfterYearFour_label_en-US" xlink:label="lab_ccrn_LongTermDebtMaturityAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, After Year Four</link:label>
    <link:label id="lab_ccrn_LongTermDebtMaturityAfterYearFour_documentation_en-US" xlink:label="lab_ccrn_LongTermDebtMaturityAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, After Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_LongTermDebtMaturityAfterYearFour" xlink:href="ccrn-20220930.xsd#ccrn_LongTermDebtMaturityAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_LongTermDebtMaturityAfterYearFour" xlink:to="lab_ccrn_LongTermDebtMaturityAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_c77f01db-0030-4b4f-8b14-9ee52b62d9c2_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_3d51f0d7-95ab-48a4-b18f-b2ed46058334_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_9ad832d0-209a-4b2f-80d0-9a0cd7180f52_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, net of impairment loss, beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_8a692283-9076-443e-ab37-1adf50119707_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, net of impairment loss, ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_987d2a5f-4933-43cf-b0b4-b5c3d210e867_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by (used in) operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_74e19099-8e58-47e4-9415-1f89344d43d2_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_60a47a23-782f-4c74-84e0-74b8a6fb2933_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_OperatingLeaseExpenseNonCash_7fa6c993-9ab7-443f-b61b-d0bb0ed7ffcb_terseLabel_en-US" xlink:label="lab_ccrn_OperatingLeaseExpenseNonCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash lease expense</link:label>
    <link:label id="lab_ccrn_OperatingLeaseExpenseNonCash_label_en-US" xlink:label="lab_ccrn_OperatingLeaseExpenseNonCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Expense, Non-Cash</link:label>
    <link:label id="lab_ccrn_OperatingLeaseExpenseNonCash_documentation_en-US" xlink:label="lab_ccrn_OperatingLeaseExpenseNonCash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Expense, Non-Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_OperatingLeaseExpenseNonCash" xlink:href="ccrn-20220930.xsd#ccrn_OperatingLeaseExpenseNonCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_OperatingLeaseExpenseNonCash" xlink:to="lab_ccrn_OperatingLeaseExpenseNonCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_7ff11288-b8b2-4319-b320-34f17683379f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_ba3cd903-addc-4f5c-9d74-305e2e565e82_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_RestrictedStockAndPerformanceSharesMember_b85101fd-6b9d-42c4-9319-eeb959c0b751_terseLabel_en-US" xlink:label="lab_ccrn_RestrictedStockAndPerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock And Performance Shares</link:label>
    <link:label id="lab_ccrn_RestrictedStockAndPerformanceSharesMember_label_en-US" xlink:label="lab_ccrn_RestrictedStockAndPerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock And Performance Shares [Member]</link:label>
    <link:label id="lab_ccrn_RestrictedStockAndPerformanceSharesMember_documentation_en-US" xlink:label="lab_ccrn_RestrictedStockAndPerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock And Performance Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_RestrictedStockAndPerformanceSharesMember" xlink:href="ccrn-20220930.xsd#ccrn_RestrictedStockAndPerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_RestrictedStockAndPerformanceSharesMember" xlink:to="lab_ccrn_RestrictedStockAndPerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_f43e2c43-4edd-48b7-9f62-f458ebbaac25_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_6787b467-c048-4b80-882f-78ca1cf08210_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_bf50947b-2980-40e2-a864-ad5e84c66e59_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityExpirationPeriod_3bd94381-fc91-45e6-a27c-72222868013b_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit term</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityExpirationPeriod" xlink:to="lab_us-gaap_LineOfCreditFacilityExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d7d23e9c-8a72-409e-abe6-a8f2388c2d58_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_77dfb106-e987-451e-855a-39394a8ec985_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares - Diluted (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_eaa1f4cb-252b-43b1-85e6-bf13caa9c4fa_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_DebtInstrumentVariableInterestRateFloor_6b456d1f-4cec-46e1-adfb-de274a6d59dc_terseLabel_en-US" xlink:label="lab_ccrn_DebtInstrumentVariableInterestRateFloor" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest margin floor percentage</link:label>
    <link:label id="lab_ccrn_DebtInstrumentVariableInterestRateFloor_label_en-US" xlink:label="lab_ccrn_DebtInstrumentVariableInterestRateFloor" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Variable Interest Rate Floor</link:label>
    <link:label id="lab_ccrn_DebtInstrumentVariableInterestRateFloor_documentation_en-US" xlink:label="lab_ccrn_DebtInstrumentVariableInterestRateFloor" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Variable Interest Rate Floor</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_DebtInstrumentVariableInterestRateFloor" xlink:href="ccrn-20220930.xsd#ccrn_DebtInstrumentVariableInterestRateFloor"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_DebtInstrumentVariableInterestRateFloor" xlink:to="lab_ccrn_DebtInstrumentVariableInterestRateFloor" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_FairValueMeasurementTable_da13bdcd-8eb6-4e21-81ff-21e083dc583b_terseLabel_en-US" xlink:label="lab_ccrn_FairValueMeasurementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Table]</link:label>
    <link:label id="lab_ccrn_FairValueMeasurementTable_label_en-US" xlink:label="lab_ccrn_FairValueMeasurementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Table]</link:label>
    <link:label id="lab_ccrn_FairValueMeasurementTable_documentation_en-US" xlink:label="lab_ccrn_FairValueMeasurementTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_FairValueMeasurementTable" xlink:href="ccrn-20220930.xsd#ccrn_FairValueMeasurementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_FairValueMeasurementTable" xlink:to="lab_ccrn_FairValueMeasurementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_7abc90ef-e8a2-4e6c-8a35-23db98530b01_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_372f0ac9-f400-46db-8f4d-d43befb81dac_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BaseRateMember_86c5723a-4662-4400-a373-a08a419ee461_terseLabel_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate</link:label>
    <link:label id="lab_us-gaap_BaseRateMember_label_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BaseRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BaseRateMember" xlink:to="lab_us-gaap_BaseRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_ccaff6a8-2654-4ef4-8a7b-dfb69f8e5a22_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_d7f8a7a3-2311-4cbb-ade9-cc70926e03eb_terseLabel_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Amount</link:label>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:to="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_eb11e944-0988-4979-955e-8c58aad34d67_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAttainmentPercentage_71a3d804-203b-46ba-bf66-7a69ed4ea937_terseLabel_en-US" xlink:label="lab_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAttainmentPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance attainment percentage</link:label>
    <link:label id="lab_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAttainmentPercentage_label_en-US" xlink:label="lab_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAttainmentPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Performance Attainment Percentage</link:label>
    <link:label id="lab_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAttainmentPercentage_documentation_en-US" xlink:label="lab_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAttainmentPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Performance Target Attainment Level, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAttainmentPercentage" xlink:href="ccrn-20220930.xsd#ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAttainmentPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAttainmentPercentage" xlink:to="lab_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAttainmentPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_5421f92a-9e2a-46b3-9d37-ad2c242be514_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_ProvisionForDoubtfulAccountsAndOtherAllowances_a7b3ccdf-829f-4055-a51c-74885dac9ebf_verboseLabel_en-US" xlink:label="lab_ccrn_ProvisionForDoubtfulAccountsAndOtherAllowances" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for allowances</link:label>
    <link:label id="lab_ccrn_ProvisionForDoubtfulAccountsAndOtherAllowances_label_en-US" xlink:label="lab_ccrn_ProvisionForDoubtfulAccountsAndOtherAllowances" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision For Doubtful Accounts And Other Allowances</link:label>
    <link:label id="lab_ccrn_ProvisionForDoubtfulAccountsAndOtherAllowances_documentation_en-US" xlink:label="lab_ccrn_ProvisionForDoubtfulAccountsAndOtherAllowances" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision For Doubtful Accounts And Other Allowances</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_ProvisionForDoubtfulAccountsAndOtherAllowances" xlink:href="ccrn-20220930.xsd#ccrn_ProvisionForDoubtfulAccountsAndOtherAllowances"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_ProvisionForDoubtfulAccountsAndOtherAllowances" xlink:to="lab_ccrn_ProvisionForDoubtfulAccountsAndOtherAllowances" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_7fe3e81a-52bf-4b99-9210-776ce761c836_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_48632a7c-dc9e-4347-9c08-859fb9a8f27b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_9f063eda-02c1-40a1-9587-93561b92b9e4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Estimated Fair Values of Financial Assets and Liabilities Measured on a Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_ff6f0e0c-23cb-40c4-9311-3d30de7d3843_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term lease expense</link:label>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_label_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermLeaseCost" xlink:to="lab_us-gaap_ShortTermLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f8b72a1f-2d15-49fb-ba16-405e6efa13c0_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_dc3d4487-7b03-469f-a372-92454bf7cec1_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_5cd55c22-4201-493c-af3d-0c175f46ab8e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment, net of taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_90ee2ffb-59b5-46f9-8ba2-f6c57f2554c2_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_249d874c-84ae-40df-be72-877d601da008_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated impairment loss, beginning balance</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_23b23110-39fd-42f7-8afd-50b6b332c75d_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated impairment loss, ending balance</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impaired, Accumulated Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_774d2e68-d74e-47a1-b412-4f10fc0ea0d6_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_902b6b74-6175-4b87-be63-633b35041747_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to common stockholders - Basic and Diluted - Basic</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_9a7f3ef9-0ee3-49fc-833f-7c65b71bf2dc_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f49f4964-dbbf-463f-a128-4c91f5940804_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_199f1792-14a6-4db0-bf75-a3760ea9d6c5_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_e044c130-2c26-45ab-acf4-497fe5f015a3_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_d64936f6-59a0-460a-a92d-a76449318180_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_ea90c3d2-ad22-4531-beb6-a27eef7537e5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLongTermLinesOfCredit_8db854f3-4006-456a-954a-ddae4755b312_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings under Senior Secured Asset-Based revolving credit facility</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLongTermLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Long-Term Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_c3ce6225-85c3-4576-8c69-f19a18af3cae_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_SeniorSecuredAssetBasedLoanMember_bdfe3069-26e5-4a2b-b881-1886baa7f93a_terseLabel_en-US" xlink:label="lab_ccrn_SeniorSecuredAssetBasedLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Asset-Based Loan</link:label>
    <link:label id="lab_ccrn_SeniorSecuredAssetBasedLoanMember_label_en-US" xlink:label="lab_ccrn_SeniorSecuredAssetBasedLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Asset-Based Loan [Member]</link:label>
    <link:label id="lab_ccrn_SeniorSecuredAssetBasedLoanMember_documentation_en-US" xlink:label="lab_ccrn_SeniorSecuredAssetBasedLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Asset-Based Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_SeniorSecuredAssetBasedLoanMember" xlink:href="ccrn-20220930.xsd#ccrn_SeniorSecuredAssetBasedLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_SeniorSecuredAssetBasedLoanMember" xlink:to="lab_ccrn_SeniorSecuredAssetBasedLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_24d7f239-0faf-4cf9-ad13-36c8920937de_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities assumed</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_68a8fee9-7102-4e18-90bd-f9d1265536e9_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0f55a182-4fd1-4f08-b7e2-6b4ec54de89f_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_f0ab7778-a676-4023-a852-21232ed88aa7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_73215a76-bd2a-446f-ba63-b99f94017039_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtByMaturityAbstract_66e841e9-2ac6-441c-804c-043857df6497_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtByMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Fiscal Year Maturity [Abstract]</link:label>
    <link:label id="lab_us-gaap_LongTermDebtByMaturityAbstract_label_en-US" xlink:label="lab_us-gaap_LongTermDebtByMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtByMaturityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtByMaturityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract" xlink:to="lab_us-gaap_LongTermDebtByMaturityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_30464110-d974-4ce9-8fca-9fc804d7a768_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring" xlink:to="lab_us-gaap_PaymentsForRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_SalesAllowanceBillingRelatedAdjustments_c36146ee-0c19-4d6a-93a2-f9d31c51db9a_terseLabel_en-US" xlink:label="lab_ccrn_SalesAllowanceBillingRelatedAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales allowance, billing-related adjustments</link:label>
    <link:label id="lab_ccrn_SalesAllowanceBillingRelatedAdjustments_label_en-US" xlink:label="lab_ccrn_SalesAllowanceBillingRelatedAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Allowance, Billing-Related Adjustments</link:label>
    <link:label id="lab_ccrn_SalesAllowanceBillingRelatedAdjustments_documentation_en-US" xlink:label="lab_ccrn_SalesAllowanceBillingRelatedAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Allowance, Billing-Related Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_SalesAllowanceBillingRelatedAdjustments" xlink:href="ccrn-20220930.xsd#ccrn_SalesAllowanceBillingRelatedAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_SalesAllowanceBillingRelatedAdjustments" xlink:to="lab_ccrn_SalesAllowanceBillingRelatedAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_8e270057-39ef-4e52-babe-70601afd3707_verboseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_2b92e39b-a6f2-43b3-9501-037c045d1d3b_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_abe8ed9b-6b82-4af5-b9b2-e98c671ab3aa_netLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_9c8970cd-b3b7-4b3d-a079-118fa1f503d3_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_PriorRepurchaseProgramAndNewRepurchaseProgramMember_38085986-1115-43c7-8666-28c904e8f94f_terseLabel_en-US" xlink:label="lab_ccrn_PriorRepurchaseProgramAndNewRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior Repurchase Program And New Repurchase Program</link:label>
    <link:label id="lab_ccrn_PriorRepurchaseProgramAndNewRepurchaseProgramMember_label_en-US" xlink:label="lab_ccrn_PriorRepurchaseProgramAndNewRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior Repurchase Program And New Repurchase Program [Member]</link:label>
    <link:label id="lab_ccrn_PriorRepurchaseProgramAndNewRepurchaseProgramMember_documentation_en-US" xlink:label="lab_ccrn_PriorRepurchaseProgramAndNewRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior Repurchase Program And New Repurchase Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_PriorRepurchaseProgramAndNewRepurchaseProgramMember" xlink:href="ccrn-20220930.xsd#ccrn_PriorRepurchaseProgramAndNewRepurchaseProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_PriorRepurchaseProgramAndNewRepurchaseProgramMember" xlink:to="lab_ccrn_PriorRepurchaseProgramAndNewRepurchaseProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_bcb2d90f-166b-4fe6-a5d9-21e50ba634eb_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly commitment fee on the average daily unused portion percentage</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Unused Capacity, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_04f24675-f2fb-461c-8b6d-95a2b0fb8020_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal payments on note payable</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfNotesPayable" xlink:to="lab_us-gaap_RepaymentsOfNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_b78d5279-5740-4aaf-bcf4-3216c96608a5_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Termination</link:label>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_label_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeSeveranceMember" xlink:to="lab_us-gaap_EmployeeSeveranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseImpairmentLoss_602fd5af-7d13-4ba8-97f5-3db08c3d1692_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, impairment loss</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseImpairmentLoss" xlink:to="lab_us-gaap_OperatingLeaseImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_d614e9e5-8542-4907-9b79-e9a1ef1996d4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Fair Value of Assets Acquired and Liabilities Assumed</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_8051364d-57fb-495d-82de-8ce70fdd3629_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_6b66e14c-87d9-44a9-a805-bdfa5b40db6d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_1eb60064-466b-432d-8a64-8125823a8158_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_e1de1419-64e3-4280-be4f-ff8930197c63_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnout liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Contingent Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_e4fdcb94-73b4-43f4-8061-bd5711499697_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e12d9284-8324-4411-aa33-e6fa925b291f_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_17d4a7cd-335b-42fd-94dd-6ddeff85842b_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net of accumulated depreciation of $19,846 in 2022 and $17,729 in 2021</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_56b8cd4d-0883-417d-9533-5c0669d52a77_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for amounts included in the measurement of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_623dfeca-ca27-4630-89af-23381133a787_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Estimated Annual Amortization Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_2664e967-5ea9-4b11-9d44-c031e32f32a4_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayableOtherPayablesMember_efade081-970e-46a5-8630-82c676bd78d0_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note Payable</link:label>
    <link:label id="lab_us-gaap_NotesPayableOtherPayablesMember_label_en-US" xlink:label="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Other Payables [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableOtherPayablesMember" xlink:to="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DatabasesMember_1cdc454e-a5ee-40cd-b4d5-b0b6e0120471_terseLabel_en-US" xlink:label="lab_us-gaap_DatabasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Databases</link:label>
    <link:label id="lab_us-gaap_DatabasesMember_label_en-US" xlink:label="lab_us-gaap_DatabasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Database Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DatabasesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DatabasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DatabasesMember" xlink:to="lab_us-gaap_DatabasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_b7155656-5645-4525-81fe-c52041e1646b_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, allowance for credit losses</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_3338e58d-dcbf-4617-acca-a47afbe22bfc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_120d9d72-dd8e-4a76-893a-ce1d92c31dd0_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_57e25691-e2d9-4898-a35c-9510472994e3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current earnout liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c7288ab4-f014-4a67-90df-17e3d4158cab_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_ThresholdPeriodPastDueForPaymentOfServicesProvided_1485579b-f70e-441d-8ce1-98fe312c9b4a_terseLabel_en-US" xlink:label="lab_ccrn_ThresholdPeriodPastDueForPaymentOfServicesProvided" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold period, past due for payment of services provided</link:label>
    <link:label id="lab_ccrn_ThresholdPeriodPastDueForPaymentOfServicesProvided_label_en-US" xlink:label="lab_ccrn_ThresholdPeriodPastDueForPaymentOfServicesProvided" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold Period, Past Due For Payment Of Services Provided</link:label>
    <link:label id="lab_ccrn_ThresholdPeriodPastDueForPaymentOfServicesProvided_documentation_en-US" xlink:label="lab_ccrn_ThresholdPeriodPastDueForPaymentOfServicesProvided" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold Period, Past Due For Payment Of Services Provided</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_ThresholdPeriodPastDueForPaymentOfServicesProvided" xlink:href="ccrn-20220930.xsd#ccrn_ThresholdPeriodPastDueForPaymentOfServicesProvided"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_ThresholdPeriodPastDueForPaymentOfServicesProvided" xlink:to="lab_ccrn_ThresholdPeriodPastDueForPaymentOfServicesProvided" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_6bfeecf5-834a-47ba-88e3-19e5f86470fd_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f25b05a3-fc3f-4049-a6de-dda67a7de045_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e66539a0-7d1f-4575-bba2-bc355511e972_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_cd11e7f2-d969-4e20-bff0-166af31530ec_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase and retirement</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_dfd61901-6cf7-4df9-9262-3b6be7029796_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase and retirement</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_eb035ad0-db2b-48ad-a41c-68636f9b6769_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_7ba2352f-645a-46e7-be3d-4d1bd5d2a252_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_1f548b0f-1bea-47c0-9b73-ed53dce8becd_terseLabel_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax payable</link:label>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_label_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxesPayableCurrent" xlink:to="lab_us-gaap_TaxesPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_929542d1-f8b3-4d31-a75a-22606975bc16_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_02c3f0ae-4aeb-43bd-ab97-f484e17aaf27_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_163d49a7-a3c0-4804-9256-05b38e55b9ba_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_a08587fa-9535-46e8-887f-3160813f1cea_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_72a411e2-2c1b-49df-86e6-66558ecf30e7_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_efc42112-5615-4b1e-a5a4-e48dc6213e4d_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_71d74585-e2dd-491f-8234-614b338fc710_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_9ab6e792-d448-4f6d-9a27-7568e1c02c7a_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_9c3a5bf7-e342-4f04-958a-1bb4c3070292_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_8e986104-29b7-43d2-8ea3-b6bc1feec0c7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution to noncontrolling shareholder</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_758a9ba4-f677-4a1d-884a-bbbf4f36bb99_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_RisksAndUncertaintiesPolicyTextBlock_68b385f9-4c51-4228-b478-943d136c49ed_terseLabel_en-US" xlink:label="lab_ccrn_RisksAndUncertaintiesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risks and Uncertainties</link:label>
    <link:label id="lab_ccrn_RisksAndUncertaintiesPolicyTextBlock_label_en-US" xlink:label="lab_ccrn_RisksAndUncertaintiesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risks And Uncertainties [Policy Text Block]</link:label>
    <link:label id="lab_ccrn_RisksAndUncertaintiesPolicyTextBlock_documentation_en-US" xlink:label="lab_ccrn_RisksAndUncertaintiesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risks And Uncertainties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_RisksAndUncertaintiesPolicyTextBlock" xlink:href="ccrn-20220930.xsd#ccrn_RisksAndUncertaintiesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_RisksAndUncertaintiesPolicyTextBlock" xlink:to="lab_ccrn_RisksAndUncertaintiesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_02db7b0c-0c3b-4f98-b2e0-fc01a77bc935_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchased and retired (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_5f698d75-1387-4c15-9e36-dd0767787916_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchased and retired (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLongTermDebtNoncurrent_e153a4b8-47e9-42ea-87c8-5a2c67febd50_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, less current portion</link:label>
    <link:label id="lab_us-gaap_OtherLongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-Term Debt, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLongTermDebtNoncurrent" xlink:to="lab_us-gaap_OtherLongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_23f90df7-db6b-4b33-9d84-cdfa2b332d7c_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_e35c8175-7b3b-4c9d-99c8-9e2f47ebde6e_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_5c91c0c0-681a-4f8c-964f-76fa3c8bee23_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ORGANIZATION AND BASIS OF PRESENTATION</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_0c145648-ebba-4d22-8753-bd1024c1772a_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_76afd999-943b-4691-9f3f-69f198d1dcea_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_d6202d9e-510c-4d0a-bf6c-623145442b2f_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting of restricted stock (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_3efaa569-8528-41fd-bc59-2fbdb61b7f56_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_b4b5d8ac-c3ad-43f5-b6dc-2c7573a0ba16_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of future minimum lease payments</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_2506adbc-ea08-4253-ac21-0f9d6c914bac_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEGMENT DATA</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_9ccb9f99-cf71-46a3-9d14-bda917c2b2b4_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_46cf3137-1b3a-4816-a6d7-dac10ab35723_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_48f85ac6-e3ff-403f-a71e-bc908447a5f4_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_02578130-e178-4487-83b9-d88acf1e2483_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_badc25ba-2c25-4200-9a38-43dfc8f92afc_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_PaymentsForRestructuringAndAdjustments_b2e5aa7a-518c-4b5a-b09f-8454545d3bc2_negatedTerseLabel_en-US" xlink:label="lab_ccrn_PaymentsForRestructuringAndAdjustments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments and adjustments</link:label>
    <link:label id="lab_ccrn_PaymentsForRestructuringAndAdjustments_label_en-US" xlink:label="lab_ccrn_PaymentsForRestructuringAndAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For Restructuring And Adjustments</link:label>
    <link:label id="lab_ccrn_PaymentsForRestructuringAndAdjustments_documentation_en-US" xlink:label="lab_ccrn_PaymentsForRestructuringAndAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For Restructuring And Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_PaymentsForRestructuringAndAdjustments" xlink:href="ccrn-20220930.xsd#ccrn_PaymentsForRestructuringAndAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_PaymentsForRestructuringAndAdjustments" xlink:to="lab_ccrn_PaymentsForRestructuringAndAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f1cbfce5-0650-4262-9592-a05be42edc7a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_cb56b279-7a30-40b4-9b18-e39ea38cf0e5_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_b3ed03da-f159-469c-a94a-715ab06081d2_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments_63a19ff7-f889-428c-bc60-cd1e4fb5a490_terseLabel_en-US" xlink:label="lab_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of vesting installments</link:label>
    <link:label id="lab_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments_label_en-US" xlink:label="lab_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number Of Vesting Installments</link:label>
    <link:label id="lab_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments_documentation_en-US" xlink:label="lab_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number Of Vesting Installments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments" xlink:href="ccrn-20220930.xsd#ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments" xlink:to="lab_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_a88fb9c5-1598-498e-a5d3-31f10efd263f_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring costs</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_bdf61431-390b-48a9-b687-f84ebe060431_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charged to restructuring</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_21b8f2fb-4c0d-4a2d-ab96-07d7ca89c339_netLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring costs</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_eb58fc25-8fd0-47c5-92a9-bc4bbaaf3273_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_4370ecae-afc7-4cc9-861c-efcac5772e35_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_b343e2f4-cde9-406a-bca7-8aca8268a79f_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_ac8d2f6f-f3fc-45cb-b801-95127468d4f5_terseLabel_en-US" xlink:label="lab_ccrn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_ccrn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_label_en-US" xlink:label="lab_ccrn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite Lived Intangible Asset, Expected Amortization, After Year Four</link:label>
    <link:label id="lab_ccrn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_documentation_en-US" xlink:label="lab_ccrn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite Lived Intangible Asset, Expected Amortization, After Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:href="ccrn-20220930.xsd#ccrn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:to="lab_ccrn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost_fd67482e-c9a7-4312-9307-2b31fc1f55cf_terseLabel_en-US" xlink:label="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write off of debt issuance costs</link:label>
    <link:label id="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost_label_en-US" xlink:label="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write off of Deferred Debt Issuance Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:to="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_5c0b6428-e87b-4020-b6bb-947f98fe4152_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f1c51b07-db68-4015-9483-477178d4a0e0_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_fc44e781-32eb-43ed-99a2-63e0fd82d212_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares - Basic (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_NurseAndAlliedStaffingMember_5d2b5d91-67aa-44da-9a69-5449f4af758e_verboseLabel_en-US" xlink:label="lab_ccrn_NurseAndAlliedStaffingMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nurse And Allied Staffing</link:label>
    <link:label id="lab_ccrn_NurseAndAlliedStaffingMember_d36ae474-4d10-4173-85b3-6dd76b447b34_terseLabel_en-US" xlink:label="lab_ccrn_NurseAndAlliedStaffingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nurse And Allied Staffing</link:label>
    <link:label id="lab_ccrn_NurseAndAlliedStaffingMember_be4151f2-b0e6-4e6d-8894-36c8664d2ea8_netLabel_en-US" xlink:label="lab_ccrn_NurseAndAlliedStaffingMember" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nurse and Allied Staffing</link:label>
    <link:label id="lab_ccrn_NurseAndAlliedStaffingMember_label_en-US" xlink:label="lab_ccrn_NurseAndAlliedStaffingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nurse And Allied Staffing [Member]</link:label>
    <link:label id="lab_ccrn_NurseAndAlliedStaffingMember_documentation_en-US" xlink:label="lab_ccrn_NurseAndAlliedStaffingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nurse and allied staffing [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_NurseAndAlliedStaffingMember" xlink:href="ccrn-20220930.xsd#ccrn_NurseAndAlliedStaffingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_NurseAndAlliedStaffingMember" xlink:to="lab_ccrn_NurseAndAlliedStaffingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_a4064261-4686-4117-8f3c-5425fcd32b31_verboseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_e538178f-56d3-4b19-a444-1a7278f6fa0f_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_41dba763-b65b-4114-9cb2-03f65001001e_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_ee66ed79-cd01-4cae-85bd-b7293aa65969_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets not subject to amortization:</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets (Excluding Goodwill) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_11a3d582-8c50-4e2c-b900-f9590c41fd18_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average useful life</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_f1d5884a-8f0a-4965-81d8-b30c137a9a7a_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of credit outstanding</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_bfa927ee-4ce3-4321-993b-e40fb1417e29_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Awards</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_FairValueMeasurementLineItems_a13365d7-146d-4a4c-8a8f-0056f98cbb38_terseLabel_en-US" xlink:label="lab_ccrn_FairValueMeasurementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Line Items]</link:label>
    <link:label id="lab_ccrn_FairValueMeasurementLineItems_label_en-US" xlink:label="lab_ccrn_FairValueMeasurementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Line Items]</link:label>
    <link:label id="lab_ccrn_FairValueMeasurementLineItems_documentation_en-US" xlink:label="lab_ccrn_FairValueMeasurementLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_FairValueMeasurementLineItems" xlink:href="ccrn-20220930.xsd#ccrn_FairValueMeasurementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_FairValueMeasurementLineItems" xlink:to="lab_ccrn_FairValueMeasurementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_66129acd-7a91-48d4-8572-ba60a0022b1e_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from services</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2ffc613e-9e37-43ec-a0a7-b38606401b8e_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from services:</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_aa46a531-e938-46b7-a696-50402c4bc18e_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_49916646-ddba-48fd-b7ea-6785888e3653_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity consideration for acquisition, value</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Equity Interests Issued and Issuable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_e5e3cde6-4725-471f-a891-ebaa0b9ab86e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares reserved for share-based payments (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_c054180a-d587-4987-b6a1-6307ec68e33d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_6c15d21a-5403-4bb1-922d-a26e690788dc_periodStartLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_da1e8cf2-902c-421b-9764-3270370661e7_periodEndLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_d773461a-4ddd-4491-bb34-df284d2e0ade_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">REVENUE RECOGNITION</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_904ae24c-594f-4d45-b833-0b570902684d_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_StandbyLettersOfCreditSublimitMember_3ade42e8-97be-4629-9018-370dede5e6d0_terseLabel_en-US" xlink:label="lab_ccrn_StandbyLettersOfCreditSublimitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standby Letters Of Credit Sublimit</link:label>
    <link:label id="lab_ccrn_StandbyLettersOfCreditSublimitMember_label_en-US" xlink:label="lab_ccrn_StandbyLettersOfCreditSublimitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standby Letters Of Credit Sublimit [Member]</link:label>
    <link:label id="lab_ccrn_StandbyLettersOfCreditSublimitMember_documentation_en-US" xlink:label="lab_ccrn_StandbyLettersOfCreditSublimitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standby Letters Of Credit Sublimit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_StandbyLettersOfCreditSublimitMember" xlink:href="ccrn-20220930.xsd#ccrn_StandbyLettersOfCreditSublimitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_StandbyLettersOfCreditSublimitMember" xlink:to="lab_ccrn_StandbyLettersOfCreditSublimitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_bce4f197-0b65-488b-aabc-a0a36ac00c48_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest in Subsidiary</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_e245951b-2769-41de-9152-c284b43ce764_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for shares withheld for taxes</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_dd8c30e2-870f-40d2-9307-3f7617c5dea5_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_05c8cd53-552a-46cb-bed7-9c684b347846_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt term</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b8323c43-5e0f-4f52-9105-419b76f839f0_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_ade19273-b8cf-4d22-9020-180a3103f687_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_d3913eb5-5c19-4cdf-981b-bcb35dcf7e53_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit_9ed758ad-8695-4bc1-ad56-7f64c2bd4096_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments on Senior Secured Asset-Based revolving credit facility</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-Term Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:to="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_63f7a203-64ea-4a3b-9513-c6f5f959f140_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common shares amount left remaining to repurchase under the plan (up to)</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_LineOfCreditAmountOfIndebtednessPermittedBySeniorSecuredAssetBasedLoanToBeBorrowedFromOtherSources_009c13b2-d666-44c5-834f-624ca54e4f76_terseLabel_en-US" xlink:label="lab_ccrn_LineOfCreditAmountOfIndebtednessPermittedBySeniorSecuredAssetBasedLoanToBeBorrowedFromOtherSources" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of indebtedness permitted from other sources</link:label>
    <link:label id="lab_ccrn_LineOfCreditAmountOfIndebtednessPermittedBySeniorSecuredAssetBasedLoanToBeBorrowedFromOtherSources_label_en-US" xlink:label="lab_ccrn_LineOfCreditAmountOfIndebtednessPermittedBySeniorSecuredAssetBasedLoanToBeBorrowedFromOtherSources" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit, Amount Of Indebtedness Permitted By Senior Secured Asset Based Loan To Be Borrowed From Other Sources</link:label>
    <link:label id="lab_ccrn_LineOfCreditAmountOfIndebtednessPermittedBySeniorSecuredAssetBasedLoanToBeBorrowedFromOtherSources_documentation_en-US" xlink:label="lab_ccrn_LineOfCreditAmountOfIndebtednessPermittedBySeniorSecuredAssetBasedLoanToBeBorrowedFromOtherSources" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit, Amount Of Indebtedness Permitted By Senior Secured Asset Based Loan To Be Borrowed From Other Sources</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_LineOfCreditAmountOfIndebtednessPermittedBySeniorSecuredAssetBasedLoanToBeBorrowedFromOtherSources" xlink:href="ccrn-20220930.xsd#ccrn_LineOfCreditAmountOfIndebtednessPermittedBySeniorSecuredAssetBasedLoanToBeBorrowedFromOtherSources"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_LineOfCreditAmountOfIndebtednessPermittedBySeniorSecuredAssetBasedLoanToBeBorrowedFromOtherSources" xlink:to="lab_ccrn_LineOfCreditAmountOfIndebtednessPermittedBySeniorSecuredAssetBasedLoanToBeBorrowedFromOtherSources" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_28c933d9-c1ca-4290-87bb-7d6ac3dea5aa_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based awards (shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2982c98e-d445-4553-a987-8e3688f67525_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_ExitCostsMember_4f579883-f76f-4896-b5f4-0d1c5e1b76f2_terseLabel_en-US" xlink:label="lab_ccrn_ExitCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease-Related</link:label>
    <link:label id="lab_ccrn_ExitCostsMember_label_en-US" xlink:label="lab_ccrn_ExitCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exit Costs [Member]</link:label>
    <link:label id="lab_ccrn_ExitCostsMember_documentation_en-US" xlink:label="lab_ccrn_ExitCostsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exit Costs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_ExitCostsMember" xlink:href="ccrn-20220930.xsd#ccrn_ExitCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_ExitCostsMember" xlink:to="lab_ccrn_ExitCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_08784c6d-a19e-436e-8372-160a99fc3ea0_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_44cf959a-c714-4f73-99e1-796b84390d60_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_0b3a1fe3-8f4a-4efd-adfb-d941b43324b2_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Information on Operating Segments and Reconciliation to Income from Operations</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_45a69043-68c2-4025-ad91-52bb4b233588_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationCurrent_bddd81c2-d201-40ec-8b5d-27e59f7e5f9d_terseLabel_en-US" xlink:label="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liability - current</link:label>
    <link:label id="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationCurrent_label_en-US" xlink:label="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation, Current</link:label>
    <link:label id="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationCurrent_documentation_en-US" xlink:label="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationCurrent" xlink:href="ccrn-20220930.xsd#ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationCurrent" xlink:to="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_16bb0eee-821f-4e53-a3cd-949eb5d06187_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: amount of lease payments representing interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_5b85a5fb-9b9f-4d44-bb51-22900a60b252_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to common stockholders - Basic and Diluted - Diluted</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_4ef1121f-12e7-4dd9-adbd-ccde6cce4c7b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_OtherServicesMember_3cf9f41a-e5d1-4002-8e89-b066f875d985_terseLabel_en-US" xlink:label="lab_ccrn_OtherServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Services</link:label>
    <link:label id="lab_ccrn_OtherServicesMember_label_en-US" xlink:label="lab_ccrn_OtherServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Services [Member]</link:label>
    <link:label id="lab_ccrn_OtherServicesMember_documentation_en-US" xlink:label="lab_ccrn_OtherServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_OtherServicesMember" xlink:href="ccrn-20220930.xsd#ccrn_OtherServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_OtherServicesMember" xlink:to="lab_ccrn_OtherServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_6eb327ab-5111-4fd8-b53e-525d481c4c34_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per share attributable to common stockholders - Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensationAndBenefits_adad16e0-06b1-473f-98ca-acd9832f1f40_terseLabel_en-US" xlink:label="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensationAndBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation and benefits</link:label>
    <link:label id="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensationAndBenefits_label_en-US" xlink:label="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensationAndBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Accrued Compensation And Benefits</link:label>
    <link:label id="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensationAndBenefits_documentation_en-US" xlink:label="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensationAndBenefits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Accrued Compensation And Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensationAndBenefits" xlink:href="ccrn-20220930.xsd#ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensationAndBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensationAndBenefits" xlink:to="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensationAndBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_eec4929b-6dc8-45a4-90ff-c339bfb14b20_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_63202a7c-ae2e-406c-b783-b024656693d8_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_5cb1343f-3f8c-4650-8ce3-a15e21d9cd14_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_976aa86b-f0be-4cb4-8e49-0971168291a4_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_4c9fd203-92ed-4f54-abd8-765ee445dc1f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_9d2855db-1834-47f4-9544-7ea12c229308_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_d8a15ae5-c770-4ae4-a363-bc0acf8822cb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_29cc210a-158c-4bf0-9450-5a2d37541b23_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Allowance for Doubtful Accounts</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:to="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_5db2c945-f6b3-4184-bc78-85e41fda4829_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expenses (income):</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_OmnibusPlanMember_6281aa35-832d-430a-b29b-f95f38ef6651_terseLabel_en-US" xlink:label="lab_ccrn_OmnibusPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Omnibus Plan</link:label>
    <link:label id="lab_ccrn_OmnibusPlanMember_label_en-US" xlink:label="lab_ccrn_OmnibusPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Omnibus Plan [Member]</link:label>
    <link:label id="lab_ccrn_OmnibusPlanMember_documentation_en-US" xlink:label="lab_ccrn_OmnibusPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Omnibus Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_OmnibusPlanMember" xlink:href="ccrn-20220930.xsd#ccrn_OmnibusPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_OmnibusPlanMember" xlink:to="lab_ccrn_OmnibusPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_4c169e92-0ffd-4bd3-a9d3-301d3b7d5d74_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating Lease Maturity</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_a9e8bd4c-b9c6-4a44-a88f-ec81553cc720_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_0210eaf0-a30c-40c6-b243-0eeb8de39f1a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_264d09e6-b462-4685-90f4-e6ad13ff12dc_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_5f8773a1-266a-47c7-8128-8c457c869ed6_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment_47fe2841-bb59-43fc-8872-fbea88cf80eb_terseLabel_en-US" xlink:label="lab_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net working capital adjustment</link:label>
    <link:label id="lab_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment_label_en-US" xlink:label="lab_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Net Working Capital Adjustment</link:label>
    <link:label id="lab_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment_documentation_en-US" xlink:label="lab_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Net Working Capital Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment" xlink:href="ccrn-20220930.xsd#ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment" xlink:to="lab_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnbilledContractsReceivable_0dfe82df-cdc3-4d03-aab1-4e2aafdbd6db_terseLabel_en-US" xlink:label="lab_us-gaap_UnbilledContractsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled contracts receivable</link:label>
    <link:label id="lab_us-gaap_UnbilledContractsReceivable_label_en-US" xlink:label="lab_us-gaap_UnbilledContractsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled Contracts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnbilledContractsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnbilledContractsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnbilledContractsReceivable" xlink:to="lab_us-gaap_UnbilledContractsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_acbd2b69-932c-49cc-a2c7-57627f04547e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_6436c2da-ae78-471f-9d23-fcfa357fd0d0_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowing availability</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_644ad765-30f8-4ac0-8f64-50ff4734bb8c_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_9730cbe3-9436-4c18-b32a-6bc6a5545652_terseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade names</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_a7a1a312-565f-42c1-a4c3-5f4b63d6f94a_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_AcquisitionAndIntegrationRelatedCosts_1108e850-b41d-465b-85b6-87574958f0ef_terseLabel_en-US" xlink:label="lab_ccrn_AcquisitionAndIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition and integration-related costs</link:label>
    <link:label id="lab_ccrn_AcquisitionAndIntegrationRelatedCosts_da7a3606-2d2c-4f60-b37d-2406834d494a_verboseLabel_en-US" xlink:label="lab_ccrn_AcquisitionAndIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition and integration-related costs</link:label>
    <link:label id="lab_ccrn_AcquisitionAndIntegrationRelatedCosts_label_en-US" xlink:label="lab_ccrn_AcquisitionAndIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition And Integration-Related Costs</link:label>
    <link:label id="lab_ccrn_AcquisitionAndIntegrationRelatedCosts_documentation_en-US" xlink:label="lab_ccrn_AcquisitionAndIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition and integration-related costs include costs for prior acquisitions, costs incurred for potential transactions, and accretion and valuation adjustments on contingent consideration liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_AcquisitionAndIntegrationRelatedCosts" xlink:href="ccrn-20220930.xsd#ccrn_AcquisitionAndIntegrationRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_AcquisitionAndIntegrationRelatedCosts" xlink:to="lab_ccrn_AcquisitionAndIntegrationRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_aed02c64-1c65-4f8d-9741-a304b3b3e713_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_49d1bb9a-3872-4f36-96b6-23c1503cb156_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_LineOfCreditBorrowingBasePercentageOfAssets_204f87eb-fd5b-46f3-a6b9-1d73923e2802_terseLabel_en-US" xlink:label="lab_ccrn_LineOfCreditBorrowingBasePercentageOfAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowing base, percentage of assets</link:label>
    <link:label id="lab_ccrn_LineOfCreditBorrowingBasePercentageOfAssets_label_en-US" xlink:label="lab_ccrn_LineOfCreditBorrowingBasePercentageOfAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit, Borrowing Base, Percentage Of Assets</link:label>
    <link:label id="lab_ccrn_LineOfCreditBorrowingBasePercentageOfAssets_documentation_en-US" xlink:label="lab_ccrn_LineOfCreditBorrowingBasePercentageOfAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit, Borrowing Base, Percentage Of Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_LineOfCreditBorrowingBasePercentageOfAssets" xlink:href="ccrn-20220930.xsd#ccrn_LineOfCreditBorrowingBasePercentageOfAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_LineOfCreditBorrowingBasePercentageOfAssets" xlink:to="lab_ccrn_LineOfCreditBorrowingBasePercentageOfAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_09d467c6-bc1b-457e-88ef-e5aeb3403394_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_978ca8f3-2981-4ac2-8fdc-34061b3677e3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_83ae3eb9-5440-4d1c-95ca-973767963d50_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_6faed285-f2e9-49ad-8acb-4bd4570c633a_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Costs</link:label>
    <link:label id="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs Associated with Exit or Disposal Activities or Restructurings, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:to="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_dd0c98aa-c181-4a01-b55b-6e3f8f65d38c_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_683f2084-4806-4da7-83da-d9bbb737528d_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_5219755a-51a0-40e2-af2b-db66a4bad2a3_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_4fae7e32-6548-404e-ae69-bd2488f17b10_terseLabel_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-compete agreements</link:label>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_label_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncompete Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncompeteAgreementsMember" xlink:to="lab_us-gaap_NoncompeteAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_HealthCareSystemAffiliatedWithABoardMemberMember_7b6390ab-4c89-4eaa-9ca0-fe10e9ba035a_terseLabel_en-US" xlink:label="lab_ccrn_HealthCareSystemAffiliatedWithABoardMemberMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care System Affiliated with a Board Member</link:label>
    <link:label id="lab_ccrn_HealthCareSystemAffiliatedWithABoardMemberMember_label_en-US" xlink:label="lab_ccrn_HealthCareSystemAffiliatedWithABoardMemberMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care System Affiliated With A Board Member [Member]</link:label>
    <link:label id="lab_ccrn_HealthCareSystemAffiliatedWithABoardMemberMember_documentation_en-US" xlink:label="lab_ccrn_HealthCareSystemAffiliatedWithABoardMemberMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care System Affiliated With A Board Member</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_HealthCareSystemAffiliatedWithABoardMemberMember" xlink:href="ccrn-20220930.xsd#ccrn_HealthCareSystemAffiliatedWithABoardMemberMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_HealthCareSystemAffiliatedWithABoardMemberMember" xlink:to="lab_ccrn_HealthCareSystemAffiliatedWithABoardMemberMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_adc222c5-b238-428d-9b0b-46856f527189_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_432013ec-f801-4212-a9ad-590a6de9a508_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_ee9f7132-6f73-4403-998c-fbddd579a5d3_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_9c1e3dbb-fb2d-4064-82c9-24aa7cb47665_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfSecuredDebt_c79bdc48-af0f-4af1-9022-74155e921f97_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfSecuredDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal payments on term loan</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfSecuredDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfSecuredDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Secured Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfSecuredDebt" xlink:to="lab_us-gaap_RepaymentsOfSecuredDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c918a827-d3f9-4955-bc83-48cad382d337_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7c2aebd9-fb1f-470c-adf3-2d25b523cbba_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_NewRepurchaseProgramMember_a5177613-c32a-4548-b42d-da7d2fa09832_terseLabel_en-US" xlink:label="lab_ccrn_NewRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Repurchase Program</link:label>
    <link:label id="lab_ccrn_NewRepurchaseProgramMember_label_en-US" xlink:label="lab_ccrn_NewRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Repurchase Program [Member]</link:label>
    <link:label id="lab_ccrn_NewRepurchaseProgramMember_documentation_en-US" xlink:label="lab_ccrn_NewRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Repurchase Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_NewRepurchaseProgramMember" xlink:href="ccrn-20220930.xsd#ccrn_NewRepurchaseProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_NewRepurchaseProgramMember" xlink:to="lab_ccrn_NewRepurchaseProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_4011e22f-de9c-4ede-9b5b-77f51fcf5fe6_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_79f0b45b-e81c-4a8b-b6ce-dbe77c41455a_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_93cb24b8-40a6-4cf9-bf5d-74442d09ad7b_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of intangible assets (excluding goodwill)</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_911661a9-830e-4478-86f6-44a2e8d22f65_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_1e93587e-ec6c-41d8-9ec5-88a5dfc3af71_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_309ab6ed-73d8-4154-9cb2-982d93a975e1_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_e2f6163c-ab1d-41f3-9e4f-f203a3affd9a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByAssetClassAxis" xlink:to="lab_us-gaap_FairValueByAssetClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_827d8cb9-1664-4640-8044-9f8a9f47451f_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_69c5c679-7296-4592-9784-a6aac35f30ac_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_b1b6af9d-8068-419a-b3ad-e6fb112c5c22_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_a740ecb9-f176-474c-967f-df77e6e52cd4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_ea1286eb-84e0-4779-8204-4ce939867491_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_c2ac1e07-2d89-4d69-8701-6b345857231f_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_7477b9dc-56bb-490b-b02e-af29f9ae805c_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_51dfd5f1-c61c-427b-bf76-c77d1f2dfd87_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment charges</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_ceb3e874-d2fb-41ae-975a-ca3665153685_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment charges</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_ef6e6e15-2905-4c49-918b-20b2f81d1fc9_netLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment charges</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_aa47853d-8965-4cf6-9fa0-6ec466f62075_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_A2021TermLoanCreditAgreementMember_e54b7ef0-51fd-409a-9895-503f506aaaa1_terseLabel_en-US" xlink:label="lab_ccrn_A2021TermLoanCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Term Loan Credit Agreement</link:label>
    <link:label id="lab_ccrn_A2021TermLoanCreditAgreementMember_label_en-US" xlink:label="lab_ccrn_A2021TermLoanCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Term Loan Credit Agreement [Member]</link:label>
    <link:label id="lab_ccrn_A2021TermLoanCreditAgreementMember_documentation_en-US" xlink:label="lab_ccrn_A2021TermLoanCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Term Loan Credit Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_A2021TermLoanCreditAgreementMember" xlink:href="ccrn-20220930.xsd#ccrn_A2021TermLoanCreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_A2021TermLoanCreditAgreementMember" xlink:to="lab_ccrn_A2021TermLoanCreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_db308026-cf48-4d12-b424-d6cdf9694c8b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_1e993a9d-4371-4465-937d-628eda6e8962_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Numerator and Denominator for Computation of Basic and Diluted Earnings per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_a0b7a8f9-591b-4af7-a59b-7a0cc665f273_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets acquired under operating lease</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_7ffc8963-e583-472b-8efe-7d05f5c037b6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Option, Quantitative Disclosures [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Option, Quantitative Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOptionQuantitativeDisclosuresLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems" xlink:to="lab_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceMember_label_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceMember" xlink:to="lab_us-gaap_ServiceMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>ccrn-20220930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:9f036714-f865-4798-af5a-08fe5047afca,g:b4ca6da5-78c3-4063-9a30-7dfc7d463cab-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/Cover" xlink:type="simple" xlink:href="ccrn-20220930.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_afb0f501-6b7d-45ff-84f2-83bb163950c2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_c5ebcb76-d2c2-4602-8fb6-553b4c94a20d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_afb0f501-6b7d-45ff-84f2-83bb163950c2" xlink:to="loc_dei_DocumentType_c5ebcb76-d2c2-4602-8fb6-553b4c94a20d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_7e70870c-be4b-4e38-bfb8-00745bd8b69e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_afb0f501-6b7d-45ff-84f2-83bb163950c2" xlink:to="loc_dei_DocumentQuarterlyReport_7e70870c-be4b-4e38-bfb8-00745bd8b69e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_d0c08a69-8e60-455d-8a06-ea12fade1e6d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_afb0f501-6b7d-45ff-84f2-83bb163950c2" xlink:to="loc_dei_DocumentPeriodEndDate_d0c08a69-8e60-455d-8a06-ea12fade1e6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_31cff9e0-866c-4389-a7c8-c4e1e7720da6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_afb0f501-6b7d-45ff-84f2-83bb163950c2" xlink:to="loc_dei_DocumentTransitionReport_31cff9e0-866c-4389-a7c8-c4e1e7720da6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_89b26597-b54b-427f-9460-53b42c18de4f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_afb0f501-6b7d-45ff-84f2-83bb163950c2" xlink:to="loc_dei_EntityRegistrantName_89b26597-b54b-427f-9460-53b42c18de4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_70629be3-55d0-4aec-9242-0dff05827e4c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_afb0f501-6b7d-45ff-84f2-83bb163950c2" xlink:to="loc_dei_EntityIncorporationStateCountryCode_70629be3-55d0-4aec-9242-0dff05827e4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_aa728292-9ef0-4e95-9b0e-6975bce5ef63" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_afb0f501-6b7d-45ff-84f2-83bb163950c2" xlink:to="loc_dei_EntityFileNumber_aa728292-9ef0-4e95-9b0e-6975bce5ef63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_45654c1c-2e7e-4cea-a9f5-7e6d0dc70a7c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_afb0f501-6b7d-45ff-84f2-83bb163950c2" xlink:to="loc_dei_EntityTaxIdentificationNumber_45654c1c-2e7e-4cea-a9f5-7e6d0dc70a7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_98c61f9e-8ad2-468a-931e-3a07beef88fa" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_afb0f501-6b7d-45ff-84f2-83bb163950c2" xlink:to="loc_dei_EntityAddressAddressLine1_98c61f9e-8ad2-468a-931e-3a07beef88fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_1918deb3-b53f-4b51-832a-2364ac9038e6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_afb0f501-6b7d-45ff-84f2-83bb163950c2" xlink:to="loc_dei_EntityAddressCityOrTown_1918deb3-b53f-4b51-832a-2364ac9038e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_5767d82a-329f-47c3-94a4-91dbb6d4d2ac" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_afb0f501-6b7d-45ff-84f2-83bb163950c2" xlink:to="loc_dei_EntityAddressStateOrProvince_5767d82a-329f-47c3-94a4-91dbb6d4d2ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_3ce68138-17d7-4de6-be47-8d85866e47e5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_afb0f501-6b7d-45ff-84f2-83bb163950c2" xlink:to="loc_dei_EntityAddressPostalZipCode_3ce68138-17d7-4de6-be47-8d85866e47e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_355a7b1b-ab0c-4608-b0ce-85596221902f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_afb0f501-6b7d-45ff-84f2-83bb163950c2" xlink:to="loc_dei_CityAreaCode_355a7b1b-ab0c-4608-b0ce-85596221902f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_a4f5d645-cd7f-4618-9ecc-8ca0daa35991" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_afb0f501-6b7d-45ff-84f2-83bb163950c2" xlink:to="loc_dei_LocalPhoneNumber_a4f5d645-cd7f-4618-9ecc-8ca0daa35991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_40660670-72f9-4e8f-9a08-b48631b5eb70" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_afb0f501-6b7d-45ff-84f2-83bb163950c2" xlink:to="loc_dei_Security12bTitle_40660670-72f9-4e8f-9a08-b48631b5eb70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_622abd68-cc8f-4bb1-8f80-4b2421baa3d3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_afb0f501-6b7d-45ff-84f2-83bb163950c2" xlink:to="loc_dei_TradingSymbol_622abd68-cc8f-4bb1-8f80-4b2421baa3d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_8d31308b-1aab-41c1-a07a-e67edeef60f2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_afb0f501-6b7d-45ff-84f2-83bb163950c2" xlink:to="loc_dei_SecurityExchangeName_8d31308b-1aab-41c1-a07a-e67edeef60f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_b1f30132-d0f2-4861-8dc2-180a1558c5f8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_afb0f501-6b7d-45ff-84f2-83bb163950c2" xlink:to="loc_dei_EntityCurrentReportingStatus_b1f30132-d0f2-4861-8dc2-180a1558c5f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_cf779ced-ba12-4f95-9fe8-6bb79fcb7389" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_afb0f501-6b7d-45ff-84f2-83bb163950c2" xlink:to="loc_dei_EntityInteractiveDataCurrent_cf779ced-ba12-4f95-9fe8-6bb79fcb7389" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_825c78f2-53aa-4474-b67f-d193a249a446" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_afb0f501-6b7d-45ff-84f2-83bb163950c2" xlink:to="loc_dei_EntityFilerCategory_825c78f2-53aa-4474-b67f-d193a249a446" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_3c6db5c3-2ade-4517-a7ac-7f0af98cc3ec" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_afb0f501-6b7d-45ff-84f2-83bb163950c2" xlink:to="loc_dei_EntitySmallBusiness_3c6db5c3-2ade-4517-a7ac-7f0af98cc3ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_90dfa296-f660-44fb-8c12-042f6b55ff47" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_afb0f501-6b7d-45ff-84f2-83bb163950c2" xlink:to="loc_dei_EntityEmergingGrowthCompany_90dfa296-f660-44fb-8c12-042f6b55ff47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_52d6ade7-8632-4708-acc6-edb547338452" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_afb0f501-6b7d-45ff-84f2-83bb163950c2" xlink:to="loc_dei_EntityShellCompany_52d6ade7-8632-4708-acc6-edb547338452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_72b2d59f-749c-4742-b4e5-781a61ffeb07" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_afb0f501-6b7d-45ff-84f2-83bb163950c2" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_72b2d59f-749c-4742-b4e5-781a61ffeb07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_83037144-cb3a-42ee-895f-9d8b28803ceb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_afb0f501-6b7d-45ff-84f2-83bb163950c2" xlink:to="loc_dei_EntityCentralIndexKey_83037144-cb3a-42ee-895f-9d8b28803ceb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_7a4920d8-68ef-49fb-9505-ec4ac552fde0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_afb0f501-6b7d-45ff-84f2-83bb163950c2" xlink:to="loc_dei_CurrentFiscalYearEndDate_7a4920d8-68ef-49fb-9505-ec4ac552fde0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_9dc39cdf-7cea-44e7-a40c-d829273e0167" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_afb0f501-6b7d-45ff-84f2-83bb163950c2" xlink:to="loc_dei_DocumentFiscalYearFocus_9dc39cdf-7cea-44e7-a40c-d829273e0167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_a9174e2b-0662-4997-a013-acabb37fa366" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_afb0f501-6b7d-45ff-84f2-83bb163950c2" xlink:to="loc_dei_DocumentFiscalPeriodFocus_a9174e2b-0662-4997-a013-acabb37fa366" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_f6802c25-e6b4-49cb-bb41-6ec159aab859" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_afb0f501-6b7d-45ff-84f2-83bb163950c2" xlink:to="loc_dei_AmendmentFlag_f6802c25-e6b4-49cb-bb41-6ec159aab859" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="ccrn-20220930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_761c9e48-9373-44b2-b84b-ddd590d70008" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_1989c475-735d-4541-8024-abb5ac247971" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_761c9e48-9373-44b2-b84b-ddd590d70008" xlink:to="loc_us-gaap_AssetsAbstract_1989c475-735d-4541-8024-abb5ac247971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_c5d6b974-7151-423b-9570-f0e636bf4579" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1989c475-735d-4541-8024-abb5ac247971" xlink:to="loc_us-gaap_AssetsCurrentAbstract_c5d6b974-7151-423b-9570-f0e636bf4579" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f2367740-33df-4b00-9d26-c5e53290cbcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_c5d6b974-7151-423b-9570-f0e636bf4579" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f2367740-33df-4b00-9d26-c5e53290cbcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_88716783-5c3f-4c8d-9737-41e83832a53c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_c5d6b974-7151-423b-9570-f0e636bf4579" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_88716783-5c3f-4c8d-9737-41e83832a53c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_750f39ca-365f-400f-95c1-a86f6126cacd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_c5d6b974-7151-423b-9570-f0e636bf4579" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_750f39ca-365f-400f-95c1-a86f6126cacd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceSettlementsReceivableCurrent_0ef3f116-7420-49f0-b99a-c3e342ef6966" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceSettlementsReceivableCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_c5d6b974-7151-423b-9570-f0e636bf4579" xlink:to="loc_us-gaap_InsuranceSettlementsReceivableCurrent_0ef3f116-7420-49f0-b99a-c3e342ef6966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_014e999e-99db-4754-9f4c-7634197688db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_c5d6b974-7151-423b-9570-f0e636bf4579" xlink:to="loc_us-gaap_OtherAssetsCurrent_014e999e-99db-4754-9f4c-7634197688db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_130c99d4-4dc8-4d74-8ff4-102388b8f423" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_c5d6b974-7151-423b-9570-f0e636bf4579" xlink:to="loc_us-gaap_AssetsCurrent_130c99d4-4dc8-4d74-8ff4-102388b8f423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_7b736336-92b8-4c73-b11e-3126b4bf554c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1989c475-735d-4541-8024-abb5ac247971" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_7b736336-92b8-4c73-b11e-3126b4bf554c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_95dc70f4-f9d9-4960-866a-46cd9aa176f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1989c475-735d-4541-8024-abb5ac247971" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_95dc70f4-f9d9-4960-866a-46cd9aa176f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_48df3cfa-0e37-4856-a6b9-3c10bea84d94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1989c475-735d-4541-8024-abb5ac247971" xlink:to="loc_us-gaap_Goodwill_48df3cfa-0e37-4856-a6b9-3c10bea84d94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedTradeNames_1324b155-c1b0-4757-8869-be10e8a419bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedTradeNames"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1989c475-735d-4541-8024-abb5ac247971" xlink:to="loc_us-gaap_IndefiniteLivedTradeNames_1324b155-c1b0-4757-8869-be10e8a419bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_a0044e42-fed9-4c1d-96ea-c07be0029696" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1989c475-735d-4541-8024-abb5ac247971" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_a0044e42-fed9-4c1d-96ea-c07be0029696" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_41a0654e-f388-4579-9483-dcb1a41edaa2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1989c475-735d-4541-8024-abb5ac247971" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_41a0654e-f388-4579-9483-dcb1a41edaa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceSettlementsReceivableNoncurrent_0a70d410-875c-4f54-b934-b812ff6ad239" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceSettlementsReceivableNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1989c475-735d-4541-8024-abb5ac247971" xlink:to="loc_us-gaap_InsuranceSettlementsReceivableNoncurrent_0a70d410-875c-4f54-b934-b812ff6ad239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_32b51882-c944-44ab-9aed-27bfe95b4ecc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1989c475-735d-4541-8024-abb5ac247971" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_32b51882-c944-44ab-9aed-27bfe95b4ecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_02e90681-5c24-4ba0-998e-75fec5cac3fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1989c475-735d-4541-8024-abb5ac247971" xlink:to="loc_us-gaap_Assets_02e90681-5c24-4ba0-998e-75fec5cac3fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4e230774-e920-41b8-8c34-48082cb15430" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_761c9e48-9373-44b2-b84b-ddd590d70008" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4e230774-e920-41b8-8c34-48082cb15430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_705891e9-b042-412b-8549-3467d81e4317" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4e230774-e920-41b8-8c34-48082cb15430" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_705891e9-b042-412b-8549-3467d81e4317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_ddbd7e09-d514-483d-8cc1-1b2952b1da3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_705891e9-b042-412b-8549-3467d81e4317" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_ddbd7e09-d514-483d-8cc1-1b2952b1da3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_b8fb409c-326b-4eb5-a75b-b0e1c1d68e8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_705891e9-b042-412b-8549-3467d81e4317" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_b8fb409c-326b-4eb5-a75b-b0e1c1d68e8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_01a978cf-0bce-471a-834e-be98b08d5922" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_705891e9-b042-412b-8549-3467d81e4317" xlink:to="loc_us-gaap_LongTermDebtCurrent_01a978cf-0bce-471a-834e-be98b08d5922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_b2a708eb-77e6-455b-a8a7-76e2a0dd08e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_705891e9-b042-412b-8549-3467d81e4317" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_b2a708eb-77e6-455b-a8a7-76e2a0dd08e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_1908ddfd-0c68-4654-aa68-e75540d86c24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_705891e9-b042-412b-8549-3467d81e4317" xlink:to="loc_us-gaap_TaxesPayableCurrent_1908ddfd-0c68-4654-aa68-e75540d86c24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_5d3103d6-87e9-43d2-a16c-b9f446c3eb7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_705891e9-b042-412b-8549-3467d81e4317" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_5d3103d6-87e9-43d2-a16c-b9f446c3eb7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_2e905511-acda-47b2-8267-d1caeea8f1b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_705891e9-b042-412b-8549-3467d81e4317" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_2e905511-acda-47b2-8267-d1caeea8f1b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_c3838c47-35e7-4395-9b19-8417f9ef48d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_705891e9-b042-412b-8549-3467d81e4317" xlink:to="loc_us-gaap_LiabilitiesCurrent_c3838c47-35e7-4395-9b19-8417f9ef48d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermDebtNoncurrent_d5406c5d-8a83-42ea-a386-da4cda1bd0e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4e230774-e920-41b8-8c34-48082cb15430" xlink:to="loc_us-gaap_OtherLongTermDebtNoncurrent_d5406c5d-8a83-42ea-a386-da4cda1bd0e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_5171c017-8bf6-48ec-88bf-6b8bf6bb2b7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4e230774-e920-41b8-8c34-48082cb15430" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_5171c017-8bf6-48ec-88bf-6b8bf6bb2b7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_84d044dd-63dc-4908-aa44-2047325979b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4e230774-e920-41b8-8c34-48082cb15430" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_84d044dd-63dc-4908-aa44-2047325979b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_ff89b309-1f40-4e34-882f-7ca819c9150c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4e230774-e920-41b8-8c34-48082cb15430" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_ff89b309-1f40-4e34-882f-7ca819c9150c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_f24adb6e-a4be-426f-b2f2-3cc881dea74e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4e230774-e920-41b8-8c34-48082cb15430" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_f24adb6e-a4be-426f-b2f2-3cc881dea74e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_817d63f0-3747-41c7-b8b0-581994b5333b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4e230774-e920-41b8-8c34-48082cb15430" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_817d63f0-3747-41c7-b8b0-581994b5333b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_f324dd13-2167-45ed-aaf4-e15041f8c3e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4e230774-e920-41b8-8c34-48082cb15430" xlink:to="loc_us-gaap_Liabilities_f324dd13-2167-45ed-aaf4-e15041f8c3e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_ea82f208-fcc0-4609-8ee9-4df2ebfd4c41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4e230774-e920-41b8-8c34-48082cb15430" xlink:to="loc_us-gaap_CommitmentsAndContingencies_ea82f208-fcc0-4609-8ee9-4df2ebfd4c41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_c69381f3-293b-4230-944c-8ad3c0b72294" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4e230774-e920-41b8-8c34-48082cb15430" xlink:to="loc_us-gaap_StockholdersEquityAbstract_c69381f3-293b-4230-944c-8ad3c0b72294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_1c3b5dbc-8132-44bd-913d-90eb6ba599a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c69381f3-293b-4230-944c-8ad3c0b72294" xlink:to="loc_us-gaap_CommonStockValue_1c3b5dbc-8132-44bd-913d-90eb6ba599a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_a5f54753-5694-43a8-b9f2-a822084387e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c69381f3-293b-4230-944c-8ad3c0b72294" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_a5f54753-5694-43a8-b9f2-a822084387e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_784f687c-194b-40dd-a8d3-dde7522e1c19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c69381f3-293b-4230-944c-8ad3c0b72294" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_784f687c-194b-40dd-a8d3-dde7522e1c19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_84603910-60af-49af-9a7d-07dbbd654a40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c69381f3-293b-4230-944c-8ad3c0b72294" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_84603910-60af-49af-9a7d-07dbbd654a40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_469a9940-54b2-4c3f-97b5-d99796e4cac5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c69381f3-293b-4230-944c-8ad3c0b72294" xlink:to="loc_us-gaap_StockholdersEquity_469a9940-54b2-4c3f-97b5-d99796e4cac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_11fc094f-276d-4bed-a253-4c1018e33a10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4e230774-e920-41b8-8c34-48082cb15430" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_11fc094f-276d-4bed-a253-4c1018e33a10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="ccrn-20220930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_cabc2a99-bdf6-4603-8765-af32621583f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_47b9dd36-7383-4e4b-b730-e1d772f65f73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_cabc2a99-bdf6-4603-8765-af32621583f1" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_47b9dd36-7383-4e4b-b730-e1d772f65f73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_6cc45eea-5ded-4d00-bb2c-56dabea82f66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_cabc2a99-bdf6-4603-8765-af32621583f1" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_6cc45eea-5ded-4d00-bb2c-56dabea82f66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceSettlementsReceivableNoncurrent_8e36b132-c2a2-42a3-8da4-1a8ddb97a8a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceSettlementsReceivableNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_cabc2a99-bdf6-4603-8765-af32621583f1" xlink:to="loc_us-gaap_InsuranceSettlementsReceivableNoncurrent_8e36b132-c2a2-42a3-8da4-1a8ddb97a8a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="ccrn-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_fce3499a-151e-49f1-a7c0-7468994f79e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList_a61bf21d-2a0a-439e-aaf7-92c9dc9d9eeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fce3499a-151e-49f1-a7c0-7468994f79e5" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList_a61bf21d-2a0a-439e-aaf7-92c9dc9d9eeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_457f3173-3ab2-4cf6-ba69-ff1b2079dbbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fce3499a-151e-49f1-a7c0-7468994f79e5" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_457f3173-3ab2-4cf6-ba69-ff1b2079dbbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_f016de95-429b-4c39-95c5-1fd40ffb7d81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fce3499a-151e-49f1-a7c0-7468994f79e5" xlink:to="loc_us-gaap_OperatingExpensesAbstract_f016de95-429b-4c39-95c5-1fd40ffb7d81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectOperatingCosts_359bde01-0407-4666-b9cb-6a1d44a239a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DirectOperatingCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_f016de95-429b-4c39-95c5-1fd40ffb7d81" xlink:to="loc_us-gaap_DirectOperatingCosts_359bde01-0407-4666-b9cb-6a1d44a239a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_ec99dc58-5bbb-4a21-abf5-5e1d140593c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_f016de95-429b-4c39-95c5-1fd40ffb7d81" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_ec99dc58-5bbb-4a21-abf5-5e1d140593c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_908b9341-0110-4e29-b32c-329e8aff1a16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_f016de95-429b-4c39-95c5-1fd40ffb7d81" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_908b9341-0110-4e29-b32c-329e8aff1a16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_155cedc4-234e-4524-b51e-efcf47fae345" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_f016de95-429b-4c39-95c5-1fd40ffb7d81" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_155cedc4-234e-4524-b51e-efcf47fae345" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_AcquisitionAndIntegrationRelatedCosts_bc078767-dc45-420b-b1d4-b404d00a5c60" xlink:href="ccrn-20220930.xsd#ccrn_AcquisitionAndIntegrationRelatedCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_f016de95-429b-4c39-95c5-1fd40ffb7d81" xlink:to="loc_ccrn_AcquisitionAndIntegrationRelatedCosts_bc078767-dc45-420b-b1d4-b404d00a5c60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_a5e65c74-d847-493f-9ec8-5cf43a1e9c40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_f016de95-429b-4c39-95c5-1fd40ffb7d81" xlink:to="loc_us-gaap_RestructuringCharges_a5e65c74-d847-493f-9ec8-5cf43a1e9c40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_38a9f862-f650-42f9-b6f2-5d879cd61be0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_f016de95-429b-4c39-95c5-1fd40ffb7d81" xlink:to="loc_us-gaap_AssetImpairmentCharges_38a9f862-f650-42f9-b6f2-5d879cd61be0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_9ebb5687-53d7-4b57-a400-ed61338ee5bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_f016de95-429b-4c39-95c5-1fd40ffb7d81" xlink:to="loc_us-gaap_CostsAndExpenses_9ebb5687-53d7-4b57-a400-ed61338ee5bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_32a286bb-46c2-4a06-a7fe-9edb3acd412b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fce3499a-151e-49f1-a7c0-7468994f79e5" xlink:to="loc_us-gaap_OperatingIncomeLoss_32a286bb-46c2-4a06-a7fe-9edb3acd412b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_6f9c53f8-a01a-4c55-9796-d25ee6348b42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fce3499a-151e-49f1-a7c0-7468994f79e5" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_6f9c53f8-a01a-4c55-9796-d25ee6348b42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_685b64bb-8887-4d2c-89b1-9162eb93f648" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_6f9c53f8-a01a-4c55-9796-d25ee6348b42" xlink:to="loc_us-gaap_InterestExpense_685b64bb-8887-4d2c-89b1-9162eb93f648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_96ee85e1-8872-4aba-a9e6-ac334f7db802" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_6f9c53f8-a01a-4c55-9796-d25ee6348b42" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_96ee85e1-8872-4aba-a9e6-ac334f7db802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_ba5d3d15-dea5-4b20-9f25-6cb92ac4c4d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_6f9c53f8-a01a-4c55-9796-d25ee6348b42" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_ba5d3d15-dea5-4b20-9f25-6cb92ac4c4d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_40b4b87b-7fab-443b-b689-30854a640c3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fce3499a-151e-49f1-a7c0-7468994f79e5" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_40b4b87b-7fab-443b-b689-30854a640c3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c902218f-4a42-4e60-9014-b38055bb2386" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fce3499a-151e-49f1-a7c0-7468994f79e5" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_c902218f-4a42-4e60-9014-b38055bb2386" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_95142b62-ade1-40fc-a484-a0d0cf194591" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fce3499a-151e-49f1-a7c0-7468994f79e5" xlink:to="loc_us-gaap_NetIncomeLoss_95142b62-ade1-40fc-a484-a0d0cf194591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_12679f85-0b8b-42e7-8502-09f6437b66f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fce3499a-151e-49f1-a7c0-7468994f79e5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_12679f85-0b8b-42e7-8502-09f6437b66f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_efa7073a-ae96-413b-b439-0f7090208abb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_12679f85-0b8b-42e7-8502-09f6437b66f3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_efa7073a-ae96-413b-b439-0f7090208abb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_18562ecc-0566-40a2-8a1b-44315d98a4f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_12679f85-0b8b-42e7-8502-09f6437b66f3" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_18562ecc-0566-40a2-8a1b-44315d98a4f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_3c494412-073a-49ef-a3fb-b2491b898da6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fce3499a-151e-49f1-a7c0-7468994f79e5" xlink:to="loc_us-gaap_EarningsPerShareBasic_3c494412-073a-49ef-a3fb-b2491b898da6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_25d4cb36-5e69-4199-b03a-958edc829048" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fce3499a-151e-49f1-a7c0-7468994f79e5" xlink:to="loc_us-gaap_EarningsPerShareDiluted_25d4cb36-5e69-4199-b03a-958edc829048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_bcae13c8-ce3a-4e0b-8f78-93110697b679" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fce3499a-151e-49f1-a7c0-7468994f79e5" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_bcae13c8-ce3a-4e0b-8f78-93110697b679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e763e47c-b997-43e9-97a1-6fcc76b4a587" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_bcae13c8-ce3a-4e0b-8f78-93110697b679" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e763e47c-b997-43e9-97a1-6fcc76b4a587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b901349b-22b7-4aeb-a622-dd66dc3c27a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_bcae13c8-ce3a-4e0b-8f78-93110697b679" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b901349b-22b7-4aeb-a622-dd66dc3c27a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="ccrn-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_1b484f90-222c-4ba0-9afc-0b0e87663d3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_e3c7daa3-3ede-4444-84b4-f5b22832448e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_1b484f90-222c-4ba0-9afc-0b0e87663d3e" xlink:to="loc_us-gaap_StatementTable_e3c7daa3-3ede-4444-84b4-f5b22832448e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_cfb918a0-80c4-4527-bc5d-7577ed8da7c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e3c7daa3-3ede-4444-84b4-f5b22832448e" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_cfb918a0-80c4-4527-bc5d-7577ed8da7c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d1ca93a0-bfb9-4ca1-8386-2639790704b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_cfb918a0-80c4-4527-bc5d-7577ed8da7c4" xlink:to="loc_us-gaap_EquityComponentDomain_d1ca93a0-bfb9-4ca1-8386-2639790704b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_245b5e3b-7e51-4360-8273-84bbe9fd3a52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d1ca93a0-bfb9-4ca1-8386-2639790704b3" xlink:to="loc_us-gaap_CommonStockMember_245b5e3b-7e51-4360-8273-84bbe9fd3a52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_8b4d7233-6fa4-4a5b-832e-8051e462423a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d1ca93a0-bfb9-4ca1-8386-2639790704b3" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_8b4d7233-6fa4-4a5b-832e-8051e462423a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_0ac509c5-6a86-4a40-966c-0b56e2cf979f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d1ca93a0-bfb9-4ca1-8386-2639790704b3" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_0ac509c5-6a86-4a40-966c-0b56e2cf979f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_2fdf0375-90f7-4abd-a0c9-b746311e72ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d1ca93a0-bfb9-4ca1-8386-2639790704b3" xlink:to="loc_us-gaap_RetainedEarningsMember_2fdf0375-90f7-4abd-a0c9-b746311e72ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_1c84bf34-84f0-4e9f-9caa-5a28fb47539f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d1ca93a0-bfb9-4ca1-8386-2639790704b3" xlink:to="loc_us-gaap_NoncontrollingInterestMember_1c84bf34-84f0-4e9f-9caa-5a28fb47539f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_2b5eb006-8e5b-4fe8-82b5-faf8b60314ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e3c7daa3-3ede-4444-84b4-f5b22832448e" xlink:to="loc_us-gaap_StatementLineItems_2b5eb006-8e5b-4fe8-82b5-faf8b60314ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_680ed177-002d-416c-89fe-c10d09572962" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2b5eb006-8e5b-4fe8-82b5-faf8b60314ae" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_680ed177-002d-416c-89fe-c10d09572962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_0f9f92f8-d505-4b5f-98a7-8f179d37f78e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_680ed177-002d-416c-89fe-c10d09572962" xlink:to="loc_us-gaap_SharesOutstanding_0f9f92f8-d505-4b5f-98a7-8f179d37f78e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1224f0f9-e5fc-439f-8336-413510a9123e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_680ed177-002d-416c-89fe-c10d09572962" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1224f0f9-e5fc-439f-8336-413510a9123e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_aae03a77-179e-4038-acf6-c432d2658b1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_680ed177-002d-416c-89fe-c10d09572962" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_aae03a77-179e-4038-acf6-c432d2658b1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_2b548ed8-af20-432a-a3f9-dd54f0aeb3d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_680ed177-002d-416c-89fe-c10d09572962" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_2b548ed8-af20-432a-a3f9-dd54f0aeb3d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1ea5d49c-4fd8-441b-89f6-e65dcbb8510d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_680ed177-002d-416c-89fe-c10d09572962" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1ea5d49c-4fd8-441b-89f6-e65dcbb8510d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_4142a8e0-1fe7-4558-92df-035089b4ac2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_680ed177-002d-416c-89fe-c10d09572962" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_4142a8e0-1fe7-4558-92df-035089b4ac2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_f786a828-580e-4033-b4bd-e0c601cf4d11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_680ed177-002d-416c-89fe-c10d09572962" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_f786a828-580e-4033-b4bd-e0c601cf4d11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_6b90a189-d185-4339-b9a0-449fdacb5b68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_680ed177-002d-416c-89fe-c10d09572962" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_6b90a189-d185-4339-b9a0-449fdacb5b68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_ca154a07-9b4f-4cbf-af06-4a7f016d883d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_680ed177-002d-416c-89fe-c10d09572962" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_ca154a07-9b4f-4cbf-af06-4a7f016d883d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_4932820b-2399-4bb8-a67e-feaa3c5d765f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_680ed177-002d-416c-89fe-c10d09572962" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_4932820b-2399-4bb8-a67e-feaa3c5d765f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_5ec20a32-e0d4-41fa-971e-67fb0d3ee22b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_680ed177-002d-416c-89fe-c10d09572962" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_5ec20a32-e0d4-41fa-971e-67fb0d3ee22b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_1471aff5-8fb9-4cc7-8685-88295246cb4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_680ed177-002d-416c-89fe-c10d09572962" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_1471aff5-8fb9-4cc7-8685-88295246cb4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_17c14d39-0413-46c5-a815-5cee33835b58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_680ed177-002d-416c-89fe-c10d09572962" xlink:to="loc_us-gaap_NetIncomeLoss_17c14d39-0413-46c5-a815-5cee33835b58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_304b5459-e3af-458f-a335-64d6a3f04d70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_680ed177-002d-416c-89fe-c10d09572962" xlink:to="loc_us-gaap_SharesOutstanding_304b5459-e3af-458f-a335-64d6a3f04d70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d8c43c9e-935d-45ff-8dc3-aa6e55171af6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_680ed177-002d-416c-89fe-c10d09572962" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d8c43c9e-935d-45ff-8dc3-aa6e55171af6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="ccrn-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_901068a7-3295-4707-8191-87573443849e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b319702a-9451-42ad-a7f4-ee38db8682c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_901068a7-3295-4707-8191-87573443849e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b319702a-9451-42ad-a7f4-ee38db8682c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_62fed8dd-56c4-4525-bad6-bf9ddb954503" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b319702a-9451-42ad-a7f4-ee38db8682c9" xlink:to="loc_us-gaap_NetIncomeLoss_62fed8dd-56c4-4525-bad6-bf9ddb954503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_498f40f6-bb28-442d-9c1d-0ecfcef726dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b319702a-9451-42ad-a7f4-ee38db8682c9" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_498f40f6-bb28-442d-9c1d-0ecfcef726dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_b93eae56-6ada-485c-a820-05ae38fc70a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_498f40f6-bb28-442d-9c1d-0ecfcef726dc" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_b93eae56-6ada-485c-a820-05ae38fc70a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_ProvisionForDoubtfulAccountsAndOtherAllowances_9a58241d-bb8a-40b7-a36c-8b70a2cec60b" xlink:href="ccrn-20220930.xsd#ccrn_ProvisionForDoubtfulAccountsAndOtherAllowances"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_498f40f6-bb28-442d-9c1d-0ecfcef726dc" xlink:to="loc_ccrn_ProvisionForDoubtfulAccountsAndOtherAllowances_9a58241d-bb8a-40b7-a36c-8b70a2cec60b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_d74b80ac-a041-4e64-ba8d-d75810db17d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_498f40f6-bb28-442d-9c1d-0ecfcef726dc" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_d74b80ac-a041-4e64-ba8d-d75810db17d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_OperatingLeaseExpenseNonCash_78dc8d6b-0869-4ed6-bae4-08f784debb93" xlink:href="ccrn-20220930.xsd#ccrn_OperatingLeaseExpenseNonCash"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_498f40f6-bb28-442d-9c1d-0ecfcef726dc" xlink:to="loc_ccrn_OperatingLeaseExpenseNonCash_78dc8d6b-0869-4ed6-bae4-08f784debb93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_0a7203b7-ef84-43bc-b5fb-17b701487b6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_498f40f6-bb28-442d-9c1d-0ecfcef726dc" xlink:to="loc_us-gaap_AssetImpairmentCharges_0a7203b7-ef84-43bc-b5fb-17b701487b6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_8446a3a3-7b24-4503-9da1-d43fa6a51885" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_498f40f6-bb28-442d-9c1d-0ecfcef726dc" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_8446a3a3-7b24-4503-9da1-d43fa6a51885" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_5e9f8f30-fc04-4465-bd27-9c3d7ce4886b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_498f40f6-bb28-442d-9c1d-0ecfcef726dc" xlink:to="loc_us-gaap_ShareBasedCompensation_5e9f8f30-fc04-4465-bd27-9c3d7ce4886b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_b3595cb9-b6c0-477a-a93a-d2f8791007ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_498f40f6-bb28-442d-9c1d-0ecfcef726dc" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_b3595cb9-b6c0-477a-a93a-d2f8791007ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_fdfa4e6b-4fa5-4f36-a6f1-4ab6bfe5758a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_498f40f6-bb28-442d-9c1d-0ecfcef726dc" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_fdfa4e6b-4fa5-4f36-a6f1-4ab6bfe5758a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_0b19037b-8186-451e-a7c3-7d128cc03327" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_fdfa4e6b-4fa5-4f36-a6f1-4ab6bfe5758a" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_0b19037b-8186-451e-a7c3-7d128cc03327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_bc27c329-c4ca-42ba-a1d5-05562aee18d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_fdfa4e6b-4fa5-4f36-a6f1-4ab6bfe5758a" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_bc27c329-c4ca-42ba-a1d5-05562aee18d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_5969294e-5bf0-4c23-b0e3-38b8e796bc47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_fdfa4e6b-4fa5-4f36-a6f1-4ab6bfe5758a" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_5969294e-5bf0-4c23-b0e3-38b8e796bc47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_7b144e60-9ec0-4341-a083-3f1529fa5c46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_fdfa4e6b-4fa5-4f36-a6f1-4ab6bfe5758a" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_7b144e60-9ec0-4341-a083-3f1529fa5c46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_IncreaseDecreaseInOperatingLeaseLiabilities_a37a4aeb-43d1-495d-b3b5-adca60df49a3" xlink:href="ccrn-20220930.xsd#ccrn_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_fdfa4e6b-4fa5-4f36-a6f1-4ab6bfe5758a" xlink:to="loc_ccrn_IncreaseDecreaseInOperatingLeaseLiabilities_a37a4aeb-43d1-495d-b3b5-adca60df49a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_09f7c81f-93b6-4abc-9047-b2a3d0e7af12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_fdfa4e6b-4fa5-4f36-a6f1-4ab6bfe5758a" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_09f7c81f-93b6-4abc-9047-b2a3d0e7af12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_617c7e56-7228-44f2-989d-2347866b4bff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b319702a-9451-42ad-a7f4-ee38db8682c9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_617c7e56-7228-44f2-989d-2347866b4bff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_be347f94-f928-45f8-b685-535d02e6c034" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_901068a7-3295-4707-8191-87573443849e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_be347f94-f928-45f8-b685-535d02e6c034" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_2f5e2dd4-0845-4b9c-94ad-c1a9883c1204" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_be347f94-f928-45f8-b685-535d02e6c034" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_2f5e2dd4-0845-4b9c-94ad-c1a9883c1204" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_8edd1277-456d-4bf5-b317-b0d7c182c47b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_be347f94-f928-45f8-b685-535d02e6c034" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_8edd1277-456d-4bf5-b317-b0d7c182c47b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_892cf539-1075-4bbd-9903-5f774441ce10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_be347f94-f928-45f8-b685-535d02e6c034" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_892cf539-1075-4bbd-9903-5f774441ce10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_70e0bf12-9c39-4a61-a390-4d11f3d8d991" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_901068a7-3295-4707-8191-87573443849e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_70e0bf12-9c39-4a61-a390-4d11f3d8d991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_6e073b29-0e04-410b-8a2b-af95759ffa6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_70e0bf12-9c39-4a61-a390-4d11f3d8d991" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_6e073b29-0e04-410b-8a2b-af95759ffa6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt_4146a62c-62f3-49cd-b92a-f9af6cc53400" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_70e0bf12-9c39-4a61-a390-4d11f3d8d991" xlink:to="loc_us-gaap_RepaymentsOfSecuredDebt_4146a62c-62f3-49cd-b92a-f9af6cc53400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_cf00ba95-c76a-4514-a12e-a420b16006d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_70e0bf12-9c39-4a61-a390-4d11f3d8d991" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_cf00ba95-c76a-4514-a12e-a420b16006d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_5b200356-2d64-48dd-a51a-4771038e2bca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_70e0bf12-9c39-4a61-a390-4d11f3d8d991" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_5b200356-2d64-48dd-a51a-4771038e2bca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_d1a272ee-fb68-4380-a190-543149bb5fef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_70e0bf12-9c39-4a61-a390-4d11f3d8d991" xlink:to="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_d1a272ee-fb68-4380-a190-543149bb5fef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2761393e-7216-4671-a34c-1c96bab4c043" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_70e0bf12-9c39-4a61-a390-4d11f3d8d991" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2761393e-7216-4671-a34c-1c96bab4c043" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_d8a721a3-ce49-4ac3-9d46-9a0f86732885" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_70e0bf12-9c39-4a61-a390-4d11f3d8d991" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_d8a721a3-ce49-4ac3-9d46-9a0f86732885" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_8e0d529d-0331-4b4e-ba59-68a648ac5a77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_70e0bf12-9c39-4a61-a390-4d11f3d8d991" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_8e0d529d-0331-4b4e-ba59-68a648ac5a77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_16203506-f764-46fb-ac06-c61ab3edb684" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_70e0bf12-9c39-4a61-a390-4d11f3d8d991" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_16203506-f764-46fb-ac06-c61ab3edb684" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_fda0e4b6-ecaa-4c83-86a4-2ca3759022f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_70e0bf12-9c39-4a61-a390-4d11f3d8d991" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_fda0e4b6-ecaa-4c83-86a4-2ca3759022f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0d8c7ee4-2f83-40cd-b6f9-904201bc17a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_70e0bf12-9c39-4a61-a390-4d11f3d8d991" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0d8c7ee4-2f83-40cd-b6f9-904201bc17a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7d383df5-6035-4581-afa3-234912e459bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_901068a7-3295-4707-8191-87573443849e" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7d383df5-6035-4581-afa3-234912e459bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0f5b4db9-bd38-49cf-9d5e-fc7ab9309d3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_901068a7-3295-4707-8191-87573443849e" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0f5b4db9-bd38-49cf-9d5e-fc7ab9309d3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_36360ed1-a13f-4599-8d03-0b2a8398acfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_901068a7-3295-4707-8191-87573443849e" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_36360ed1-a13f-4599-8d03-0b2a8398acfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_deda4228-a473-4c00-9aa2-3008512c28e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_901068a7-3295-4707-8191-87573443849e" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_deda4228-a473-4c00-9aa2-3008512c28e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/ORGANIZATIONANDBASISOFPRESENTATION" xlink:type="simple" xlink:href="ccrn-20220930.xsd#ORGANIZATIONANDBASISOFPRESENTATION"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/ORGANIZATIONANDBASISOFPRESENTATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1d5543ba-e223-466d-9f1c-f254164c8e56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_8f2b443e-8a27-4778-b2cb-66f5f2b2dd95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1d5543ba-e223-466d-9f1c-f254164c8e56" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_8f2b443e-8a27-4778-b2cb-66f5f2b2dd95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="ccrn-20220930.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_4fd766d6-3f38-468c-9d3f-c00f0bbce2fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_dec67533-eec1-48b9-a35e-28128e3798c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4fd766d6-3f38-468c-9d3f-c00f0bbce2fd" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_dec67533-eec1-48b9-a35e-28128e3798c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/REVENUERECOGNITION" xlink:type="simple" xlink:href="ccrn-20220930.xsd#REVENUERECOGNITION"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/REVENUERECOGNITION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f86714a5-cfb4-4ec1-a55f-a3119dc7cb1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_927c4609-981b-48b1-8f7b-490bf886065e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f86714a5-cfb4-4ec1-a55f-a3119dc7cb1e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_927c4609-981b-48b1-8f7b-490bf886065e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/ACQUISITIONS" xlink:type="simple" xlink:href="ccrn-20220930.xsd#ACQUISITIONS"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/ACQUISITIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_dce779fa-5220-48cb-8a9d-7f50f5da6d16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_21123475-2596-4465-8ced-4c67ec42dfa4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_dce779fa-5220-48cb-8a9d-7f50f5da6d16" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_21123475-2596-4465-8ced-4c67ec42dfa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/COMPREHENSIVEINCOME" xlink:type="simple" xlink:href="ccrn-20220930.xsd#COMPREHENSIVEINCOME"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/COMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_16a41549-4451-4476-bd5b-4f3c4d37bcd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_b64e2507-06f3-48c8-be87-822e6a1cf60e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_16a41549-4451-4476-bd5b-4f3c4d37bcd0" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_b64e2507-06f3-48c8-be87-822e6a1cf60e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/EARNINGSPERSHARE" xlink:type="simple" xlink:href="ccrn-20220930.xsd#EARNINGSPERSHARE"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/EARNINGSPERSHARE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_e5aeea04-998c-42ba-837b-6b8d595d9f1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_632278ea-86d8-4526-a43c-0505e906911e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e5aeea04-998c-42ba-837b-6b8d595d9f1b" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_632278ea-86d8-4526-a43c-0505e906911e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETS" xlink:type="simple" xlink:href="ccrn-20220930.xsd#GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETS"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_73786be0-2eee-447b-9565-54b74d3b5f9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_0239ecda-04ce-466c-9603-ef3434f3b900" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_73786be0-2eee-447b-9565-54b74d3b5f9c" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_0239ecda-04ce-466c-9603-ef3434f3b900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DEBT" xlink:type="simple" xlink:href="ccrn-20220930.xsd#DEBT"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/DEBT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_ed21dbf6-909a-417d-ac2d-343b23aaf469" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_86ea30e1-47fd-4efb-8930-f9f3de670c70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ed21dbf6-909a-417d-ac2d-343b23aaf469" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_86ea30e1-47fd-4efb-8930-f9f3de670c70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/LEASES" xlink:type="simple" xlink:href="ccrn-20220930.xsd#LEASES"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/LEASES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_e144198d-a836-479d-ba7c-de961089ff1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_ee29dfdb-70da-4f3e-b859-d2a5204fd6e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e144198d-a836-479d-ba7c-de961089ff1c" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_ee29dfdb-70da-4f3e-b859-d2a5204fd6e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTS" xlink:type="simple" xlink:href="ccrn-20220930.xsd#FAIRVALUEMEASUREMENTS"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_4ef51785-eb8b-4b40-940a-fcda6716daf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_8ac6a3b8-f474-431c-8656-5dfe5fadfeb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_4ef51785-eb8b-4b40-940a-fcda6716daf8" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_8ac6a3b8-f474-431c-8656-5dfe5fadfeb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="ccrn-20220930.xsd#STOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_10c37c49-a89c-4bdd-bd66-7edc97fc5205" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_07883968-d869-472a-b710-50c36e50c652" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_10c37c49-a89c-4bdd-bd66-7edc97fc5205" xlink:to="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_07883968-d869-472a-b710-50c36e50c652" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SEGMENTDATA" xlink:type="simple" xlink:href="ccrn-20220930.xsd#SEGMENTDATA"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/SEGMENTDATA" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_a33cd067-b734-4609-b34c-bea28db9e8fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_193df0d1-ecfa-4621-b5d6-ce4fbfec6b66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_a33cd067-b734-4609-b34c-bea28db9e8fb" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_193df0d1-ecfa-4621-b5d6-ce4fbfec6b66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/CONTINGENCIES" xlink:type="simple" xlink:href="ccrn-20220930.xsd#CONTINGENCIES"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/CONTINGENCIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6c778e1f-c019-4b95-ac08-243a3c381199" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_b8ce2f34-d5e4-436b-8446-a84b012a22a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6c778e1f-c019-4b95-ac08-243a3c381199" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_b8ce2f34-d5e4-436b-8446-a84b012a22a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/INCOMETAXES" xlink:type="simple" xlink:href="ccrn-20220930.xsd#INCOMETAXES"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/INCOMETAXES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_ef906e14-2182-4678-a79c-f7baf709b0e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_1d3e378a-f77e-4af0-8a86-c814a9cafd4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ef906e14-2182-4678-a79c-f7baf709b0e5" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_1d3e378a-f77e-4af0-8a86-c814a9cafd4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/RELATEDPARTYTRANSACTIONS" xlink:type="simple" xlink:href="ccrn-20220930.xsd#RELATEDPARTYTRANSACTIONS"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/RELATEDPARTYTRANSACTIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_ce855c1f-0439-45e9-9d67-80cfe505b8d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_3ee3804e-bc53-4d72-af65-7a5602029de0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_ce855c1f-0439-45e9-9d67-80cfe505b8d8" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_3ee3804e-bc53-4d72-af65-7a5602029de0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/RECENTACCOUNTINGPRONOUNCEMENTS" xlink:type="simple" xlink:href="ccrn-20220930.xsd#RECENTACCOUNTINGPRONOUNCEMENTS"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/RECENTACCOUNTINGPRONOUNCEMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_93b01c15-d654-47bb-8f86-d3f2374d4b2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_23b7632a-48b9-4c29-9d6b-f185ca856ef0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_93b01c15-d654-47bb-8f86-d3f2374d4b2c" xlink:to="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_23b7632a-48b9-4c29-9d6b-f185ca856ef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SUBSEQUENTEVENTS" xlink:type="simple" xlink:href="ccrn-20220930.xsd#SUBSEQUENTEVENTS"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/SUBSEQUENTEVENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_b28aaf18-5091-4f06-a519-b41146cea24c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_c7ea2481-fd19-4091-b9fc-a2f4e3c52ef0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_b28aaf18-5091-4f06-a519-b41146cea24c" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_c7ea2481-fd19-4091-b9fc-a2f4e3c52ef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="ccrn-20220930.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_b1e6a77e-369c-4286-8837-ebd7c4c01089" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_7a5644fb-c854-4eee-a82d-9bde9335eb31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b1e6a77e-369c-4286-8837-ebd7c4c01089" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_7a5644fb-c854-4eee-a82d-9bde9335eb31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_b1479009-eb0b-4a97-b253-93fbf7f8c005" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b1e6a77e-369c-4286-8837-ebd7c4c01089" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_b1479009-eb0b-4a97-b253-93fbf7f8c005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_4d7bd443-71b3-42ed-9823-d51cfba28064" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b1e6a77e-369c-4286-8837-ebd7c4c01089" xlink:to="loc_us-gaap_UseOfEstimates_4d7bd443-71b3-42ed-9823-d51cfba28064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_RisksAndUncertaintiesPolicyTextBlock_42ed8d13-5e1c-42f0-8395-552a8d42d055" xlink:href="ccrn-20220930.xsd#ccrn_RisksAndUncertaintiesPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b1e6a77e-369c-4286-8837-ebd7c4c01089" xlink:to="loc_ccrn_RisksAndUncertaintiesPolicyTextBlock_42ed8d13-5e1c-42f0-8395-552a8d42d055" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_7a1f6e5c-781a-4a53-bbbf-a7bd11e2b43c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b1e6a77e-369c-4286-8837-ebd7c4c01089" xlink:to="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_7a1f6e5c-781a-4a53-bbbf-a7bd11e2b43c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_270428f7-d44c-484c-9cd8-92118f77d3c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b1e6a77e-369c-4286-8837-ebd7c4c01089" xlink:to="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_270428f7-d44c-484c-9cd8-92118f77d3c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_61076db6-4d4c-424e-b630-8830851934a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b1e6a77e-369c-4286-8837-ebd7c4c01089" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_61076db6-4d4c-424e-b630-8830851934a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="simple" xlink:href="ccrn-20220930.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_663cd6a0-a17f-4ff5-8748-0bf2ad27850b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_15a387d8-b994-4043-a5de-431e7f6d7c5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_663cd6a0-a17f-4ff5-8748-0bf2ad27850b" xlink:to="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_15a387d8-b994-4043-a5de-431e7f6d7c5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_b45b6443-1b1a-4022-8a05-4138377e4f26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_663cd6a0-a17f-4ff5-8748-0bf2ad27850b" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_b45b6443-1b1a-4022-8a05-4138377e4f26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/REVENUERECOGNITIONTables" xlink:type="simple" xlink:href="ccrn-20220930.xsd#REVENUERECOGNITIONTables"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/REVENUERECOGNITIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_bf3633ce-1766-4a66-8068-6cf676e13ebe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_26bcaaf9-4269-44e7-9957-3fa23064ba60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_bf3633ce-1766-4a66-8068-6cf676e13ebe" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_26bcaaf9-4269-44e7-9957-3fa23064ba60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/ACQUISITIONSTables" xlink:type="simple" xlink:href="ccrn-20220930.xsd#ACQUISITIONSTables"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/ACQUISITIONSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_6bb2677a-5aad-4a21-948b-7023e3633862" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_04242ea4-9b09-41f9-b40d-f26a037ff40e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_6bb2677a-5aad-4a21-948b-7023e3633862" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_04242ea4-9b09-41f9-b40d-f26a037ff40e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/EARNINGSPERSHARETables" xlink:type="simple" xlink:href="ccrn-20220930.xsd#EARNINGSPERSHARETables"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/EARNINGSPERSHARETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_c884a33a-1eb2-4acc-9eba-0ea0ac8e094e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_e4cb180b-c9e2-4a72-a3f8-dbb50a56dad3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_c884a33a-1eb2-4acc-9eba-0ea0ac8e094e" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_e4cb180b-c9e2-4a72-a3f8-dbb50a56dad3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_03d7af1e-eb02-44f8-8a4a-b1cc157b366a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_c884a33a-1eb2-4acc-9eba-0ea0ac8e094e" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_03d7af1e-eb02-44f8-8a4a-b1cc157b366a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSTables" xlink:type="simple" xlink:href="ccrn-20220930.xsd#GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSTables"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2265f15f-ba6c-41de-829b-57239bf4091b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_7d142e1d-0ed4-48af-8c0a-38711cc167f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2265f15f-ba6c-41de-829b-57239bf4091b" xlink:to="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_7d142e1d-0ed4-48af-8c0a-38711cc167f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_a4b6816f-9ab8-4721-ab20-455a686ee589" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2265f15f-ba6c-41de-829b-57239bf4091b" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_a4b6816f-9ab8-4721-ab20-455a686ee589" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_39d7dfb6-dfc9-44c2-a63e-65472ded3e1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2265f15f-ba6c-41de-829b-57239bf4091b" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_39d7dfb6-dfc9-44c2-a63e-65472ded3e1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DEBTTables" xlink:type="simple" xlink:href="ccrn-20220930.xsd#DEBTTables"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/DEBTTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_f0e205db-ee6c-4d03-a690-78ded3aef287" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_fbfe8242-4c23-40c3-b0f7-f63f08665339" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f0e205db-ee6c-4d03-a690-78ded3aef287" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_fbfe8242-4c23-40c3-b0f7-f63f08665339" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_686fff9e-11a5-4553-95c5-61ab7b65b1f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f0e205db-ee6c-4d03-a690-78ded3aef287" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_686fff9e-11a5-4553-95c5-61ab7b65b1f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/LEASESTables" xlink:type="simple" xlink:href="ccrn-20220930.xsd#LEASESTables"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/LEASESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_91797451-6c48-4f2f-9543-7256b36d453a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_AssetsAndLiabilitiesLeasesTableTextBlock_7d14ca37-7860-48ef-a252-58b92ce9bd78" xlink:href="ccrn-20220930.xsd#ccrn_AssetsAndLiabilitiesLeasesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_91797451-6c48-4f2f-9543-7256b36d453a" xlink:to="loc_ccrn_AssetsAndLiabilitiesLeasesTableTextBlock_7d14ca37-7860-48ef-a252-58b92ce9bd78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_fa8fe965-4c1d-43ef-9e88-3057349e0da2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_91797451-6c48-4f2f-9543-7256b36d453a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_fa8fe965-4c1d-43ef-9e88-3057349e0da2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_adaac678-eaef-45b3-8fda-bf78bd731908" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_91797451-6c48-4f2f-9543-7256b36d453a" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_adaac678-eaef-45b3-8fda-bf78bd731908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="simple" xlink:href="ccrn-20220930.xsd#FAIRVALUEMEASUREMENTSTables"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_68ce6bea-dd80-4801-9d8c-2bc69ea7a45f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_04d0f06d-e503-44bb-ac66-0b9f845a1018" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_68ce6bea-dd80-4801-9d8c-2bc69ea7a45f" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_04d0f06d-e503-44bb-ac66-0b9f845a1018" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_65a10f02-6c26-418f-9458-1c73b297f198" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_68ce6bea-dd80-4801-9d8c-2bc69ea7a45f" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_65a10f02-6c26-418f-9458-1c73b297f198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYTables" xlink:type="simple" xlink:href="ccrn-20220930.xsd#STOCKHOLDERSEQUITYTables"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_392cb805-a8d4-4de3-a3cc-6e7d35fbb9e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_26de6540-cf08-44dc-83c5-583880f3b68e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_392cb805-a8d4-4de3-a3cc-6e7d35fbb9e6" xlink:to="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_26de6540-cf08-44dc-83c5-583880f3b68e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SEGMENTDATATables" xlink:type="simple" xlink:href="ccrn-20220930.xsd#SEGMENTDATATables"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/SEGMENTDATATables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_14f06fa2-6f6a-4235-a5db-b7bce37e58c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_215121c3-605a-4875-b88a-c4e16ae89c7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_14f06fa2-6f6a-4235-a5db-b7bce37e58c6" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_215121c3-605a-4875-b88a-c4e16ae89c7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails" xlink:type="simple" xlink:href="ccrn-20220930.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_5ba0c43c-3d8c-4211-917d-c9607965532e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_31d06cb3-cc13-44ed-8177-428968380331" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5ba0c43c-3d8c-4211-917d-c9607965532e" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_31d06cb3-cc13-44ed-8177-428968380331" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_75ca002a-a24b-4bc9-8fba-c1d4003593be" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_31d06cb3-cc13-44ed-8177-428968380331" xlink:to="loc_srt_RangeAxis_75ca002a-a24b-4bc9-8fba-c1d4003593be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7c5fc214-783c-41d2-80b5-e5e7da16b482" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_75ca002a-a24b-4bc9-8fba-c1d4003593be" xlink:to="loc_srt_RangeMember_7c5fc214-783c-41d2-80b5-e5e7da16b482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_40da1972-3d4b-410c-96d9-82e2a14940f4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_7c5fc214-783c-41d2-80b5-e5e7da16b482" xlink:to="loc_srt_MinimumMember_40da1972-3d4b-410c-96d9-82e2a14940f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_582b1760-a46b-4bb8-b2f0-d0908ebdcd90" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_7c5fc214-783c-41d2-80b5-e5e7da16b482" xlink:to="loc_srt_MaximumMember_582b1760-a46b-4bb8-b2f0-d0908ebdcd90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_b4c5ed4f-8579-4d85-83e6-88ee20887c8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_31d06cb3-cc13-44ed-8177-428968380331" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_b4c5ed4f-8579-4d85-83e6-88ee20887c8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnbilledContractsReceivable_e50c3393-00a5-44d5-825a-c9d70fe50a19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnbilledContractsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_b4c5ed4f-8579-4d85-83e6-88ee20887c8d" xlink:to="loc_us-gaap_UnbilledContractsReceivable_e50c3393-00a5-44d5-825a-c9d70fe50a19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_SalesAllowanceBillingRelatedAdjustments_c45f981d-7ea5-481e-a983-cf196fa96212" xlink:href="ccrn-20220930.xsd#ccrn_SalesAllowanceBillingRelatedAdjustments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_b4c5ed4f-8579-4d85-83e6-88ee20887c8d" xlink:to="loc_ccrn_SalesAllowanceBillingRelatedAdjustments_c45f981d-7ea5-481e-a983-cf196fa96212" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_ThresholdPeriodPastDueForPaymentOfServicesProvided_0365342e-40af-444a-b41f-af288491628a" xlink:href="ccrn-20220930.xsd#ccrn_ThresholdPeriodPastDueForPaymentOfServicesProvided"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_b4c5ed4f-8579-4d85-83e6-88ee20887c8d" xlink:to="loc_ccrn_ThresholdPeriodPastDueForPaymentOfServicesProvided_0365342e-40af-444a-b41f-af288491628a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAllowanceforDoubtfulAccountsDetails" xlink:type="simple" xlink:href="ccrn-20220930.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAllowanceforDoubtfulAccountsDetails"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAllowanceforDoubtfulAccountsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_08d55889-2732-4128-844e-b05717659674" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_a615842b-3e2a-4175-8aea-8869011c4364" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_08d55889-2732-4128-844e-b05717659674" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_a615842b-3e2a-4175-8aea-8869011c4364" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_c84cf0d3-678b-462e-b0f2-109b11698f34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_a615842b-3e2a-4175-8aea-8869011c4364" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_c84cf0d3-678b-462e-b0f2-109b11698f34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_2cd47723-f724-4881-88a8-a3a2555f9b75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_a615842b-3e2a-4175-8aea-8869011c4364" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_2cd47723-f724-4881-88a8-a3a2555f9b75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_a813b717-7287-4b46-ad5a-378355a49b42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_a615842b-3e2a-4175-8aea-8869011c4364" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_a813b717-7287-4b46-ad5a-378355a49b42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_73021608-8051-455e-9bc9-00c5bb3ecdfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_a615842b-3e2a-4175-8aea-8869011c4364" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_73021608-8051-455e-9bc9-00c5bb3ecdfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRestructuringBenefitsCostsDetails" xlink:type="simple" xlink:href="ccrn-20220930.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRestructuringBenefitsCostsDetails"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRestructuringBenefitsCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_4385394b-36b2-4052-877a-05b20b135a9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f165617f-44ab-4693-ac19-7cf972ca045a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4385394b-36b2-4052-877a-05b20b135a9e" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f165617f-44ab-4693-ac19-7cf972ca045a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_8f81f60f-68f1-4659-a521-770c5e98672b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f165617f-44ab-4693-ac19-7cf972ca045a" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_8f81f60f-68f1-4659-a521-770c5e98672b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_39c41bfb-4d5a-40ac-bfef-f9261e12d5b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_8f81f60f-68f1-4659-a521-770c5e98672b" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_39c41bfb-4d5a-40ac-bfef-f9261e12d5b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_62189c83-c05f-40ff-8166-439679a9459a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_39c41bfb-4d5a-40ac-bfef-f9261e12d5b7" xlink:to="loc_us-gaap_EmployeeSeveranceMember_62189c83-c05f-40ff-8166-439679a9459a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_ExitCostsMember_e88bbfe4-16d6-4904-a208-1d493bfc5c85" xlink:href="ccrn-20220930.xsd#ccrn_ExitCostsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_39c41bfb-4d5a-40ac-bfef-f9261e12d5b7" xlink:to="loc_ccrn_ExitCostsMember_e88bbfe4-16d6-4904-a208-1d493bfc5c85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_5248534b-857c-4d95-a7f0-862c8c9e3277" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f165617f-44ab-4693-ac19-7cf972ca045a" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_5248534b-857c-4d95-a7f0-862c8c9e3277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_00a22f8b-ffee-41d4-b101-ae0860558fb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5248534b-857c-4d95-a7f0-862c8c9e3277" xlink:to="loc_us-gaap_RestructuringReserveRollForward_00a22f8b-ffee-41d4-b101-ae0860558fb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_2be25edd-a767-402f-af06-52ca3e654186" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_00a22f8b-ffee-41d4-b101-ae0860558fb5" xlink:to="loc_us-gaap_RestructuringReserve_2be25edd-a767-402f-af06-52ca3e654186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_9b39e985-a437-4fac-b3e3-f4dd068dafab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_00a22f8b-ffee-41d4-b101-ae0860558fb5" xlink:to="loc_us-gaap_RestructuringCharges_9b39e985-a437-4fac-b3e3-f4dd068dafab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_PaymentsForRestructuringAndAdjustments_57309bae-aafe-4d9c-b8fd-ea03b2872f99" xlink:href="ccrn-20220930.xsd#ccrn_PaymentsForRestructuringAndAdjustments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_00a22f8b-ffee-41d4-b101-ae0860558fb5" xlink:to="loc_ccrn_PaymentsForRestructuringAndAdjustments_57309bae-aafe-4d9c-b8fd-ea03b2872f99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_9c8f8062-1520-4ee3-89d3-b7950a6886f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_00a22f8b-ffee-41d4-b101-ae0860558fb5" xlink:to="loc_us-gaap_PaymentsForRestructuring_9c8f8062-1520-4ee3-89d3-b7950a6886f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_13f73075-39a3-4a6f-b557-113e06ae272a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_00a22f8b-ffee-41d4-b101-ae0860558fb5" xlink:to="loc_us-gaap_RestructuringReserve_13f73075-39a3-4a6f-b557-113e06ae272a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1_6c273140-b382-4199-a1d6-5a68b8b1cb20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessExitCosts1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5248534b-857c-4d95-a7f0-862c8c9e3277" xlink:to="loc_us-gaap_BusinessExitCosts1_6c273140-b382-4199-a1d6-5a68b8b1cb20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/REVENUERECOGNITIONDetails" xlink:type="simple" xlink:href="ccrn-20220930.xsd#REVENUERECOGNITIONDetails"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/REVENUERECOGNITIONDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_0c4884f2-64ce-4a4c-b548-4880aadb967d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_a39b35ab-6945-4913-81b7-ff92e679e5bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_0c4884f2-64ce-4a4c-b548-4880aadb967d" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_a39b35ab-6945-4913-81b7-ff92e679e5bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_5eb47678-9d92-4960-8dc7-b5975771ec8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_a39b35ab-6945-4913-81b7-ff92e679e5bf" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_5eb47678-9d92-4960-8dc7-b5975771ec8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_64e0c42e-a642-4cbd-800d-3459214b7773" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_5eb47678-9d92-4960-8dc7-b5975771ec8d" xlink:to="loc_us-gaap_SegmentDomain_64e0c42e-a642-4cbd-800d-3459214b7773" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_NurseAndAlliedStaffingMember_918650f2-cafc-4ca7-a4d8-1385c0844ccf" xlink:href="ccrn-20220930.xsd#ccrn_NurseAndAlliedStaffingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_64e0c42e-a642-4cbd-800d-3459214b7773" xlink:to="loc_ccrn_NurseAndAlliedStaffingMember_918650f2-cafc-4ca7-a4d8-1385c0844ccf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_PhysicianStaffingMember_8ff40de3-ada5-413d-8a75-ec9ac8536d2d" xlink:href="ccrn-20220930.xsd#ccrn_PhysicianStaffingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_64e0c42e-a642-4cbd-800d-3459214b7773" xlink:to="loc_ccrn_PhysicianStaffingMember_8ff40de3-ada5-413d-8a75-ec9ac8536d2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_c194d117-e7a5-4c0b-aefb-b3c93aaf54ac" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_a39b35ab-6945-4913-81b7-ff92e679e5bf" xlink:to="loc_srt_ProductOrServiceAxis_c194d117-e7a5-4c0b-aefb-b3c93aaf54ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_cb9e820c-bbcb-4841-94d1-1142d1884fa4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_c194d117-e7a5-4c0b-aefb-b3c93aaf54ac" xlink:to="loc_srt_ProductsAndServicesDomain_cb9e820c-bbcb-4841-94d1-1142d1884fa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_TemporaryStaffingServicesMember_175a75b0-e59e-4dc0-9646-49514f3e90b3" xlink:href="ccrn-20220930.xsd#ccrn_TemporaryStaffingServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_cb9e820c-bbcb-4841-94d1-1142d1884fa4" xlink:to="loc_ccrn_TemporaryStaffingServicesMember_175a75b0-e59e-4dc0-9646-49514f3e90b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_OtherServicesMember_a0360756-0176-4355-b24b-75321ba8f80f" xlink:href="ccrn-20220930.xsd#ccrn_OtherServicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_cb9e820c-bbcb-4841-94d1-1142d1884fa4" xlink:to="loc_ccrn_OtherServicesMember_a0360756-0176-4355-b24b-75321ba8f80f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_371a8929-8c63-4d15-bae5-ddb5e7032db9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_a39b35ab-6945-4913-81b7-ff92e679e5bf" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_371a8929-8c63-4d15-bae5-ddb5e7032db9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_79dbe620-fab8-4d65-94e2-2ae3cd4393ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_371a8929-8c63-4d15-bae5-ddb5e7032db9" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_79dbe620-fab8-4d65-94e2-2ae3cd4393ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/ACQUISITIONSAdditionalInformationDetails" xlink:type="simple" xlink:href="ccrn-20220930.xsd#ACQUISITIONSAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/ACQUISITIONSAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_c0c20882-40c3-45db-a89e-8534508657f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e9c16159-2661-4c18-b08b-bf9bcafe3113" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_c0c20882-40c3-45db-a89e-8534508657f1" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e9c16159-2661-4c18-b08b-bf9bcafe3113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_000cad95-a752-4256-88ad-0eb310bf8bce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e9c16159-2661-4c18-b08b-bf9bcafe3113" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_000cad95-a752-4256-88ad-0eb310bf8bce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0f31305d-a88c-4607-866e-477690d51697" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_000cad95-a752-4256-88ad-0eb310bf8bce" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0f31305d-a88c-4607-866e-477690d51697" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_SelectedIncMember_59a22fdf-cc61-48ed-832d-4d1fcaf90ba5" xlink:href="ccrn-20220930.xsd#ccrn_SelectedIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0f31305d-a88c-4607-866e-477690d51697" xlink:to="loc_ccrn_SelectedIncMember_59a22fdf-cc61-48ed-832d-4d1fcaf90ba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_WorkforceSolutionsGroupIncMember_cb306978-420b-4a43-8105-3b916b432909" xlink:href="ccrn-20220930.xsd#ccrn_WorkforceSolutionsGroupIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0f31305d-a88c-4607-866e-477690d51697" xlink:to="loc_ccrn_WorkforceSolutionsGroupIncMember_cb306978-420b-4a43-8105-3b916b432909" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ff46a853-d49a-41f4-bda1-05ef0f1d1efc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e9c16159-2661-4c18-b08b-bf9bcafe3113" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ff46a853-d49a-41f4-bda1-05ef0f1d1efc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5f45dcac-97b7-4d87-8d05-350cec6e4c80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ff46a853-d49a-41f4-bda1-05ef0f1d1efc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5f45dcac-97b7-4d87-8d05-350cec6e4c80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_017a0456-973f-463b-9f78-16c91cf2e48f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5f45dcac-97b7-4d87-8d05-350cec6e4c80" xlink:to="loc_us-gaap_TradeNamesMember_017a0456-973f-463b-9f78-16c91cf2e48f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_9b7539d6-c97c-46be-829b-3d38f4de5149" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5f45dcac-97b7-4d87-8d05-350cec6e4c80" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_9b7539d6-c97c-46be-829b-3d38f4de5149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DatabasesMember_47518144-1d81-48b6-ba2b-b6504c10ddfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DatabasesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5f45dcac-97b7-4d87-8d05-350cec6e4c80" xlink:to="loc_us-gaap_DatabasesMember_47518144-1d81-48b6-ba2b-b6504c10ddfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_3482d499-6072-4c86-a589-2c4c69976200" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5f45dcac-97b7-4d87-8d05-350cec6e4c80" xlink:to="loc_us-gaap_CustomerRelationshipsMember_3482d499-6072-4c86-a589-2c4c69976200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_bd489b33-cd33-43e8-8f74-3f40aecc11eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e9c16159-2661-4c18-b08b-bf9bcafe3113" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_bd489b33-cd33-43e8-8f74-3f40aecc11eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_e74675ca-2fae-442e-92ba-f0f3329574c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bd489b33-cd33-43e8-8f74-3f40aecc11eb" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_e74675ca-2fae-442e-92ba-f0f3329574c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_5747e825-82a4-4440-8a10-713404c3bf04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bd489b33-cd33-43e8-8f74-3f40aecc11eb" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_5747e825-82a4-4440-8a10-713404c3bf04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_d490418f-cd7a-478a-a4cd-fb446df592f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bd489b33-cd33-43e8-8f74-3f40aecc11eb" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_d490418f-cd7a-478a-a4cd-fb446df592f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_24329039-a7cd-41ff-a377-1ea98e6dde57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bd489b33-cd33-43e8-8f74-3f40aecc11eb" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_24329039-a7cd-41ff-a377-1ea98e6dde57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_a04957d6-7e9d-444a-a2dd-e75a232042fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bd489b33-cd33-43e8-8f74-3f40aecc11eb" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_a04957d6-7e9d-444a-a2dd-e75a232042fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_ed05130e-868e-4710-b76e-e4c064b942a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bd489b33-cd33-43e8-8f74-3f40aecc11eb" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_ed05130e-868e-4710-b76e-e4c064b942a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_953cc97d-a343-4592-9ddd-1b0de80d7575" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bd489b33-cd33-43e8-8f74-3f40aecc11eb" xlink:to="loc_us-gaap_Goodwill_953cc97d-a343-4592-9ddd-1b0de80d7575" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment_9551b535-694a-4374-929c-5ca24a297da7" xlink:href="ccrn-20220930.xsd#ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bd489b33-cd33-43e8-8f74-3f40aecc11eb" xlink:to="loc_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment_9551b535-694a-4374-929c-5ca24a297da7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_BusinessCombinationContingentConsiderationTerm_2d5a8d26-6c54-4b06-b252-762b354dd7ee" xlink:href="ccrn-20220930.xsd#ccrn_BusinessCombinationContingentConsiderationTerm"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bd489b33-cd33-43e8-8f74-3f40aecc11eb" xlink:to="loc_ccrn_BusinessCombinationContingentConsiderationTerm_2d5a8d26-6c54-4b06-b252-762b354dd7ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_1d941130-3701-426c-997d-a6a723e0c30d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bd489b33-cd33-43e8-8f74-3f40aecc11eb" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_1d941130-3701-426c-997d-a6a723e0c30d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_0a549383-b44b-4938-a56d-dba72fd181c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bd489b33-cd33-43e8-8f74-3f40aecc11eb" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_0a549383-b44b-4938-a56d-dba72fd181c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="ccrn-20220930.xsd#ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_3ea2862e-3ae9-4329-ba20-7fb1050143ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_883204ba-beee-4dcc-8100-b698b9be4eec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_3ea2862e-3ae9-4329-ba20-7fb1050143ce" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_883204ba-beee-4dcc-8100-b698b9be4eec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_f05874a4-83d6-481d-8694-41c2ddcff3ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_883204ba-beee-4dcc-8100-b698b9be4eec" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_f05874a4-83d6-481d-8694-41c2ddcff3ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3305d38b-1ec5-4cca-b873-b4d536a1ddc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f05874a4-83d6-481d-8694-41c2ddcff3ea" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3305d38b-1ec5-4cca-b873-b4d536a1ddc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_WorkforceSolutionsGroupIncMember_ce48a44f-3643-4436-923a-aa6ad8a1a34d" xlink:href="ccrn-20220930.xsd#ccrn_WorkforceSolutionsGroupIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3305d38b-1ec5-4cca-b873-b4d536a1ddc6" xlink:to="loc_ccrn_WorkforceSolutionsGroupIncMember_ce48a44f-3643-4436-923a-aa6ad8a1a34d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_ea937ff2-3609-48f0-b544-3afe4637b0f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_883204ba-beee-4dcc-8100-b698b9be4eec" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_ea937ff2-3609-48f0-b544-3afe4637b0f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_7e8943f1-ee93-4eb6-88bc-62827ea97e9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ea937ff2-3609-48f0-b544-3afe4637b0f7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_7e8943f1-ee93-4eb6-88bc-62827ea97e9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_af69c5b6-63a7-4b05-af90-2b503a3f00ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ea937ff2-3609-48f0-b544-3afe4637b0f7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_af69c5b6-63a7-4b05-af90-2b503a3f00ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_7a478d8e-01a7-4eee-9d66-2ab7b73a5aa5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ea937ff2-3609-48f0-b544-3afe4637b0f7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_7a478d8e-01a7-4eee-9d66-2ab7b73a5aa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_db2f63d2-3f67-4756-a0f0-665f082ec3b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ea937ff2-3609-48f0-b544-3afe4637b0f7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_db2f63d2-3f67-4756-a0f0-665f082ec3b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_b46927e5-9f61-4259-a953-f3820a3fd64e" xlink:href="ccrn-20220930.xsd#ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ea937ff2-3609-48f0-b544-3afe4637b0f7" xlink:to="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_b46927e5-9f61-4259-a953-f3820a3fd64e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_babeecab-9f71-4b5b-a5da-15bc40965cd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ea937ff2-3609-48f0-b544-3afe4637b0f7" xlink:to="loc_us-gaap_Goodwill_babeecab-9f71-4b5b-a5da-15bc40965cd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_eb441b70-d2d7-4784-8577-17be78d168d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ea937ff2-3609-48f0-b544-3afe4637b0f7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_eb441b70-d2d7-4784-8577-17be78d168d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_35fe825e-62e8-484d-b46b-e9a8211298a6" xlink:href="ccrn-20220930.xsd#ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ea937ff2-3609-48f0-b544-3afe4637b0f7" xlink:to="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_35fe825e-62e8-484d-b46b-e9a8211298a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_b8cd071f-5530-4dcf-bf0e-f434766d8938" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ea937ff2-3609-48f0-b544-3afe4637b0f7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_b8cd071f-5530-4dcf-bf0e-f434766d8938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensationAndBenefits_6552390d-562c-459c-ab1f-cf1ce51be14c" xlink:href="ccrn-20220930.xsd#ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensationAndBenefits"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ea937ff2-3609-48f0-b544-3afe4637b0f7" xlink:to="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensationAndBenefits_6552390d-562c-459c-ab1f-cf1ce51be14c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationCurrent_22f5ab8e-7c82-487f-9e75-cf6c467541b4" xlink:href="ccrn-20220930.xsd#ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationCurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ea937ff2-3609-48f0-b544-3afe4637b0f7" xlink:to="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationCurrent_22f5ab8e-7c82-487f-9e75-cf6c467541b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationNoncurrent_822e1de2-344c-4a16-9809-98986dc26e9d" xlink:href="ccrn-20220930.xsd#ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationNoncurrent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ea937ff2-3609-48f0-b544-3afe4637b0f7" xlink:to="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationNoncurrent_822e1de2-344c-4a16-9809-98986dc26e9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_5054f488-7ff0-4c5e-90e2-28e80299b3e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ea937ff2-3609-48f0-b544-3afe4637b0f7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_5054f488-7ff0-4c5e-90e2-28e80299b3e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_1fc25e96-86a1-4a98-9503-eea9a3695bad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ea937ff2-3609-48f0-b544-3afe4637b0f7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_1fc25e96-86a1-4a98-9503-eea9a3695bad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_999aa24c-fb89-4a6c-87fa-0d55b638d546" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ea937ff2-3609-48f0-b544-3afe4637b0f7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_999aa24c-fb89-4a6c-87fa-0d55b638d546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/COMPREHENSIVEINCOMEDetails" xlink:type="simple" xlink:href="ccrn-20220930.xsd#COMPREHENSIVEINCOMEDetails"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/COMPREHENSIVEINCOMEDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_2ff2e870-c33f-4d19-8932-e2949a8a67f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax_9f73e050-e6df-41b7-ab12-370e4aa39ec5" xlink:href="ccrn-20220930.xsd#ccrn_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_2ff2e870-c33f-4d19-8932-e2949a8a67f9" xlink:to="loc_ccrn_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax_9f73e050-e6df-41b7-ab12-370e4aa39ec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREComponentsofNumeratorandDenominatorforComputationofBasicandDilutedEarningsperShareDetails" xlink:type="simple" xlink:href="ccrn-20220930.xsd#EARNINGSPERSHAREComponentsofNumeratorandDenominatorforComputationofBasicandDilutedEarningsperShareDetails"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREComponentsofNumeratorandDenominatorforComputationofBasicandDilutedEarningsperShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_14951589-c630-46fa-abf5-f0c430ca8ffd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_9d72cd48-9e26-4781-9f7a-fa212bfa702f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_14951589-c630-46fa-abf5-f0c430ca8ffd" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_9d72cd48-9e26-4781-9f7a-fa212bfa702f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_1d342d2d-5b42-4faa-9007-2529b1b359cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_9d72cd48-9e26-4781-9f7a-fa212bfa702f" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_1d342d2d-5b42-4faa-9007-2529b1b359cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_30a0ec28-8561-4a56-8109-36b9b1610186" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_9d72cd48-9e26-4781-9f7a-fa212bfa702f" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_30a0ec28-8561-4a56-8109-36b9b1610186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_8978d926-e64f-4b04-a2be-9f843eda1187" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_14951589-c630-46fa-abf5-f0c430ca8ffd" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_8978d926-e64f-4b04-a2be-9f843eda1187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_80af7973-70c9-4e8e-89f8-fe03f865473a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_8978d926-e64f-4b04-a2be-9f843eda1187" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_80af7973-70c9-4e8e-89f8-fe03f865473a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_102a190c-efc8-49cc-9cfc-4a57f6ec325d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_8978d926-e64f-4b04-a2be-9f843eda1187" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_102a190c-efc8-49cc-9cfc-4a57f6ec325d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_e77b9dca-ddcb-4737-9dd2-b82d4ef714b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_102a190c-efc8-49cc-9cfc-4a57f6ec325d" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_e77b9dca-ddcb-4737-9dd2-b82d4ef714b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_bf18b301-549a-4f5b-b6fd-c5accf63de62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_8978d926-e64f-4b04-a2be-9f843eda1187" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_bf18b301-549a-4f5b-b6fd-c5accf63de62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_5c3784b0-406f-48c6-a223-c7b55a773264" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_14951589-c630-46fa-abf5-f0c430ca8ffd" xlink:to="loc_us-gaap_EarningsPerShareBasic_5c3784b0-406f-48c6-a223-c7b55a773264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_edc246a8-e6b7-42b1-a6c8-335fcb94181f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_14951589-c630-46fa-abf5-f0c430ca8ffd" xlink:to="loc_us-gaap_EarningsPerShareDiluted_edc246a8-e6b7-42b1-a6c8-335fcb94181f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREAntidilutiveSecuritiesDetails" xlink:type="simple" xlink:href="ccrn-20220930.xsd#EARNINGSPERSHAREAntidilutiveSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREAntidilutiveSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_b6899aea-878d-45ad-b145-3f096c57438a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_a893adbc-d682-4a4b-912c-54d33a828d5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b6899aea-878d-45ad-b145-3f096c57438a" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_a893adbc-d682-4a4b-912c-54d33a828d5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a3b6b948-65b3-4f50-81c5-b973bc1c4cd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_a893adbc-d682-4a4b-912c-54d33a828d5a" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a3b6b948-65b3-4f50-81c5-b973bc1c4cd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_502fd690-2e0e-45f2-a6b1-78c79b5550b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a3b6b948-65b3-4f50-81c5-b973bc1c4cd6" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_502fd690-2e0e-45f2-a6b1-78c79b5550b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_ShareBasedPaymentAwardsMember_182d5ec1-d8eb-4041-95c1-d342575c78bb" xlink:href="ccrn-20220930.xsd#ccrn_ShareBasedPaymentAwardsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_502fd690-2e0e-45f2-a6b1-78c79b5550b8" xlink:to="loc_ccrn_ShareBasedPaymentAwardsMember_182d5ec1-d8eb-4041-95c1-d342575c78bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_59973eca-517f-48a2-bf75-1a68bdfced8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_a893adbc-d682-4a4b-912c-54d33a828d5a" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_59973eca-517f-48a2-bf75-1a68bdfced8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2bfd36e1-e625-4b12-bd52-8e6b2f1b8b17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_59973eca-517f-48a2-bf75-1a68bdfced8c" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2bfd36e1-e625-4b12-bd52-8e6b2f1b8b17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails" xlink:type="simple" xlink:href="ccrn-20220930.xsd#GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8b227377-2368-49e9-81dd-bf96d58f772c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable_e428dd88-0200-4607-9917-5fd1d1faddba" xlink:href="ccrn-20220930.xsd#ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8b227377-2368-49e9-81dd-bf96d58f772c" xlink:to="loc_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable_e428dd88-0200-4607-9917-5fd1d1faddba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e590e258-1881-4b0f-8366-c422d916b79a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable_e428dd88-0200-4607-9917-5fd1d1faddba" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e590e258-1881-4b0f-8366-c422d916b79a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c24764ba-416c-4ef0-83d7-e2173403c2f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e590e258-1881-4b0f-8366-c422d916b79a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c24764ba-416c-4ef0-83d7-e2173403c2f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DatabasesMember_7c65aaf3-ee62-4652-a6de-ea620ab0eeaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DatabasesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c24764ba-416c-4ef0-83d7-e2173403c2f1" xlink:to="loc_us-gaap_DatabasesMember_7c65aaf3-ee62-4652-a6de-ea620ab0eeaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_1fbd9d18-a3b4-45c5-98eb-ef62b6253f83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c24764ba-416c-4ef0-83d7-e2173403c2f1" xlink:to="loc_us-gaap_CustomerRelationshipsMember_1fbd9d18-a3b4-45c5-98eb-ef62b6253f83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_b7d9db71-501c-47d0-9378-10e0e73c63d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c24764ba-416c-4ef0-83d7-e2173403c2f1" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_b7d9db71-501c-47d0-9378-10e0e73c63d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_9d28c7cd-b6f4-426f-9941-9d33a8a8a025" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c24764ba-416c-4ef0-83d7-e2173403c2f1" xlink:to="loc_us-gaap_TradeNamesMember_9d28c7cd-b6f4-426f-9941-9d33a8a8a025" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_cfb89433-9ae4-4342-bff0-88b13c07bb02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c24764ba-416c-4ef0-83d7-e2173403c2f1" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_cfb89433-9ae4-4342-bff0-88b13c07bb02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_073f833d-12c4-4fb1-b096-6271d7bfac06" xlink:href="ccrn-20220930.xsd#ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable_e428dd88-0200-4607-9917-5fd1d1faddba" xlink:to="loc_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_073f833d-12c4-4fb1-b096-6271d7bfac06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_719ac280-1bec-4b3a-853b-05a805bddb01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_073f833d-12c4-4fb1-b096-6271d7bfac06" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_719ac280-1bec-4b3a-853b-05a805bddb01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_98d68974-d76a-4164-8c64-72a1d71254cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_719ac280-1bec-4b3a-853b-05a805bddb01" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_98d68974-d76a-4164-8c64-72a1d71254cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_6cc027a6-c6a1-44aa-978f-eefc460ad236" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_719ac280-1bec-4b3a-853b-05a805bddb01" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_6cc027a6-c6a1-44aa-978f-eefc460ad236" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f963c453-96d4-44e1-b458-b72bf4e96631" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_719ac280-1bec-4b3a-853b-05a805bddb01" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f963c453-96d4-44e1-b458-b72bf4e96631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_949bbe6d-cd91-475e-9102-9085c666918d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_073f833d-12c4-4fb1-b096-6271d7bfac06" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_949bbe6d-cd91-475e-9102-9085c666918d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedTradeNames_d9f303eb-e108-4879-b61f-cda2572a3207" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedTradeNames"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_949bbe6d-cd91-475e-9102-9085c666918d" xlink:to="loc_us-gaap_IndefiniteLivedTradeNames_d9f303eb-e108-4879-b61f-cda2572a3207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSEstimatedAnnualAmortizationExpenseDetails" xlink:type="simple" xlink:href="ccrn-20220930.xsd#GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSEstimatedAnnualAmortizationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSEstimatedAnnualAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1c350f48-2aa0-40b8-bb7f-7f08c22a4fdd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_9b1157e7-a3ed-40ee-8291-6e766d69885c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1c350f48-2aa0-40b8-bb7f-7f08c22a4fdd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_9b1157e7-a3ed-40ee-8291-6e766d69885c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_abcb8a79-c062-4f4e-8145-a43161fa1a56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1c350f48-2aa0-40b8-bb7f-7f08c22a4fdd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_abcb8a79-c062-4f4e-8145-a43161fa1a56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_2cca9877-310d-4ee6-8063-ae3aa3eecc9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1c350f48-2aa0-40b8-bb7f-7f08c22a4fdd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_2cca9877-310d-4ee6-8063-ae3aa3eecc9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_529f481e-a0f1-492c-bc46-76806130da82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1c350f48-2aa0-40b8-bb7f-7f08c22a4fdd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_529f481e-a0f1-492c-bc46-76806130da82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_b6433fd5-6955-442a-bcee-cf618f46e774" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1c350f48-2aa0-40b8-bb7f-7f08c22a4fdd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_b6433fd5-6955-442a-bcee-cf618f46e774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_e27e3691-d0c8-4b90-b103-afca45477853" xlink:href="ccrn-20220930.xsd#ccrn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1c350f48-2aa0-40b8-bb7f-7f08c22a4fdd" xlink:to="loc_ccrn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_e27e3691-d0c8-4b90-b103-afca45477853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2d342ce3-0e87-4f23-a8c4-d4ca601673f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1c350f48-2aa0-40b8-bb7f-7f08c22a4fdd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2d342ce3-0e87-4f23-a8c4-d4ca601673f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails" xlink:type="simple" xlink:href="ccrn-20220930.xsd#GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9e1f582f-2848-41e0-a93c-2f9d513abb63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_d87c8c83-4cc2-43ee-a705-cef755cbadd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9e1f582f-2848-41e0-a93c-2f9d513abb63" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_d87c8c83-4cc2-43ee-a705-cef755cbadd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_837d2b58-0e57-46c4-970c-d8edd71bd6bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_d87c8c83-4cc2-43ee-a705-cef755cbadd0" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_837d2b58-0e57-46c4-970c-d8edd71bd6bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f14eb066-e807-49c9-ad31-70c9e97057fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_837d2b58-0e57-46c4-970c-d8edd71bd6bc" xlink:to="loc_us-gaap_SegmentDomain_f14eb066-e807-49c9-ad31-70c9e97057fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_NurseAndAlliedStaffingMember_62463bd6-ce2f-4ec8-bc3a-15b2e6abfcdc" xlink:href="ccrn-20220930.xsd#ccrn_NurseAndAlliedStaffingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f14eb066-e807-49c9-ad31-70c9e97057fb" xlink:to="loc_ccrn_NurseAndAlliedStaffingMember_62463bd6-ce2f-4ec8-bc3a-15b2e6abfcdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_PhysicianStaffingMember_3ebb8e8d-273b-4c49-b2d8-4e3fb53598cf" xlink:href="ccrn-20220930.xsd#ccrn_PhysicianStaffingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f14eb066-e807-49c9-ad31-70c9e97057fb" xlink:to="loc_ccrn_PhysicianStaffingMember_3ebb8e8d-273b-4c49-b2d8-4e3fb53598cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_00d60041-32bc-4e3e-9db0-c43070088bba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_d87c8c83-4cc2-43ee-a705-cef755cbadd0" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_00d60041-32bc-4e3e-9db0-c43070088bba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_118746a9-04dd-4bf9-9ab6-98566dafd468" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_00d60041-32bc-4e3e-9db0-c43070088bba" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_118746a9-04dd-4bf9-9ab6-98566dafd468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_2ad55d63-397a-4ca7-b84d-071d7a4a743d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_118746a9-04dd-4bf9-9ab6-98566dafd468" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_2ad55d63-397a-4ca7-b84d-071d7a4a743d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_e8d25f82-bc73-4f41-a556-3c856c799b16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_d87c8c83-4cc2-43ee-a705-cef755cbadd0" xlink:to="loc_us-gaap_GoodwillLineItems_e8d25f82-bc73-4f41-a556-3c856c799b16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_61aa3cbf-c5bb-4063-aceb-6ac41db3dab6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_e8d25f82-bc73-4f41-a556-3c856c799b16" xlink:to="loc_us-gaap_GoodwillRollForward_61aa3cbf-c5bb-4063-aceb-6ac41db3dab6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_605cc896-0963-45ab-a4e3-e29c47ee5a10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_61aa3cbf-c5bb-4063-aceb-6ac41db3dab6" xlink:to="loc_us-gaap_GoodwillGross_605cc896-0963-45ab-a4e3-e29c47ee5a10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_06f8a5bd-6c0c-4611-8ebb-f4ad0bf93aff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_61aa3cbf-c5bb-4063-aceb-6ac41db3dab6" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_06f8a5bd-6c0c-4611-8ebb-f4ad0bf93aff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_89690875-6ebd-499c-8f71-a6a6e394f2e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_61aa3cbf-c5bb-4063-aceb-6ac41db3dab6" xlink:to="loc_us-gaap_Goodwill_89690875-6ebd-499c-8f71-a6a6e394f2e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_97b318d8-a729-4372-a09d-825e78a2f150" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_61aa3cbf-c5bb-4063-aceb-6ac41db3dab6" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_97b318d8-a729-4372-a09d-825e78a2f150" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_8aecf45e-1bef-4ada-97d0-9955a8b16ce2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillGross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_61aa3cbf-c5bb-4063-aceb-6ac41db3dab6" xlink:to="loc_us-gaap_GoodwillGross_8aecf45e-1bef-4ada-97d0-9955a8b16ce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_b803f658-d20b-4333-86be-a815bd017a3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_61aa3cbf-c5bb-4063-aceb-6ac41db3dab6" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_b803f658-d20b-4333-86be-a815bd017a3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_aaa7bc47-fe30-4daa-8f00-28361802f915" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_61aa3cbf-c5bb-4063-aceb-6ac41db3dab6" xlink:to="loc_us-gaap_Goodwill_aaa7bc47-fe30-4daa-8f00-28361802f915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAdditionalInformationDetails" xlink:type="simple" xlink:href="ccrn-20220930.xsd#GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b0f82a5f-74e2-4edb-8d4f-1f0eb10ffda1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_e1bea6d5-077c-4328-80d4-b1449c7ab262" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b0f82a5f-74e2-4edb-8d4f-1f0eb10ffda1" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_e1bea6d5-077c-4328-80d4-b1449c7ab262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails" xlink:type="simple" xlink:href="ccrn-20220930.xsd#DEBTLongtermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_223eb064-938b-4904-8f19-5815d92fc40c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_dabb96d4-4544-4faa-92ff-44ea2cbc863e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_223eb064-938b-4904-8f19-5815d92fc40c" xlink:to="loc_us-gaap_DebtInstrumentTable_dabb96d4-4544-4faa-92ff-44ea2cbc863e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_249c57eb-f4db-483b-b70c-9a5411ef40fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_dabb96d4-4544-4faa-92ff-44ea2cbc863e" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_249c57eb-f4db-483b-b70c-9a5411ef40fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_783bce22-cfe8-4330-b226-c345de4a6d3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_249c57eb-f4db-483b-b70c-9a5411ef40fb" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_783bce22-cfe8-4330-b226-c345de4a6d3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_670b07d2-48c5-4b81-8a5b-4a634fc41f62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_783bce22-cfe8-4330-b226-c345de4a6d3e" xlink:to="loc_us-gaap_SecuredDebtMember_670b07d2-48c5-4b81-8a5b-4a634fc41f62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_e655c914-6df2-4946-adc8-a43f4eef74be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_783bce22-cfe8-4330-b226-c345de4a6d3e" xlink:to="loc_us-gaap_LineOfCreditMember_e655c914-6df2-4946-adc8-a43f4eef74be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_f054f43e-a848-42bd-9557-0e0703d34dd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_783bce22-cfe8-4330-b226-c345de4a6d3e" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_f054f43e-a848-42bd-9557-0e0703d34dd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_13831b43-e536-408b-b4a6-63d6a9e910a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_dabb96d4-4544-4faa-92ff-44ea2cbc863e" xlink:to="loc_us-gaap_DebtInstrumentAxis_13831b43-e536-408b-b4a6-63d6a9e910a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_046cdda5-e01a-4877-b72c-353cda05610e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_13831b43-e536-408b-b4a6-63d6a9e910a4" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_046cdda5-e01a-4877-b72c-353cda05610e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_A2021TermLoanCreditAgreementMember_413c5d69-8fd1-4640-913d-07104ceaac8b" xlink:href="ccrn-20220930.xsd#ccrn_A2021TermLoanCreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_046cdda5-e01a-4877-b72c-353cda05610e" xlink:to="loc_ccrn_A2021TermLoanCreditAgreementMember_413c5d69-8fd1-4640-913d-07104ceaac8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_EarnoutNotesPayableMember_80be26be-34db-4e5f-b070-fd6910834b98" xlink:href="ccrn-20220930.xsd#ccrn_EarnoutNotesPayableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_046cdda5-e01a-4877-b72c-353cda05610e" xlink:to="loc_ccrn_EarnoutNotesPayableMember_80be26be-34db-4e5f-b070-fd6910834b98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_b473a61a-f978-4d5f-ab4f-745f48ec6fab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_dabb96d4-4544-4faa-92ff-44ea2cbc863e" xlink:to="loc_us-gaap_CreditFacilityAxis_b473a61a-f978-4d5f-ab4f-745f48ec6fab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_d6892715-7732-484d-8c30-fc033727930c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_b473a61a-f978-4d5f-ab4f-745f48ec6fab" xlink:to="loc_us-gaap_CreditFacilityDomain_d6892715-7732-484d-8c30-fc033727930c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_SeniorSecuredAssetBasedLoanMember_195b8d26-ec1e-41ec-ae68-56ee7acd0900" xlink:href="ccrn-20220930.xsd#ccrn_SeniorSecuredAssetBasedLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_d6892715-7732-484d-8c30-fc033727930c" xlink:to="loc_ccrn_SeniorSecuredAssetBasedLoanMember_195b8d26-ec1e-41ec-ae68-56ee7acd0900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_ebc17f55-bb2d-4fd8-8162-7bf65c3f402f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_dabb96d4-4544-4faa-92ff-44ea2cbc863e" xlink:to="loc_us-gaap_DebtInstrumentLineItems_ebc17f55-bb2d-4fd8-8162-7bf65c3f402f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_d7c5ecbe-9d50-4e2d-90dd-381ea839ae78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebc17f55-bb2d-4fd8-8162-7bf65c3f402f" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_d7c5ecbe-9d50-4e2d-90dd-381ea839ae78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_24ab8646-2346-49e6-9359-590bec420903" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebc17f55-bb2d-4fd8-8162-7bf65c3f402f" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_24ab8646-2346-49e6-9359-590bec420903" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_009ef3fb-a517-4715-83fe-e2dbce747d43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebc17f55-bb2d-4fd8-8162-7bf65c3f402f" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_009ef3fb-a517-4715-83fe-e2dbce747d43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_f732be18-6736-4d95-b0ab-a49e68f3bff2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebc17f55-bb2d-4fd8-8162-7bf65c3f402f" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_f732be18-6736-4d95-b0ab-a49e68f3bff2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_3a9df7c3-85eb-4355-a718-69c2f2ef0d89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebc17f55-bb2d-4fd8-8162-7bf65c3f402f" xlink:to="loc_us-gaap_LongTermDebtCurrent_3a9df7c3-85eb-4355-a718-69c2f2ef0d89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_49ac0915-8ee4-4be5-b9ed-977185cd8779" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebc17f55-bb2d-4fd8-8162-7bf65c3f402f" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_49ac0915-8ee4-4be5-b9ed-977185cd8779" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DEBT2021TermLoanCreditAgreementNarrativeDetails" xlink:type="simple" xlink:href="ccrn-20220930.xsd#DEBT2021TermLoanCreditAgreementNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/DEBT2021TermLoanCreditAgreementNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_65ee278a-1f9d-4eea-be7f-05b9f8afe3bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_c4a04060-0526-4e90-9052-2691098f322b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_65ee278a-1f9d-4eea-be7f-05b9f8afe3bd" xlink:to="loc_us-gaap_DebtInstrumentTable_c4a04060-0526-4e90-9052-2691098f322b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_f3339721-a003-4276-b7c7-d45887639774" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c4a04060-0526-4e90-9052-2691098f322b" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_f3339721-a003-4276-b7c7-d45887639774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_bf044dda-7cf9-4a11-b409-07d34a3e598d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f3339721-a003-4276-b7c7-d45887639774" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_bf044dda-7cf9-4a11-b409-07d34a3e598d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_4979d454-60fa-4883-8dc7-afb74f616632" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_bf044dda-7cf9-4a11-b409-07d34a3e598d" xlink:to="loc_us-gaap_SecuredDebtMember_4979d454-60fa-4883-8dc7-afb74f616632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_681cf294-9de3-4244-9731-1ec66d23bc1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c4a04060-0526-4e90-9052-2691098f322b" xlink:to="loc_us-gaap_DebtInstrumentAxis_681cf294-9de3-4244-9731-1ec66d23bc1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e9bedfbb-b9b7-418d-b854-a09e7e53ae59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_681cf294-9de3-4244-9731-1ec66d23bc1e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e9bedfbb-b9b7-418d-b854-a09e7e53ae59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_A2021TermLoanCreditAgreementMember_07617354-3228-490b-887e-2fa20b6aaf22" xlink:href="ccrn-20220930.xsd#ccrn_A2021TermLoanCreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e9bedfbb-b9b7-418d-b854-a09e7e53ae59" xlink:to="loc_ccrn_A2021TermLoanCreditAgreementMember_07617354-3228-490b-887e-2fa20b6aaf22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_A2021TermLoanCreditAgreementIncrementalTermLoanMember_c89d5e7c-1cc1-45f1-8d9e-a1f89b510902" xlink:href="ccrn-20220930.xsd#ccrn_A2021TermLoanCreditAgreementIncrementalTermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_A2021TermLoanCreditAgreementMember_07617354-3228-490b-887e-2fa20b6aaf22" xlink:to="loc_ccrn_A2021TermLoanCreditAgreementIncrementalTermLoanMember_c89d5e7c-1cc1-45f1-8d9e-a1f89b510902" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_A2021TermLoanCreditAgreementAggregateAmountOfAllPossibleIncreasesMember_10bb02e3-4479-41f1-a626-6c03ffa27627" xlink:href="ccrn-20220930.xsd#ccrn_A2021TermLoanCreditAgreementAggregateAmountOfAllPossibleIncreasesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_A2021TermLoanCreditAgreementMember_07617354-3228-490b-887e-2fa20b6aaf22" xlink:to="loc_ccrn_A2021TermLoanCreditAgreementAggregateAmountOfAllPossibleIncreasesMember_10bb02e3-4479-41f1-a626-6c03ffa27627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_287d3abe-7364-4761-a0b8-5df5c20086aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c4a04060-0526-4e90-9052-2691098f322b" xlink:to="loc_us-gaap_VariableRateAxis_287d3abe-7364-4761-a0b8-5df5c20086aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_00d7c551-f21d-4ae9-a736-88dcad4a48c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_287d3abe-7364-4761-a0b8-5df5c20086aa" xlink:to="loc_us-gaap_VariableRateDomain_00d7c551-f21d-4ae9-a736-88dcad4a48c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_3a568f8b-a55e-442e-a104-de9bbb749495" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_00d7c551-f21d-4ae9-a736-88dcad4a48c1" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_3a568f8b-a55e-442e-a104-de9bbb749495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_047b0fc1-303d-4f0d-9bfd-c80b66830f9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c4a04060-0526-4e90-9052-2691098f322b" xlink:to="loc_us-gaap_DebtInstrumentLineItems_047b0fc1-303d-4f0d-9bfd-c80b66830f9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_PaymentForDebtPrepayment_bcdd1545-32c9-4042-82db-64ee0261f29e" xlink:href="ccrn-20220930.xsd#ccrn_PaymentForDebtPrepayment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_047b0fc1-303d-4f0d-9bfd-c80b66830f9b" xlink:to="loc_ccrn_PaymentForDebtPrepayment_bcdd1545-32c9-4042-82db-64ee0261f29e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_05fef9b0-d55c-4833-9312-bb5cf50d3361" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_047b0fc1-303d-4f0d-9bfd-c80b66830f9b" xlink:to="loc_us-gaap_DebtInstrumentTerm_05fef9b0-d55c-4833-9312-bb5cf50d3361" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_34eec517-d529-426e-bf76-f07006308d75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_047b0fc1-303d-4f0d-9bfd-c80b66830f9b" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_34eec517-d529-426e-bf76-f07006308d75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_efd0de77-7a02-4beb-b990-44126ad484e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_047b0fc1-303d-4f0d-9bfd-c80b66830f9b" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_efd0de77-7a02-4beb-b990-44126ad484e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_DebtInstrumentVariableInterestRateFloor_c667256f-780a-4981-9341-96a27558d8a3" xlink:href="ccrn-20220930.xsd#ccrn_DebtInstrumentVariableInterestRateFloor"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_047b0fc1-303d-4f0d-9bfd-c80b66830f9b" xlink:to="loc_ccrn_DebtInstrumentVariableInterestRateFloor_c667256f-780a-4981-9341-96a27558d8a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_dac554cf-d187-4117-9a22-6273be5c83d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_047b0fc1-303d-4f0d-9bfd-c80b66830f9b" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_dac554cf-d187-4117-9a22-6273be5c83d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_bb648269-1957-4180-8b37-bfcd1bd6418e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_047b0fc1-303d-4f0d-9bfd-c80b66830f9b" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_bb648269-1957-4180-8b37-bfcd1bd6418e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_3cadd080-2fa4-4b9d-b02b-7abaf7eec67b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_047b0fc1-303d-4f0d-9bfd-c80b66830f9b" xlink:to="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_3cadd080-2fa4-4b9d-b02b-7abaf7eec67b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails" xlink:type="simple" xlink:href="ccrn-20220930.xsd#DEBTMaturitiesofDebtDetails"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_5aeb8237-4a95-4e1f-9ddb-fed815019fa5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_9d26cb43-7c53-44e1-b5aa-1e0830356edb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_5aeb8237-4a95-4e1f-9ddb-fed815019fa5" xlink:to="loc_us-gaap_DebtInstrumentTable_9d26cb43-7c53-44e1-b5aa-1e0830356edb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_942b5fcf-5e04-486d-9d6f-258bcadf8f0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9d26cb43-7c53-44e1-b5aa-1e0830356edb" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_942b5fcf-5e04-486d-9d6f-258bcadf8f0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_ea1957e1-e558-47db-be80-3e645b2381c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_942b5fcf-5e04-486d-9d6f-258bcadf8f0a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_ea1957e1-e558-47db-be80-3e645b2381c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_856d1dcc-db0b-4556-9943-0b62435740bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_ea1957e1-e558-47db-be80-3e645b2381c0" xlink:to="loc_us-gaap_SecuredDebtMember_856d1dcc-db0b-4556-9943-0b62435740bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_897ba653-d340-4438-80dd-71700c3d2ad6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_ea1957e1-e558-47db-be80-3e645b2381c0" xlink:to="loc_us-gaap_LineOfCreditMember_897ba653-d340-4438-80dd-71700c3d2ad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_5ba02cfa-bd2f-42cc-a4f6-0a4a46254de6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9d26cb43-7c53-44e1-b5aa-1e0830356edb" xlink:to="loc_us-gaap_DebtInstrumentAxis_5ba02cfa-bd2f-42cc-a4f6-0a4a46254de6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8921b654-d389-4462-894c-79d420ca9d96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_5ba02cfa-bd2f-42cc-a4f6-0a4a46254de6" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8921b654-d389-4462-894c-79d420ca9d96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_A2021TermLoanCreditAgreementMember_89fc5767-8006-41ec-8227-dc1c1260939c" xlink:href="ccrn-20220930.xsd#ccrn_A2021TermLoanCreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8921b654-d389-4462-894c-79d420ca9d96" xlink:to="loc_ccrn_A2021TermLoanCreditAgreementMember_89fc5767-8006-41ec-8227-dc1c1260939c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_8b364e41-e4b7-4693-af8a-34faff78c058" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9d26cb43-7c53-44e1-b5aa-1e0830356edb" xlink:to="loc_us-gaap_CreditFacilityAxis_8b364e41-e4b7-4693-af8a-34faff78c058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_95132634-063c-4d91-b23f-4c9c9740899b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_8b364e41-e4b7-4693-af8a-34faff78c058" xlink:to="loc_us-gaap_CreditFacilityDomain_95132634-063c-4d91-b23f-4c9c9740899b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_SeniorSecuredAssetBasedLoanMember_1812519b-a444-463d-a61e-6f2c5973e49c" xlink:href="ccrn-20220930.xsd#ccrn_SeniorSecuredAssetBasedLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_95132634-063c-4d91-b23f-4c9c9740899b" xlink:to="loc_ccrn_SeniorSecuredAssetBasedLoanMember_1812519b-a444-463d-a61e-6f2c5973e49c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_75837fb5-58cc-4bc0-aaeb-3381b00d7952" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9d26cb43-7c53-44e1-b5aa-1e0830356edb" xlink:to="loc_us-gaap_DebtInstrumentLineItems_75837fb5-58cc-4bc0-aaeb-3381b00d7952" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtByMaturityAbstract_79bec060-bb1d-4eaa-8ed9-58cee172afed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtByMaturityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_75837fb5-58cc-4bc0-aaeb-3381b00d7952" xlink:to="loc_us-gaap_LongTermDebtByMaturityAbstract_79bec060-bb1d-4eaa-8ed9-58cee172afed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_ced93a34-d2ba-4248-9f52-b39170926253" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_79bec060-bb1d-4eaa-8ed9-58cee172afed" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_ced93a34-d2ba-4248-9f52-b39170926253" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_9edb7b96-2ac8-4da1-a583-7d2536cdb0e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_79bec060-bb1d-4eaa-8ed9-58cee172afed" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_9edb7b96-2ac8-4da1-a583-7d2536cdb0e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_01076505-50d5-4e11-bf85-0eb93e9f6ecc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_79bec060-bb1d-4eaa-8ed9-58cee172afed" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_01076505-50d5-4e11-bf85-0eb93e9f6ecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_660c1328-b378-49aa-bd82-c28cf1507692" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_79bec060-bb1d-4eaa-8ed9-58cee172afed" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_660c1328-b378-49aa-bd82-c28cf1507692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_d0c934ef-fb7d-4b79-b8ee-7e5f26aa8927" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_79bec060-bb1d-4eaa-8ed9-58cee172afed" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_d0c934ef-fb7d-4b79-b8ee-7e5f26aa8927" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_LongTermDebtMaturityAfterYearFour_890d6fbe-a4a7-4fd3-b176-c652febbb85a" xlink:href="ccrn-20220930.xsd#ccrn_LongTermDebtMaturityAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_79bec060-bb1d-4eaa-8ed9-58cee172afed" xlink:to="loc_ccrn_LongTermDebtMaturityAfterYearFour_890d6fbe-a4a7-4fd3-b176-c652febbb85a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_6d025dff-59c7-40a7-b308-76803dc4e3fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_79bec060-bb1d-4eaa-8ed9-58cee172afed" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_6d025dff-59c7-40a7-b308-76803dc4e3fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails" xlink:type="simple" xlink:href="ccrn-20220930.xsd#DEBT2019LoanAgreementDetails"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_cee53f81-ba4c-4a72-97f4-fc2ca11d1e49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_4a5e520b-3d48-4438-8c93-b7e306f360cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_cee53f81-ba4c-4a72-97f4-fc2ca11d1e49" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_4a5e520b-3d48-4438-8c93-b7e306f360cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_9d9068a2-9814-4edd-968e-5db206afb568" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_4a5e520b-3d48-4438-8c93-b7e306f360cd" xlink:to="loc_us-gaap_CreditFacilityAxis_9d9068a2-9814-4edd-968e-5db206afb568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_0cee9449-b4b4-423d-ba55-ecbac65aee41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_9d9068a2-9814-4edd-968e-5db206afb568" xlink:to="loc_us-gaap_CreditFacilityDomain_0cee9449-b4b4-423d-ba55-ecbac65aee41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_SeniorSecuredAssetBasedLoanMember_14b7c889-1a9f-4675-9567-db9a7c0397a6" xlink:href="ccrn-20220930.xsd#ccrn_SeniorSecuredAssetBasedLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_0cee9449-b4b4-423d-ba55-ecbac65aee41" xlink:to="loc_ccrn_SeniorSecuredAssetBasedLoanMember_14b7c889-1a9f-4675-9567-db9a7c0397a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_LineOfCreditSublimitAxis_21c2c0ed-aa35-4608-a069-71d4189c6201" xlink:href="ccrn-20220930.xsd#ccrn_LineOfCreditSublimitAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_4a5e520b-3d48-4438-8c93-b7e306f360cd" xlink:to="loc_ccrn_LineOfCreditSublimitAxis_21c2c0ed-aa35-4608-a069-71d4189c6201" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_LineOfCreditSublimitDomain_146186ba-03e0-4cc5-ab0a-907c8e40e9d9" xlink:href="ccrn-20220930.xsd#ccrn_LineOfCreditSublimitDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_LineOfCreditSublimitAxis_21c2c0ed-aa35-4608-a069-71d4189c6201" xlink:to="loc_ccrn_LineOfCreditSublimitDomain_146186ba-03e0-4cc5-ab0a-907c8e40e9d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_SwingLoansSublimitMember_b154d429-4a18-4e7e-9a5a-303ba8ebd164" xlink:href="ccrn-20220930.xsd#ccrn_SwingLoansSublimitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_LineOfCreditSublimitDomain_146186ba-03e0-4cc5-ab0a-907c8e40e9d9" xlink:to="loc_ccrn_SwingLoansSublimitMember_b154d429-4a18-4e7e-9a5a-303ba8ebd164" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_StandbyLettersOfCreditSublimitMember_ee41bc7a-8a64-4235-8ce6-4764888847ed" xlink:href="ccrn-20220930.xsd#ccrn_StandbyLettersOfCreditSublimitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_LineOfCreditSublimitDomain_146186ba-03e0-4cc5-ab0a-907c8e40e9d9" xlink:to="loc_ccrn_StandbyLettersOfCreditSublimitMember_ee41bc7a-8a64-4235-8ce6-4764888847ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_b3ecc199-0132-4463-8aa3-c6c1f8b0a4ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_4a5e520b-3d48-4438-8c93-b7e306f360cd" xlink:to="loc_us-gaap_VariableRateAxis_b3ecc199-0132-4463-8aa3-c6c1f8b0a4ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_407e6fa8-dd17-4ae1-9860-8a1d6d1884e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_b3ecc199-0132-4463-8aa3-c6c1f8b0a4ae" xlink:to="loc_us-gaap_VariableRateDomain_407e6fa8-dd17-4ae1-9860-8a1d6d1884e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_SecuredOvernightFinancingRateSOFRMember_1af0a02a-14af-47d4-a021-6c60dac22a8e" xlink:href="ccrn-20220930.xsd#ccrn_SecuredOvernightFinancingRateSOFRMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_407e6fa8-dd17-4ae1-9860-8a1d6d1884e7" xlink:to="loc_ccrn_SecuredOvernightFinancingRateSOFRMember_1af0a02a-14af-47d4-a021-6c60dac22a8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_e27848a9-d819-4bef-b156-5d16bb1bf6c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_407e6fa8-dd17-4ae1-9860-8a1d6d1884e7" xlink:to="loc_us-gaap_BaseRateMember_e27848a9-d819-4bef-b156-5d16bb1bf6c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_d0727938-4355-42f7-9f07-a57438bfc323" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_4a5e520b-3d48-4438-8c93-b7e306f360cd" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_d0727938-4355-42f7-9f07-a57438bfc323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityExpirationPeriod_335267f5-2cbd-4958-b2c7-a53d0eb5c9da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityExpirationPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_d0727938-4355-42f7-9f07-a57438bfc323" xlink:to="loc_us-gaap_LineOfCreditFacilityExpirationPeriod_335267f5-2cbd-4958-b2c7-a53d0eb5c9da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_48eb4b9e-8f74-4c51-b837-e39b3e097148" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_d0727938-4355-42f7-9f07-a57438bfc323" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_48eb4b9e-8f74-4c51-b837-e39b3e097148" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_LineOfCreditAmountOfIndebtednessPermittedBySeniorSecuredAssetBasedLoanToBeBorrowedFromOtherSources_687c5096-2cf1-429c-b137-2365352e8be0" xlink:href="ccrn-20220930.xsd#ccrn_LineOfCreditAmountOfIndebtednessPermittedBySeniorSecuredAssetBasedLoanToBeBorrowedFromOtherSources"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_d0727938-4355-42f7-9f07-a57438bfc323" xlink:to="loc_ccrn_LineOfCreditAmountOfIndebtednessPermittedBySeniorSecuredAssetBasedLoanToBeBorrowedFromOtherSources_687c5096-2cf1-429c-b137-2365352e8be0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_LineOfCreditFacilityBasisSpreadOnVariableRateAdditionalCreditSpreadAssociatedWithSOFR_560547e5-8290-40ac-a0aa-4d7495fa97a5" xlink:href="ccrn-20220930.xsd#ccrn_LineOfCreditFacilityBasisSpreadOnVariableRateAdditionalCreditSpreadAssociatedWithSOFR"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_d0727938-4355-42f7-9f07-a57438bfc323" xlink:to="loc_ccrn_LineOfCreditFacilityBasisSpreadOnVariableRateAdditionalCreditSpreadAssociatedWithSOFR_560547e5-8290-40ac-a0aa-4d7495fa97a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_LineOfCreditBorrowingBasePercentageOfAssets_bc25b71a-4a2b-4245-90e8-db8b48ec665e" xlink:href="ccrn-20220930.xsd#ccrn_LineOfCreditBorrowingBasePercentageOfAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_d0727938-4355-42f7-9f07-a57438bfc323" xlink:to="loc_ccrn_LineOfCreditBorrowingBasePercentageOfAssets_bc25b71a-4a2b-4245-90e8-db8b48ec665e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_LineOfCreditFacilityBorrowingBaseAvailability_ff0174d1-384c-4cd9-b290-baa545dc5707" xlink:href="ccrn-20220930.xsd#ccrn_LineOfCreditFacilityBorrowingBaseAvailability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_d0727938-4355-42f7-9f07-a57438bfc323" xlink:to="loc_ccrn_LineOfCreditFacilityBorrowingBaseAvailability_ff0174d1-384c-4cd9-b290-baa545dc5707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_b5e85eff-0965-448b-bc3c-f1ab0ea92763" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_d0727938-4355-42f7-9f07-a57438bfc323" xlink:to="loc_us-gaap_LineOfCredit_b5e85eff-0965-448b-bc3c-f1ab0ea92763" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_ab83e55d-5a5e-4840-a74c-5831b0e1c04c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_d0727938-4355-42f7-9f07-a57438bfc323" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_ab83e55d-5a5e-4840-a74c-5831b0e1c04c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_447a6f95-39a3-408e-ae3d-6e0b09b78d02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_d0727938-4355-42f7-9f07-a57438bfc323" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_447a6f95-39a3-408e-ae3d-6e0b09b78d02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_8988182e-f514-430a-9833-c04448c3d9e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_d0727938-4355-42f7-9f07-a57438bfc323" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_8988182e-f514-430a-9833-c04448c3d9e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_b1ecf88d-690a-4f2c-b60a-a6f1e65d0f2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_d0727938-4355-42f7-9f07-a57438bfc323" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_b1ecf88d-690a-4f2c-b60a-a6f1e65d0f2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/LEASESAdditionalInformationDetails" xlink:type="simple" xlink:href="ccrn-20220930.xsd#LEASESAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/LEASESAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_5bf3882a-c2d2-4ff8-9c50-02752e575fdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseImpairmentLoss_f9b84b5e-9242-4ae4-bc6c-5f4bf542fb6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseImpairmentLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5bf3882a-c2d2-4ff8-9c50-02752e575fdf" xlink:to="loc_us-gaap_OperatingLeaseImpairmentLoss_f9b84b5e-9242-4ae4-bc6c-5f4bf542fb6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/LEASESSupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="ccrn-20220930.xsd#LEASESSupplementalBalanceSheetInformationDetails"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/LEASESSupplementalBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_7cce02d9-219a-4c1c-826c-018f3449281d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_f8876912-c0af-4dd0-a097-f0cfc0a0bf44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7cce02d9-219a-4c1c-826c-018f3449281d" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_f8876912-c0af-4dd0-a097-f0cfc0a0bf44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_5473078b-f5f9-4c30-a48d-fbead8e40d4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7cce02d9-219a-4c1c-826c-018f3449281d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_5473078b-f5f9-4c30-a48d-fbead8e40d4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_3aa7bee0-86bb-4a8c-925f-ad1cc70db71a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7cce02d9-219a-4c1c-826c-018f3449281d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_3aa7bee0-86bb-4a8c-925f-ad1cc70db71a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_6160797e-08e8-4391-bba3-143b483362a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7cce02d9-219a-4c1c-826c-018f3449281d" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_6160797e-08e8-4391-bba3-143b483362a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_5b5a8664-ea7a-4502-913c-d82182d62c5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7cce02d9-219a-4c1c-826c-018f3449281d" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_5b5a8664-ea7a-4502-913c-d82182d62c5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails" xlink:type="simple" xlink:href="ccrn-20220930.xsd#LEASESOperatingLeaseMaturityDetails"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_53350e10-a2a6-44f9-bfa5-a5ab4e7d0f03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_88d9170a-56bb-4700-943b-82e616d9acde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_53350e10-a2a6-44f9-bfa5-a5ab4e7d0f03" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_88d9170a-56bb-4700-943b-82e616d9acde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_ff253830-f017-426e-9f20-523e4a07bf08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_53350e10-a2a6-44f9-bfa5-a5ab4e7d0f03" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_ff253830-f017-426e-9f20-523e4a07bf08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_e010b3bd-e8a7-454c-a0d7-fc94ecdc21ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_53350e10-a2a6-44f9-bfa5-a5ab4e7d0f03" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_e010b3bd-e8a7-454c-a0d7-fc94ecdc21ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_54bb488b-c5fa-473a-b465-6d6048a1d119" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_53350e10-a2a6-44f9-bfa5-a5ab4e7d0f03" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_54bb488b-c5fa-473a-b465-6d6048a1d119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f5b1745e-2799-4eea-852a-8d8690c65d7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_53350e10-a2a6-44f9-bfa5-a5ab4e7d0f03" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f5b1745e-2799-4eea-852a-8d8690c65d7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_9857d4f9-6ecb-46f7-9efc-6ec4dd65e069" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_53350e10-a2a6-44f9-bfa5-a5ab4e7d0f03" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_9857d4f9-6ecb-46f7-9efc-6ec4dd65e069" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_8c1130a7-337e-4d2f-9fbb-48c220906109" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_53350e10-a2a6-44f9-bfa5-a5ab4e7d0f03" xlink:to="loc_us-gaap_OperatingLeaseLiability_8c1130a7-337e-4d2f-9fbb-48c220906109" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_a424899b-1aec-44ea-8937-d15802dedf2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_53350e10-a2a6-44f9-bfa5-a5ab4e7d0f03" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_a424899b-1aec-44ea-8937-d15802dedf2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_04e02f4c-7459-410a-a8e2-d144e93a6f82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_53350e10-a2a6-44f9-bfa5-a5ab4e7d0f03" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_04e02f4c-7459-410a-a8e2-d144e93a6f82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails_1" xlink:type="simple" xlink:href="ccrn-20220930.xsd#LEASESOperatingLeaseMaturityDetails_1"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/LEASESLeaseCostsDetails" xlink:type="simple" xlink:href="ccrn-20220930.xsd#LEASESLeaseCostsDetails"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/LEASESLeaseCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_321700fe-3023-4a5e-a911-fd82f2b43a05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_97cdb407-54b0-4cf7-bad1-7d31b78127c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_321700fe-3023-4a5e-a911-fd82f2b43a05" xlink:to="loc_us-gaap_OperatingLeasePayments_97cdb407-54b0-4cf7-bad1-7d31b78127c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_6ca915ce-8627-4800-bb89-1a347c968bf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_321700fe-3023-4a5e-a911-fd82f2b43a05" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_6ca915ce-8627-4800-bb89-1a347c968bf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_f30ce667-be1a-45cc-a88b-d259c9b4283f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_321700fe-3023-4a5e-a911-fd82f2b43a05" xlink:to="loc_us-gaap_OperatingLeaseCost_f30ce667-be1a-45cc-a88b-d259c9b4283f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_668d5402-920b-4246-9025-815caebb5430" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_321700fe-3023-4a5e-a911-fd82f2b43a05" xlink:to="loc_us-gaap_ShortTermLeaseCost_668d5402-920b-4246-9025-815caebb5430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_VariableAndOtherLeaseCost_0d0be0c9-ba95-43b0-8ba2-d9b1ec28c1d7" xlink:href="ccrn-20220930.xsd#ccrn_VariableAndOtherLeaseCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_321700fe-3023-4a5e-a911-fd82f2b43a05" xlink:to="loc_ccrn_VariableAndOtherLeaseCost_0d0be0c9-ba95-43b0-8ba2-d9b1ec28c1d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSEstimatedFairValuesofFinancialAssetsandLiabilitiesMeasuredonaRecurringBasisDetails" xlink:type="simple" xlink:href="ccrn-20220930.xsd#FAIRVALUEMEASUREMENTSEstimatedFairValuesofFinancialAssetsandLiabilitiesMeasuredonaRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSEstimatedFairValuesofFinancialAssetsandLiabilitiesMeasuredonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_e94705fe-f8da-4939-84e7-0cec326ee968" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fa2c6945-c2c8-4614-9f33-a86ad4bea244" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_e94705fe-f8da-4939-84e7-0cec326ee968" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fa2c6945-c2c8-4614-9f33-a86ad4bea244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_60c1cf84-883e-4f3d-83d0-e51aa831f7a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fa2c6945-c2c8-4614-9f33-a86ad4bea244" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_60c1cf84-883e-4f3d-83d0-e51aa831f7a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_d92e513a-0c55-4e07-957f-580839e88a71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_60c1cf84-883e-4f3d-83d0-e51aa831f7a5" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_d92e513a-0c55-4e07-957f-580839e88a71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_DeferredCompensationMember_23a37838-8ecc-409f-b1a8-f6266913efad" xlink:href="ccrn-20220930.xsd#ccrn_DeferredCompensationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_d92e513a-0c55-4e07-957f-580839e88a71" xlink:to="loc_ccrn_DeferredCompensationMember_23a37838-8ecc-409f-b1a8-f6266913efad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_ed151215-a050-465b-a49c-824c2ce84d17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fa2c6945-c2c8-4614-9f33-a86ad4bea244" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_ed151215-a050-465b-a49c-824c2ce84d17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_88d90375-7eb1-4c5c-9f74-11ebb10c675f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_ed151215-a050-465b-a49c-824c2ce84d17" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_88d90375-7eb1-4c5c-9f74-11ebb10c675f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_DeferredCompensationMember_cdaade3d-5045-45c6-b351-b9abcb313cb0" xlink:href="ccrn-20220930.xsd#ccrn_DeferredCompensationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_88d90375-7eb1-4c5c-9f74-11ebb10c675f" xlink:to="loc_ccrn_DeferredCompensationMember_cdaade3d-5045-45c6-b351-b9abcb313cb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_580b1383-6912-4dbb-a256-a6f162b4d58e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fa2c6945-c2c8-4614-9f33-a86ad4bea244" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_580b1383-6912-4dbb-a256-a6f162b4d58e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_74358771-0ac7-4574-8d2e-fdea5da9878b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_580b1383-6912-4dbb-a256-a6f162b4d58e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_74358771-0ac7-4574-8d2e-fdea5da9878b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_a443bb51-493b-4597-8f3a-99aaff4e6603" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_74358771-0ac7-4574-8d2e-fdea5da9878b" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_a443bb51-493b-4597-8f3a-99aaff4e6603" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a16a8f6b-f130-4e16-87f2-c628ad1006be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fa2c6945-c2c8-4614-9f33-a86ad4bea244" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a16a8f6b-f130-4e16-87f2-c628ad1006be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_ee2bf8e9-8cc4-473d-9247-5d97347f2020" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a16a8f6b-f130-4e16-87f2-c628ad1006be" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_ee2bf8e9-8cc4-473d-9247-5d97347f2020" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_6dc97337-7e50-4e06-85e8-a7ba147e3a48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a16a8f6b-f130-4e16-87f2-c628ad1006be" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_6dc97337-7e50-4e06-85e8-a7ba147e3a48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="simple" xlink:href="ccrn-20220930.xsd#FAIRVALUEMEASUREMENTSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_c3bae216-47b6-45fb-b565-e09a147c3b8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_FairValueMeasurementTable_f78c5c65-eb35-45f5-b884-ef62dbacfecb" xlink:href="ccrn-20220930.xsd#ccrn_FairValueMeasurementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_c3bae216-47b6-45fb-b565-e09a147c3b8d" xlink:to="loc_ccrn_FairValueMeasurementTable_f78c5c65-eb35-45f5-b884-ef62dbacfecb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_bdb2460c-0e7b-4106-ad6c-1b69f589aa27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_FairValueMeasurementTable_f78c5c65-eb35-45f5-b884-ef62dbacfecb" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_bdb2460c-0e7b-4106-ad6c-1b69f589aa27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9ddcee12-d5da-41d9-a7af-4f0f908eec84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_bdb2460c-0e7b-4106-ad6c-1b69f589aa27" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9ddcee12-d5da-41d9-a7af-4f0f908eec84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_WorkforceSolutionsGroupIncMember_8bdce88a-bb3d-4535-b848-210cf071ffb6" xlink:href="ccrn-20220930.xsd#ccrn_WorkforceSolutionsGroupIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9ddcee12-d5da-41d9-a7af-4f0f908eec84" xlink:to="loc_ccrn_WorkforceSolutionsGroupIncMember_8bdce88a-bb3d-4535-b848-210cf071ffb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_FairValueMeasurementLineItems_461fb89a-c6cc-4bd8-b9f3-80256f316825" xlink:href="ccrn-20220930.xsd#ccrn_FairValueMeasurementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_FairValueMeasurementTable_f78c5c65-eb35-45f5-b884-ef62dbacfecb" xlink:to="loc_ccrn_FairValueMeasurementLineItems_461fb89a-c6cc-4bd8-b9f3-80256f316825" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_ae47ceea-d6f2-4375-baa8-d17b2e8d93cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_FairValueMeasurementLineItems_461fb89a-c6cc-4bd8-b9f3-80256f316825" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_ae47ceea-d6f2-4375-baa8-d17b2e8d93cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails" xlink:type="simple" xlink:href="ccrn-20220930.xsd#FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_db5899af-2aa5-4749-8a87-00100c8e5729" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_a5ecf73b-37bd-4fcb-89fb-1daf47683893" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOptionQuantitativeDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_db5899af-2aa5-4749-8a87-00100c8e5729" xlink:to="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_a5ecf73b-37bd-4fcb-89fb-1daf47683893" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4ebb8b4b-51c6-4648-9a71-c6ba7d440607" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_a5ecf73b-37bd-4fcb-89fb-1daf47683893" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4ebb8b4b-51c6-4648-9a71-c6ba7d440607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_529701f2-fd11-46f8-9cdd-19f6838493ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4ebb8b4b-51c6-4648-9a71-c6ba7d440607" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_529701f2-fd11-46f8-9cdd-19f6838493ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_bbbaa95b-9781-48d9-bb41-fcc70c23203c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_529701f2-fd11-46f8-9cdd-19f6838493ce" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_bbbaa95b-9781-48d9-bb41-fcc70c23203c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_994c46dc-539f-4e93-84cf-3beb49f04c90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_a5ecf73b-37bd-4fcb-89fb-1daf47683893" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_994c46dc-539f-4e93-84cf-3beb49f04c90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_70756c0f-185b-4764-8b5b-fc90538d991a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_994c46dc-539f-4e93-84cf-3beb49f04c90" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_70756c0f-185b-4764-8b5b-fc90538d991a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_EarnoutNotesPayableMember_d798bd84-ce27-41f5-9b19-dc50fd826d17" xlink:href="ccrn-20220930.xsd#ccrn_EarnoutNotesPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_70756c0f-185b-4764-8b5b-fc90538d991a" xlink:to="loc_ccrn_EarnoutNotesPayableMember_d798bd84-ce27-41f5-9b19-dc50fd826d17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_02a56fa3-7a38-40b4-a80e-b5592be1ffc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_70756c0f-185b-4764-8b5b-fc90538d991a" xlink:to="loc_us-gaap_SecuredDebtMember_02a56fa3-7a38-40b4-a80e-b5592be1ffc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_65e3c92f-c549-49a1-b2a0-850ea36024e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_a5ecf73b-37bd-4fcb-89fb-1daf47683893" xlink:to="loc_us-gaap_CreditFacilityAxis_65e3c92f-c549-49a1-b2a0-850ea36024e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_d94d0aaf-5781-42e6-844c-567cc411a498" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_65e3c92f-c549-49a1-b2a0-850ea36024e1" xlink:to="loc_us-gaap_CreditFacilityDomain_d94d0aaf-5781-42e6-844c-567cc411a498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_SeniorSecuredAssetBasedLoanMember_dfa48b83-18a0-4d45-a4e1-2a7635cdbd9d" xlink:href="ccrn-20220930.xsd#ccrn_SeniorSecuredAssetBasedLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_d94d0aaf-5781-42e6-844c-567cc411a498" xlink:to="loc_ccrn_SeniorSecuredAssetBasedLoanMember_dfa48b83-18a0-4d45-a4e1-2a7635cdbd9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_af64b0c5-de26-4903-b44a-2d40130bc5a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_a5ecf73b-37bd-4fcb-89fb-1daf47683893" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_af64b0c5-de26-4903-b44a-2d40130bc5a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_e74478d6-2267-4bc5-a567-4dd925f94839" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_af64b0c5-de26-4903-b44a-2d40130bc5a7" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_e74478d6-2267-4bc5-a567-4dd925f94839" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_afdc4658-93a5-440c-afcb-756fe3a3b54d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_e74478d6-2267-4bc5-a567-4dd925f94839" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_afdc4658-93a5-440c-afcb-756fe3a3b54d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_b285a420-f9ce-4c87-9396-9e7635ed04f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_afdc4658-93a5-440c-afcb-756fe3a3b54d" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_b285a420-f9ce-4c87-9396-9e7635ed04f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_1bc51b16-08e9-405f-a2ca-1e06a9f7123c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_afdc4658-93a5-440c-afcb-756fe3a3b54d" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_1bc51b16-08e9-405f-a2ca-1e06a9f7123c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_3e0b6e17-fa08-48fb-b5b9-31e8bf95d0a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_a5ecf73b-37bd-4fcb-89fb-1daf47683893" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_3e0b6e17-fa08-48fb-b5b9-31e8bf95d0a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ec18783d-96de-4b8a-9089-c51d062ec516" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3e0b6e17-fa08-48fb-b5b9-31e8bf95d0a9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ec18783d-96de-4b8a-9089-c51d062ec516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_WorkforceSolutionsGroupIncMember_5d278845-b8f4-48d4-a0b2-0b5535ded480" xlink:href="ccrn-20220930.xsd#ccrn_WorkforceSolutionsGroupIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ec18783d-96de-4b8a-9089-c51d062ec516" xlink:to="loc_ccrn_WorkforceSolutionsGroupIncMember_5d278845-b8f4-48d4-a0b2-0b5535ded480" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_SelectedIncMember_176e61b8-cda8-4095-82a0-c735452f6ca8" xlink:href="ccrn-20220930.xsd#ccrn_SelectedIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ec18783d-96de-4b8a-9089-c51d062ec516" xlink:to="loc_ccrn_SelectedIncMember_176e61b8-cda8-4095-82a0-c735452f6ca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_260a01be-014d-453a-8f14-3b5eda119af4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOptionQuantitativeDisclosuresLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_a5ecf73b-37bd-4fcb-89fb-1daf47683893" xlink:to="loc_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_260a01be-014d-453a-8f14-3b5eda119af4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_5de859a2-4168-40c2-b4a6-21877b95155d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_260a01be-014d-453a-8f14-3b5eda119af4" xlink:to="loc_us-gaap_DebtInstrumentFairValue_5de859a2-4168-40c2-b4a6-21877b95155d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditFairValueDisclosure_f88cd8d0-4769-4366-a012-e2b0afb63ea8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LinesOfCreditFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_260a01be-014d-453a-8f14-3b5eda119af4" xlink:to="loc_us-gaap_LinesOfCreditFairValueDisclosure_f88cd8d0-4769-4366-a012-e2b0afb63ea8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_eb375a21-b8a7-4283-9984-098dd412029f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_260a01be-014d-453a-8f14-3b5eda119af4" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_eb375a21-b8a7-4283-9984-098dd412029f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails" xlink:type="simple" xlink:href="ccrn-20220930.xsd#STOCKHOLDERSEQUITYAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_93cf53a6-e1f1-4645-98ca-0f48bff77028" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_08b0db42-ead9-4959-859b-78c9768e7bda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_93cf53a6-e1f1-4645-98ca-0f48bff77028" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_08b0db42-ead9-4959-859b-78c9768e7bda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_112a9f0d-0671-4605-b355-e0a27033dc1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_08b0db42-ead9-4959-859b-78c9768e7bda" xlink:to="loc_us-gaap_PlanNameAxis_112a9f0d-0671-4605-b355-e0a27033dc1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_41706697-d9d6-4ef2-b8ed-ac9bcb8e3dce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_112a9f0d-0671-4605-b355-e0a27033dc1c" xlink:to="loc_us-gaap_PlanNameDomain_41706697-d9d6-4ef2-b8ed-ac9bcb8e3dce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_OmnibusPlanMember_d375068c-a0ef-4ccf-927b-6ccde9a9c4c4" xlink:href="ccrn-20220930.xsd#ccrn_OmnibusPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_41706697-d9d6-4ef2-b8ed-ac9bcb8e3dce" xlink:to="loc_ccrn_OmnibusPlanMember_d375068c-a0ef-4ccf-927b-6ccde9a9c4c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_b0365561-87c7-4e0f-9451-86b9ea4494d2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_08b0db42-ead9-4959-859b-78c9768e7bda" xlink:to="loc_srt_RangeAxis_b0365561-87c7-4e0f-9451-86b9ea4494d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a3d9628a-c0bc-4634-b75a-422c8bc78497" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_b0365561-87c7-4e0f-9451-86b9ea4494d2" xlink:to="loc_srt_RangeMember_a3d9628a-c0bc-4634-b75a-422c8bc78497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f682006f-32a5-4a0b-aec9-641e67a34f83" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a3d9628a-c0bc-4634-b75a-422c8bc78497" xlink:to="loc_srt_MinimumMember_f682006f-32a5-4a0b-aec9-641e67a34f83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_7524f87f-8cf7-4544-baf8-988e4080405e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_08b0db42-ead9-4959-859b-78c9768e7bda" xlink:to="loc_srt_TitleOfIndividualAxis_7524f87f-8cf7-4544-baf8-988e4080405e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_59d64244-7ff1-417e-83c7-a5b135be1d3a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_7524f87f-8cf7-4544-baf8-988e4080405e" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_59d64244-7ff1-417e-83c7-a5b135be1d3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_6233680f-0fd7-48a1-a254-434fffdaed36" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_DirectorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_59d64244-7ff1-417e-83c7-a5b135be1d3a" xlink:to="loc_srt_DirectorMember_6233680f-0fd7-48a1-a254-434fffdaed36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_d579eba1-9642-438a-a782-9235916235d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_08b0db42-ead9-4959-859b-78c9768e7bda" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_d579eba1-9642-438a-a782-9235916235d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_9b1a0606-9f58-4dc2-a1df-1497a37bf44e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_d579eba1-9642-438a-a782-9235916235d7" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_9b1a0606-9f58-4dc2-a1df-1497a37bf44e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_7b78b084-b299-4e0e-a56c-0db0737aff25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_9b1a0606-9f58-4dc2-a1df-1497a37bf44e" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_7b78b084-b299-4e0e-a56c-0db0737aff25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_e76e6d2e-8fd2-446c-8628-e8d4831f485c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_08b0db42-ead9-4959-859b-78c9768e7bda" xlink:to="loc_us-gaap_AwardTypeAxis_e76e6d2e-8fd2-446c-8628-e8d4831f485c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_eb6ef45a-a65e-4f7b-a864-cade179d5b31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_e76e6d2e-8fd2-446c-8628-e8d4831f485c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_eb6ef45a-a65e-4f7b-a864-cade179d5b31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_RestrictedStockAndPerformanceSharesMember_cd2617bd-84ef-4dbf-80f8-0ce7015dfbb8" xlink:href="ccrn-20220930.xsd#ccrn_RestrictedStockAndPerformanceSharesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_eb6ef45a-a65e-4f7b-a864-cade179d5b31" xlink:to="loc_ccrn_RestrictedStockAndPerformanceSharesMember_cd2617bd-84ef-4dbf-80f8-0ce7015dfbb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_840a3dce-ee56-46ae-9dbb-d8403adc9db4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_RestrictedStockAndPerformanceSharesMember_cd2617bd-84ef-4dbf-80f8-0ce7015dfbb8" xlink:to="loc_us-gaap_PerformanceSharesMember_840a3dce-ee56-46ae-9dbb-d8403adc9db4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_e3c4fd75-d2d9-429e-bcc5-cd639beb0214" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_RestrictedStockAndPerformanceSharesMember_cd2617bd-84ef-4dbf-80f8-0ce7015dfbb8" xlink:to="loc_us-gaap_RestrictedStockMember_e3c4fd75-d2d9-429e-bcc5-cd639beb0214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_34b5bfb8-ea90-450a-a8a4-0f34538b0800" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_08b0db42-ead9-4959-859b-78c9768e7bda" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_34b5bfb8-ea90-450a-a8a4-0f34538b0800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_df67e472-138c-45c8-8b55-367745aa5e4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_34b5bfb8-ea90-450a-a8a4-0f34538b0800" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_df67e472-138c-45c8-8b55-367745aa5e4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_PriorRepurchaseProgramAndNewRepurchaseProgramMember_c97311bb-5666-46e1-899b-b18ca8bf39a9" xlink:href="ccrn-20220930.xsd#ccrn_PriorRepurchaseProgramAndNewRepurchaseProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_df67e472-138c-45c8-8b55-367745aa5e4b" xlink:to="loc_ccrn_PriorRepurchaseProgramAndNewRepurchaseProgramMember_c97311bb-5666-46e1-899b-b18ca8bf39a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_NewRepurchaseProgramMember_ded4738e-9312-46bb-bd9b-0d43427a573b" xlink:href="ccrn-20220930.xsd#ccrn_NewRepurchaseProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_PriorRepurchaseProgramAndNewRepurchaseProgramMember_c97311bb-5666-46e1-899b-b18ca8bf39a9" xlink:to="loc_ccrn_NewRepurchaseProgramMember_ded4738e-9312-46bb-bd9b-0d43427a573b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_277cf4a7-7f54-4dd8-ac74-8c8b921c30c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_08b0db42-ead9-4959-859b-78c9768e7bda" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_277cf4a7-7f54-4dd8-ac74-8c8b921c30c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_a49f7849-f76b-424d-9cba-46f0fa2807b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_277cf4a7-7f54-4dd8-ac74-8c8b921c30c6" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_a49f7849-f76b-424d-9cba-46f0fa2807b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_cdc71879-ef1e-48ba-9b5d-86d933629475" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_277cf4a7-7f54-4dd8-ac74-8c8b921c30c6" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_cdc71879-ef1e-48ba-9b5d-86d933629475" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_f942eaab-3887-4321-9e3b-117c291e99e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_277cf4a7-7f54-4dd8-ac74-8c8b921c30c6" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_f942eaab-3887-4321-9e3b-117c291e99e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_4bd69e58-b9c4-4b33-aa37-1c36e743120c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_277cf4a7-7f54-4dd8-ac74-8c8b921c30c6" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_4bd69e58-b9c4-4b33-aa37-1c36e743120c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_51640aeb-51f8-4f6e-a8e3-e38e523c7265" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_277cf4a7-7f54-4dd8-ac74-8c8b921c30c6" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_51640aeb-51f8-4f6e-a8e3-e38e523c7265" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_2e4ea8eb-2396-4856-bcbe-b76950db2da9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_277cf4a7-7f54-4dd8-ac74-8c8b921c30c6" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_2e4ea8eb-2396-4856-bcbe-b76950db2da9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_c8020433-bdc5-4ac1-9ff3-5524d6b5e6b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_277cf4a7-7f54-4dd8-ac74-8c8b921c30c6" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_c8020433-bdc5-4ac1-9ff3-5524d6b5e6b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_6a5f3d50-11eb-4391-9a4a-8f27069e6383" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_277cf4a7-7f54-4dd8-ac74-8c8b921c30c6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_6a5f3d50-11eb-4391-9a4a-8f27069e6383" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments_9b64006c-4791-4434-b6ad-13cbf2757bf4" xlink:href="ccrn-20220930.xsd#ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_277cf4a7-7f54-4dd8-ac74-8c8b921c30c6" xlink:to="loc_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments_9b64006c-4791-4434-b6ad-13cbf2757bf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAttainmentPercentage_1a41967c-deb8-4193-a78a-712724643da2" xlink:href="ccrn-20220930.xsd#ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAttainmentPercentage"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_277cf4a7-7f54-4dd8-ac74-8c8b921c30c6" xlink:to="loc_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAttainmentPercentage_1a41967c-deb8-4193-a78a-712724643da2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1a541fc5-0a89-4547-abcc-f5d43bcde022" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_277cf4a7-7f54-4dd8-ac74-8c8b921c30c6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1a541fc5-0a89-4547-abcc-f5d43bcde022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_f4c9d110-6411-4c26-a7e2-741d3f7e4bdd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_277cf4a7-7f54-4dd8-ac74-8c8b921c30c6" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_f4c9d110-6411-4c26-a7e2-741d3f7e4bdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet_96b7eed9-d091-486d-989e-ab983c0d4cb2" xlink:href="ccrn-20220930.xsd#ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_277cf4a7-7f54-4dd8-ac74-8c8b921c30c6" xlink:to="loc_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet_96b7eed9-d091-486d-989e-ab983c0d4cb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYRestrictedStockActivityDetails" xlink:type="simple" xlink:href="ccrn-20220930.xsd#STOCKHOLDERSEQUITYRestrictedStockActivityDetails"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYRestrictedStockActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_d85b89b1-1b9f-4ec8-97ce-4f2779620baa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0fb3652f-7bab-4319-9288-e8282a20db54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_d85b89b1-1b9f-4ec8-97ce-4f2779620baa" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0fb3652f-7bab-4319-9288-e8282a20db54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_e23b0772-b5a8-4d80-8128-62ae4c72b09f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0fb3652f-7bab-4319-9288-e8282a20db54" xlink:to="loc_us-gaap_AwardTypeAxis_e23b0772-b5a8-4d80-8128-62ae4c72b09f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_397bb2ec-cea8-4ea0-b8a3-413e72fc61af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_e23b0772-b5a8-4d80-8128-62ae4c72b09f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_397bb2ec-cea8-4ea0-b8a3-413e72fc61af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_2d3b27cf-62c1-4f06-a3f9-9cabe9a9ab57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_397bb2ec-cea8-4ea0-b8a3-413e72fc61af" xlink:to="loc_us-gaap_RestrictedStockMember_2d3b27cf-62c1-4f06-a3f9-9cabe9a9ab57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_bcf42d68-f76f-4292-872f-d64864d1864e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_397bb2ec-cea8-4ea0-b8a3-413e72fc61af" xlink:to="loc_us-gaap_PerformanceSharesMember_bcf42d68-f76f-4292-872f-d64864d1864e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_74563561-5fe5-455e-a448-7f05f3bad8fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0fb3652f-7bab-4319-9288-e8282a20db54" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_74563561-5fe5-455e-a448-7f05f3bad8fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_3563795a-58ba-456f-ae1b-8db1d308ad39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_74563561-5fe5-455e-a448-7f05f3bad8fa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_3563795a-58ba-456f-ae1b-8db1d308ad39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4d241b6c-3133-4fa1-a83f-f6903c007df5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_3563795a-58ba-456f-ae1b-8db1d308ad39" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4d241b6c-3133-4fa1-a83f-f6903c007df5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_17f1da4d-0701-44a8-b5e2-8370c1c3ab5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_3563795a-58ba-456f-ae1b-8db1d308ad39" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_17f1da4d-0701-44a8-b5e2-8370c1c3ab5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_960f86a7-f83e-4b24-83b8-50ccfad06cdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_3563795a-58ba-456f-ae1b-8db1d308ad39" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_960f86a7-f83e-4b24-83b8-50ccfad06cdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_39416b04-94e3-42b9-8cdf-241216eba667" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_3563795a-58ba-456f-ae1b-8db1d308ad39" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_39416b04-94e3-42b9-8cdf-241216eba667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_e2cb2650-ea6b-4181-9f5e-44cb267eb023" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_3563795a-58ba-456f-ae1b-8db1d308ad39" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_e2cb2650-ea6b-4181-9f5e-44cb267eb023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_cb4abfd4-6b9b-4bdc-9848-aa9ca8ea9dce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_74563561-5fe5-455e-a448-7f05f3bad8fa" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_cb4abfd4-6b9b-4bdc-9848-aa9ca8ea9dce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_a0171c18-a664-4e55-a57f-2a8e2df7822b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_cb4abfd4-6b9b-4bdc-9848-aa9ca8ea9dce" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_a0171c18-a664-4e55-a57f-2a8e2df7822b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1740889e-9bda-4f13-bfed-0a747a8a3fcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_cb4abfd4-6b9b-4bdc-9848-aa9ca8ea9dce" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1740889e-9bda-4f13-bfed-0a747a8a3fcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_7b3f9170-2a27-4d69-bd24-e5b4cb09c2b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_cb4abfd4-6b9b-4bdc-9848-aa9ca8ea9dce" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_7b3f9170-2a27-4d69-bd24-e5b4cb09c2b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_5f2b525f-b5d9-4d5b-836e-41472bc42c65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_cb4abfd4-6b9b-4bdc-9848-aa9ca8ea9dce" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_5f2b525f-b5d9-4d5b-836e-41472bc42c65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_affd8002-93c4-4708-8517-90546a6d2512" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_cb4abfd4-6b9b-4bdc-9848-aa9ca8ea9dce" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_affd8002-93c4-4708-8517-90546a6d2512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SEGMENTDATADetails" xlink:type="simple" xlink:href="ccrn-20220930.xsd#SEGMENTDATADetails"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/SEGMENTDATADetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_96e75c0d-9a3c-4d24-9b5d-f4a1983e2165" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_98c985d5-8e7a-4948-a606-55eea25d3b4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_96e75c0d-9a3c-4d24-9b5d-f4a1983e2165" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_98c985d5-8e7a-4948-a606-55eea25d3b4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b70c70ff-9122-4cfc-980f-96e040b10851" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_98c985d5-8e7a-4948-a606-55eea25d3b4e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b70c70ff-9122-4cfc-980f-96e040b10851" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_36d74f41-377e-4e43-87a9-f365a732bbfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b70c70ff-9122-4cfc-980f-96e040b10851" xlink:to="loc_us-gaap_SegmentDomain_36d74f41-377e-4e43-87a9-f365a732bbfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_NurseAndAlliedStaffingMember_6c1754c3-55b7-4c5b-a62b-be35c75153cd" xlink:href="ccrn-20220930.xsd#ccrn_NurseAndAlliedStaffingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_36d74f41-377e-4e43-87a9-f365a732bbfe" xlink:to="loc_ccrn_NurseAndAlliedStaffingMember_6c1754c3-55b7-4c5b-a62b-be35c75153cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_PhysicianStaffingMember_219a2318-0c91-49eb-adb3-ac1b53243c67" xlink:href="ccrn-20220930.xsd#ccrn_PhysicianStaffingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_36d74f41-377e-4e43-87a9-f365a732bbfe" xlink:to="loc_ccrn_PhysicianStaffingMember_219a2318-0c91-49eb-adb3-ac1b53243c67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_ec3b4f7d-de62-4a59-8dd6-203dc29dcb8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_98c985d5-8e7a-4948-a606-55eea25d3b4e" xlink:to="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_ec3b4f7d-de62-4a59-8dd6-203dc29dcb8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_25d86ef5-f8b6-41ca-8283-35664fa83ab5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_ec3b4f7d-de62-4a59-8dd6-203dc29dcb8e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_25d86ef5-f8b6-41ca-8283-35664fa83ab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard_a892d8c2-b215-469a-9a8c-c495ca3c2b41" xlink:href="ccrn-20220930.xsd#ccrn_OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_ec3b4f7d-de62-4a59-8dd6-203dc29dcb8e" xlink:to="loc_ccrn_OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard_a892d8c2-b215-469a-9a8c-c495ca3c2b41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_SegmentReportingUnallocatedCorporateExpenses_0f16c345-eb09-449f-a50a-d7c30f840fb3" xlink:href="ccrn-20220930.xsd#ccrn_SegmentReportingUnallocatedCorporateExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_ec3b4f7d-de62-4a59-8dd6-203dc29dcb8e" xlink:to="loc_ccrn_SegmentReportingUnallocatedCorporateExpenses_0f16c345-eb09-449f-a50a-d7c30f840fb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_4982d65b-0922-4771-ba54-0f8d38b6fba4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_ec3b4f7d-de62-4a59-8dd6-203dc29dcb8e" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_4982d65b-0922-4771-ba54-0f8d38b6fba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_AcquisitionAndIntegrationRelatedCosts_61cfd538-b16c-4c5b-948a-bdb564b3644b" xlink:href="ccrn-20220930.xsd#ccrn_AcquisitionAndIntegrationRelatedCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_ec3b4f7d-de62-4a59-8dd6-203dc29dcb8e" xlink:to="loc_ccrn_AcquisitionAndIntegrationRelatedCosts_61cfd538-b16c-4c5b-948a-bdb564b3644b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_9feaed60-bd1d-4023-9c3c-0785b75698fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_ec3b4f7d-de62-4a59-8dd6-203dc29dcb8e" xlink:to="loc_us-gaap_RestructuringCharges_9feaed60-bd1d-4023-9c3c-0785b75698fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_4342ce48-38e6-4b3d-8fb2-f54dae6e3a16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_ec3b4f7d-de62-4a59-8dd6-203dc29dcb8e" xlink:to="loc_us-gaap_AssetImpairmentCharges_4342ce48-38e6-4b3d-8fb2-f54dae6e3a16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_f13686d8-0b82-4849-92ab-cefbf55f7d35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_ec3b4f7d-de62-4a59-8dd6-203dc29dcb8e" xlink:to="loc_us-gaap_OperatingIncomeLoss_f13686d8-0b82-4849-92ab-cefbf55f7d35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/INCOMETAXESDetails" xlink:type="simple" xlink:href="ccrn-20220930.xsd#INCOMETAXESDetails"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/INCOMETAXESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_402493a7-321f-47f6-a78b-58ca5daf5018" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationTable_5b1adaa7-908b-44b3-a8b2-e4a570243ea3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_402493a7-321f-47f6-a78b-58ca5daf5018" xlink:to="loc_us-gaap_IncomeTaxExaminationTable_5b1adaa7-908b-44b3-a8b2-e4a570243ea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_51170757-e745-48c7-8858-de03e2383177" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_5b1adaa7-908b-44b3-a8b2-e4a570243ea3" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_51170757-e745-48c7-8858-de03e2383177" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_157a35b5-ff4a-4aa3-962a-01523eb02197" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_51170757-e745-48c7-8858-de03e2383177" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_157a35b5-ff4a-4aa3-962a-01523eb02197" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_8b826134-823a-4b64-b765-b2d4d6092459" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_157a35b5-ff4a-4aa3-962a-01523eb02197" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_8b826134-823a-4b64-b765-b2d4d6092459" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationLineItems_8dac8612-1168-4d40-b5fc-4b247d47690f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_5b1adaa7-908b-44b3-a8b2-e4a570243ea3" xlink:to="loc_us-gaap_IncomeTaxExaminationLineItems_8dac8612-1168-4d40-b5fc-4b247d47690f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_3e92ca57-6aba-45bb-87b5-9bd7a62f2975" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_8dac8612-1168-4d40-b5fc-4b247d47690f" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_3e92ca57-6aba-45bb-87b5-9bd7a62f2975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems_10f93d17-b0b9-47fa-a206-131356ff7f7d" xlink:href="ccrn-20220930.xsd#ccrn_EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_8dac8612-1168-4d40-b5fc-4b247d47690f" xlink:to="loc_ccrn_EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems_10f93d17-b0b9-47fa-a206-131356ff7f7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_23cb4f57-ec29-427c-aec9-3a2c11776130" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_8dac8612-1168-4d40-b5fc-4b247d47690f" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_23cb4f57-ec29-427c-aec9-3a2c11776130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/RELATEDPARTYTRANSACTIONSDetails" xlink:type="simple" xlink:href="ccrn-20220930.xsd#RELATEDPARTYTRANSACTIONSDetails"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/RELATEDPARTYTRANSACTIONSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_f6f4c205-f0ed-4c84-b658-6832610a2238" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_b70f6a41-34d0-4870-ba89-ad56df543a12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_f6f4c205-f0ed-4c84-b658-6832610a2238" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_b70f6a41-34d0-4870-ba89-ad56df543a12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2b770dd8-f43b-40c8-bcd8-100afa339edc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_b70f6a41-34d0-4870-ba89-ad56df543a12" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2b770dd8-f43b-40c8-bcd8-100afa339edc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_2052b35d-23ff-4f4d-8b29-ef4e17679023" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2b770dd8-f43b-40c8-bcd8-100afa339edc" xlink:to="loc_us-gaap_RelatedPartyDomain_2052b35d-23ff-4f4d-8b29-ef4e17679023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_HealthCareSystemAffiliatedWithABoardMemberMember_43e8d1ed-e249-43b8-98b3-d576b133b103" xlink:href="ccrn-20220930.xsd#ccrn_HealthCareSystemAffiliatedWithABoardMemberMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_2052b35d-23ff-4f4d-8b29-ef4e17679023" xlink:to="loc_ccrn_HealthCareSystemAffiliatedWithABoardMemberMember_43e8d1ed-e249-43b8-98b3-d576b133b103" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_c7c96197-917f-4408-91e4-dc295d842514" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_b70f6a41-34d0-4870-ba89-ad56df543a12" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_c7c96197-917f-4408-91e4-dc295d842514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromRelatedParties_f437026c-b599-4079-ac4d-307a0cf9b516" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromRelatedParties"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_c7c96197-917f-4408-91e4-dc295d842514" xlink:to="loc_us-gaap_RevenueFromRelatedParties_f437026c-b599-4079-ac4d-307a0cf9b516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>ccrn-20220930_g1.jpg
<TEXT>
begin 644 ccrn-20220930_g1.jpg
M_]C_X1#?17AI9@  34T *@    @ !P$2  ,    !  $   $:  4    !
M8@$;  4    !    :@$H  ,    !  (   $Q  (    D    <@$R  (    4
M    EH=I  0    !    K    -@ +<;    G$  MQL   "<0061O8F4@4&AO
M=&]S:&]P($-#(#(P,3D@*$UA8VEN=&]S:"D ,C Q.3HP-CHQ-R Q-#HT-CHR
M,@     #H $  P    $  0  H ( !     $   Z<H , !     $   7=
M      8! P #     0 &   !&@ %     0   28!&P %     0   2X!*  #
M     0 "   " 0 $     0   38" @ $     0  #Z$         2     $
M  !(     ?_8_^T #$%D;V)E7T--  '_[@ .061O8F4 9(     !_]L A  ,
M" @("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,# P,#!$,# P,# P,# P,
M# P,# P,# P,# P,# P,# P, 0T+"PT.#1 .#A 4#@X.%!0.#@X.%!$,# P,
M#!$1# P,# P,$0P,# P,# P,# P,# P,# P,# P,# P,# P,# S_P  1" !
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M4')I;G0 .$))300E       0UPI0%;\,*P7ZOCQ>"-2! 3A"24T$.@
MY0   !     !       +<')I;G1/=71P=70    %     %!S=%-B;V]L 0
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M;VP      $-R;D-B;V]L      !#;G1#8F]O;       3&)L<V)O;VP
M $YG='9B;V]L      !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/
M8FIC     0       %)'0D,    #     %)D("!D;W5B0&_@
M1W)N(&1O=6) ;^            !";" @9&]U8D!OX            $)R9%15
M;G1&(U)L=                $)L9"!5;G1&(U)L=                %)S
M;'15;G1&(U!X;$!RP           "G9E8W1O<D1A=&%B;V]L 0    !09U!S
M96YU;0    !09U!S     %!G4$,     3&5F=%5N=$8C4FQT
M    5&]P(%5N=$8C4FQT                4V-L(%5N=$8C4')C0%D
M       08W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M
M;&]N9P         ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12
M:6=H=&QO;F<         "V-R;W!296-T5&]P;&]N9P      .$))30/M
M   0 2P    !  $!+     $  3A"24T$)@      #@             _@
M.$))300-       $    'CA"24T$&0      !    !XX0DE- _,       D
M          $ .$))32<0       *  $          3A"24T#]0      2  O
M9F8  0!L9F8 !@       0 O9F8  0"AF9H !@       0 R     0!:
M!@       0 U     0 M    !@       3A"24T#^       <   ________
M_____________________P/H     /____________________________\#
MZ     #_____________________________ ^@     ________________
M_____________P/H   X0DE-!         (  #A"24T$ @       @  .$))
M300P       ! 0 X0DE-!"T       8  0    (X0DE-! @      !     !
M   "0    D      .$))300>       $     #A"24T$&@     #60    8
M            !=T   Z<    $@!# $, 2 !? $8 :0!N &$ ; !? $P ;P!G
M &\ 7P!2 $( 1P    $                          0             .
MG   !=T                      0                         0
M 0       &YU;&P    "    !F)O=6YD<T]B:F,    !        4F-T,0
M  0     5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M;&]N
M9P  !=T     4F=H=&QO;F<   Z<    !G-L:6-E<U9L3',    !3V)J8P
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M;VYG   .G     -U<FQ415A4     0       &YU;&Q415A4     0
M $US9V5415A4     0      !F%L=%1A9U1%6%0    !       .8V5L;%1E
M>'1)<TA434QB;V]L 0    AC96QL5&5X=%1%6%0    !       ):&]R>D%L
M:6=N96YU;0    ]%4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV97)T
M06QI9VYE;G5M    #T53;&EC959E<G1!;&EG;@    =D969A=6QT    "V)G
M0V]L;W)4>7!E96YU;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE
M"71O<$]U='-E=&QO;F<         "FQE9G1/=71S971L;VYG          QB
M;W1T;VU/=71S971L;VYG          MR:6=H=$]U='-E=&QO;F<      #A"
M24T$*       #     (_\        #A"24T$%       !     (X0DE-! P
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MQ $_   !!0$! 0$! 0         #  $"! 4&!P@)"@L!  $% 0$! 0$!
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MDTFLUL%=I-=;+6V_V_\ 1KJ$DDB;32DDDD%/_]D .$))300A      !=
M 0$    / $$ 9 !O &( 90 @ %  : !O '0 ;P!S &@ ;P!P    %P!! &0
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M(
M    $6-P<G0   %0    ,V1E<V,   &$    ;'=T<'0   'P    %&)K<'0
M  ($    %')865H   (8    %&=865H   (L    %&)865H   )     %&1M
M;F0   )4    <&1M9&0   +$    B'9U960   -,    AG9I97<   /4
M)&QU;6D   /X    %&UE87,   0,    )'1E8V@   0P    #')44D,   0\
M   (#&=44D,   0\   (#&)44D,   0\   (#'1E>'0     0V]P>7)I9VAT
M("AC*2 Q.3DX($AE=VQE='0M4&%C:V%R9"!#;VUP86YY  !D97-C
M !)S4D="($E%0S8Q.38V+3(N,0              $G-21T(@245#-C$Y-C8M
M,BXQ
M          !865H@        \U$  0    $6S%A96B
M    6%E:(        &^B   X]0   Y!865H@        8ID  +>%   8VEA9
M6B         DH   #X0  +;/9&5S8P         6245#(&AT=' Z+R]W=W<N
M:65C+F-H               6245#(&AT=' Z+R]W=W<N:65C+F-H
M                                                     &1E<V,
M        +DE%0R V,3DV-BTR+C$@1&5F875L="!21T(@8V]L;W5R('-P86-E
M("T@<U)'0@              +DE%0R V,3DV-BTR+C$@1&5F875L="!21T(@
M8V]L;W5R('-P86-E("T@<U)'0@                            !D97-C
M         "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@245#-C$Y
M-C8M,BXQ               L4F5F97)E;F-E(%9I97=I;F<@0V]N9&ET:6]N
M(&EN($E%0S8Q.38V+3(N,0                                  =FEE
M=P      $Z3^ !1?+@ 0SQ0  ^W,  03"P #7)X    !6%E:(       3 E6
M %    !7'^=M96%S          $                        "CP    )S
M:6<@     $-25"!C=7)V        !      %  H #P 4 !D '@ C "@ +0 R
M #< .P!  $4 2@!/ %0 60!> &, : !M '( =P!\ ($ A@"+ )  E0": )\
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M>!%X;GC,>2IYB7GG>D9ZI7L$>V-[PGPA?(%\X7U!?:%^ 7YB?L)_(W^$?^6
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M 1$  A$! Q$!_\0!00 !  (" P$! 0$           0* PD'" L&!0(! 0$
M  <! 0$              0(#! 4&!P@)"A    ,' 00%"0D! 0$  P$! 0($
M #$#!08'"" P0!$)$#05-0I0(4$3%!8V.!E@<!(R,Q<W&#F &D+0(B0E(Q$
M 00! @(% @\*" P$ @$5 @$#! 4&$0< $B A@1,(,100,$#P05%Q(A75EK9W
MMSA0D;'!M7;6-Y=X8:'A,B,6-IA@<-'Q0M(STR34%X> E"4U4C2G8D-3E;AR
M@I,F9B<8T&-S@T1T158)$@ "  ($!@P)!0T%" (" @,! A$# "$Q!"!!47$2
M!3! 88&1H;'1(C)R$Q#!0E*2LM(S!E!B(W,48/#A@J+"D[,T=)0U!W" 0R05
M\5-CH\/3U-7B@T2T%M E5,3_V@ , P$! A$#$0   +_
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                             !^;/#\:K+)EC]%1F
M                     'SM:6--#]6G-^M3B                 (TT/G:
MTH^DH3YX                 !\Q7EQQA^K3F_6IQ
M
M
M            '1/;,?J,Z-A=:N\8OH[M6/ZNY^TXKR%'^0?9VL_:+ WG>S4\
MALYT3*[C>:9SNYJU^                              !^/5EU:[[B=3?
M0\-KJW3&=,-GL>N&;M?E;B0#DVPJ]G\%=]X]4R&RK1\IMZYQF^^&I9
M       =(=JL-1_1<+K7W?%]'MKQ_5S/6G$&2HQ9H"9+'F7&5^U6OW?>+5,A
MLFTC*;:N=YGNMJ]^           !PKE*&H?HV%UB[WB>@VWX[J/L=EP-E[?\
M*K*!R38U>R>$NNZ6KW^Q#3,EM2T#,;.]$RO[%*8
M
M
M     #C:^I5X^RZU7?[-K/2':K      #8/IV2L?\3VC?WQ_8_HJ,P     %
M';U5H/7[,6P       _L^HMYON[2KSOB;CM9KUYWSU+([+M&RG,&-K@
M    =7,_:5J>X:MH"Z_K?"65H      =X-5O[%_%MGL-\:V7[FTJ
M #CV\I5Z>RZW7<[-K/1?;,>      .\.JW]@+CVR6&^-;+S+C*X        '
M\1:<^E8.MSVW5]0O1\+^74@     !S!C:^]3D^P6.N*;/WUU'(@
M
M
M               ?GSPK@=LU>JGZ U#A?*4        .U6OWEN[SEN>\OE.P
M     #S2?<?+.J6P68          GR1V>:)EK!/'=DWU\CV'Z2A.       .
M.KVE5)]!:?6Y[=J_SM:4       #GW#W-M+SQN-@_CFRY8       !BBKS]E
MUJI=Z'TW@K+6X        Y"LJMEWAVTVAN#;;]]9U       !KJW3&4V_2^C
MZU=XQ8        S0;K>79ZV_YUW/NCK%\
M
M                                                        .K&?
MLZ/7JG0=9&]XH         #=_P KS]TOS#O7+..K    #S2?<?+.J6P68
M        ':K7[RXUYJW;<_S'.@     #7-NN,HV>K- ZD;%9          ;B
M.:YN[EY:WWFG%UP     !Q5D*-(3U/H6FSIF#          ':O7[RZ_Y=WO:
MSS[,      ?X5A.[ZG4O]$:=^14E          ^FH3VM//NWV?N#[9+EB
M
M
M                  !K8W?%T-O6W/.#,M;@          =Q]9OK[/D?HG</
M6KT   #S2?<?+.J6P68            _N"TSP/;K8WGG<?\ 0    #2QT_!4
M=O56@_&75,          #N'K5[?L\A]&[::[>     #A;*4//^]@<XZ#;?C@
M          !^E)&WAYQW2S#PW:@    /\*=GI32:V';]6            W+\
MSSEXGRKOW(=E5
M
M                                  UO;MBZ _K_ )SQK?4@
M   .QV$NO0(\?='[FZQ?   #S2?<?+.J6P68             MK>=]RM&\$V
MT    :>^DX2A[ZUY[^%5E            [5:_>>A5XWZ3V/PET    /P:TOG
M[^P><:PM\Q(            %J#@.W6P_/6X@   "KSWG4JD7HK30
M    -F^B96_%Y%Z+R58U0
M
M                                        .L>=M/.P]G\SX'R]N
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M8\=WM/J9L-EKBW7&:>>E83K)G;0    ;<^<YJ^UY&Z)^M3B
M
M
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M&K$]VU33WTG"    6D.";;;3\[[D
M
M                                              !70[3K%,OTUHX
M '8##W-Y#RIO^U/G^7     &**N%VO5Z@'I'2OG:TH  %S[S'O-B7C&S  #S
M2?<?+.J6P68  ]6/Y^=?      $.:%?SL.N4X?2VD?$W5,  3)8^FIX7ZKV#
MPUR  *YG:M8IG^F='   YBQE>\CY4W_;ASK,@    "--"KUWG4ZF7H;3H\T
M !^]1F]'?Q3T_N=K%\  !4_]":=5<[_J(  ^]LZEZ;RAT'<!S?-      ?@5
MI:S7<]5JF^@M/^2N)  !RC85KW/DSH.UGGV8  &O[<,;YSOM/F0  %G#A6UV
MY/.FYSY(@     :CNBX:F1Z;T;J)L=D  /Z+2_ MNME>>=Q
M
M
M     'PUW3\U'W#RW@/+VP  ['82Z]!WQUTCMQKEZ      !J:Z'AJ'WK3GO
MP5Y3  '.>)N/2N\/=2Y"LZH 'FD^X^6=4M@LP !ZL?S\Z^       -+/3\%1
M$]:<]_D  %WWROON^;DFQ  ?-UY/-.]P\MZXYNU  '*N/K>@=X\Z/L T_)
M     5S^TZQ3.]-:/_(  -]G(]BN[^6-]   \WWVSR_H]M5@  +N7EG?=^/(
MMB       '0G;L=11]8\^Z@;)9 #LY@KN^KY'Z'WRU'(@  5/_0FG57._P"H
M@ #=IRW/7KO)W0?]       ..KVE2L]0:+HTZMKX _4IQN1^:-XL6<7V8
M
M
M               "N!VS5Z;?I?2  !^Q2F]"'QSTC95H^5        TY]*PE
M#CUMSS\^>   N%^;=VLL<.VD #S2?<?+.J6P68  ]6/Y^=?        \^[V)
MS?5;O^(  %IC@6W6R_/.X@ :$NN:[2)]3Z$  !>T\F]!W7\NSP       %,S
MTUH]<_M.L  #]NE-Z8GAKJG83#7( '%60H^7K[RY-CB  [;:[>>E1X?ZGE@
M       X1RMO0C]<\[US;KC!L T_)7TO(_0^R.$N@  !0(]?\YU)]$PP  ]%
M3Q?TS8?IF3        Q15"O1VEUENZ:H.0K*K>4\J;_N-YIFP
M
M           !^/2ONB&F^A>%,7O6W'I?C/\ U    =.>*>ANM?,.R?S&'^31
M_F9_,8_S%_,S^9H_S%_,T?XB_F=_,8_Q%_,T?YG?Q&/\S1_B9_,T?XF?S&/\
M3OYF?Q&/\3OYFC_$8_Q._4N;*55HR:U#Z*^Q7VF1P').7U/FO8-!YCSFBYYJ
M8                              \Z#VES+7WN.-  %F;AFU6_?-^Z@
M      54/0.H52_06G@#]"2.[GEF>M,\"V[8#I^2  \TGW'RSJEL%F  /5C^
M?G7P       *M7?-1J8^A].  %B;C&S7/?,>\@ 4'?7?.]/W2,(  -T?,,[?
M \E]"        '&-_2\U?V_RSA+*T  !<%\W;K9>X;M0 &O;<L;YTOM'F0
MWB<JS]Y_RCT         #B;(T?/N]A\W["8:YO.^4N@<DV-4   #S4O</+.I
M.Q68 'Z]./J@^ NNRY8@       #_"GSZ2TK15UC7KYODCH>P_3,F
M
M               !PEAM^K:^>_J7HLX]] ^)[;;H]Q"QQWCYA6L?0_R$_P!0
M   XYUG;ZJOR2^YO4_DW<OXJ38JK%/-AGFQ5&*M'#4CAGCAJ38J[!4FPSL%6
M?#78*DV&>."O'%5FC5(X:LV&O&/4CAJ38*Z/6FP5)L%:."M-@J31ZS!7FP5)
MHU6.&XC^_D,7VGW/C?>+H?GS8WTWRWM1ZOX^YFS6B@
M         =.=EL?-B]O<N  'U5O/Z8GAKJG.N)N         /Q:LOG3^T>9]
M#MMQWUUM/8"X_LEG#A6U]P]:O0  /-)]Q\LZI;!9@ #U8_GYU\       "O9
MV36J5_I_10 !8%X]LEU[R[O8 ^(NJ?E[>\N3?.5Y0 !Z&/C7I6S+1LJ
M   !5+]!:?50] Z@  -MO.LS?V\@]&  U8[_ (CSZO8G-P !N+YKF[['D;H@
M         X(RUOR_CJW[%*8    >8[[KY3U^S%L !(ECZCW@GK7WMI4
M    C30X%RUOV#P]R
M                                       !IBXY[LJ/^5?M#Q3:;;@N
M(1[F,>XA@N%CONGS"M:^@_D)_J   ''.M;A51^2GW+ZH<G[KBJL4\V&>;%48
MJT<-2.&>.&I-BKL%2;#.P59\-=@J389XX*\<56:-4CAJS8:\8]2.&I-@KH]:
M;!4FP5HX*TV"I-'K,%>;!4FC58X;B,>K/'J,%Q&/5GDW-MM)ZSY"L&>@?FML
M[Z7Y-                           KB]KUBFMZ8T<  ;PN59^]#Y1Z
M       !J/Z+AM4G0</9.XCM'/N'N0   /-)]Q\LZI;!9@ #U8_GYU\
M  "OUV'6Z4/J+1  !8)X[LEUKR]O8 U1]!P_G\>PN<  #M[KE[Z4OA_J7^@
M       '3K9;'S8?;W+@ !]U:5/47\%=:_2DB -=^YXSSK/:',P !]G:S^E1
MX@ZGV(PMR              !YHWN/EG578+,  72_,.]6&.-;*
M
M                      /\1K0>9_JY6=\X?5R+7C@N&"XA'N8Q[B&"X1[E
M8_[A\PK7/?OD)_J   ''&M;A50^2_P!S.IO*>Z8IYL,\V*HQ5HX:D<,\<-2;
M%78*DV&=@JSX:[!4FPSQP5XXJLT:I'#5FPUXQZD<-2;!71ZTV"I-@K1P5IL%
M2:/68*\V"I-&JQPW$8]6>/48+B,>K/'JQP5XQZT^SSI_DJV-ZF^.':[9^.@
M                        4G?4>AU_NP:X  +J?E_>["''-D
M      \TGW'RSJEL%F  /5C^?G7P       *]?9-:I8>G]%  %DGB.T7&O-6
M[@"MAV_5J=?I320 !8FXQLUSWS'O(         'F@>Y.5]6\_:  #TF/$74>
MY>LWP X9R=#S!/>')_Y  !M)T'+WU/(_0^1K*J              //Z]@\XU
M0]"PX  Y6Q];T /'_1MANF9,
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MO[G?F3>=J?/\N             !4[]"Z=5@[]J(  'V]I4MJ^>-RL><3V?\
M;I3
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M(            Z/[58><%[8Y?AB   ';'7KRROP[:=_7(-CYAQM<
M
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M.7,=6
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MWR/Y2XD  ^KMY_4X\"=<                'FD^X^6=4M@LP !ZL?S\Z^
M    !U)V*RH(^O>==0-DL@ !;I\Y[G9ZX1M@ %';U5H.B7K.O  "^_Y%Z+N$
MYMF@         *>_I+2JTG<=5  %U[R[O=@7CVR  #3!T[!41_6?/H<T
M !RYCJVX7FV;W,\RSFXCFN;YAQM<         #@[*V_G6>T.9]8,]:     #
M]FE-M#T/+;FN99S<US+.=T]7OP
M                                                 !$DKU)/%7VQ
MTB\'^@<>NPW"/<,-S"-<1P7$,%PP7$(]S&/<0P7"/<H]RP7$,%P_R(6BNU?*
M*T-VKY2   #BK5=XJ;?*7[J=6N:=JPSQPU)L5=@J389V"K/AKL%2;#/'!7CB
MJS1JD<-6;#7C'J1PU)L%='K38*DV"M'!6FP5)H]9@KS8*DT:K'#<1CU9X]1@
MN(QZL\>K'!7C'K3QZD8]S&/5FP5)HUS&/5CO=[%\^+>_I3XOS)J
M              'EC^^^1_*7$@ 'U=O/ZG'@3K@                \TGW'
MRSJEL%F  /5C^?G7P    !$FATAVJPT2=9UZM3W#5N-KZD  -KW/<Q?N\A=%
M_7IS  4=O56@Z)>LZ\  +[_D7HNX3FV:          I[^DM*K2=QU4  77O+
MN]V!>/;(  !7C[+K5,CTWHWY\\      !^M3CM'T'+[MN6Y[>#RO/]C\)=
M       ='MJQ] _U]SKK;F[4      #NCK%]NSY;GMX_*M@V*Z7D_P"X
M
M                  /SJ5U4@\1_;?2MPCWU@N$>NPW"/<,-S"-<1P7$,%PP
M7$(]S&/<0P7"/<H]RP7$,%P_R("TYVWY,6=.S_*X   <5:MO%3'Y3?=7JSS7
MM6&I-BKL%2;#.P59\-=@J389XX*\<56:-4CAJS8:\8]2.&I-@KH]:;!4FP5H
MX*TV"I-'K,%>;!4FC58X;B,>K/'J,%Q&/5GCU8X*\8]:>/4C'N8QZLV"I-&N
M8QZL8]2?=9UGPE<B]+?$G]JK8@                     #RQ_??(_E+B0
M#ZNWG]3CP)UP                >:3[CY9U2V"S  ':W7[P    #\6I+PME
M*'RMQ(   -T_+\[=Y\L[[R'950 !1V]5:#HEZSKP  OO^1>B[A.;9H
M   "GOZ2TJM)W'50 !=>\N[W8%X]L@   U"]'PM)?U)H?7[,6P       F2Q
MVO<]S%A;C>R[O^5Y[Z2A.       !ULSEK2(]3:%JFZ#AP       .Y.LWU@
M7CVQV$>.;+V$PUR
M                                   /S:-W43\,_<'37PSW?@KL%PCU
MV&X1[AAN81KB."XA@N&"XA'N8Q[B&"X1[E'N6"XA@N'^1 "TYVWY,6=.S_*X
M   <4ZMO%2WY4_=;JQS;M>*NP5)L,[!5GPUV"I-AGC@KQQ59HU2.&K-AKQCU
M(X:DV"NCUIL%2;!6C@K38*DT>LP5YL%2:-5CAN(QZL\>HP7$8]6>/5C@KQCU
MIX]2,>YC'JS8*DT:YC'JQCU)\%Q';STOQ==1]-?#+Z6OBP
M       /+']]\C^4N)  /J[>?U./ G7                !YI/N/EG5+8+,
M           #O9J>0M-<"V[>UR;8?[@   H[>JM!T2]9UX  7W_(O1=PG-LT
M         !3W]):56D[CJH  NO>7=[L"\>V0   #B/(T:J/H'3ZY_:=9^6N)
M        .P6'N;+_  W:K(_$=H^[M*@       CS0K[]AURJ%Z$T[K3G+4
M     #Z&C-OKY'L5IC@6W=O];O0
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MNL"                     /+']]\C^4N)  /J[>?U./ G7
M    !YI/N/EG5+8+,          ?KTYMOO-\U: X/MFT[0,O_H   !1V]5:#
MHEZSKP  OO\ D7HNX3FV:          I[^DM*K2=QU4  77O+N]V!>/;(
M !URS=K6^[9J]?'L>M]>,S;        =CL)=7 /-^Z[U>3[        !\S7D
MT+]<UZN3VK6-<&[8L       #]ZC-96X?M-KGSYN'VUK4
M
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M+NCK%\
M                      /F[/+4^OG]]V=57%?9N"X8+AAN(8*[!<(]=AN$
M>X8;F$:XC@N(8+A@N(1[F,>XA@N$>Y1[E@N(8+A_D0  _P!0MA=T^0EDWL'S
M#   '%&K[Q4@^6GW9ZJ<X[5@JSX:[!4FPSQP5XXJLT:I'#5FPUXQZD<-2;!7
M1ZTV"I-@K1P5IL%2:/68*\V"I-&JQPW$8]6>/48+B,>K/'JQP5XQZT\>I&/<
MQCU9L%2:-<QCU8QZD^"XC'JQC59\%S'OKMWGB];Z;^ O,N0TD
M         >6/[[Y'\I<2  ?5V\_J<>!.N                #S2?<?+.J6P
M68            &ZKE^=NY>6=]Y'LJH  H[>JM!T2]9UX  7W_(O1=PG-LT
M        !3W]):56D[CJH  NO>7=[L"\>V0       1IH:[=SQNH#I&$U$]&
MPNLO>L5^!6E      VM<^S%]GR-T3["VG         '6/.VFGSI.%U$=&PNI
M?HF&X:R=      #FG%U_0!\?]'[\ZAD0
M                                              !\O8YFG1\\OO-K
M&XYZ^PUX8+A@N&&XA@KL%PCUV&X1[AAN81KB."XA@N&"XA'N8Q[B&"X1[E'N
M6"XA@N'^1   ?ZA;"[I\A+)O8/F&   .)]8WBHW\M_NSU3YSVW#78*DV&>."
MO'%5FC5(X:LV&O&/4CAJ38*Z/6FP5)L%:."M-@J31ZS!7FP5)HU6.&XC'JSQ
MZC!<1CU9X]6."O&/6GCU(Q[F,>K-@J31KF,>K&/4GP7$8]6,:K/@N8QZD>ZV
MR<,O:>F_@#V%RW.                    /+']]\C^4N)  /J[>?U./ G7
M               !YI/N/EG5+8+,  7!_-NZ@    ?/5Y> <O;=#]MQ^K;?L
M1\A<R   ;8>>YB_AY!Z-^E)$ "CMZJT'1+UG7@ !??\ (O1=PG-LT
M  !3W]):56D[CJH  NO>7=[L"\>V0         <?7E/5/T'#Z>^DX33-TW!]
M4M@LP    -^'(MBNY^6=]           @SPUX;GC-/O2,+IMZ9@]:^[XN+-
M    =F\%=^B_XMZ;S3BZX
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MS\_W:/-\G                   'EC^^^1_*7$@ 'U=O/ZG'@3K@
M         \TGW'RSJEL%F  /5C^?G7P     !Q'D:-5KO^H5H.Y:K_$0  N/
M^:=WLB<2V@ "CMZJT'1+UG7@ !?7\C=$W&<US8         %/#TGI-:ON&K
M "Z]Y=WNP+Q[9           /XBUU;IC-"77-=T ]@USA_)4    +Z'DCH>Y
M/F><            '7C,VVBGK&O5XNS:UT6VS'@   6%^-[+=,\P;T
M
M       !\/B]CIT?./[VZY.1^K<%>&"O'#7A@N&"X8;B&"NP7"/78;A'N&&Y
MA&N(X+B&"X8+B$>YC'N(8+A'N4>Y8+B&"X?Y$   !_J%L;NGR"LD]@^8H
MXFUG>*B7R_\ NWU0YWVW#/'!7CBJS1JD<-6;#7C'J1PU)L%='K38*DV"M'!6
MFP5)H]9@KS8*DT:K'#<1CU9X]1@N(QZL\>K'!7C'K3QZD8]S&/5FP5)HUS&/
M5C'J3X+B,>K&-5GP7,8]2/\ D0[)9CF-[KTY^?[N)L'%@
M   /,)]W<HX2RMN  /5 \!]=^CH3                >:3[CY9U2V"S  'J
MQ_/SKX       J0^BM,J]=YU,  =O=<O?2C\0=2_N  4J?4&B5\NQZV  +SG
ME'H&\?E6?          I:>GM%KS]EUH  7D?*>_[TN4;             /@;
MRG6L[?JU6;ONH_#7=,  #9[HF6]";QOTD             8XM,?3<%4']'Z7
MTTV:Q   _6IQ]+;PYU3LO@[H
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MTU\!.]FS\                   'G&^UN8]#MMQP  ])#Q)U#NGJ]^
M          !YI/N/EG5+8+,  >K'\_.O@      #X"\I^8Y[KY1Q]>4P !Z1
M/B7J'=K5K\ 5$/1NEUB^[:H  +AOFS=K*W#]I          H2^N>=Z=NE80
M 7]_('1MMG.\R             .C^U6%![UUSKJ[G[0  ?W!Z9OAGJO9/!W0
M             'Q-U3I$^IM"TD=3P(  %Q3S7NUD_B&T@
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MG@  !=W\L;[OLY'L0               'FD^X^6=4M@LP !ZL?S\Z^
M !06]><ZU"]'PH  O*^4]_WG<HV  5Q.UZQ37],:.  +"?&]DNH>8-[
M     \ROW1RKKAF[4  >E3X?ZEVZUR]              U_;AC?.S]G\S_)J
M0  %[#R=T'=GRW/              #YRO+YVWL[F?0C;L<  -^'(MBNY^6=]
M
M            XOP&YTX/F=]^^BW+O2&&M+AKQPW#!7A@KQPUX8+A@N&&XA@K
ML%PCUV&X1[AAN81KB."XA@N&"XA'N8Q[B&"X1[E'N6"XA@N'^1     #(EMS
M=Z^.-B;K7S7   '"VJ="I_\ S)^\'6'1>Q1JD<-6;#7C'J1PU)L%='K38*DV
M"M'!6FP5)H]9@KS8*DT:K'#<1CU9X]1@N(QZL\>K'!7C'K3QZD8]S&/5FP5)
MHUS&/5C'J3X+B,>K&-5GP7,8]2/^1  <C7>M7A_2GP9VA[KY2
M      %6KOFHU,?0^G  #?-R38;OOE??@         -;.[XNJSW_ %"T9P7;
M=H&AY8   #S2?<?+.J6P68  ]6/Y^=?        ID>FM&KI]IUD  7'?-.[V
M1N);0 -8&^8GSV_8_-@ !VEP%WZ77ASJF2         #HWM>/\X#VQS   <G
M6%7U#/!O69,L0             !0\]:\]TO].P0  N/>:=WLB\2V@
M       "OUV'6Z4/J+1  !MEYYF;_P!X_P"C
M                                               #BS7MUII?,']
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MFQV7\1=OM;O0         -=NYXSSKO:',P !M9Y]F/0*\>]'
M                                                           X
M>UC?J;'R]_0+T[YSWO%7A@KQPUI<->.&X8*\,%>.&O#!<,%PPW$,%=@N$>NP
MW"/<,-S"-<1P7$,%PP7$(]S&/<0P7"/<H]RP7$,%P_R(     ?MU+&[-Z/\
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M\3YZ_LCFP  W7<NSU[7R;T$
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MMEN+SIN8
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M=M?/Z]@\XZ<[+8@ #NSJU_Z.GBGI_P"M3B !YI/N/EG5+8+,  >K'\_.O@
M     56._P"H50_0FG@ "V[YUW*T-P;;0 /RZD/-E]N\MZE;%9@ #D2RJ^@%
MX_Z-L=TG*       5H^Y:K3X](Z4  !8DXQLUS_S'O(  X1RMOYXGLOFO478
M[( 2Y8V7.&[3;#\][C]S:5       !KRW/&>=A[/YG@B  Y.L*OI\^$.L?N4
MI@ /\*57J#1*^78];  VCZ#E[I_F#>NYNLWP       _#JR^<;[6YCTJVBP
M %]3R/T3<?S3-@
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MXFCEZJT#K9G+4  ?T7X/(G1-P/-\V  /-)]Q\LZI;!9@ #U8_GYU\
M"KSWG4JD7HK30 !:T\^[A:O\_;>  -!?7M=I(>I="   Y1L*UWGRQONYGF6<
M     'Y\\*J'H'4*K_?M0QQ  #[*VG](_P 1]1[18&[  ^5N)* OK_G.L#?,
M2  !VCP%W;3\\;EOAY)L,R6(     '!V5M_/J]B<WZ1;58  "P;QS9+JWE_>
MP !5R[WJ52GT1IH  'T]">RWPW:;0'!]LYAQM<     "/-"FGZ8T>NAVG60
M!SABKCTT?"_5?HJ,P
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M^;0               '%M_1\X3VQS#K3G+4  #^C=QRS/6CN";=L;TK)@
M=2=BLJN7>]2KV]CUN#/   "P[QG9;HWF+>@  /-)]Q\LZI;!9@ #U8_GYU\
M      "LWW/5:@'I#2@ !:@X#MUL/SUN(  Q1>?U[!YQJFZ#AP  ,D&^CDFQ
M6HN ;=W5U>_   &*+41T;"U,/0^FZY]UQ@   MK^=MRM&<%VT  5$/1NEUB^
M[:H    .Y6LWUC_B>T;WN2[!SYB+D   #'%I@Z=@J<WI72.K&?M  !.DCZ-'
MBSIW>W4L@ !K&WO$^>[[&YO'F@   !R38U;!G'=DL%<=V38'IV2_T    Z;;
M-8T\O26DZ<NEX0  "V7YYW&TQP+;@
M                                     .N6@==IO?*']"'7W3^HX:K'
M68:[#58:[%7A@KQPUI<->.&X8*\,%>.&O#!<,%PPW$,%=@N$>NPW"/<,-S"-
M<1P7$,%PP7$(]S&/<0P7"/<H]RP7$,%P_P B   _;J6-UKT;\,MS?0_$0
M      X1UCH=-SYR?>?JOI?8\%2;!6C@K38*DT>LP5YL%2:-5CAN(QZL\>HP
M7$8]6>/5C@KQCUIX]2,>YC'JS8*DT:YC'JQCU)\%Q&/5C&JSX+F,>I'_ "(
M   #M?G.0^BWZW_-1FC(               !JLZ!B*!'K[G/XU64   #NMJ]
M_MQYSF>_^H9+L]@;ODFQJ?G5(<!Y>WZ+;7C]271<-K WS$Q)H   #8WI63]!
M?QUTG[&VG   \TGW'RSJEL%F  /5C^?G7P       *]'9-:I9^G]%  &_3D.
MQ7;_ "UOH  '5W/6GG5>T>9<)Y2@   ,D&RC2,KMLYUF>^.I9#L)AKGZBA/Q
MQ>TNL.>M-=VYXW3ETO!]3=ALP   -KW/<Q?U\@]&_0DB  .&LG0HW>J] U)=
M%PP    $R6.Q#3,GLUT7*]W]5O\ LM@[OE;'5?V:<WPEW3ZUYRUU];CC=-'3
M,'TUV:Q   %DGB.T7&O-6[@ #'%5D[[J-4;T'I\2:     ':? 7>T[0,OWYU
M#)=K]>O.9\97^QMI_P .K+P5EK?H[M5AJ9Z)AM5V_P"(B30   [@:W>^C;XJ
MZ=]M:U
M              !PGI_2*8GR/_1%U[TOJN*O##58ZS#78:K#78J\,%>.&M+A
MKQPW#!7A@KQPUX8+A@N&&XA@KL%PCUV&X1[AAN81KB."XA@N&"XA'N8Q[B&"
MX1[E'N6"XA@N'^1  #].>UNF^BOASNPZ/X7          '".L=#II?.?[U=6
MM,[%@K1P5IL%2:/68*\V"I-&JQPW$8]6>/48+B,>K/'JQP5XQZT\>I&/<QCU
M9L%2:-<QCU8QZD^"XC'JQC59\%S&/4C_ )$     +_?J?\[FQ7;?-0
M          KW]CUNEAZ?T3'$           !W.UB^]!CQWTCGW#W(   \TGW
M'RSJEL%F  /5C^?G7P       -1_1<-0,]?<Y  ',^,K^EOX<ZGR+950  -7
M6^XF@EZ]YS\=<R            =V-6O_ $(O'/2>:<77   'YL\*I?H+3ZMW
M?-2AS0             V':9D_0C\<=)^RMIP  !I^Z1A:27J70N"LM;@
M        ?:VM3T%O'?2-C&E9,
M                                 1Z=6G-\F?T(:^^(>J<-6.*O##58
MZS#78:K#78J\,%>.&M+AKQPW#!7A@KQPUX8+A@N&&XA@KL%PCUV&X1[AAN81
MKB."XA@N&"XA'N8Q[B&"X1[E'N6"XA@N'^1  ?ISVMT'T1\0-WG2?"
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M3L9A;H    #5;O\ B*4OJ+1.I&Q60           '>S4\A?]\?\ 1^>L1<
M  #K_F+:E_Z<T;2YT_!            ?96T]ZCR?T'<3S7-@
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M        HK^L.?:1.IX$  "PQQK9;I?F'>@  !T9VO'T9O5N@=&]KQX
M    &\GE.?NH>8-[Y*L:H     'PUW3JQ=]U&LYW/5?E;B0          ;E^
M9YR[GY9WWEG'5@     -&W5M?J$^CM+ZMY^T          ':; 7=YGRET#9)
MI&4
M            P25:/'QB_2UULT'K^.JPU8XJ\,-5CK,-=AJL-=BKPP5XX:TN
M&O'#<,%>&"O'#7A@N&"X8;B&"NP7"/78;A'N&&YA&N(X+B&"X8+B$>YC'N(8
M+A'N4>Y8+B&"X?Y$!^G/:W0?1'Q W>=)\(             #K]JO3:8GSS^]
MO6;4^M1ZS!7FP5)HU6.&XC'JSQZC!<1CU9X]6."O&/6GCU(Q[F,>K-@J31KF
M,>K&/4GP7$8]6,:K/@N8QZD?\B     &WS?O&=Y3TM\$P
M  .(LC1J9^A]-KN]FUK\>K*       !W4U>^N">;MVW%\US8     \TGW'RS
MJEL%F  /5C^?G7P       !U-V&S\\GV7S3@3+VX  W7\NSU[3R;T$   #Y.
MXDJT=]U&LCW75/C;F0       #L]@;NW=YRW3>OR?8        .JNP6=6/ON
MHZ!>OZY\Y7E        '8/#7-M3SON5@CCVR9(       /D;F2N'VO6*R/==
M3ZZ9JV        '[=*:QGQ79[8GGK<.4;"L
M                                            .@G"O5%-SY(_H7_B
MK#'58:L<5>&&JQUF&NPU6&NQ5X8*\<-:7#7CAN&"O#!7CAKPP7#!<,-Q#!78
M+A'KL-PCW##<PC7$<%Q#!<,%Q"/<QCW$,%PCW*/<L%Q#!</\B'Z<]K=!]$?$
M#=YTGP@              .ONJ]-I??/;[X=9=6ZO@KS8*DT:K'#<1CU9X]1@
MN(QZL\>K'!7C'K3QZD8]S&/5FP5)HUS&/5C'J3X+B,>K&-5GP7,8]2/^1
M  #;_OWC&\CZ6^"H                  '4C8K*MEV_5]!_7==X0RMN
M /[@V7Z-E;(G$]HWK\FV']:G$     "DYZCT/@/+VP  OO\ D7HH
M'6'/6E5[OVHZA^CX7@/+VV*(#=#S'.WE_*6_@    =>,S;5MNW:M7S['K?7C
M,VP     &P;3LE8TXKL]@'C^Q_46\X         Z_9BVKW=DUO0=UW7.C^U6
M       V":=DK$?&=FL#<=V/[:UJ         ?.UI='W5<!7W[#K>I[H>'_(
MJ2@     <\8BXWY<BV.R7Q':.UVO7@
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MO'5[2']P<IV%;M-@+OO=J61V>Z'E=Q/-LYVSUV\
M          _/GAK,WK%:E^AX;7'NV+Z8;-8];<Y:_"7=,9H.5\?6[08"[[T:
MID-E^C97<!S?-]S]8O@           !TVV:QU.="P^M?>,5T;VNPZL9^SX1R
MMO\ DU(#]"2/-.+K]I\!>=Y-4R&RC1\IMUYSFNX6MWH           '$61HZ
MF>B8;61O6)Z#;?CNHFQV77O,VWQUS(/[@Y.L:W9'!W7=/6+[8EI>3VL\_P Q
MLST7*_H21
M                    %47Y=_=/4WY@]V?Q5ACJL-6.*O##58ZS#78:K#78
MJ\,%>.&M+AKQPW#!7A@KQPUX8+A@N&&XA@KL%PCUV&X1[AAN81KB."XA@N&"
MXA'N8Q[B&"X1[E'N6"XA@N$R>A<R]#?$C>CTSP*                .OFK=
M-I9> ?OCUDU7K4:K'#<1CU9X]1@N(QZL\>K'!7C'K3QZD8]S&/5FP5)HUS&/
M5C'J3X+B,>K&-5GP7,8]2/\ D0     MH]V^/EC_ *]\R@
M        /S9X?C59?W*4T^2(
M_(J0_+J2_049I<L0                 /F:\N.,/JK><
M  #\>K+^9/#]^C-,EB
M                                *>OR6_03KKX+ZV_BK#'58:L<5>&&
MJQUF&NPU6&NQ5X8*\<-:7#7CAN&"O#!7CAKPP7#!<,-Q#!78+A'KL-PCW##<
MPC7$<%Q#!<,%Q"/<QCW$,%PCW*/<L%Q#+=4+DGH3XG[W^G_/X
M      =>]7Z=2N\!_?+K!J_6<-Q&/5GCU&"XC'JSQZL<%>,>M/'J1CW,8]6;
M!4FC7,8]6,>I/@N(QZL8U6?!<QCU(_Y$     /09]6?G,[[[1YZ
M
M
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M/\VG]H
M
M
M   "K=\SOMQIR\F_0?\ BK#'58:L<5>&&JQUF&NPU6&NQ5X8*\<-:7#7CAN&
M"O#!7CAKPP7#!<,-Q#!78+A'KL-PCW##<PC7$<%Q#!<,%Q"/<QCW$,%PCW++
M=T+C/I'XG;V^I?/X                   =>=8Z=2C\&_?3J_K/6X]1@N(Q
MZL\>K'!7C'K3QZD8]S&/5FP5)HUS&/5C'J3X+B,>K&-5GP7,8]2/^1     7
M!._?&&P9U;YR@
M
M
M          :.?%GTPK3_ #O^Q_\ %6&.JPU8XJ\,-5CK,-=AJL-=BKPP5XX:
MTN&O'#<,%>&"O'#7A@N&"X8;B&"NP7"/78;A'N&&YA&N(X+B&"X8+B$>YC'N
M(8+AENZ%Q3TO\3M['5?G\                    .O&L].I.^$/OMU>UGK.
M"XC'JSQZL<%>,>M/'J1CW,8]6;!4FC7,8]6,>I/@N(QZL8U6?!<QCU(_Y$
M  .X^P<5]"SU?^<']VKCP
M
M
M                  .M?.^QT=_C#^EO%48ZK#5CBKPPU6.LPUV&JPUV*O#!
M7CAK2X:\<-PP5X8*\<->&"X8+AAN(8*[!<(]=AN$>X8;F$:XC@N(8+A@N(1[
MF,>XAENZ%Q#TW\3MZO6?G\                     .NFL]0I$>#_O_ -<,
M%T^/5GCU8X*\8]:>/4C'N8QZLV"I-&N8QZL8]2?!<1CU8QJL^"YC'J1_R(
M #]>I9WT?4'Y\ME&X>8                      !Q;?T>D6U6'5_/6G#63
MH?+UY/T9)N6L=6[/X&[[U:GD.:,97              AS0Z@[)9=/-ELNO\
MF+;CJ]I18P^RMJG-6+K]K=?O.[FJW_V]K4
M
M                                              IY?)O]!&NO@OK;
M'58:L<5>&&JQUF&NPU6&NQ5X8*\<-:7#7CAN&"O#!7CAKPP7#!<,-Q#!78+A
M'KL-PCW##<PC7$<%Q#!<,%Q"/<Q7-*WYZ>^*V^;L'SS
M     '635>LTDO#7WWZW8#J,>K'!7C'K3QZD8]S&/5FP5)HUS&/5C'J3X+B,
M>K&-5GP7,8]2/^1   #_ %"X-W_XP6">J_.<                    #'%J
MZWW$:.NJX#41T;"])]IL,,0  ']P=T]8O]QG-,WOBY+L.Q_2<H
M!Q'D:.C/J^OZ5^GX+5MOV(XUOJ0   _3IQV"Z=DMQ'-LWO>Y+L/>75,@
M  ./KRGPIE+<  <EV-7F'&UP        ..;VEPSDZ   Y+L:O,.-K@")-#J]
MGK0  =I<!>9X         !UXS-M\U7D  E2Q[18&[ XNOZ/$F1H@
M       <MXZMRC85@/F:\G7G,VP        _4DCRGCZW(ME5     ' >7MOC
M[F0  #L5A;KZ*C,         !QU>TN&,G0   [#8:Y^FH3@
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M$  !:"X-MEN'SKN8         %!SUWSK3_TC"@ #NUJU_P"C/XKZ=]%1F
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MJ,WHR^+.G=X-5OP        -,73L'0Y]:\\  &:#T"O'O2-J?/\ +@
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MG60*O/>=2J1>BM-                MN^==RM#<&VT#6CO.*\\KV5S4
M        ?34)[9?GG<;-W"MKR0 #J7L5GYQ/M;F'PUW3  &VCG>9O]>0.C?Z
M        ?/UI?.(]K\PZ9[-8@ "P;QS9+JWE_>P
M          /G;#+U ?E?]^-=_$?5^&JQUF&NPU6&NQ5X8*\<-:7#7CAN&"O#
M!7CAKPP7#!<,-Q#!78+A'KL-PCW##<PC7$?]NJ5MOU=\7=]/</G6
M                   /@['8M;//O4G1C3^_]>\+TGX6EGL4\<4\V*JQ3QQ3
MQQ58XIXSIZ'*5[J7;7/<>V4;AY@[U;/P'^T                    !CBI^
M^D-*K1=RU4           2)8V^?.&Z68N&[4    !P[DJ% CU_SG7KN6-
M        'WMG4OB>2NA[8N>Y@   5^NPZW2A]1:(  ++?#MJN$>;=U
M   KG]IUFF9Z:T8  66^';5<(\V[J .*,A1\O/WGR8   ;_>/['=F\N;X
M     //*]E<UUH[SB@ .5L?6]0WP9UD"KSWG4JD7HK30               +
M;OG7<K0W!MM UH[SBO/*]E<U             %C+BNSW+O,^\?W  *QG=M4J
M'^C=+   O&^5-_WK<GV        "L=W75*AOH[2P !S?BKCTB_$O4.:<77
M                              'P>$VBFW\I_P!!O2GE7HG'68:[#58:
M[%7A@KQPUI<->.&X8*\,%>.&O#!<,%PPW$,%=@N$>NPW"/<,-S#^;J2VQZS^
M+N^;N?SJ
M     %33T-IU6?ONH@    ??V=3L;A;K[:TJ?*W$G6C.VG'UY3    ']%P_S
M7NUE+B&T@   ?,5Y//\ ?8/.=8N]XD    ?W!SQB;CG/$W$^2/%^0I=;,W:_
MBU90   !R)95?0>\<](V Z?D@  *_78=;I0^HM$  %EOAVU7"/-NZ@
M  5S^TZS3,]-:,  ++?#MJN$>;=U '%&0H^7G[SY,   !=U\L[[ONY%L0
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M]^]?-\
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MI^94@  +./"MKMY><=T       I<>G=%KQ]FUH  ;7>>YCT O'_1\D
M                            '7;1>LTN_E+^A[@S6.CX:K#78J\,%>.&
MM+AKQPW#!7A@KQPUX8+A@N&&XA@KL%PCUV&X8[F6U?ZV^-U@/T%\UP
M                                                  !UWS-MYOOM
MGE_$V1H@  ; =/R5RKS/N^SC1,L    (\T-!O7==J#>C]+X/RMN  !S;BJ_H
M]>*.G\^8BY  &J7H.'\_KV#SC'$  !N YOFKD_F?>.WFN7H    ^-N9*OO>=
M2JT]\U+\:K*  !8[XIL]RCS/O   K]=AUNE#ZBT0  66^';5<(\V[J
M  !7/[3K-,STUHP  LM\.VJX1YMW4 <49"CY>?O/DP    V0:3E/0E\<=)_>
MHS       >>5[*YKK1WG%  <K8^MZAO@SK('%U_1XDR-$     #SD_:O,>-+
MZD !R78U?1L\5=.      Y;QU;E&PK :T=YQ7GE>RN:@ #>UR;8;Q/E7?@
M  !QK?4M;^[8O0?UW7=!/7M<_,J0   M!<&VRW#YUW, "H-Z/TNLKW35  !^
MW2F]&+Q9TWO-JF0      UY[EC/.T]G\TAS0  ^GH3^C3XKZ;W3U>_
M                             Z@\Q[W3'^6'Z$^+\-N&&NQ5X8*\<-:7
M#7CAN&"O#!7CAKPP7#!<,-Q#!78+A'KOXN9;5?KKXWV /0WS6
M                                               I+>I-#T"]?UP
M #?QR#8[HOF+>?IJ$X     '7+-VM$SUCS[6YN^+   W\\@V.[5Y;WP #!%Y
MU'M'F6OK<<:  !:%X-MEM;SON4B6(     &J7H.'H@>M.>\:WU(  ?H21]''
MQ3T[O%JN0  K]=AUNE#ZBT0  66^';5<(\V[J        !7/[3K-,STUHP
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MV6?Q5X8*\<-:7#7CAN&"O#!7CAKPP7#!<,-Q#!78+ACN);5'K_XW[_/1/S6
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M*YKK1WG%  <K8^MZAO@SK(       'EY>\^3<4Y"B !RMCZWJ&^#.L@
M  :T=YQ7GE>RN:@ #>UR;8;Q/E7?@      !7N['K=*WU!H@  'IS^$^K<^8
MBY  T\])PE"3UUSO^0  7?/+&^[Y^1[$    !HLZQK]&_P!5Z   .Z&L7WHU
M^*^G?46\X                                    U]<8]3U#?FQ]X.)
M<+NV"O'#6EPUXX;A@KPP5XX:\,%PP7##<0P5WZ=_C[6OLCXR[T?0/SN
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M7-=:.\XH #E;'UO4-\&=9        \O+WGR;BG(40 .5L?6]0WP9UD
M #6CO.*\\KV5S4  ;VN3;#>)\J[\       /Q*LOF&>[N4<59"B  /0Q\:]*
MV9:-E0 !2!]4:#H:ZWKP  [%X6Z]([Q)U#DJQJ@   ?&75/S=?;7+^K.?M
M/[@O]>0.C;9N>9D                                     <#:ATVKW
MX)^S&J7@?MC!6AAKQPW#!7A@KQPUX8+A@N&&XAWDZ7YTM@>T/BYWNZ)YR
M                                                       'X-:7
MS&O=?*>'\E0  %XSRKO^]?DVP         :P=\Q/GR^Q>;Q)H#^C;?SK,V@.
M#[;MOYUF?[@ XOOZ/F%>[N4?@UI0 !?$\E="W/\ ,<Z        /@KNGYI/N
M/EG!^5MP !=B\N;Y8!X_L8 K]=AUNE#ZBT0  66^';5<(\V[J        !7/
M[3K-,STUHP  LM\.VJX1YMW4 <49"CY>?O/DP     &X?FV;OJ^1NB9X
M !YY7LKFNM'><4 !RMCZWJ&^#.L@       >7E[SY-Q3D*( '*V/K>H;X,ZR
M       !K1WG%>>5[*YJ  -[7)MAO$^5=^        \^+V-S;5SON)  %^;R
M'T7;[SC-  #@C+6_F[^VN7\-Y.@  +,'#=JN!^;MU    JK>@-0JB^@]/  &
M_KD&QW:?+>^                                       =&.4>DM(?E
M[Z*ZN.'^R>O^M]-P5X8*\<->'(^P:?LM[/Y'W7^A_GWM4[/XSSS4P
M                                                   -3O0L/Y_W
ML'G   [38"[]*[P]U.?)$         4L_3^BU^NPZWO%Y3G[/_"-LV&Z9DP
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M==GYQEC(
M        *H_H/3ZJGH#4  !9TX3M=N_SEN@         ' F7M_@KREVXUR]
M  %3/T-IU6CONH@ "S+PS:K?WF_=0        !K4WC%>>/[+YJ  .X^M7WI.
M>(>H@"OUV'6Z4/J+1  !9;X=M5PCS;NH        %<_M.LTS/36C  "RWP[:
MKA'FW=0!Q1D*/EY^\^3  #:MS_,=%=LQW">4H  #Z&C-Z%?C;I6Q?2\F
M!YY7LKFNM'><4 !RMCZWJ&^#.L@       >7E[SY-Q3D*( '*V/K>H;X,ZR
M      !K1WG%>>5[*YJ  -[7)MAO$^5=^        H0>NN=:>^DX4  7[O(7
M1=NO.<T  !CBH">O^<:F^AX<  ;4- R_H'>/.D98  !2!]4:#H:ZWKP  NG>
M8-ZL*\;V4
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M/R%S(  +M?EO?-_'(-C  UB;WB?/=]C\VPQ  ;3= R_H(^/.D98
M
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MP$::'G@>S.::Y-UQ@ 'T-&;T8/%G3>\6JY
M
M                   #R^?>/)N(LE1  D2Q]4OP#UW]"2(
M 'G!>V.8=&=KQX  ],CPSU3LW@KL         #SSO9/-=9N]8H  >CQXHZ?W
MKU/( 5^NPZW2A]1:(  ++?#MJN$>;=U         KG]IUFF9Z:T8  66^';5
M<(\V[J .*,A1\O/WGR8  ;VN3;#>)\J[]Q=?T?.4]J\QZL9^T   NY>6=]WX
M\BV(   #SRO97-=:.\XH #E;'UO4-\&=9        \O+WGR;BG(40 .5L?6]
M0WP9UD       #6CO.*\\KV5S4  ;VN3;#>)\J[\       -;^[8OSO/9O-
M !L%T[)>B]XMZ:    /Q*LOG6>T.9]"MNQP  LJ\/VFX=YLW8"OGV+6Z5'J'
M1  !:;X%MULCSSN(                                         'Y\
M\.),C1_2DCRICZV6
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MGVYR[KWF;8 #N#K=[Z.?BGI_U]M.
M        .@^WXZOYV#6]171L-TCVK'_D5(#[6UJ;!M.R6Y+F>;L#\>V3L?A+
MH
M>6/[[Y'\I<2  ?5V\_J<>!.N               #S=/;?+^D^T6   ].+PIU
M;L#A[D         #S]?87.-4W0<.  /1@\6]-V!Z=D@*_78=;I0^HM$  %EO
MAVU7"/-NZ@        5S^TZS3,]-:,  ++?#MJN$>;=U '%&0H^7G[SY,  -
M[7)MAO$^5=^ JG>@=/JF^@M0   V.:5E/0I\;])_>HS   >>5[*YKK1WG%
M<K8^MZAO@SK(       'EY>\^3<4Y"B !RMCZWJ&^#.L@       :T=YQ7GE
M>RN:@ #>UR;8;Q/E7?@     !UPS=K2K]0:)I_Z1A0 !W8U:_P#1A\6]-^JM
MYP    !3J]*:36Q[?JP  V@Z'EO0=\<])J2^B=,J]]YU, #^B_9Y"Z+MUYSF
M@                                       .LN=M*=OI/2=)?4L#_$0
M   ^BHS63.(;3:[\^;A]U:5
M                     !Y8_OOD?REQ( !]7;S^IQX$ZX
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M&I_,UY  -\W)-AN^^5]^
MU+]#PU&3U=H'#^2H     #O)JF0OD>2>A=M]=O0
M                                    /+']]\C^4N)  /J[>?U./ G7
M               !YNGMOE_2?:+   >G%X4ZMV!P]R         !Y^OL+G&J
M;H.'  'HP>+>F[ ].R0%?KL.MTH?46B  "RWP[:KA'FW=0        *Y_:=9
MIF>FM&  %EOAVU7"/-NZ@#BC(4?+S]Y\F  &]KDVPWB?*N_ #@/+VWG/^T^9
M=>,S;  "1+&^_P"1>B;?.<9H  >>5[*YKK1WG%  <K8^MZAO@SK(       '
MEY>\^3<4Y"B !RMCZWJ&^#.L@       :T=YQ7GE>RN:@            ;8.
M>YBZYY=WOM/@+P      #2YT_!4/_6G/0    !RYCJWI%^).H<^8BY
M                                 &FOIF#HK>L.?_,UY      !V.PE
MUZ _C[H_<[6+X
M          >6/[[Y'\I<2  ?5V\_J<>!.N               #S=/;?+^D^T
M6   ].+PIU;L#A[D         #S]?87.-4W0<.  /1@\6]-V!Z=D@*_78=;I
M0^HM$  %EOAVU7"/-NZ@        5S^TZS3,]-:,  ++?#MJN$>;=U '%&0H
M^7G[SY,  -[7)MAO$^5=^  U3=!P] ?U_P Y_-G@  .?\/<^C3XKZ=SWB+@
M#SRO97-=:.\XH #E;'UO4-\&=9        \O+WGR;BG(40 .5L?6]0WP9UD
M      #6CO.*\\KV5S4           ?76T^X'F^;L7<6V;<+S;-_Z
M 49?5O/]&W5L     !<[\R;S8HXOLP
M         U%]&PM#[UISWY&YD       '8["77H#^/NC]SM8O@
M                                              /+']]\C^4N)  /
MJ[>?U./ G7               !YNGMOE_2?:+   >G%X4ZMV!P]R
M !Y^OL+G&J;H.'  'HP>+>F[ ].R0%?KL.MTH?46B  "RWP[:KA'FW=0
M    *Y_:=9IF>FM&  %EOAVU7"/-NZ@#BC(4?+S]Y\F  &]KDVPWB?*N_  "
MK'WW4:G'H;3@  -P?-LW?9\C=$SP #SRO97-=:.\XH #E;'UO4-\&=9
M   \O+WGR;BG(40 .5L?6]0WP9UD       #6CO.*\\KV5S4          #F
M+&5]YO*<_MMYUFMPO-LUR%9U0       !UZS-MYN_MKE_%.0H@   ;/=#RWH
M.^.ND298@                                      :B^C86B#ZTY[\
M=<R        #L=A+KT!_'W1^YVL7P
M                         \L?WWR/Y2XD  ^KMY_4X\"=<
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M       !78[/K-,/TYHP   _;I3>BQXNZ9WPU+(@
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M8;Q/E7?@  .#LK;^=#[2YEUKSEJ  /H:,WH5^-NE;%]+R8'GE>RN:ZT=YQ0
M'*V/K>H;X,ZR       !Y>7O/DW%.0H@ <K8^MZAO@SK(       &M'><5YY
M7LKFH             V-Z5D[]'D/HO,&-K@      #!%Y]OL3F^K7?L0  !:
M'X-MMMSSKN0                                      &HOHV%H@^M.
M>_'7,@          ['82Z] ?Q]T?N=K%\
M                            /+']]\C^4N)  /J[>?U./ G7
M       !YNGMOE_2?:+   >G%X4ZMV!P]R         !Y^OL+G&J;H.'  'H
MP>+>F[ ].R0%?KL.MTH?46B  "RWP[:KA'FW=0        *Y_:=9IF>FM&
M%EOAVU7"/-NZ@#BC(4?+S]Y\F  &]KDVPWB?*N_   #5UON)\_CV%SC\BI*
M .XVM7WHM^+>F<A6=4>>5[*YKK1WG%  <K8^MZAO@SK(       'EY>\^3<4
MY"B !RMCZWJ&^#.L@       :T=YQ7GE>RN:@ #>7RG8+MOEK?    !@BXXO
MJ76#/6FMG=\5H,Z[KNLW>L4  !N+YKF[Z_D;HG^@       Z#[?CO.4]J<Q
M '8'#W/I6^'NI?:VM0                                      :JN@
M8>A%ZZYW\=<R           #L'AKF_UY Z-WFU3(
M        <4Y"CUBSUIQ%DJ/RU>3^X1RP?Z#\FI*!+EC]-0GY.L*O/>(N.P6'
MN94L0                 !Y:WOCDGPMW3  _:I3>J3X!ZZ
M  /-]]L\OZ/;58  #TSO#'5>RN#N@         //5]D<VUC;WB0 !Z.?BGI_
M?#4L@!7Z[#K=*'U%H@  LM\.VJX1YMW4        "N?VG6:9GIK1@ !9;X=M
M5PCS;NH XHR%'R\_>?)@ !O:Y-L-XGRKOP   %7[O&IU'?1>F   6).,;-<_
M\Q[R//*]E<UUH[SB@ .5L?6]0WP9UD       #R\O>?)N*<A1  Y6Q];U#?!
MG60       -:.\XKSRO97-0 !O:Y-L-XGRKOP      _PK<]MU>G/Z5TC'$
M +[WD7HFX7FV;       '%&0H^7G[SY,  -@6G9+T8?%O30
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M$NZ?G(>U>8]1MCL@            !SWB+CT O'W1^\VJ9
M          8(M4?0L/IHZ9@_EKB2=)-.EA,DC.DC.A&;)&;)-,E9)0    ER
MQV=:+EMLG/,Q,EB                //5]D<UUC;WB@ !Z%GC;I6S?1<J
M            !1(]9\]TI]0P0  O?^2^A;I.89T         0YH>7%[VY+\+
M=TP ,\'J7>!NN?76TX%?KL.MTH?46B  "ROP[:;AGFW=@        *Y_:=9I
MF>FM&  %GSA&V6Y_.>Y@#BC(4?+S]Y\F  &]KDVPWB?*N_    #AK)T/.D]H
M\RZN9^T  '83#7/HZ^*>GT-/6W/-:.\XH #E;'UO4-\&=9        \O+WGR
M;BG(40 .5L?6]0WP9UD       #6CO.*\\KV5S4  ;VN3;#>)\J[\
M-<.[8OSNO9O-  !V'PUSZ;GA7JP       XHR%'R\_>?)@ !L"T[)>C#XMZ:
M                                     !5+]!:?50] Z@
M    .>\1<>@%X^Z/WFU3(                       #CN]I5S>TZQTMVBP
MG233)(S81GR33983:<9TL9LL9LD9TDTJ5_<     '<'6[[>YR?8/V*4P
M           %+ST[HM=_LVM  "W-YTW.S[P?;          /E;B3K_F+;M5K
M]X   *BWHS3*PO=]3  %I7@>W6SO/&X@        #H+M^.\Y;VIS$  =J=?O
M/2Z\.=3 &BSK&OT;_5>@  "P#Q_8[L7ES?         *Q?=M4J(>C=+  %K#
MS]M]K/S[N  XHR%'R\_>?)@ !O:Y-L-XGRKOP    &LS>L5Y]GL3F_X564
M;QN59_K/G+76CO.*  Y6Q];U#?!G60       /+R]Y\FXIR%$ #E;'UO4-\&
M=9        UH[SBO/*]E<U  &]KDVPWB?*N_       #\FI#RR???(OR*D
M!ZEO@;K?VUK4       XHR%'R\_>?)@ !L"T[)>C#XMZ:
M                      /D[B3S*O='*N'<G0               Y[Q%QZ
M7C[H_>;5,@                      .),C1JY=ZU+@?+VTZ6,V6,VG&;+-
M-E3I9ITD)LD9TL9LLTV1.DFD2OZ@     [R:KD-Y_*-@_H
M %>KLFM4L?3^B@ #8_I.4]$3QETL         "N?VG6*<_I72=\/)=AM!\&V
MSO)JF0  &C3JVOT9_5N@  #OIJ.1]&_Q5TX         57^_:C4\]"Z<  -X
MO*L_>>\H]  &JKH&'\_'V'S@  ;/]#RWH2>..D@        4W_2VD5O.VZN
M +FOF7>;%W%MF '%&0H^7G[SY,  -[7)MAO$^5=^     %9GN>JU O2&E
M?4V\_P M<2  <K8^MZAO@SK(       'EY>\^3<4Y"B !RMCZWJ&^#.L@
M    :T=YQ7GE>RN:@ #>UR;8;Q/E7?@       /,3]V\HX(RUN  /3B\*=6[
M X>Y       XHR%'R\_>?)@ !L"T[)>C#XMZ:
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MX7ZKV-PET      !Q1D*/EY^\^3  #8%IV2]&'Q;TT
M                   5$?1NEUBN[:H                .=\3<7[/(71=@
M&GY(                    </Y*A5+]!:AP%E[:;",V2,^G&=*FRQFRS3:<
M9TL9LL9LL9TD)U.:;",V6,VG&;+'-*     ^TMJEEOAVT_34)P
M    !YZOLCFNL;>\4  -E>CY7T*/&_2?T)(@       "F%Z<T:NSV?60 !;;
M\[;E:(X+MH H!>P.<ZF>AX8  ;2M!R_H)>.^D9X        *VG;M7IS^E=(
M 'ZE./IF>&.J]@\/<@ >99[HY5UOS=J  +LWES?-_O']C        ZJ;!9^:
MC[AY;%F@ !^I3CZ@O@[K/)5C5 '%&0H^7G[SY,  -[7)MAO$^5=^      XE
MR-'SI_:/,NIVPV8    '*V/K>H;X,ZR       !Y>7O/DW%.0H@ <K8^MZAO
M@SK(       &M'><5YY7LKFH  WM<FV&\3Y5WX       #S5?<'+>HVQV0
M]+?PYU/M9K]X      !Q1D*/EY^\^3  #8%IV2]&'Q;TT
M                      43/67/M)_4<"                !S3BZ]_KR!
MT;8!I^2                   '%.0HU+?1&F]?LQ;S9$V6,Z6,V2,^G&;+&
M=!-DFF21G2QG233I83)(SY(S81FR1FR33)624    !MUYUFMH&AY8
M        : NP:Y29]1Z&  !:0X)MMM/SON0       %=CL^LTP_3FC  "1+'
MT:O%?3>^.I9$ :(.M:]1[]4Z"  !;Q\X[I9RX5M8       Z/[58>=][,YIQ
M[>T@ !NVY;GKUOD[H(  I2>H=$K[]BUL  =Q=:O?1O\ %73_ *^VG
M%,OTUH]=#M.L  #:5H.7]!GQUT@ #BC(4?+S]Y\F  &]KDVPWB?*N_
M#7!NV+\][V-S;YRO*    .5L?6]0WP9UD       #R\O>?)N*<A1  Y6Q];U
M#?!G60       -:.\XKSRO97-0 !O:Y-L-XGRKOP       'FZ>V^7])]HL
M !Z6_ASJ?:S7[P      #BC(4?+S]Y\F  &P+3LEZ,/BWIH
M                        \_SV#SC4_P!"PX                 YIQ=>
M_P!>0.C; -/R0                  XGR-&I7Z'T[K7G+.;+--DC-E398SI
M9IM-.DC.EC-E3I)IDD9T(SI)ILL)M.,Z6,V6,V2,Z2:5*_N     <P8ZO94X
M?M/^@              'XE67S;/;G+^I6Q60  _HMD>>=QM+<#V[^X
M!74[1K--7TQH\&>   W[<AV.[;Y:WP #\FI#S=?;7+NGFRV0  G21NL>7][W
M^\?V,      =/]DLO/\ O8'..KN?M  !_<'H:>->E;+-'RH  U!=(PM!GUWS
MH  #?UR#8[L/EW>Y$L0     !IFZ;@Z'_K3GL6:   N;^9-YL6<7V8 #BC(4
M?+S]Y\F  &]KDVPWB?*N_       5K^WZM3L]*:2    .5L?6]0WP9UD
M   #R\O>?)N*<A1  Y6Q];U#?!G60       -:.\XKSRO97-0 !O:Y-L-XGR
MKOP       'G,>U.8] ]OQP  ])CQ%U'N7K-\      !Q1D*/EY^\^3  #8%
MIV2]&'Q;TT                                     4.O6O/-,/3L&
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M^).H=V-7OP      .*,A1\O/WGR8  ; M.R7HP^+>F@
M                   "G5Z4TFMCV_5@                 !S3BZ]_KR!T
M;8!I^2                '$>1HU!_1^E=8<]:3I)ILB;+-/D38)M.:;+&;+
M&;)&?33I8S98SI9IDB=)-.EC-EC.DA-DFFRITLTR2,Z2.>#_ &    #<7S;-
M[*M'RH               %%OU?S_ $@=4P    ^QMI]]_(MCW[<@V+9KHV5_
M8I3  #I-M-AH%Z_KE<SM.L<19*B  !F@O7>3N@[K^79X   48?5W/]'75<
M  .QV$NK)?$=HWP<EV'M5K]X  ./;REIKZ9A*V?;]6U?;YB0  !SGB;CT;_%
M73NP.'N0  !I+ZE@:*'K'GP   Y?QM:QSQ3:-\?)-A[RZKD/[@  ''5[2T[]
M)PE;+M^KZMM^Q    N0>:=WLA\2V@  <49"CY>?O/DP  WM<FV&\3Y5WX
M    <77]'SKO:',^GVR60   Y6Q];U#?!G60       /+R]Y\FXIR%$ #E;'
MUO4-\&=9        UH[SBO/*]E<U  &]KDVPWB?*N_        >>W['YMK W
MS$@ #T2/&/2]C>E90      #BC(4?+S]Y\F  &P+3LEZ,/BWIH
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M]I1ZC@0 !<Z\R;S8IXOLP      '%&0H^7G[SY,  -@6G9+T8?%O30
M                              !\!>4_,I]T<IXQOZ0
M     '-.+KWXO(G1=C&EY,              <67]&G3Z5TGJ+LEG/IPFR1FR
MS381FTXSY)ILL)TLTZ2,R1.EC-EC-DC/IQFRQG039)ILD9LL9TDTZ6$R2,^2
M,V$9LD9LDTR5DE   #NIK%_OAY+L(                ZI[!9^?=[$YOU9S
M]H           !9[X1MEN?SGN?\ H    .INPV?GX>P^;]7<_:
M "=)&[!Y=WS?KR'8@    .,KZEY[GL?FW0S;L<           !VZUR]]"SQO
MTGGW#W(  '%&0H^7G[SY,  -[7)MAO$^5=^        %<OM6L4T/3.C@  <K
M8^MZAO@SK(       'EY>\^3<4Y"B !RMCZWJ&^#.L@       :T=YQ7GE>R
MN:@ #>UR;8;Q/E7?@       *D/HK3*O7>=3  '>C4\AZ*/C#IGU5O.
M .*,A1\O/WGR8  ; M.R7HP^+>F@
M     5.?0NG58N_:B                   .6<=6OW^0NB[&]*R@
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MFXIR%$ #E;'UO4-\&=9        UH[SBO/*]E<U  &]KDVPWB?*N_
M :F.AX:@'[ YR  !N%YMF[OWE??>8,;7      XHR%'R\_>?)@ !L"T[)>C#
MXMZ:                                     !\-=T_.B]H\RZ9;/8@
M                 #EG'5K]_D+HNQO2LH            .*<A1IB^F]&Z>;
M+939(SI)IL$V5/IQFR1G2QFRS39$V2;]"1,@G4YILL9D$Z2:=33I8SI8S98S
M:<9TLTV5-EFG20FTXSI8S8339$Z2:1*_J   =Z]4R.\KE.?
M    'R%S)4=]%:96Y[=J\.:         '<G6;ZZWY>WO9_H>6       ^"NZ
M=/[TCI5>#LVLX8@        -@^G9*[AY9WWO9J>0       X^O*=-/TSH^@G
MKVN          ;R^4[!= \Q;SRQCZP   '%&0H^7G[SY,  -[7)MAO$^5=^
M        XYO:7G9^S^9]+MGL0 .5L?6]0WP9UD       #R\O>?)N*<A1  Y
M6Q];U#?!G60       -:.\XKSRO97-0 !O:Y-L-XGRKOP       $>:'G;>S
MN::[=SQ@  %U[R[O=@7CVR      <49"CY>?O/DP  V!:=DO1A\6]-
M                                '1+;<?Y\7L7FW$V1H@
M        #EG'5K]_D+HNQO2LH           .)\C1I:>G=%Z;[-83I9ILD9L
MD9TLTV5.EA-ISSI8S94Z2:;(FRS?H2)D$VG-.EC,EC-DC/IITL9LL9TLTR1.
MDFG2QFPC.IPFR3394Z6:9)&=)'/!_L  &T70\OMPYUF0
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MK.A)ZYYWTKVBP  %U[R[O=@7CVR      <49"CY>?O/DP  V!:=DO1A\6]-
M                                      UR;KBZ"'KWG7$V1H@
M             #EG'5K]_D+HNQO2LH          .,[ZE2E]1:)TAVC'SY(S
M81G21FR33)4Z6:;+&?)";)&=+-,E3J<TZ2,V"?)--E3:<9LL9L(S9(SZ<9TJ
M;+&;+--IQG2QFRQFRQGTX39)IL$V6:;3C-ECFE  ;T^4;!WBU7(
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M/&=.=ELNO^8MN.;VECB^JMYN;<5<=K]?O.^.HY'8/IV2^@HS
M ?Q%T\V2QU_[ACNH>R677O,6W&U]2@3PGR1Y*L:O83#7/;S7+WO_ *?D>X6M
MWV2
M                                                         :_]
MPQM CU_SGA/*4                   !RSCJU]WR-T39;HV5        '&%
M_2I#^I] Z);78381G2QFR1GTTV6,Z6:;*FTYITL9DL9L'Z%*,R5.EFFRQFTX
MSI9I\D)LLTV2,V5-EC.EFFTTZ2,Z6,V5.DFFR338)TDTZ2$V2,V6,V6,Z2,V
M2:5*_N =Y=5R&]#E&P
M
M
M                   =&=KQ_G^^P><<"9>W                   ')5C5
MOQ>1>B[-]$RH       XNOZ-'7U5H/0_;L=-D39)ILL9LL9TDT^FFP39)ITL
M9DD9TDTV";*GTXS9(SI8S99ILB;+-^A33()U.:;+&9!.DFG4TZ6,Z6,V6,VG
M&=+--E399ITD)U.,V6,V$TV2,Z2,B5DA&Q+QC9>QV%N@
M
M
M                                            !TCVFPH#>O\ G/7'
M-VH                   Y*L:M^+R+T79OHF5      ''5[2HP^KM U^[AC
MI\B;!-DC-DC.DC-A&;3F_0D394V6:;)&;)&=+--E3I83:<\Z6,V5.DFFR)LL
MWZ$B9!.I3381F2QFR1GTTZ6,V6,Z6:9(G233I8S81G4X3I)IDJ=+--DC-DCL
M%T[);N.6YX
M
M
M            =,=GL: GK_G/67.V@                   Y*L:M^+R+T79
MOHF5     ''-[2HO>K^?ZZ=TQDZ2:;+&?)"9+&=)--D3I9ILL9M-/DC.A&;)
M&;)-,E3I9ILL9\D)LD9TLTR5.IS3I(S8)\DTV5-IQFRQFPC-DC/IQG2ILL9L
MLTVG&=+&;+&;+&?3A-DFFP399N9,77L@<3VC[&VG
M
M
M                                           ZD;%9>?K["YQU=S]H
M                   .2K&K?B\B]%V;Z)E0   !QQ>TJ)WK'GVN/=L7.EFF
MR)LDTV6,^2$V$9M.:;+&=+&=)&;33I8SI9ILJ=3FFRQF0C-EC^A3A,DC.EFF
MRQFR1G233I83I9ILD9LB;+&=+&9)&?3C.EC-E399ILD9TL9LLT^2$R2,Z2/W
MEK4L6<6V?L)AKD
M
M
M                 #JSG[3S^?87..I&Q60                   Y*L:M^
M+R+T79OHF5    I$^I]"TE=2P$ZG--E399ILD9LL9TD9\L)DL9M.:=+&;",Z
MG-.IPG0C-EFFR1FR1G2S394V5/IQFRILLTZ2,R2,Z6:?)";+&;)--EC-E399
MIU-.DC.EC-EC-DC.DFF2ITLT^2')5A5L/\:V;LU@KL
M
M
M                                              #J[GK2@7Z^YSTR
MV>Q                   ')5C5OJ>1^B;1="RP   ZF[#9T&/7O.NN&:M)L
MDTZ6,V6,VG--E3I8SI$V6,V2,Z6,V6,VG-/D394Z6:;+&;3C.EFFP394ZE&;
M+&=+&=+-,IITLT^1,@G4YIDL9L$Z2:=3398SI8SI8S:<9LLTV5S;B[BQSQ39
M^=\1<
M
M
M           =<<U:^?\ >P><]*]HL                   !][9U+Z/DCH>
MU7G^8   '4W8K.@UZ\YWUQS-I-EC-DC-A&=3FFRQG2)LJ=)&;+&=)&;+&;)&
M?)&;+&=+&;)-,D3I9ILJ=+"=3FFRS394Z2:;)&;+&?(FRIM.:;",V6,V2/Z%
M-,EC.EC-EFFR.RF#N[)7$=HY7Q]8
M
M
M                                  #@7+V_G^^P><=&-KQX
M           ^]LZE]'R1T/:KS_,   #J=L5G0<]=\ZZX9FUFRQG2QFRQFR33
M9(SY8398S:<TV5.EFG2QFTTZ2,Z6,V6,Z2:9+&;+&=+&=)";3C.EFFP3:<TZ
M2,V"?)--E3:<9LL9L(S*<?T)(S94V6/<;6;^R;Q':/NK2H
M   !JSS%@ !^K+'9OB;X  #X&I)KQREF !RG1J=^<;=@ :TLK8_@3P
M YRMZO=K'W0    '2+(6O"%Q2  ^EDCLGQ5\    !QO5DU]Y.S  Y>H5.]V.
MNP     -;N5LOE9Y0       !LCQ5[]3),!K2RMC^!/  #:%B+^5   /P)I=
M:66L@ /M*<VQC%WH   '$]:GIISN,U>9:PZ8W]KPO7I0XPY'I5.TEG<;$L9>
M[EL'DN\&/NP      -8^6L?RYH  <_VU;N;87(    'RT\NMS*V0    'TLD
M>P-M6[/6EQ(@    _ FEUI9:R       ';&RN.S=I7
M                                     '!66MZ"/KWG6O\ W#&@
M              #[VSJ7T?)'0]JO/\P   .IVPV=!_UWSKKAFK6;+&=+--DC
M,DC.EC/DA-A&;3FFRQFRQG21G4TZ6,Z6:;*FTYILL9LL9L$^G&;(G2S398S)
M(SI)ITL)TLTV2,V1-EC.EC,DC^A3CL U#)60.)[1])0F
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M;%&L9H
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M-]O5    '6RZH>?OTG3P      /NZ<]Q+1]DVG8C(  #A&XI>>ETO30
M !9SU/.V*-8S0
M         XFR-&@AZ]YUKDW7%@                  #[VSJ7T?)'0]JO/\
MP   .I^PV=!3UYSGK_F+>=+&;+&;3FFRITL9TB;+&;)&=+&;+&;3FGR)LJ=+
M--EC-IQG2S38)LJ=2C-EC.EC-EFF2)TLWZ%-,@G4YYLK<GS3.;_>/['E@
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MGG;%&L9H
M    #C*^I4(/77.M9&]XH                   ?>V=2^5Y)Z'M<Y]F   !
MTYV6QH4>N>=\"9>WFR1FPC.IS398SI(398SI(S98SI(S98S9(SY(S98SI8S9
M)IDB=+--E3I83J<TV6:;*G2339(S98SY$Z5OKY%L>\'E>?
M      'FR=3T@ #DJE/Z*/,=T   Z17]I1!Z)J8 &R?%7UW30=I  \]/I>F\
M(7%(      #<K@\G<&TC9    !2VWO6-5N8QX  '*=&IZ'/,]RGPB   !K]R
M5G1FZ#J@ &TS#W]T_1-H      \_CI&G]:[N@        /0(YMN'9.UK@>>G
MTO3>$+BD !Z.W+]V^EDB  .$;BEYZ72]-  [<V5Q?BYSMX %>39L-5_VW @
M "?",",   +&&KYJS7JF=    ^:GE\[SIFF?&5)0  -Q.#R5Q+2-E    '6R
MZH>?OTG3P       -[&O9:V'INP@ <(W%+STNEZ:       +.>IYVQ1K&:
M                                                       '&M]2
MH:>MN>:L=_Q                    ^QMI[WWDOH6W3G.:   '3K9;&A3ZX
MYYP)E[:=+&;+&;3FG2QG2PFRQFTYILJ=+-.EC-IITD9TL9LL9TDTR6,Z6,V6
M,^2$RG&=+--@FTYITD?UY(V0.);1M\YQF@                    /-DZGI
M  ')5*?T4>8[H  !TBO[2B#T34P -D^*OKNF@[2 !YZ?2]-X0N*0 &TS#WX
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M#*[C<'DP
M     /@KNG0U];\\U1]!PX                   ^QMI[WWDOH6W3G.:
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MV^EDB  .$;BEYZ72]-  [<V5Q?BYSMX U"YO&TWMXUH #G.WJWR^=[=R[0J
M 4_-VUO3/G<8 !?;YUMW<"QN0  !5GV_ 5_-DPX   %WK0-JV0XN]    ZV7
M5#S]^DZ> !W=Q]U>^YYMH '"E>EY_?2=/^3GE  ]&SE^Z_7R3 #A&XI>>ETO
M30 .[N/NKWW/-M
M                  ^/N9*('K3GNHOHV%                   'V-M/>^
M\E]"VZ<YS0   Z=[+94+?6_.^!<O;399ILD9TL9LD9\L)DL9M.:=+&;",ZG-
M.IPG0C-EFFR1G21FRS394V5/IQFRN1+*M:[\^;AL$T[)
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M2J #A&XI>>ETO30 .[N/NKWW/-M
M                               'Q]S)1@]7<_TU],P8
M       ^QMI[WWDOH6W3G.:   '3O9;*A?ZWYWP-E[>;+&;3FFRITL9TJ;)&
M;)&=)&;",VG-/D394Z6:;+&;3C.EFFP397,V*N+=?G/<^Y>LWP
M            \V3J>D  <E4I_11YCN@  '2*_M*(/1-3  V3XJ^NZ:#M( 'G
MI]+TWA"XI  >DWRS=P        !0"Z1I_6&[H #=E@,II-S^+ &0]!_FFX\\
M6]8   :_<E9T9N@ZH !M,P]_=/T3:         --6<QE/G=];  L":UF+2^H
MY\    >>GTO3>$+BD !Z.W+]V^EDB  .$;BEYZ72]-  [<V5Q?BYSMX IG[S
MK.I3-8X "YUHNS;8<-D0 !TBO[2B#T34P +E6C;-MQPN1   ZN7=O0'Z1J
M^RIS;4<1D-/F;QH [HV%U?*YWMH   '6RZH>?OTG3P .[N/NKWW/-M  %&;H
M.J:_<E9@ >BCS'<^2J50 <(W%+STNEZ: !W=Q]U>^YYMH
M                                                 'S->2C-ZMT#
M2WT_!                   #[&VGO?>2^A;=.<YH   =/-ELJ&/K;G? N7M
MYTL9LDTV6,Z2$V6,Z2,V6,Z2:;*FR1GR1FRQG2QFR339$V6;LEA+FX1YMW7L
MU@KL                      #S9.IZ0 !R52G]%'F.Z   =(K^TH@]$U,
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MO?<\VT
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M^ZO?<\VT
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M4@ ._6.O)$   _'FAT5R%H !VYLKB_%SG;P!2PWO5]6>8L  +NF@[3LGQ5\
M       !\E/+YW?3=,^5GE %Z?GNV=\\==^>]TK3N!KFB -MF%R-R_1MF
M'6RZH>?OTG3P .[N/NKWW/-M '\FBC8<34]W+7@ + 6MYBTSJ&?  X1N*7GI
M=+TT #]66/+5&H  !<AT?9MA>,O
M                             !^74A2C]0Z'H,Z]KH
M     ^FH3WJ?)_0-RG,\X   .GNR6-#?UMSW@;+V\Z2,V6,V2,^5,E3J<9LL
MTV$9U.:=3AM4T#,6]_..Z_8VTX                        \V3J>D
M     ;)\5?7=-!VD #ST^EZ;PA<4@    !:7U#/V!-;S     ^+J2^=WTS3/
MG)Y0!>3Y]M>PC&WFD7/XJH]NFN@ 7;]!VG99BKX  #7[DK.C-T'5  -IF'O[
MI^B;0        !IJSF,I\[OK8 %@36LQ:7U'/@   #ST^EZ;PA<4@
M!VYLKB_%SG;P!2PWO5]6>8L  +NF@[3LGQ5\        !JIS&/I=;WK  Y+H
MS^B%S/<YT(U ]VUO3!G<8 /N:<_HA<RW/Z"6(  '6RZH>?OTG3P /L:<W=&Q
MN@/Y. KBCU\NJ( '>3'W=W/0=IY$I3@ <(W%+STNEZ:     !=TT':=D^*O@
M
M  (4\*6'I[1:_'8M;                   'TU">]3Y/Z!N4YGG   !T]V2
MRH<^MN><#Y>WFTYILJ=+&=*FR1FR1G21_5EFL0<7V:R[P[:?T)(@
M                >;)U/2         -D^*OKNF@[2 !YZ?2]-X0N*0
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M:#M.R?%7P
M            CS0J?^A-/JW=[U*+-                   #Z:A/>I\G] W
M*<SS@   Z>[)94//6O/>!\O;39)ILL9TD)LL9TD>[>K7]K_SWN.R#2<H
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M!VG9/BKX
M            :P=\Q-2[T/INJ[?\1_$0                  ^FH3WJ?)_0
M-RG,\X   .GVR65#WUKSW@?+VTVG-^I)-LITC)6"..[)N;YEG9TD0
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MFZ/HFS@  <W4*OTLDP
M                       ZF[#9ZK>@8?IQLME\%>4P
M /IJ$UIC@6W<E6-4   =/MDLM%76=>[NZKD-G&B97L#A[D
M             #S9.IZ0 !]]2GO2\^VP  #J)>VU-?>=9  V3XJ^NZ:#M( '
MGI]+TWA"XI  >DWRS=P       .GE];4)^BZB !=UT#:>[EA= :8<[C*IFXZ
M^ !:VT[8-\NNY<  :_<E9T9N@ZH !M,P]_=/T3:         --6<QE/G=];
M L":UF+2^HY\    >>GTO3>$+BD !?#YYMOT$DP  XBKTJ/._P"J@ =N;*XO
MQ<YV\ 4L-[U?5GF+  "[IH.T[)\5?        "OMLN'JV[=@ !RU0J7\N<;?
ME *E6YZ]J#S>-  O]\WV_M!:7   ZV75#S]^DZ> !W/L+F\%H&U #B2M3KX;
M-A]#&Q8@ #8OB[V\)H&U  <(W%+STNEZ: !W=Q]U>^YYMH
M
M                                                  'FR=3T@ #D
MJE/Z*/,=T   Z17]I1!Z)J8 &R?%7UW30=I  \]/I>F\(7%( #TF^6;N
M   !7IV;#5>MMP(      &V+#9"YSHNS@ #7[DK.C-T'5  -IF'O[I^B;0
M      !IJSF,I\[OK8 %@36LQ:7U'/@   #ST^EZ;PA<4@ /1VY?NWTLD0 !
MPC<4O/2Z7IH ';FRN+\7.=O %+#>]7U9YBP  NZ:#M.R?%7P  UUY.RIA;WK
M  %U_0MH[Y8Z\  I2[YJ^K[+V       %J;3]@WZZYEP !ULNJ'G[])T\ #N
M[C[J]]SS;0 ,10DZ-J/42]M@!G@]%+F6Z<A4IP!PC<4O/2Z7IH '=W'W5[[G
MFV@
M
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MA&XI>>ETO30 .[N/NKWW/-M
M
M                            \V3J>D  <E4I_11YCN@  '2*_M*(/1-3
M  V3XJ^NZ:#M( 'GI]+TWA"XI  >DWRS=P      !\'4D\[SINF?AS0
M  %U30]HVCXB_  U^Y*SHS=!U0 #:9A[^Z?HFT         ::LYC*?.[ZV !
M8$UK,6E]1SX    \]/I>F\(7%( #T=N7[M]+)$  <(W%+STNEZ: !VYLKB_%
MSG;P!5,W'7]"^Q8@ "SSJ6=L1:SF@ !I]S>-IS;QK0 %Z'GNU]^L=> #4SF<
M=3*WK60      !]1)-Z(W,MS^MDF  ZV75#S]^DZ> !W=Q]U>^YYMH  J/;I
MKND7/XH "_'SG;^W%E< #A&XI>>ETO30 .[N/NKWW/-M
M
M                                                 \V3J>D  <E4
MI_11YCN@  '2*_M*(/1-3  V3XJ^NZ:#M( 'GI]+TWA"XI  >DWRS=P
M !J)S6.IM;SK(       &_[6\Q:=U#/@ :_<E9T9N@ZH !M,P]_=/T3:
M     --6<QE/G=];  L":UF+2^HY\    >>GTO3>$+BD !Z.W+]V^EDB  .$
M;BEYZ72]-  [<V5Q?BYSMX TG9[%U%=UUP #L=:U[Y/.]MY$I3@ 4^-VUO37
MG<8 !Z"?-MQ[$6M8 52-QU[0WL6)        NAZ)L^UC#Y  #K9=4//WZ3IX
M '=W'W5[[GFV@ "H]NFNZ1<_B@ +\?.=O[<65P .$;BEYZ72]-  [NX^ZO?<
M\VT
M
M       #S9.IZ0 !R52G]%'F.Z   =(K^TH@]$U, #9/BKZ[IH.T@ >>GTO3
M>$+BD !W=Q]T    -I.(R%G74\Z !4YW+7M%6PXD =BK6M</TC90 !PU7I4R
M]ZUD #M39W%_+G&W@ :_<E9T9N@ZH !R32G[<V5R    ++NJ9S9YB;\   ::
MLYC*?.[ZV !8$UK,6E]1SX    \]/I>F\(7%( #T=N7[M]+)$  <(W%+STNE
MZ: !VYLKB_%SG;P!Q=6I^>_TK3OE9Y0 .\N/N[36H9_8GC+V3!QA6IUW=FPU
M=;9\+_@ .Q5K7]!#FVX?Z ?X>?ITG3^N%U0 &XC!Y*PCK69  &IW,XZN1M&%
M  WW:YE[5NG[  !ULNJ'G[])T\ #N[C[J]]SS;0 !4>W37=(N?Q0 %^/G.W]
MN+*X '"-Q2\]+I>F@ ?523=L[*X    &_P!UO,;P<!E0
M
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MW<"QN0!PC<4O/2Z7IH       LYZGG;%&L9H
M
M                                   >;)U/2  .2J4_HH\QW0  #I%?
MVE$'HFI@ ;)\5?7=-!VD #ST^EZ;PA<4@      -RN#R=P;2-D '2R_M:&_1
M-2  N/:/LNWW"9(  "J%N.O:(=BQ( %IS4,_O_UO, #7[DK.C-T'5
M!<&TC9-RN#R8   TU9S&4^=WUL "P)K68M+ZCGP   !YZ?2]-X0N*0 'H[<O
MW;Z62(  X1N*7GI=+TT #MS97%^+G.W@ ? 5)*)?0]3ZKWEN      .QMK7O
MG<ZVWD"G. *\^S8:KYMN! 'Z,(^A_P RW/DNE.  !Y_G2-/ZSW=  "^]SG;N
MWME<@#K9=4//WZ3IX '=W'W5[[GFV@ "K-M^ K^[)AP +F>B[-MHPV1 '"-Q
M2\]+I>F@      "SGJ>=L4:QF@
M
M                        !YLG4](  Y*I3^BCS'=   .D5_:40>B:F !L
MGQ5]=TT':0 //3Z7IO"%Q2       W*X/)W!M(V0 5VMGPM8G;,$ /TY8^B#
MS/<^1Z4X  &H#-XVG'O&M  ;1L1?W5=#V@ :_<E9T9N@ZH       +@VD;)N
M5P>3   &FK.8RGSN^M@ 6!-:S%I?4<^    //3Z7IO"%Q2  ]';E^[?2R1
M'"-Q2\]+I>F@ =N;*XOQ<YV\  =5[RWI.;[J_6^ZH     #EBC4NRZ%M/=['
MW0 %)7?=6UG9:Q &Q#&7MXOG^U   "IYN6O:)]AQ( %HO4<]80UK,@#K9=4/
M/WZ3IX '=W'W5[[GFV@ #2WGL74(W77  -G^(O[J^A[1E .$;BEYZ72]-
M    %G/4\[8HUC-
M
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M.G@ =W<?=7ON>;:  /F)Y:)W0M3Z>7UL !=GT+:=FF)O@.$;BEYZ72]-
M   %G/4\[8HUC-
M
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MS.8SBVM3 &XW!Y/LW:5P/EIY=-V<Q@       [UXZ[[GV-T
M
M
M                                                           (
M<7&-6G#C#DBE4_>EB
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MZ0G 3^S<\EX*4RE'&W"7RY=-55*6<2I@3IDZ2#N,YD$HJ!-5MHIE*@$!*.X
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M!$ ";7#I"3BOOC+R,JO54\5HMUZYB#^Y5;L6YE<$,FN[6L 4%\5Y1E=W:1F
MHI@AF4'973H$);$V%"TL>JY[!A0D\+83:IJ?D83&]-.)A67PG,08]W*UC">Y
ME<G-^Y5;M NM7$$45[:@A#+;UR!2,IJ>GYZ&RN%0T&JY?&@Q4\7_ (7(0\0]
MO:/)2DFUG.2&2J+ORF5C/:QJ.HS;!S4[<JIZ?&E;BR"J-C<:C"53*C%,4VJD
MOA75^\U7M^\U7M^\U7M^\U7M^\U7M^\U7M^\U7M^\U7M^\U7M^\U7M^\U7M^
M\U7LGO?/RC+KW2B,,EJRG:@#875IXLZIG7"AQ(T2@Z3A4I)-9C%(6J;ORJ5&
MGM75!49]@ B T[<RIY -*W!D%4AL+P4>$2%L*<DL:H9VD2)T"74<Y(9*IO!+
M)::>5=4-1'V**8+I;'I^\TX1#3]62&IH6PC082B#7U(1*2G.NVE-A3M-ZZIK
M^0TJ%071JB>"8QC&V!3&*:07/JJ1C35T:<G^RNY101(?_"]GZ3"8S#7/)]+*
M=05C<*;U7$V@")1HF[*F7BG4IUD#7=ZD@EDPU4E\*[H0YX9Z0NU,Y7$1+4DR
M2ZCD)$)4,K-))YJL[2P3"8ZYO-Y?(D%:7%FE51-H4QB&H6[!X1BF*<NI1 @J
MH%84[%IB?:[)2, )J7KT<L1UQ<28U3%VJ=1'21J0O#&@BD5I5Z?5,YH@DZ*N
MZ\55@IU4'(PJ"J==P[GF0Q(D2)%/M:3N5/::&G*JDU4I=3FN)<^$4G_"R%$H
MF2V0R=-()1JJ"?R^FY94]3S*JIEMZ%K]=22E O1S-'JGDH2SZ4S% IE:[327
MPKNUM*VB4W,GZ[S2\$M5:4R:,L4T[)8-/275-)HBDR"L:QF%7S#;VTN*>517
MZ[OT[VI(==$2L)/2FJZ]8Q)Q--PI2M)Q22JF:JE-5(=%0U'*Z8E]6UC-*N6Z
M['2L AZKI5@>G)2_<)?,5TJ5T+<Q'4>F+%A0(5P+GQ9M_P ,67I\%<TU1HT)
M/!KRKX]6S?<;=UU&I9=#B0XT/5>FGP33#327PKN]LYZ:>TGJOFF 8.FSLB"9
M5%KN=6AJCFFXVEK0TT2ZH\"$I@5#*(DBG>F4H^T)J   ::MFXR*FQ$3#N,FG
M4QD"^BZU05>@Z*OK.5T@CG]0S2I9AL+5HO8Z*U7 G)IW5FX@(E&W%RQ7#T3"
M8(I4CKNXBVJHOW41X\!-"77'HI 9'=BD%J[8W-OG3UJ%_P#<^US?W.M>P9F6
MO%O[E6P;^Y-L6_N1;%@S&MD+!F';,6_N%;-@S MH+?V_MHP9>6V%O[=6V;^W
M-MV#+>W C_;2W+!EE;D6_MC;H6#*ZW8M_:RWC?VJMZP946]$?[2V_8,H[?BW
M]HJ 8,GZ!%@R=H(6#)N@Q8,F*$%H62% Q"_V,M^T+(>WT0T*_=NHAH-[+:1F
M3W2M\I9-55,+6*<IR^7J"DH2&E=5Y*J%*EW.T-:#QT1(D.##J*[=.RAJFKF?
MU7JI+X5W>QJT0CZKW0Q&G=-JI.$JI'5=2J!D$@W*5S)5*)A))LFGLIU7MDX0
M)CIM]!"/6FJ\<4\.CMSE4U7R5?1M7H:NEE=7#0TI!F,R73=9L:0@>S4KIC1/
M503G-$/N3FME<4TQ:?3^64Y+ZQK69U>L^Z>>5#)J<25'?"8JAF$XFLYC$>5]
MN+C"DV-7TA(*YD%WK03^TL^!BL'0#%8&!P.!P.8'%_,#RO!B.!P,5X,5P,5Q
M6!B.!@8K%8'@P.2+UR$\NN97DM&5W]JI,$GOS2JUI34<AGQ/+-'2D)Y4VI6J
M@HDL]FT>>S?<X$:*FC434T.JI"RM8D00*BO-*433ZKJ@J0^NDOA7=[)',%3Z
MKV?"NA"DB3!<F3PDB;5<6?#/ZJW.R<^$==TY6$RHW3:X"C7>J[*(ZRB]TDT\
MFE/K(T:,HB[*G?A_28I3EF".)+U^YE,8AIU/YO4$?[IZ_NU+Z9--)S-)ZL(X
MCB/*\K6[N)[+L:NI&05S(+NVAG]II^5@Z 8K P.!P.!S XOY@>5X,1P.!BO!
MBN!BN*P,1P,#%8K \&!P/!BN!\"-&3Q:<O#5TE:E[JTM4@^5[)2WU\[U7?G(
MRVEMUMK5A*7GE17JA$:<3^<3^/L:2^%=WLG\5:KVB'NMHM<@!?6NJKIN,BII
M^Z4?-QD=2ZEZ0B]#%AG@Q-%O(Q8%::EJ.!,$=02153LWW^DXWM%+ZKPTP>7S
M?[NG-<Z[X\0$1$C$<1Q'E>5BOM[<$4NQJZD9#7,ANW:*?6GGP= ,5@8' X'
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MBL1B.(XCRO*Q7E>&B'#B1HE#T/#D4/?JPH^35M)JTHJ<T+.2L5@># X'@Q7
M\&+^4'@Q7%8&*Q6!BL#@>&VMF3\56>1Y#5D_IN)(;U2^.$KGDHG<+:"( $]N
M-2DA:H;P3^9A%C18\7:T_<ZCD$A_=FB&_=FB&_=FB&_=FB&_=FB&_=FB-TD%
M2SBF5<BO/)%94564S,"@L2"'M:5O:TK>UI6NZH@1*.V<FJ&<T^HD%ZX)PE-1
M2.>P]K/*]I:0-4-YINM94J5+8^Z2BH)U(8TBO;&($FK:EY]MYU7M*R$*@O/-
M%@+%RR8J-S3J5"2-(;PU'+6DMTZ2F[0HT%1#VLUGTFDD.?7K0P0GM53ZI(OW
M'9JSXW C \O05Q&*Q7$8K%8CBL#@<5Q'E>#P8KB.(Q/S%>5@8K$8CB.(\KRL
M5Y7ATPX<2-$H>AX<BA^0*PH^35M)JRHN<4-.2L#P8' \&*X'@Q?R@\&*XK Q
M6*P,5@<#PVUIX GGWDF%&BP(DJN?64K"7WQ9%=VBU3):UI)8T&92Y0'0(@ 1
MYM*DS*Z^HU$"^\U*IFF=[9U'";U94<]^P$.)$@GE-RZQE(2Z^)N"*[M%JV2U
MI2:P(*] IZ1$"A'G$H2LJK^C$8+KS4HF:97NFT9IM6=43L-ZE595/)0EU[)Z
MG!#>JFX[)+D42L:!45/J@AQH44.@\2'""/4$A2LJN-12-EUZ:93M,KVSN.TV
MK"IIV&\R^<364Q)9>&K43(+X2X[([JT2K9-5U+*PA+4:CI$0 (TUE:<%-<T@
MD9;>"C4H3"^,40FMRZQFH1(D2,?[D,O)@*R[)&!Y>@KB,5BN(Q6*Q'%8' XK
MB/*\'@Q7$<1B?F*\K Q6(Q'$<1Y7E8KRO#H(0\0]"40$DA^0JOI"3UK)ZRHR
M<4/. ># X'@Q7 \&+^4'@Q7%8&*Q6!BL#@>&VM&B$B#R>2+$A#[6J8\2)$'[
M%0XT:$WM:ICG/$-Y%!4I*'M:KR,2-&A![6J8YSQ#?<MD_%/$O<1@>7H*XC%8
MKB,5BL1Q6!P.*XCRO!X,5Q'$8GYBO*P,5B,1Q'$>5Y6*\KP8A#Q#4+0I).3R
M)5U(R>LY/65&SBB)P# X'@Q7 \&+^4'@Q7%8&*Q6!BL#@>&VHN6C*Z9_YDRE
M3# O41@>7H*XC%8KB,5BL1Q6!P.*XCRO!X,5Q'$8GYBO*P,5B,1Q'$>5Y6*\
MKX9#Q#4+0I),3R-5M)2BLY16-&S>B9N#@>#%<#P8OY0>#%<5@8K%8&*P.!X;
M6E90,[GP  !_S)F/*Q27)(P/+T%<1BL5Q&*Q6(XK X'%<1Y7@\&*XCB,3\Q7
ME8&*Q&(XCB/*\K%?"(>)$H*@R24GDBK:2E%92BKZ.F]%38'@Q7 \&+^4'@Q7
M%8&*Q6!BL#@>&UM;(11R[_F7-"GC*J7(P/+T%<1BL5Q&*Q6(XK X'%<1Y7@\
M&*XCB,3\Q7E8&*Q&(XCB/*\K0B'B1* H DD)Y*JRDY36,IJ^CYM1<W!BN!X,
M7\H/!BN*P,5BL#%8' \-I3$AC5%-X$&$F@_\RW9I'WYMV4!*(/+T%<1BL5Q&
M*Q6(XK X'%<1Y7@\&*XCB,3\Q7E8&*Q&(XCB/*^$0\4]OK?$D9/)E64I*JQE
M%54I-J/FQ7 \&+^4'@Q7%8&*Q6!BL#@>&SA0HD>+1=,$IN5^3D<JFDQ%+;:M
ME;0+-UA&:'9"?BW['35CV/G(!'LM5<)E=KZW2,NDDXEF_$(>(9'1E5KV36DK
M:.T*R=3G8MCYN)?V.FK1+(U"#*+.UC!97;RM$0*D*Y"?_@G(ZWYJ%N2#R]!7
M$8K%<1BL5B.*P.!Q7$>5X/!BN(XC$_,5Y6!BL1B.(XCX13'/;BWW8L/R=5](
M2FLY35%*S:D)H#P8OY0>#%<5@8K%8&*P.!X;.W]%#*R>2P 1&26TJV=A*;)2
MN"TMHBDY4  !0UB "$SHJE9N$WLE+HS3RWM5R$-WELHFDXCR:RT[5M*K34?+
MF12R6RTFPBPH48DSMY1TU"<60AB$\HFIJ>VZ&73"9Q?=*JF]TJJ;W2JIO=*J
MF]TJJ;W2JIETFG$K)N:&6S&9Q/=*JF]TJJ;W2JIO=*JF]TJJ;W2JIETFG$K)
MH(0\0_NE53>Z55-[I54WNE53>Z55-[I54QBF*;=$U.5"M@>Z55-[I54WNE53
M>Z55-[I54QZ5JB&3I0RJ:30?=*JF]TJJ;W2JIO=*JF]TJJ;W2JIO=*JF]TJJ
M;W2JIO=*JF]TJJ;W2JIO=*JF]TJJ;W2JIO=*JF]TJJ;W2JIO=*JF]TJJ;W2J
MIO=*JF]TJJ;W2JIO=*JF]TJJ;W2JIO=*JF]TJJ;W2JIO=*JF]TJJ;W2JIETJ
MFDK'I3)5*V/[I54WNE53>Z55-[I54WNE53>Z55-[I54WNE53>Z55-[I54WNE
M53>Z55-[I54WNE53>Z55-[I54WNE53>Z55-$I>I831I;,4^U24_/E\#W2JIO
M=*JF]TJJ;W2JIO=*JF]TJJ;W2JIE"90CC[JAELQF<3W2JIO=*JF]TJJ;W2JI
MO=*JF]TJJ;W2JIE*52BC^7;]6R"YE#&(>%$+T%<1BL5Q&*Q6(XK X'%<1Y7@
M\&*XCB,3\Q7E8&*Q&(XCH13'/;BW!9,7RA55*2BKY76-#SJBEX,7\H/!BN*P
M,5BL#%8' \-C#AQ(IZ)M^67>2X<.)&B4U9^<S-I!1=.4V7;U#;ZF:C"J+63^
M0 [<Y'3DYJ-33EFI6B!(B1R^!MGM4-LZ7G[51;:H::VMD_BK5?'NK<[(?$&J
M^/=6B4]ZZKMT3[)&W2VOP1IFW=738SK7D&^?6NFVOQONBF72]8RRWU&+@F%E
M:<4--;,U*C"92>:R>+KM/5_8LTUWCI/UT'=;94K[N2'56-2P*5D:E1'5J/+V
M4MF3RM<7H*XC%8KB,5BL1Q6!P.*XCRO!X,5Q'$8GYBO*P,5B,1T(ICC;6VQ9
M,7RE,I9+YPBK:RLRE1OPF((/!BN*P,5BL#%8' \-A)*=FU0**6HB6TV7R52=
M"3NK(M,4/(:5A[G5MM9'4P5%2TYI=7MRE,<U'6ACJP0H$4L3;D]JNM5*)Z$Y
MDDSD"W963^*M5\>ZMSLA\0:KX]U:)3WKJ4IX"M/7-)1Z2G.YVU^"-,V[JZ;&
M=:\@WSZUTVU^-]X4I4RV#45GI%,@J&D9[3$;2YK:5=[S274H@054"LJ:C4K/
M=SM=2OO!/=0B!0N+5HU3//+ZM(F7I;\6,66UF3%<1BL5Q&*Q6(XK X'%<1Y7
M@\&*XCB,3\Q7E8&*Q&A%,<;96T+)2>5:HM[3-5A4%EJFE1E*-6AC%<5@8K%8
M&*P.!X:I33,]G9I':I(G%,E3(X'DJ@[51%X0($%-!W692Q!-T==6T6TT.UED
ML7SA;1%N)=2\/=I_3TJJ5#65#S.D%6QLG\5:KX]U;G9#X@U7Q[JT2GO775E,
MI*JD\QEZN5+MRMK\$:9MW5TV,ZUY!OGUKIMK\;[TI2IEL"N+2G2%$! =%+5"
MII>=(5J:9(]5R:3"IY$[<DZ>,K44A3L&EY%JNY5W94L^P,TE<OG<NO?9F86M
MG17$8K%<1BL5B.*P.!Q7$>5X/!BN(XC$_,5Y6!BM"*8YK86Q+)">6%\LELTA
M3&T-%+A56)3B,2QT\*(65JD&"R]4@P69J@&"SE3 P6>J8&"T-2@P6DJ,&_::
MHV)::H!&#:)<9DEI91#&7T;3,L$   \E  B-NK9$0EW@Q2G+<:V?L ;.42A?
M/9A1U%RVD$.\+T".9HZ]H132*S863^*M5\>ZMSLA\0:KX]U:)3WKL+JT3VTA
MW*VOP1IFW=738SK7D&^?6NFVOQOOER+;PYI"$! =%GJN]FCZ[KTGV).-QLY2
MOM"G5.YPDD,KG4W5SV9_8*HJ>E%5R6[EIYQ:N?D8K%<1BL5B.*P.!Q7$>5X/
M!BN(XC$_,5Y6!H93'-:ZUY9&3[:6MM\$,NS4S"7HFBUI24%OW HQH-;4A'9+
M,9>NV;VN=;L):.Q2I5"U30E%)J1ENR$0 %-02%&,2NZ.AL%?T:88%64NH:%'
M@J";*8R]'-45:TBKI&;:[)_%6J^/=6YV0^(-5\>ZM$I[UV-TZ)["7[C;7X(T
MS;NKIL9UKR#?/K73;7XWWV[=$E11=$*+$@1:%JJ'5<CU5%(TM1R>92]5*E^W
MD4F53^;2N6I91+]5VZN[7FGV$K*CI%7=/W'MQ/+95&5BN(Q6*Q'%8' XKB/*
M\'@Q7$<1B?F*\K% 3#:BV'8Q/MI;"B/>)>[8.:?7-I61#-KTS]4,PJZIYJ(B
M(CT@(E&6UK54I&37M7PAD%:4Y4@; Y"127(H@U+3'86FHH)<EV$>/ 30I]>"
MG)8,UN[5TP%=.)M,QT0%"A+$EEQZRE8R2]L$XR>?R:?P-A5--HZID\SERN4+
M]5D_BK5?'NK<[(?$&J^/=6B4]Z[&92Y)-T%5TTKI6<;A;7X(TS;NKIL9UKR#
M?/K73;7XWU1E$!,3M:5-VM*F[6E3=K2INUI4W:TJ;M:5-VM*F[6E3=K2INUI
M4T.8R^,.R6HT\P25))(].SO10E51*4GD*+#CPM5XJ3]H3[>T%*]FRS5<:K0I
M>1B(B/V%N';^17(IVMJ)GM 5 5Q&*Q6(XK X'%<1Y7@\&*XCB,3\Q7D 3#:F
MU(2DOVTI^2*ZBF\IE:.2R[755;R2DX-3W#J*IC;(IC$-2EW)O*1D\[E<_1:Y
MU)T<^ED^DJRGYKJMQ2?O1/0  #76-R912[5!5D]J>/LD:U7+U%(7B$308T%1
M"UW?I(%Z#59/XJU7Q[JW.R'Q!JOCW5HE/>NRKND8-6R=1 C)8^WMK\$:9MW5
MTH9K-)6/O;53>]M5-[VU4WO;53>]M5-[VU4WO;53>]M5-[VU4WO;53>]M5-[
MVU4WO;532LYXDMTS0YX<M][:J;WMJIO>VJF][:J;WMJIO>VJF][:J;WMJIO>
MVJF][:J;WMJIO>VJF][:J9=-9I-!Z;:_&^J\WPAM$DSF2 97=*LI8-.WBDDR
M-"BPH\/7>R1!$3:;/U?[4GU1X$%3!K.F8U*SW:T+2YZJGY"$ADTJE4!$FK"I
M8]53S[#W4M?)KH4]4E-3FD)V1BL5B.*P.!Q7$>5X/!BN(XC$_-# 3'M-:<)2
M'VUM%2P2J3Z[@7+@R!E*I0M4;60U#-:;7497$MJ]+KNY2H3:4:2E,8U"TT6E
MZ>UW%N<9*<QC'-M:(K^8TE'ELR13=%JB0X<:'6E.GIBH=-D_BK5?'NK<[(?$
M&J^/=6B4]Z[.[=$^T0]O;7X(TS;NK<93W5IFW=6XVU^-]5YOA#;T77\SI)1+
MIBBFR+55LK"=4UI0+E4L6TO4*6IY+JN-2@51(A 0'9@ B-NJ5"F)!JO%5W /
ML3>.T<MN?))M)9I3TT*Q6(XK X'%<1Y7@\&*XCB-# 3'M):4)0'VUHV0&J6H
MB$)#)JN57GNTE,8QS;= O62M90E;):OE^HQ2G+6]/#3-1Z+54\$[J?7=2O#2
MN'N%OJWCTG,8,6$HA:KPT]VE(=-D_BK5?'NK<[(?$&J^/=6B4]Z[,Q2G+<>C
M#4M-=M;7X(TS;NK<93W5IFW=6XVU^-]5YOA#<+0U4>6S;74"()=/=-LZO]VI
MT_7=FD^QIOL[3TIVW.M57U(GI:1JE2A:I^Q5WK-R>Y\OJ:E9]1LW*Q'%8' X
MKB/*\'@Q7$<B2J5RFUMG(5/#]MK+2($LIU514":F)+,9@KFJ[<9-.%TAF5,5
M&BJB4:KU19&IAZ+3R3LFE-5:5-"I61*5,=8HW&SU7C$+J5)H*U+-Y;&D\TT6
M3^*M5\>ZMSLA\0:KX]U:)3WKM)])$512J>R5;3\TVMM?@C3-NZMQE/=6F;=U
M;C;7XWU7F^$-P@1XJ:/*5Y)I*]5RH/J*XU6HJ_MN5:JADB6HI/,Y<JE,PV*)
M&HF"NF) GIJ2:1$ "Y%6C5$\^QE9T+3->RNXN/%7488H"#%8' XKB/*\'@Q7
M41;"JJV-0MLZ<H2!]MD\"*JCR>6PI/*M5VZF&;S[<[?U=$I2=$.2(3H<U17/
MIF0-45SZFGS"(B/3*T$6:S)/ A)8&JZM2#/*CW) N4RQ;(YM GDHU7GE((ZC
MT63^*M5\>ZMSLA\0:KX]U:)3WKM;DT66J)68IBFVEM?@C3-NZMQE/=6F;=U;
MC;7XWU7F^$-QMBH%10^J[!0"N-4BG*N0363S9)/)9JO%2?M:78V;I3B.J[57
M=CRO['UK9>@:Y&IL6:NEQYW0E9TTP.*XCROE5.S^>1*=QZKJ;#2=BJ*IL2$)
M#)]M[72OM2LM54SDM/R")$/%B;I:"JAF<KB18<&'45W:>E35%7M2U+KM%+07
M5AJJN<A(*=,8QS;G9*=C%2ZKRRWVJEM%D_BK5?'NK<[(?$&J^/=6B4]Z[:[=
M$^R1MI;7X(TS;NK<93W5IFW=6XVU^-]5YOA#<;3?!&J[/QOKM)5_9,RU1H,)
M1!K:F8M*S[73<B4U).D*)-+4>F<39)(Y9.YPKGTU^R4PI6F)L:+:2VL8Q+1V
MUAF0T11LM$I2D+]NK'2\/PZKW388:+=9%.UU/32?59/ZDB;"QJ'A U7OF@PI
M=NEN)IV56.JLD(3&E=%D_BK5?'NK<[(?$&J^/=6B4]ZZKCSQ93LFDLX13Z6:
ME"> K@5S2,>DIQL[:_!&F;=U;C*>ZM,V[JW&VOQOJO-\(;C:;X(U77.!JYU@
M(@-N*M"J))JN+2@51(1 2CJM+2O8TGU7<J[M69?>E:)'[+1>J[4P%=6>_P!G
M4P0*.U7B7"JJ_=($:(GC)5!%:;3$AEBPU$$R91TV3^*M5\>ZMSLA\0:KX]U:
M)3WKJO-\(6OK/W=F>NK*:255)YC+U<J7;*VOP1IFW=6XRGNK3-NZMQMK\;ZK
MS?"&XVLA>JH;5<90"FMMA251J*6G:-6G7I-5VZ3['FNFWE+#5$_  *&FXE6!
M2TB$1,/WI4.G!+2&JJ%0K:DW^VL'U%#ZJ_CBIK/=:*4"JI+554'V>I^FR?Q5
MJOCW5N=D/B#5?'NK1*>]=5YOA!K4UGVU+]=U*)[;0[*VOP1IFW=6XRGNK3-N
MZMQMK\;ZKS?"&XTQ+S2JG=(B!0FZWM*;;&SU7^JB:I_)4M0RB:2U7)YCTE*8
MYJ"I<M*R#2H40$B>LJFCU5//O3D\+U$HTF,4A8D0T6)O]"D"'1^JJ#A%J;=;
M:F U#ZJ[AC#K'ILG\5:KX]U;G9#X@U7Q[JT2GO75>;X0:5S-9)YA3-0HZGD^
MNZ=$]AKMC;7X(TS;NK<93W5IFW=6XVU^-]5YOA#<+?2 U0U1JKZ;!)J2V4"/
M&31J*JB#5<CU7AI+VQ)TVAI7M2:ZKQ5=^ OV5APXD4T.1SJ*T643:"P@)1^W
M:3JNE7U7R!1/PAJJ+X@W6UGP'JN!\9]-D_BK5?'NK<[(?$&J^/=6B4]ZZKS?
M"'1;NL3TI."')$)JF4N239#5=-*Z5G&PMK\$:9MW5N,I[JTS;NK<;:_&^J\W
MPAMX$",JC6_H\E)2?5>>HBJYALZ!JL]*3R'$)%)IBPH<>%7%+Q*5GS2V7*IL
MOI^2I:>E&FK*C3TO)%BM0O5_9*04+4U1M*+(R^$$OH.D)8$*#!@$Z%*%$M+,
MK:T9,FG-D8I G-.3NGXWVX2=5TJ^J^0*)^$-51?$&ZVL^ ]5P/C/ILG\5:KX
M]U;G9#X@U7Q[JT2GO75>;X0Z;25OL*ZI&#5LG40(R6/KMK\$:9MW5N,I[JTS
M;NK<;:_&^J\WPAMI)3LYJ)30]NI?29=57U.EI23*U2A<IVEH*O\ ;4FJX=*!
M5,A$!*-FZ4]3 TN:Y57>\T[^R,@IN<5*KI6U4BD0   &P4)DZN#5EG$J@%R!
M9+57VV2=5TJ^J^0*)^$-51?$&ZVL^ ]5P/C/ILG\5:KX]U;G9#X@U7Q[JT2G
MO75>;X0Z8<0\*);NM(=5RO7=NB?:86NVOP1IFW=6XRGNK3-NZMQMK\;ZKDR"
M9U'3O[35NW[35NW[35NW[35NW[35NW[35NW[35NW[35NW[35NW[35NW[35NT
M*T%9Q&1V/G,0939ZEI>*5(D0P-4\GLMIV7U;52^K9IM9=,%<I74U/TE2R?56
M%LHTQK%*F@(DVF[%7=BRG[(T-;]?5L>4RB72-%M*JH^45:DJ:EYI2LP^VJ3J
MNE7U7R!1/PAJJ+X@W6UGP'JN!\9]-D_BK5?'NK<[(?$&J^/=6B4]ZZKS?"&B
M13M=3TTD$]0U'*M1BE.6X]%FI::ZK:_!&F;=U;C*>ZM,V[JW&VOQOO=6W'D=
M,%J*IIM5"[;VOJ_W=G&TF\T2266SZ=*ZAFWV0M_;]152A*E3HD^VG\@EM22V
MJJ5F5)S+[:).JZ5?5?(%$_"&JHOB#=;6? >JX'QGTV3^*M5\>ZMSLA\0:KX]
MU:)3WKJO-\(:;>UI$I.:0HL.-#U3Z2(JAE4]DJVGIIIMK\$:9MW5N,I[JTS;
MNK<;:_&^\*EB1#"G5VZ5E@5#=.IYZ#]RM75_;THV=WJN[2F'V0H&@556*DB1
M,@2[A/Y!+:DEM54K,J3F7VS2=5TJ^J^0*)^$-51?$&ZVL^ ]5P/C/ILG\5:K
MX]U;G9#X@U7Q[JT2GO75>;X0U6DK?\!M=R*++5,K,4Q3:+:_!&F;=U;C*>ZM
M,V[JW&VOQON\REHS*'-[-IYC$FEGJL0@NER^61]RI^=JZ=F\JF:2<R[8W"JP
MM*R,QC'-]CZ!H%55BI&C2R]+N4_D$MJ26U52LRI.9?;))U72KZKY HGX0U5%
M\0;K:SX#U7 ^,^FR?Q5JOCW5N=D/B#5?'NK1*>]=5YOA#40YX9[<5J6J99KN
MW1/LL;1;7X(TS;NK<93W5IFW=6XVU^-]ZF$ME\U3U59J&)5:-4@4[C:*K^S)
MAL(\>"F@UK4\:JI[]CZ!H%55BI&C2R]+ND_D$MJ26U52LRI.9?;%)U72KZKY
M HGX0U5%\0;K:SX#U7 ^,^FR?Q5JOCW5N=D/B#5?'NK1*>]=5YOA#7))RND$
MSIV?H:EE6I0G@*X%<TC'I*<=-M?@C3-NZMQE/=6F;=U;C;7XWWRLJ(EE7))O
M*5TCF&X%,8IK>5:6JI'KO%5WJ87V/H&@556*D:-++TN[3^02VI);55*S*DYE
M]L$G5=*OJOD"B?A#547Q!NMK/@/5<#XSZ;)_%6J^/=6YV0^(-5\>ZM$I[UU7
MF^$-A0%8Q:3FT&-"40M564TDJJ3S&7JY4NZ+:_!&F;=U;C*>ZM,V[JW&VOQO
MJO'$B0Z2]K5-[6J;VM4WM:IO:U3>UJF]K5-[6J;VM4WM:IBK5A1@U!/DXI+B
M5HB&57LG, U.W$IFI#:[E4:2II2[<:'GZJGJCU5!->PY(M6J9BL^QU"4(LJY
M8C1I9>EWB>R&65'+ZNI&8TC,?+*64S):$"BIU%:'04<6"@X8![B0N/N+";W%
MA-[BPF]QTC>XZ1O<=(QJ&3BQZ%%HM%3,C**=G*8#$,0WD9 <(B'3'(,6#Y H
M<Q3T?JJ>'ZJI=UMF0I*&U5Y$")6/39/XJU7Q[JW.R'Q!JOCW5HE/>NJ\WPAL
M;35QZB)KNU1G:B+HMK\$:9MW5N,I[JTS;NK<;:_&^J\WPAMG-;^Z"A!% 0$-
M5TJ=+(JFW"4]ZZK@?!GV.HBCU57S1 @1RQ'O4\D<NJ&75=2,QI&8^54B-4NB
MRZ@8YP14])Y>PAP8> ,(,(,(-YQV2E&E6%7T6BC-,)/,)8;R)2\?VFFM4X3"
MCF^_VXBA&HG57< 4U8[K0L#V>C]56QO7U3TV3^*M5\>ZMSLA\0:KX]U:)3WK
MJO-\(;$IC%-;:MBU/+=0@ A<RC1IF:M;7X(TS;NK<93W5IFW=6XVU^-]5YOA
M#<+052>:2O5>&4@OI;<)3WKJN!\&?8U A4S-;2U.)*6DV^3R1RZH9=5U(S&D
M9CY2*4QC22A8Z@$B%(@@LYA!A!N#"P@P@+#Y]F<A(A9S2!# <AX9_(5M%7M=
M$ZKE(105KO\ :!2$>C-5WD0I:SW0A#1#H$I4*'28P%*LCBJ5]-D_BK5?$![)
MW.R'Q!JOF<P(M$I[UU7F^$-E)YNND4RIJH453RC5/Y&CJ*53J4+)#,[:_!&F
M;=U;C*>ZM,V[JW&VOQOJO-\(;A;N:FE%8:JB0A,I!N$I[UU7 ^#/L;9BF0X;
M]/)'+JAEU74C,:1F/E!!+U<S4R"E4<D*+"##T<&$&$.+>=A808?,P[2?4_!F
ML.-!BIXOD&R:X(U/:KWRK\"S=4B6.N53REI[3D786.6_B1:KX2P30-TH*6#-
MJNU56M"74UHLU%]75^J]4 8E+;G8V#^)?JOI%TRGO75>;X0V=!5A&I*;P(\%
M5 U71HSW@EEM?@C3-NZMQE/=6F;=U;C;7XWU7F^$-P@Q3P(L&*6/!U+H()UN
MWE/>NJX'P9]C$:6,N5R:60)-*M_GDCEU0RZKJ1F-(S'R=*Y6LG"R32)'(TO#
MCT"P^81!A#BW!C P@PL+"#>8&$.&TJ:1!,8 @(#Y LK,@35#JN%(QGU*;K9N
MFO;II'@0%,*H[/R.9M4%%5%3)M5G9E['5NJNI*,_I;=+(R41B:KPS+V.D=%K
ME/LU<:KF(1745N=D$?JY+JO<J_'/]$I[UU7F^$-I:6M_8XVM,E3HX.F;=U;C
M*>ZM,V[JW&VOQOJO-\(;C(#FB2+547Q!MY3WKJN!\&?8RTDJ"8U?Y!GDCEU0
MRZKJ1F-(S'R9*I4LG"R22)'(T8AQ808?/T<&'S,(<&$.@0X,/F86$&$&X;6K
MI."6/Y IB:]AU  @(:KB4V:FZDW.6R]7-E].R--3LGZ#%*<M16GIR<M4=OJE
MIO3(YD>3SB'$)&AZKC4Z-/5/N4"!%4QZ6D<.G)#JO7-04SO13:WLZH-2Q+"7
M)%R.-+UNY6[E@RJCM5TEH+:VT2GO75>;X0V@"(#;2MPJ67[2;=U;C*>ZM,V[
MJW&VOQOJO-\(;C2IS1*8U5*0T.H]O*>]=5P/@S[&6.0 5!Y"G<CEM0R^L:.F
M%(3#R5*I4LG*R1R)'(48@PL(,/F86$.+"'%N'0/F8080X,YA!A!A!O..T6I(
M2Y*J3Q4BCR!;B=A/*3U5_2A:KD42'$@Q-RM/10RI)JO)+*;EQ-%KYT$XI'5<
M2E/>F0F*8IMQL]28K5VJ+%AP(50S:)/)WIIN9=KR#5>*GQET^W&EI(>H9^0I
M2%TQ8L.!"F:T\RF6B4]ZZKS?"&UE,U6R68TO4:*J)1LYMW5N,I[JTS;NK<;:
M_&^J\WPAN-'G*>D]56_%6WE/>NJX'P9]C+/P A49Y#G$GE\^E]8T=,*0F'DB
M5RM9-UDBD*.0HQ#CT.86$&<P@P@Q@XL(<>AS"#"#<&%A!A 6'S[2M9?^"+Y
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M\JSJ)ZR::I3"]5+?(,P[PW>JHG FJE8?"'HJH_&/JI:'P3;K44/\$SU4^?\
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M;'7PI6]]*BP.Z >Q6%@<#"P/;T WI!P.%X/!PL#RL+F*P]!>DK>GT@X'^GT
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M>C_Y8&!@<#P8' P,#@=M#D)$)F'AX>CC["V-SJLM)5EE[TTG>ZDP<#"P/;T
MWI!P.%X/!PL#RL+F*P]!>DK>GT@X'^GT \&%X.!VFL*/INO:;R=Q?J&PL_\
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MO!P.VG,MJHBNL?)XE S>KAL  7[%B4IF]7#8   \B_@(+>KA^1A*4S>KAL
M ?<M@RGA0<8!<#S/%P.%O0#>EO0# YA<+N@'@]A86%[>C_Y8&!@<#P8' P,#
ME*E,B39>Y>J;HJ?(EI;M5=9JKK-WCI&]E)%87,5AZ"])6]/I!P/]/H!X,+P<
M#MIE371;A7[_ .9,$5H*L91<#S/%P.%O0#>EO0# YA<+N@'@]A86%[>C_P"6
M!@8' \&!P,#*%*9$FR\R]4W04>1K2W:JZS57V:O'2-[*1%S%8>@O25O3Z0<#
M_3Z >#"\' [9Y$W+AVFLZ8QCF_YDY<$]"865%P/,\7 X6] -Z6] ,#F%PNZ
M>#V%A87MZ/\ Y8&!@<#P8' RA2F1)\O,O5-T%'DBTMVJNLU5UG+R4A>RD&*P
M]!>DK>GT@X'^GT \&%X.!VSYAMX2U/6__,O+3K B"N1<#S/%P.%O0#>EO0#
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M8L># +VA+V[0E[=H2]NT)>W:$O;M"7MVA+V)$)%)Y=Q,OB-D+J08L*/#,\7
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M,Q@^68BB!"8\T2E89L1NUC"/:IF[5,W:IF[5,W:L1NU8C=JQ&":G8)J#%FD
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M;%A$CPY@AB2]3Y(3J(J6++)G"F,+>E"B$FA+UT5?$ >@!8!X,(<&>P"SNE[
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M6]=TJ/U]I)_T]E,XGJTNB&08D0  H,HA^M@:9/%X'US#J>F6=<W.;=5TR?\
M5V2C]?<DG6M$SZYIEO4MSF\7\471*X?XU71-X?XH&F6Q?6)=:KJVV@IXT<8$
MI !(0L,NI1^AM9;U+[@! !";4^("(" ^1R'/"/)YP1>38+D,%?!5I(R*,SV
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M=_K5Y,6Q\E5Y\<::#^./(6=_SP[WRXN<G>/#]?:.[MM[[V\U>(?^?G5R(_\
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MM7AIOYQT7X_@[5RAL;+>Y;9#9%6!N'C!>752=5U)0E3\LW/.FL\L?MGSA_\
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MS&'8W.#$C)&'JN-=NUEGY+D?X@##2T4/,#FZ9B9@0]AC=CU<;*:\^+>-]O\
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M\<KG\N?F,6PS[MAOEZ;TVZQ_MUF=FG</,:XI#\6(=B'X,4S$/Q8AVAQ&(?\
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M#,;#FT>:]HLL,3KNX:W=AG:$?@Q#\&AGXM#B-"B,0[0SM#/Q:'$XM#/P$A^
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M-&?!^K)GY;]. _SJZ/$ UY'6W9T\@2RR,R75SD[=(JZP2T\FF;#,L MAG)>
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M :Q.(^BBJ3FU>5EDE8&55CA7IY$-XAJ_&W8<T[Y ]/)H^?S<^>A\E6GP_O\
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MA1E'V^IW[A+Z8*8@Y*#<SPY^&U4Q:J\,U44$_P#YIKXM_P"::^+?^::^+?\
MFFOBW_FFOBW_ )IKXM_YIKXM_P"::^+?^::^+?\ FFOBW_FFOBW_ )IKXM_Y
MIKXM_P"::^+?^::^+?\ FFOBW_FFOBW_ )IKXM_YIKXM_P"::^+?^::^+?\
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M_-I^PZS_ $-T_P#-I^PZS_0W7_S:?L.L_P!#=?\ S:?L.L_T-U_\VG[#K/\
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MFD^5B5R>E4&Z5;?*=PN_^[N\E>"6HQ8<Z]$Q[V8[QRZ3$XZ\>/Y"U9^Z7?\
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M-;]9JH*,$88PDU%KJ9D63-8[PEN?48]DGJ[#.^'/B.3WLB;6"(!Y3B.C-E-
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M)8^:H7D V%KCJXK>;]9H@Q25NS"#ULDL'2\[1!$7O^L9AFSIABS-:<@R  5
M"  @  ,-OWB9ZLO#O/8D_JEVM?OK4]3#N_[I+_73]A%SO$;Q<B:Y9/2EQM,H
MFS*4/1)\TDM07[5,X34QBQD/FNIK4YZC:"17M$RY@#*:B"(@C=!MH9B2/LDT
M^7(@@CNRX&7G@H)RT,[5;+?I8Q+T)H&ZC&!_$=B?-HUVO<MI4Q:BKJ589P0"
M-I"_ZJF:#6,IK1U\UUQCC!K4@UT6[L1=[Y"N4QZV[*:K3&.%3BN(@-([1)UG
M=$9S_B*-"9Z:08PR,2-RAG?#MYTQ_NYU1S"8H@3D#(HRM3N=;W9Y!)@"1%6[
M+B*-^*Q_LC>\WIUERY8+,S$*JJ!$EB8  "LDU"CZ@U S2]5RSTFK5KRP-3,*
MB)0(BB&LF#N(Z*IAC#&P)J/7C]*I94UC;B".3CQ*QML-<"=@G?#OQ%)[V1-K
M!$ \IP#HS930.A,2-1K!!*L&1F4G5>M!WMVFQ:[7E00DY =_0FI$"9+))4D$
M%D9'; &QC: \(PUN%^)F7%C6+6E$VLFY&MDQUE>E'22]75Q,EN(JRF((.,'Y
M.E=A>084WL-R'Y#U9^Z7?]2FVBNL;R#-'^%+Z<S,5'5CB+E1NT:Z:H!N5W,0
M2IC.8;KB&AF2!%8+L*1.P-^\3/5EX=Y[$G]4NUK]]:GJ8=W_ '27^NG[$M^U
M7.:3-7&IM&1@8AE.-6!!R46Z?$R?9YEG?("9;=I:V0[HTEM/0%5%O5SF+-EN
M(JR,&4C<()!VEW&M[NDX0@"1TE[+B#+^*11KS\,3N]%O<S2 ^9)D IW X6 M
M8FC7/6$II,U+5<%3GKM!Q$5&T$C:(="008@BH@BP@Y:+<]?J;Y(%0>/TRC=)
M,)GXQ#97-E._U1>%FP$66QU[2&##)&$#B)VDUWO4M9LMJF5U#*1D*D$'?%&O
M&HF^QSC7HF+22<W63.I*C$E-#6T@JA,%F+TI;9G%43;HM!H6K_9!,OE\F+*E
M2E+.[$*JJHB68FH "LDT;4NI6:5JJ4VZK7EE-4R8+1+!KERSN.XTM%4V 88V
M%-1Z\?I5+*FL;<01R<>)6-MAK@3L$[X=^(I/>R)M8(@'E. =&;*:!T)B1J-8
M()5@R,RDZKUF.]NTV+7:\J"$G(#OZ$U(@3)9)*D@@LC*S>$;&-H#PC8/L\^,
MVYS#TDQH?/2./*M0;<,"$OMR<3)4P15A81XB+"#6#$$ CY-E=A>084WL-R'Y
M#U9^Z7?]2FURZ(9A'DKHQ.;295X2*,-5ZB8PL=IJ38__ %26TOR_%$W?7$V=
M=08CNE1KN(8P1!78;C%MC;]XF>K+P[SV)/ZI=K7[ZU/4P[O^Z2_UT_9._P!4
M7AY,3$J#%&[2&*MOB(Q$461\27<J;.]DUC.TMC$9259MQ13O=4WF7/QD ],=
MI#!U_&4;2-UUO(6:*]%K'0G&CCI*<Q@;&!%5&OVJ"U[NHK,!]++'SE'748V4
M9254".TEO-TF-*F+8R,589B""*+(UW+%\EBK2$$FC? T7AD*AB;7H$NUY$J:
M?\.="6\<@B=!SN(S;2:[WE%F2W$&5@&5AD(,01GH]^^%CW4RTR&/0;<EN:T.
M16)6-0*"CW._RVDS4,&5@01O'$;01416"1_8[,UAK"8LF1)4N[N0%51622<5
M&U-J<M(U3+:H5A[P5-3S1B0&N7*Q5,\7"A-A&&-B346NGZ5DF:QZV26Y/E>8
MQZW5/2A'8)WP[\12>]D3:P1 /*< Z,V4T#H3$C4:P02K!D9E)U9K,=[=IL6N
MUY402<@._H34B!,EDDJ2""R,K-X!L8V@/"-AT3&9=7/TDN-GSTC4'&\&%1Q%
M4OUP<3)3BHCC!%H(L(-8^3)787D&%-[#<A^0]6?NEW_4IMDR;PBS$-JL P.<
M&(H6DR?L<P^5)Z(WY9BD.RJG=L@UYN8^VW=:]*6#WBC*TJLYRA<"TP&PM^\3
M/5EX=Y[$G]4NUK]]:GJ8=W_=)?ZZ?LPFR6*.M89200=PBL4$N;.%[ECR9PTC
M^D!69'M,PW+:!-<29ET?&R_2R]TQ4!QEAH-GRZ6JKU+GXX*P+#.G6&^!M%]9
MZB"W>^6LG5ES3CB+$<^<.BQZXB2X>YWR6TJ;+,&5A @[HXQE%8JVF$U?>W[L
M?X;_ $DN&0*\0OXFB=V@EZ_N>=Y!_P"FY_ZF]0+<[ZBN?(F'NGCD >&D>P6I
M$;0[G6":,U1T)JP$Q#G\I<J&HXH&##[)K!8HT3+FKU)@&3(PB-)36IRJ0Q_L
M:F:QUE-21(DKI/,=@JJ,I)JMJ&,D@")(H=5:J+2=4R6Z*V->&!JFS1DQRY9Z
MO6;IP"[$,,;&FI-=O]+4LJ:QZ^1'/GXE8]>P]*!;8)WP]\0R>]D3:P14\MQ'
M1FRF@=&8L:C6""58,C,I.K-9CO;M-B;M>0().0<.C,6($R622I((+(RLU!L8
MV@/"-BTY/3D.1WDHFIMU?-<"PX[&B+$O^KW#RWX5.-6&)AC&^(@@_)<KL+R#
M"F]AN0_(>K/W2[_J4VX]^U<%NU^K.D!!)IR3 /*/^\ TJ^D&JA,U?K&694Z6
M8,IQ;H(J((K!!((K!(PV_>)GJR\.\]B3^J7:U^^M3U,.[_NDO]=/VB'0D$5@
MBH@[AH%D7QYB#R9L)HAD!>+*-Q66@375R#97DM#_ );QC^D&:@7[5]G<^3/!
MEPSO7+_+H)UV=9B&QE8,IS$$@[,9TD"5?I8^CF0AI?\ #F0M4XC64-8B-)6F
M7*^RS*FRB596$""/OB"*B($$@[5 U7?)LE1Y(8E-]&BAWUH$UK(E7I1C$93G
M.1I)P2Q0)?>\NC'SUTTCN-+TCOLJ@8ZJZ:>K+S*GCYCJQ&< Q&8@;-,U9K.6
M)DJ8-]3B93Y++B.\8@D'[+>/I)$R)E30*G48CD=:M)<Q$00?[&9NM-:35D7>
M0I>9,<P55&,[N( 1+$@ $D"GV&X:4C5,AHRI9J::PJ$Z<!Y7F)6)8.-BS'8Q
MAC9$U)KM_I:EE36/7R(Y\_$K'KV'I0+;!.^'OB&3WLB;6"*GEN(Z,V4T#HS%
MC4:P02K!D9E)U9K(=[=IL3=KR!!)R#AT9BQ F2R25)!!9&5F&QC: \(V/[3=
MNE+: F2R8*X\3#R6A5N@D%;_ '!M)6J(/61L:L,1' 1 @D$'Y*E=A>084WL-
MR'Y#U9^Z7?\ 4IA_L,KTWI^PRO3>G[#*]-Z?L,KTWI^PRO3>G[#*]-Z?L,KT
MWI^PRO3>G[#*]-Z?L,KTWI^PRO3>GT^KD:OR9K+5OHU>[Q4'VRX398QZ$Q)G
MK"7'BH%:\-=V.*<A7A9=-!OM"@O%RFI.EFQD8,IWU)&P&;=P%OT@$RFJ&F+3
M*8^:WDD]1C&PL"TF<I5T)5E(@008$$&L$&H@V'";]XF>K+P[SV)/ZI=K7[ZU
M/4P[O^Z2_P!=/VKWVKY\R0^66[(>%2*!+Q,2]H,4U!&';308G=8MOT":XNLR
M[MYTLB:F<@Z##, ] -5WR7-8V)I:,S]&^B_Y.R'7FK4_SEW6+ "N=+%HAC=!
M6N,B*5G0AM<3)9*L+"# C,10+(OKS$'DSH31#)%XL!V6% FN[D&RO(:'_+>,
M?T@H%E7M9+GR)P[H[@TFZ!)R*YH'0@@U@BL$;AV.9JJ_"IJT:%<MP#HNNZ(U
MY5)4U$TG:JOZZ,R2T#D(M5ERJP@1N'+_ &+SM;ZWG+(NTA2SNQ@ !QDDP"J
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MM<:X;0E)%;O=U),N1+)ZHLTG: ,R80"Y J5%1%VH,,;,LB0I=W("J!$DFH
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MG .C,EM Z++'=# E6!4D%M5:U73E/%I$]00DY ;1;HNL0)DLDE"165*LU!M
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M(8T9[S=S-DC_ !949B0RF TD_'5=B"ZINS3%QS"-&6,L9C06(R EL@-%O?Q
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M)D6/1E2ECW4B5&*RY:FP"UF/2=HLQ).V!AC8UD2%+NY 50(DDU  "TF@O]_
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MK59&!J&U7U?JDK>;[88&,N4?GD'I,/,4U>45J!>_ZRFM.FS#$LQX@+ !B4
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ME!WLV9=R?]Y*;EE]X!G)A0=QK&[UXFFJAX'*GBH/L\^7,CYKJUMEA-OA+,8
M6FG^9O4F7VIJ+NXV&*A,[6,DP\PF;^J#QWJ$71)UX.+10(N^796'H&A755SE
MR!EF,TULXAW:@YPPST*ZQOLQD/D*>[3?1 JG?!.[ML+JZ^S$06(3IH,R/I*-
MX"@765VE7D#&I:4QSGIKP(*!;[(GR#C("S%&^&#?D4^COZ*<DQ7E\;JHX#"D
M;M?KO,[,Z6>1J1E,&AD(/)X=*8P4920.6G^9OMWE]J=+7<QL*?2:PEMV \S]
M6K#CH5N4F?>&%AT513OLVD/0H5U9=95W!QN6FL,W46.=2*%=97V8Z&U ="6<
MZ)HH=\';7>:LO,R0;3H.R@YP# YB"*!+V95[4?[Q-%H;C2R@CNLK;L370#6=
MQF2LIE.LS?@W=P&^=^@#7HR2<4R7,'&JLM7:I]!K&[DY#.0'T6(/%3Z":CQ\
MUE/(3X8FD;Q>94OM3$7<QD8ZJ'OM8R##S'$S]7I4/V=YMY/_  Y1'ZTR_ORT
M*ZIN 7(TURW"B!?UE"CWLR$/DR0)?Y0^DX7-#-FL69C$DDDDY2363_8B+K&(
MNERN\J$;-)IL[>)[T6UPABAMP88P!+E@LS$  "))-0  M)Q"@UIK10;VXZ*V
M]R#BR:9'6/DCH@UL3\A/JC7"1!KES!#3E/"IT.(C&+&$58$&C:JUJL08F5-
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M2F'3@=U00N]_=EUI-K^FEW1Z[*KI)E]'*/H^&(Q;<&&/ )<L%F8@  1))J
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M0 &8?W9M:_#:+I3ITAFDC'W\HB;) .+2F(JDCR6(K!()5A C;8PEERP69C
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M<918^4J]V_I2]%CODT,S4E[>2V))H$Q<P9=%E&Z0YH9EYNQFRE_Q)/TB0RF
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M4_EE[_AYWL4_EE[_ (>=[%/Y9>_X>=[%/Y9>_P"'G>Q3^67O^'G>Q3^67O\
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M5 4#,!5\EIK?XG4I),"DBM7<8C,QHAQ*(,UI*CK+=[LBRY: !54!54"P "H
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MF[38)/48T)J8#SI9Z0RC26(TC19TE@R. RD&(((B"#C!%8.&OQ3<4Z<H!)X
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MNG\SO?\ $3O;I_,[W_$3O;I_,[W_ !$[VZ?S.]_Q$[VZ7>9,)9FE2R23$DE
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MBH/]0OLF4/\ AJ\P_E"4([]!,OQF7QQB=M%/02!WF9A1;M<I2R9:V*BA5&8
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M)E@U&'G-UFW3"P#[D/M5ZC*N,H]-["Y'^'+W?.:Q1E) I+N5REB5*E *JJ(
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M1JBZV2EZ30@7<UNYW6:)W!!; /"4< @B!!K!!M!&2C3[@/L,\UQEB,LG=E1
M'XA3=C1IMYD]]=U_QI722&5AUDW2RA8U!C@W76B?X$U'.ZH8:0_&6(WZ+-E$
M,K $$6$$1!&X1ASI<M82+P>^E9(.3I*.P\0!;HZ)-NTTNUW4O,F,%51:68P
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M\Y6'19?G*2-_94UCK]6NUTM"'HS9HQ5&N6AQL>D1U0 0X2YW.6LJ5+$%51
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M>JT2%&U6N.J2M[OE8,#&5*-G38=9@?(4XCI,M0+ZPUG-,V:]I.(8@!8JC$H
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M6&(Y#8PK%6''P1\$#L%>!$;!&D:1P(&#SV'12/Y39%XVL&,AKU?'+NV/(,0
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M7QS,FS#%F-I/B L %0$   /N&F_B^NN%+["\@V67V3R[&LI;6( WS"@EK8H
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M !634*77^J']59"S-<D+,N=Q< K<":UG3P:FO@$"B=6ZFLZ5X@9&S7K^K?\
M22Z_2]*;K'5TI?>6L][NB*/>6M/D*/I*YLH=YI+,V"[?%WPC>3=KY=C4;4F(
M8:<F<D0)DJ8!!T.XRE756'^JZLA=M8W4(M]N9,6D3&!@R&K3D3=%C*F0Q%'
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M@RF)E3I1(TY$](CO)4R TEB""%=&68J.HUWJ0B1?9 5;Y<V8&;=II&]WDF9
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M4Y0?&+#PX\-DQ,AX00>2/]B5W^#_ (*N;7R_7F,%$ J(O7FS7:"2I2 Q9W(
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M%2C(.<XSXH4$Z0VBPX]PC&*"6W0FXUR[JY<UHW;=JS3E '"P&&&\U6/B\?\
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MP[#]NG#HIU=ULN9>7-AP-#>+@-TI[/L\&2D#41LD)$UE&2,1P&(XJ0FJKC-
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MFT&L4,W5YC\PGU2>0\-#+FJ586@B!VEH7="V4XAG-GCR4$V\?23/R1F&/.>
M;2T;P@.0V$9C;O6;E"]T/>+D-3#Q'B.Y0I,!4BT$0.T^[NR%CQ#.;!03;W"8
MXQ>2/:WZMRD!M RYJAE-H(B*&9<6T#YK5C>-HWX[U-"\(5W<1S&P[3"("2;
M*R=Z@FWXZ"^:.L<YL'&<U!*D*%48A]]9W37_ &&ZEDWE-.[:J+ZSG8X"YZ+2
M(@U%3>VNRL#:I(H-F&"?"-I3M9:RG)=[O=T:9-FS&"2Y<M 6=W=B%5%4%F9B
M  "284F_ 7P%->[_  Q=WA,F"*3-93$,1,F P9;JK#2D2&@7($Z<-/NY<G;T
MGXM^$IVBZP6?(8GN;U)B"TF<H-:FU6'3EO!T(84E_%/PM,T76"7F[.1WUTG0
MB9<P"U3694T#0FI6(,'1:#PC:(V?6,HB/?WNX)')"\+,CN^[AOQQ?)$+P@)R
MV,-^W>LW*%KF^F/-:H\-AWX4T;PA0[HJ.8V'>V8%4T%/E-4."T[PH'O![UMV
MI>#'OF&Y0*@@!8!4-FFS9: JSL1TEL+$C'3J#TEYZ=0>DO/3J#TEYZ=0>DO/
M3J#TEYZ=0>DO/M3N[PL<AQC,?O!QBA:Z,)@R'HMQU'/$9J0F27'XI(X152!4
M\!IU3P4ZIX*=4\% 2".BVR:%Y0,.,9C:*%[D\?FM;O,/&!GI"\2RNZ15O$5'
M>.S RY9"GRFZ(XZSO T#WMN\.05+SGBS4$N6H518 (#:NC>$#9[1F-HWC0M<
MYD/FM9Z0KX0<]"9TLP&,5CA%F_#9XRY9 RMT1QV[P- ][;O#D%2\YXLU!+E*
M%48@(#BVH4F ,#B(B. T+2"93;E:\!\1 W*$JO>+E6OBMX ::+@@C$:MFT;N
MA?,*M\V#?H&OKZ(\U:SPV#>C2%W0 XS:3G)KWK-S^P_XI^.9R5C[+<)+PQ'O
M+Q>5CO74PW*[10;,,$^$;1G:RUE.2[W>[HTR;-F,$ERY: L[N[$*J*H+,S$
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M=$1PB/&!33DL'&4$'DVFUWFV,+<AQ$9J-(FB#*8'GS&T;$%8?1I6WB&_R1I
M5 ?<AH)TIK6#)NGQ#'FH9LTZ3-62=IB?(,"+1B(R'<_VBG>RJB.LN,'FR''G
MB/NS;.<)<X^09_;;EPY787U1M:;^+ZBX<GLX"?6#U7PYO9'+M27V_P TX<WL
MCEP7[+<APSV&Y5PX&L&G>2Q]$]FX<:\VYF.P"X3STAU#E'FYQBW*L6#.SCU1
MA)VEY1M)^TW*<).TO*-I3LP]8;;[R0Q0Y084$N_B(\\#E'C'!03)1#*;"*QM
M+[;*'3ECI;JY<Z\D<@V$(@B28 92:"3Y1K8Y3S"P?<AH)TIK6#)NGQ#'FH9L
MTZ3-62=JB?(,"+1B(R'<_P!HIWLJHCK+C!YLAQYXC[LFSG"7./D&?VVY<.5V
M%]4;6F_B^HN')[. GU@]5\.;V1R[4E]O\TX<WLCEP7[+<APSV&Y5V!KO.$5;
MB.(C=%&N\VT6'$1B(S\5F&)B&!!B",1H'L=:F&[ES'%OC%@3LX]482=I>4;2
M?M-RG"3M+RC:4[,/6&W>CTI9ZR^,9#]YHL^28JWWP.Z,>T8&A"#Z-ZU\8WN2
M&P?ZA-%0J3/C;>L&[')]R&@G2FM8,FZ?$,>:AFS3I,U9)VN)\@P(M&(C(=S_
M &BG>RJB.LN,'FR''GB/NQ;.<)<X^09_;;EPY787U1M:;^+ZBX<GLX"?6#U7
MPYO9'+M27V_S3AS>R.7!?LMR'#/8;E78>C5,2M3^:=P\1H4<0(J(R'#$]*Q8
MPRC)XQNT6=*,581!^_CR'PSLX]482=I>4;2?M-RG"3M+RC:4[,/6&&01'H'E
M6G5'!3JC@IU1P4ZHX*=4<%.J."G5'!3JC@IU1P4ZHX*0*C@%.G*0YU4^*G2D
MJ,T5Y"*1N[LAR'I#Q'C-"[KI(/*6L;^,;XAN[!W<P_13# [AQ-XCN9AM)Y;V
MJ"RG(0/'8=PX:7>,-,@1Y:+*EB"J( ;@^X_17I36L&3=.YR\)!FS3I,U9)VR
M)T@P(X",ARBG>2ZF'67&#XP<1\?RU](X&_7P6TJBV8<\*=%"<YAXC3W?'^"G
M4X_P4Z@X?P4Z@X?P4Z@X?P4Z@XZ=0<=.H..E:#AITDX_P4Z0(X#XZ5.!GJY:
M1%?R.RG$3RX08XC\@SX^>W+AR6RHGJC:TZ.4>J,.2/FCCKP$^L'JOAS>R.7:
MDOM_FG#F]D<N"_9;D.&>PW*NQ&_W<5CKC*/.WL>Y7B.P?8IQZ#GHG(V3,W+G
M/AG9QZHPD[2\HVD_:;E.$G:7E&TIV8>L,,]AN5=H&\W)8/:5%C9AB.Y8<]L#
MAA7,7E]$YO)/!5G!VB_9;D.')[7W'Z9K=JE&4Y3N#'P4,V:=)FK).VQ/D&!'
M 1D.4'[ZZ=Y+J8=9<8/C!Q'Q_*VE,( W:0D+'=-G!;R4Z3F&05#B\?@K\$1L
MD9;$9J0FC2&6P\U/HS7DQ_(LY,CMZQPY<SSE4\(!^0)PW0>$ ^/#DGYH'!5X
MMK3C\\C@J\6')7YB>J,!/K!ZKX<WLCEVI+[?YIPYO9'+@OV6Y#AGL-RKL4#3
MO90^B<U?-/F\VYFV#NII^EEV[HQ-XCNUX_!.SCU1A)VEY1M)^TW*<).TO*-I
M3LP]889[#<J[1%[EB"S;=QO_ )6YP</N2:I@(WQ6/&-_:+]EN0X<GM?<<TZ:
M8*HB:-/F5"P#(,0Y]W;HGR# C@(R'*#]]=.\EU,.LN,'Q@XCX_E.)H4NW2.7
M%O9>3/32FDD^"OPPI72.RQ%1IH7BL9>?GI$5@_(<T92#P@'EPY1QJ"O 2!Q0
M^0"WG*IXM'Q8:KYC,./2_.VK$V"C33Y1)X3'"@*++\T < P$^L'JOAS1\T<N
MU)?;_-.'..XO*<%^RW(<,]AN5=C:[SA%6XLA&Z,5&N\W%8<HQ$??48C#6\2K
M5Q91C!ST6\2CT6'!E!W0:J3LX]482=I>4;2?M-RG"3M+RC:4[,/6&&>PW*NT
M9JXU&D,ZU\8B-_#E3?-93O1KXMHOV6Y#AR>U]QRW"6<C-^:/'P;?$^08$<!&
M0Y0?OKIWDNIAUEQ@^,'$?'\HF9-, /O@-VFB.BF3+GYK/!$>&&!#9]%JT.+)
MNB@93$'Y"2;B=8;ZD^(C#FW8XB&&_4>0<.UFFN8*H))W!2-W<,<EA&<6^+89
M,[*"O 8CE.'-NQQ@,-ZH\HVK-F8RNB,[5>..'*E976.:,3Q8(.1U/$1X\-E.
M-#Q%?P[4DIE+'@ Y\.>W8'K?@P7[+<APSV&Y5V316J8M:GQ'</$8&A1Q @P(
M.(X?V>:?HYA]%L1S&P[QQ4G9QZHPD[2\HVD_:;E.$G:7E&TIV8>L,,]AN5=H
ME38:J%3:###5SC /"-H/V6Y#AR>U]QK37J502<PK-'O#VN2>8;PJ^0!/D&!'
M 1D.4'[ZZ=Y+J8=9<8/C!Q'Q_)YF3#5QDY!33>S$,0^_&?!"D#2.%&E=(;-W
M;]0\1RYLOR$D\6RVXFJY0,-'8P5NBV8\Q@=[:PN:'I3*SV1SGB!H'0D$6$5$
M;] EZ'>KEL;AL._6<M/H'Z7FFIN#'O1P^\%LM@=X]$\HX,.7-)@L8',:N*W>
MVK+N:GYYY%\? ,/O#9+4G?/1'*3O8,V&+1/ PCQ1PY1-C$KP@@<<-J2Y7FJ3
MZ1_^.',F><\. #GP7[+<APSV&Y5V4W^0.D.N,H\[.,>YFV#3F&)J$<P@.(82
M=I>4;2?M-RG"3M+RC:4[,/6&&>PW*NTIH&)V]8X<KL+ZHV@_9;D.')[7W&E!
M;,(7>M/$(;_R$)\@P(X",AR@_?73O)=3#K+C!\8.(^/Y-,R8:N,G(*:<RH"P
M8@/OM.## CX8C:'<O:MFZ/P<GR#,N^-E,,]HXP*0.&K,8NG1;.+#OBO/':C3
MYI@JB)^_*;!NT>\3/*-0R#$-X<_AB*!9WTJ[O6WFYXT"HVBY\EJCO8CO&.Y@
MS)!\M2-\BH[QKH5:HBK#4L8NG1;.+#OB&_':9=S  1)R 6T>\&QC5N 5 <''
MAO>#;,: S+^$G@P9LKSD8#/ PX\-9J6J01G!C19J6, 1F(CM.:PL!T1^+5R@
MG#EQM:+<),.*&"_9;D.&>PW*NRP-.^DCZ)S5\TY,V3@Q;*G:7E&TG[3<IPD[
M2\HVE.S#UAAGL-RKM*>!BF/ZQPY)&-$]4;0?LMR'#D]K[C94C("W"8#U3\AB
M?(,&' 1D(QC[[:::5..LN3G!Q'Q_)9FS3 <9.04[Q[,0Q ??::1&#'P0P:_!
M$;,)BVB@=;#7\@NH'1?I#,;> Q&&';J-4V;+O6YHC'0,IB#6#M/[%(/00](^
M<PQ9ARYAANLQRTI!"!KK-@!M@!&JRS!<@=&9TAOV\<>+#!<_1O4VYD.]R1I$
M;2^PRCTGK;<7$-_DSX85:R:A27=QY  W\9WS$X4R1B5B!FC5Q0PS=F/2E&KL
MFS@,1P;2>\&U15G-0X^*D3:<(*M9-0HDD6(H' (8+]EN0X9[#<J[,TB<(JPA
M^$;HQ4,B9O'*,1Y\AV1.TO*-I/VFY3A)VEY1M*=F'K##/8;E7:4\'_>/ZQPY
M'U:>J-H/V6Y#AR>U]QI'FJH\?C^1!/D&##CW#E!III4XZRY.<'$?'\DF;-,
M./<&[3O'J L&(#[[3CX*0\$<&K K\,*5TCLQD'%6/']^[\@B\H.E*M[)MX#
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MW<V"M3E4V<QW0<,,I@107:]&$T5 XG_^6YCQ9-G[V<:\2XV.YXSBH9\\YAB
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MHZ++6"*:+=&:MHR[HW.3@)V R9PS'&#E'C&.ADSA7B.(C*/OJI X-?@B*0I
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MJ;41U6Q@\V48\\#3Z2=P+XR1R4C,+/G,!Q0/'3Z"6J[H%?#;Q_+Z@Y13W:\
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MHD&*WH#$=IMEM$ !1/2(U?71),^?-?;C0X4)AV5+ER7C1MF/&C,(1N&9*@B
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MYNGC^T.R^(S\RSC(G#6/!B\C,*MKHZCY_?7]H^HL0:^*)"4B7(,0'4012<,
M*JS;)6*O=;Q'O0T*TW)L(1N4^'OR6M)=1MA4ST_X-H$562MG6TG21YU58S+J
MQ ],EUUC$C3Z^?&?A3X$UAJ5#FPY32L2HDN*^A XTX!$#C9BHD*JBHJ+QD&^
MW@>Q]FKO&0?MLO\ #Q"-&JRZ%%5Z?:;3K)+EC2TZW"Q\C1EU$4*_NG$:A/RH
M$^+(A3H4AZ),ARV7(TN)+C.*S(BRH[R";;C9BH&!HBBJ*BHBIT\>S+$K>;C^
M4XG=U>28W>UKRQ[&FO:2<%E4VD%]/YCK#[;;K9>P0IQMUO9#6'&R>7#/&MRZ
M*(X))CNXV.H,3(X?=#_LV96K5G! M52)*8YEYN;3I[*>$R@LE&-$C/[T[CQ&
M'"Y7Y4HY&+[<U\DVT1$5EL+J6[',BU[V(ZHCRMD72Q?:_:_%[3,\\S.T9I\=
MQVG91V9.F.HIF9F:BVRPRV)ORI3Y@RPR!O/&#0&:5&X&;QJC<OQ,SH NVV<R
M8WG5)M\Y-BH$['=LHLL4[D00C8?N7&QF214T'S:.XL9/3;?$<TQRCR[%;^&Y
M7WF-9+50;RAN(#JHKD.TJ;-MUA]I51%4'6R35$735$XN=SO Y(:QN_3SFQL=
M@\EM53&[APN9]QO;G++5Q2K7R+WK5;:/%$)2T"7":;%HKO!-Q,5O\)S/&YA0
M+[&,GJYE-=U4L11Q&Y=?. '!0P(7&STY3 A,%("%5Z6.;3[/XA;9OG>4RTC5
M=+4L\R@T/OI=G9RW%%F'"BAJ]+FR7 99;13<,137B=?V]N&;>(+/*2-6[AYC
M"D30QFIK4DMV2X7A-?(%E5@,R&FW'9\MA),IP$<48[7)&:Z6\^Y%39)6YM<4
MH[<;;N@7+,'-\]4J.%8UNJHBOU<0IMR"$JII#+43_F%T\4\3_B\IW"P*T8CW
MVV.R<M#CNYG =0)%3F&X2@J&%2\*J["J$Y3ECR/22&(J,2H%-2UT"GIZJ'&K
MJNIJX<>OK:VOALI'B08$&((-,LM-B(-M-@@B*(@HB)IZ=<9E25[6R.^<L'Y(
M;D8561DJ<ELB'WA;B8:V3,>RYEUYYL<XTY545.2Z (RJ8CO=ASD*ML'WPQ/<
M"B)^UV_S:.RG,3N/9!W;:=\(^^>@2VV9;2*A.,"! 1=(1$5(B5!$115(B5=$
M$43RJOL)QA7BI\7%59X]%JIM1E^TNRSY2JJ^F6,%]FWQ[-]Q'&'&WX3#+@ _
M#HU07GC03F]TR*Q9/_@6S?=+/+(*?#=O<7N\OR6Q)!(X]10UYV,Q(S)*/>OF
M+:MQV!7F==(&P12)$7<W?C-W7?AC<')IMI$K3DG*8QO'6B2'B^*0'7-/^'K*
M]N/":71%)&^<M3(E7I8SLIM+4K-N[ISSV[N9 DE)A>)Q9#;5WF.1R45$;B0Q
M=#WJ+WCSI-1F!-]YH"K=K-JJQ'YKJ,3\ZSZQC1PRK<+)D91N1=7<AKF[MD.L
M(->V:LQ6O>!S.$Z\[Z?+R['&JO!?$KC=0;6'[@(SYO798S$!#B8=N.,4".3"
M-![J)/03D0"+G;1UCO8KV4;7[H8O:89GF&6CU/D6.W#*-3(,QI$,# P4FWF'
MFR!^+*8,V7V3!YDS:,#7I;:;[X"^K>1;=9)%MTAJXK4>]IG@*OR7&)YHA*D:
MTKGI4"0HIS"#JD"H8B28'NW@5@EIAVXN*TV78]+]XCJUUU""8W&F- I=U)84
MB8E,*O,T\!MEH0JG2\9?[UGB'^MVX]3S]V]N:5L/$CM#02YV/N0VE23N3A=:
M+ME:;=3@;_VLI$)V31N$*D,GFC:BW+,VR$A42%5$A)%0A)%T421?(J>RG3O-
MOIKJ%(V<WBRV@K&$-"5O&<NA1,\AND/E%3LY]PFFFF@ZHJJJH/1RG.\NLF*;
M%<+QVZRK)+>2JI'K*''ZYRVMI[VG7RM,-.&J)UKIU=?&[&_>1I)CNY_E4R;2
M5,IY'SQW$(*#5X;C2&*J"K K&(L=PF]!<<$W-$4UZ>'[.;3X\_DV=YO:!64U
M<V8LQVD0%D3K2TFN>\C0H; .29DESWK30$2ZZ:*&+XN$?)]T,GCPI.ZFZDF$
M+%IE5HP/.%75@?,<*EA&1C @":^57GE<D.&:^GY1XJ_#;CH1-[:>([<[F;?4
ML9IJ/N]5Q10Y^24\0.41R2,RA// ":V;8**"4] \Z(2%1(542$D5"$D711)%
M\BI[*=.=L#E%FXQ@7B1AL5%4#[XC!JMV,?:=F8A+T=UY%LXY3*=1:1">D.P4
M-5%I.7I^)'<@)93*AS<>UP_%G4<YXY8EMT 8%C<B& Z"V$F+7-S"$4ZW'C,E
M(R(BZ5=XG=Q:1MS>S?*@C6.-#8,"LK;[::S09M)7P@<'5F;>M]S93W->9(ZQ
M(VC1-R4=]0%5[BU"8UN14P'V,%WCQN%%',<6?5"<C0[!"5L;:I[U5)^IF.(*
MH3A1G8D@DD@YM_O#1 5;8=_*PC<&C1^7A6>T[3BAY[26+@B3<AKJ&972A;DQ
MR45-M67&'G>A7[4[+8V=G/+N9F3Y-/[V+B6"8^;W=/Y%EEP(D+# Z$C+(";\
M@T[J,TZZJ!PF-8#$#)=Q+^)%_P"I&[MM :CY+F<YG1Q8L5GG>^#:AESKAU+#
MQ &B./.2)*G(/I^&WPZ09:"S&@9+O5E,'FYB><G2"P; I:"BIRHVD?) 551>
M;G33EY"YNE8[I;H4P6>Q>Q$BKLK:IG1T=K,^W!FJ4K%\-E-O: ]"C@T=E;-I
MSHH#&BNAW<WF01$4$11!$11$$11-$$43R(GL)Z@OML=W,,H\^P3)HRQ;C',@
MB^<1'T3K8E1GFU!Z+*8+1R+,BNMOL.(+C+@."))<[R;&C>;G>'%7Y4VU!6"G
MYKM!&55>1O+0B#K,IP'5&[MIH4:0>2<+1=V](Z%3CF.5-C?9!?6,*GI*2GA2
M+*VM[:RD##KZRLKX8FZ^^^Z8-M--@I&2H(HJJB<8YXB/%?35V2[V"D2YP?:^
M5YI:XQM,\J-RX5QD J)M3\E8-$5KD,XM>:*;2ORD:D1__ O@/A7QFP1J^WKL
M4S'/@8D<LB-MMA5BVY3UTE@="0+6[%MUMS711K'VU14-=.E1XKC-5-O<DR:X
MK,?Q^DK&#E65Q>74T*VIJJ^*WJ3C\A]QMEIL4U(B1$ZUX@TD^) G;X;A1:K(
M-Z<ICDW)4[IJ.1P,*J)H:H592=^\PP0KH^\3\K0>^$&_4+VXFW5=7U7B;VZI
MW2Q2U01C#N/CD$79CFVF02.8 YS-PW:>8\B^;R%5HB"/)>,+.BO*Z;3W5+83
M:FXJ;.*]!LJNTKI)0["NL(4D1<9?8= VG6G!0@(5$D145.GN3X2\FLN^M=I)
M9[B[:L/N<SY;?9=:*WEU5$;3R,5EZ\W+(BZU.WY47E!$'H^,O]ZSQ#_6[<>J
M-QX./P6Z_!]W8T/>S#(K  $>#'S29)9RFK9;9 &F@CWT2U2-';3^BBE'3V45
M>EXML ==4F)]+M)F$)A1+E8=J)U[2VCH$*::NI.AH2$6O]&/*G4?2I=CJ"?Y
MME?B1R,Z>P1EUQN5'VUP=R->Y<ZVXUUCYU-=J*XP-41V._*#WR(2>D,[O;ET
M(,^(O>>GASKD+"*(V6VV RN2PI-OF$=U-B6^J-S[Q$Y"5_N8C@*L$3/U"/B]
MV?H0A[7[HWWF6ZM!511;@X/N;9<S[.1L,,?[*OR(D=-WWB-LV*&*FGGT=D.E
MC^6XU82*C(\6NZK(Z"UB&K<JLNJ2>W9U5A&<3^:XR^TVX"^PHHO&S>_5.,=I
MO<K!JF[M(40C.-492P)5.9T++CGOB2OMX\Z#SK_.[K7V>EO)NDAHVNVNU6X>
M?HX30OB"X=B,S(D,F"U0T3S;505-%\G#K[[KC[[[AO///&3CKSKA*;CKKAJJ
MD1*JJ1*NJKUKTM@=DK&.Y*H,QS^O=RZ,UWHN/X/C##N79Q'!UDA)LG*F!,;!
MU"]X1(77IHK,6*RU&C1FFV(\=AL&6&&&01MEEEEM$$0$401$41$1-$ZO460;
M0;TXE"RO$+YHB:5UMINXQRX!@V(&48I;$!N0+.)WAK'E-=>A&TX+C#CK1I66
MJS,OV9RV9*/:[=1J%W46U9!%D'B^3ML:MP[R(WUNL:HW);3SF-J'>ML>@M)A
M<<\6VOQV;&'<C=RVA/.X_B\8T%\ZFJ:10^$KIYE4*+6LN)IS [)<CQU[WBKV
MEV3QD*:FC=W*OKZ=YM+RW.+Y&49DY-F5TPTTLN8ZB:(@M@RR'*S&998 &A](
MWIBMO=_6[=UF [<U1<Z'R#3X9#M[MG055!Y+:PL0Y47V-5T)5%.EL-B'F"0L
MER[%8F[&=F;334V1EVY49O)'V+)641">KX3D&G0EU7NX;8J1:<R^H7HLIEJ3
M&DM.,2([[8/,/L/ K;S+S+B*) 0JHD)(J*BZ+U<9%XI/"/C#I;>M>>W>[6SM
M,R[(<P0",I<_-L"@M\Q+1CJ1V%6VB_!PHKT=/@]'&X/H8WM?M1B%UG.>9;/"
MOH\=HHI29DEQ44WY4@UT;CQ8[:$_+F2#!B.R!O/.-M 1I!W*W"^"-P_$Y;5Q
M-V&5MMG)QW;:+81U:GXUMTW+ "YS B8FW+K02) <S;0QXYNM._XJ)5[E%Y3X
MW2010YMQ?6<*GJH8*NB'*L+ VV6T_A,TX?B77B/P^]G,N=UYKM]"R+<AMUQ%
MT(6[3!H<^"B(FJJ1RA'JT15+1%QO;V+?Y_CJY/:L4\3-,PQ.%08+7RY<=3B'
M=VS]@4B(PX_R1%D.PT:;<-#>-N.AO@A"J$)(A"0JBB0JFJ*BIY47TFJJ=QMN
M]WID"]BK(I,LQ:BQ&RQ6S>:3696L3[&\AO!*CZIWS#T<"Y5$PYVR0U_L/OG\
MF<!_2;C^P^^GR9P#])^/[#;Z?)G /TGX_L-OK\F< _2?C^PV^WR9V_\ TGX_
ML+OM\F-O_P!)^-/ZB[[_ "8V_P#THX_L+OQ\F-OOTHX_L)OQ\F-OOTHX_L)O
MS\F-O?THX_L)OU\E]O?TIXT_J'OW\E]O?TIX_L'OW\E]O/TIX_L'OY\E]O/T
MIX_L%O[\EMN_TJX_L%O]\EMN_P!*N/[ [_\ R6VZ_2KC^P.__P EMNOTJX_L
M#X@/DKMU^E?']@/$#\E=N?TKX7_\@/$%U?\ YJ[<_I7QK_T_\0?R4VX_2OC]
M7_B$^2FW'Z6<:?\ 3[Q"?)3;?]+./U?>(7Y*;;_I9Q^K[Q#=7_YI[;?I;Q^K
MWQ#_ "3VV_2WC]7OB(^2>VOZ6\?J\\1/R2VU_2[A79&-[YUAH9#YO-PS$G'E
M$414=0JW(9#?*NNB?TFO4NJ)U:_^V;T?(BB^.N%:D!N[6!W9'YS.P6"XRI(J
M(C2#6V<ASF775/Z/3J754ZM3:DY?G-4 MDXDB?MUD+C)D)(*,B-8,ESF5%4D
M500=$74D71%8$M\SJY#YDVD>UVVW6C*TJ$J"3\QJC<C )(FJ*K_NZ+U<-K"\
M2FV['>(XH_#,^=CFB-+RESID,>+RJO\ HH6G-Y1U3@!Q;?O9?)#-5$6Z+='"
M+9Q2110@[N!.<+F13!%%4U121%354X:E0Y#$N,^/.S(C.MOL/ O4AM/-*HDG
M\*+]W]\<^C3EFXIC^2/;8[?\CA.0PPS;IT\=A3:[F(E%FRE-S+G35/?S#7E#
M7E3I7_C2W#IPD8[MQ.EX=LO$GL\[%CN _"1,HS,&'4T,*>'("'!<43!9<EUP
M%"1 %4]1R?'/L[0]VX)P*WQ#X]41?Z-U'"&OI=VFX[7D/F5FONU;'0M8\PA1
M4FOET(%+15EA=7-K+8@5=34PI-C9V4Z2XC4:% @0Q-UYUPE00;;!2)51$15X
MK,FWC2-X:-NYC;$M#S* =MN=917"UY8&W$=YAR$6B$)_#<N$Z&HD,=X55$<N
M=I\5LKG<B=4%2W.ZV<62WF93JY\FGID" +(,0*V,ZZT)N-5T)DG$01><>0!T
MZ/C+_>L\0_UNW'JCPJ[KL1T"177FY&WEK+%IQ2D,W4"MR3'X[KZ HHC)0+,F
MP(T5>]-1$D0E'I;VTJN.H_/\.=E:-LIS=P;51N9CD1YQS1=.<%G @:IKH1:>
MSKT=P,?A3CDXIL165>S="T+HK'&UI$.VSN0K#2J(OI=S)L)PU53)N*RAZ<@@
M'2:W"S6I6?M)X=DJ<XO6I#*'79#GCTLBV\Q60+@J+C7?QW[26VJ*)-0^X<1!
MD)KZBS[9K<:M^%<*W&QFQQB^C K8R6F)S7_#V5:\X)HU,A/BU,A/\JJT^TVX
MB:@G&YVQ.<M*F0[;95/H7):,FPQ=5::3,>R2"TXJDD:SKW8MA&0EU[MX4+1=
M4Z>]?ALN)QNR]M,HKMR,-9D."IIBV>M%79#70&T75&(5I &6YJ/^TLE7F770
M>CXL;%E7!.3M@]CZJTVRX7=99>0L5?11?U'E4)I(9)[X1U(/?H/39G2V^>1C
MFR>Y5U6%RLEW4Y^368\XYJZ!$/\ PT^0.K:B77HI<BD)>H\IV?W@Q:%EV"Y=
M"6)95LM.21%D![^#<4\X/Z6'/AN\K\26P0N-."A"OE17\(R/SG(]M\G6;;;3
M;E-Q#;@97CS4E0*NLC 4:CW5>A-MV<$2]ZI-OMZQY#)E#S[-4M]N?#/36*A<
MYNL7N+O/WX+W+-Q?;5F8*@Z7,),3+<P.-$+F%!D2&RC<8WM5M'B%3@^ XE"&
M#28_4-N=RR&O/(ES)<DG)$N7(<4GI4V4ZX^^Z1.O.&X1$OI/BXOU?22S*\1N
M\<6!($9(([4U.>SJ>F/DF*K@KYHPSJ)(/*O4@@B("=&DIB>6.-O;UM84@01P
MF!GS BJ\+:JG,H\_,B:IKIIJG$*L@,!&@UT2-!A1F^;DCQ(C*1XS <RJN@ (
MBFJJO5ZC(2%"$D42$D11(5311)%\J+[*<7_BX\,6->;[9R)$BTWFVRIV&PB[
M<RI3PJYG.(0&M%&C?=-?A" T"I7&O?,HD C"#4;1;)8L[D&0S^67;6<@UAXU
MA] V\+4_*,NN2$@B0HZ$FJZ$Z\:BQ&:?DN-,G\'XNPQF.[N1P([6XN\%I7,L
M7=ZXBB^Y1X\P1.K5TK3HH34!ITB=(0=E./N@!!_BG=SG>S<"CP:CU-JO:G.N
M2;N_F /-\'8UCL 79UA(T7F)N(P?(.KCG(V)&EIC/A5PR'MO0HZ_&C;D9S%@
M9+G$]A.8&I]7BSPNU%8JZH2-R_A%51$5>[55%#R7=[<G,]Q;I2,F9>67]A;A
M!%Q=2CU4.2:L0V4_T6(K3;8^013A?7[/"=O&-^%WQ0Y(I822Q:/:;=B\E*I8
M82Z1Z[",WL9"]=.OO6JZQ=+_ (#WK#Y>8]VY"0A5"$D0A(511(535%14\J+Z
M1<[>;ATS5UCETUH8+RMSJV<V*^9W%/,T4H\R.2J3+PI[8DA-D8$5+=B[=85=
M.R'L'SAF.3<&\@M+S%!FB.HQ[&.*BDJ*I>TXVI-&)<=O"^@ON\+[OH>OVN%]
M!?07W>%]U>%]Q?P<+QV\)QV<+PO;Q][CMX[.%]?L<+V^A]_A>.Q>.WT%[>%X
M3M]#SS#LNRC$Y8GWHRL:O[6BDB[[W^D1^K=:)"]Z/7KKU)[2<1UH/$EN//;C
MHH!'S6QB[C1U:4^962:S]FS][_HCIHH#U HHB:1XVXN!;6;F5[2)W\F/"N,'
MR226O6I6-7(DUXII[ U">[['$6'NKB6X>S5@[R>=3RA-[A8C$YB02_\ 5,9
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M.ZH4;;[*G$8B7B*J+W;  Q.444BA *<R^K?#GXDJ^)S1IM??[)97-1M11B5
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M5.;S.:YRZHA:+U>HFLWV&W(O,*G&_'.ZI&WO/\/RR-'542ORW$YO/!GM*!&
M&ZUWS/,IQW674%P:?;7?EJGV$WME]Q"@R)ED0;5Y[8$(@(8[D%F2%53'SYD;
MJ[1TD)>1N/-DO&C2>H;+$,]Q7',UQ2X:1BVQK+*2MR&ALV1)#%N?46S;T=U$
M)$(4-M=%1%3K3BQR;PX9/;^'K+Y"O24QF0$K-=JYT@E-Y6FJJ>^%I5*ZX2"K
MD6P>CL@B(U ZM%GV.8;0V.=81!5\BW'VB\ZW Q,8C"_TEA9LUS 6M6PB<O\
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M=OH+V\+PG;Z"\)Q][A>$X7L_!PO9^'A."[>$]WCL]$NWH=G"^[Z-=NML[>I
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MT\ID ++;9Z2=TKBJ@..NMF7>JY$AQW$->54$A;4=0U7U86+[H4P5.:5$20.
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M[>.:$A1KV^QF/D-]'7F55_HYLM\$7JUTUT'R)ZMO\"D0ZZ'NIB[$W)MF,RD
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MBFW$@0F$2?EV"B\O,A"J*[/J54G(R+WC9O1T,VON'OU50HA2K_;VFA[Q8[R
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M,)EP8K^[F,QF9"BJ-.R(F&B[)9 _(I-B\T1)["&/MIZ3<;P;DN+932<6GP+
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MISNIZ1CF[&S^7VV$9WBTM)-7=5+W*IM%[V766<1Q"9F0I0:LRX4ELV7FU4'
M(5TXI=M=RW*?:+Q)I'CQ#Q67.2/B.Y<T 1MZ?MG9V!\RR'2172H)+A2VD548
M<G-M.OAZ98WE[9U]+2T\*59VUQ;38U=5U=;!9*3-L+&PF$#3##+8DXZZZ8B
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MV2T<CR6E%UEQ!<:,'!$DM]Q/ [;.7]4BOSI6P^:W+87T%O4G"C;>YO:$+<T
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M]2H=LW_!KQ&G[W[V;E;KRF59=*GQ&LI]KL:?-.M^+/1P[NR>:\HH<:PB&O\
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M414YFWLB>;)0E2@51B"I1XY*2O/.?<RXVNW)K@('VWIF+9/'8;.]PC)ACDU
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MG#N+!62[OF+E 74YD0>;1>9/LS[K?*[$?]3@QN/#IO-!C(T2@]6W>$6KY/\
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M6_!=;"?71.9J0E@VB:HBDJH8R_Z_^)W=4Z^:KGG&/XCD#FW>,.LF7,,9_',
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M26;953QNY;/']U3A[J5TB(PNK< 9><MS;"*TG4*>838YB*( D@)R\0ZOQ/\
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MPI_WA]HOCCC[9?A3_O#[1?'''VR_"G_>'VB^../ME^%/^\/M%\<<?;+\*?\
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M=9B^FY)NON_F%1@^"8K#.7:75O(1L3<Y5\UJZR*.KTR=*-$9AP8P&^^ZHMM
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M8&"HHJB*BHJ<8QX7/%OD3#.XQMPZ+:O>:YE*V.XLA%\W@XCN!.DERC?&G(W
MLS5!LBT:?5+ @<G^EY=O1N]D#>.X/AL#SJ=(0$D6-E->-&*N@H8',)2K"<^0
M1XD<23F,D4R!L3,7+C)I$G%MH\:L99[7[2PY?>5.-Q#!8H7-XZT@)874AK7S
MF<Z*HWSFS%%EA5 O5&+[H;7Y1:89GF&6C-QCN14[R-3(,QI% P,#0FWF'FR-
MB5%? V7V3-EX#:,P61096%'AGB.PB&#F<8-!?-BNR:I!09#/\%BSG''R@..&
M+4V(KKKD%]1!PR:>C//>D;5_O68/]46<]/Q+_11B7SO+U)L3^\"U]7-WT_$O
M]%&)?.\NCO-]%&XGS0F>DM>&+=V\[G8_=R^:_JE<6<DDA[9[FV2A#BO=ZZJB
MS579(W&G(NC;,GN96K8%,-SU%XI_SKQ/ZM*3I;-?2MMY\[H?0\(WYU[P?DC'
M_N%XN?SKV?\ R1D'0\4_YJ8G]9=)ZMQKPP>)_)W[/92T?A46W&Y%_.5R3L[*
M(!AUM!>V$LO?8N>@--N.%_Z6JHNOF/,D8'6C!QIP!<;<;)#;<;-.8# QU145
M%U14\O1B>-[;&GY\DPR%7XYOO706#.1<X:TH0,8S]6VE]\[3DHU]@?(1%"<C
MN$0,P#5>FNP>?7*R]Y?#U5P*R.]->)RPS#:1"&OQ3(%==)2>?JB4::>2(N@#
M!><,G91:>H:7P3[?6O)?YW'K,RWJEP9&CU9A<:7YWBF$O$UUBY:RF1L98*0D
MD6.P)(;,TDZ>WVQ>VT+SG*<_OH]6W+=:?=KZ"J!%E7N472QT(PA5D,'ILHA1
M2[MM1!",A%=O]C=M(/F6);?T+%3%><;8"?<V!D4N[R2X*.(@<VRF./S99B*(
MKKA<J"*"*?X!9)MON'1Q<AQ+*JYVNM*^4V!$*&G-'GP7B158E1G$!^+);T-I
MT <!4(4X=HK%)M_MOD+K\K;K/BBHW'NH :&[3VI,?T3-I"0D"4RG*C@\LAL4
M:<01X[/Q\)Z"=OH]G"]GX/0[>%]Q>%]Q>%X^_P =GH+V^@GN\=GX^%[.(\*%
M'?F3)C[,6)$BLN2),J3(<1IB/'8:13-PS5! !15551$157BC\17B*HV)F],Q
MAJQP/ [%IN1&VFC2&^=BWMV#U \C,%U$5U2N1=$UEJ11_P##3*O!7X<<A5JH
MBK-Q[Q![A5+R<UQ)_P#E[':?&YS?\V*U[]K()+1:OGK $A9"6,CTM$P#;7/\
MY4E(13#\-R+)E4A%PB%$I8S_ %HC3JJGM ?_ ,*Z-'7^#_Q%M"])"(V5QM+F
M6.BKCB H.DN01(O*S[\=9!:-)[[4TY2T^R9NO_\ :ZL_YKA[X0\('B!D=QW/
M/\ [9Y+E/-W^G)W/]6&)G>::IS]WS<G7S::+H@;B;9[@8$:GW:!FF&9'BQJ>
M@KR(-Y&8770P73_ZI/;3TL2$E$A5"$A54(21=4(53R*GL+Q1>$GQ-90K^ZL)
M@*_9[<J]E-BYN/61&$"/@^4V4DT)W(6!%4@2SU*Q:3NW56>"'.])R3/<ZOJ[
M%\.P^EL,AR;(;=](U;3TU7&*7.G2W5U7E !5>444B7010B5$5QRO=LL>V"P*
M?-B;3X*ZXXP4EM=8TC/<LB@:MN7%@"+R#HHPHQ#%:4B\X?D^E TT!N.N&+;;
M;8J;CCAKR@  .JJJJNB(GEX;D8)X<=^,SCNIS-R<5VBW R",8((&KB2*JO=#
ME07&R4N;1$(55=%3AXHOA&WK:1A0$_A/$WZ4B4T51[D;DF%<3J756T5$ZM=-
M4U>D.>$O=PFV&G'C%BGARGR!H%,D9BQ9!NN&J)[UML"(EZA155$X)W(?"5XC
MZ^, -F<Y=F-PI5:'>*J !V<*O<CB:\J^\5SF3RJFBIP59DU#=8[9 G,5?>U<
MZHG"/,H\Q1+!MMQ$U14UY?+Z7B.[&UV1S<3SS!KB/>8[>0%!7(TMC4'&),=U
M":D1I#1''EQ7P)I]DW&70-LR%8N=580,?W/Q)85#O#MZQ*5UW&<D=9(HEO6@
M_HZ=/;@T[)K7RYD11?BDXX_$>7TC:O\ >LP?ZHLYZ?B7^BC$OG>7J38G]X%K
MZN;OI^)?Z*,2^=Y='>;Z*-Q/FA,]*;\-V[U\+V_&T-&R&/6UI*(['=+;2O0(
MD2U<D/KS/VU.BMQ++55<?85B8JNN+,-OU#XI_P Z\3^K2DZ6S7TK;>?.Z'T/
M"-^=>\'Y(Q_[A>+G\Z]G_P D9!T/%/\ FIB?UETGJYCP5;TWRR\TP^F>F;$9
M):2D.;E&%TT97K/;J6\^O.]-I8X+*K%0C)RN%YI4;&O!7NA<8WD%;#N:'(*N
MPI+NHL6 E5]K46L0X%E6SHSJ*+C+[+AM.MDFA"2HO4O&0X#$8FR=J,P\ZS/9
M>_D^</\ GF&3)I N-SK!U.5VRI'?^ F^^YW 2/+(&QEMCT]N]^<&(WY^&7#9
M75&LA8T3+<1GIYGE.)SW.4T%N=#)QH'5;)67>[D *N-!I@V[VW%J%UA&X>.5
MV38]/3NQ>6'8,\YPYS+9&C,N*ZCD69'4E)E]MQHO? OJ#<C?C/WM*#;_ !^1
M9-5S;S;,W([Z00P<:Q6K)SJ\YLI[L>&RI>]!7.\-1; R3/MY=QK+X5S7<;)K
M')[Z2".#&:?G._\ #UM:RX1JU#A,"U#A,<RHTPTVVBZ G3=\4.X])YONUOO3
MQBP^-/CB,W#]FWR;L:A&Q<%#:D9"X#5G(T)46($ = -'A7_ 2]VMW-I@ML>N
M01Z-(;Y&K7'[IAHPK<DQ^:J*L>;%5PE;<1%$A(V71<8==;.=MWF[7G]=)%RR
MPO,HD5]BES/'N]Y&K"%WO,C4AI5%J?"5PBCN]7,XT;3SO9^/A/03M]'LX7L_
M!Z';PON+PON+PO'W^.ST%[?03W>.S\? ,,-N///. TRRT!..NNN$@-MMMAJI
M$2JB(B)JJ]2<5/B3\1F.,'NS/8C6&V> V\?O'-KH3S:N#D=_$>U!,@D"0+'8
M(>:M#K)4FF0P_P##0=BMH;U8WB(W>HY*E:ULA6Y^U.W<PCKIF7 ^TJ&S:V!"
M_#I%!4-E0?F\S9QXZ/$1$I$2J1$2JI$2KJI$J^55]E?2!$14B)4$1%%4B)5T
M011/*J^PG%=?MX QLS@%@C;[.;;SNS<429#-I) R*7#VF'[R4+K9"49]:]N(
MZJII*%.8AAV&^VXVX>]URV#)2J>H<9VPP=UQ44I#+D2G<EW+B(N@@ZW=L*J(
MI*VBDB!$_P"F?AFV>H)T'3S6_EX;5Y-EC/*G*FF8Y8,ZU7^'FF+JO6O7PTPP
MTVPPPV#+++("VTRTV* VTTV"(@B*(B"*)HB=2=!Z+*9:DQI+3C$B.^V#S#[#
MP*V\R\RXBB0$*J)"2*BHNB]7$L=Q?#)M3+GS>99.0XSCK6W^5NN+IRNO97@)
M5EBXHZ)RH[))/*BHJ*J+87'A@WHR/ KA0-Z'A>Z\=K+\1D2.3E"#&RJC:C6E
M<PJZ$KK\6S<1>9.545.1^1O+M/;,X>#O=Q=S,1-,NVYF"1HVT;N25*%\'FX2
MJ+4:W:B2#T5194=%7TBON*>PFU-O4S8EG56M9+?@65990'QE0;"OG12!UE]E
MT!<:=;)" D0A5%1%X>P+<FSB->)+:>LAMYBT7F\4]Q,5YA@UVY57#:$![Q7%
M"+=,L!R,22:=1&VIC#0^D3/!OL[?]YMEMO<(N\5Y52T*+G.XU6\BAB(NL+HY
M7XZ\*C)%2Y7;)#Y@_P"!9</TBKQ?$,?N\JR:\EMP*7'<;JI]Y>V\YW56H574
M5C;LB0Z6B\K;39$OL)Q6Y#O+88_X;<0F=V\L7)FERO<IV(YH0NLX+3/M,QE5
M-4)JTM8CX+IS,+Q!FYO09GOSD48&W'INXV3RX&/I-%-''8>)85\&QU875>6/
M8N343V2)41>&6MI=F-K-M$8:5D'<%P'%L6E$!-]TXK\REBLNNFXBKWKCAD1J
MJJ:DJJJ]!ZCS'&<?RVDD?_,4^34U;?5;_P#_ !J^U;=9+_\ "!>)16_AXQ?!
M;>1WA-Y!M"<K;";$>=UYY#=5BQ,U+QZJI:2ZUX=>OEXGWGA3WOCY$VWW[T;;
M_>>(U4VY- 2&W'A[@XNPL20^8J0B$BFAMH0HI/HAJH)B^_FTV7;;V+SKS-=,
MN((2,<O5C_[8\;RZJ.1560!_IG F.H/^DJ+Z3BN]6"N.S848TI,_Q!9!,5^=
MX%826W+W&IJIJ(N+W;<F#((2[B6TP\HF($V>#;Q[97 7N"[AX_#R/'K!!%M_
MS:4BA(@6$82+N)D-\'8DZ,1*3,AIUH_? O3VK_>LP?ZHLYZ?B7^BC$OG>7J3
M8G]X%KZN;OI^)?Z*,2^=Y='>;Z*-Q/FA,]*PO=[;&\?Q[.<"O(E]063*FK??
MQU49$&>P)"C\26R3D69&)>5YAQQHO>DO&+;SX8<>OMG02CW%PP9229N"9] C
MMG=8_)(D0C8+G"77R"%._B.LN*@.*;8>H/%/^=>)_5I2=+9KZ5MO/G=#Z'A&
M_.O>#\D8_P#<+Q<_G7L_^2,@Z'BG_-3$_K+I.F55B>.7V46@QW)95N.U%A=S
MQB,D(.RBAUK;KB-B1@A'RZ(I(BKUIQ^IK=;]GF7?\GQ^IK=;]GF7?\GQ^IK=
M;]GF7?\ )\?J:W6_9YEW_)\?J:W6_9YEW_)\?J:W6_9YEW_)\?J:W6_9YEW_
M "?'ZFMUOV>9=_R?'ZFMUOV>9=_R?'ZFMUOV>9=_R?'ZFMUOV>9=_P GPV[=
M[9[@4[3W>=TY:X9D=>#O=(A.]V<N,"%RHJ*6GDU37TO#]R\#MY%#F6"9'495
MC5O%(A<A6]+-"=#<(15.=M2! >:+WKC:D!HHDJ+M9OYC/F\<,YQQAW(*:.ZK
MO]6<TK#*JS+&CYU5S2'8LR&F#<1"=8[I]$Y715>A?X/"C0(^[>%)+S'9?()2
M-M+#RV+&_P"*QF9-5.9N!>,!YC*Z^0'/-I9 X44!6VQZ_K9M->T-G/I;NGLX
MSL.RJK>KE'!LJVPAOH)M/L/-FTZV8H0D*BJ(J=.S\$NY-WW>-YQ+LLKV-F6,
MG2/49LC*S,HP-AY[J;:MV6RL(+7.#:36I  )R+!$+T^N\)^ VRO[=["VCTS<
M%^(^BP\BWG<C'!E030%(3#&XCKM>BKRD,V18-&*HRT:]*$_E]4Y)V)V><K,P
MW5>=:+S+('2D&>*[=(YY%*X?8<66**BI!8EJA"XK6K3##3;###8,LLL@+;3+
M38H#;338(B"(HB((HFB)U)_@-:;9[@QB94B6QQ;*(3++EWAN1M-*W#NZHG=$
M)-%5J5&(D!]DC;)151,+K:W<RK\RN*U$F5=E'YW*?*,>D/N-5F34$LT3O8LC
MNS1-40VW <8=$'FG %/03M]'LX7L_!Z';PON+PON+PO'W^.ST%[?03W>&V66
MW'GGC!IIIH"<===<+D;;;;#52(E5$1$355ZDXH/$IXD\?;>W0>"/;[:[:V\<
M7&MMVG!1Z'E.40WD5"OR14.)$--*U-'#3S_1(7^&FX6_.X+J'4874$Y64K<A
MN/89;E,\TA8SB52IH2J_/EFVTIH!(RUWDAQ$99<(<ZWIW0MSN<VW OI5Y;/H
MKR0X3;FC-=25##YN$Q KXP,PH,?G7NF&FPU7EU7IBFW5$F+[7UMB,'+=Y<LC
MRHV%TA-HCLROIT!$=N+0&U11KH&O(1M>=O1&71>XJ+REQ)K=+=^"#+TG=_<>
M%"M;N+9"*$X_A=$:' HFQ/G[@H;93$;+NWILC3F7TJ5 GQ8\V#-CO1)D.6RW
M)B2XDEM69$65'>0@<;< E P-%0D545%1>+;.?#$53X>]U7 =D_U888?39C*9
MA&IDW+H8+;KU X2*@B_3-K&!$ZZXS)74L-K]\\$M\%RR"BOQVIPMR*F]K2-0
M9N\9O89.1+&$XJ*@R(KQB)(39\CH& ]/ ]\=L;%8&5X)=,V+4=QQ\*Z]JW/^
M'N\8NVV"$G8-C%)V)*;147D-2!1<$"' -]=MY8.X_F].U*E5A2 D6&+Y#&_X
M;(L2N>00TEUTL78SB\@BX@B\WJRZV1=*<F&V;<7?+>!;#"MJQ;,5ET )'#^M
M>X*-ZHJ)417@2(?6GG[\3F VD=1'7WW7'WWW#>>>>,G'7G7"4W'77#55(B55
M4B5=57K7TBJW"R@I.S'A\D.=\&X%Y6&]D&;1FB1'&=ML:D*TLMHU_HUMI)-P
M@5#[HI3K1Q^!H]C=N:^JN9$1N+?[B7J,WNY65J( CI7N72&Q=1HR!'?,(01X
M+9J1,Q6U)=?2K7!MRL.QO/,.O&%CVV,Y93P+VFG-JBH).P;$' YP5>9IT40P
M+0@(21%2ZW0\#$J0:L@]/L?#WD]J4EPP%2<>';/-+EWO"41Y$;J[IXR+WY!8
M*2M1EM\8RFDML;R2@L)53>4%[7RZFYI[2"\L>;76=9.!MYA]HQ4'&G0$A5%1
M41?2)/@YW&N#' -W[-ZTVGE37G#9QG=8F1%_&V3<+E9B9#':Y6P3J2P:9%L.
M>:\?3VK_ 'K,'^J+.>GXE_HHQ+YWEZDV)_>!:^KF[Z?B7^BC$OG>71WF^BC<
M3YH3/2X&3S'["PV9SPZ_&]YL4C*X\DFB&07F&75D)-4*SI3=<D1N5.9UDI$7
MF%)"D-!F.(W-?D6+933UV08[?5,EN967-+;Q GUEG E-*HN-/,F#@$GE14]0
M>*?\Z\3^K2DZ6S7TK;>?.Z'T*B+O)M!M=NU&Q]V8_0Q]S< Q//&*1^Q!MNP>
MJ&<IB2QC&^++0O$R@J: "%J@II]C3PI_W>-HOB?C[&GA3_N\;1?$_'V-/"G_
M '>-HOB?C[&GA3_N\;1?$_'V-/"G_=XVB^)^/L:>%/\ N\;1?$_'V-/"G_=X
MVB^)^/L:>%/^[QM%\3\?8T\*?]WC:+XGX^QIX4_[O&T7Q/Q]C3PI_P!WC:+X
MGX^QIX4_[O&T7Q/Q]C3PI_W>-HOB?C=BLK(42NK:[<O.X%?7P([,.# @P\IE
M1XD*%$CH+;3338B#;8"@B*((HB(B=+:>LLX42QK;'<O!(%A7SX[,R#/@S,IB
MQY<*;$D(3;K3K9$#C9BHD*J)(J*J<?8T\*?]WC:+XGX^QIX4_P"[QM%\3\?8
MT\*?]WC:+XGX^QIX4_[O&T7Q/Q]C3PI_W>-HOB?C[&GA3_N\;1?$_'V-/"G_
M '>-HOB?C[&GA3_N\;1?$_'V-/"G_=XVB^)^/L:>%/\ N\;1?$_'V-/"G_=X
MVB^)^/L:>%/^[QM%\3\?8T\*?]WC:+XGXMXNS>T&UVTL;('8;]]'VRP#$\#8
MNWZX'&Z]ZW9Q:)$&2; O.BR3R$H(9H.B$NOH^*?\U,3^LNDZ=Q^[]N)\Y<?]
M-?:W*VHVUW":DMDS);SC!<7RQN0T3*1R:?"^BR$,5;$04214Y41/(B)Q.>A;
M2S-GL@F(?)D6SF13\7\U-5Y@\WQ*Q\_Q\11==4"H%5151"305&TR[PYY+ \1
M6(0T?EGBJ0VL3W9@PPU=4(M(^\[7W*LMIH2PIC4I\]$8KR4N5+*@R&ILZ&]I
MILFLN*2Z@2JNWJK*&ZK$ROLJV<#;S#[1B0.-.@)"2*A(BIZ1N_X2K^P0:S+(
M'_6+;IA\^46\FI&X]!GE9%U55-V;7?!TP6T1$$*]\^M27I,>-S;&E4,5SJ?7
MT&^E?7QQ&-0YR\(P<>STVF>IMB[$0A3W.012>#3AF;]BO3H<NQ:VFT.38O<5
MN08]=UKQ1K&HNJ>8%A5V<&0'6#K#S8.-DGD)$7C#=VXQP(F=5[88ENWC<(^5
M,?W$IXK?PL3$8E4FX5B!M6=>BD?*P^+1.&ZT[IZ;EFX4"5%7=++$>P;9NJ>%
MA]7\WMH;BAD$B$]JCD2ECHY92$(5!PFV8Q**R 7B=:VDR38V=G,DV%C837W)
M,R=/FOE)F3)<EY5-QUUPB-PR55(E5575>EB^ X533,BR_-+^IQC&:*O;[V;;
M7MY."NK($<5T3F=>< =25!374E1$5>,,V:ITASLI)M,GW1R>*WR_UKW&N(K2
M7T\'"03*+&%MJOKD)$5(L=GG3O%<(O\  >3B.0A&I<VI@?F[=Y^$-'['%;D^
M4G&'D!1-^NF<@LSX:EH0\KH<K[3+@9'MAN31OT.68Q.<B3(S@N+%FQU76%<5
M$HQ%),*6WRO19()RN-DB]2ZHG"=OH]G"]GX/0[>%]Q>%]Q>%X^_QV>@O;Z#3
M++9O//. TTTT!..NNN+R-MMMAJI$2JB(B)JJ\8_XD_$GC[;VZ#S<>VVUVUMX
MXN-;;M."CT/*,HAO(J%?DBH<2(::5J:&XGG^B0O\-8_AHP:Y\XVN\/,Z3'R5
M8,A3@Y+O+(86-D3SZ!H)IC[)%3,H0\S<I;+12!P%3ITN_?B2KKC$O#HG<66)
MXR+SM5DV]/(^J(3#K)#)KL?7D7O; 4!^8)(,$A EEMT6$8'C5)A^'XS7LU6/
M8SCE;%J*2FKH^O=1*^NA"#38(JJ2\H]9*I%J2JJ^FS=K]\\-BY+3.)(?HKJ,
MK<'+L)N7F>Z;R+#,A0#<A2V]!4DY38?$>YE,R(Y&R3(W)NYQLME5@_&V\W:@
M0"BQ)SPLK*7&<M@MDZ-;<--H9(R3BM2FP-^*9(#[<?IGX9,YMG&]J_$+:1HV
M,^=/(D+%MY^Y"%02VD<70 OV6VZ:0@"I')&N5>4&W%7HR)DR0Q$AQ&'9,J5)
M=;8C1HS#:NOR)#[JH(  HI&9*B(B*JKIQG&Y5=-G'MECAI@FT%;*5QMN+@U"
M\8-7'F9KHT_<2BD6KZ*G./?@P2JC :=/&?$_XP\9?_JQ*6'>[5['73!,)D\(
MFU?K\QW+@.HCB5SBJV_74Y\OG8HCLP5B&+$F+ @18\*#"CLQ(<.(RW&B1(D9
MM&8\6+'900;;; 4  !$041$1$1/3I645 5>W?B/HZU6\4W.9AF,7)&8<=1A8
MAN1'A^^F0#5 ;8GH!RX&B$QWK/>Q'\JVFW9Q6QPW/<-L3K;RCL@%#;-!1V--
MA26E)J3$DM$$B',CF;+[)@ZT9 2*O2K+VEGRZJYI;"%;5-I ?<C3JVSKI(S(
M$^%):5";=9= '&S%4421%1=4XVXWB<D1%S9J(6&[KU\4661K-R\99:CY"21&
M$0&&K #CV\1D>H(\MH%7F%43H[5_O68/]46<]/Q+_11B7SO+U)L3^\"U]7-W
MT_$O]%&)?.\NCO-]%&XGS0F>F0?!!O/?$F,9'/D/>'_([64(LX]DL]XI5AM@
M^^^J(,6T>)R54)JG)-)V,B'YXR+7I_BG_.O$_JTI.ELU]*VWGSNA^HMY?I6W
M#^=TSI;-?2MMY\[H?J+Q3_FIB?UETG3N/W?MQ/G+C_J";>Q(U5MSXAZN" 8I
MNU"KU1+48O\ L<;W%AP>4K*O,4[MJ02%*A*J''(FD=BR,MVDW6QF?B&?X1:'
M4Y#0V" KD=_NAE19460RI-2(LJ.XU*ARV#)I]AQMYHR;,27I>'?=Y9:P:W&-
MS:"+DTA'>Z0<+RETL1S="->K1:B?-30NK7373RIT<RVLW%I8^181GN/V.,Y+
M3R=1&766;"L.JR\'OV7VE47H\AM4<9=$'6R$P%4SK8K,%?FL4LD;?",G<CK&
M8S7;ZW></%LIC FH(3K;9QYC39$+$QF3'0R5E27I5B9;:K%V-WA6NPC==I]S
ME@T2E)),4W#7540"II3Q^=&NJ>8/S$0"=[I0!UHP<:< 7&W&R0VW&S3F P,=
M45%1=45/+Z8;KI@VTV!....$@-MM@G,9F9:(B(B:JJ^3B[E8O:G+V4VD.PP+
M:1EET3@6T6-+0<FS]KNU436\ELH['<ZE\Q:A 8HX!Z]*=XYMSZ35MOX5Q3P^
MUUE%ZB=U<J\SW-9;?#_0T=I:MX#5-5L2(=1CN?X%*4485%O+B,"46W>8NJ;#
M#O,2R7,2R<V0<)VLE.:J)(!.17B[]G42?9?R# ,_Q^PQ?+\7L':R[I+-I&Y,
M22VB&)"8*0.LN@0O1Y#)$T\T0.M&;9B2IV^CV<+V?@]#MX7W%X7W%X7C[_'9
MZ"]O#;++;CSSS@---- 3CKKKA(#;;;8:J1$JHB(B:JO&/^)'Q)8^V]N>Z$>W
MVUVVMXXN-;;MN"CT/*,HAO(J%?DBH<2(::5J:.&GG^B0O\-=UMYPDL-Y=&J%
MQ;;*(\T$A)^Y65 =;BJ+&<T%UJ&:N6DMLB3FC17D34M$6=:VDR38V=G,DV%C
M837W),R=/FOE)F3)<EY5-QUUPB-PR55(E5575>F6]N]-/,;\->WENC UCR/P
MTW?S&%H]_56)) @<2IA*K;EQ):75Q5&$T2&;[D:)75T2- KX$9B% @0F&HL.
M%#BM(Q%B1(K""#;38"(-M@*"(HB(B(GJ#)]L-TL5J<TP3,*QZIR#';ECOHDR
M*\FH.M. HN,2&307HLJ.8/,.B#K+@. ))S5R6>4>'[.["2>U6X$H6G93)BSY
MY*P3,2C"+;-O!'G[MU !N='%)3(@:28T7I19\"5(A3H4AF7#F1'G(TN)+C.(
M]'E19#*B;;C9BA@8*BBJ(J*BIQMAN]-EQG\YBPW,&W6CQD$$B;DXDRU%O7W&
M 1!92R9<B73+ ZHVS-:#55%>C<X7C=D<#<7Q&39.UM <60+,^OPXHB3-SKYH
M5]\3:5Q-TY$VJ&V[9,NBOO/2*[Q?[_8^DO:K%;=Q-H<'N(0.0=QLMIY2"]E]
MU&E(HOT=4^!-,1U!0F307O"[B(XS*]0'?XC#KZCQ(;:U4^3MKD9(S$3+*\=9
MTK;+)YA* G$F.(2ULA\M(,LU<$@8?F ]<XSD=9-I,AQVVL:*]IK..Y$L:BYJ
M)AU]I66$1Y$-I^.^V;3K9(BB0JBIJG3N/#WDEDD?"?$;5C%IAE25:B5NZF(Q
M7[/&W&E>+NVULX*SZTA$>=^2L!M%7D$5Z.U?[UF#_5%G/3\2_P!%&)?.\O4F
MQ/[P+7U<W?3\2_T48E\[RZ.\WT4;B?-"9Z9$L:Z7)@6$"2Q-@3X3[L69"F17
M4?BRXDIA1-MULQ$VW )"$D145%3A,6SRSCCXB]H:^OJ]PXSIL,R,XHM$ATVY
M]=$#E14E*@Q[8&AY69J*7*TS*B@OIWBG_.O$_JTI.ELU]*VWGSNA^HMY?I6W
M#^=TSI;-?2MMY\[H?J+Q3_FIB?UETG3N/W?MQ/G+C_J$?%?A%2PWNAL- $,W
M.(R RLOV??F)Y]YX0IJX]CLATK*.9$*##<L$7G+N!'I^'O="5(.3/S_9;;++
M+1YP>5U;B[PV'.N0=3R<X2C> ^551515%5315Z+V88%3>>;^;'Q+3)<%"#&
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M$1$5(B5!$115(B5=$$43RJOL)Q79#;8L&PNV,T&)29ONS$G5=I9P'M"1[%<
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MQYLES3ZC.QK)&(_,7(S:5KT2Q8%254;?#7KZ>9[+V<Y9-OL!N+(:K(ZKJL+
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M($E7:_*]X'6UA93:$H:"XW2 I4D75%Y7DL' ,FI Z=)_Q7[D4W<;H[Y4C+&
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MX=G D"B*3$V!(&5%>%%ZM1,!)-?:XQG+((\D+)\?I<AAAJX7+%NJUNRCCS/
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M"@ #=;7(0CK'8%P@%UUU5_QI[VY(CK#Z9!N[N3>(]&$AC/);9E-G]['$E54
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M9[JNR)+Y(B"*>06VFQ%ML$%ML ;$13U!0[R;-WRUEY6*D.ZI9BO/8UFN-//
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M,@%5>9V91-LDV(Z#7/D2F-%GVW654.;87DT$+&AR?&K*+;4UI$-5!7(LV(1
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ML:V?$?1#:>8> VW )$42147IXOO)B!2K*C14HMR,*"3YO#SK Y[PE;4KZEJ
MR6B$)E=(5/Z&4TT1<S2NMGA>[6VE[&R3!<_H(.1XW<1231^#-#4H\IG528E1
MG4<C3(KFCC#[;C+HBXV0IZ'BG_.O$_JTI.ELU]*VWGSNA^HMY?I6W#^=TSI;
M-?2MMY\[H?J+Q3_FIB?UETG3MXEM70+2*FP6X3R1K&''FQT=#)* 0=1F2)#S
M(BJB%IJFJ^WQ_8S%/D[4?[GC^QF*?)VH_P!SQ_8S%/D[4?[GC^QF*?)VH_W/
M']C,4^3M1_N>/[&8I\G:C_<\?V,Q3Y.U'^YX_L9BGR=J/]SQ_8S%/D[4?[GC
M^QF*?)VH_P!SP]$F8)ALN+(;)F1&DXQ2/QWVC3E-IYEUA1(53J42147@F<H\
M.&PV2-$T+!-7VT&WMPV3 N]\+)!85SB*"'[]!TTYNOR\2&[GPL;?4SCX.($G
M G<AVW>C.'UB_'# YM<UJ"HA"!M$"Z:$!"I"LN;L+O)N-M9<D!N1ZG-8U7N5
MB*NBJ*W&:[@:FTC@:(HD\[.E**JA(V7+R%9Y3EN!L;A;85BONR-S]JGY658]
M6P6EYDG9/5DRS:5+2"H][(G00BB:]V$EQ=%7IQL!SV[<;\.>\]O J<Y8G2'%
MK<#RIY!KZ+="$TJ$C*-?T<.Z5OE[V$J.N(ZY!BB(D)(0DB$)"J*)"J:H0JGE
M1?87U#NIA64BU"N\0QZWW+V\R?S='Y6,9KAE/(LX4AOV5CS6$?K9X)KK'D.$
M"=Z#1#TMFMB2NOZN1]SL[I<9GWHM=^]5U4AY7[>9#85"$Y Q6WO-@-$ G>1#
M404B3#]LMOZ6-CN%8)CM5B^,TT1%[J#44\08<1LW"U)UTD'G??<57'7")QPB
M,R)?\#EI*1:O,_$9F=6\YM_M^X\KL.BANJ<8,]ST(QBXS6,N"21HR$#U@\!,
MLD#029,;)=QMQLEMLQSC,;:3=Y+DMW)6596ME*7W[SQ]0B B@MLLMB+;38@T
MT -@(IZHIMW=E,H?Q[(ZY6XUI7N]Y(QW+\?64W*GXKEM2) ,N!)5H.\#F%QL
MD%YAQE]MMT&,ZP5]NASBA;A0=T-KYTUJ1?8+?2&E42$D0%F54Q0<.LLP;$'@
M$@,6I+3[#7W9>9S3<K#Z*:PIH[5R+J(_="H:\Z? <(G9BZ::+HPO7U>7JX,:
ME_-,O5.=&W*+&2A,&2)[Q2+*7ZYP15?9[I51-?>^1%-*/:*\L!0E[M;;+(%,
M1CWBHBF,.%/05Y-"T15Z_>ZZ>^4U8V<K6F%7^C![-I3[HC[1NA5MH2_PH">Y
MQ^J&IU_/&9\7<:IM%4_+"9\7\?JBJ?EA,^+^/U15/RPF?%_"Z;98HB:KHBV]
MNJHGL(J\J?@X_5GBG_VWN/\ )Q^K/%/_ +;W'^3@_/=JL>D:\O=>:Y'90^33
M7GY^]C/\VO5IIRZ:+Y=>H!MMG'FM!3G?KLY!_F/F]\H19-4WRIIJJ:O+U]7L
MZH#=WC.?4+A:<SPP*:U@M]>B\SL::#Z^W[V,O5K[.B*VS6[GT,"2:B'FV2C.
MQ4Q=--1:1[(FHS)K["=TZ2*O4BJO5PU-KID6?#?'G8EPI#,J,\/_ ,33["D!
M)_"B_<?<2IEJVLJKSK+:Z2K)*;2R(5_(C/*T9(BJ/,*\JJB:I["=*AN'VW'6
M*FZJ[)YIGE[UQJ#.;E.-M<ZHG,J J#JJ)KY5^X/B\8EM*RZ>_&?3 !5$E6-8
MW)V$)W4%5-'&76S1/*B+HJ(NJ=/PGW(LK'&W\-6Q5F,<C1PF!G[754I&2<1$
MYE'GY571-=-=$]3>*1^8[WSK>08)! ^1MO2+6;2T%;!:Y6D%/>,--AS*FI::
MDJDJJO2\(\5QT'B=V6Q6S0P111&[IH[EII4+V0%] )?95%5.KH;5_O68/]46
M<]/Q+_11B7SO+U)L3^\"U]7-WT_$O]%&)?.\NCO-]%&XGS0F=.X_=^W$^<N/
M^E7/CAV1HN;(Z&"PYX@L4JHNKEYC\!D8K.ZD&,PFI2:YH6VKM!%>>((S2Y/-
M9)N]-OPB[LWC<;:?=J\[[;.YLWR2/@^ZUF01F:-7C71JNR(D!C1?>-6",&B
M,J4ZGH>*?\Z\3^K2DZ6S7TK;>?.Z'ZBWE^E;</YW3.ELU]*VWGSNA^HO%/\
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M_P"SQK[?L_R<?B_EXU]KV?Y./Q?R\+K]_P#DXT^]^/TN+95<Z76V,)X)$.?
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M^5B$M<>?$$\I-3DCNBGMBG3PG<7&GO-LCP'+L;S6@D:JG<76+7+-Y5/:I_\
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M1T<EPS?41(U@O30; G3;TCS(<AB7#EL-28LJ,ZV_&DQGVT=8D1WVE43 Q5"
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MP_-_.-;+#<T@PXDC)-O\LCAI R.@=DI__)FQN<!E1C<8(@YT,+7:C>"B<CN
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M$-\T0VZ^ !H[+>3D#E;%YYK$MD-I*E:[&,7C<TJPE(RY>95D,H!6ZR[)IC
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M +(<A)_']O<??EQ]NMN8\LG:['*YXN0K&Q,$$9=K+$1*9,4?:::0&0$..O\
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M4U3O$70D>/ _%EE]"WJ91X^7;54V6GR\[A T],IKJD3515H5<%CJ43+D5"0
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M\7\?K1R7]F.X'Q?Q^M')?V8[@?%_'ZT<E_9CN!\7\/;;;.9K<9!EK%!89,Y
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M4T8:<ZHD;E9$1=.2X]Z=BV\.!/FX_4O>89-CIRG(U;FF'S7@6]Q6V44-.[D
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MKQEMJ[%*;#D11DM(B*KD=7Q'G'WP]8ZIUI[?I&<>%#)[#6!>,3MR=K_.7?\
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M_:=M_P#&''ZKL:_:=M_\8<?JNQK]IVW_ ,8<?JNQK]IVW_QAQ^J[&OVG;?\
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MMM]YD2<E370$UC0(PDX:IS&K3*&\$";FV.2-]\U:9:6==;BZ'BZ2Q)#>^"<
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M^$JVI:05ZM7-=>K1>@#C9DVXV0FVX!*!@8+S"8$/6BHO6BIQLINYYP$F=F6
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MDQ#0X,94T)*EHTDGKI**-R''=KJ2CK:^FI:B%%K*FHJH<>NJZNM@LC&A5]=
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MJ/DEE_\ K<?:7VH^267_ .MQ]I?:CY)9?_K<?:7VH^267_ZW'VE]J/DEE_\
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MS7?\J<W(EZVO)SKR\VN@\^I='&\4.0CMUL[EN68'8@9?\24"=9EFM!)(-?\
M9)&M$ALDB(B^;$/6HDJ]#Q!?0CNO\PY_J'Q/?G+M;^2[S_'MM3])."_.B+Z1
MXF?HVF_E&-TO#U_W9^H[)NEX@OINW7^?D_U!:?0CG7Y?I.CL=L+ E*CN0WMQ
MNEDL9IQ ,8..Q"QG%0D"/OC:D/SK,T%?><\82T4A%0Z%304\5V=;WEE!IZJ$
MRG,],LK.4$*#%:'V2<=,0%/;7C;7:NH(7:[;K!<6PR-($.3SQ,<I6:IR>XG5
M[^0;1/N$O6I&JKUJOI$K-H<57;C9?.,;S(766R<DECUT\6%7\013_P"M<UC$
MG/DB:B,5"54%#UZ.!5LR6D6DW<I[_:FT)PT1I9=TR%UBP(V2*BN.W%?7Q05-
M%1'BT715$NAXC_S:QKZP*CU#:?3=G7Y I/2:OZ;L%_(%WTO$#]&N,_.@O2_$
M%]-VZ_S\G]+$_P VJ+\EM=/Q!?0CNO\ ,.?TO"Y]-VW_ .7V>G8;:YZU\'6<
M8G;/!LWA1&)%Y@^2HUR,V4'O>578SR(+5A!5P DL]7,VZ#+S4_;K=6C..O.^
M_C&60&I#N*YM2@YRM7..6;H"C@Z*/?QS07HYKW;P 6FOIE'M?M-C$O*,MO72
M[J.SRL0*R"S[Z;<WED]HS#A1Q]\](>)$\@#S.& $UBU446_W'R8(=CNAGH,N
M@YD-RP!K'K:L9'OV:NO[UQF$SH*GJ;[HH\\:)T=SF8TI)5)M7'J-HJ54(2[D
ML3:.5E+!("JB$W?3+8/+KH*<VBHJ)T-F8,F-YQ28#93-V+XE'O!CLX!&^%:!
MPV]40A.[6J8)%731Q55"TY2](VSW=AQ19K]U-O':2Q= .N3E.W5BD67)?<1-
M-2K+&I9!%Z]&5TZDT3H[T;$SY2E+P[**O<?'F7C0C.FS""E'>QX8J2JC4676
MQWC'E1$.;KJJDNG0\5O[MF^GU7VG2\,WTE0?R?)Z='N;40SEV>R.<1+FS5L5
M<<:PK,64QF^<;9!%)5">M.\X2=0,MNF7O14AZ*P,WLUK]G=W8\'%,[E/&7F6
M-VD60;F(YO(!%1.[@O//QIAJN@1)4AWE,VFQX:D1W6I$>0TV\P^RX#K+S+H(
M;3K3H*HD)"J*)(JHJ+JG0\07T([K_,.?ZA\3WYR[6_DN\_Q[;4_23@OSHB^D
M>)GZ-IOY1C=+P]?]V?J.R;I>(+Z;MU_GY/\ 4%I]".=?E^DZ.[+D26DNEVU.
MMVCI%$T<1@<):)K)(Z$G5HEZ_;+HGM^5>CLY$E1?.J/;Z=.W8OE5OO1CLX'&
M^$,>=,%1142O#JF2YE1-'%5%4M!+TC<W:JS[D8>X>"93AYO/H7=Q';ZF>KHL
M_5M%)"CNF#X$**J$"*B:IQ94MM$>@6M1/F5=G!D#ROPK"OD%$FQ'Q370VW (
M"37RHO1Q7-\>D+$R##<DH\JHY8JJ%%N,>LVK>LD(HZ+J#[(%U+['&#[C8^7/
M1Y[B..9C4+W@.DE;DM0S<0P-P.I2%MX1+3V47J3H>(_\VL:^L"H]0VGTW9U^
M0*3TFK^F[!?R!=]+Q _1KC/SH+TOQ!?3=NO\_)_2Q/\ -JB_);73\07T([K_
M ##G]+PN?3=M_P#E]GTBRVVW@Q&ORW&9^KS"2!5FTH[(6R:CW>.6[.C\&:RA
M$@/L&BJ*DV:&T9ME;9ELBQ:[X;3-$]+%BKAH_N;BL$1)XFKW&X(I\(M,BG*L
MZK;)21%<=BQ@3@VW )MQLB!QLQ4# P7E(#$NM%1>I47TJMODIY&UVT+QM.R]
MS<RK9+#5E"-.92P?'GE9D7!DFJ \V3<-%14.4)H@$F&[38\C4Z>$4\MSBW1B
M9F>:SXHJC4J^M@ /Z)M2-8T&.#<9CG-6VD-QTSZ.X6YUVH_!.WV%9/F<\"-&
M^_CXW3/6YQ6U54U-WNNZ;%.LB)!3551.,@RV_E%.OLHO+;(KN:>O/,M[N>Y9
MV4H]=>MQYTS7K]GH[][\38RZ29%#M+C4OD5$TB@.7YHSSDG6BJ[0JB"75RKS
M(NHZ>D2,XB1^\M=F,ZQO,%<;'FD%C]\\N$7D4!T55#O+"%,=TTT&-S*O**HO
M1VUBRY21:/=>+;[1W"FXH"X_E#83,4:$/YI&Y>0ZQD=?(CA:=?4O0\5O[MF^
MGU7VG2\,WTE0?R?)Z>3X'F-6Q=XIF-#:XUD53)YT9L*>YA' GQE-M4,%)LRY
M7 )# M"%4)$5+C!<DB3[+";"5*G[9Y^L4DK,QQ@W.>*IR&Q1INSB 0L6D+J)
MIY%,$.,['>=Z.T,G(+>QNI-=/SNA@R;26_.D1:6DS6=7TU4R](4B1B)' (\9
MK7E;: &P1 $13T?$%]".Z_S#G^H?$]^<NUOY+O/\>/ZR/$G\L-K_ -#N/UD>
M)/Y8;7_H=Q^LCQ)_+#:_]#N/UD>)/Y8;7_H=Q^LCQ)_+#:_]#N,?RBNW#\13
MUAC=Y4W\%F;ENVCD-V93SV[&,W+;8Q%LR:(VQ1Q <$E'5$(5ZTZ><[/9A-O*
MW&=P*-V@N9V-R8$.]C0WG@?)RLDVD:9'!W5M$178K@Z:^]X_61XD_EAM?^AW
M'ZR/$G\L-K_T.X_61XD_EAM?^AW'ZR/$G\L-K_T.X_61XD_EAM?^AW&&[Y8#
MFV]]OEF#_P!8?@FNR_),#GX[(_K+BL[$)WPC$I<:KY)\D:P>-GNY;>CH@1<P
M(0%T<QSRYW!\0T:XS;*<ARZUC5F5[;LUL>RR2V>N9S%>S*Q-YT& =>(6A<><
M)!1$(R74E_61XD_EAM?^AW'ZR/$G\L-K_P!#N/UD>)/Y8;7_ *'<?K(\2?RP
MVO\ T.X_61XD_EAM?^AW'ZR/$G\L-K_T.X_61XD_EAM?^AW'ZR/$G\L-K_T.
MX_61XD_EAM?^AW'ZR/$G\L-K_P!#N/UD>)/Y8;7_ *'<?K(\2?RPVO\ T.X_
M61XD_EAM?^AW'ZR/$G\L-K_T.X_61XD_EAM?^AW$C=G;/+]X;S(Y.+6V(G"S
MJ_PNSI$K;B9%FR7PC4&/UC_?B<1M&R62HHBEJ!*J*/0NLDNMTO$O.N<@MK&[
MMIKN8[8*Y+L[:8<^?*<5<.55)QUPS7^%>/UD>)/Y8;7_ *'<?K(\2?RPVO\
MT.X_61XD_EAM?^AW'ZR/$G\L-K_T.XRS-=KKS<O(\@R_'H^+S)6X5UBUJE;3
MM606TB/4#C=+4J"R'V8Y/J\KNO<M\J!H7-Z3G>YUOF.^M#<;@Y9>YE<5.+Y1
MM_#QZ%;Y'8N6UH%1$M,7F/M,$^ZX8-.27.77E1>5$1/UD>)/Y8;7_H=Q^LCQ
M)_+#:_\ 0[C]9'B3^6&U_P"AW'ZR/$G\L-K_ -#N/UD>)/Y8;7_H=QA&S6+7
MF4Y'CF ULBGI;;-9M78Y([6N63]A%BSYE-#KXQC%%Y(L9&HC?*PVV)<Q(1EZ
M.;;*YO89!5XMGD&#7V\_%95=!R",S7W$:[9*ME6\2=& E=BMB2NQ7$4%)$1%
M5"3]9'B3^6&U_P"AW'ZR/$G\L-K_ -#N/UD>)/Y8;7_H=Q^LCQ)_+#:_]#N/
MUD>)/Y8;7_H=Q^LCQ)_+#:_]#N/UD>)/Y8;7_H=Q^LCQ)_+#:_\ 0[C]9'B3
M^6&U_P"AW'ZR/$G\L-K_ -#N/UD>)/Y8;7_H=Q^LCQ)_+#:_]#N/UD>)/Y8;
M7_H=Q^LCQ)_+#:_]#N/UD>)/Y8;7_H=Q^LCQ)_+#:_\ 0[B1M-MG<YG>8Y)R
MFVRXYN=6%)9W:65Q#BPI+ 2:"NK&.X$(C:MBL9215+4R140?2(^TVYESF='C
MD;*:G+@FX+84E9=K94\.5"C,')OZZS8[@@EN*X*1D)50=#%$5"_61XD_EAM?
M^AW'ZR/$G\L-K_T.X_61XD_EAM?^AW'ZR/$G\L-K_P!#N/UD>)/Y8;7_ *'<
M9CE&U>4;IW]AFU'!H+5G<"[Q*UAQX=?/6Q9<KV\<HZHP=4UT(G''!4>I!1>O
MTO,<\N=P?$-&N,VRG(<NM8U9E>V[-;'LLDMGKF<Q7LRL3>=!@'7B%H7'G"04
M1",EU)?UD>)/Y8;7_H=Q^LCQ)_+#:_\ 0[C]9'B3^6&U_P"AW'ZR/$G\L-K_
M -#N/UD>)/Y8;7_H=Q7U<<G3CUL&)7L&\0$\;,..,=HG2 1%241125!1-?(B
M>3IYC@=R_.C4^;8MD.(VLFL<89LH];DE2]33GZ]Z4T\T#X-/$31.,N"A(BD!
M)J*_K(\2?RPVO_0[C]9'B3^6&U_Z'<?K(\2?RPVO_0[C]9'B3^6&U_Z'<?K(
M\2?RPVO_ $.XP+=G%\]W\GY'MWE-/EU)"O\ *-O)5)*LJ28,V(Q:1J[%HKYL
M$8HC@LR6B5/(8KU^E3;'<7;:'59G,YS+<? S9Q+.5D'U+*GV,1HXUD:)J@_"
M\26(_P"B**B*DVQV$W?Q?-:Q%[V+C>XL.7B&1MM::+$9O*@)T"8[KH2..M00
M5%5%1%%%-T,F\-^Y4UAKO"*PPFH#<BM%EO55DNSMOW+-MH%1.;5]05$_G(B]
M7'F&1T=Q03M.;S*[K)M5+Y=$77S:<#9Z:*GL>RGHM1HK#TF2^8M,1X[1O/O.
MFN@-M--HI$2KU(B)JO$=<$\/.[=W$EKRL7#F%75/CIESH"HN37K4:O%45>M"
MDIHFJKU(J\1)F\&68+LM3N<JS(+<L=Q<R8]E6PK,<=;J2\FBFEXNBKJ@EQ"O
M)V)O[RYQ%Y' R?=5(=W7PI"#[\Z;"V6VZEE$)$-ER3&DR6E1%"2G7J#;8"VV
MV(@VV H   )RB "/4B(G4B)T\RV6RZ^RS&\9SF-70KNSPF;45V1I!@7$>Y*'
M#F7D&QC@$@HPL2.:(2DR9B*BI(2?K(\2?RPVO_0[C]9'B3^6&U_Z'<?K(\2?
MRPVO_0[C]9'B3^6&U_Z'<?K(\2?RPVO_ $.XK-G-LI&0S\=KK:[NW;;+9=5/
MR2VL[V<LN3*M9E+"KXQDV'=16>[B!HRTV)<Q(IEZ1GFU67C+7&-P\3O</NSK
MG([%G&@7U<Y7O3:M^6T^TW*8YT>BN.,N"#H 2@2)RK^LCQ)_+#:_]#N/UD>)
M/Y8;7_H=Q^LCQ)_+#:_]#N/UD>)/Y8;7_H=Q^LCQ)_+#:_\ 0[C'<NH-T/$K
M#O<6O:C(Z66.8;8\T6VH[!NSKI*<F'BNH/- 742+U=2IT=P=KLADV4.@W)PC
M*\!O)E*]%CW$2GS"AD8]9R:F1.9D,-R6V))DP;T=T!-!4VS%%%?UD>)/Y8;7
M_H=Q^LCQ)_+#:_\ 0[C]9'B3^6&U_P"AW'ZR/$G\L-K_ -#N/UD>)/Y8;7_H
M=Q@V\.(9UOQ99-M_>-7]-!R3)]OIE%)F,LFP+=G&J\7AR#:T<746I39:Z>^]
M(L,"W6PNASO$;/E*52W\,93(/MZ]Q-@OBHO19+6JJS*C.-O-KU@8KP_/VUW0
MW,VU:D.DY\"V+=/GE+"%3148K?/1@SQ!!U1/.K"0>O6IJB<O'VGLE_9;5_'G
M'VGLE_9;5_'G'VGLE_9;5_'G'VGLE_9;5_'G&,['UV6RLWBXW8Y+8!D4VH9H
MY$LLCOG[TVCK6)$D01I7U;14>7F1-=$UT3T<QP.Y?G1J?-L6R'$;636.,,V4
M>MR2I>IIS]>]*:>:!\&GB)HG&7!0D12 DU%?UD>)/Y8;7_H=Q^LCQ)_+#:_]
M#N/UD>)/Y8;7_H=Q^LCQ)_+#:_\ 0[C]9'B3^6&U_P"AW'ZR/$G\L-K_ -#N
M/UD>)/Y8;7_H=Q^LCQ)_+#:_]#N/UD>)/Y8;7_H=Q^LCQ)_+#:_]#N/UD>)/
MY8;7_H=Q^LCQ)_+#:_\ 0[C]9'B3^6&U_P"AW'ZR/$G\L-K_ -#N/UD>)/Y8
M;7_H=Q^LCQ)_+#:_]#N,[J]J<BW%R"/N%.H+"Z/<&VQJU>BO8['E1X0U98Y4
M5(@)#,<5U'1<550>51T5"_\ $$L6R@P["*I":QIT9F6PI@NH&K+XD.J>PNG5
MPW\+[*[2VO=$9M?"6W&'3N[-W3O#;\ZAEHI:)S*GETZ^&Y<'8?9F'*9529DQ
M=K\(CR&E(5 E;>9@H0JJ*J+HOD73CS?&L<H<>8Y2#N:.GKZEGD)U7R#NX#;:
1:*9$:II_.55\J_\ [5E__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696789949184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Oct. 20, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CROSS COUNTRY HEALTHCARE, INC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">0-33169<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">13-4066229<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">6551 Park of Commerce Boulevard, N.W.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Boca Raton<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">FL<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">33487<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">561<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">998-2232<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, par value $0.0001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CCRN<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,295,465<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001141103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696789635856">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 30,320<span></span>
</td>
<td class="nump">$ 1,036<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowances of $12,763 in 2022 and $6,881 in 2021</a></td>
<td class="nump">610,897<span></span>
</td>
<td class="nump">493,910<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="nump">3,952<span></span>
</td>
<td class="nump">7,648<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceSettlementsReceivableCurrent', window );">Insurance recovery receivable</a></td>
<td class="nump">6,202<span></span>
</td>
<td class="nump">5,041<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">8,646<span></span>
</td>
<td class="nump">638<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">660,017<span></span>
</td>
<td class="nump">508,273<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net of accumulated depreciation of $19,846 in 2022 and $17,729 in 2021</a></td>
<td class="nump">18,556<span></span>
</td>
<td class="nump">15,833<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">3,249<span></span>
</td>
<td class="nump">7,488<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">113,360<span></span>
</td>
<td class="nump">119,490<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedTradeNames', window );">Trade names, indefinite-lived</a></td>
<td class="nump">5,900<span></span>
</td>
<td class="nump">5,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Other intangible assets, net</a></td>
<td class="nump">40,843<span></span>
</td>
<td class="nump">42,344<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Non-current deferred tax assets</a></td>
<td class="nump">8,791<span></span>
</td>
<td class="nump">11,525<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceSettlementsReceivableNoncurrent', window );">Non-current insurance recovery receivable</a></td>
<td class="nump">20,753<span></span>
</td>
<td class="nump">13,998<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="nump">11,043<span></span>
</td>
<td class="nump">7,958<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">882,512<span></span>
</td>
<td class="nump">732,809<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">192,032<span></span>
</td>
<td class="nump">109,753<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation and benefits</a></td>
<td class="nump">70,947<span></span>
</td>
<td class="nump">65,580<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,176<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities - current</a></td>
<td class="nump">4,489<span></span>
</td>
<td class="nump">4,090<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrent', window );">Income tax payable</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">7,307<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent', window );">Current portion of earnout liability</a></td>
<td class="nump">7,500<span></span>
</td>
<td class="nump">7,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">1,803<span></span>
</td>
<td class="nump">1,364<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">276,790<span></span>
</td>
<td class="nump">199,770<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLongTermDebtNoncurrent', window );">Long-term debt, less current portion</a></td>
<td class="nump">129,755<span></span>
</td>
<td class="nump">176,366<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities - non-current</a></td>
<td class="nump">5,493<span></span>
</td>
<td class="nump">10,853<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Non-current deferred tax liabilities</a></td>
<td class="nump">237<span></span>
</td>
<td class="nump">190<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Long-term accrued claims</a></td>
<td class="nump">33,104<span></span>
</td>
<td class="nump">25,314<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Non-current earnout liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">9,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">14,424<span></span>
</td>
<td class="nump">13,788<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">459,803<span></span>
</td>
<td class="nump">435,281<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">297,143<span></span>
</td>
<td class="nump">321,552<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(1,373)<span></span>
</td>
<td class="num">(1,293)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings (accumulated deficit)</a></td>
<td class="nump">126,935<span></span>
</td>
<td class="num">(22,735)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="nump">422,709<span></span>
</td>
<td class="nump">297,528<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
<td class="nump">$ 882,512<span></span>
</td>
<td class="nump">$ 732,809<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedTradeNames">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the rights acquired through registration of a trade name to gain or protect exclusive use thereof for a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedTradeNames</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceSettlementsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due in settlement of a claim for reimbursement from an insurance company when the Company has suffered a loss covered under an insurance policy. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceSettlementsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceSettlementsReceivableNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due after one year of the balance sheet date (or one operating cycle, if longer) of amount due in settlement of a claim for reimbursement from an insurance company when the Company has suffered a loss covered under an insurance policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceSettlementsReceivableNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt classified as other, payable after one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126905020&amp;loc=d3e5879-108316<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696789830912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Accounts receivable, allowance for credit losses</a></td>
<td class="nump">$ 12,763<span></span>
</td>
<td class="nump">$ 6,881<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Property and equipment, accumulated depreciation</a></td>
<td class="nump">19,846<span></span>
</td>
<td class="nump">17,729<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceSettlementsReceivableNoncurrent', window );">Non-current insurance recovery receivable</a></td>
<td class="nump">$ 20,753<span></span>
</td>
<td class="nump">$ 13,998<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceSettlementsReceivableNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due after one year of the balance sheet date (or one operating cycle, if longer) of amount due in settlement of a claim for reimbursement from an insurance company when the Company has suffered a loss covered under an insurance policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceSettlementsReceivableNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696791029360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList', window );">Revenue from Contract with Customer, Product and Service [Extensible List]</a></td>
<td class="text">Service [Member]<span></span>
</td>
<td class="text">Service [Member]<span></span>
</td>
<td class="text">Service [Member]<span></span>
</td>
<td class="text">Service [Member]<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from services</a></td>
<td class="nump">$ 636,098<span></span>
</td>
<td class="nump">$ 374,905<span></span>
</td>
<td class="nump">$ 2,178,391<span></span>
</td>
<td class="nump">$ 1,035,973<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DirectOperatingCosts', window );">Direct operating expenses</a></td>
<td class="nump">492,553<span></span>
</td>
<td class="nump">291,111<span></span>
</td>
<td class="nump">1,689,647<span></span>
</td>
<td class="nump">808,124<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">80,216<span></span>
</td>
<td class="nump">52,847<span></span>
</td>
<td class="nump">243,038<span></span>
</td>
<td class="nump">149,518<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Bad debt expense</a></td>
<td class="nump">1,101<span></span>
</td>
<td class="nump">1,441<span></span>
</td>
<td class="nump">6,662<span></span>
</td>
<td class="nump">2,411<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">3,214<span></span>
</td>
<td class="nump">2,680<span></span>
</td>
<td class="nump">9,414<span></span>
</td>
<td class="nump">7,132<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ccrn_AcquisitionAndIntegrationRelatedCosts', window );">Acquisition and integration-related costs</a></td>
<td class="nump">490<span></span>
</td>
<td class="nump">61<span></span>
</td>
<td class="nump">530<span></span>
</td>
<td class="nump">985<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring costs</a></td>
<td class="nump">2,493<span></span>
</td>
<td class="nump">318<span></span>
</td>
<td class="nump">1,859<span></span>
</td>
<td class="nump">2,391<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charges</a></td>
<td class="nump">3,856<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,597<span></span>
</td>
<td class="nump">2,070<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating expenses</a></td>
<td class="nump">583,923<span></span>
</td>
<td class="nump">348,458<span></span>
</td>
<td class="nump">1,956,747<span></span>
</td>
<td class="nump">972,631<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">52,175<span></span>
</td>
<td class="nump">26,447<span></span>
</td>
<td class="nump">221,644<span></span>
</td>
<td class="nump">63,342<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other expenses (income):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">3,498<span></span>
</td>
<td class="nump">2,182<span></span>
</td>
<td class="nump">10,876<span></span>
</td>
<td class="nump">4,049<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,912<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="num">(27)<span></span>
</td>
<td class="num">(375)<span></span>
</td>
<td class="num">(1,119)<span></span>
</td>
<td class="num">(616)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">48,704<span></span>
</td>
<td class="nump">24,640<span></span>
</td>
<td class="nump">209,975<span></span>
</td>
<td class="nump">59,909<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">13,911<span></span>
</td>
<td class="nump">1,207<span></span>
</td>
<td class="nump">60,305<span></span>
</td>
<td class="nump">5,480<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to common stockholders</a></td>
<td class="nump">34,793<span></span>
</td>
<td class="nump">23,433<span></span>
</td>
<td class="nump">149,670<span></span>
</td>
<td class="nump">54,429<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Unrealized foreign currency translation loss, net of tax</a></td>
<td class="num">(38)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(80)<span></span>
</td>
<td class="num">(32)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income</a></td>
<td class="nump">$ 34,755<span></span>
</td>
<td class="nump">$ 23,431<span></span>
</td>
<td class="nump">$ 149,590<span></span>
</td>
<td class="nump">$ 54,397<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net income per share attributable to common stockholders - Basic (in dollars per share)</a></td>
<td class="nump">$ 0.94<span></span>
</td>
<td class="nump">$ 0.63<span></span>
</td>
<td class="nump">$ 4.02<span></span>
</td>
<td class="nump">$ 1.49<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net income per share attributable to common stockholders - Diluted (in dollars per share)</a></td>
<td class="nump">$ 0.93<span></span>
</td>
<td class="nump">$ 0.62<span></span>
</td>
<td class="nump">$ 3.97<span></span>
</td>
<td class="nump">$ 1.46<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average common shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (shares)</a></td>
<td class="nump">37,101<span></span>
</td>
<td class="nump">36,963<span></span>
</td>
<td class="nump">37,200<span></span>
</td>
<td class="nump">36,593<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (shares)</a></td>
<td class="nump">37,492<span></span>
</td>
<td class="nump">37,582<span></span>
</td>
<td class="nump">37,741<span></span>
</td>
<td class="nump">37,276<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_AcquisitionAndIntegrationRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Acquisition and integration-related costs include costs for prior acquisitions, costs incurred for potential transactions, and accretion and valuation adjustments on contingent consideration liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_AcquisitionAndIntegrationRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DirectOperatingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate direct operating costs incurred during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DirectOperatingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30304-110892<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126980362&amp;loc=d3e28129-110885<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a-c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates product and service for revenue from satisfaction of performance obligation by transferring promised product and service to customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920602&amp;loc=SL49130690-203046-203046<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696787477248">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss, net</div></th>
<th class="th"><div>(Accumulated Deficit) Retained Earnings</div></th>
<th class="th"><div>Noncontrolling Interest in Subsidiary</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,177,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2020</a></td>
<td class="nump">$ 154,909<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 310,388<span></span>
</td>
<td class="num">$ (1,280)<span></span>
</td>
<td class="num">$ (154,737)<span></span>
</td>
<td class="nump">$ 534<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Vesting of restricted stock (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">479,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Vesting of restricted stock</a></td>
<td class="num">(2,230)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,230)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Equity compensation</a></td>
<td class="nump">$ 5,257<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,257<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Shares repurchased and retired (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment, net of taxes</a></td>
<td class="num">$ (32)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(32)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Acquisition of WSG (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">308,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Acquisition of WSG</a></td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromRedemptions', window );">Dissolution of noncontrolling interest</a></td>
<td class="num">(324)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(324)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distribution to noncontrolling shareholder</a></td>
<td class="num">(210)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(210)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">54,429<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54,429<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,964,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Sep. 30, 2021</a></td>
<td class="nump">216,799<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">318,415<span></span>
</td>
<td class="num">(1,312)<span></span>
</td>
<td class="num">(100,308)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,962,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Jun. 30, 2021</a></td>
<td class="nump">192,131<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">316,644<span></span>
</td>
<td class="num">(1,310)<span></span>
</td>
<td class="num">(123,741)<span></span>
</td>
<td class="nump">534<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Vesting of restricted stock (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Equity compensation</a></td>
<td class="nump">$ 1,771<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,771<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Shares repurchased and retired (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment, net of taxes</a></td>
<td class="num">$ (2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromRedemptions', window );">Dissolution of noncontrolling interest</a></td>
<td class="num">(324)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(324)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distribution to noncontrolling shareholder</a></td>
<td class="num">(210)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(210)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">23,433<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,433<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,964,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Sep. 30, 2021</a></td>
<td class="nump">216,799<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">318,415<span></span>
</td>
<td class="num">(1,312)<span></span>
</td>
<td class="num">(100,308)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,024,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2021</a></td>
<td class="nump">297,528<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">321,552<span></span>
</td>
<td class="num">(1,293)<span></span>
</td>
<td class="num">(22,735)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Vesting of restricted stock (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">499,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Vesting of restricted stock</a></td>
<td class="num">(5,267)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,267)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Equity compensation</a></td>
<td class="nump">5,206<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,206<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Shares repurchased and retired (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,015,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Stock repurchase and retirement</a></td>
<td class="num">(24,348)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24,348)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment, net of taxes</a></td>
<td class="num">(80)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(80)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">149,670<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">149,670<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (shares) at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,508,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Sep. 30, 2022</a></td>
<td class="nump">422,709<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">297,143<span></span>
</td>
<td class="num">(1,373)<span></span>
</td>
<td class="nump">126,935<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (shares) at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,523,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Jun. 30, 2022</a></td>
<td class="nump">410,811<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">320,000<span></span>
</td>
<td class="num">(1,335)<span></span>
</td>
<td class="nump">92,142<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Equity compensation</a></td>
<td class="nump">1,491<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,491<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Shares repurchased and retired (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,015,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Stock repurchase and retirement</a></td>
<td class="num">(24,348)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24,348)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment, net of taxes</a></td>
<td class="num">(38)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(38)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">34,793<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,793<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (shares) at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,508,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Sep. 30, 2022</a></td>
<td class="nump">$ 422,709<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 297,143<span></span>
</td>
<td class="num">$ (1,373)<span></span>
</td>
<td class="nump">$ 126,935<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromRedemptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569655-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4616395-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromRedemptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased and retired during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696789660352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Consolidated net income</a></td>
<td class="nump">$ 149,670<span></span>
</td>
<td class="nump">$ 54,429<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by (used in) operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">9,414<span></span>
</td>
<td class="nump">7,132<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ccrn_ProvisionForDoubtfulAccountsAndOtherAllowances', window );">Provision for allowances</a></td>
<td class="nump">10,016<span></span>
</td>
<td class="nump">3,836<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax expense</a></td>
<td class="nump">2,797<span></span>
</td>
<td class="nump">2,797<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ccrn_OperatingLeaseExpenseNonCash', window );">Non-cash lease expense</a></td>
<td class="nump">1,437<span></span>
</td>
<td class="nump">1,866<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charges</a></td>
<td class="nump">5,597<span></span>
</td>
<td class="nump">2,070<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="nump">1,912<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Equity compensation</a></td>
<td class="nump">5,206<span></span>
</td>
<td class="nump">5,257<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other non-cash costs</a></td>
<td class="nump">64<span></span>
</td>
<td class="nump">833<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(127,003)<span></span>
</td>
<td class="num">(122,887)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Prepaid expenses and other assets</a></td>
<td class="nump">1,236<span></span>
</td>
<td class="num">(259)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income taxes</a></td>
<td class="num">(13,220)<span></span>
</td>
<td class="nump">759<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">87,156<span></span>
</td>
<td class="nump">36,675<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ccrn_IncreaseDecreaseInOperatingLeaseLiabilities', window );">Operating lease liabilities</a></td>
<td class="num">(3,817)<span></span>
</td>
<td class="num">(4,592)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Other</a></td>
<td class="num">(735)<span></span>
</td>
<td class="num">(169)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by (used in) operating activities</a></td>
<td class="nump">129,730<span></span>
</td>
<td class="num">(12,253)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisitions, net of cash acquired</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(24,470)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(6,763)<span></span>
</td>
<td class="num">(4,890)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(6,763)<span></span>
</td>
<td class="num">(29,360)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSecuredDebt', window );">Proceeds from term loan</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfSecuredDebt', window );">Principal payments on term loan</a></td>
<td class="num">(50,438)<span></span>
</td>
<td class="num">(250)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Debt issuance costs</a></td>
<td class="num">(3,159)<span></span>
</td>
<td class="num">(4,573)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLongTermLinesOfCredit', window );">Borrowings under Senior Secured Asset-Based revolving credit facility</a></td>
<td class="nump">1,275,808<span></span>
</td>
<td class="nump">288,467<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermLinesOfCredit', window );">Repayments on Senior Secured Asset-Based revolving credit facility</a></td>
<td class="num">(1,275,808)<span></span>
</td>
<td class="num">(337,876)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Cash paid for shares withheld for taxes</a></td>
<td class="num">(5,267)<span></span>
</td>
<td class="num">(2,230)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Principal payments on note payable</a></td>
<td class="num">(2,426)<span></span>
</td>
<td class="num">(2,426)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Stock repurchase and retirement</a></td>
<td class="num">(24,348)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities', window );">Payment of contingent consideration</a></td>
<td class="num">(7,500)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other</a></td>
<td class="num">(536)<span></span>
</td>
<td class="num">(243)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash (used in) provided by financing activities</a></td>
<td class="num">(93,674)<span></span>
</td>
<td class="nump">40,869<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash</a></td>
<td class="num">(9)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Change in cash and cash equivalents</a></td>
<td class="nump">29,284<span></span>
</td>
<td class="num">(758)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="nump">1,036<span></span>
</td>
<td class="nump">1,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">$ 30,320<span></span>
</td>
<td class="nump">$ 842<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_IncreaseDecreaseInOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Operating Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_IncreaseDecreaseInOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_OperatingLeaseExpenseNonCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Lease Expense, Non-Cash</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_OperatingLeaseExpenseNonCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_ProvisionForDoubtfulAccountsAndOtherAllowances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Provision For Doubtful Accounts And Other Allowances</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_ProvisionForDoubtfulAccountsAndOtherAllowances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from amounts received from issuance of long-term debt that is wholly or partially secured by collateral. Excludes proceeds from tax exempt secured debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLongTermLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLongTermLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfSecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfSecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696793512672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ORGANIZATION AND BASIS OF PRESENTATION<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">ORGANIZATION AND BASIS OF PRESENTATION</a></td>
<td class="text">ORGANIZATION AND BASIS OF PRESENTATION<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nature of Business</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements include the accounts of Cross Country Healthcare, Inc. and its direct and indirect wholly-owned subsidiaries (collectively, the Company). In the opinion of management, all adjustments necessary for a fair presentation of such unaudited condensed consolidated financial statements have been included. All such adjustments consisted of all normal recurring items, including the elimination of all intercompany transactions and balances.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cross Country Talent Acquisition Group, LLC was a joint venture controlled but not wholly-owned by the Company. Effective December 31, 2020, the sole professional staffing services agreement held by this joint venture was terminated and, as a result, the Company dissolved Cross Country Talent Acquisition Group, LLC in the third quarter of 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (U.S. GAAP) for interim financial information and with the instructions to Form&#160;10-Q and Article 10 of Regulation&#160;S-X. Accordingly, they do not include all of the information and notes required by U.S. GAAP for complete financial statements. These operating results are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These unaudited interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended December 31, 2021 included in the 2021 Form 10-K. The December&#160;31, 2021 condensed consolidated balance sheet included herein was derived from the December&#160;31, 2021 audited consolidated balance sheet included in the 2021 Form&#160;10-K.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior year amounts have been reclassified to conform to the current year presentation. See the condensed consolidated balance sheets and statements of cash flows.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696792176448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts in the condensed consolidated financial statements and accompanying notes. Management has assessed various accounting estimates and other matters, including those that require consideration of forecasted financial information, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in context of the unknown future impacts of the global COVID pandemic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> using information that is reasonably available to the Company at the time. Significant estimates and assumptions are used for, but not limited to: (i) the valuation of accounts receivable; (ii) goodwill, trade names, and other intangible assets; (iii) other long-lived assets; (iv) revenue recognition; (v) accruals for health, workers&#8217; compensation, and professional liability claims; (vi) valuation of deferred tax assets; (vii) legal contingencies; and (viii) income taxes. Accrued insurance claims and reserves include estimated settlements from known claims and actuarial estimates for claims incurred but not reported. As additional information becomes available to the Company, its future assessment of these estimates</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, including management's expectations at the time regarding the duration, scope, and severity of the pandemic, as well as other factors,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> could materially and adversely impact the Company's consolidated financial statements in future reporting periods. Actual results could differ from those estimates.  </span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks and Uncertainties</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s future results of operations and liquidity could be materially adversely affected by macroeconomic factors contributing to delays in payments from clients and inflationary pressure, uncertain or reduced demand, and the impact of any initiatives or programs that the Company may undertake to address financial and operational challenges faced by its clients.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company is also subject to additional risks and uncertainties due to the ongoing COVID pandemic. The extent of the impact on the Company&#8217;s business is highly uncertain and difficult to predict.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounts Receivable, net</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The timing of revenue recognition, billings, and collections results in billed and unbilled accounts receivable from customers, which are classified as accounts receivable on the condensed consolidated balance sheets and are presented net of allowances for doubtful accounts and sales allowances. Estimated revenue for the Company employees', subcontracted employees', and independent contractors&#8217; time worked but not yet billed at September 30, 2022 and December 31, 2021 totaled $161.2&#160;million and $140.0&#160;million, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generally does not require collateral and mitigates its credit risk by performing credit evaluations and monitoring at-risk accounts. The allowance for doubtful accounts is established for losses expected to be incurred on accounts receivable balances. Accounts receivable are written off against the allowance for doubtful accounts when the Company determines amounts are no longer collectible. Judgment is required in the estimation of the allowance and the Company evaluates the collectability of its accounts receivable and contract assets based on a combination of factors. The Company bases its allowance for doubtful account estimates on its historical write-off experience, current conditions, an analysis of the aging of outstanding receivable and customer payment patterns, and specific reserves for customers in adverse condition adjusted for current expectations for the customers or industry. Based on the information currently available, the Company also considered current expectations of future economic condition</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s, including the impact of COVID, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">when estimating its allowance for doubtful accounts.</span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The opening balance of the allowance for doubtful accounts is reconciled to the closing balance for expected credit losses as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,087&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,416&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bad Debt Expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,369&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-Offs, net of Recoveries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(365)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(699)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,091&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,221&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bad Debt Expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,192&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-Offs, net of Recoveries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(426)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(358)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,857&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,329&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bad Debt Expense</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,101&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,441&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-Offs, net of Recoveries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(593)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(138)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,365&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,632&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the allowance for doubtful accounts, the Company maintains a sales allowance for billing-related adjustments which may arise in the ordinary course of business and adjustments to the reserve are recorded as contra-revenue. The balance of this allowance as of September 30, 2022 and December 31, 2021 was $1.4&#160;million and $0.8&#160;million, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s contract terms typically require payment between 30 to 60 days from the date of invoice and are considered past due based on the particular negotiated contract terms. The majority of the Company's customers are U.S. based healthcare systems with a significant percentage in acute-care facilities. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No single customer accounted for more than 10% of the Company&#8217;s revenue for the three and nine months ended September 30, 2022 and 2021, or the accounts receivable balance as of September 30, 2022 and December 31, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restructuring Costs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers restructuring activities to be programs whereby it fundamentally changes its operations, such as closing and consolidating facilities, reducing headcount, and realigning operations in response to changing market conditions. As a result, restructuring (benefits) costs on the condensed consolidated statements of operations primarily include employee termination costs and lease-related exit costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reconciliation of the employee termination costs and lease-related exit costs (benefits) beginning and ending liability balance is presented below:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:50.437%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.593%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.728%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.742%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Employee Termination</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lease-Related</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,423&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charged to restructuring</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments and adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(160)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(192)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2022</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,620&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charged to restructuring</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,379)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(202)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,039&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charged to restructuring</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,755&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(254)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">911&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,540&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Restructuring costs in the condensed consolidated statements of operations for the nine months ended September 30, 2022 include a benefit of $1.4&#160;million in the second quarter of 2022 associated with the early termination of the lease for one of the Company's corporate offices which was previously restructured.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696793509744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE RECOGNITION<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">REVENUE RECOGNITION</a></td>
<td class="text">REVENUE RECOGNITION<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's revenues from customer contracts are generated from temporary staffing services and other services. Revenue is disaggregated by segment in the following table. Sales and usage-based taxes are excluded from revenue.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.961%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months ended September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nurse<br/>And Allied<br/>Staffing</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Physician<br/>Staffing</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Segments</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Temporary Staffing Services</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">592,398&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,811&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615,209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,872&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,017&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,889&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">612,270&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,828&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">636,098&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nurse<br/>And Allied<br/>Staffing</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Physician<br/>Staffing</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Segments</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Temporary Staffing Services</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347,115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,055&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365,170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,024&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">711&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,735&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356,139&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,766&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374,905&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">  Nine Months ended September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nurse<br/>And Allied<br/>Staffing</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Physician<br/>Staffing</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Segments</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Temporary Staffing Services</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,053,935&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,120,057&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,358&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,976&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,334&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,109,293&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,098&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,178,391&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> Nine Months ended September 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nurse<br/>And Allied<br/>Staffing</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Physician<br/>Staffing</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Segments</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Temporary Staffing Services</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">961,608&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,534&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,010,142&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,727&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,104&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,831&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">985,335&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,638&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,035,973&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">     </span></div>See Note 12 - Segment Data.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696791266064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">ACQUISITIONS</a></td>
<td class="text">ACQUISITIONS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selected</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 16, 2021, the Company purchased and acquired substantially all of the assets and assumed certain liabilities of Selected, Inc. (Selected) for a purchase price of $3.5&#160;million in cash, subject to adjustment, and $1.5&#160;million in shares (or 59,429 shares) of the Company's common stock. The transaction was treated as a purchase of assets for income tax purposes. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The sellers were eligible to receive up to an additional $1.5&#160;million in earnout cash consideration, based on Selected's revenues for each of the twelve-month periods ending on the first and second anniversaries of the first day after the closing date. In the </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">second quarter of 2022, the Company determined that the contingent consideration earnout related to the Selected acquisition would not be achieved for 2022 and 2023 and, as a result, the entire liability was reversed. See Note 10 - Fair Value Measurements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assigned the following values to other identifiable intangible assets: (i) an immaterial amount to trade names with a weighted average estimated useful life of 2 years; (ii) $1.7&#160;million to software with a weighted average estimated useful life of 5 years; and (iii) $2.9&#160;million to a database, consisting of education professionals, with a weighted average estimated useful life of 5 years, for a total of $4.6&#160;million in definite life intangible assets with a weighted average estimated useful life of 5 years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The remaining excess purchase price over the fair value of net assets acquired of $0.4&#160;million was recorded as goodwill on the Company's condensed consolidated balance sheets. See Note 7 - Goodwill, Trade Names, and Other Intangible Assets. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisition was not significant and has been accounted for using the acquisition method of accounting. Associated immaterial acquisition-related costs incurred have been included in acquisition and integration-related costs on the Company's condensed consolidated statements of operations for the nine months ended September 30, 2022. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cross Country Workforce Solutions Group (CCWSG)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 8, 2021, the Company purchased and acquired substantially all of the assets and assumed certain liabilities of Workforce Solutions Group, Inc. (WSG) for a purchase price of $25.0&#160;million in cash and $5.0&#160;million in shares (or 307,730 shares) of the Company's common stock. The parties agreed to a final net working capital reduction of $1.1&#160;million, which was received in the fourth quarter of 2021. The transaction was treated as a purchase of assets for income tax purposes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The sellers are also eligible to receive an earnout based on the business' performance through three years after the acquisition date that could provide up to an additional $15.0&#160;million in cash. In the third quarter of 2022, the Company determined that the contingent consideration earnout was achieved for the 2021 through 2022 period and, as a result, the Company made a $7.5&#160;million earnout payment. The remaining earnout liability's carrying amount of $7.5&#160;million is included in current portion of earnout liability on the condensed consolidated balance sheets. See Note 10 - Fair Value Measurements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value of the assets acquired and liabilities assumed on June 8, 2021:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,991&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,078&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,066&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,361&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,562&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation and benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,387&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability - current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability - non-current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">762&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnout liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities assumed</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,027&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets acquired</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,334&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assigned a value to other identifiable intangible assets of $14.2&#160;million in customer relationships with a weighted average estimated useful life of 11.5 years.</span></div>The remaining excess purchase price over the fair value of net assets acquired of $22.1&#160;million was recorded as goodwill on the Company's condensed consolidated balance sheets. See Note 7 - Goodwill, Trade Names, and Other Intangible Assets. The acquisition was not significant and has been accounted for using the acquisition method of accounting. The pro-forma impact on the Company's consolidated revenue from services and net income, including the pro forma effect of events that are directly attributable to the acquisition, was not significant.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI https://asc.fasb.org/topic&amp;trid=2303972<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4946-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696788861312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMPREHENSIVE INCOME<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">COMPREHENSIVE INCOME</a></td>
<td class="text">COMPREHENSIVE INCOME<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total comprehensive income includes net income or loss and foreign currency translation adjustments, net of any related deferred taxes, and is included within the accompanying condensed consolidated statements of operations. Certain of the Company&#8217;s foreign subsidiaries use their respective local currency as their functional currency. Assets and liabilities of these operations are translated at the exchange rates in effect on the balance sheet date. Income statement items are translated at the average exchange rates for the period. The cumulative impact of currency fluctuations related to the balance sheet translation is included in accumulated other comprehensive loss in the accompanying condensed consolidated balance sheets and was an unrealized loss of</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $1.4&#160;million at September 30, 2022 and $1.3 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> at December&#160;31, 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI https://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696794957616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">EARNINGS PER SHARE</a></td>
<td class="text">EARNINGS PER SHARE<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the components of the numerator and denominator for the computation of the basic and diluted earnings per share:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.695%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.115%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr style="height:15pt"><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(amounts in thousands, except per share data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to common stockholders - Basic and Diluted</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,793&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,433&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,670&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,429&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares - Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,963&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,593&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of diluted shares:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Share-based awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">619&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">683&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares - Diluted</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,492&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,582&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,741&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,276&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share attributable to common stockholders - Basic</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.94&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.63&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.02&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.49&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share attributable to common stockholders - Diluted</span></td><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.93&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.62&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.97&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.46&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the share-based awards that could potentially dilute net income per share attributable to common stockholders in the future that were not included in the computation of diluted net income per share attributable to common stockholders because to do so would have been anti-dilutive for the periods presented.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.699%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based awards</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696895575152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS</a></td>
<td class="text">GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had the following acquired intangible assets:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.239%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.846%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="36" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets subject to amortization:</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Databases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,430&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,530&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,738&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,649&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,089&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,738&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,581&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,430&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,902&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,059&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,843&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,572&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,228&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,344&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="36" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets not subject to amortization:</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names, indefinite-lived</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,900&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,900&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, estimated annual amortization expense was as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:80.811%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.989%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ending December&#160;31:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,020&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,051&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,399&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,840&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,632&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,901&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,843&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The changes in the carrying amount of goodwill by reportable segment are as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.447%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nurse<br/>And Allied<br/>Staffing</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Physician<br/>Staffing</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances as of December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate goodwill acquired</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396,446&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,405&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439,851&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sale of business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,889)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,889)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated impairment loss</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(269,874)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,598)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(310,472)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill, net of impairment loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,683&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,807&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,490&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Changes to aggregate goodwill in 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquisition adjustment - Selected </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,130)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,130)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances as of September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate goodwill acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390,316&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,405&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">433,721&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sale of business</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,889)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,889)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated impairment loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(269,874)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,598)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(310,472)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill, net of impairment loss</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,553&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,807&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,360&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Represents an adjustment to the fair value of the identifiable net assets acquired, with a corresponding offset to goodwill, made during the measurement period related to the acquisition of Selected. See Note 4 - Acquisitions.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Goodwill, Trade Names, and Other Intangible Assets Impairment </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company tests reporting units&#8217; goodwill and intangible assets with indefinite lives for impairment annually during the fourth quarter and more frequently if impairment indicators exist. The Company performs quarterly qualitative assessments of significant events and circumstances such as reporting units&#8217; historical and current results, assumptions regarding future performance, strategic initiatives and overall economic factors,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> including COVID,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and macro-economic developments, to determine the existence of potential indicators of impairment and assess if it is more likely than not that the fair value of reporting units or intangible assets is less than their carrying value. If indicators of impairments are identified a quantitative impairment test is performed.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2022 and 2021, the Company performed a qualitative assessment of each of its reporting units and determined it was not more likely than not that the fair value of its reporting units dropped below their carrying value. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">lthough management believes that the Company's current estimates and assumptions utilized in its qualitative testing are reasonable and supportable, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">including its assumptions on the impact and timing related to COVID,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> there can be no assurance that the estimates and assumptions management used for purposes of its qualitative assessment as of September 30, 2022 will prove to be accurate predictions of future performance.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For its long-lived assets and definite-lived intangible assets, the Company reviews for impairment whenever events or changes in circumstances indicate the carrying amount may not be recoverable. As of September 30, 2022, the Company performed a qualitative assessment of its trade names and other intangible assets and, as a result, the Company wrote off a discontinued IT project and recorded a $1.9&#160;million impairment charge. During the nine months ended September 30, 2021, the Company wrote off a discontinued software development project, resulting in an immaterial impairment charge.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI https://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696792820304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">DEBT</a></td>
<td class="text">DEBT<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's long-term debt consists of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.478%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.699%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Principal</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Debt Issuance Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Principal</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Debt Issuance Costs</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="21" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan, interest of 8.83% and 6.50% at September 30, 2022 and December 31, 2021, respectively</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,320)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174,312&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,396)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Secured Asset-Based Loan, interest of 4.58% and 1.60% at September 30, 2022 and December 31, 2021, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,642)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(991)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Note Payable, interest of 2.00% per annum at December 31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,426&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133,075&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,962)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185,938&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,387)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion - Note Payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,426&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion - Term Loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133,075&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,962)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181,762&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,387)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, the current portion of the term loan and the note payable are included in current portion of debt on the condensed consolidated balance sheets. The final installment of the note payable, related to contingent consideration assumed as part of a prior period acquisition, was paid in the first quarter of 2022. The Company has elected to present the debt issuance costs associated with its revolving line-of-credit as an asset, which is included in other non-current assets on the                                                                                                                                                                   condensed consolidated balance sheets. As a result, the long-term debt in the above table will not agree to long-term debt, net of current portion on the condensed consolidated balance sheets herein.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Late in the second quarter of 2022, the Company made an optional prepayment of $50.0&#160;million on its term loan. The Company was entitled to determine the application of the prepayment, which was applied to all future amortization payments, with the balance applied to the remaining balloon payment in 2027. As of September 30, 2022, the aggregate schedule for maturities of debt are as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.882%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.545%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Term Loan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Senior Secured Asset-Based Loan</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Through Years Ending December&#160;31:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,875&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,200&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2021 Term Loan Credit Agreement</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On June 8, 2021, the Company entered into a Term Loan Credit Agreement (Term Loan Agreement) with</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> certain lenders identified therein (collectively, the Lenders) and Wilmington Trust</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, National Association as administrative agent and collateral agent, pursuant to which the Lenders extended to the Company a six-year second lien subordinated term loan in the amount of $100.0&#160;million (term loan). The term loan has an interest rate of one-month London Inter-Bank Offered Rate (LIBOR) plus 5.75% per annum, subject to a 0.75% LIBOR floor. The term loan was used to pay the cash consideration, as well as any costs, fees, and expenses in connection with the WSG acquisition (see Note 4 - Acquisitions), with the remainder used to pay down a  portion of the asset-based credit facility. Fees paid in connection with the Term Loan Agreement have been included as debt issuance costs and as a reduction to the carrying amount of the term loan and are expected to be amortized to interest expense over the term of the Term Loan Agreement.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The borrowings under the Term Loan Agreement generally bear interest at a variable rate based on either LIBOR or Base Rate (as defined in the Term Loan Agreement) and are subject to mandatory prepayments of principal payable in quarterly installments, commencing on September 30, 2021, with each installment being in the aggregate principal amount of $0.3 million (subject to adjustment as a result of prepayments) provided that, to the extent not previously paid, the aggregate unpaid principal balance would be due and payable on the maturity date. The Term Loan Agreement contains various restrictions and covenants applicable to the Company and its subsidiaries, including a covenant to maintain a minimum net leverage ratio. The Company was in compliance with this covenant as of September 30, 2022. Obligations under the Term Loan Agreement are secured by substantially all the assets of the borrowers and guarantors under the Term Loan Agreement, subject to customary exceptions.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 18, 2021, the Company amended its Term Loan Agreement (Term Loan First Amendment), which provided the Company an incremental term loan in an aggregate amount equal to $75.0&#160;million. Additionally, the Term Loan First Amendment increased the aggregate amount of all increases (as defined in the Term Loan Agreement) to be no greater than $115.0&#160;million. The borrowings will be used primarily to fund organic growth. Commencing on December 31, 2021, installments of the mandatory prepayments will be in the aggregate principal amount of $0.4&#160;million. All other terms, conditions, covenants, and pricing of the Term Loan Agreement remain the same. In conjunction with the Term Loan First Amendment, the Company entered into the Term Loan First Amendment to the Intercreditor Agreement, effective as of November 18, 2021, which sets forth the lien priority, relative rights, and other creditors&#8217; rights issues in respect of the collateral lenders.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to its scheduled payments, on June 23, 2022, the Company made an optional prepayment of $50.0&#160;million to reduce interest costs, and paid a prepayment premium of $0.5&#160;million pursuant to the Term Loan Agreement. As a result of the early prepayment, debt issuance costs of $1.4&#160;million were written off in the three months ended June 30, 2022. The prepayment premium and the write-off of debt issuance costs are included as loss on early extinguishment of debt in the condensed consolidated statements of operations. </span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The term loan is secured by a second-priority security interest in the collateral as defined in the ABL Credit Agreement (Loan Agreement) (as described below), and Wells Fargo Bank, National Association as agent, as amended by the First Amendment, Second Amendment, Third Amendment, Fourth Amendment, and Fifth Amendment to the Loan Agreement. The lien priority, relative rights, and other creditors&#8217; rights issues in respect of the collateral lenders are set forth in the Intercreditor Agreement, by and among Wells Fargo Bank, National Association, as first lien agent, and Wilmington Trust, National Association, as second lien agent, as amended, restated, amended and restated, supplemented or otherwise modified from time to time in accordance with the terms thereof dated June 8, 2021 (Intercreditor Agreement).</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2019 Loan Agreement</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective October 25, 2019, the Company terminated its commitments under its prior senior credit facility entered into in August 2017 and entered into a Loan Agreement, by and among the Company and certain of its domestic subsidiaries, as borrowers or guarantors, Wells Fargo, PNC Bank N.A., as well as other Lenders (as defined therein) from time to time parties thereto. The Loan Agreement provides for a five-year revolving senior secured asset-based credit facility (ABL) in the aggregate principal amount of up to $120.0&#160;million (as described below), including a sublimit for swing loans up to $15.0&#160;million and a $35.0&#160;million sublimit for standby letters of credit.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 30, 2020, the Company amended its Loan Agreement (First Amendment), which increased the current aggregate committed size of the ABL from $120.0&#160;million to $130.0&#160;million. All other terms, conditions, covenants, and pricing of the Loan Agreement remained the same. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 8, 2021, the Company amended its Loan Agreement (Second Amendment), which increased the current aggregate committed size of the ABL from $130.0&#160;million to $150.0&#160;million, increased certain borrowing base sub-limits, and decreased both the cash dominion event and financial reporting triggers.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 8, 2021, the Company amended its Loan Agreement (Third Amendment), which permits the incurrence of indebtedness and grant of security as set forth in the Loan Agreement and in accordance with the Intercreditor Agreement, and provides mechanics relating to a transition away from LIBOR as a benchmark interest rate to a replacement alternative benchmark rate or mechanism for loans made in U.S. dollars.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 18, 2021, the Company amended its Loan Agreement (Fourth Amendment), whereby the permitted indebtedness (as defined in the Loan Agreement), was increased to $175.0 million.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 21, 2022, the Company amended its Loan Agreement (Fifth Amendment), which increased the current aggregate committed size of the ABL from $150.0 million to $300.0 million, extended the credit facility for an additional five years, and increased certain borrowing base sub-limits. In addition, the agreement provides the option for all or a portion of the borrowings to bear interest at a rate based on the Secured Overnight Financing Rate (SOFR) or Base Rate, at the election of the </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">borrowers, plus an applicable margin. The applicable margin will increase 10 basis points due to the credit spread associated with the transition to SOFR.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These amendments were treated as modifications of debt and, as a result, the associated fees and costs were included in debt issuance costs and will be amortized ratably over the remaining term of the Loan Agreement.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Availability of the ABL commitments is subject to a borrowing base of up to 85% of secured eligible accounts receivable, subject to adjustment at certain quality levels, minus customary reserves and subject to customary adjustments. Revolving loans and letters of credit issued under the Loan Agreement reduce availability under the ABL on a dollar-for-dollar basis. Availability under the ABL will be used for general corporate purposes. At September 30, 2022, borrowing base availability under the ABL was $300.0&#160;million and the Company had $9.2&#160;million of borrowings drawn, as well as $17.5&#160;million of letters of credit outstanding related to workers' compensation and professional liability policies, leaving $273.3&#160;million of excess availability.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2022, the interest rate spreads and fees under the Loan Agreement were based on SOFR plus 1.60% for the revolving portion of the borrowing base. The Base Rate (as defined by the Loan Agreement) margin would have been 0.50%  for the revolving portion</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The SOFR and Base Rate margins are subject to monthly pricing adjustments, pursuant to a pricing matrix based on the Company&#8217;s excess availability under the revolving credit facility. In addition, the facility is subject to an unused line fee, letter of credit fees, and an administrative fee. The unused line fee is 0.375% of the average daily unused portion of the revolving credit facility.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Loan Agreement contains various restrictions and covenants applicable to the Company and its subsidiaries, including a covenant to maintain a minimum fixed charge coverage ratio. The Company was in compliance with this covenant as of September 30, 2022. Obligations under the ABL are secured by substantially all the assets of the borrowers and guarantors, subject to customary exceptions.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696895575152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">LEASES</a></td>
<td class="text">LEASES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's lease population of its right-of-use assets and lease liabilities is substantially related to the rental of office space. The Company enters into lease agreements as a lessee that may include options to extend or terminate early. Some of these real estate leases require variable payments of property taxes, insurance, and common area maintenance, in addition to base rent. Certain of the leases have provisions for free rent months during the lease term and/or escalating rent payments and, particularly for the Company&#8217;s longer-term leases for its corporate offices, it has received incentives to enter into the leases, such as receiving up to a specified dollar amount to construct tenant improvements. These leases do not include residual value guarantees, covenants, or other restrictions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in the second quarter of 2020, in connection with the continuing developments from COVID, the Company expedited restructuring plans and either reduced or fully vacated leased office space. The Company is in the process of seeking to sublet some of the space where possible. The decision and change in the use of space resulted in a right-of-use asset impairment charge of $2.8&#160;million and $1.7&#160;million for the nine months ended September 30, 2022 and 2021, respectively. This loss was determined by comparing the fair value of the impacted right-of-use assets to the carrying value of the assets as of the impairment measurement date. The fair value of the right-of-use assets was based on the estimated sublease income for the space taking into consideration the time period it will take to obtain a subtenant, the applicable discount rate, and the sublease rate. For the nine months ended September 30, 2022 and 2021, the Company wrote off an immaterial amount of leasehold improvements and other property and equipment related to these locations. The measurement of the right-of-use asset impairments, using the assumptions described, is a Level 3 fair value measurement. See Note 10 - Fair Value Measurements for a description of Level 3 inputs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the lease-related assets and liabilities included on the condensed consolidated balance sheets:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.853%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.854%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Classification on Condensed Consolidated Balance Sheets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,249&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,488&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities - current</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,489&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,090&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities - non-current</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,493&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,853&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.853%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.854%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below reconciles the undiscounted cash flows for each of, and total of, the remaining years to the operating lease liabilities (which do not include short-term leases) recorded on the condensed consolidated balance sheets as of September 30, 2022:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:75.811%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.989%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ending December&#160;31:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">854&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,047&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,886&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total minimum lease payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,922&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amount of lease payments representing interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(940)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of future minimum lease payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,982&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: operating lease liabilities - current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,489)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities - non-current</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,493&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Information</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below provides information regarding supplemental cash flows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental Cash Flow Information:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of operating lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,446&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,692&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets acquired under operating lease</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,088&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense are as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts Included in Condensed Consolidated Statements of Operations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease expense</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">596&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">848&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease expense</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,743&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,033&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable and other lease costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,027&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts Included in Condensed Consolidated Statements of Operations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease expense</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,043&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,700&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease expense</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,523&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable and other lease costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,674&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,638&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease expense, short-term lease expense, and variable and other lease costs are included in selling, general and administrative expenses, direct operating expenses, and restructuring costs in the condensed consolidated statements of operations, depending on the nature of the leased asset. Operating lease expense is reported net of sublease income, which is not material. Variable and other lease costs for the nine months ended September 30, 2022 include a benefit associated with the early termination of a lease for one of the Company's corporate offices which was previously restructured.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2022, the Company did not have any material operating leases which had not yet commenced. The Company has an immaterial</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">amount of finance lease contracts related to other equipment rentals which are not included in the above disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696793542784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">FAIR VALUE MEASUREMENTS</a></td>
<td class="text">FAIR VALUE MEASUREMENTS<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. A fair value hierarchy was established which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. There are three levels of inputs that may be used to measure fair value:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Quoted prices in active markets for identical assets or liabilities.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Items Measured at Fair Value on a Recurring Basis:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s financial assets/liabilities required to be measured on a recurring basis were its: (i) deferred compensation asset included in other non-current assets; and (ii) deferred compensation liability included in other long-term liabilities on its condensed consolidated balance sheets.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;The Company utilizes Level 1 inputs to value its deferred compensation assets and liabilities. The Company&#8217;s deferred compensation assets and liabilities are measured using publicly available indices, as per the plan documents.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the Company&#8217;s financial assets and liabilities measured on a recurring basis is as follows:&#160;</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value Measurements</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:58.284%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.401%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.412%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.403%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Level 1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation asset</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,398&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Liabilities:</span></td><td colspan="9" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Level 1)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liability</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,317&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,457&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Items Measured at Fair Value on a Non-Recurring Basis:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's non-financial assets, such as goodwill, trade names, other intangible assets, right-of-use assets, and property and equipment, are measured at fair value when there is an indicator of impairment and are recorded at fair value only when an impairment charge is recognized. </span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The nine months ended September 30, 2022 and 2021 included impairment charges to right-of-use assets along with related property and equipment in connection with leases that were vacated. The nine months ended September 30, 2022 also included impairment charges primarily related to the write-off of a discontinued IT project in the third quarter of 2022. Accordingly, as of September 30, 2022 and 2021, these assets were recorded at fair value using Level 3 inputs. See Note 7 - Goodwill, Trade Names, and Other Intangible Assets and Note 9 - Leases for more information about these fair value measurements. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Fair Value Disclosures:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Financial instruments not measured or recorded at fair value in the condensed consolidated balance sheets consist of cash and cash equivalents, accounts receivable, and accounts payable and accrued expenses. The estimated fair value of accounts receivable and accounts payable and&#160;accrued expenses approximate their carrying amount due to the short-term nature of these instruments. Other financial instruments not measured or recorded at fair value include: (i) note payable, (ii) ABL, (iii) term loan, (iv) earnout liabilities related to the WSG acquisition, and (v) earnout liabilities related to the Selected acquisition, as discussed below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(i) The Company paid the third and final installment on its note payable in the first quarter of 2022. Due to its relatively short-term nature, the carrying value of the note payable approximated its fair value. (ii) The carrying amount of the Company's ABL approximates fair value because the interest rates are variable and reflective of market rates. (iii) The estimated fair value of the Company's term loan was calculated applying an interest rate lattice model using Level 2 inputs from available market information. (iv) Potential earnout payments related to the WSG acquisition are contingent upon meeting certain performance requirements based on 2021 through 2023 performance. The Company performed an analysis using multiple forecasted scenarios to determine the fair value of the earnout liability. In the third quarter of 2022, the Company determined that the contingent consideration earnout related to the WSG acquisition was achieved for the 2021 through 2022 period and, as a result, the Company made a $7.5&#160;million earnout payment. The remaining earnout liability's carrying amount approximates fair value and is included in current portion of earnout liability on the condensed consolidated balance sheets. See Note 4 - Acquisitions. (v) Potential earnout payments related to the Selected acquisition were contingent upon meeting certain performance requirements based on 2022 and 2023 revenues. The earnout liability's carrying amount approximates fair value and was included in current portion of earnout liability and non-current earnout liability on the condensed consolidated balance sheets. In the second quarter of 2022, the Company determined that the contingent consideration earnout related to the Selected acquisition would not be achieved for 2022 and 2023 and, as a result, the entire liability was reversed. See Note 4 - Acquisitions.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts and estimated fair value of the Company&#8217;s significant financial instruments that were not measured at fair value are as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Level 2)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Note Payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,426&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,426&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Secured Asset-Based Loan</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,200&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,200&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,200&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,200&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan, net</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,875&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,023&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174,312&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174,845&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnout Liability (WSG)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,500&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,500&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,000&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,000&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnout Liability (Selected)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentration of Credit Risk:</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See discussion of credit losses and allowance for doubtful accounts in Note 2 - Summary of Significant Accounting Policies. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Overall, based on the large number of customers in differing geographic areas, primarily throughout the United States and its territories, the Company believes the concentration of credit risk is limited.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696792295248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock', window );">STOCKHOLDERS' EQUITY</a></td>
<td class="text">STOCKHOLDERS&#8217; EQUITY<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Repurchase Program</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 16, 2022, the Company's Board of Directors authorized a new stock repurchase program (the New Repurchase Program), whereby the Company may repurchase up to $100.0&#160;million of its shares of common stock, subject to the terms of its current credit agreements. The shares may be repurchased from time-to-time in the open market or in privately negotiated transactions. The New Repurchase Program was effective immediately and may be discontinued at any time at the Board's discretion. In addition to the repurchase of $100.0&#160;million of its shares of common stock under the New Repurchase Program, the Company was authorized to continue to repurchase any remaining shares available for repurchase under the Company's previous stock repurchase program, which was approved by the Board of Directors on February 28, 2008 (the Prior Repurchase Program). Upon completion of the authorized number of shares available for repurchase under the Prior Repurchase Program, the Company commenced repurchases under the New Repurchase Program during the third quarter of 2022. During the third quarter, the Company repurchased and retired, under both the Prior Repurchase Program and the New Repurchase Program, a total of 1,014,815 shares of common stock for $24.3&#160;million, at an average market price of $23.97 per share. During the three and nine months ended September 30, 2021, the Company did not repurchase any shares of its common stock.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, the Company had $87.2&#160;million remaining for share repurchase under the New Repurchase Program, subject to certain conditions in the Company's Loan Agreement and Term Loan Agreement. At September 30, 2022, the Company had 36,508,529 unrestricted shares of common stock outstanding.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share-Based Payments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 19, 2020, the Company's stockholders approved the Cross Country Healthcare, Inc. 2020 Omnibus Incentive Plan (2020 Plan), which replaced the 2017 Omnibus Incentive Plan (2017 Plan), and applies to awards granted after May 19, 2020. The remaining shares available for grant under the 2017 Plan were cancelled and no further awards will be granted under that plan. The 2020 Plan generally mirrors the terms of the 2017 Plan and includes the following provisions: (i) an aggregate share reserve of 3,000,000 shares; (2) annual dollar and share limits of awards granted to employees and consultants, as well as non-employee directors, based on type of award; (3) awards granted generally will be subject to a minimum one-year vesting schedule; and (4) awards may be granted under the 2020 Plan until March 24, 2030.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes restricted stock awards and performance stock awards activity issued under the 2017 Plan and the 2020 Plan (Plans) for the nine months ended September&#160;30, 2022:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:42.741%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.389%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.389%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.389%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.393%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restricted Stock Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Performance Stock Awards</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant Date<br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of Target <br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant Date<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested restricted stock awards, January&#160;1, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,039,455&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.75&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522,166&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.64&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287,774&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171,873&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.94&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(575,051)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(170,278)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.03&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79,520)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47,675)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested restricted stock awards, September 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">672,658&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">476,086&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted stock awards granted under the Company&#8217;s Plans entitle the holder to receive, at the end of a vesting period, a specified number of shares of the Company&#8217;s common stock. Share-based compensation expense is measured by the market value of the Company&#8217;s stock on the date of grant. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Awards granted to non-employee directors under the 2017 Plan, prior to the adoption of the 2020 Plan, vest in three equal installments on the first, second, and third anniversaries of the grant date, while restricted shares granted under the 2020 Plan on and subsequent to June 2020 will vest on the first anniversary of such grant date, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or earlier subject to retirement eligibility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In addition, effective in the three months ended June 30, 2020, the Company implemented modified guidelines that provide for accelerated vesting of restricted stock grants on the last date of service when a retirement-eligible director retires.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Plans, the number of target shares that are issued for performance-based stock awards are determined based on the level of attainment of the targets. During the first quarter of 2022, the Company's Compensation Committee of the Board of Directors approved a 120% level of attainment for the 2019 performance-based share awards, resulting in the issuance of 170,278 performance shares that vested on March 31, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the three and nine months ended September 30, 2022, $1.5 million and $5.2&#160;million, respectively, was included in selling, general and administrative expenses related to share-based payments. During the nine months ended September 30, 2022, a net of 499,700 shares of common stock were issued upon the vesting of restricted and performance stock. No shares vested during the three months ended September 30, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and nine months ended September 30, 2021, $1.8 million and $5.3&#160;million, respectively, was included in selling, general and administrative expenses related to share-based payments, and a net of 2,576 and 479,206 shares, respectively, of common stock were issued upon the vesting of restricted stock.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696794943472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT DATA<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">SEGMENT DATA</a></td>
<td class="text">SEGMENT DATA<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s segments offer services to its customers as described below:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9679;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nurse and Allied Staffing </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211; Nurse and Allied Staffing provides traditional staffing, recruiting, and value-added total talent solutions including: temporary and permanent placement of travel and local nurse and allied professionals, managed services programs (MSP) services, education healthcare services, in-home care services, and outsourcing services. In addition, Nurse and Allied Staffing provides retained search services for healthcare professionals, as well as contingent search and recruitment process outsourcing services. Its clients include: public and private acute-care and non-acute care hospitals, government facilities, local and national healthcare plans, managed care providers, public schools and charter schools, outpatient clinics, ambulatory care facilities, physician practice groups, and many other healthcare providers throughout the United States.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9679;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Physician Staffing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Physician Staffing provides physicians in many specialties, as well as certified registered nurse anesthetists, nurse practitioners, and physician assistants as independent contractors on temporary assignments throughout the United States at various healthcare facilities, such as acute and non-acute care facilities, medical group practices, government facilities, and managed care organizations.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates performance of each segment primarily based on revenue and contribution income. The Company defines contribution income as income (loss) from operations before depreciation and amortization, acquisition and integration-related costs, restructuring (benefits) costs, legal settlement charges, impairment charges, and corporate overhead. The Company does not evaluate, manage, or measure performance of segments using asset information; accordingly, total asset information by segment is not prepared or disclosed. The information in the following table is derived from the segments&#8217; internal financial information as used for corporate management purposes. Certain corporate expenses are not allocated to and/or among the operating segments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information on operating segments and a</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reconciliation to income from operations for the periods indicated are as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.057%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.526%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from services:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nurse and Allied Staffing</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">612,270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356,139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,109,293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">985,335&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Physician Staffing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,828&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,766&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,098&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,638&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">636,098&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374,905&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,178,391&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,035,973&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution income:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nurse and Allied Staffing</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,838&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,645&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285,506&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Physician Staffing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">837&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">910&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,822&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,675&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,555&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289,328&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,246&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate overhead </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,447&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,049&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,284&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,326&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,214&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,680&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and integration-related costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">490&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">530&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">985&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,493&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,859&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,391&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,856&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,597&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,070&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,175&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,447&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221,644&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,342&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Corporate overhead includes unallocated executive leadership and other centralized corporate functional support costs such as finance, IT, legal, human resources, and marketing, as well as public company expenses and corporate-wide projects (initiatives).</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696794943472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">CONTINGENCIES</a></td>
<td class="text">CONTINGENCIES<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Legal Proceedings</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company is involved in various litigation, claims, investigations, and other proceedings that arise in the ordinary course of its business. These matters primarily relate to employee-related matters that include individual and collective claims, professional liability, tax, and payroll practices. The Company establishes reserves when available information indicates that a loss is probable and an amount or range of loss can be reasonably estimated. These assessments are performed at least quarterly and are based on the information available to management at the time and involve significant management judgment to determine the probability and estimated amount of potential losses, if any. Based on the available information considered in its reviews, the Company adjusts its loss contingency accruals and its disclosures as may be required. Actual outcomes or losses may differ materially from those estimated by the Company's current assessments, including available insurance recoveries, which would impact the Company's profitability. Adverse developments in existing litigation claims or legal proceedings involving the Company or new claims could require management to establish or increase litigation reserves or enter into unfavorable settlements or satisfy judgments for monetary damages for amounts in excess of current reserves, which could adversely affect the Company's financial results. The Company believes the outcome of any outstanding loss contingencies as of September 30, 2022 will not have a material adverse effect on its business, financial condition, results of operations, or cash flows.</span></div>Sales and Other State Non-Income Tax Liabilities The Company's sales and other state non-income tax filings are subject to routine audits by authorities in the jurisdictions where it conducts business in the United States which may result in assessments of additional taxes. The Company accrues sales and other non-income tax liabilities based on the Company's best estimate of its probable liability utilizing currently available information and interpretation of relevant tax regulations. Given the nature of the Company's business, significant subjectivity exists as to both whether sales and other state non-income taxes can be assessed on its activity and how the sales tax will ultimately be measured by the relevant jurisdictions. The Company makes a determination for each reporting period whether the estimates for sales and other non-income taxes in certain states should be revised. The expense is included in selling, general and administrative expenses in the Company's condensed consolidated statements of operations and the liability is reflected in sales tax payable within other current liabilities in its condensed consolidated balance sheets.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696794943472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text">INCOME TAXES<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended September 30, 2022, the Company calculated its effective tax rate estimating its annual effective tax rate, as opposed to the three and nine months ended September 30, 2021 whereby the Company calculated its effective tax rate based on year-to-date results. The Company&#8217;s effective tax rate for the three and nine months ended September 30, 2022 was 28.6% and 28.7%, respectively, including the impact of discrete items, and 28.6% and 29.3%, respectively, excluding discrete items. The Company's effective tax rate for the three and nine months ended September 30, 2021 was 4.9% and 9.1%, respectively, including the impact of discrete items, and 4.9% and 5.9%, respectively, excluding discrete items. The effective tax rate for the three and nine months ended September 30, 2022 was primarily impacted by federal and state taxes. As a result of the Company's valuation allowance on substantially all of its domestic deferred tax assets, the effective tax rate for the three and nine months ended September 30, 2021 was primarily impacted by international taxes and state taxes, while the effective tax rate for the nine months ended September 30, 2021 was also impacted by additional valuation allowance required as a result of the WSG acquisition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2021, the Company concluded that it was more likely than not that a benefit from a substantial portion of its United States federal and state deferred tax assets would be realized and released the majority of its valuation allowance. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, the Company had an immaterial amount of valuation allowance on its deferred tax assets related to state net operating losses not expected to be realized before expiration. There was no valuation allowance related to state net operating losses as of September 30, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 16, 2022, President Biden signed the Inflation Reduction Act (the IRA) into law in the U.S. Among other changes, the IRA introduced an excise tax on certain stock repurchases by certain covered corporations for taxable years beginning after December 31, 2022. Based on its current estimates and pending future guidance to be issued by the Internal Revenue Service, the Company does not believe these provisions will have a material impact on its consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax years 2012 through 2021 remain open to examination by certain taxing jurisdictions to which the Company is subject to tax.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696794943472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">RELATED PARTY TRANSACTIONS</a></td>
<td class="text">RELATED PARTY TRANSACTIONS<div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company has entered into an arrangement for digital marketing services provided by a firm that is related to Mr. Clark, the Company's non-executive Chairman of the Board of Directors since April 1, 2022, and the Company's Co-Founder &amp; Chief Executive Officer through March 31, 2022. Mr. Clark is a minority shareholder in the firm's parent company and is a member of the parent company's Board of Directors. Management believes the terms of the arrangement are equivalent to those prevailing in an arm's-length transaction and have been approved by the Company through its related party process. The digital marketing firm manages a limited number of digital publishers covering various Company brands for a monthly management fee. During the three and nine months ended September 30, 2022 and 2021, the Company incurred an immaterial amount in expenses. The Company had immaterial payable balances at September 30, 2022 and December 31, 2021.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides services to entities which are affiliated with certain members of the Company&#8217;s Board of Directors. Management believes the services were conducted on terms equivalent to those prevailing in an arm's-length transaction. Revenue related to these transactions was $0.7&#160;million and $1.5 million for the three and nine months ended September 30, 2022, respectively, and an immaterial amount for the three and nine months ended September 30, 2021. Accounts receivable due from these entities was an immaterial amount at September 30, 2022 and December 31, 2021.</span></div>Following the WSG acquisition on June 8, 2021, the Company continued to rent WSG's headquarters. The Chief Executive Officer and Founder of WSG, who is currently a business unit president with the Company, is an agent of the lessor. The lease term for WSG's headquarters expires on December 31, 2024. The Company paid an immaterial amount in rent expense for these premises for the three and nine months ended September 30, 2022 and the three months ended September 30, 2021. The Company had no payable balance at September 30, 2022 and December 31, 2021.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI https://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696793507760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RECENT ACCOUNTING PRONOUNCEMENTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>Accounting Standards Update and Change in Accounting Principle [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">RECENT ACCOUNTING PRONOUNCEMENTS</a></td>
<td class="text">RECENT ACCOUNTING PRONOUNCEMENTS<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 28, 2021, the FASB issued ASU No. 2021-08, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which requires contract assets and contract liabilities such as deferred revenue acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, Revenue from Contracts with Customers. Generally, this amendment will result in the acquirer recognizing contract assets and contract liabilities at the same amounts recorded by the acquiree. Historically such amounts were recognized by the acquirer at fair value in acquisition accounting. This guidance is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The amendments should be applied prospectively to business combinations occurring on or after the effective date of the amendments. Early adoption is permitted, including adoption in an interim period. The Company is currently in the process of evaluating this standard and expects to adopt this standard in its first quarter of 2023.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI https://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 11.M.Q2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038215&amp;loc=d3e31137-122693<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL122150809-237846<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=122038215&amp;loc=SL108384541-122693<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL126732908-238011<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (f)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL126732908-238011<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL126732908-238011<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696792377872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text">SUBSEQUENT EVENTS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 3, 2022, the Company completed the acquisition of substantially all of the assets and certain liabilities of Mint Medical Physician Staffing, LP (Mint) and Lotus Medical Staffing LLC (Lotus). Mint and Lotus place healthcare professionals in locum tenens positions throughout the country. The purchase price of the acquisition was paid for with a proportional combination of cash and shares of the Company's common stock. The acquisition was not significant to the Company's condensed consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt Prepayment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 26, 2022, the Company made an optional prepayment on its term loan, resulting in a prepayment premium and the write-off of debt issuance costs. The prepayment was applied to the remaining balloon payment in 2027.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI https://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696785758480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Nature of Business</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nature of Business</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements include the accounts of Cross Country Healthcare, Inc. and its direct and indirect wholly-owned subsidiaries (collectively, the Company). In the opinion of management, all adjustments necessary for a fair presentation of such unaudited condensed consolidated financial statements have been included. All such adjustments consisted of all normal recurring items, including the elimination of all intercompany transactions and balances.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cross Country Talent Acquisition Group, LLC was a joint venture controlled but not wholly-owned by the Company. Effective December 31, 2020, the sole professional staffing services agreement held by this joint venture was terminated and, as a result, the Company dissolved Cross Country Talent Acquisition Group, LLC in the third quarter of 2021.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Accounting</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (U.S. GAAP) for interim financial information and with the instructions to Form&#160;10-Q and Article 10 of Regulation&#160;S-X. Accordingly, they do not include all of the information and notes required by U.S. GAAP for complete financial statements. These operating results are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These unaudited interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended December 31, 2021 included in the 2021 Form 10-K. The December&#160;31, 2021 condensed consolidated balance sheet included herein was derived from the December&#160;31, 2021 audited consolidated balance sheet included in the 2021 Form&#160;10-K.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text">Use of Estimates<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts in the condensed consolidated financial statements and accompanying notes. Management has assessed various accounting estimates and other matters, including those that require consideration of forecasted financial information, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in context of the unknown future impacts of the global COVID pandemic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> using information that is reasonably available to the Company at the time. Significant estimates and assumptions are used for, but not limited to: (i) the valuation of accounts receivable; (ii) goodwill, trade names, and other intangible assets; (iii) other long-lived assets; (iv) revenue recognition; (v) accruals for health, workers&#8217; compensation, and professional liability claims; (vi) valuation of deferred tax assets; (vii) legal contingencies; and (viii) income taxes. Accrued insurance claims and reserves include estimated settlements from known claims and actuarial estimates for claims incurred but not reported. As additional information becomes available to the Company, its future assessment of these estimates</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, including management's expectations at the time regarding the duration, scope, and severity of the pandemic, as well as other factors,</span> could materially and adversely impact the Company's consolidated financial statements in future reporting periods. Actual results could differ from those estimates.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ccrn_RisksAndUncertaintiesPolicyTextBlock', window );">Risks and Uncertainties</a></td>
<td class="text"><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks and Uncertainties</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s future results of operations and liquidity could be materially adversely affected by macroeconomic factors contributing to delays in payments from clients and inflationary pressure, uncertain or reduced demand, and the impact of any initiatives or programs that the Company may undertake to address financial and operational challenges faced by its clients.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company is also subject to additional risks and uncertainties due to the ongoing COVID pandemic. The extent of the impact on the Company&#8217;s business is highly uncertain and difficult to predict.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy', window );">Accounts Receivable, net</a></td>
<td class="text"><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounts Receivable, net</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The timing of revenue recognition, billings, and collections results in billed and unbilled accounts receivable from customers, which are classified as accounts receivable on the condensed consolidated balance sheets and are presented net of allowances for doubtful accounts and sales allowances. Estimated revenue for the Company employees', subcontracted employees', and independent contractors&#8217; time worked but not yet billed at September 30, 2022 and December 31, 2021 totaled $161.2&#160;million and $140.0&#160;million, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generally does not require collateral and mitigates its credit risk by performing credit evaluations and monitoring at-risk accounts. The allowance for doubtful accounts is established for losses expected to be incurred on accounts receivable balances. Accounts receivable are written off against the allowance for doubtful accounts when the Company determines amounts are no longer collectible. Judgment is required in the estimation of the allowance and the Company evaluates the collectability of its accounts receivable and contract assets based on a combination of factors. The Company bases its allowance for doubtful account estimates on its historical write-off experience, current conditions, an analysis of the aging of outstanding receivable and customer payment patterns, and specific reserves for customers in adverse condition adjusted for current expectations for the customers or industry. Based on the information currently available, the Company also considered current expectations of future economic condition</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s, including the impact of COVID, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">when estimating its allowance for doubtful accounts.</span></div>In addition to the allowance for doubtful accounts, the Company maintains a sales allowance for billing-related adjustments which may arise in the ordinary course of business and adjustments to the reserve are recorded as contra-revenue. The balance of this allowance as of September 30, 2022 and December 31, 2021 was $1.4&#160;million and $0.8&#160;million, respectively.The Company&#8217;s contract terms typically require payment between 30 to 60 days from the date of invoice and are considered past due based on the particular negotiated contract terms. The majority of the Company's customers are U.S. based healthcare systems with a significant percentage in acute-care facilities.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock', window );">Restructuring Costs</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restructuring Costs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers restructuring activities to be programs whereby it fundamentally changes its operations, such as closing and consolidating facilities, reducing headcount, and realigning operations in response to changing market conditions. As a result, restructuring (benefits) costs on the condensed consolidated statements of operations primarily include employee termination costs and lease-related exit costs.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Accounting Pronouncement</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 28, 2021, the FASB issued ASU No. 2021-08, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which requires contract assets and contract liabilities such as deferred revenue acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, Revenue from Contracts with Customers. Generally, this amendment will result in the acquirer recognizing contract assets and contract liabilities at the same amounts recorded by the acquiree. Historically such amounts were recognized by the acquirer at fair value in acquisition accounting. This guidance is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The amendments should be applied prospectively to business combinations occurring on or after the effective date of the amendments. Early adoption is permitted, including adoption in an interim period. The Company is currently in the process of evaluating this standard and expects to adopt this standard in its first quarter of 2023.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_RisksAndUncertaintiesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Risks And Uncertainties</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_RisksAndUncertaintiesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and reporting costs associated with exiting, disposing of, and restructuring certain operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e4975-111524<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5212-111524<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953423-111524<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5093-111524<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5033-111524<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696793771536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock', window );">Schedule of Allowance for Doubtful Accounts</a></td>
<td class="text"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The opening balance of the allowance for doubtful accounts is reconciled to the closing balance for expected credit losses as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,087&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,416&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bad Debt Expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,369&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-Offs, net of Recoveries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(365)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(699)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,091&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,221&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bad Debt Expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,192&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-Offs, net of Recoveries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(426)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(358)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,857&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,329&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bad Debt Expense</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,101&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,441&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-Offs, net of Recoveries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(593)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(138)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,365&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,632&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Schedule of Restructuring and Related Costs</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reconciliation of the employee termination costs and lease-related exit costs (benefits) beginning and ending liability balance is presented below:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:50.437%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.593%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.728%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.742%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Employee Termination</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lease-Related</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,423&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charged to restructuring</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments and adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(160)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(192)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2022</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,620&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charged to restructuring</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,379)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(202)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,039&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charged to restructuring</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,755&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(254)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">911&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,540&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Restructuring costs in the condensed consolidated statements of operations for the nine months ended September 30, 2022 include a benefit of $1.4&#160;million in the second quarter of 2022 associated with the early termination of the lease for one of the Company's corporate offices which was previously restructured.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696791333664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE RECOGNITION (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of Disaggregation of Revenue</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's revenues from customer contracts are generated from temporary staffing services and other services. Revenue is disaggregated by segment in the following table. Sales and usage-based taxes are excluded from revenue.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.961%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months ended September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nurse<br/>And Allied<br/>Staffing</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Physician<br/>Staffing</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Segments</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Temporary Staffing Services</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">592,398&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,811&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615,209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,872&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,017&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,889&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">612,270&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,828&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">636,098&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nurse<br/>And Allied<br/>Staffing</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Physician<br/>Staffing</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Segments</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Temporary Staffing Services</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347,115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,055&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365,170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,024&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">711&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,735&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356,139&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,766&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374,905&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">  Nine Months ended September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nurse<br/>And Allied<br/>Staffing</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Physician<br/>Staffing</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Segments</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Temporary Staffing Services</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,053,935&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,120,057&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,358&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,976&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,334&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,109,293&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,098&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,178,391&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> Nine Months ended September 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nurse<br/>And Allied<br/>Staffing</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Physician<br/>Staffing</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Segments</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Temporary Staffing Services</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">961,608&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,534&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,010,142&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,727&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,104&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,831&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">985,335&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,638&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,035,973&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696880011152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Summary of Fair Value of Assets Acquired and Liabilities Assumed</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value of the assets acquired and liabilities assumed on June 8, 2021:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,991&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,078&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,066&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,361&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,562&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation and benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,387&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability - current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability - non-current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">762&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnout liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities assumed</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,027&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets acquired</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,334&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696793603520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Components of Numerator and Denominator for Computation of Basic and Diluted Earnings per Share</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the components of the numerator and denominator for the computation of the basic and diluted earnings per share:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.695%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.115%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr style="height:15pt"><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(amounts in thousands, except per share data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to common stockholders - Basic and Diluted</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,793&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,433&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,670&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,429&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares - Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,963&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,593&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of diluted shares:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Share-based awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">619&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">683&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares - Diluted</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,492&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,582&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,741&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,276&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share attributable to common stockholders - Basic</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.94&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.63&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.02&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.49&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share attributable to common stockholders - Diluted</span></td><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.93&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.62&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.97&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.46&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the share-based awards that could potentially dilute net income per share attributable to common stockholders in the future that were not included in the computation of diluted net income per share attributable to common stockholders because to do so would have been anti-dilutive for the periods presented.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.699%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based awards</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696789438960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Schedule of Acquired Intangible Assets</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had the following acquired intangible assets:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.239%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.846%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="36" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets subject to amortization:</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Databases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,430&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,530&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,738&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,649&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,089&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,738&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,581&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,430&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,902&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,059&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,843&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,572&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,228&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,344&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="36" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets not subject to amortization:</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names, indefinite-lived</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,900&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,900&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Estimated Annual Amortization Expense</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, estimated annual amortization expense was as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:80.811%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.989%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ending December&#160;31:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,020&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,051&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,399&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,840&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,632&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,901&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,843&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Changes in Carrying Amount of Goodwill by Segment</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The changes in the carrying amount of goodwill by reportable segment are as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.447%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nurse<br/>And Allied<br/>Staffing</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Physician<br/>Staffing</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances as of December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate goodwill acquired</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396,446&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,405&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439,851&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sale of business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,889)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,889)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated impairment loss</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(269,874)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,598)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(310,472)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill, net of impairment loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,683&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,807&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,490&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Changes to aggregate goodwill in 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquisition adjustment - Selected </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,130)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,130)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances as of September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate goodwill acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390,316&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,405&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">433,721&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sale of business</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,889)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,889)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated impairment loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(269,874)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,598)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(310,472)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill, net of impairment loss</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,553&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,807&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,360&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Represents an adjustment to the fair value of the identifiable net assets acquired, with a corresponding offset to goodwill, made during the measurement period related to the acquisition of Selected. See Note 4 - Acquisitions.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=SL108378252-109267<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696793609232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Long-term Debt</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's long-term debt consists of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.478%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.699%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Principal</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Debt Issuance Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Principal</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Debt Issuance Costs</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="21" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan, interest of 8.83% and 6.50% at September 30, 2022 and December 31, 2021, respectively</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,320)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174,312&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,396)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Secured Asset-Based Loan, interest of 4.58% and 1.60% at September 30, 2022 and December 31, 2021, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,642)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(991)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Note Payable, interest of 2.00% per annum at December 31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,426&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133,075&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,962)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185,938&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,387)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion - Note Payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,426&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion - Term Loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133,075&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,962)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181,762&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,387)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Aggregate Scheduled Maturities of Debt</a></td>
<td class="text">As of September 30, 2022, the aggregate schedule for maturities of debt are as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.882%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.545%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Term Loan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Senior Secured Asset-Based Loan</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Through Years Ending December&#160;31:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,875&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,200&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696786782416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ccrn_AssetsAndLiabilitiesLeasesTableTextBlock', window );">Schedule of Supplemental Balance Sheet Information</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the lease-related assets and liabilities included on the condensed consolidated balance sheets:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.853%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.854%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Classification on Condensed Consolidated Balance Sheets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,249&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,488&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities - current</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,489&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,090&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities - non-current</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,493&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,853&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.853%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.854%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Operating Lease Maturity</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below reconciles the undiscounted cash flows for each of, and total of, the remaining years to the operating lease liabilities (which do not include short-term leases) recorded on the condensed consolidated balance sheets as of September 30, 2022:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:75.811%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.989%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ending December&#160;31:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">854&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,047&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,886&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total minimum lease payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,922&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amount of lease payments representing interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(940)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of future minimum lease payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,982&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: operating lease liabilities - current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,489)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities - non-current</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,493&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Lease Costs</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below provides information regarding supplemental cash flows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental Cash Flow Information:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of operating lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,446&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,692&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets acquired under operating lease</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,088&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense are as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts Included in Condensed Consolidated Statements of Operations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease expense</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">596&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">848&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease expense</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,743&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,033&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable and other lease costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,027&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts Included in Condensed Consolidated Statements of Operations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease expense</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,043&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,700&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease expense</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,523&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable and other lease costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,674&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,638&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_AssetsAndLiabilitiesLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Assets And Liabilities, Leases [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_AssetsAndLiabilitiesLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696793585088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Estimated Fair Values of Financial Assets and Liabilities Measured on a Recurring Basis</a></td>
<td class="text">The estimated fair value of the Company&#8217;s financial assets and liabilities measured on a recurring basis is as follows:&#160;<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value Measurements</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:58.284%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.401%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.412%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.403%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Level 1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation asset</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,398&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Liabilities:</span></td><td colspan="9" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Level 1)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liability</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,317&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,457&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Schedule of Carrying Amounts and Estimated Fair Values of Significant Financial Instrument that were not Measured at Fair Value</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts and estimated fair value of the Company&#8217;s significant financial instruments that were not measured at fair value are as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Level 2)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Note Payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,426&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,426&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Secured Asset-Based Loan</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,200&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,200&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,200&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,200&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan, net</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,875&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,023&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174,312&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174,845&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnout Liability (WSG)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,500&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,500&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,000&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,000&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnout Liability (Selected)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13467-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696789547840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock', window );">Summary of Restricted Stock Activity</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes restricted stock awards and performance stock awards activity issued under the 2017 Plan and the 2020 Plan (Plans) for the nine months ended September&#160;30, 2022:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:42.741%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.389%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.389%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.389%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.393%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restricted Stock Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Performance Stock Awards</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant Date<br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of Target <br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant Date<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested restricted stock awards, January&#160;1, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,039,455&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.75&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522,166&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.64&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287,774&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171,873&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.94&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(575,051)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(170,278)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.03&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79,520)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47,675)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested restricted stock awards, September 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">672,658&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">476,086&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696788846304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT DATA (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock', window );">Schedule of Information on Operating Segments and Reconciliation to Income from Operations</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information on operating segments and a</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reconciliation to income from operations for the periods indicated are as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.057%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.526%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from services:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nurse and Allied Staffing</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">612,270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356,139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,109,293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">985,335&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Physician Staffing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,828&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,766&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,098&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,638&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">636,098&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374,905&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,178,391&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,035,973&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution income:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nurse and Allied Staffing</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,838&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,645&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285,506&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Physician Staffing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">837&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">910&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,822&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,675&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,555&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289,328&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,246&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate overhead </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,447&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,049&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,284&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,326&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,214&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,680&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and integration-related costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">490&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">530&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">985&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,493&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,859&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,391&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,856&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,597&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,070&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,175&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,447&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221,644&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,342&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Corporate overhead includes unallocated executive leadership and other centralized corporate functional support costs such as finance, IT, legal, human resources, and marketing, as well as public company expenses and corporate-wide projects (initiatives).</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696789916208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnbilledContractsReceivable', window );">Unbilled contracts receivable</a></td>
<td class="nump">$ 161.2<span></span>
</td>
<td class="nump">$ 140.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ccrn_SalesAllowanceBillingRelatedAdjustments', window );">Sales allowance, billing-related adjustments</a></td>
<td class="nump">$ 1.4<span></span>
</td>
<td class="nump">$ 0.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ccrn_ThresholdPeriodPastDueForPaymentOfServicesProvided', window );">Threshold period, past due for payment of services provided</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ccrn_ThresholdPeriodPastDueForPaymentOfServicesProvided', window );">Threshold period, past due for payment of services provided</a></td>
<td class="text">60 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_SalesAllowanceBillingRelatedAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sales Allowance, Billing-Related Adjustments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_SalesAllowanceBillingRelatedAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_ThresholdPeriodPastDueForPaymentOfServicesProvided">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Threshold Period, Past Due For Payment Of Services Provided</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_ThresholdPeriodPastDueForPaymentOfServicesProvided</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnbilledContractsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unbilled amounts due for services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the entity and, at a minimum, one other party. An example would be amounts associated with contracts or programs where the recognized revenue for performance thereunder exceeds the amounts billed under the terms thereof as of the date of the balance sheet.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126938201&amp;loc=d3e55302-109406<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnbilledContractsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696789590000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Allowance for Doubtful Accounts (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="6">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward', window );"><strong>Accounts Receivable, Allowance for Credit Loss [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Beginning balance</a></td>
<td class="nump">$ 10,857<span></span>
</td>
<td class="nump">$ 8,091<span></span>
</td>
<td class="nump">$ 6,087<span></span>
</td>
<td class="nump">$ 3,329<span></span>
</td>
<td class="nump">$ 3,221<span></span>
</td>
<td class="nump">$ 3,416<span></span>
</td>
<td class="nump">$ 6,087<span></span>
</td>
<td class="nump">$ 3,416<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Bad Debt Expense</a></td>
<td class="nump">1,101<span></span>
</td>
<td class="nump">3,192<span></span>
</td>
<td class="nump">2,369<span></span>
</td>
<td class="nump">1,441<span></span>
</td>
<td class="nump">466<span></span>
</td>
<td class="nump">504<span></span>
</td>
<td class="nump">6,662<span></span>
</td>
<td class="nump">2,411<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs', window );">Write-Offs, net of Recoveries</a></td>
<td class="num">(593)<span></span>
</td>
<td class="num">(426)<span></span>
</td>
<td class="num">(365)<span></span>
</td>
<td class="num">(138)<span></span>
</td>
<td class="num">(358)<span></span>
</td>
<td class="num">(699)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Ending balance</a></td>
<td class="nump">$ 11,365<span></span>
</td>
<td class="nump">$ 10,857<span></span>
</td>
<td class="nump">$ 8,091<span></span>
</td>
<td class="nump">$ 4,632<span></span>
</td>
<td class="nump">$ 3,329<span></span>
</td>
<td class="nump">$ 3,221<span></span>
</td>
<td class="nump">$ 11,365<span></span>
</td>
<td class="nump">$ 4,632<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of direct write-downs of accounts receivable charged against the allowance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696790889168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Restructuring (Benefits) Costs (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charged to restructuring</a></td>
<td class="nump">$ 2,493<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 318<span></span>
</td>
<td class="nump">$ 1,859<span></span>
</td>
<td class="nump">$ 2,391<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Early termination benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Employee Termination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance at beginning of period</a></td>
<td class="nump">200<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charged to restructuring</a></td>
<td class="nump">735<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ccrn_PaymentsForRestructuringAndAdjustments', window );">Payments and adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(160)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments</a></td>
<td class="num">(24)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance at end of period</a></td>
<td class="nump">911<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">911<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=ccrn_ExitCostsMember', window );">Lease-Related</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance at beginning of period</a></td>
<td class="nump">1,039<span></span>
</td>
<td class="nump">2,620<span></span>
</td>
<td class="nump">2,423<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,423<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charged to restructuring</a></td>
<td class="nump">1,755<span></span>
</td>
<td class="num">(1,379)<span></span>
</td>
<td class="nump">389<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ccrn_PaymentsForRestructuringAndAdjustments', window );">Payments and adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(192)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments</a></td>
<td class="num">(254)<span></span>
</td>
<td class="num">(202)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance at end of period</a></td>
<td class="nump">$ 2,540<span></span>
</td>
<td class="nump">$ 1,039<span></span>
</td>
<td class="nump">$ 2,620<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,540<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_PaymentsForRestructuringAndAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments For Restructuring And Adjustments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_PaymentsForRestructuringAndAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessExitCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Includes, but is not limited to, one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and termination benefits associated with an ongoing benefit arrangement. Excludes expenses associated with special or contractual termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessExitCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=ccrn_ExitCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=ccrn_ExitCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696789535328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE RECOGNITION (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from services</a></td>
<td class="nump">$ 636,098<span></span>
</td>
<td class="nump">$ 374,905<span></span>
</td>
<td class="nump">$ 2,178,391<span></span>
</td>
<td class="nump">$ 1,035,973<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ccrn_TemporaryStaffingServicesMember', window );">Temporary Staffing Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from services</a></td>
<td class="nump">615,209<span></span>
</td>
<td class="nump">365,170<span></span>
</td>
<td class="nump">2,120,057<span></span>
</td>
<td class="nump">1,010,142<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ccrn_OtherServicesMember', window );">Other Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from services</a></td>
<td class="nump">20,889<span></span>
</td>
<td class="nump">9,735<span></span>
</td>
<td class="nump">58,334<span></span>
</td>
<td class="nump">25,831<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_NurseAndAlliedStaffingMember', window );">Nurse And Allied Staffing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from services</a></td>
<td class="nump">612,270<span></span>
</td>
<td class="nump">356,139<span></span>
</td>
<td class="nump">2,109,293<span></span>
</td>
<td class="nump">985,335<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_NurseAndAlliedStaffingMember', window );">Nurse And Allied Staffing | Temporary Staffing Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from services</a></td>
<td class="nump">592,398<span></span>
</td>
<td class="nump">347,115<span></span>
</td>
<td class="nump">2,053,935<span></span>
</td>
<td class="nump">961,608<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_NurseAndAlliedStaffingMember', window );">Nurse And Allied Staffing | Other Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from services</a></td>
<td class="nump">19,872<span></span>
</td>
<td class="nump">9,024<span></span>
</td>
<td class="nump">55,358<span></span>
</td>
<td class="nump">23,727<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_PhysicianStaffingMember', window );">Physician Staffing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from services</a></td>
<td class="nump">23,828<span></span>
</td>
<td class="nump">18,766<span></span>
</td>
<td class="nump">69,098<span></span>
</td>
<td class="nump">50,638<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_PhysicianStaffingMember', window );">Physician Staffing | Temporary Staffing Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from services</a></td>
<td class="nump">22,811<span></span>
</td>
<td class="nump">18,055<span></span>
</td>
<td class="nump">66,122<span></span>
</td>
<td class="nump">48,534<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_PhysicianStaffingMember', window );">Physician Staffing | Other Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from services</a></td>
<td class="nump">$ 1,017<span></span>
</td>
<td class="nump">$ 711<span></span>
</td>
<td class="nump">$ 2,976<span></span>
</td>
<td class="nump">$ 2,104<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ccrn_TemporaryStaffingServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ccrn_TemporaryStaffingServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ccrn_OtherServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ccrn_OtherServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_NurseAndAlliedStaffingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ccrn_NurseAndAlliedStaffingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_PhysicianStaffingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ccrn_PhysicianStaffingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696786800944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 16, 2021</div></th>
<th class="th"><div>Jun. 08, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 113,360<span></span>
</td>
<td class="nump">$ 119,490<span></span>
</td>
<td class="nump">$ 113,360<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities', window );">Payment of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,500<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent', window );">Current portion of earnout liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,500<span></span>
</td>
<td class="nump">7,500<span></span>
</td>
<td class="nump">7,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ccrn_SelectedIncMember', window );">Selected, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash consideration, gross</a></td>
<td class="nump">$ 3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Equity consideration for acquisition, value</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Equity consideration for acquisition (shares)</a></td>
<td class="nump">59,429<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Earnout liabilities</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Other intangible assets</a></td>
<td class="nump">$ 4,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average useful life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ccrn_SelectedIncMember', window );">Selected, Inc | Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Other intangible assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average useful life</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ccrn_SelectedIncMember', window );">Selected, Inc | Software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Other intangible assets</a></td>
<td class="nump">$ 1,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average useful life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ccrn_SelectedIncMember', window );">Selected, Inc | Databases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Other intangible assets</a></td>
<td class="nump">$ 2,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average useful life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ccrn_WorkforceSolutionsGroupIncMember', window );">Workforce Solutions Group, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash consideration, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Equity consideration for acquisition, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Equity consideration for acquisition (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">307,730<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Earnout liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Other intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,066<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment', window );">Net working capital adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ccrn_BusinessCombinationContingentConsiderationTerm', window );">Contingent consideration liability, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities', window );">Payment of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent', window );">Current portion of earnout liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ccrn_WorkforceSolutionsGroupIncMember', window );">Workforce Solutions Group, Inc. | Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Other intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">11 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Net Working Capital Adjustment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_BusinessCombinationContingentConsiderationTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_BusinessCombinationContingentConsiderationTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ccrn_SelectedIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ccrn_SelectedIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DatabasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DatabasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ccrn_WorkforceSolutionsGroupIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ccrn_WorkforceSolutionsGroupIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696789464112">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACQUISITIONS - Recognized Identified Assets Acquired and Liabilities Assumed (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jun. 08, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 113,360<span></span>
</td>
<td class="nump">$ 119,490<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ccrn_WorkforceSolutionsGroupIncMember', window );">Workforce Solutions Group, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 957<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,991<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther', window );">Other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets', window );">Right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,078<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,066<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Other intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,200<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill', window );">Total assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,361<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable and accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,562<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensationAndBenefits', window );">Accrued compensation and benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,387<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationCurrent', window );">Lease liability - current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">316<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationNoncurrent', window );">Lease liability - non-current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">762<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability', window );">Earnout liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Total liabilities assumed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,027<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Net assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29,334<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensationAndBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Accrued Compensation And Benefits</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensationAndBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired Including Goodwill</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right-Of-Use Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liability arising from an inherited contingency (as defined) which has been recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ccrn_WorkforceSolutionsGroupIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ccrn_WorkforceSolutionsGroupIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696787306928">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>COMPREHENSIVE INCOME (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ccrn_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax', window );">Loss on currency fluctuations</a></td>
<td class="nump">$ 1.4<span></span>
</td>
<td class="nump">$ 1.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Before Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696787259360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE - Components of Numerator and Denominator for Computation of Basic and Diluted Earnings per Share (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net income attributable to common stockholders - Basic and Diluted - Basic</a></td>
<td class="nump">$ 34,793<span></span>
</td>
<td class="nump">$ 23,433<span></span>
</td>
<td class="nump">$ 149,670<span></span>
</td>
<td class="nump">$ 54,429<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Net income attributable to common stockholders - Basic and Diluted - Diluted</a></td>
<td class="nump">$ 34,793<span></span>
</td>
<td class="nump">$ 23,433<span></span>
</td>
<td class="nump">$ 149,670<span></span>
</td>
<td class="nump">$ 54,429<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares - Basic (shares)</a></td>
<td class="nump">37,101<span></span>
</td>
<td class="nump">36,963<span></span>
</td>
<td class="nump">37,200<span></span>
</td>
<td class="nump">36,593<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Effect of diluted shares:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Share-based awards (shares)</a></td>
<td class="nump">391<span></span>
</td>
<td class="nump">619<span></span>
</td>
<td class="nump">541<span></span>
</td>
<td class="nump">683<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares - Diluted (shares)</a></td>
<td class="nump">37,492<span></span>
</td>
<td class="nump">37,582<span></span>
</td>
<td class="nump">37,741<span></span>
</td>
<td class="nump">37,276<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net income per share attributable to common stockholders - Basic (in dollars per share)</a></td>
<td class="nump">$ 0.94<span></span>
</td>
<td class="nump">$ 0.63<span></span>
</td>
<td class="nump">$ 4.02<span></span>
</td>
<td class="nump">$ 1.49<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net income per share attributable to common stockholders - Diluted (in dollars per share)</a></td>
<td class="nump">$ 0.93<span></span>
</td>
<td class="nump">$ 0.62<span></span>
</td>
<td class="nump">$ 3.97<span></span>
</td>
<td class="nump">$ 1.46<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126962052&amp;loc=d3e4991-113900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1707-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1500-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696788862848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE - Anti-dilutive Securities (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ccrn_ShareBasedPaymentAwardsMember', window );">Share-based Payment Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Shares excluded from diluted weighted average shares (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">73<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ccrn_ShareBasedPaymentAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ccrn_ShareBasedPaymentAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696789789088">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS - Acquired Intangible Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Intangible assets subject to amortization:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 82,902<span></span>
</td>
<td class="nump">$ 78,572<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">42,059<span></span>
</td>
<td class="nump">36,228<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">40,843<span></span>
</td>
<td class="nump">42,344<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract', window );"><strong>Intangible assets not subject to amortization:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedTradeNames', window );">Trade names, indefinite-lived</a></td>
<td class="nump">5,900<span></span>
</td>
<td class="nump">5,900<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DatabasesMember', window );">Databases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Intangible assets subject to amortization:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">33,430<span></span>
</td>
<td class="nump">30,530<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">21,125<span></span>
</td>
<td class="nump">18,375<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">12,305<span></span>
</td>
<td class="nump">12,155<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Intangible assets subject to amortization:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">47,738<span></span>
</td>
<td class="nump">47,738<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">20,649<span></span>
</td>
<td class="nump">17,581<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">27,089<span></span>
</td>
<td class="nump">30,157<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-compete agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Intangible assets subject to amortization:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">304<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">272<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Intangible assets subject to amortization:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareDevelopmentMember', window );">Software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Intangible assets subject to amortization:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">1,700<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">270<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 1,430<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedTradeNames">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the rights acquired through registration of a trade name to gain or protect exclusive use thereof for a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedTradeNames</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DatabasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DatabasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696787366464">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS - Estimated Annual Amortization Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">2022</a></td>
<td class="nump">$ 2,020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2023</a></td>
<td class="nump">8,051<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2024</a></td>
<td class="nump">7,399<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2025</a></td>
<td class="nump">6,840<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2026</a></td>
<td class="nump">5,632<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ccrn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour', window );">Thereafter</a></td>
<td class="nump">10,901<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 40,843<span></span>
</td>
<td class="nump">$ 42,344<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finite Lived Intangible Asset, Expected Amortization, After Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696789679600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS - Goodwill Rollforward (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Aggregate goodwill acquired, beginning balance</a></td>
<td class="nump">$ 439,851<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment loss, beginning balance</a></td>
<td class="num">(310,472)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net of impairment loss, beginning balance</a></td>
<td class="nump">119,490<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Goodwill acquisition adjustment - Selected</a></td>
<td class="num">(6,130)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Aggregate goodwill acquired, ending balance</a></td>
<td class="nump">433,721<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment loss, ending balance</a></td>
<td class="num">(310,472)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net of impairment loss, ending balance</a></td>
<td class="nump">113,360<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember', window );">Sale of business</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Aggregate goodwill acquired, beginning balance</a></td>
<td class="nump">9,889<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Aggregate goodwill acquired, ending balance</a></td>
<td class="nump">9,889<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_NurseAndAlliedStaffingMember', window );">Nurse And Allied Staffing</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Aggregate goodwill acquired, beginning balance</a></td>
<td class="nump">396,446<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment loss, beginning balance</a></td>
<td class="num">(269,874)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net of impairment loss, beginning balance</a></td>
<td class="nump">116,683<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Goodwill acquisition adjustment - Selected</a></td>
<td class="num">(6,130)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Aggregate goodwill acquired, ending balance</a></td>
<td class="nump">390,316<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment loss, ending balance</a></td>
<td class="num">(269,874)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net of impairment loss, ending balance</a></td>
<td class="nump">110,553<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_NurseAndAlliedStaffingMember', window );">Nurse And Allied Staffing | Sale of business</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Aggregate goodwill acquired, beginning balance</a></td>
<td class="nump">9,889<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Aggregate goodwill acquired, ending balance</a></td>
<td class="nump">9,889<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_PhysicianStaffingMember', window );">Physician Staffing</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Aggregate goodwill acquired, beginning balance</a></td>
<td class="nump">43,405<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment loss, beginning balance</a></td>
<td class="num">(40,598)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net of impairment loss, beginning balance</a></td>
<td class="nump">2,807<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Goodwill acquisition adjustment - Selected</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Aggregate goodwill acquired, ending balance</a></td>
<td class="nump">43,405<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment loss, ending balance</a></td>
<td class="num">(40,598)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net of impairment loss, ending balance</a></td>
<td class="nump">2,807<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_PhysicianStaffingMember', window );">Physician Staffing | Sale of business</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Aggregate goodwill acquired, beginning balance</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Aggregate goodwill acquired, ending balance</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairedAccumulatedImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e961-128460<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_NurseAndAlliedStaffingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ccrn_NurseAndAlliedStaffingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_PhysicianStaffingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ccrn_PhysicianStaffingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696788846304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS - Additional Information (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Impairment of intangible assets (excluding goodwill)</a></td>
<td class="nump">$ 1.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696790779808">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DEBT - Long-term Debt (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt</a></td>
<td class="nump">$ 133,075<span></span>
</td>
<td class="nump">$ 185,938<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Debt Issuance Costs</a></td>
<td class="num">(6,962)<span></span>
</td>
<td class="num">(6,387)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less current portion</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,176<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 133,075<span></span>
</td>
<td class="nump">$ 181,762<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Term Loan | 2021 Term Loan Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate percentage</a></td>
<td class="nump">8.83%<span></span>
</td>
<td class="nump">6.50%<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt</a></td>
<td class="nump">$ 123,875<span></span>
</td>
<td class="nump">$ 174,312<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Debt Issuance Costs</a></td>
<td class="num">(3,320)<span></span>
</td>
<td class="num">(5,396)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less current portion</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,750<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Senior Secured Asset-Based Loan | Senior Secured Asset-Based Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate percentage</a></td>
<td class="nump">4.58%<span></span>
</td>
<td class="nump">1.60%<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt</a></td>
<td class="nump">$ 9,200<span></span>
</td>
<td class="nump">$ 9,200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Debt Issuance Costs</a></td>
<td class="num">(3,642)<span></span>
</td>
<td class="num">$ (991)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember', window );">Note Payable | Earnout Notes Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 2,426<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Debt Issuance Costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less current portion</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2,426<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ccrn_A2021TermLoanCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ccrn_A2021TermLoanCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=ccrn_SeniorSecuredAssetBasedLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=ccrn_SeniorSecuredAssetBasedLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ccrn_EarnoutNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ccrn_EarnoutNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696787776192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT - 2021 Term Loan Credit Agreement Narrative (Details) - Term Loan - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 23, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 08, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Nov. 18, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">2021 Term Loan Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ccrn_PaymentForDebtPrepayment', window );">Payment for debt prepayment</a></td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Quarterly installment amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtExtinguishmentCosts', window );">Prepayment premium paid</a></td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WriteOffOfDeferredDebtIssuanceCost', window );">Write off of debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">2021 Term Loan Credit Agreement | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest margin percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ccrn_DebtInstrumentVariableInterestRateFloor', window );">Interest margin floor percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">2021 Term Loan Credit Agreement, Incremental Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">2021 Term Loan Credit Agreement, Aggregate Amount of All Possible Increases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 115,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_DebtInstrumentVariableInterestRateFloor">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Variable Interest Rate Floor</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_DebtInstrumentVariableInterestRateFloor</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_PaymentForDebtPrepayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment For Debt Prepayment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_PaymentForDebtPrepayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments applied to principal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPaymentPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtExtinguishmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtExtinguishmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WriteOffOfDeferredDebtIssuanceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Write-off of amounts previously capitalized as debt issuance cost in an extinguishment of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WriteOffOfDeferredDebtIssuanceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ccrn_A2021TermLoanCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ccrn_A2021TermLoanCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ccrn_A2021TermLoanCreditAgreementIncrementalTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ccrn_A2021TermLoanCreditAgreementIncrementalTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ccrn_A2021TermLoanCreditAgreementAggregateAmountOfAllPossibleIncreasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ccrn_A2021TermLoanCreditAgreementAggregateAmountOfAllPossibleIncreasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696787737536">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DEBT - Maturities of Debt (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtByMaturityAbstract', window );"><strong>Long-term Debt, Fiscal Year Maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt</a></td>
<td class="nump">$ 133,075<span></span>
</td>
<td class="nump">$ 185,938<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Term Loan | 2021 Term Loan Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtByMaturityAbstract', window );"><strong>Long-term Debt, Fiscal Year Maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear', window );">2022</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2023</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2024</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2025</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2026</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ccrn_LongTermDebtMaturityAfterYearFour', window );">Thereafter</a></td>
<td class="nump">123,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt</a></td>
<td class="nump">123,875<span></span>
</td>
<td class="nump">174,312<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Senior Secured Asset-Based Loan | Senior Secured Asset-Based Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtByMaturityAbstract', window );"><strong>Long-term Debt, Fiscal Year Maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear', window );">2022</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2023</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2024</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2025</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2026</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ccrn_LongTermDebtMaturityAfterYearFour', window );">Thereafter</a></td>
<td class="nump">9,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt</a></td>
<td class="nump">$ 9,200<span></span>
</td>
<td class="nump">$ 9,200<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_LongTermDebtMaturityAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-Term Debt, Maturity, After Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_LongTermDebtMaturityAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtByMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtByMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ccrn_A2021TermLoanCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ccrn_A2021TermLoanCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=ccrn_SeniorSecuredAssetBasedLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=ccrn_SeniorSecuredAssetBasedLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696788736656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT - 2019 Loan Agreement (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 21, 2022</div></th>
<th class="th"><div>Oct. 25, 2019</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Nov. 18, 2021</div></th>
<th class="th"><div>Mar. 08, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ccrn_LineOfCreditAmountOfIndebtednessPermittedBySeniorSecuredAssetBasedLoanToBeBorrowedFromOtherSources', window );">Amount of indebtedness permitted from other sources</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 175,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=ccrn_SeniorSecuredAssetBasedLoanMember', window );">Senior Secured Asset-Based Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationPeriod', window );">Line of credit term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">$ 300,000,000<span></span>
</td>
<td class="nump">$ 120,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="nump">$ 130,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ccrn_LineOfCreditFacilityBasisSpreadOnVariableRateAdditionalCreditSpreadAssociatedWithSOFR', window );">Basis spread on variable rate, additional credit spread associated with SOFR</a></td>
<td class="nump">0.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ccrn_LineOfCreditBorrowingBasePercentageOfAssets', window );">Borrowing base, percentage of assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ccrn_LineOfCreditFacilityBorrowingBaseAvailability', window );">Borrowing base availability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Line of credit, carrying amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letters of credit outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Borrowing availability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 273,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Quarterly commitment fee on the average daily unused portion percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=ccrn_SeniorSecuredAssetBasedLoanMember', window );">Senior Secured Asset-Based Loan | SOFR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest margin percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=ccrn_SeniorSecuredAssetBasedLoanMember', window );">Senior Secured Asset-Based Loan | Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest margin percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=ccrn_SeniorSecuredAssetBasedLoanMember', window );">Senior Secured Asset-Based Loan | Swingline Sublimit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=ccrn_SeniorSecuredAssetBasedLoanMember', window );">Senior Secured Asset-Based Loan | Standby Letters Of Credit Sublimit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_LineOfCreditAmountOfIndebtednessPermittedBySeniorSecuredAssetBasedLoanToBeBorrowedFromOtherSources">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line Of Credit, Amount Of Indebtedness Permitted By Senior Secured Asset Based Loan To Be Borrowed From Other Sources</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_LineOfCreditAmountOfIndebtednessPermittedBySeniorSecuredAssetBasedLoanToBeBorrowedFromOtherSources</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_LineOfCreditBorrowingBasePercentageOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line Of Credit, Borrowing Base, Percentage Of Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_LineOfCreditBorrowingBasePercentageOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_LineOfCreditFacilityBasisSpreadOnVariableRateAdditionalCreditSpreadAssociatedWithSOFR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line Of Credit Facility, Basis Spread On Variable Rate, Additional Credit Spread Associated With SOFR</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_LineOfCreditFacilityBasisSpreadOnVariableRateAdditionalCreditSpreadAssociatedWithSOFR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_LineOfCreditFacilityBorrowingBaseAvailability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line Of Credit Facility, Borrowing Base Availability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_LineOfCreditFacilityBorrowingBaseAvailability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period remaining on line of credit facility before it terminates, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=ccrn_SeniorSecuredAssetBasedLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=ccrn_SeniorSecuredAssetBasedLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=ccrn_SecuredOvernightFinancingRateSOFRMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=ccrn_SecuredOvernightFinancingRateSOFRMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_LineOfCreditSublimitAxis=ccrn_SwingLoansSublimitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_LineOfCreditSublimitAxis=ccrn_SwingLoansSublimitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_LineOfCreditSublimitAxis=ccrn_StandbyLettersOfCreditSublimitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_LineOfCreditSublimitAxis=ccrn_StandbyLettersOfCreditSublimitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696785682112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseImpairmentLoss', window );">Operating lease, impairment loss</a></td>
<td class="nump">$ 2.8<span></span>
</td>
<td class="nump">$ 1.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from impairment of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 25<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123399704&amp;loc=SL77918431-209957<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696791181712">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES - Supplemental Balance Sheet Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">$ 3,249<span></span>
</td>
<td class="nump">$ 7,488<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities - current</a></td>
<td class="nump">4,489<span></span>
</td>
<td class="nump">4,090<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities - non-current</a></td>
<td class="nump">$ 5,493<span></span>
</td>
<td class="nump">$ 10,853<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term</a></td>
<td class="text">2 years 4 months 24 days<span></span>
</td>
<td class="text">3 years 4 months 24 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate</a></td>
<td class="nump">6.31%<span></span>
</td>
<td class="nump">6.39%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696786789760">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES - Operating Lease Maturity (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2022</a></td>
<td class="nump">$ 854<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">5,135<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">3,047<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">1,886<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total minimum lease payments</a></td>
<td class="nump">10,922<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: amount of lease payments representing interest</a></td>
<td class="num">(940)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of future minimum lease payments</a></td>
<td class="nump">9,982<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Less: operating lease liabilities - current</a></td>
<td class="num">(4,489)<span></span>
</td>
<td class="num">$ (4,090)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities - non-current</a></td>
<td class="nump">$ 5,493<span></span>
</td>
<td class="nump">$ 10,853<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696786790176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES - Lease Costs (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Cash paid for amounts included in the measurement of operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,446<span></span>
</td>
<td class="nump">$ 4,692<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets acquired under operating lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="nump">1,088<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease expense</a></td>
<td class="nump">$ 596<span></span>
</td>
<td class="nump">$ 848<span></span>
</td>
<td class="nump">2,043<span></span>
</td>
<td class="nump">2,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermLeaseCost', window );">Short-term lease expense</a></td>
<td class="nump">1,743<span></span>
</td>
<td class="nump">1,033<span></span>
</td>
<td class="nump">4,128<span></span>
</td>
<td class="nump">2,523<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ccrn_VariableAndOtherLeaseCost', window );">Variable and other lease costs</a></td>
<td class="nump">$ 2,027<span></span>
</td>
<td class="nump">$ 419<span></span>
</td>
<td class="nump">$ 1,674<span></span>
</td>
<td class="nump">$ 1,638<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_VariableAndOtherLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Variable And Other Lease, Cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_VariableAndOtherLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term lease cost, excluding expense for lease with term of one month or less.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696791087456">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS - Estimated Fair Values of Financial Assets and Liabilities Measured on a Recurring Basis (Details) - Level 1 - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=ccrn_DeferredCompensationMember', window );">Deferred compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Deferred compensation liability</a></td>
<td class="nump">$ 2,317<span></span>
</td>
<td class="nump">$ 2,457<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=ccrn_DeferredCompensationMember', window );">Deferred compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Deferred compensation asset</a></td>
<td class="nump">$ 2,219<span></span>
</td>
<td class="nump">$ 1,398<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of obligations measured on a recurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=ccrn_DeferredCompensationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=ccrn_DeferredCompensationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=ccrn_DeferredCompensationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=ccrn_DeferredCompensationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696789653216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ccrn_FairValueMeasurementLineItems', window );"><strong>Fair Value Measurement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities', window );">Payment of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,500<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ccrn_WorkforceSolutionsGroupIncMember', window );">Workforce Solutions Group, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ccrn_FairValueMeasurementLineItems', window );"><strong>Fair Value Measurement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities', window );">Payment of contingent consideration</a></td>
<td class="nump">$ 7,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_FairValueMeasurementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value Measurement [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_FairValueMeasurementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ccrn_WorkforceSolutionsGroupIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ccrn_WorkforceSolutionsGroupIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696785829312">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS - Carrying Amounts and Estimated Fair Values of Significant Financial Instrument that were not Measured at Fair Value (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 16, 2021</div></th>
<th class="th"><div>Jun. 08, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ccrn_WorkforceSolutionsGroupIncMember', window );">Workforce Solutions Group, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems', window );"><strong>Fair Value, Option, Quantitative Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Earnout liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ccrn_SelectedIncMember', window );">Selected, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems', window );"><strong>Fair Value, Option, Quantitative Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Earnout liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Carrying Amount | Workforce Solutions Group, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems', window );"><strong>Fair Value, Option, Quantitative Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Earnout liability</a></td>
<td class="nump">$ 7,500<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Carrying Amount | Selected, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems', window );"><strong>Fair Value, Option, Quantitative Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Earnout liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Fair Value | Workforce Solutions Group, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems', window );"><strong>Fair Value, Option, Quantitative Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Earnout liability</a></td>
<td class="nump">7,500<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Fair Value | Selected, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems', window );"><strong>Fair Value, Option, Quantitative Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Earnout liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Senior Secured Asset-Based Loan | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems', window );"><strong>Fair Value, Option, Quantitative Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LinesOfCreditFairValueDisclosure', window );">Senior Secured Asset-Based Loan</a></td>
<td class="nump">9,200<span></span>
</td>
<td class="nump">9,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Senior Secured Asset-Based Loan | Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems', window );"><strong>Fair Value, Option, Quantitative Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LinesOfCreditFairValueDisclosure', window );">Senior Secured Asset-Based Loan</a></td>
<td class="nump">9,200<span></span>
</td>
<td class="nump">9,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Earnout Notes Payable | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems', window );"><strong>Fair Value, Option, Quantitative Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Note payable, fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,426<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Earnout Notes Payable | Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems', window );"><strong>Fair Value, Option, Quantitative Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Note payable, fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,426<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Term Loan | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems', window );"><strong>Fair Value, Option, Quantitative Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Note payable, fair value</a></td>
<td class="nump">123,875<span></span>
</td>
<td class="nump">174,312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Term Loan | Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems', window );"><strong>Fair Value, Option, Quantitative Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Note payable, fair value</a></td>
<td class="nump">$ 120,023<span></span>
</td>
<td class="nump">$ 174,845<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOptionQuantitativeDisclosuresLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LinesOfCreditFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LinesOfCreditFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ccrn_WorkforceSolutionsGroupIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ccrn_WorkforceSolutionsGroupIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ccrn_SelectedIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ccrn_SelectedIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=ccrn_SeniorSecuredAssetBasedLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=ccrn_SeniorSecuredAssetBasedLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=ccrn_EarnoutNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=ccrn_EarnoutNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696786923024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - Additional Information (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>installment </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 16, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 19, 2020 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Shares repurchased and retired (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Stock repurchase and retirement | $</a></td>
<td class="nump">$ 24,348<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,348<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Unrestricted shares of common stock outstanding (in shares)</a></td>
<td class="nump">36,508,529<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,508,529<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAttainmentPercentage', window );">Performance attainment percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=ccrn_PriorRepurchaseProgramAndNewRepurchaseProgramMember', window );">Prior Repurchase Program And New Repurchase Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Shares repurchased and retired (in shares)</a></td>
<td class="nump">1,014,815<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Stock repurchase and retirement | $</a></td>
<td class="nump">$ 24,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Average market price (in usd per share) | $ / shares</a></td>
<td class="nump">$ 23.97<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=ccrn_NewRepurchaseProgramMember', window );">New Repurchase Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program, authorized amount | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Common shares amount left remaining to repurchase under the plan (up to) | $</a></td>
<td class="nump">$ 87,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 87,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=ccrn_RestrictedStockAndPerformanceSharesMember', window );">Restricted Stock And Performance Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet', window );">Vested in period, net (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">499,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">170,278<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">170,278<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">575,051<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet', window );">Vested in period, net (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,576<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">479,206<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, General and Administrative Expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation | $</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800<span></span>
</td>
<td class="nump">$ 5,200<span></span>
</td>
<td class="nump">$ 5,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ccrn_OmnibusPlanMember', window );">Omnibus Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares reserved for share-based payments (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ccrn_OmnibusPlanMember', window );">Omnibus Plan | Member of the Board of Directors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments', window );">Number of vesting installments | installment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ccrn_OmnibusPlanMember', window );">Omnibus Plan | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAttainmentPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Performance Target Attainment Level, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAttainmentPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other than Options, Vested In Period, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Number Of Vesting Installments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased and retired during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=ccrn_PriorRepurchaseProgramAndNewRepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=ccrn_PriorRepurchaseProgramAndNewRepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=ccrn_NewRepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=ccrn_NewRepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=ccrn_RestrictedStockAndPerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=ccrn_RestrictedStockAndPerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ccrn_OmnibusPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ccrn_OmnibusPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696788743104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - Restricted Stock Activity (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested restricted stock awards, beginning balance (shares)</a></td>
<td class="nump">1,039,455<span></span>
</td>
<td class="nump">1,039,455<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">287,774<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(575,051)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(79,520)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested restricted stock awards, ending balance (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">672,658<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract', window );"><strong>Weighted Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested restricted stock awards, beginning balance (in dollars per share)</a></td>
<td class="nump">$ 9.75<span></span>
</td>
<td class="nump">$ 9.75<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.76<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested restricted stock awards, ending balance (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14.47<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested restricted stock awards, beginning balance (shares)</a></td>
<td class="nump">522,166<span></span>
</td>
<td class="nump">522,166<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">171,873<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="num">(170,278)<span></span>
</td>
<td class="num">(170,278)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(47,675)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested restricted stock awards, ending balance (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">476,086<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract', window );"><strong>Weighted Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested restricted stock awards, beginning balance (in dollars per share)</a></td>
<td class="nump">$ 8.64<span></span>
</td>
<td class="nump">$ 8.64<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.94<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.03<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.33<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested restricted stock awards, ending balance (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.56<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696789461536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT DATA (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from services:</a></td>
<td class="nump">$ 636,098<span></span>
</td>
<td class="nump">$ 374,905<span></span>
</td>
<td class="nump">$ 2,178,391<span></span>
</td>
<td class="nump">$ 1,035,973<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ccrn_OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard', window );">Contribution income:</a></td>
<td class="nump">78,675<span></span>
</td>
<td class="nump">41,555<span></span>
</td>
<td class="nump">289,328<span></span>
</td>
<td class="nump">116,246<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ccrn_SegmentReportingUnallocatedCorporateExpenses', window );">Corporate overhead</a></td>
<td class="nump">16,447<span></span>
</td>
<td class="nump">12,049<span></span>
</td>
<td class="nump">50,284<span></span>
</td>
<td class="nump">40,326<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">3,214<span></span>
</td>
<td class="nump">2,680<span></span>
</td>
<td class="nump">9,414<span></span>
</td>
<td class="nump">7,132<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ccrn_AcquisitionAndIntegrationRelatedCosts', window );">Acquisition and integration-related costs</a></td>
<td class="nump">490<span></span>
</td>
<td class="nump">61<span></span>
</td>
<td class="nump">530<span></span>
</td>
<td class="nump">985<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring costs</a></td>
<td class="nump">2,493<span></span>
</td>
<td class="nump">318<span></span>
</td>
<td class="nump">1,859<span></span>
</td>
<td class="nump">2,391<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charges</a></td>
<td class="nump">3,856<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,597<span></span>
</td>
<td class="nump">2,070<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">52,175<span></span>
</td>
<td class="nump">26,447<span></span>
</td>
<td class="nump">221,644<span></span>
</td>
<td class="nump">63,342<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_NurseAndAlliedStaffingMember', window );">Nurse and Allied Staffing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from services:</a></td>
<td class="nump">612,270<span></span>
</td>
<td class="nump">356,139<span></span>
</td>
<td class="nump">2,109,293<span></span>
</td>
<td class="nump">985,335<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ccrn_OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard', window );">Contribution income:</a></td>
<td class="nump">77,838<span></span>
</td>
<td class="nump">40,645<span></span>
</td>
<td class="nump">285,506<span></span>
</td>
<td class="nump">113,346<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_PhysicianStaffingMember', window );">Physician Staffing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from services:</a></td>
<td class="nump">23,828<span></span>
</td>
<td class="nump">18,766<span></span>
</td>
<td class="nump">69,098<span></span>
</td>
<td class="nump">50,638<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ccrn_OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard', window );">Contribution income:</a></td>
<td class="nump">$ 837<span></span>
</td>
<td class="nump">$ 910<span></span>
</td>
<td class="nump">$ 3,822<span></span>
</td>
<td class="nump">$ 2,900<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_AcquisitionAndIntegrationRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Acquisition and integration-related costs include costs for prior acquisitions, costs incurred for potential transactions, and accretion and valuation adjustments on contingent consideration liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_AcquisitionAndIntegrationRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Income Loss Before D And A Acquisition And Integration Contingent Consideration Restructuring Legal Impairment And Corporate Overheard</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_SegmentReportingUnallocatedCorporateExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Segment Reporting Unallocated Corporate Expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_SegmentReportingUnallocatedCorporateExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_NurseAndAlliedStaffingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ccrn_NurseAndAlliedStaffingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_PhysicianStaffingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ccrn_PhysicianStaffingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696787320624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationLineItems', window );"><strong>Income Tax Examination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="nump">28.60%<span></span>
</td>
<td class="nump">4.90%<span></span>
</td>
<td class="nump">28.70%<span></span>
</td>
<td class="nump">9.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ccrn_EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems', window );">Effective tax rate, excluding discrete items</a></td>
<td class="nump">28.60%<span></span>
</td>
<td class="nump">4.90%<span></span>
</td>
<td class="nump">29.30%<span></span>
</td>
<td class="nump">5.90%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationLineItems', window );"><strong>Income Tax Examination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate, Continuing Operations, Excluding Discrete Items</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139696790957312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ccrn_HealthCareSystemAffiliatedWithABoardMemberMember', window );">Health Care System Affiliated with a Board Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">Revenue from related parties</a></td>
<td class="nump">$ 0.7<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 1.5<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07.1(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874292-224272<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(e))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ccrn_HealthCareSystemAffiliatedWithABoardMemberMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ccrn_HealthCareSystemAffiliatedWithABoardMemberMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>ccrn-20220930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:ccrn="http://www.crosscountryhealthcare.com/20220930"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="ccrn-20220930.xsd" xlink:type="simple"/>
    <context id="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ied6e0a816b61418c9a09c38a78d39512_I20221020">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
        </entity>
        <period>
            <instant>2022-10-20</instant>
        </period>
    </context>
    <context id="i8ad9340f357e45ba914eff9e31b0661b_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i51f0077b9e4442588bd8299663a1ef5a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i710725bce0f34e3784365685f226641d_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id786e43d12924467a670b39ccb2288b8_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i26fb2cd916aa4101ac98bfb0aeed6193_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i23e6ed6a9fed48d29307fabb2d2666ab_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="if342abafe0424c4cbbb239c9eeb5a10b_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i68cf390bfea94f56a817690cbbf4744d_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="iaff6ed2ab3394341b1987107614ed158_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i0c0a4267d8174093be4955cfd3a6d031_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i37a23fb61a8646c29cb106b4e9684e9b_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia3fb9c1cd31c4e1181518b558a62bf13_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie0f02a13f7ad4906acc11dee942a7413_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if62eba6a38e6444bbfe404803ad71c18_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i677effe12d9f4d44bd5f1ca7944e48b0_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i7f59e0723d41435fbc923108afeebf77_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i849d2660af354dc7b3da49f0e86fc52c_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i8e8d1bdde3804c1baf7ae857af6e5e52_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i4401d4d9ee924023b8f1ec25533e9a67_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i1252820f59e947b4976a678884ff7d91_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i3fc079c274124a6cac569e4f34366c7b_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i532e051d438e418eb3e83be7ed3362f2_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i725e0cb0ad514e69b7e4c7c6064bc911_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ibc57b01ed27040b3bf77a29981bb957d_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i61328c0ca95341349cdc1ca533a6d2bf_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ic538be4345284146ae03043536ae0bfa_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8bc3a63bad324d3b92636e8a32d4f412_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ibe8f646189004462a689d8e6ab700027_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if1c4bd146f604316b819aa100137bf51_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iadcfed8870184b00ac8df3ef3a6c7332_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3edda426942249bf91dae3b40fcf7ae9_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i661f31a4c8174df5accdb1e19dbc9603_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ic78b970907494e82bd28d42c18310a5f_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i89f83f5578c9454b87f8cf964b36d386_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i4fefba535da24f6faa17aa6af4553338_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="idb81780210de40218de77358d91c73ba_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i0adb8d88d43c4f0699c9c108560ff3c3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if3eb9dcc1ff645df99ce9eb18565e9a4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i76c4c8c1ba544b218b38c4841b734300_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic7e684e1ca5746c9987a351de57e7a33_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0d0df14b23af42f8bf234fae71fdabce_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i36a03f0a3609488882bcc1d53ba8b90a_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3ebd46f32725469a851e253627061ba5_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i55f1d59f3df544b3b26a366b71c31170_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i4db29b7907044e1ca81a2082beb7444a_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i46d38e032f6045d5811f4c3961253386_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6641a1756e67403d810b23655f4e192e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i24f2241f06ba4fd28714f067a2014198_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie1ae1d5ee1d14280ac3f645f56e7bb1a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5affaa8d5f934c798b6c95e386f76904_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i119af728c7ce4ee8bb64043a29f00ca5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i702dc94df8644dde8f1cce342f5d1e3b_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic0e5daec688e4f149d1bb1d3c238f468_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8aff35e423dc48b2880bbf459a28b4cb_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3ea4b9a9c7024e24b7056df5589337d5_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i253197afe06e45bca28e963b592a33ea_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i657bd17dcadf4f3f873d0850b774cdc3_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie61694e1851449ffa2f39478d3d2f3ea_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="icc853726046a4b378bd788e398d13c55_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib6501a0fcaad471fa6d6fbf55f3864ae_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i320641181a3f49a494c3423b25911ae6_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ie812f572e01c4d7abf8b2fd4eddf3b89_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i95a7cda144014872b12df15aa0c33624_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i5982bacc53f943e49e2bf300695325b5_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i8c3d33c67aba46cb8fc17a6c9810c45e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i57398b99b0b54c5392ab2d17dc37cf50_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ccrn:ExitCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if703479963674b69a8f48728a5151e98_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic15931a9518a4f40ad076daec66714fd_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ccrn:ExitCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8e32834817d9496dad1cbdc249093f30_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i73c497336ca74c4cb8a55c150456d5e0_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ccrn:ExitCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i91f31431ce5340419942d52145b80cc7_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i443dd9fb273b4d53a90b0b46a22ab602_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ccrn:ExitCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ib3adac1127fa4edf8e0147861c16ad9b_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="if4bc6735e5214a54a2a33460e10c2956_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ccrn:ExitCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i5db7b078db0441d0a155ca8727612378_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if5f07aa56cb14c10aa23331198ec4f7c_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ccrn:ExitCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i181005f5e3c34e41a45e7b5a7e5a9e66_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i869ddd0d1a6943ae82d12eccf68afcde_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ccrn:ExitCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i20197ff1c85d452da87fc706b7d58649_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:TemporaryStaffingServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i1fe76aa84e634f068c08458605422754_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:TemporaryStaffingServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i8ae604777193442b9bf2a6f5b9f7aae1_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:TemporaryStaffingServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic24c88a8321b4d8dba9854a06196bffe_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:OtherServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i27fae63222bc430e9e3478596f2ad536_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:OtherServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i873a486d6fa84b97a6f676f640c8635e_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:OtherServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i755b00d6551346d08633c51f6fffcbd4_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i60312c6dd2494d66bf19248b38166eaf_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i0bb46cc7c58c478889fb6b980f9b2f4d_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:TemporaryStaffingServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib0348b7044e44bc5bb758dc707fdab77_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:TemporaryStaffingServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib6ef97c37f2146c5ba8dfa5c5720ad24_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:TemporaryStaffingServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i44f9d44db6904ef587268af1cde4de4f_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:OtherServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0e5ea3b7faeb44c297e0371081833165_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:OtherServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i970c8a42e53c487fae9182764d96ad09_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:OtherServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i15f558e83a4a479e8674ab636a78ba79_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ibeef5c5a5e6e4d08b2e5036ccd0186a0_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1a40960a329848b3b4404d32532a0aed_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:TemporaryStaffingServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ideb77c0531ff491fa1c4616654d0b2ba_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:TemporaryStaffingServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i525c2bf9e1cf47589d1b503039abb3a7_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:TemporaryStaffingServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i2bed4acdcaa54423bb59a2fc3eeb6cce_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:OtherServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ifea86757fdc544f2b14e84330796599b_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:OtherServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i98bb8473f28b40109171e65f44dcded9_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:OtherServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i7aaf74b211ba45b9bea92196b8c48cd7_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia4be1f35efe045ebabfe8d9154e1c3cb_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i108501803abb4e229cf67a62dd7cd7ae_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:TemporaryStaffingServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib62929d26b494926b11bb88b62b6ef78_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:TemporaryStaffingServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iebb1b15335074656a1c0ac1d3c9f6eb6_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:TemporaryStaffingServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib20154f39f37474fa466a1c719e5b181_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:OtherServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i375deb87100c4072a7f2a5d3d9e2e846_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:OtherServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8f29bfe22ab24268b44e0608ba26a4ad_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:OtherServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id76ab6905df5463b9046aaf30a35075d_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7c425883600f44a6aedb244f1adafb03_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia84d03e68bab4f9592492ba9084b94f0_D20211216-20211216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:SelectedIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-16</startDate>
            <endDate>2021-12-16</endDate>
        </period>
    </context>
    <context id="iab7b6d3f615249b3813ea0de2e0a5b00_I20211216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:SelectedIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-16</instant>
        </period>
    </context>
    <context id="ide7cad6e03e54feaafb84434e9dee12b_I20211216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:SelectedIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-16</instant>
        </period>
    </context>
    <context id="i86b3f925edb2419baa7dc8060115c5af_D20211216-20211216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:SelectedIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-16</startDate>
            <endDate>2021-12-16</endDate>
        </period>
    </context>
    <context id="i52e3ba7395c24be49c40b9fc7a7fe5c3_I20211216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:SelectedIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-16</instant>
        </period>
    </context>
    <context id="i3eb40c4ead40484d99ab7accabf6eb87_D20211216-20211216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:SelectedIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-16</startDate>
            <endDate>2021-12-16</endDate>
        </period>
    </context>
    <context id="i5a4b1bc6463449928078dc019cd5ef53_I20211216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:SelectedIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DatabasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-16</instant>
        </period>
    </context>
    <context id="i096a7bcfbf9b4f69a384857b9b34921a_D20211216-20211216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:SelectedIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DatabasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-16</startDate>
            <endDate>2021-12-16</endDate>
        </period>
    </context>
    <context id="i29d504aa7a7e4656aed1f0f0211e399c_D20210608-20210608">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:WorkforceSolutionsGroupIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-08</startDate>
            <endDate>2021-06-08</endDate>
        </period>
    </context>
    <context id="i29e631219d674e4fae9fb8f7e977e6af_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:WorkforceSolutionsGroupIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8ae5c1283dfc4659b9287a5a52e51af8_I20210608">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:WorkforceSolutionsGroupIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-08</instant>
        </period>
    </context>
    <context id="id9fe5b9beae44701b72bcee962193e53_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:WorkforceSolutionsGroupIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic3eab37833864980aa79e31112a0c6e2_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:WorkforceSolutionsGroupIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i4b533d4786024f299c29a873781660b2_I20210608">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:WorkforceSolutionsGroupIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-08</instant>
        </period>
    </context>
    <context id="icc7d3370d9844826a664e9ed960c303a_D20210608-20210608">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:WorkforceSolutionsGroupIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-08</startDate>
            <endDate>2021-06-08</endDate>
        </period>
    </context>
    <context id="i2caa7dba2bf946eeba1cabe94a429f67_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ccrn:ShareBasedPaymentAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia2bdc4ad60944e738242ef9a6814d745_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ccrn:ShareBasedPaymentAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i955dad9273e74d0b9b508f98c422598d_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ccrn:ShareBasedPaymentAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i2bf81d4651a84b7d903fab0b74c4d6c6_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ccrn:ShareBasedPaymentAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8596209ef08040d2bfd996b39f79a2cc_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DatabasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ie4f8278712e840b2b0b1388f6f6d449a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DatabasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iee283e580b834384a505bf9085488f0c_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i1393e7a548df431795ee6a40b27a3d83_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifffbe09f8f09467eb7e5b113f3801e46_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i66cd55e77f1246b18919d2e35b249926_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id346bd8243c84b70924309b05565c2d3_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i7d2f558a2d464d13a6a45fd804204c56_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4f28bc2f1f144f9b8079211ca0ac2719_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i6df5cca2f9f94120b8172ac27441142a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9689395cb7444c7c8ae6b2bb1d17f429_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3141d307889e400f8613ac4e53dfd7bf_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i92f6c3cc4f5c4abda295b3072437fb45_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i98085908a4ff4bfabc746d90f51c8c01_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8a09ea9a925140449a60d73ca6cea3cb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie4a8ed4c652b409b9c9e62d38384449a_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ic0b4574bdbb84488a12b61c871791cd5_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i50f6f534fc28456f8f17929b1cef9416_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i87608f5be1294b2c81227b913215f1f0_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ie01c32b128c342b89c4718d3db15e20c_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ide03ccfd1d5f459fbf0f366e300c2751_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:A2021TermLoanCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="if64036e453b84955b51e99497013571c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:A2021TermLoanCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iaed1e277c72c475e9d7788035f2b51e8_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i6e5c22515f804ea29736c66d5982b201_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2fc39805f3624e12ba3b38847a2f8810_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:EarnoutNotesPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if7bf7274f80f465789bbdcc936e17070_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:EarnoutNotesPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i679839afbf554bacadf5512f89216250_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:A2021TermLoanCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i870a1a5ad08d4d2187f8499d8bb665d1_D20210608-20210608">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:A2021TermLoanCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-08</startDate>
            <endDate>2021-06-08</endDate>
        </period>
    </context>
    <context id="ib9754d616f5a4ee8a091ad6be918e235_I20210608">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:A2021TermLoanCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-08</instant>
        </period>
    </context>
    <context id="iedb34638d63143a8b4c18058a909b8c5_D20210608-20210608">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:A2021TermLoanCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-08</startDate>
            <endDate>2021-06-08</endDate>
        </period>
    </context>
    <context id="i34f7f97d2f20459aa4e94c8f8c9526d2_D20210930-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:A2021TermLoanCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-30</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9f569e337ebb415d913c1f6a219076e4_I20211118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:A2021TermLoanCreditAgreementIncrementalTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-18</instant>
        </period>
    </context>
    <context id="i41f166769fd2450f9e1ac7343566e768_I20211118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:A2021TermLoanCreditAgreementAggregateAmountOfAllPossibleIncreasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-18</instant>
        </period>
    </context>
    <context id="i1203eeee9648493cab15c9a9c56887ea_D20211231-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:A2021TermLoanCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-31</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie2b5f4df2dca4db3b15dfee015bb5eb9_D20220623-20220623">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:A2021TermLoanCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-23</startDate>
            <endDate>2022-06-23</endDate>
        </period>
    </context>
    <context id="i6158fa637abd4af3ae6d409e2ff6470e_D20191025-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-25</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="ic7e12eb577054a99aa4bc801b8f7a4e2_I20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-25</instant>
        </period>
    </context>
    <context id="if4c7c74b2761411095a93a4e4420b8ba_I20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ccrn:LineOfCreditSublimitAxis">ccrn:SwingLoansSublimitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-25</instant>
        </period>
    </context>
    <context id="i939e68a3ba5c42dba3abaaad4215f029_I20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ccrn:LineOfCreditSublimitAxis">ccrn:StandbyLettersOfCreditSublimitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-25</instant>
        </period>
    </context>
    <context id="i04b66ed81c9249438ac7e6deac027e0c_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i0a067d85b7ce45c29144e8ce39c70993_I20210308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-08</instant>
        </period>
    </context>
    <context id="i624be7ef98974a18acd4dff1b7f88e73_I20211118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
        </entity>
        <period>
            <instant>2021-11-18</instant>
        </period>
    </context>
    <context id="i270723f4cdb7481096cce56fef2c5108_I20220321">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-21</instant>
        </period>
    </context>
    <context id="id9318eec3ae14553b2ee10834ffd5fa2_D20220321-20220321">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-21</startDate>
            <endDate>2022-03-21</endDate>
        </period>
    </context>
    <context id="i429f9d7a920e4e42bf93ded0492112f6_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ib9a9d68a6c6e40568eec79a197a10ad1_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">ccrn:SecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ib8d17efeeb2945f986a5af6c590ab452_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i30a646dd77584028b2f4405de20d759d_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i817acb52936447dcac8bfc2fdc5f10c2_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ccrn:DeferredCompensationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="idb72a3bcd2bb48b4bb23ea38343be599_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ccrn:DeferredCompensationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8e7a429958f04663bc3d74b1a3aab9a6_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ccrn:DeferredCompensationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i5ed93b80dd314c62b7cd4dea1d5c7981_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ccrn:DeferredCompensationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i04893fd47a664b8aa11c6aef5de1bfea_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ccrn:EarnoutNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i355e48f54cd24775841d981acdad6c9f_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ccrn:EarnoutNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="id9435c564ca74ddbb50ac50871543b66_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ccrn:EarnoutNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib59536cd34df4b5c927d7dfd92e21775_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ccrn:EarnoutNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i25845230e0a34aa3b524e0cd4fac58b2_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i4ab3f84da58d407297c219a1e6bee204_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i3ca241ad2cc548f6a38311595d2c1a51_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia8042af3a5af441cbbd4f8aa3c656853_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia987e32d35a64bc58e5674f1e07ff056_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i736980e5039d40a593f5402597dcedea_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ifec1ee9f27f84876ae61fc5e20677f66_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i877c790a76d546a8a90babc735c8b376_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iba8724e196ad45edae8eaee777dfc4d7_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:WorkforceSolutionsGroupIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ia3b246daadb64fa58cf94501ca9e81e5_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:WorkforceSolutionsGroupIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i1946fe4694af480aa180b00058e1d6d9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:WorkforceSolutionsGroupIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iba126d3e52b14305be4c3c515f9637d2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:WorkforceSolutionsGroupIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iadeeceae9c3742b0916a9a12a86f2fe7_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:SelectedIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i17bfcb8a0ca943179adb5a32cc2af8ba_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:SelectedIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i8da530a9cdbc4804980eefdbbd0e900a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:SelectedIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9b515cd81555467898b20fbdbc0994cb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:SelectedIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i39fd50bbb06e42f18218bf500c01d1b1_I20220816">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">ccrn:NewRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-16</instant>
        </period>
    </context>
    <context id="i9313064d9eac40ad83fdaf7a1b2db9e0_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">ccrn:PriorRepurchaseProgramAndNewRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i8d6c70caf3ac4c6493c60fe74f5d510e_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">ccrn:NewRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i60a43dc77674425480d2db76cf79177d_I20200519">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ccrn:OmnibusPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-19</instant>
        </period>
    </context>
    <context id="i3d793cc2e5cf4606b38b48e7c4f5d2b2_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ccrn:OmnibusPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i0898a126dbc046e795ecb209d0f68153_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i94cacdf9f5e14894bd9a7ee09ceefd0b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7b01283f3c6e441b93fffe6cdf6495d8_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ife7c8285d238454bad645c20b406a43d_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i57cbf98f9a5e41dbb52fc4305ececb04_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i850fcfe043314c1a9fece0d4d68b2919_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i4b68237ebf9d475aaf3f35fd14b2fefc_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ccrn:OmnibusPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia1b0163339fb42deac2d52ca0dc626cd_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ice9fa15cb07246a2819aa90ca0b090f2_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i00ee87f771334f0c8220e9eb0575e200_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i69cc0e8a27234c22915bdde908a717c2_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ccrn:RestrictedStockAndPerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic57dcdd480124d9d9ce70d9d0fe56d2b_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ccrn:RestrictedStockAndPerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i51e864c08ce54f8c91f98492c469e4a5_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i01b4eae42d8043bc9669c54efc17b3be_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i259a723688ef4b07876c5e5858c322e8_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic3d043883a0640a8beb08731478b973f_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0d13486d3d1b4e47be1e347be955262c_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i72783f7b11ce4ca8bd07eb8c76ae894f_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ccrn:HealthCareSystemAffiliatedWithABoardMemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia4db74b0466540ea968402c2e9e28c01_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ccrn:HealthCareSystemAffiliatedWithABoardMemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iee3c22d82f244073ab396a419446f087_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ccrn:HealthCareSystemAffiliatedWithABoardMemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i05804f1d8c774ac48c5ecb8daa790dd0_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ccrn:HealthCareSystemAffiliatedWithABoardMemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="installment">
        <measure>ccrn:installment</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80L2ZyYWc6NWQwNjQ0MGUyNmRmNDhkNWJkOTMxNzNjYTJmOWRlYWQvdGFibGU6YmI1YjNiYjUxYzlkNDhjMWFiOWU5ZjVhMTZmNmI0Y2UvdGFibGVyYW5nZTpiYjViM2JiNTFjOWQ0OGMxYWI5ZTlmNWExNmY2YjRjZV8zLTEtMS0xLTQ2MzM0_72170866-5c0d-428e-813c-7692cd960765">0001141103</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80L2ZyYWc6NWQwNjQ0MGUyNmRmNDhkNWJkOTMxNzNjYTJmOWRlYWQvdGFibGU6YmI1YjNiYjUxYzlkNDhjMWFiOWU5ZjVhMTZmNmI0Y2UvdGFibGVyYW5nZTpiYjViM2JiNTFjOWQ0OGMxYWI5ZTlmNWExNmY2YjRjZV80LTEtMS0xLTQ2MzM0_f6bf8ebc-66ac-4eaf-b313-20ccbe823c61">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80L2ZyYWc6NWQwNjQ0MGUyNmRmNDhkNWJkOTMxNzNjYTJmOWRlYWQvdGFibGU6YmI1YjNiYjUxYzlkNDhjMWFiOWU5ZjVhMTZmNmI0Y2UvdGFibGVyYW5nZTpiYjViM2JiNTFjOWQ0OGMxYWI5ZTlmNWExNmY2YjRjZV81LTEtMS0xLTQ2MzM0_2676fab4-ecc7-4c56-8ab7-a2ab14359920">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80L2ZyYWc6NWQwNjQ0MGUyNmRmNDhkNWJkOTMxNzNjYTJmOWRlYWQvdGFibGU6YmI1YjNiYjUxYzlkNDhjMWFiOWU5ZjVhMTZmNmI0Y2UvdGFibGVyYW5nZTpiYjViM2JiNTFjOWQ0OGMxYWI5ZTlmNWExNmY2YjRjZV82LTEtMS0xLTQ2MzM0_4f3ba951-d810-4611-949e-f8f62032ec25">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80L2ZyYWc6NWQwNjQ0MGUyNmRmNDhkNWJkOTMxNzNjYTJmOWRlYWQvdGFibGU6YmI1YjNiYjUxYzlkNDhjMWFiOWU5ZjVhMTZmNmI0Y2UvdGFibGVyYW5nZTpiYjViM2JiNTFjOWQ0OGMxYWI5ZTlmNWExNmY2YjRjZV83LTEtMS0xLTQ2MzM0_e09e8e91-1e03-433c-89ec-b6d076ab2730">false</dei:AmendmentFlag>
    <us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList
      contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfNC0wLTEtMS00NjMzNA_7f0cb4b5-60f2-4271-bceb-9dc3c10c40e8">http://fasb.org/us-gaap/2022#ServiceMember</us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList>
    <us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList
      contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfNC0wLTEtMS00NjMzNA_a67cd947-3a68-403c-8e8c-ba747270e9d1">http://fasb.org/us-gaap/2022#ServiceMember</us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList>
    <us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfNC0wLTEtMS00NjMzNA_cf74a3bf-47ff-4a52-9ecb-7fdf95acc284">http://fasb.org/us-gaap/2022#ServiceMember</us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList>
    <us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfNC0wLTEtMS00NjMzNA_fe67965c-2b70-4154-8270-1dfa06b11c02">http://fasb.org/us-gaap/2022#ServiceMember</us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList>
    <dei:DocumentType
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xL2ZyYWc6NTYzYjU3ZGYxMWNlNDc5MGJhNWY5ZjRhYTM3NzU2NWEvdGV4dHJlZ2lvbjo1NjNiNTdkZjExY2U0NzkwYmE1ZjlmNGFhMzc3NTY1YV85Mzgy_8f2e2dad-79b6-4c0c-8ca8-c983b493723e">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xL2ZyYWc6NTYzYjU3ZGYxMWNlNDc5MGJhNWY5ZjRhYTM3NzU2NWEvdGV4dHJlZ2lvbjo1NjNiNTdkZjExY2U0NzkwYmE1ZjlmNGFhMzc3NTY1YV85Mzcw_bdcf28ca-5885-4478-b358-d40663b9cd7d">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xL2ZyYWc6NTYzYjU3ZGYxMWNlNDc5MGJhNWY5ZjRhYTM3NzU2NWEvdGV4dHJlZ2lvbjo1NjNiNTdkZjExY2U0NzkwYmE1ZjlmNGFhMzc3NTY1YV83Mjc1_d97f0cff-9c00-4532-9de3-a7668b52f3d4">2022-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xL2ZyYWc6NTYzYjU3ZGYxMWNlNDc5MGJhNWY5ZjRhYTM3NzU2NWEvdGV4dHJlZ2lvbjo1NjNiNTdkZjExY2U0NzkwYmE1ZjlmNGFhMzc3NTY1YV85Mzg0_a17555e3-1db8-46d5-9852-00ac9fdb3073">false</dei:DocumentTransitionReport>
    <dei:EntityRegistrantName
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xL2ZyYWc6NTYzYjU3ZGYxMWNlNDc5MGJhNWY5ZjRhYTM3NzU2NWEvdGV4dHJlZ2lvbjo1NjNiNTdkZjExY2U0NzkwYmE1ZjlmNGFhMzc3NTY1YV85Mzg5_cd66d79e-d1a8-4e1d-8e48-cf93ea282c56">CROSS COUNTRY HEALTHCARE, INC</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xL2ZyYWc6NTYzYjU3ZGYxMWNlNDc5MGJhNWY5ZjRhYTM3NzU2NWEvdGFibGU6MDhhYzJkZGQ5MDhhNGI2Yzk4MjIzMWQwOGQxZjFjNGEvdGFibGVyYW5nZTowOGFjMmRkZDkwOGE0YjZjOTgyMjMxZDA4ZDFmMWM0YV8wLTAtMS0xLTQ2MzM0_a0067837-d65e-4763-b68b-bffe53755694">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xL2ZyYWc6NTYzYjU3ZGYxMWNlNDc5MGJhNWY5ZjRhYTM3NzU2NWEvdGFibGU6MDhhYzJkZGQ5MDhhNGI2Yzk4MjIzMWQwOGQxZjFjNGEvdGFibGVyYW5nZTowOGFjMmRkZDkwOGE0YjZjOTgyMjMxZDA4ZDFmMWM0YV8wLTEtMS0xLTQ2MzM0_086f07e9-190e-4e0f-b361-1a932e438a56">0-33169</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xL2ZyYWc6NTYzYjU3ZGYxMWNlNDc5MGJhNWY5ZjRhYTM3NzU2NWEvdGFibGU6MDhhYzJkZGQ5MDhhNGI2Yzk4MjIzMWQwOGQxZjFjNGEvdGFibGVyYW5nZTowOGFjMmRkZDkwOGE0YjZjOTgyMjMxZDA4ZDFmMWM0YV8wLTItMS0xLTQ2MzM0_49930de6-84d0-4702-8869-793a241d6ab8">13-4066229</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xL2ZyYWc6NTYzYjU3ZGYxMWNlNDc5MGJhNWY5ZjRhYTM3NzU2NWEvdGV4dHJlZ2lvbjo1NjNiNTdkZjExY2U0NzkwYmE1ZjlmNGFhMzc3NTY1YV85Mzc1_9bae633c-0a94-418d-a276-4b7a3c2a090a">6551 Park of Commerce Boulevard, N.W.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xL2ZyYWc6NTYzYjU3ZGYxMWNlNDc5MGJhNWY5ZjRhYTM3NzU2NWEvdGV4dHJlZ2lvbjo1NjNiNTdkZjExY2U0NzkwYmE1ZjlmNGFhMzc3NTY1YV85Mzc2_707caf62-470e-4cb7-aa67-4c46cf07563d">Boca Raton</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xL2ZyYWc6NTYzYjU3ZGYxMWNlNDc5MGJhNWY5ZjRhYTM3NzU2NWEvdGV4dHJlZ2lvbjo1NjNiNTdkZjExY2U0NzkwYmE1ZjlmNGFhMzc3NTY1YV85Mzkx_8d036ccf-398f-485a-90fb-00db5870501f">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xL2ZyYWc6NTYzYjU3ZGYxMWNlNDc5MGJhNWY5ZjRhYTM3NzU2NWEvdGV4dHJlZ2lvbjo1NjNiNTdkZjExY2U0NzkwYmE1ZjlmNGFhMzc3NTY1YV85Mzg2_ec0020f1-609a-4e89-9a56-444be5225550">33487</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xL2ZyYWc6NTYzYjU3ZGYxMWNlNDc5MGJhNWY5ZjRhYTM3NzU2NWEvdGV4dHJlZ2lvbjo1NjNiNTdkZjExY2U0NzkwYmE1ZjlmNGFhMzc3NTY1YV85Mzc3_c7b07ee5-06c9-4cff-be37-5431f1025cc4">561</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xL2ZyYWc6NTYzYjU3ZGYxMWNlNDc5MGJhNWY5ZjRhYTM3NzU2NWEvdGV4dHJlZ2lvbjo1NjNiNTdkZjExY2U0NzkwYmE1ZjlmNGFhMzc3NTY1YV85Mzg3_7f58f9be-9892-4530-bd5f-8101373a8e15">998-2232</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xL2ZyYWc6NTYzYjU3ZGYxMWNlNDc5MGJhNWY5ZjRhYTM3NzU2NWEvdGFibGU6YzgyZGYyYWNhMmE2NDYyZDg0ZTAwMGQ3NDI1MzEzOTEvdGFibGVyYW5nZTpjODJkZjJhY2EyYTY0NjJkODRlMDAwZDc0MjUzMTM5MV8xLTAtMS0xLTQ2MzM0_4d5df14f-37e4-4319-93a0-832041f39c9e">Common stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xL2ZyYWc6NTYzYjU3ZGYxMWNlNDc5MGJhNWY5ZjRhYTM3NzU2NWEvdGFibGU6YzgyZGYyYWNhMmE2NDYyZDg0ZTAwMGQ3NDI1MzEzOTEvdGFibGVyYW5nZTpjODJkZjJhY2EyYTY0NjJkODRlMDAwZDc0MjUzMTM5MV8xLTEtMS0xLTQ2MzM0_0ed91fe1-c06e-48a5-a465-2a6317f76c2e">CCRN</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xL2ZyYWc6NTYzYjU3ZGYxMWNlNDc5MGJhNWY5ZjRhYTM3NzU2NWEvdGFibGU6YzgyZGYyYWNhMmE2NDYyZDg0ZTAwMGQ3NDI1MzEzOTEvdGFibGVyYW5nZTpjODJkZjJhY2EyYTY0NjJkODRlMDAwZDc0MjUzMTM5MV8xLTItMS0xLTQ2MzM0_99f75e3d-74ed-4fc1-b28a-0b71051e8843">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xL2ZyYWc6NTYzYjU3ZGYxMWNlNDc5MGJhNWY5ZjRhYTM3NzU2NWEvdGV4dHJlZ2lvbjo1NjNiNTdkZjExY2U0NzkwYmE1ZjlmNGFhMzc3NTY1YV85Mzc4_ad82941e-1586-4753-9b3b-fc1665675856">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xL2ZyYWc6NTYzYjU3ZGYxMWNlNDc5MGJhNWY5ZjRhYTM3NzU2NWEvdGV4dHJlZ2lvbjo1NjNiNTdkZjExY2U0NzkwYmE1ZjlmNGFhMzc3NTY1YV85Mzcy_bc9a4c71-721a-4f4f-8352-a0853b685ed8">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xL2ZyYWc6NTYzYjU3ZGYxMWNlNDc5MGJhNWY5ZjRhYTM3NzU2NWEvdGV4dHJlZ2lvbjo1NjNiNTdkZjExY2U0NzkwYmE1ZjlmNGFhMzc3NTY1YV85Mzc5_77e0e93e-f744-4845-aee3-0def2d6c7a98">Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xL2ZyYWc6NTYzYjU3ZGYxMWNlNDc5MGJhNWY5ZjRhYTM3NzU2NWEvdGV4dHJlZ2lvbjo1NjNiNTdkZjExY2U0NzkwYmE1ZjlmNGFhMzc3NTY1YV85Mzg4_7ce31ca7-65f5-498d-b4d0-4ee525e1cf70">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xL2ZyYWc6NTYzYjU3ZGYxMWNlNDc5MGJhNWY5ZjRhYTM3NzU2NWEvdGV4dHJlZ2lvbjo1NjNiNTdkZjExY2U0NzkwYmE1ZjlmNGFhMzc3NTY1YV85Mzgx_1a4858fe-a1ae-46b6-966c-3e55e3ae04ba">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xL2ZyYWc6NTYzYjU3ZGYxMWNlNDc5MGJhNWY5ZjRhYTM3NzU2NWEvdGV4dHJlZ2lvbjo1NjNiNTdkZjExY2U0NzkwYmE1ZjlmNGFhMzc3NTY1YV85Mzk0_9b7ff721-642e-4b79-8bc6-d481e496406c">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="ied6e0a816b61418c9a09c38a78d39512_I20221020"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xL2ZyYWc6NTYzYjU3ZGYxMWNlNDc5MGJhNWY5ZjRhYTM3NzU2NWEvdGV4dHJlZ2lvbjo1NjNiNTdkZjExY2U0NzkwYmE1ZjlmNGFhMzc3NTY1YV85MzA2_d3ffccdc-ed54-4cbc-9d2b-d670dec0dd9b"
      unitRef="shares">37295465</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfNC0xLTEtMS00NjMzNA_f7cbb14c-e1b2-4aff-8a2e-51907163d1bf"
      unitRef="usd">30320000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfNC0zLTEtMS00NjMzNA_b11e23b2-62a0-4599-a977-600d6e0de683"
      unitRef="usd">1036000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfNS0wLTEtMS00NjMzNC90ZXh0cmVnaW9uOjk3ODcxZWQwYmViYzQ4NTk5MTM2OGY4YWNhNzY4Yzc4XzQ3_352269cf-186e-420b-b29f-f9f5173f1933"
      unitRef="usd">12763000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfNS0wLTEtMS00NjMzNC90ZXh0cmVnaW9uOjk3ODcxZWQwYmViYzQ4NTk5MTM2OGY4YWNhNzY4Yzc4XzYz_65c6a284-77b7-4a7a-8b0f-5da3a59acc0f"
      unitRef="usd">6881000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfNS0xLTEtMS00NjMzNA_19d7e0f3-ca06-4ca1-8d9d-0ce27ee51f08"
      unitRef="usd">610897000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfNS0zLTEtMS00NjMzNA_0e923d77-88d5-486e-b19d-f7eddde463ee"
      unitRef="usd">493910000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfNi0xLTEtMS00NjMzNA_1192a05d-0605-4ec0-9b18-9c55435c5037"
      unitRef="usd">3952000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfNi0zLTEtMS00NjMzNA_d3ba9ff4-54cd-4d25-a7a8-fc03e4506673"
      unitRef="usd">7648000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:InsuranceSettlementsReceivableCurrent
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfNy0xLTEtMS00NjMzNA_3ce7faad-63fd-4685-b1a2-451e36935475"
      unitRef="usd">6202000</us-gaap:InsuranceSettlementsReceivableCurrent>
    <us-gaap:InsuranceSettlementsReceivableCurrent
      contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfNy0zLTEtMS00NjMzNA_de5318e4-922d-4f74-af6d-284752d640ac"
      unitRef="usd">5041000</us-gaap:InsuranceSettlementsReceivableCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfOC0xLTEtMS00NjMzNA_e29b09a5-1f23-4c5d-9d65-703c3e0d7a95"
      unitRef="usd">8646000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfOC0zLTEtMS00NjMzNA_42de2c9d-8e8f-4e48-9af0-fc231951a8f3"
      unitRef="usd">638000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfOS0xLTEtMS00NjMzNA_8730582c-7451-43ce-b610-9d616832e3d5"
      unitRef="usd">660017000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfOS0zLTEtMS00NjMzNA_5a9a36e5-7484-49a0-90f5-26674a2b609b"
      unitRef="usd">508273000</us-gaap:AssetsCurrent>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMTAtMC0xLTEtNDYzMzQvdGV4dHJlZ2lvbjozYzUyMjkwODFmYTY0MmFmOGVhZDAzMjk2N2Y2YzVkMF82NA_b3e2a9c8-464f-4520-bd81-5ba052fa975d"
      unitRef="usd">19846000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMTAtMC0xLTEtNDYzMzQvdGV4dHJlZ2lvbjozYzUyMjkwODFmYTY0MmFmOGVhZDAzMjk2N2Y2YzVkMF84MA_2ab0166f-7cab-4ae0-afff-5ff69f88030c"
      unitRef="usd">17729000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMTAtMS0xLTEtNDYzMzQ_61248d63-5a44-4777-8349-4fd906c0f741"
      unitRef="usd">18556000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMTAtMy0xLTEtNDYzMzQ_9639dce9-9cb5-484e-9b70-e96dbbce3c95"
      unitRef="usd">15833000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMTEtMS0xLTEtNDYzMzQ_3c8796c4-7017-42fa-afd1-5fe922e7b9b0"
      unitRef="usd">3249000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMTEtMy0xLTEtNDYzMzQ_bba993a4-1ed7-48df-8044-d6f90a3cbd97"
      unitRef="usd">7488000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMTItMS0xLTEtNDYzMzQ_4ce2b0a4-697c-451e-a7df-511ea8aacd47"
      unitRef="usd">113360000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMTItMy0xLTEtNDYzMzQ_150345d5-42af-4ac1-8399-7fe8c3583fac"
      unitRef="usd">119490000</us-gaap:Goodwill>
    <us-gaap:IndefiniteLivedTradeNames
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMTMtMS0xLTEtNDYzMzQ_a13c4d8d-a2a2-4334-a946-68a78ddabd38"
      unitRef="usd">5900000</us-gaap:IndefiniteLivedTradeNames>
    <us-gaap:IndefiniteLivedTradeNames
      contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMTMtMy0xLTEtNDYzMzQ_d1cf26a4-42cf-4778-8c88-ddf3c513e212"
      unitRef="usd">5900000</us-gaap:IndefiniteLivedTradeNames>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMTQtMS0xLTEtNDYzMzQ_fa7c86a4-a499-4fef-92fb-c691a522266e"
      unitRef="usd">40843000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMTQtMy0xLTEtNDYzMzQ_5c5d3a51-8108-490f-8e28-856539edc5c6"
      unitRef="usd">42344000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMTUtMS0xLTEtNDYzMzQ_f600a9ff-1f5d-46af-b032-ae44452429d0"
      unitRef="usd">8791000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMTUtMy0xLTEtNDYzMzQ_8ed12ed9-f514-4a8d-bd63-394d05322f11"
      unitRef="usd">11525000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:InsuranceSettlementsReceivableNoncurrent
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMTYtMS0xLTEtNTEwNjQ_8b379a81-20ed-41c3-86bc-91dadebf5155"
      unitRef="usd">20753000</us-gaap:InsuranceSettlementsReceivableNoncurrent>
    <us-gaap:InsuranceSettlementsReceivableNoncurrent
      contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMTYtMy0xLTEtNTEwNjQ_93488d53-a2d2-45be-881a-2f7e9ba836c8"
      unitRef="usd">13998000</us-gaap:InsuranceSettlementsReceivableNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMTYtMS0xLTEtNDYzMzQ_18ab8c40-3e77-40e5-a460-bdcebcbfa1d7"
      unitRef="usd">11043000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMTYtMy0xLTEtNDYzMzQ_149ff6ed-6937-40ef-aceb-ba629be07ea1"
      unitRef="usd">7958000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMTctMS0xLTEtNDYzMzQ_7a6a2f35-1e1b-40d9-a7a4-32c781aae49a"
      unitRef="usd">882512000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMTctMy0xLTEtNDYzMzQ_72720633-a652-467e-97fd-913d3c7cff1d"
      unitRef="usd">732809000</us-gaap:Assets>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMjEtMS0xLTEtNDYzMzQ_e7b48b79-1327-4c94-81e4-a5754eebc0c6"
      unitRef="usd">192032000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent
      contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMjEtMy0xLTEtNDYzMzQ_d2ed297e-3be3-4ecd-9365-89046149252d"
      unitRef="usd">109753000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMjItMS0xLTEtNDYzMzQ_795fcfde-9c61-4de6-bcac-27c30a3b0b09"
      unitRef="usd">70947000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMjItMy0xLTEtNDYzMzQ_8489ddbd-f3f7-466a-a9cf-ba70c3ff8b44"
      unitRef="usd">65580000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMjMtMS0xLTEtNDYzMzQ_6995c3ca-d4d0-4317-aeb0-a7a1f119079a"
      unitRef="usd">0</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMjMtMy0xLTEtNDYzMzQ_9eb8235b-59e1-405f-8d99-0b4e5fd03398"
      unitRef="usd">4176000</us-gaap:LongTermDebtCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMjQtMS0xLTEtNDYzMzQ_5efce532-d10e-4ab2-83b8-5114d5131ed9"
      unitRef="usd">4489000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMjQtMy0xLTEtNDYzMzQ_c8cb9809-e88f-4a3f-bed7-1bf1c59cccf9"
      unitRef="usd">4090000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMjUtMS0xLTEtNDYzMzQ_e0d7a952-bb3d-4692-bf62-a9582fce29af"
      unitRef="usd">19000</us-gaap:TaxesPayableCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMjUtMy0xLTEtNDYzMzQ_ace7a8de-4cd4-406f-aab2-42527f343222"
      unitRef="usd">7307000</us-gaap:TaxesPayableCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMjYtMS0xLTEtNDYzMzQ_845b7f95-31db-4634-b1e2-f4b813660f89"
      unitRef="usd">7500000</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent
      contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMjYtMy0xLTEtNDYzMzQ_cd8f3e3f-89a1-47b6-9816-6df1c792fb6d"
      unitRef="usd">7500000</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMjctMS0xLTEtNDYzMzQ_75eebc8f-84c7-41fa-8aba-6cbe0d1fc213"
      unitRef="usd">1803000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMjctMy0xLTEtNDYzMzQ_5a53403e-dc52-4d7d-862a-7a1ff69cfae8"
      unitRef="usd">1364000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMjgtMS0xLTEtNDYzMzQ_af877fbe-e4d7-4acd-a007-a0265ddc48fa"
      unitRef="usd">276790000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMjgtMy0xLTEtNDYzMzQ_8574ce0a-7fae-4a5d-90aa-1166faff2496"
      unitRef="usd">199770000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OtherLongTermDebtNoncurrent
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMjktMS0xLTEtNDYzMzQ_4087a5c6-3053-49a1-9391-a3c5c6800c37"
      unitRef="usd">129755000</us-gaap:OtherLongTermDebtNoncurrent>
    <us-gaap:OtherLongTermDebtNoncurrent
      contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMjktMy0xLTEtNDYzMzQ_a6c57f66-aaee-4073-b56f-6cc79c09e765"
      unitRef="usd">176366000</us-gaap:OtherLongTermDebtNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMzAtMS0xLTEtNDYzMzQ_cdf50d07-26d5-45a3-90e1-7ef7b4143541"
      unitRef="usd">5493000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMzAtMy0xLTEtNDYzMzQ_56e712e7-4788-4d72-9490-b953d3ca3a47"
      unitRef="usd">10853000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMzEtMS0xLTEtNDYzMzQ_22b83efb-0499-485e-8bdd-5fa6f42660c6"
      unitRef="usd">237000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMzEtMy0xLTEtNDYzMzQ_59f80dff-763f-4c2e-980d-bafad16882ee"
      unitRef="usd">190000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMzItMS0xLTEtNDYzMzQ_351e026e-0ca2-4851-846c-716bab43004e"
      unitRef="usd">33104000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMzItMy0xLTEtNDYzMzQ_b5f00376-4cba-405c-b007-17122e470ed4"
      unitRef="usd">25314000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMzMtMS0xLTEtNDYzMzQ_253bd0e2-e32b-431d-8d31-af0d71c62ba8"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMzMtMy0xLTEtNDYzMzQ_c0f42a6d-ecd6-4a72-9581-bf41acadee76"
      unitRef="usd">9000000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMzQtMS0xLTEtNDYzMzQ_05bae783-9147-4b2f-a94f-35209df4a47a"
      unitRef="usd">14424000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMzQtMy0xLTEtNDYzMzQ_2815ec9d-9b27-493d-a714-d93870291d1d"
      unitRef="usd">13788000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMzUtMS0xLTEtNDYzMzQ_f20a4334-5c22-4257-a41c-696369d861ef"
      unitRef="usd">459803000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMzUtMy0xLTEtNDYzMzQ_1abf8b86-1b62-490c-bf9f-486b9631c231"
      unitRef="usd">435281000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMzctMS0xLTEtNDYzMzQ_f4938aba-cd07-41c4-8dd3-1ce5cca7220b"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfMzctMy0xLTEtNDYzMzQ_a910ea14-c4a5-486e-9b51-63c355632681"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfNDAtMS0xLTEtNDYzMzQ_723fd940-3fa0-4692-92ff-df26b5ac7429"
      unitRef="usd">4000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfNDAtMy0xLTEtNDYzMzQ_844d8032-f195-44c8-864f-0cb4bb737c2b"
      unitRef="usd">4000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfNDEtMS0xLTEtNDYzMzQ_071d8a1b-91e5-4320-b985-8dacd05b58ec"
      unitRef="usd">297143000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfNDEtMy0xLTEtNDYzMzQ_b23232fc-8486-43bc-8792-b6089b98b006"
      unitRef="usd">321552000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfNDItMS0xLTEtNDYzMzQ_d6f23d0d-6c93-4a27-b487-90ae7bc09a57"
      unitRef="usd">-1373000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfNDItMy0xLTEtNDYzMzQ_71411697-642c-4460-be70-a4683df983d7"
      unitRef="usd">-1293000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfNDMtMS0xLTEtNDYzMzQ_f0e69d4c-e704-49eb-856c-cb6ccd9f2c7d"
      unitRef="usd">126935000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfNDMtMy0xLTEtNDYzMzQ_92d2ea5c-8b2c-4d71-baa3-9ba15bbe2eeb"
      unitRef="usd">-22735000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfNDYtMS0xLTEtNDYzMzQ_3483af4d-e797-4410-9d86-68d8849038c6"
      unitRef="usd">422709000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfNDYtMy0xLTEtNDYzMzQ_e8b82cf7-9f1b-4ad9-8f37-889152cb8fcb"
      unitRef="usd">297528000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfNDctMS0xLTEtNDYzMzQ_32530ca0-3e37-40f7-96a3-6a237640933e"
      unitRef="usd">882512000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xOS9mcmFnOmViY2IyODYzNGY2YjRjMTU5NmEwYTdjMjg4NjRmMTQwL3RhYmxlOmJiYThkZTcxODExZDQxZDQ4YTM1MThhZTFjMDgyYjg2L3RhYmxlcmFuZ2U6YmJhOGRlNzE4MTFkNDFkNDhhMzUxOGFlMWMwODJiODZfNDctMy0xLTEtNDYzMzQ_b7bfbaf0-31ee-468b-b8b5-ffa0fec6cc94"
      unitRef="usd">732809000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfNC0xLTEtMS00NjMzNA_b00450e7-f963-4c5c-91b3-0d0f75ed8bbf"
      unitRef="usd">636098000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfNC0zLTEtMS00NjMzNA_d0eb2111-0aa7-4260-8227-c8f1d312e3d8"
      unitRef="usd">374905000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfNC01LTEtMS00NjMzNA_1e7c8aa9-efe6-4abf-aed6-99b4b7864de6"
      unitRef="usd">2178391000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfNC03LTEtMS00NjMzNA_ada37fd3-bbbe-4d50-bb47-de8cd1845fdf"
      unitRef="usd">1035973000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:DirectOperatingCosts
      contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfNi0xLTEtMS00NjMzNA_180307d7-abb2-4098-9c4a-81a3d205141b"
      unitRef="usd">492553000</us-gaap:DirectOperatingCosts>
    <us-gaap:DirectOperatingCosts
      contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfNi0zLTEtMS00NjMzNA_c3c51c58-8de0-45b6-a1e3-382d6201fbc5"
      unitRef="usd">291111000</us-gaap:DirectOperatingCosts>
    <us-gaap:DirectOperatingCosts
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfNi01LTEtMS00NjMzNA_96a87e17-c38c-4e90-b28d-3cdeb986fa6a"
      unitRef="usd">1689647000</us-gaap:DirectOperatingCosts>
    <us-gaap:DirectOperatingCosts
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfNi03LTEtMS00NjMzNA_d52b7ae2-3a81-4e78-90c7-3710873b011e"
      unitRef="usd">808124000</us-gaap:DirectOperatingCosts>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfNy0xLTEtMS00NjMzNA_20116dff-edff-4dc9-905d-6e675118f9ca"
      unitRef="usd">80216000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfNy0zLTEtMS00NjMzNA_6cd59ad5-eb5a-4bb9-b9ec-b5c169f05a2b"
      unitRef="usd">52847000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfNy01LTEtMS00NjMzNA_5496f2f9-7d69-44aa-8e07-465b091dec64"
      unitRef="usd">243038000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfNy03LTEtMS00NjMzNA_b148065d-bd47-416d-b549-21b6d5931b69"
      unitRef="usd">149518000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfOC0xLTEtMS00NjMzNA_0eeb75e1-c4d0-4bd0-b9c5-a64fa8ad5ea2"
      unitRef="usd">1101000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfOC0zLTEtMS00NjMzNA_5b292ea2-78d6-4922-95b1-be01ca8639b2"
      unitRef="usd">1441000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfOC01LTEtMS00NjMzNA_f1edbc43-516b-4f23-9391-2530fc942e92"
      unitRef="usd">6662000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfOC03LTEtMS00NjMzNA_76e30aca-f35d-4b8a-accb-7e95d82b39b7"
      unitRef="usd">2411000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfOS0xLTEtMS00NjMzNA_7c8c095b-5523-444d-a75a-07170a48d340"
      unitRef="usd">3214000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfOS0zLTEtMS00NjMzNA_9022feb2-33b0-42b8-8793-9b9b75ff230b"
      unitRef="usd">2680000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfOS01LTEtMS00NjMzNA_36fc341e-c911-4179-992f-db99e3d6d3c0"
      unitRef="usd">9414000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfOS03LTEtMS00NjMzNA_ea3a6d43-e876-427d-9055-73fd59d15d68"
      unitRef="usd">7132000</us-gaap:DepreciationDepletionAndAmortization>
    <ccrn:AcquisitionAndIntegrationRelatedCosts
      contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTAtMS0xLTEtNDYzMzQ_18f56545-362d-43d1-8248-b29f3a08373c"
      unitRef="usd">490000</ccrn:AcquisitionAndIntegrationRelatedCosts>
    <ccrn:AcquisitionAndIntegrationRelatedCosts
      contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTAtMy0xLTEtNDYzMzQ_996b1ec3-639c-4d86-bd12-662eb1bd1aa8"
      unitRef="usd">61000</ccrn:AcquisitionAndIntegrationRelatedCosts>
    <ccrn:AcquisitionAndIntegrationRelatedCosts
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTAtNS0xLTEtNDYzMzQ_cf9b94a9-f910-4886-88f1-9268daa2fedc"
      unitRef="usd">530000</ccrn:AcquisitionAndIntegrationRelatedCosts>
    <ccrn:AcquisitionAndIntegrationRelatedCosts
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTAtNy0xLTEtNDYzMzQ_c6682a0b-f9c1-4fa2-8d55-4237e0081034"
      unitRef="usd">985000</ccrn:AcquisitionAndIntegrationRelatedCosts>
    <us-gaap:RestructuringCharges
      contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTEtMS0xLTEtNDYzMzQ_dc9ae810-4da9-4492-8c4d-d43df782b383"
      unitRef="usd">2493000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTEtMy0xLTEtNDYzMzQ_abc21ad0-0ba4-461b-97d4-0aa1f0c44a3b"
      unitRef="usd">318000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTEtNS0xLTEtNDYzMzQ_ef0db481-67fc-4459-ae97-fc62a9749d0e"
      unitRef="usd">1859000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTEtNy0xLTEtNDYzMzQ_cab1d26b-32ce-40ca-8573-1666560c79ae"
      unitRef="usd">2391000</us-gaap:RestructuringCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTItMS0xLTEtNDYzMzQ_6a6d4177-3b2d-4563-93d1-79dc46c8fe7b"
      unitRef="usd">3856000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTItMy0xLTEtNDYzMzQ_d27eb0e5-e4ba-459e-98de-b1dcee73d206"
      unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTItNS0xLTEtNDYzMzQ_99b5a20a-ed37-4d3b-9221-df9c566ec4b6"
      unitRef="usd">5597000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTItNy0xLTEtNDYzMzQ_9925d9ba-dc2c-4c67-b26a-982bdfa821b6"
      unitRef="usd">2070000</us-gaap:AssetImpairmentCharges>
    <us-gaap:CostsAndExpenses
      contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTMtMS0xLTEtNDYzMzQ_b1eceb9a-1323-49d9-9b39-4d7dbcf5a266"
      unitRef="usd">583923000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTMtMy0xLTEtNDYzMzQ_537d1b58-bf28-42dd-94a7-a7561c762cae"
      unitRef="usd">348458000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTMtNS0xLTEtNDYzMzQ_0baae02c-cb66-4cce-a151-4a68456006e7"
      unitRef="usd">1956747000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTMtNy0xLTEtNDYzMzQ_ae5f8c0b-5f54-4e37-9565-1cbbd0a42da7"
      unitRef="usd">972631000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTQtMS0xLTEtNDYzMzQ_7965c58c-1968-48da-a954-5e5ef0604d10"
      unitRef="usd">52175000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTQtMy0xLTEtNDYzMzQ_9226d29d-a0ea-4d5d-8402-322da6886c87"
      unitRef="usd">26447000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTQtNS0xLTEtNDYzMzQ_6ba766c2-660d-4047-9f54-aa9b721ddaca"
      unitRef="usd">221644000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTQtNy0xLTEtNDYzMzQ_a2f13035-1765-499f-90a3-2f18d840f76b"
      unitRef="usd">63342000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTYtMS0xLTEtNDYzMzQ_a4ff4d21-f3a6-4f63-bd55-8d33bff002fc"
      unitRef="usd">3498000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTYtMy0xLTEtNDYzMzQ_d4c64ff4-0a48-4eb8-8e48-de07f6a6b3d7"
      unitRef="usd">2182000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTYtNS0xLTEtNDYzMzQ_c916d241-7d4b-41eb-b19b-451da36b1bfc"
      unitRef="usd">10876000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTYtNy0xLTEtNDYzMzQ_b02557d8-5bed-4b0a-ae06-0fdc9045991a"
      unitRef="usd">4049000</us-gaap:InterestExpense>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTctMS0xLTEtNDYzMzQ_8839a86f-b27d-4903-a6ce-99fe9e6f5e49"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTctMy0xLTEtNDYzMzQ_5f7844ee-4e02-4448-8b6a-9c0d56c3ac30"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTctNS0xLTEtNDYzMzQ_2bf1ebe8-5622-48ac-947d-f40000d0dae9"
      unitRef="usd">-1912000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTctNy0xLTEtNDYzMzQ_a5ea1a5a-d12a-40da-a418-c0a0fc605b48"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTgtMS0xLTEtNDYzMzQ_401136fe-da19-4e6e-9688-b54323e83d5f"
      unitRef="usd">27000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTgtMy0xLTEtNDYzMzQ_aa597015-12ec-4e35-b751-50b86082c9ac"
      unitRef="usd">375000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTgtNS0xLTEtNDYzMzQ_7effdfb2-f8b8-4cdb-a679-4c2f32169ced"
      unitRef="usd">1119000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTgtNy0xLTEtNDYzMzQ_f6bf1359-5b2f-4ed2-84e7-cd4a6d18cb46"
      unitRef="usd">616000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTktMS0xLTEtNDYzMzQ_88084327-4129-4a24-9ae9-5b7c3a3ce668"
      unitRef="usd">48704000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTktMy0xLTEtNDYzMzQ_931de9e8-74f4-4b34-a1ca-36cb30158463"
      unitRef="usd">24640000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTktNS0xLTEtNDYzMzQ_cb40946d-612f-4fd0-bb6b-9aec329151f2"
      unitRef="usd">209975000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMTktNy0xLTEtNDYzMzQ_5e570d54-d166-4ea0-8f6a-b7e09b96c787"
      unitRef="usd">59909000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMjAtMS0xLTEtNDYzMzQ_06529471-d0ae-4862-b35b-3cebfbd44fc9"
      unitRef="usd">13911000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMjAtMy0xLTEtNDYzMzQ_b8086078-9876-42d5-870e-be3da7fe71ec"
      unitRef="usd">1207000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMjAtNS0xLTEtNDYzMzQ_ccb6b763-6939-45d9-95ec-2e2f1998886b"
      unitRef="usd">60305000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMjAtNy0xLTEtNDYzMzQ_996a21ff-1ab2-4e8f-8c17-241969185016"
      unitRef="usd">5480000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMjMtMS0xLTEtNDYzMzQ_b69c6e13-181b-4f11-ac6a-c922b98c0222"
      unitRef="usd">34793000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMjMtMy0xLTEtNDYzMzQ_7cc5b1ee-97a1-4c97-9c70-543b97436a0f"
      unitRef="usd">23433000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMjMtNS0xLTEtNDYzMzQ_524d6fd4-cd81-4f12-843d-6aa13caf245a"
      unitRef="usd">149670000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMjMtNy0xLTEtNDYzMzQ_85bf906f-686b-4d21-b527-2017d3b88967"
      unitRef="usd">54429000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMjYtMS0xLTEtNDYzMzQ_39bc7c42-edbe-4e63-9fa8-2d171a5281e7"
      unitRef="usd">-38000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMjYtMy0xLTEtNDYzMzQ_e8528fa5-b989-43cb-bab5-b205527cdc54"
      unitRef="usd">-2000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMjYtNS0xLTEtNDYzMzQ_bf7acc6b-d528-4953-949e-8a220b5dc678"
      unitRef="usd">-80000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMjYtNy0xLTEtNDYzMzQ_895c9088-2d20-4ab7-ae25-09cc5aa791e9"
      unitRef="usd">-32000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMjctMS0xLTEtNDYzMzQ_f608c67c-8420-457e-8e29-cd3654f6ce43"
      unitRef="usd">34755000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMjctMy0xLTEtNDYzMzQ_72ce214e-ac5c-4f7e-9bfd-4f50e132edcf"
      unitRef="usd">23431000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMjctNS0xLTEtNDYzMzQ_0e832cb0-1ca2-475f-83a2-7a67b431836b"
      unitRef="usd">149590000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMjctNy0xLTEtNDYzMzQ_9c430520-b1f8-4531-aff3-09d1d30e1b2a"
      unitRef="usd">54397000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:EarningsPerShareBasic
      contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMjktMS0xLTEtNDYzMzQ_d669096e-50a4-48b1-842a-f48e66ef2d2c"
      unitRef="usdPerShare">0.94</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMjktMy0xLTEtNDYzMzQ_10ae553e-0486-44f2-81a8-43d92129c126"
      unitRef="usdPerShare">0.63</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMjktNS0xLTEtNDYzMzQ_8cdfea8e-f184-48d8-b4e4-56949125c9f1"
      unitRef="usdPerShare">4.02</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMjktNy0xLTEtNDYzMzQ_96b0404e-142a-45d8-a128-467585a711cc"
      unitRef="usdPerShare">1.49</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMzEtMS0xLTEtNDYzMzQ_5a8d3721-df48-44b4-91cf-5f27948c9027"
      unitRef="usdPerShare">0.93</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMzEtMy0xLTEtNDYzMzQ_dba6b928-63e4-4abd-be0d-45427a8f14b7"
      unitRef="usdPerShare">0.62</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMzEtNS0xLTEtNDYzMzQ_91b038db-cd04-4353-ae04-1b3dcd55e534"
      unitRef="usdPerShare">3.97</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMzEtNy0xLTEtNDYzMzQ_49b6de5d-ad5a-4a65-ad0e-b404b419fb1e"
      unitRef="usdPerShare">1.46</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMzQtMS0xLTEtNDYzMzQ_0c37c1a3-cecb-4779-8dd1-de55627cff7b"
      unitRef="shares">37101000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMzQtMy0xLTEtNDYzMzQ_035f8b8e-7e3c-40fa-9af2-86c1a9151d22"
      unitRef="shares">36963000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMzQtNS0xLTEtNDYzMzQ_a1066aa0-939b-46f9-a08a-24c03a67e6e2"
      unitRef="shares">37200000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMzQtNy0xLTEtNDYzMzQ_207f8657-552d-4f80-ab64-76b225070210"
      unitRef="shares">36593000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMzUtMS0xLTEtNDYzMzQ_ed6251e5-6544-4cfa-837b-0a05dd594535"
      unitRef="shares">37492000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMzUtMy0xLTEtNDYzMzQ_53675095-4b71-480a-9241-559f3a6b6edf"
      unitRef="shares">37582000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMzUtNS0xLTEtNDYzMzQ_e7edcf59-43b3-4be3-a78e-56d8de5be40a"
      unitRef="shares">37741000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yMi9mcmFnOmRjYzhmYTFiYjViMDRmMTc4YjM0OWI4M2U0ZTQxZjY4L3RhYmxlOjViZjg5MGQwM2E1YzQ5NTU5MmFhYTI5MDAxNGIzZGNhL3RhYmxlcmFuZ2U6NWJmODkwZDAzYTVjNDk1NTkyYWFhMjkwMDE0YjNkY2FfMzUtNy0xLTEtNDYzMzQ_93b678be-160a-48d5-8986-266cafedb483"
      unitRef="shares">37276000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="i26fb2cd916aa4101ac98bfb0aeed6193_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMi0xLTEtMS00NjMzNA_eff2fc9a-7f69-42fa-911d-b0f02b1105a2"
      unitRef="shares">37523000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i26fb2cd916aa4101ac98bfb0aeed6193_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMi0zLTEtMS00NjMzNA_9c176327-af68-49ad-a850-518e41fc34f6"
      unitRef="usd">4000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i23e6ed6a9fed48d29307fabb2d2666ab_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMi01LTEtMS00NjMzNA_8b15326b-37c9-4362-a57a-80aaa1e085a4"
      unitRef="usd">320000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if342abafe0424c4cbbb239c9eeb5a10b_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMi03LTEtMS00NjMzNA_33f2ffb1-ad1a-4157-899f-08383a3e4f9e"
      unitRef="usd">-1335000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i68cf390bfea94f56a817690cbbf4744d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMi05LTEtMS00NjMzNA_6161fc6f-faed-400f-a0c4-121d6f105ba4"
      unitRef="usd">92142000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iaff6ed2ab3394341b1987107614ed158_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMi0xMS0xLTEtNDYzMzQ_ff093f88-2e6e-419f-b7d6-20e52b7e4d52"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0c0a4267d8174093be4955cfd3a6d031_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMi0xMy0xLTEtNDYzMzQ_0edd2211-8aa0-4089-9cc7-36eade0e13c3"
      unitRef="usd">410811000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i37a23fb61a8646c29cb106b4e9684e9b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfNC01LTEtMS00NjMzNA_90db00f7-6f1e-4742-9065-7fdfd5005f53"
      unitRef="usd">1491000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfNC0xMy0xLTEtNDYzMzQ_78be4e48-321c-4c38-ac78-81523e7c5fa0"
      unitRef="usd">1491000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="ia3fb9c1cd31c4e1181518b558a62bf13_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfNS0xLTEtMS00OTA0Nw_d54b0947-37a7-4385-9176-ab445b68dd3e"
      unitRef="shares">1015000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i37a23fb61a8646c29cb106b4e9684e9b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfNS01LTEtMS00OTA0Nw_bba1eba2-c8dc-4a98-9141-9e0e9f1d1387"
      unitRef="usd">24348000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfNS0xMy0xLTEtNDkwNDc_c30ba9ef-6e7a-4561-b866-2c5b201b7ac2"
      unitRef="usd">24348000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ie0f02a13f7ad4906acc11dee942a7413_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfNS03LTEtMS00NjMzNA_307b78d9-fb44-4ac7-ab20-d655c209b9e4"
      unitRef="usd">-38000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfNS0xMy0xLTEtNDYzMzQ_912dcf55-9d93-4af4-bf80-8d5b81077024"
      unitRef="usd">-38000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="if62eba6a38e6444bbfe404803ad71c18_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfOC05LTEtMS00NjMzNA_884caa12-e92a-429a-9230-235645c2f2d4"
      unitRef="usd">34793000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfOC0xMy0xLTEtNDYzMzQ_6035e648-7fc5-4697-ac68-0ed9869ae03e"
      unitRef="usd">34793000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="i677effe12d9f4d44bd5f1ca7944e48b0_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfOS0xLTEtMS00NjMzNA_99946ecd-6ce3-4006-a677-57bc4f32699e"
      unitRef="shares">36508000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i677effe12d9f4d44bd5f1ca7944e48b0_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfOS0zLTEtMS00NjMzNA_235ae5a7-ef35-495f-9316-0a354fdefd17"
      unitRef="usd">4000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7f59e0723d41435fbc923108afeebf77_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfOS01LTEtMS00NjMzNA_4703085e-ad47-4dd9-aedf-545a1f218d3f"
      unitRef="usd">297143000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i849d2660af354dc7b3da49f0e86fc52c_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfOS03LTEtMS00NjMzNA_8f098cff-5ffc-426c-bd80-798a06d821d8"
      unitRef="usd">-1373000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8e8d1bdde3804c1baf7ae857af6e5e52_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfOS05LTEtMS00NjMzNA_45bd3a7d-a454-4503-8a29-18e4b42965ef"
      unitRef="usd">126935000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4401d4d9ee924023b8f1ec25533e9a67_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfOS0xMS0xLTEtNDYzMzQ_d6f26285-9cb8-4286-b6d6-3c496a342b62"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfOS0xMy0xLTEtNDYzMzQ_c84653f0-ab03-4868-8e39-ac811596b198"
      unitRef="usd">422709000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="i1252820f59e947b4976a678884ff7d91_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMTMtMS0xLTEtNDYzMzQ_43405d9a-bc1d-4bd7-bdbb-25fa09c0868b"
      unitRef="shares">36962000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1252820f59e947b4976a678884ff7d91_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMTMtMy0xLTEtNDYzMzQ_729ce86f-6760-4f60-82aa-b88cdddcdd71"
      unitRef="usd">4000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3fc079c274124a6cac569e4f34366c7b_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMTMtNS0xLTEtNDYzMzQ_238d9fec-92cc-4625-987a-c850503ecbae"
      unitRef="usd">316644000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i532e051d438e418eb3e83be7ed3362f2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMTMtNy0xLTEtNDYzMzQ_cd388d8c-e896-41d8-b361-34c5306d9adf"
      unitRef="usd">-1310000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i725e0cb0ad514e69b7e4c7c6064bc911_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMTMtOS0xLTEtNDYzMzQ_5c986483-70da-447e-ab47-17a4bbd90a53"
      unitRef="usd">-123741000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibc57b01ed27040b3bf77a29981bb957d_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMTMtMTEtMS0xLTQ2MzM0_65265df7-3957-4ba8-85cc-d3279342e029"
      unitRef="usd">534000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i61328c0ca95341349cdc1ca533a6d2bf_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMTMtMTMtMS0xLTQ2MzM0_4b48b0e5-62c1-48b1-a4c2-93859b75d794"
      unitRef="usd">192131000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ic538be4345284146ae03043536ae0bfa_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMTQtMS0xLTEtNDYzMzQ_ed43c159-8578-472b-adcc-36ad87fbf1cd"
      unitRef="shares">2000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i8bc3a63bad324d3b92636e8a32d4f412_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMTUtNS0xLTEtNDYzMzQ_299baef0-441b-4cd4-b67e-06c6e1b52978"
      unitRef="usd">1771000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMTUtMTMtMS0xLTQ2MzM0_93091db9-1570-4670-af91-20ccdf7b327e"
      unitRef="usd">1771000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ibe8f646189004462a689d8e6ab700027_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMTYtNy0xLTEtNDYzMzQ_8ee9aac2-7790-4bbd-8e02-f8435e694e97"
      unitRef="usd">-2000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMTYtMTMtMS0xLTQ2MzM0_480f1e31-741b-4e2a-8e3c-565cff3bbffd"
      unitRef="usd">-2000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="if1c4bd146f604316b819aa100137bf51_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMTgtMTEtMS0xLTQ3NzA2_f95ef268-b0f4-4fa0-b62b-2df4bdc50edb"
      unitRef="usd">324000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMTgtMTMtMS0xLTQ3NzA2_8062e2a7-551d-4338-b990-9852111f40b5"
      unitRef="usd">324000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="if1c4bd146f604316b819aa100137bf51_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMTktMTEtMS0xLTQ3NzA2_c930a064-113b-4176-ba11-cdcce03d1026"
      unitRef="usd">210000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMTktMTMtMS0xLTQ3NzA2_97b5395a-3148-4196-a2e8-bb4485c2d6c6"
      unitRef="usd">210000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:NetIncomeLoss
      contextRef="iadcfed8870184b00ac8df3ef3a6c7332_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMTgtOS0xLTEtNDYzMzQ_92e4910b-96a8-447b-8799-9ea55f1dc4ea"
      unitRef="usd">23433000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMTgtMTMtMS0xLTQ2MzM0_93ae70aa-f281-40c6-be88-bfccf3f3be5a"
      unitRef="usd">23433000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="i3edda426942249bf91dae3b40fcf7ae9_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMTktMS0xLTEtNDYzMzQ_bf750998-8957-4af9-b264-70afe611775a"
      unitRef="shares">36964000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3edda426942249bf91dae3b40fcf7ae9_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMTktMy0xLTEtNDYzMzQ_b2007b9c-907e-411f-bfb5-bb2a69407468"
      unitRef="usd">4000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i661f31a4c8174df5accdb1e19dbc9603_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMTktNS0xLTEtNDYzMzQ_41029410-2664-4940-be28-f725a7a3e8f0"
      unitRef="usd">318415000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic78b970907494e82bd28d42c18310a5f_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMTktNy0xLTEtNDYzMzQ_66ac27a8-c88e-4a28-b9f6-04eff52e7e9a"
      unitRef="usd">-1312000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i89f83f5578c9454b87f8cf964b36d386_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMTktOS0xLTEtNDYzMzQ_1e361594-c0d1-4ca8-a5c7-968a5fbad963"
      unitRef="usd">-100308000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4fefba535da24f6faa17aa6af4553338_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMTktMTEtMS0xLTQ2MzM0_e969489f-4815-4c09-bfdb-663aedce8535"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idb81780210de40218de77358d91c73ba_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yNS9mcmFnOjFkOWY1NjUxODkzNjQ0YmE4NzNiYzJjZDkyYTY5YjhkL3RhYmxlOjMwMjQ1ZWNlY2FjNjRjN2ViOTBjMmFmYWI3MDU0ZTM2L3RhYmxlcmFuZ2U6MzAyNDVlY2VjYWM2NGM3ZWI5MGMyYWZhYjcwNTRlMzZfMTktMTMtMS0xLTQ2MzM0_a7937e0c-2ea5-4c2e-ab8c-2f58ca8f8f1d"
      unitRef="usd">216799000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="i0adb8d88d43c4f0699c9c108560ff3c3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMi0xLTEtMS00NjMzNA_4a031624-3ca0-4a01-ac9c-72e10280ebe0"
      unitRef="shares">37024000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0adb8d88d43c4f0699c9c108560ff3c3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMi0zLTEtMS00NjMzNA_dca1aa4c-b80f-4961-bd5f-b533408d8136"
      unitRef="usd">4000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if3eb9dcc1ff645df99ce9eb18565e9a4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMi01LTEtMS00NjMzNA_708cf1f4-1376-4b5d-ae65-04e70606ec4e"
      unitRef="usd">321552000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i76c4c8c1ba544b218b38c4841b734300_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMi03LTEtMS00NjMzNA_c4901cc2-4087-4eda-a2d3-0aa0ddf13927"
      unitRef="usd">-1293000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic7e684e1ca5746c9987a351de57e7a33_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMi05LTEtMS00NjMzNA_98a54fa8-03b6-4a16-837a-1fe54ab2919c"
      unitRef="usd">-22735000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0d0df14b23af42f8bf234fae71fdabce_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMi0xMS0xLTEtNDYzMzQ_8724b103-b8f9-4703-b38b-d5d7ead67804"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMi0xMy0xLTEtNDYzMzQ_d27e6329-40cd-4ee1-a9ed-a0714741237f"
      unitRef="usd">297528000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i36a03f0a3609488882bcc1d53ba8b90a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMy0xLTEtMS00NjMzNA_9cf20d48-20f0-4ce0-84ec-68c42d59d135"
      unitRef="shares">499000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i3ebd46f32725469a851e253627061ba5_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMy01LTEtMS00NjMzNA_83073cb3-5a0a-4969-8d28-0d8194a6a9ba"
      unitRef="usd">-5267000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMy0xMy0xLTEtNDYzMzQ_f2ed7303-654b-4ece-a899-68347dcfb143"
      unitRef="usd">-5267000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i3ebd46f32725469a851e253627061ba5_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfNC01LTEtMS00NjMzNA_ab90c5d9-7e3c-4126-beb3-cc70a6160589"
      unitRef="usd">5206000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfNC0xMy0xLTEtNDYzMzQ_0078f2e5-2b79-4434-b06d-efe9de934db5"
      unitRef="usd">5206000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i36a03f0a3609488882bcc1d53ba8b90a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfNS0xLTEtMS00OTA1Nw_db3f1dbd-657b-441d-8764-ff067b135c75"
      unitRef="shares">1015000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i3ebd46f32725469a851e253627061ba5_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfNS01LTEtMS00OTA1Nw_0191923e-5f14-4cf6-8689-60c5206de712"
      unitRef="usd">24348000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfNS0xMy0xLTEtNDkwNTc_374b070e-0e8c-483d-ae42-3c80589ccaab"
      unitRef="usd">24348000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i55f1d59f3df544b3b26a366b71c31170_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfNS03LTEtMS00NjMzNA_d85ee0fa-59f4-4dbe-a0f0-a4870426fcc2"
      unitRef="usd">-80000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfNS0xMy0xLTEtNDYzMzQ_aee81ad2-c19b-4236-999e-ab61f8083208"
      unitRef="usd">-80000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="i4db29b7907044e1ca81a2082beb7444a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfOS05LTEtMS00NjMzNA_a06c1292-c441-4e5f-945e-29dea74baf15"
      unitRef="usd">149670000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfOS0xMy0xLTEtNDYzMzQ_e638a823-c6a8-4815-87a8-6570258a1284"
      unitRef="usd">149670000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="i677effe12d9f4d44bd5f1ca7944e48b0_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMTAtMS0xLTEtNDYzMzQ_2b0e8848-58f1-4ef6-965b-a44e142ca248"
      unitRef="shares">36508000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i677effe12d9f4d44bd5f1ca7944e48b0_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMTAtMy0xLTEtNDYzMzQ_1d3e1303-2971-44b2-9972-e95bb04fee4c"
      unitRef="usd">4000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7f59e0723d41435fbc923108afeebf77_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMTAtNS0xLTEtNDYzMzQ_70000dad-0d44-435b-ba44-34e34826d9be"
      unitRef="usd">297143000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i849d2660af354dc7b3da49f0e86fc52c_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMTAtNy0xLTEtNDYzMzQ_482af2b3-5251-4000-a58b-0520154f6d89"
      unitRef="usd">-1373000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8e8d1bdde3804c1baf7ae857af6e5e52_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMTAtOS0xLTEtNDYzMzQ_fba5a2f4-443b-4157-9714-873f7f9b4e4a"
      unitRef="usd">126935000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4401d4d9ee924023b8f1ec25533e9a67_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMTAtMTEtMS0xLTQ2MzM0_4623bbb6-e9c2-478c-b887-ea53b127bdfb"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMTAtMTMtMS0xLTQ2MzM0_2005693f-3627-47f0-ab1a-820554cead50"
      unitRef="usd">422709000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="i46d38e032f6045d5811f4c3961253386_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMTQtMS0xLTEtNDYzMzQ_45911051-16d7-45b1-9d7b-a74e43906f5d"
      unitRef="shares">36177000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i46d38e032f6045d5811f4c3961253386_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMTQtMy0xLTEtNDYzMzQ_ea0520b1-8668-4caa-af06-938efb255111"
      unitRef="usd">4000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6641a1756e67403d810b23655f4e192e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMTQtNS0xLTEtNDYzMzQ_fb6af5cb-3c6e-460d-b444-61ce94c27a5d"
      unitRef="usd">310388000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i24f2241f06ba4fd28714f067a2014198_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMTQtNy0xLTEtNDYzMzQ_a4f7d35f-a56b-4e8d-b196-67bf4ca5bc90"
      unitRef="usd">-1280000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie1ae1d5ee1d14280ac3f645f56e7bb1a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMTQtOS0xLTEtNDYzMzQ_b8a14752-1b44-414d-b498-034138b7636a"
      unitRef="usd">-154737000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5affaa8d5f934c798b6c95e386f76904_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMTQtMTEtMS0xLTQ2MzM0_aa700887-3275-44a9-96d0-4d7d7d6c7a7d"
      unitRef="usd">534000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i119af728c7ce4ee8bb64043a29f00ca5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMTQtMTMtMS0xLTQ2MzM0_aa3f748c-c7c7-4fb8-921e-9c2569d0da6a"
      unitRef="usd">154909000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i702dc94df8644dde8f1cce342f5d1e3b_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMTUtMS0xLTEtNDYzMzQ_ee777ae8-11a1-44eb-8828-549aba41ae3e"
      unitRef="shares">479000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ic0e5daec688e4f149d1bb1d3c238f468_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMTUtNS0xLTEtNDYzMzQ_81df6c19-3c5f-48ce-85d0-e38ac4d863cf"
      unitRef="usd">-2230000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMTUtMTMtMS0xLTQ2MzM0_1711c957-3ba7-435a-8116-35f18dc70326"
      unitRef="usd">-2230000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ic0e5daec688e4f149d1bb1d3c238f468_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMTYtNS0xLTEtNDYzMzQ_76ad008a-2105-4ceb-8d07-0e2252eb957d"
      unitRef="usd">5257000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMTYtMTMtMS0xLTQ2MzM0_732c7be4-09f3-4d3c-9ea1-3109fa54c961"
      unitRef="usd">5257000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i8aff35e423dc48b2880bbf459a28b4cb_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMTctNy0xLTEtNDYzMzQ_50577a1a-203c-45f2-9f36-8e930ea4641a"
      unitRef="usd">-32000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMTctMTMtMS0xLTQ2MzM0_fcf86537-14ea-463e-b70b-17d95666d701"
      unitRef="usd">-32000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="i702dc94df8644dde8f1cce342f5d1e3b_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMTgtMS0xLTEtNDYzMzQ_0e65c996-7af9-47cb-9358-0df25bcb1d3c"
      unitRef="shares">308000</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="ic0e5daec688e4f149d1bb1d3c238f468_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMTgtNS0xLTEtNDYzMzQ_fe29b8ba-14ab-4819-8a08-ee45f4be0a0a"
      unitRef="usd">5000000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMTgtMTMtMS0xLTQ2MzM0_6e058d5b-0f5d-420c-8943-3d1e443e586c"
      unitRef="usd">5000000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="i3ea4b9a9c7024e24b7056df5589337d5_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMTktMTEtMS0xLTQ3NzE3_39423cf1-0264-412a-810d-80688029d9f0"
      unitRef="usd">324000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMTktMTMtMS0xLTQ3NzE3_c618be52-cca4-4493-a133-8317c1ed4951"
      unitRef="usd">324000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i3ea4b9a9c7024e24b7056df5589337d5_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMjAtMTEtMS0xLTQ3NzE3_046c94c8-85af-4dc6-9fc8-4faee680a2a1"
      unitRef="usd">210000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMjAtMTMtMS0xLTQ3NzE3_520ed7bc-58cd-47b6-a884-24f61a3e115b"
      unitRef="usd">210000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:NetIncomeLoss
      contextRef="i253197afe06e45bca28e963b592a33ea_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMTktOS0xLTEtNDYzMzQ_0de5ecae-8cd3-48c1-a20a-7bd1d360c8b9"
      unitRef="usd">54429000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMTktMTMtMS0xLTQ2MzM0_e8101e71-89b7-41d9-9c75-091ef285d2a5"
      unitRef="usd">54429000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="i3edda426942249bf91dae3b40fcf7ae9_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMjAtMS0xLTEtNDYzMzQ_cb306190-30ac-4645-98e3-4a629e55be94"
      unitRef="shares">36964000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3edda426942249bf91dae3b40fcf7ae9_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMjAtMy0xLTEtNDYzMzQ_05221ec2-4e8e-4f7b-a1e0-42c6e948efaa"
      unitRef="usd">4000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i661f31a4c8174df5accdb1e19dbc9603_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMjAtNS0xLTEtNDYzMzQ_0b6cc071-9239-445a-a73d-7b5cef2c1257"
      unitRef="usd">318415000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic78b970907494e82bd28d42c18310a5f_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMjAtNy0xLTEtNDYzMzQ_23979cca-92e3-4bf2-8991-1ec3ed448099"
      unitRef="usd">-1312000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i89f83f5578c9454b87f8cf964b36d386_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMjAtOS0xLTEtNDYzMzQ_d1020cbb-ccc9-4702-bbc1-251ca42dd5eb"
      unitRef="usd">-100308000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4fefba535da24f6faa17aa6af4553338_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMjAtMTEtMS0xLTQ2MzM0_4c416505-47c6-4fdc-aa2a-b55d956c29f1"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idb81780210de40218de77358d91c73ba_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8yOC9mcmFnOjNjOTdhZmU5YzY3ODRiMTU4MzFkODg0ODFhOTM4MTA0L3RhYmxlOjYzMDEwY2NlYzRjNDQ1NGZiMTMwZmYxNTBlOTFkYWJlL3RhYmxlcmFuZ2U6NjMwMTBjY2VjNGM0NDU0ZmIxMzBmZjE1MGU5MWRhYmVfMjAtMTMtMS0xLTQ2MzM0_f5e58e7a-c97f-4b8e-a8e6-f488a82dfaad"
      unitRef="usd">216799000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfNC0xLTEtMS00NjMzNA_7316b42a-5808-4b4c-bb45-fe059a1200c0"
      unitRef="usd">149670000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfNC0zLTEtMS00NjMzNA_676a43b7-2d28-4b99-8be5-8dec292e2aae"
      unitRef="usd">54429000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfNi0xLTEtMS00NjMzNA_5f8bf8f0-9741-4e93-9523-c3e92cf4e454"
      unitRef="usd">9414000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfNi0zLTEtMS00NjMzNA_5aa7e102-cfbe-4e71-b645-1cfb04119050"
      unitRef="usd">7132000</us-gaap:DepreciationDepletionAndAmortization>
    <ccrn:ProvisionForDoubtfulAccountsAndOtherAllowances
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfNy0xLTEtMS00NjMzNA_ee0a63d5-c31d-49ac-8d86-fb037c0be7b6"
      unitRef="usd">10016000</ccrn:ProvisionForDoubtfulAccountsAndOtherAllowances>
    <ccrn:ProvisionForDoubtfulAccountsAndOtherAllowances
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfNy0zLTEtMS00NjMzNA_4a7582fa-739c-45cc-891b-eba0e8cf51d1"
      unitRef="usd">3836000</ccrn:ProvisionForDoubtfulAccountsAndOtherAllowances>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfOC0xLTEtMS00NjMzNA_5c65d79c-57a4-4a0d-b936-e741755cb787"
      unitRef="usd">2797000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfOC0zLTEtMS00NjMzNA_bdf03d3b-9861-4e30-a176-dcc7fbcd9c81"
      unitRef="usd">2797000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <ccrn:OperatingLeaseExpenseNonCash
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfOS0xLTEtMS00NjMzNA_a0d48e5b-7b55-44fb-842c-a7dea5ace413"
      unitRef="usd">1437000</ccrn:OperatingLeaseExpenseNonCash>
    <ccrn:OperatingLeaseExpenseNonCash
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfOS0zLTEtMS00NjMzNA_1137a8c7-7d79-483f-a54e-6362e4f58c69"
      unitRef="usd">1866000</ccrn:OperatingLeaseExpenseNonCash>
    <us-gaap:AssetImpairmentCharges
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMTAtMS0xLTEtNDYzMzQ_96021f6f-74bf-4b68-9dfd-334fbe55bdd0"
      unitRef="usd">5597000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMTAtMy0xLTEtNDYzMzQ_075c9b3d-cb9e-41db-9e8e-b97d1c55d508"
      unitRef="usd">2070000</us-gaap:AssetImpairmentCharges>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMTEtMS0xLTEtNDYzMzQ_2eebb0e1-d3ae-4ed4-a095-3f6c5c515da0"
      unitRef="usd">-1912000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMTEtMy0xLTEtNDYzMzQ_b74d917c-da54-4712-8eec-90cd988da813"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:ShareBasedCompensation
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMTItMS0xLTEtNDYzMzQ_32a67d51-e2bf-4d00-9ca8-fc404a1f68d4"
      unitRef="usd">5206000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMTItMy0xLTEtNDYzMzQ_b8358571-12ef-425e-93af-a73f064a2d81"
      unitRef="usd">5257000</us-gaap:ShareBasedCompensation>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMTMtMS0xLTEtNDYzMzQ_d800fc6a-ddf3-4a29-98a0-cd2a0670bf47"
      unitRef="usd">-64000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMTMtMy0xLTEtNDYzMzQ_025881e3-bc93-4b19-a4fd-6eb69947a66d"
      unitRef="usd">-833000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMTUtMS0xLTEtNDYzMzQ_2146f8b3-8ecd-4fc1-b0d9-43d5f4c6c320"
      unitRef="usd">127003000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMTUtMy0xLTEtNDYzMzQ_77e9cb52-3943-493f-bcb3-e46e31b6c8e1"
      unitRef="usd">122887000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMTYtMS0xLTEtNDYzMzQ_77674c47-cb86-4ce4-a834-27ddcc7b98e6"
      unitRef="usd">-1236000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMTYtMy0xLTEtNDYzMzQ_f0c450fd-2900-4615-bbd4-2bc186949103"
      unitRef="usd">259000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMTctMS0xLTEtNDYzMzQ_b931446a-3228-4a6f-a5f7-daacb6cadb2a"
      unitRef="usd">-13220000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMTctMy0xLTEtNDYzMzQ_a5a51d91-8eb6-440b-8ec8-1c2668b77c28"
      unitRef="usd">759000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMTgtMS0xLTEtNDYzMzQ_d163f48f-8488-4c7f-9b0c-56727e118fc2"
      unitRef="usd">87156000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMTgtMy0xLTEtNDYzMzQ_d90e96f8-6c5a-49c7-8652-bbd8aff41a5f"
      unitRef="usd">36675000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <ccrn:IncreaseDecreaseInOperatingLeaseLiabilities
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMTktMS0xLTEtNDYzMzQ_b10fdbfd-c77c-454b-abac-6d41bbbd18f5"
      unitRef="usd">-3817000</ccrn:IncreaseDecreaseInOperatingLeaseLiabilities>
    <ccrn:IncreaseDecreaseInOperatingLeaseLiabilities
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMTktMy0xLTEtNDYzMzQ_8b83eee5-9409-4789-a75f-4a25abfb83e7"
      unitRef="usd">-4592000</ccrn:IncreaseDecreaseInOperatingLeaseLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMjAtMS0xLTEtNDYzMzQ_eaf13f87-598a-4fb4-98d7-a2e30c3605cd"
      unitRef="usd">-735000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMjAtMy0xLTEtNDYzMzQ_b4abdf26-55ce-4c3c-8c40-6b6292308eb2"
      unitRef="usd">-169000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMjEtMS0xLTEtNDYzMzQ_68ae6cc5-af60-4df5-ade2-90d1983b474a"
      unitRef="usd">129730000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMjEtMy0xLTEtNDYzMzQ_f0d3d082-c353-43d8-bdb4-af65a032d0e6"
      unitRef="usd">-12253000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMjQtMS0xLTEtNDYzMzQ_1dfec5a4-7ed2-499b-8ddf-14b838a5415f"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMjQtMy0xLTEtNDYzMzQ_a75091ae-112a-490f-88db-a47f5c762ded"
      unitRef="usd">24470000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMjUtMS0xLTEtNDYzMzQ_2a0de595-1597-4b02-ad1c-73a8efa4cb6b"
      unitRef="usd">6763000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMjUtMy0xLTEtNDYzMzQ_85cd5b01-7871-4161-80cf-7b2cef025659"
      unitRef="usd">4890000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMjYtMS0xLTEtNDYzMzQ_81143c4c-a5aa-45b1-9be2-38640613560f"
      unitRef="usd">-6763000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMjYtMy0xLTEtNDYzMzQ_4a76099f-b789-43cc-8e28-3ad7f7128093"
      unitRef="usd">-29360000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfSecuredDebt
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMjktMS0xLTEtNDYzMzQ_3b9d1989-0655-4b50-983b-b7d9481123ee"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfSecuredDebt>
    <us-gaap:ProceedsFromIssuanceOfSecuredDebt
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMjktMy0xLTEtNDYzMzQ_931cd3df-1d30-45a8-b67d-463cee44f5c8"
      unitRef="usd">100000000</us-gaap:ProceedsFromIssuanceOfSecuredDebt>
    <us-gaap:RepaymentsOfSecuredDebt
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMzAtMS0xLTEtNDYzMzQ_76487915-ed7c-48aa-bba1-06808c0ae022"
      unitRef="usd">50438000</us-gaap:RepaymentsOfSecuredDebt>
    <us-gaap:RepaymentsOfSecuredDebt
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMzAtMy0xLTEtNDYzMzQ_9d454dab-0f28-4d88-b72d-b85ec0e1f312"
      unitRef="usd">250000</us-gaap:RepaymentsOfSecuredDebt>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMzEtMS0xLTEtNDYzMzQ_6018d55a-0bc8-4b77-8d98-82dbc455b8ce"
      unitRef="usd">3159000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMzEtMy0xLTEtNDYzMzQ_0f789b27-3b49-4bc2-abac-ff276397964f"
      unitRef="usd">4573000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMzItMS0xLTEtNDYzMzQ_bee49ad5-fd15-4dc0-abc6-ed10aeeb4c24"
      unitRef="usd">1275808000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMzItMy0xLTEtNDYzMzQ_2d43c5fa-a3a9-47cd-b8b0-4ee8084991d3"
      unitRef="usd">288467000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:RepaymentsOfLongTermLinesOfCredit
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMzMtMS0xLTEtNDYzMzQ_d34b91b6-94f8-48da-83d2-9c5e5a3f5755"
      unitRef="usd">1275808000</us-gaap:RepaymentsOfLongTermLinesOfCredit>
    <us-gaap:RepaymentsOfLongTermLinesOfCredit
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMzMtMy0xLTEtNDYzMzQ_985493c5-4237-4ac8-9d56-68bd45f27961"
      unitRef="usd">337876000</us-gaap:RepaymentsOfLongTermLinesOfCredit>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMzQtMS0xLTEtNDYzMzQ_50679674-451c-4580-a82b-6ad8edf296b0"
      unitRef="usd">5267000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMzQtMy0xLTEtNDYzMzQ_6da060cf-c0cf-47b3-ab5e-0063cf94408f"
      unitRef="usd">2230000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMzUtMS0xLTEtNDYzMzQ_c24cdc82-fa2d-4cc4-b888-9ab6d13b9a83"
      unitRef="usd">2426000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMzUtMy0xLTEtNDYzMzQ_0637c2c2-fe85-40e1-8391-bfa964e6c61c"
      unitRef="usd">2426000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMzctMS0xLTEtNTAxOTQ_7974c1bf-c73e-45bd-a68c-b9452612c747"
      unitRef="usd">24348000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMzctMy0xLTEtNTAxOTQ_9543af2d-110d-46ca-9450-049067893f29"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMzctMS0xLTEtNTE1ODk_d490fdd4-f666-4440-8175-d313fa58271b"
      unitRef="usd">7500000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMzctMy0xLTEtNTE1ODk_823a94fb-a2df-4793-aca1-c76860cfcffd"
      unitRef="usd">0</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMzctMS0xLTEtNDYzMzQ_d2fc1087-1d69-437e-80a3-516fd1e2c76b"
      unitRef="usd">-536000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMzctMy0xLTEtNDYzMzQ_c3b7608a-e8f0-43d8-894c-d8d66eb65471"
      unitRef="usd">-243000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMzgtMS0xLTEtNDYzMzQ_f155b602-08ba-48b9-b274-b5ffa421948b"
      unitRef="usd">-93674000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfMzgtMy0xLTEtNDYzMzQ_e8225ed8-1dbf-4499-9592-f3604668818d"
      unitRef="usd">40869000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfNDAtMS0xLTEtNDYzMzQ_5c1cfec7-f27e-4dcd-8912-e39270325ae8"
      unitRef="usd">-9000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfNDAtMy0xLTEtNDYzMzQ_0670e5e5-2a00-47c8-8884-f89acb67a67b"
      unitRef="usd">-14000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfNDEtMS0xLTEtNDYzMzQ_bb591d5e-68e6-40b3-879c-fdf22ffefc2f"
      unitRef="usd">29284000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfNDEtMy0xLTEtNDYzMzQ_8903cb12-a448-467e-84dd-c65a358dbeda"
      unitRef="usd">-758000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfNDItMS0xLTEtNDYzMzQ_f4851bfc-6f50-4f69-be32-654e2208dea2"
      unitRef="usd">1036000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i119af728c7ce4ee8bb64043a29f00ca5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfNDItMy0xLTEtNDYzMzQ_53150104-94bc-4dbf-914d-1e237636e3a9"
      unitRef="usd">1600000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfNDMtMS0xLTEtNDYzMzQ_e6cc5810-aec9-4c71-9acc-a40c288defac"
      unitRef="usd">30320000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="idb81780210de40218de77358d91c73ba_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zMS9mcmFnOmVhOTQ4NDY2MWI2YTRlOTM5Y2JkMzQ1OGRiNzhhYTRiL3RhYmxlOmZiZTdjYzUxYTdiNzQzMjZhZTNiNWY0NTE1YWJlNDcwL3RhYmxlcmFuZ2U6ZmJlN2NjNTFhN2I3NDMyNmFlM2I1ZjQ1MTVhYmU0NzBfNDMtMy0xLTEtNDYzMzQ_fc93fb75-88e6-43bc-91a8-0c2da461ecab"
      unitRef="usd">842000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zNy9mcmFnOjhjYWYyYTQyZjhjYzQ2NDhhZDgwMDgyOGIwNzJjMWNiL3RleHRyZWdpb246OGNhZjJhNDJmOGNjNDY0OGFkODAwODI4YjA3MmMxY2JfMTYzMg_167000cc-1461-4551-befb-bd3534d67f77">ORGANIZATION AND BASIS OF PRESENTATION&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Nature of Business&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying condensed consolidated financial statements include the accounts of Cross Country Healthcare, Inc. and its direct and indirect wholly-owned subsidiaries (collectively, the Company). In the opinion of management, all adjustments necessary for a fair presentation of such unaudited condensed consolidated financial statements have been included. All such adjustments consisted of all normal recurring items, including the elimination of all intercompany transactions and balances.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cross Country Talent Acquisition Group, LLC was a joint venture controlled but not wholly-owned by the Company. Effective December 31, 2020, the sole professional staffing services agreement held by this joint venture was terminated and, as a result, the Company dissolved Cross Country Talent Acquisition Group, LLC in the third quarter of 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (U.S. GAAP) for interim financial information and with the instructions to Form&#160;10-Q and Article 10 of Regulation&#160;S-X. Accordingly, they do not include all of the information and notes required by U.S. GAAP for complete financial statements. These operating results are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These unaudited interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended December 31, 2021 included in the 2021 Form 10-K. The December&#160;31, 2021 condensed consolidated balance sheet included herein was derived from the December&#160;31, 2021 audited consolidated balance sheet included in the 2021 Form&#160;10-K.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain prior year amounts have been reclassified to conform to the current year presentation. See the condensed consolidated balance sheets and statements of cash flows.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zNy9mcmFnOjhjYWYyYTQyZjhjYzQ2NDhhZDgwMDgyOGIwNzJjMWNiL3RleHRyZWdpb246OGNhZjJhNDJmOGNjNDY0OGFkODAwODI4YjA3MmMxY2JfMTYyNA_3059a92a-82d1-4c2c-87f6-faa908d520dc">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Nature of Business&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying condensed consolidated financial statements include the accounts of Cross Country Healthcare, Inc. and its direct and indirect wholly-owned subsidiaries (collectively, the Company). In the opinion of management, all adjustments necessary for a fair presentation of such unaudited condensed consolidated financial statements have been included. All such adjustments consisted of all normal recurring items, including the elimination of all intercompany transactions and balances.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cross Country Talent Acquisition Group, LLC was a joint venture controlled but not wholly-owned by the Company. Effective December 31, 2020, the sole professional staffing services agreement held by this joint venture was terminated and, as a result, the Company dissolved Cross Country Talent Acquisition Group, LLC in the third quarter of 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8zNy9mcmFnOjhjYWYyYTQyZjhjYzQ2NDhhZDgwMDgyOGIwNzJjMWNiL3RleHRyZWdpb246OGNhZjJhNDJmOGNjNDY0OGFkODAwODI4YjA3MmMxY2JfMTYyMQ_4001de67-6419-4737-8a8e-41341c897a9b">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (U.S. GAAP) for interim financial information and with the instructions to Form&#160;10-Q and Article 10 of Regulation&#160;S-X. Accordingly, they do not include all of the information and notes required by U.S. GAAP for complete financial statements. These operating results are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These unaudited interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended December 31, 2021 included in the 2021 Form 10-K. The December&#160;31, 2021 condensed consolidated balance sheet included herein was derived from the December&#160;31, 2021 audited consolidated balance sheet included in the 2021 Form&#160;10-K.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RleHRyZWdpb246Y2FkODJmNTczYmFkNGUzNjg2YzhmZjFjYjY2MDVhNTZfNjc1Ng_5f564b1f-ba66-4573-baf8-24c659d6a09a">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts in the condensed consolidated financial statements and accompanying notes. Management has assessed various accounting estimates and other matters, including those that require consideration of forecasted financial information, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in context of the unknown future impacts of the global COVID pandemic&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; using information that is reasonably available to the Company at the time. Significant estimates and assumptions are used for, but not limited to: (i) the valuation of accounts receivable; (ii) goodwill, trade names, and other intangible assets; (iii) other long-lived assets; (iv) revenue recognition; (v) accruals for health, workers&#x2019; compensation, and professional liability claims; (vi) valuation of deferred tax assets; (vii) legal contingencies; and (viii) income taxes. Accrued insurance claims and reserves include estimated settlements from known claims and actuarial estimates for claims incurred but not reported. As additional information becomes available to the Company, its future assessment of these estimates&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, including management's expectations at the time regarding the duration, scope, and severity of the pandemic, as well as other factors,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; could materially and adversely impact the Company's consolidated financial statements in future reporting periods. Actual results could differ from those estimates.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Risks and Uncertainties&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s future results of operations and liquidity could be materially adversely affected by macroeconomic factors contributing to delays in payments from clients and inflationary pressure, uncertain or reduced demand, and the impact of any initiatives or programs that the Company may undertake to address financial and operational challenges faced by its clients.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company is also subject to additional risks and uncertainties due to the ongoing COVID pandemic. The extent of the impact on the Company&#x2019;s business is highly uncertain and difficult to predict.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounts Receivable, net&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The timing of revenue recognition, billings, and collections results in billed and unbilled accounts receivable from customers, which are classified as accounts receivable on the condensed consolidated balance sheets and are presented net of allowances for doubtful accounts and sales allowances. Estimated revenue for the Company employees', subcontracted employees', and independent contractors&#x2019; time worked but not yet billed at September 30, 2022 and December 31, 2021 totaled $161.2&#160;million and $140.0&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company generally does not require collateral and mitigates its credit risk by performing credit evaluations and monitoring at-risk accounts. The allowance for doubtful accounts is established for losses expected to be incurred on accounts receivable balances. Accounts receivable are written off against the allowance for doubtful accounts when the Company determines amounts are no longer collectible. Judgment is required in the estimation of the allowance and the Company evaluates the collectability of its accounts receivable and contract assets based on a combination of factors. The Company bases its allowance for doubtful account estimates on its historical write-off experience, current conditions, an analysis of the aging of outstanding receivable and customer payment patterns, and specific reserves for customers in adverse condition adjusted for current expectations for the customers or industry. Based on the information currently available, the Company also considered current expectations of future economic condition&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;s, including the impact of COVID, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;when estimating its allowance for doubtful accounts.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The opening balance of the allowance for doubtful accounts is reconciled to the closing balance for expected credit losses as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bad Debt Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Write-Offs, net of Recoveries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(365)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(699)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bad Debt Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Write-Offs, net of Recoveries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(426)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(358)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June 30&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bad Debt Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Write-Offs, net of Recoveries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(593)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(138)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to the allowance for doubtful accounts, the Company maintains a sales allowance for billing-related adjustments which may arise in the ordinary course of business and adjustments to the reserve are recorded as contra-revenue. The balance of this allowance as of September 30, 2022 and December 31, 2021 was $1.4&#160;million and $0.8&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s contract terms typically require payment between 30 to 60 days from the date of invoice and are considered past due based on the particular negotiated contract terms. The majority of the Company's customers are U.S. based healthcare systems with a significant percentage in acute-care facilities. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No single customer accounted for more than 10% of the Company&#x2019;s revenue for the three and nine months ended September 30, 2022 and 2021, or the accounts receivable balance as of September 30, 2022 and December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Restructuring Costs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers restructuring activities to be programs whereby it fundamentally changes its operations, such as closing and consolidating facilities, reducing headcount, and realigning operations in response to changing market conditions. As a result, restructuring (benefits) costs on the condensed consolidated statements of operations primarily include employee termination costs and lease-related exit costs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reconciliation of the employee termination costs and lease-related exit costs (benefits) beginning and ending liability balance is presented below:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.593%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.728%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Employee Termination&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Lease-Related&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charged to restructuring&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments and adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(160)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(192)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charged to restructuring&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,379)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(202)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charged to restructuring&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;________________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) Restructuring costs in the condensed consolidated statements of operations for the nine months ended September 30, 2022 include a benefit of $1.4&#160;million in the second quarter of 2022 associated with the early termination of the lease for one of the Company's corporate offices which was previously restructured.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RleHRyZWdpb246Y2FkODJmNTczYmFkNGUzNjg2YzhmZjFjYjY2MDVhNTZfNjc3NA_3ef7e19a-96ad-45a4-b648-1771150b2f20">Use of Estimates&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts in the condensed consolidated financial statements and accompanying notes. Management has assessed various accounting estimates and other matters, including those that require consideration of forecasted financial information, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in context of the unknown future impacts of the global COVID pandemic&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; using information that is reasonably available to the Company at the time. Significant estimates and assumptions are used for, but not limited to: (i) the valuation of accounts receivable; (ii) goodwill, trade names, and other intangible assets; (iii) other long-lived assets; (iv) revenue recognition; (v) accruals for health, workers&#x2019; compensation, and professional liability claims; (vi) valuation of deferred tax assets; (vii) legal contingencies; and (viii) income taxes. Accrued insurance claims and reserves include estimated settlements from known claims and actuarial estimates for claims incurred but not reported. As additional information becomes available to the Company, its future assessment of these estimates&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, including management's expectations at the time regarding the duration, scope, and severity of the pandemic, as well as other factors,&lt;/span&gt; could materially and adversely impact the Company's consolidated financial statements in future reporting periods. Actual results could differ from those estimates.</us-gaap:UseOfEstimates>
    <ccrn:RisksAndUncertaintiesPolicyTextBlock
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RleHRyZWdpb246Y2FkODJmNTczYmFkNGUzNjg2YzhmZjFjYjY2MDVhNTZfMjE5OTAyMzI2NjU0Nw_fdc04ff6-d981-4156-b96e-4de948f0cb8c">&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Risks and Uncertainties&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s future results of operations and liquidity could be materially adversely affected by macroeconomic factors contributing to delays in payments from clients and inflationary pressure, uncertain or reduced demand, and the impact of any initiatives or programs that the Company may undertake to address financial and operational challenges faced by its clients.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company is also subject to additional risks and uncertainties due to the ongoing COVID pandemic. The extent of the impact on the Company&#x2019;s business is highly uncertain and difficult to predict.&lt;/span&gt;&lt;/div&gt;</ccrn:RisksAndUncertaintiesPolicyTextBlock>
    <us-gaap:TradeAndOtherAccountsReceivablePolicy
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RleHRyZWdpb246Y2FkODJmNTczYmFkNGUzNjg2YzhmZjFjYjY2MDVhNTZfNjc1OA_09a1982e-fba2-4b7d-a603-b37d21abc2b5">&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounts Receivable, net&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The timing of revenue recognition, billings, and collections results in billed and unbilled accounts receivable from customers, which are classified as accounts receivable on the condensed consolidated balance sheets and are presented net of allowances for doubtful accounts and sales allowances. Estimated revenue for the Company employees', subcontracted employees', and independent contractors&#x2019; time worked but not yet billed at September 30, 2022 and December 31, 2021 totaled $161.2&#160;million and $140.0&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company generally does not require collateral and mitigates its credit risk by performing credit evaluations and monitoring at-risk accounts. The allowance for doubtful accounts is established for losses expected to be incurred on accounts receivable balances. Accounts receivable are written off against the allowance for doubtful accounts when the Company determines amounts are no longer collectible. Judgment is required in the estimation of the allowance and the Company evaluates the collectability of its accounts receivable and contract assets based on a combination of factors. The Company bases its allowance for doubtful account estimates on its historical write-off experience, current conditions, an analysis of the aging of outstanding receivable and customer payment patterns, and specific reserves for customers in adverse condition adjusted for current expectations for the customers or industry. Based on the information currently available, the Company also considered current expectations of future economic condition&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;s, including the impact of COVID, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;when estimating its allowance for doubtful accounts.&lt;/span&gt;&lt;/div&gt;In addition to the allowance for doubtful accounts, the Company maintains a sales allowance for billing-related adjustments which may arise in the ordinary course of business and adjustments to the reserve are recorded as contra-revenue. The balance of this allowance as of September 30, 2022 and December 31, 2021 was $1.4&#160;million and $0.8&#160;million, respectively.The Company&#x2019;s contract terms typically require payment between 30 to 60 days from the date of invoice and are considered past due based on the particular negotiated contract terms. The majority of the Company's customers are U.S. based healthcare systems with a significant percentage in acute-care facilities.</us-gaap:TradeAndOtherAccountsReceivablePolicy>
    <us-gaap:UnbilledContractsReceivable
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RleHRyZWdpb246Y2FkODJmNTczYmFkNGUzNjg2YzhmZjFjYjY2MDVhNTZfMzY0Mg_603a1ea3-f48e-4448-9efd-38ea36b6ac0b"
      unitRef="usd">161200000</us-gaap:UnbilledContractsReceivable>
    <us-gaap:UnbilledContractsReceivable
      contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RleHRyZWdpb246Y2FkODJmNTczYmFkNGUzNjg2YzhmZjFjYjY2MDVhNTZfMzY0OQ_3377525d-063d-4ac4-b5e8-6877ece1299c"
      unitRef="usd">140000000</us-gaap:UnbilledContractsReceivable>
    <us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RleHRyZWdpb246Y2FkODJmNTczYmFkNGUzNjg2YzhmZjFjYjY2MDVhNTZfNjc3NQ_4b7e4932-c83e-4456-89ff-12cd43035f76">&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The opening balance of the allowance for doubtful accounts is reconciled to the closing balance for expected credit losses as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bad Debt Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Write-Offs, net of Recoveries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(365)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(699)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bad Debt Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Write-Offs, net of Recoveries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(426)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(358)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June 30&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bad Debt Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Write-Offs, net of Recoveries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(593)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(138)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOmVkMWU0OTIyZjA3NzQyZmViNDJkYTQwMGJhN2Q3ODdmL3RhYmxlcmFuZ2U6ZWQxZTQ5MjJmMDc3NDJmZWI0MmRhNDAwYmE3ZDc4N2ZfNC0xLTEtMS00NjMzNA_fb40f234-2f4a-47c8-b80c-236139609c12"
      unitRef="usd">6087000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i119af728c7ce4ee8bb64043a29f00ca5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOmVkMWU0OTIyZjA3NzQyZmViNDJkYTQwMGJhN2Q3ODdmL3RhYmxlcmFuZ2U6ZWQxZTQ5MjJmMDc3NDJmZWI0MmRhNDAwYmE3ZDc4N2ZfNC0zLTEtMS00NjMzNA_fb35645c-96e8-45b0-bbad-3902ef1a1ea2"
      unitRef="usd">3416000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i657bd17dcadf4f3f873d0850b774cdc3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOmVkMWU0OTIyZjA3NzQyZmViNDJkYTQwMGJhN2Q3ODdmL3RhYmxlcmFuZ2U6ZWQxZTQ5MjJmMDc3NDJmZWI0MmRhNDAwYmE3ZDc4N2ZfNS0xLTEtMS00NjMzNA_dec361cd-d77a-4b59-b423-04fd57978552"
      unitRef="usd">2369000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="ie61694e1851449ffa2f39478d3d2f3ea_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOmVkMWU0OTIyZjA3NzQyZmViNDJkYTQwMGJhN2Q3ODdmL3RhYmxlcmFuZ2U6ZWQxZTQ5MjJmMDc3NDJmZWI0MmRhNDAwYmE3ZDc4N2ZfNS0zLTEtMS00NjMzNA_185150ab-54f1-45b7-a808-0f8d2b090c49"
      unitRef="usd">504000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="i657bd17dcadf4f3f873d0850b774cdc3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOmVkMWU0OTIyZjA3NzQyZmViNDJkYTQwMGJhN2Q3ODdmL3RhYmxlcmFuZ2U6ZWQxZTQ5MjJmMDc3NDJmZWI0MmRhNDAwYmE3ZDc4N2ZfNi0xLTEtMS00NjMzNA_ee66e166-69b1-4b20-8fce-f6e832377af2"
      unitRef="usd">365000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="ie61694e1851449ffa2f39478d3d2f3ea_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOmVkMWU0OTIyZjA3NzQyZmViNDJkYTQwMGJhN2Q3ODdmL3RhYmxlcmFuZ2U6ZWQxZTQ5MjJmMDc3NDJmZWI0MmRhNDAwYmE3ZDc4N2ZfNi0zLTEtMS00NjMzNA_0f1f3510-eca2-4930-82f2-c953a53e0238"
      unitRef="usd">699000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="icc853726046a4b378bd788e398d13c55_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOmVkMWU0OTIyZjA3NzQyZmViNDJkYTQwMGJhN2Q3ODdmL3RhYmxlcmFuZ2U6ZWQxZTQ5MjJmMDc3NDJmZWI0MmRhNDAwYmE3ZDc4N2ZfNy0xLTEtMS00NjMzNA_9eb26b63-1eea-4e54-960e-e6c4b4fddab9"
      unitRef="usd">8091000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="ib6501a0fcaad471fa6d6fbf55f3864ae_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOmVkMWU0OTIyZjA3NzQyZmViNDJkYTQwMGJhN2Q3ODdmL3RhYmxlcmFuZ2U6ZWQxZTQ5MjJmMDc3NDJmZWI0MmRhNDAwYmE3ZDc4N2ZfNy0zLTEtMS00NjMzNA_99e506f4-ff84-4a4a-9c25-140e1a8cd3fe"
      unitRef="usd">3221000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i320641181a3f49a494c3423b25911ae6_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOmVkMWU0OTIyZjA3NzQyZmViNDJkYTQwMGJhN2Q3ODdmL3RhYmxlcmFuZ2U6ZWQxZTQ5MjJmMDc3NDJmZWI0MmRhNDAwYmE3ZDc4N2ZfOC0xLTEtMS00NjMzNA_ca2b8292-9e7c-4c26-9a8b-ce27dfa6ff22"
      unitRef="usd">3192000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="ie812f572e01c4d7abf8b2fd4eddf3b89_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOmVkMWU0OTIyZjA3NzQyZmViNDJkYTQwMGJhN2Q3ODdmL3RhYmxlcmFuZ2U6ZWQxZTQ5MjJmMDc3NDJmZWI0MmRhNDAwYmE3ZDc4N2ZfOC0zLTEtMS00NjMzNA_7f60c10c-7686-4612-87a9-22f346e20914"
      unitRef="usd">466000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="i320641181a3f49a494c3423b25911ae6_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOmVkMWU0OTIyZjA3NzQyZmViNDJkYTQwMGJhN2Q3ODdmL3RhYmxlcmFuZ2U6ZWQxZTQ5MjJmMDc3NDJmZWI0MmRhNDAwYmE3ZDc4N2ZfOS0xLTEtMS00NjMzNA_d9bfde2a-eadb-4c82-bd63-041857c8eacc"
      unitRef="usd">426000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="ie812f572e01c4d7abf8b2fd4eddf3b89_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOmVkMWU0OTIyZjA3NzQyZmViNDJkYTQwMGJhN2Q3ODdmL3RhYmxlcmFuZ2U6ZWQxZTQ5MjJmMDc3NDJmZWI0MmRhNDAwYmE3ZDc4N2ZfOS0zLTEtMS00NjMzNA_52a79295-bc76-4c75-b092-6476a23f83f6"
      unitRef="usd">358000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i0c0a4267d8174093be4955cfd3a6d031_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOmVkMWU0OTIyZjA3NzQyZmViNDJkYTQwMGJhN2Q3ODdmL3RhYmxlcmFuZ2U6ZWQxZTQ5MjJmMDc3NDJmZWI0MmRhNDAwYmE3ZDc4N2ZfMTAtMS0xLTEtNDYzMzQ_c05c0d4d-b252-4c29-aa66-f9867ccc99d4"
      unitRef="usd">10857000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i61328c0ca95341349cdc1ca533a6d2bf_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOmVkMWU0OTIyZjA3NzQyZmViNDJkYTQwMGJhN2Q3ODdmL3RhYmxlcmFuZ2U6ZWQxZTQ5MjJmMDc3NDJmZWI0MmRhNDAwYmE3ZDc4N2ZfMTAtMy0xLTEtNDYzMzQ_07204eb3-032a-4b81-8ab0-ce0cd8a5a454"
      unitRef="usd">3329000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOmVkMWU0OTIyZjA3NzQyZmViNDJkYTQwMGJhN2Q3ODdmL3RhYmxlcmFuZ2U6ZWQxZTQ5MjJmMDc3NDJmZWI0MmRhNDAwYmE3ZDc4N2ZfMTEtMS0xLTEtNDYzMzQ_fc24622a-45cd-43b1-aa51-d879b7c60137"
      unitRef="usd">1101000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOmVkMWU0OTIyZjA3NzQyZmViNDJkYTQwMGJhN2Q3ODdmL3RhYmxlcmFuZ2U6ZWQxZTQ5MjJmMDc3NDJmZWI0MmRhNDAwYmE3ZDc4N2ZfMTEtMy0xLTEtNDYzMzQ_69a99f75-7795-4287-8828-b5f969d05111"
      unitRef="usd">1441000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOmVkMWU0OTIyZjA3NzQyZmViNDJkYTQwMGJhN2Q3ODdmL3RhYmxlcmFuZ2U6ZWQxZTQ5MjJmMDc3NDJmZWI0MmRhNDAwYmE3ZDc4N2ZfMTItMS0xLTEtNDYzMzQ_3ff66520-baed-432c-87d6-b15510179cb5"
      unitRef="usd">593000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOmVkMWU0OTIyZjA3NzQyZmViNDJkYTQwMGJhN2Q3ODdmL3RhYmxlcmFuZ2U6ZWQxZTQ5MjJmMDc3NDJmZWI0MmRhNDAwYmE3ZDc4N2ZfMTItMy0xLTEtNDYzMzQ_16acbf68-7a95-47a1-b925-0a005aec744c"
      unitRef="usd">138000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOmVkMWU0OTIyZjA3NzQyZmViNDJkYTQwMGJhN2Q3ODdmL3RhYmxlcmFuZ2U6ZWQxZTQ5MjJmMDc3NDJmZWI0MmRhNDAwYmE3ZDc4N2ZfMTMtMS0xLTEtNDYzMzQ_ad5d9e6e-137f-493b-9382-e74c6e213d60"
      unitRef="usd">11365000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="idb81780210de40218de77358d91c73ba_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOmVkMWU0OTIyZjA3NzQyZmViNDJkYTQwMGJhN2Q3ODdmL3RhYmxlcmFuZ2U6ZWQxZTQ5MjJmMDc3NDJmZWI0MmRhNDAwYmE3ZDc4N2ZfMTMtMy0xLTEtNDYzMzQ_c354458f-aebe-4781-aa88-ea799bc42378"
      unitRef="usd">4632000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <ccrn:SalesAllowanceBillingRelatedAdjustments
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RleHRyZWdpb246Y2FkODJmNTczYmFkNGUzNjg2YzhmZjFjYjY2MDVhNTZfNTI0OA_75f706b3-f9c5-47d8-a4c0-03c4e6e241d9"
      unitRef="usd">1400000</ccrn:SalesAllowanceBillingRelatedAdjustments>
    <ccrn:SalesAllowanceBillingRelatedAdjustments
      contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RleHRyZWdpb246Y2FkODJmNTczYmFkNGUzNjg2YzhmZjFjYjY2MDVhNTZfNTI1NQ_2f6c1442-dcc6-41fc-9a57-8553887e7e8c"
      unitRef="usd">800000</ccrn:SalesAllowanceBillingRelatedAdjustments>
    <ccrn:ThresholdPeriodPastDueForPaymentOfServicesProvided
      contextRef="i95a7cda144014872b12df15aa0c33624_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RleHRyZWdpb246Y2FkODJmNTczYmFkNGUzNjg2YzhmZjFjYjY2MDVhNTZfNTMzNw_73ae9213-c8ef-43b2-90bb-273b221386b6">P30D</ccrn:ThresholdPeriodPastDueForPaymentOfServicesProvided>
    <ccrn:ThresholdPeriodPastDueForPaymentOfServicesProvided
      contextRef="i5982bacc53f943e49e2bf300695325b5_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RleHRyZWdpb246Y2FkODJmNTczYmFkNGUzNjg2YzhmZjFjYjY2MDVhNTZfNTM0Mw_02c099e8-7c53-4760-bd78-6ac74680e975">P60D</ccrn:ThresholdPeriodPastDueForPaymentOfServicesProvided>
    <us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RleHRyZWdpb246Y2FkODJmNTczYmFkNGUzNjg2YzhmZjFjYjY2MDVhNTZfNjc2OQ_ac04026c-6aa4-4302-8e1f-b4a790d05879">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Restructuring Costs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers restructuring activities to be programs whereby it fundamentally changes its operations, such as closing and consolidating facilities, reducing headcount, and realigning operations in response to changing market conditions. As a result, restructuring (benefits) costs on the condensed consolidated statements of operations primarily include employee termination costs and lease-related exit costs.&lt;/span&gt;&lt;/div&gt;</us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RleHRyZWdpb246Y2FkODJmNTczYmFkNGUzNjg2YzhmZjFjYjY2MDVhNTZfNjc2OA_2ec61189-6630-49d1-9f72-aff80b59bbd7">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reconciliation of the employee termination costs and lease-related exit costs (benefits) beginning and ending liability balance is presented below:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.593%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.728%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Employee Termination&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Lease-Related&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charged to restructuring&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments and adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(160)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(192)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charged to restructuring&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,379)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(202)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charged to restructuring&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;________________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) Restructuring costs in the condensed consolidated statements of operations for the nine months ended September 30, 2022 include a benefit of $1.4&#160;million in the second quarter of 2022 associated with the early termination of the lease for one of the Company's corporate offices which was previously restructured.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="i8c3d33c67aba46cb8fc17a6c9810c45e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOjljMGQ5ZDAzNWVlMDQyNjI4ODA1NzY0MDkyNzMwODNkL3RhYmxlcmFuZ2U6OWMwZDlkMDM1ZWUwNDI2Mjg4MDU3NjQwOTI3MzA4M2RfMy0xLTEtMS00NjMzNA_38c2951b-a17f-49cc-8c02-348f03756cb0"
      unitRef="usd">160000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i57398b99b0b54c5392ab2d17dc37cf50_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOjljMGQ5ZDAzNWVlMDQyNjI4ODA1NzY0MDkyNzMwODNkL3RhYmxlcmFuZ2U6OWMwZDlkMDM1ZWUwNDI2Mjg4MDU3NjQwOTI3MzA4M2RfMy0zLTEtMS00NjMzNA_7de54ff9-79da-4eca-b8d6-40f1b60be429"
      unitRef="usd">2423000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="if703479963674b69a8f48728a5151e98_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOjljMGQ5ZDAzNWVlMDQyNjI4ODA1NzY0MDkyNzMwODNkL3RhYmxlcmFuZ2U6OWMwZDlkMDM1ZWUwNDI2Mjg4MDU3NjQwOTI3MzA4M2RfNC0xLTEtMS00NjMzNA_8a828ee3-08ab-4e9b-8bed-f49b78238489"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ic15931a9518a4f40ad076daec66714fd_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOjljMGQ5ZDAzNWVlMDQyNjI4ODA1NzY0MDkyNzMwODNkL3RhYmxlcmFuZ2U6OWMwZDlkMDM1ZWUwNDI2Mjg4MDU3NjQwOTI3MzA4M2RfNC0zLTEtMS00NjMzNA_a69c94da-e541-480a-af42-05a710f5f111"
      unitRef="usd">389000</us-gaap:RestructuringCharges>
    <ccrn:PaymentsForRestructuringAndAdjustments
      contextRef="if703479963674b69a8f48728a5151e98_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOjljMGQ5ZDAzNWVlMDQyNjI4ODA1NzY0MDkyNzMwODNkL3RhYmxlcmFuZ2U6OWMwZDlkMDM1ZWUwNDI2Mjg4MDU3NjQwOTI3MzA4M2RfNS0xLTEtMS00NjMzNA_1b90be6b-aa76-4bd1-80d0-30d24ad8680a"
      unitRef="usd">160000</ccrn:PaymentsForRestructuringAndAdjustments>
    <ccrn:PaymentsForRestructuringAndAdjustments
      contextRef="ic15931a9518a4f40ad076daec66714fd_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOjljMGQ5ZDAzNWVlMDQyNjI4ODA1NzY0MDkyNzMwODNkL3RhYmxlcmFuZ2U6OWMwZDlkMDM1ZWUwNDI2Mjg4MDU3NjQwOTI3MzA4M2RfNS0zLTEtMS00NjMzNA_926d9115-04df-471b-bfd8-d0d7128ece85"
      unitRef="usd">192000</ccrn:PaymentsForRestructuringAndAdjustments>
    <us-gaap:RestructuringReserve
      contextRef="i8e32834817d9496dad1cbdc249093f30_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOjljMGQ5ZDAzNWVlMDQyNjI4ODA1NzY0MDkyNzMwODNkL3RhYmxlcmFuZ2U6OWMwZDlkMDM1ZWUwNDI2Mjg4MDU3NjQwOTI3MzA4M2RfNi0xLTEtMS00NjMzNA_3b83b965-2e56-4edd-a2a9-532e65f935c3"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i73c497336ca74c4cb8a55c150456d5e0_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOjljMGQ5ZDAzNWVlMDQyNjI4ODA1NzY0MDkyNzMwODNkL3RhYmxlcmFuZ2U6OWMwZDlkMDM1ZWUwNDI2Mjg4MDU3NjQwOTI3MzA4M2RfNi0zLTEtMS00NjMzNA_cf780e78-8508-42b2-97f5-362147a44d97"
      unitRef="usd">2620000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="i91f31431ce5340419942d52145b80cc7_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOjljMGQ5ZDAzNWVlMDQyNjI4ODA1NzY0MDkyNzMwODNkL3RhYmxlcmFuZ2U6OWMwZDlkMDM1ZWUwNDI2Mjg4MDU3NjQwOTI3MzA4M2RfNy0xLTEtMS00NjMzNA_2d749ebe-fd56-4c97-8bcb-6d741e9a8b62"
      unitRef="usd">200000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i443dd9fb273b4d53a90b0b46a22ab602_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOjljMGQ5ZDAzNWVlMDQyNjI4ODA1NzY0MDkyNzMwODNkL3RhYmxlcmFuZ2U6OWMwZDlkMDM1ZWUwNDI2Mjg4MDU3NjQwOTI3MzA4M2RfNy0zLTEtMS00NjMzNA_cf05c471-efe1-40f0-aeea-332b17bdd866"
      unitRef="usd">-1379000</us-gaap:RestructuringCharges>
    <us-gaap:PaymentsForRestructuring
      contextRef="i91f31431ce5340419942d52145b80cc7_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOjljMGQ5ZDAzNWVlMDQyNjI4ODA1NzY0MDkyNzMwODNkL3RhYmxlcmFuZ2U6OWMwZDlkMDM1ZWUwNDI2Mjg4MDU3NjQwOTI3MzA4M2RfOC0xLTEtMS00NjMzNA_11e36b08-3e82-4c9a-b6b1-616eb6457b67"
      unitRef="usd">0</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i443dd9fb273b4d53a90b0b46a22ab602_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOjljMGQ5ZDAzNWVlMDQyNjI4ODA1NzY0MDkyNzMwODNkL3RhYmxlcmFuZ2U6OWMwZDlkMDM1ZWUwNDI2Mjg4MDU3NjQwOTI3MzA4M2RfOC0zLTEtMS00NjMzNA_c1da0dea-479b-465e-86f7-31eeb7da002d"
      unitRef="usd">202000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve
      contextRef="ib3adac1127fa4edf8e0147861c16ad9b_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOjljMGQ5ZDAzNWVlMDQyNjI4ODA1NzY0MDkyNzMwODNkL3RhYmxlcmFuZ2U6OWMwZDlkMDM1ZWUwNDI2Mjg4MDU3NjQwOTI3MzA4M2RfOS0xLTEtMS00NjMzNA_81d0bd06-fd5c-40fc-8307-442960a7ecd2"
      unitRef="usd">200000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="if4bc6735e5214a54a2a33460e10c2956_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOjljMGQ5ZDAzNWVlMDQyNjI4ODA1NzY0MDkyNzMwODNkL3RhYmxlcmFuZ2U6OWMwZDlkMDM1ZWUwNDI2Mjg4MDU3NjQwOTI3MzA4M2RfOS0zLTEtMS00NjMzNA_3f6c47b9-9e6a-485b-b6f4-ad672521e086"
      unitRef="usd">1039000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="i5db7b078db0441d0a155ca8727612378_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOjljMGQ5ZDAzNWVlMDQyNjI4ODA1NzY0MDkyNzMwODNkL3RhYmxlcmFuZ2U6OWMwZDlkMDM1ZWUwNDI2Mjg4MDU3NjQwOTI3MzA4M2RfMTAtMS0xLTEtNDYzMzQ_681b05e0-7a0a-44b3-9bd1-09b603615c2f"
      unitRef="usd">735000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="if5f07aa56cb14c10aa23331198ec4f7c_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOjljMGQ5ZDAzNWVlMDQyNjI4ODA1NzY0MDkyNzMwODNkL3RhYmxlcmFuZ2U6OWMwZDlkMDM1ZWUwNDI2Mjg4MDU3NjQwOTI3MzA4M2RfMTAtMy0xLTEtNDYzMzQ_4d85632c-a9d6-43e0-b60e-7b0b67bf8861"
      unitRef="usd">1755000</us-gaap:RestructuringCharges>
    <us-gaap:PaymentsForRestructuring
      contextRef="i5db7b078db0441d0a155ca8727612378_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOjljMGQ5ZDAzNWVlMDQyNjI4ODA1NzY0MDkyNzMwODNkL3RhYmxlcmFuZ2U6OWMwZDlkMDM1ZWUwNDI2Mjg4MDU3NjQwOTI3MzA4M2RfMTEtMS0xLTEtNDYzMzQ_c151836b-72e8-4cf1-bf6c-5b1d90390b50"
      unitRef="usd">24000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="if5f07aa56cb14c10aa23331198ec4f7c_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOjljMGQ5ZDAzNWVlMDQyNjI4ODA1NzY0MDkyNzMwODNkL3RhYmxlcmFuZ2U6OWMwZDlkMDM1ZWUwNDI2Mjg4MDU3NjQwOTI3MzA4M2RfMTEtMy0xLTEtNDYzMzQ_b388c268-1b6b-4e0a-af76-4f06fbe3b051"
      unitRef="usd">254000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve
      contextRef="i181005f5e3c34e41a45e7b5a7e5a9e66_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOjljMGQ5ZDAzNWVlMDQyNjI4ODA1NzY0MDkyNzMwODNkL3RhYmxlcmFuZ2U6OWMwZDlkMDM1ZWUwNDI2Mjg4MDU3NjQwOTI3MzA4M2RfMTItMS0xLTEtNDYzMzQ_b6257be4-41c7-4f8a-a9bd-7392f70808fa"
      unitRef="usd">911000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i869ddd0d1a6943ae82d12eccf68afcde_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RhYmxlOjljMGQ5ZDAzNWVlMDQyNjI4ODA1NzY0MDkyNzMwODNkL3RhYmxlcmFuZ2U6OWMwZDlkMDM1ZWUwNDI2Mjg4MDU3NjQwOTI3MzA4M2RfMTItMy0xLTEtNDYzMzQ_c5cbddef-0610-4928-9f4b-60357fac1219"
      unitRef="usd">2540000</us-gaap:RestructuringReserve>
    <us-gaap:BusinessExitCosts1
      contextRef="i320641181a3f49a494c3423b25911ae6_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80MC9mcmFnOmNhZDgyZjU3M2JhZDRlMzY4NmM4ZmYxY2I2NjA1YTU2L3RleHRyZWdpb246Y2FkODJmNTczYmFkNGUzNjg2YzhmZjFjYjY2MDVhNTZfNjU2NA_264c035a-4365-4de8-af58-4541400c0aaa"
      unitRef="usd">1400000</us-gaap:BusinessExitCosts1>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RleHRyZWdpb246YThhNmQ2MWIwZDdiNDczOTg3ODIyMmE3ZWQ5NTc4ZjZfMzk0_f7290d4b-20e8-46ce-a724-e62d3fc85d7d">REVENUE RECOGNITION&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's revenues from customer contracts are generated from temporary staffing services and other services. Revenue is disaggregated by segment in the following table. Sales and usage-based taxes are excluded from revenue.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.961%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nurse&lt;br/&gt;And Allied&lt;br/&gt;Staffing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Physician&lt;br/&gt;Staffing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Segments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Temporary Staffing Services&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;592,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;615,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;612,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;636,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nurse&lt;br/&gt;And Allied&lt;br/&gt;Staffing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Physician&lt;br/&gt;Staffing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Segments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Temporary Staffing Services&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;356,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;374,905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;  Nine Months ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nurse&lt;br/&gt;And Allied&lt;br/&gt;Staffing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Physician&lt;br/&gt;Staffing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Segments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Temporary Staffing Services&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,053,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,120,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,109,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,178,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt; Nine Months ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nurse&lt;br/&gt;And Allied&lt;br/&gt;Staffing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Physician&lt;br/&gt;Staffing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Segments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Temporary Staffing Services&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;961,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,010,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;985,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,035,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;     &lt;/span&gt;&lt;/div&gt;See Note 12 - Segment Data.</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RleHRyZWdpb246YThhNmQ2MWIwZDdiNDczOTg3ODIyMmE3ZWQ5NTc4ZjZfMzk1_d845c157-3952-4f94-9f68-24d48ccbe7a6">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's revenues from customer contracts are generated from temporary staffing services and other services. Revenue is disaggregated by segment in the following table. Sales and usage-based taxes are excluded from revenue.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.961%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nurse&lt;br/&gt;And Allied&lt;br/&gt;Staffing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Physician&lt;br/&gt;Staffing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Segments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Temporary Staffing Services&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;592,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;615,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;612,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;636,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nurse&lt;br/&gt;And Allied&lt;br/&gt;Staffing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Physician&lt;br/&gt;Staffing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Segments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Temporary Staffing Services&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;356,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;374,905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;  Nine Months ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nurse&lt;br/&gt;And Allied&lt;br/&gt;Staffing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Physician&lt;br/&gt;Staffing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Segments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Temporary Staffing Services&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,053,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,120,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,109,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,178,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt; Nine Months ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nurse&lt;br/&gt;And Allied&lt;br/&gt;Staffing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Physician&lt;br/&gt;Staffing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Segments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Temporary Staffing Services&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;961,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,010,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;985,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,035,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i20197ff1c85d452da87fc706b7d58649_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfMy0xLTEtMS00NjMzNA_f4263f34-6e99-4850-a767-ef9622c0abab"
      unitRef="usd">592398000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1fe76aa84e634f068c08458605422754_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfMy0zLTEtMS00NjMzNA_c164996d-28b2-454f-8654-0162a8338e56"
      unitRef="usd">22811000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8ae604777193442b9bf2a6f5b9f7aae1_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfMy03LTEtMS00NjMzNA_e829eaa6-ead5-47e5-8592-fc4935adb464"
      unitRef="usd">615209000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic24c88a8321b4d8dba9854a06196bffe_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfNC0xLTEtMS00NjMzNA_1002b7e7-23cd-46b0-8514-6ee38a1d5f2b"
      unitRef="usd">19872000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i27fae63222bc430e9e3478596f2ad536_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfNC0zLTEtMS00NjMzNA_ef19db21-c45b-4097-b56e-a1b2891596dc"
      unitRef="usd">1017000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i873a486d6fa84b97a6f676f640c8635e_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfNC03LTEtMS00NjMzNA_eafbba53-d9c8-435a-8b9d-b5991a916156"
      unitRef="usd">20889000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i755b00d6551346d08633c51f6fffcbd4_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfNS0xLTEtMS00NjMzNA_078b9d65-d223-4cc4-96e8-1c747693896a"
      unitRef="usd">612270000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i60312c6dd2494d66bf19248b38166eaf_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfNS0zLTEtMS00NjMzNA_8b095d0d-7a9e-4ad1-8a36-764524f837a5"
      unitRef="usd">23828000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfNS03LTEtMS00NjMzNA_eef5f7eb-5603-4451-8d01-1510aa1980a7"
      unitRef="usd">636098000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0bb46cc7c58c478889fb6b980f9b2f4d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfMTAtMS0xLTEtNDYzMzQ_b1a10933-8981-4199-aae2-7e492a7399ec"
      unitRef="usd">347115000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib0348b7044e44bc5bb758dc707fdab77_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfMTAtMy0xLTEtNDYzMzQ_393f3112-a9d5-4654-a682-cbb5d5f51345"
      unitRef="usd">18055000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib6ef97c37f2146c5ba8dfa5c5720ad24_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfMTAtNy0xLTEtNDYzMzQ_668ffb59-1cbe-4530-918a-46b132061b5c"
      unitRef="usd">365170000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i44f9d44db6904ef587268af1cde4de4f_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfMTEtMS0xLTEtNDYzMzQ_4429d394-b402-412d-834c-6c0e639a93a3"
      unitRef="usd">9024000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0e5ea3b7faeb44c297e0371081833165_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfMTEtMy0xLTEtNDYzMzQ_f88c9991-251b-49cb-b194-37b482380616"
      unitRef="usd">711000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i970c8a42e53c487fae9182764d96ad09_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfMTEtNy0xLTEtNDYzMzQ_5b416a8b-fa27-412f-b2f3-b9abd90fb301"
      unitRef="usd">9735000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i15f558e83a4a479e8674ab636a78ba79_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfMTItMS0xLTEtNDYzMzQ_7da464fe-2a25-4310-af36-92d8f9173da4"
      unitRef="usd">356139000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibeef5c5a5e6e4d08b2e5036ccd0186a0_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfMTItMy0xLTEtNDYzMzQ_7cc3dd97-0864-4bbd-a9b8-71e36b6d30f6"
      unitRef="usd">18766000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfMTItNy0xLTEtNDYzMzQ_5bd3514c-e8a0-458b-bfc8-f039a0a5c8bf"
      unitRef="usd">374905000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1a40960a329848b3b4404d32532a0aed_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfMTctMS0xLTEtNDYzMzQ_06259539-37b6-407d-bd8f-d9c3ab69b55d"
      unitRef="usd">2053935000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ideb77c0531ff491fa1c4616654d0b2ba_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfMTctMy0xLTEtNDYzMzQ_cd34e384-46b9-4864-b626-9b3d66742953"
      unitRef="usd">66122000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i525c2bf9e1cf47589d1b503039abb3a7_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfMTctNy0xLTEtNDYzMzQ_0a0a7cfe-f101-42fa-bd44-c8d8a4decfcf"
      unitRef="usd">2120057000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2bed4acdcaa54423bb59a2fc3eeb6cce_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfMTgtMS0xLTEtNDYzMzQ_ff5004dc-ee88-4e66-a29c-c702e3dfa9e1"
      unitRef="usd">55358000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifea86757fdc544f2b14e84330796599b_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfMTgtMy0xLTEtNDYzMzQ_3eee3b4c-4f4b-4d8c-afa6-82fc1a96f7f7"
      unitRef="usd">2976000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i98bb8473f28b40109171e65f44dcded9_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfMTgtNy0xLTEtNDYzMzQ_bcefdc76-5b06-4c61-8a5b-b5212d8d1d0c"
      unitRef="usd">58334000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7aaf74b211ba45b9bea92196b8c48cd7_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfMTktMS0xLTEtNDYzMzQ_cd03bc9e-4340-4a71-9581-02a23877f809"
      unitRef="usd">2109293000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia4be1f35efe045ebabfe8d9154e1c3cb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfMTktMy0xLTEtNDYzMzQ_5487e4bd-fea3-4a59-b336-329d7fe93e04"
      unitRef="usd">69098000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfMTktNy0xLTEtNDYzMzQ_0cad15b4-5be1-4655-8027-938bed68eb30"
      unitRef="usd">2178391000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i108501803abb4e229cf67a62dd7cd7ae_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfMjQtMS0xLTEtNDYzMzQ_3585a06b-bac3-412f-a853-05461f9432e0"
      unitRef="usd">961608000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib62929d26b494926b11bb88b62b6ef78_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfMjQtMy0xLTEtNDYzMzQ_d91b7d4d-0696-49a5-a37d-419adad4a05d"
      unitRef="usd">48534000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iebb1b15335074656a1c0ac1d3c9f6eb6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfMjQtNy0xLTEtNDYzMzQ_5fd3b808-f053-4077-9331-3a8d7f34f705"
      unitRef="usd">1010142000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib20154f39f37474fa466a1c719e5b181_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfMjUtMS0xLTEtNDYzMzQ_cda63440-32a0-4cce-9a59-646ffc92b6ca"
      unitRef="usd">23727000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i375deb87100c4072a7f2a5d3d9e2e846_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfMjUtMy0xLTEtNDYzMzQ_a44e3dcb-ba3d-4e99-919e-0ce80ddfdf91"
      unitRef="usd">2104000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8f29bfe22ab24268b44e0608ba26a4ad_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfMjUtNy0xLTEtNDYzMzQ_e70fe885-f3d1-45be-9aac-76a10afe3d5f"
      unitRef="usd">25831000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id76ab6905df5463b9046aaf30a35075d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfMjYtMS0xLTEtNDYzMzQ_607c713f-6f95-4ff9-99ab-b9714c452398"
      unitRef="usd">985335000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7c425883600f44a6aedb244f1adafb03_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfMjYtMy0xLTEtNDYzMzQ_52f03c29-9c35-4666-ae46-eb326cf43508"
      unitRef="usd">50638000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80My9mcmFnOmE4YTZkNjFiMGQ3YjQ3Mzk4NzgyMjJhN2VkOTU3OGY2L3RhYmxlOjc0NWFiYWUzOGM5YzQ4NThhOTE1ZWY4OTA5YzU3MzVmL3RhYmxlcmFuZ2U6NzQ1YWJhZTM4YzljNDg1OGE5MTVlZjg5MDljNTczNWZfMjYtNy0xLTEtNDYzMzQ_515361ae-1c6b-4ce8-a093-4a4f7cd62791"
      unitRef="usd">1035973000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RleHRyZWdpb246YmQ5M2Y5MWY0NzRlNGMzMzgxZGRlNjE0MDVlMjdlZWNfMzcwMw_0c1a40f6-9710-4f1e-b82b-44804ec5139f">ACQUISITIONS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Selected&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 16, 2021, the Company purchased and acquired substantially all of the assets and assumed certain liabilities of Selected, Inc. (Selected) for a purchase price of $3.5&#160;million in cash, subject to adjustment, and $1.5&#160;million in shares (or 59,429 shares) of the Company's common stock. The transaction was treated as a purchase of assets for income tax purposes. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The sellers were eligible to receive up to an additional $1.5&#160;million in earnout cash consideration, based on Selected's revenues for each of the twelve-month periods ending on the first and second anniversaries of the first day after the closing date. In the &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;second quarter of 2022, the Company determined that the contingent consideration earnout related to the Selected acquisition would not be achieved for 2022 and 2023 and, as a result, the entire liability was reversed. See Note 10 - Fair Value Measurements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assigned the following values to other identifiable intangible assets: (i) an immaterial amount to trade names with a weighted average estimated useful life of 2 years; (ii) $1.7&#160;million to software with a weighted average estimated useful life of 5 years; and (iii) $2.9&#160;million to a database, consisting of education professionals, with a weighted average estimated useful life of 5 years, for a total of $4.6&#160;million in definite life intangible assets with a weighted average estimated useful life of 5 years.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The remaining excess purchase price over the fair value of net assets acquired of $0.4&#160;million was recorded as goodwill on the Company's condensed consolidated balance sheets. See Note 7 - Goodwill, Trade Names, and Other Intangible Assets. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The acquisition was not significant and has been accounted for using the acquisition method of accounting. Associated immaterial acquisition-related costs incurred have been included in acquisition and integration-related costs on the Company's condensed consolidated statements of operations for the nine months ended September 30, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cross Country Workforce Solutions Group (CCWSG)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 8, 2021, the Company purchased and acquired substantially all of the assets and assumed certain liabilities of Workforce Solutions Group, Inc. (WSG) for a purchase price of $25.0&#160;million in cash and $5.0&#160;million in shares (or 307,730 shares) of the Company's common stock. The parties agreed to a final net working capital reduction of $1.1&#160;million, which was received in the fourth quarter of 2021. The transaction was treated as a purchase of assets for income tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The sellers are also eligible to receive an earnout based on the business' performance through three years after the acquisition date that could provide up to an additional $15.0&#160;million in cash. In the third quarter of 2022, the Company determined that the contingent consideration earnout was achieved for the 2021 through 2022 period and, as a result, the Company made a $7.5&#160;million earnout payment. The remaining earnout liability's carrying amount of $7.5&#160;million is included in current portion of earnout liability on the condensed consolidated balance sheets. See Note 10 - Fair Value Measurements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the fair value of the assets acquired and liabilities assumed on June 8, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued compensation and benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liability - current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liability - non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnout liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assigned a value to other identifiable intangible assets of $14.2&#160;million in customer relationships with a weighted average estimated useful life of 11.5 years.&lt;/span&gt;&lt;/div&gt;The remaining excess purchase price over the fair value of net assets acquired of $22.1&#160;million was recorded as goodwill on the Company's condensed consolidated balance sheets. See Note 7 - Goodwill, Trade Names, and Other Intangible Assets. The acquisition was not significant and has been accounted for using the acquisition method of accounting. The pro-forma impact on the Company's consolidated revenue from services and net income, including the pro forma effect of events that are directly attributable to the acquisition, was not significant.</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ia84d03e68bab4f9592492ba9084b94f0_D20211216-20211216"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RleHRyZWdpb246YmQ5M2Y5MWY0NzRlNGMzMzgxZGRlNjE0MDVlMjdlZWNfMjA2_19665828-a092-47c2-a522-ee88cfa683f0"
      unitRef="usd">3500000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="ia84d03e68bab4f9592492ba9084b94f0_D20211216-20211216"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RleHRyZWdpb246YmQ5M2Y5MWY0NzRlNGMzMzgxZGRlNjE0MDVlMjdlZWNfMjQ1_47c9d87f-ec40-4d88-b6f6-fa02454b9566"
      unitRef="usd">1500000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="ia84d03e68bab4f9592492ba9084b94f0_D20211216-20211216"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RleHRyZWdpb246YmQ5M2Y5MWY0NzRlNGMzMzgxZGRlNjE0MDVlMjdlZWNfMjYy_58ffc5be-cbc8-477e-becc-d14aa9fa86ab"
      unitRef="shares">59429</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="iab7b6d3f615249b3813ea0de2e0a5b00_I20211216"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RleHRyZWdpb246YmQ5M2Y5MWY0NzRlNGMzMzgxZGRlNjE0MDVlMjdlZWNfNDQw_25a97c04-0570-4037-9d6e-01862a070611"
      unitRef="usd">1500000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ide7cad6e03e54feaafb84434e9dee12b_I20211216"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RleHRyZWdpb246YmQ5M2Y5MWY0NzRlNGMzMzgxZGRlNjE0MDVlMjdlZWNfOTgx_7f621107-a306-4984-8004-c5634e509c94"
      unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i86b3f925edb2419baa7dc8060115c5af_D20211216-20211216"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RleHRyZWdpb246YmQ5M2Y5MWY0NzRlNGMzMzgxZGRlNjE0MDVlMjdlZWNfMzY5Ng_3b6e3757-4538-4983-9f3e-0f11bfb5d72e">P2Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i52e3ba7395c24be49c40b9fc7a7fe5c3_I20211216"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RleHRyZWdpb246YmQ5M2Y5MWY0NzRlNGMzMzgxZGRlNjE0MDVlMjdlZWNfMTA3MA_046ed0ec-5888-46b6-83a6-6e68771cb5d0"
      unitRef="usd">1700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i3eb40c4ead40484d99ab7accabf6eb87_D20211216-20211216"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RleHRyZWdpb246YmQ5M2Y5MWY0NzRlNGMzMzgxZGRlNjE0MDVlMjdlZWNfMzY5OA_933b0de2-fadb-4afd-aeb4-406e42d5bcee">P5Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i5a4b1bc6463449928078dc019cd5ef53_I20211216"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RleHRyZWdpb246YmQ5M2Y5MWY0NzRlNGMzMzgxZGRlNjE0MDVlMjdlZWNfMTE1NA_a186898b-4016-43a3-929d-181ccec434e1"
      unitRef="usd">2900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i096a7bcfbf9b4f69a384857b9b34921a_D20211216-20211216"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RleHRyZWdpb246YmQ5M2Y5MWY0NzRlNGMzMzgxZGRlNjE0MDVlMjdlZWNfMzcwMA_cbcf1a77-5292-42f4-bf86-5fe1dc0c4467">P5Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="iab7b6d3f615249b3813ea0de2e0a5b00_I20211216"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RleHRyZWdpb246YmQ5M2Y5MWY0NzRlNGMzMzgxZGRlNjE0MDVlMjdlZWNfMTI4NQ_15f3aa59-56ec-48cc-973d-b944f0c77011"
      unitRef="usd">4600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ia84d03e68bab4f9592492ba9084b94f0_D20211216-20211216"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RleHRyZWdpb246YmQ5M2Y5MWY0NzRlNGMzMzgxZGRlNjE0MDVlMjdlZWNfMzcwMQ_0cef6f58-18a5-4864-9ccd-f55e9f2a5104">P5Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:Goodwill
      contextRef="iab7b6d3f615249b3813ea0de2e0a5b00_I20211216"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RleHRyZWdpb246YmQ5M2Y5MWY0NzRlNGMzMzgxZGRlNjE0MDVlMjdlZWNfMTQ2NQ_85ea9a87-b3f6-4c90-ae2e-a54598915503"
      unitRef="usd">400000</us-gaap:Goodwill>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i29d504aa7a7e4656aed1f0f0211e399c_D20210608-20210608"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RleHRyZWdpb246YmQ5M2Y5MWY0NzRlNGMzMzgxZGRlNjE0MDVlMjdlZWNfMjE4MQ_2b038404-9945-497e-8be9-8613ca895de6"
      unitRef="usd">25000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="i29d504aa7a7e4656aed1f0f0211e399c_D20210608-20210608"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RleHRyZWdpb246YmQ5M2Y5MWY0NzRlNGMzMzgxZGRlNjE0MDVlMjdlZWNfMjE5Ng_3a5013dd-e211-4d56-8638-23f20c809c02"
      unitRef="usd">5000000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="i29d504aa7a7e4656aed1f0f0211e399c_D20210608-20210608"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RleHRyZWdpb246YmQ5M2Y5MWY0NzRlNGMzMzgxZGRlNjE0MDVlMjdlZWNfMjIxMw_571f92de-ec65-4418-a0b7-ff94a9a44599"
      unitRef="shares">307730</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <ccrn:BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment
      contextRef="i29e631219d674e4fae9fb8f7e977e6af_D20211001-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RleHRyZWdpb246YmQ5M2Y5MWY0NzRlNGMzMzgxZGRlNjE0MDVlMjdlZWNfMjMxOA_95bec285-ffc2-4cc9-bd09-71324c1681a3"
      unitRef="usd">1100000</ccrn:BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment>
    <ccrn:BusinessCombinationContingentConsiderationTerm
      contextRef="i29d504aa7a7e4656aed1f0f0211e399c_D20210608-20210608"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RleHRyZWdpb246YmQ5M2Y5MWY0NzRlNGMzMzgxZGRlNjE0MDVlMjdlZWNfMjU0NA_e515dc9c-aabc-4ac1-a536-92ef9b9379c5">P3Y</ccrn:BusinessCombinationContingentConsiderationTerm>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i8ae5c1283dfc4659b9287a5a52e51af8_I20210608"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RleHRyZWdpb246YmQ5M2Y5MWY0NzRlNGMzMzgxZGRlNjE0MDVlMjdlZWNfMjYxMw_7756d8c7-7885-42a6-b157-b1b6aaa323f9"
      unitRef="usd">15000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="id9fe5b9beae44701b72bcee962193e53_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RleHRyZWdpb246YmQ5M2Y5MWY0NzRlNGMzMzgxZGRlNjE0MDVlMjdlZWNfNTQ5NzU1ODE3OTAx_f922a4d2-e406-4156-927f-cd17a0bd3765"
      unitRef="usd">7500000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent
      contextRef="ic3eab37833864980aa79e31112a0c6e2_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RleHRyZWdpb246YmQ5M2Y5MWY0NzRlNGMzMzgxZGRlNjE0MDVlMjdlZWNfMjY2NQ_fbedfbea-c5ce-466e-8463-908b5ac8f1d5"
      unitRef="usd">7500000</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RleHRyZWdpb246YmQ5M2Y5MWY0NzRlNGMzMzgxZGRlNjE0MDVlMjdlZWNfMzcwMg_74202cc8-2f46-4e4f-81c4-e87ceb4a8b91">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the fair value of the assets acquired and liabilities assumed on June 8, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued compensation and benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liability - current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liability - non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnout liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="i8ae5c1283dfc4659b9287a5a52e51af8_I20210608"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RhYmxlOjhiNzRjOTJiYzUwZDQ4ZjM4YmI3MDEwZWJjZjExYWE5L3RhYmxlcmFuZ2U6OGI3NGM5MmJjNTBkNDhmMzhiYjcwMTBlYmNmMTFhYTlfMS0xLTEtMS00NjMzNA_e3db1d17-902c-41cd-802d-0aaac98c1e0a"
      unitRef="usd">957000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="i8ae5c1283dfc4659b9287a5a52e51af8_I20210608"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RhYmxlOjhiNzRjOTJiYzUwZDQ4ZjM4YmI3MDEwZWJjZjExYWE5L3RhYmxlcmFuZ2U6OGI3NGM5MmJjNTBkNDhmMzhiYjcwMTBlYmNmMTFhYTlfMi0xLTEtMS00NjMzNA_ca4cdc79-3ac5-406a-88d7-c1f02205a1c7"
      unitRef="usd">11991000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
      contextRef="i8ae5c1283dfc4659b9287a5a52e51af8_I20210608"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RhYmxlOjhiNzRjOTJiYzUwZDQ4ZjM4YmI3MDEwZWJjZjExYWE5L3RhYmxlcmFuZ2U6OGI3NGM5MmJjNTBkNDhmMzhiYjcwMTBlYmNmMTFhYTlfMy0xLTEtMS00NjMzNA_e8911872-b75b-45a8-8ee1-2d39ff878e0f"
      unitRef="usd">59000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i8ae5c1283dfc4659b9287a5a52e51af8_I20210608"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RhYmxlOjhiNzRjOTJiYzUwZDQ4ZjM4YmI3MDEwZWJjZjExYWE5L3RhYmxlcmFuZ2U6OGI3NGM5MmJjNTBkNDhmMzhiYjcwMTBlYmNmMTFhYTlfNC0xLTEtMS00NjMzNA_23c5f9f7-e66a-4f90-b42d-555ed2473353"
      unitRef="usd">10000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <ccrn:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets
      contextRef="i8ae5c1283dfc4659b9287a5a52e51af8_I20210608"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RhYmxlOjhiNzRjOTJiYzUwZDQ4ZjM4YmI3MDEwZWJjZjExYWE5L3RhYmxlcmFuZ2U6OGI3NGM5MmJjNTBkNDhmMzhiYjcwMTBlYmNmMTFhYTlfNS0xLTEtMS00NjMzNA_6e7f8f3b-6fa0-402d-b9eb-f2c5884e6afe"
      unitRef="usd">1078000</ccrn:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets>
    <us-gaap:Goodwill
      contextRef="i8ae5c1283dfc4659b9287a5a52e51af8_I20210608"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RhYmxlOjhiNzRjOTJiYzUwZDQ4ZjM4YmI3MDEwZWJjZjExYWE5L3RhYmxlcmFuZ2U6OGI3NGM5MmJjNTBkNDhmMzhiYjcwMTBlYmNmMTFhYTlfNi0xLTEtMS00NjMzNA_89d29219-4144-4621-bc14-a666fb3c31db"
      unitRef="usd">22066000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i8ae5c1283dfc4659b9287a5a52e51af8_I20210608"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RhYmxlOjhiNzRjOTJiYzUwZDQ4ZjM4YmI3MDEwZWJjZjExYWE5L3RhYmxlcmFuZ2U6OGI3NGM5MmJjNTBkNDhmMzhiYjcwMTBlYmNmMTFhYTlfNy0xLTEtMS00NjMzNA_c5f9dbdc-e067-4fe3-af79-f6c69ae80921"
      unitRef="usd">14200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <ccrn:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill
      contextRef="i8ae5c1283dfc4659b9287a5a52e51af8_I20210608"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RhYmxlOjhiNzRjOTJiYzUwZDQ4ZjM4YmI3MDEwZWJjZjExYWE5L3RhYmxlcmFuZ2U6OGI3NGM5MmJjNTBkNDhmMzhiYjcwMTBlYmNmMTFhYTlfOC0xLTEtMS00NjMzNA_60c03bd1-8aca-4abe-95be-56d77d341bc3"
      unitRef="usd">50361000</ccrn:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="i8ae5c1283dfc4659b9287a5a52e51af8_I20210608"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RhYmxlOjhiNzRjOTJiYzUwZDQ4ZjM4YmI3MDEwZWJjZjExYWE5L3RhYmxlcmFuZ2U6OGI3NGM5MmJjNTBkNDhmMzhiYjcwMTBlYmNmMTFhYTlfOS0xLTEtMS00NjMzNA_e9d2ca77-a6cc-4d1e-b190-c175a6ea32d3"
      unitRef="usd">3562000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <ccrn:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensationAndBenefits
      contextRef="i8ae5c1283dfc4659b9287a5a52e51af8_I20210608"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RhYmxlOjhiNzRjOTJiYzUwZDQ4ZjM4YmI3MDEwZWJjZjExYWE5L3RhYmxlcmFuZ2U6OGI3NGM5MmJjNTBkNDhmMzhiYjcwMTBlYmNmMTFhYTlfMTAtMS0xLTEtNDYzMzQ_cb34133b-8a19-403d-9174-ae4733eca9eb"
      unitRef="usd">1387000</ccrn:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensationAndBenefits>
    <ccrn:BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationCurrent
      contextRef="i8ae5c1283dfc4659b9287a5a52e51af8_I20210608"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RhYmxlOjhiNzRjOTJiYzUwZDQ4ZjM4YmI3MDEwZWJjZjExYWE5L3RhYmxlcmFuZ2U6OGI3NGM5MmJjNTBkNDhmMzhiYjcwMTBlYmNmMTFhYTlfMTEtMS0xLTEtNDYzMzQ_99468ed8-941b-4337-a725-ea871d80539d"
      unitRef="usd">316000</ccrn:BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationCurrent>
    <ccrn:BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationNoncurrent
      contextRef="i8ae5c1283dfc4659b9287a5a52e51af8_I20210608"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RhYmxlOjhiNzRjOTJiYzUwZDQ4ZjM4YmI3MDEwZWJjZjExYWE5L3RhYmxlcmFuZ2U6OGI3NGM5MmJjNTBkNDhmMzhiYjcwMTBlYmNmMTFhYTlfMTItMS0xLTEtNDYzMzQ_97c31a11-11d4-4a35-a009-f01a85a6ed78"
      unitRef="usd">762000</ccrn:BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationNoncurrent>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability
      contextRef="i8ae5c1283dfc4659b9287a5a52e51af8_I20210608"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RhYmxlOjhiNzRjOTJiYzUwZDQ4ZjM4YmI3MDEwZWJjZjExYWE5L3RhYmxlcmFuZ2U6OGI3NGM5MmJjNTBkNDhmMzhiYjcwMTBlYmNmMTFhYTlfMTMtMS0xLTEtNDYzMzQ_50a7befe-7313-4cc7-b9f1-b3b0d56e6722"
      unitRef="usd">15000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i8ae5c1283dfc4659b9287a5a52e51af8_I20210608"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RhYmxlOjhiNzRjOTJiYzUwZDQ4ZjM4YmI3MDEwZWJjZjExYWE5L3RhYmxlcmFuZ2U6OGI3NGM5MmJjNTBkNDhmMzhiYjcwMTBlYmNmMTFhYTlfMTQtMS0xLTEtNDYzMzQ_d50aba1d-f349-4ef6-95fd-2acef015ac52"
      unitRef="usd">21027000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i8ae5c1283dfc4659b9287a5a52e51af8_I20210608"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RhYmxlOjhiNzRjOTJiYzUwZDQ4ZjM4YmI3MDEwZWJjZjExYWE5L3RhYmxlcmFuZ2U6OGI3NGM5MmJjNTBkNDhmMzhiYjcwMTBlYmNmMTFhYTlfMTUtMS0xLTEtNDYzMzQ_74fd79a8-29f7-4824-8e0b-579fd2b0c3cf"
      unitRef="usd">29334000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i4b533d4786024f299c29a873781660b2_I20210608"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RleHRyZWdpb246YmQ5M2Y5MWY0NzRlNGMzMzgxZGRlNjE0MDVlMjdlZWNfMzA3MQ_b6d5575d-ef87-44c0-8a7b-be5aa6022594"
      unitRef="usd">14200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="icc7d3370d9844826a664e9ed960c303a_D20210608-20210608"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RleHRyZWdpb246YmQ5M2Y5MWY0NzRlNGMzMzgxZGRlNjE0MDVlMjdlZWNfMzE0OQ_a66effee-2752-4250-ae50-ec030aed5847">P11Y6M</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:Goodwill
      contextRef="i8ae5c1283dfc4659b9287a5a52e51af8_I20210608"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80Ni9mcmFnOmJkOTNmOTFmNDc0ZTRjMzM4MWRkZTYxNDA1ZTI3ZWVjL3RleHRyZWdpb246YmQ5M2Y5MWY0NzRlNGMzMzgxZGRlNjE0MDVlMjdlZWNfMzIzNg_f2574fbd-bac0-4d24-a7ad-eaa52d1cfdd7"
      unitRef="usd">22100000</us-gaap:Goodwill>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80OS9mcmFnOjlkZDExOWI1ODI0YjQxOGFhZGNiYTQ2OWVjM2UzMmM5L3RleHRyZWdpb246OWRkMTE5YjU4MjRiNDE4YWFkY2JhNDY5ZWMzZTMyYzlfODM3_78ecea3b-641d-49cf-9285-2533d85ec86c">COMPREHENSIVE INCOME&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total comprehensive income includes net income or loss and foreign currency translation adjustments, net of any related deferred taxes, and is included within the accompanying condensed consolidated statements of operations. Certain of the Company&#x2019;s foreign subsidiaries use their respective local currency as their functional currency. Assets and liabilities of these operations are translated at the exchange rates in effect on the balance sheet date. Income statement items are translated at the average exchange rates for the period. The cumulative impact of currency fluctuations related to the balance sheet translation is included in accumulated other comprehensive loss in the accompanying condensed consolidated balance sheets and was an unrealized loss of&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; $1.4&#160;million at September 30, 2022 and $1.3 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; at December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <ccrn:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80OS9mcmFnOjlkZDExOWI1ODI0YjQxOGFhZGNiYTQ2OWVjM2UzMmM5L3RleHRyZWdpb246OWRkMTE5YjU4MjRiNDE4YWFkY2JhNDY5ZWMzZTMyYzlfNzk3_d48114ee-76f9-4e64-8ebb-633602b21a8c"
      unitRef="usd">-1400000</ccrn:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax>
    <ccrn:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax
      contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV80OS9mcmFnOjlkZDExOWI1ODI0YjQxOGFhZGNiYTQ2OWVjM2UzMmM5L3RleHRyZWdpb246OWRkMTE5YjU4MjRiNDE4YWFkY2JhNDY5ZWMzZTMyYzlfODIx_d11b77e0-4a08-4ee7-8b8c-030de949dcf5"
      unitRef="usd">-1300000</ccrn:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RleHRyZWdpb246ZDNkN2Y0NGMyNzVmNDU3MWE3NTYwNWNlZmUzNWVhYTdfNTI4_2c1185c3-d15a-43a3-a39d-9c97596c95b9">EARNINGS PER SHARE&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the components of the numerator and denominator for the computation of the basic and diluted earnings per share:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(amounts in thousands, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to common stockholders - Basic and Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares - Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of diluted shares:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Share-based awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares - Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income per share attributable to common stockholders - Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income per share attributable to common stockholders - Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents the share-based awards that could potentially dilute net income per share attributable to common stockholders in the future that were not included in the computation of diluted net income per share attributable to common stockholders because to do so would have been anti-dilutive for the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based awards&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RleHRyZWdpb246ZDNkN2Y0NGMyNzVmNDU3MWE3NTYwNWNlZmUzNWVhYTdfNTI0_8aeaaebe-a711-4f6f-8fe1-aadbf998998d">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the components of the numerator and denominator for the computation of the basic and diluted earnings per share:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(amounts in thousands, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to common stockholders - Basic and Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares - Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of diluted shares:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Share-based awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares - Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income per share attributable to common stockholders - Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income per share attributable to common stockholders - Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOjY4NmQ0ZDAxNDg0ZTQxYzI5YzRjZGZlYTBlYzIzYzI4L3RhYmxlcmFuZ2U6Njg2ZDRkMDE0ODRlNDFjMjljNGNkZmVhMGVjMjNjMjhfNS0xLTEtMS00NjMzNA_55a49eca-2328-4e9f-aa26-3131877417d0"
      unitRef="usd">34793000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOjY4NmQ0ZDAxNDg0ZTQxYzI5YzRjZGZlYTBlYzIzYzI4L3RhYmxlcmFuZ2U6Njg2ZDRkMDE0ODRlNDFjMjljNGNkZmVhMGVjMjNjMjhfNS0xLTEtMS00NjMzNA_80181fd1-4c52-4b4a-9797-73d4e026edf2"
      unitRef="usd">34793000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOjY4NmQ0ZDAxNDg0ZTQxYzI5YzRjZGZlYTBlYzIzYzI4L3RhYmxlcmFuZ2U6Njg2ZDRkMDE0ODRlNDFjMjljNGNkZmVhMGVjMjNjMjhfNS0zLTEtMS00NjMzNA_24abf0e2-4ac3-485e-b571-c61551e65186"
      unitRef="usd">23433000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOjY4NmQ0ZDAxNDg0ZTQxYzI5YzRjZGZlYTBlYzIzYzI4L3RhYmxlcmFuZ2U6Njg2ZDRkMDE0ODRlNDFjMjljNGNkZmVhMGVjMjNjMjhfNS0zLTEtMS00NjMzNA_fae7bfed-c307-4f6f-b3fa-b04efd02933e"
      unitRef="usd">23433000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOjY4NmQ0ZDAxNDg0ZTQxYzI5YzRjZGZlYTBlYzIzYzI4L3RhYmxlcmFuZ2U6Njg2ZDRkMDE0ODRlNDFjMjljNGNkZmVhMGVjMjNjMjhfNS01LTEtMS00NjMzNA_437ba786-6f36-45a9-9a03-31fd29714826"
      unitRef="usd">149670000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOjY4NmQ0ZDAxNDg0ZTQxYzI5YzRjZGZlYTBlYzIzYzI4L3RhYmxlcmFuZ2U6Njg2ZDRkMDE0ODRlNDFjMjljNGNkZmVhMGVjMjNjMjhfNS01LTEtMS00NjMzNA_a541d251-1ab5-4a0c-a2a7-8bc7f059b509"
      unitRef="usd">149670000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOjY4NmQ0ZDAxNDg0ZTQxYzI5YzRjZGZlYTBlYzIzYzI4L3RhYmxlcmFuZ2U6Njg2ZDRkMDE0ODRlNDFjMjljNGNkZmVhMGVjMjNjMjhfNS03LTEtMS00NjMzNA_e3c928f0-6949-43a6-b437-c76802602388"
      unitRef="usd">54429000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOjY4NmQ0ZDAxNDg0ZTQxYzI5YzRjZGZlYTBlYzIzYzI4L3RhYmxlcmFuZ2U6Njg2ZDRkMDE0ODRlNDFjMjljNGNkZmVhMGVjMjNjMjhfNS03LTEtMS00NjMzNA_e5615f2b-c442-45db-b4bd-b108788ae51d"
      unitRef="usd">54429000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOjY4NmQ0ZDAxNDg0ZTQxYzI5YzRjZGZlYTBlYzIzYzI4L3RhYmxlcmFuZ2U6Njg2ZDRkMDE0ODRlNDFjMjljNGNkZmVhMGVjMjNjMjhfOC0xLTEtMS00NjMzNA_63004e17-6b26-479b-b5b7-ae0c921462d8"
      unitRef="shares">37101000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOjY4NmQ0ZDAxNDg0ZTQxYzI5YzRjZGZlYTBlYzIzYzI4L3RhYmxlcmFuZ2U6Njg2ZDRkMDE0ODRlNDFjMjljNGNkZmVhMGVjMjNjMjhfOC0zLTEtMS00NjMzNA_b39c1fe5-a0c0-40ab-aa95-67e44aa67cba"
      unitRef="shares">36963000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOjY4NmQ0ZDAxNDg0ZTQxYzI5YzRjZGZlYTBlYzIzYzI4L3RhYmxlcmFuZ2U6Njg2ZDRkMDE0ODRlNDFjMjljNGNkZmVhMGVjMjNjMjhfOC01LTEtMS00NjMzNA_21b48c99-a2d2-484d-b3fd-250d5cf38f33"
      unitRef="shares">37200000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOjY4NmQ0ZDAxNDg0ZTQxYzI5YzRjZGZlYTBlYzIzYzI4L3RhYmxlcmFuZ2U6Njg2ZDRkMDE0ODRlNDFjMjljNGNkZmVhMGVjMjNjMjhfOC03LTEtMS00NjMzNA_6d441565-e881-4b98-a456-3c41e39e2d58"
      unitRef="shares">36593000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOjY4NmQ0ZDAxNDg0ZTQxYzI5YzRjZGZlYTBlYzIzYzI4L3RhYmxlcmFuZ2U6Njg2ZDRkMDE0ODRlNDFjMjljNGNkZmVhMGVjMjNjMjhfMTAtMS0xLTEtNDYzMzQ_d66d464f-b9d2-41db-a8ee-13b27225aa04"
      unitRef="shares">391000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOjY4NmQ0ZDAxNDg0ZTQxYzI5YzRjZGZlYTBlYzIzYzI4L3RhYmxlcmFuZ2U6Njg2ZDRkMDE0ODRlNDFjMjljNGNkZmVhMGVjMjNjMjhfMTAtMy0xLTEtNDYzMzQ_1661e8bd-b7e8-4cd6-93da-7a0ef43c595a"
      unitRef="shares">619000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOjY4NmQ0ZDAxNDg0ZTQxYzI5YzRjZGZlYTBlYzIzYzI4L3RhYmxlcmFuZ2U6Njg2ZDRkMDE0ODRlNDFjMjljNGNkZmVhMGVjMjNjMjhfMTAtNS0xLTEtNDYzMzQ_e5a6aae2-b57b-4cca-93f6-327c14dce96a"
      unitRef="shares">541000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOjY4NmQ0ZDAxNDg0ZTQxYzI5YzRjZGZlYTBlYzIzYzI4L3RhYmxlcmFuZ2U6Njg2ZDRkMDE0ODRlNDFjMjljNGNkZmVhMGVjMjNjMjhfMTAtNy0xLTEtNDYzMzQ_bf49d86a-4631-4e43-b5e0-9ca235be56f9"
      unitRef="shares">683000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOjY4NmQ0ZDAxNDg0ZTQxYzI5YzRjZGZlYTBlYzIzYzI4L3RhYmxlcmFuZ2U6Njg2ZDRkMDE0ODRlNDFjMjljNGNkZmVhMGVjMjNjMjhfMTEtMS0xLTEtNDYzMzQ_3d9c1c87-f3d3-47b9-8e82-aed0827651d0"
      unitRef="shares">37492000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOjY4NmQ0ZDAxNDg0ZTQxYzI5YzRjZGZlYTBlYzIzYzI4L3RhYmxlcmFuZ2U6Njg2ZDRkMDE0ODRlNDFjMjljNGNkZmVhMGVjMjNjMjhfMTEtMy0xLTEtNDYzMzQ_48206876-a723-43cf-96f3-31daecd6ab9c"
      unitRef="shares">37582000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOjY4NmQ0ZDAxNDg0ZTQxYzI5YzRjZGZlYTBlYzIzYzI4L3RhYmxlcmFuZ2U6Njg2ZDRkMDE0ODRlNDFjMjljNGNkZmVhMGVjMjNjMjhfMTEtNS0xLTEtNDYzMzQ_bedd6d99-e8db-4202-bcd3-a4b3a18791c8"
      unitRef="shares">37741000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOjY4NmQ0ZDAxNDg0ZTQxYzI5YzRjZGZlYTBlYzIzYzI4L3RhYmxlcmFuZ2U6Njg2ZDRkMDE0ODRlNDFjMjljNGNkZmVhMGVjMjNjMjhfMTEtNy0xLTEtNDYzMzQ_612ac084-d2ec-445e-a25e-46715e6f2185"
      unitRef="shares">37276000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOjY4NmQ0ZDAxNDg0ZTQxYzI5YzRjZGZlYTBlYzIzYzI4L3RhYmxlcmFuZ2U6Njg2ZDRkMDE0ODRlNDFjMjljNGNkZmVhMGVjMjNjMjhfMTMtMS0xLTEtNDYzMzQ_1ff5a045-3ccd-40b9-80b2-5227a7235661"
      unitRef="usdPerShare">0.94</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOjY4NmQ0ZDAxNDg0ZTQxYzI5YzRjZGZlYTBlYzIzYzI4L3RhYmxlcmFuZ2U6Njg2ZDRkMDE0ODRlNDFjMjljNGNkZmVhMGVjMjNjMjhfMTMtMy0xLTEtNDYzMzQ_d43b1875-339f-4a7d-a174-8dee4c41c229"
      unitRef="usdPerShare">0.63</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOjY4NmQ0ZDAxNDg0ZTQxYzI5YzRjZGZlYTBlYzIzYzI4L3RhYmxlcmFuZ2U6Njg2ZDRkMDE0ODRlNDFjMjljNGNkZmVhMGVjMjNjMjhfMTMtNS0xLTEtNDYzMzQ_6b70651d-c728-47b7-8c38-0b579887a7d1"
      unitRef="usdPerShare">4.02</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOjY4NmQ0ZDAxNDg0ZTQxYzI5YzRjZGZlYTBlYzIzYzI4L3RhYmxlcmFuZ2U6Njg2ZDRkMDE0ODRlNDFjMjljNGNkZmVhMGVjMjNjMjhfMTMtNy0xLTEtNDYzMzQ_29c38e28-cfff-40ee-96ea-fa18f495e122"
      unitRef="usdPerShare">1.49</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOjY4NmQ0ZDAxNDg0ZTQxYzI5YzRjZGZlYTBlYzIzYzI4L3RhYmxlcmFuZ2U6Njg2ZDRkMDE0ODRlNDFjMjljNGNkZmVhMGVjMjNjMjhfMTUtMS0xLTEtNDYzMzQ_a817aeea-433c-42d6-95e4-964a3b69a14c"
      unitRef="usdPerShare">0.93</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOjY4NmQ0ZDAxNDg0ZTQxYzI5YzRjZGZlYTBlYzIzYzI4L3RhYmxlcmFuZ2U6Njg2ZDRkMDE0ODRlNDFjMjljNGNkZmVhMGVjMjNjMjhfMTUtMy0xLTEtNDYzMzQ_50b1172d-effe-4428-b2ef-32eaef2ac27e"
      unitRef="usdPerShare">0.62</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOjY4NmQ0ZDAxNDg0ZTQxYzI5YzRjZGZlYTBlYzIzYzI4L3RhYmxlcmFuZ2U6Njg2ZDRkMDE0ODRlNDFjMjljNGNkZmVhMGVjMjNjMjhfMTUtNS0xLTEtNDYzMzQ_99f4f1d9-8e25-437a-a5e7-708499394b66"
      unitRef="usdPerShare">3.97</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOjY4NmQ0ZDAxNDg0ZTQxYzI5YzRjZGZlYTBlYzIzYzI4L3RhYmxlcmFuZ2U6Njg2ZDRkMDE0ODRlNDFjMjljNGNkZmVhMGVjMjNjMjhfMTUtNy0xLTEtNDYzMzQ_ed486507-ff22-487e-bc9d-15e433a5f9b5"
      unitRef="usdPerShare">1.46</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RleHRyZWdpb246ZDNkN2Y0NGMyNzVmNDU3MWE3NTYwNWNlZmUzNWVhYTdfNTIx_1276e958-fdfb-4c4f-a368-cd3e45a665f8">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents the share-based awards that could potentially dilute net income per share attributable to common stockholders in the future that were not included in the computation of diluted net income per share attributable to common stockholders because to do so would have been anti-dilutive for the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based awards&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i2caa7dba2bf946eeba1cabe94a429f67_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOmRiZWRiOGRjMTBhMzQxNjNiMDQxMzc0ZmQyMWExM2FjL3RhYmxlcmFuZ2U6ZGJlZGI4ZGMxMGEzNDE2M2IwNDEzNzRmZDIxYTEzYWNfNC0xLTEtMS00NjMzNA_13d10746-1b84-457a-9807-c05264e588c0"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ia2bdc4ad60944e738242ef9a6814d745_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOmRiZWRiOGRjMTBhMzQxNjNiMDQxMzc0ZmQyMWExM2FjL3RhYmxlcmFuZ2U6ZGJlZGI4ZGMxMGEzNDE2M2IwNDEzNzRmZDIxYTEzYWNfNC0zLTEtMS00NjMzNA_6a0bd348-22b3-454b-90ed-8ec859a951ee"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i955dad9273e74d0b9b508f98c422598d_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOmRiZWRiOGRjMTBhMzQxNjNiMDQxMzc0ZmQyMWExM2FjL3RhYmxlcmFuZ2U6ZGJlZGI4ZGMxMGEzNDE2M2IwNDEzNzRmZDIxYTEzYWNfNC01LTEtMS00NjMzNA_f6c18caf-9faf-4f37-b9a4-721607eafdfd"
      unitRef="shares">73000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i2bf81d4651a84b7d903fab0b74c4d6c6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81Mi9mcmFnOmQzZDdmNDRjMjc1ZjQ1NzFhNzU2MDVjZWZlMzVlYWE3L3RhYmxlOmRiZWRiOGRjMTBhMzQxNjNiMDQxMzc0ZmQyMWExM2FjL3RhYmxlcmFuZ2U6ZGJlZGI4ZGMxMGEzNDE2M2IwNDEzNzRmZDIxYTEzYWNfNC03LTEtMS00NjMzNA_20805b4e-d6bd-4d87-8c7d-69b2fd035444"
      unitRef="shares">9000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RleHRyZWdpb246YTllYmQyNjJjYTVmNDkzYTg3MGVlOWNiNzM3NzA5NTdfMjU4Mg_84e5ec1f-fbe6-4728-85eb-fd363781a395">GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had the following acquired intangible assets:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.239%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="36" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets subject to amortization:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Databases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-compete agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="36" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets not subject to amortization:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names, indefinite-lived&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2022, estimated annual amortization expense was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:80.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.989%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ending December&#160;31:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The changes in the carrying amount of goodwill by reportable segment are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.447%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nurse&lt;br/&gt;And Allied&lt;br/&gt;Staffing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Physician&lt;br/&gt;Staffing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balances as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aggregate goodwill acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;439,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sale of business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,889)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,889)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated impairment loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(269,874)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,598)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(310,472)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill, net of impairment loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Changes to aggregate goodwill in 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquisition adjustment - Selected &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,130)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,130)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balances as of September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aggregate goodwill acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;433,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sale of business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,889)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,889)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated impairment loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(269,874)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,598)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(310,472)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill, net of impairment loss&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;________________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) Represents an adjustment to the fair value of the identifiable net assets acquired, with a corresponding offset to goodwill, made during the measurement period related to the acquisition of Selected. See Note 4 - Acquisitions.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Goodwill, Trade Names, and Other Intangible Assets Impairment &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company tests reporting units&#x2019; goodwill and intangible assets with indefinite lives for impairment annually during the fourth quarter and more frequently if impairment indicators exist. The Company performs quarterly qualitative assessments of significant events and circumstances such as reporting units&#x2019; historical and current results, assumptions regarding future performance, strategic initiatives and overall economic factors,&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; including COVID,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and macro-economic developments, to determine the existence of potential indicators of impairment and assess if it is more likely than not that the fair value of reporting units or intangible assets is less than their carrying value. If indicators of impairments are identified a quantitative impairment test is performed.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September 30, 2022 and 2021, the Company performed a qualitative assessment of each of its reporting units and determined it was not more likely than not that the fair value of its reporting units dropped below their carrying value. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;lthough management believes that the Company's current estimates and assumptions utilized in its qualitative testing are reasonable and supportable, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;including its assumptions on the impact and timing related to COVID,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; there can be no assurance that the estimates and assumptions management used for purposes of its qualitative assessment as of September 30, 2022 will prove to be accurate predictions of future performance.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For its long-lived assets and definite-lived intangible assets, the Company reviews for impairment whenever events or changes in circumstances indicate the carrying amount may not be recoverable. As of September 30, 2022, the Company performed a qualitative assessment of its trade names and other intangible assets and, as a result, the Company wrote off a discontinued IT project and recorded a $1.9&#160;million impairment charge. During the nine months ended September 30, 2021, the Company wrote off a discontinued software development project, resulting in an immaterial impairment charge.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RleHRyZWdpb246YTllYmQyNjJjYTVmNDkzYTg3MGVlOWNiNzM3NzA5NTdfMjU4Ng_449c084b-3177-4658-be5a-3d9f5d5d120c">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had the following acquired intangible assets:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.239%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="36" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets subject to amortization:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Databases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-compete agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="36" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets not subject to amortization:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names, indefinite-lived&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i8596209ef08040d2bfd996b39f79a2cc_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfNC0xLTEtMS00NjMzNA_542b76f2-adca-4ee4-9ad3-74b60da50960"
      unitRef="usd">33430000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i8596209ef08040d2bfd996b39f79a2cc_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfNC0zLTEtMS00NjMzNA_5123b3db-b002-41c7-9e1f-44c6b9f7dc66"
      unitRef="usd">21125000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i8596209ef08040d2bfd996b39f79a2cc_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfNC01LTEtMS00NjMzNA_053cf007-6652-4d69-b609-d52bd076ddb4"
      unitRef="usd">12305000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ie4f8278712e840b2b0b1388f6f6d449a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfNC03LTEtMS00NjMzNA_7d19a2b7-65be-4491-914e-9945d13e9009"
      unitRef="usd">30530000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ie4f8278712e840b2b0b1388f6f6d449a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfNC05LTEtMS00NjMzNA_c61b2e82-3fb9-47bf-b03b-fd1a5e04bb98"
      unitRef="usd">18375000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ie4f8278712e840b2b0b1388f6f6d449a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfNC0xMS0xLTEtNDYzMzQ_93453b2a-69de-461b-9419-ad14a08ebcc4"
      unitRef="usd">12155000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="iee283e580b834384a505bf9085488f0c_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfNS0xLTEtMS00NjMzNA_caf4dea4-e0a7-4d35-9841-4ecb67490b38"
      unitRef="usd">47738000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iee283e580b834384a505bf9085488f0c_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfNS0zLTEtMS00NjMzNA_4041809f-f416-4032-b1d3-60e3709a3ffb"
      unitRef="usd">20649000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="iee283e580b834384a505bf9085488f0c_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfNS01LTEtMS00NjMzNA_d0e80c35-bced-43c3-8efe-e33fc9c4284b"
      unitRef="usd">27089000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i1393e7a548df431795ee6a40b27a3d83_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfNS03LTEtMS00NjMzNA_df682b4d-8a80-4e4e-a9c4-638ee72f4259"
      unitRef="usd">47738000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i1393e7a548df431795ee6a40b27a3d83_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfNS05LTEtMS00NjMzNA_7996b0a9-fd2b-4875-a360-57c597af7585"
      unitRef="usd">17581000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i1393e7a548df431795ee6a40b27a3d83_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfNS0xMS0xLTEtNDYzMzQ_d1dc5617-c803-485c-aacc-ba2fa2f32680"
      unitRef="usd">30157000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ifffbe09f8f09467eb7e5b113f3801e46_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfNi0xLTEtMS00NjMzNA_97cb3ab3-fdaa-4c7b-9938-c2be12e4ce1b"
      unitRef="usd">4000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ifffbe09f8f09467eb7e5b113f3801e46_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfNi0zLTEtMS00NjMzNA_8f652b8a-cd11-41a1-a26e-594d4e4a3fd0"
      unitRef="usd">3000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ifffbe09f8f09467eb7e5b113f3801e46_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfNi01LTEtMS00NjMzNA_e607c233-1db8-4535-93f0-e0d86153d065"
      unitRef="usd">1000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i66cd55e77f1246b18919d2e35b249926_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfNi03LTEtMS00NjMzNA_a9387ec9-ad81-4d88-9193-9506280cd2d4"
      unitRef="usd">304000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i66cd55e77f1246b18919d2e35b249926_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfNi05LTEtMS00NjMzNA_0dc4d257-2ddf-42f0-a4c7-01d7ae7daee7"
      unitRef="usd">272000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i66cd55e77f1246b18919d2e35b249926_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfNi0xMS0xLTEtNDYzMzQ_e9046757-8b0c-4a5a-a373-b36ab13df6c1"
      unitRef="usd">32000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="id346bd8243c84b70924309b05565c2d3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfNy0xLTEtMS00NjMzNA_855cf020-e7bf-44f3-a735-2bcea792f873"
      unitRef="usd">30000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="id346bd8243c84b70924309b05565c2d3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfNy0zLTEtMS00NjMzNA_471c805d-8d6b-4f6d-a5c1-031220f3a632"
      unitRef="usd">12000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="id346bd8243c84b70924309b05565c2d3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfNy01LTEtMS00NjMzNA_647ad8d5-f4f1-449f-8577-c0fa1bde6731"
      unitRef="usd">18000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i7d2f558a2d464d13a6a45fd804204c56_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfNy03LTEtMS00NjMzNA_34e05066-966d-4b66-873b-0bb28101a8c8"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i7d2f558a2d464d13a6a45fd804204c56_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfNy05LTEtMS00NjMzNA_8676ec3d-7ab9-460b-a29b-09b3e8716b7b"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i7d2f558a2d464d13a6a45fd804204c56_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfNy0xMS0xLTEtNDYzMzQ_ff435c89-85af-4d94-8fe6-7f41c6b6ead4"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i4f28bc2f1f144f9b8079211ca0ac2719_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfOC0xLTEtMS00NjMzNA_3ac8f0c6-5ceb-4f1c-8d14-90826727fa35"
      unitRef="usd">1700000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i4f28bc2f1f144f9b8079211ca0ac2719_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfOC0zLTEtMS00NjMzNA_e9ae594d-623e-4ac9-b223-4b1a6bde8144"
      unitRef="usd">270000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i4f28bc2f1f144f9b8079211ca0ac2719_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfOC01LTEtMS00NjMzNA_4cde058e-1831-4913-b886-1d620e0235a8"
      unitRef="usd">1430000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i6df5cca2f9f94120b8172ac27441142a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfOC03LTEtMS00NjMzNA_26dcc791-6e85-4c0e-b424-7cd144c2c248"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i6df5cca2f9f94120b8172ac27441142a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfOC05LTEtMS00NjMzNA_34ab06f3-6682-4dcb-8301-0ae4a69fe7e8"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i6df5cca2f9f94120b8172ac27441142a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfOC0xMS0xLTEtNDYzMzQ_992fb4cf-4511-4612-9ff6-42decdc00bfe"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfOS0xLTEtMS00NjMzNA_be5ded49-9103-466d-ad1f-0ae2748b014a"
      unitRef="usd">82902000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfOS0zLTEtMS00NjMzNA_042a6edc-32c5-4ad9-aa6d-9dd585e7e742"
      unitRef="usd">42059000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfOS01LTEtMS00NjMzNA_fb23bd28-e67a-4526-a69f-9916056cdeb0"
      unitRef="usd">40843000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfOS03LTEtMS00NjMzNA_d071ce89-9cb5-477a-beb2-07c17943ac58"
      unitRef="usd">78572000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfOS05LTEtMS00NjMzNA_b1383290-c31f-42c5-88b0-2e82a92fad36"
      unitRef="usd">36228000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfOS0xMS0xLTEtNDYzMzQ_9cd7c4a3-3394-4fe8-b027-bb053326cafa"
      unitRef="usd">42344000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IndefiniteLivedTradeNames
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfMTItNS0xLTEtNDYzMzQ_1636f331-ed76-4b78-8608-78df258520ab"
      unitRef="usd">5900000</us-gaap:IndefiniteLivedTradeNames>
    <us-gaap:IndefiniteLivedTradeNames
      contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjAyMzk0NWY5NmE4ODQ4MTQ4ZmU1NDg1NWJlYmM3ZjkyL3RhYmxlcmFuZ2U6MDIzOTQ1Zjk2YTg4NDgxNDhmZTU0ODU1YmViYzdmOTJfMTItMTEtMS0xLTQ2MzM0_f2c87cb1-9d3b-4292-a410-173f8eb00c26"
      unitRef="usd">5900000</us-gaap:IndefiniteLivedTradeNames>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RleHRyZWdpb246YTllYmQyNjJjYTVmNDkzYTg3MGVlOWNiNzM3NzA5NTdfMjU5MQ_ed01488d-82de-4feb-ab1e-6ac83abd6d77">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2022, estimated annual amortization expense was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:80.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.989%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ending December&#160;31:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjBmYmRmM2Q5MzUyZjQ2NjZhMjE2YjU0NmU5OWRjOGE5L3RhYmxlcmFuZ2U6MGZiZGYzZDkzNTJmNDY2NmEyMTZiNTQ2ZTk5ZGM4YTlfMi0xLTEtMS00NjMzNA_894e8e6c-14a7-492c-a70c-d24006770b44"
      unitRef="usd">2020000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjBmYmRmM2Q5MzUyZjQ2NjZhMjE2YjU0NmU5OWRjOGE5L3RhYmxlcmFuZ2U6MGZiZGYzZDkzNTJmNDY2NmEyMTZiNTQ2ZTk5ZGM4YTlfMy0xLTEtMS00NjMzNA_ff04c5cf-83a0-4a69-90ec-5d3ae815346e"
      unitRef="usd">8051000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjBmYmRmM2Q5MzUyZjQ2NjZhMjE2YjU0NmU5OWRjOGE5L3RhYmxlcmFuZ2U6MGZiZGYzZDkzNTJmNDY2NmEyMTZiNTQ2ZTk5ZGM4YTlfNC0xLTEtMS00NjMzNA_5a54803d-b8a5-4e1d-9802-2b19388d6611"
      unitRef="usd">7399000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjBmYmRmM2Q5MzUyZjQ2NjZhMjE2YjU0NmU5OWRjOGE5L3RhYmxlcmFuZ2U6MGZiZGYzZDkzNTJmNDY2NmEyMTZiNTQ2ZTk5ZGM4YTlfNS0xLTEtMS00NjMzNA_b4420518-f77f-455e-9464-95347efbdf5f"
      unitRef="usd">6840000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjBmYmRmM2Q5MzUyZjQ2NjZhMjE2YjU0NmU5OWRjOGE5L3RhYmxlcmFuZ2U6MGZiZGYzZDkzNTJmNDY2NmEyMTZiNTQ2ZTk5ZGM4YTlfNi0xLTEtMS00NjMzNA_323bf913-e83c-4d38-98d6-e491809aea07"
      unitRef="usd">5632000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <ccrn:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjBmYmRmM2Q5MzUyZjQ2NjZhMjE2YjU0NmU5OWRjOGE5L3RhYmxlcmFuZ2U6MGZiZGYzZDkzNTJmNDY2NmEyMTZiNTQ2ZTk5ZGM4YTlfNy0xLTEtMS00NjMzNA_e482d510-6d61-41ce-be67-a759ea2f728e"
      unitRef="usd">10901000</ccrn:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjBmYmRmM2Q5MzUyZjQ2NjZhMjE2YjU0NmU5OWRjOGE5L3RhYmxlcmFuZ2U6MGZiZGYzZDkzNTJmNDY2NmEyMTZiNTQ2ZTk5ZGM4YTlfOC0xLTEtMS00NjMzNA_86cbb1f2-9e81-4ed3-a303-6bd6e5056bc4"
      unitRef="usd">40843000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RleHRyZWdpb246YTllYmQyNjJjYTVmNDkzYTg3MGVlOWNiNzM3NzA5NTdfMjU5OQ_3d2bff40-e11d-4654-ac20-6d8f4cc829dd">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The changes in the carrying amount of goodwill by reportable segment are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.447%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nurse&lt;br/&gt;And Allied&lt;br/&gt;Staffing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Physician&lt;br/&gt;Staffing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balances as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aggregate goodwill acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;439,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sale of business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,889)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,889)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated impairment loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(269,874)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,598)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(310,472)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill, net of impairment loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Changes to aggregate goodwill in 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquisition adjustment - Selected &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,130)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,130)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balances as of September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aggregate goodwill acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;433,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sale of business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,889)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,889)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated impairment loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(269,874)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,598)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(310,472)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill, net of impairment loss&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;________________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) Represents an adjustment to the fair value of the identifiable net assets acquired, with a corresponding offset to goodwill, made during the measurement period related to the acquisition of Selected. See Note 4 - Acquisitions.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:GoodwillGross
      contextRef="i9689395cb7444c7c8ae6b2bb1d17f429_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjI2NjU3ZDU1MmM1YjQ0ZTVhZjhmY2RlYWRhMDJjOGU2L3RhYmxlcmFuZ2U6MjY2NTdkNTUyYzViNDRlNWFmOGZjZGVhZGEwMmM4ZTZfMy0xLTEtMS00NjMzNA_9e73831b-95d6-41dd-ac59-c19bc816b4ee"
      unitRef="usd">396446000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="i3141d307889e400f8613ac4e53dfd7bf_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjI2NjU3ZDU1MmM1YjQ0ZTVhZjhmY2RlYWRhMDJjOGU2L3RhYmxlcmFuZ2U6MjY2NTdkNTUyYzViNDRlNWFmOGZjZGVhZGEwMmM4ZTZfMy0zLTEtMS00NjMzNA_24f6a94e-1a2c-4551-ae8d-3540b9042080"
      unitRef="usd">43405000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjI2NjU3ZDU1MmM1YjQ0ZTVhZjhmY2RlYWRhMDJjOGU2L3RhYmxlcmFuZ2U6MjY2NTdkNTUyYzViNDRlNWFmOGZjZGVhZGEwMmM4ZTZfMy01LTEtMS00NjMzNA_26d1fed9-bc5b-4d51-818e-ddf422f1ed59"
      unitRef="usd">439851000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="i92f6c3cc4f5c4abda295b3072437fb45_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjI2NjU3ZDU1MmM1YjQ0ZTVhZjhmY2RlYWRhMDJjOGU2L3RhYmxlcmFuZ2U6MjY2NTdkNTUyYzViNDRlNWFmOGZjZGVhZGEwMmM4ZTZfNC0xLTEtMS00NjMzNA_012f3bf7-c9f6-47d0-ac5d-d85fd2b3a0b3"
      unitRef="usd">9889000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="i98085908a4ff4bfabc746d90f51c8c01_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjI2NjU3ZDU1MmM1YjQ0ZTVhZjhmY2RlYWRhMDJjOGU2L3RhYmxlcmFuZ2U6MjY2NTdkNTUyYzViNDRlNWFmOGZjZGVhZGEwMmM4ZTZfNC0zLTEtMS00NjMzNA_8c7bf239-2b7c-4a46-9a23-4a94ea6f1526"
      unitRef="usd">0</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="i8a09ea9a925140449a60d73ca6cea3cb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjI2NjU3ZDU1MmM1YjQ0ZTVhZjhmY2RlYWRhMDJjOGU2L3RhYmxlcmFuZ2U6MjY2NTdkNTUyYzViNDRlNWFmOGZjZGVhZGEwMmM4ZTZfNC01LTEtMS00NjMzNA_dd575bef-9197-4a3f-be3b-bc0c31d348bd"
      unitRef="usd">9889000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i9689395cb7444c7c8ae6b2bb1d17f429_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjI2NjU3ZDU1MmM1YjQ0ZTVhZjhmY2RlYWRhMDJjOGU2L3RhYmxlcmFuZ2U6MjY2NTdkNTUyYzViNDRlNWFmOGZjZGVhZGEwMmM4ZTZfNS0xLTEtMS00NjMzNA_9c4e1562-f497-4c7e-af55-e289104a89ea"
      unitRef="usd">269874000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i3141d307889e400f8613ac4e53dfd7bf_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjI2NjU3ZDU1MmM1YjQ0ZTVhZjhmY2RlYWRhMDJjOGU2L3RhYmxlcmFuZ2U6MjY2NTdkNTUyYzViNDRlNWFmOGZjZGVhZGEwMmM4ZTZfNS0zLTEtMS00NjMzNA_c59ad7a5-77c4-410c-b5c7-ce73eaf2b19a"
      unitRef="usd">40598000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjI2NjU3ZDU1MmM1YjQ0ZTVhZjhmY2RlYWRhMDJjOGU2L3RhYmxlcmFuZ2U6MjY2NTdkNTUyYzViNDRlNWFmOGZjZGVhZGEwMmM4ZTZfNS01LTEtMS00NjMzNA_6f2f7d01-749f-4022-9235-f717917fe27c"
      unitRef="usd">310472000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:Goodwill
      contextRef="i9689395cb7444c7c8ae6b2bb1d17f429_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjI2NjU3ZDU1MmM1YjQ0ZTVhZjhmY2RlYWRhMDJjOGU2L3RhYmxlcmFuZ2U6MjY2NTdkNTUyYzViNDRlNWFmOGZjZGVhZGEwMmM4ZTZfNi0xLTEtMS00NjMzNA_6751c264-7f29-47b2-8659-093b9417cd57"
      unitRef="usd">116683000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i3141d307889e400f8613ac4e53dfd7bf_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjI2NjU3ZDU1MmM1YjQ0ZTVhZjhmY2RlYWRhMDJjOGU2L3RhYmxlcmFuZ2U6MjY2NTdkNTUyYzViNDRlNWFmOGZjZGVhZGEwMmM4ZTZfNi0zLTEtMS00NjMzNA_f23e1117-91b3-4bcf-b4f7-b91b550dffad"
      unitRef="usd">2807000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjI2NjU3ZDU1MmM1YjQ0ZTVhZjhmY2RlYWRhMDJjOGU2L3RhYmxlcmFuZ2U6MjY2NTdkNTUyYzViNDRlNWFmOGZjZGVhZGEwMmM4ZTZfNi01LTEtMS00NjMzNA_5de5bf33-3ade-4492-8dff-fa5164bf358c"
      unitRef="usd">119490000</us-gaap:Goodwill>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i7aaf74b211ba45b9bea92196b8c48cd7_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjI2NjU3ZDU1MmM1YjQ0ZTVhZjhmY2RlYWRhMDJjOGU2L3RhYmxlcmFuZ2U6MjY2NTdkNTUyYzViNDRlNWFmOGZjZGVhZGEwMmM4ZTZfOS0xLTEtMS00NjMzNA_a373fb21-9494-40f0-8331-33c9a19b7901"
      unitRef="usd">-6130000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="ia4be1f35efe045ebabfe8d9154e1c3cb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjI2NjU3ZDU1MmM1YjQ0ZTVhZjhmY2RlYWRhMDJjOGU2L3RhYmxlcmFuZ2U6MjY2NTdkNTUyYzViNDRlNWFmOGZjZGVhZGEwMmM4ZTZfOS0zLTEtMS00NjMzNA_3249e1c7-6482-449f-9fa1-6a1a97ed3c3b"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjI2NjU3ZDU1MmM1YjQ0ZTVhZjhmY2RlYWRhMDJjOGU2L3RhYmxlcmFuZ2U6MjY2NTdkNTUyYzViNDRlNWFmOGZjZGVhZGEwMmM4ZTZfOS01LTEtMS00NjMzNA_d5e41c68-7bb4-49a4-aabf-fb451b564f50"
      unitRef="usd">-6130000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillGross
      contextRef="ie4a8ed4c652b409b9c9e62d38384449a_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjI2NjU3ZDU1MmM1YjQ0ZTVhZjhmY2RlYWRhMDJjOGU2L3RhYmxlcmFuZ2U6MjY2NTdkNTUyYzViNDRlNWFmOGZjZGVhZGEwMmM4ZTZfMTItMS0xLTEtNDYzMzQ_b3ef18ee-c41e-4e88-bcf2-9aebf53ddb84"
      unitRef="usd">390316000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="ic0b4574bdbb84488a12b61c871791cd5_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjI2NjU3ZDU1MmM1YjQ0ZTVhZjhmY2RlYWRhMDJjOGU2L3RhYmxlcmFuZ2U6MjY2NTdkNTUyYzViNDRlNWFmOGZjZGVhZGEwMmM4ZTZfMTItMy0xLTEtNDYzMzQ_674b72fa-0e99-47e3-a6e1-f9f1b83d33eb"
      unitRef="usd">43405000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjI2NjU3ZDU1MmM1YjQ0ZTVhZjhmY2RlYWRhMDJjOGU2L3RhYmxlcmFuZ2U6MjY2NTdkNTUyYzViNDRlNWFmOGZjZGVhZGEwMmM4ZTZfMTItNS0xLTEtNDYzMzQ_b17cb3f5-7283-4f3f-b4dd-d8b9ad2ba2db"
      unitRef="usd">433721000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="i50f6f534fc28456f8f17929b1cef9416_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjI2NjU3ZDU1MmM1YjQ0ZTVhZjhmY2RlYWRhMDJjOGU2L3RhYmxlcmFuZ2U6MjY2NTdkNTUyYzViNDRlNWFmOGZjZGVhZGEwMmM4ZTZfMTMtMS0xLTEtNDYzMzQ_e79d156e-412c-49e9-b668-b0804bc52cd6"
      unitRef="usd">9889000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="i87608f5be1294b2c81227b913215f1f0_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjI2NjU3ZDU1MmM1YjQ0ZTVhZjhmY2RlYWRhMDJjOGU2L3RhYmxlcmFuZ2U6MjY2NTdkNTUyYzViNDRlNWFmOGZjZGVhZGEwMmM4ZTZfMTMtMy0xLTEtNDYzMzQ_23a28b00-4be9-4d56-8b61-561d90192dda"
      unitRef="usd">0</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="ie01c32b128c342b89c4718d3db15e20c_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjI2NjU3ZDU1MmM1YjQ0ZTVhZjhmY2RlYWRhMDJjOGU2L3RhYmxlcmFuZ2U6MjY2NTdkNTUyYzViNDRlNWFmOGZjZGVhZGEwMmM4ZTZfMTMtNS0xLTEtNDYzMzQ_25328b5a-1693-44ff-9615-fb72f765de06"
      unitRef="usd">9889000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="ie4a8ed4c652b409b9c9e62d38384449a_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjI2NjU3ZDU1MmM1YjQ0ZTVhZjhmY2RlYWRhMDJjOGU2L3RhYmxlcmFuZ2U6MjY2NTdkNTUyYzViNDRlNWFmOGZjZGVhZGEwMmM4ZTZfMTQtMS0xLTEtNDYzMzQ_37f3f078-95d9-4599-a469-6658ca85fd83"
      unitRef="usd">269874000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="ic0b4574bdbb84488a12b61c871791cd5_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjI2NjU3ZDU1MmM1YjQ0ZTVhZjhmY2RlYWRhMDJjOGU2L3RhYmxlcmFuZ2U6MjY2NTdkNTUyYzViNDRlNWFmOGZjZGVhZGEwMmM4ZTZfMTQtMy0xLTEtNDYzMzQ_396f8b2a-c11a-4838-8869-1d30de8c0afa"
      unitRef="usd">40598000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjI2NjU3ZDU1MmM1YjQ0ZTVhZjhmY2RlYWRhMDJjOGU2L3RhYmxlcmFuZ2U6MjY2NTdkNTUyYzViNDRlNWFmOGZjZGVhZGEwMmM4ZTZfMTQtNS0xLTEtNDYzMzQ_ded0bb5c-b518-4973-b36b-f56716c5457f"
      unitRef="usd">310472000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:Goodwill
      contextRef="ie4a8ed4c652b409b9c9e62d38384449a_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjI2NjU3ZDU1MmM1YjQ0ZTVhZjhmY2RlYWRhMDJjOGU2L3RhYmxlcmFuZ2U6MjY2NTdkNTUyYzViNDRlNWFmOGZjZGVhZGEwMmM4ZTZfMTUtMS0xLTEtNDYzMzQ_92c641f0-5b77-474d-b3e9-8ffec4238144"
      unitRef="usd">110553000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ic0b4574bdbb84488a12b61c871791cd5_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjI2NjU3ZDU1MmM1YjQ0ZTVhZjhmY2RlYWRhMDJjOGU2L3RhYmxlcmFuZ2U6MjY2NTdkNTUyYzViNDRlNWFmOGZjZGVhZGEwMmM4ZTZfMTUtMy0xLTEtNDYzMzQ_89000c83-551b-4ad5-9d7b-31f2d621de28"
      unitRef="usd">2807000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RhYmxlOjI2NjU3ZDU1MmM1YjQ0ZTVhZjhmY2RlYWRhMDJjOGU2L3RhYmxlcmFuZ2U6MjY2NTdkNTUyYzViNDRlNWFmOGZjZGVhZGEwMmM4ZTZfMTUtNS0xLTEtNDYzMzQ_2dcd032f-678c-4a0a-9d9f-518aed5fb71a"
      unitRef="usd">113360000</us-gaap:Goodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81NS9mcmFnOmE5ZWJkMjYyY2E1ZjQ5M2E4NzBlZTljYjczNzcwOTU3L3RleHRyZWdpb246YTllYmQyNjJjYTVmNDkzYTg3MGVlOWNiNzM3NzA5NTdfNTQ5NzU1ODE2ODkx_3ee17431-3627-4656-b2a8-1895474b8f08"
      unitRef="usd">1900000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfOTc3MA_10e4e0de-ef8e-4765-b279-f24a01376a40">DEBT&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's long-term debt consists of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Principal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Debt Issuance Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Principal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Debt Issuance Costs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="21" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan, interest of 8.83% and 6.50% at September 30, 2022 and December 31, 2021, respectively&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,320)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,396)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Secured Asset-Based Loan, interest of 4.58% and 1.60% at September 30, 2022 and December 31, 2021, respectively&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,642)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(991)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Note Payable, interest of 2.00% per annum at December 31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,962)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,387)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less current portion - Note Payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less current portion - Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,962)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,387)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2021, the current portion of the term loan and the note payable are included in current portion of debt on the condensed consolidated balance sheets. The final installment of the note payable, related to contingent consideration assumed as part of a prior period acquisition, was paid in the first quarter of 2022. The Company has elected to present the debt issuance costs associated with its revolving line-of-credit as an asset, which is included in other non-current assets on the                                                                                                                                                                   condensed consolidated balance sheets. As a result, the long-term debt in the above table will not agree to long-term debt, net of current portion on the condensed consolidated balance sheets herein.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Late in the second quarter of 2022, the Company made an optional prepayment of $50.0&#160;million on its term loan. The Company was entitled to determine the application of the prepayment, which was applied to all future amortization payments, with the balance applied to the remaining balloon payment in 2027. As of September 30, 2022, the aggregate schedule for maturities of debt are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Senior Secured Asset-Based Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Through Years Ending December&#160;31:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2021 Term Loan Credit Agreement&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On June 8, 2021, the Company entered into a Term Loan Credit Agreement (Term Loan Agreement) with&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; certain lenders identified therein (collectively, the Lenders) and Wilmington Trust&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;, National Association as administrative agent and collateral agent, pursuant to which the Lenders extended to the Company a six-year second lien subordinated term loan in the amount of $100.0&#160;million (term loan). The term loan has an interest rate of one-month London Inter-Bank Offered Rate (LIBOR) plus 5.75% per annum, subject to a 0.75% LIBOR floor. The term loan was used to pay the cash consideration, as well as any costs, fees, and expenses in connection with the WSG acquisition (see Note 4 - Acquisitions), with the remainder used to pay down a  portion of the asset-based credit facility. Fees paid in connection with the Term Loan Agreement have been included as debt issuance costs and as a reduction to the carrying amount of the term loan and are expected to be amortized to interest expense over the term of the Term Loan Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The borrowings under the Term Loan Agreement generally bear interest at a variable rate based on either LIBOR or Base Rate (as defined in the Term Loan Agreement) and are subject to mandatory prepayments of principal payable in quarterly installments, commencing on September 30, 2021, with each installment being in the aggregate principal amount of $0.3 million (subject to adjustment as a result of prepayments) provided that, to the extent not previously paid, the aggregate unpaid principal balance would be due and payable on the maturity date. The Term Loan Agreement contains various restrictions and covenants applicable to the Company and its subsidiaries, including a covenant to maintain a minimum net leverage ratio. The Company was in compliance with this covenant as of September 30, 2022. Obligations under the Term Loan Agreement are secured by substantially all the assets of the borrowers and guarantors under the Term Loan Agreement, subject to customary exceptions.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 18, 2021, the Company amended its Term Loan Agreement (Term Loan First Amendment), which provided the Company an incremental term loan in an aggregate amount equal to $75.0&#160;million. Additionally, the Term Loan First Amendment increased the aggregate amount of all increases (as defined in the Term Loan Agreement) to be no greater than $115.0&#160;million. The borrowings will be used primarily to fund organic growth. Commencing on December 31, 2021, installments of the mandatory prepayments will be in the aggregate principal amount of $0.4&#160;million. All other terms, conditions, covenants, and pricing of the Term Loan Agreement remain the same. In conjunction with the Term Loan First Amendment, the Company entered into the Term Loan First Amendment to the Intercreditor Agreement, effective as of November 18, 2021, which sets forth the lien priority, relative rights, and other creditors&#x2019; rights issues in respect of the collateral lenders.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to its scheduled payments, on June 23, 2022, the Company made an optional prepayment of $50.0&#160;million to reduce interest costs, and paid a prepayment premium of $0.5&#160;million pursuant to the Term Loan Agreement. As a result of the early prepayment, debt issuance costs of $1.4&#160;million were written off in the three months ended June 30, 2022. The prepayment premium and the write-off of debt issuance costs are included as loss on early extinguishment of debt in the condensed consolidated statements of operations. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The term loan is secured by a second-priority security interest in the collateral as defined in the ABL Credit Agreement (Loan Agreement) (as described below), and Wells Fargo Bank, National Association as agent, as amended by the First Amendment, Second Amendment, Third Amendment, Fourth Amendment, and Fifth Amendment to the Loan Agreement. The lien priority, relative rights, and other creditors&#x2019; rights issues in respect of the collateral lenders are set forth in the Intercreditor Agreement, by and among Wells Fargo Bank, National Association, as first lien agent, and Wilmington Trust, National Association, as second lien agent, as amended, restated, amended and restated, supplemented or otherwise modified from time to time in accordance with the terms thereof dated June 8, 2021 (Intercreditor Agreement).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2019 Loan Agreement&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effective October 25, 2019, the Company terminated its commitments under its prior senior credit facility entered into in August 2017 and entered into a Loan Agreement, by and among the Company and certain of its domestic subsidiaries, as borrowers or guarantors, Wells Fargo, PNC Bank N.A., as well as other Lenders (as defined therein) from time to time parties thereto. The Loan Agreement provides for a five-year revolving senior secured asset-based credit facility (ABL) in the aggregate principal amount of up to $120.0&#160;million (as described below), including a sublimit for swing loans up to $15.0&#160;million and a $35.0&#160;million sublimit for standby letters of credit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 30, 2020, the Company amended its Loan Agreement (First Amendment), which increased the current aggregate committed size of the ABL from $120.0&#160;million to $130.0&#160;million. All other terms, conditions, covenants, and pricing of the Loan Agreement remained the same. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 8, 2021, the Company amended its Loan Agreement (Second Amendment), which increased the current aggregate committed size of the ABL from $130.0&#160;million to $150.0&#160;million, increased certain borrowing base sub-limits, and decreased both the cash dominion event and financial reporting triggers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 8, 2021, the Company amended its Loan Agreement (Third Amendment), which permits the incurrence of indebtedness and grant of security as set forth in the Loan Agreement and in accordance with the Intercreditor Agreement, and provides mechanics relating to a transition away from LIBOR as a benchmark interest rate to a replacement alternative benchmark rate or mechanism for loans made in U.S. dollars.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 18, 2021, the Company amended its Loan Agreement (Fourth Amendment), whereby the permitted indebtedness (as defined in the Loan Agreement), was increased to $175.0 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 21, 2022, the Company amended its Loan Agreement (Fifth Amendment), which increased the current aggregate committed size of the ABL from $150.0 million to $300.0 million, extended the credit facility for an additional five years, and increased certain borrowing base sub-limits. In addition, the agreement provides the option for all or a portion of the borrowings to bear interest at a rate based on the Secured Overnight Financing Rate (SOFR) or Base Rate, at the election of the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;borrowers, plus an applicable margin. The applicable margin will increase 10 basis points due to the credit spread associated with the transition to SOFR.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These amendments were treated as modifications of debt and, as a result, the associated fees and costs were included in debt issuance costs and will be amortized ratably over the remaining term of the Loan Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Availability of the ABL commitments is subject to a borrowing base of up to 85% of secured eligible accounts receivable, subject to adjustment at certain quality levels, minus customary reserves and subject to customary adjustments. Revolving loans and letters of credit issued under the Loan Agreement reduce availability under the ABL on a dollar-for-dollar basis. Availability under the ABL will be used for general corporate purposes. At September 30, 2022, borrowing base availability under the ABL was $300.0&#160;million and the Company had $9.2&#160;million of borrowings drawn, as well as $17.5&#160;million of letters of credit outstanding related to workers' compensation and professional liability policies, leaving $273.3&#160;million of excess availability.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September 30, 2022, the interest rate spreads and fees under the Loan Agreement were based on SOFR plus 1.60% for the revolving portion of the borrowing base. The Base Rate (as defined by the Loan Agreement) margin would have been 0.50%  for the revolving portion&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The SOFR and Base Rate margins are subject to monthly pricing adjustments, pursuant to a pricing matrix based on the Company&#x2019;s excess availability under the revolving credit facility. In addition, the facility is subject to an unused line fee, letter of credit fees, and an administrative fee. The unused line fee is 0.375% of the average daily unused portion of the revolving credit facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Loan Agreement contains various restrictions and covenants applicable to the Company and its subsidiaries, including a covenant to maintain a minimum fixed charge coverage ratio. The Company was in compliance with this covenant as of September 30, 2022. Obligations under the ABL are secured by substantially all the assets of the borrowers and guarantors, subject to customary exceptions.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfOTc3NQ_fba29c0c-1c3c-4505-a10f-61ad807df0d8">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's long-term debt consists of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Principal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Debt Issuance Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Principal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Debt Issuance Costs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="21" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan, interest of 8.83% and 6.50% at September 30, 2022 and December 31, 2021, respectively&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,320)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,396)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Secured Asset-Based Loan, interest of 4.58% and 1.60% at September 30, 2022 and December 31, 2021, respectively&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,642)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(991)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Note Payable, interest of 2.00% per annum at December 31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,962)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,387)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less current portion - Note Payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less current portion - Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,962)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,387)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="ide03ccfd1d5f459fbf0f366e300c2751_I20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOjk0OGJlNDUxNjA3YzRkYzFiNTYwMjIzNDI5ZmViZmI0L3RhYmxlcmFuZ2U6OTQ4YmU0NTE2MDdjNGRjMWI1NjAyMjM0MjlmZWJmYjRfMy0wLTEtMS00NjMzNC90ZXh0cmVnaW9uOjMzZDRmMGJjMThkMDQ0MWFiOGQyNmRiOTUyMjg1MGRmXzI3_3733e49b-f6b0-466f-9160-88275b573215"
      unitRef="number">0.0883</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="if64036e453b84955b51e99497013571c_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOjk0OGJlNDUxNjA3YzRkYzFiNTYwMjIzNDI5ZmViZmI0L3RhYmxlcmFuZ2U6OTQ4YmU0NTE2MDdjNGRjMWI1NjAyMjM0MjlmZWJmYjRfMy0wLTEtMS00NjMzNC90ZXh0cmVnaW9uOjMzZDRmMGJjMThkMDQ0MWFiOGQyNmRiOTUyMjg1MGRmXzM0_fd90c9dc-2e50-49c2-a639-268becda472f"
      unitRef="number">0.0650</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ide03ccfd1d5f459fbf0f366e300c2751_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOjk0OGJlNDUxNjA3YzRkYzFiNTYwMjIzNDI5ZmViZmI0L3RhYmxlcmFuZ2U6OTQ4YmU0NTE2MDdjNGRjMWI1NjAyMjM0MjlmZWJmYjRfMy0xLTEtMS00NjMzNA_93ca010f-4e0e-4724-962d-52c30141a497"
      unitRef="usd">123875000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="ide03ccfd1d5f459fbf0f366e300c2751_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOjk0OGJlNDUxNjA3YzRkYzFiNTYwMjIzNDI5ZmViZmI0L3RhYmxlcmFuZ2U6OTQ4YmU0NTE2MDdjNGRjMWI1NjAyMjM0MjlmZWJmYjRfMy0zLTEtMS00NjMzNA_fb51f4bc-2edf-4f95-a847-6f7667b89d34"
      unitRef="usd">3320000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="if64036e453b84955b51e99497013571c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOjk0OGJlNDUxNjA3YzRkYzFiNTYwMjIzNDI5ZmViZmI0L3RhYmxlcmFuZ2U6OTQ4YmU0NTE2MDdjNGRjMWI1NjAyMjM0MjlmZWJmYjRfMy01LTEtMS00NjMzNA_20ebbb05-c147-4fd9-9fc0-0a47678a336e"
      unitRef="usd">174312000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="if64036e453b84955b51e99497013571c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOjk0OGJlNDUxNjA3YzRkYzFiNTYwMjIzNDI5ZmViZmI0L3RhYmxlcmFuZ2U6OTQ4YmU0NTE2MDdjNGRjMWI1NjAyMjM0MjlmZWJmYjRfMy03LTEtMS00NjMzNA_5d6847d7-94e4-4925-8dd7-b4efbc73f187"
      unitRef="usd">5396000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="iaed1e277c72c475e9d7788035f2b51e8_I20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOjk0OGJlNDUxNjA3YzRkYzFiNTYwMjIzNDI5ZmViZmI0L3RhYmxlcmFuZ2U6OTQ4YmU0NTE2MDdjNGRjMWI1NjAyMjM0MjlmZWJmYjRfNC0wLTEtMS00NjMzNC90ZXh0cmVnaW9uOjdhMDgyYzEyOWU1MjRjNDc5MDE3MWIwMDUwY2RkMDA1XzQ5_3b9a8589-a51b-4197-b04d-5a9ac2d10066"
      unitRef="number">0.0458</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="i6e5c22515f804ea29736c66d5982b201_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOjk0OGJlNDUxNjA3YzRkYzFiNTYwMjIzNDI5ZmViZmI0L3RhYmxlcmFuZ2U6OTQ4YmU0NTE2MDdjNGRjMWI1NjAyMjM0MjlmZWJmYjRfNC0wLTEtMS00NjMzNC90ZXh0cmVnaW9uOjdhMDgyYzEyOWU1MjRjNDc5MDE3MWIwMDUwY2RkMDA1XzU2_098d627c-f9c1-4e3f-ba63-89a8e0abb6b0"
      unitRef="number">0.0160</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="iaed1e277c72c475e9d7788035f2b51e8_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOjk0OGJlNDUxNjA3YzRkYzFiNTYwMjIzNDI5ZmViZmI0L3RhYmxlcmFuZ2U6OTQ4YmU0NTE2MDdjNGRjMWI1NjAyMjM0MjlmZWJmYjRfNC0xLTEtMS00NjMzNA_1e6ff19a-09cd-4897-ba19-9d13b3426060"
      unitRef="usd">9200000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="iaed1e277c72c475e9d7788035f2b51e8_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOjk0OGJlNDUxNjA3YzRkYzFiNTYwMjIzNDI5ZmViZmI0L3RhYmxlcmFuZ2U6OTQ4YmU0NTE2MDdjNGRjMWI1NjAyMjM0MjlmZWJmYjRfNC0zLTEtMS00NjMzNA_16aa541a-66a3-44a4-89c7-14f0d9e92582"
      unitRef="usd">3642000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i6e5c22515f804ea29736c66d5982b201_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOjk0OGJlNDUxNjA3YzRkYzFiNTYwMjIzNDI5ZmViZmI0L3RhYmxlcmFuZ2U6OTQ4YmU0NTE2MDdjNGRjMWI1NjAyMjM0MjlmZWJmYjRfNC01LTEtMS00NjMzNA_e37a2e22-5a43-4ea8-9e93-0d850c598cb4"
      unitRef="usd">9200000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i6e5c22515f804ea29736c66d5982b201_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOjk0OGJlNDUxNjA3YzRkYzFiNTYwMjIzNDI5ZmViZmI0L3RhYmxlcmFuZ2U6OTQ4YmU0NTE2MDdjNGRjMWI1NjAyMjM0MjlmZWJmYjRfNC03LTEtMS00NjMzNA_76fee0ee-31b9-41af-9022-1960b02e48ac"
      unitRef="usd">991000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2fc39805f3624e12ba3b38847a2f8810_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOjk0OGJlNDUxNjA3YzRkYzFiNTYwMjIzNDI5ZmViZmI0L3RhYmxlcmFuZ2U6OTQ4YmU0NTE2MDdjNGRjMWI1NjAyMjM0MjlmZWJmYjRfNS0wLTEtMS00NjMzNC90ZXh0cmVnaW9uOmNjM2I3YTJmNjJlMzRmZTdiOGQ2MTQ3YTY1ZmUwYTRiXzMw_27f17496-d21b-4a38-be5d-bec2b6105698"
      unitRef="number">0.0200</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="if7bf7274f80f465789bbdcc936e17070_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOjk0OGJlNDUxNjA3YzRkYzFiNTYwMjIzNDI5ZmViZmI0L3RhYmxlcmFuZ2U6OTQ4YmU0NTE2MDdjNGRjMWI1NjAyMjM0MjlmZWJmYjRfNS0xLTEtMS00NjMzNA_f05233b1-22ac-4bef-8ffe-48524e726059"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="if7bf7274f80f465789bbdcc936e17070_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOjk0OGJlNDUxNjA3YzRkYzFiNTYwMjIzNDI5ZmViZmI0L3RhYmxlcmFuZ2U6OTQ4YmU0NTE2MDdjNGRjMWI1NjAyMjM0MjlmZWJmYjRfNS0zLTEtMS00NjMzNA_6ff4ce4e-e13f-41af-878b-0422f2a7c041"
      unitRef="usd">0</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i2fc39805f3624e12ba3b38847a2f8810_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOjk0OGJlNDUxNjA3YzRkYzFiNTYwMjIzNDI5ZmViZmI0L3RhYmxlcmFuZ2U6OTQ4YmU0NTE2MDdjNGRjMWI1NjAyMjM0MjlmZWJmYjRfNS01LTEtMS00NjMzNA_69cdb70a-15fb-4434-bc41-0f7775d5beab"
      unitRef="usd">2426000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i2fc39805f3624e12ba3b38847a2f8810_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOjk0OGJlNDUxNjA3YzRkYzFiNTYwMjIzNDI5ZmViZmI0L3RhYmxlcmFuZ2U6OTQ4YmU0NTE2MDdjNGRjMWI1NjAyMjM0MjlmZWJmYjRfNS03LTEtMS00NjMzNA_a1f93422-7973-4361-95b9-b521d486c852"
      unitRef="usd">0</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOjk0OGJlNDUxNjA3YzRkYzFiNTYwMjIzNDI5ZmViZmI0L3RhYmxlcmFuZ2U6OTQ4YmU0NTE2MDdjNGRjMWI1NjAyMjM0MjlmZWJmYjRfNi0xLTEtMS00NjMzNA_d6f9f35f-9df7-4730-a4f5-4e725a7117f2"
      unitRef="usd">133075000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOjk0OGJlNDUxNjA3YzRkYzFiNTYwMjIzNDI5ZmViZmI0L3RhYmxlcmFuZ2U6OTQ4YmU0NTE2MDdjNGRjMWI1NjAyMjM0MjlmZWJmYjRfNi0zLTEtMS00NjMzNA_2d5d27a9-ca45-4e26-a40c-d0751931da7d"
      unitRef="usd">6962000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOjk0OGJlNDUxNjA3YzRkYzFiNTYwMjIzNDI5ZmViZmI0L3RhYmxlcmFuZ2U6OTQ4YmU0NTE2MDdjNGRjMWI1NjAyMjM0MjlmZWJmYjRfNi01LTEtMS00NjMzNA_3b0ad32c-a6c1-4b89-9d39-53f4367240d6"
      unitRef="usd">185938000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOjk0OGJlNDUxNjA3YzRkYzFiNTYwMjIzNDI5ZmViZmI0L3RhYmxlcmFuZ2U6OTQ4YmU0NTE2MDdjNGRjMWI1NjAyMjM0MjlmZWJmYjRfNi03LTEtMS00NjMzNA_f9e471e8-6379-4fd3-9311-f0e9218102d6"
      unitRef="usd">6387000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:LongTermDebtCurrent
      contextRef="if7bf7274f80f465789bbdcc936e17070_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOjk0OGJlNDUxNjA3YzRkYzFiNTYwMjIzNDI5ZmViZmI0L3RhYmxlcmFuZ2U6OTQ4YmU0NTE2MDdjNGRjMWI1NjAyMjM0MjlmZWJmYjRfNy0xLTEtMS00NjMzNA_867ab110-9de8-4f9a-b170-7f4dbd52aaba"
      unitRef="usd">0</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i2fc39805f3624e12ba3b38847a2f8810_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOjk0OGJlNDUxNjA3YzRkYzFiNTYwMjIzNDI5ZmViZmI0L3RhYmxlcmFuZ2U6OTQ4YmU0NTE2MDdjNGRjMWI1NjAyMjM0MjlmZWJmYjRfNy01LTEtMS00NjMzNA_c6f9ba96-d2a7-4f22-a430-370d44e9fa24"
      unitRef="usd">2426000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="ide03ccfd1d5f459fbf0f366e300c2751_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOjk0OGJlNDUxNjA3YzRkYzFiNTYwMjIzNDI5ZmViZmI0L3RhYmxlcmFuZ2U6OTQ4YmU0NTE2MDdjNGRjMWI1NjAyMjM0MjlmZWJmYjRfOC0xLTEtMS00NjMzNA_ee79cb7f-6b96-456f-840f-39f7e198fdd8"
      unitRef="usd">0</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="if64036e453b84955b51e99497013571c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOjk0OGJlNDUxNjA3YzRkYzFiNTYwMjIzNDI5ZmViZmI0L3RhYmxlcmFuZ2U6OTQ4YmU0NTE2MDdjNGRjMWI1NjAyMjM0MjlmZWJmYjRfOC01LTEtMS00NjMzNA_ec16b17e-5965-44d8-a78f-d0735d94c436"
      unitRef="usd">1750000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOjk0OGJlNDUxNjA3YzRkYzFiNTYwMjIzNDI5ZmViZmI0L3RhYmxlcmFuZ2U6OTQ4YmU0NTE2MDdjNGRjMWI1NjAyMjM0MjlmZWJmYjRfOS0xLTEtMS00NjMzNA_073d50d1-4269-4dd8-9ad7-9d88db0a7d52"
      unitRef="usd">133075000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOjk0OGJlNDUxNjA3YzRkYzFiNTYwMjIzNDI5ZmViZmI0L3RhYmxlcmFuZ2U6OTQ4YmU0NTE2MDdjNGRjMWI1NjAyMjM0MjlmZWJmYjRfOS0zLTEtMS00NjMzNA_ed15188b-6274-4a58-877d-e167b9f173de"
      unitRef="usd">6962000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOjk0OGJlNDUxNjA3YzRkYzFiNTYwMjIzNDI5ZmViZmI0L3RhYmxlcmFuZ2U6OTQ4YmU0NTE2MDdjNGRjMWI1NjAyMjM0MjlmZWJmYjRfOS01LTEtMS00NjMzNA_c5b49ed7-00c4-4d10-b835-7face04987e1"
      unitRef="usd">181762000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOjk0OGJlNDUxNjA3YzRkYzFiNTYwMjIzNDI5ZmViZmI0L3RhYmxlcmFuZ2U6OTQ4YmU0NTE2MDdjNGRjMWI1NjAyMjM0MjlmZWJmYjRfOS03LTEtMS00NjMzNA_e1831728-b561-44ac-88f1-9315f3051535"
      unitRef="usd">6387000</us-gaap:DeferredFinanceCostsNet>
    <ccrn:PaymentForDebtPrepayment
      contextRef="i679839afbf554bacadf5512f89216250_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfODY1_33d1811e-61b4-4f12-9ee2-eca070ed13b9"
      unitRef="usd">50000000</ccrn:PaymentForDebtPrepayment>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfOTc4MA_f30212e8-069f-4f4f-8208-8c93ffec9e16">As of September 30, 2022, the aggregate schedule for maturities of debt are as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Senior Secured Asset-Based Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Through Years Ending December&#160;31:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
      contextRef="ide03ccfd1d5f459fbf0f366e300c2751_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOmYxNDIxZDY5NWEzNDQyNTU4MGE0OWYyOWE3N2VmZjBlL3RhYmxlcmFuZ2U6ZjE0MjFkNjk1YTM0NDI1NTgwYTQ5ZjI5YTc3ZWZmMGVfMy0xLTEtMS00NjMzNA_46033dc6-2a8e-4e63-880c-9a6a1835960a"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
      contextRef="iaed1e277c72c475e9d7788035f2b51e8_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOmYxNDIxZDY5NWEzNDQyNTU4MGE0OWYyOWE3N2VmZjBlL3RhYmxlcmFuZ2U6ZjE0MjFkNjk1YTM0NDI1NTgwYTQ5ZjI5YTc3ZWZmMGVfMy0zLTEtMS00NjMzNA_6b068527-c79c-43d7-af05-a824c152f0ea"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="ide03ccfd1d5f459fbf0f366e300c2751_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOmYxNDIxZDY5NWEzNDQyNTU4MGE0OWYyOWE3N2VmZjBlL3RhYmxlcmFuZ2U6ZjE0MjFkNjk1YTM0NDI1NTgwYTQ5ZjI5YTc3ZWZmMGVfNC0xLTEtMS00NjMzNA_22e00431-b567-476f-8715-d708f1efbe73"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="iaed1e277c72c475e9d7788035f2b51e8_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOmYxNDIxZDY5NWEzNDQyNTU4MGE0OWYyOWE3N2VmZjBlL3RhYmxlcmFuZ2U6ZjE0MjFkNjk1YTM0NDI1NTgwYTQ5ZjI5YTc3ZWZmMGVfNC0zLTEtMS00NjMzNA_e482b4f9-b491-40de-9b6d-f6bd8712aabe"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="ide03ccfd1d5f459fbf0f366e300c2751_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOmYxNDIxZDY5NWEzNDQyNTU4MGE0OWYyOWE3N2VmZjBlL3RhYmxlcmFuZ2U6ZjE0MjFkNjk1YTM0NDI1NTgwYTQ5ZjI5YTc3ZWZmMGVfNS0xLTEtMS00NjMzNA_d92e5e25-2091-417e-b37f-150015d199dc"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="iaed1e277c72c475e9d7788035f2b51e8_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOmYxNDIxZDY5NWEzNDQyNTU4MGE0OWYyOWE3N2VmZjBlL3RhYmxlcmFuZ2U6ZjE0MjFkNjk1YTM0NDI1NTgwYTQ5ZjI5YTc3ZWZmMGVfNS0zLTEtMS00NjMzNA_7f318b23-8188-4b9b-90da-4be1a6df577b"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="ide03ccfd1d5f459fbf0f366e300c2751_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOmYxNDIxZDY5NWEzNDQyNTU4MGE0OWYyOWE3N2VmZjBlL3RhYmxlcmFuZ2U6ZjE0MjFkNjk1YTM0NDI1NTgwYTQ5ZjI5YTc3ZWZmMGVfNi0xLTEtMS00NjMzNA_3b90f438-8810-4b69-ad9f-7ab54c513fba"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="iaed1e277c72c475e9d7788035f2b51e8_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOmYxNDIxZDY5NWEzNDQyNTU4MGE0OWYyOWE3N2VmZjBlL3RhYmxlcmFuZ2U6ZjE0MjFkNjk1YTM0NDI1NTgwYTQ5ZjI5YTc3ZWZmMGVfNi0zLTEtMS00NjMzNA_5e7e49d3-1fb4-442a-9967-b49b21763f66"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="ide03ccfd1d5f459fbf0f366e300c2751_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOmYxNDIxZDY5NWEzNDQyNTU4MGE0OWYyOWE3N2VmZjBlL3RhYmxlcmFuZ2U6ZjE0MjFkNjk1YTM0NDI1NTgwYTQ5ZjI5YTc3ZWZmMGVfNy0xLTEtMS00NjMzNA_f95384bf-a81a-4d2f-b132-33eb8bc15e4e"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="iaed1e277c72c475e9d7788035f2b51e8_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOmYxNDIxZDY5NWEzNDQyNTU4MGE0OWYyOWE3N2VmZjBlL3RhYmxlcmFuZ2U6ZjE0MjFkNjk1YTM0NDI1NTgwYTQ5ZjI5YTc3ZWZmMGVfNy0zLTEtMS00NjMzNA_f448bb7a-ed32-47b0-8e38-3f59ffe87155"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <ccrn:LongTermDebtMaturityAfterYearFour
      contextRef="ide03ccfd1d5f459fbf0f366e300c2751_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOmYxNDIxZDY5NWEzNDQyNTU4MGE0OWYyOWE3N2VmZjBlL3RhYmxlcmFuZ2U6ZjE0MjFkNjk1YTM0NDI1NTgwYTQ5ZjI5YTc3ZWZmMGVfOC0xLTEtMS00NjMzNA_bf14ff66-99ac-451d-9b29-f1dd0afb231e"
      unitRef="usd">123875000</ccrn:LongTermDebtMaturityAfterYearFour>
    <ccrn:LongTermDebtMaturityAfterYearFour
      contextRef="iaed1e277c72c475e9d7788035f2b51e8_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOmYxNDIxZDY5NWEzNDQyNTU4MGE0OWYyOWE3N2VmZjBlL3RhYmxlcmFuZ2U6ZjE0MjFkNjk1YTM0NDI1NTgwYTQ5ZjI5YTc3ZWZmMGVfOC0zLTEtMS00NjMzNA_1b18b85c-5938-490f-a250-6869a30f1472"
      unitRef="usd">9200000</ccrn:LongTermDebtMaturityAfterYearFour>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ide03ccfd1d5f459fbf0f366e300c2751_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOmYxNDIxZDY5NWEzNDQyNTU4MGE0OWYyOWE3N2VmZjBlL3RhYmxlcmFuZ2U6ZjE0MjFkNjk1YTM0NDI1NTgwYTQ5ZjI5YTc3ZWZmMGVfOS0xLTEtMS00NjMzNA_0955eb0c-9f3c-4fd9-a2f8-a5b99489bbfa"
      unitRef="usd">123875000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="iaed1e277c72c475e9d7788035f2b51e8_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RhYmxlOmYxNDIxZDY5NWEzNDQyNTU4MGE0OWYyOWE3N2VmZjBlL3RhYmxlcmFuZ2U6ZjE0MjFkNjk1YTM0NDI1NTgwYTQ5ZjI5YTc3ZWZmMGVfOS0zLTEtMS00NjMzNA_6bcfc552-e834-47bf-b775-3a061036759b"
      unitRef="usd">9200000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentTerm
      contextRef="i870a1a5ad08d4d2187f8499d8bb665d1_D20210608-20210608"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfOTc4MQ_ef78dc45-7f1e-4228-9880-55d020586086">P6Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ib9754d616f5a4ee8a091ad6be918e235_I20210608"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfMTU2NA_31ee8f89-3e36-471c-bf68-7c821b7f5220"
      unitRef="usd">100000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="iedb34638d63143a8b4c18058a909b8c5_D20210608-20210608"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfMTY3Mg_3f2fce38-18fd-48ca-b66c-7dd53f41019e"
      unitRef="number">0.0575</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <ccrn:DebtInstrumentVariableInterestRateFloor
      contextRef="iedb34638d63143a8b4c18058a909b8c5_D20210608-20210608"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfMTY5OQ_d90accce-ece7-4354-87ba-18bfa483f3da"
      unitRef="number">0.0075</ccrn:DebtInstrumentVariableInterestRateFloor>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="i34f7f97d2f20459aa4e94c8f8c9526d2_D20210930-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfMjU1NA_830ce139-1cd3-48fc-bca1-6a296c73b799"
      unitRef="usd">300000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i9f569e337ebb415d913c1f6a219076e4_I20211118"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfMzM1NA_0359231f-94f0-49ba-9121-d46867135ead"
      unitRef="usd">75000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i41f166769fd2450f9e1ac7343566e768_I20211118"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfMzUxMg_a3f1b7c0-e84a-4153-ac03-ec3469c8fcc0"
      unitRef="usd">115000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="i1203eeee9648493cab15c9a9c56887ea_D20211231-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfMzY5OA_edbd62e3-f3c9-458e-9d79-e5229e9ab8b3"
      unitRef="usd">400000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <ccrn:PaymentForDebtPrepayment
      contextRef="ie2b5f4df2dca4db3b15dfee015bb5eb9_D20220623-20220623"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfNDE5NA_4b6e8eee-24f2-434e-b569-c83777c067cc"
      unitRef="usd">50000000</ccrn:PaymentForDebtPrepayment>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="ie2b5f4df2dca4db3b15dfee015bb5eb9_D20220623-20220623"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfNDI1Ng_5ad462aa-d41d-4f7f-b1b1-85e8dd4ef28b"
      unitRef="usd">500000</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:WriteOffOfDeferredDebtIssuanceCost
      contextRef="i679839afbf554bacadf5512f89216250_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfNDM1Ng_48f79eac-5111-46f7-94f9-715cdaea0c7f"
      unitRef="usd">1400000</us-gaap:WriteOffOfDeferredDebtIssuanceCost>
    <us-gaap:LineOfCreditFacilityExpirationPeriod
      contextRef="i6158fa637abd4af3ae6d409e2ff6470e_D20191025-20191025"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfOTc3Ng_4cf6d4e3-09a3-47f4-b699-a99671edf134">P5Y</us-gaap:LineOfCreditFacilityExpirationPeriod>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ic7e12eb577054a99aa4bc801b8f7a4e2_I20191025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfNTk2MA_c3020ba7-2b2a-42d9-9830-04178d3ba53d"
      unitRef="usd">120000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="if4c7c74b2761411095a93a4e4420b8ba_I20191025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfNjAyOA_d06314bd-58d3-4097-9335-86af7b0bacca"
      unitRef="usd">15000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i939e68a3ba5c42dba3abaaad4215f029_I20191025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfNjAzNw_f0b74d79-afc1-4095-bc4a-d2cf35fbcf64"
      unitRef="usd">35000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ic7e12eb577054a99aa4bc801b8f7a4e2_I20191025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfNjIyNQ_5c58f340-6dac-48be-ace0-71be8bc57c47"
      unitRef="usd">120000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i04b66ed81c9249438ac7e6deac027e0c_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfNjIzMQ_f84df364-0652-456c-b17d-b77942b46b90"
      unitRef="usd">130000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i04b66ed81c9249438ac7e6deac027e0c_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfNjQ3NQ_92254a75-306b-49c8-a490-1952121f3b2e"
      unitRef="usd">130000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i0a067d85b7ce45c29144e8ce39c70993_I20210308"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfNjQ4MQ_414feffc-4069-463e-bd23-0d84cac295a0"
      unitRef="usd">150000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <ccrn:LineOfCreditAmountOfIndebtednessPermittedBySeniorSecuredAssetBasedLoanToBeBorrowedFromOtherSources
      contextRef="i624be7ef98974a18acd4dff1b7f88e73_I20211118"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfNzE4Nw_b09442f9-5194-4302-868b-2fac2a5b2200"
      unitRef="usd">175000000</ccrn:LineOfCreditAmountOfIndebtednessPermittedBySeniorSecuredAssetBasedLoanToBeBorrowedFromOtherSources>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i0a067d85b7ce45c29144e8ce39c70993_I20210308"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfNzMzNw_429fd22d-ce03-43bd-8f1a-444df94bf47c"
      unitRef="usd">150000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i270723f4cdb7481096cce56fef2c5108_I20220321"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfNzM0Mw_4ca88f33-c17a-434b-a1cd-22bf025085ba"
      unitRef="usd">300000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityExpirationPeriod
      contextRef="id9318eec3ae14553b2ee10834ffd5fa2_D20220321-20220321"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfOTc4Mg_fa2c82c8-7051-4f94-8a91-95f48ca95c86">P5Y</us-gaap:LineOfCreditFacilityExpirationPeriod>
    <ccrn:LineOfCreditFacilityBasisSpreadOnVariableRateAdditionalCreditSpreadAssociatedWithSOFR
      contextRef="id9318eec3ae14553b2ee10834ffd5fa2_D20220321-20220321"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfNzczMg_e7536cc8-7e79-4ef1-b02b-c109922d9521"
      unitRef="number">0.0010</ccrn:LineOfCreditFacilityBasisSpreadOnVariableRateAdditionalCreditSpreadAssociatedWithSOFR>
    <ccrn:LineOfCreditBorrowingBasePercentageOfAssets
      contextRef="ic7e12eb577054a99aa4bc801b8f7a4e2_I20191025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfODEwNg_1e9b714e-9aa9-4e98-9669-8670ff880f96"
      unitRef="number">0.85</ccrn:LineOfCreditBorrowingBasePercentageOfAssets>
    <ccrn:LineOfCreditFacilityBorrowingBaseAvailability
      contextRef="i429f9d7a920e4e42bf93ded0492112f6_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfODUzMg_98372e22-855e-44e5-9d50-32bc5dde5abd"
      unitRef="usd">300000000</ccrn:LineOfCreditFacilityBorrowingBaseAvailability>
    <us-gaap:LineOfCredit
      contextRef="i429f9d7a920e4e42bf93ded0492112f6_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfODU1NQ_934df52a-304b-418c-a53c-6d6998e16027"
      unitRef="usd">9200000</us-gaap:LineOfCredit>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="i429f9d7a920e4e42bf93ded0492112f6_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfODU5MA_78c6bd3c-20b7-43e4-b182-1dce06b13d29"
      unitRef="usd">17500000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="i429f9d7a920e4e42bf93ded0492112f6_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfODcwNA_fdfa3813-49fb-473a-9b8d-98cbf0bef605"
      unitRef="usd">273300000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ib9a9d68a6c6e40568eec79a197a10ad1_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfODgzNg_f6b6aca8-e52c-4468-bc9a-e31e6a808e28"
      unitRef="number">0.0160</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ib8d17efeeb2945f986a5af6c590ab452_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfODk2MA_9b6d75ea-6200-4f44-9628-fb593b1b1713"
      unitRef="number">0.0050</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="i30a646dd77584028b2f4405de20d759d_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV81OC9mcmFnOjg5YjNhN2U0NTBlNzQyODM5M2Y0NTNmNDRjYzQwYzdjL3RleHRyZWdpb246ODliM2E3ZTQ1MGU3NDI4MzkzZjQ1M2Y0NGNjNDBjN2NfOTMwOA_5535c443-d4d4-450f-8ecc-2c28e3a7551b"
      unitRef="number">0.00375</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RleHRyZWdpb246ZTk3ZmNkODQ3Y2IxNDRkOWE0YzZhZWEwYjkxMTFlZGJfMzU4Mg_4cfaf14f-f19b-490c-b7ca-261cc058af69">LEASES&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's lease population of its right-of-use assets and lease liabilities is substantially related to the rental of office space. The Company enters into lease agreements as a lessee that may include options to extend or terminate early. Some of these real estate leases require variable payments of property taxes, insurance, and common area maintenance, in addition to base rent. Certain of the leases have provisions for free rent months during the lease term and/or escalating rent payments and, particularly for the Company&#x2019;s longer-term leases for its corporate offices, it has received incentives to enter into the leases, such as receiving up to a specified dollar amount to construct tenant improvements. These leases do not include residual value guarantees, covenants, or other restrictions.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning in the second quarter of 2020, in connection with the continuing developments from COVID, the Company expedited restructuring plans and either reduced or fully vacated leased office space. The Company is in the process of seeking to sublet some of the space where possible. The decision and change in the use of space resulted in a right-of-use asset impairment charge of $2.8&#160;million and $1.7&#160;million for the nine months ended September 30, 2022 and 2021, respectively. This loss was determined by comparing the fair value of the impacted right-of-use assets to the carrying value of the assets as of the impairment measurement date. The fair value of the right-of-use assets was based on the estimated sublease income for the space taking into consideration the time period it will take to obtain a subtenant, the applicable discount rate, and the sublease rate. For the nine months ended September 30, 2022 and 2021, the Company wrote off an immaterial amount of leasehold improvements and other property and equipment related to these locations. The measurement of the right-of-use asset impairments, using the assumptions described, is a Level 3 fair value measurement. See Note 10 - Fair Value Measurements for a description of Level 3 inputs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents the lease-related assets and liabilities included on the condensed consolidated balance sheets:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.853%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.854%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Classification on Condensed Consolidated Balance Sheets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities - current&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities - non-current&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.853%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.854%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below reconciles the undiscounted cash flows for each of, and total of, the remaining years to the operating lease liabilities (which do not include short-term leases) recorded on the condensed consolidated balance sheets as of September 30, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.989%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ending December&#160;31:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amount of lease payments representing interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(940)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of future minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: operating lease liabilities - current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,489)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities - non-current&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other Information&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below provides information regarding supplemental cash flows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Supplemental Cash Flow Information:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets acquired under operating lease&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease expense are as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amounts Included in Condensed Consolidated Statements of Operations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable and other lease costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amounts Included in Condensed Consolidated Statements of Operations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable and other lease costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease expense, short-term lease expense, and variable and other lease costs are included in selling, general and administrative expenses, direct operating expenses, and restructuring costs in the condensed consolidated statements of operations, depending on the nature of the leased asset. Operating lease expense is reported net of sublease income, which is not material. Variable and other lease costs for the nine months ended September 30, 2022 include a benefit associated with the early termination of a lease for one of the Company's corporate offices which was previously restructured.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September 30, 2022, the Company did not have any material operating leases which had not yet commenced. The Company has an immaterial&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;amount of finance lease contracts related to other equipment rentals which are not included in the above disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RleHRyZWdpb246ZTk3ZmNkODQ3Y2IxNDRkOWE0YzZhZWEwYjkxMTFlZGJfMTMxMw_6da96a09-832c-4b0f-8cd8-2e78f7a0f8fa"
      unitRef="usd">2800000</us-gaap:OperatingLeaseImpairmentLoss>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RleHRyZWdpb246ZTk3ZmNkODQ3Y2IxNDRkOWE0YzZhZWEwYjkxMTFlZGJfMTM2Mg_21f2c82a-38f5-42c6-bd8b-20ec67fda798"
      unitRef="usd">1700000</us-gaap:OperatingLeaseImpairmentLoss>
    <ccrn:AssetsAndLiabilitiesLeasesTableTextBlock
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RleHRyZWdpb246ZTk3ZmNkODQ3Y2IxNDRkOWE0YzZhZWEwYjkxMTFlZGJfMzU4Mw_22e8787c-206a-44ed-9d0f-34a4f985c718">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents the lease-related assets and liabilities included on the condensed consolidated balance sheets:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.853%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.854%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Classification on Condensed Consolidated Balance Sheets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities - current&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities - non-current&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.853%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.854%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ccrn:AssetsAndLiabilitiesLeasesTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOjlhYjVmOWZjZDhhYzQ1Zjg5NDA2YWI4YWE4ZDUxZmQxL3RhYmxlcmFuZ2U6OWFiNWY5ZmNkOGFjNDVmODk0MDZhYjhhYThkNTFmZDFfMi0xLTEtMS00NjMzNA_3c8796c4-7017-42fa-afd1-5fe922e7b9b0"
      unitRef="usd">3249000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOjlhYjVmOWZjZDhhYzQ1Zjg5NDA2YWI4YWE4ZDUxZmQxL3RhYmxlcmFuZ2U6OWFiNWY5ZmNkOGFjNDVmODk0MDZhYjhhYThkNTFmZDFfMi0zLTEtMS00NjMzNA_badde80e-483d-4d13-98a7-f8490ca0a2be"
      unitRef="usd">7488000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOjlhYjVmOWZjZDhhYzQ1Zjg5NDA2YWI4YWE4ZDUxZmQxL3RhYmxlcmFuZ2U6OWFiNWY5ZmNkOGFjNDVmODk0MDZhYjhhYThkNTFmZDFfMy0xLTEtMS00NjMzNA_5efce532-d10e-4ab2-83b8-5114d5131ed9"
      unitRef="usd">4489000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOjlhYjVmOWZjZDhhYzQ1Zjg5NDA2YWI4YWE4ZDUxZmQxL3RhYmxlcmFuZ2U6OWFiNWY5ZmNkOGFjNDVmODk0MDZhYjhhYThkNTFmZDFfMy0zLTEtMS00NjMzNA_d1a8c80f-233d-40a3-8210-900d239ace8f"
      unitRef="usd">4090000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOjlhYjVmOWZjZDhhYzQ1Zjg5NDA2YWI4YWE4ZDUxZmQxL3RhYmxlcmFuZ2U6OWFiNWY5ZmNkOGFjNDVmODk0MDZhYjhhYThkNTFmZDFfNC0xLTEtMS00NjMzNA_cdf50d07-26d5-45a3-90e1-7ef7b4143541"
      unitRef="usd">5493000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOjlhYjVmOWZjZDhhYzQ1Zjg5NDA2YWI4YWE4ZDUxZmQxL3RhYmxlcmFuZ2U6OWFiNWY5ZmNkOGFjNDVmODk0MDZhYjhhYThkNTFmZDFfNC0zLTEtMS00NjMzNA_4a44b9e2-5082-4a66-a114-c5d29fffd9d9"
      unitRef="usd">10853000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOmI5Zjg4ZTFlOWZlMDRhZGRiZjE1MmM3NDk5MGQ3NGIwL3RhYmxlcmFuZ2U6YjlmODhlMWU5ZmUwNGFkZGJmMTUyYzc0OTkwZDc0YjBfMS0xLTEtMS00NjMzNA_91238271-4aaf-4dda-97b1-8810d135b77a">P2Y4M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOmI5Zjg4ZTFlOWZlMDRhZGRiZjE1MmM3NDk5MGQ3NGIwL3RhYmxlcmFuZ2U6YjlmODhlMWU5ZmUwNGFkZGJmMTUyYzc0OTkwZDc0YjBfMS0zLTEtMS00NjMzNA_fc6f1b00-029c-4b12-abf5-7320d6666871">P3Y4M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOmI5Zjg4ZTFlOWZlMDRhZGRiZjE1MmM3NDk5MGQ3NGIwL3RhYmxlcmFuZ2U6YjlmODhlMWU5ZmUwNGFkZGJmMTUyYzc0OTkwZDc0YjBfMi0xLTEtMS00NjMzNA_80aea736-6ee7-4ca1-bbab-cfda8cd8b902"
      unitRef="number">0.0631</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i51f0077b9e4442588bd8299663a1ef5a_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOmI5Zjg4ZTFlOWZlMDRhZGRiZjE1MmM3NDk5MGQ3NGIwL3RhYmxlcmFuZ2U6YjlmODhlMWU5ZmUwNGFkZGJmMTUyYzc0OTkwZDc0YjBfMi0zLTEtMS00NjMzNA_2a093bfa-6104-4d2b-a4c6-6034245498f3"
      unitRef="number">0.0639</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RleHRyZWdpb246ZTk3ZmNkODQ3Y2IxNDRkOWE0YzZhZWEwYjkxMTFlZGJfMzU4NQ_91898afe-01a4-436d-b0a6-b0b6b63897ca">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below reconciles the undiscounted cash flows for each of, and total of, the remaining years to the operating lease liabilities (which do not include short-term leases) recorded on the condensed consolidated balance sheets as of September 30, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.989%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ending December&#160;31:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amount of lease payments representing interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(940)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of future minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: operating lease liabilities - current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,489)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities - non-current&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOjMzMDM1OTUxNDhjNjQxZTA5ODY5NDM2NGUzMmI4MjU5L3RhYmxlcmFuZ2U6MzMwMzU5NTE0OGM2NDFlMDk4Njk0MzY0ZTMyYjgyNTlfMi0xLTEtMS00NjMzNA_2093ac8e-0fa9-4490-b825-b7a8de94f698"
      unitRef="usd">854000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOjMzMDM1OTUxNDhjNjQxZTA5ODY5NDM2NGUzMmI4MjU5L3RhYmxlcmFuZ2U6MzMwMzU5NTE0OGM2NDFlMDk4Njk0MzY0ZTMyYjgyNTlfMy0xLTEtMS00NjMzNA_78cbf9cb-9786-4046-a851-6061a4b23c9d"
      unitRef="usd">5135000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOjMzMDM1OTUxNDhjNjQxZTA5ODY5NDM2NGUzMmI4MjU5L3RhYmxlcmFuZ2U6MzMwMzU5NTE0OGM2NDFlMDk4Njk0MzY0ZTMyYjgyNTlfNC0xLTEtMS00NjMzNA_afc64d82-9fc4-40ce-9590-19ac1c670753"
      unitRef="usd">3047000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOjMzMDM1OTUxNDhjNjQxZTA5ODY5NDM2NGUzMmI4MjU5L3RhYmxlcmFuZ2U6MzMwMzU5NTE0OGM2NDFlMDk4Njk0MzY0ZTMyYjgyNTlfNS0xLTEtMS00NjMzNA_4f965e93-927b-451a-9236-8fcbca3b2068"
      unitRef="usd">1886000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOjMzMDM1OTUxNDhjNjQxZTA5ODY5NDM2NGUzMmI4MjU5L3RhYmxlcmFuZ2U6MzMwMzU5NTE0OGM2NDFlMDk4Njk0MzY0ZTMyYjgyNTlfNy0xLTEtMS00NjMzNA_faf849bf-870c-4a48-9358-adcf835f4047"
      unitRef="usd">10922000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOjMzMDM1OTUxNDhjNjQxZTA5ODY5NDM2NGUzMmI4MjU5L3RhYmxlcmFuZ2U6MzMwMzU5NTE0OGM2NDFlMDk4Njk0MzY0ZTMyYjgyNTlfOC0xLTEtMS00NjMzNA_da380a13-c249-43da-8de0-f62bced49c52"
      unitRef="usd">940000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOjMzMDM1OTUxNDhjNjQxZTA5ODY5NDM2NGUzMmI4MjU5L3RhYmxlcmFuZ2U6MzMwMzU5NTE0OGM2NDFlMDk4Njk0MzY0ZTMyYjgyNTlfOS0xLTEtMS00NjMzNA_5490e653-aded-478b-99b0-e915a9e494fe"
      unitRef="usd">9982000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOjMzMDM1OTUxNDhjNjQxZTA5ODY5NDM2NGUzMmI4MjU5L3RhYmxlcmFuZ2U6MzMwMzU5NTE0OGM2NDFlMDk4Njk0MzY0ZTMyYjgyNTlfMTAtMS0xLTEtNDYzMzQ_9950e4de-be22-4e60-9b94-f91679f21d94"
      unitRef="usd">4489000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOjMzMDM1OTUxNDhjNjQxZTA5ODY5NDM2NGUzMmI4MjU5L3RhYmxlcmFuZ2U6MzMwMzU5NTE0OGM2NDFlMDk4Njk0MzY0ZTMyYjgyNTlfMTEtMS0xLTEtNDYzMzQ_1051b231-b739-49e2-bbfa-25005c87b8e8"
      unitRef="usd">5493000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RleHRyZWdpb246ZTk3ZmNkODQ3Y2IxNDRkOWE0YzZhZWEwYjkxMTFlZGJfMzU4Nw_2b7a6848-1c63-42ac-be8c-78197d4bb9ab">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below provides information regarding supplemental cash flows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Supplemental Cash Flow Information:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets acquired under operating lease&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease expense are as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amounts Included in Condensed Consolidated Statements of Operations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable and other lease costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amounts Included in Condensed Consolidated Statements of Operations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable and other lease costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeasePayments
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOmFjNjgxNzRmOWExZDQzOTA5NDVkZmY0NjQyNDYxMjlkL3RhYmxlcmFuZ2U6YWM2ODE3NGY5YTFkNDM5MDk0NWRmZjQ2NDI0NjEyOWRfNS0xLTEtMS00NjMzNA_d41fe614-951c-4f92-8dfe-b93a2a7a9914"
      unitRef="usd">4446000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOmFjNjgxNzRmOWExZDQzOTA5NDVkZmY0NjQyNDYxMjlkL3RhYmxlcmFuZ2U6YWM2ODE3NGY5YTFkNDM5MDk0NWRmZjQ2NDI0NjEyOWRfNS0zLTEtMS00NjMzNA_5c3a1050-06f0-4c9f-87e5-dd007a3d7817"
      unitRef="usd">4692000</us-gaap:OperatingLeasePayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOmFjNjgxNzRmOWExZDQzOTA5NDVkZmY0NjQyNDYxMjlkL3RhYmxlcmFuZ2U6YWM2ODE3NGY5YTFkNDM5MDk0NWRmZjQ2NDI0NjEyOWRfNi0xLTEtMS00NjMzNA_b4fe0dce-9bf1-45f3-af74-35df439746e0"
      unitRef="usd">59000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOmFjNjgxNzRmOWExZDQzOTA5NDVkZmY0NjQyNDYxMjlkL3RhYmxlcmFuZ2U6YWM2ODE3NGY5YTFkNDM5MDk0NWRmZjQ2NDI0NjEyOWRfNi0zLTEtMS00NjMzNA_2f618ab8-2946-46b0-ad87-ce7c1fce399e"
      unitRef="usd">1088000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:OperatingLeaseCost
      contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOmJlNDFmNmYwMDBhZTRlOTY5MDZiMjE3M2YxMTRjYmIwL3RhYmxlcmFuZ2U6YmU0MWY2ZjAwMGFlNGU5NjkwNmIyMTczZjExNGNiYjBfNS0xLTEtMS00NjMzNA_a8a6e111-7193-4c05-b7b1-83fb44aba8d7"
      unitRef="usd">596000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOmJlNDFmNmYwMDBhZTRlOTY5MDZiMjE3M2YxMTRjYmIwL3RhYmxlcmFuZ2U6YmU0MWY2ZjAwMGFlNGU5NjkwNmIyMTczZjExNGNiYjBfNS0zLTEtMS00NjMzNA_693aa2ac-a80f-4336-a93c-bdf82b1e81d3"
      unitRef="usd">848000</us-gaap:OperatingLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOmJlNDFmNmYwMDBhZTRlOTY5MDZiMjE3M2YxMTRjYmIwL3RhYmxlcmFuZ2U6YmU0MWY2ZjAwMGFlNGU5NjkwNmIyMTczZjExNGNiYjBfNi0xLTEtMS00NjMzNA_d434f8de-d3b1-4673-aa44-569cdf7d95bf"
      unitRef="usd">1743000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOmJlNDFmNmYwMDBhZTRlOTY5MDZiMjE3M2YxMTRjYmIwL3RhYmxlcmFuZ2U6YmU0MWY2ZjAwMGFlNGU5NjkwNmIyMTczZjExNGNiYjBfNi0zLTEtMS00NjMzNA_f519b090-aa30-4714-9d68-615d281b09e5"
      unitRef="usd">1033000</us-gaap:ShortTermLeaseCost>
    <ccrn:VariableAndOtherLeaseCost
      contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOmJlNDFmNmYwMDBhZTRlOTY5MDZiMjE3M2YxMTRjYmIwL3RhYmxlcmFuZ2U6YmU0MWY2ZjAwMGFlNGU5NjkwNmIyMTczZjExNGNiYjBfNy0xLTEtMS00NjMzNA_71e4819c-b9af-4ab4-a351-9866bfe53e28"
      unitRef="usd">2027000</ccrn:VariableAndOtherLeaseCost>
    <ccrn:VariableAndOtherLeaseCost
      contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOmJlNDFmNmYwMDBhZTRlOTY5MDZiMjE3M2YxMTRjYmIwL3RhYmxlcmFuZ2U6YmU0MWY2ZjAwMGFlNGU5NjkwNmIyMTczZjExNGNiYjBfNy0zLTEtMS00NjMzNA_889b24aa-f08f-4de5-883f-90d6d27168f4"
      unitRef="usd">419000</ccrn:VariableAndOtherLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOmJlNDFmNmYwMDBhZTRlOTY5MDZiMjE3M2YxMTRjYmIwL3RhYmxlcmFuZ2U6YmU0MWY2ZjAwMGFlNGU5NjkwNmIyMTczZjExNGNiYjBfMTQtMS0xLTEtNDYzMzQ_b937e433-3d10-443e-ba1a-581c5314582a"
      unitRef="usd">2043000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOmJlNDFmNmYwMDBhZTRlOTY5MDZiMjE3M2YxMTRjYmIwL3RhYmxlcmFuZ2U6YmU0MWY2ZjAwMGFlNGU5NjkwNmIyMTczZjExNGNiYjBfMTQtMy0xLTEtNDYzMzQ_8712c35e-ef6b-48f1-9a98-c4d5646ea280"
      unitRef="usd">2700000</us-gaap:OperatingLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOmJlNDFmNmYwMDBhZTRlOTY5MDZiMjE3M2YxMTRjYmIwL3RhYmxlcmFuZ2U6YmU0MWY2ZjAwMGFlNGU5NjkwNmIyMTczZjExNGNiYjBfMTUtMS0xLTEtNDYzMzQ_03d634b9-bc3f-4067-8df4-0dbbaa414226"
      unitRef="usd">4128000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOmJlNDFmNmYwMDBhZTRlOTY5MDZiMjE3M2YxMTRjYmIwL3RhYmxlcmFuZ2U6YmU0MWY2ZjAwMGFlNGU5NjkwNmIyMTczZjExNGNiYjBfMTUtMy0xLTEtNDYzMzQ_aa7e11db-bb69-4b7f-a307-0ec1ff992008"
      unitRef="usd">2523000</us-gaap:ShortTermLeaseCost>
    <ccrn:VariableAndOtherLeaseCost
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOmJlNDFmNmYwMDBhZTRlOTY5MDZiMjE3M2YxMTRjYmIwL3RhYmxlcmFuZ2U6YmU0MWY2ZjAwMGFlNGU5NjkwNmIyMTczZjExNGNiYjBfMTYtMS0xLTEtNDYzMzQ_94977d41-e135-4a65-bbba-92d2abfb9576"
      unitRef="usd">1674000</ccrn:VariableAndOtherLeaseCost>
    <ccrn:VariableAndOtherLeaseCost
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82MS9mcmFnOmU5N2ZjZDg0N2NiMTQ0ZDlhNGM2YWVhMGI5MTExZWRiL3RhYmxlOmJlNDFmNmYwMDBhZTRlOTY5MDZiMjE3M2YxMTRjYmIwL3RhYmxlcmFuZ2U6YmU0MWY2ZjAwMGFlNGU5NjkwNmIyMTczZjExNGNiYjBfMTYtMy0xLTEtNDYzMzQ_fdf7c852-77a3-4420-b57d-0e56514a1ec0"
      unitRef="usd">1638000</ccrn:VariableAndOtherLeaseCost>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82NC9mcmFnOjkxNWIyYjk1NWNjYTRjOWViZTJmYWM0NzhlN2QwZTU1L3RleHRyZWdpb246OTE1YjJiOTU1Y2NhNGM5ZWJlMmZhYzQ3OGU3ZDBlNTVfNTMxNw_0dc46db6-ea22-4141-b6de-4972fb63a63a">FAIR VALUE MEASUREMENTS&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. A fair value hierarchy was established which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. There are three levels of inputs that may be used to measure fair value:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Level 1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;Quoted prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Level 2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Level 3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Items Measured at Fair Value on a Recurring Basis:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s financial assets/liabilities required to be measured on a recurring basis were its: (i) deferred compensation asset included in other non-current assets; and (ii) deferred compensation liability included in other long-term liabilities on its condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Deferred compensation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;The Company utilizes Level 1 inputs to value its deferred compensation assets and liabilities. The Company&#x2019;s deferred compensation assets and liabilities are measured using publicly available indices, as per the plan documents.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of the Company&#x2019;s financial assets and liabilities measured on a recurring basis is as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.284%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation asset&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Items Measured at Fair Value on a Non-Recurring Basis:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's non-financial assets, such as goodwill, trade names, other intangible assets, right-of-use assets, and property and equipment, are measured at fair value when there is an indicator of impairment and are recorded at fair value only when an impairment charge is recognized. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The nine months ended September 30, 2022 and 2021 included impairment charges to right-of-use assets along with related property and equipment in connection with leases that were vacated. The nine months ended September 30, 2022 also included impairment charges primarily related to the write-off of a discontinued IT project in the third quarter of 2022. Accordingly, as of September 30, 2022 and 2021, these assets were recorded at fair value using Level 3 inputs. See Note 7 - Goodwill, Trade Names, and Other Intangible Assets and Note 9 - Leases for more information about these fair value measurements. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other Fair Value Disclosures:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Financial instruments not measured or recorded at fair value in the condensed consolidated balance sheets consist of cash and cash equivalents, accounts receivable, and accounts payable and accrued expenses. The estimated fair value of accounts receivable and accounts payable and&#160;accrued expenses approximate their carrying amount due to the short-term nature of these instruments. Other financial instruments not measured or recorded at fair value include: (i) note payable, (ii) ABL, (iii) term loan, (iv) earnout liabilities related to the WSG acquisition, and (v) earnout liabilities related to the Selected acquisition, as discussed below.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(i) The Company paid the third and final installment on its note payable in the first quarter of 2022. Due to its relatively short-term nature, the carrying value of the note payable approximated its fair value. (ii) The carrying amount of the Company's ABL approximates fair value because the interest rates are variable and reflective of market rates. (iii) The estimated fair value of the Company's term loan was calculated applying an interest rate lattice model using Level 2 inputs from available market information. (iv) Potential earnout payments related to the WSG acquisition are contingent upon meeting certain performance requirements based on 2021 through 2023 performance. The Company performed an analysis using multiple forecasted scenarios to determine the fair value of the earnout liability. In the third quarter of 2022, the Company determined that the contingent consideration earnout related to the WSG acquisition was achieved for the 2021 through 2022 period and, as a result, the Company made a $7.5&#160;million earnout payment. The remaining earnout liability's carrying amount approximates fair value and is included in current portion of earnout liability on the condensed consolidated balance sheets. See Note 4 - Acquisitions. (v) Potential earnout payments related to the Selected acquisition were contingent upon meeting certain performance requirements based on 2022 and 2023 revenues. The earnout liability's carrying amount approximates fair value and was included in current portion of earnout liability and non-current earnout liability on the condensed consolidated balance sheets. In the second quarter of 2022, the Company determined that the contingent consideration earnout related to the Selected acquisition would not be achieved for 2022 and 2023 and, as a result, the entire liability was reversed. See Note 4 - Acquisitions.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amounts and estimated fair value of the Company&#x2019;s significant financial instruments that were not measured at fair value are as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.108%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Note Payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Secured Asset-Based Loan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnout Liability (WSG)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnout Liability (Selected)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Concentration of Credit Risk:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See discussion of credit losses and allowance for doubtful accounts in Note 2 - Summary of Significant Accounting Policies. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Overall, based on the large number of customers in differing geographic areas, primarily throughout the United States and its territories, the Company believes the concentration of credit risk is limited.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82NC9mcmFnOjkxNWIyYjk1NWNjYTRjOWViZTJmYWM0NzhlN2QwZTU1L3RleHRyZWdpb246OTE1YjJiOTU1Y2NhNGM5ZWJlMmZhYzQ3OGU3ZDBlNTVfNTMyOA_296f18cb-17e4-4790-9fa1-9d4b402a0816">The estimated fair value of the Company&#x2019;s financial assets and liabilities measured on a recurring basis is as follows:&#160;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.284%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation asset&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i817acb52936447dcac8bfc2fdc5f10c2_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82NC9mcmFnOjkxNWIyYjk1NWNjYTRjOWViZTJmYWM0NzhlN2QwZTU1L3RhYmxlOjIwYWVlNDNjYTM4MjQ1OTZhYWM2MGYwNjE0NzgzNTljL3RhYmxlcmFuZ2U6MjBhZWU0M2NhMzgyNDU5NmFhYzYwZjA2MTQ3ODM1OWNfNC0xLTEtMS00NjMzNA_137e8cdf-034f-4620-8a5e-1e8337e6dcd5"
      unitRef="usd">2219000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="idb72a3bcd2bb48b4bb23ea38343be599_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82NC9mcmFnOjkxNWIyYjk1NWNjYTRjOWViZTJmYWM0NzhlN2QwZTU1L3RhYmxlOjIwYWVlNDNjYTM4MjQ1OTZhYWM2MGYwNjE0NzgzNTljL3RhYmxlcmFuZ2U6MjBhZWU0M2NhMzgyNDU5NmFhYzYwZjA2MTQ3ODM1OWNfNC0zLTEtMS00NjMzNA_290e9626-2394-4c8b-bb23-216b30d40773"
      unitRef="usd">1398000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="i8e7a429958f04663bc3d74b1a3aab9a6_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82NC9mcmFnOjkxNWIyYjk1NWNjYTRjOWViZTJmYWM0NzhlN2QwZTU1L3RhYmxlOjIwYWVlNDNjYTM4MjQ1OTZhYWM2MGYwNjE0NzgzNTljL3RhYmxlcmFuZ2U6MjBhZWU0M2NhMzgyNDU5NmFhYzYwZjA2MTQ3ODM1OWNfNy0xLTEtMS00NjMzNA_9a22d99a-7573-4ec8-b5e9-77782b8e2036"
      unitRef="usd">2317000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="i5ed93b80dd314c62b7cd4dea1d5c7981_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82NC9mcmFnOjkxNWIyYjk1NWNjYTRjOWViZTJmYWM0NzhlN2QwZTU1L3RhYmxlOjIwYWVlNDNjYTM4MjQ1OTZhYWM2MGYwNjE0NzgzNTljL3RhYmxlcmFuZ2U6MjBhZWU0M2NhMzgyNDU5NmFhYzYwZjA2MTQ3ODM1OWNfNy0zLTEtMS00NjMzNA_ac2189cb-c236-44df-b92d-984aab167af5"
      unitRef="usd">2457000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="id9fe5b9beae44701b72bcee962193e53_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82NC9mcmFnOjkxNWIyYjk1NWNjYTRjOWViZTJmYWM0NzhlN2QwZTU1L3RleHRyZWdpb246OTE1YjJiOTU1Y2NhNGM5ZWJlMmZhYzQ3OGU3ZDBlNTVfMjc0ODc3OTA3NTIzMA_415be30f-de5a-4303-a45a-95c13d72fb96"
      unitRef="usd">7500000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:FairValueByBalanceSheetGroupingTextBlock
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82NC9mcmFnOjkxNWIyYjk1NWNjYTRjOWViZTJmYWM0NzhlN2QwZTU1L3RleHRyZWdpb246OTE1YjJiOTU1Y2NhNGM5ZWJlMmZhYzQ3OGU3ZDBlNTVfNTMzMQ_0d9b68a9-43a8-4bcf-b051-e944a23977bc">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amounts and estimated fair value of the Company&#x2019;s significant financial instruments that were not measured at fair value are as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.108%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Note Payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Secured Asset-Based Loan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnout Liability (WSG)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnout Liability (Selected)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i04893fd47a664b8aa11c6aef5de1bfea_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82NC9mcmFnOjkxNWIyYjk1NWNjYTRjOWViZTJmYWM0NzhlN2QwZTU1L3RhYmxlOmVkMzAwNGU1NjdjNTQyYTZiMTEyM2M1ZWMzOGI0MDc2L3RhYmxlcmFuZ2U6ZWQzMDA0ZTU2N2M1NDJhNmIxMTIzYzVlYzM4YjQwNzZfNS0xLTEtMS00NjMzNA_505ea950-b1da-4614-8a8b-5d47fb01ac5a"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i355e48f54cd24775841d981acdad6c9f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82NC9mcmFnOjkxNWIyYjk1NWNjYTRjOWViZTJmYWM0NzhlN2QwZTU1L3RhYmxlOmVkMzAwNGU1NjdjNTQyYTZiMTEyM2M1ZWMzOGI0MDc2L3RhYmxlcmFuZ2U6ZWQzMDA0ZTU2N2M1NDJhNmIxMTIzYzVlYzM4YjQwNzZfNS0zLTEtMS00NjMzNA_9b74f8e0-edf5-44e4-9495-4f01bf3cbb84"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="id9435c564ca74ddbb50ac50871543b66_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82NC9mcmFnOjkxNWIyYjk1NWNjYTRjOWViZTJmYWM0NzhlN2QwZTU1L3RhYmxlOmVkMzAwNGU1NjdjNTQyYTZiMTEyM2M1ZWMzOGI0MDc2L3RhYmxlcmFuZ2U6ZWQzMDA0ZTU2N2M1NDJhNmIxMTIzYzVlYzM4YjQwNzZfNS01LTEtMS00NjMzNA_74b5cf18-26f0-4ffc-b315-1ef3555d2cf5"
      unitRef="usd">2426000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ib59536cd34df4b5c927d7dfd92e21775_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82NC9mcmFnOjkxNWIyYjk1NWNjYTRjOWViZTJmYWM0NzhlN2QwZTU1L3RhYmxlOmVkMzAwNGU1NjdjNTQyYTZiMTEyM2M1ZWMzOGI0MDc2L3RhYmxlcmFuZ2U6ZWQzMDA0ZTU2N2M1NDJhNmIxMTIzYzVlYzM4YjQwNzZfNS03LTEtMS00NjMzNA_01f2f41a-6f4e-4755-871f-bafd45087bf2"
      unitRef="usd">2426000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:LinesOfCreditFairValueDisclosure
      contextRef="i25845230e0a34aa3b524e0cd4fac58b2_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82NC9mcmFnOjkxNWIyYjk1NWNjYTRjOWViZTJmYWM0NzhlN2QwZTU1L3RhYmxlOmVkMzAwNGU1NjdjNTQyYTZiMTEyM2M1ZWMzOGI0MDc2L3RhYmxlcmFuZ2U6ZWQzMDA0ZTU2N2M1NDJhNmIxMTIzYzVlYzM4YjQwNzZfNi0xLTEtMS00NjMzNA_d350d939-e7b7-4ef1-99d8-c36d1ee946f6"
      unitRef="usd">9200000</us-gaap:LinesOfCreditFairValueDisclosure>
    <us-gaap:LinesOfCreditFairValueDisclosure
      contextRef="i4ab3f84da58d407297c219a1e6bee204_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82NC9mcmFnOjkxNWIyYjk1NWNjYTRjOWViZTJmYWM0NzhlN2QwZTU1L3RhYmxlOmVkMzAwNGU1NjdjNTQyYTZiMTEyM2M1ZWMzOGI0MDc2L3RhYmxlcmFuZ2U6ZWQzMDA0ZTU2N2M1NDJhNmIxMTIzYzVlYzM4YjQwNzZfNi0zLTEtMS00NjMzNA_190cbe2b-1bc8-4d30-9070-922fd7055a1b"
      unitRef="usd">9200000</us-gaap:LinesOfCreditFairValueDisclosure>
    <us-gaap:LinesOfCreditFairValueDisclosure
      contextRef="i3ca241ad2cc548f6a38311595d2c1a51_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82NC9mcmFnOjkxNWIyYjk1NWNjYTRjOWViZTJmYWM0NzhlN2QwZTU1L3RhYmxlOmVkMzAwNGU1NjdjNTQyYTZiMTEyM2M1ZWMzOGI0MDc2L3RhYmxlcmFuZ2U6ZWQzMDA0ZTU2N2M1NDJhNmIxMTIzYzVlYzM4YjQwNzZfNi01LTEtMS00NjMzNA_8b45aef6-7014-4050-9b0b-ed54c8774742"
      unitRef="usd">9200000</us-gaap:LinesOfCreditFairValueDisclosure>
    <us-gaap:LinesOfCreditFairValueDisclosure
      contextRef="ia8042af3a5af441cbbd4f8aa3c656853_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82NC9mcmFnOjkxNWIyYjk1NWNjYTRjOWViZTJmYWM0NzhlN2QwZTU1L3RhYmxlOmVkMzAwNGU1NjdjNTQyYTZiMTEyM2M1ZWMzOGI0MDc2L3RhYmxlcmFuZ2U6ZWQzMDA0ZTU2N2M1NDJhNmIxMTIzYzVlYzM4YjQwNzZfNi03LTEtMS00NjMzNA_e0e8ef55-f554-4cad-82c5-42f5c57b37c4"
      unitRef="usd">9200000</us-gaap:LinesOfCreditFairValueDisclosure>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ia987e32d35a64bc58e5674f1e07ff056_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82NC9mcmFnOjkxNWIyYjk1NWNjYTRjOWViZTJmYWM0NzhlN2QwZTU1L3RhYmxlOmVkMzAwNGU1NjdjNTQyYTZiMTEyM2M1ZWMzOGI0MDc2L3RhYmxlcmFuZ2U6ZWQzMDA0ZTU2N2M1NDJhNmIxMTIzYzVlYzM4YjQwNzZfNy0xLTEtMS00NjMzNA_2d4320ff-7c79-4b47-8fff-35aba5cf5eb7"
      unitRef="usd">123875000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i736980e5039d40a593f5402597dcedea_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82NC9mcmFnOjkxNWIyYjk1NWNjYTRjOWViZTJmYWM0NzhlN2QwZTU1L3RhYmxlOmVkMzAwNGU1NjdjNTQyYTZiMTEyM2M1ZWMzOGI0MDc2L3RhYmxlcmFuZ2U6ZWQzMDA0ZTU2N2M1NDJhNmIxMTIzYzVlYzM4YjQwNzZfNy0zLTEtMS00NjMzNA_ec7f064c-0220-4ad4-b79a-a794139e0061"
      unitRef="usd">120023000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ifec1ee9f27f84876ae61fc5e20677f66_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82NC9mcmFnOjkxNWIyYjk1NWNjYTRjOWViZTJmYWM0NzhlN2QwZTU1L3RhYmxlOmVkMzAwNGU1NjdjNTQyYTZiMTEyM2M1ZWMzOGI0MDc2L3RhYmxlcmFuZ2U6ZWQzMDA0ZTU2N2M1NDJhNmIxMTIzYzVlYzM4YjQwNzZfNy01LTEtMS00NjMzNA_f1c47c7c-b0f2-4b55-aebd-9b951242573e"
      unitRef="usd">174312000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i877c790a76d546a8a90babc735c8b376_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82NC9mcmFnOjkxNWIyYjk1NWNjYTRjOWViZTJmYWM0NzhlN2QwZTU1L3RhYmxlOmVkMzAwNGU1NjdjNTQyYTZiMTEyM2M1ZWMzOGI0MDc2L3RhYmxlcmFuZ2U6ZWQzMDA0ZTU2N2M1NDJhNmIxMTIzYzVlYzM4YjQwNzZfNy03LTEtMS00NjMzNA_39ea7a94-becf-4a2a-850a-084853c2c734"
      unitRef="usd">174845000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="iba8724e196ad45edae8eaee777dfc4d7_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82NC9mcmFnOjkxNWIyYjk1NWNjYTRjOWViZTJmYWM0NzhlN2QwZTU1L3RhYmxlOmVkMzAwNGU1NjdjNTQyYTZiMTEyM2M1ZWMzOGI0MDc2L3RhYmxlcmFuZ2U6ZWQzMDA0ZTU2N2M1NDJhNmIxMTIzYzVlYzM4YjQwNzZfOC0xLTEtMS00NjMzNA_63fc7fa6-f4f5-428c-ae19-d64b308aebe3"
      unitRef="usd">7500000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ia3b246daadb64fa58cf94501ca9e81e5_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82NC9mcmFnOjkxNWIyYjk1NWNjYTRjOWViZTJmYWM0NzhlN2QwZTU1L3RhYmxlOmVkMzAwNGU1NjdjNTQyYTZiMTEyM2M1ZWMzOGI0MDc2L3RhYmxlcmFuZ2U6ZWQzMDA0ZTU2N2M1NDJhNmIxMTIzYzVlYzM4YjQwNzZfOC0zLTEtMS00NjMzNA_7bfcc109-0c65-47c7-9ddb-ed94b4ddc22e"
      unitRef="usd">7500000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i1946fe4694af480aa180b00058e1d6d9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82NC9mcmFnOjkxNWIyYjk1NWNjYTRjOWViZTJmYWM0NzhlN2QwZTU1L3RhYmxlOmVkMzAwNGU1NjdjNTQyYTZiMTEyM2M1ZWMzOGI0MDc2L3RhYmxlcmFuZ2U6ZWQzMDA0ZTU2N2M1NDJhNmIxMTIzYzVlYzM4YjQwNzZfOC01LTEtMS00NjMzNA_941b13c7-3cdc-4446-905f-e567a4282d6e"
      unitRef="usd">15000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="iba126d3e52b14305be4c3c515f9637d2_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82NC9mcmFnOjkxNWIyYjk1NWNjYTRjOWViZTJmYWM0NzhlN2QwZTU1L3RhYmxlOmVkMzAwNGU1NjdjNTQyYTZiMTEyM2M1ZWMzOGI0MDc2L3RhYmxlcmFuZ2U6ZWQzMDA0ZTU2N2M1NDJhNmIxMTIzYzVlYzM4YjQwNzZfOC03LTEtMS00NjMzNA_ab8c19d9-c27f-4683-991d-ef61c903a55d"
      unitRef="usd">15000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="iadeeceae9c3742b0916a9a12a86f2fe7_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82NC9mcmFnOjkxNWIyYjk1NWNjYTRjOWViZTJmYWM0NzhlN2QwZTU1L3RhYmxlOmVkMzAwNGU1NjdjNTQyYTZiMTEyM2M1ZWMzOGI0MDc2L3RhYmxlcmFuZ2U6ZWQzMDA0ZTU2N2M1NDJhNmIxMTIzYzVlYzM4YjQwNzZfOS0xLTEtMS00NjMzNA_5d47c47e-f8ce-4408-839a-c8ef63b2188a"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i17bfcb8a0ca943179adb5a32cc2af8ba_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82NC9mcmFnOjkxNWIyYjk1NWNjYTRjOWViZTJmYWM0NzhlN2QwZTU1L3RhYmxlOmVkMzAwNGU1NjdjNTQyYTZiMTEyM2M1ZWMzOGI0MDc2L3RhYmxlcmFuZ2U6ZWQzMDA0ZTU2N2M1NDJhNmIxMTIzYzVlYzM4YjQwNzZfOS0zLTEtMS00NjMzNA_340bc15e-0955-4c68-a0f6-0e8aad447b5f"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i8da530a9cdbc4804980eefdbbd0e900a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82NC9mcmFnOjkxNWIyYjk1NWNjYTRjOWViZTJmYWM0NzhlN2QwZTU1L3RhYmxlOmVkMzAwNGU1NjdjNTQyYTZiMTEyM2M1ZWMzOGI0MDc2L3RhYmxlcmFuZ2U6ZWQzMDA0ZTU2N2M1NDJhNmIxMTIzYzVlYzM4YjQwNzZfOS01LTEtMS00NjMzNA_ff9e8f73-ac41-499c-9541-29762c234fc4"
      unitRef="usd">1500000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i9b515cd81555467898b20fbdbc0994cb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82NC9mcmFnOjkxNWIyYjk1NWNjYTRjOWViZTJmYWM0NzhlN2QwZTU1L3RhYmxlOmVkMzAwNGU1NjdjNTQyYTZiMTEyM2M1ZWMzOGI0MDc2L3RhYmxlcmFuZ2U6ZWQzMDA0ZTU2N2M1NDJhNmIxMTIzYzVlYzM4YjQwNzZfOS03LTEtMS00NjMzNA_5dddffb0-9cf9-447b-8b90-f2230cff1fe9"
      unitRef="usd">1500000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RleHRyZWdpb246YWIxMGRlY2Q5MDAzNGIxYTkwZDgyMzI1YWRiZjI3ZjlfMzY2Mw_157f86c9-dc5d-42df-b403-328b6d15af4d">STOCKHOLDERS&#x2019; EQUITY&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock Repurchase Program&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 16, 2022, the Company's Board of Directors authorized a new stock repurchase program (the New Repurchase Program), whereby the Company may repurchase up to $100.0&#160;million of its shares of common stock, subject to the terms of its current credit agreements. The shares may be repurchased from time-to-time in the open market or in privately negotiated transactions. The New Repurchase Program was effective immediately and may be discontinued at any time at the Board's discretion. In addition to the repurchase of $100.0&#160;million of its shares of common stock under the New Repurchase Program, the Company was authorized to continue to repurchase any remaining shares available for repurchase under the Company's previous stock repurchase program, which was approved by the Board of Directors on February 28, 2008 (the Prior Repurchase Program). Upon completion of the authorized number of shares available for repurchase under the Prior Repurchase Program, the Company commenced repurchases under the New Repurchase Program during the third quarter of 2022. During the third quarter, the Company repurchased and retired, under both the Prior Repurchase Program and the New Repurchase Program, a total of 1,014,815 shares of common stock for $24.3&#160;million, at an average market price of $23.97 per share. During the three and nine months ended September 30, 2021, the Company did not repurchase any shares of its common stock.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2022, the Company had $87.2&#160;million remaining for share repurchase under the New Repurchase Program, subject to certain conditions in the Company's Loan Agreement and Term Loan Agreement. At September 30, 2022, the Company had 36,508,529 unrestricted shares of common stock outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Share-Based Payments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 19, 2020, the Company's stockholders approved the Cross Country Healthcare, Inc. 2020 Omnibus Incentive Plan (2020 Plan), which replaced the 2017 Omnibus Incentive Plan (2017 Plan), and applies to awards granted after May 19, 2020. The remaining shares available for grant under the 2017 Plan were cancelled and no further awards will be granted under that plan. The 2020 Plan generally mirrors the terms of the 2017 Plan and includes the following provisions: (i) an aggregate share reserve of 3,000,000 shares; (2) annual dollar and share limits of awards granted to employees and consultants, as well as non-employee directors, based on type of award; (3) awards granted generally will be subject to a minimum one-year vesting schedule; and (4) awards may be granted under the 2020 Plan until March 24, 2030.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes restricted stock awards and performance stock awards activity issued under the 2017 Plan and the 2020 Plan (Plans) for the nine months ended September&#160;30, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.741%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restricted Stock Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Performance Stock Awards&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Grant Date&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of Target &lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Grant Date&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested restricted stock awards, January&#160;1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,039,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;522,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(575,051)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(170,278)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(79,520)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47,675)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested restricted stock awards, September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;672,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;476,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted stock awards granted under the Company&#x2019;s Plans entitle the holder to receive, at the end of a vesting period, a specified number of shares of the Company&#x2019;s common stock. Share-based compensation expense is measured by the market value of the Company&#x2019;s stock on the date of grant. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Awards granted to non-employee directors under the 2017 Plan, prior to the adoption of the 2020 Plan, vest in three equal installments on the first, second, and third anniversaries of the grant date, while restricted shares granted under the 2020 Plan on and subsequent to June 2020 will vest on the first anniversary of such grant date, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;or earlier subject to retirement eligibility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. In addition, effective in the three months ended June 30, 2020, the Company implemented modified guidelines that provide for accelerated vesting of restricted stock grants on the last date of service when a retirement-eligible director retires.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to the Plans, the number of target shares that are issued for performance-based stock awards are determined based on the level of attainment of the targets. During the first quarter of 2022, the Company's Compensation Committee of the Board of Directors approved a 120% level of attainment for the 2019 performance-based share awards, resulting in the issuance of 170,278 performance shares that vested on March 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;During the three and nine months ended September 30, 2022, $1.5 million and $5.2&#160;million, respectively, was included in selling, general and administrative expenses related to share-based payments. During the nine months ended September 30, 2022, a net of 499,700 shares of common stock were issued upon the vesting of restricted and performance stock. No shares vested during the three months ended September 30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three and nine months ended September 30, 2021, $1.8 million and $5.3&#160;million, respectively, was included in selling, general and administrative expenses related to share-based payments, and a net of 2,576 and 479,206 shares, respectively, of common stock were issued upon the vesting of restricted stock.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i39fd50bbb06e42f18218bf500c01d1b1_I20220816"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RleHRyZWdpb246YWIxMGRlY2Q5MDAzNGIxYTkwZDgyMzI1YWRiZjI3ZjlfNTQ5NzU1ODE4OTcy_34624ce1-71a8-422a-924b-9f76d23cf0a3"
      unitRef="usd">100000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i39fd50bbb06e42f18218bf500c01d1b1_I20220816"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RleHRyZWdpb246YWIxMGRlY2Q5MDAzNGIxYTkwZDgyMzI1YWRiZjI3ZjlfNDM5ODA0NjUxODQzMw_dbedf0a0-2a90-4caf-851e-c9d7ba261afe"
      unitRef="usd">100000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i9313064d9eac40ad83fdaf7a1b2db9e0_D20220701-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RleHRyZWdpb246YWIxMGRlY2Q5MDAzNGIxYTkwZDgyMzI1YWRiZjI3ZjlfNTQ5NzU1ODE5NzY3_2d0876f8-0432-4409-ab07-12e0fb3d809b"
      unitRef="shares">1014815</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i9313064d9eac40ad83fdaf7a1b2db9e0_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RleHRyZWdpb246YWIxMGRlY2Q5MDAzNGIxYTkwZDgyMzI1YWRiZjI3ZjlfNTQ5NzU1ODE5Nzg2_9fe13ff4-c306-41ca-878f-aa46ec0e7d8f"
      unitRef="usd">24300000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i9313064d9eac40ad83fdaf7a1b2db9e0_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RleHRyZWdpb246YWIxMGRlY2Q5MDAzNGIxYTkwZDgyMzI1YWRiZjI3ZjlfNTQ5NzU1ODE5ODA2_85002cef-db32-43f3-9f25-5181d79f5792"
      unitRef="usdPerShare">23.97</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RleHRyZWdpb246YWIxMGRlY2Q5MDAzNGIxYTkwZDgyMzI1YWRiZjI3ZjlfNDc4_4a1dbdf6-fecd-43bf-b229-a14bd871a793"
      unitRef="shares">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RleHRyZWdpb246YWIxMGRlY2Q5MDAzNGIxYTkwZDgyMzI1YWRiZjI3ZjlfNDc4_844dd011-84ce-4d43-9b7e-6436eeeab373"
      unitRef="shares">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i8d6c70caf3ac4c6493c60fe74f5d510e_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RleHRyZWdpb246YWIxMGRlY2Q5MDAzNGIxYTkwZDgyMzI1YWRiZjI3ZjlfNTQ5NzU1ODIwMDc3_29466d34-22d3-4490-b9ea-fa444a4b0785"
      unitRef="usd">87200000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i8ad9340f357e45ba914eff9e31b0661b_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RleHRyZWdpb246YWIxMGRlY2Q5MDAzNGIxYTkwZDgyMzI1YWRiZjI3ZjlfNTQ5NzU1ODE5OTkz_7bb22bd7-3108-4e47-9877-1184f41f24ce"
      unitRef="shares">36508529</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i60a43dc77674425480d2db76cf79177d_I20200519"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RleHRyZWdpb246YWIxMGRlY2Q5MDAzNGIxYTkwZDgyMzI1YWRiZjI3ZjlfMTI1Ng_a0e59c18-2d9d-4219-9a14-f4c8ddc074a2"
      unitRef="shares">3000000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i3d793cc2e5cf4606b38b48e7c4f5d2b2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RleHRyZWdpb246YWIxMGRlY2Q5MDAzNGIxYTkwZDgyMzI1YWRiZjI3ZjlfMzY1MA_78c73029-b12b-478a-aa92-91045f8e6d3f">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RleHRyZWdpb246YWIxMGRlY2Q5MDAzNGIxYTkwZDgyMzI1YWRiZjI3ZjlfMzY1OQ_49afe9bc-174e-4ee8-861a-54273e6fd94b">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes restricted stock awards and performance stock awards activity issued under the 2017 Plan and the 2020 Plan (Plans) for the nine months ended September&#160;30, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.741%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restricted Stock Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Performance Stock Awards&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Grant Date&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of Target &lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Grant Date&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested restricted stock awards, January&#160;1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,039,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;522,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(575,051)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(170,278)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(79,520)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47,675)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested restricted stock awards, September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;672,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;476,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i0898a126dbc046e795ecb209d0f68153_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RhYmxlOmNhYjdkOTEzNjY0MDRmNzNhYjYxYjRlZDEzMTc4NWFlL3RhYmxlcmFuZ2U6Y2FiN2Q5MTM2NjQwNGY3M2FiNjFiNGVkMTMxNzg1YWVfMi0xLTEtMS00NjMzNA_33fe16a7-5da7-4b88-87ef-81bae84169ad"
      unitRef="shares">1039455</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i0898a126dbc046e795ecb209d0f68153_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RhYmxlOmNhYjdkOTEzNjY0MDRmNzNhYjYxYjRlZDEzMTc4NWFlL3RhYmxlcmFuZ2U6Y2FiN2Q5MTM2NjQwNGY3M2FiNjFiNGVkMTMxNzg1YWVfMi0zLTEtMS00NjMzNA_6fbdcaac-8611-4bc3-b4b1-8f2dc5380fea"
      unitRef="usdPerShare">9.75</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i94cacdf9f5e14894bd9a7ee09ceefd0b_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RhYmxlOmNhYjdkOTEzNjY0MDRmNzNhYjYxYjRlZDEzMTc4NWFlL3RhYmxlcmFuZ2U6Y2FiN2Q5MTM2NjQwNGY3M2FiNjFiNGVkMTMxNzg1YWVfMi01LTEtMS00NjMzNA_352d5304-cc96-477a-b3a4-2bf9781796b2"
      unitRef="shares">522166</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i94cacdf9f5e14894bd9a7ee09ceefd0b_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RhYmxlOmNhYjdkOTEzNjY0MDRmNzNhYjYxYjRlZDEzMTc4NWFlL3RhYmxlcmFuZ2U6Y2FiN2Q5MTM2NjQwNGY3M2FiNjFiNGVkMTMxNzg1YWVfMi03LTEtMS00NjMzNA_412967e8-27d0-45b4-80c7-4b53e476f53b"
      unitRef="usdPerShare">8.64</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i7b01283f3c6e441b93fffe6cdf6495d8_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RhYmxlOmNhYjdkOTEzNjY0MDRmNzNhYjYxYjRlZDEzMTc4NWFlL3RhYmxlcmFuZ2U6Y2FiN2Q5MTM2NjQwNGY3M2FiNjFiNGVkMTMxNzg1YWVfMy0xLTEtMS00NjMzNA_d1315fab-ad21-4dd2-87a9-f08f0748b042"
      unitRef="shares">287774</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i7b01283f3c6e441b93fffe6cdf6495d8_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RhYmxlOmNhYjdkOTEzNjY0MDRmNzNhYjYxYjRlZDEzMTc4NWFlL3RhYmxlcmFuZ2U6Y2FiN2Q5MTM2NjQwNGY3M2FiNjFiNGVkMTMxNzg1YWVfMy0zLTEtMS00NjMzNA_b7fd6647-4a0c-4487-ac6b-61c59babf1e8"
      unitRef="usdPerShare">20.76</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ife7c8285d238454bad645c20b406a43d_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RhYmxlOmNhYjdkOTEzNjY0MDRmNzNhYjYxYjRlZDEzMTc4NWFlL3RhYmxlcmFuZ2U6Y2FiN2Q5MTM2NjQwNGY3M2FiNjFiNGVkMTMxNzg1YWVfMy01LTEtMS00NjMzNA_a3de0afc-48e9-4e7d-8e9e-c3186bfe1571"
      unitRef="shares">171873</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ife7c8285d238454bad645c20b406a43d_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RhYmxlOmNhYjdkOTEzNjY0MDRmNzNhYjYxYjRlZDEzMTc4NWFlL3RhYmxlcmFuZ2U6Y2FiN2Q5MTM2NjQwNGY3M2FiNjFiNGVkMTMxNzg1YWVfMy03LTEtMS00NjMzNA_c2311d2f-879c-4ca8-b45c-085676c7b048"
      unitRef="usdPerShare">18.94</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i7b01283f3c6e441b93fffe6cdf6495d8_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RhYmxlOmNhYjdkOTEzNjY0MDRmNzNhYjYxYjRlZDEzMTc4NWFlL3RhYmxlcmFuZ2U6Y2FiN2Q5MTM2NjQwNGY3M2FiNjFiNGVkMTMxNzg1YWVfNC0xLTEtMS00NjMzNA_45842715-17d2-4983-87ba-c2cf0decddd0"
      unitRef="shares">575051</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i7b01283f3c6e441b93fffe6cdf6495d8_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RhYmxlOmNhYjdkOTEzNjY0MDRmNzNhYjYxYjRlZDEzMTc4NWFlL3RhYmxlcmFuZ2U6Y2FiN2Q5MTM2NjQwNGY3M2FiNjFiNGVkMTMxNzg1YWVfNC0zLTEtMS00NjMzNA_4a0feb4c-8ed8-4cc9-b64b-21e221755491"
      unitRef="usdPerShare">9.14</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="ife7c8285d238454bad645c20b406a43d_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RhYmxlOmNhYjdkOTEzNjY0MDRmNzNhYjYxYjRlZDEzMTc4NWFlL3RhYmxlcmFuZ2U6Y2FiN2Q5MTM2NjQwNGY3M2FiNjFiNGVkMTMxNzg1YWVfNC01LTEtMS00NjMzNA_f470f17b-000d-47d2-b249-cac11695704d"
      unitRef="shares">170278</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="ife7c8285d238454bad645c20b406a43d_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RhYmxlOmNhYjdkOTEzNjY0MDRmNzNhYjYxYjRlZDEzMTc4NWFlL3RhYmxlcmFuZ2U6Y2FiN2Q5MTM2NjQwNGY3M2FiNjFiNGVkMTMxNzg1YWVfNC03LTEtMS00NjMzNA_d947bd4c-0b06-4996-92f7-7fd17606819b"
      unitRef="usdPerShare">7.03</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i7b01283f3c6e441b93fffe6cdf6495d8_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RhYmxlOmNhYjdkOTEzNjY0MDRmNzNhYjYxYjRlZDEzMTc4NWFlL3RhYmxlcmFuZ2U6Y2FiN2Q5MTM2NjQwNGY3M2FiNjFiNGVkMTMxNzg1YWVfNS0xLTEtMS00NjMzNA_c2d37329-e1fb-4961-8a53-8115ef09f7f4"
      unitRef="shares">79520</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i7b01283f3c6e441b93fffe6cdf6495d8_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RhYmxlOmNhYjdkOTEzNjY0MDRmNzNhYjYxYjRlZDEzMTc4NWFlL3RhYmxlcmFuZ2U6Y2FiN2Q5MTM2NjQwNGY3M2FiNjFiNGVkMTMxNzg1YWVfNS0zLTEtMS00NjMzNA_58c223a8-0aee-41ec-a222-16d4cec3efc7"
      unitRef="usdPerShare">14.10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="ife7c8285d238454bad645c20b406a43d_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RhYmxlOmNhYjdkOTEzNjY0MDRmNzNhYjYxYjRlZDEzMTc4NWFlL3RhYmxlcmFuZ2U6Y2FiN2Q5MTM2NjQwNGY3M2FiNjFiNGVkMTMxNzg1YWVfNS01LTEtMS00NjMzNA_1541771a-ad42-473f-9b88-cf2894f70e7d"
      unitRef="shares">47675</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="ife7c8285d238454bad645c20b406a43d_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RhYmxlOmNhYjdkOTEzNjY0MDRmNzNhYjYxYjRlZDEzMTc4NWFlL3RhYmxlcmFuZ2U6Y2FiN2Q5MTM2NjQwNGY3M2FiNjFiNGVkMTMxNzg1YWVfNS03LTEtMS00NjMzNA_ea1137d4-4b03-44a4-9266-95ee15d79dd6"
      unitRef="usdPerShare">12.33</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i57cbf98f9a5e41dbb52fc4305ececb04_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RhYmxlOmNhYjdkOTEzNjY0MDRmNzNhYjYxYjRlZDEzMTc4NWFlL3RhYmxlcmFuZ2U6Y2FiN2Q5MTM2NjQwNGY3M2FiNjFiNGVkMTMxNzg1YWVfNi0xLTEtMS00NjMzNA_5e45c046-addb-4ee8-8368-c54c6e6c5a65"
      unitRef="shares">672658</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i57cbf98f9a5e41dbb52fc4305ececb04_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RhYmxlOmNhYjdkOTEzNjY0MDRmNzNhYjYxYjRlZDEzMTc4NWFlL3RhYmxlcmFuZ2U6Y2FiN2Q5MTM2NjQwNGY3M2FiNjFiNGVkMTMxNzg1YWVfNi0zLTEtMS00NjMzNA_7337febb-373f-42c1-b788-e74e0740bfc5"
      unitRef="usdPerShare">14.47</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i850fcfe043314c1a9fece0d4d68b2919_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RhYmxlOmNhYjdkOTEzNjY0MDRmNzNhYjYxYjRlZDEzMTc4NWFlL3RhYmxlcmFuZ2U6Y2FiN2Q5MTM2NjQwNGY3M2FiNjFiNGVkMTMxNzg1YWVfNi01LTEtMS00NjMzNA_c19b4dcf-025c-44ae-9c62-43dc0b736108"
      unitRef="shares">476086</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i850fcfe043314c1a9fece0d4d68b2919_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RhYmxlOmNhYjdkOTEzNjY0MDRmNzNhYjYxYjRlZDEzMTc4NWFlL3RhYmxlcmFuZ2U6Y2FiN2Q5MTM2NjQwNGY3M2FiNjFiNGVkMTMxNzg1YWVfNi03LTEtMS00NjMzNA_9c5d4a8d-c90f-490c-92b0-931a6cb37e99"
      unitRef="usdPerShare">12.56</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <ccrn:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments
      contextRef="i4b68237ebf9d475aaf3f35fd14b2fefc_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RleHRyZWdpb246YWIxMGRlY2Q5MDAzNGIxYTkwZDgyMzI1YWRiZjI3ZjlfMjE0Nw_72e778eb-5b92-4678-ba99-24c35006c0eb"
      unitRef="installment">3</ccrn:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments>
    <ccrn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAttainmentPercentage
      contextRef="i657bd17dcadf4f3f873d0850b774cdc3_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RleHRyZWdpb246YWIxMGRlY2Q5MDAzNGIxYTkwZDgyMzI1YWRiZjI3ZjlfMjkzOA_e040f02d-f1ea-4449-b756-2b0298d56d1f"
      unitRef="number">1.20</ccrn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAttainmentPercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="ia1b0163339fb42deac2d52ca0dc626cd_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RleHRyZWdpb246YWIxMGRlY2Q5MDAzNGIxYTkwZDgyMzI1YWRiZjI3ZjlfMzAzNQ_2f58c8c6-37f1-4412-8f94-9d9a9be79e1a"
      unitRef="shares">170278</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ice9fa15cb07246a2819aa90ca0b090f2_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RleHRyZWdpb246YWIxMGRlY2Q5MDAzNGIxYTkwZDgyMzI1YWRiZjI3ZjlfMzEzMQ_d7c09a5f-7187-4e6c-8ba0-7f3d1506147c"
      unitRef="usd">1500000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i00ee87f771334f0c8220e9eb0575e200_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RleHRyZWdpb246YWIxMGRlY2Q5MDAzNGIxYTkwZDgyMzI1YWRiZjI3ZjlfMzEzOA_90f8cbd5-d761-4b06-b975-82a7f0334e4f"
      unitRef="usd">5200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <ccrn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet
      contextRef="i69cc0e8a27234c22915bdde908a717c2_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RleHRyZWdpb246YWIxMGRlY2Q5MDAzNGIxYTkwZDgyMzI1YWRiZjI3ZjlfMzI3MA_cff50142-3dc4-4950-ae45-aeb091e0c386"
      unitRef="shares">499700</ccrn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet>
    <ccrn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet
      contextRef="ic57dcdd480124d9d9ce70d9d0fe56d2b_D20220701-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RleHRyZWdpb246YWIxMGRlY2Q5MDAzNGIxYTkwZDgyMzI1YWRiZjI3ZjlfNTQ5NzU1ODIwMjk0_f0bd1d58-c5db-4eef-8381-4047abed3944"
      unitRef="shares">0</ccrn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i51e864c08ce54f8c91f98492c469e4a5_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RleHRyZWdpb246YWIxMGRlY2Q5MDAzNGIxYTkwZDgyMzI1YWRiZjI3ZjlfMzQyMA_b6d1d30d-666b-469e-b173-760670380d98"
      unitRef="usd">1800000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i01b4eae42d8043bc9669c54efc17b3be_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RleHRyZWdpb246YWIxMGRlY2Q5MDAzNGIxYTkwZDgyMzI1YWRiZjI3ZjlfMzQyNw_b30860d1-506c-49a4-bdce-d6c822b3c7b6"
      unitRef="usd">5300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <ccrn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet
      contextRef="i259a723688ef4b07876c5e5858c322e8_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RleHRyZWdpb246YWIxMGRlY2Q5MDAzNGIxYTkwZDgyMzI1YWRiZjI3ZjlfMzU1Mg_c6e06b98-e405-4375-bf44-4a5d1286e778"
      unitRef="shares">2576</ccrn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet>
    <ccrn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet
      contextRef="ic3d043883a0640a8beb08731478b973f_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV82Ny9mcmFnOmFiMTBkZWNkOTAwMzRiMWE5MGQ4MjMyNWFkYmYyN2Y5L3RleHRyZWdpb246YWIxMGRlY2Q5MDAzNGIxYTkwZDgyMzI1YWRiZjI3ZjlfMzU1OQ_90847616-6239-43a1-a866-0eb29989eb60"
      unitRef="shares">479206</ccrn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RleHRyZWdpb246MjMwNDNmMzMxN2JhNGE0M2JmMWQwMzc4ODMzZWQyOWZfMjU4MA_d644d40e-d42f-421e-974e-e4474e94e6fb">SEGMENT DATA&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s segments offer services to its customers as described below:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25cf;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Nurse and Allied Staffing &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2013; Nurse and Allied Staffing provides traditional staffing, recruiting, and value-added total talent solutions including: temporary and permanent placement of travel and local nurse and allied professionals, managed services programs (MSP) services, education healthcare services, in-home care services, and outsourcing services. In addition, Nurse and Allied Staffing provides retained search services for healthcare professionals, as well as contingent search and recruitment process outsourcing services. Its clients include: public and private acute-care and non-acute care hospitals, government facilities, local and national healthcare plans, managed care providers, public schools and charter schools, outpatient clinics, ambulatory care facilities, physician practice groups, and many other healthcare providers throughout the United States.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25cf;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Physician Staffing&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; Physician Staffing provides physicians in many specialties, as well as certified registered nurse anesthetists, nurse practitioners, and physician assistants as independent contractors on temporary assignments throughout the United States at various healthcare facilities, such as acute and non-acute care facilities, medical group practices, government facilities, and managed care organizations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates performance of each segment primarily based on revenue and contribution income. The Company defines contribution income as income (loss) from operations before depreciation and amortization, acquisition and integration-related costs, restructuring (benefits) costs, legal settlement charges, impairment charges, and corporate overhead. The Company does not evaluate, manage, or measure performance of segments using asset information; accordingly, total asset information by segment is not prepared or disclosed. The information in the following table is derived from the segments&#x2019; internal financial information as used for corporate management purposes. Certain corporate expenses are not allocated to and/or among the operating segments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information on operating segments and a&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;reconciliation to income from operations for the periods indicated are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.057%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.526%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue from services:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nurse and Allied Staffing&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;612,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;356,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,109,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;985,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Physician Staffing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;636,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;374,905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,178,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,035,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contribution income:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nurse and Allied Staffing&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Physician Staffing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;289,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate overhead &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition and integration-related costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) Corporate overhead includes unallocated executive leadership and other centralized corporate functional support costs such as finance, IT, legal, human resources, and marketing, as well as public company expenses and corporate-wide projects (initiatives).&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RleHRyZWdpb246MjMwNDNmMzMxN2JhNGE0M2JmMWQwMzc4ODMzZWQyOWZfMjU4OQ_25277468-1646-4b6c-914d-da3dab79ea0b">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information on operating segments and a&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;reconciliation to income from operations for the periods indicated are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.057%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.526%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue from services:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nurse and Allied Staffing&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;612,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;356,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,109,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;985,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Physician Staffing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;636,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;374,905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,178,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,035,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contribution income:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nurse and Allied Staffing&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Physician Staffing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;289,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate overhead &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition and integration-related costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) Corporate overhead includes unallocated executive leadership and other centralized corporate functional support costs such as finance, IT, legal, human resources, and marketing, as well as public company expenses and corporate-wide projects (initiatives).&lt;/span&gt;&lt;/div&gt;</us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i755b00d6551346d08633c51f6fffcbd4_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfNS0xLTEtMS00NjMzNA_a652c8ab-d950-4d2a-b89a-013e0f7f6858"
      unitRef="usd">612270000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i15f558e83a4a479e8674ab636a78ba79_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfNS0zLTEtMS00NjMzNA_d3e2c77e-f61c-4473-9c72-b8362f9ab925"
      unitRef="usd">356139000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7aaf74b211ba45b9bea92196b8c48cd7_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfNS01LTEtMS00NjMzNA_3cd886f3-45a5-49ac-85b1-f7400521de29"
      unitRef="usd">2109293000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id76ab6905df5463b9046aaf30a35075d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfNS03LTEtMS00NjMzNA_c5b20f2b-a3f5-4091-92e1-5fd69d3407d6"
      unitRef="usd">985335000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i60312c6dd2494d66bf19248b38166eaf_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfNi0xLTEtMS00NjMzNA_13e85084-c069-40b0-9875-9d3fbaa126f1"
      unitRef="usd">23828000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibeef5c5a5e6e4d08b2e5036ccd0186a0_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfNi0zLTEtMS00NjMzNA_b37e9fac-29e6-4f46-af68-402998b981d1"
      unitRef="usd">18766000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia4be1f35efe045ebabfe8d9154e1c3cb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfNi01LTEtMS00NjMzNA_1980166b-1f79-4973-a5b7-70d071a6a9b3"
      unitRef="usd">69098000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7c425883600f44a6aedb244f1adafb03_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfNi03LTEtMS00NjMzNA_e7a22a49-289b-44e1-876e-8b1979e033ad"
      unitRef="usd">50638000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfNy0xLTEtMS00NjMzNA_9e2ad9ce-b8af-4562-a297-023b45edf529"
      unitRef="usd">636098000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfNy0zLTEtMS00NjMzNA_146304c3-cb8e-4852-b0c4-2bea3ce76a96"
      unitRef="usd">374905000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfNy01LTEtMS00NjMzNA_a01790c7-a14f-46ae-ae6d-42ecad2eb510"
      unitRef="usd">2178391000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfNy03LTEtMS00NjMzNA_272d3962-6fe7-4164-a435-edb1a0c064e4"
      unitRef="usd">1035973000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard
      contextRef="i755b00d6551346d08633c51f6fffcbd4_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTAtMS0xLTEtNDYzMzQ_72a890a6-5e6b-4d0b-8584-a094d33e7a52"
      unitRef="usd">77838000</ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard>
    <ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard
      contextRef="i15f558e83a4a479e8674ab636a78ba79_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTAtMy0xLTEtNDYzMzQ_98ed19fa-ddb0-40e2-8cd7-4e8ee1359cbb"
      unitRef="usd">40645000</ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard>
    <ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard
      contextRef="i7aaf74b211ba45b9bea92196b8c48cd7_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTAtNS0xLTEtNDYzMzQ_6e5d83d4-88bc-4641-8eb1-ceb8e8a5d821"
      unitRef="usd">285506000</ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard>
    <ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard
      contextRef="id76ab6905df5463b9046aaf30a35075d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTAtNy0xLTEtNDYzMzQ_96917070-7b88-405a-adfa-a4f6cc237402"
      unitRef="usd">113346000</ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard>
    <ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard
      contextRef="i60312c6dd2494d66bf19248b38166eaf_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTEtMS0xLTEtNDYzMzQ_dbeaefef-4446-4f00-9dd8-c41cfbc9eacb"
      unitRef="usd">837000</ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard>
    <ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard
      contextRef="ibeef5c5a5e6e4d08b2e5036ccd0186a0_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTEtMy0xLTEtNDYzMzQ_8ded68dc-7944-4cb0-95a2-e89cd21f5eb6"
      unitRef="usd">910000</ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard>
    <ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard
      contextRef="ia4be1f35efe045ebabfe8d9154e1c3cb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTEtNS0xLTEtNDYzMzQ_d296bf2d-77c8-4f51-b05e-645c834d95c5"
      unitRef="usd">3822000</ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard>
    <ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard
      contextRef="i7c425883600f44a6aedb244f1adafb03_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTEtNy0xLTEtNDYzMzQ_660b777f-6c7f-4954-a85e-91cbc6d02bbd"
      unitRef="usd">2900000</ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard>
    <ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard
      contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTItMS0xLTEtNDYzMzQ_98116f71-a87e-41bf-ade4-e338f8b09daf"
      unitRef="usd">78675000</ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard>
    <ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard
      contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTItMy0xLTEtNDYzMzQ_0c91911b-d434-4946-afcc-42cf608b4808"
      unitRef="usd">41555000</ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard>
    <ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTItNS0xLTEtNDYzMzQ_bd3caf52-45f3-4030-ab1a-b87be713c7fd"
      unitRef="usd">289328000</ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard>
    <ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTItNy0xLTEtNDYzMzQ_9c1432a9-2640-4743-9933-2c554905f990"
      unitRef="usd">116246000</ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard>
    <ccrn:SegmentReportingUnallocatedCorporateExpenses
      contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTQtMS0xLTEtNDYzMzQ_0cc7fb46-dbd3-4dbe-b9a0-ac10673aee3e"
      unitRef="usd">16447000</ccrn:SegmentReportingUnallocatedCorporateExpenses>
    <ccrn:SegmentReportingUnallocatedCorporateExpenses
      contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTQtMy0xLTEtNDYzMzQ_e7c01c92-9e3f-4efd-9a47-3ee4a3f65d15"
      unitRef="usd">12049000</ccrn:SegmentReportingUnallocatedCorporateExpenses>
    <ccrn:SegmentReportingUnallocatedCorporateExpenses
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTQtNS0xLTEtNDYzMzQ_a0e251c1-d975-43ff-9d9d-9f813ada29b0"
      unitRef="usd">50284000</ccrn:SegmentReportingUnallocatedCorporateExpenses>
    <ccrn:SegmentReportingUnallocatedCorporateExpenses
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTQtNy0xLTEtNDYzMzQ_083a0a86-0c8c-4a92-a4eb-a6dbd67febf6"
      unitRef="usd">40326000</ccrn:SegmentReportingUnallocatedCorporateExpenses>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTUtMS0xLTEtNDYzMzQ_107d0bfa-0607-4dea-9a56-76ffb736b2dc"
      unitRef="usd">3214000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTUtMy0xLTEtNDYzMzQ_839ee671-a7a0-4fb9-a059-ce94a3c039b0"
      unitRef="usd">2680000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTUtNS0xLTEtNDYzMzQ_c0d8fe9d-dfc4-48f6-92b7-19836c8d1214"
      unitRef="usd">9414000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTUtNy0xLTEtNDYzMzQ_cda98d86-4392-492e-8c4f-d7c280664008"
      unitRef="usd">7132000</us-gaap:DepreciationDepletionAndAmortization>
    <ccrn:AcquisitionAndIntegrationRelatedCosts
      contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTYtMS0xLTEtNDYzMzQ_bda9c268-f373-42c2-95f3-7491d5cef5a9"
      unitRef="usd">490000</ccrn:AcquisitionAndIntegrationRelatedCosts>
    <ccrn:AcquisitionAndIntegrationRelatedCosts
      contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTYtMy0xLTEtNDYzMzQ_c747cf48-e36a-4d92-95e7-f7c313c6a11a"
      unitRef="usd">61000</ccrn:AcquisitionAndIntegrationRelatedCosts>
    <ccrn:AcquisitionAndIntegrationRelatedCosts
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTYtNS0xLTEtNDYzMzQ_32b2abb7-b9f3-436c-b8ca-214acd151149"
      unitRef="usd">530000</ccrn:AcquisitionAndIntegrationRelatedCosts>
    <ccrn:AcquisitionAndIntegrationRelatedCosts
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTYtNy0xLTEtNDYzMzQ_2340ff13-9079-4486-aa8e-a94151e40af3"
      unitRef="usd">985000</ccrn:AcquisitionAndIntegrationRelatedCosts>
    <us-gaap:RestructuringCharges
      contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTctMS0xLTEtNDYzMzQ_cb1b2526-af6f-455b-9412-67dfebbf36b0"
      unitRef="usd">2493000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTctMy0xLTEtNDYzMzQ_eccf8bca-a6b7-4869-b96e-c5c6c7ec8c04"
      unitRef="usd">318000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTctNS0xLTEtNDYzMzQ_d71d4eb8-b49e-46d7-8d6d-cd388db87c3b"
      unitRef="usd">1859000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTctNy0xLTEtNDYzMzQ_4e1ffc23-9494-45a0-8aa3-63d160a4b3d4"
      unitRef="usd">2391000</us-gaap:RestructuringCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTgtMS0xLTEtNDYzMzQ_4b7bae98-1e4b-48fe-a5ed-204ef37482df"
      unitRef="usd">3856000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTgtMy0xLTEtNDYzMzQ_72f2069c-5f00-45a1-a729-fae895a30b78"
      unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTgtNS0xLTEtNDYzMzQ_bb53aec5-1bd9-4f06-8474-c5e63e67abfb"
      unitRef="usd">5597000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTgtNy0xLTEtNDYzMzQ_4f07f971-c394-41f1-8b42-c93b67e28d08"
      unitRef="usd">2070000</us-gaap:AssetImpairmentCharges>
    <us-gaap:OperatingIncomeLoss
      contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTktMS0xLTEtNDYzMzQ_43efb997-e810-4fe7-b7c1-77f3eee0708e"
      unitRef="usd">52175000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTktMy0xLTEtNDYzMzQ_cf90b04d-79c0-4b27-8fc5-8deb10eb4fe7"
      unitRef="usd">26447000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTktNS0xLTEtNDYzMzQ_8eab2238-70b4-47a8-81fc-735304952702"
      unitRef="usd">221644000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83MC9mcmFnOjIzMDQzZjMzMTdiYTRhNDNiZjFkMDM3ODgzM2VkMjlmL3RhYmxlOjVjZjA0OWVkYTVmZDRkOWJiYTJiY2RmN2ZkYmJiOThlL3RhYmxlcmFuZ2U6NWNmMDQ5ZWRhNWZkNGQ5YmJhMmJjZGY3ZmRiYmI5OGVfMTktNy0xLTEtNDYzMzQ_1c3a55f8-9834-447e-9302-1096a8552ebf"
      unitRef="usd">63342000</us-gaap:OperatingIncomeLoss>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83My9mcmFnOjY4YzFkMDk3MzNmYjQ3MDU4ODNiOGY0YjE0NzA0ZDMxL3RleHRyZWdpb246NjhjMWQwOTczM2ZiNDcwNTg4M2I4ZjRiMTQ3MDRkMzFfMjg1Mw_0dc509fc-0a71-4208-8b46-3bbd32fd4574">CONTINGENCIES&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Legal Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, the Company is involved in various litigation, claims, investigations, and other proceedings that arise in the ordinary course of its business. These matters primarily relate to employee-related matters that include individual and collective claims, professional liability, tax, and payroll practices. The Company establishes reserves when available information indicates that a loss is probable and an amount or range of loss can be reasonably estimated. These assessments are performed at least quarterly and are based on the information available to management at the time and involve significant management judgment to determine the probability and estimated amount of potential losses, if any. Based on the available information considered in its reviews, the Company adjusts its loss contingency accruals and its disclosures as may be required. Actual outcomes or losses may differ materially from those estimated by the Company's current assessments, including available insurance recoveries, which would impact the Company's profitability. Adverse developments in existing litigation claims or legal proceedings involving the Company or new claims could require management to establish or increase litigation reserves or enter into unfavorable settlements or satisfy judgments for monetary damages for amounts in excess of current reserves, which could adversely affect the Company's financial results. The Company believes the outcome of any outstanding loss contingencies as of September 30, 2022 will not have a material adverse effect on its business, financial condition, results of operations, or cash flows.&lt;/span&gt;&lt;/div&gt;Sales and Other State Non-Income Tax Liabilities The Company's sales and other state non-income tax filings are subject to routine audits by authorities in the jurisdictions where it conducts business in the United States which may result in assessments of additional taxes. The Company accrues sales and other non-income tax liabilities based on the Company's best estimate of its probable liability utilizing currently available information and interpretation of relevant tax regulations. Given the nature of the Company's business, significant subjectivity exists as to both whether sales and other state non-income taxes can be assessed on its activity and how the sales tax will ultimately be measured by the relevant jurisdictions. The Company makes a determination for each reporting period whether the estimates for sales and other non-income taxes in certain states should be revised. The expense is included in selling, general and administrative expenses in the Company's condensed consolidated statements of operations and the liability is reflected in sales tax payable within other current liabilities in its condensed consolidated balance sheets.</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83Ni9mcmFnOjdhYjU3Y2Q2MDlhYTRmMDc5OTM5MjMyNGNjMDlmNTY3L3RleHRyZWdpb246N2FiNTdjZDYwOWFhNGYwNzk5MzkyMzI0Y2MwOWY1NjdfMTc3Nw_55791ead-bfc0-4f85-8642-c25ca65c9092">INCOME TAXES&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three and nine months ended September 30, 2022, the Company calculated its effective tax rate estimating its annual effective tax rate, as opposed to the three and nine months ended September 30, 2021 whereby the Company calculated its effective tax rate based on year-to-date results. The Company&#x2019;s effective tax rate for the three and nine months ended September 30, 2022 was 28.6% and 28.7%, respectively, including the impact of discrete items, and 28.6% and 29.3%, respectively, excluding discrete items. The Company's effective tax rate for the three and nine months ended September 30, 2021 was 4.9% and 9.1%, respectively, including the impact of discrete items, and 4.9% and 5.9%, respectively, excluding discrete items. The effective tax rate for the three and nine months ended September 30, 2022 was primarily impacted by federal and state taxes. As a result of the Company's valuation allowance on substantially all of its domestic deferred tax assets, the effective tax rate for the three and nine months ended September 30, 2021 was primarily impacted by international taxes and state taxes, while the effective tax rate for the nine months ended September 30, 2021 was also impacted by additional valuation allowance required as a result of the WSG acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of 2021, the Company concluded that it was more likely than not that a benefit from a substantial portion of its United States federal and state deferred tax assets would be realized and released the majority of its valuation allowance. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2021, the Company had an immaterial amount of valuation allowance on its deferred tax assets related to state net operating losses not expected to be realized before expiration. There was no valuation allowance related to state net operating losses as of September 30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 16, 2022, President Biden signed the Inflation Reduction Act (the IRA) into law in the U.S. Among other changes, the IRA introduced an excise tax on certain stock repurchases by certain covered corporations for taxable years beginning after December 31, 2022. Based on its current estimates and pending future guidance to be issued by the Internal Revenue Service, the Company does not believe these provisions will have a material impact on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tax years 2012 through 2021 remain open to examination by certain taxing jurisdictions to which the Company is subject to tax.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83Ni9mcmFnOjdhYjU3Y2Q2MDlhYTRmMDc5OTM5MjMyNGNjMDlmNTY3L3RleHRyZWdpb246N2FiNTdjZDYwOWFhNGYwNzk5MzkyMzI0Y2MwOWY1NjdfMzky_b5e1db9d-8a08-489e-84ae-638b602b9721"
      unitRef="number">0.286</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83Ni9mcmFnOjdhYjU3Y2Q2MDlhYTRmMDc5OTM5MjMyNGNjMDlmNTY3L3RleHRyZWdpb246N2FiNTdjZDYwOWFhNGYwNzk5MzkyMzI0Y2MwOWY1NjdfMzk5_de9ef6e0-5303-4b2b-8c2e-40de668a4fcd"
      unitRef="number">0.287</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <ccrn:EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems
      contextRef="i710725bce0f34e3784365685f226641d_D20220701-20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83Ni9mcmFnOjdhYjU3Y2Q2MDlhYTRmMDc5OTM5MjMyNGNjMDlmNTY3L3RleHRyZWdpb246N2FiNTdjZDYwOWFhNGYwNzk5MzkyMzI0Y2MwOWY1NjdfNDYx_d442ec51-f37b-4353-9dbc-8039ec58d4e0"
      unitRef="number">0.286</ccrn:EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems>
    <ccrn:EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83Ni9mcmFnOjdhYjU3Y2Q2MDlhYTRmMDc5OTM5MjMyNGNjMDlmNTY3L3RleHRyZWdpb246N2FiNTdjZDYwOWFhNGYwNzk5MzkyMzI0Y2MwOWY1NjdfNDY4_d967058a-4aef-4c29-a5f4-2192a6801d72"
      unitRef="number">0.293</ccrn:EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83Ni9mcmFnOjdhYjU3Y2Q2MDlhYTRmMDc5OTM5MjMyNGNjMDlmNTY3L3RleHRyZWdpb246N2FiNTdjZDYwOWFhNGYwNzk5MzkyMzI0Y2MwOWY1NjdfNTk4_bdc8640a-b0a5-4c59-808c-8d3679b49c9b"
      unitRef="number">0.049</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83Ni9mcmFnOjdhYjU3Y2Q2MDlhYTRmMDc5OTM5MjMyNGNjMDlmNTY3L3RleHRyZWdpb246N2FiNTdjZDYwOWFhNGYwNzk5MzkyMzI0Y2MwOWY1NjdfNjA1_89109b97-243d-4631-9c06-7516fd50300a"
      unitRef="number">0.091</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <ccrn:EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems
      contextRef="id786e43d12924467a670b39ccb2288b8_D20210701-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83Ni9mcmFnOjdhYjU3Y2Q2MDlhYTRmMDc5OTM5MjMyNGNjMDlmNTY3L3RleHRyZWdpb246N2FiNTdjZDYwOWFhNGYwNzk5MzkyMzI0Y2MwOWY1NjdfNjY3_3c9538bc-fcbc-4e8a-a136-e91715630ae2"
      unitRef="number">0.049</ccrn:EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems>
    <ccrn:EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems
      contextRef="iaba40e2cc4814837ac6aef0802b1b2d6_D20210101-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83Ni9mcmFnOjdhYjU3Y2Q2MDlhYTRmMDc5OTM5MjMyNGNjMDlmNTY3L3RleHRyZWdpb246N2FiNTdjZDYwOWFhNGYwNzk5MzkyMzI0Y2MwOWY1NjdfNjc0_b090821a-f1e9-4c9c-905e-947d60a68d49"
      unitRef="number">0.059</ccrn:EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i0d13486d3d1b4e47be1e347be955262c_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83Ni9mcmFnOjdhYjU3Y2Q2MDlhYTRmMDc5OTM5MjMyNGNjMDlmNTY3L3RleHRyZWdpb246N2FiNTdjZDYwOWFhNGYwNzk5MzkyMzI0Y2MwOWY1NjdfMjc0ODc3OTA3MzU1NA_e82592ad-6ce5-49f3-b67c-6ce376135728"
      unitRef="usd">0</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83OS9mcmFnOjk2ZGU3ZTMzYmE5ZjQwMTU4MjhjZjIyZjM3ZGYyZGNhL3RleHRyZWdpb246OTZkZTdlMzNiYTlmNDAxNTgyOGNmMjJmMzdkZjJkY2FfMjA2OQ_e977de57-7911-4e4e-b620-c7bf47cb8d7d">RELATED PARTY TRANSACTIONS&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company has entered into an arrangement for digital marketing services provided by a firm that is related to Mr. Clark, the Company's non-executive Chairman of the Board of Directors since April 1, 2022, and the Company's Co-Founder &amp;amp; Chief Executive Officer through March 31, 2022. Mr. Clark is a minority shareholder in the firm's parent company and is a member of the parent company's Board of Directors. Management believes the terms of the arrangement are equivalent to those prevailing in an arm's-length transaction and have been approved by the Company through its related party process. The digital marketing firm manages a limited number of digital publishers covering various Company brands for a monthly management fee. During the three and nine months ended September 30, 2022 and 2021, the Company incurred an immaterial amount in expenses. The Company had immaterial payable balances at September 30, 2022 and December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company provides services to entities which are affiliated with certain members of the Company&#x2019;s Board of Directors. Management believes the services were conducted on terms equivalent to those prevailing in an arm's-length transaction. Revenue related to these transactions was $0.7&#160;million and $1.5 million for the three and nine months ended September 30, 2022, respectively, and an immaterial amount for the three and nine months ended September 30, 2021. Accounts receivable due from these entities was an immaterial amount at September 30, 2022 and December 31, 2021.&lt;/span&gt;&lt;/div&gt;Following the WSG acquisition on June 8, 2021, the Company continued to rent WSG's headquarters. The Chief Executive Officer and Founder of WSG, who is currently a business unit president with the Company, is an agent of the lessor. The lease term for WSG's headquarters expires on December 31, 2024. The Company paid an immaterial amount in rent expense for these premises for the three and nine months ended September 30, 2022 and the three months ended September 30, 2021. The Company had no payable balance at September 30, 2022 and December 31, 2021.</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:RevenueFromRelatedParties
      contextRef="i72783f7b11ce4ca8bd07eb8c76ae894f_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83OS9mcmFnOjk2ZGU3ZTMzYmE5ZjQwMTU4MjhjZjIyZjM3ZGYyZGNhL3RleHRyZWdpb246OTZkZTdlMzNiYTlmNDAxNTgyOGNmMjJmMzdkZjJkY2FfMTI0Nw_5a47ab65-585c-4d5e-9637-af5e76fcc60a"
      unitRef="usd">700000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="ia4db74b0466540ea968402c2e9e28c01_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83OS9mcmFnOjk2ZGU3ZTMzYmE5ZjQwMTU4MjhjZjIyZjM3ZGYyZGNhL3RleHRyZWdpb246OTZkZTdlMzNiYTlmNDAxNTgyOGNmMjJmMzdkZjJkY2FfMTI1NA_a7388ef4-00da-4d6a-b293-c8b4ccb0c519"
      unitRef="usd">1500000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="iee3c22d82f244073ab396a419446f087_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83OS9mcmFnOjk2ZGU3ZTMzYmE5ZjQwMTU4MjhjZjIyZjM3ZGYyZGNhL3RleHRyZWdpb246OTZkZTdlMzNiYTlmNDAxNTgyOGNmMjJmMzdkZjJkY2FfMjc0ODc3OTA3MTg5Mg_5a881990-f000-4e9b-aa92-8d5c89a25944"
      unitRef="usd">0</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="i05804f1d8c774ac48c5ecb8daa790dd0_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV83OS9mcmFnOjk2ZGU3ZTMzYmE5ZjQwMTU4MjhjZjIyZjM3ZGYyZGNhL3RleHRyZWdpb246OTZkZTdlMzNiYTlmNDAxNTgyOGNmMjJmMzdkZjJkY2FfMjc0ODc3OTA3MTg5Mg_efb7c8c2-5921-4bbd-94ec-0e4032b45ce9"
      unitRef="usd">0</us-gaap:RevenueFromRelatedParties>
    <us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV84NS9mcmFnOjMzZjk2MDQ5MTcwYTQ5MjJhNjU4YzEwNmFjMTc3YjFlL3RleHRyZWdpb246MzNmOTYwNDkxNzBhNDkyMmE2NThjMTA2YWMxNzdiMWVfMTE5Mw_e9aed9b4-3cef-4fd6-8594-3892d00aab4e">RECENT ACCOUNTING PRONOUNCEMENTS&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 28, 2021, the FASB issued ASU No. 2021-08, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which requires contract assets and contract liabilities such as deferred revenue acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, Revenue from Contracts with Customers. Generally, this amendment will result in the acquirer recognizing contract assets and contract liabilities at the same amounts recorded by the acquiree. Historically such amounts were recognized by the acquirer at fair value in acquisition accounting. This guidance is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The amendments should be applied prospectively to business combinations occurring on or after the effective date of the amendments. Early adoption is permitted, including adoption in an interim period. The Company is currently in the process of evaluating this standard and expects to adopt this standard in its first quarter of 2023.&lt;/span&gt;</us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV84NS9mcmFnOjMzZjk2MDQ5MTcwYTQ5MjJhNjU4YzEwNmFjMTc3YjFlL3RleHRyZWdpb246MzNmOTYwNDkxNzBhNDkyMmE2NThjMTA2YWMxNzdiMWVfMTIwMg_a3df96b7-59f5-4ed5-aefd-35233863fb74">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 28, 2021, the FASB issued ASU No. 2021-08, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which requires contract assets and contract liabilities such as deferred revenue acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, Revenue from Contracts with Customers. Generally, this amendment will result in the acquirer recognizing contract assets and contract liabilities at the same amounts recorded by the acquiree. Historically such amounts were recognized by the acquirer at fair value in acquisition accounting. This guidance is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The amendments should be applied prospectively to business combinations occurring on or after the effective date of the amendments. Early adoption is permitted, including adoption in an interim period. The Company is currently in the process of evaluating this standard and expects to adopt this standard in its first quarter of 2023.&lt;/span&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNDdkZDFjM2Q1YTQwZmY4ZTA0MGE5NGFlMjMyZDc1L3NlYzo1YjQ3ZGQxYzNkNWE0MGZmOGUwNDBhOTRhZTIzMmQ3NV8xMzgzL2ZyYWc6YTY2NjE5NzU0MTQzNDMzM2IzZjU5OTZmMjZkOWJkOTQvdGV4dHJlZ2lvbjphNjY2MTk3NTQxNDM0MzMzYjNmNTk5NmYyNmQ5YmQ5NF8yNzQ4Nzc5MDcwMzQ4_ffa58c8b-3685-4773-ba84-603bd8d31ee0">SUBSEQUENT EVENTS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 3, 2022, the Company completed the acquisition of substantially all of the assets and certain liabilities of Mint Medical Physician Staffing, LP (Mint) and Lotus Medical Staffing LLC (Lotus). Mint and Lotus place healthcare professionals in locum tenens positions throughout the country. The purchase price of the acquisition was paid for with a proportional combination of cash and shares of the Company's common stock. The acquisition was not significant to the Company's condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt Prepayment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 26, 2022, the Company made an optional prepayment on its term loan, resulting in a prepayment premium and the write-off of debt issuance costs. The prepayment was applied to the remaining balloon payment in 2027.&lt;/span&gt;&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>76
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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MMT#J'H?T*652<1F^DBE?"ZE,>+B5DJFI4EQ451.O5^#UCL.;<!D(7_=" N.
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MB2@[7''F<ZD?@/L+(=3^1/] L:4]_!=02P,$%     @ :%EC574WD25,!P
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M;C_?1%?W^F)QK_]\B;_>+]#M;^CV+OYV=7^C >@4?5]$Z-=?/J%RDTA>HK1
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M$ 'E5 ]JR][PB<UEWX"X_=*][][<X,V!N$'],E U#JHFH-3TY&C!&_:#MZ]
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M'K<#]<M U3BHFH!2TU_&TB(WZD=N?KCMS EJTRJ*<6R]TX:>YFT.*3R)$35
M&G/8G2$2F[S-88;P:&+Q-H?=$=Y&6]Y&_?N\NF_?=C<J*&"C]LXN$D>8V!T-
MU"\#5>.@:@)*3<^/%I[1OJ\5ZY06#MB%PC$R-P;N[+Q]S?$RL7ICJ/D J\-.
M]36S#W&'V00CBLVNYMODIC=E"YPH^8%HFT)2FBFHV@Q4C8&J<5 U :6FI]3!
M2\E Z!:U29.:\5F=$91N=?+)0'UR4#4!I:;'MJ5;]'O2+;]X[^&A,]T"]<M
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MR*5K<UH$V\2KZMP&7'SC8PD]LI,#>%]82*I;B(/-_R['_P)02P,$%     @
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MU&"6)1ZHX44>!D;NW"NXEH:N,&=NZ2,&E0V@^8V49AS8!:;/HN4_4$L#!!0
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M'@P<6H.(#W$BB=?:D4AB<2A^E,J(WV31D'A%TC:&&)TM"#I' 1BU"FXBA+I
MB^2 W;*894\T'@!,&1^]Q+F BJI0?@$U 6\OQ#/UG &CT%<1.%2FD*5N*E\9
M &]&HI(E%*X5LBP!/6Y5'!J8CLXKR#I5^N UEI9- 1>7'M!C<8_PVN]P HX
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MV;+;9E/;,XGK3G-(-Y.TW</.'F@)LMA2I$I2<;)?OX^4K+J[269[$042>'@
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M? W@:.9[43!NP8W!5Y/P_P):T"'6CD:1*PF"EV8B+QK[[+=G?PZ@6^'.2\I
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M0>"35%O1R.>U+3L#;]R6?#0:(6;>V&4\6!OC$ 3^KWIV0 E5B"Q!] >CU4(
M$L(V NZO$S#+5;J"?+):V ,E]1$"<9F[IR[NB9.MXJG6(-%O1_T6@(_/0)5
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M.\LSR)Q!*S ]>T2G9'0"W[%??-LQ6OE>)7-0R_SRR# +P\FSP*\^/Y[81:$
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M?G[]YN/M#^S-WS^_^_2/\S,+R?3^+ U2KKV4Y!$I<_:+*NW:L#=E)K+=_6=
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M:&]\'SR3V8K$C5R)"^4S;7WC2/PUG?G@D!!_[X.<+![LM\A%\MS7,J/3#JK
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M @I@R99QE@M3,E=PQX3%&#<= .:MZ;&YA/<QWG:Q?[%,:75"CY36?E[9O.
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MEO19A(X#:+ZP-FP'7*#_T)K\#5!+ P04    " !H66-5B6,]-(P#  "K!P
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MZ.V;!%S_-/0+MFULQ[EE:>YQ*CE;D@L"<EY9R\,B7'!XG^?_ %!+ P04
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M"TXW'-44"9XCE0(=/,!U+W7;X8EJ<GRP>FF .<-'.M*?\KSDE:!1XY![7(<
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M'/IW+"M1'YP,#!';\$'>DIPU).$+)".XE,(L-9R+ HOM^ $)[E2'&]5GX5[
M.:X.(?(]"/TPW(,7=5\A<GC1"WB3/)>U,%S<PXTL><Y1PQ^33!M%KOES5\(-
M7KP;SU;2L5ZQ'$][5"H:U0/VQF]>!:G_;H_:N%,;[T,?SZDRB[I$D N8E%16
M3.0(5*#P7M:96=0EM GI7=+W@N^6?K<D,NH#]@-EK'1\1&[H,=L24&P$L%8
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M9+N1A)<J2K3=%0@Q7VE[ZO+B5(B/;*'^K[5#1'4=X1%-ID_1_B]G./5A-O>
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M50<:EZ?!+#H^2YR^5_A#XMJ\D,%Y,E?JP2TN%Z=!Z AA@Y5U"((>CWB.3>.
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M#I"O+XM"/!_4 [1;+6?_ E!+ P04    " !H66-5*&_=,X4(  #56P  &0
M 'AL+W=O<FMS:&5E=',O<VAE970S.2YX;6RUG%USXC84AO^*AG8ZNS-IP!]
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M    >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;*U6;6_:,!#^*Z=,FEII;4*
M=F6 Q$NV5EHK!'OY,.V#FQS$6F)GMD/:?S_;"1FT@58;7[!]N>>Y\SW8OG[!
MQ2\9(RIX2!,F!TZL5-9S71G&F!)YSC-D^LN2BY0HO10K5V8"261!:>+ZGG?A
MIH0R9]BWMID8]GFN$LIP)D#F:4K$XQ@37@R<EK,QS.DJ5L;@#OL96>$"U==L
M)O3*K5DBFB*3E#,0N!PXHU8OZ!I_Z_"-8B&WYF!V<L_Y+[.XB0:.9Q+"!$-E
M&(@>UCC!)#%$.HW?%:=3AS3 [?F&_:/=N][+/9$XX<EW&JEXX+QW(,(ER1,U
MY\4U5ONQ"88\D?87BLK7<R#,I>)I!=89I)25(WFHZK %T#S- +\"^$\!G3V
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M/ Y0WV\8DZ\G\>N<[/7=Z']02P,$%     @ :%EC5<'P(XP- P  N@D  !D
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M @_VP*M>O;X#7FI](GB8@X?'P(,B\' //*SYNTNEU/I$\&H.7CT&'A:!5_?
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M91FG).,QS1 CJ[$U=:\BSRD$JL3?,=GQO6M4=.6!TF_%S?5R;#E%BTA"%J)
M8/GQ2.8D20J2;,=_%=2JZRR$^]?/]%!U7G;F 7,RI\G7>"DV8^O"0DNRPMM$
MW-'=[Z3J4+_@+6C"U5^TJ\HZ%EILN:!I)98M2..L_,3?JQ>Q)W![1P1>)?!.
M%70K0?=40:\2]$X5]"M!_Z6@?T0PJ 2#4VL85H*A"E;Y=E5H?"SP9,3H#K&B
MM*05%RJ^2BTC$F>%%>\%D]_&4B<F?C#[C#X@S_%<])FP%-U0G*$Y(\M8H.F:
M$2)])] GS!@N3(/>^D3@..'OI*H1?$!?[GWT]LV[D2UDJPJVO:A:$)8M\(ZT
MH(L^TDQL. JR)5FV];;L3=TE[[E+,\\(_&.;=9#7?5]TRM.T9VZ6^V3105U7
MR5V-W#?+[TDNY<Y1>7!"XYV+H_+P!'E5NZ[OD5G^B3YVD*NMO16*;NVNKN+U
MCO!>L96F@3,CL)B8KWB.%V1LR9F7$_9(K,FOO[@#YS==I"%A/B0L@(2%D+ (
M"-;R2Z_V2T_1NT?'WH- UQD7;*NFG7]N9 %T+4C*_]69I0=I%DB8#PD+(&$A
M)"P"@K7,TJ_-TC=.+K?X29E$[L?DYD,:1]:1E\]T7BEA P4K-FB/D[Y3_HSL
MQWT?&&L]UP>0L  2%I[Z/B*@6ELQ'M0Q'AACK"8$(1<0742-TG-'/R3,AX0%
MYC<T0$\$,ZZ+,&0K(B!8RP7#V@5#8Q]#"48XI5O]R#:*S_4!),R'A 7#@P'K
M.MH1&T)6&P'!6H&_J -_80S\7UO,Y.A/GE L-P4X2=2$?]P)1MJY3K@X>-\]
MS<OV#XMU-<4"R*:%D+ ("-8*\&4=X$OS&EXOV<7JG<;;%.4X7NIB>WEDO7JQ
M>AOK.W?\0L("2%@("8N 8"T'N$Z3@7",'OC*8D$07:WD;[F1BSG?XDS.^0O*
MA6YIFYF1YXYT4)H/2@M :6%%:RTBNEDM@JJV[8F]K)3[,XD#]#^ZN9[]>:>U
MAI%\MC4@:3XH+0"EA:"T"(K6]H_7^,<#3214."C30-)\4%H 2@M!:1$4K6V:
M)EGIFK.5UYG<:Q(N4(K9.LY03MA"F@>OB=8RH)E*4)H/2@LJVN7>HN%TG/ZP
M_^+?#M!:(RA:VPQ-)M(UYJX.S+!**&6O60(T'PE*\T%I045[80GGT!*@V48H
M6ML23;[1-2<<7]F4O)<+SH*I2YPTY;1&@<SDS4%I/B@M *6%H+0(BM:V4Y/:
M= >P>Q30?"<HS0>E!:"T$)060=':IFDRH>Y/I4+-ZK,] IH,!:4%H+00E!:Y
MAZG:8?]%IK8=_R8AZIHSHJ^N0=.UO%YC0=!4N:1(JDR3!-U2SN.'A)2+%.9$
MGU<!S:""TGQ06@!*"T%I$12M[;$F)^M>PBY,D,G(.2C-!Z4%H+00E!9!T=IG
MKIHLKF?.XKZR,)G5YWH$E.:#T@)06@A*BSQ-^M?5KTSVWIG"E+"U.B[*T:((
M<'F\L'Y:'TF=JH.8=E.\/,_Z4?T'S5%"5E+J=(9RW\W*(Z+EC:"Y.J'X0(6@
MJ;K<$+PDK"@@OU]1*IYOB@KJ@[J3'U!+ P04    " !H66-5Z6\UAKD#  !-
M$P  &0   'AL+W=O<FMS:&5E=',O<VAE970U,"YX;6RU6.&/VC8<_5>LK)I:
MJ7>)$PAP Z0#5G52*YW*==,T[8-)?H#5)&:V.5II?_SL)"30,_8:<5\@3OR>
MW_O%\;,\/C#^16P!)/J:9X68>%LI=W>^+Y(MY$3<LAT4ZLF:\9Q(U>0;7^PX
MD+0$Y9D?!D'LYX06WG1<WGO@TS';RXP6\,"1V.<YX=]FD+'#Q,/>\<8GNME*
M?<.?CG=D TN0GW</7+7\AB6E.12"L@)Q6$^\>WPW#TM V>-W"@=Q<HVTE15C
M7W3CMW3B!5H19)!(34'4WQ/,(<LTD]+Q3TWJ-6-JX.GUD?U=:5Z961$!<Y;]
M05.YG7A##Z6P)OM,?F*']U ;ZFN^A&6B_$6'JF\<>RC9"\GR&JP4Y+2H_LG7
MNA G -R[  AK0/A_ 5$-B$JCE;+2UH)(,AUS=D!<]U9L^J*L38E6;FBA7^-2
M<O64*IR<+GZ=/:(;])'(/:>2@D!LC1:PDNCU B2AF7BC'G]>+M#K5V_0*T0+
M]+AE>T&*5(Q]J11H'C^I1YM5HX471EO"[A9%P5L4!F%H@,_M\ 4D"HY+.#Z'
M^\IW8SYLS(<E7W2![P,K-C<2>%XZ?HO>49&0#/T)A!\K\@W]=;\2DJOI]K?)
M;S5 SSR _@;OQ(XD,/'41R: /X$W_?DG' >_F-Q?B>RL%E%3B\C&/GUD4EE/
M51U,-BML7&+URO TQ5$4#/IC_^G4@*';L#^*ADVW,VF]1EK/+DV_H0^,%.C?
M\LVC]L:<0THENM]P +6X&+5;R7_T%5V)[*P._:8._9>>KOUKUN)*9&>UB)M:
MQ-8Y<6$!F56H_LD,#+Z;HU;>CJH'C>J!2W5D4CUPJK;R=E0];%0/7:I[)M5#
MIVHK;T?5HT;UR*6Z;U(]<JJV\G94C8,VD .7[MB8K(%3N)VYJ_*3K02VK]-;
M4#O)M5JAC/KQ,_TXC(;/,L0^2%<3[98 6U/6D8,UV&W"T&_0BW!H3D+<IC2V
MQ_02"LHX6D*R5]&'[H4 >3-3^]CTF)".'D97UC%_-!:NQ79>H7:S@'LOG9+X
MJEN&:[&=UZ/=-&!K#E],RAIF74]>(N%Q&_'8F?'&M,3ND+<S=U7>QCQVYKPQ
M,;$[Z.W,796W48^=66],3>P.>SMS5^5MW&-GWIMSTQWX=N:.RL,V\4-[XMMS
M,WR>^Z,P^-Z"?8BN%MKH#QW1;TW-&AP[+#AZ5=+\D[,.?=#TD? -+03*8*U@
MP>U %8I79S=50[)=>?RQ8E*RO+S< DF!ZP[J^9HQ>6SH$Y7F!&WZ'U!+ P04
M    " !H66-5]*[NC+4&   ?.P  &0   'AL+W=O<FMS:&5E=',O<VAE970U
M,2YX;6RUFUUSXC88A?^*AG8ZNS/98)L R39A)L$?W<ZFNPW=]J+3"V$$>-:V
MJ"R29:8_OI(Q-B9&P>U)+@+&>A_)Z*!7.K:NG[CXFBT9D^1;$J?936<IY>I]
MMYN%2Y;0[)RO6*K.S+E(J%2'8M'-5H+161Z4Q%W'L@;=A$9I9W2=?_99C*[Y
M6L91RCX+DJV3A(K-'8OYTTW'[NP^>(@62ZD_Z(ZN5W3!)DQ^67T6ZJA;4F91
MPM(LXBD1;'[3N;7?!\Y0!^0E?H_84[;WGNA+F7+^51]\F-UT+-TB%K-0:@15
M+X]LS.)8DU0[_BZ@G;).';C_?D?W\XM7%S.E&1OS^(]H)I<WG<L.F;$Y7<?R
M@3_]Q(H+ZFM>R.,L_T^>MF6'PPX)UYGD21&L6I!$Z?:5?BN^B+T ^^)(@%,$
M.*<&](J WF% _TC 11%P<6H-_2*@?VK H @8G!HP+ +RWN]NO]V\:UPJZ>A:
M\"<B=&E%TV_R_LVC58]$J9;B1 IU-E)Q<N1Z=[^1=\2Q["ORD=.4W"X$8TIK
MDKQQF:11G+U5Y[],7/+F^[?77:GJU)'=L."[6[YSA']%[GDJEQGQTAF;U>.[
MJJUE@YU=@^\<(_">BG/BV&>JR8[3T)ZQ.?Q3*%5X_RR_XJ;+,8=/V.J<]*RC
MM7OF\%_XXSFQ+_-PNR'</^':K>/A@3G\YW5:-MXR=$6OU$XOY_6.\#ZJ8\+G
M9"S8+)+$IV$41W)#_LQ/?) LR?YJ:.7=EGK13-5C[_ML14-VTU&#:\;$(^N,
M?OC.'E@_-G4W$N8B81X2YB-A 0A6$\U%*9H+$WUTF_"U&ER4;"(U(DPEFZ4L
MR\B*B222ZHC,!4\(ETNF$B9?BY!E31HR5M)60TB8BX1Y6]@@A^E9Q>/('O:M
M_.^Z^[@O$&2U 0A6$TB_%$C?*) )2R,NR(2%:S6ND-LL8_+=G9IMS/($U20&
M(["M&) P%PGSD# ?"0M L)I>!J5>!J^2A09(T2!A+A+F(6$^$A: 8#71#$O1
M#(V#S$XTX58T4F6?)HV8(7VR850TI:?Q?PUTC8%M^QX)\Y&P  2K]?UEV?>7
MQF__GGZ+DG5"IERHR"A=D)"JRM28T22!RV<9N&=931EX_+RD[326=(WM:]O)
M2)C?< W]QFL(&DKV#DO6NN>J[)XK8_>H5!]E9&NL$)Z21RHB.HT9$52R,T)G
MZ@<;\93&NQ]O491F&0\CJJ>03Y%<DLDG_Z&I0[>U7^TUW#JW+/N@,XUM;#N@
M(V$>$N8C80$(5E.-;55&AF763?ESUM;4F5Y1A"R5=)$/]%1/(QM7$F9LVXE
M0=,O>_JZ[!^, -!*/2C-A]("%*VNBCU[RVZA"D(?:133:3Y#;!2#D=9:#$B:
M6]!.2$4>M&(?2@M0M+H@G$H03HN9WYG*_4)LM#YH;DPTBL)(;"T*),TM:/T]
M45PYC9) 5NM#:0&*5I=$96/:1L-K])%)M0#(]M8#?"TS2=.9TD6C(* .)I3F
M%K1]0>PLHT-%0 U**"U T>J*J#Q*VVQ25EGCQ80!-2*A--=^[AXZPUZO40O(
MBGTH+4#1ZEJH[$C;[$?^NJ9"#0_QAH0\22*9WQN;,Z;7)G*IIQ1,Z$GF3 EE
M0];I6CN5*R[R.ZW5)+11/%#C$DIS"YIM'RR4>L/^H7:@OB24%J!H=>U4UJ1M
M-+%>\K+)/T=7J69P:VE _4DHS8/2?"@M0-'J\JE,2GOX*M:VC?3JQE":"Z5Y
M4)H/I04H6ET\E<MIFVW.#ZG*6BR3)*%B$;V8BI VXAA*<PO:@65G#P[S$-0)
MA=("%*VNA<I2M<V>ZLMY2!^0!RJ;Q8&T"<=0F@NE>5":#Z4%*%K]L:O*7W6L
M5TE&#M1?A=)<*,V#TGPH+4#1ZN*I;%C';,.V2T9F6&O)0%W8@G9X_^AP402M
MU(?2 A2MKH7*@77,#NP)BR)MO>@P,EE/XT@MNAM5 K5EH3072O.@-!]*"U"T
MNI@J[]9YG6=0':B%"Z6Y4)H'I?E06H"BU<53V;R.V>9M]R2(&=9:,L_-6;OQ
MR4X76J\'I?E06H"BU>50.;W._WKR5"<F?5-HNB&[.T:?RH''F*B@-B^4YD)I
M'I3F0VD!BE875V4%.Z_SF*H#-8*A-!=*\Z T'TH+4+2Z>"HCV#$_,-HR44'M
MWX)6>^SD2**"6KM0F@^E!2C:5@[=O>U["1.+?&=F1D+]/,IV)U_Y:;G[\S;?
M\]BMBF^WCM[GR^N,Q&RN0JWSH1KTQ'8WYO9 \E6^&7#*I>1)_G;)Z(P)74"=
MGW,N=P>Z@G)/[.A?4$L#!!0    ( &A98U7S:X];8@(  *L%   9    >&PO
M=V]R:W-H965T<R]S:&5E=#4R+GAM;*U4WV_:,!#^5ZRLFEJI(R$PREB(Q(]6
MJS0T5-3M8=J#20YBU;$SVT#WW^]LAXQV@/:P%^*S[_ONON/NDIU43[H ,.2Y
MY$(/@\*8:A"&.BN@I+HE*Q#XLI*JI 9-M0YUI8#F#E3R,(ZB7EA2)H(T<7=S
ME29R8S@3,%=$;\J2JE]CX'(W#-K!_N*!K0MC+\(TJ>@:%F >J[E"*VQ8<E:"
MT$P*HF U#$;MP:1K_9W#5P8[?7 F5LE2RB=KW.?#(+() 8?,6 :*GRU,@'-+
MA&G\K#F#)J0%'I[W['=..VI94@T3R;^QW!3#H!^0'%9TP\V#W'V"6L][RY=)
MKMTOV7G?7B\@V48;6=9@S*!DPG_I<UV' P#R' ?$-2!^#>B> '1J0,<)]9DY
M65-J:)HHN2/*>B.;/;C:.#2J8<+^BPNC\)4ASJ2?;T>+VP5Y1T9YSFQA*2?W
MPG>'+?/E% QE7%^AR^-B2BXOKL@%88+,&.?HH)/08!J6+,SJD&,?,CX1\@.9
M26$*36Y%#OE+?(CI-QKBO89Q?)9P 56+=*)K$D=Q?"2?R;_#VV?2Z30E[3B^
MSJF2 K:5)M]'2VT4MNF/8R7R%-WC%'9T![JB&0P#G$T-:@M!^O9-NQ=]/*;O
M/Y&]4-MMU';/L:=?*E#8*F)-N-5]35A94:9PT WA4A_M#\_8=XQVS6S3N-5/
MPNVAIK]]VJV;QL>G&A[T?0EJ[=:!)IG<"./;I[EM-L[(#=JK^S%N(K\X_M#X
M-3:C:LV$1G$KI(Q:-SC'RJ\&;QA9N>E:2H.SZHX%;E-0U@'?5U*:O6$#-/LY
M_0U02P,$%     @ :%EC51*XT _E @  ,0@  !D   !X;"]W;W)K<VAE971S
M+W-H965T-3,N>&ULK59=;]HP%/TK5E9-K31(2,)7!Y%:Z+1*FU8UZ_HP[<$D
M%V+5L3/;0/OO=YW0#&A K;878COW',ZY]]K.:"W5@\X #'G,N=!C)S.F.'==
MG6204]V6!0A\,Y<JIP:G:N'J0@%-2U#.7=_S>FY.F7"B4;EVHZ*17!K.!-PH
MHI=Y3M73)7"Y'CL=YWGAEBTR8Q?<:%30!<1@[HH;A3.W9DE9#D(S*8B"^=BY
MZ)Q/^C:^#/C!8*VWQL0ZF4GY8"?7Z=CQK"#@D!C+0/&Q@@EP;HE0QN\-IU/_
MI05NCY_9/Y7>T<N,:IA(?L]2DXV=@4-2F-,E-[=R_1DV?KJ6+Y%<E[]DO8GU
M')(LM9'Y!HP*<B:J)WW<Y&$+X'</ /P-P'\M(-@ @M)HI:RT-:6&1B,EUT39
M:&2S@S(W)1K=,&&K&!N%;QGB3/3EZB*^BDF+Q,NBX(#U,9232\JI2(#$92-=
MBZI;;-I/IV HX_H,(7?QE)R>G)$3P@3YGLFEIB+5(]>@+LON)AL-EY4&_X"&
M&(HV";P/Q/=\OP$^.0Z?0H+P3@GO[,)=S$:=$K].B5_R!8=2 M@6FOR\F&FC
ML,U^-3FJ*,)F"KOUSG5!$Q@[N+<TJ!4XT?MWG9[WL<G??R+;<1O4;H-C[-&W
M A265BP(M[Z)LGW?DO/6$B=4:S"-%:U(>R6I/2E64>"'PY&[VO;U,J@?#@9U
MT([>L-8;ODDO9W3&.#,,2];"':,4MG"3XHJVNR4F# ?[BAN"O*'7K+A;*^[^
M@V(A1>N(ZNZ+%';#8;"G^F50QQMT@V;9O5IV[ZCL^_($A)30%>I?8&> O17^
M^C"@\B;)QVE]\@14:1*27 J3:>*')*5/34TV.<X4O(IIQWN_]MY_F_>4Z40N
MA2%826@R7?$-MTK@M;U>T-FKU(&PX5ZIW*T#W5ZF7ZE:,*$Q\7,$>NT^5EQ5
M%U0U,;(HS_B9-'ACE,,,[W10-@#?SZ4TSQ-[;=1?"=$?4$L#!!0    ( &A9
M8U6-=O/O,0,  %H+   9    >&PO=V]R:W-H965T<R]S:&5E=#4T+GAM;*V6
M76^;,!B%_XK%JJF3EO)-H$N0VJ33)K5JU+3;Q;0+)W$2JV SVR3MOY]M*$V
MT"[:3<#@<_P<.\;O8$O9(U\C),!3FA ^--9"9.>FR>=KE$)^1C-$Y)LE92D4
MLLE6)L\8@@LM2A/3L:S 3"$F1CS0SR8L'M!<))B@"0,\3U/(GB]10K=#PS9>
M'MSAU5JH!V8\R. *39%XR"9,MLS*98%31#BF!#"T'!H7]OG(U@+=XP=&6[YS
M#U24&:6/JO%],30L1802-!?* LK+!HU0DB@GR?&G-#6J,95P]_[%_:L.+\/,
M($<CFOS$"[$>&J$!%F@)\T3<T>TW5 ;RE=^<)ES_@FW1-X@,,,^YH&DIE@0I
M)L45/I43L2.PO0,"IQ0X[Q6XI<#500LR'6L,!8P'C&X!4[VEF[K1<Z/5,@TF
M:AFG@LFW6.I$?'UU,;V:@AZXS1"# I,5N$9R6L -%#G#XAF<CI& ..&?9*>'
MZ1B<GGP")P 3<+^F.8=DP0>FD"3*SYR7HUX6HSH'1IVB[ RXUF?@6([3(A]U
MR\=H+N6VEMO[<E/FKR;!J2;!T7[NH4E0B3GX=3'C@LD_UN^V1(6%UVZA=MLY
MS^ <#0VYG3AB&V3$'S_8@?6E+=]_,MM+ZU9IW2[W^,"<7Q:J0*O4[M_$H>\-
MS,TN=Z?SD=Q>Q>V]Q>VV<1<J?X?;MUV_!MYI?22X7X'[;X%[;>!^ ]RUO'X-
MO-/Z2/"@ @_> O?;P(,&N!V&00V\T_I(\'X%WN\$OZ<")NISB=,\!8G^H&7P
M61X_HO5KU6\&LB*U2_82=8YY9**P2A1V)KI&G)\#F-*<"$"7M4SR0-5C$OT!
MQT0@V1)M2<-&TE[D6;6@G2A'!HVJH%%GT$F1 VQ@DB.5=)G+@PC]PV)&C8A1
M%-;7LA/BR(BV]7KH6N]835H=N46H!,,93K# \BSJR<.?,1FQ]7"UFJOH>6%4
MRUAV"_:Z6='K:N_3[Y0,=B?];2<WH:37Q6XWH'PO<NOHS5ZV%?IN#=W<*7Q4
MU7D#V0H3+KF64F>=]>44L:*0*QJ"9KH6FE$A*RM]NY;%+V*J@WR_I%2\-%1Y
M5973\5]02P,$%     @ :%EC5<Y<%+B# P  90P  !D   !X;"]W;W)K<VAE
M971S+W-H965T-34N>&ULK5?;;MLX$/T50BV*%MA$5\M*:@M(+!==(,4&];9]
M*/I 2[1%5")5DHJS?[]#2=$Z$J--6[_8$GWF#,\97L:+ Q??94Z(0O=EP>32
MRI6J+FU;ICDIL3SG%6'PRXZ+$BMX%7M;5H+@K DJ"]MSG- N,656O&C&;D6\
MX+4J*".W LFZ++'XYYH4_+"T7.MAX"/=YTH/V/&BPGNR(>I3=2O@S>Y9,EH2
M)BEG2)#=TKIR+]>1QC> SY0<Y-$STDJVG'_7+W]F2\O1$R(%295FP/!U1U:D
M*#013.-'QVGU*77@\?,#^[M&.VC98DE6O/A",Y4OK<A"&=GANE ?^>$]Z?3,
M-%_*"]E\HD.'=2R4UE+QL@N&&924M=_XOO/A* !XS %>%^ - X(G OPNP']N
MAJ +")Z;8=8%--+M5GMC7((5CA>"'Y#0:&#3#XW[333X19E>)QLEX%<*<2J^
M65]MUAMTAFX(V(U67"J)7B=$85K(-S#^:9.@UR_?H)>(,O1WSFN)6287MH+D
MFL).NT37;2+OB40^^L"9RB5:LXQDAOAD.OYB(MX&T;UR[T'YM3=)N"'5.?*=
M/Y#G>)YA/JOGA[LF.;^7??W+V1^9X??+P&_X_*>6@:Z^1%^OME()V+S?3 5N
M*0(SA3[0+F6%4[*TX,221-P1*W[UP@V=MR9W3TF6G))L?2*R1W4(^CH$4^SQ
M"LL<59AF"*X A$M>,]B/E*5%#:M>;T&5$U1"M6I!X+A6B.\07!H"*\KVJ&@V
M<4'QEA9446+<IY,S^-DRGI(L:<G"ADQ?<'=Q$ 3APKX[+H\!%%YX/>B1[;/>
M]MFD[<WU>,9W9S78AZ4D8#I.?]14@.DU'#AB:++)V,D</VOL*<F2EFQVY-GL
M8F#K&.(Z462V->QM#2=M_6NP,,D]M#=F[\)156<7@\JOQI@HB!YCDG DPW,"
M?Z#5 )H[CEGKO-<ZG]2ZR;E09XJ(\O_%SL=>SX>37!E CC\ )6-0X'H#3]9C
MD#?S?+/<J)<;3<K]C 6<,@7L%I8A#H>2Z&2GNH,PB8Y&U8.[:SX0/08%[F"E
M)F.,&\Z#@683R!\N9_NH;RJ)V#<-JP0)<.JV=V<_VO?$5TTK.!B_=B]7KF$\
M@1ZZ;7G_HV\;\ ]8["F38-H.4CGG<RB/:)O:]D7QJNG:MEQ!#]@\YO _@ @-
M@-]WG*N'%YV@_V<1_PM02P,$%     @ :%EC5:8=F;C2 @  =0D  !D   !X
M;"]W;W)K<VAE971S+W-H965T-38N>&ULS59=;]HP%/TK5UDUM5+7?/'1=A")
M\J%5@JJ"TCU,>S#A E8=.[,=:/_][)"FT$+53CSLA=C./<?WG)S@-%9"/J@%
MHH;'A''5=!9:IY>NJ^(%)D2=B12YN3,3,B':3.7<5:E$,LU!"7,#SZNY":'<
MB1KYVJV,&B+3C'*\E:"R)"'RZ0J96#4=WWE>&-+Y0ML%-VJD9(XCU./T5IJ9
M6[),:8)<4<%!XJSIM/S+=MW6YP7W%%=J8PQ6R42(!SNYGC8=SS:$#&-M&8BY
M++&-C%DBT\:?@M,IM[3 S?$S>R_7;K1,B,*V8#_I5"^:SKD#4YR1C.FA6/W
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MDLL)TQOE> $SX'?Y-14CLZ)$<0H9BTF&*,S'QH4]#/K27AG<Q[!A>]=(1O)
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M4GRC )4&XOZ<$+X;2 ?55X_W$U!+ P04    " !H66-5:S4;*]T"  !U"0
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M$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:<Z10J[4+!XUA]) 1-MC0[!:+#Y
M+AEFM[UD%J=SI%>(7->=I3W;+T]!;X"O.DQQ0FE(2S,.\,W2?S+W\PPU1>5*
M(Y5;&GC3Y?YVX$G1H2)8%II%R=.B':5_'<?VD-/IKV,BM'I;Z/EQ:%0*CMQC
M)8QQ8K3^-8+)#^Q^ %!+ P04    " !H66-52A8Y5D %  !F*0  #P   'AL
M+W=O<FMB;V]K+GAM;,6:6V_;-A2 _PKAEVU ,]NZM0GJ HS,.$)M*9/D;-W+
MH-BT0U07@Z*3M;]^E!RG5*,<[.7$3[K+GX[)\QV1^OA8R:]W5?65_%OD93T9
MW"NUNQ@.Z]4]+[+Z]VK'2WUD4\DB4WI3;H?U3O)L7=]SKHI\:(U&WK#(1#GX
M]/%XKQLY-#<JQ5=*5*7>V>RX%?RQ_G&\V20/HA9W(A?JVV30KN=\0 I1BD)\
MY^O)8#0@]7WU>%U)\;TJ598G*UGE^60P/ARXY5*)U8O=20.99G=UNT=E=W&F
M028#;Z1ON!&R5NT9[?TSS?C ]<F'K;VJKD2NN)QFBL]DM=^)<MO<1C_%T'B,
M-@['Y2&(%_+_A+':;,2*3ZO5ON"E.L11\KP!+.M[L:L'I,P*/AGXU0.7S?/H
M'PC6AV=3&LJ(E+P0^H ,UBT>(DH43EF8L"G1:TDT#Z8TU1N7=$Y#GQ$#T@(@
MK1-"_F,9D#8 :9\$,DGU8L%" ](!()T30G8BZ0*0[BDA;0/2 R ]7,@HGM$P
M^)NF0102&C:M,0D2$EV1FY@ES(!\#T"^QX5,EHL%C;\T5$DP"X.KP*=A2JCO
M1\LP#0S(#P#D!US(F-VR<,E(S/Q(,S8!-<#. ;!S7##J_[$,DA8H,;/U"$K7
M(^R^L=#MZUIWC^"6D2#4VV9;&X,J078)HW$8A+.$W+"8)-<T[I!!_A@C"V06
M1=,_@_G\'4EC.F4DI N6O&N[;91>=S A@XR1%3)EEZG) HEBC&R*.:,)ZS1[
MR AC9"5<T2 FMW2NT\1"@RWC1JEI!P]RP1A9!DD:^9^OH_F4Q<DOA.FTD7XQ
MV2 %C+$=P&9-K(B6*#69H(P_1D[YVNNISA0L](-N&X.R_1@YW1^2*4GI7QTF
M"TKW%G*ZC]F\K7UN:)Q^:9)7F%#_9R%94-*WD).^MC8S2HIPINN?*-3K?MM%
M34SP#0+9 ,GR,M']LD%MRHU.ZK"@G&\AYWRP1.M4Y!:D PM9!S"F69-;D"<L
M9$_TU)+DUS33$/5O)B,D"PM9%F99V0L'V<)"ML7+&JX7$9*'A2P/L)CK]AA(
M)Q:R3IIBKB]V-N03&]DGAZJN%PN2B(TLD5?*NR.GB0E)Q,:62$^9UQM+<!@*
M6RA&O=<+!VG$/JE&'!,3THB-K!$8TS4Q(9/8V*\=(*9G8D).L9&=TBOE*5>9
MR+LM$[**C6R5CI7/"%VO17-.EI.@U#<T,2&KV&\X)J4Q8[ZJMF4SHT*"M;[2
M'&6&/..<8)BJ]S]W(.TX;SY@I4/J5\6N*O6%IG8<2#L.LG9Z,6FIQ-E:Y/O.
M?PZ)QT$6#UR7F:\(#C@#@JP@&--4D ,IR$%6$(QI*LB!%.0@*PC&-!7D0 IR
MD!74%N-G9%Z5VS/%94&F_$[U)R1(0@ZRA)XPK9$U)FF#.:^RDOB2:QD1NC4Q
M(0DY;_%J<T86F=I+;4E>DVIC1-2<180DY")+Z#F:X_-#(.E6<MY<U'*:F)"%
M7&0+/;V3O:PYBO9<$Q.RD(MLH6?,9+_;Y6T8->AEEF?EBA-S/,V%+.0B6^@9
M,]IQJ0^76S+G6<V?6JN)"5G(?9/IE28EM7!^5:NZ-Q^YX$3\::9=-#:KE2A,
M3$A"+K*$7L<,,RD[^0B2D(LLH=<Q?8WYS<2$).0B2ZAWE.-'=C(Q(0FYR!)Z
M!3/FM9)B969W#Y*0ARRA[G!,3P?W(/=XR.XQY[SZZ2#E>,C*>7WVZV>!>Y!R
MO%8YP^-W?6N^$25?A_HG:KU_E>6K&TF:Q>$[!<=MIB$W^SSW];ZHU*7#^OB9
MX/$3QT__ 5!+ P04    " !H66-5)V75I0P"  "$)0  &@   'AL+U]R96QS
M+W=O<FMB;V]K+GAM;"YR96QSS=D[;MM %(7AK0A<@$?W-;8#RU4:MX$W0,BC
M!RR)!(=![-U'D OI$"G2&#P5,21X^1?$!V+X]*L<VG'?G>INW]?%Q_%PJJMF
M-X[]CY3J>E>.;;WK^G(Z7]ETP[$=S\MAF_IV_=YN2]+E,J?A=D;S_'0[<_'Z
MV9?_F=AM-OMU^=FM?Q_+:?S'X/2G&][KKI2Q6;RVP[:,JR9]'*ZG:[H<Y.X\
MN5F\O*V:X>5-FC1WD$*0SA]D$&3S!SD$^?Q! 4$Q?U"&H#Q_T#T$W<\?] !!
M#_,'/4+0X_Q!LD09EP1)$ZP)M!;D6@B\%@1;",06)%L(S!9$6PC4%F1;"-P6
MA%L(Y!:D6PCL%L1;"/16U%L)]%;46PGTULG'-H'>BGHK@=Z*>BN!WHIZ*X'>
MBGHK@=Z*>BN!WHIZ*X'>BGHK@=Z&>AN!WH9Z&X'>AGH;@=XVV2PAT-M0;R/0
MVU!O(]#;4&\CT-M0;R/0VU!O(]#;4&\CT-M1;R?0VU%O)]#;46\GT-M1;R?0
MVR>;W01Z.^KM!'H[ZNT$>COJ[01Z.^KM!'H[ZNT$>@?J'01Z!^H=!'H'ZAT$
M>@?J'01Z!^H=!'K'Y&<E@=Z!>@>!WH%Z!X'>@7H'@=Z!>@>!WAGUS@1Z9]0[
M$^B=4>],H'=&O?-WZEW'ST.IUYZO-3[_.ZD>S_>6Z^,ORZ^3DU?E@G.ZK:C/
M?P%02P,$%     @ :%EC5>[5[1CF 0  ]20  !,   !;0V]N=&5N=%]4>7!E
M<UTN>&ULS=I=3\(P% ;@OT)V:UCIU_R(<*/>JA?^@;H=9&%;F[8@_'N[ 28:
M)1I,?&]8H.UYSWJ2YXKKIZVC,-JT31>FV2)&=\58*!?4FI!;1UU:F5O?FIB^
M^A?F3+DT+\3$9%*PTG:1NCB.?8UL=GU+<[-JXNANDWX.M>VFF:<F9*.;W<8^
M:YH9YYJZ-#&MLW57?4H9[Q/R='+8$Q:U"V=I0\:^3.A7O@_8GWM8D_=U1:-'
MX^.]:=,NMFE8B-N&0GZ\Q!<]VOF\+JFRY:I-1_+@/)DJ+(ABV^2[HF?'DV.Z
M8=I]\I/SAS+' M/.1V]=2!/S]/NXPTCZTV.7"I&/]?%7?$],I4]^/^JG75'U
MP^QTO:_6+X=Y!#8\3K_CCS-^K__+/@1('Q*D#P72AP;IHP#IXQRDCPN0/BY!
M^N 3E$901.4HI'(44SD*JAQ%58["*D=QE:/ RE%D%2BR"A19!8JL D56@2*K
M0)%5H,@J4&05*+(*%%DEBJP215:)(JM$D56BR"I19)4HLDH4626*K!)%5H4B
MJT*15:'(JE!D52BR*A19%8JL"D56A2*K0I%5H\BJ4635*+)J%%DUBJP:15:-
M(JM&D56CR*I19"U09"U09"U09"W^4]9G:Y=_'#\\\];4W2&?#?]VFKT!4$L!
M A0#%     @ :%EC50=!36*!    L0   !               ( !     &1O
M8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " !H66-5I:;_5.T    K @  $0
M            @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " !H
M66-5F5R<(Q &  "<)P  $P              @ '+ 0  >&PO=&AE;64O=&AE
M;64Q+GAM;%!+ 0(4 Q0    ( &A98U45M3[ZY04  -X>   8
M  " @0P(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " !H
M66-5=3>1)4P'   )(   &               @($G#@  >&PO=V]R:W-H965T
M<R]S:&5E=#(N>&UL4$L! A0#%     @ :%EC51RU,.[/ @  MP8  !@
M         ("!J14  'AL+W=O<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0
M   ( &A98U4U]$N/P@<  ,<D   8              " @:X8  !X;"]W;W)K
M<VAE971S+W-H965T-"YX;6Q02P$"% ,4    " !H66-5H(>.DHL*  "C8@
M&               @(&F(   >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L!
M A0#%     @ :%EC55AGNJ6T!P  [2   !@              ("!9RL  'AL
M+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    ( &A98U7TA^QC-@4
M ,<,   8              " @5$S  !X;"]W;W)K<VAE971S+W-H965T-RYX
M;6Q02P$"% ,4    " !H66-5THP!4>$+  "F'@  &               @(&]
M.   >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @ :%EC51UN
M,12V P  (@D  !@              ("!U$0  'AL+W=O<FMS:&5E=',O<VAE
M970Y+GAM;%!+ 0(4 Q0    ( &A98U4("24;H <  -\3   9
M  " @<!(  !X;"]W;W)K<VAE971S+W-H965T,3 N>&UL4$L! A0#%     @
M:%EC50)[GY5S P  Z0<  !D              ("!EU   'AL+W=O<FMS:&5E
M=',O<VAE970Q,2YX;6Q02P$"% ,4    " !H66-5SGM$*]$#  "@"0  &0
M            @(%!5   >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4
M Q0    ( &A98U7,E3]G(@@  'D4   9              " @4E8  !X;"]W
M;W)K<VAE971S+W-H965T,3,N>&UL4$L! A0#%     @ :%EC5>@"9$9Z#P
MDB\  !D              ("!HF   'AL+W=O<FMS:&5E=',O<VAE970Q-"YX
M;6Q02P$"% ,4    " !H66-5/:5F)@@)  #Y%P  &0              @(%3
M<   >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    ( &A98U6#
MY9O.;0H   0>   9              " @9)Y  !X;"]W;W)K<VAE971S+W-H
M965T,38N>&UL4$L! A0#%     @ :%EC5:F^;&)="0  3AD  !D
M     ("!-H0  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4
M" !H66-589UM/H('  "*$0  &0              @('*C0  >&PO=V]R:W-H
M965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( &A98U7W0#]<^ 0  "0+   9
M              " @8.5  !X;"]W;W)K<VAE971S+W-H965T,3DN>&UL4$L!
M A0#%     @ :%EC5=%;@CYP!0  .0X  !D              ("!LIH  'AL
M+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4    " !H66-5IE4O5VT$
M  #!"@  &0              @(%9H   >&PO=V]R:W-H965T<R]S:&5E=#(Q
M+GAM;%!+ 0(4 Q0    ( &A98U48&[I@)@0  '0)   9              "
M@?VD  !X;"]W;W)K<VAE971S+W-H965T,C(N>&UL4$L! A0#%     @ :%EC
M58EC/32, P  JP<  !D              ("!6JD  'AL+W=O<FMS:&5E=',O
M<VAE970R,RYX;6Q02P$"% ,4    " !H66-5-%N@]_,,  !V(P  &0
M        @($=K0  >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0
M   ( &A98U5_6D)*Q@0  !(+   9              " @4>Z  !X;"]W;W)K
M<VAE971S+W-H965T,C4N>&UL4$L! A0#%     @ :%EC5<DI<RW- P  *0D
M !D              ("!1+\  'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q0
M2P$"% ,4    " !H66-5I?1 ?T\#   P!P  &0              @(%(PP
M>&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    ( &A98U7U\'74
M# 0  )P*   9              " @<[&  !X;"]W;W)K<VAE971S+W-H965T
M,C@N>&UL4$L! A0#%     @ :%EC5><!.528!0  BPT  !D
M ("!$<L  'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q02P$"% ,4    " !H
M66-5_LN5S-0#  "M"0  &0              @('@T   >&PO=V]R:W-H965T
M<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( &A98U6&J2DF^@0  .L-   9
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M970S-2YX;6Q02P$"% ,4    " !H66-5]2\-W0L$  !J$   &0
M    @('TZ0  >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4 Q0    (
M &A98U7^* 8[:P4  "4F   9              " @3;N  !X;"]W;W)K<VAE
M971S+W-H965T,S<N>&UL4$L! A0#%     @ :%EC5;I/"Z2=!0  =BD  !D
M             ("!V/,  'AL+W=O<FMS:&5E=',O<VAE970S."YX;6Q02P$"
M% ,4    " !H66-5*&_=,X4(  #56P  &0              @(&L^0  >&PO
M=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    ( &A98U4QO(QGN@0
M 'T9   9              " @6@" 0!X;"]W;W)K<VAE971S+W-H965T-# N
M>&UL4$L! A0#%     @ :%EC56L4)+\O @  ^00  !D              ("!
M60<! 'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q02P$"% ,4    " !H66-5
M][."2TD$   O$@  &0              @(&_"0$ >&PO=V]R:W-H965T<R]S
M:&5E=#0R+GAM;%!+ 0(4 Q0    ( &A98U5LGHM[[0(  ,()   9
M      " @3\. 0!X;"]W;W)K<VAE971S+W-H965T-#,N>&UL4$L! A0#%
M  @ :%EC59DEES#G!   RAL  !D              ("!8Q$! 'AL+W=O<FMS
M:&5E=',O<VAE970T-"YX;6Q02P$"% ,4    " !H66-5P? CC T#  "Z"0
M&0              @(&!%@$ >&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+
M 0(4 Q0    ( &A98U6:K* F_P0  #(;   9              " @<49 0!X
M;"]W;W)K<VAE971S+W-H965T-#8N>&UL4$L! A0#%     @ :%EC50ZMO;M_
M @  $P4  !D              ("!^QX! 'AL+W=O<FMS:&5E=',O<VAE970T
M-RYX;6Q02P$"% ,4    " !H66-5LCP**UT$   P%   &0
M@(&Q(0$ >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4 Q0    ( &A9
M8U6&Q]4L3P4  +0K   9              " @44F 0!X;"]W;W)K<VAE971S
M+W-H965T-#DN>&UL4$L! A0#%     @ :%EC5>EO-8:Y P  31,  !D
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M=#4T+GAM;%!+ 0(4 Q0    ( &A98U7.7!2X@P,  &4,   9
M  " @<0_ 0!X;"]W;W)K<VAE971S+W-H965T-34N>&UL4$L! A0#%     @
M:%EC5:8=F;C2 @  =0D  !D              ("!?D,! 'AL+W=O<FMS:&5E
M=',O<VAE970U-BYX;6Q02P$"% ,4    " !H66-5%@1W"N8"  #)"@  &0
M            @(&'1@$ >&PO=V]R:W-H965T<R]S:&5E=#4W+GAM;%!+ 0(4
M Q0    ( &A98U7:K.6><08  %X\   9              " @:1) 0!X;"]W
M;W)K<VAE971S+W-H965T-3@N>&UL4$L! A0#%     @ :%EC51><Y*@I"0
M!F   !D              ("!3% ! 'AL+W=O<FMS:&5E=',O<VAE970U.2YX
M;6Q02P$"% ,4    " !H66-5GBX0XM,$   M&P  &0              @(&L
M60$ >&PO=V]R:W-H965T<R]S:&5E=#8P+GAM;%!+ 0(4 Q0    ( &A98U4V
MFB;!404  '09   9              " @;9> 0!X;"]W;W)K<VAE971S+W-H
M965T-C$N>&UL4$L! A0#%     @ :%EC57A7V=(7 P   0T  !D
M     ("!/F0! 'AL+W=O<FMS:&5E=',O<VAE970V,BYX;6Q02P$"% ,4
M" !H66-5:S4;*]T"  !U"0  &0              @(&,9P$ >&PO=V]R:W-H
M965T<R]S:&5E=#8S+GAM;%!+ 0(4 Q0    ( &A98U5'M<FN- ,  ,X3   -
M              "  :!J 0!X;"]S='EL97,N>&UL4$L! A0#%     @ :%EC
M59>*NQS     $P(   L              ( !_VT! %]R96QS+RYR96QS4$L!
M A0#%     @ :%EC54H6.59 !0  9BD   \              ( !Z&X! 'AL
M+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( &A98U4G9=6E# (  (0E   :
M          "  55T 0!X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4
M Q0    ( &A98U7NU>T8Y@$  /4D   3              "  9EV 0!;0V]N
E=&5N=%]4>7!E<UTN>&UL4$L%!@    !' $< :!,  +!X 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>230</ContextCount>
  <ElementCount>293</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>52</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/ORGANIZATIONANDBASISOFPRESENTATION</Role>
      <ShortName>ORGANIZATION AND BASIS OF PRESENTATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - REVENUE RECOGNITION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/REVENUERECOGNITION</Role>
      <ShortName>REVENUE RECOGNITION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - ACQUISITIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/ACQUISITIONS</Role>
      <ShortName>ACQUISITIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - COMPREHENSIVE INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/COMPREHENSIVEINCOME</Role>
      <ShortName>COMPREHENSIVE INCOME</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - EARNINGS PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/EARNINGSPERSHARE</Role>
      <ShortName>EARNINGS PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETS</Role>
      <ShortName>GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - DEBT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/DEBT</Role>
      <ShortName>DEBT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - LEASES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/LEASES</Role>
      <ShortName>LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - FAIR VALUE MEASUREMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTS</Role>
      <ShortName>FAIR VALUE MEASUREMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITY</Role>
      <ShortName>STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - SEGMENT DATA</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/SEGMENTDATA</Role>
      <ShortName>SEGMENT DATA</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/CONTINGENCIES</Role>
      <ShortName>CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/INCOMETAXES</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - RELATED PARTY TRANSACTIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/RELATEDPARTYTRANSACTIONS</Role>
      <ShortName>RELATED PARTY TRANSACTIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - RECENT ACCOUNTING PRONOUNCEMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/RECENTACCOUNTINGPRONOUNCEMENTS</Role>
      <ShortName>RECENT ACCOUNTING PRONOUNCEMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/SUBSEQUENTEVENTS</Role>
      <ShortName>SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - REVENUE RECOGNITION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/REVENUERECOGNITIONTables</Role>
      <ShortName>REVENUE RECOGNITION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.crosscountryhealthcare.com/role/REVENUERECOGNITION</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - ACQUISITIONS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/ACQUISITIONSTables</Role>
      <ShortName>ACQUISITIONS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.crosscountryhealthcare.com/role/ACQUISITIONS</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - EARNINGS PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/EARNINGSPERSHARETables</Role>
      <ShortName>EARNINGS PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.crosscountryhealthcare.com/role/EARNINGSPERSHARE</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSTables</Role>
      <ShortName>GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETS</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - DEBT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/DEBTTables</Role>
      <ShortName>DEBT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.crosscountryhealthcare.com/role/DEBT</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - LEASES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/LEASESTables</Role>
      <ShortName>LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.crosscountryhealthcare.com/role/LEASES</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSTables</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTS</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - STOCKHOLDERS' EQUITY (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYTables</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITY</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - SEGMENT DATA (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/SEGMENTDATATables</Role>
      <ShortName>SEGMENT DATA (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.crosscountryhealthcare.com/role/SEGMENTDATA</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Allowance for Doubtful Accounts (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAllowanceforDoubtfulAccountsDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Allowance for Doubtful Accounts (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Restructuring (Benefits) Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRestructuringBenefitsCostsDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Restructuring (Benefits) Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - REVENUE RECOGNITION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/REVENUERECOGNITIONDetails</Role>
      <ShortName>REVENUE RECOGNITION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.crosscountryhealthcare.com/role/REVENUERECOGNITIONTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - ACQUISITIONS - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/ACQUISITIONSAdditionalInformationDetails</Role>
      <ShortName>ACQUISITIONS - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - ACQUISITIONS - Recognized Identified Assets Acquired and Liabilities Assumed (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails</Role>
      <ShortName>ACQUISITIONS - Recognized Identified Assets Acquired and Liabilities Assumed (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - COMPREHENSIVE INCOME (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/COMPREHENSIVEINCOMEDetails</Role>
      <ShortName>COMPREHENSIVE INCOME (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.crosscountryhealthcare.com/role/COMPREHENSIVEINCOME</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - EARNINGS PER SHARE - Components of Numerator and Denominator for Computation of Basic and Diluted Earnings per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREComponentsofNumeratorandDenominatorforComputationofBasicandDilutedEarningsperShareDetails</Role>
      <ShortName>EARNINGS PER SHARE - Components of Numerator and Denominator for Computation of Basic and Diluted Earnings per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - EARNINGS PER SHARE - Anti-dilutive Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREAntidilutiveSecuritiesDetails</Role>
      <ShortName>EARNINGS PER SHARE - Anti-dilutive Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS - Acquired Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails</Role>
      <ShortName>GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS - Acquired Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0000045 - Disclosure - GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS - Estimated Annual Amortization Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSEstimatedAnnualAmortizationExpenseDetails</Role>
      <ShortName>GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS - Estimated Annual Amortization Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0000046 - Disclosure - GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS - Goodwill Rollforward (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails</Role>
      <ShortName>GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS - Goodwill Rollforward (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0000047 - Disclosure - GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAdditionalInformationDetails</Role>
      <ShortName>GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0000048 - Disclosure - DEBT - Long-term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails</Role>
      <ShortName>DEBT - Long-term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0000049 - Disclosure - DEBT - 2021 Term Loan Credit Agreement Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/DEBT2021TermLoanCreditAgreementNarrativeDetails</Role>
      <ShortName>DEBT - 2021 Term Loan Credit Agreement Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0000050 - Disclosure - DEBT - Maturities of Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails</Role>
      <ShortName>DEBT - Maturities of Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0000051 - Disclosure - DEBT - 2019 Loan Agreement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails</Role>
      <ShortName>DEBT - 2019 Loan Agreement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0000052 - Disclosure - LEASES - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/LEASESAdditionalInformationDetails</Role>
      <ShortName>LEASES - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>0000053 - Disclosure - LEASES - Supplemental Balance Sheet Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/LEASESSupplementalBalanceSheetInformationDetails</Role>
      <ShortName>LEASES - Supplemental Balance Sheet Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>0000054 - Disclosure - LEASES - Operating Lease Maturity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails</Role>
      <ShortName>LEASES - Operating Lease Maturity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>0000055 - Disclosure - LEASES - Lease Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/LEASESLeaseCostsDetails</Role>
      <ShortName>LEASES - Lease Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>0000056 - Disclosure - FAIR VALUE MEASUREMENTS - Estimated Fair Values of Financial Assets and Liabilities Measured on a Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSEstimatedFairValuesofFinancialAssetsandLiabilitiesMeasuredonaRecurringBasisDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS - Estimated Fair Values of Financial Assets and Liabilities Measured on a Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>0000057 - Disclosure - FAIR VALUE MEASUREMENTS - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>0000058 - Disclosure - FAIR VALUE MEASUREMENTS - Carrying Amounts and Estimated Fair Values of Significant Financial Instrument that were not Measured at Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS - Carrying Amounts and Estimated Fair Values of Significant Financial Instrument that were not Measured at Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>0000059 - Disclosure - STOCKHOLDERS' EQUITY - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>0000060 - Disclosure - STOCKHOLDERS' EQUITY - Restricted Stock Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYRestrictedStockActivityDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - Restricted Stock Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>0000061 - Disclosure - SEGMENT DATA (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/SEGMENTDATADetails</Role>
      <ShortName>SEGMENT DATA (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.crosscountryhealthcare.com/role/SEGMENTDATATables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>0000062 - Disclosure - INCOME TAXES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/INCOMETAXESDetails</Role>
      <ShortName>INCOME TAXES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.crosscountryhealthcare.com/role/INCOMETAXES</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="ccrn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>0000063 - Disclosure - RELATED PARTY TRANSACTIONS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/RELATEDPARTYTRANSACTIONSDetails</Role>
      <ShortName>RELATED PARTY TRANSACTIONS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.crosscountryhealthcare.com/role/RELATEDPARTYTRANSACTIONS</ParentRole>
      <Position>63</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="ccrn-20220930.htm">ccrn-20220930.htm</File>
    <File>ccrn-20220930.xsd</File>
    <File>ccrn-20220930_cal.xml</File>
    <File>ccrn-20220930_def.xml</File>
    <File>ccrn-20220930_lab.xml</File>
    <File>ccrn-20220930_pre.xml</File>
    <File>ccrn20220930-10qex31x1.htm</File>
    <File>ccrn20220930-10qex31x2.htm</File>
    <File>ccrn20220930-10qex32x1.htm</File>
    <File>ccrn20220930-10qex32x2.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>ccrn-20220930_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="783">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>81
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "ccrn-20220930.htm": {
   "axisCustom": 1,
   "axisStandard": 24,
   "contextCount": 230,
   "dts": {
    "calculationLink": {
     "local": [
      "ccrn-20220930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "ccrn-20220930_def.xml"
     ]
    },
    "inline": {
     "local": [
      "ccrn-20220930.htm"
     ]
    },
    "labelLink": {
     "local": [
      "ccrn-20220930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ccrn-20220930_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "ccrn-20220930.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 475,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 4,
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 9
   },
   "keyCustom": 32,
   "keyStandard": 261,
   "memberCustom": 22,
   "memberStandard": 28,
   "nsprefix": "ccrn",
   "nsuri": "http://www.crosscountryhealthcare.com/20220930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover",
     "role": "http://www.crosscountryhealthcare.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - ACQUISITIONS",
     "role": "http://www.crosscountryhealthcare.com/role/ACQUISITIONS",
     "shortName": "ACQUISITIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - COMPREHENSIVE INCOME",
     "role": "http://www.crosscountryhealthcare.com/role/COMPREHENSIVEINCOME",
     "shortName": "COMPREHENSIVE INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - EARNINGS PER SHARE",
     "role": "http://www.crosscountryhealthcare.com/role/EARNINGSPERSHARE",
     "shortName": "EARNINGS PER SHARE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS",
     "role": "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETS",
     "shortName": "GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - DEBT",
     "role": "http://www.crosscountryhealthcare.com/role/DEBT",
     "shortName": "DEBT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - LEASES",
     "role": "http://www.crosscountryhealthcare.com/role/LEASES",
     "shortName": "LEASES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - FAIR VALUE MEASUREMENTS",
     "role": "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTS",
     "shortName": "FAIR VALUE MEASUREMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - STOCKHOLDERS' EQUITY",
     "role": "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITY",
     "shortName": "STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - SEGMENT DATA",
     "role": "http://www.crosscountryhealthcare.com/role/SEGMENTDATA",
     "shortName": "SEGMENT DATA",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - CONTINGENCIES",
     "role": "http://www.crosscountryhealthcare.com/role/CONTINGENCIES",
     "shortName": "CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "i8ad9340f357e45ba914eff9e31b0661b_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS",
     "role": "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "i8ad9340f357e45ba914eff9e31b0661b_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - INCOME TAXES",
     "role": "http://www.crosscountryhealthcare.com/role/INCOMETAXES",
     "shortName": "INCOME TAXES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - RELATED PARTY TRANSACTIONS",
     "role": "http://www.crosscountryhealthcare.com/role/RELATEDPARTYTRANSACTIONS",
     "shortName": "RELATED PARTY TRANSACTIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - RECENT ACCOUNTING PRONOUNCEMENTS",
     "role": "http://www.crosscountryhealthcare.com/role/RECENTACCOUNTINGPRONOUNCEMENTS",
     "shortName": "RECENT ACCOUNTING PRONOUNCEMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - SUBSEQUENT EVENTS",
     "role": "http://www.crosscountryhealthcare.com/role/SUBSEQUENTEVENTS",
     "shortName": "SUBSEQUENT EVENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "role": "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "role": "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - REVENUE RECOGNITION (Tables)",
     "role": "http://www.crosscountryhealthcare.com/role/REVENUERECOGNITIONTables",
     "shortName": "REVENUE RECOGNITION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - ACQUISITIONS (Tables)",
     "role": "http://www.crosscountryhealthcare.com/role/ACQUISITIONSTables",
     "shortName": "ACQUISITIONS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - EARNINGS PER SHARE (Tables)",
     "role": "http://www.crosscountryhealthcare.com/role/EARNINGSPERSHARETables",
     "shortName": "EARNINGS PER SHARE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS (Tables)",
     "role": "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSTables",
     "shortName": "GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "i8ad9340f357e45ba914eff9e31b0661b_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "i8ad9340f357e45ba914eff9e31b0661b_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - DEBT (Tables)",
     "role": "http://www.crosscountryhealthcare.com/role/DEBTTables",
     "shortName": "DEBT (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ccrn:AssetsAndLiabilitiesLeasesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - LEASES (Tables)",
     "role": "http://www.crosscountryhealthcare.com/role/LEASESTables",
     "shortName": "LEASES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ccrn:AssetsAndLiabilitiesLeasesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)",
     "role": "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSTables",
     "shortName": "FAIR VALUE MEASUREMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - STOCKHOLDERS' EQUITY (Tables)",
     "role": "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYTables",
     "shortName": "STOCKHOLDERS' EQUITY (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - SEGMENT DATA (Tables)",
     "role": "http://www.crosscountryhealthcare.com/role/SEGMENTDATATables",
     "shortName": "SEGMENT DATA (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:TradeAndOtherAccountsReceivablePolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "i8ad9340f357e45ba914eff9e31b0661b_I20220930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnbilledContractsReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details)",
     "role": "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:TradeAndOtherAccountsReceivablePolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "i8ad9340f357e45ba914eff9e31b0661b_I20220930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnbilledContractsReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "i0c0a4267d8174093be4955cfd3a6d031_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Allowance for Doubtful Accounts (Details)",
     "role": "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAllowanceforDoubtfulAccountsDetails",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Allowance for Doubtful Accounts (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "i320641181a3f49a494c3423b25911ae6_D20220401-20220630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ProvisionForDoubtfulAccounts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "i710725bce0f34e3784365685f226641d_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Restructuring (Benefits) Costs (Details)",
     "role": "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRestructuringBenefitsCostsDetails",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Restructuring (Benefits) Costs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "i320641181a3f49a494c3423b25911ae6_D20220401-20220630",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:BusinessExitCosts1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "i710725bce0f34e3784365685f226641d_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - REVENUE RECOGNITION (Details)",
     "role": "http://www.crosscountryhealthcare.com/role/REVENUERECOGNITIONDetails",
     "shortName": "REVENUE RECOGNITION (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "i8ae604777193442b9bf2a6f5b9f7aae1_D20220701-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "i8ad9340f357e45ba914eff9e31b0661b_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - ACQUISITIONS - Additional Information (Details)",
     "role": "http://www.crosscountryhealthcare.com/role/ACQUISITIONSAdditionalInformationDetails",
     "shortName": "ACQUISITIONS - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ia84d03e68bab4f9592492ba9084b94f0_D20211216-20211216",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "i710725bce0f34e3784365685f226641d_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "role": "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "i710725bce0f34e3784365685f226641d_D20220701-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DirectOperatingCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "i8ad9340f357e45ba914eff9e31b0661b_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - ACQUISITIONS - Recognized Identified Assets Acquired and Liabilities Assumed (Details)",
     "role": "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails",
     "shortName": "ACQUISITIONS - Recognized Identified Assets Acquired and Liabilities Assumed (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "i8ae5c1283dfc4659b9287a5a52e51af8_I20210608",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "i8ad9340f357e45ba914eff9e31b0661b_I20220930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "ccrn:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - COMPREHENSIVE INCOME (Details)",
     "role": "http://www.crosscountryhealthcare.com/role/COMPREHENSIVEINCOMEDetails",
     "shortName": "COMPREHENSIVE INCOME (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "i8ad9340f357e45ba914eff9e31b0661b_I20220930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "ccrn:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "i710725bce0f34e3784365685f226641d_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - EARNINGS PER SHARE - Components of Numerator and Denominator for Computation of Basic and Diluted Earnings per Share (Details)",
     "role": "http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREComponentsofNumeratorandDenominatorforComputationofBasicandDilutedEarningsperShareDetails",
     "shortName": "EARNINGS PER SHARE - Components of Numerator and Denominator for Computation of Basic and Diluted Earnings per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "i710725bce0f34e3784365685f226641d_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "i2caa7dba2bf946eeba1cabe94a429f67_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - EARNINGS PER SHARE - Anti-dilutive Securities (Details)",
     "role": "http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREAntidilutiveSecuritiesDetails",
     "shortName": "EARNINGS PER SHARE - Anti-dilutive Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "i2caa7dba2bf946eeba1cabe94a429f67_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "i8ad9340f357e45ba914eff9e31b0661b_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS - Acquired Intangible Assets (Details)",
     "role": "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails",
     "shortName": "GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS - Acquired Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "i8ad9340f357e45ba914eff9e31b0661b_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "i8ad9340f357e45ba914eff9e31b0661b_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS - Estimated Annual Amortization Expense (Details)",
     "role": "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSEstimatedAnnualAmortizationExpenseDetails",
     "shortName": "GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS - Estimated Annual Amortization Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "i8ad9340f357e45ba914eff9e31b0661b_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "i51f0077b9e4442588bd8299663a1ef5a_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS - Goodwill Rollforward (Details)",
     "role": "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails",
     "shortName": "GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS - Goodwill Rollforward (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "i51f0077b9e4442588bd8299663a1ef5a_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS - Additional Information (Details)",
     "role": "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAdditionalInformationDetails",
     "shortName": "GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "i8ad9340f357e45ba914eff9e31b0661b_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - DEBT - Long-term Debt (Details)",
     "role": "http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails",
     "shortName": "DEBT - Long-term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "i8ad9340f357e45ba914eff9e31b0661b_I20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DeferredFinanceCostsNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ie2b5f4df2dca4db3b15dfee015bb5eb9_D20220623-20220623",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "ccrn:PaymentForDebtPrepayment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000049 - Disclosure - DEBT - 2021 Term Loan Credit Agreement Narrative (Details)",
     "role": "http://www.crosscountryhealthcare.com/role/DEBT2021TermLoanCreditAgreementNarrativeDetails",
     "shortName": "DEBT - 2021 Term Loan Credit Agreement Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ie2b5f4df2dca4db3b15dfee015bb5eb9_D20220623-20220623",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "ccrn:PaymentForDebtPrepayment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "i46d38e032f6045d5811f4c3961253386_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "role": "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "i46d38e032f6045d5811f4c3961253386_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "i8ad9340f357e45ba914eff9e31b0661b_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000050 - Disclosure - DEBT - Maturities of Debt (Details)",
     "role": "http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails",
     "shortName": "DEBT - Maturities of Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ide03ccfd1d5f459fbf0f366e300c2751_I20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "i624be7ef98974a18acd4dff1b7f88e73_I20211118",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "ccrn:LineOfCreditAmountOfIndebtednessPermittedBySeniorSecuredAssetBasedLoanToBeBorrowedFromOtherSources",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000051 - Disclosure - DEBT - 2019 Loan Agreement (Details)",
     "role": "http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails",
     "shortName": "DEBT - 2019 Loan Agreement (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "i624be7ef98974a18acd4dff1b7f88e73_I20211118",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "ccrn:LineOfCreditAmountOfIndebtednessPermittedBySeniorSecuredAssetBasedLoanToBeBorrowedFromOtherSources",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseImpairmentLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000052 - Disclosure - LEASES - Additional Information (Details)",
     "role": "http://www.crosscountryhealthcare.com/role/LEASESAdditionalInformationDetails",
     "shortName": "LEASES - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseImpairmentLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ccrn:AssetsAndLiabilitiesLeasesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "i8ad9340f357e45ba914eff9e31b0661b_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000053 - Disclosure - LEASES - Supplemental Balance Sheet Information (Details)",
     "role": "http://www.crosscountryhealthcare.com/role/LEASESSupplementalBalanceSheetInformationDetails",
     "shortName": "LEASES - Supplemental Balance Sheet Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "i8ad9340f357e45ba914eff9e31b0661b_I20220930",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "i8ad9340f357e45ba914eff9e31b0661b_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000054 - Disclosure - LEASES - Operating Lease Maturity (Details)",
     "role": "http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails",
     "shortName": "LEASES - Operating Lease Maturity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "i8ad9340f357e45ba914eff9e31b0661b_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000055 - Disclosure - LEASES - Lease Costs (Details)",
     "role": "http://www.crosscountryhealthcare.com/role/LEASESLeaseCostsDetails",
     "shortName": "LEASES - Lease Costs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "i8e7a429958f04663bc3d74b1a3aab9a6_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000056 - Disclosure - FAIR VALUE MEASUREMENTS - Estimated Fair Values of Financial Assets and Liabilities Measured on a Recurring Basis (Details)",
     "role": "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSEstimatedFairValuesofFinancialAssetsandLiabilitiesMeasuredonaRecurringBasisDetails",
     "shortName": "FAIR VALUE MEASUREMENTS - Estimated Fair Values of Financial Assets and Liabilities Measured on a Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "i8e7a429958f04663bc3d74b1a3aab9a6_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000057 - Disclosure - FAIR VALUE MEASUREMENTS - Narrative (Details)",
     "role": "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
     "shortName": "FAIR VALUE MEASUREMENTS - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "i8ae5c1283dfc4659b9287a5a52e51af8_I20210608",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000058 - Disclosure - FAIR VALUE MEASUREMENTS - Carrying Amounts and Estimated Fair Values of Significant Financial Instrument that were not Measured at Fair Value (Details)",
     "role": "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails",
     "shortName": "FAIR VALUE MEASUREMENTS - Carrying Amounts and Estimated Fair Values of Significant Financial Instrument that were not Measured at Fair Value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "iba8724e196ad45edae8eaee777dfc4d7_I20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "id786e43d12924467a670b39ccb2288b8_D20210701-20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchasedAndRetiredDuringPeriodShares",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000059 - Disclosure - STOCKHOLDERS' EQUITY - Additional Information (Details)",
     "role": "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails",
     "shortName": "STOCKHOLDERS' EQUITY - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "i657bd17dcadf4f3f873d0850b774cdc3_D20220101-20220331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "ccrn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAttainmentPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "ccrn:ProvisionForDoubtfulAccountsAndOtherAllowances",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "i0898a126dbc046e795ecb209d0f68153_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000060 - Disclosure - STOCKHOLDERS' EQUITY - Restricted Stock Activity (Details)",
     "role": "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYRestrictedStockActivityDetails",
     "shortName": "STOCKHOLDERS' EQUITY - Restricted Stock Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "i7b01283f3c6e441b93fffe6cdf6495d8_D20220101-20220930",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "i710725bce0f34e3784365685f226641d_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000061 - Disclosure - SEGMENT DATA (Details)",
     "role": "http://www.crosscountryhealthcare.com/role/SEGMENTDATADetails",
     "shortName": "SEGMENT DATA (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "i710725bce0f34e3784365685f226641d_D20220701-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "i710725bce0f34e3784365685f226641d_D20220701-20220930",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000062 - Disclosure - INCOME TAXES (Details)",
     "role": "http://www.crosscountryhealthcare.com/role/INCOMETAXESDetails",
     "shortName": "INCOME TAXES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "i710725bce0f34e3784365685f226641d_D20220701-20220930",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "i72783f7b11ce4ca8bd07eb8c76ae894f_D20220701-20220930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromRelatedParties",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000063 - Disclosure - RELATED PARTY TRANSACTIONS (Details)",
     "role": "http://www.crosscountryhealthcare.com/role/RELATEDPARTYTRANSACTIONSDetails",
     "shortName": "RELATED PARTY TRANSACTIONS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "i72783f7b11ce4ca8bd07eb8c76ae894f_D20220701-20220930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromRelatedParties",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000007 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION",
     "role": "http://www.crosscountryhealthcare.com/role/ORGANIZATIONANDBASISOFPRESENTATION",
     "shortName": "ORGANIZATION AND BASIS OF PRESENTATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "role": "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000009 - Disclosure - REVENUE RECOGNITION",
     "role": "http://www.crosscountryhealthcare.com/role/REVENUERECOGNITION",
     "shortName": "REVENUE RECOGNITION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220930.htm",
      "contextRef": "ib17ae2d876084fedbbe3bc65fe6b74c2_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 52,
   "tag": {
    "ccrn_A2021TermLoanCreditAgreementAggregateAmountOfAllPossibleIncreasesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2021 Term Loan Credit Agreement, Aggregate Amount Of All Possible Increases",
        "label": "2021 Term Loan Credit Agreement, Aggregate Amount Of All Possible Increases [Member]",
        "terseLabel": "2021 Term Loan Credit Agreement, Aggregate Amount of All Possible Increases"
       }
      }
     },
     "localname": "A2021TermLoanCreditAgreementAggregateAmountOfAllPossibleIncreasesMember",
     "nsuri": "http://www.crosscountryhealthcare.com/20220930",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2021TermLoanCreditAgreementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ccrn_A2021TermLoanCreditAgreementIncrementalTermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2021 Term Loan Credit Agreement, Incremental Term Loan",
        "label": "2021 Term Loan Credit Agreement, Incremental Term Loan [Member]",
        "terseLabel": "2021 Term Loan Credit Agreement, Incremental Term Loan"
       }
      }
     },
     "localname": "A2021TermLoanCreditAgreementIncrementalTermLoanMember",
     "nsuri": "http://www.crosscountryhealthcare.com/20220930",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2021TermLoanCreditAgreementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ccrn_A2021TermLoanCreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2021 Term Loan Credit Agreement",
        "label": "2021 Term Loan Credit Agreement [Member]",
        "terseLabel": "2021 Term Loan Credit Agreement"
       }
      }
     },
     "localname": "A2021TermLoanCreditAgreementMember",
     "nsuri": "http://www.crosscountryhealthcare.com/20220930",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2021TermLoanCreditAgreementNarrativeDetails",
      "http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails",
      "http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ccrn_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Before Tax",
        "label": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Before Tax",
        "negatedTerseLabel": "Loss on currency fluctuations"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax",
     "nsuri": "http://www.crosscountryhealthcare.com/20220930",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/COMPREHENSIVEINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ccrn_AcquisitionAndIntegrationRelatedCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisition and integration-related costs include costs for prior acquisitions, costs incurred for potential transactions, and accretion and valuation adjustments on contingent consideration liabilities",
        "label": "Acquisition And Integration-Related Costs",
        "terseLabel": "Acquisition and integration-related costs",
        "verboseLabel": "Acquisition and integration-related costs"
       }
      }
     },
     "localname": "AcquisitionAndIntegrationRelatedCosts",
     "nsuri": "http://www.crosscountryhealthcare.com/20220930",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.crosscountryhealthcare.com/role/SEGMENTDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ccrn_AssetsAndLiabilitiesLeasesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets And Liabilities, Leases [Table Text Block]",
        "label": "Assets And Liabilities, Leases [Table Text Block]",
        "terseLabel": "Schedule of Supplemental Balance Sheet Information"
       }
      }
     },
     "localname": "AssetsAndLiabilitiesLeasesTableTextBlock",
     "nsuri": "http://www.crosscountryhealthcare.com/20220930",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Consideration Transferred, Net Working Capital Adjustment",
        "label": "Business Combination, Consideration Transferred, Net Working Capital Adjustment",
        "terseLabel": "Net working capital adjustment"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment",
     "nsuri": "http://www.crosscountryhealthcare.com/20220930",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ccrn_BusinessCombinationContingentConsiderationTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Term",
        "label": "Business Combination, Contingent Consideration, Term",
        "terseLabel": "Contingent consideration liability, term"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationTerm",
     "nsuri": "http://www.crosscountryhealthcare.com/20220930",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation, Current",
        "label": "Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation, Current",
        "terseLabel": "Lease liability - current"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationCurrent",
     "nsuri": "http://www.crosscountryhealthcare.com/20220930",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation, Noncurrent",
        "label": "Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation, Noncurrent",
        "terseLabel": "Lease liability - non-current"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationNoncurrent",
     "nsuri": "http://www.crosscountryhealthcare.com/20220930",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensationAndBenefits": {
     "auth_ref": [],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Accrued Compensation And Benefits",
        "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Accrued Compensation And Benefits",
        "terseLabel": "Accrued compensation and benefits"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensationAndBenefits",
     "nsuri": "http://www.crosscountryhealthcare.com/20220930",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired Including Goodwill",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired Including Goodwill",
        "totalLabel": "Total assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
     "nsuri": "http://www.crosscountryhealthcare.com/20220930",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 3.0,
       "parentTag": "ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right-Of-Use Assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right-Of-Use Assets",
        "terseLabel": "Right-of-use assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets",
     "nsuri": "http://www.crosscountryhealthcare.com/20220930",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ccrn_DebtInstrumentVariableInterestRateFloor": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Variable Interest Rate Floor",
        "label": "Debt Instrument, Variable Interest Rate Floor",
        "terseLabel": "Interest margin floor percentage"
       }
      }
     },
     "localname": "DebtInstrumentVariableInterestRateFloor",
     "nsuri": "http://www.crosscountryhealthcare.com/20220930",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2021TermLoanCreditAgreementNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ccrn_DeferredCompensationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Compensation [Member]",
        "label": "Deferred Compensation [Member]",
        "terseLabel": "Deferred compensation"
       }
      }
     },
     "localname": "DeferredCompensationMember",
     "nsuri": "http://www.crosscountryhealthcare.com/20220930",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSEstimatedFairValuesofFinancialAssetsandLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ccrn_EarnoutNotesPayableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earnout Notes Payable",
        "label": "Earnout Notes Payable [Member]",
        "terseLabel": "Earnout Notes Payable"
       }
      }
     },
     "localname": "EarnoutNotesPayableMember",
     "nsuri": "http://www.crosscountryhealthcare.com/20220930",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails",
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ccrn_EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate, Continuing Operations, Excluding Discrete Items",
        "label": "Effective Income Tax Rate, Continuing Operations, Excluding Discrete Items",
        "terseLabel": "Effective tax rate, excluding discrete items"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems",
     "nsuri": "http://www.crosscountryhealthcare.com/20220930",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ccrn_ExitCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exit Costs [Member]",
        "label": "Exit Costs [Member]",
        "terseLabel": "Lease-Related"
       }
      }
     },
     "localname": "ExitCostsMember",
     "nsuri": "http://www.crosscountryhealthcare.com/20220930",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRestructuringBenefitsCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ccrn_FairValueMeasurementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value Measurement [Line Items]",
        "label": "Fair Value Measurement [Line Items]",
        "terseLabel": "Fair Value Measurement [Line Items]"
       }
      }
     },
     "localname": "FairValueMeasurementLineItems",
     "nsuri": "http://www.crosscountryhealthcare.com/20220930",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ccrn_FairValueMeasurementTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value Measurement [Table]",
        "label": "Fair Value Measurement [Table]",
        "terseLabel": "Fair Value Measurement [Table]"
       }
      }
     },
     "localname": "FairValueMeasurementTable",
     "nsuri": "http://www.crosscountryhealthcare.com/20220930",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]",
        "label": "Finite Lived And Indefinite Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://www.crosscountryhealthcare.com/20220930",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ccrn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSEstimatedAnnualAmortizationExpenseDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite Lived Intangible Asset, Expected Amortization, After Year Four",
        "label": "Finite Lived Intangible Asset, Expected Amortization, After Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour",
     "nsuri": "http://www.crosscountryhealthcare.com/20220930",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSEstimatedAnnualAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ccrn_HealthCareSystemAffiliatedWithABoardMemberMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care System Affiliated With A Board Member",
        "label": "Health Care System Affiliated With A Board Member [Member]",
        "terseLabel": "Health Care System Affiliated with a Board Member"
       }
      }
     },
     "localname": "HealthCareSystemAffiliatedWithABoardMemberMember",
     "nsuri": "http://www.crosscountryhealthcare.com/20220930",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/RELATEDPARTYTRANSACTIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ccrn_IncreaseDecreaseInOperatingLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) In Operating Lease Liabilities",
        "label": "Increase (Decrease) In Operating Lease Liabilities",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiabilities",
     "nsuri": "http://www.crosscountryhealthcare.com/20220930",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ccrn_LineOfCreditAmountOfIndebtednessPermittedBySeniorSecuredAssetBasedLoanToBeBorrowedFromOtherSources": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line Of Credit, Amount Of Indebtedness Permitted By Senior Secured Asset Based Loan To Be Borrowed From Other Sources",
        "label": "Line Of Credit, Amount Of Indebtedness Permitted By Senior Secured Asset Based Loan To Be Borrowed From Other Sources",
        "terseLabel": "Amount of indebtedness permitted from other sources"
       }
      }
     },
     "localname": "LineOfCreditAmountOfIndebtednessPermittedBySeniorSecuredAssetBasedLoanToBeBorrowedFromOtherSources",
     "nsuri": "http://www.crosscountryhealthcare.com/20220930",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ccrn_LineOfCreditBorrowingBasePercentageOfAssets": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line Of Credit, Borrowing Base, Percentage Of Assets",
        "label": "Line Of Credit, Borrowing Base, Percentage Of Assets",
        "terseLabel": "Borrowing base, percentage of assets"
       }
      }
     },
     "localname": "LineOfCreditBorrowingBasePercentageOfAssets",
     "nsuri": "http://www.crosscountryhealthcare.com/20220930",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ccrn_LineOfCreditFacilityBasisSpreadOnVariableRateAdditionalCreditSpreadAssociatedWithSOFR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line Of Credit Facility, Basis Spread On Variable Rate, Additional Credit Spread Associated With SOFR",
        "label": "Line Of Credit Facility, Basis Spread On Variable Rate, Additional Credit Spread Associated With SOFR",
        "terseLabel": "Basis spread on variable rate, additional credit spread associated with SOFR"
       }
      }
     },
     "localname": "LineOfCreditFacilityBasisSpreadOnVariableRateAdditionalCreditSpreadAssociatedWithSOFR",
     "nsuri": "http://www.crosscountryhealthcare.com/20220930",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ccrn_LineOfCreditFacilityBorrowingBaseAvailability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line Of Credit Facility, Borrowing Base Availability",
        "label": "Line Of Credit Facility, Borrowing Base Availability",
        "terseLabel": "Borrowing base availability"
       }
      }
     },
     "localname": "LineOfCreditFacilityBorrowingBaseAvailability",
     "nsuri": "http://www.crosscountryhealthcare.com/20220930",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ccrn_LineOfCreditSublimitAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line Of Credit Sublimit [Axis]",
        "label": "Line Of Credit Sublimit [Axis]",
        "terseLabel": "Line Of Credit Sublimit [Axis]"
       }
      }
     },
     "localname": "LineOfCreditSublimitAxis",
     "nsuri": "http://www.crosscountryhealthcare.com/20220930",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ccrn_LineOfCreditSublimitDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Line Of Credit Sublimit [Axis]",
        "label": "Line Of Credit Sublimit [Domain]",
        "terseLabel": "Line Of Credit Sublimit [Domain]"
       }
      }
     },
     "localname": "LineOfCreditSublimitDomain",
     "nsuri": "http://www.crosscountryhealthcare.com/20220930",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ccrn_LongTermDebtMaturityAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-Term Debt, Maturity, After Year Four",
        "label": "Long-Term Debt, Maturity, After Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LongTermDebtMaturityAfterYearFour",
     "nsuri": "http://www.crosscountryhealthcare.com/20220930",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ccrn_NewRepurchaseProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "New Repurchase Program",
        "label": "New Repurchase Program [Member]",
        "terseLabel": "New Repurchase Program"
       }
      }
     },
     "localname": "NewRepurchaseProgramMember",
     "nsuri": "http://www.crosscountryhealthcare.com/20220930",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ccrn_NurseAndAlliedStaffingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nurse and allied staffing [Member]",
        "label": "Nurse And Allied Staffing [Member]",
        "netLabel": "Nurse and Allied Staffing",
        "terseLabel": "Nurse And Allied Staffing",
        "verboseLabel": "Nurse And Allied Staffing"
       }
      }
     },
     "localname": "NurseAndAlliedStaffingMember",
     "nsuri": "http://www.crosscountryhealthcare.com/20220930",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails",
      "http://www.crosscountryhealthcare.com/role/REVENUERECOGNITIONDetails",
      "http://www.crosscountryhealthcare.com/role/SEGMENTDATADetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ccrn_OmnibusPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Omnibus Plan",
        "label": "Omnibus Plan [Member]",
        "terseLabel": "Omnibus Plan"
       }
      }
     },
     "localname": "OmnibusPlanMember",
     "nsuri": "http://www.crosscountryhealthcare.com/20220930",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ccrn_OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Income Loss Before D And A Acquisition And Integration Contingent Consideration Restructuring Legal Impairment And Corporate Overheard",
        "label": "Operating Income Loss Before D And A Acquisition And Integration Contingent Consideration Restructuring Legal Impairment And Corporate Overheard",
        "terseLabel": "Contribution income:"
       }
      }
     },
     "localname": "OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard",
     "nsuri": "http://www.crosscountryhealthcare.com/20220930",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SEGMENTDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ccrn_OperatingLeaseExpenseNonCash": {
     "auth_ref": [],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease Expense, Non-Cash",
        "label": "Operating Lease Expense, Non-Cash",
        "terseLabel": "Non-cash lease expense"
       }
      }
     },
     "localname": "OperatingLeaseExpenseNonCash",
     "nsuri": "http://www.crosscountryhealthcare.com/20220930",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ccrn_OtherServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Services [Member]",
        "label": "Other Services [Member]",
        "terseLabel": "Other Services"
       }
      }
     },
     "localname": "OtherServicesMember",
     "nsuri": "http://www.crosscountryhealthcare.com/20220930",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ccrn_PaymentForDebtPrepayment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment For Debt Prepayment",
        "label": "Payment For Debt Prepayment",
        "terseLabel": "Payment for debt prepayment"
       }
      }
     },
     "localname": "PaymentForDebtPrepayment",
     "nsuri": "http://www.crosscountryhealthcare.com/20220930",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2021TermLoanCreditAgreementNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ccrn_PaymentsForRestructuringAndAdjustments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments For Restructuring And Adjustments",
        "label": "Payments For Restructuring And Adjustments",
        "negatedTerseLabel": "Payments and adjustments"
       }
      }
     },
     "localname": "PaymentsForRestructuringAndAdjustments",
     "nsuri": "http://www.crosscountryhealthcare.com/20220930",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRestructuringBenefitsCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ccrn_PhysicianStaffingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Physician staffing [Member]",
        "label": "Physician Staffing [Member]",
        "netLabel": "Physician Staffing",
        "terseLabel": "Physician Staffing",
        "verboseLabel": "Physician Staffing"
       }
      }
     },
     "localname": "PhysicianStaffingMember",
     "nsuri": "http://www.crosscountryhealthcare.com/20220930",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails",
      "http://www.crosscountryhealthcare.com/role/REVENUERECOGNITIONDetails",
      "http://www.crosscountryhealthcare.com/role/SEGMENTDATADetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ccrn_PriorRepurchaseProgramAndNewRepurchaseProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prior Repurchase Program And New Repurchase Program",
        "label": "Prior Repurchase Program And New Repurchase Program [Member]",
        "terseLabel": "Prior Repurchase Program And New Repurchase Program"
       }
      }
     },
     "localname": "PriorRepurchaseProgramAndNewRepurchaseProgramMember",
     "nsuri": "http://www.crosscountryhealthcare.com/20220930",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ccrn_ProvisionForDoubtfulAccountsAndOtherAllowances": {
     "auth_ref": [],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Provision For Doubtful Accounts And Other Allowances",
        "label": "Provision For Doubtful Accounts And Other Allowances",
        "verboseLabel": "Provision for allowances"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccountsAndOtherAllowances",
     "nsuri": "http://www.crosscountryhealthcare.com/20220930",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ccrn_RestrictedStockAndPerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Stock And Performance Shares",
        "label": "Restricted Stock And Performance Shares [Member]",
        "terseLabel": "Restricted Stock And Performance Shares"
       }
      }
     },
     "localname": "RestrictedStockAndPerformanceSharesMember",
     "nsuri": "http://www.crosscountryhealthcare.com/20220930",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ccrn_RisksAndUncertaintiesPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Risks And Uncertainties",
        "label": "Risks And Uncertainties [Policy Text Block]",
        "terseLabel": "Risks and Uncertainties"
       }
      }
     },
     "localname": "RisksAndUncertaintiesPolicyTextBlock",
     "nsuri": "http://www.crosscountryhealthcare.com/20220930",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ccrn_SalesAllowanceBillingRelatedAdjustments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales Allowance, Billing-Related Adjustments",
        "label": "Sales Allowance, Billing-Related Adjustments",
        "terseLabel": "Sales allowance, billing-related adjustments"
       }
      }
     },
     "localname": "SalesAllowanceBillingRelatedAdjustments",
     "nsuri": "http://www.crosscountryhealthcare.com/20220930",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Indefinite Lived And Finite Lived Intangible Assets [Table]",
        "label": "Schedule Of Indefinite Lived And Finite Lived Intangible Assets [Table]",
        "terseLabel": "Schedule Of Indefinite Lived And Finite Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://www.crosscountryhealthcare.com/20220930",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ccrn_SecuredOvernightFinancingRateSOFRMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Secured Overnight Financing Rate (SOFR)",
        "label": "Secured Overnight Financing Rate (SOFR) [Member]",
        "terseLabel": "SOFR"
       }
      }
     },
     "localname": "SecuredOvernightFinancingRateSOFRMember",
     "nsuri": "http://www.crosscountryhealthcare.com/20220930",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ccrn_SegmentReportingUnallocatedCorporateExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Segment Reporting Unallocated Corporate Expenses",
        "label": "Segment Reporting Unallocated Corporate Expenses",
        "terseLabel": "Corporate overhead"
       }
      }
     },
     "localname": "SegmentReportingUnallocatedCorporateExpenses",
     "nsuri": "http://www.crosscountryhealthcare.com/20220930",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SEGMENTDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ccrn_SelectedIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Selected, Inc",
        "label": "Selected, Inc [Member]",
        "terseLabel": "Selected, Inc"
       }
      }
     },
     "localname": "SelectedIncMember",
     "nsuri": "http://www.crosscountryhealthcare.com/20220930",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSAdditionalInformationDetails",
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ccrn_SeniorSecuredAssetBasedLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Secured Asset-Based Loan [Member]",
        "label": "Senior Secured Asset-Based Loan [Member]",
        "terseLabel": "Senior Secured Asset-Based Loan"
       }
      }
     },
     "localname": "SeniorSecuredAssetBasedLoanMember",
     "nsuri": "http://www.crosscountryhealthcare.com/20220930",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails",
      "http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails",
      "http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails",
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAttainmentPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Performance Target Attainment Level, Percentage",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Performance Attainment Percentage",
        "terseLabel": "Performance attainment percentage"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAttainmentPercentage",
     "nsuri": "http://www.crosscountryhealthcare.com/20220930",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other than Options, Vested In Period, Net",
        "label": "Share-based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other than Options, Vested In Period, Net",
        "terseLabel": "Vested in period, net (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet",
     "nsuri": "http://www.crosscountryhealthcare.com/20220930",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Number Of Vesting Installments",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number Of Vesting Installments",
        "terseLabel": "Number of vesting installments"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments",
     "nsuri": "http://www.crosscountryhealthcare.com/20220930",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ccrn_ShareBasedPaymentAwardsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Payment Awards [Member]",
        "label": "Share-Based Payment Awards [Member]",
        "terseLabel": "Share-based Payment Awards"
       }
      }
     },
     "localname": "ShareBasedPaymentAwardsMember",
     "nsuri": "http://www.crosscountryhealthcare.com/20220930",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ccrn_StandbyLettersOfCreditSublimitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Standby Letters Of Credit Sublimit [Member]",
        "label": "Standby Letters Of Credit Sublimit [Member]",
        "terseLabel": "Standby Letters Of Credit Sublimit"
       }
      }
     },
     "localname": "StandbyLettersOfCreditSublimitMember",
     "nsuri": "http://www.crosscountryhealthcare.com/20220930",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ccrn_SwingLoansSublimitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Swing Loans Sublimit [Member]",
        "label": "Swing Loans Sublimit [Member]",
        "terseLabel": "Swingline Sublimit"
       }
      }
     },
     "localname": "SwingLoansSublimitMember",
     "nsuri": "http://www.crosscountryhealthcare.com/20220930",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ccrn_TemporaryStaffingServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Staffing Services [Member]",
        "label": "Temporary Staffing Services [Member]",
        "terseLabel": "Temporary Staffing Services"
       }
      }
     },
     "localname": "TemporaryStaffingServicesMember",
     "nsuri": "http://www.crosscountryhealthcare.com/20220930",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ccrn_ThresholdPeriodPastDueForPaymentOfServicesProvided": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold Period, Past Due For Payment Of Services Provided",
        "label": "Threshold Period, Past Due For Payment Of Services Provided",
        "terseLabel": "Threshold period, past due for payment of services provided"
       }
      }
     },
     "localname": "ThresholdPeriodPastDueForPaymentOfServicesProvided",
     "nsuri": "http://www.crosscountryhealthcare.com/20220930",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "ccrn_VariableAndOtherLeaseCost": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable And Other Lease, Cost",
        "label": "Variable And Other Lease, Cost",
        "terseLabel": "Variable and other lease costs"
       }
      }
     },
     "localname": "VariableAndOtherLeaseCost",
     "nsuri": "http://www.crosscountryhealthcare.com/20220930",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/LEASESLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ccrn_WorkforceSolutionsGroupIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Workforce Solutions Group, Inc.",
        "label": "Workforce Solutions Group, Inc. [Member]",
        "terseLabel": "Workforce Solutions Group, Inc."
       }
      }
     },
     "localname": "WorkforceSolutionsGroupIncMember",
     "nsuri": "http://www.crosscountryhealthcare.com/20220930",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSAdditionalInformationDetails",
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails",
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r607"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r602"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r604"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_DirectorMember": {
     "auth_ref": [
      "r184"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Director [Member]",
        "terseLabel": "Member of the Board of Directors"
       }
      }
     },
     "localname": "DirectorMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r258",
      "r259",
      "r260",
      "r261",
      "r281",
      "r315",
      "r354",
      "r356",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r587",
      "r589",
      "r600",
      "r601"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r258",
      "r259",
      "r260",
      "r261",
      "r281",
      "r315",
      "r354",
      "r356",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r587",
      "r589",
      "r600",
      "r601"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails",
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r179",
      "r259",
      "r260",
      "r333",
      "r335",
      "r537",
      "r586",
      "r588"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r179",
      "r259",
      "r260",
      "r333",
      "r335",
      "r537",
      "r586",
      "r588"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r239",
      "r258",
      "r259",
      "r260",
      "r261",
      "r281",
      "r315",
      "r343",
      "r354",
      "r356",
      "r383",
      "r384",
      "r385",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r587",
      "r589",
      "r600",
      "r601"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails",
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r239",
      "r258",
      "r259",
      "r260",
      "r261",
      "r281",
      "r315",
      "r343",
      "r354",
      "r356",
      "r383",
      "r384",
      "r385",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r587",
      "r589",
      "r600",
      "r601"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails",
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r184",
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]",
        "terseLabel": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Domain]",
        "terseLabel": "Title of Individual [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesAndLoansReceivableLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]",
        "terseLabel": "Accounts, Notes, Loans and Financing Receivable [Line Items]"
       }
      }
     },
     "localname": "AccountsNotesAndLoansReceivableLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.",
        "label": "Accounts Payable and Other Accrued Liabilities, Current",
        "terseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "AccountsPayableAndOtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock": {
     "auth_ref": [
      "r206"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss [Table Text Block]",
        "terseLabel": "Schedule of Allowance for Doubtful Accounts"
       }
      }
     },
     "localname": "AccountsReceivableAllowanceForCreditLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r185",
      "r186"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net of allowances of $12,763 in 2022 and $6,881 in 2021"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r12",
      "r234"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "terseLabel": "Property and equipment, accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r25",
      "r48",
      "r49",
      "r50",
      "r573",
      "r594",
      "r597"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r47",
      "r50",
      "r56",
      "r57",
      "r58",
      "r101",
      "r102",
      "r103",
      "r448",
      "r510",
      "r590",
      "r591"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Loss, net"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Weighted average useful life"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r23"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r101",
      "r102",
      "r103",
      "r388",
      "r389",
      "r390",
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r358",
      "r391",
      "r392"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Equity compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash provided by (used in) operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r387"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-Based Payment Arrangement, Expense",
        "verboseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "auth_ref": [
      "r29",
      "r191",
      "r201",
      "r202",
      "r205"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAllowanceforDoubtfulAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r29",
      "r191",
      "r201"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, allowance for credit losses"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]",
        "terseLabel": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableRollforward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAllowanceforDoubtfulAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": {
     "auth_ref": [
      "r204"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Writeoff",
        "negatedTerseLabel": "Write-Offs, net of Recoveries"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAllowanceforDoubtfulAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Shares excluded from diluted weighted average shares (shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetImpairmentCharges": {
     "auth_ref": [
      "r87",
      "r232"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
        "label": "Asset Impairment Charges",
        "netLabel": "Impairment charges",
        "terseLabel": "Impairment charges",
        "verboseLabel": "Impairment charges"
       }
      }
     },
     "localname": "AssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.crosscountryhealthcare.com/role/SEGMENTDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r16",
      "r95",
      "r163",
      "r169",
      "r175",
      "r197",
      "r265",
      "r266",
      "r267",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r276",
      "r277",
      "r445",
      "r449",
      "r470",
      "r521",
      "r523",
      "r557",
      "r572"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r9",
      "r32",
      "r95",
      "r197",
      "r265",
      "r266",
      "r267",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r276",
      "r277",
      "r445",
      "r449",
      "r470",
      "r521",
      "r523"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r460"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "terseLabel": "Deferred compensation asset"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSEstimatedFairValuesofFinancialAssetsandLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails",
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BaseRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum rate investor will accept.",
        "label": "Base Rate [Member]",
        "terseLabel": "Base Rate"
       }
      }
     },
     "localname": "BaseRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Accounting"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r353",
      "r355",
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSAdditionalInformationDetails",
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails",
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r353",
      "r355",
      "r421",
      "r422",
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSAdditionalInformationDetails",
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails",
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": {
     "auth_ref": [
      "r438"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of equity interests issued or issuable to acquire entity.",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares",
        "terseLabel": "Equity consideration for acquisition (shares)"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSAdditionalInformationDetails",
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable": {
     "auth_ref": [
      "r433",
      "r434"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.",
        "label": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable",
        "terseLabel": "Equity consideration for acquisition, value"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r432",
      "r435",
      "r439"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "terseLabel": "Earnout liabilities",
        "verboseLabel": "Earnout liability"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSAdditionalInformationDetails",
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent": {
     "auth_ref": [
      "r432",
      "r436"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Liability, Current",
        "terseLabel": "Current portion of earnout liability",
        "verboseLabel": "Current portion of earnout liability"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSAdditionalInformationDetails",
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent": {
     "auth_ref": [
      "r432",
      "r436"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Liability, Noncurrent",
        "terseLabel": "Non-current earnout liability"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r427",
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "ACQUISITIONS"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "auth_ref": [
      "r424"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 7.0,
       "parentTag": "ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability": {
     "auth_ref": [
      "r423",
      "r424"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of liability arising from an inherited contingency (as defined) which has been recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Contingent Liability",
        "terseLabel": "Earnout liability"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther": {
     "auth_ref": [
      "r424"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 5.0,
       "parentTag": "ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r424"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 2.0,
       "parentTag": "ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "auth_ref": [
      "r424"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable",
        "terseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r423",
      "r424"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 6.0,
       "parentTag": "ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Other intangible assets",
        "verboseLabel": "Other intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSAdditionalInformationDetails",
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "auth_ref": [
      "r424"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities",
        "totalLabel": "Total liabilities assumed"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r423",
      "r424"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 4.0,
       "parentTag": "ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Property and equipment"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r424"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "totalLabel": "Net assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessExitCosts1": {
     "auth_ref": [
      "r87"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Includes, but is not limited to, one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and termination benefits associated with an ongoing benefit arrangement. Excludes expenses associated with special or contractual termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Business Exit Costs",
        "terseLabel": "Early termination benefit"
       }
      }
     },
     "localname": "BusinessExitCosts1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRestructuringBenefitsCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CarryingReportedAmountFairValueDisclosureMember": {
     "auth_ref": [
      "r468",
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as reported on the statement of financial position (balance sheet).",
        "label": "Reported Value Measurement [Member]",
        "terseLabel": "Carrying Amount"
       }
      }
     },
     "localname": "CarryingReportedAmountFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r7",
      "r11",
      "r89"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r84",
      "r89",
      "r90"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents at end of period",
        "periodStartLabel": "Cash and cash equivalents at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r84",
      "r479"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Change in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r41",
      "r561",
      "r577"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r255",
      "r256",
      "r257",
      "r262",
      "r599"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONTINGENCIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Shares reserved for share-based payments (in shares)"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r101",
      "r102",
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r21",
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Unrestricted shares of common stock outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r21",
      "r523"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r52",
      "r54",
      "r55",
      "r63",
      "r565",
      "r580"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r62",
      "r72",
      "r564",
      "r579"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "COMPREHENSIVE INCOME"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/COMPREHENSIVEINCOME"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r92",
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Nature of Business"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock": {
     "auth_ref": [
      "r247",
      "r248",
      "r254"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and reporting costs associated with exiting, disposing of, and restructuring certain operations.",
        "label": "Costs Associated with Exit or Disposal Activities or Restructurings, Policy [Policy Text Block]",
        "terseLabel": "Restructuring Costs"
       }
      }
     },
     "localname": "CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails",
      "http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails",
      "http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails",
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails",
      "http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails",
      "http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails",
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSAdditionalInformationDetails",
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DatabasesMember": {
     "auth_ref": [
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exclusive legal rights granted to the owner or licensee of collections of information stored in electronic form (such as on computer disks or files).",
        "label": "Database Rights [Member]",
        "terseLabel": "Databases"
       }
      }
     },
     "localname": "DatabasesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSAdditionalInformationDetails",
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r93",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r295",
      "r302",
      "r303",
      "r305",
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "DEBT"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r17",
      "r18",
      "r19",
      "r94",
      "r99",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r285",
      "r291",
      "r292",
      "r293",
      "r294",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r308",
      "r309",
      "r310",
      "r311",
      "r491",
      "r558",
      "r559",
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2021TermLoanCreditAgreementNarrativeDetails",
      "http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails",
      "http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Interest margin percentage"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails",
      "http://www.crosscountryhealthcare.com/role/DEBT2021TermLoanCreditAgreementNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r19",
      "r306",
      "r559",
      "r571"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-Term Debt, Gross",
        "totalLabel": "Total debt"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails",
      "http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r278",
      "r308",
      "r309",
      "r489",
      "r491",
      "r492"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Face amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2021TermLoanCreditAgreementNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r293",
      "r308",
      "r309",
      "r467"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "verboseLabel": "Note payable, fair value"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "auth_ref": [
      "r38",
      "r307",
      "r489",
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "terseLabel": "Effective interest rate percentage"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r38",
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Stated interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2021TermLoanCreditAgreementNarrativeDetails",
      "http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails",
      "http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r39",
      "r94",
      "r99",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r285",
      "r291",
      "r292",
      "r293",
      "r294",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r308",
      "r309",
      "r310",
      "r311",
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2021TermLoanCreditAgreementNarrativeDetails",
      "http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails",
      "http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentPeriodicPaymentPrincipal": {
     "auth_ref": [
      "r39"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the required periodic payments applied to principal.",
        "label": "Debt Instrument, Periodic Payment, Principal",
        "terseLabel": "Quarterly installment amount"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPaymentPrincipal",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2021TermLoanCreditAgreementNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r39",
      "r94",
      "r99",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r285",
      "r291",
      "r292",
      "r293",
      "r294",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r304",
      "r308",
      "r309",
      "r310",
      "r311",
      "r317",
      "r318",
      "r319",
      "r320",
      "r488",
      "r489",
      "r491",
      "r492",
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2021TermLoanCreditAgreementNarrativeDetails",
      "http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails",
      "http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Debt term"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2021TermLoanCreditAgreementNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "auth_ref": [
      "r291",
      "r490"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Net",
        "negatedTerseLabel": "Debt Issuance Costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r394",
      "r395"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Non-current deferred tax assets"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r87",
      "r96",
      "r404",
      "r412",
      "r413",
      "r414"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income tax expense"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r394",
      "r395"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Non-current deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r402"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "terseLabel": "Valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r87",
      "r158"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "netLabel": "Depreciation and amortization",
        "terseLabel": "Depreciation and amortization",
        "verboseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.crosscountryhealthcare.com/role/SEGMENTDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DirectOperatingCosts": {
     "auth_ref": [
      "r68"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 7.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate direct operating costs incurred during the reporting period.",
        "label": "Direct Operating Costs",
        "terseLabel": "Direct operating expenses"
       }
      }
     },
     "localname": "DirectOperatingCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r333",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r333"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Schedule of Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/REVENUERECOGNITIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r233",
      "r238"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that has been sold. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]",
        "terseLabel": "Sale of business"
       }
      }
     },
     "localname": "DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r64",
      "r110",
      "r111",
      "r112",
      "r113",
      "r114",
      "r121",
      "r124",
      "r134",
      "r135",
      "r136",
      "r140",
      "r141",
      "r455",
      "r456",
      "r566",
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Net income per share attributable to common stockholders - Basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREComponentsofNumeratorandDenominatorforComputationofBasicandDilutedEarningsperShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r64",
      "r110",
      "r111",
      "r112",
      "r113",
      "r114",
      "r124",
      "r134",
      "r135",
      "r136",
      "r140",
      "r141",
      "r455",
      "r456",
      "r566",
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Net income per share attributable to common stockholders - Diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREComponentsofNumeratorandDenominatorforComputationofBasicandDilutedEarningsperShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r137",
      "r138",
      "r139",
      "r142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "EARNINGS PER SHARE"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/EARNINGSPERSHARE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r479"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "terseLabel": "Effect of exchange rate changes on cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r36"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued compensation and benefits"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeSeveranceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Employee Severance [Member]",
        "terseLabel": "Employee Termination"
       }
      }
     },
     "localname": "EmployeeSeveranceMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRestructuringBenefitsCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r56",
      "r57",
      "r58",
      "r101",
      "r102",
      "r103",
      "r107",
      "r115",
      "r117",
      "r143",
      "r198",
      "r316",
      "r321",
      "r388",
      "r389",
      "r390",
      "r405",
      "r406",
      "r454",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r510",
      "r590",
      "r591",
      "r592"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r293",
      "r308",
      "r309",
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as an estimate of fair value.",
        "label": "Estimate of Fair Value Measurement [Member]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSEstimatedFairValuesofFinancialAssetsandLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r460",
      "r461",
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSEstimatedFairValuesofFinancialAssetsandLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "auth_ref": [
      "r462"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of asset.",
        "label": "Asset Class [Domain]",
        "terseLabel": "Asset Class [Domain]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSEstimatedFairValuesofFinancialAssetsandLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "auth_ref": [
      "r460",
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of asset.",
        "label": "Asset Class [Axis]",
        "terseLabel": "Asset Class [Axis]"
       }
      }
     },
     "localname": "FairValueByAssetClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSEstimatedFairValuesofFinancialAssetsandLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTextBlock": {
     "auth_ref": [
      "r460",
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]",
        "terseLabel": "Schedule of Carrying Amounts and Estimated Fair Values of Significant Financial Instrument that were not Measured at Fair Value"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r293",
      "r308",
      "r309",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r352",
      "r461",
      "r526",
      "r527",
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails",
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSEstimatedFairValuesofFinancialAssetsandLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "auth_ref": [
      "r463",
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of liability.",
        "label": "Liability Class [Axis]",
        "terseLabel": "Liability Class [Axis]"
       }
      }
     },
     "localname": "FairValueByLiabilityClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSEstimatedFairValuesofFinancialAssetsandLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "auth_ref": [
      "r293",
      "r308",
      "r309",
      "r460",
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement basis.",
        "label": "Measurement Basis [Axis]",
        "terseLabel": "Measurement Basis [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementBasisAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "auth_ref": [
      "r293",
      "r308",
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.",
        "label": "Fair Value Measurement [Domain]",
        "terseLabel": "Fair Value Measurement [Domain]"
       }
      }
     },
     "localname": "FairValueDisclosureItemAmountsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "FAIR VALUE MEASUREMENTS"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r293",
      "r344",
      "r345",
      "r350",
      "r352",
      "r461",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSEstimatedFairValuesofFinancialAssetsandLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r293",
      "r308",
      "r309",
      "r344",
      "r345",
      "r350",
      "r352",
      "r461",
      "r527"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations": {
     "auth_ref": [
      "r460",
      "r461"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of obligations measured on a recurring basis.",
        "label": "Obligations, Fair Value Disclosure",
        "terseLabel": "Deferred compensation liability"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisObligations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSEstimatedFairValuesofFinancialAssetsandLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "auth_ref": [
      "r462"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents classes of liabilities measured and disclosed at fair value.",
        "label": "Fair Value by Liability Class [Domain]",
        "terseLabel": "Fair Value by Liability Class [Domain]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSEstimatedFairValuesofFinancialAssetsandLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r293",
      "r308",
      "r309",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r352",
      "r526",
      "r527",
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value, Measurements, Fair Value Hierarchy [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails",
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSEstimatedFairValuesofFinancialAssetsandLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOptionQuantitativeDisclosuresLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Option, Quantitative Disclosures [Line Items]",
        "terseLabel": "Fair Value, Option, Quantitative Disclosures [Line Items]"
       }
      }
     },
     "localname": "FairValueOptionQuantitativeDisclosuresLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueOptionQuantitativeDisclosuresTable": {
     "auth_ref": [
      "r471",
      "r472",
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value under fair value option.",
        "label": "Fair Value Option, Disclosures [Table]",
        "terseLabel": "Fair Value Option, Disclosures [Table]"
       }
      }
     },
     "localname": "FairValueOptionQuantitativeDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r14",
      "r226"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "verboseLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r227"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSEstimatedAnnualAmortizationExpenseDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSEstimatedAnnualAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSEstimatedAnnualAmortizationExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSEstimatedAnnualAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r227"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSEstimatedAnnualAmortizationExpenseDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSEstimatedAnnualAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r227"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSEstimatedAnnualAmortizationExpenseDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSEstimatedAnnualAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r227"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSEstimatedAnnualAmortizationExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSEstimatedAnnualAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r222",
      "r224",
      "r226",
      "r229",
      "r538",
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSAdditionalInformationDetails",
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r226",
      "r542"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Gross Carrying Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r222",
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSAdditionalInformationDetails",
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r226",
      "r538"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSEstimatedAnnualAmortizationExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "terseLabel": "Other intangible assets, net",
        "totalLabel": "Net Carrying Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails",
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSEstimatedAnnualAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Net [Abstract]",
        "terseLabel": "Intangible assets subject to amortization:"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r87",
      "r312",
      "r313"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedTerseLabel": "Loss on early extinguishment of debt"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r13",
      "r209",
      "r210",
      "r217",
      "r221",
      "r523",
      "r556"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 1.0,
       "parentTag": "ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
       "weight": 1.0
      },
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Goodwill, net of impairment loss, ending balance",
        "periodStartLabel": "Goodwill, net of impairment loss, beginning balance",
        "terseLabel": "Goodwill",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSAdditionalInformationDetails",
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r231"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillGross": {
     "auth_ref": [
      "r210",
      "r217",
      "r221"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Gross",
        "periodEndLabel": "Aggregate goodwill acquired, ending balance",
        "periodStartLabel": "Aggregate goodwill acquired, beginning balance"
       }
      }
     },
     "localname": "GoodwillGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": {
     "auth_ref": [
      "r210",
      "r217",
      "r221"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impaired, Accumulated Impairment Loss",
        "negatedPeriodEndLabel": "Accumulated impairment loss, ending balance",
        "negatedPeriodStartLabel": "Accumulated impairment loss, beginning balance"
       }
      }
     },
     "localname": "GoodwillImpairedAccumulatedImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r216",
      "r420"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Purchase Accounting Adjustments",
        "terseLabel": "Goodwill acquisition adjustment - Selected"
       }
      }
     },
     "localname": "GoodwillPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r87",
      "r230"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.",
        "label": "Impairment of Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Impairment of intangible assets (excluding goodwill)"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r60",
      "r163",
      "r168",
      "r171",
      "r174",
      "r177",
      "r555",
      "r562",
      "r568",
      "r582"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r236",
      "r243"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r243"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r97",
      "r398",
      "r401",
      "r403",
      "r410",
      "r415",
      "r417",
      "r418",
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/INCOMETAXES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExaminationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Tax Examination [Line Items]",
        "terseLabel": "Income Tax Examination [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxExaminationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxExaminationTable": {
     "auth_ref": [
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A summary of income tax examinations that an enterprise is currently subject to or that have been completed in the current period typically including a description of the examination, the jurisdiction conducting the examination, the tax year(s) under examination, the likelihood of an unfavorable settlement, the range of possible losses, the liability recorded, the Increase or Decrease in the liability from the prior period, and any penalties and interest that have been incurred or accrued.",
        "label": "Income Tax Examination [Table]",
        "terseLabel": "Income Tax Examination [Table]"
       }
      }
     },
     "localname": "IncomeTaxExaminationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r98",
      "r116",
      "r117",
      "r161",
      "r396",
      "r411",
      "r416",
      "r583"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "terseLabel": "Income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedLabel": "Prepaid expenses and other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Liabilities",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r125",
      "r126",
      "r127",
      "r136",
      "r360"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREComponentsofNumeratorandDenominatorforComputationofBasicandDilutedEarningsperShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "terseLabel": "Share-based awards (shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREComponentsofNumeratorandDenominatorforComputationofBasicandDilutedEarningsperShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill) [Abstract]",
        "terseLabel": "Intangible assets not subject to amortization:"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedTradeNames": {
     "auth_ref": [
      "r228"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 9.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the rights acquired through registration of a trade name to gain or protect exclusive use thereof for a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Trade Names",
        "terseLabel": "Trade names, indefinite-lived",
        "verboseLabel": "Trade names, indefinite-lived"
       }
      }
     },
     "localname": "IndefiniteLivedTradeNames",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InsuranceSettlementsReceivableCurrent": {
     "auth_ref": [
      "r22"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due in settlement of a claim for reimbursement from an insurance company when the Company has suffered a loss covered under an insurance policy. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.",
        "label": "Insurance Settlements Receivable, Current",
        "terseLabel": "Insurance recovery receivable"
       }
      }
     },
     "localname": "InsuranceSettlementsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InsuranceSettlementsReceivableNoncurrent": {
     "auth_ref": [
      "r15"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount due after one year of the balance sheet date (or one operating cycle, if longer) of amount due in settlement of a claim for reimbursement from an insurance company when the Company has suffered a loss covered under an insurance policy.",
        "label": "Insurance Settlements Receivable, Noncurrent",
        "terseLabel": "Non-current insurance recovery receivable"
       }
      }
     },
     "localname": "InsuranceSettlementsReceivableNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r59",
      "r157",
      "r487",
      "r490",
      "r567"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Schedule of Lease Costs"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Schedule of Operating Lease Maturity"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r506"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total minimum lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r506"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r506"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r506"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r506"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r506"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less: amount of lease payments representing interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "LEASES"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/LEASES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters of Credit Outstanding, Amount",
        "terseLabel": "Letters of credit outstanding"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r35",
      "r95",
      "r170",
      "r197",
      "r265",
      "r266",
      "r267",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r276",
      "r277",
      "r446",
      "r449",
      "r450",
      "r470",
      "r521",
      "r522"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r28",
      "r95",
      "r197",
      "r470",
      "r523",
      "r560",
      "r575"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and Stockholders' Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r10",
      "r37",
      "r95",
      "r197",
      "r265",
      "r266",
      "r267",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r276",
      "r277",
      "r446",
      "r449",
      "r450",
      "r470",
      "r521",
      "r522",
      "r523"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r584",
      "r585"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.",
        "label": "Liability for Claims and Claims Adjustment Expense",
        "terseLabel": "Long-term accrued claims"
       }
      }
     },
     "localname": "LiabilityForClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r19",
      "r559",
      "r571"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-Term Line of Credit",
        "verboseLabel": "Line of credit, carrying amount"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityExpirationPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period remaining on line of credit facility before it terminates, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Line of Credit Facility, Expiration Period",
        "terseLabel": "Line of credit term"
       }
      }
     },
     "localname": "LineOfCreditFacilityExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Line of Credit Facility [Line Items]",
        "terseLabel": "Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r33"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "auth_ref": [
      "r33"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).",
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "terseLabel": "Borrowing availability"
       }
      }
     },
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "auth_ref": [
      "r33",
      "r94"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Line of Credit Facility [Table]",
        "terseLabel": "Line of Credit Facility [Table]"
       }
      }
     },
     "localname": "LineOfCreditFacilityTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.",
        "label": "Line of Credit Facility, Unused Capacity, Commitment Fee Percentage",
        "terseLabel": "Quarterly commitment fee on the average daily unused portion percentage"
       }
      }
     },
     "localname": "LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Senior Secured Asset-Based Loan"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails",
      "http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LinesOfCreditFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time.",
        "label": "Lines of Credit, Fair Value Disclosure",
        "terseLabel": "Senior Secured Asset-Based Loan"
       }
      }
     },
     "localname": "LinesOfCreditFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "LIBOR"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2021TermLoanCreditAgreementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebtByMaturityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Long-term Debt, Fiscal Year Maturity [Abstract]"
       }
      }
     },
     "localname": "LongTermDebtByMaturityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r34"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-Term Debt, Current Maturities",
        "terseLabel": "Current portion of debt",
        "verboseLabel": "Less current portion"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r99",
      "r263",
      "r297"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r99",
      "r263",
      "r297"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r99",
      "r263",
      "r297"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r99",
      "r263",
      "r297"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.",
        "label": "Long-Term Debt, Maturity, Remainder of Fiscal Year",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r19"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "verboseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2021TermLoanCreditAgreementNarrativeDetails",
      "http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails",
      "http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails",
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r39",
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2021TermLoanCreditAgreementNarrativeDetails",
      "http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails",
      "http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails",
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "auth_ref": [
      "r321"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.",
        "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedTerseLabel": "Distribution to noncontrolling shareholder"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromRedemptions": {
     "auth_ref": [
      "r321",
      "r443",
      "r444"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).",
        "label": "Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests",
        "negatedTerseLabel": "Dissolution of noncontrolling interest"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromRedemptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash (used in) provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r84",
      "r85",
      "r88"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by (used in) operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r5",
      "r51",
      "r53",
      "r58",
      "r61",
      "r88",
      "r95",
      "r106",
      "r110",
      "r111",
      "r112",
      "r113",
      "r116",
      "r117",
      "r132",
      "r163",
      "r168",
      "r171",
      "r174",
      "r177",
      "r197",
      "r265",
      "r266",
      "r267",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r276",
      "r277",
      "r456",
      "r470",
      "r563",
      "r578"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Consolidated net income",
        "totalLabel": "Net income attributable to common stockholders",
        "verboseLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r110",
      "r111",
      "r112",
      "r113",
      "r121",
      "r122",
      "r133",
      "r136",
      "r163",
      "r168",
      "r171",
      "r174",
      "r177"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "terseLabel": "Net income attributable to common stockholders - Basic and Diluted - Basic"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREComponentsofNumeratorandDenominatorforComputationofBasicandDilutedEarningsperShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
     "auth_ref": [
      "r123",
      "r128",
      "r129",
      "r130",
      "r131",
      "r133",
      "r136"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted",
        "terseLabel": "Net income attributable to common stockholders - Basic and Diluted - Diluted"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREComponentsofNumeratorandDenominatorforComputationofBasicandDilutedEarningsperShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]",
        "terseLabel": "Numerator:"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREComponentsofNumeratorandDenominatorforComputationofBasicandDilutedEarningsperShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update and Change in Accounting Principle [Abstract]",
        "terseLabel": "New Accounting Pronouncements and Changes in Accounting Principles [Abstract]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r2",
      "r104",
      "r105",
      "r108",
      "r109",
      "r118",
      "r119",
      "r120",
      "r195",
      "r196",
      "r199",
      "r200",
      "r407",
      "r408",
      "r409",
      "r453",
      "r457",
      "r458",
      "r459",
      "r474",
      "r475",
      "r476",
      "r493",
      "r494",
      "r509",
      "r511",
      "r539",
      "r540",
      "r541",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Text Block]",
        "terseLabel": "RECENT ACCOUNTING PRONOUNCEMENTS"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/RECENTACCOUNTINGPRONOUNCEMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Accounting Pronouncement"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncompeteAgreementsMember": {
     "auth_ref": [
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.",
        "label": "Noncompete Agreements [Member]",
        "terseLabel": "Non-compete agreements"
       }
      }
     },
     "localname": "NoncompeteAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r101",
      "r102",
      "r103",
      "r321",
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Noncontrolling Interest in Subsidiary"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other expenses (income):"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NotesPayableOtherPayablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A written promise to pay a note to a third party.",
        "label": "Notes Payable, Other Payables [Member]",
        "terseLabel": "Note Payable"
       }
      }
     },
     "localname": "NotesPayableOtherPayablesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r163",
      "r168",
      "r171",
      "r174",
      "r177"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Income from operations",
        "totalLabel": "Income from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.crosscountryhealthcare.com/role/SEGMENTDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r499",
      "r507"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease expense"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/LEASESLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseImpairmentLoss": {
     "auth_ref": [
      "r495"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from impairment of right-of-use asset from operating lease.",
        "label": "Operating Lease, Impairment Loss",
        "terseLabel": "Operating lease, impairment loss"
       }
      }
     },
     "localname": "OperatingLeaseImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/LEASESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r497"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "totalLabel": "Present value of future minimum lease payments"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r497"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "negatedLabel": "Less: operating lease liabilities - current",
        "terseLabel": "Operating lease liabilities - current",
        "verboseLabel": "Operating lease liabilities - current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails",
      "http://www.crosscountryhealthcare.com/role/LEASESSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r497"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating lease liabilities - non-current",
        "verboseLabel": "Operating lease liabilities - non-current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails",
      "http://www.crosscountryhealthcare.com/role/LEASESSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r498",
      "r501"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Cash paid for amounts included in the measurement of operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/LEASESLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r496"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets",
        "verboseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.crosscountryhealthcare.com/role/LEASESSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r504",
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted average discount rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/LEASESSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r503",
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted average remaining lease term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/LEASESSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r6",
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "ORGANIZATION AND BASIS OF PRESENTATION"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ORGANIZATIONANDBASISOFPRESENTATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r31",
      "r523"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r15"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other non-current assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r46",
      "r48",
      "r477",
      "r478",
      "r480"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax",
        "terseLabel": "Unrealized foreign currency translation loss, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r45"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustment, net of taxes"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r36",
      "r523"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLongTermDebtNoncurrent": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt classified as other, payable after one year or the operating cycle, if longer.",
        "label": "Other Long-Term Debt, Noncurrent",
        "terseLabel": "Long-term debt, less current portion"
       }
      }
     },
     "localname": "OtherLongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedTerseLabel": "Other non-cash costs"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r71"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "negatedLabel": "Other income, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.",
        "label": "Payment for Contingent Consideration Liability, Financing Activities",
        "negatedTerseLabel": "Payment of contingent consideration",
        "terseLabel": "Payment of contingent consideration"
       }
      }
     },
     "localname": "PaymentForContingentConsiderationLiabilityFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSAdditionalInformationDetails",
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedTerseLabel": "Stock repurchase and retirement"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRestructuring": {
     "auth_ref": [
      "r83",
      "r242"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.",
        "label": "Payments for Restructuring",
        "negatedTerseLabel": "Payments"
       }
      }
     },
     "localname": "PaymentsForRestructuring",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRestructuringBenefitsCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtExtinguishmentCosts": {
     "auth_ref": [
      "r81"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.",
        "label": "Payment for Debt Extinguishment or Debt Prepayment Cost",
        "verboseLabel": "Prepayment premium paid"
       }
      }
     },
     "localname": "PaymentsOfDebtExtinguishmentCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2021TermLoanCreditAgreementNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments of Debt Issuance Costs",
        "negatedTerseLabel": "Debt issuance costs"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-Based Payment Arrangement",
        "negatedTerseLabel": "Cash paid for shares withheld for taxes"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r73",
      "r437"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Cash consideration, gross"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Acquisitions, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance Stock Awards"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails",
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYRestrictedStockActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r466"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured at fair value for financial reporting purposes.",
        "label": "Portion at Fair Value Measurement [Member]",
        "terseLabel": "Portion at Fair Value Measurement"
       }
      }
     },
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "auth_ref": [
      "r8",
      "r30",
      "r207",
      "r208"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense, Current",
        "terseLabel": "Prepaid expenses"
       }
      }
     },
     "localname": "PrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSecuredDebt": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from amounts received from issuance of long-term debt that is wholly or partially secured by collateral. Excludes proceeds from tax exempt secured debt.",
        "label": "Proceeds from Issuance of Secured Debt",
        "terseLabel": "Proceeds from term loan"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSecuredDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLongTermLinesOfCredit": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.",
        "label": "Proceeds from Long-Term Lines of Credit",
        "verboseLabel": "Borrowings under Senior Secured Asset-Based revolving credit facility"
       }
      }
     },
     "localname": "ProceedsFromLongTermLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r76",
      "r82"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r235",
      "r523",
      "r569",
      "r576"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net of accumulated depreciation of $19,846 in 2022 and $17,729 in 2021"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r65",
      "r203"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 6.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Bad debt expense",
        "verboseLabel": "Bad Debt Expense"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAllowanceforDoubtfulAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable": {
     "auth_ref": [
      "r168",
      "r171"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]",
        "terseLabel": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SEGMENTDATADetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r168",
      "r171"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]",
        "terseLabel": "Schedule of Information on Operating Segments and Reconciliation to Income from Operations"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SEGMENTDATATables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r351",
      "r514",
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/RELATEDPARTYTRANSACTIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Related Party Transaction [Line Items]",
        "terseLabel": "Related Party Transaction [Line Items]"
       }
      }
     },
     "localname": "RelatedPartyTransactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/RELATEDPARTYTRANSACTIONSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]",
        "terseLabel": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r351",
      "r514",
      "r518",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/RELATEDPARTYTRANSACTIONSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r512",
      "r513",
      "r515",
      "r519",
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "terseLabel": "RELATED PARTY TRANSACTIONS"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/RELATEDPARTYTRANSACTIONS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfLongTermLinesOfCredit": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.",
        "label": "Repayments of Long-Term Lines of Credit",
        "negatedLabel": "Repayments on Senior Secured Asset-Based revolving credit facility"
       }
      }
     },
     "localname": "RepaymentsOfLongTermLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfNotesPayable": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.",
        "label": "Repayments of Notes Payable",
        "negatedTerseLabel": "Principal payments on note payable"
       }
      }
     },
     "localname": "RepaymentsOfNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfSecuredDebt": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt.",
        "label": "Repayments of Secured Debt",
        "negatedLabel": "Principal payments on term loan"
       }
      }
     },
     "localname": "RepaymentsOfSecuredDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted Stock Awards"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails",
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYRestrictedStockActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r87",
      "r240",
      "r247",
      "r251"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "netLabel": "Restructuring costs",
        "terseLabel": "Restructuring costs",
        "verboseLabel": "Charged to restructuring"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.crosscountryhealthcare.com/role/SEGMENTDATADetails",
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRestructuringBenefitsCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [
      "r241",
      "r242",
      "r251",
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRestructuringBenefitsCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRestructuringBenefitsCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r242",
      "r249"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRestructuringBenefitsCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Restructuring Reserve [Roll Forward]",
        "terseLabel": "Restructuring Reserve [Roll Forward]"
       }
      }
     },
     "localname": "RestructuringReserveRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRestructuringBenefitsCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r24",
      "r321",
      "r523",
      "r574",
      "r593",
      "r597"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings (accumulated deficit)"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r101",
      "r102",
      "r103",
      "r107",
      "r115",
      "r117",
      "r198",
      "r388",
      "r389",
      "r390",
      "r405",
      "r406",
      "r454",
      "r590",
      "r592"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "(Accumulated Deficit) Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r154",
      "r155",
      "r167",
      "r172",
      "r173",
      "r179",
      "r180",
      "r182",
      "r332",
      "r333",
      "r537"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Revenue from services",
        "verboseLabel": "Revenue from services:"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.crosscountryhealthcare.com/role/REVENUERECOGNITIONDetails",
      "http://www.crosscountryhealthcare.com/role/SEGMENTDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList": {
     "auth_ref": [
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates product and service for revenue from satisfaction of performance obligation by transferring promised product and service to customer.",
        "label": "Revenue from Contract with Customer, Product and Service [Extensible Enumeration]",
        "terseLabel": "Revenue from Contract with Customer, Product and Service [Extensible List]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerProductAndServiceExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r334",
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "REVENUE RECOGNITION"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/REVENUERECOGNITION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromRelatedParties": {
     "auth_ref": [
      "r67",
      "r268",
      "r270",
      "r271",
      "r275",
      "r276",
      "r277",
      "r598"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.",
        "label": "Revenue from Related Parties",
        "terseLabel": "Revenue from related parties"
       }
      }
     },
     "localname": "RevenueFromRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/RELATEDPARTYTRANSACTIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r502",
      "r507"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Right-of-use assets acquired under operating lease"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/LEASESLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule itemizing specific types of trade accounts and notes receivable, and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]",
        "terseLabel": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of Antidilutive Securities"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/EARNINGSPERSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r421",
      "r422",
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSAdditionalInformationDetails",
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r39",
      "r99",
      "r308",
      "r310",
      "r317",
      "r318",
      "r319",
      "r320",
      "r488",
      "r489",
      "r492",
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Long-term Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Components of Numerator and Denominator for Computation of Basic and Diluted Earnings per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/EARNINGSPERSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r460",
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Estimated Fair Values of Financial Assets and Liabilities Measured on a Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Changes in Carrying Amount of Goodwill by Segment"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": {
     "auth_ref": [
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.",
        "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Acquired Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r263"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]",
        "terseLabel": "Schedule of Aggregate Scheduled Maturities of Debt"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Summary of Fair Value of Assets Acquired and Liabilities Assumed"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "auth_ref": [
      "r516",
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Schedule of Related Party Transactions, by Related Party [Table]",
        "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/RELATEDPARTYTRANSACTIONSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r241",
      "r242",
      "r243",
      "r244",
      "r251",
      "r252",
      "r253"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRestructuringBenefitsCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r245",
      "r246",
      "r250"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "terseLabel": "Schedule of Restructuring and Related Costs"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r357",
      "r359",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails",
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Summary of Restricted Stock Activity"
       }
      }
     },
     "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Schedule of Estimated Annual Amortization Expense"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.",
        "label": "Secured Debt [Member]",
        "terseLabel": "Term Loan"
       }
      }
     },
     "localname": "SecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2021TermLoanCreditAgreementNarrativeDetails",
      "http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails",
      "http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails",
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r151",
      "r154",
      "r155",
      "r156",
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r177",
      "r182",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r221",
      "r244",
      "r253",
      "r586"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]",
        "verboseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails",
      "http://www.crosscountryhealthcare.com/role/REVENUERECOGNITIONDetails",
      "http://www.crosscountryhealthcare.com/role/SEGMENTDATADetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r151",
      "r152",
      "r153",
      "r163",
      "r166",
      "r171",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r181",
      "r182",
      "r183"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "SEGMENT DATA"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SEGMENTDATA"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]",
        "terseLabel": "Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SEGMENTDATADetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 5.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "Selling, General and Administrative Expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Equity compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "terseLabel": "Vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedTerseLabel": "Forfeited (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r372",
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Unvested restricted stock awards, ending balance (shares)",
        "periodStartLabel": "Unvested restricted stock awards, beginning balance (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Number of Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r372",
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Unvested restricted stock awards, ending balance (in dollars per share)",
        "periodStartLabel": "Unvested restricted stock awards, beginning balance (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedTerseLabel": "Vested (in shares)",
        "terseLabel": "Vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails",
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails",
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails",
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYRestrictedStockActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]",
        "terseLabel": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the share repurchase program.",
        "label": "Share Repurchase Program [Domain]",
        "terseLabel": "Share Repurchase Program [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted Average Grant Date Fair Value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r323",
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).",
        "label": "Shareholders' Equity and Share-Based Payments [Text Block]",
        "terseLabel": "STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "ShareholdersEquityAndShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITY"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending balance (shares)",
        "periodStartLabel": "Beginning balance (shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermLeaseCost": {
     "auth_ref": [
      "r500",
      "r507"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.",
        "label": "Short-Term Lease, Cost",
        "terseLabel": "Short-term lease expense"
       }
      }
     },
     "localname": "ShortTermLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/LEASESLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r91",
      "r100"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SoftwareDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Internally developed software for sale, licensing or long-term internal use.",
        "label": "Software Development [Member]",
        "terseLabel": "Software"
       }
      }
     },
     "localname": "SoftwareDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSAdditionalInformationDetails",
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r3",
      "r151",
      "r154",
      "r155",
      "r156",
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r177",
      "r182",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r221",
      "r237",
      "r244",
      "r253",
      "r586"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]",
        "verboseLabel": "Business Segments"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails",
      "http://www.crosscountryhealthcare.com/role/REVENUERECOGNITIONDetails",
      "http://www.crosscountryhealthcare.com/role/SEGMENTDATADetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r43",
      "r56",
      "r57",
      "r58",
      "r101",
      "r102",
      "r103",
      "r107",
      "r115",
      "r117",
      "r143",
      "r198",
      "r316",
      "r321",
      "r388",
      "r389",
      "r390",
      "r405",
      "r406",
      "r454",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r510",
      "r590",
      "r591",
      "r592"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r101",
      "r102",
      "r103",
      "r143",
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "auth_ref": [
      "r20",
      "r21",
      "r321"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.",
        "label": "Stock Issued During Period, Shares, Acquisitions",
        "terseLabel": "Acquisition of WSG (shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r20",
      "r21",
      "r316",
      "r321"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Vesting of restricted stock (shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueAcquisitions": {
     "auth_ref": [
      "r43",
      "r316",
      "r321"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued pursuant to acquisitions during the period.",
        "label": "Stock Issued During Period, Value, Acquisitions",
        "terseLabel": "Acquisition of WSG"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r20",
      "r21",
      "r321",
      "r378"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Vesting of restricted stock"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Stock repurchase program, authorized amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Common shares amount left remaining to repurchase under the plan (up to)"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": {
     "auth_ref": [
      "r20",
      "r21",
      "r316",
      "r321"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased and retired during the period.",
        "label": "Stock Repurchased and Retired During Period, Shares",
        "negatedTerseLabel": "Shares repurchased and retired (in shares)",
        "terseLabel": "Shares repurchased and retired (in shares)"
       }
      }
     },
     "localname": "StockRepurchasedAndRetiredDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodValue": {
     "auth_ref": [
      "r20",
      "r21",
      "r316",
      "r321"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).",
        "label": "Stock Repurchased and Retired During Period, Value",
        "negatedTerseLabel": "Stock repurchase and retirement",
        "terseLabel": "Stock repurchase and retirement"
       }
      }
     },
     "localname": "StockRepurchasedAndRetiredDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r21",
      "r26",
      "r27",
      "r95",
      "r193",
      "r197",
      "r470",
      "r523"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders' equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r0",
      "r1",
      "r57",
      "r95",
      "r101",
      "r102",
      "r103",
      "r107",
      "r115",
      "r197",
      "r198",
      "r321",
      "r388",
      "r389",
      "r390",
      "r405",
      "r406",
      "r441",
      "r442",
      "r451",
      "r454",
      "r470",
      "r481",
      "r482",
      "r486",
      "r510",
      "r591",
      "r592"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]",
        "terseLabel": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r524",
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "SUBSEQUENT EVENTS"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SUBSEQUENTEVENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TaxesPayableCurrent": {
     "auth_ref": [
      "r34"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Taxes Payable, Current",
        "terseLabel": "Income tax payable"
       }
      }
     },
     "localname": "TaxesPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TradeAndOtherAccountsReceivablePolicy": {
     "auth_ref": [
      "r187",
      "r188",
      "r189",
      "r190",
      "r192",
      "r194"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for accounts receivable.",
        "label": "Accounts Receivable [Policy Text Block]",
        "terseLabel": "Accounts Receivable, net"
       }
      }
     },
     "localname": "TradeAndOtherAccountsReceivablePolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "terseLabel": "Trade names"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSAdditionalInformationDetails",
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockAcquiredAverageCostPerShare": {
     "auth_ref": [
      "r322"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.",
        "label": "Treasury Stock Acquired, Average Cost Per Share",
        "terseLabel": "Average market price (in usd per share)"
       }
      }
     },
     "localname": "TreasuryStockAcquiredAverageCostPerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [
      "r241",
      "r242",
      "r251",
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRestructuringBenefitsCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnbilledContractsReceivable": {
     "auth_ref": [
      "r536"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unbilled amounts due for services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the entity and, at a minimum, one other party. An example would be amounts associated with contracts or programs where the recognized revenue for performance thereunder exceeds the amounts billed under the terms thereof as of the date of the balance sheet.",
        "label": "Unbilled Contracts Receivable",
        "terseLabel": "Unbilled contracts receivable"
       }
      }
     },
     "localname": "UnbilledContractsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r144",
      "r145",
      "r146",
      "r147",
      "r148",
      "r149",
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails",
      "http://www.crosscountryhealthcare.com/role/DEBT2021TermLoanCreditAgreementNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails",
      "http://www.crosscountryhealthcare.com/role/DEBT2021TermLoanCreditAgreementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted, Adjustment [Abstract]",
        "terseLabel": "Effect of diluted shares:"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREComponentsofNumeratorandDenominatorforComputationofBasicandDilutedEarningsperShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r123",
      "r136"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREComponentsofNumeratorandDenominatorforComputationofBasicandDilutedEarningsperShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (shares)",
        "totalLabel": "Weighted average common shares - Diluted (shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREComponentsofNumeratorandDenominatorforComputationofBasicandDilutedEarningsperShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted average common shares outstanding:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r121",
      "r136"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREComponentsofNumeratorandDenominatorforComputationofBasicandDilutedEarningsperShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (shares)",
        "verboseLabel": "Weighted average common shares - Basic (shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREComponentsofNumeratorandDenominatorforComputationofBasicandDilutedEarningsperShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]",
        "terseLabel": "Denominator:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREComponentsofNumeratorandDenominatorforComputationofBasicandDilutedEarningsperShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WriteOffOfDeferredDebtIssuanceCost": {
     "auth_ref": [
      "r70"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Write-off of amounts previously capitalized as debt issuance cost in an extinguishment of debt.",
        "label": "Write off of Deferred Debt Issuance Cost",
        "terseLabel": "Write off of debt issuance costs"
       }
      }
     },
     "localname": "WriteOffOfDeferredDebtIssuanceCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2021TermLoanCreditAgreementNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    }
   },
   "unitCount": 5
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=SL108384541-122693"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "https://asc.fasb.org/topic&trid=2122394"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e4975-111524"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5212-111524"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5093-111524"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(1)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(2)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "https://asc.fasb.org/topic&trid=2144416"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2420-110228"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2443-110228"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "b",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(4)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "https://asc.fasb.org/topic&trid=2303972"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569655-111683"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4616395-111683"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a-c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594809&loc=d3e13220-108610"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14172-108612"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14210-108612"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14217-108612"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=126980362&loc=d3e28129-110885"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123602790&loc=d3e30304-110892"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123399704&loc=SL77918431-209957"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/subtopic&trid=77888251"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "https://asc.fasb.org/topic&trid=2122745"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "https://asc.fasb.org/topic&trid=2122774"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=126938201&loc=d3e55302-109406"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(1)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(2)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(3)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(cc)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07.1(c))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691"
  },
  "r602": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r603": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r604": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r605": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r606": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r607": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1(e))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "https://asc.fasb.org/topic&trid=2134417"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>82
<FILENAME>0001628280-22-028033-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-22-028033-xbrl.zip
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M+XGQ>J\L >"MO.-,\R"8<K/M-\#1+-7ZE@KN<-E=]?!-UH+;'F?>+$3@FR*
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MP+ADV$>#A,78(?)3(O/J?J:I##&4H>U"YXD$64K+K7:J!"D(5:U*TZUVK\Y
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MT1"WI&(_A!&A+&,!":2L(<(PXV= ?GYU"+T4)LV"XVD+64&M3F793:3()*+
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MH)8/HIJB[8OV-O1Y:4W[="?& $U(Q[W=_FMG=PX$<_)&C;(HHTX3RH%#<6W
MLFGF5%1.<R(\&4@Q4.ZI7R+\JUJWAT)TEWB/J?Y Y$('2F6PEF'N-:8.1V$(
MUDB*P :Q/,;S90&WVZZLWICF\(@Y$*?[D3W\-PIGR7#$0DBAHR>,HZ@#-DY2
M1KD000HU_1(R*D1>5B37CN#=4?*DK:+7[N[$M6;S7='II%4 E;B.8UWUB&0&
M$T1#2*40&01KU!F+N=-&.RZ4DN&F;#&=_HJD"]?T.$\XGOJG@5@>F8_$.\.
ML8,,^1@"PMQ:'JP>I(\$H=GPS4*(IEB(JIP0H<\1H@>'_H00"<Q5-()*8STS
MD9H@/$,ZD!@%DZC:]1MKC C/AF^F58A>8 SK)R'%.M5%)OP9D#X\]&?JL\J
M2;!<2L29T2GPL4XAG$I>0PQ4E?]<(/D]GO\A.#\S#I26\DEFB115OVEN- 54
M&$M+,JWY)<'YYKVKZ]\="=[KV6;>RN^ZBKV+O'V4;M89_C@C(J&I#D(9:@UW
MC'AKJ+'&&,_2+%;47^@YG2+Q+%B@6[R]>ANZX&,[#P\<E0^?8XN!F(5 TBOL
MTH:9C"J(+L%)!^,0D6$P/Q5-\^#@M(%#T/W1MY\!QR AO>)6NL"X(QHS%I0+
M5#N)M!Y46T)T>A/D4P<.SA =S3"&2)O4R1"UTI(9#(KC(5R*V,JH5)!T?)F9
M2>49B$224. <WDJF@&T(YP(7,43B.$;#>8J43&UZ8>K$DR3Q)",I2:0I5B$X
MB+DPXYQ:$@)@0EF,GD=#!O$[@),M4/J1:/HN3M^(IN\>^A.A5ZIAKKTTFJ
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MNGQ+#J\./CG1V#^X/CCY .<=7-8_-9J-#<?K;_X^;GPZX(<GN\<'^W7:N/Y
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M&*6='Q6CP)H@WFB8CC?_J57;<-7JICP-W6]/GWCF0/!D%KBE#=U=F@1AKR!
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M6@?[!ZC>VH)G_GA\N+%V#=^3!H%GNOYX6M]2)*VGH8$8[53&!(.XAA.4@1/
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M$9?G'A[%M]-XZN+X;L,/SY?AD0\_E$KE!S%2%DS"D-5A$(EZJPR6LF-'SCM
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M%L/NV;@07;Z/49AE C4??[23&$KR<AQ.;+G$2F'+4-B'A;P?XQ,C 76V4"*
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MY@WI#/JH"LGU<N?'6]&.)V$J+=<7LCN->/Z=9W\"3B"2G+U:P&EIX+0W1SB
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MB7OI&<WA,*K:&,]O30LWRRQTLHEZO70'5='K>]?K&;JI5#3>"8J8X4 W#4M
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MUO#DD*4A1V@,0]9; G:)U#ERXU,*3:P=],1<)U4;\>(@>8!BTA<S]"]86)5
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MUN&;LYL7.2,?TTVA>C&O75BEZ/]6J^)J49'K'G?"(^ )8QR?7S\/"NZ1M[<
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MV).==W2NN;5^ B1. B[3*'RO"R0T5)OO-$!P$4#.P*,FW'68Y\CZX0!VIOX
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M#6/G[?_ !.$>16TQXD([Y)+7*&%F++;":Y> ="K>-GA9*0]-/.)S;0?K11+
M?](%^_8'=%9CE/>SFSWLDR_LFKKI<%?V1%*KU<D-?9?8C6@I,K]IB_F&S^Z=
M'E2ZEU,N*S;AJW%$J4ANF8>3EH+:Y=32HPO1E%-+3S[=E5B.C<264:-S%2''
M.>:!4<$HF$DQ7-D]N%C"C;6$_5SX!4LJC& FI[I(Q+$*R 6=<N5+9ITT3HBP
MMD';6+"V630:7LXM%>QZ."]>=$IY6+<D)6Y(LL1S2:04/&!'G2W8M7+8->/%
M\R$78-(\Y^;G;FN2(R>I1,:Q(*7B%(!M;4/*-J$+5LTOYY8*&#XJ,!14>.J2
MB<0GKH0V@3B!679W.\>L*F"X:F X&]+ 0,B53Q&E+$1.DP4BQSGR.FC+89:3
M3YG($8J!S"W8J*"<7"HGEWZE,XJ+@5L?O+6"<\J<$\;2Y%F,3L(**JBS6JAS
M,&<^IB0PYL&C&+5&/$J)+#4>>85I9"%9V''6-H1H,[%@J<1R=.G.U3-%JZ42
M*@4/ZIFH(SQJSAA61@IC7%'/E5//V<H.,4;FN$<\<8=XT![99"72 ,+$&IE4
M4ID4&+5@*MEJV4%%XZ<GF[1SFBN6J'8<%-L01:(4B0.$AQA,T?A5T_A9,\#Y
M"'"N)!(.2\2]S/7AA4-.4$*##B1@#QNR;C/V &>)GT3<K!QM*EFF-ZDC;VU2
MW%%"G.7"&1>MH;FAJ_9<^U!<,BN&Q9_GC",?,',^M^E@'"-N%4%&:((PM91I
MI9+&IG+)8-.FAJU*GFE)O"^0>#>0:+F+)#$14\1<1&==BCH8(G@DGOEBD*X>
M),XFWG.M(G<!I6@90*(PR#$F$:,FJ!0- \&O;4BS2JTU5CB>5S#VR6&L(\I&
ML 25Q)JG&)R+0%*D2%$ZQ3TM&+MJ&#L7"?0V$.$X$K";YG*N FE,%3),NQBD
MC@Y$FFFGTFUF%BQI5(XWE>--Y7C3;1+E?W:1IB7)7W/NZ0;'GA;JQ%2./2WY
MV-,-]**<JEFM\U!%I(_@H-3"0FSR%)<35.4$54F\_=$)*JP%)AHSZQR/E!J?
M<D$1&H+R 2SQ22T14FJ)K(2Y_>GU7)2'"2TLE@[!RF9U+5&K!4-8<$F2X8Q&
M,+>-)&V)E^737*$P3D&N)CW;0JU.J*$F4.FXX09^$.*<UO!R;H*B=$&NE4.N
M&4=A,,2IP /"TDC$C17(,A5R[SH;;. 6Y[.?7+?%HKE"Y?Q4 <-'!8;1.>*(
M8$Q@Q:60EGAL/0G,FR2CDP4,5PT,YTK"I<"<QKD&') WCE4.F#""F-5!)<:3
MPKD)7AMDW":\2>=)R_FIQYJN[2@F@B=F$E-<\62YS,BCB(G"$4T*ZJP6ZKR]
M(D702L8Y1KF@"N* "LCDI!C)94K> -7V=FV#LK:B"Q[9+.>G[EP]F1(A.JW@
MBQXV#&I5HE8$%DRD4?-""E9//6=(@>4\LI"[05D&=E$T!AD 7X1]U#B$%)(A
M=09O8QJSE?-3=ZCQ.E'C4J34.LJIU [6!Y98.TNEY384C5\UC9\U Z+"*6HM
M4&*!("Y<WI"M1PJ(%[8)T$#D,@JBK=D#-(-[$E&S6YR?F@2OK\CW*9FN2YN@
M1X/F 90Z-]45(0DNF3.82VL3PS:[>41!\Q5#\_=SYI7$"JQEEI!,1B">$O W
M8X'.&46XYX(RH]<VC!9MMK3:ALO3M(9']@KF%LQ=_-2KYU1HS23&B7,K;0Q
MI7DB-MCD,"N8NW*8.^M(IPDS3P%I/0/,E;DD4.021<>H](G#W@J8*W!;LB4?
M\6H<Y*Y$3++ >('QQ4_J.LMQI-YS3;AFRGI \H0UIHXX&HKK<^5@?"X>2@23
MQ$9$O'2(^ZB1!3$B;GE2/DBJLNN3M#$3;:.67+S@ 9'\)RZ6VT'ZG5[\*7^R
M2&T5/UDFMDSL:GVR3.PJ3FR16I%:^629V#*Q*_K):F+_/;9@"<+/T/VR,;4W
M.R='<=CU&_^I7KQGKPFM.\#"?V=V[MG8LKNDVS^QE3'\<*/[S\Q0:F>(-X0%
M[ VF'O-(L<$V6)H4RUW 4I!K&WLQMCJ#<6P1VD+3T]*M+3NVZ_./U[KC_R[/
M[ME<;E2'\N?>K!]1.*Y"()X%83E.24?,L37<1LIH4.(CEVMS5[P[Z<R=1:^D
MP]=K-\G\O_^YM+R74,+ILKOMCY,1#&8T>CXX<MU^)<6M[LCW!J.38=R'._W1
M&_C/#^PZZW2GKK._/N_N=XYV]U\>=;8\_K#_YM/.]QV^\^[-YP_[[[]UMC8)
M?(]]>/?/I[_9FU[\[YO3#^_"L:-<OC]Z+7;H>['S[CWN?'_3Z_P)W_Q^\.W#
MG_#[)[C_UC\PQM#[\*Z3=K[[KSM?/V*?VQXFB8PB&/%$(G*:.L2Y!F7Q@C"3
M:G<H*$ ,F]D!F7"R0C A4E!<>@I_4!$"+#L'$F)DK15'WAZ#!,;#$X"US>>O
MWV[O;>]O[W;VYJ#LYJO]2N7^^5@NCYUJ;9/3GD5L<@, QX6*(A%/)<-,FK6[
M59#JBL^Z8]OK^ANHS%[L13^.83%,>!CPW>VWMJ*O:^(06=?$:;?&A[$%>@?C
M.6T=GPS]H1W%T+)]^+__WY/N$/X8G;C1V(*0;*]WVH)_6H-4?<^.1G$\JC\\
M&L&"@2TT#L>V^__8^]*F-H^E[;^BXGV6<ZH8,OOBG***&.)#*A*Q+<</?*%F
M!6$M'"W&\.O?GEL2BX1L"01(^$XE1*![G>GKZF5ZNMN59L.Z1K/1;\#SP]'C
M<=JL[+?]5N4?X]__F:/F%7M]Y\HYR%S,9_S7(O%_S0-F46IG0:B,,)0;ZJP!
M0G*&)SR,_Q-*)!I_N!/_%Y.$])>]+.IQU#L[PT$8,U3LO>MV>KWY@OWR9V.L
MLQUZ3(R40M,B/D\15YXB*R@M6K+X9*5F"6]LLZU9"2X@^,V"/-H5;WNGFUGZ
MSD!6*OU.Q8:S0:^?9V:S$+H7E9%[E-;;3KO7"+%;_%+O E93[ *"]D"&^I?[
MN3)*[/5[^X 58+MVR!^R%5F*T_WB])X<@P 9L"T2BCY7K0Y:([ ))3 DIES
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MB&KKC[-:_;<OM=W35O7JM'%X!L9#_;?F8:O6JM9_/SVL-].XSQ#\']?@J7(
MB@5'P']"N:@:^%0^((UI0."B6&^T)Q';C6TC%FSC^I*=HZ?OG8I_UHI_=X;Y
M->.@><;'''VEYWKU5]C?<A6I:NC\#8_\<#V)<\9Z2C:;@\T:4VSF+??!*X.8
M]2+O';)(ZZ"0)RE[J")W(=_8)F33F 7;8,Y+*F5_S!EP'B93CD,B0X?O08PV
MKUU9,MI3,EHQG25=+4)7E]/&ES:$:$614\(A+JQ&.D:":& F):UTQ"D7GRIM
MKV?%Z5_=G"+<ORS\W^SZGN>P:FE^K1-9C>?PKZ8%RAJZC.?#I)^2L^;FK-K;
M*<ZBS(MDDD)1@G7%D\'(<7 8A1 Q4*X8$SDO:-8Z<VE>/0U</^3/J)/0H!=+
MZ^J)"6M6ZM.#V:J8O8/TJ3<ZN'02E\9@TR$O&572B3DDD\T5"FG>I1L=2M0+
MK7G.1HU%BT"UK$:OI>$U'X3'>_%*4^NI3:W%-K"61#,'T4Q'H[0)U%!B$"><
M(RXI0<X3CJR4,CGF&0EN8YO232QGE04HS:6GC$9-U58H3:9U\O$6KDU2\M@<
M/#8=ILH.7W#!HXBE0KD9"[))&92DE\9&C8'DP&#BFQ0_VNU;/8NIN+=:<3ZK
M%_6&)M*H'F-&S6Q87?+<\[J&=P_9;X\:RI<&W+*)[V ZUB6QQ\P%@K3U%G'K
M(LK;XI"00:G .'&>;6P+O,GDLI83Y\-=:=K-D3EQ;B^+=,]A&0C?'<10B=_.
M<Y;UHPR]DAI7QP0<K4G>_F(T_7\-9[_DQZ7QXSW)8^#@^EPJT4KO$0^YY2 Q
M&'FBA)71,AJ ']FFD'1)=N&*T>,:QMAV1DSH.ZU,A?:ZS)*+[9@:#_2!R^#;
MB]B&P[E\>VLJX;C?1A-94M_24C?J._UQ[FQM]_"J>O7^V#NP_QAS8!OF"!]F
M 1FB.+(QKX%&;TUT>16!Z4>GSI:QO840_6?,I2%N=MBA<=99&=U;(6:[A]@N
M1[163."!@Q$<[G =[V M&6L!QMJ;8BQCN-0Q:&3 <46<,;#;%!4H6JU(T%@P
M$\!:(X]>BUB]&-Z:\16,/7H,9Y76V$MS5JW3]B5M/8"V]J=I2WE&+"&(D, 1
MMTP@B[%!"1.KLYL9E-[85H]W,4LS:R&H[DV6,BC-J[6*G%W7#5FPPE+)8_/P
M6'6*QP2VRL44D6*$Y8)Z"CF3"'*Y\9&042I*<XFF35RNHK[H*NH]A2?*E=37
M07JW_E*2W?+([OT4V05@.V=)0(EQ@WA,$AF1 J+61S#<A/4"R(Z234R7%1Y;
ML:6![U#PJM-@;;K1R@/7:4;5<AB\>.@,\F)L,2&/H,25&ZR%JX4L96A*+;$<
M+3%.H[E76P .2BVQ/"WQ:4I+*)Z",E8CFC>4<4TYTA$[))1)@3KLF4^@)<PF
M8[.:!+T$^AZE0WXIRHF-JY)-5/-=X0+54TWF[:B$VYQ]Y1<MF<F=8"QPI26F
M/%%C/,W-I)C21$KLZ",J#9?-$)^N8N$.J[X_=C((H41 ,6G -?<8:7!^D8O"
M6IA/*G)K><*W9L7L;E<C'O0 0B!>1>NGW'/GM'&^Y":(X(L'QA0.1G-@(6FE
MY-'$8"10$&;V.U70RR:(RY2>/7SP_AA&'Y@Z1D25R U81>X;!S^BQPS;&(3F
M11&7K?GZ(.9CAN6H!X7\_)ADQ_0ZXD!.MU2N]WC>&197?S.4Q*_QILSC?V_<
M.7&D7?#-*=;U<LNHV:=,%47<F.L19YWVW!HB[_>^,^BW?IYV;RI!GD3DNM%^
M0479^C>V>6$O>QN_W'FG5J.-)H9^<M1FC\T+:\I_30C;$,!<61X93=ICPV54
MAN'$J"7:42R)%QNC>NFYLU)F 48,DX1*0X3B>:N%D\J)%&W 3CH>7KJ-YK*Z
M )1M-+]/A_M7M9/C1$$(D@L(;%J,>  CV2H+NM7"> ?B4P@J[R+\42>6E>RC
M.<7-:]"NY7Z,SX?99^K(631VZG90 :M* ^;5]^^=YIO)[<:O$0BHDKJ=5@5&
MYBM0R+ K8B:,86N=S5%Y\_&#P"V&R*UDA>V+LOCY,OW>L!-$;F83@&!\/[=<
M[/>[#3<8EF &IV'B33;O&X^M:0E9L OG<'*$XRH 5E@0EN.4P,ODV!IN(V4T
M*'',S<8]VG7D]*$<='K#Y#@2U<CHZ+]!^2]/KF_O;^HIMH;8GO[YQ!7=L_1T
MXRFP QA ^X549 I8E1+M!Q]'''W6A'OL?3OXO$\.=O<Q7./;P;O?3X_>U1IP
M3WH W%REG^"\JICDZ /@\6I]3QR>?>+5LP_PO'O\\//O7P[I'Z>UW4-Q]+EZ
M=52O7AY>-=/!;I4=*QU]M+F@!"<!<>,3,KES%LT>K!;1:^DG5;Q0VD6L+;8Z
M<A:9"1[<CBBC8 (SR28+NK\]J/[U8>_?>[6/^W_O5?9K\/O>5/1@LK+_-$O]
M\+:SK,O<,ZV1+E_(O)R(];QP-*18)?2W@3!N/3;J_M"[Q9D5H.YF[L";J13(
M$JXT[@SA+X=MSIJC)/SKQG2@-_,%,JFW+ROCGL<A#CO:Y09G8]5ZN^-$=HE'
MG=6R+BA8ONC=MUA3Y*W*VU'[V[O= __G_VE*U*^]ZY?('74;H6&[>:$TEQV"
M@QO93^^=Q]S:)L)[^SQ2XY>UO=$A:=#VH^93XR^W1D;!5.G_X4/D7F\W;9NS
M7AF/7+9EACV'P H^!0L##&/X:U&_?:R51EW2;ILO18>LW.6HF*/KL:B \]Z:
M=8/K&,/=&XV[%PU[%0V5KQ^T!D,G\5K[IIN!2,V![P]&+S.>WI%*O/N4M^5C
MHKL(S/'P)ME^'Q;7O".2A= M( ]WK;MB'HHF3=D3 )>MF>-EPXMVTAB)M^$W
M<V'NN7"YH L3# -3@ D5N7#6$ [2DIOR."PE<;,[\F3S!#[=22/<N9F+PMB]
M1TO^"2/W^Q Y;T=R4+^9W)NFE+_%C*^Z_;8>3M%S*]S:U1=V'+@F,%\1*9GR
MZK+,ZP8.]"]C$E-'B=4^]Z:<M6@P]H@ U]-]WA?NSBQ(PE@I9R+GG JM7=#4
M&"F9)3$)._2&[^MH6HK2R]IN^]^. R%.J0B.M<4:1"DJI)WV"#,<HN%@'R61
M18E--]D=2=%]7/ALE <2O O&9Q;@H6@S,FR-\_@@Z'R.4T[C6"?'2;Z4XY33
M96%(>G_%;M$%>T4\)E*]CFJ]OSK:#:W:[H>SZIDG1V?O2>WJ]]/:U2=:W?W[
M[.CS4;-Z]7?S\/,>FT3=T2[<AQ[BVKOJ9>WJ;[C&)U:%XVKUPXO:YUKSJ/7I
MJO;Y[]/#>DBU^CX_IIX0+3Q#@0B+.+,,6?!%D/%&"2.]$<Y,>DQ*&Y&(E,Y9
M$$4+T$R,Z&@M,<($X2<]IKV=#[7]VKN/E;_V/E0^_GOGPP_\I0>)[XR6:M..
MUP^??H3(Y^K'-BF.O]E>P^^TPVXC+U.L5-^UEQ!1?*PM3$YT$5E%".)))J13
M),C:X)(Q&OX-4UW77FIQ?JKAVJ@E=O]TU%RP==YICUV]_)=V%C#;!\\E6SL@
MUIU67AR'W\?>3#YGT+?CQH5#UP1D9'C"4$J*=H99BK+O,VPZ?]V2;6U:K0F]
M)8U8>JLUO47([&^_=]7O?R?8PZ[Z_,]*MA1>EV=]NG&=3[)&Z:43*\]$%(IF
M(N6TV[F83#_]83<^L_+=^*;,M6%&?M'YO K'G?8J>Z!_9Z?B_P2C48._S!Z,
MN65H75__CJ_^,\O![(%8A$?NZN;IG,=[TAY7?%RRV3N'7,SUQG,T-KV;2SI]
MJ=<ULF09B/M9!Z\4R^<1R\=V+:9DK7A1/[RE\6:1-08O=NVZY24Q^_-U.JZ-
M7>$W\V#T1V\\#S[+:[SP->9DB=M[/<@P$?4'@MQJA-!\@4#0];:]4<[!9*X5
M_+'5R0_4\5]..TW@M5X%57Z[CN>,HGXS-M.\GDUYKW,/G2)84>%\Q(GQR)3F
M3 JI1:)4YI2D46!8W0D,?V\S'4C2S4KCSE?;:!;AX,[;0HP^WI*B0H368I/<
M0Z/(HTURA[S6>H^/=G>^U79/\%$]WW-?'%Y].#MZ=]0\S)O=KO:OX#\^N4FN
M=G9"CW8_?*GN[N&#W0_-6GZ_L^99[5WMRU'K[]/JN[_A]QK\=WI?MR(A+#?1
M6T09S0N4)B%KJ42,,**5XD0%O"[2,J*94EZ>4%XT)IJD0!#W>?>,XQ899112
M+/"(J8PAT8UMQC>5F5[37FR3Y3+V1"YFIY<*:2T44E!:1LX"H89R+I65"CMF
MO'>4:NWT:#_=B&)(23&K33%7DRU N74)1V 7ZQGB6D3DA"+(2R($B5(0+==%
M7DH#YJFE)=FH7(K@F#&LA@OICB6+'.8Q!4P-8^ Q4;;)6:F02H7T) KI0:DS
M)<&L)L&0"8+A3#D+&@3)Q"3BPAID+&;@(:5 C2)Y1_^Z2$MIOCR]O%@!7BX5
M!!'K1,[[]<A2F_-^O4I8&">PR=4IS":8(:5&*C724V@DZRP'$]I[KH&@F+)>
MVIBPQM011X,<F;RD=)'6@F/89&<DY@W5"2-I<OU#9B5RH*>05Q*F6&+*M%X7
M>2DMF">7%@&><Z(.><[!JQ;!@;3DB@\$:Z5SM0T2-K8%W^34K(!">DB2T5.N
M\=U:J9\HZ+9HYD3YE*_V*1=;\UUI2VGW)EU_GIR%!0;\9SITJ15]Y\H.>%&A
M&5>?N][%/LX)R*D_U]D 90^'H;TU')6G7CF=J A8&^2<WH-4;,CJ'0SZO;YM
MYR$M+;"E6F#W=7IF&/-(%)*.2L25 0M,.(5LQ&#($RYI 'N=J4TPL%>H.<.R
M56^)\B=8C"I1_E(HGUR*RM-(4LP-I'(I/6P=LM8()%7DW,)$>V<!Y7+3R.FE
MJ!+EKPGE2X_QERA_*91/QO<I<5Q[8Y"E@2*N><@+S@%1@8/PB>G$6*'+Z4HU
M6BI1OGR4+SUJ6J+\I5 ^&3.5@7,BI$!1:X*X,QI9+B1BGI/(#'"[T(4N%_?D
M.:YL.[4U#2[L79=_'5>&&,*Q#$^]='AJI<5F5BFFX<^"5)&SN5*AO;#=T"NC
M4\\9G=IO^VY1%-,V1XN"Q6UW;NTMJG?&Q8-B^,M>YH-WNMU<&[,H+%KJN 5T
M7+6^,]U&3X*:DSPA9[(I2P(XK#I&1)BCBE)A+>:@Y$P9DWK=V%YZ3*K$]O-C
M^_(NMHF4).J\RJ^B1MP'B0P+%BF+8^+,"R/LQK8DTRO^);9?$[:7'HDJL?WL
MV*Y-Z.THK+0PJWE?C,N]OBU@.X%S2I4G//AHI,T)/:7>?MW87GK\J<3V\V-[
M0F^[Q$W0TB(N&4$<S#) ><3(>$N9<%'(9$!OZS+J].(I+3/*6MQ'40_O2+WN
M'/5<62VCR9@*E9=1\N6QU=Y4!($%XXG7"B46&.+*&:2CILC&@#554I!</H*I
M36YF-6.=15A/VBOYH?6[2D0_7P9+B>AG0?2$_<$UQ1*\1605!42SW&U,IKS=
M,=CH@[3.^ +10I>(?B6(?JYLE1+1SX'HR6B!BR'(8 R*.CC$80:1\Z"M+7?,
M$JT,*/ "T6KA@$&)Z!5%]'-EII2(?A9$3^AH2:CU0-4HT.@1YR(B2^$'&&-$
M1)DHT6*8@J;D*B%Z?7;VK<%6M#5XQ#5_RN7NZ5N5XJTW!9D7*.-:EFY=G5?X
MWK;^<;^MY0;AZ(^ZS8WR44=J'9=J?0ZU7IT*II&4A,5<(.9]0!SG8!IV% E*
M5?;&A91D8QMOF5F-1\LJ,24]/(0>'AG1*^GA:>AAPNH/G#EPUX$>F$F(6Q60
M)8HC'6+DGA-/J<GTL.CFLI(>2GKX+CT\,CQ8TL.3T,-DF _F N?U-N15KN2N
MG$+:,XVP$\IH#19$ .N!;^$%P_8E/93T\%UZ>&2LL:2'IZ&'">N!&B"#",S@
M4P+K <>(C(P6I(CHQ(V(A-+<B9XOF!#\<\4%USRB53YE&1U<;G3P^ZV=[O8*
M_,[(KK^.7^Q57YT1\-01QNNJLJ49L( 9\&DJQFAU=N9 [W/&/.(T;PL2D8,M
MP"USTEC"?1%C7#2_>!'Q?U8WHN2@GX6#GCJ,67+0 SEHPA41V!&B:$!@>47$
M.3@ECL:$&(W@.%+KJ8I%(/-A"88E!Y4<]&ICI24'/8R#)J.EQB2>2,C;%:@
M8TA99$542,&T&<,,=U)N;+,MHTH.*CEHO3CHJ0.R)0<]D(,F[* 8N)8"*Y3
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M'3N$G:.:8&*UU\MN5EX"^><$\EP)Y"6T'PKMR0BYEDI&SP)2-M>QD=@A2PU
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M]CS&A9G+MO@'R.F@W>]5&NU*_[0S@$N%WC^?(IRZ(O:ENG<8#J/M]BI[[?S
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M;-T"L6G0!S".'S??:!.FO@MP/&GX2A[#1O'$PP?J #_#P%4B& >=%AR00&?
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M9X.-?\VZX.!_SW7]?*^M[IORSZ4R[Y$(H[#S"EO.2:&TQ30JZ@-0%.:"F9?
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M^WM:%6:E'Z<$>X83[IHD0Y*M)?&9#JR6P"%@N3S78X%9'/K?JRF[5+'E_+[
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MK,?^Z4/,A/^^C;-#="DB/DDLN%DPO<:"^\:">59 #>"SC085!',@W-0BPQU
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M#,)J&TS@7&)B);4NI.0,HED0K#HR*%?)AXOY0-_?I5F]Z?5?37KFU73'C .
M9]6"WCW8+I4? )*O%NXK'F>X[\;G"IM'#N_N.+:[M\U:J1W;7SD1-C <H6^$
M09QAA@R'G[1PA/DD-:>+C9=R2ZP(W,&*TYDVT@H,RHD(DQ<F=59WG9\M26]T
M#GQ7X6S"SW1T<$H>8*PQD(1 *GG3A2>,%<*NIA-P[I-P\"FVS^=5 NAKP=ZR
MU;_TD6X%_"9N&(/O? _@YXTIX"]V<<*/:_=QNG!:].%71Z&"T$%(W[][#%T^
M5EDF+[%0&V81=;;[ET-HLA(8Z_,.2/V:1JH_2!&!U696*U7<OU*%7G^EBJLJ
M3]R30.N?9W^64_9CFK%O@5B<P(1[Q@?U?S;??\5>VT(9C=+0(&Y=1!8+@H+F
MW%"FI;1N_N#]@X7)Y]:$,IIV'0F :26MY1[\>21TQI>?]=^3.S"E!? P!]UA
M<F[A<H)>]Z0[8UM4%+=_>)QO$7RS _27G'3'JF[LXVKLU6[[?#0$]%5>:@U/
MQ=^-AL!C[8V[U0A84%98:XV *W;9JVK-SM1Q.Z_;5TEOOTH'/*^.3#PV=V(F
ML_>GY/''$^K#VACOWAA_]?#%KP@>W-I(W;B1USOK-3?3UL0&;DW]Y5%8P*,^
M1W<W!Q8?NTY-?8_GJMM#;P6 'NNYQP>4&*J[K.ZRNLMN[4#R(]?<RMN$?Y?Y
M3+7(UC,1V<)<:18]EZ8HN%7&$)++8PL?B(W!7/7L\$ZPPW>3+9G)]MUL7DQL
M_P@>_0S]WM,X 7?\S[?FS^W3UMM/I'7DCUI[[\_V][ZTFWNOSYJT2;Y\;O[<
M??L.-W<<G3\!]^7S^Y_-G6T,]Z,M^&YKY]^'K>-W/YK0MOV?_\![-#F\QVGK
MYY?8^KAP+%A@$8P6&%GB#>(%X4@999& D8P6$^.$F<C@/S]]K1J.UNG=K@%'
M3(C 513<><JE%(H3KQ68LS>^<#K6<+06<#1_(%=;R5,]8A1\%(CSP)'F&GZ*
M&%81YJQ5O(:C&H[6XMVNE63,F7"BX,Y([KVU L/*BI4D@C-;%%<5$;@2'#U)
MD8#[PR0RATF26^$B48@6$0,218<L(P*1$&&5$9ZZ2B2 %C4BU8CT2!#)"BU8
MX3SC/B8#UU1ZZ:/7-% "A*E&I/5!)#:'2)A$&CDQJ(@\("Z%0+"21&0-..!I
M5;&1KA\B/3==OH^AV^[U&Q^3*D7PY1%P]&<^$?%7SW2O/ 27BH0^:1"^YML_
M&7RFX+(*RG# AG%CF!64!^P\CT <E;VR:/U?T(C!;GP%)M@>/D^5Y_L"ZO9"
M=,TS@;UF&@5I)>(A$J2U5\BQPI,0-"]BL?%2;U*,;U=?ZK)Y\CCD]FJL>QY8
MQXUE47%OA$K*YU1+1XDV)!0V!(IYC75KB'7SH3NBL;.!6D2L4XA[AI'&$OZ@
M-'J)A3#$UEA78]TSQSKF# 77S5/G!%>Q2!4[" %G''Y#C+BRG&B-=?>(=?,A
M066Y,"$62&+"$<<"8,YBBX(7W"DIN>2TQKH:ZYXYUAF%.361&6$BY\19"^ZK
M F?6%:)0@M58MX98-Q]L##BH$(5 \/]4J<AXI*@3B-,HG)"62<<?%=8]MW2\
MO22[]5<6D>M>O^KE,X7L:[[]TX%LK61@U#-A"FZ=4$$4DD<2L(P1BRN7 *FW
MA>X:J1=+?%#/&<4Q(NFD1MQRB13@*8*QM$:X*(*5&R]AN=U4<I4LUAU-D#7?
MQ:Y![EF!G&2%5C@(S+3GV C-HN"8"BV]"_Z6<Y5KD/LED)L/,P8G(RZX0VF$
M$#>>(RNU049J3I@.&!<D@1S>Q)35(%>#W',%N1A<VF*,5$;%E2Q,*$AT(E!<
M2!GKE,-U KGY^&(DC@.)<\CB2(')@?=M@O5(6RT(Y51(%@#D)-]DA-8@5X/<
M<P4Y)9.O@XTLO."%449C:ZR33#AEF:Q!;HU ;CZP"&3-2*.!OP47@<E1@Y3
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M&G_W.FW7#H.MQKAO'L*\=@%QX+TV&S9K\/92X=+0Z)C^06C FI4*>Z>^& T
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M54/VZ9MV*X5.]IJTE=1!WL);I]\=P?_?_O,-?O^C]?. ['_^)S;;"ZJCC,5
M"B.1\/ 'MTHA)4-$BE@3%">%-CYG(C.]R<4=E->[%.(?@033#:%D[;#X5^J(
M7O+^CQ1"5^<^WPQ'%U*>[P%%QR2DXA^9>B3F,56]M,;0ZV#HO*)H$:UWQK@4
MA": H8XARRU!*E+O!%,X!K/Q4F_)YP:?-2N[\JDM[HSS44<1"%>:6Z^-# 'K
MU#D>KQ!EJUG9$T&4>=E,)J@7#'/DG"X0E](@RPQ'U$8M%9&ZL'3CI:!TDQ3%
M,P.5FI/5G&S5>;0;H6C-R9X @LZK87)"=2&#0E1ZC+BP'"GLDH<K6."RB(+9
MC9=JJ^"/!3YOLV:\+/-KUAGWWI;I7S<*]"UY\R?)&J7%A"H6F2L"Y\1J!J\=
M"H# @FOAU=+DI >BCWD\!^^Z95IES1YO#?O.%F)ZGC BHK'(> K^J/<4*6DT
MBEA%++FRF*=#P4IN2OG+\'<!RJQI'<VGS &7O>(C1;S5-.\78>\>^=XLZ-6D
M[Y:!;SX09V7T1<&!Y1F<2@LKB8PK+"J($]H:&TE0*6EY2_ZRT[Q^L%<SHRF(
MB$$Z197PE"DNN#6^X,)1;#DNTA&IFAD]"X"8CZL9Y@,V$;!!!8UXD![!#P$Y
M1E1A8R!"DHV71))-)5?IZ3QBB*B9T1-G1K\(>S4S>BK -Q\.<Y01XFD$1U"[
M))BID 7+0%B)0A8.&#4'9D34EEXGA_ V"XL_@I#7/SDT_"NI;8^0U_WV=$->
MY7C6Q.ZV\:WU:B'DQ87B5!*!B/04<:T8()TUR%$7,?2Q]QYOO!12;&)!%A#N
M]^L&^Q_1=NA3YG3+7G&]T>Y)1[MF\:[F=+>,>?/1+FYP#)8[<&&] D[G-+(%
MMXB20"F10G!-4MH9N:TMSC5"O9H4/=9H5TV*[@P@%HHO<XDCD1:!L7K$$S.R
ME&ODC".DT$)BGG+[)=ZD4M6DJ"9%CX<4/9Y 5TV*[A3SY@-=7G-I/9 B;)-<
MOM8%TC1*)*,GLL"%(JFR@MS"OQS>OT74>V:I76]Z_1C:SR^YZPF'NB9#6A.[
M6P>YCPO1+D<]DXQJ%$BT '(%0<H(AA0A(D2LHXP<0$YO"KHH)GEU7E=O8*X3
MKWL6&YB/)]A5(=X(<+LF=;>,=_.1+J$<I<PHA$T(B)/@D*&4(E( TPN.A>@D
M.+)\BZPJ]_>(,:\F18\UU%63HKL$B?EH%Q&<2$D,,IY3Q"6+2"<Y"Q>ITCS*
M5"IMXR67F\62<]@U*5HG3*A)T2,-=M6DZ.[P;C[2%0PA3'J.N,6I/I'A2-.B
M0%J$0(27VOL"2!'=8NN4R5I+FB5)L\6Z2[<@:%8I)C,8&=\;)?WE\:L^;VT-
M(9V-6D5M1.#$6RMH=)QA$<!WL)A?N215K:WQ^'!S4?$,C$ DR2;@B=Y6XO&L
M )XHN"M"X80IQ,;+0M+-0BSNBO[2X?!;F*'UQFJ]L7J77/-F8%E+:#P!H)R/
MNDG&9 S6(I9\:4X=05:"0QTD#UAR;*,3.>K&%VM+/ZL$LYI_75P25.#H8L"<
M,<(=,3H"EF#/?:$LU437_.M)P\I\G,X1;;EW$6$JTB%M$Y!V12I>[QVVDA7D
M_V?O39O;1I)%T;^"T.T^XXX V%@*FSW7$6K;[:.^+<FVY.EG?W$44 41,DAP
M %"R_.M?9A4 @IM$4I0$4CAQQG836U7NF96+[F&<SE%U;\N]S3K[J[._6B$G
ME]M?FPG+SO[: T$Y&^#S0YL1Z@']^SK87[X>:KX9Z)IO&=0) \OEOB\"?/:V
MQ.36 GR_BU%>KQNC&!L3(%LZ7_G3XF#=@CF4Y=#E__D_GFFXKW(Q6PT'J!5Q
M 2H%[Y!SF''F:0;L&U]Q5:&%N,*'3$Q0K<=@CL3)(%Q7\A'P<Q3#IX;U(([)
MS.U%'V[.X>XI<K"U'-8:-KA>X3_PWUR)<V7 :3[.X(;@1KQQ0+/OO%"ND%^7
M?:4<\RW'S#.<4@PW"JCTE%T8G'TX-PYW\:#;14/T5&4$Z!&8Q-\I2X44G Q\
M+D?KJ0*?2CQ</K Y!IE*DP2%ZHS,)X'CF<#.X'@SXMJ41E9DV1$S2&!&/ I7
M/],.PVRXN>R7QN]I5 [ /9HL.)^?@@LT6D_!W6TYO_DTRLMW^LGU-]?DKNOQ
M0+,#'\Q8Q_6 "7U?,TEHV;KNA#H/#EX7_8SS^<G._+\XS+E!&WG%:5&<Y86J
M *S3(5/+:8YQAM/,AR!1LIQF\40TR%GHR)UB4'O"IPX?I!2Y;:)N*N=%YN,@
MAR7!.I#D_QH/RWO$-&=!XLW5-99R(Z35..Q/K:22 $VV7WJ\]%CR -B9TRR)
M 0:-X=09+T 0( 84#FHM#N($#*%%&WBL=?:4(T *:&2D%%4!!<UQZB='*2-&
MSR-%38_O% @KCY3@SX8T5V*0=V)[<-L@95+17(QCQO'+>3GW'F?3,RX&A%(P
M"A(P[?"!2ED!CN?.M 2^:ZI-:%[42@)GQ<<A!X+DL),&B#4)XF0B?<N+>6\7
M-,J'<893[XM*+0@#0()[HKH+.4.KY#T!7AS37@YL10@WIKN6:GMZQBO<S7C!
MLP$L@#6FL".8^15/A"%1%#0>"K(M)8'\;MY3WHXS,7"VYE80-5DA%X=Z9(H^
M_I4K36V!_S&(BX+75L$?*2P*_^-MK2_I".D%%D67:[UA&5"94GB.[0;,<%E(
M641 V7FNQ73P? +7)2$+K5F%9RUM>W\_A7>GL],8Q7A8 QI^Q%%CX//4FD\S
MGYWJ^_[S]/ ;^*EZI)M,BPQ.-4*(KP6N[6C@IIB^QVR'&1&Z*/-IF;\N).%J
M,#'@WE_$'HC%^A =V&J<"+%4"D1D+3$U$UZZ7HB2&H%N.)9E^5% 3,9I:#+;
M#*G.0L=TPKD,F^4$V170MH(\?\+UC]_,R/9"+W0TRXT,($_#U+S()YK/?.H'
MW/6Y09<7P$Y/WVZ(\3*[ ZCJF&9@\5CE4+JVZR[#!MW5T K2@$"S[Y9!X'6&
MBJK\<EL\:X:C0NY'U+##0'<!=]3T#)]27P>6"G1?C\R2H]PE/HUFSS+489*D
M(1HCBSGKG?1Q5V,'Y]FQP[N?QQ^_,3?4?6I'FFMXKD:X$VI>0'7-C2QFV+IC
M$#<$=NC-I\<J0(A)7/H(ZY"!KG/NN9'K&I9%(CWT -7<YX%NNS8W=?T.U[8C
M@VV3 2AM8#\O#)BM,=?!<56ZHP6^:VN>2=T(5!OA!)2VW3.71!5+6A *>"1=
MDN0&O$Z:@R(.DS&*#]#(.8?;AA>J<L&'X$8D@G8H V,V!MU&A2=31J9R>%5"
MR^!,W@ACC:1BG#9F5Q-65!GR8GU+P/%#\-<]:KJF14+3] T[8(S[ND==PPW-
MQXK%K&D&G/"BLP06T_R1=7SX+8PB6S>(J5DL)!KQ;5VCG-CP!Z@C@^NAY3D'
MKXGOJZX^;ZPVPK#-D*MRS2<.W7A4NF:+?64D_BE[0L9LUR/.T :?B3'BZ89)
M&%@Q(7=UAB,'.9C:9G"'4FT-<4;Q#\ZTGSQ+GRU=GIQ_M$]^?C9.WQY=@S.E
M?XMT<(F9C7F(,BTQTCS+ _FL$Y<&G%D^(0>O3]*EQ%E:I6S6OKM#4K;=:!4!
METV-5F,]H]4VN.>04/=";A-0DKX1^1[QS9 X/B?4%OQE5/QE=-;*PTKNCS<@
MN0,'V,+2F>8X#O %($(+#-?2L)F'JUL>R#_L7-M;X+]M;+0: >&@'DSFZ<0*
M0M\!J\ F/ H--[ "7I*!T9'!(Y'!R?6WP-(]1V>&!GY*" J<$BU@(=>8@SY%
M8(5NX*#1NJS6Y0F,5GEFLZ$=:MH^!1/4\3P>@8GN>JX3VMSV;"^T3)-[=XBB
MUJCZS@ZMR/BS<7SQ+72X[@2^IW&BVQJQP.T*(@(6*;6987H.GB0>O#95>\&$
M$D%.:QJ,%@,)YGD6U1VB4R\ <]=S+7#T/7#YK.@.2=9140NIZ/0C>/ > =_=
MT1S3\H&*J*%1SW$TG0>F[WL^#QP=4RA]U=07T)$DE5E1> _G1CHST[8B?A5I
M,1Z.!97<;5I*5-H!<1DS@')M2O0H\O",@?J$<M,RF6M_<_6#YD.E)5JF+FF8
MW_C2<JJDQQCLPF'Q4L-?'CP)T%UHNQIF3ZJ@^3__/948-<VZ8.3 EAG(?4!V
MQ%D0<#!%'#OB3N"2)8&(F3,(?H',]HF/T@RQ]C;.PR3%_)]S^,P?8)-\?UK^
ML8[?E/QS";^]_?CSZ^7QS^-S%G^!^T[>G@#=__G]^.VQ=?KVXN>Q^9_OQY?)
M8)9_X/OP[I,!//GCQ/RK?_(>OFG^-3C^YR/P84A.WQ[__/K/QYO3?[Y&QY>?
M"=B4S"&$$1VL!V)B98/!-=\E'(0R@;]\PITHD)(4J)>S0Y1"@<L RL2W# ,(
MTG%]P[(#;ONA#M3I&=&!PD$HC0#\(./XP>NS=^^/WYV<*V\/SP_G,N#F2']M
M*E[$0S,<)U%[][JG]^FQ0+=YY%BF8Q/'\'U=#SS;<BW79)38UL$3NH'GB[+3
M))%C<";"C Z9<I"C41;#K^$8A!- /5? TF. HBP.\#"=)^GUR_5<WQ619'B/
M(&H6P^=__H\/"%X@:*;301]H:>*-+^.")G&XPF)/QEDN'7EPCS 9Y:R@483*
MY2F3;@1=&:^4Y:LK<V2 PC(J<W/ 3<C+JZA4PPR,'?%O?%RD5F*MJ7 4 #@*
M_ _/NO,T&0O;IW1 ,/%6*?@ A#6F4Y4!0]@0WCQ*:,CK+(^,XM$YWH%^9:(,
MZ\52N5A88\3S7*P-%#V\A%Z@GJZ8 ZY?9'20*R^.SS[\5O^N*IR-0RD\^IPF
M13_$ _?)Y7BH]8&;E)F?\<OIN,C3<18BB*HK,QE,*\ TXY@+()8JCE;K%6-F
M0&-),QL$WKX&SPW_EM+L0D!8O@,_6&)%0!">A3?FRU:,0@-6AR*E] Q?*J-Q
M $0M<9+%5YC>1,-QP36Q&!&,2H>:^$G"II_F(^0$6-M%>L6S,KV!AIA5%B/,
M).;$H[0DHN;^9$91A;AJSPBD#'XOUY.'_31-<O&6L"^3>\K?5-S>"-Z,WX7]
M#.,0X30(QN"SID!?XI7-!8WZ-WD<QL!R(V$IAIA4F(Y')7X'F$26HMD^@P>Y
M)HS+I>.+/GQ5&(J?A]CX"#%<+$KJ6E^6=D+Y,83RAYH(*MY\2F&L5-)X?ED3
MD5'3+?*K)%.120\T*NBZ*1NP<$$D/F;\(@:/,Q/)]E(J@3O3YP7\"L_(WR0?
M(',*IA/<7R^$@O0!J8]B0L20&!]Q06Q" N&3F"*';M-$I,,C%T-IK=S&+E@K
M<$7!$1[G35YK,JO(M(7O2I&S0  U;QYPAN4:DIUK[EXNFDIVGTB>-+N@P_BG
MD%.SS+R!GU=248EJ8LJ.Q:,T%[!^*<)JX)2^NHY9T:]*J1H/EF5\^N01&@AM
MNOR11@T+YN[Q;#6ILNRQQV8$TY@!>N//?C:1@1=<"S).OVLT@L6^I,DUO<D/
M?I_:TP"5^#3H9Z&V'#:W.!H[XC@H'"TRP6;-\U@PJS@5!L=%:23$ V#!Y&:2
M=YOQ*PYNDM2VR.-Q,);;'X9@%/64YE<8CT1:]8(;I;P0_WH![GC^FQ)EZ4!)
M1YAL+0S"@,.Z,/EWE*$@*ZI###I 1U[R(;!I^-]Q+!E 7(V!0"_D*[0J-!VF
M0IZ)6,TX+.0QVHN #V%Y!7RYO)[P"S1B>5'(''%A35P(BP^V$V?3OTD 9"C5
M,,\;9 A(*3:S_Q0V/TR+&MR5,0.&25:5(<UBH/;EQCFN$^0EQYH:&0F$;;W"
MI/0T0T6/$2MI3L_=A;5-%1ICN0B XXBBL(=O,QD%X>6"FP^6>:11FH!W* X<
ML8P-7P(F3HR9S@)3>$^UU-(/%<#/T(@#M,-V8E'4,7DSQ3V5:=\3T$F(2'H;
MPX\Y&J!O0$F!#=RXK3YP0%F,VZ'5>1)ZN8"-WS%=?Y"6)Z0E(0FK5BYRG3/>
MAPU)?<)J%M0T BRGT6FUU@]@T,?%W\ .?P*(R\A5?IZ^ 7[ 8FS<[7..6IU^
M_&;:INL2Q],,AS@:"9Q0\PW"-$8M1@/7YU0/9J-03R=RCQK4C_\_1Y12HK7+
M_'T4D_S6%613#"*B6%)5S.J(*E5>UH\*"S26,D&XI'DIQ?(U@URO_RUE7FUJ
MB;X(L/N$CG+^LOK'*Y"BX*/>O(R'8@_BH5>@,2_ NBCM,[0L9DJ%A3TE+T^,
MCIXN#8^R*V#YY?)R3UR:*6"6URRWI]ONTLMZSUAZ[;;7&E;/-OR-7GO[-=M:
M_M&6+=;HN?K.+/;A(&LZ*[WVCIZ6=[88\N=N7="X0_H?3]3>8NYD2Y=6-:9B
M'<L,K'>8@;6TB^4S@,8)IJ,M!<9SI9&IE+SG3![+ ;$B:>Q",Y_%;4<6-3Y:
MH]]2RQ%[:_?>-7>\E.KGWE/:6/.OVB_(&ML0&<\5>!U9/@Y9/A\!;AH[)<']
MU2;0T$$ZEL>]X%&G8W@5RW];!\-[T;7^4QG>%H&&ZCS\Y2HB9(/=MZ]7W^JF
MR\:M9/>,8#J(=1![ H@]LV&Y2Y.F[C4C:<]:P^[7&*C9F9BV'>@Z<VS;L(C#
M=,^QK- V(@>V' :,W-5*PYH_A!.:'@_:WI2Y*O_$1?]-F2K[[D>9CGB8YQS^
MGYW3'ZN58UB[>3 G&[U>_N?RZ^6A?OK/?[Y_.?_/X.O;3]]/__D+GH7_F9\&
M)^;7[U\&?\6GY_VY1J\G_YP,X'OVUW_@._]\_7[R_J,-]_:/!W]=?GW_Q?HZ
M^!1_&1S9I^\7CO.ECFV&'@TTAG7IA)E4"SR?:KIA<3UR(\>SO8/7CF&JIKN'
M RX[P;6G@LNP(]OVN&=10HGK<\]Q"0T<RZ&N%U#7OZN<NA-<+1-<LQ-"F,7-
MT'6Y%CD&MO)W+<T/71.DE^68D4\#W[0/7ENVHQJ6WPFN3G#MB.!R*8U<$IB&
M$5!B!W[ J6\:OA-X(?%"YM[5M:H37"T37+,S2*R0>9X361JQJ8W=!$+-LP-#
M ZSKNFT:C)L^EF&#3E)-OTWS,SO1U8FNVT07<QTPL7S=9I%-'"OP=>)@0WF=
M6K;NVNRNWB6=Z&J9Z)J="A+:@:E'9J!1*P+1I?N&YIO<T.R(.3ZSB.[BV%_?
MLU7+FF_DN/.#?W<E;+>\D&J3"7/[-"-N7F8YNF68H<.827S"'">(#-\D7F!Y
MAN-P&G4!KIV26?,C=PV+>[;N$2W4'1]D%@XQ\EQ; WD5!90:IA,98&Y9JF=N
M:^)NBV:V=8Q>%Y# 'NT03&[N<,)T+S"YK5M.&#+=\!RJ=P&A'6/TV8"0&$H6
M@3=E^MS12(13MB/' Y;'OD2![QD,&-WP5-=IT\RRCM&WS.B4!-R(+)OC)$.;
M!S2(N,=\PR;<"*TPZ (H.\;HLP$4P_=T QMR&I$+&MUW+8W:@:NY.M-=@SK4
M#ZR#UXZOZGZGT?>8T=V0F+;G68ZN1X0 WCD+3$(B@S(:!;K5A1MVC-%GPPW<
MI:9)B:^9GA]H!.2WYKD.U[S \%V?ZY9%V<%K6U<=JTV,?M\DH77CI4NS89]#
M)'7%S>^/T ,7Q;2#D.N11;CE>L1R;,>S(]-T'&*P+EZQ4T+O9BY>X7.3XG %
M+?!HI!';,35J^JZFFU8 YBR+;#P><BQG&^;-6DS4\F.C3@P^(S'(7,_AQ&*&
MZ8/)Y[C4<?7 \L,P,$W/"^YJ4=Z)P;:)P=EHCD$<2R>AI86!QS7BV:86Z"'1
MS(!3*^0N>'G.P6O+):JO;^NHJ1.#G1ALP:[7"6IOTA6I$X/M%8.SL2ZJ&ZZO
MAZY&#0+6H$.Y1KG#-&+RD#*3![:ABV0AUU,MW^@$82<(GZ4@I $E.C?#D'@&
M\2R7AL JD>[I9F $)G.Z6."."<+96*#IFLSRP1EV(NYJQ'"(1HEE:Z#S#*J'
MND,X.7AMJ+IEJ[Z[K:S)AQ6$9:"P6D5%^T2(N2<HSFSLUH(ML72,W=@V:<C0
MK7)O5[FE$MA6JULA\:<;YV[6C. .$Z9[1PO?\<R21>]?X[WJ87/KMKZZ5;UH
MBWMC.V^MQEO,Z:N[*A\)N8E=E?\0+<7?'@[9X>&D;SC\Y]&D:SB*7#DZ!;LN
MXU@/\?.G9O/PO[%3^%'=%!Q>\*;J4WTJ&X%GK#/"MV6$'Y\?H@$NSJ=.WG[Y
M>?SSXS?7I)ZO4T>S.0[$97J@>;8'IKCN$V99W*6V>?#:=56O52?R6[*L.@FX
MIQ)P:\7BG03<.PEX,RT!?8\SPX^HQEB@:QASTK J5R/<X]RP;#\,@H/71%<=
M<N]CJ4X"=A)PUZK..PFX;Q+P9,8&=+C-/(L1S?."4",.,32/!X86\@!4*(6+
M)A94>;9J+Q@ W8G 3@2V4P1NK7J]$X%[)P)GC4#'-UQP!S0W\+# S*8:96 3
M4A(Y86A:+M'!#38,2[5(FT3@,VM?N:4Z^%7;DNRT]-M:'7P[I%\GX-80<._F
MXGP,['\>\4@C!,>]1;JN^8QY6DB,, I"G],0O%S/<EO4Y&/;YT?/7B1LK6*^
M$PF[*!)F;!Z/<>9X+-1<GQ"-A-A'PZ:FQCT_9*81V3S WC_&'C:)[43"UFOK
MVR$2.A]I>_)B-DS$3!^,2)-IKAN"CQ39AH8SNC6'V*%G$>:#:CEXC6UWS$YB
M[*_$V%J1?B<Q]DYBS%@8CJ,'KNM&FA/"'\2WB48]D!B^$0;@F>IF$#"L=?#U
M-MD8]TT7NT]_CWN4..RV4-E6$7PG5/9+J!S-13)\SS"<R#5 E+A<(T80:91Q
MHG'+\B(OT'U00P>O74]UW&V=U[>C>JH3,^TI,N_$S-Z)F1G;10]]PS>,0&/$
M(F"[B.:#8:@1,XP<W0N(IWL'KXFAVG8G9CHQ\S!%W)V8V3<Q,QM4"9@5TL@V
M-6+C  G=TC4:&#BRRPVX:UC@.*&+Y/FJM;5NQIV<V1,YL[4:Z4[.[)V<F4UP
M"0UBF=373(?H&G&)I?F^96EF:-O$U^W(]W5,<'%4<VL)+CM0:[T+Y8O=.UI;
M$KIRLA2+KZIWEZ_0\/Z7CLBY>K*BZ%(&*ZD4PDRI6'RKRW%Z]@KK>35*I7IY
MF?$$5,@5?X620[/$T[. I3G'%QR\?D%_J^420+EKJ_S0P=4S?H$Z_!,'VD'%
M_WE(DR0-@8PF2OW=CQ$?YCSO=/KV=/K'N4BH'H)W$!!'8^!%:(0%7 M\"@Y$
M:.B.:U'.+6 04.F$W#NMJWUI^QU_/TQ4L^/O)^/O&9N=NZ%NA+ZI^=R*-,(C
MIOF4N)K%.:%6Y-C,L(&_354G]YZ'V_%W>_E[N^'$CK^?BK]G8W]4YZ9MA(;&
M?-?6B!5%FL]\8/+(,RS*J.D'NIB&8'JDX^_]Y>_MAO$Z_GXR_IX]0O0LJE//
MT?30"S5"09-3P@.-.F"P.V[$@\@1G04LLZLI>S)&?<M'&1"\"%J+KEET@(SS
M4_S0E9<]VMB2)A[@WPDOCQH.&^CHY-7VY-7GN7@"8)3I040UW=%=C3!.P=^P
M'<UUHBAP+0=T48@)WJ9Q;W.D2_!N+V=O?1)'Q]F/SMFSI5Z6S[F#.9,NU342
M!;Y&==O70NX3:H6Z)3P-4W6\-B5B=YS=UD!"Q]E/Q=FS,8109U[$?::Q*"0:
M\2)'\\W U0S?LYS0 R%ND(/7ODHZG;W/G+WU:0D=9S\Z9\_H[)!1WV.>HQ'+
M-S7BFUSS0A)IS U-3P<?2\<$9%<UK#:56SZS7MN-K#@1.X@G>7&:2&/@"(:\
MR#<*)#R+Z.=VLQ.6IBE^DMAX@\CH9--:LNG+7*0@ -D4FHZG199K84F$J?F8
MO^P2WV!VR".;^@>OB7]O;Z([MF@OXVXW[:!CW =AW%FCPB5N&!%/XY9#-<(P
MN<#FKA:YH6588#0:!CUX[=Q[[%S'M^WEV^VF$W1\^Q!\.^OF6V9@T@#\^L#'
M,B%P[;7 "ZD&WCT-F6$;!@&%:UN=PMUCQMUNGD#'N _"N#,*U[2('D6&I?FZ
MZVN$@#]/J<<UZA/@6DYT&ED'KWVO3:,%GED"P%2EVCV\]6<1:-SZL?\4]-_T
M:7;1I25M4R2%<\Y[B-K"-K&?@1-IQ+8##821J3DNBW@01)8C#P.)OZVAJ]V1
M00LY>>O'_(LYN6/6]9AUM@8@#",O $N?@G.F@?G@@PO@<"VT0R=T>>B%.CEX
M;1GW[@W0L6I[677KY_:=TGUH/IYKGNH:C/# TP+B<XTXS-4\Y@ 9,\OS6."Y
MH17@M'//OG<I3\?)[>7DK9_3=YS\X)P\HY$)-Z(H-,&C)SX!\YGJFD>II3E@
M2CDZ)8'%")K/EG_O*'IW+K\I2TYZS2BA9(KN /[17/K#/.?%! .=5-JZ5+J8
M<^I)X :4^YYF<!)@'B#7J,T98(SPR'*)9[)(-&>WVU1JU!T1M-VI7X67H_@'
M4-I/GJ4=&Z_+QC>SX]@C4W?\4+-Q0A,8%YBR;_I 5]SS;6KI@>L= ,-ZIF&^
MZAAY?QEYZRY_IY0?GIOGFGL&MD5Y:&M&P'P<NN9H'G&)%MK<L3A(YR "I]]6
M;;_KS[/'O+QUI[_CY4?@Y5FW/]+=R'<-+;30[3<B0_,"8FJA;P6.RTV/83J^
MJ8)MU2)>WM)1?KM]?=&N5HFR=*"DH[+][)R_?]>.RV:E<B<O+8 W2\=!PF7#
MTGMT&&X=O%:?#KY-T.R---]ZN&1!W^5.E&]/E'^?CY58/ I\W]6X9V U-'>U
MP T-S74CBW,.J/,XF&6F:MQ_@LP66>B)#W$Z =H)T';&J#H!^M "=+:*)/+U
M0"=,<_T0!&A@NIH7@9OK,1X8.@]0I((MO)7&LYT 52KN7;K+3HRN"Z"]$:9;
MCQ-VPO2!A>ELD-#C%!2?Y6F@!8E&7.IIGA&%FFO9EDY\VW1U$X2I::@.V58/
MC^UQ4B=36R4Y.IG:QGAM)U,?6J;.&*A&:%';CCS-]W!X(W&Y!D@R-<"50SW;
M-GD0';QV+-4BVVJ>\O0B5<1Z?R\H?+2:A2+^>&1N,Y';ODW_W_2$EB=;U0OZ
MF[)@Z$T\#),Q@\^,)ZV2%?Z#AV.<0J,D< _/\GX\$BU>TJ+/,R7DPR(#+/P4
M#5ZJ5T;CH: AFBCY>(0-F&4]&?Q7V%=HKD3QD Y#KBI'YRJ\^((FJM(?P\:4
MC.?I. MYKHJO#&CVG:/(4/&Q:YXD^/<(*"H.X9T#@-X-K%&V<19/U*O0KF/&
ME5&67O(0/OTB!DD7BX$Z^6^]F5DYDO1/Q@, :"C_&T5A/!R+*'H#5Z__'62_
MOYY#I)1/=D!<QH#KF$VQWM'C.M&I3\ TM4SFVM]<Z^ 1L>\NQ+YA]21KS_^Y
M:.S14DY_K/7^>PHY6S#[IY72FW0PB L\/\S%/+YRBE\8\_QMG(=)FH\S?@Y?
M_ -8XOM3*Z*;2A%](5]^HM+Y;AW_/!G@.X[??B:GH(Q.WW_1OUR^TT]^'NI?
MWQ[_ *62\/_]=//U'S8*3.*<7/8OC__Y>'UZ'H*R^@KK#:]/SB_(L7E$OEY^
MBH_/\5V?OA___#,ZOKPPCJ^_Z2RT=1^,<9VZAD9,W<-#/T>S@H!99L2([1)I
M/ #'<':(ZMRQ=9-1@Y@1T4GD. $PA.Z')O7](/1<,#8X:/<18*+(QOS@]9O3
MD_.CD_?O3MX<O3N;Y\@FO\UPIT3)W=^;61]S#&:3P#4CCQB1']B19=C,H*9E
M<Y.3Z6EE#15T.<Z+.+IY?/M-<,.,5GYP42+>^#(N8._A"LL3$RZ5#UD:<HZ:
M/%^RTB5B],E$S^+=_(EGJ06\42E2\;>J@-8#W2GU3IR#SKQ*DRN.RE.YHEF<
MCG,E 3US(2A35<*$Q@/097 ?SZN?2]TF->AH BMX.2T4>$O.\7WX*3"60%5F
M-T"\XPQ^3B,E!F46C'-8;)[WE/,^AY_!@BY -\/+P&[. !"*[+J&Z^:#49+>
M<%XW8JMN%E\KE3[\#>"/V1BP)[5HDH#:1+U?;0$6&L$GI5I/P#N(8:,W !'Z
M0^YG1&\R> QN1 L25+A870TMV#_89'$."T8MSS. B'+=YT.%7M$X07L-5B'=
M <'5L"*T02JP*""*<X0Y+"00=XLN]4-L5#\>%@ J):,@NA%&XM80K@4<OD5S
M6'.0B"4 ?  &%=QH#F9#+H0_P!VL!9[A @!(\$4P>/)"^>^89@ N>%I\#F["
MH7N /8F@YHHG^P"P _'1"RY2[^%=>*L@)-D=3Q"-DH,XB2/8)-S3N/URS,3H
M"GP+X_#M >!:O$'N7,!=O*C>3PV#2!FE!3P;(XY2W!W07@0WW_24/YKK7@SS
ML!Q=*PD:*2WC5S&_SJ<)GS(4@KFX08*Z5IMP,0PS("-IC>$=K%:C.1IO WHC
MT?+?<9PA*@[# LDN'1?H%>:(2+ET<2N+HPC8!+>9P:X #R+#H>BG@+\) (*;
MY@K_!4L:9YD _@3%:DGMV-^@N7]8&EJCL*00C>$8@7;=C\%4O4['"6P"WAD6
M,^]'=@"Q*+$!FV#P)*R(\2N>I"-)4@!#_B/.$30-J5!RE-BG$)=-$2!I Q]H
M AQN'8)(*Q\,Q:I* #8I![F]XC)\!K:+U,^;'Z]9#Z[#,QSO@N?&PXA>@=V,
M$,EY421<;@'NRN'!/+JIZ3)'GUT9I$->H&1B= #?ES]*,BPW#A(@1XJL,%%]
MN0*NW :5@$/^ D3/@5EZ"DC.\/@X*6:$2L"3F%\)&<$K"L)O"J"-"P#&4*![
MADIC28IPXQD?%7P0 !@L75702%2N8Q!BP[10^A28E-:D5RU5X7*AZ7!*%JN-
MM<*76"PU0+EL_-8D*T=%N(84L!0EZ76^P!U9T_TH-6:IO8@I2Y/F1XF"3U3T
MJU!0X\'27]<GC]  7/-QL?R1ADD4"D(Z6&F)RQY[;$/*-&> WOBS7X]3'@%I
M:P$PT7>-1K#8ES2YIC?YP>]3>P(!K<V ?A9JRV&SCF6TDMGT=-;?$LO\+DM[
MQC(''X[IGNO;-@N)%W+?\"(?^_5QW;=#&RSS,YJ4WOZIL*'."K1U3M*A5B;!
MG=,?RM^EB8*\OH"EV@'@#<!Y-WC.IR1H7@-+&IRY !8X5UHL@04&'(BN1*@?
MM&_R<7 I!'&J@/%=H/%!06FBJ ,A/0;-FTFHEC;JY1@L5K#5A&1#BP[>$1="
M!H[#AH"L[O\\C%%C"Z3EI2Y 32\E)=[5-,M0F#,I3$&PPEIG[4IA;_#Y?<[L
M,&F0PY0%-X%4 ,JS-BDJ4[NV-FN35P&8)/%/T25)JC947@OMJ:H7<C;*0%F*
MG^"U((WY%1I]N*Z,7XP3J15ZRGN0T7)50UJ P81WSZRQUC9-Z[%$&5CPQ8TT
M.81^ PR"8.\C3B3J5R %7AO.$@L24 @)6GT 7]!/K\7*Y"MQ(T)M @(%]!)A
MXPW ^!AG$^NLWO@4R4RC<T"_XQIKRU="#8T+3H%0LFJ>&]KJ<<KJO>'[*]Q)
M8^1V@I#T&_*LH/%00@)HJ"]L$F&>7H$;)AV%*L H'3[A+PG[&*R61(0FP:0
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MO.DW\9:_TV*<U_=7=RE___U&>2&N_=:3KYS</$HH:-8^ITG1#T6/WD8?8M'
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MX'1DM1VRNBOX/Y<2'H:<1]&Z4>\GE;R?%I4P+:4?\^[-KTP0NK( /ADNK54
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M0.\;?DVB.F3#*JP.OSN!7]WI^/?N/>TB<GUW[5;A:X'A>1@NNYO$ ];*O<[
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MELZ3Z#&%O#*?9E)(,2OXZ(HFXY*MDB2]%D(>Z]/& ;P&?"GX]08O59S$8$5
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M<29:_&H,T))"]\$!GA<=:I-S#P0&O."16X'.*B*"1*C4CG!^LK?4-*YDLIH
M>\7#\\0/IIBSQMD5Z .HD-1D'T](EV35OEPU,J4;#SEZY4!C\FWX<<CX=V['
MZ"!C+HSA03AVIB3UX2A )9VC4NC"B]%#G4PYBCWRW0%9AO$4OI3L!'_98R0(
M4#'06M78^:T&$]]9KL;&,6P*Y$7HQR!(0HW> @?3-XYN02+*!PZ*%OP[C0>
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M:11Y89L0>[G@3MZ\K$AMY: -3PJK'1%&0MT3\*?/4O8(W0-FLV6F0!7Q"*U
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ME0C0F1)R4<D:8]+@W([J0K0K$L 5R5NDT[TP!FXQHI\+#7KH&I<5JD)PIA:
M2*^ADU+4\H>$<]</2_P&0CTJ=QZLG?^UK%K;?+-_.F:K4L<\N;J\O;ZZN"']
M\NOUU<G9*:F4]=<@G]*\;"L(,'L3V1Y[&-U;;BP+NK*H1QA/L0]6F!RQ:<R%
M6M]AFG82,D<"/!D[?,3.TKOJKJB;A.CN)G[[DAZ0\C<MS?U-\ODHD45^.>0A
M #+?)"M[F6RU)+D \U:I&9[OADF^ALV'R"M)'Z899>LZQI9)1M,Z,MKON"@Y
M,MI#^9=<0*X/4]J#Z=@F.6GTFRVJ?9.I,:+-$#R3'_A>DX$GVB)N8Y3D[SB^
MB)4%R<GBA-(3J).&B WQ9/@PCYLUX8S D?G)U#**&I ]"3JAGB>8T=GI<D\(
MM(F3!K0D'$XO=3RZ;"@2_4S^B!W9Y0)+DF:%F0 %]85&(@TPNBFSA3+R+."$
MX(?99(@+6E$8XL<PGF!9PW_Q,Z8<Q9YCI\U;+,^ZD]EE6;220K8+8)S]7D+/
M."#UZ"*_2,4^ OZ5> \9*IFB1[W\]>;L)(T.!T29E. "X I%''9)9#T+]$"&
M,15-)<!/1U: O)0-  ^6;<>36&@;LD=P >R(X/5 7PEV))M@*)183#]_((!3
MW;%-\@MW<V<%(ASM/69[RR!;%ZUG":6!XN&@+R1J@N2:M+>AI!%J;ER:,5H4
MA@6LDF24.H00CR/9:,ZW*8MOF#2:(3SZJ&22(]-]%/%Y+FRA$&,CLA!3/$^J
M3J+B8'4<B18I.T7O%2OTL9O=(W.=;UR4(LT]H*VV5WV1F6(:9MOL;_>HI6UC
MY28:M7#H>C;QQ6.F[0D;(V&-V9V%U6@$?I\Z$4]R02(!9\*)/"<Y(,1_Y%(^
M) WT C[QR8I>)]ULZS#+]50[N?K7^2FH&R!;)HZ]2T16Z]+*>;Z\\[RS&>=Y
MIR;.\Y>':\4U2L?7M^S\7">UV !M]^KVE[-K=G[YY>KZU^/;\ZO+O4W\6)HF
M^GMH>1J5EN?%V<_'%\+D/#L]O_SY9DLFY\YSB\]SJBG9E]('2U7N,CE?7%8M
M6\52WES6E)D4&(RJLW--.BLU&6-MLB-VXLN&;92647[C\4O 8$57U@7M^&NV
MXUKFA0M[%G#QS[3?QC7I)FE[8Z-Q]$]A% F,):TFAPSU6(?N.PK0^XQ:T9;2
M&EKF/DJ&XTK1@"%,]N7XY/;J>EM2X27NZS53:\82QDR5\[,0> ##)=< I=H)
MND[RE+H3\R55P>Y&5,%6NR:J(,#!/@+8XGT<'X73Z?%3S85,IU+&G/W[E_//
MY[=KR)?=JHT1A<E3ID*7$)Z-KC4-^<?D WJ-IZ[U^-'Q:#YZZ%.QM!VIX1ZO
MDK0M5^Z3MBQ^EH32[^O=1A=I)0K@?\/DQ9*,="*C#]%P_K>^WFDT*W]MZ,9:
MOP$5-\VUGERTUEY;-SOM9:<%(",J_O:F^289EX#;\S&/3XS\0! +JAZ1C//1
MG'YG1K'EH9!:L\@1>'EY9B)1<>EG)TTU&!;L">7#CG8TQU6-$F-LWS95CJ93
MZD$YS9=9KD>U,\>]T28Q7CZ-%$+8NQ/@PRA;A"5[3:#70-@M9J(5AF[JE9OE
MVS)R@"7NB,#_TC1T8_/TO;L-;8MCQ8X660BCT=:VM2@?_*]6J>K%OX^=@1-]
MVOD"V1@,6P"4'7B89=;H-QM'1N,/_KUI?#?T<012\$3<52U[->6+DS$(DXO!
MM-Y9(D2=^QZ#U?0]F-!_]\<>.]:Q=4/D>*$FAGP-.#8*PQ!;15!-8Z=T:; ?
ML'=?T\YK<\/>__6#-:O_;D)P-A?(S>V(1B7]4NEG*NFGI-].I)^YC/1C\X*/
M%63>[YCJ:TW8WW7V.0ZPUU0FM_X%4HO-B;_YM)B<T,M5X>#[YL8J&7AH,O O
M35.I@$H([D0(FD^K@$:/.HF=8!T"58HF^F"[H50^)>[6$G=*YU/B;C?B[DF=
M[PEQI[0])?Z>)?Z,AJ&?7]XH 5CG'?W[\_4%.\=;!+#%UZEOQX5[L10'[C%N
MB0-O3GXY)'H]4 Z\M;[[GC]YA#,VXAZ5?]W88SZQ%$L>'DN>GGTY) )^/2QY
MB@4\HM7YA>-]H_:5BC\/CC\OCC\?$C6_'OZ\L ;<5:QYP*QY<GQQ2(3\>ECS
MQ')M+%!69^=A,^C7Z[-#(N?7PZ#HS<5;.16''BZ'&HW6"J2\ EQKO_,3*NC_
MBO<44.M&2UQE=VI%%OOBN)R]$S61D;A/\IS*%!CQBNBG0?<G)+T;*/K#0-R]
M5WRQ@"_*'MGMR$-;\-[PWY]>J=RYYE-QKN)->%D''M%H!-N'X&69_@1;;\HK
MFUV\+1B;LP18DJG.WD/A@+\<DA)Y>&KQ%VI[AL71V!)!L=Q!L)SBN5KOZ$L<
M>$XXWA#??:"BXI\.KW] :9U[;9H*]#;35""[W4OUEZ)[2\Y_OCR^Q=:W^]80
M8,?M&K_F,AS%Y8[4=E+<(;!.EUE\X)K?T56-'K94#-DPQLZ+5BRN6D[[R,K^
MGK(AJ.\QO,][P,>6.TIZF5/JIAR 0B_&^P]H.BN.QCYU35VCA_1N,?ZR+2 ,
MO ]2L/:J/2!:?=WH;[Y=0U-O=WL;G[75U/O-ZI_STRZIL%6J@YV];"YP<GUU
M<Y-T#?_M\O;Z_\0?OYP=7]S^<G)\?29+-,XO3XK=(FJMIV]6^TXQM N!+'I
M6!'_R"[]>[H#1&"D*>X!63K=NYYD6;[?SX\?][:+1_F./H0?YJH!ROCI99EG
MJ9X;M;>!YN"*.FI5H07[T9I,/XEJ"\%(:1F%^#.INZCZO]7J,68Q?+ 65FV,
MJ7ZU,?5AX \?X9]Q-'%_^A]02P,$%     @ :%EC5>]\5%8"$@  H;L  !$
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MX*M$\8,(;FUF.![S*8$/<:8(N"+)5F 79UPC]/2GQT=M_"=,@KW/@UZWU]+
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MU\?1?,5L&'NNSC',[.YL_VJ0V;P*D_YPX=I3GXW <(KP,-FP"OI'$R6L.3*
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MZV X]L4^;>N^G]BWY+@7EY>\LA4QQ4M#*E,!(B^0,UC"%OC3+_\'4$L#!!0
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M]^N+MW^]]?XO<O%N[KU_LWCU\JVSX5UOI(_E;_[SC[W#=(PG 8;CV3R,4WW
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MN9(^I00IT2<9R87)K8/<'P+J4Q#;0G$WF_QF?-@=S\ZFM=3@$.?S$58G8G:
M"8>? T4:5\R+9XDQQ 0R4N"L<F2DEQ1]QSAZD7(F3[,Q-5;%M@I+W,MA22<B
M:4B8C.5[5'HT#1D_A!.<#1(S+"CR.+R) 53R!BCV<&"9UDG&&*5MG0NX%\PJ
ME/ OB1(M)KW+/=<L:'A."^ 2:]01Z^@\@V2Y$U:Z@*&UJ__0GFNS8H/E&&-T
M@A63+C8Q2#F#%QJ! JN<E5'<L6ZMXTU$?4IVK<F)%:L-GB**9K0_"E]Q]C%\
MJVIX":1DKPO%U4 ^6QVCE!!%(I\]Z.)L3 6;UQK< :-/J:[&1%AWTI]S^VB)
MEWD5F:?07,0Z?J\T$$T]!!52]C(+Z?SS[QWUNW"E!9<V),)VP7A:%*<NZ;\U
MSN>IGY2F9YCOJL917"6+ ;)%\C%B+(229HCE3+.&J1C>VDE_+,8^Y>(:TZM3
M<756/+4$HX5D)3$/B+EN(N@ G@<$$PU/KN[8Y]:6[!XH?4KHM79K&DQ^.S?^
M2G'&$HCQG+D:2B0*5D")J,"7F" 9<J^R9(I[V]J/OPVC3WF_Q@Q8=]*;27_G
MY'0T^89X@*-Z+.>.83JC1<TA '.1U).G[X+V$IR27!F.032W)@^"ZE-&L#$S
MV@JD&4\.YY/TK^/)B*9V5C<:Y]\&*CAZ.">"JLQ ,9D@^B*!_*#D8^'1L-9*
MXC:*=<=U@/- WF#>"=,Q>8 S,M-G)V>+J7^'99B&Y/2%X!S+'(SCI)451P@\
M6R@A>2S,TG)MO:GU,*H^!?UK<N/F"F@LDF9+@.*%D\EX,=C_$T9G., B6/+)
MU^.'DA2V$5!+G.E'+H)Q6L74NLK\)H8^A?R-:;#6=+<,OI;D6WAMA.ITBL=(
M4>)G/"_"V9O,:OW-?CD*7P?DKS-,28,TFD :;L'I5$NS6'%62"YUZ_3W(R'V
M*;)O3)DNA=6.43D/Z]2$T<<PS+OC[7 ZG(?1%;H/LK9>)2] 6M)Q*BLD3] C
MD&&/R+0S18K6)'H059]"]M:\:2N2+G98ML;YCD%CW21.3H.1A1S-F!-X"A)K
M>BK'(J2G?[O;;[D34PLK.UR<.%V<0ETFYE*M&L>$V4?)@0=)Z]6A@\ H4J95
MG*65@9:RZ<#@W@.G3RY84Z;<98E;B*3+8"1E36M>:& L4?"L0J3Q)0..2RG1
M.Y-]:R?](>[W9@.F/2/6%$ 7"G*0I/79)@'924MA,3'1%^W .B:<0)ZL[W#O
MN4]>5:>B?^J4=U2;Z*41644!1I#M5\)9\"%'<#E933Y<3JSUNO]!;>(3S%V8
M'5>E2G]4X7P.HX6:G6^'Z?0;J=GST$?80&M)&TA<DW,CHX.8.2G=6)SP!4O&
MUJ-<"5B?3.#3>7'+WC672?.]P"N58'B90,Y2<A.=@6@2+4?-'3AF+4B5;'0E
M9&-:>X,_PM,G:]B.',TDT/ (#IY2V'+1H.6RKABM9C%Q8*;JYA($!)D4:&M*
MR3R$XEJ;PSN!],DPMF/!^G.^H=K=RU(IQ8L1,55_S(#BCL89902NBC9."\^;
MG\E;"5B?L@KMZ-%>)EV<T;K<>$S:^YPRI)+(DMGH(03O@#Q$Q;'FR&(G71 >
M?<ACL^=W6A!AS=F^(?6_O[DY.7OT<X<-^PZ/Z.L?.Q^.#O??[W_<.=@ZVJ57
MKZ-;HW/?/1^_H19^JPRN42^_[<ELD3NYL!>S01:(PC@&(M3*U6 5.0HZ@_9<
MBB"83;QUF<U-#$WBL-T3,H/3JM^VC\/T4XT)<[ 6LZQAI:,O/$.P-<!$BP%=
M*DYW<ECL%I(^Q29KR?_.\V/K37S#+@"G4TS#Q1S0]R-<3/ X;YU,IO/A?R]^
M/Q!.>AF8AB0\N44L9Z!A%N#%,RZ<#IJUKB!9!5>?XI.F!&DNE&9T.<#9?'J6
MYF=3"J.7Q V.PB:&&H2UA8;*R"'*CJQB8<1?I6K+L.;U%;=Q]"E0:4J'M2=]
M;?%7=X "Y_\Z&\Z&%US<'<_QTWF5]46ETV+, Z\$^F0BB,@R*)<$.,]<I27&
M9+2UOCSD:ZS^N#Y%'TUDWM%,M]NYP1&]].EW'.,TC*I.RB?#\9 (2@ _X[+)
MK. >I>&U*93UH&KM7!#D@0OC'2N!T_^M,UFK(>M3E-)4270@F)8]9CX/:Z/Y
M]Y/IN\E9G)>ST3(--Z!P2?&8:=!:(X53*4+D%@%3"%$(@<JU[JGU(SQ]JEEN
M2I!F0FCG>P[)RYE?'A$\UVI9&B^39,"5B^0%U[I8'\BM"09+]B*FV-S7O -'
MGPJ4V_J6ZTYZRW+,F\5=EX5=& I&+25(M^B'Q1D0'@Z&DV7C183VV<X?P%EW
MI/0YWXO7!A85)QV<:[VW I4*0JA=V,E@B^BM2:'YV8QK /H55[?AP$V6/WW&
MV^9I[Q@?J5^:V?%Y-C%].YJ&\2RD"U]O\=.Y-'X/PW%%OS4EK3W^]&[A_7_$
MZ7"2+Z>(^Z@+J@P&8XT!M0%?5 'M/.92 KW:^D3J!H;5K[B^&X+VC1T-=[.6
MR^X]3>9YK=D98;NP.)/Q["T6&N1E_T.<[7PE)Y7D.AR'Z;==$L>B'QK]39)4
M]6EK #2E&'C@8\1$R,$$5YU7+.!=4A!MSMJ3.'QNK3D[',[:3=N( K.*#&?[
M8WHH?31%C<<UI;A?ZKFT 9<^BNPCF&QJ7]&<(2(Y>2882P:?)QM;-TU_$%2?
MK$]?N'JK=UQ3R;:U:#3<R=)Y/)^796@9-2;%K8.4TV(WE$:LO0<:J2J!V6)Y
MZ]7Y8T1]LB-]I5I#F38T(><#6X*07L;D&-DQ)^J%-/2=EU9#DESDJ+2WV/HT
MQ0T(CTPMP[\EE=816_O&B%?<?^:X#MHB81 TJ(R6QD-,UJ;PB(IQ;IJ71]R&
MT:=4=5\IM*[TFM'H>OSH;3V72IX]AGHCCO$)@E;TQ5O-,Q?"-C^V\H.(O5\^
MN3(A<J\Y9')(0'E!L;5UM,J1UK<*H63W8GWRY_5.G\[!VYJY'_)O'&02T M;
M\Q;'6(;S@=%6Z<Q)5Z1Z(0TC6%&6"%X8F7.TQKC6 <\]4![I>W;K,;1FTGH3
MWZFMURP[CB8 IT>"$IF#3XK\5\-DS,6PP%O[B@_:^@;E9B[:*$S6$+TA/SR@
M!X]H(#&;,LN+JY W6F[VH&KLEM'KBO[V"<DU)KQA=<UG')_A4DE/0YK_-9P?
M;Y_-YC3(Z<[7-#JK%W37 C+Z+]<DGPM*N!@BZ&P794 $66( SU*6SF84,C<O
MOGDTS#Z%XJVYT[74^E1#O+UU^,_W>_M_=5-"_/W3GZ&"^)ZA-2H@KF>,PNQX
ML0E/G_;VVY^S>@?0>_*OQJF2(\V'G\\/96J?T-7^!"5BM<^6U8.X'K*C%VR]
MNSFTWM19'5V#4I"$F!>.Z+*'VE[MYKE?MJ>8R960J)(-F?2MSZ1Y%]TYR2LA
MUU*B5)QQAJVW?A\$U;.PH LFW5$NTE!0#4WD:?BV.(ZS7^Z&5:S&4F( AJ4>
MX<NE7J!CP 4M11&+5GS-#>(#H/H6#6R"0&TEU:X6[1)4W4C9G<W.ZC&O\S(8
M)P7R$B1(P14HE21$I!A)R.)3B3KFYO?D_ !.KY+.F](ZC:33LG3Q4@TNX>R7
M0TQGT]K-+LX'P0?%"R<'SM6;4'FP$+DN%$X''K(6VN36.8<'0?4IU_P,]FI]
M075BKZZ"82Q)Y+9 UB92 !!IJ )KP"$S>B&BLJU5S3U0'ED1_5.HF192Z80B
M'R;SRVL2!I%,HJ^MA'VNU\(&1'!>1D@\:XG.%&9:)WWNP_+(JNB?CB1/EDMS
MO^7B",C1Y"A\K6F&VAB(QOQ^,CT\IH#W;9C5\R$G-8UU?D[,..^2BP(RUBU\
M%!Q<9!XT<Z0#HT@EM\Z(/A7K(XNN?PJ6;42NG;A#2^0$<5%%<N?,F%2DQ4@<
MJ9>UZX@0M243K*/7T6 2J74P]DB(?;IU[AE<I=9";*[O"!@IXK-I.J850*'C
ME9:>48O(DDO@L)"U%I[BQX 6D"6NI!(FV=9;SP^C>N25=3^5#FLDJ]8<(E@/
MW0]TUXR02:\M8Q4D'^M=0;* XXF!3JADB9Z%YDU\UP*\4I*2_9S4VX"(6]86
MW34SN^//.)M?QR>T$\E$ RS4VB>F'<1(D8G-@8G .#+3NLO(ZNA::?BCR>*\
M\Q3IF:<XG7_[. KC>=V,I=^>GIQ?D2J*YE(#TI^@4MTI4Z1,B"%>6V<LQZX2
M<P^CZ]7&>$?DND_C-Y9=<^_A$M_RSC@\;QZ_Z!!Y_DH>E&*P.&XI@+/UUB8*
MZASW%-05*WWBC"7?.LY^#+Z7L'G0.;]:R:]K+7Y97'!E(JRPWC"3(; B0/&B
M(&+)M"!T).^'Q=S\&,[JZ-9J"?*C,^67]^:-1I,O-1M+C+ JYV 3D8%LKBJ>
MDQ/H AB==-#<190W)N*>WB"/>^X+V+U=ES;7VH=T*)6."JR=U2;$A)"M)!RV
M. @Y:3!.\J!I#J3I8(4\KC9_4^5)'3-D?0$T/T^6:+C7CQVE+(-$X:I&IVB1
MYQHW1@>LY.2X-BZ6UDT@[@7S$K9A6Y.CC60VVZ1.D:X26=, 90Z@A.6U^EA#
M#C(:\CAL,*W+IEHUJ7OFK=C6[&DNKI;G!J;U(OIW>/[G[OCB5M\K)Q^6NSR"
MPA-$Y<%R42I #S$(!%%\YBP%08:Q_5F"5>'UJ8_5AFC5E?"Z9=>-JZ1OWR(]
M\('@4614TU\T)U(A1,$S:*=JOWFC,V]]-\33D/:I-=9S<JZM2-NUYKM[GU"Y
MJ&*,%GBB"%Q)FR'JPD$DQZ)C"HUKG=UHLKO[,]"G@4C:].Z\S>/+H>[5GZ^2
M-XND8CW ZV2L-X)%&G#M"(9&!TDP!1<W]CWNB=(?\= 7L O;-$3O2AX;L&7?
MKT$8."=U%M9"T0[K]5$&G+(!=/8&$7/VS6\67P772]B"W9RA>J*\.F32(KK\
M/@&+RQ4&F;PR57?A;-$T>"T8F<RDP0E-8+F7!EN?8UL-V8O85NV>3FL+;6.$
MNJH[C<E<AV(@N7KO=/"J7CF-(),R/LC@>!?="5:%MQ*U?I+,=-?2:YAL*CB=
M7HDJ;QQUMRS+Q17%6)0&Q42$4.\S%UIY'7.P!=M?AO!#2"O1Z"=+7[>44AL7
M^[H#=P'GPV1<9V,0F/9*2P."@C]BLL[@A4<P*0>.4BDGW4H^]8^>LA(/-G4#
MPB:\Z&93WO9NTSNN=I'"</*P #,+H%!Z"O@8 ^-<DI(S[UCK&'R-.W5^LG1T
M YDTX\?#G1V90YL5#3+HDD"INAL;%2?%5;3A(J>,K3V6-CT[G_N,4&O:M!55
MNZ[I-/0;%]LN[H<9IGHQR/G%M]=_<>6=YPV";[M@%QTJ=KZFXS#^A =ACCNE
M8)H/BE"NYLLA"&XH9/3U5G"NH)@4LY).&]\Z+-OL"#=8!\0$9D]*!R06!ZHD
M!2$8!L5%;IC3M<U=3^J GKDK?'\Y?D<911?B?XYB8R><M(ST%UJ>R6%* 6(*
M!F2]7[Z(PC7?4)G:@\7&S]P3_L73<UWQ=TW/.VOUM2Q,)0_<)5H^6.\Z<X3/
M^,2U,LZZYN<8G]H6YYGOGGOQ]%Q7_,WH>3[$_7)UV/OCM29X8+1R>G%E3ZKU
M\!D=A"@M<#1*B$"OY=;=B#L81I_*FEX0X9^;4!OL);>U_;__W#W<7=S)?(!I
M\FD\_&]:W)DP#\L0\_D6PK*(/XRO%E#0:V<GM2?#/ Q'L^O@5^LUU_#I[7O1
M=34UC7K5+<]:;$].(FGB\XLG;Z)<%+]<P_G[9)*_#$?U[L';>$G3#QPW7LCL
M0(O J@JO9T I?)8Y<\Q<%ME<\W4TE+42Q4_$=">6ZV^YU%I+_ .G2R2GKEX/
M6F^)560UHS$(O$0N0M#.>O[04MHTZ#Y%HGU8"M=2WGTE3S.7J^4 K^XE"F$C
M5T: M=*#$J7VF4L<C.8V,R]X$+$?RN>AH?3J/&"?%DB?*-1F3W&3JSW%R()E
M&H+R];J6S" 4A9!SB%H412_VW%0\83MF.7AILT+O2;<9&K*2J=:+EP*<JV)3
MDIJ)U@?M^V3N>DVV6QLS3Q%:+^W3^2V/\_-W?J_3HY"N1"T39X!9*U F(GAG
M'"1&,:;P10K=N@?R)L;5AR3NBZ)Z[\C6/[-V4+FR7_Z<7;QY8$UBEJL$2?H(
M*C#R' IRB)D&D[6QC)6-V[&;*/N0+WX1*Z%??.FE%;F_]4IP9 1MIK&84NN]
M56V]LCC?';46-MF$K8_$;F1@?4@^OXC5TU^Z]7(E73.1B[+D0=;%8[8* M:.
MP%QF\+%6) OA.).*F="Z9J/;$?7AX/"_[=I9DV"]7#2[XWD8?QJ>NY+)$6BO
MH4BG:3"1@8N&0PE%<FNX-LW[=G0TE#Z<=?ZW729/I50OU\?%_NW5'5O.DO*U
M#M7H4CLNH09G6"!R>ZTU+T;GUJTENAU1'XYV_]NNEC4)ULM%<ZV9@N3>N]K!
M0YD"*BOZ+DH!(KKHDW$84I^-RKT[-\^LEB[;Y5YVR!WDVJFQMNKDG'QW1?H5
M?&(&BM8E)R\P9=;CF;YC2'U(KO=I?72JA]9DU'/D%N\8T+?E%-<ZL/TX&GY:
M?$CMAG;NO0]\LD*'PD"D>BT]1P_!Z #,Z>11&R\Z*:IX"M8^9-S[R/\^4J5_
MN?6+SD97>]?0^RZ.V,X&+BDN>'6 R+D Y5EM)X$"M#/22*ZT$JL=:MT<YC[D
MW7^2]; QZO320;W(Y%Q]X7ICL(%!+JU=F#Y=RW)#@I!2W6;@BNAB-%.]=J8>
M&F ?DO!]7$K]9UN_':V+L0YR*2EG;^N6')E.M 8BEP@I6G2*)UL\>U8O:WMU
M%VM3G3C[M YZ1Y(-GGW8V3KXL/OA]\./.P>'_]PZV*EF<#*NJ9E)^4##F=:%
M%<;Y'8XG)W5>)M-2;[ Y.3V;+Z!,RMLP&Z;ZEN'H;(YY)TS'%%S-3O'\/K@U
MCD9L#ES[DQ//-+&-#E;\M= !Q._/!/03$N"(T_UR@63Q^-G^V7PV)WB$:8#:
M,U<OFI3"F%J%;6KTK*$$IY)D+"K?NC/L(R&NZY+=\[A;SUD(;1!,,38)!YJE
MVE:5<_(:I00O0Q$YI9I:V,Q\W VP3]FF+KEVT]7I3HIMF\;5*H4PNKB6;@%N
M:SZ?#B/I!C)!1Y/O[5HO[I_9FD[K*;W%530#,GU>.F7!!>- 15ZO070<N#-&
M1N]B%JTOH5H?=9\20)NDY(;EO4'?XO?]_7=_[>[M'1ULO=OYL/7'SN'6AW?[
M1__<.=C]<+3UX??=MWL[6X>'.T>'W[>NEMNIYV[?&KY#NX>W]PTZFIA&MO_]
M<$RK8V_X^?9CZWF7+&R,/ KBNHZ@$GT7C<X@A,J)T;]2M3;U/T:TKL+]P:?_
M7@59MP8H5*T-)KBBY:5JCW0*5,'1HA>AH+6\=3^'AS#UR7XWY,M-W=A4-,TL
M] ]0;:5T=G*VN!_[^ATBB6<3N2"S4+.(@L7:9K^VU?%>IL)"YJT/%#\>9:^.
MZST/JUK(KY<6=F<V'YXLAC4>GX71U<%==*/<B*U='<9S6MTG3M9F[*_3$GVI
M[1\M2T1%I4GE%01#+)0!!1:[06O4K?V]8^8/\"0,:9;)'7\_G!$U_B^&Z4!9
MD7BP%HSQM8RH2 B9D3$H*<;@199QD_IU1=@OR(H_AG6/T;=="'@CAOXV\(KS
MZ,MD$(7D6.\E%#)H\DE$ "=2 %N$9=PZS53K*K G >U3P-T;]CU%B,_(M_>3
ML^G V"2U3Q)8D;*6=T9PR0LH1M,?V7FGY+,3KB+M4TU#KQCW:#$^$^4^D(MS
M] 5'G_&/R7A^/!L(:>@?-*"CJ&="C =G[>*R%HJ],,JTR63 "HC[5 O0&PJN
M)=8V>_3W ZX8TXUX;*O,<7JY<$2*2B5GP4<* Y4)")Z9 LDJ18"YU'&UZJXU
M0/1I;[T#7FU41L_IOQ$_<&"8=%XC@371@I+20RB&HGVG46>7$S;O;/]$J'TX
M_-4[=?8T06XP;?-NY^W1WF3\B1;(2>W/OT;JY;Z/:I\^60ETHQ1(_?S=\6P^
M/5O<@Q&FTV^UQ^Y)13?@D4P1J1-(3-<2GVC 6U7OALL8JJ_D9?MKC>['LZZ2
MJG-Z=#&GRV*ADH- G11H9*0M%9,4?3@'7&54,DM/BZ7Q$.^ T:?T1#-&W%0M
MZTY_,V-U%<B5NOR('G/AM764)A66>("0HJQWP8AHE%2&M][+OQM)G](%&V'#
M$X6P83OR1YB?31>UCY/2P);<]W'=V).5P&_"I@A>E'<2 :.K5RP5"T'7V#L;
MJ[BB4,BUSA]ORJ9\G^,#/#TO'IGMEX_3X3@-3\-H=[Q,>1GD)67MZY)Q]"5E
M")FTGN>*_#9IH\;6<_ 4G"_&*CV&4S_20YT(L!.SM1+213B8I0A:H <C% >E
M24?'B E<O7(^1"EY\RZ63P+Z8HS>1LGV:!$^!]ONWD=RGHGD J%>E.$+6B,^
M20XR9L4C+1F76S<:6Q=SG[+F?>#@^H)MD[*\ _*WZTDO3R/VJ2"XD#4MD6#K
MQ9X"T%)@H=$$P=1#3MEJC^I36KLY1SJ8[><Q?[?R[#R6H+7-(#E%FRH(#=$(
M#K8H081U1<K6K=[7 MRG+'<?5-&:(GT^)^PB/:HQ.QL1M'&"'$86:>VP#-I:
M&:*)*>C65V8^#6F?TMS]X-W3A+C!W$2MI=LYO'[O]5)OKY&C6.5CV^<J'CV8
M1CF+/9S-$*\_]_*\Z<5)D-F[,QQ$E$0M94 X8H+*I']B<A*X%G%QOZ]SK?NT
MK8IM;=VVRG/N\0E1:&.D!*D$!<04K4"@6)BBXF"R3LJK]"RSTOMBP$YX=TO?
M;4:P[8SLBI.R3,>XXH(SR8.29 8()"EF'S74HUI*U"OO>.NK$1X)L4_9C?Y0
M[HDBW#C/;KF>R+"X2/.ALN,$V11P62&P@$EFJU+&UG6 3\7:IYQ&KYBWEE"?
M1]4MO%!'"MDGBG.*R(;"GD(K12<*>U*)]406S_A<#LBCHHA-)4EZ1;JGB;$9
MV^X!.)#>8W!)@RXVU$T-#C$H"9I[KGGV4LO6313N@=+1")?U!D8&'6(.D%EB
MH#B%CE'30A>AE"0Y*RJVOL_^QXCZY(NV8,?-A=%0'EVO@BM5".1LF.*\!Y8$
M>2-,UH;.)E&D'VVQF5O#6J=K'@35)Q=R@TQYHE3ZE7\9W-B?:Y:!H0]^EAS,
MS0%M.@OC)9'), M&V$7SL02^Y 0LF\ E2LF:=T'J11;FSW$>GHL.\\[71&^]
M2(=:E\EAL1JD)Y=%<28@6)H:;87V.LL8L;4%?Q+0/MF[3MCV*,^PB3@[]PYC
M=LSG%"'7^P*4E0P"RPBV!,ZL,LHW+])?R3M\(6F4==C30B0KFL*+W]<OD9[U
MC[_]?U!+ P04    " !H66-5(CUMG:A0  #K=0, %0   &-C<FXM,C R,C Y
M,S!?9&5F+GAM;.R]67=;27(N^NY?4;?NZPU7SD,OM\^B)*I:YZA$F51UVT]8
M.4HX#0(R *I*_O4W$@-%@00)<&<"("@/*HJDL+^,^'9D1&8,__:__KP<_/0E
MC2?]T?"O/]-_)3__E(9A%/O#CW_]^?</K\'\_+_^_5_^Y=_^'X#_?''^]J=7
MHW!UF8;3GUZ.DYNF^-,?_>FGG_X1T^2?/^7QZ/*G?XS&_^Q_<0#_/OM'+T>?
MOX[['S]-?V*$L=6?CO]B,^%*4P'9* E"6P,N2P?$Y"2)T"X']_]]_(L7P:GH
M)&@3. BB.%C'">B8@XY"\>#\[$,'_>$__U+^\&Z2?L+%#2>SO_[UYT_3Z>>_
M_/++'W_\\:]_^O'@7T?CC[\P0O@OR]_^>?'K?][Z_3_X[+>IM?:7V4^O?W72
MO^L7\6/I+__YV]N+\"E=.N@/)U,W#-\>@(^/T^M_>!.-_&7^0_S52?\OD]F_
M?SL*;CI3SX-+^&GM;Y2_P?+7H'P+* -.__7/2?SYW__EIY_FDG/C,!X-TGG*
M/RV^_/W\S6VD_>'TE]B__&7Q.[^XP0 1SSYA^O5S^NO/D_[EYT%:?N_3..6U
MZ)=++J!D@?/_ED_[I3.F3PAD'*Y\ OQN&A:"5\1XUZ=WQWS]61!3=E>#:47$
MMS^[*M[1I>O7%/"MCZZ =O9!<)DN?1K7A/K=Y][ N02YBK!\)$*:3,+H:C@=
M?_V4W&#Z*;AQ^M<PNOQE!O;EV;M7I^\N3E_A%Q=G;]^\.OEP^NKB _[YV^F[
M#Q=GKR\^G+W\/W\[>_OJ]/SB]#]^?_/AOQY>4@CC(11#3"PG,^R/><R-%2*5
M^L-^L4YO\:^+9Q7\NUUK^G.:AC'%GW_JQ[_^W(^91<H8E]('(0FSU$8M8]:>
M2IV<[CWF@671RV4/1N&[YP^*B1Y=<VK@?!K,OMN[FL!'YS[W+J:X6Y:-$^64
MWN"7DQ[S,GE"%)@D/8B<#!C\'F27C5>$4^'N8.1DR?#L)G[&R<4C?BEZ_24-
MII/E=V::GFEY/8JY,A^_KC?#@([ )+U*\_^^&5Y,1^&?GT:#B$[%Z7]?]:=?
MST>#P>O1^ \WCCUE2(I4:R"$11!4!3 V)PB41&*E9E:QRHO>$N+W$OE&\)/Q
M4C8+>_)(@U.\I*K<F(YVIY(Y+7!]/_\T&N/'_?5GTI5!%Y_0%DS.KJ;%22I^
M9X]DFRW+!J(DZ!-ZF<$:I\%DJFWD.FM3_<58!;%[%C15VZBFS&^3@'8FP:VE
MHC@&5P7:^]%X)OCI=-SW5U/G!^G#Z-T(@Q3<3E >^"MOAM.$ZYGVT.B+C$N!
M)', P6T&P[E"Z7!)B;.4\?HFM0;R(Z?;[K5[FZ.L"D??3"97*;ZZ&A?L:=P?
MQ?F[-/OS!<HQOAQ=?D;/=1:R]9Q+A#N4&KY%">-6CN%MR J"X"PR)8VGH04A
MMX/Y#-C74&^WJ<8;4>WO;G"5UB!&[T"8%,OQ"2/X<C 'CN.[$J/$E\8ESR/=
M#=/N0?DLB59+:[=Y)KKR["3^WZO)M+B>DP^CDQAGRG"#]ZX?WPQ?NL_]J1O,
MD/M5Y.<)13?I3]-%&G_IAS1?ZGD*HX]SE<Y6W:/)R2@L6NN,BQ2"^B).!4G)
M&+PW:+=C95:V7M-Q<_B@&'&;\;**93U/GZ_&X5-9P<D0(4[[X[OVAIZ@@CF3
M"-"<- @I#5@6,Q NB;%>N,!R"YNZ(;[C9F(S3=UFE=H-J^8O $92RAEF0*)P
MBFO!P0L?(9&@" U91-IDH]X,W@]./49/MRFENU+J;/HIC8M]':=/Y2#\"PHF
MC"[3V]%D@J)(_8_#EU?C<1J&KQ_&#FUPF*EI&&=_&\Q,\C=C_BY-S_(']V=/
M>4L<->AA4(-Q/N<6O'7H>@B;HPM>>F4JLZ_-2HZ;J >@_=N<-DTCZ),P]Q\0
M^:07')7"$0UHNS.(X#-ZR 1#?:<SH2H:PVO[C1N#.V[FM='1;3+9EC'R=SB%
MY<PPXH%Q:T&@CPE.Z00Y.<>#C%K))E[<!MB>)96Z:>B.P^?.5Q"_]8>C\>Q4
M<G[2N!3.:Q3?>8KI\O,<ITR!$<<9^@!1H#"R ZMI J6S)Y&GQ)BOS*0-H1TW
MD5KHYPX>=;[%N _GJ_YD?L1=D*X[XO[;7'H]*C1U.4LPV>,+$8(&HW#'-H99
MR80*7M2^QZB%_?DRL9F&[Z!JY\L,= F_>90]J@,5$;U!(B@'?+H$9Z@$&5+B
MW'#I9>VHX#L QTV:Q\OZ#LUWOUNX=??+B?!22 N).W3DI$%'CG,)2D3E>"8B
M:K+;^_:]72!'$P0/-H'E$M4L<P83 P?G5)*2EG=6/8$+Y [Y21_*4WJ)!QW1
M^0*.VRN&AT* $5Y EIXQPYD0]5,POD-0T2+<2$YMGGO308QW957\-$\U_$L8
MC"8I_O7GZ?@J??LFLB#].3T=S![XUY\GZ6/YHAH3YF0LAQ"C8;D/./FSCT$?
M;E?4. *&!'2Q)-/@T4,'+;5.T42G@VA%C+L 5>3)/0G#]_#F$8I>QYG. F^0
MF+."Z=5L=]T(5&\EA;D2&^X$5--_6)>"?0\'NBMNU$KJ.Z-$I,%9CN#\W*%U
M% PW"ICB5ENBT<?@3Y<*WV6W[Y\)VPB[ 0,0SN5H[C#_-O.S>TR@VYJX!YTD
M!<$5+I9I7HR@3S9'[F3MM-Y;('8?1%10SJBF9!MDYZY) 5B ,QYC \8YJ.R0
MV0[])=SL$A)=TB04$XR[ZND=]P Z!@K4DWB#-_\DA*O+JT&I_%MW1;4 2ER0
MQ&)PJYPI=P*"@%48-1,O56(AHQQJG[IO#.XH:-)$$PW29L_3%->:XJD;#S%@
MG2SM6HZ9<"W!DJP1E8_@2+#@M5"<TJ19JLV/NY$< QDJR+A!%NO=)Q4+;#3@
M#I9YB9,R 8%;&=C@'$C'3/9"2U[=/MR'YQA84$W>:S--_^V7%?&\Q;_6J7>\
M^/VWWT[._^OL]<6;7]^]>?WFY<F[#R<O7Y[]_N[#FW>_OC][^^;EF].+;YOC
MFV$>C2]GB0ZO"OL'D\>4/U9X:O5JR-J26"F.Y(DSSYW75F81B#'(*H^V02:F
M)-*@5^'YG9V,(IW)N]$T34Z&\>W(#2?G*:3^EW+8\NVDSHL@4Q09C-3XLL1R
M?\*3 F-28K@R'4SU[.(-L76UG;\/?7\P*!FV2!,7IC>>T4N2!,XM!T*<!"$B
M+IM)!\%&34K;!$=MY67? V?WEK,)/U:-:2T%5(S)BOGJ7;@!+GHP&/U16DJ\
MZ,]L_7F:.8(WDK=[0<AL#8T8-Q:,AB9PUG (F5J,':QBE#UD';=YX)'1H)FL
M*P9E,XP?4'F3<GTT3ZYY[R;35U?I]6C\WGTMZ,[R(A]_\GX\^M+'?:!'N))<
ML)+46N[[A'#@!2W96\P88:EBQFU$C>V??8PL::R!%I6,X5.*5X-TEK^3SDPT
M**+7_2'R?4;UI9CFMQR<1J*"1V*'<G4M4@13[L0%,U:AFTHXKYZZ_CBHN[H^
MW,E6M MU[?OV<3*>]L[=\&.:G9AK&1PAI1B."0_"8\R*00INL#0*0KBTW&]T
M_8R?>H-D^+=O!/ON@7N[1=R%9D==)5QQR[H&L8A*-X&QS47B)@JO'_ _?&78
M0?BKZNL@N9:*##('1@5HPP,(&AD8XB4DF71T5'EA-KH VK<"UUST-=#?%@*K
MK+??4%*75Y<+((+@XZQFP&-9#"4!K(JX(I:8H\(*DC?*Z'A <]\]='=N8">Q
MCVK(K&( . /B_KP!1!KFJ58$G%!^GCGO6280B24F^1BBW2AU[R'EW7SH$U3>
MHV6V]LW;^TGH>9J@/Q:FL\**%VF(0*:3EZ/)=-+\./3A1^_I3'1+F:P<C**#
MGG64T0;FT(QC1)]2$I9%*7FD06QX,/HPB*[W:3<^OWSNK(AU@B'FC7!#,F$P
MPO0EW, W)5H)I2H+C&+!!)LXT[KZ[=K#N+K?)=YXQN+#;V9I$^(8R\9#SBD5
M R' 4T+!)6(4D1)W:=ERV;<A[?[ HSH_;E\VUE-"@XR5N^#UF$\,X^^(JU08
M)A&VJ%64+#@,PZ6@IG9>]UTX]LR&KLK:@ A;2;I!@LKW[/_DQA_3I&<]M\D:
MY+C@B"F[ )XG#EE$C*--=-G5KMN["\<1:_\QDJYXL#D[AUT<MY;Z^.^PH?V[
M>5@O-2?6NP3.Y51,'T(T.4)RA'MF-,O6/N0G;?&\XU!Z*P$WR#I9A[)G@\F&
M* 94EEY;"6EI;.10;L*)4\:H7#M#>1V6XR!%58DWZ&YVY_Y$>49^:@G<.@["
MJ0Q>2@V4\D242TRSVBFK#WL"VZ_MQ=4$G;G)Y/3/_G067-">"DQS*@A:7,-0
MA=:"HQ%W7I2T+PT+/:M=QG<;Q1'ZNQU%W:);[O6UP:H=7EQ.SV#.KPHR55)1
M76X9G0>A+ <7J 5=$C_1)R-"UN;[%O!V=4_7G"2M5++O>[D-!#@[$D=#3[,B
M&93)%-<D\8V0C(+6)$CT")6NWAKC 4C[O].KS(1[_>]N&FE@HS[@[ZV(8)'B
MN@FP1L6#:T'MIX"PJ@I'+>6_4X)P&P3U&5^(*%U)D<$ (J<,V3)%$V51^MJ'
MESLFQ@/EA/OAQ39B;U%6>OEY,/J:TD7ZDL8EWVYQ7:,8-1A(< A$HJ$DI24#
M5:KT?U?:.BNDK>W K(&R>]^VDK)6:THK2+IV6NNU<[W DHSQN" !5*%?+2P1
MX!@Q@(&IY3X'&<S*2?Z:4YJ5#W[J.NPLK'W<:)Z?_OWTW>^GYZ<OSWY]]^;#
MF[-W'>XHUW]8]5O'#7&OW".*A&&$4EY+ED0(TAAJ<N8*3;;*4N3>^H_M9D%?
M]2?NX\=Q^CBKQ2B<^Y*&5S<"'*ZI,Y99,$%Q9!V5X%V2$*.721/.HJ]=./ 0
MINYQR>SS2O^M9:;^/_K33R^O)M/191J?_KEHI7,RF6 (GV+I@JIM]$DQ MEY
M@V)0$JQ(#)A+/$2T=MS5+AMY!,S=6ZJJ_+D=KK155(.;Q#7RF(=NCEO/)49M
M"O=%M+F4XV;I-62TW@FWRR1][?K%^_#LZB"E*4>J"?Q03DVN^X(LSQ OYI\[
M[PLBDQ=::0,V6H8K*JT=8M#@I2VM06BJ7[YV+Z!]G9C44_NZSDJ=Q=_B$'>.
M9>$+;@*FT:'(=T#VW$FINZ)6*=!9RLU5KT0BH10#.258Z:,=P1 2@6.\Q:CP
M6NO:]Y([4/FF'9,::WP;X=8NS7MW-9ZD<CD^&/13Q!5G%.W'1<QFJ5&29 ;!
ME6%VP6EP(F+,QHT,Q B,'/)#H="#3]G#+-/'2W_40G2USRG>?_HZZ8>^&ZY@
MP@A/D)@XN#*E7E".*W5:0@K68?3-561Q(W6N><"3U60-@56N?W@_'L6K,#T;
M+^HRYTW:J"T3730D7? $XL&E[,'S@&&&P\#=;32I\8%,^KN>?31^5Q7A5DP+
MNX&GE-,MRW"7[10W %6Q]FPMD-U7HG77T6V%5Q)PFU?]+G#>)L-( .^#!V$$
MA8(6*!4L4F-$=C7*GG:L]7O*UW:E]"WD6KT70KK\/!J[\=?E7K/$MNR!I"5N
M,9Y DF6J:PRE$YHH)^:2BLR3):L]2M<U/KC_0;NMD*JDBU$C0=;VP&;=[E;P
M.,(5T5(!H;K<5TD)OI1F:LD9]:YD(6[F3-_QX4]>F5T%MH\;HY.7__'[FXO9
MW4CUGE\;?W;U^Z3'K6KE>LDY09A6S 2J!4G,6^NB,%0GZKB/O+?Q4^IDH-Z8
MY/3M%-@C(O0?.82(?PA>>NAG+8"CT^]2")2FVNE@]^&IE5/^833[]'%:/BQ-
M?BTZ[R4M5*D*!Y9=Z?^.@9)EWD$FF7-FI1:A=O_CAS#M/F*LQHAU">95Q-_@
MHF@)Y^7HTO>'LW?LY0@],OSTV5]F0QES&H]37$[XF/=FG,RGHZ&Q+U_,XB[$
MJM'.EXYBI<&O$ 3C8DI 4RZ("-QG4GO 0D7X1T2Z?2FUP7GS'3*Z$_+9>(GX
MW561^EF>S^F9_[072V8)-1FEJ1T(;1PX$2)D+X2*65J66Q48=$-^A*S<H2H;
M-""[^]V:8J"!9OZ[M^QMW_G^ -?78P(M.>$6G YE E<N4ZJT!IJ<-4G%F&3M
MK-!'P#Q"JK524H/:OSL@GZ<P^CCL_T^*;R+B[N=^>2E*ELETLO FBJE>+J&?
M)OBSJTO\]>'4#3_V\9<G&"YA9*NC IULG/?K<RQ&2!@',\Z(0+^C/?=J+.6X
M^;ES93>H6ESB?%TTD][VO]Q$-U_*/U+_XZ?2@[3D[WY,OT]2OAJ\[>?42Y%(
MRDDJPR31$=;H8WBM$B01B!+>"N9J;]%=\!X1&W>FMMN4DUTI]^MH%/_H#P8]
M*WD(5D<TV@(%@&X V(C4IY[$9$C44M?NG[)\]A%1X5'BO*U6U>F8=(OPY5V:
M_F,T_F>I-9G/FOE6S8]+D-3+,@S4HAT4'$5@F0V P383CN'BW(K7M>9DM0Z>
M(V#)OK1SFV"Z <'N<@\_I/%ECT7I3&0*5) 8 GNBP#/)0"OFN10QZO3@R>TC
MGGO<A*DB[=O$,)7.2U^/Q@]%#-<M;D_"M/]EYI+U:+2"XG8(7!,*@JD =F9%
ME=.,)Q(XJ9T7VPGP$7!L]XJ[S3J[AU.%EU=H8M&0$B>%Y8:#%Z6A)WX)3JH(
MT2/R'*FAH78.YN/1'A'?=J2R.\Y4.Q_Z?ZOSOT,ZDQ=?;_QM,2/8!JJHM,"4
MPK<C4 .>& \^6Q]<3AQ?G=IYOEMBW%4523,^-57*H525W+&T63(/(22X>=<2
MW.H%DV6\@(M DN>4^&Q\J#VT?0V4_??>:*'^AX_BMU;#;BY[%F<3:9%)L@G
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M8S8(G9)TM/9DU^\ [$_!CU;)&A5O+\\&(=$2S)O+SV[6J>Q;7LG\6V7[?5N
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M@6=PB7HPT=/(B7&Q^N3;W:[P  \OZS)_=XUO.A.HQ92$]JN==X[KB<@$]2H
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M[.SL[,[.[&QYXD+M0MNZEGW>S@X Z.@ $0# &L  6P_@4 H&_0.PS8".F@;
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MW8[HD.UEK6E]. :C!![93H_0J%]J\,7,#JATA3OFO49%C(,/6VY/JY8O@(;
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M4Y3->N[_0"%(W8H3!%) $B"  EC>#Z5=W+=C &M@E)U7L-"V6=F)1')3E)#
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M8 PP%A@';!-, +8=)@J3@LG#5&#[8(=@!C SF W,$8:#><".PT[!SL,NP6[
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M$GD!6X,:XQ\%G'SD%J6*R?V0/VX2D"QM@;_U7_P?!H![R)P$,A _6KK^W0<
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MN#PRBF0>*;22?_A^\UVWJD@6[Z)X7N2.0DO^=$BE)]/=3"@:J[9)D66\K)G
M*P=IS)N\47PK?^)(;Q&==U&22IEBX*6DD%Y\*%]RW9?N[TAMX%7IRQ>82Y\%
M:'H#K)O[MQ3)JJW*_AV_2I[0.1;.'_,1<M'"/P]P;QXS&01)P?BJ^)H>G6V
M[FS6Z_?$%L20X'*7_S2H:UKU=.X68-,.8_?@[^B3>\:ZZ>V',=K)8.%Y-<"C
M_8$P63FJJO'91625+I3G\TZ5(C4^/&H%"N8"YA_@17,\MCD.A_X);0E\0KJ.
MQM6\Z_/IZ^EW^;DU*X@IB.EGK>P+?C_;9&EE:V6;!6?-ICYA($WMA-R\?'4F
MX[W9R)GKE<V'FQZ5R8I<,(X-NNM6!BGCE>7)N[6.-@DJF_NY=D#J,PT52=.$
MM.3PP@K1J\6B_<A4*PE2CTT2+]?]0@,G\C71]Y"Q/2QB>8FNBD9I,E&-+;70
M"M&GQW\W(&W7R8R:^ #IP>*4+]^Q-5B7?W^S<U)3PP8 _UCV"J6:OSE\M;I6
M[06PF:C&1!VG8FF2^88,XJWOR'P &YK&DCN<<"P9)T08NN=$TO@JC ',/0R)
MFSCX26F9DWY1]>R8CJ4T/:"9"]#HSO7NVG0+C/E"46,/*Q0U B]3TX+LENMR
M4?%CLUE?*S<:^I#C<41IX@X _GGW#AZ;:B>D=G'4+0#<E6=_7V&P4 YCP[>J
MZ(21KI9[WCC;S9_DQ2'3.OF)?1#-_VFC./O@X<$CXEL<FEM&,RK\<S]#)B_?
M?K2A-VS4:S#08$K/\]7A<^ENE:&;VH/NUB90#*N?R_$%57FAC".O3)RJM@8E
MUKJ\1NUOBY=E["9#RL)RQ9ZD&!I_&IW/(Z,;R"-M61=\TXH>%+IO)#N&F<B+
MOD8YMU=>\+O6_C"=.S;_D!E3_O'\WTH.+[G<I!R7/)5@ _CO63'T!1*=]?^S
MSDX'9'?Y>O<<40/<4Z,,F@VF2B4G=FGUBJTOX LV!S!?@9TDEC;"T^7-?X.^
MBAPQ;S_9],4U<^:3MQGK0(+6\<ICCMW^\M!X_Y@QZ'']<?"Z>B^>]](Q2;J"
M*_7'SA@'W^3.4 C8"+FF!C[?T7>S2LXM-8*U4\$\%G]?<3;A]PQF3TV8[XD.
MF-;@;POJ9$_>>A)2V&KWR-]!P6P@#@B()BDT!$ 6#@\A)SU_H"J<WTV6"_=2
M_G?,#=WX&F4&:?9MP,DIO).J^O&;U'#IUS#Z<;)LZY>$> #O[M;I_:E5)6=U
M[G>C$EA*7A%/E]D JR.K$V!0^(1#R3Q%5 7Z7GC&J.2;L.>CA%G-"6#M\J:)
MPUVY1G:)$^?X>/CEHP&4[>"<R0BO7)J1@5^ ?,(6K?>1#4]S%_>[X3$(;IYW
M'4KT@PH.?LXYK-83NU;\(2/*-V[/1[:C$&O 4/XATNUX@]S3 .-'./1U1P4B
MWQ'P-X%^[3&COM<+P"E=ZYG*N;8LK2S;[-/?\YTV$"9XBBM*2?5=GZYGRV6H
M[*<\4^_XLK<+(,??HK,IX9\+4;S)Z)-/T=71J/U%V9!UVL3+N%RKM<XZ7OVD
M)59%U>'"B=^JLVBR9>O4P;, WCO0198?%OYFD']W <Y@X"DJLF9Z,LH#;O\8
MP' Q"H.>OFT\-N!P0]51UK.^I4\!S<S\ON[<TYUUMY88Q17<37]8[L5G!.AJ
MGN;FU7*'84\ F<**1T9:Y!B58*IWY\T.3<JR<HUL+),JQ6V]T;G*XN251/'4
M 53-3*:PA$\XZZ2CV,2RDS$W&VND2KWT3 O^IC[9MZ48Z''YIY9+,$PS\.>R
M/$>]8"G9:J%%]U+20M)"'56";M2@>XYZARJF8%3?G+F3:_I.5,,SY0K4J9^2
M((5FOK/.B3K:&97 //+" &M,4:(G8UI;,N0[I:$ Y%."S+&++TRPR';^NU!<
M0T?RK;"!G.O'0HI2P\Q./H4*;$YT:]1$F;57VE"=:P(O5SM_^DBO)E1[%479
M%J]11X:\4H]_R2RXIR)1<N,W^H1UA WE:XU&K(<6% UEO>ZMNEFKL[]GGNP[
M@O=[)K"L]XCR?8)Z8=+NTJL&9//*B-R#H]S[YGR)B^=^W1&)?<^ 1,%GJ_-9
MNJXWEO@Q^DT?/) D[%ZE!BA+C::?O">@J<8T['&?T9OQYI"IL6?4 =-G&/IQ
MG#=_(!OGYZV<HEH[NWUIXYR/OSYUG(T\J=B'PRT>50V&IOKGJIA'-ZN*U,J*
MWON\ +YIP'\-\+%X2Z-3+P-=QY.>H\B0>_W/FCV1WN4ZA7#4+1N%JN8U3L!S
M(:9T)DT3E&N>V,;+BE!<K1*=V7 -I+U-[2>?NAO?0.YO2Y#=/!(&&:O.R1R4
M,S2ATCFU4ERO5F*A%:3>$!-Y'#40E;2@J+<*FF3#CGJ3MT(^OY?BDI/1_(GH
MRAB/*,?GID+CF2]CZA/L?M.28H&6XV$=XML 6T)F3&7[LRBWU=D^=V?"PCT.
MVJ0!6'U3 "4T97L5+\&$V7D\Z24T3)I4)4J;NHJ5AK;404&.%M[827%[G^(P
M8!J:XKXSR!'IL#24:*+G+Y4G:#=ZZ -NJ]'!2<HJ$JI;/T^ 23O0P,F?LM2C
MTMFGUD^B2HZ8A_3G%G3X#-V]+4_%,YA+AZ?_3)8]\Q!W*GB1Y:!NFC_$)K56
M*Q2;=YJR0?K7@>U]K-=A5>:YP@IKYLD QG[N->1:'/O@QM\-@4ZVS>\%WRC4
M$%*HV)3AI'D";\.33U3K?&0<PT)99D3+BQ9QF<4:A6Y.LTW92-X*!4>BL=60
MX3TR"66$K%7&MX2K$YI(J]!!GQ"]9?RQ=-2)]$@K1!P79H" :DZD6#&DU=<H
M[6$++3Q*XE7-X?&:%Q+W4L[_IBV[ _U'5:]D_0)4DIL##<-H/)ZMRH5U7J8L
MS<1.EJP,@+P;T>H5%DRXYIH=M8%04U;/GH%O\KC=;C8LA\F<D^/A5X_JMC\\
ML6KV!/"?1V6.Q7;SJ63/Q9E-N9Q=I%6B"\Y^O !8ZA/#7GJ&Y:8_H&+7C*GG
MSP5;/.2^+3.8WB6F1D6J!%UHZ/OLQW5??D-3PQQN_&]H<M;/K_?$%^G!H#O>
M,9F/( OT9#KMVR^W9I)93C+$G9=[7:%;H?N:2428.S/WFLF=D[LIF 4@!)@H
MD^@&4O\"$(5"M%>*&2,&85=C/*932W--_JFEHK+OQ3#B1K(#I.L:1)@)HE?O
M)*3P(F<4PULOS_&NPJ&LG&<G?M4@Y=2YR3?S!I_4P'2NSYRN\MJ:U;F_.6$3
M2-%US1\[7G5+7J4N?0 N,0_QXZ0<V-ZQ2DL!('\!7/05;U/(6/XYC%U#/6(B
MZ5%%D/5Z#(D/>=*U-PA":#["^_KJF8QCY)%^WQ8K:=G%(<07^MS2 OY^)IGL
MH[*(@8TA/W\HL*A)N%S_),0-5TN]D0#8FF.15[,"*EQB5' "KB[?"??^),"^
M;,A6/.'-,QA]7S[FR2,+R?]"H;!CT2VC!TKF(CIN03-]K&FSR,'1HL$"8Y\B
M[+_E:"EV>^%86O\IOS&Z]CGDL-X5O(?:W],G"!C8E5%01MR@]4E)LVLJU&ON
M+Q@H *KB=Y$2'X;KY7KKYR-\/=E.I&U85&!+D6#M8& GJJM/K&N1!1]/_<CT
M[M[I^<LYX0RW9CR5OBQ>4QBB3PCTD]@Q+M[=Q_WLKRH4WMD_6CD]-3?I:&QA
M6I<%+5 VXK:<S(7F24^>TWY!/-<TLT*9H C7)NNTW[4B*,0][7?%+YR"";P(
M +1RR. F3:VU;RX<8X9\[N&$(2[!*>=)QX<WVY_\P^L5)!0;7?"]W I%3*DA
M)L>Y$4/)35WGJZ?QK1)2GV5^^;99?SX^6BZ0DVP=E1L1[M6L]?@AH EM?OB!
M=+#:HQ5PMXQ*[&L4EGV_1$B'FMM^S^1R5N\M()[7T33X[*D?]3^ !;3.MY.;
MRG@>L%X\7:FG^;Q/PO=5 )VS&J6/72QF$/XQ6TEZCS)N+E57K3QP/T91E_LP
M'P]3?,#9H+;$*&I&YTW+0#4!@?& V=Y-Z_ZJ4H_GA3I$"2CGC[GPA/K.L'A3
MU&>;%?1GIU$0^,"<*>?XZ<=XFZD@ %B%J^7.A<QFSJ15J1 ;W/X],VV%UC(7
M!S/>OI!P[BDX@3I33#SQ;;O^]$Q*5SC;D'."X@VK.EIY\S(U)AH#DC+[M=Y8
M0&&K:W!TIT3;9_Z0:8.]8.= ;Q+#WCQ'*P#SAYS4N.5S(G;YMH=A2_E18V>E
M4&@\]#5;-O<S%66H+>8P"%@95JGN>=$S=+=-YGV%FS]UZ009;[!0;7)71]3*
MA'E*&=F6W2XS4RZ9X]IS#>4R^"4KC<+#$T_GU5WPJ3GRO7Q.ZU_4LHH<3TR<
M:6E9GF)5^WPZ- NZO*"#_K&\E#2%5J3)+]S"W%X0U]2P%T*.F)E['33134*>
M.(P01J!@V$8%OZOH\\=S9C*KQ/WJA_^5N?4UTFP86MWLAZ8]SR*E-Q(^/65E
MDTYCQV]^VS;^(_,SGP-WN0L"?\NG\W'\M'VKA\)W=X\8V#\[5;D4]'+=&CR:
M,K(.,(5-Q7D]%EY?_XTUUXS*[6UT1+Y?8D>GC!*^6YV2=>S9KZP9 M6?GU3E
MH&6VUR";P 0+,7B4<@=*XO;GT.!L%<>O\O)YES0XQ26Z5'WJKZ_9EU'B#7$]
M\Z6YF%0FB5?[:YJ%#7_)"XT2D)^?Z+M\<3J3SMLFA1?9!EEK6]"GC:*/++;6
MV/ZG?0C(=S!,GTG-C7LCNFV"[=HM:.WJZNC](*)X >3ZZW?Y9_Z[NF5]ZZ 0
M,IBG,#4_N*/PU8EO6L<F&>-%"%W_K@%:G*H-"UA.*W*LSEZUP.DM&AM+H1:F
MN:MRKD*$W.PA"?CR:B3\=\[NJ2S( ISQ9/JSUN)%22? TZXKOO0C4R;'E]CL
M<NX9V/!T+N(H@/D([!J:*>_@^5K'%YYW'HD#TT_,<@=CAVM(SP!+=/=UO#J>
M9_SK/$(OGUY4X6;,,!X04:%SXR4 <\?<QS.&NXSZ\UF_=ZCP)X#MU,O^RKJI
ME,DNZZ=Q%;6XC:(OZ+S;4BCFR2RWKM#RSRU;(='V9G0.6?-B=:KS74X ^%ED
M5&=,C/C\N,=Y]?Z-_^S21A-UY'6""M.UHGB!44&%,N%;S445UC"ENK1?727E
M=\^O[D2Q-K@_ ZAMRMJ52G$)+:O5_EVMPELE=DV%^J5<<2=W2 +^BRK;>_GJ
MJU*><:T;QT4<R1]X"$ 6/E+.1=1M[NX2GYT'^Z*]XG!73P-88* @R36#^/3K
M.1=E5_<,0YY':4YN3#J S17V1+9%)]0I\WV]OP>.ZU0I[IV.5"_7,H1">V[.
M,:L!^_DMZ:ME_?/ *O?<-;UI*FYRZ/;QE/)K+D4L+_ZBL8)-ZQLB\XZ[I\H=
MG4J&&'-73G/M4;'S;^VC#ZE%_#M3+24H)[R?B/&5.#3+7)O<T'GKF\;=*4M4
MF/\E)YKR'\[/IN8/I5WL5UNM\>]>VN'<0.Y2I-S7ABPRY<KD7!<AY 3,0K<F
MT="Z8K,\8%H[DG>IE]^F^=F2QDI2FG@3DC?EZ@/^JRH"O98Y-1)?*X%;-P3)
ME9;5S991KO_1]2M'??!R+"8^^RJ$"N%IOF=S::?_FH;49T"N[4V&:/:4H_]?
M4B;X-$O?I<MVO25@6JPX;TM0>M;?T2=<R)SHE1(JNZ//&OD,P)[7QZG'+8"2
MF*=\MA_]./^1'<*B>!5*J+RQRK$0<L9;H<B--\0KR4J@/(;>,SAG:O_JML%,
MDJ<>5!9]F'8#+&,$G:"A?--E^X2;*^6+)Z"@6#[=D:[!\Z?;E&OGW[]VL.MB
M3]+F'/\X,P!S;Y$9G-#\9*X&/\+3*5R&KYVM!0S.;MP!$5:\O=<%EUC'^EFI
MEL(;>)\!!N$CQF3F8;S9Y=VK1I'^6/73R8-S2K2 IKW9N:G__,N,$U]S:0HL
M@\WOL3U(5P,\F*[KD0O >P'$_B7=PL\C!ZIO6$L&JC6)=S:?I$1+!X.>NC5*
MF@8QCKRPVOA?+GR@V;6B^I7O3M^:,<NZFV5BT#/3L3S&&&MIE1$/KWW]?WLW
M'U(K69ARYH;>G/A%',U_-Q!R_/X>QU&->5N'(W \7:%JJYM7K4D^-U8QH8<$
ML G/M&GT%Y>'8[KB2VL>FM/\.5V^?CWR>]*;X!).T2P9@Z(W.JD[KM]UR\!P
MJ%S1V$DI' I\6^==F[#9+S)N,;QKU.Z8'.+7&S$U@BR>_LM8[(!Y3.=2_?&J
M=TCU.5Y)^P%]^]1]W'2T5C?$JDIKSXO^BGW%_GQKE[1*<W\^J.+AVQ:/=8";
M=<QA &,E +E>^(-(OH@1;OR3W&5'78/KNC"6/!$L#6"4BX_CC"-#6G])[_)^
M1UKB4T<GQYDJ\HG-(U1M'[5 M@>UG7PJ:1JZ>;C0K=#MA3LS5ZTX>]^CQJV-
MDHW/D2_=+#2@4/KE5FCI"<VY6QMC&Q]1,+.4A3=LQF,W[GWW CCC%]:ML@O"
M\(H^'!?QG2V;>575))#:]H]/NP#>+=*>?+D[)=@OKCN?=W7SUCD&7W?,43"U
M)FYX!G97/9_(/3[U@K0TY+6B3&'[%H I<1A0[HME.M[,1.42;W[X':T;G?^H
MZ&KE5WT7T#0'N#?M;GN>\0C<44V<&KRJ&+0&T#<KO#Y&.1J_M<@]F&"D7(5Z
M4>P=MV4OH"N>??_T2,6Y_E9 ?W^:?_.IYIPNORWEA(C;HV%J_?R;E^[^PO3_
M#W7O'=!4UOP/GYB%K"*PKH65ZJY=!%9I2@FH*Z@(J"A5BJ(@TJ49:EQ741%0
M%%!:4 1$"+UW&PA(#;WWA%X26B#PWIO "JSZK.7Y/=_W_ .YY]:9,S.?F3-G
MCKE\CXWWH%\P8$F>,G9L2?FU-A>P_?:NG%PZKB;:QAV:U9D9D3,0'M@]/[PY
MWS2/H.UGWW5#VEV[**$F:=3\P->, \0K/]SA<%113!G?B:D:V]?:=^CLKVB+
MX19?O1X:#!8UL"Z_R75++QIRDK1OMGUVUI:O$WX_YR8%+KR]>)M/-Y7O%DQ$
M[IV1UKNN.E9,%U0U\<?)?V=0#1&=0DQ*]WPZRS68$'+UPN+O.ZU?[G=1;SH[
M#"#'(O++U/*=-AMR;F/,?B*?3_/X!J8D8,+9.B'DFI'B8]<T/BIPZQ-*?M<U
MDB(ZT@F>%4:8MD@,JMYL;;@$C-9&M.Z(Z6-S!D"'I;!A?!(C^(I!V:,Y)TGV
MH)^S%;#C4W $A5<TM<=[O'.!=<BE6#I;VZ7<U]1&"10WS\3EF#H$+>@,<MNX
MN%A5]?1M@"!=ZT#[QDMOWD%?E'$@1IN,5Z;LWD?;N=G8'&VVP:,UPZ3N-\95
M_(<:DS2=[.6/ <0E7O9D+;<2_Z_*);2X&5*Q,W(TA\)3Y<Z2>.[%=QD1R/%>
M]2;C\IS5*>)E,W_0:7]#U.R&4HX_'\8^Z9GM[N\\'H"3HHGB%.WH5'<M<Q51
M;]'GL<4:XJ5JG'**G&T3@\%^XAI+TN:.DOM-@9HS]/X^M&U-:5^M5$>X)#00
MV/I[:V8]@G;VS &\TJ9%@114)%]I"2.] W'&8PX\/\->YG<5L)A-U5Q)%&=N
MD$6.]AXJ]FW(3(G06O\(L/T1'TEBZIAUCVO:OH-^E:IGVN7$28K'0P#4']PU
MJ9&!LU&1?UU)GKT:5-2==;BV'_MSE[OO/C."B8STH,Q"E@CG:.-(D"UO:??5
MWP";4FQD#[F-+6[Z81A@'PY5>RYR;,I6V@2(>09W#>*Z6?O2THL9[H@,6U0V
MW1'95;\; %V5=[2UEC,$,? 5K95G>X2*>9<A23B**J[W6OMF)*OMKN%OQ@W_
M4!F09K+/.10N5)R3F:55(<G[A5DX^9'P\(%@0YSG*4<83.QY4?HG9$7DZ;;*
M3N%\6_-?:/Q,I_/ V<6K?9DD:=N?52? <0_4W@[^II@BA^[.J2#Z3*,H)KO]
M4E<O'HE_7'0"\)4[L_]FK9A+=JS]5&)<YD3@L6<Z=PBR0)-0FG$C<H:6@@5E
MNCHU1K_V:O\(0!?7JAK,:-YT6M!%>MC$V7'XA6NPS:J8B8%#W+( 75CO @WG
M-6.\Y7IFN<@NLRW!0C%3);'B[X\ 1+T44U/BS$B:N:N7B?!6>N#;PE:UI32R
M-J#EF=89+&!A'BGVZFW6A3R*,T59O6=V4N3\(+F07MF?\MK67];"*>&195(N
M=-D*J;(P7)B(/<DV\ ) [3L?+2WB*%3E?.=N[E>,#AO"P3YKTI0&E;E/Q[/&
MLOI<].LS-S/6TWV%T-<Z^[[6M:>#BR12RTTM?Y+SO,;CWAI)V64QTSQ=7A4H
M')O_'2+GGJ=DZ/9+*R=KQB2.76,J<=&G(=ZF4!S;I./>2Q "DB"1"K'C3I"^
M-+@RQ<3\6 $T8FVVGX^/]'6HC&RH'4L5AH@7.[2QSLR]6X#TJ337J!:KJLN(
M'M8=BQ?7[3E,'.OGM61,'^\]D.UQ-$[3#6O:5%4U!+E+=P3^L#81."[-'M:'
ML\F#%_?-VC;B-[ZT+0.+@@. K<M8O%JFW4%N(DWP9>DCMWL K+8TNAZN%U'<
MH[TY<N.T+%C[S#-$WDW"SL%F-Q88<SF\F1J<YO+/AS,;N!_HJ[X,L+L0J\93
M)X8*OY #H4]D6(.HNU36UF<]1:%M +!<G"):)N:O:,!^Q2#I\[E68Y0UZDKY
MM:9)YGG;BWR-FQFLJIS]9V#C4NW+>K4M52]F]?J.FYGP</B2J30@8Q;J7IW%
M-5QDY<3^1I;Q.+8UU1(\XN@K3L3>;-_:X>\4((#734Z5'"*E]+D4RUU:G.*-
M>%%R[5:P?$Q::0>\R!*97I\UVX@I,<RAWE1(J.7*/AH7,57U:R[&P=G-]"KM
MJ/59,4BDCQ\-!H#5O4=#YH +CS4N#IX0^41RM/R%Z@C#'MHZP$S;S_;6=@X(
MF <#E)I5=9"-3GGWV>T/H3NMOF<2<J1P("'0P*$CXH+DRIMIU#MK1]X.",82
M\:)-:1W6717#3HJU)M PI>>ZC(VRR]%6_@:0-^.M=S3U9B%/:7/ "X9_*-"/
M8Q7>GJ#-P=]$4YT#\;62V:KY9VA^5HY;F]!)1 &;L=0.ZW+"[TZB=5&R '$A
M:'/B6>-BK51HO)UYD-TK*D?AQ?T,S^$BZAV9F@F)JW.<;5;[&H_UE1CFJ4US
M&<T!MJC,]3XII,&J<Q%!MV]60=]SZ[8(Q+568[ML]^Q=/2U?-R]K$82KV'E[
M5(9RN"9+Z$5[S&I1];[?:[X/GI%1<M *H_*WE?1+R-S(77B@1UQ93R@9-Z2F
MFECR]COA&" TT>M2TOW6MD5T\<>MFAB7-H-SKO?\79$"T3AP?KI,'\*W.(N)
M39\:/)4NAU^?$*YI[ 0HX0Y^JM:D5<2H@/<)@%33&MSVITX648;':M/"+5&V
MHL9SX* 0-R7(Z&T-]+N[=%4HE44YTLZQ\DGQA[<1XPF[0/MQQK+"N; >LI1&
MT\_.&6WMU6;Y>U$^W)SP>.4#YCP4][M&&A]6V?[KAN -U+1R?$S[T7CHEGTX
MJ_IW92B":E7?A"KG^TD<4^'X]^>S@4JJJ7"VC5-?GUQ$]>_?A9T"AHW.<AIV
M<3-+LD97P/'X,+6P1/."B(5CR/-^.DI4WB,DQSGPF:42[7=O\/WN8C?J4@1=
M">>",K4XQF3/=NW$ M;C%"G1M5D72U-+J OA>T2+MOQF9Z'?K)7RSIEAH0-5
M9I"\A0H]3U1Z9J(JN_!PGO[*40[:R!R0)T8=SH4.],V>K_>=#2A/3",,_WT6
MWT53Z5XI7)G=VF(KO2]G*3#R?Y?SQZXALOF K424J#[$QBK]J.^$*&$1#:9N
M;F<>DE#^Z^\GHG3'E/R/XP+G@(-$Z0N;@&\,*T*MA5UY:OH*)"4S1Y=\VV6K
M)VT1'+VF[-&8R'GUA:*HR[OWIW"350?&?9+ DAP*WB@7&8GY].VG.5'[Q^]+
M!/T 08A\SCHSWVX>"$+P;*P?H1B,F5TKSXKAG7\(5T'7_NGGF.L.G9&<P3!W
MAVNL>]^VV'"6V$FK07AQ@>EISH8!&3@?NV:-?%7X "N7C:GS$[1'!34%MP!Q
M$/4F3$W=CJ%E8D>?7?P*9H*76S6E',_3!&P2#O1-]L96>>P:?GW&(X'5EC-*
MM#821GUX0<Z1UQ8O=7[AS__2N7=43ZFQ-=\?CK)-Q*/#V+^?B8RICU$,VUXJ
MDY5E4$FM_*9@$@#,+>)#&YM5*EI^R%W\8<A;\2)PXKQ81I:_YHQ]/./Q=BIJ
MV:G;_5-,WY+/UH)/9>X#&_%S">2"<5V1UN-9J8"U9K1_;$#*OTP6 +12^[%$
MNR:Y>.F:TY,-CQFG2TI?RTBQ"TA1[!MU8CP'^2*#*5!]>C D6"<GFKZ"C3Z6
M](9KQ"K)V5UZ'M+Q%QAG3G$]YG>M'[OS;D);.?IQI!Z#K=/687&X]74#MXGX
MUP]-^+^&LQ(K7V6=5"SUDGGBTAZUI^I<)/>9MIN1/ :<_:+JQG'?&CIT#AA/
M.4"1?\/:;(W[<=%3^P8C"49.Y(8A5PT;LYAOD]*&65H'USNJ5NOS)1^&J'2_
M4YBLG:-6YJ)=<_40OQE\<+:USMG=.W[[VGKQF()DONIP>KK),^)S"IJ^@IN>
MF<9PX@'/N5+-,PXYER5<29,Z4._Y6ZQE9.Z!KIG0'(@GB)J[Q4FF&;9X770^
M?JQ#F%XXB(N9$*\JTIXAC;TZFS^V@8R=IS'M47*,W85J"D^-38GG %U,@=C*
M\ M1\GFVQDC+)L\!_.7YMR8GA99/G,E5:XGMLP\B775Y%T%_':N\WSJ<S[KI
MQ^NNJ9?4CM'Y&E:#&-QU=$Q-RLLYH"YS)S;_S,TH2[6;G%$VCXQCJ\Y%OZ7+
MKI%%C0?7S57#7YY:(40(JB:A;TU>RRAYT+;XL39DU9[*U*FQB9RH]'R-;Y%A
MFKUO*;\[E:4]>.F'H3HK;T(X6RE"@HU/NR%,.$Q2U/.LL&VFC<,1%XLK@3?,
M"'J"TTT1%VP=GG1!!BTA,*'&_!,T8B\-XGS?'*?I2[IJ:CE8F_W(I%K:M$1S
M9FO3'C\VM?SJ >850UF<88<N4L74++A;Q!MIYS^4Y;)N,(BK)!Y\W:=[]:VU
MN7%L;YYSZ5]7DN? @U-(RA9/D?:^<1P"TZRH\FN\.]_.%!TKO\$-*?8+5R/>
M:'!*/"8],KU@KDZOI_74Q%;;X7V#H\W[Z]/7'T09V\JC;)JDST^?U]11-I::
M WL2I#GXJ3__\56#8?WA*;L)915GO0G#$=5?OJ].WVO/L9<B_L:=1"E=@5WT
M3+;LRTUB/CJ(Z8YJ137\-R"MD*9LM/H<B'$L_,=WR8A==1;5<+GRD-#YN<I&
M,W?NS:1[T9@VAA8M33F;\AOMN(M^T6RQ]'3[^-D+PS2J\/'YY=U?WG;VC6I1
MUD9GL_29?V=-*U#%XF6_MMUY@NI2VKKXD2B=,>? 8T,(VF@?<TSU5^I7RL8Q
M0Z)P]K1\$/8KO_R[MO7(*<F).:"5[3R.^IX#5\,,/RA-*KT]W=PS!V2P2YYI
MTZ?>4QD^+-XB&&?L=/DKB(BZ8LN[G72[3Z8X?!S[L:_Z?]U6X%N$LQN-B@IR
M#LR![V<+BNP.=J#O3P9F98>2EU4KY,%42]CLF.&:($122[4\3_Y)-P%1%FIW
M[0GY$;],0,(.!VP@DNGS/IN$-8+^&1S3>_U*3WIJ <</0RV_F&RLRKZ"_5_0
M:WEC]G#4H+Q*G .2L_ES8/TYC\COX;;Z#-YX*RTT(NG HT9<7K:N+R^!$"'9
MQI[=I%-M7_)E04]DZC1J/67WF L1-7&Y(_=_0*]_-"3><2BNO*6#O<=\O=SW
M\!"UTCE^HK2\&>@=P^%RESV,+=U8^N!]7O;I.5"SFD/Y"[(/@(Q.:"#%Z<#4
M:)U<6_<_OH);RT7^F=895S5R=8#H@R>C8YVTC=NZHFS,2EO-IJLB.O>';%RT
MYO#78K;@?A]MJ3J3]#GP*+DCLOZD/GM\<D2Q>CH-7S,DF?:BA9:%E_TO4GV^
MK<(X^M-^,([YD]K H\H9!TG[Y;BO#>>KB>"G>H;N-'3W\TGE+G^0S8,S?2)>
MPS4MSBEZ$G?_]7B= R=2Q5TF7^H%19*7)<F"U9:7^YS>7.I[T2JZICPV:WN]
MR>]O '"QL%-6SVDT%"D><O/JE^2K^%M-P"FRI-+(/JI:SZ2 EGFMAVCV,PCF
M$<)Y_NRI$WAC9=(\D2;XNEE;91-\-M(S9N=PV*E&@-I:6]7-;3J/ O9UC_NN
MAN>1.S,X,U^[1X/;(A)908F08WV6J7MAC@E.BG6LPH 5I^,&-C#WLPGFA+QY
MS+EIT;MSIWC@"\768R&,84-DN S0"#MU9#0(G?);W1GXEP6O3D/'X 7(6UQ_
M(WV^."G\%3PZ%6UW Z$7C*TUQH7-+TC[1[,^=-O>V4]WB\RA^^&X;])(L]I'
MS7 G'+5;? VFJO_Q'+948^UCOKP[IE\2%!52]?Y=0@=E>W**$&:RZUQV'-EZ
MV0V='8?AR;-=M&91]+UY#XGYG4A Z/-)YJ:T6?U 1N5'>!'!^RZ\1D9WB&[T
M6_R,*;WP&) ),0Z8V',Y1V9@6I-8!Q]B<LY@2SG&=_(2%NQ.>9T<^1<FQ8;Q
MI!7P^K PP[!$/;!!JZWAS"NIAG3LOI!?Y8M*FQT? :9LJ;9TC9@; WJ,T]FE
M8BY::5\:VA<,NDR<S$^T,-O<VT5NMMEUWYY?<?$7) \%VO$?LC!-9(5.CH&O
M6@@-_:IQ9E LR2$V4')K4K/#X\;\O257!B5B >()6T9TA5!E_4\  1>BTW(M
MR5B8UC]A5>/8ITS;O H@,S23YD"(S!VJW2=+'S.9S#HXN9:+N\WZMWT]K*2E
MA9K)J#CJM+@8?83E +WA];E(.Y_9=%+X;:>5UTYE_F>D/H V]VI\4(9;)^:6
M/B6[['[&.)N\4S6$>L&<E-7S"\'@^H7^.(RG_8!/%D.JY/S6APQ*)"E+LX0[
M;FUBQ)81-*[W75Q,!5+E&62/7:W0$;6^V#[K)V,;;H$518Z2EU/E_>WFB<^/
MJ[?Q,[ WE@.(B]D\26<W%V<\1][9N\XQDT8LP *G]1NS6!Q-*Y)WAG;F,JX@
M%XZKB59[D.\ -M7\ZC'684.-CY3$!(O2 >"3Z5<M=*$(93C[1G^])'9$0X8;
M7A>@)NG\/,$#\W/B>3&IJ+TDL)E5E9&6 %CW6/?SL#D9EP)@<+V,/S]K\V7'
M.2#X<5X#9].LKF/9.K3FJI9 I\BO,YN"$0W7JV0X[.H:G&VP_WP$2E[$4U9-
MH12G1)DJ=(H9/5DD_^DI=T2#R01/'$IC*D5O%D]^T-O7OGQT&CEXX$_RR?6X
MW%9=F.WI;.!,41\=G\@85,/!O]F$<D+E<TZ3."UZKBX,%)Y[K[1U7A<TH2[8
MRYU8DACY07 9 P*N?T<0)FC^#E@$A@=>M/&:-LERG[P7TD4<0A\'P&Z[1C9%
M;<3E>*?D?-499"E_W=D:3<F2'?2",Y7B+P,O+)K2_] $,HC:A66-7*9(Z&1^
M^*K*O_N<1%<.^!(#\XH;^8T+ #+"83TN0#DIS?6U-@$@DCWL'N?4W),0IS).
M=J09.;9+Q[R7,$Q0QX)8<^XZ07P7K?\3/$823?:.(:9T)SJT9^2K)K_8.M/2
M0TUSU"#MK6SQ,5&&L_+C:I,22K..EKO+Y(P-L50X;_!Q6#?R5JKV19PRMTK^
M>O7V(.'P)X5JZ;ZF5HT.%[E<'TE6)0SS#2R[#\)CES/UT#$\QY6J!;(A?E-O
M()9PA3Y*I2][1[%U/C^QN6:&J)/A\W>A&SX'PU.30<=(#N>):=AOD%]$3K-,
M7)-_D7\KX_3O(+P J!?=Z9\0)*-':+D@RM"V:A<?J6DW )GFWN*TOBOSH=L5
M<4TUIY^;AR3& NZ6.ZD4MQ&A$]T!VDNC!HOH-'Q5\:F_R\XY<"!K9Y?.[2^:
M%I\U>Y:<'S4K..2?-M/[B0=\K)TFE-7;:$P//H79T%)7V6^VH6\ O\L1_R;P
M4DD]??T!I$PYV,DZ Q<%Z<L!'-]BI.: T_42&[>L=HBAJ F4U'FS_:5K+=%'
M1IP/^FH)V^:XP4*,>.=SQ@F5:54AA@SOQ()5-%L>LX?HI^4 :)B[FJK]2#9;
M*.5G-:V4<+Q4\5+N(D-L*7?0TQ>7.?4[G&;OF) ]E''?A#%\>#$ZA=WIY<V6
MLHC"6FKSD^S5?9O.$#-[S_Q&4?5;]&D?DO0XH9-UX*N"/W1:\(D/)I]O\S\!
M9VJ53-<%$'0D@WX'*/UA7YW[S5MZN=WG:SNWFF3E^/.E8,Q_::D "%L^P2&?
M%1T-OWR*H,A;HJ;41[H[7 X%GBN7W/9O3:R,VV.!&WWF=Z<GAG3%<_\]_SCW
M]%)I7-(:P2Z;8*.G3JQS'[\B[6;2.+2G0=I^8@LX[Q8Z+7W3CVK EJGMJ]FS
M :[9M+)";K(9DBS/[L>Q *@85U"E+1P,H'_9&T+%AM-471S.^NO5VUY_U-5O
MJH<JK?;5\?<15N YQ*33G(\?9CY?"RG>E!ISIU\<-0@8P;SGW\!;U%;U*HKF
MB)WBP.Q\E/.;T!1<4#8U"8[RH[I.^T) '1JP[ E)N JK-]H*\8\D@YG3)XX;
M!O'%3X5WG\8"EGW#^.AF'<LF^@U7G;6W.QS#9U"-!:9V0=W2(-.E?%3VDZ3G
ML2VW+Q:</37KFBJL3IJ\'%MSGBZ>GUD?H9_F4S6;/-FD)W/ L>:3-_YGLVD1
M-NV>'@C2?5,'.0O,N=8SWH69I1G]'7\4 ;A4P:$#67;:S\5#*-GL\/(Q[H8[
M,:2Q=@\</?6',Y2TST4F1H]\UQ*"3]CNJ<@'4[BK ]UI,+W18MW'LB&CAI<F
MGYJY'(\%&R3;_:4+I4HSEY3A\YFTK;+P%!L,9KR/FDQBG\A[2O7=1<H8M>["
MCBG,="E<X(?UGM%^Y8.ZW-:XYA Z($,0O?NCC?$\Q'6 &^^)[^5J+8E'<>B6
MMQ]WIX=6R0_&8_9T*/3*(@IL19VXI,X0(,8!I,](59K<J]A%\BN>5)#,]69*
MC;[#A"5^3,!\L#8+-=9D=T#:X>Q,X3W('#.]3"ZRF*JQ JNNV\LH1,585\'I
MA3NS?LG4(#@4OZ"G!R-U''R$2PAU,Q7<98 ]_(E,B/(=JKGUF,.G=P) /I?*
MSR+P=;F2E-V&&V[^)[T\U-ZM=8;:U^&$E68E?TFUI9T"O8KLLEDN9P$0'WDG
M)OETR@U#O;P6I@?J;()MXO$Q3W1U]Y ;U$V&NI,PYHY@]1I,I8/\8^,^RSR(
M@S=:&RXF90ZE':''H1$O=*Z[/D7A]P]QMIP"".K/\N7Y;Z4E,S6C90'_6*U-
M^@FJVQ^+3"?C+=:7#D@4"TN+A@ 0W\)6'[VFNZD2\7;C*K2.,YD.@S7Z_C+U
MZ2'/9RUCNASX_?KD,6\!BE^_S_[FI' 4EM&!<2A]8*ET\!:XDHQ.>6Y^78*1
M*L6<:!>@%J06G_8<L Y<,;VY4-L;L&J:U][AH'8$668-; (\R9":X7>4KL0B
MVP1[IEY-ZSZRD3^7 !!)SDZ/*"M')N1G6V'>3+K1,Q]5_<<W :9(R#ZEU+>4
M+A02_5A#'4BM>6[TELPR-/&FSO"SZQ]^&=R:)!\S*SY$+I<1_<PMES=DJ.1A
M5_^)9,Q?^X,!$B,5+H/AVV4^>I$^Y8 8%G](VM.7;1/%0_X9K/@CCF(^HJ8T
M9!!^#QB%A.F1#/N<(>]&@^6V*<>O9*5!^@U9%2E2HDQ9F)*<;<\ ,"?>,[&[
M/-H\"=93^R6:=C@=?KJ(5XQ76$4<#S1X'.17CEVDE^&4$2$9S*@>=,)6!:YA
M#,=34V( HP#.]^,C0F<P'U^14@GI*T1/:1L:3]=%A-*CKTX\J#D[!->N)A=Q
M#4Y-\<(I3,QN$GDY<G/@# D R2=1NO:BDS'A3H<S6S]#7MVS^I5CK%-Q$]=O
M6V0D?XI_+>$NGDDQ\>B]0_)E,I)?P#ZZ73P,V<5H@$Q*IQ%#<'?L[7YE1&
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M;G]N?6QZ7, $H"QM(EODYL!ZZSD0,[]MS;HB2K6G-AL!P@WUJM=]*1M':HZ
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M\&9Q,B^9Y! R78ALW,?MWJ9 %V6Z,I8(V'Y0& X,P%X<'". >9GV<V$27&3
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M 7MJ[,U?OUM6O? =>ORKD=K]ZG7>W5H^Q'?#IG^EQ?^F_*T=C]]P7C"AWYE
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M:*1R2V%QVT;J"6BT6 = WRU8X],36GZ.;J1W%;WOC;T.X,CQXA>-46TN$8!
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MRP;#QR-7/),4C">D+&L:\I-3J2ABCI\Y3*QEXD,INZRG>7&6!,EKLSWZ$&/
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M_W2&MFXLEZP(Q*HT:)_*'#5H2DXC+B.H%V-W^FTCR=<GY!/EU]OL.1D9%<]
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M@>I J89@=*"_I.O9<RKE8CU_ CQ3$?$<N\[0;TQ8!;@D-J78&06JU[P>_DE
MC2-X=7O=<@5:W2*D?N![*,ND$$3JE^7!Z">C=EIH\VHK"^1MT7.1UAZ5;)_M
M7L-7,MD2@P/Q"_>!)6_A*_?"82U#BLA$TT!F&>D-RAG&B.S*1VG ZTFZ^V#W
MB<^0M[5.WX!\[AJEJEV_D39K>UNE?B15A7;5OPB]LUQTA:NM9PZP#5Q+09P'
M1_N4U,Q=^$F(03*M+"0N?>R0A>1T9:@ZT1V&/TUC;\N>]5Y353QH8C'5@+Y
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M&!.7&8NPFYPUHNR,1H"A2:ZRRBD/):CLC?#Y]\>=4I!8-J!1ES:](D&2]9W
MFI$$?H0Z?L9;G:-3V](,6/IF]FFZ,9UJ^JKP.HP896:&)_D\Z_&B%Q6K-:A
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MG5H$FVL\SE,B^Z"8P\@D:&Q\/NFXS\J,JSJ55BALDVB9 U]\KWVN6I%F&^]
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M'/#][0?(9>_WPEO?/_P39ZMZ2_C>*2?\7ZJQ^B?*HR1.GBA-']Q:<3#,A#O
M<#CQ'JJT70G* _0+P-N0^'@XTK)+A['8;=D,QF"4O4#KNTR_='4!ZSL@Y1@*
M%,@) ##?TW)9F:=F^($B[")=*(AIE[^GIV.[FG3&>O45>,_;V0:I*4?/'VA:
M;ASE;C%RMYK:>&G$:FW;Q+9V3='GT9_>K09KVK2[!&GX<[HJA69D)EHF<+92
MU?)[49/AMO"C)+<<FX![=KA Q5.&T.ZW5GP]"IT5D&QZ\2F?#ON)RH)*!<6[
M#E8/TGLDAA5L(<0;Z7 ""'T&!>G3F/IV]%?8XA0+NK1%>-;;O36T?%=G^)]
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M@?YF>??>:2!CA(87IO0=&]1G@@F+]\LL+_<#@<2T0#)C6A)'NT9O?'RD>;8
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MX7S3X!OR6/&6-S!V3KQBW5#7:%U[5"H]/?0^-2!\J*OWN>W2T1$RV"FTG]Q
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MJ4:W5IO :$GA%4 8QN*5X['1]2+Z6RZ&KIOH]05U3/9'7NGAD'./C6$1ESD
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MTGA/.>*I@6PNS+7EM"#DBY'4-Q!BF"#R%AC)=BBB@V/N]F@Y+I9+^4SF*WK
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M37BM:"'RR10)/88^$QV51ML/,,ZMKZ?K<O!&["-(S50:B'B IY6 E+-V(IG
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MUUQ 9TN:#V]631:R*_DE=@OK%EBAX.O,"%'[+)]<>*\-+P8QX.%7KBFPX<_
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MGJE%7/<$ZI'_6_C)YO1?Z::X)8:9_3N?Q\:,&WDHU_Z["]\=\ <<0*S5?G?
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M6A/.U@R,"^[R@U3S-@\@H+=#7G-#C@0!S,[%62^>#!G/?!Q^N#.KJ;T<>^$
MI)/?D:3R:F(JKLP:"]9_U@1"NRCH4A2.3FG2O2B_\:579YO=%Q<MMKRL$7,G
MR'5R*!<]X8]P^4XH&0*Y$GK_##=!(4<>"!<J]R749NPK4Y<P&V-81N3W2+U
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M;)L+4QSUIP!F64<H:E4XB$'Y[KR?[";$,=;4--I<GB)R<!3_O#WVN[XL<!D
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MV>*4G>M"ITQ6 J+ C3X/>@<[ZY(!$I0JZSW=1='M3-IYK3)]E)$N:'9 B@;
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M6]^9424LW*8<;:V;="> #+T]O $Y5G?@.J#3+V-Y-HX) .J::<$9L=DZCB]
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MR#>ODT2SV_]U/NI"LC\VT[%X6-YXM2*1UE1#-F>0%9VLH.0E_97##CDEA>D
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M><99W5=P*M(,9CEZG'_VSFV$I K^B[GD:[CL7%TFVG?@Z+45N@RM#\(Q3QC
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M> 863?Z6Z109O]GAF6!RANMCE,]\1&392[3 D*4KC"]JZ.['1PP2=X0/?CZ
M_]C[Z5)\*%@,B$@4!Z[ZI-5F3 B?0@Y#C0L=&E;[1R03^XJ&IE9ZVU)F=B.\
MF\4C8J@6L=1H/F4).WBUW*5C'R3KT$.<@T>/>]U9*0UJDT@=9"Z%A$[3)P^W
MMV<F0=:_DX0.=?206\KX6MA*,OFU,K=LU7-RF,Z1'XB,B AJA_$*\^4;,.?
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MA/QL;KJE^45">:MJ!]) VBO,&+\[,YX\G+)9RM!=C5(TYKH9;Y;@N<V^Y,0
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M+!\%^3V\T[J,-:9 Y='$,76]"QO.FH[ )B6L$&L^9O? [?#7)VXENJN<DG0
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MO^,#Z,5$J4LN+-QS")9V*L-,T3#C40)= IU(UZ..*9J2;(HSJGWROF/$-[9
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MVV(\E5A!)-(R]M8R<T#PUJJ-A!<3@XS(/%*B(XR"^9+_K?2<%+U$S'O2%/]
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M@1_C0B F/)L^^?OTV&Z>2^S<M"&0_!?=+-.((EQ)V?F#%\35_ZXJY!WLUW&
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M0^K1KI2P201S6#6 K80GR.3SO!(2FO8!K:?5BX^S>_*=1,P%.D4K>K>Y8W_
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M(U=(9#EX^#GL.%EMZUKY>KI$&H_G37^HB5OR@EUE!7_]^*_.V M?V[S[B[Y
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M9! 88U@UB4Y!\B9&2@,P#J#&4H1ME!-ZI;KWRJ]G-KM9_Q&@DJXFER)3"PI
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M,ODL&7,UY;, ;B?W;,+&%V_YW).BJYBYN=G;-*L[NX):[KN-TJFM(JJK8Y2
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MG #J8DR/OP?J10M>1D>8T=KYXEDED;N$6].'\.K-()YWNR,R(Z&I[,3^]1@
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M?G&<< P^!0Q3NTP@I3<Q3E2>(CZ%%K@(W\?M=\:TY$*\,B'LH8H4475'4UX
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M69S;G-Z4:!,GV+E#@FDER&>Y/5"23Y^QER2P:<YYG4U2Q&:6C>.E;;(67C_
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MG3\?.UEJ+F]J01:CP"C3-XRF1/%$0KN]SL\DE/;?.4CU(=/GUX>D>^KF5>&
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M.B2&= "1H8:. 884)0>&;AA*ND%I140ZA^[N'CJ4DAH:E"X!E5!"00D5$'C
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M53+ELX0/6M+5<7YY9IRF-R_M'_GY+0;M]^-NRBT7JM=W?X7_<?'1>2:1?SR
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M##7BBE.TQSC9DVJAEZ!1.3]6SK4^S5'!8GIJL<PWY?TG^J7DX=;/!KAB?61
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M3RHBSF=4/#ROZDI8MRH*VYV1Y"QV<!J*5.,6R_:2V-4,%FR$(,  (0H0F@H
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M7- 868R/W/*;+6YG!A,%GC-G@M]5M&UJN3[B@1;;8CFTO]NI'G>/^0?;M&K
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MV!-1HU< HB8 <0 8LAIRX3*B[:>4%FQ1&=T KI9'X_-QI@X0YD:\?B6:4O8
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M\?2Q]&7^)!PQ(/?I1W7>)/VH)L,F+0R'X *=<;5;TM#3G::ND(7D5]]:/-0
M-A;<?(UE=7.-J*49$NPX(?4@1?0@@'BDZ/VCA,Z'D37#VZ.QU9QW<02/X_B
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M],75TSST]$[192V6"4$I"D ?HN6JRX9TF&5[V9SM\*@%?+NV2F-.;&HF99*
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M.7&,#DXB5<QM9/9.R36-I-@'-)M"A]?'S.D_,^N..B(F]-&(;YX.UVV!;+C
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M*6.@"60)5Z'[DH!55=2J8"^G]!T<V<%!^Z',W<LH0,T/07<[-0_E)I+MD:L
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MFLK%X^P-<<"!02<4 ?NBW$4@\YV9\S:V!U/M%<-=0K..2C$*2-6,S'Q\JGU
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M,66M4UX1)M2@*XV1"8VZ+%TN/%9E9B(/M8L?>R<F3K=JP[?"3:?X5I>@19
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M8!8DJ%=**^@$6$%E0&EN65:(KY,.;'@J8NLBT =CZ[+"LOH)4&X1XA<=4S1
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M9CMOZ,ZZ6+8^?*M>S^U^Q\HF3ZD.VAC92>+E"C#0D*%0FFYYJ:K1J_'PN8]
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MIZS]6DC5?22>0%EIL/K_U!8X*0Y+;!1+HU$_(E<-L0*>N-C>6("5'P?2)#N
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M;E_0WB)-%R(/KUEC5.^XCTPJRL)K:NB!=X-E2"-0@?2/G9X/N@XZ[DN68O\
M$-B=(MGQL P5L/MM8JK@3T;&+9<2]8 +6#F*RZ9A6WU?A;),;^%G^K>.S/Z
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M6_Y" BVW\/T9@5/0;(]HY1]="<P7GW6,88A7_IB:ZHR%$A%H.2^!8,BO]<_
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MR%M@D+]#(4XY9J#,BCK83[?WCZ*U&X:BF\CF:<_(9__I$IV2YT_P@+SXE#\
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MSEB+G%'EIZA[2%%I-Z):'T\(L=R(<KV;ZZ3UFRC!N<?]:S\ 2%F.E7=C7_X
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M^I?C,8M1X_VRG Z+>\C-&BCBFY"Q>OSV6<'0X'+N536]C\'>L&_ZWG?P/H6
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M.^>J!_TJ7O0</3%R2G!KW$6B,^^!P;Y;Y<Z=@GKLQNQJ7."3C)!]D7RQ<LC
M2&[8JW#\2$."'X"/+DQC&#DP ,HME0H !C);ZOP!T']9+:+]>:DGQ[-=0]MP
M&]\YH(L!%?]LSG:,X6NM>M\Q[^V'J1^^W?N>:OXH"^G+[P[43B7*7ZR E+I:
MRH=UWF=,I(M/,.74FW=S?5*]<'L]UE"QG$;4IZF^#2-F4D<EB/%,KZZJIQPS
M3/%;,+(L^N+%=3MUMU;P+^H&_4O=BF8]%,9$,B!T2ACM,@&?VMH'O<\*?C\
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MK,HC#"C [O"D>2W9<53N&V!.'$^W@D4S#:MXA;JRN>WTZ7CKB<GZJ.ORZ\B
M'JIF0LYH3 2>$L',B3LN"+:%Q0KI_O2J_6#L,IK[U4#AI$;I>V(@!;YSC]/Z
MLS#W2L+\5O?*<^+<7"-[_-SI?,K!3]^'=YQ63)A.;\>>W)BXYI)9/+D*%H<K
MP$?+'JK"#- U&GI),ZHVU'\YP[^3+?'B'E<_7H>-@NG[41][3>-(])%4'_&1
MM"XT)XN7U2$S:G73/F6'U.9L#U=JKCJ+6*_\FJ]QI!([&F/\2QH_XKX<^ $
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M=3L+MCPV*<)%WJBMGB['5@."+MM,9M)[QB4!VQX))LS877Z16WHJP'0+4^B
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M15-FM]:\!*IK(#<'Y!)8(>X>:G:>03IDZ_9BRSLJ8=XEDVV3""GL7V6DQ5\
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M#85/VN!TEU(U]TF:EGK@H/56-S.^_?QP@-*0'@@$2%ZK8R72RFD@8%ES @G
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MV52"WS3>KAJ,*=3/'L;P."R4XQ@VVJ )0JMAM$1I$DT07JRM!AD=KZ(9Y7@
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M?S_2*K3*=OB%' ?\,;I"2QR(YU\UW@C^KQ?.NP]TN^L_2W7W!QL\7$X-((*
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MF0IBZTVQC!;E=5D]%<\*CBS+BVA73D"/UG;H16$QK$/(6IX/T=1"2 ?[ VC
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MV3_+Z21,:3%T*B8FDI C'4KA%A->VE?"2V>:+4<N%\VD#/2C;K=Z=$ QFB0
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MFO/5.47[_BF*$0N9>T8)J$56A;]Z_[SOKT+J&[HC7H;?L5_X5!,C/N1E/&*
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M(#922\^3W'7X=[ %YUT+-Y!D=_1O#E?G!_G"J> M$4-5$NTUDMVBGF$*<;I
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MEA39XE3CTW7T;>@,\S2\2?GD(B75Q[1+Y!(S;""1X)95T-5NQO<7=E%];=B
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MLEG4\D#>76>A*D^L!->.0@P%F$$SV.]=#C2\*;3&M_P-Q0GEV181_QEC2*)
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M'O&$7<RFW.DJLKT@H6A]&GOA^0\L"_R8K1WTML9NN3$&Q$D8U(8/6JFNK]M
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ML(U5"_"7Z5*A(V,JN4VEY?2<YH9M4C*JZ=W&1H;#P.,Q A4"P4G(/ZDY#T:
M2XKO7\U0G'7RND]4,LH87>YEV59B-L= I]%4]&^8ZMH:1.&>2OTK/145P<PD
M-TE6>;^0!0..*^[M(0:0J0,GS^W1JJ+3^;4.0+:,V$Q<JA,_5_9#Y/O=A;G6
MEPB9PMA0)EM"=E!Y;)OX0(^B;[HH(F:\>%I<X+H_^:UGSE'NXZR^:'3P$]!
M]->6%*QHAM1A<8$0H.$Y R?<T# Z*:Y)_FGA5P.!2_3E<%)<0K)-RG!JAZWG
M7RROTTKW1]PY(2^I+ FE2D>C)1*7?TT!.2BH=8&<8 IJ31C*8 AU6$-/VG/-
MW5[3/HQY@FX@(Q>F$<]AD;O=GUG*J7GR>(!;@[36]>?W39'VF_S.7?XPA*M)
M[LXT<*C&=KBQO:LC#S2UNC1BB?[3=JDOJKH:L*L)BQDD44WQ@/\6E[ +W)I?
M<#*-G; 9B>(:0-A,K<*TW[1EIIC;FB$Z)\N2=#AFQ2&S +U(YMRS86!WV/J:
M.#K_C 2;\16/ $?FE89D^TPMV*C*9319?Q]'B6R-32V.HG0E]545:*>OOJH>
MQ1#@$4W /Q8L3SR@"X;6E@SJ(N9R'$,P+@3@T%>A< #M7RR<H68S1*9SF($!
M[WW34OI4&TO*B .Y2/: $F$9=DI:?%(G3,6Z=;$. %"XLEQU.OZ]W2#2V;S7
M@_@H+L&+'$%ZKP;'6#3A@Y<9?G9N10\Z5\&A\]#Y9>3T;UFCG:E5QE_ZL5\M
M7V <?"C)B)<)W]5<W)1TDL.5;<1P]U\VOM$%PT5? JWG%SUB!I?\(#$(P_BG
MQZ2K2YU+UL8!\:-1:U76%=C!:_T>D+5G#5:R*,4GPT,'SO7?BJ]'[P_DE.Z=
MEGTKF=^-MQ@+(UL8.9\PNM"F$Q.[PV"P68!<MJ4\0Z>MU:Y$NW'=)XG-OL=_
M5JSAW1M%@(6!@P7H7RP'NM&4\C:<LHF1\^C?$JHE@Y24BI1@-C:8#AML%A\N
M5][=<VMU5+R4QB<J1#7_:W_K'5A#*W^)1Y^?[>5P@[[OY-ZQ1,"]M<CO]'-H
MVC!U!H$/RZ:3EAXRTY8>D75Y0Z,>P+]C9*05WWV]+/)=H9::9N%M 4V&HT+I
M1\9'U+_E$/U+?J'O<[\.Z4CB.%6QB/2UD+'&L7?)C+Z[9<T:05#//2Y&0BDT
MHE(TTUC?_I2M:&RVP4R.9RZOX35YREC[!212J6TFMYP9<BHB^BA=B7?^8A4D
M3[EA%P17B>]E2)R?"&JRTO6<1=RV;IQ_MO-Z=YWV-7U.W&B,6V+ +K*%0=0^
M\Z>6E&8])A;;FCXK*OIH0.3/PIUEDT?]JF<2567\+J_A OV[I&KK9K;=2RZ<
M\4*Q(5&F1P6_(=:_'U?%,!_Q7Z<V7L$NBN>,88M?_*T5ZBKK0EY>D-7_C(J1
MFT0% LG1(.!9C+?;68P'89'+%A-(H&MU+ZR/T&1? 5LY.,Z)X2?QUU:7>.7G
MA>2#V38QG?QJ"M*YJ6!PT'\E/0B(0B> ;BB>IVRRG[:L:W.GX-BOOP"EN5^9
M11K761\[IFI:?NM#$N'O<ZW*X(8L+\8D"A3N8QQ.O42^_=;46CPV3O/+6D^$
MU1/0H>6H1'*:C.*\$@4]5R'!'YE[&)*F>%:]V>74;(8'_)>18V[NGGF"91,N
M<O64VD5#Y5M>9QS-856JT7<V08<^PBM4%C H%MFSGUG:$J2/"#_\<*P:YW.-
M.1JWU$ U^B'9=A,ZZ*/)A27YAN> 1=%Z^E<1FTODT@*KAM%TO*U__"L\O6Q!
M=6,-RR-]AS5"_-&P97%J>S$>G4P%>S'5<7R5<%(I''X1K.F73WE0^YG,6XL=
MVY6=E;!P#W5A,S^&<619[A/'.KGZIB(RJ5#V>(/RT#E3FBT5Y"<2B1_]R^--
M*:?6]P89^L=:RPMJ=G_BG$7L^*E0YB\2<";8H,<KKM7C_W1'\Y'?7+$XERQ+
MPO]:WR56W*R_6/$55RX%Q4)D/EU]@2<"#@Z;O-73IEH^.FH:-@I:@?-P^%Q(
MOAM;"T%9%X^+9M?[[I.^[DV]87[Y3UL$.A+G06JRN"W<[)$6B-:J3MP5C2>-
M]$(HQ@B=S4Y2T^U%CY52]62KYB2G<^*@8\<H/K\L/]['H("4Y!NPEMS%! 5]
M1B(:?8N.\O:L_S)NF>5QD\HH:'QHV1&*DCEGCA6.%YL7>?<N9PMJNLADA(TY
M*HSG217JZM"TVX6U((C51Z25"?Q"MA,LQ8YV&!,'R2[=V*B*/I%6=4^*<P8A
MPS-=ND!_L81'JQW.EHUIRNJ&1/@.[ 1Z*TM+RB/<#@]W1SQ>&=NEOEP6,0<"
MS]CV432PK$<MT[OZ1S0,%W&U#98%_':RH<F*NEO&#@I:R,>LUSPC%(\T!I3.
MGQM$7(//C!.E?CW)#HP^S#TU'>9FKO'HH8/=(?,,Y=$E="F*SY]7E%3P#=-
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M"_G"Z,YV;%$LAWTNM,.<ZG8&Z(XP6SVKH:.NR;B?4$9&8P[3XMQT8_5@"D]
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M4^6 =2H6 ZOJ:GI5U]K<T8H-3HLX9")\2.S:2M:OV1T 8U%W("+?AER*FQ+
M]$IJ%\+3.?C3!/LMG 8\;:8U-1/2G& VYRH+]?HZY+DU(5L,[IRS?JV(R 2[
ML>Z"?P1ZG<2@KB4,E#T*'I/O_5+5.3K6&LF!"RI45"TO;Q<RH*>-U,:_[BUI
MJ?(Y6CUR/!(5''+#Q19)>R'Q);]E3%U9)F$!WAQUZE+8Q2Q/IL(8_-/2S[R)
M+G3.+=>ZH:<[CKDP4M<&BM31O-$E<7>2,SPJ>"%H%8S'7H]W,2'QG:*8>619
M*$B2K&^["2GY-J5Y<7C0<TD@Q,/^O7B+YBB6H!LV%]=R^W?5>*;Q1N'-K"K9
M!Q"GV39M\O4*!X52%C+ EC 730?Z&0[J^8*Q;GR@$EN_3C-C/[U;'&M;\:E>
M4QQJ86LQ@7P/[=!@8+K^9U'1"2,4^Y, =;")L[/%VN[U_M9EI5[?N"BQ%@"/
MR%S0Q$,JW,OQ/E UHC?N'&Q$VJN<Y?)]56*SH!M?L5Q1-80#%,D!RBPL+$NA
MG;)'>S$Z7?E:$2U4 )/X^\OK&/GUQW>2C%(JM>LZPT[5XM!>8\^9B%+ O3GU
M2N:'\C=_,KY\@+8^])Z4#6?C_,J+.Y2X]<_X\@)Z_=#K7//_/KKSS\#\Q9IZ
M_Z*VX^C<TODO%O1Z^C:J^R\6E\1?K%]%<8>"?_S3,2=3L2]JL\[^+?BL)O70
MX_QM.*;KGF?SCN"S.>?EU:^RF!?E?E?GYLX?U+P?OIZL#0=TWO-NWCWYG,=Y
M>?&K+.Z0YN%/*N;S5/6+6N/[<V.GOUAJK0]?3OYB#2/:[T&;=SB?_V)Q-A_\
MJH@[)(L@2^SPN#48O,3I(QLV;;OG6__PY^/9X]F_6#O5RP\I9S7W+\Z>G.LY
MO5"[OC>_#KGA;6$MR;;[BZ7=J>B?C/DP-?'"8)7MO1KB\YXM:\4)^8KY@]U1
MRYXS:\4:^5\LCDO,KY:XV9.(N$0_AUOCP?V+/NUA@:9[P773A)B3G+<%\3>=
MRZ*4R&T*,,R#L(4M?@UT4/@!6J.[CYJM>5CL8@7R=,NLOXYG[#!D7F3-GOCZ
MIG4D$004"S:V99NPGH<]Q&F5S.I5Z-EKF6?/8C5K<:#N/.);A^,3"478#45,
M=F!P#C@N,X4'ARF%(>6::$7\39(=RSRBY;5(8[E:D/:8?<S0%PX4&O3Y^&>7
MB41MIQJB@WE#JNAT[&9A)V+J/$W&2GCC'/T7JS"T3#+90PL+B;A;](\?AT':
M!29[!+)U(=1/CW]HN;0E:%! ]&"Z8-BL7EB)4GQ?Z[<X61%V&<RA'-%,V/0X
M",5]6GB_ML9T*[:=%6EYPXZQ;/D32Q7?2XPITV8.E>A(1T&R>#7'VJ9A5Q<D
M/DIFL#WSZZEE&9>$V*.^/6_/T;[<;[(TLA__<&@4B>(Q:Q+SK@_ANYCH/#-R
M-76AYG@)T-89/OO6T/@<$^3"YZ^T.4OQH<B#B:VF9*5TLVE+WMJF^\B8F<CP
M E]'UV'[>Z ZQ.BMAYN#0 3 0_Q9\<+BHE;BAC@#-3YYWXK//,$KA>:OJBDZ
M% #ORN&6&';O=YBVF#H!,I&/GI@<:T#/?"K>LHI/.!M-A.('DM&0G_8<PJL
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M&I6^LY=&^+=]2V^0%@45N5;'=Q9'BVQ> 0%+ P8Z)Y8=.SO[\V4M@%1!B;Z
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MB&^*-Z;K^HLY G2AII_35&I$HIJ#VG[U>5W$7VV^XX#VASHMPTRH[-Q=RU=
MF3'G[P]1]BQZ-!5_5$\,>U68$;MJ;??]=2F&F]62A;S)7@SL^YH .(!"1Z],
MLB?7U.G[L7R?S\RR $H;J#[LF;CQI:2V3GH^8YYGMWN+NY^"HK7FI0+D^\R'
M_JD$$'XD+P5E(7XD%QI=L07>N.O=#?'/Z=8ZNLWI6;WEE=LI]FUX08^1/O(
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ME1>7H\VF8SXU6IC\7UJ%'I>NO.#0PS]RW-2+#TO;7H9FMK$C%^W^84$.\95
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MU3=K*FIN$7 CPD)W07PU0WR1$OL5Y'=1W!@T)Q6.I?KTT[BC#&$?TP7SK0!
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MDN'C\Y_T0 "_*)?SJ-'&6Q0TT0)?4JD<YQY3U3L"77_CJ3D94@*@9(2ZD*\
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M/W;W'VU[(@Q+R(59!R?U55U8EG?087S]DYHJ"T)+NY_#O[+EQX!CMYUYW((
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M696379%^^I#XNH1XKJLHAZ(QSK2^\_SDC[-[^,/!J6HC&COT>E] Q!)7+K7
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M \#D<;D-9H!!2;NT3-Z9B+7Z.]=L]34*DY7WSR,U\"-*/C,"HOQCA[WKY+@
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MV[46[R;]VMI<*!C,F4(PV;5?_MV[=_G,1EZ[JB".O6Y&2&1^C]]O5I'8@S[
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M]5)D6EDJ/FQY4P<Q>)DM1._ 9CCE+54YP1SK5)U(YAR>B+U^<2:U;D&(=MA
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MPA[98>+-?>U,S2(WJ&(%?E>?*7LV9S^=Z_Z-]*D;C<5;&FSW_0+_03EB$C
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M/N+;&QF])5!@[WJM?NG4[8BHJA#=<18ERQ$8-$Y<N:823(-UV'5(I=G]>;.
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M_GY7K![;9DO;7.S;25I\E+_2L5@2/W@I]W(:N1&@;H.D0ZG-) GA)+QW3Q#
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MBCV."09\<FN8KUEY1<H[L  *IJ0+3[1+!%O011ITW B 5<\# ..^@L9&-8\
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M>0&F,(A=N]R@77GX1$J5<;1K:AS'.%1MZUAC52D-A5QPM=P<3]*VVEC/5+8
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MP:J2F3C=SO31AP^0B#>XP5<<5-2[)U3'_)R\/%Q\3M:%\;D/+ZOL<(8>OZ&
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M?I_2G6*1%$>-5<W-FM3>:8<C3/>*PXWUMM[FE[(P#3Y>2M%///P5,75E"(]
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MF3YO\H-X3Y\*>IU1N;54O5UI=URI9LR+?-K_:TW_(&U[SFLR;R<[P?)E9](
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MD>>NH=*CI<D$^3_Q'__]/[JV5GQBLY:'+<PG"_ZP&E">I_(@!KDHF0133WT
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M-3SN \(ZD@AP55ZFK"F]R/:J$8L/W0C9K!1-MM96TIG3:H2K?<)U'3$C&A+
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M(<;J^0$<+.CCXT/QKG4>JKUU@7Q?\E/Y>/!TV..YS/>?UMZO+FV:WQ7X\]P
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MXTCJ3-72S[-.KF.C&GR.DZ4<KH'2MG+&E]9'E&T1:N#JL'5$_D#,250RJ<W
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M[WY(*W[#OAMU+E>)XD27T=;R6[.V! E'0%T]DYAB'^-Z--"?M@=Q+RJYF*.
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MB?(NTL('53Z!PD$=A0$%F+PS6YB2KZ6I*9ED:6O.?;EM18]Q)^78?E#]$;;
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MI,[S]0G__CBO(\;TJ0"551*YPU )$DMWFM]F!#I&GCT$4I),$F8IXUW&7=@
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M!;[X<C/%G[P[N:WJI=9)X-V?< 3H:$W3LWT);T6T[3&D4R0VGB4[ZX)GF3-
M<V42S&%)!YRV(#I1G.'BU2HUJ=K*7+SK#[:[E"] W^EE\&5D#C8?A\"$Y2Q\
MFI#EZ+?T]^UB1R]RSI,;60_U H9L0ABUY36?PS0 >&Y\5;!/1B>@HF.'))2)
M?>KM3RN]Z@"J8#[^MY?ILPH1:MER=,J1N_]HH+ ?%1-?\O<"_W13!,@0:8K%
M@7A#+*'"=""3@@(K,4!RQDH^_HJ6!4*<45Q^<O$KND]"9<:_9>N1--(WN_0W
M@MO #2_AO:C:\U[<L17SI6?!KPFJA5&-[1.YQYQWM6DE0TMQMV+^YMRJ28U4
MIY^>^\URF>S>+?]OWM,SR6B2YM!<1\9H(9L4K?Z.XB9&&%"2[A&*3Z12]&>4
MUM.'Q80<!.0G^=@(M.&234W824AGOFSQ.MI"D6A??J$"A%N?VN4=][K[US2$
M[H0"F9"\:.!>!4)^9D_.WW?G^4M9:-#(I#&+0Y!9I.IVCSDN'07F#.+)$@[=
M=&9]DL'ED-+*?OOF-YGRZS:1]%?U16^A^726(X-:WBKZ@;7-^J8ZU6UT;C=E
M][I:XOHH1;L*B^*Z/&-%2O(LXO\7;6\9U6:[=?]2P:58BEMP=Y<6=RB0X%*\
M2/#@4)S@[AX\.(4@15K<"Z6X:XM;L4+;0Y^]][O/.7N/,\[SCO'_=B>?X,X8
MOSGG6NM:UV'4I Q+]K4Y8_^47CG%HT].R\Z]^1=+'RHG]//H^FL^G)<G.GQK
MD2%2"8LM-IOJ;=>]]9M7B6^-;T-C@24FXR?386+!H[#**F0J=^2O2+Z(5X9;
M [^P=\A2MRQW=@S?K]"DQ=JT6DO$B&A37.E*S!+\6%C//J"6#<-<#963Y,R>
M3V[_5:NX?'B<05;@R^EU IY1\C%KR<(-ER%*Y#7R&P^:0LG;EM5"!:J]<$3^
M2A<2#W^=>:3+'3LM)W]<^$6GC]250AA;&_I9^FO -< 8VL-,">0'FIV*VK$^
MK^,_(\N:Z=A=.[I+8*__5M1>3LJ__)V>M'7<D@N3X<W0R\O0#VJ-+R>54RC^
M#A@JRE964D=H!AO%=IP$2_TZMV.]N =G==S*-]L@2HDXK83@PI,GF<:.B:;F
M V:0%NG8 ]2 =LK-\-977K(.7]7MY:^P ^A*M>@87AJDZ1!3BHWR.$JO$SYY
M7M)TAQNPX),[[5;_@[6:M;C9C0O^PH.-_*+\@TO40DQ9-E<LMYE>1E4H><:%
M6J=.'H5;#!F+&AG0KQ\X8E;K(J^W<)RF)7C=):>C(@GOJ"=F/)Y=X@A64Y#<
MA+/&BNA,ZJ7(3 %\?QZW^^T(6MJR&YKK_>#Q$TJ]@TM-M0,@1=RGA<QM@_L1
MY6:?R I(7!$0@.8H9@')V0]XY:TY_^:O%R#P"PXF?[.>/:0^G*D*SMG9CF"N
MC^ZHO!'Y:;!9\+.E]3<*,TV5A,YO%.0US?;Z_;5]PQ[Y^;6I0]*"[/:T:6#@
M%?_]XJ5=.5<V=X9I(04DUZ<&572M=D+ZE^7N]0B!U8SP2+9]9=7HW,SA?M#*
M*G_!JU9#=PD>UIK7+7/P"W'R-U)=:YVQG89W8D#DN-/7R0_)]G2["RP3_6HF
M E\,%1N9BOD<#ID]]H!UVFQU>KCJM5G/_84'\Z)<2OC9^'M_H_1-'[(^8CZ%
M_QQ<5LFR7QRIFFA<W&,;9FUJI#,;BCUOLH(A)'HZ$!79Y?5Y;!212ZZS;$Z(
MPWR[?-/+@<())YVXYHF*W)&@"C$$4Q?X+G3S+ K"SI5_;SN- I!+L]1?S@MC
MAJ*"I@9,'*<D*F+@<*[*Z=,"-XYJUY;3F09=2\HX2B:TP#FPBH)RG]RNUM<=
M\)3@M G1EU56FLP3_P,?-,RGSY*0WV,,FIH ]88[=JB26[A"E"/9Z=G)E6R(
M[QWT_:Z3WGD+CKKC. 3R!._+XG?*TK 7'@6@9"P\F/#:B)E?EYDO9IZ[_ZL*
MQ*WMJ'GR^,$KK?U+)-K%Q[]KM18(,/U[< '\*9XJ";X[].UU_5<8AS:"J];4
M\I2,M/JXA'2,J92IK0A2U41@ZAW"KYHR;I73*70//![?<D46>-:)'[UK>^>?
M+/6L?=:*(*M8+\[#_CV0 4W S'LFA.=-$%^I6'[D_W92MCPQL0@3&(4)9$E$
MO($K=8',K$6&.J1O)/K,M\2;41E-=N\D$QJ_4#J[6P9571SQ("(2#8(3@<#6
M5P\)O][$QPBSKYQSEL9N@,:\UWK7]#%DUL0QE=)N=IQ +ESK5;@.R+1T;VJK
MS>1]^ON<C5]6 34CVVI^78U-@_1]%WEM0SM)6:WVEZ_O*;<C8_)N>1C:#2OM
MNPK_IZBPP;]G^O[<JNY4\K!1U86/<WGL,U3HTSJAL=3Q[EF$O/6V\-$@CS<K
M8FI@)1N2F%*FUN_X84V18D18UH,O1NV3Q-@1=>M0(WMDTD)*F1@,!07E 2]\
M\Z$$%O4HHSA!?$-/7J+D(P:]<FS<F%G<$"2 +%=J1:M7.P)\5$^:^OG:ZWF4
MTZ;Q4:GLE-1PI*]P*W'Y+AQM]=F/)K\2<_:$ME.8B3EH<]<;[>&R/;S QV.(
MS,*-68-0BV<HB:3-C.7S#L=5;=1^J9\W4\?9$O*7Q^W9I/:9A7-DS,$FB>?E
M%P:O<>;F 9M@W1'S$ZMD(V9R9_:Q'G43 I;]H'L<7[JP/=P,;?BP+UE9=/3B
M0=TSX=1C^2VP,^MOE&\B!Y6Q4S%R[25>A=KT4F[TOZ)'F55_HR# 6Z?EZP=;
M9EN_- 3NAN\[N+K?WHI,WW1G)*R;V2Y_+RD(MVY#XV54,W:IK&'LL5&)S\:9
MKR$4N+ED*CS%KVO,50QN:X+>SKSYAF<T&TKZ2^5QU:^9#['4EO1I8DE-\3UU
M:2;KFIC#F9Y?#$Y*-Z]@@ED"!,0S_9XUFV"/)R#90-:.$3:X5_9E0/^93HS7
MRU&0*= KOXNVA:Q5+<U//,HB[1,O+IS.KH7T>!G2P"A-*#=75=YHL(6'/6:S
M)(]<<.=*8,.NL<IT9$]?)G[B*L#@ Q!P25D$GM=5W8/U6KFCE,;?.&LQN'E%
MDVD\TDH1DAV"Y4;S31E>^8A"9Z![-PK-Z''?HQJ]XWG*G-GW&<,&.'@69$'J
M!(U!-3"[$P)\05,3O2]=7$>/^J' DWSG.%:BVHX*?>ODC=TU\2$V&"JJ-"I1
MJI:H/$@+X&M*8$=IM344N5%G->*.=N%<I:M]M=L.*7YSH?)2*9D2BIZ8ZC%%
M !8P_=^Q  1SIV_@HD12Q;%QI.<$"F1^0M:\H);%@T<%1U=D$K*QL<'+<M]^
M,4%6O/V-,O/>Z^BK2I_$2@M57 N9 TSW^7M;P>VYI& \'Y#"?I$XOK&EGG'8
M7?EG=$-^R.S8GX50T@/+J'\60@$  $%Y36::[W>NM49)F_36586SN^B,'S#;
MKBC#$EV/!LU+I]1WKA.=4D43K0NE3.8GK(NV_I<[%P2DF*]^5;"?OL#W?,[[
M#L8#9W_%<IV,38.I/^\5!Q>BF57*VPD1+!<=C;.X92N&A7[V<F#6%Z6A/$,-
M7K48Q<BE#=NUC1AT%^YG[IX-70W3G\.WK 3NZQ"CKY'[1OZKF500]JG4]V0X
MN?O#X314&&L%P<&.,LC)EYL^L[U[8=^>6<IX9IYZ/=&U"_OB^40'^AGM(_$P
M@=O/@W'<&\%I&C%(=Q_XUR\FW""]85?7>S=1O!!GVBRE EHYOUNGCGT,3&SS
M_3$O'Z0MT"V2K<C5((-@VU,>3T>6;E)<38>]ZLG3+!->%*W9U+ /?32O%Q.G
MN84&H"%=*WBN,LLLXD7-%V7-P#O4KL3/%8G)M!PCE=%X5-:90K2GF(]BM T#
M(KKVE/XLJ@/*_7\NJNN[5WR]]7'L)(L^CEVB'MVX]V"%4'=5A26HILUF'<'-
M$4X;4\<:,@(!B[QE7:8L6V+O2$)P+"E3;I"5FF@+^C,EDD:/<%_HQTY#RNM9
M![K6&NX['.J<:8*E?J.\>_CX[CXWD'MGR\QAX9?&"Y+ST_:?OU&VMS0[;WYR
M<:89[T&1//F8^%\_)'\7;6 0ZACO?@YR(W+L]^T+2M*9-Z7=%-_=T*QCM!>@
M^AA'INO/_1V5#\:;\HNN4T ^@ZKKN\?,P*HV,QIC*6@^'8PD6,Q ZWD:4=J3
M!3A5)$MYKHKU<IT4\: S\/*48YHHV.-/7@\!BK;_'4R#%OF(P=T1JXJAWAN?
MX$6.D%Q9%%A0^S$8/)?E:TK)7/7M*((NP0126BRE';&[MGW!.Y*.ZY^=9LE#
MH_YBRI7 ]_(N.&4E-7!#F,)!Z#T?NE^JPZ?'N++O?1M%)Y]T3%: :Z'TTRDI
M6:(^3THCMSI_H_C_FC[6V%TGQ(_"'.CX<2G,)6[594)0'88OVCRIA4HB+:>I
MK='<F+@LMC_D5LT\Z@,FC\$B0F4"18(%35\] G(2#>4Z,6VJ*A*:!N19MY64
M>)-#OB2EK@UU^%"A"3[ELIW+>N2CY9]GPG*ZR;<=I;UF+_#F,#JG;BB@SR[=
M\-'!GV$8N7/$6=@&!)_".X(^;O,HQSX,C9AX[$OP(VP($%YL""^6_HVR^BQ)
MDNK?E1:M<&A3P'A)_PHDC5?1V"ZW_]%7Z683D+0Q!"-)0)Y._KRLJ_A_JC Q
M%/0.!@T\>=6A5,=>1.]CS/W<@98FB]S BUQ=DLQPL*@'0 XH_\WY/Y*K3^WP
M<3^;B;E/I\&';,X*06L=4;@R@ Q W$MTX8=U"URN2' CI ^"O894!EN_IVH]
MK#KY(I*>F:X]I@><L?66C#G&D\SX@ED)?QKLN)C<(^) KJ,-3$IJ5.GD( GP
MG-7C/*:Q03?7N#M^IY>^Q1=%/N1R-[$'T&4,<[)12P1E2RDN3NWFT'VX'G3D
MT VDS__<;$N6,9P05NEH*!@%C5MY1SEFF&?"V5(TZJ@63@D!803+_>?U?___
MB"5%Y_H;10"3)%,!>'6R^<G+8CLS0]RHUH"3-NKMY0(T5E^W+,^>3QE]C<WC
M7L+)73N>0E_C M)_&5.T[1;/I$?RXR/NB@#820Z0V%L1'5UH!:OHM-O'_>=.
M!K% (JFT@VXFE=\H3^I/GF:"4VH::T!.GE?B>)KL;CZYPL@+M%Q<!"LMB[\D
M:X:\O+(#%>KNX^F9^>,+QPFY'3RPS.8[+OJAPVC*L@C90L_,,CU=-$R^=@N4
MXAI6S&"8U,=FNC)3R-\*/).-$RUX/SAQ45W.,=N5W!V_DA(,5)2%L*^JI%^S
M>CD*1+?3D;DAT2S90NIWS/U 8^'Z(K'*Y&KOT7)G)>Y[++%+(DGD>&'8NT=<
MV?3QS_R5\INW1O^!$]!50,'VULJ5B$G@;Y1SU_)5S8?O[GZC# ]N_.MIH*#_
MOL,O/XLZY'8A(\?,DE5WI #D:RKU/838[8!&3VQ*4<,6[D[O5,X'QT9$]MLH
MQAOTM1:WPI;W1T6XZ!M*!Z"2>\'0!V5DR22D>P2, A*R,2]3P5?0Z*\%ES(:
MQSYW[0LH)9^K=XS8--N<=V\SDM\91GP1^/)*"PS&)! SI;L7UTS-=XW9 1EU
MQ@YX3.;[=G/5X*ARD ZIE'#T!R(JA@CPM8;MS2;XYKZT.6W8Z#IJ;^I+"7NE
M;\^>*Z-&+U+Z-H\Z&-0ZE%4LX9*]R7,HBYKMP"WK<QH039]OQFR;G;<\J>%:
MMQPG\'+BW"5Q6-&TJW?7[?A&)C*@_)-H JN(N\3;=*6LN A/,<S6#RJE__A"
M0-_DNUIZF?BQCX K=UG*@['[(CI]QKQQWJ/ME0$@+3O9G +U";"Q*D;:[(:H
M5J:$BD6FH4KN"]BWP\NY*R54=FO4+L3].#OJEY9=/S"2R28ZN1<%?4A"SZCK
MC$Y'%R3Y26P5Y1ON&TB*O!Y/-E:+]!=:=])G%) 9J.+SOA95+O>:J]!33'V3
M78;(9L7RV_[V,F>9Y_K2*_!J=\?8*Z,C.F%JU?+G/>3MM-F+XPR-+MD7EJ;Y
MFUO)N/4X+;UE^F,"(.K+)4/C"XHFZT(@[W77&WZU,+DHD+QO.&: \H8.D9Z
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M_O>/E=$J\$WE/-4)T@LFL9/T,N%>=;XV?W-;GH\!!J 5VL4B_..IPM!PCY.
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M4UOBK/:HN0KPJ:.NAW]&YY9N28"!MZHA8.Y=VHE^\I.19<?P:X*6<'Q'#&I
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M5<9I&.2@L]F[P0*]JR5#GZ5?9$W_C3O*MZA.SS:%-KLIS@@,T' 5.#/T52P
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M2RR6$[',"MN^O3$0^NS&KR<BOY"JD@N?QSYM>VK1Z/Q#XV^6&TP @]*;7J[
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MQP0Y N=1BFCQ&S@I7.?C'F_/HT%ES6-V]:$K\:(IEK,U7L^)K\%\*I0W?-(
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M_RBBO-N\1ZEVOM=#70_! ?7//>9^ Y65,W#KHQY@*9[$T!!W%HRESA)JSG-
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M8'1>L:A=^K/F"OP8BZ5EE-^"0RJ^[*%RJ4<,B?HDDJ^X3@+']KCZA*YP%"7
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MD_#4=8U.*UXE+]B">\EA@1V>-#7 :7Q^I:?!BHQ'C>K#7W'-7#ONOTD7PWN
M9W1@+:'"L3@7KN7FELI8WNXRQ]/!G+_/I*@ZRT5@K?BR/%W<6E'N%0XB&>LU
M&6N%^=BGU_)A\W4';F0M27:NQG,#E20T[Y:HGH*V:_ V))5[OL3^>(Q=0#9L
MR!Y!$_*8*]GP4X\["'RD[5%"$-JN\X80-S']@C6S,5!# UTT)X%'(ZVH,[2[
MX(](R;ET^Q"[W>=.<WG,ZMG7"8.=-J@!;:MU+]F:Y@J3[9#$#<R-OM3L0 $1
M1%!*2>VN@&RFOA,9+CI$"%O=\0=6C+M],]Y6V\I<H..#C":^HQ-6"D-0Z]_#
M)\6B87],)/*"/^,G8;?VO\/8H(N_]SXZ%V[Y<]O\7?_O-I:6SK8[DW'Z8Q].
MA%!HFF7AZBV+*%'MG[LO\6\-N55,IF]57I-:8B+TV>UJ9@EXR1TGXU%0P$ @
M< 1'J%%U1"D\?(W(,IG%4)(AZM% ZHO/VC9KDOY?JPFD"&0:T9[ZS;#>DBF@
MSN7;J'U4XS5BM:OER>64B5U*C*-VMU[Q[J6$Z%Z$*9AH;OO/O4>AHC/EZ0@J
MK7& ,+RI."I_8_9JG NR8\/=E>$Q4]S'+DC_6F@9/U)<N9Q(QU4_BJHFAVO%
MY(R:8#X]M[?(<>X,L_P)HV#O&#[/P"/=N,>V%JHI<;@*DD[K$M&H?3O)59O8
MN%EG]MX40?OK9 ;$M9RV77(O^- EB"YW RY&\"JL3.O% QBE?Q*%F\@!Q"/H
MM/),9[_4ZPC[4G]8YMXP 8.-K=^AA$8@@K$X+95[$FE'40&2;S$GY]FL/E'3
M2/%??X-W]2ZK+UK8\JQ+?APWYNXNS^AS?I/E)WG2L32A!$DCCB!**?O^6.#X
M=J/\NI$>= CQ4,8!;YWQ3<Z<\OU!-;E.\B@-!/FN#2<Q)B=WK^Y6Y39H[3O>
MOA\::=[%WSEH;>GAX3]NL[J[[NB6\JX>[L+O&7+LW\Y .&8@5E8.K_3_;"-X
M4S(H^M@7JUETRU?FD7Y[&7]QNIXSZ7H$)(F'X9I')O5B8/(S[ZM%D\8W:.($
M7"K7O JS!KW0NU-W%<IG?;I+H'^>NOLN[E-!_MVINQ&U%MHK_N.Y 3['ZJ11
M5&&OOBRD>2W-\KS;6($00/A9"0:=VKR30F*7:W( 47>GO'6%BYWO6?<'I;C*
MXNU),S4(*B5H?Z_;(S,FU'1/R&6P2WE<38<_-?B9FX[F(W2E/_@%9N(TI]7P
M"UJIO;ES0<S%?IYZ=GOSZ?#8UX[80:PGLQC'6?2FHSVN@>B:$9NLQ%VQDH&D
MBJ6*/6<:8 [/'0G4#J;!KKV]CIY[9>+2*^*!)#GTIGVQ/Q[@ -A0M_>2N(9Q
M8@%G=M=44%M#*B,JMT6[7G$7N&4PV>5&\D4YGKJ]:56./X/T.%V$"4)=/0:@
M!;*^\IU\_IYOTK#T]_I% K#D21YZ/5)<V.QZD=.#'&J1.,KWYS*_6U_'AWG%
M?/\,DJW3Y=/^)CPTMS3_RM C9Y0>I%76/(FQ _%[]K?T^_;6Z4T)<NVV,;(B
ML=KK>102D&=V_M;9)T($J5*(0"W7:<"WYV/63VA&E0;*JY0E/F6;=<B='G.I
M2;T6%[-J-M(R>&%'@%\MSTR-'Q1=P$#U4+9-/PR@ (/M-&"4W'],'L(2TWR5
M5M!O"H.&9-'?DNVXY8$+&T)L(9V1&.F3,F^/(AI[,2-_I/;RIH^E9P^39=YK
ME_Y2E1;<NU1QK$4FT3!^TU$CV'.>JW6O=HAHJ-S%.^5#W I>.OZ&Y<]5GP\C
MR)GE. CSSV]Q9C>8GK&%(3"''&>Q*[(;B]DE;(>!!6RY76", G::*AE*4WX4
MV^:>5.7W]QA9W39:I^QOC:I'PEQX^DUC'[P+8/<KF5))QQ&D^ZB0PR">XR#F
MT<452\,P:N;Y1JV^H3!>R^B<Y;F^FY:[F[0LIC\N+RD^P\!G03K]1%GB$)QW
MO"#7UMQWX3%$,2T!;#<A'<RFA#.[=;*4%I@/5_P,.%5X -9*_1^AT5+HT_XC
M198=\NHT\K?/; H-N:6V52P*IU=4&M,-#/<I0>X]TXBEE;[)Z;MDW\(1V&GM
MS#O=&\!J$7?7XZ34)L)OJ U\U:S<XA+P'0G8:.B-$,\K@9M!H2:#=,/]Y\$]
MR/];.Q-*UX?XH8'J$(ES1V"O1HC/(OU?3[S]T"KS*$!AA9'5R'?VW: $N?1,
M( [^4*1(PY$"K6[_61?;1A\76?U;GV),[K%6M[&6-6LB'0V.:-CL=X'+IL!3
M^+6^IE&2G=XDR:/^R&4:\RK"V8=2_'AT(H8G'TD>TE-Z3#Q\1 #TL ZZ7VD2
M-Y,#J8N4C=C<K4[B[F4WC@DE%@OK-\))&%-2:E,^' /^0FF/*!EW>(3G3,:S
MVMO!2<PL35[K4,%+*A858URC@L$D'?HBUH2PJ->*(/%KJV?1;SLZC[KXPXZ\
MV7W:.UMO?]O19,SP^)T=:1D+- ;W3W,<_S<:A^)N]H(N1JI/)5P_L>A4CP"6
M<CVGQ9?CI(Q'5D"W)):[8_OE?BK=R'UOPE!'R4<3L=>EK!=\(WZ)4<B'"4&?
MJI6^6ZF5R5('C-7=(S>G[<DH$]#RSDIO2U1M!('&H9MCRO;VZ;G4UK6^ERAR
MB%MYD=Z"E*6YQ2'@R.U"D&]RZE3C&FD!-[[*HGWGYV,&@GYH%(8M[E&L"]?Z
MGK]0HB*(D/8P>>T7]7L$XOL+965E\EH??/D+Y;W'[3-07!3H\""C[2"EM/3<
M0^I4V!?I84Y^H3S#V+Z:HP<AQY"\K.<W>3M/##BYV<,#WKU*</[FB?)-Y_BR
MN(CFBT"=1Q2$.7IZBB/20F\@B$;7IBH<<0X<PW5<3J\TG?*^V'4'24(S>3PJ
M]R58;H]BMIAM )!40MTQKA$,A#P4/=APJA)L4EGL\&O,##5S)'O+$8[&@(J1
MSR_"SC]B*"-A*#,EK!L[&L>*P2,?PF3GSL':5D7H"S:J%8S3PSB?&OR^$B[P
M?N-D\SO_^IC)<<U\NEYD:KD^U=D@PDTH\7;5N*&R:AH829;QO8;*3 :B:QPT
M_:E0W4@I? M/W5C.,E*HVQEEVB>.)_W^?4W5@N@RMDQL^!=FB%YP3<#A0ZN!
MFF4)/_:O!O&FJ[V)^JI:*>KT2WR;[%2*<B$</@"$#:]R _PC(DU[J6["U>T9
M_>Q<VM1><D,.9)Y_1OA>W0$YE[6&7+=W[BN!B:Z1O349IY>11[Y,\5_1D$C&
M_L$[)3#.1,- \B\DVT,B64AHUH5?5&F481H82>20:W,&Z:4]#W=LK@W2Z!,/
M3P_/A4NX)_R>.Z W@<(JHRR0(UFP.TM0KMZY]O9Z'E89@42%YPZD-GFE4]^Y
MD:3@<&WK].2:'.RS?W2X?<O"=7)ZN':U&!99"FI ).[[LMS9S?;)5=J=M40=
M^;(@*:'?_</)[5O\%2GD7-\_W+[Z<><B*MOH#_WB?F]#.V1%;VX>_+NA %@O
MFA:0;^ST[%D;4\2$AMELPS2F0'S2@%'LYVG]OH>:]X95ZJQ$<SS&8LH!1YR1
MRR-!!AU=V1D:'^7?WI^E*3/#\)J<P&](&L!)D8(^S!HNU4T-6,G[A1*LMYNZ
M((]?F5TIE:P QB2QH&VK>*/#4^C<K]PS+,J;^CPMKD@N+X6>NMMN:@\^K3![
MTUOL.T10Z:N?7CO_>.N">=DK4+(G*P?*FLF'*(^DFYJ>X/LA3-!&,#&UAXC^
MA3(7#G+E:6&H:N?LYQA)#7<'Y$%(DU%-9#^]?6NIU-@^$%/.R+1TAPJL]ZK,
M'\<GVF@%>82W,TZ[./+<U";DNY?-J(9#]A[B*J9YEF^@JRN:47LVK1 :4ENN
MR,7](!34J0?/=^0*+2,>#1:NE$%$%DW7$:X#\]2#5H,CFYA#[[YGJZ<H2ZRQ
M6WTKX8ER9Q3\75^O#T,1\?@&"2=;'6=.)4G;HA>4R:/>H8Q$@#$2 Q2!1)-Y
ME*"CPRRD#Z>PN06N''CIV\!N180*SAOXD%HKP4.Y:@SYI]2$EU!3H\U$Z:&;
M4QYH9?>[4'JS\J!0X?F5QRGW+<N@0.)U4Z,E+!-I0J##W_80H>;CUXXH/8<C
M)_4Y):CI'+YU<H5$EE\H'PZ=UJ[NC .TJ")Q_ILM"OOXM:71EY8C$8-H\LYY
M/'./$/9)^PT8*JVW?V+(/:EP-F \P1;+ZD7:U!"_DAA1;\0Q&J,H^R*-Y5M+
MB^ME54M]1X"1!X6N!'31[:8X+5++[HA,TE3'=V'=&. >F<FJ&OK$+J_1$@4'
M#?EV)(3]^SP"\Z=,WC/"N'J,XUX[NI>"T@00PY>6;VVPNDB3F90_11/CE)T+
M4DPF.UT3"1CU[5!>]%36M+B^:',3Q@)+4(R+XQ)HR+J5#<\^$6AWC(BC8J,W
M$6C?N^GN/).P.0I3Y!1J?T4"1S@SNL<41)MSA:*BH@;,]@M-D^%F-=\I@HH#
M,NFW!7)NU1X6T'Z.XD3>!PZS$-U@+\POZ(B,)3&:'D0AI6,@39<Z;^$"N]DR
M3R17LDB,275J'FA.P620F4U_JUX0+6[W5-G677%^5&@];9?RW=PY%BGWRYQ5
M$0W"=.L5RS/G;"2B0$0)>]_R7"Q?K+,YQ*DZZUO;Y".O32LM\Q2D6*4SQ&'7
M!!DV>OY<Z?N6H=S<S'5U.VF!-(M2RJ[,SFE$)7*6;Y\AO8@4<OD?I%OE'2#Q
M88+ 2ZC1B_07"I$%QMJU3R-]'-(T2NX,8K)P<M=IYU9D0>#V[(+O;OI)+WQ\
M$92@EO-SY#.BYVO7WA#/%J09P.XPY%:E$U&ZS_H9YGFG'T].'>_*.V]IOR,Y
M" [2V1SFE59&'I;R(WB64Q1,XLPC.VEM$]"5>IE=#93E>%"?P"[T(ADCA:_7
M4]TJT;Y:4:N93+PV&'>#I,6P:$ S7,S,V ?T8VC7)+4,7>,3)?&'):5$EF^K
MG$'3D4O>(,2V#.U-TAY:Y[7OOQCJ%!'6J$LF.ZW]5OUSHHAR9B/\P3?"V+:G
M/!$;GU[<QPMBR)&'9@ U561[SR1$,FX,R0*!_"[14]+O.0;.$W8%F%.+7Y>B
M48(AX1H)9<!;+%%=?M8=A*,(Z\I)=NQMO_N#Y=M_.40Z0U$RY,!26=3P/?/=
M-MW;Y$ N*U$4DZ,C+Y&CWF]DBKP]6/C!>(U._/&J,NHT4INK<'N).AU\A6OY
MVQ62QM!O<Q;J*1%.$L9KP#2W-1E_)?B+8VF&%=,LV910&"/K\V+RQ%,3^'.B
MP\N1'C]SP?>'?O\7APY.9VW7;9RBS8I4M4T'7V<&F6D^I1763SJDDY6;9-<Q
MDU568(CX?,P"RP^%-B>E6C1,GP3RF,:#IQ],)&A'JL2$RU]94-H_5DR4(3A-
M\>A,<(=S2DCW5&JNL0-O+%=;*BF^GK=$?8M4N&*?>Q9V_J^&PK70$+7BJ_O'
MS)&)!-GV[0['GG 6_55"I?&):HY!5VQC0<FK@9#FBS"[K *X.'I.1F*\??/*
MM&Q^F^-FN?GB5&=)NAV &5*C.([@V2X4FYP'^DJ(YT\Q9K$4CH<V_BMS^V<6
M*#UN)PUVAZ0:2M6D&ACPHO454#=1QE;WV> )DEE&L#U^RF4*E0Z53Z&#Y6>D
M)^WNZ< O'I+G/>AU)N>D#1B<M\!+#HXV/AU2F^NTMI6E&VN;^TA^#YS]@DO9
M""@E]6_:X?\30UASS,H:E>6VQX2(2B%KFQ%3,4]ST7C-2HC2RRGU#@K3M/ K
M<R6!^V\+>V5#0].?)F)VNS,!0OQ"0',FO#&ZL^%;&FHE#+;ZL,K(N?P#N=J'
ME):=Y+;Q<GAJ_QOW@6JJ@]N9^;Q\O8L#]S[?4;+,-/<#24T@KM2(AN:I)X3.
M++J;+YXXX5&7$N1E+F7\CK4GZ<8KVU5>0@&\2&R.D5B>J0+<7/]06,B_9P1_
M'S(6M NT?W43J9<&^K;"MXI!YI6J5<ZR/"/;\8%B>NSS@U<8) "F2-+'$*":
M,,-1^O*<MXJ#5;2^]M[JFR+I=',[>LZ8_(+4C=2WE_2@U-;(;1@4]CZ+%7?K
ME-K6N6DL9:2^#\*CQ<#S"P5/1'VDH/H@I.!C1:KF]MX727^DGY8C=Z%IK<E]
M,#<0H(B'5I1RSO[-/] LHWBL>RLR;:]"R6M7\U'5"'88]2%K,QX9MSB#6BTK
M<T'ANI(:)N/+-9G0 *@D5':PGB7EQU=AJXSUCRH\%&/V4V:\<>1VS68B.U@2
MJ_D"L!)HO77C@XBU:4%['G$[.-$IDD,UMKT5W\O/;[(L:!,,VS\],>F*C)L9
MW?OHI$OS'?HA8$DB[;Y^VWVZ .0G0.NSK-H?//<IYLC'9/)9L_<1"S?;[27\
M*8FV^XHJ(1:092D_O@0\@FU/=C (GI2/$XUPH^:NIFK9\5*6FWU^12B[G*P0
MEQ2[%77\SL[8_R-,Z,.GG,=%3UQ?J*^[/7Y56=OP[E[0.DLOQ_"+;YUE3L8Z
M0@7[#?7)L0EX0 -^!165VL]E\TP3F7)6(EG6';-I>Z; 1#WF[SW:8]1?Z>8=
MTI[$?*7%54('JFG\>UCT]Z'JKVX@OK*67JO#'G[]WEDA#1H$@1755!<L@9%S
MLCP)#5B;*X-K5Z$NR6+'):7YLQ'A6-&CW-I9)J1'U7^D4]09P[_I<<NJ?K+6
MG_M9$@^\;,^)15PUC).2QY %RW+Z/P7W..VW3=Y$=#(^OU">.-7,5CZ![]4E
MW@+<OTIA0P(@'VZIP.,R%]M][3CE*KAZ_#RVL2AA.H("V9]JXU<R^^VYI<5W
M=%B(:EZ,PKQ>MG.^Z(GBH8F6,>F%'CM3BXSX<7>!S#1EM:;4@"KR/9S,06(=
MGSKR63AL>I38?N:9: Q/\MM84,'+A],<WW\,CZGIE$W@P@=J*O\_AG-_&^*8
MI8CJ*7*6A4O"H#HX4R9:4]\E8SSZ@[?%/C49!8*?F@C!BK,^;:;\@-G<$AO:
MGIXL]YN>!XY6OXS%.U9H]-QBB-4R36KZ"JA[[&WO(KWHH/F"GL2#PFA2E[/S
MZ%U,W*ZO"L VO7!>=C@DM!%6[+\AT/ :ZVT@&!T=U?L^]U%V?V',W -0'7'S
MIIVOFE6019)9-B_QGI3R$3?'TZZ8UU^_#J="@E.IC36UOMZI7L,'EOT$+UF^
ME3X]) D"5JPOV5TY,*GN&U5])CZ>0Z=)YCLQ&<3.2>J5/O'J8FZ4'NF*HQ]E
M=JMTW;X*481T!F&F32),C^R:>P8B?Z36:Z6M(:4LRN\ 'E=:<*_Q6+&^'>6>
MICMNTC[]\K0BZJ*0C5 7YI$UED*$$A@O/7LLYO29C$E]0%\;'6/8VJU("5+I
MPMRN%!"EA@NBSZJGNS(1.X=K2*EC00I&\E.N+:0(!OP.?FPKB0;W=.7?T=>C
M/"33G3ZY\J;7M4*^#M&J[)OM:M*]([H4-MNWE%R3DTCU>R'L:RC4XG7H= M"
MW*F<HYM?* C$@>?EV/ )DN0^=MJ^ZD-HQ4VN_FY\[C?PF\=&^&1:0"\,E3F=
MBC-A:50FCI]LM==*9;AU\).RX *,@#QW1N>M68%\?[XM;$R1YT&C;8AR&+$1
M:FY6(SIUYUL"V02Y3FHG!(8<(L.U!_$T!($>#DW<,QR_H5EJ$0!<RH1D9ENU
MQ)NX-@K[S6?F[Z1^67[RHP%\ZZMR\BAO.!)\X1LWQKOH/!5?R?C*958^W.S6
M3-4=MT.5G5SGM!6HBC.%K>T1H*5L0KL-!!J&"S)>L$ID@AB%-CFI4VH!S-U1
M--!1;4?/CJ\=LG)"H=!&.Y8]";JJ.7(TDAYSCE'_<*:0$[N$7>,SW[,4FO$8
MXF'/Z/=JPJP=?NO?N$_>JXW.[ \4#UZVE/W<)VAIS+CTL=3UC&I+W)LN]P.>
M^#S#!BG-EAX?^2G@7<]D77^<5.D@&H[<OF[/'#VH^SE?^PLE<?IGF&WAJT98
MUR&,F'7: &0P&*&C ;S/=MS"XOK#%+/F?H8Z0+D)K[>@LWGQ7/#=,->TW'M6
MKXJ4*M?,L]#%M-U;*G-T %07SZ5$A\6^ZOBALLR;=LXYVQ;J08X&<?'T:#/"
M8_OBYSBT=$ER&N'=) [)4A\?2,\^][P/@&;$!C#^O6DR(R.$@*^PJ[*/OV&E
MJI_9HV0E.3"NU*P*^V$T1K\,5W2D'(%5E9@U@7]W^#N&60FRU";"XZ:,7M(:
M8U''0:D([2>.'-<"G0<:I',946D#_BP:TB#;M,C+>_CNZ3A %<5%BBEKK60=
MXU0_\(U!PH*[P3>0YX.([QDW^$#^XER)YYZ-\[YGBU9C4SLIFE5A,M&K/;7\
M /AR-8$U+Z9_9ZJO55Y,?AR-9(9\DVP1(%&=-=>C^&:6=VRK>6PLI6(F8FR(
MYU)")<??@;!G%_9)WHD(2$::OY>C\QKTHYHV$:4Q@*F#T0&'+YWG<,52B9N:
M ;'RNNT,BUI>OZ2'YP6*AK;S8WH:/\X 2=V"WNTM_4QS%P^M$DFS8-9#G6YN
M2 G#]M:GIZL>8ZNE'(R6K^=RK[J'&!(=K_)#FV.6GVS*@&^-ADZ>A>P/&A1?
M)T)N24QGN1OA_=Z93WI6-E=L>CN_T&;?!Z&:PB<R7Y(S$4O+KUJ]ROI1P+,$
M[XODL0+&\9SJ5$&4 D9F,:<^X*<6M80/5J"&O7C+'UN_&^3Z$CL\GD*,USAU
M "/?Y[]9@#=\ <W)WPEPV_4_!+CB_TR +_X6X/$(H6N]E^]F-\(M/'J:E<1[
MG I*LERJ/)U%6C=WW%63/20[U5Q!:RM]M\K<RHMV=Y&7&(^3[5G$ 1)V*)O^
MB+'\CK:, $61@KOD#K,,2SM_2_,QS;M(;]9=7%>%WB$.B3)19J)]B,12)/BH
M@.XB=PY+*X5()7T7EKD+SV3=[!\YG1,=LG[>WKI]M#)Y-A;9 CI@?=ZZO:TL
M[(=H\WK2Z;9A7Z53E2K9/G]BIL:<1"0(50)#VQPARL):O!ICKZ/G1_3"\QN'
M*@VDI P>9Z5DX7MNU==O[DJ^!]VGENVPC*%F@V+63 '0H5D @,_ 3&9.&M&&
M)$CVD/.G'>]1N'UB<.E5Y0E%G&NCF ^O?<M0S^VGJDN<P1;644_#2_L/ZMZC
MHV'W:MY'- >]4%J;%L=B"A$@7QQ<K4@E:</?5B,84V%T/:(H2J5OJIX6.O)F
M"&=J^LX-M6A:UY#_3L7*=JSCS3.5F]98G,<(.WYQJ07]A3)09+-]/_M+]6*J
M7OJ)G]&/!28_B/#/R^&JD^>!K/.5QK>%6Y>4+YI3:T$;J[<?Z2^JI2Y>E61"
M63]33%X$BW[Y[O*CP>$7"FOE6/>9@FL%7U(76;BD#N=&SQ^5?Q1 3;:_5?YE
M_5'Y)V,3T@-7[AE5<>H7M5U64-:1'PN-.5)<D/3!]4GV?PQEC/>PRI>F-(9<
M4":KU)/)Q/5T'7EF[2W@2\6H^6BN^+LX7<?F3Y EHXH_I@[/U(Y]4HSGP#/[
MB=^<[U[41M*R1.E<>K.OO"@O"3QZ-$[CA8 L+5V)]8=@5!"CM;\=W[MCY?N>
MAA.V523R<S<#@[1KO$^KY&'K[+5E4KA<GPE&[FTS,:AP]V><9R6R'C_)[<@O
M;2+5M$B)(55T5TK&6>6P7&$M.[8.0'T(%1?/S\\/#2LE$VZ(@(^T9.S><OM8
M,W\*<ZH@*GR?EH*2;4G]"P73&#>[E"'+FD(VY(<ODY_;P,_+TJJ31RS?[8)T
MG +-/:X#8H ^<O3PV-Y2C9$<+DLEV7"D9<L :#[.F2T![;[U8TCIMU:^L3D4
MQ>8K5E=JR X9G&!Q4B$1%PIOP$4# JO1GN+Z6)&0/19?,5VA,9A4^,L[;#W'
M6TQKT+M@.;[F['7S\V"WU'%[DBBN_1%8,18KJ7-O?VE.8_#9#Z.AH'VF0]HR
M\17EQ]BE"41+?:+"?34@EE3FTTK7-GH:+]GO18&=%?&1Z>."W79^-18+M;3E
M.NQQ<4U64?^]W(>GUK7P[]SG[1WWB;CC/C+_D+S\D_N8>O$W$&!)5,%\IOEN
MQ2CR8C_P=Z;'KG#S^[*_&LPSEL<V$--J-!IW%ER>W>6;NORY4GKA<725,7EP
M^%<6J._:QZ?1]YE-!!B$F&UCU;HC.M<^C9:PNV N7K&7Z'-*!'),N04QBR@_
M;^!3 B-I$,2SJ<D/C33K\A=*,!(]G/)*:W_G?L">-PNB/>=P)+GI"KOU^XZ$
M#HC'R<E=*#GUG"@*!#K((V4M/2<*M5M=A"4"EO:>\&B[+2K)K SUN=(XOUI0
M;/L4QRV90NX!RW?!DW!"9664-V=^HQM!RJE43BF(^8&9K?U%1%7?*QXHX#Z#
M/X !"DVAUYK;+;B4:_5UE?H9A2<J/>;'T/7#P_,72H.HVC0OTBC&W+:OKS.W
MGJA\)M\^NJ'_LDO9K=7[.AD^'1%DX3TFW;1_XGXO .=MQT=T R6YLDJKTQ."
M=3Z;K#Q UL\=G@77P?5,SP/!4#IJLO0QK#6X/PM(@JH-Y)G#EE0;/@S+8^^6
M)%C7Q/U9BH/\B=J3WQ[)*-BT\-0*;MVVCS6^N3WR^G'RV6I+]#&HP;SS1FOB
MI]"?X';#K')L'7:D9R"*#1(7+#W&\E-HVQAS6[P%67RQBP9IM^=G9Q6GN[C8
MO;UR>@N< ';RU_!PYM3GOZIH?V%?;YKO#X UR;4BLN($*HT/^,< NR4\QV8X
M?5I$VF.<_?[L7FOI?!K2I"XP&OLWDE)CL2L+Z6$.6 \OX#<*"T9Q)GDONR?J
M<I]S+^G-O9F6PA2L0[F_@A5GL7ZD9RS[&-[M%+@WN#CU)9<J?42J*2^VT?_J
M]6E1?W'&F*GL.-SYWJ8+R3K0ZC3-3DL-I-!3#E?WNC1([6*?KPV>3XHWJ294
M8.S)P'E.73Q0P<?Z$KQ-@-<=\H,D<E0I>5''=M"'MG<S=+T0[]F<J@M5L9B=
M-_1-_T+*CPG8U9.2YH3EVC/;1178E8KJ<D-"[9ES^5S?4W@81,+AZ;A^% >[
MI9+0XK&!T>GX5 )%QYL%TSFK5KK^0,?B5427$/^WF,%L+L04F)Q93R /VP*0
MQ:7!23C<32NNI97>'85PC2$8P,O^)XR#U'16K2$IP=#*WZR,_+V#@N406U9T
M:>J4EKR#3)92N*<PKJT)6I*K5%>XHIK'/MFY#,>44&^7[&[&.KZ1ANVXO-8)
M/<^Q&F&V@;2EG&2T6'+_>[EP0#8=UW^FD A%^*-%50(\8CNW'U;ZU,L)=]A^
MY'I-N#CH=D";S ^HF]!\J<8_<'GVI!ZB%!O%*).C,)O>!4U(?F2L4#9;W%D*
M[9NFO!?3V'M?V3_W4\6+[E6[!L9)<L+5&NK]%)_\(Y*FZ9NE;-V^WDX=UTEV
MG(WRQB%RR(IU+6.G;1KV,=09&T.@0]]LQ"EX%CFQMMXM:RM2M\H"D]>%B*53
M^"3PVMN+U(_HC_B_YK^3_/D[,:%L65D!L99.K6@BE_]==A!))Q '?FC?E;E5
MD R#TK"E?<_I+])QERGVA\+D\Z$?ON44CD,9,H;P4\>6*6,>.UQ3-#^K(52"
MA;/20!/KQNEEBO?7^2GS+U.W=(QS8>U^+J=Y/^@?78P0C0HIWI I76>3??F^
M?;MS(V,ZS_J7DLA_)1+@4MKW,R,Q>53J8X7EJ>\'RIG+C@<@WN--]B'J7DP2
M24D9\=%>35XE,$!V*;0Q"UU8N&3><^'G%[MU2-@:K%W>7\-X=(Z;IZT.Z%EG
MBB R2?$"6*>]F=?L,_<!-J*[)<1E)W+BV>Q0A\/5IVC'5)TJ\0C&N@M^&"(]
M(D]Y:='CR(^3OG;V[A,WP7E($KYZ-K8M/C;NB]_B-A!V65JXZ>%_:3_OEQEW
MJ9VY/D&T6E/O^Z(YP!VT3GZ;&#B4N]MRW3PDG]G&\\A6;;<2G9VC:2GQT3+:
MLK&OTU"X4="QPOZ;GO50U]-JO&.W[/O'[&R=/@!^[6]#I21VA>7RMOPXT@JR
M4-@JV%LFS>?@)++@6\9BC@4E/H<7YEM#=D%GMY9!@U\H)N[W<J<&#O.ANK"+
M?C'KD8_!\0\&S.'UJ4V^<0D;)$]N[<2"3+3J#%;3Q806,BD*W19Z;O35\%?-
MXEB]9=,-K$.ZG.#3]UP6+.K<9))F2SWL0W5,:_;U%5$<+\>E$% 9D!%>@3 5
M&\910HK/3IL#.YOM %EXLK3 X@F",OX0!^!2R+9#Q1$:FN,<K<9-\[.%H*7!
M_-)':\8SC/7@RH$K]@.$_8((/F[Q%$HR=*!M/UT_9UZU]DSHR_GK'/[^M#XL
M/LLF75=O,1_TO99^_MO/A\(7?=4ML?NB[?J%5K46!"7]9<R]\&T'AIUW\>2/
M:-RXIM1UU=RXX(-0V6 ._@_]0BC;TG0,^1---M\@&\%%S:U=;$H]?,8<6_1)
M\0&MQ\/0]'$;Z51<AJ.'8B&[]X2^UBS)A9'M27/#9UUB9XVFNRCL2/=)>ZQH
MBO08"QD*]RE-+SO>!<K5)CO*U>I16PWS] ?JM7/R,CKNXQ&#9043ES%)I8H'
MMHT_59Q"WE<<OL1WIB4H*Q6GI^*3#<TCGW%M AC.[7%)%G4SX1H$S=N_\I8V
M[#YX&K&NBFM+R_V,[P-U3,U.H;ZC7NQ45+.UA-HJIU?E5:MT=2(85O&CQ)AZ
MR*3N(]]QU[P],'2:[T4L5?<JS3:.4^*CKN=V>3-.Y2<_$(G%0ND^WE9G-R6#
MPIZ':UO(!9J)F.W*0!S^*2#NLKW>Z6G6H4T9AL(1?F&5 4>W(@MX/4@40 +#
MGUF^O^7VMH\\KQMMUDZNR,%WY1[_)+EW)SF@"1,C-$-EF;10U1?M1M,:=/WQ
M6^R$--I%5&21<-,7LV\9)>7O3C[3V*>\F)2JF'_XAKE<B'_4WL!\T85[@=W(
M^F6A,XN4@JJDNC4) ,_:&5O?8B_H?QWS^.%;6%XZX[9X;838:B"]R;/[A=)%
M_O_WF,I<^DI;P>&UW$U9;_G'C:_]AWIGWY9'%TKT^;914S2&7D1+0X"=6)HC
M.$ "C='*5ZW="\?>?JB=%4^;#V^D"&#A]E]FP_ (A/$TS>+&0!;A")%N@_W]
MX_ \JK[]Y^N<^R4<>A8E1>GK3IJ)R1L#8%K@Z>4-O86%0GQ%J2,Z'D\FU;JC
M(8_I6Q5:,'K]_G'\7 YCWH 2=EV: 21.@E7N\/E%=83/6TW7FH9C&Y?FTAUA
MP0X1AY =0C&7,'/!C0:=-]SV@Q(?*@9*1*,WOA'^_*;$R3)2^QH4?FP/K9]*
MH;(49X+13[?37BC4_D(A.SQU[/%5WT7^[&N?- Y0?(/?8<MSBZ>):RR+UPZ(
MOUUVL !I]))P^K"LHB_^R7[+IXM)V!]>9O2#[3LU_MAJ4_^2C$=T0K/FF@'R
MCAA&K-%U+_&0G)1P@RB_'5'X!%) )B?[XM9C5N'NL5GOJ?C2\B-B6&N@Z=[_
MZB/_]3<+#J=F+G9+?=E>PVGEI/_Q\X9)X\D;L:BWW"=$W"5-V'.6/2',\!$\
M96S&R"S)%,9+D7]#!X[TN5S#0$DF?-+<D(^F>#@/0[EYA'77BN.^HHH'R/;)
M] KU]-?3-7G;TQV:#28O[&&IF46+M#:6!IK2I^U9Y6<+R#(6:8FC'YA80_/'
M7H2M_A"-LDO0]R!>HQX1+?$*]%M$=++SC2;(U2Q"8NAIE5P??N-";U,FS6,O
M5/S<B$VW/K4:<3:@:_8E'0ROIV2)[8A>.*='"9)#T:;%'VF@35NF*UBTE$][
MRHR'VGZ0;SQ:P<[.;)Y('LX,"V$2[Q1\ZO\X__'1CSQU+[GV\E6N<>@1J5/B
M%*0,G)CLBD]A]2T"7U86^+LAD:LA+6+.)W V%:*A.;!].8,^5:.W0'K,]#YQ
MN=G,/&Q@/]Y[.T'KHKM1?R\J2$%AOJ^-,3G1PJ]6ZU57')QOWM11AX-NN/\=
MYJ,Y<ZDG*7S2_X.]KXJ*:]NV)2&0D!""%1(D4#A!@CL$*#PXA;L[*=P)D!"\
M<+?@%!:L< C!W=T2W-WUD9R=O<^]>]\C]YWW]S[@8[;YL=I:<X[1>Q]]C++6
M18!2]U"P$(<.[P)L&W(JS^N)CL[V0P0WG^,L9[K'?'K*&\!>W2G_Y!8A#^(<
MH(<LK/!))KBEPS:>G-VP-6I(@%A8-$7^%3FICA'ND-W4A.T8_=R.IIR5M!J[
M>6B!5$[H)@V2I2+8:LKU\E%V?CJPCKL(YJ,=#J_-E_%SU'!*,L"/<B2 :!SV
M;UPWL\NJ<(KGY=MJ6$[8J^2^ZU#)4PET#XW04,:N/ :?.F!-@I6-1Z=:4 8H
MRO-O@D(XD06^_ %:96*&+%<D3"RDQ:JX#-T]^X;"]2G*J?M%' Y<'_??X8=!
M#9#,?KHTV\;B<7?]_ T+XED&=)SAU.NLY]E"J(!F[>PMPN(K@4#.:]M=IUN$
MX"\WU M*(;G[N+HM>[B2 -'OWR%9PA'N;05L+\G:EIDM@<]($KV53V#OQ5%@
MC\7:3V.?T:ZQAW:@VK!DN1>]"BXP,"TN)-I#\))\E"LC'#.,F0C @KS#0F((
M;;>6DHU$7>#)\%.;1">EK1;96V0JQ8-YCV?L$89UFHU_8DAF_)V58$]=(2/B
MQ,=8F,\R\.E0NG.W44QP#_(^Y>'_,FV4N7Q?V^0IUIGSM8J!3OEVXUDS=-21
M[5)F^N[Q.?_3:_.TVWMM%B75:O5S*!Q$CZ]B/I+A0]:^33$96B=C[69((E%$
M@2#R4N!A+=PK]B[V1GLFU[I^Q)Z-N9R.DFD_\(3=IYI<75W=]$7&TF^^^T:O
M= ^?(?!V^J8A1S#S>@0%SS=;RQL+O[>F;=M=6E0PBN=L>UIE@HY4=4(/I&Z-
M[4!59>?;I'Z&ZE]RLV2@$5+)10\G2M(;&RS:+XB)D&PMA94&-NROR!:(/U)*
M=(E]D.A0RIZ,:-D!KF-AL<U!VV?ZJ.1;[4DRF*D^,P>G?<)H$D? B!DN!I37
M>'P$M,5Z[P^#].9(#5%L]RV")'M\*B@FK,86QEN,MJ ('7-&]Z@$%>4._9FY
M"*R[*MJ1JNG]+U<RV8B%<6L%ZK MU)S4\QD25JC<3SCB#:"\5F/+JH61Z<00
M-#%2*M6@X!J&5Y=6_,,AT&)M-IEYLY\:8K$,ZXV "93QG(=S^.PZY=\O>SSW
M2JT,8;O+[@^)/&5U8J%WK)[S+@C^-'[^=( NI.*TFM,Q'KR\?#1J7SXJ/Q.K
M9Z!'W[?!JQH^-2KN'SL#&@7+8ZCX\T16!S=U.+79J[AE(IH[4,Z"XN;)HD<8
M3-./ ^"9,]VD8) 0)9GIN/-6:@V/XE&DS]5:T#HQI6=(]HU\R-#>W1,X>F:4
M6L?Z,V9OCY^?"XRJ>6!+2!'O.ML2NEGFUZ9K7[]<;G!AD'%/SZT?CJXHU:N1
MVE7L>Z!2$#E4.:YKTGD:XW!46Q;41N6"0#Y:AQ=CG#[)X&?# 0P7"\>04V5C
M,!R.''(7N[$RT%$%$-$774W-[.9?/E, 7W/H-H8Q7&B3>(9 4I.1UCW_E0R1
M^&&LB_I48S).0;=QH'JVT^9YT6HWL\O]W+Q\&52\X]T<[4_TBM( ,#<G3M?W
M@)G)%>6%EDT3?)4%@[@CRD!/L8@^-%TA<VSV.0^"721M5N1[;NV"N,^GK K3
MC:$X;0O^=K9P1Z>84'8:H_ E%@UT-64L5+?.9Q% +U8"=%,"2VXV@L9WX J5
M2IZ-[;IS!W0R,K:XAH714UG#MPN^$AT];J_<Z3)88*:[*8A"=.7W^5X\C7_S
M<4PI?:K.C2B9VC^DDQU/V.C]A+AS=Z$FQV82%>XDA8[$9"&T."Y4Y,O^DS>'
M)'H?T1//G+A2HBODJ>YCKAVILIE?FJ8'AO2.@X5/&R++^Z1B2G?@(W3PT&WQ
MT5;=S[$B!=;<$<<;4;(C14';YRI#=<HWVXGKQSIF0WN]1]$/#]Q38O3*I@.T
M>VK>I%>O?%=UJ;51-<!'E,8<7+8W-J>=Z7@&XYWZ!.3DW:KMZ2[R-M9PBWS%
M5,J+2]/QZO+LFZ15F5V(!H^T\;1Q;M)7*+,I18ZZ:3W="]+P_E7<"3\V^UL$
M5]/%Y..LEUC)NX38V, 5B(,2:-3U2 ;ZQ]=+7*=]MG0NL/"$XHYQM\'L"%\P
MY45*1"RJ0"+ 5H66F:=;=40@2G*?149VH4691]R#ON_(0XV=#1PGH7[N;1-3
M+<RG@D9J>C@*42DFB/W$AG*BKP,Q52:H@^PT $JOP]#*!6R9"MNFDV*FT?I>
M;=Z=]#$I"0K]2;":B([S(=48^0-:Z;IN'^F:20(9;[@A[1Q^?+7B1^>X9IC@
M3".ZZ1"]M8T& "FVK.=I;(!X1CAUX0=7#"Z4KR PY\IPUCKFR2HDG<+JVOR_
MJP3OLS^MHAO:LL]&6X0^L=7 ..T5-^?U8W3T<J8>@^^4*&NQ]<B<;SFQM!,[
M3Q=VE6A0@7@7"']V.>&_U=0[F?+((7CQ]_;R[AMM@8]G5<>;[24_-(%EG3L.
M$9CW2S $'GO^C58DY/RH1N#JZ%1^=>'YQ2IXZST;J9Z[7CK_5V^YG-7)O%QO
MI^U,C&D3#/:>.MLHO>HJSR8APU),KYPJ4\+Y SP1$_(5 Z!D05JCZJ)]/#<&
M'Y.(SM??0G7)&4X19?M ]H6!!0"0,^PB%\L*.\1D'R=[>CWT+U0>8%/2D=Y4
M=1\K\92NVK;AP6XE'67GB\]9)5XG>VRY7E3M^M6+8W$W)M7C.<DT1<V*O+^D
MK6(W;O9%UHKF=2[=UFV/R.NP;C>WYR"^I_5:QTP" ]5AS5)9C=(D?G#&*$07
MGXESU0G#]!3)MV4FG+?Q$E4",Z,?? +P!F_(2OX9H$NH',WZW+RN77?VOF!K
M\[3'S3K[YRJ!F"Y[$_EST3;X+ED_82!U^J! DF'CZ(HA=]Z((1F4D[2W&$AS
ML#Z'4T^TM_]4#YLXCL6"W0L0)0V,>F7.@N]G3?+=8C=%;"V<2QX;) $ /P.M
M6Q,UEWRXE"[IV+.\"8M&>AK;3FZ"#F=B&P9)3IME9FRM!:07)=,7^)7*WR*\
M8Y;NSQ,-+T'R@UH#0G83,4ARN(M33F>Z,AMN$6*UD)#XR#Q.Z0.DF-/'^<IS
MVW16P \A="*(&*VIE@#P/2)OI(_^(O8KS-H58/ :!]H4:L*YK,K(-!NQ!JB[
M2'D>S.(BS8EP,9HGM\1$$7F 98U"I9 CYN[X_*MQ\!(KZW1&<(M#G^A73ZY7
MD*1",A0'@B'55&7S1W6S,PKD(AAL+R3V-2[A-CFC'CE2S1Q#2B\Z#UP]*8"O
MS?#UMJ8 >3Z/'M--SR@W[+3.$@A*RX ^2JM(JVA)*%6 U[;%!HN>'&HSBOU1
MB?Y;E$K=?QAQE[H-P%RAS^)&.C,[(?E5G;3P,;B"VXDV6CH6IB D-I$4DO.
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M7!R">\YYQR!B\\^JAJ^NZ\RVO'#_UHD*9539*U9YGEYL$OO3MO"=MQ%:^?[
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M++%/9.L%:@C7M3-S<X5^@6?#WVT(8-KC6]*BQT6X!28$  -A=!YE,YT SIQ
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M1&Y496@4]&Q%I##?'UVW_=DWY$0,6;N!>>DB:X[D":-$B\CV3P:1=2M=%M\
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MG](QYY<PND78A)S$3D$CU+PN9CRR3C*68G1N*E_\_VW_E]O:^))U&QC8+_^
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M4-+>_T33YOFV6XO79Q#S<E [IOG[<"65]>8N'1/R85($;]TP/I0OO[<I:L6
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MZ^("':8V%[W?]9 UU'/@-KLUI4T=!WZO[WUK<US\YGIV6O<<,U)7##QG- :
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M<V(PDC-BOZZW6WM-MT,'9L&+G1RO0 ,!V,$ - 6+EQH%T,)@BG>T0.@?7WQ
MX'<##FC1F8*KY$7=^MINE?V4_W.X8%[4,=[<-2_3HN=I:K[(E_)C_F3<$O2.
MZC[?W!+]2O^S*.O<-)_T4&_/ZQC#.% X@)F@9B4KZ^R'"<11DC$6QA$63@X
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M"2&*XTQOIV,%XRSD- RRB!+JM+SMI<;46%I_](GCXK8?_)9+V\%!'7IAJPV
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M)JDECF>/=<'<+TM:+NT884^&R\?]4M)PW_GU_7U9ES,"]^N='N7_M<I+*:X
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M?;T?J[5Q>'=Z\_K\M:2+RB3_*18?]0JG]JR>181E,L *QC2*(>)"PDQE!*J
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M$(F(DX-33SVFMGQ_)Y4L30@JWTD9!N:M3<\]8U$=^\:.CT= ?.AMP%:KJYV
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ME= XY2940*$(0Q29"CN,I# 0"F<1QPG+G"Z*[$5/;;+9: Z6]#O02CH6>G0
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M#[2\"HBXVZK+ [:S"S&7YPVW-O/P<F>YYG._WS3O^'-?[[63G?0^--69)51
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MTZ>D2!NV]WCB(,3O[^EZ#+CB"=X9G\_SV5>CZGLP>9UDI90*%PH020L I9"
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MM35PGI:%VX<)5S8W^=='^E@O3>6')J?]H_[=<L)4F1)8,9 331LPE3F@&$%
M12DQY C)TNJL]]E6QL89F_H_K:5):VK2V.I>(^D0U/-L$0RJV!$F'Y2\ZB2=
M1.&J0DF'3QV\4M))QXZ52CI]L=^DX?,1-;"[OW[4;36-MIU)P02!!<Z XB0#
ML)0(T+SBH,KU_\,(IUEAE3G@TNC8Z,#8W$ATM3HGNLEGM[F#%=)V4XC0^$7F
MB#5T!\* 6YL[W@@WH7"!*-"\PJK)0:<7+B#LSS*<[@VJ1'-*[7HB*I$7DG"
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M&(@*Z@&GHAE@,,L!5%FJ>"II*IP.19QN:G03Y=:\9+JU^%]=BYF?A-6.?,*
M%9EM>D;>)&O0_E@;&G#&>QF-8#7*3S8T<&7R2PX?UB._>(<?0^B5^W;A?_N3
MUM,FNV+>$]+\/I_JYRU-[@77:^Y<SW,J"%!6Z34WPY6>IZ("H*)@19G"K().
M>G&.[8^-2TS$K6ZC=W2U6M3L9=7D/*WFFY+8/1<2T&1&\699N2Z1W?W.C8%<
MN\V.EB)V1F2N,OVP$T5--N:W)4VV KR=!S<78'=F,4_P E&;:^N#\ITG-/LD
MZ/L8/V9LF](+VY5L9V.\+>3:2GH06JE"*@)2*0N3'*)7[D6A0,51R:J,J=RN
M=*I5:V-CO>Y+VUB;K,WU5% Y#[4==P4#,#)378&=,R5981*(@,ZW-2C=6+F]
M3RYV-_E1B6N:J[[@?CY;[&2]?JYG\I.V;3E1FFT@01 (9HZS(\TZ-,LQ@)QD
MJB0PQ:G3686@UHV-JKQ3V,U5?3?7.>W&TZ1QU9'DPKX$=J3X9ET;F43?I%>=
MZ3<*^H'H.JQM@])[%%CWAX,XC;@-'T+6DUL]& DS('V<TF\3_6&HK"(YR"!%
M  J6 J;T.IP6%4HE)0+QTH;Z#YX\-MK>&)<8Z^R(]A"N\R1Y%0B1"<[2?VM*
M.NGK$3I92OZ_O\U__A]]3\LD^H<M@1P^:9"/_Z0#ZP_W] 7>@3&31ME()@DI
MWKW^OI3BT^S3[*=<FBWC6[ZJ?S9L,)$IA#PK4I#S7'^5)66 <@5--04E2Y5F
M)2TFJ_F*3JUC8I9-.WVV&P/BAF&:'/(7(^52S_3_=#8G=&.T<Z3+MA^L@UP1
MT!T@OM5D>J_--K(YO_S>HORW9&-\<GL99I_(EB-BX8):M@T/'<]R!.1(*,OU
M"9[)V^L:OMM#>0)!4B"%0$FHJ9F;4D!)+@"M$-1_R7"&4Z?$ZX,FQC:;V):^
MON)XXQ$D[0CG.GPB$\L6FBBG&T_['BKS]["!8;-V3SIXD'%[^LH0-9T^ZOYM
M:TA-]$(@Y87(C:YWKN<C10:89 C0O))2+Q>*2EJM$BXU-+;/W%B64(]2<R>1
MM/O 0^ 3^3,_*.#48'6A+-^5Y9L.@8A2OJG7S!N6;SIT]GSYIB/7^[& GD)P
M*<72".]\GL^^->>GC>3W@VHKC4^P8+B$J@ P3<WR!%% 2DB!$%3"JBQ9D>5V
MLMO6;;J\^<.(;;^;+Q;S/QOMJY>9,.I7<E;/%ZUREE&)-&&>3H)R(7_.IS_-
MF,C;6NV*<A/Y>75CE<L]8T<O0=&.S#-K6UOU,6-M)YU@[#5GDUJ+PU&.-3B!
MN.=R>X.2D+7[^VQD?Z/W49[]HT6;DX"\X!+E>0EPR34KE14"F","5$9HAJDJ
M.)4N\9(S;8TM0+)[[J_-''(^JW,26#L^"0179"8Y>T)R>]#QQE2(VLF[^D)-
M>ES0\SB7X IW^.9D2T.?M+GD\I%C-1=O\:E/V8S2W2#=C-'-$/UY3F==V6<F
ME"Q2S1XYDB6 -&> 89R!#&/$**T4*:A]'<E+S8UMR7-F%F.,=BG+=Q'I\^P2
M'K_(!',!NLM%M7TP="E!&!++H4H%7HNI8^4^6XC.5]B[^)0!*^'9>K1;L<[Z
MKNLJRVF29_6L>8<>)9]_F]7_+<4GH=^K6M5F_.TVR]L"4V)WTUS_3;^"_=],
M<B@JE1<$I(HJ +DB@(JL  7BF)A>JH331#"2G6.;1#Z9-OK'5Q+:VNQ7MRYT
MK]K-0D?05Y$'F$V-O)Z+1L]I[632]W*=QK3V\R"?J7/UIO_+\.7U(O5&X*)\
MH:U\DU)^D: ^50 P5G/N*4UWNLG5:W>,Z5'^F"_,KHC)O'U93A"F6$E)0)6E
M.8 RPX"D3 !%1):CLBR0)+893N<:&MM$OK5U<\QN8VW2FFN? 746W?/4'!*S
MR-SJ"Y=3PI0-%E[Y4V<?/%@ZE8U[_>PJJ^NOT\G0K/-)+U)FW^H-(6U%.39G
M;%-5EC3#YJRRR/1_4@Q8)7. &)2\A$)BHESV-YU:'QMQK(UO)@Q;\]?SB;Y<
MS>6CNP$ZQV[V%PWRR+P3%&UO&08GU )+,=BU_29R#$ZPG))D<'O(%8J:AT>Z
M)RJEK*HJ#"BJC,YT7@"*RQSD65[D4F!,J=/AZA/MC(W"6DE$?BC+X*%;>015
M.T8*@%5D[FEA.J;*$%CM\30*(>4:C[0RO-[B:5>/"B:>N?P*)FA9YEZ;W;VQ
M59%G)=44P$1. 81( 491 1@ABL TJ]+":A%TMI5QLL!L/@-K)J"-Q1XD< "H
M P5< ],@!- :>)-L30S\^9]"(.3'?]#&\)_^*3>/?O@G+_;49>HR+DQ.V+O7
MW_0*:J&75ILY-$(2PTP2D%.NYP$PXP"GD(,4%KBLA$*0.,T#SC<W-B)HLH::
M8C3&WIODHYY^T6GR'Y(NDK7MWHN9"\C;$44X/",SQC8!ZSHHW26=K! *)>MT
MOK%AI9VL'#^0=[*[RS-#M"W^:V2=FQ(!+]P\?O9M4J0002-E*4@% >2:<+#B
M%!#%-=V(2L] -IJC3_9L<ZH]J^]B5[7R:0"Z69OKF-QY"E0[!KD*HX%2.3L3
M$S5?)#M&!LS>O !#J*3-4\T,FZMYP=F#%,U+U_OD4]&I7-Y.I_,_C0+KNWJJ
M+_SV*!OER:V<^W+""Y1!)*6IQD$ %"9GO##2ZD04&2\SP8A#5I5=HV.;AS1F
M)W1M]TW"6LO!HC6]5V[#DCR<NN \D<0"-C*IM)C>;C'MC :=U;UR%C$P=4F_
M"H_M4$E8(3!V3,1R ^M\.I;ELP9,RG+S;C<UR_%>WZ. /Q:2UZUBE?PQE5VQ
MCMMGLTGWW^WKCF5>I6E9@8)(!: L<\#TTT"5HC2C2A156KF= [)IUN4#&>8H
M4-_J9A^']LQU/3AH@7O.2"X+P@!%*@>P8 4@99J!M*AX"DN1B8*Y'<<,B_H0
M8^G0F.L[L10:<\3,/C%5)6"$Y4 2S%&54590JI<VEO43@B&^6=W$KI4P--YV
MJY[0;V[DR4K?W)MD8W"#YZT-GAX':.T!"G:8UJ+)@0_6VH-P>,C6X5[/L;9>
MTF_?%B9 H1_VH![E3SE[D4U5\@GAF%0I%X 5K *0%0+0M"(@R["BF2K30CC5
M#C_7V.@X?L=6<SZKLS;YH['7,5)[%F=+O@F$7FR>\0;.G6 L$ E%+.>:&I90
M+)P^(!*;>SP",%\6M0GG_-#OSG>ZE%\6\V\+^FS4 ^6?![_N#@T5.,4EP4BS
MB"E$7O *8(00R#$G*918$6B5[^9KP-B(IG$AV1J;=-8FMT;=4_YYY$\.L02?
M'K*(U43&/78PV!URGP-T/M@[Q'0B]\% \9V0K[];F.<*_,Z&?'R>.USXYPJO
M=T)!USS'M_S33*[U'#YV&B:_SXPVXWNJ7RZ3S;VIAOA1RB]2OZ'Z]?TF)XRS
M7)!4@0PA!J"2"-!2$)!GLDQ-+A*43C$+;TO&-O;\^PM=Z':FKTU]E];@1$EI
M9*97WV5"?\J%-CL1M-;7O#0N)DVJO+[@Q\8MUWI3OOUH-T\>I'<BCU#&AZW
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MS+']L7W!/?.3>1/8YWT'/$H>N7:(W>HW(LR1J:*/<+MULF/[9N_$F/^W1FC
M3*FU#P%SF_S "Y7=Y-CZL/E-?M <9#AY/N;:^. Z2MF(%"[K;B'=^U<;89((
ME06AJ2GHIDFOK$K &,T!XT59EEDF2>54T,W5@+&Q7C\6M=D#Z+O0A*%ZO[@V
M'&C93ZZ1P/#H#Q@$# /\%=$_-_2"!_XLFW^CF)\;.*?#?8[/\23$U9S_UZ/\
MH5_3[R;;II&M6AG5U@\O"Z.+V"P!FRII$RXTWU4J!X(@ J#,4\"42D&&$%5%
M5A:I]$K:M#=AI$F7C0?)8N-"(X&T:'QX/K?->76/""501M(,(*XJ (4B@.0H
M!P5#3%9I3BJ"G$:GP%TQY,#T5GU@.?+$03;VH-. VC.[TU9L#$]:RS<1OL;X
M@*.-.V*A!AJ'EH<=8]PA.1A>/![A-[)T(HA[TH>WJ_=TL7C5+;5?CV1I45*1
M L%R!B"F E"8<8 P*I B#%6(N#"85:MCXZY&1,Q\64:'MA$N[.QV8RT[Q.WX
M*CB.D9EJ ^&AVBM=)6NK0W.4$TJ!V,FNS4%YR0F&?49RN]DSU-F(VZS/ U9Z
M 5^4N0((EA1 )"O 9"'T_"ECHA0YS4N]II^OZ-0RD-E_NA.W;-J(N!-GVDC6
M&9(^)0UWP;,,.OI"$CNDV*EGA3\$><SA4&' G6</&^0[YM9!"._H17Y?ZA/]
M:R/$L'[E,E5"S%(%,B;-IB!/38GS DA1%H)+S"1WJF=ZI(VQS0BZT/:*_F6R
M1=P55H[!:/?E7@E.Y.^WL6ZKI!+\,S[C?:"/^5@+@W[29US<_[#/77K%&6-V
M^>07VS_YU9WONI_/?LKE2HI_2".BH=<O/^6"?I._Z@>L/M"5_$CK13-CN&7+
MU8+RU83DI(2YR(#"K-!C?)$!6NEQ/\]1BDA5,IZYQ4@&=V%LY+0V/.DL3QK3
M$V-[8HR_,,L>RXMA&;@9=7?'CO]<?PIY<\YX \1-8O<")7^L$0FYA_%FW1GR
M7/*P#@Q_//E-.NCH*>6WL>2Z4X:]+:+/^A>?5O)Y.4ES7JB4FE/*TM1[9@)0
M1BJ@((8RJRA5N5O9NS.-C6W .K9?FOQAS$T:>QTWI\_B;#>JA$(O,O_[ ^=]
M@N\<(H$/Z!UMZDW.WYUS^M3QNK/W^-:,__I,I]-U"Y,,%0(26@%:Z#4WQ"D$
M)"\12$MFY'M*1IC5L8X3SQ\;3;0F)HV-FQP+U^KONPB>9X, N$0F #=(/.JX
M'W7\BKKMN\\;N$[[46<.Z[(?O\QOS-_,(=Z]_K8M,M.4M[S]JUY.:(I+7"EJ
M:O&4)M:- =;_!D6&4IP5*N/2ZA.V;&]LGW3/QJ2MV?J',=-QP+\$LMV8'Q"Z
MR%^],VK.H[TE%H$&_$NM#3KF6[J^/^S;WG9%7&[Y\+):KNA,U+-ODRJG,,MD
M#G*>Z?4"$0I@)!% J"RQY*I(935ICS=^7='%RB%XUF_'Y:W?;RWBO%=^JV<S
MLV',Z+21T;Q"36\'5JDXS+,L!R7*2E/.PHA 4P@DQ(*C/"LD%!VL=S-+S:@
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M%:)*$$),PHA>DR&2 :(*!1!1&<$B$X[B "?:&=N\RYB9;.V\0@GH%+!V7W@
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M !2^]-U9"$+*2!VT,;R.U"DWCPI)G;S8Y]3RND!'KXSAYWHF/ZWD\W)"LZ)
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M- 63;%T"*TK?[1[4ZMMR_LUND78"Z9H)N_CCN71YO5E<YR$QH!YK^K'%>/<
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MJJO0YKBLT"\F_%(M@%S.YZQ>;9_A*91PKE7<AK 1L!Z8*GL/K8!-*U$PP"K
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MD)H6% OBI2USFSL39'#/S/P;F\-MF#@>R .3_$41]KLFX[6I=;H;U1!Y^W$
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MYAW][W__E_XGY@];EN[?_^5_ %!+ P04    " !H66-5BIBKPGV*  !_%@8
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M$-AW&J,RCIZ$ ITIJP%/[8&OB42@](K@\.M16DAP'/<N)]/Y\'\6/W^QA^5
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MXF XNIJG.& RBN"Y IF417-;[J\29,A*DV(PS)+JYR OD-)S(YE=(&<3H3>
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M7WM+OS<TF@%776TTX!3NS68HQ<NO;C@MXMW_XJ:?T5P3IQGA:*13-ACG<1_
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M!^O!WW=@J5ZFKY*-NFD<L#^Y].A_WPS-*IT@%_>X9\/%CVY@%D/2VF8'$H6
M" CEDIB-H+,D64:G(JT=V:Y'X;86ZYFW/1>$,$I+DQD)3%JU[*5N0HH@<%M/
M0;#2CZE[.307;G:(IL=&JP-%O0^3M7_ZZZ>SP[\=GIP?_?WPZ 2_/=S$<CWW
MF$Y&5+]!;24[MIQ[?I>Q4$Y062J %PVHA%;@HRS]T7@0D6L?8NV@YR$%6Q]2
M3"Y1!5_2>#;\EI:-44N=\QVPO1*)2:*!J'*QT@0#/AD-AK&D' U9D=H>TULT
M]6M[MD# D\.%FL)_'U;E<._LY.CDE_-/AV?G?]L[V\BD/'E&!_;D=3IK&1,W
M'6/87H[P%]=8;D&5I$O)$0$6 _1E:VQ3VK0K;Z*T,MI,:[<Q>(F6K<N^'CWW
M#MR*,Z9-0M94+$U7F (G>  BB4R6*$NKAZ,O$M.S2:F!@R?E5U4$_SZLRB^G
MIP>_'QT?7YSM'1R>[/UZ>+YW<G!Z\;?#LZ.3B[V37XX^'!_NG9\?7FP4?*WQ
M] XLT::\5;)1OTPF\8_A:(3^]1%R,_X\+)VI%QW\[_S@N])7KHWRB0!+*97=
MT(.5Z M+X37NAEYF6[O:9BT"MQZ?M\K+[E8:8=RF$!T0$5(YT I@%>&0,A<<
M/01OJS<)68_"?NU>=]AZ,C&O.[V]#PMY</CA8A/;M_B[#JS:4WHJV:O2MN,9
M\*3(:/19@276@: Z@@LL NK3,^Y<%JKV1)CG*=E^./;]I]X[KE;)<9(P!-$Y
M@DC9@[%E")_-/":E2="U3<T+I/1K4RKH_^DXZ^U%_CZL1/$D-JL N/[+#BS%
M<S15LA6+"0AWY[&)"D&M0608KE"I-H)W.D!,5E%B;,ZTMO/RD()M;<-QZ<R;
M'@YXN'<8G!*S,4</FN#6AMM8 F^DA<B<9$3DJ%+M9/+K%/5K*;;0_F,+45'P
M[\-0?-P[.OO[WO%OA[_BZOSM#/]SLEEL]?R#.C C*U!<R:I\=,/IW]WH*MWM
M&?=J/E*65!L)R1M?;NX3L((XR.AM*DU5=+EV6?=K]&QK<9Y[]KT-T@7EN#>0
MA2ZST6D HZ0"&7.2V>&_OG8?NU<)ZM?>5,/%8^M33PGOP_B<7YSN_]O?3H\/
M#L_.#__]MZ.+_]RH9O'I4[JH3WR#UHZ.I4C@.@B+>YD-B*:(>UE4"G2*P>H<
M<->I7<]<]UAJD;$L39X05]=/'L>[5D^W3>#O(G9M#+?*0#3*XN[-''A-"4B4
MA$KXKY*U3<VZ-+9U;+4&0IZ=^]Z5<MZ)"3K\I3@0!WL7>QO9GGM_WH71>8FZ
M2M;F/'TN&CY+7R?318O[&U0YSD,D2J-Z>6GD0BSXTG7-)\=,]#:97/O<ZB5:
MMK9 CY[[7 * 6AXSB112R.C7*T;!RZA*3[#L<PK*J]I52BN0U:^=J8*-)Q:G
MLC+>AY'9/UU<8C@\V?1:QL,'=%)U\R*%E4Q-Z7HVG"^O"8WC;7.I4N7^3)9/
M!:U-HJ6$GMHR@DB61E(&F.".!VXHM;6SO&L16*%:Y^V7W2L?,>4. :ZV*%-Q
M_94'(X3"/5]X0IECS-7NY;<>A?V:JNZP]4RA3U=Z>Q^F;%F1=['W'YL9LOM_
MWH$9>Y&Z2D;L=N#X<P<3V1*5J !&#2N-:@TXC2YYUMYE3:PGJ7:H]@HY%6;R
M/G[TO1TZ\L2U<<B;3B!<)F"<P1W:4.%L<#F*V@4_K]'3K_&IA8EGQNS6T<#[
M,"QGA\=[%X<'G_;.+O[SXFSOY'QO?^-+%B\^JY.K8:O07>V"V*)[]B<WG?^X
MF+KQ#$&&]-]E'T,R4@;<VX@H'>MDLF CNNJ&A(SQN?0FULY*OT73]E?"GG_^
M<\N"EWG!I#31#9*#B)J!RTJ"=E(1I-S&5'^6S\KD]7TQK")VGMX(ZT9)[\5V
M[1\^N*U^=GJ"7^YO?IKVQA,[L6.K\U#)FIVD/^Y=>9Y.QOAE2+?.]:+;V>QH
M?/\S0W2U47SW6@)Q=*0#E1"51 ];>_2P,VZ$D6?&M8C"L]I'_17(WKXE[,8D
MW+OIQ+U6G+GE;7(1V&*]>\C4R.",5"G7;Q:[/=U]3^';+6:?MI7=L>;?AP4^
M_^U#.95#4U5NZF]F<Y\\HY,N)Z_162NK?^5GZ;^OD-[#;P_:\GAFG$,E@R26
M@LA$E>%3%KR@5*B0'!.UC>5+M&R=U7_TW#MP!UWX,!1R+.F=PJFW.8!C620>
M)*MOUEXDIN<,?@T</,G@5Q'\>[$JJ_0DNFG6LIG-6>L-O?5=>I['[OLO>9J4
M*RD.KLKI-L-=TABN(?FH@PBDU/-57LS=]5]ZT,UL\? ?=ZNG1#]"9 _!%*>@
MW(QPAD6P/B;+N4R>UQZX_1H]S?9:6@<13[/WE1300$?R#VXVG)WF1Y+Z\9@K
M3X6VA%B4#_$@G-7@&8;=EF>?=3:!5"\@6HVR?H<==P2P#I32 -1^*U.K#F?S
MX:6;I]E 1.VC$!PT]1P%E'"-&,8A2AJR=\P05;OZ_"$%_<XQ[@@Z6PBY1X@4
MCV9P-IS]HT2?OV$D.IV[X;A,-7F,^<*"B92#3+3(IIQ8<"M!2N9,%"P2*=_R
MEE9^6[^#."HCI!L9-V!7+J8N)N1I,:CI6FBSLQ32\%L9S;CD#O=EFE62 ;0I
M<Y(=VDGO?0:'"X32Q+S@M8/6E0CK=X1%1U:HODH:P-EBZ/O>;#8)PW)(45K5
M'7X?SD^G!\/9U\G,C>YF,9U.%SW@K\+\:KKHN?!HA3%-4*!9 ]IFE*W!?VR(
M!BRC%'^L(P^U][YZU/<[D:(SG[X7Y38 ZU=2P<^[G8H2K:)7(&+ACY4C.,5)
MD7698F"Y<+7G%JY+8[_#)SJ":*>*^C-ETB[*'M-A'NWZ^;UET9[CK_L<FE(\
M1.4(.*HSB)PE&"T,$)^9BTP;26K7\G>70WOJD^R-1I,_'"ZH,K,6P3^<'Z.N
M%J*^5R\E'3<:;;FW5H @&%@Y&5.Y19=T5KB&96TG<C-*F\V[K8.BQP9P!TIK
M8#\^#U]2O!IA&/_ S5C,%5I4QRQ<E7M9("&]*B$^]<6+1OR <42"H!QW%IU$
M9M4OG:Q'8K,YNFW V*6:WL=F_+2;_>8;[XO/VDD7_@XWU%7[J/O,%><A =5*
ME1G!Z!@294"%K+1*E"?_3GOQ8P#E/G^>EFGKBW$[UZ]]9*29\L&Y;-%-+5="
M1=)@K=3 LV.<*.&=JMZN:!7"^BZVK(^>)]V,JNOG?9BO^RWN-S=<SSREXW;\
M'1JK-=NH*^^9TMJ!="XBZA@%*TSI:L-X*H TJO8=^]TVY;^_QX?)Y_'P?U(\
MBJC081ZFY5MGB]<BP)&,XZ'SP]%R]OML=G69XJ-%1# &9\D)L)[@(J*YU,J0
M"+CU.\)USJ)Z[^S*++RK-O_KX/,U]V[7JG\?]O-Q1^S-;>@+3]I!%^\.;>F+
M/9R#,<)Q[H FSQ"5(8!-W@%)CKA@$K'5;[UUU<O[;I$\?D.I8 BX+@Z&HZOY
MD\601/#4$ _!IB*"<G6#9P/1>TF<5-'%VAGD#4EMM _X.AAZV;)UI[2FTBA[
M:+1C86GX+9VG@&%Z,=.'W\/H"I?YTK>^_'IU,P[TY3[IA$?M,DVEW@8E()!Y
MXX0#3T.@4GNNE.L,MK6XZ#<9TS&B>U'U^]BN5V\;O_E&OO8[>FV/W^'FOUXC
M<\:4S%1FP" ZH&\8$QAF/4C-N/6YE,#7/EG9:9/\N_7Y^%WX^AM*'NTV.E+T
MEVE$ Q %".,RF$ <<*-I68-*Y]H5$AN0^9[:Y:^#LI<M;#<:;,A?F)1YX,-Y
M.L8MY(E8/U[-BT@O2]>IY6CQP^]?TWCV.%OFA%>&J@S6>5,:W%%POHR:D](I
MHU*2U>\;U*2_7Q]A][#>N<X;POMIOEV_=U?K;=0Q>P4QAY+L#>CJ*YY 260+
M=T>>:.[,^#XAI]\Z[3Z,['8:>1_^:!GXL;FG>>^O.QI&TJ%W^,)(BDP2(S)Z
M2*E@)Q*..K8$M"D*=BDS4[L[6S<C2>Z 7)Y_-"['XX\ZP)8.C(8)5FZ-<Q D
M</ D:\B*9V*4DIQWM4&^3%63@TK60<7+%J6*(IK:M7YU\^OP_C0?3\:?+]+T
MLG#Y:%?&G3?G;!-0ZF39BSE8&20HZKSV2GK:81RQ&HW]>EN=PJX#);V/W6TY
MI&;S_>W!WW<V1*?#/>[1,!5+M=5E(*X* IWCS-!-EN5:&I/*<Q6%Y+53IW5&
MZ2QN3=V&NO>.^:YGNCR->8/C&I>)*H/%4P;') -IO&4A61^U>4OU:[VQJ8DY
MZRCYP:VT3N3;P&[UW!B@&Q9_7-O&'X]8S,[D9!6:P4 C"(XLVF0,<"(U%S:1
MZ&H756Q 9K][5@7<[4I%3: 0>2K5J(\3%M&Y4'J))MS.<=?U'$R.#GS6!A<2
MIY;4;O+X BG]1OA5T;2]J-^'@_/L^*S-_9W7'K>KX5\=>D.OCGI2)B3EDX,8
M3=G4" 4;30#F@[+):2=D[6Q;ER/ [KS_V[<\M[__BDL%7QM/QV?EH+;4SB_:
M7CRIFXHD$Q4A20Q!A/ ><"4I(-YF(Z2CA-8V4E49:'C$V#JX>SG$V[62&]A0
M;UG^\..#&Y7K1^=?4IK_,IU<?1V6(/<VKBVD9\)P*V$*!#6XE0AI@ ;-/;,Z
M4]O9<+\W:.O7@>L,EYVHYGWLR$\GRVUQ#_:E9^UD(EZ759D/IYYQC!J](1)*
M7Q,0,7%P/ 1024<NL_<VU;X[5WDNWJT=7A0P^3)OK90XI?%LH9C%W;1AF*=X
M/D?8+VZG/?C);^-A*61>]#9X'.<P%9.2@D#(!#UA$0,8'B1&V]P8DKE7IKMR
M]?K\-#5O;QWDO;SY]JST=V(8[Z;?;6$1GSRDVSE]'=K %R>RT=+"-3O<$[-R
M(!B7Y:*T!Z]]2%PG:4+7X^OJ37L(DW% +_2ZTO,VP?-I.LG+6^*E&O3Z];.+
MR5U/QQ3O+08J*:.!@R*RM+G6$KPQ#H)(5+ED;-"U[_O7H;S1F7_K(.SI;(B=
MJ_2=V+>5FH;LQ;BX'>5&1^,\F5XNB#A(<S<<==@JY=6W]M9 9759=-]617I'
M@N !>(EQ!*,8[5 =(5A%M%52<E;;R>JNK<J]2OSK7ATGDWF:'4_<N&0&/@['
M&)+A>^\Z>"SVN0&GD:C@.81 2P(@13!4Z](@R2IT/ BOWK5X0U*;;:RR#HY>
MN4#1F=IZS-O,IO/!69EHL?=].!MH&1PAS(%CPH/PP8+)'C< &@6^5%J^6J<%
M?.H]G.%W=QA[\,*>M^)=J':RK9Q; ,>OZ=*GZ4 'F0.C C2&/:6"DX$A7D*2
M&)DYJKPP*YV_K@*/Y2O[ <@6RGJL[@TDU[/"?QV.AY=7E]>$"X+D6<W0=!;F
M*0E@540)L,0<%5:0U6K$WE#Y@Y?VK/1-5#:I(;^^%>^^WR-<&N:I5@2<4 7U
MWH OW8XCL<0D'T.T*S6=>4OQ]U_:3^*]FN(WEE\#YS8/=L!R4%4VP;N-#^..
M=#1/E[.!%T&F*#(8J2V(:"08GDJKSI08,48'$[OQR=^DK=]SFUUZ$YUJK0$T
M_C;VP]$HQ9O&3O=X&B1) N>6 R&E(%9$9(5)W(YMU*1,T41[6QF KY#31,Q3
M6?^/QR944D;?,Q3.79D0>-,5\P/RM%B-BX:$>_&_KF;+H?.#(&2VAD;0J?!D
M: )G#:[/3*W*SBI&'WFY+Q2JKOC")EI =@.ASN3>-Y8N4/&S+Y-1_)2FPTG\
MY&;S@ZO2:?63^U&X.<WG:?IM&-+LTW3R;1A3'!"N)!<L@2 NXU(I'1,$S> R
M,T98JIAQ*\%J_7<W,<VE0X1UK(T_5:K[9AWFR?1@<N7G^6ITHZ#N,]XKO+R_
MQ/>ZDND^_TU,E-(8"TQSAI$(,V!$Z51/I,;80EJE:U_0ZK"M^+U^U(_E>V<-
MSB:C$2K@#S>- Z>H-()YX*D,TJ4:[8%+#NV!LH32('CU*5AK$]F$_[<M=IZ$
M%9VJJH'X8C4&!\&(D$GDH+3!&%ZQ(K[,@!+K*5769-X/ 'M&7;?PV B,:^EJ
M8P1^7?@7YW,WG5?!X<(=F:':GN%MP$(46C,.6;/2),90E)<SX+AC4J*O['7M
MN9*OT=-SF+)3S%73R\9(^Y:F?K)3:_?[=#A/ISG/!LY0[G&3 ,V,!N&% A<Q
MJ.?:<"F=L%[4OF:W)HD]!S0-VK_-M+<^/.T2GN/2$KV4#NUX1]:<,*H(^C)$
MTG(;/H$M!W*$!.D]3R'FZH-VZNW(W8W#;!"1:^EJRQWY<!S;"K,?S#WYD,8I
M#^>SQ=23SH/LMU_=6XB]IE2Z#[ %-Y);@:M E<ZJ1#(PI2DZD9X13[ET]CT6
MF+TZ=6>Q-C-54BT&^PA7O&7+P05J08=L-0N."-E=N]XWR6LVJ%X'+QL.15I;
M/0V$TP\8*FPLKU6DZ;=E!8W)AF9%,BB3<2=0TH*3C(+6N!4D:Y1FM7?M-TAJ
MI?"L,A2>E(77TTL#,+O SST2V<'DT@W' VZ#H#ZC?(JG*X@+X'/*D"U3-%$6
MI:_='NY%8OJ>BE11Y8\G5U>1?P- .D1O:_(CI?.$879Q9*]K=A2CQH9RY$@D
M+CB2,QA:AD9QJ[1U5DA;>U=\@91^051)T9/Z4N_[W+?,O5X8YVO:DS$>!2"
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MY]SP)>8&&%%F0Q0#*LN@D81KP=C(P6LKB5/&J%Q[CN)+M/1[-MBE*:HB_7;
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MAI<Q=89&,!@0@J"!Q1AR1J%V?Z;Y#B_UKJ7_%2_UKJ.,1C'U\,X9+Q?.N/%
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M\G)#,<1E;34'38(%D4S"6#H;R(GP;)04FM=N9+06@?TZ!7T@:$,0KZ_.)@8
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M"#O;8U>7QB@3/#"5,ZA8//@0#7BGC<FA9&5:#P=^DJAQ+Z>F$-@=7@?HHS>
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MS#!#"%(3$^2T!V8\6)X5=SX9<B)W"[8?^,+(SS!-[Y=VHNP1#]L3PY7ASL0
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MN+W@+-/?(O6'BVWZ;OUW2#+S-*4_SO^8KK[46&JB#=/*H@8GZFH#%A)%42&
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M&Q@</X<(_EC[<Z+W4::0B4*1"]WQ=+WS6E'I4!!+Q)Z7P137NC>@S?OH<.T
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ME*+0F.83 QXAIQ.<M0?!0W [4B,]@>N(2^3M]33@P$UPQ40H7)+OC=R LT5
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M%))'AX/DBF_7@;PW:6W@>7^ZVQO66 H3F1!:N=4Y)U[G%DBG\I(@S$TRAQ,
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MVZMLNQ&U]89:]1GNR_F;>^?_!U!+ P04    " !H66-5D0R<>'H%  !>$P
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M)[9YW?L\\['O.VH9?50A<PRH,MM5MGU;V/JMI[[Z+T_N&]CQ7U!+ P04
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M^08" &-C<FXM,C R,C Y,S N>'-D4$L! A0#%     @ :%EC5522=O*V(
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M,C R,C Y,S M,3!Q97@S,7@Q+FAT;5!+ 0(4 Q0    ( &A98U5KQ5[W*0@
M !0H   :              "  71*"0!C8W)N,C R,C Y,S M,3!Q97@S,7@R
M+FAT;5!+ 0(4 Q0    ( &A98U61#)QX>@4  %X3   :              "
M =52"0!C8W)N,C R,C Y,S M,3!Q97@S,G@Q+FAT;5!+ 0(4 Q0    ( &A9
M8U4/+1Q9C@4  -T3   :              "  8=8"0!C8W)N,C R,C Y,S M
C,3!Q97@S,G@R+FAT;5!+!08     "P + .P"  !-7@D    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
